data_1zxf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zxf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.919 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.7 p-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.934 -0.395 . . . . 2.1 109.934 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 5.2 p90 69.87 -40.78 0.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.413 1.485 . . . . 4.04 112.684 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.782 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 18.8 t70 -67.06 -54.58 19.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.216 -0.29 . . . . 2.78 110.216 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 32.6 Cg_endo -87.89 -64.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.66 1.573 . . . . 1.83 111.323 169.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.32 152.27 31.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.257 -1.016 . . . . 3.98 108.257 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.919 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -109.58 126.2 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.094 0.473 . . . . 2.03 109.98 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 20.6 ttp85 -130.99 135.17 47.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 3.92 110.453 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.6 ' HD1' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.79 132.42 54.17 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.567 -0.531 . . . . 1.16 109.567 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.723 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.9 p -135.44 116.27 14.05 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.883 -0.599 . . . . 1.72 110.887 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 111' ' ' VAL . 15.5 m -125.02 156.06 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.845 -0.616 . . . . 1.89 110.869 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.7 m -109.82 116.83 32.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.536 -0.756 . . . . 1.15 109.93 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.707 HG23 ' HB2' ' A' ' 19' ' ' ALA . 37.1 t -93.79 138.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.273 -0.876 . . . . 1.51 110.77 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -96.8 7.76 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 1.6 112.256 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.569 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.03 47.09 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.533 -0.467 . . . . 1.11 112.233 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.5 t70 75.07 163.17 0.26 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.075 0.941 . . . . 0.91 112.973 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 27.9 ttp180 -62.34 -25.62 67.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.387 -1.279 . . . . 2.19 110.783 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 17' ' ' LYS . 33.8 ttpt -57.65 -49.47 76.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 3.49 110.988 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.4 p -75.43 -31.93 60.51 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.808 -0.357 . . . . 1.49 110.935 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 12' ' ' VAL . . . -60.98 -46.75 89.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.755 -0.378 . . . . 1.07 110.637 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 73.4 t80 -67.14 -42.32 84.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.43 110.657 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.886 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 19.8 tptm -56.12 -52.8 63.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.45 . . . . 2.87 110.518 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.61 HG23 ' CE2' ' A' ' 30' ' ' TRP . 18.7 m -72.01 -22.58 61.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.952 -0.567 . . . . 1.21 111.553 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -88.99 -36.93 15.56 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.182 -0.324 . . . . 0.53 111.558 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -119.82 -48.88 2.35 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.245 0.832 . . . . 1.23 113.245 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.886 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 20.5 mt-10 -75.08 -29.21 60.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.808 0.813 . . . . 1.24 110.354 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.86 99.15 0.7 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 108.244 -1.942 . . . . 0.83 108.244 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.629 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.6 t80 -96.17 -56.64 0.2 Allowed Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 115.704 -0.248 . . . . 0.94 111.58 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.657 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 40.9 Cg_endo -103.43 39.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.095 2.53 . . . . 0.9 114.493 -172.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.81 -2.86 5.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.905 -0.718 . . . . 1.49 112.894 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.762 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 17.0 m95 -90.6 -155.87 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 5.66 110.748 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.533 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 10.6 m95 -110.91 6.15 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.929 1.455 . . . . 3.41 114.929 -172.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.999 ' HB2' HD13 ' A' ' 140' ' ' ILE . 74.4 Cg_endo -88.32 -140.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 122.108 1.788 . . . . 1.36 112.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.539 ' HB3' HD11 ' A' ' 140' ' ' ILE . 62.7 t30 -67.69 -20.42 65.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.848 0.832 . . . . 1.51 110.004 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.842 ' HA ' HG21 ' A' ' 40' ' ' VAL . 1.2 m-20 -77.05 19.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.567 -1.197 . . . . 1.98 111.675 -171.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.28 -3.85 19.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.937 0.399 . . . . 5.13 110.696 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.87 142.76 27.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.414 . . . . 4.7 110.89 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 m -76.83 138.63 39.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 3.11 111.298 -172.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.2 p 57.06 8.16 0.5 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.731 1.212 . . . . 1.89 113.32 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.83 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 32.4 ttmt -91.48 -73.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.98 -0.748 . . . . 3.45 108.98 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.842 HG21 ' HA ' ' A' ' 34' ' ' ASN . 3.7 m -147.08 18.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.404 -0.816 . . . . 2.3 109.142 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.657 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -140.38 51.02 0.74 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.424 -0.807 . . . . 2.2 113.3 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 1.048 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -94.25 172.8 5.25 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.634 -0.876 . . . . 1.31 108.634 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 32.7 Cg_endo -65.01 62.44 0.3 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.659 2.24 . . . . 1.94 113.475 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 42.3 tp -170.51 -91.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 2.23 110.268 175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.548 ' HA3' ' HB3' ' A' ' 27' ' ' PHE . . . 94.76 -63.62 1.54 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.811 -0.709 . . . . 0.94 112.791 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 27' ' ' PHE . 77.1 t -137.87 139.23 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.977 -0.379 . . . . 1.21 109.977 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.617 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 24.6 t70 -105.43 118.33 36.28 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.054 -0.721 . . . . 1.11 109.054 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.661 ' HZ3' ' HG2' ' A' ' 25' ' ' GLU . 14.0 mmmm -80.06 -35.5 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.613 -0.721 . . . . 3.25 111.622 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HZ1' ' HB3' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -76.41 -38.88 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.711 0.263 . . . . 3.63 111.711 -173.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -36.29 6.24 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.765 -0.731 . . . . 1.9 112.118 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 93.33 65.65 1.07 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.664 -0.779 . . . . 0.87 112.155 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HG3' ' CD2' ' A' ' 54' ' ' TYR . 11.9 ptt180 -159.34 148.06 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.647 -0.421 . . . . 4.26 111.574 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.605 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.8 m0 -95.38 108.53 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.52 110.203 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.617 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -158.57 162.48 37.38 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.993 0.425 . . . . 2.04 110.305 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 1.048 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 11.6 mp0 -122.26 165.74 15.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.122 -0.695 . . . . 2.12 109.122 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.556 HG21 ' HG2' ' A' ' 61' ' ' GLU . 47.9 mm -77.37 102.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.937 -0.764 . . . . 1.42 108.937 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.79 144.1 39.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 1.97 110.679 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.11 -27.73 69.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.138 -0.937 . . . . 2.43 111.918 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.497 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -74.91 -22.83 58.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 2.39 111.285 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.11 50.18 0.03 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.004 -1.093 . . . . 2.29 113.919 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.556 ' HG2' HG21 ' A' ' 56' ' ' ILE . 44.9 mt-10 63.02 16.34 9.2 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.368 0.877 . . . . 2.31 113.368 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.497 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 10.1 tp10 -105.34 82.39 1.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.638 0.732 . . . . 2.61 110.389 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -111.08 148.48 32.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.095 -0.957 . . . . 4.63 110.728 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.696 HG23 ' HD3' ' A' ' 82' ' ' ARG . 3.3 t -54.69 140.76 34.63 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.451 -0.944 . . . . 2.27 108.451 167.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.8 p90 -129.89 143.99 51.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.472 0.653 . . . . 7.39 112.394 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 128.22 8.44 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.55 -1.02 . . . . 1.23 110.55 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.564 HD22 ' O ' ' A' ' 93' ' ' ASN . 3.8 mp -85.87 89.23 7.71 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 111.438 0.162 . . . . 1.76 111.438 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.949 HG23 HG12 ' A' ' 71' ' ' VAL . 58.4 mt -80.62 116.16 24.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.014 -0.674 . . . . 1.26 110.024 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 67' ' ' LEU . 4.9 mpt_? -98.59 -25.24 14.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.713 -0.477 . . . . 2.65 109.713 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 72' ' ' ASP . 18.0 ttmm -139.52 121.56 15.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 2.03 111.774 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.949 HG12 HG23 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -111.79 85.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.665 -0.865 . . . . 1.47 108.665 167.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -96.45 70.74 2.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.16 -0.473 . . . . 1.42 110.69 -170.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 8.2 pt-20 49.43 -172.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 124.523 1.139 . . . . 0.96 111.188 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . 35.7 Cg_exo -63.48 77.33 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.294 1.329 . . . . 0.48 111.058 163.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.6 t70 -159.72 -68.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.5 110.549 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -139.42 143.05 37.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.559 0.577 . . . . 1.1 112.559 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.94 117.41 16.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.864 -0.607 . . . . 1.4 109.597 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.486 HG21 HG23 ' A' ' 98' ' ' THR . 41.2 t -104.35 103.18 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.475 . . . . 1.31 109.719 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.574 HG12 ' N ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -129.5 142.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.79 -0.641 . . . . 1.48 112.139 -175.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.574 ' N ' HG12 ' A' ' 79' ' ' ILE . . . -86.5 158.06 30.76 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.56 -0.745 . . . . 0.5 111.523 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -78.78 155.09 29.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.954 0.724 . . . . 3.37 112.954 -170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.696 ' HD3' HG23 ' A' ' 64' ' ' THR . 0.0 OUTLIER -125.43 -78.34 0.6 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.822 -1.081 . . . . 6.17 110.747 -176.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.682 HD21 ' HG2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 172.0 146.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.971 -1.122 . . . . 2.13 107.971 -176.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.624 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 10.1 t30 -117.88 -62.96 1.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.399 0.518 . . . . 1.93 112.399 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.69 -10.6 83.15 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.792 -0.718 . . . . 2.79 114.466 -169.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.83 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 19.6 t80 64.95 14.58 9.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.73 0.776 . . . . 6.08 110.604 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 34.06 2.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.209 -1.156 . . . . 2.43 110.209 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.682 ' HG2' HD21 ' A' ' 83' ' ' LEU . 2.6 ttp180 -137.41 162.21 34.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.889 -0.655 . . . . 5.53 110.878 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.573 ' C ' HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -109.06 127.09 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.509 -0.552 . . . . 2.42 109.509 175.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.582 ' HB2' HD22 ' A' ' 83' ' ' LEU . 6.1 m-20 -144.07 149.96 47.39 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.778 -0.647 . . . . 3.18 109.657 171.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.29 -12.95 34.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.192 2.595 . . . . 2.76 114.322 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 60.88 33.58 19.88 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.459 0.647 . . . . 2.99 109.975 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.564 ' O ' HD22 ' A' ' 67' ' ' LEU . 11.6 m-80 -141.87 -80.68 0.23 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.618 . . . . 3.06 112.603 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 m -78.41 -125.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.401 0.519 . . . . 2.11 112.401 -170.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.634 ' HB3' ' HE1' ' A' ' 115' ' ' HIS . 16.2 m 70.85 -75.29 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.733 -0.667 . . . . 1.81 110.994 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 60.4 116.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.144 0.794 . . . . 1.81 113.144 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.401 ' HB3' ' CG ' ' A' ' 115' ' ' HIS . 18.6 p90 -132.15 129.39 39.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.14 0.495 . . . . 0.81 110.985 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HG21 ' A' ' 78' ' ' VAL . 47.8 m -89.98 107.35 19.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.23 -0.896 . . . . 1.18 109.758 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.672 ' HA ' HG22 ' A' ' 113' ' ' VAL . 98.3 t -81.84 109.73 16.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.866 -0.606 . . . . 1.51 109.961 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.444 ' HA ' HG23 ' A' ' 76' ' ' THR . 27.5 m -105.9 105.95 16.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.835 0.35 . . . . 1.05 110.981 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.607 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 49.7 m-85 -86.0 110.97 19.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.75 -0.463 . . . . 0.42 109.75 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.2 t -91.87 109.35 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.312 -0.625 . . . . 1.26 109.312 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.65 132.62 42.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.46 0.648 . . . . 1.13 111.908 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -108.0 123.16 48.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.402 -0.962 . . . . 2.03 108.402 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.93 -25.48 37.89 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.623 0.609 . . . . 1.97 114.623 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -85.12 39.5 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.453 0.626 . . . . 5.46 110.909 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 42.2 mmtt 58.53 46.74 14.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.996 0.903 . . . . 3.88 110.241 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -135.6 155.39 50.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.224 -1.353 . . . . 2.94 107.853 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 48.3 m -155.13 119.46 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.873 -0.517 . . . . 1.2 111.646 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -95.78 112.71 24.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.512 -0.767 . . . . 3.1 109.705 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.769 HG13 HG23 ' A' ' 10' ' ' VAL . 14.6 p -88.7 136.89 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 120.119 -0.633 . . . . 1.13 109.822 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.432 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 7.4 t70 -126.28 108.35 11.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.426 1.079 . . . . 1.38 108.607 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 99' ' ' VAL . 10.1 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.622 -0.717 . . . . 1.58 111.425 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.69 111.49 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.632 0.583 . . . . 2.31 109.495 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.634 ' HE1' ' HB3' ' A' ' 95' ' ' SER . 6.1 t60 -123.13 118.02 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.482 -0.562 . . . . 2.32 109.482 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 120' ' ' ARG . 85.0 m -158.78 103.68 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.124 -0.23 . . . . 3.19 111.6 -174.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.98 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.865 0.364 . . . . 2.99 111.099 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.465 ' HZ ' ' HD3' ' A' ' 128' ' ' ARG . 50.4 t80 -78.24 -50.36 12.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.092 -0.503 . . . . 4.27 112.139 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -38.42 77.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.411 0.624 . . . . 1.81 110.041 -174.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.804 ' HD2' HG22 ' A' ' 116' ' ' THR . 20.0 ttt180 -63.6 -20.21 65.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 3.84 111.573 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 31.0 tpp -80.11 29.87 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.099 0.777 . . . . 2.9 113.099 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.76 177.42 16.71 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.637 -1.268 . . . . 2.26 114.547 168.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -55.88 -60.55 3.3 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.812 -0.694 . . . . 3.02 112.745 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.9 -35.54 81.48 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 121.057 -0.257 . . . . 4.23 111.306 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.543 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 24.4 m80 -59.51 -50.93 72.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.973 0.416 . . . . 2.7 110.165 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.46 63.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 1.46 111.118 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 89.0 tttt -69.38 -38.96 78.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.099 -0.5 . . . . 3.16 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.42 -31.64 65.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 2.97 109.686 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.589 HG12 ' HG2' ' A' ' 133' ' ' MET . 87.0 t -61.63 -49.72 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 1.96 111.15 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.67 ' HA ' ' HG3' ' A' ' 133' ' ' MET . 0.0 OUTLIER -65.87 -14.54 61.66 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.162 -0.336 . . . . 4.34 111.443 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -52.51 -28.58 21.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.628 0.371 . . . . 2.8 111.843 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.76 15.58 0.3 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.99 -1.1 . . . . 2.08 113.857 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.67 ' HG3' ' HA ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -84.22 -26.87 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.899 0.85 . . . . 5.19 111.438 176.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.56 -34.16 77.28 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.962 0.727 . . . . 2.83 112.962 -164.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.38 18.13 22.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.011 0.434 . . . . 4.47 110.579 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.638 ' O ' HD12 ' A' ' 140' ' ' ILE . . . -122.47 -77.34 0.4 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.04 -1.076 . . . . 1.04 112.871 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.467 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 76.0 t-105 -54.33 -51.91 73.8 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.716 0.636 . . . . 3.78 112.716 -169.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.8 -33.29 96.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.809 1.673 . . . . 0.77 111.94 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -76.56 -33.49 58.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.717 -0.674 . . . . 1.37 110.304 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -55.07 -48.16 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 108.596 -0.89 . . . . 1.32 108.596 173.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.0 mt -60.42 -28.36 68.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.261 -0.881 . . . . 1.33 112.002 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 26.4 mm-40 -72.13 -57.4 4.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.154 -0.313 . . . . 1.54 110.154 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.6 m -67.6 -25.93 66.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.12 0.486 . . . . 1.43 110.522 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 10' ' ' VAL . 62.0 t80 -57.8 -55.29 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.422 -0.808 . . . . 1.05 109.956 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.502 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 43.7 mt-30 -68.7 -24.63 64.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.763 -0.653 . . . . 1.63 110.939 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.25 -45.39 40.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.285 . . . . 1.46 111.593 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.762 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 15.2 tptm -70.23 -31.36 68.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.631 -0.828 . . . . 2.23 110.263 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.659 HG22 HG11 ' A' ' 12' ' ' VAL . 49.9 mt -63.43 -37.36 79.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.484 0.659 . . . . 1.17 109.635 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.474 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 11.5 t70 -59.33 -36.97 76.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.174 -0.921 . . . . 0.85 109.494 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 3.9 mm-40 -63.72 -41.04 98.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.507 -0.77 . . . . 1.5 110.673 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 5.7 mm-40 -75.96 -16.01 60.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.899 -1.046 . . . . 1.74 109.839 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -102.0 -75.88 1.14 Allowed Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.409 -0.814 . . . . 1.32 113.235 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.19 13.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.28 0.845 . . . . 2.42 113.28 -169.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 21.9 ttmm -71.47 -39.66 70.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 2.04 109.164 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.775 ' HB3' ' HZ2' ' A' ' 155' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.475 -0.784 . . . . 4.65 110.031 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.609 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 3.5 p-10 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.548 0.214 . . . . 2.1 110.989 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.496 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 54.8 p90 169.96 -30.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 4.04 109.62 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.835 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 31.6 t70 -65.87 -54.26 29.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 2.78 110.927 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.835 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -91.23 -68.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.133 1.889 . . . . 1.83 111.176 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 12.0 p90 -153.69 159.26 41.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.061 -0.518 . . . . 3.98 109.652 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.894 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 79.0 t -97.49 128.63 48.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.965 -0.754 . . . . 2.03 108.965 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 15.9 ttp180 -117.33 142.43 47.11 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.954 -0.698 . . . . 3.92 111.536 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.522 ' CD2' HG11 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -124.04 133.39 53.66 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.387 -0.968 . . . . 1.16 108.387 172.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.751 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 6.6 t -139.8 111.35 7.2 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.881 -0.414 . . . . 1.72 109.881 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.724 HG23 ' CG1' ' A' ' 111' ' ' VAL . 6.3 m -126.2 151.45 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 1.89 110.955 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.8 m -103.38 115.74 31.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.507 -0.769 . . . . 1.15 110.158 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.724 HG23 ' HB2' ' A' ' 19' ' ' ALA . 55.9 t -97.51 125.6 50.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.251 -0.886 . . . . 1.51 110.013 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.648 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.68 23.94 8.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.799 -0.637 . . . . 1.6 111.886 -173.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.23 31.04 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 1.11 111.055 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 37.7 t70 72.32 167.26 0.31 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.13 0.967 . . . . 0.91 113.504 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.545 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 34.3 ttp180 -63.47 -27.79 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.232 -1.349 . . . . 2.19 111.226 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.36 -45.08 84.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 3.49 111.141 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -77.36 -40.59 43.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.798 -0.361 . . . . 1.49 110.739 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.724 ' HB2' HG23 ' A' ' 12' ' ' VAL . . . -56.56 -41.68 77.28 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 120.886 -0.325 . . . . 1.07 110.904 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.31 -47.31 43.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.613 0.244 . . . . 0.43 110.949 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -54.12 -52.53 60.76 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.298 -0.41 . . . . 2.87 110.37 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -65.5 -51.03 62.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.367 -0.379 . . . . 1.21 111.031 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.763 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.4 t80 -61.22 -37.55 83.41 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.406 0.521 . . . . 0.53 112.406 -173.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.677 ' HG ' HG13 ' A' ' 46' ' ' VAL . 14.5 tp -113.02 -50.06 2.9 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.195 -0.602 . . . . 1.23 112.469 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.545 ' HA ' ' CE ' ' A' ' 48' ' ' LYS . 36.6 mt-10 -78.36 -35.28 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.071 0.462 . . . . 1.24 111.15 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.741 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -105.36 35.52 5.01 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 115.642 -0.708 . . . . 0.83 112.084 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.562 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 62.0 t80 -52.56 -51.27 74.73 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.968 0.729 . . . . 0.94 112.968 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.05 -2.01 11.79 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.11 1.873 . . . . 0.9 114.801 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.5 pt-20 -90.75 -5.45 55.68 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.227 -0.589 . . . . 1.49 112.183 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.763 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 9.7 m0 -74.52 -179.07 3.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.397 0.618 . . . . 5.66 111.259 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.52 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 79.2 m95 -96.18 -32.63 0.27 Allowed Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 114.237 1.199 . . . . 3.41 114.237 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.63 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 68.5 Cg_endo -71.54 -123.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.332 2.021 . . . . 1.36 115.244 -165.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.53 HD21 HG22 ' A' ' 40' ' ' VAL . 6.3 t30 -62.33 -22.74 66.31 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.169 -0.469 . . . . 1.51 111.452 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.79 ' HA ' HG23 ' A' ' 40' ' ' VAL . 11.8 p30 -86.91 17.22 4.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.999 -0.546 . . . . 1.98 111.497 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -71.76 -10.22 59.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.377 0.608 . . . . 5.13 110.037 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -104.3 118.88 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 4.7 111.279 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -77.25 151.39 35.14 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.63 -0.714 . . . . 3.11 109.64 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.546 HG21 ' HA ' ' A' ' 57' ' ' ASP . 51.5 p 55.74 25.39 8.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.919 0.866 . . . . 1.89 110.791 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HG2' HG21 ' A' ' 40' ' ' VAL . 16.8 ttmm -127.48 -59.67 1.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.61 -1.177 . . . . 3.45 109.723 166.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.79 HG23 ' HA ' ' A' ' 34' ' ' ASN . 2.8 m -157.72 28.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.955 -0.566 . . . . 2.3 110.492 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.88 18.31 0.85 Allowed Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.934 -1.127 . . . . 2.2 114.178 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.993 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -73.95 162.67 72.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 117.163 0.482 . . . . 1.31 109.974 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -50.05 -5.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 124.645 3.563 . . . . 1.94 116.53 -172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -105.33 -85.31 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.094 -0.379 . . . . 2.23 110.571 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.562 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.37 -48.28 2.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.884 -0.674 . . . . 0.94 112.976 174.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.677 HG13 ' HG ' ' A' ' 24' ' ' LEU . 73.3 t -140.11 141.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 1.21 111.289 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.871 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 20.7 t70 -96.38 115.07 26.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.508 -0.552 . . . . 1.11 109.508 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.545 ' CE ' ' HA ' ' A' ' 25' ' ' GLU . 36.4 mmtm -79.65 -27.99 40.85 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.95 0.781 . . . . 3.25 112.23 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -83.09 -46.84 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.425 0.528 . . . . 3.63 112.425 -170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.66 -32.01 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.446 -0.883 . . . . 1.9 111.954 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.549 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 103.95 71.18 0.84 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.348 -0.93 . . . . 0.87 112.239 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -136.25 162.55 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.929 -0.397 . . . . 4.26 109.929 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.0 m95 -116.75 107.75 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.52 108.886 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.871 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.7 p90 -162.64 159.93 25.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.228 0.537 . . . . 2.04 111.109 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.993 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 23.4 mt-10 -102.23 -176.01 3.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 2.12 110.051 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.402 HG21 ' OE2' ' A' ' 61' ' ' GLU . 43.8 mm -105.22 111.57 35.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.767 -0.827 . . . . 1.42 108.767 157.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.703 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 3.5 t70 -91.65 177.72 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.537 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -84.48 -36.14 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.851 0.686 . . . . 2.43 112.851 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.429 HE22 ' CG ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -88.26 14.68 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.55 -0.46 . . . . 2.39 111.672 -173.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.75 64.02 0.92 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.356 -0.926 . . . . 2.29 112.811 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.681 ' HA ' ' NE2' ' A' ' 63' ' ' HIS . 0.1 OUTLIER 57.35 74.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.817 1.043 . . . . 2.31 113.817 172.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.17 73.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.113 -0.699 . . . . 2.61 109.113 169.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.703 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -125.24 163.31 22.78 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.214 -0.903 . . . . 4.63 110.883 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.629 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 9.0 t -157.09 135.62 11.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.639 0.257 . . . . 2.27 110.602 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.704 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 33.5 t80 -146.93 -58.43 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 7.39 110.558 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 79' ' ' ILE . . . -155.72 159.68 29.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.53 -1.319 . . . . 1.23 114.25 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -119.01 113.81 21.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.668 -0.766 . . . . 1.76 109.696 177.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.969 HG21 HG13 ' A' ' 71' ' ' VAL . 72.3 mt -77.26 132.28 33.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 1.26 110.858 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -102.87 -24.94 13.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.047 -0.979 . . . . 2.65 109.504 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' HZ1' ' HB2' ' A' ' 72' ' ' ASP . 47.4 tttm -165.79 108.96 0.8 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.559 -0.746 . . . . 2.03 111.192 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.969 HG13 HG21 ' A' ' 68' ' ' ILE . 1.6 m -100.91 115.5 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.362 -0.607 . . . . 1.47 109.362 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB2' ' HZ1' ' A' ' 70' ' ' LYS . 1.1 t70 -122.24 74.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.73 -0.388 . . . . 1.42 110.779 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.15 -170.69 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 124.525 1.14 . . . . 0.96 111.944 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.536 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.7 Cg_exo -64.71 78.26 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.322 1.348 . . . . 0.48 111.093 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 23.5 t70 -161.76 -67.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.5 110.837 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 100' ' ' THR . 2.2 p -142.01 141.97 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.076 0.465 . . . . 1.1 111.805 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.59 126.94 28.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.433 . . . . 1.4 109.845 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 98' ' ' THR . 26.2 t -103.39 109.92 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.629 -0.878 . . . . 1.31 108.629 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.475 HD12 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -127.18 127.12 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.334 -0.394 . . . . 1.48 110.249 -174.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.825 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.56 155.75 23.53 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.5 112.339 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 58.3 t-105 -81.68 138.37 35.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.054 0.39 . . . . 3.37 112.054 -171.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.629 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 34.8 ttt-85 -148.54 23.16 1.02 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.859 -0.61 . . . . 6.17 109.997 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 78.48 145.48 0.09 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.083 -0.962 . . . . 2.13 112.917 172.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.506 ' H ' HD13 ' A' ' 83' ' ' LEU . 8.1 m-20 -77.85 48.47 0.7 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.499 -0.773 . . . . 1.93 111.37 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.22 46.9 43.19 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 116.126 -0.488 . . . . 2.79 113.916 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.402 ' H ' HD11 ' A' ' 83' ' ' LEU . 28.8 m-85 -106.96 1.81 24.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.159 -0.612 . . . . 6.08 111.211 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.42 24.62 76.62 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.53 -0.843 . . . . 2.43 111.603 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HD3' ' HB3' ' A' ' 131' ' ' ASN . 50.3 mtt180 -98.96 -174.28 2.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.41 -0.395 . . . . 5.53 110.637 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.684 ' O ' HD21 ' A' ' 83' ' ' LEU . 1.7 pp -54.74 149.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.845 0.716 . . . . 2.42 111.292 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 p-10 -146.49 135.15 11.01 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 110.0 -0.37 . . . . 3.18 110.0 175.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 81' ' ' TRP . 3.4 Cg_exo -76.58 -37.89 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.446 2.097 . . . . 2.76 111.71 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 70.06 -6.59 1.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.388 -0.824 . . . . 2.99 111.88 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -137.89 -64.69 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 3.06 111.017 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -89.54 -161.49 0.78 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.185 -0.461 . . . . 2.11 111.293 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 3.7 t 67.4 40.0 2.79 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 122.06 0.933 . . . . 1.81 108.605 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.825 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 15.7 mt-10 -81.12 136.76 35.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.359 -1.292 . . . . 1.81 110.012 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -120.23 120.67 36.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.464 0.65 . . . . 0.81 110.563 174.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.513 HG23 HG21 ' A' ' 78' ' ' VAL . 41.7 m -93.35 115.27 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.99 -1.005 . . . . 1.18 110.085 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.467 ' CB ' HG23 ' A' ' 113' ' ' VAL . 2.0 m -94.59 123.82 46.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.349 0.595 . . . . 1.51 109.459 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.444 ' HA ' HG21 ' A' ' 76' ' ' THR . 86.5 m -104.89 106.84 17.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.307 -0.86 . . . . 1.05 109.805 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.682 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.1 m-85 -82.79 110.39 17.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 0.42 109.917 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 109' ' ' THR . 58.8 t -88.17 107.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.759 0.314 . . . . 1.26 110.481 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 129.28 39.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.831 -0.622 . . . . 1.13 110.928 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 5.9 t0 -128.16 97.3 4.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 2.03 110.476 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.45 69.56 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.913 -0.66 . . . . 1.97 113.977 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 66.67 6.64 4.62 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.887 0.699 . . . . 5.46 112.887 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 41.2 mtmt -136.26 -0.42 2.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 3.88 111.378 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.751 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 42.4 tttt -138.34 157.97 45.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.223 -0.658 . . . . 2.94 109.223 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.525 ' N ' ' HG2' ' A' ' 108' ' ' LYS . 18.1 m -156.67 128.28 7.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.102 0.477 . . . . 1.2 110.99 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -106.33 115.14 29.7 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.763 -0.828 . . . . 3.1 108.763 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -95.17 141.55 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.291 -0.564 . . . . 1.13 111.005 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.557 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 11.5 t70 -128.99 104.1 7.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 124.459 1.099 . . . . 1.38 109.565 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -85.7 139.17 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-N 116.499 -0.319 . . . . 1.58 111.293 178.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 39.8 mt-10 -118.46 110.52 17.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.027 0.83 . . . . 2.31 109.823 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 3.0 t-160 -91.89 107.26 19.08 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.098 -0.955 . . . . 2.32 108.555 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 22.9 p -118.84 158.59 25.36 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.707 0.765 . . . . 3.19 112.383 -172.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.657 ' O ' ' HG3' ' A' ' 121' ' ' MET . 98.9 m-70 99.22 -78.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.486 -1.688 . . . . 2.99 111.077 164.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.454 ' HZ ' ' NH1' ' A' ' 128' ' ' ARG . 31.6 t80 -72.47 -48.84 37.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.706 -0.679 . . . . 4.27 112.592 -165.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.48 -43.36 99.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.92 0.867 . . . . 1.81 109.5 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 55.2 ttt180 -61.12 -20.71 62.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.194 -1.367 . . . . 3.84 111.931 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.657 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 93.8 mtp -78.08 25.14 0.23 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.461 0.541 . . . . 2.9 112.461 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.4 155.37 8.9 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.722 -1.228 . . . . 2.26 113.293 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 t -51.93 -47.86 64.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.234 -0.483 . . . . 3.02 112.279 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -72.66 -25.27 61.2 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.879 -0.329 . . . . 4.23 111.168 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.529 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 11.5 m170 -68.35 -50.07 55.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.403 0.621 . . . . 2.7 109.569 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' A' ' 2' ' ' TYR . . . -69.9 -30.87 68.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 1.46 111.001 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -68.37 -37.83 80.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 3.16 111.198 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.7 ptm180 -72.67 -36.27 67.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.887 -0.325 . . . . 2.97 110.248 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.0 t -68.75 -33.05 57.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.342 0.591 . . . . 1.96 110.346 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 32.9 ttm180 -57.39 -21.83 38.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.242 -0.89 . . . . 4.34 111.0 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 91.1 m-20 -64.55 -21.35 66.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.8 111.598 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.7 -58.13 0.52 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.007 -1.092 . . . . 2.08 114.155 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -80.53 -9.18 59.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.131 0.789 . . . . 5.19 113.131 -170.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 6.4 p-10 -53.42 -49.4 67.4 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.842 0.682 . . . . 2.83 112.842 -169.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -111.34 -19.88 12.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 4.47 110.955 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -63.27 -57.27 15.92 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.632 -0.587 . . . . 1.04 111.632 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.43 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.6 m0 -55.47 -53.99 56.1 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.052 0.76 . . . . 3.78 113.052 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.3 Cg_endo -56.91 -37.75 97.55 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.747 1.632 . . . . 0.77 112.097 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.9 m -70.16 -45.29 67.06 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.635 0.731 . . . . 1.37 109.958 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 27.0 mt -58.54 -54.18 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.957 -1.019 . . . . 1.32 111.548 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.44 ' HB3' HG13 ' A' ' 10' ' ' VAL . 82.2 mt -62.6 -24.66 67.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.255 0.465 . . . . 1.33 112.255 -173.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -56.56 4.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.952 0.406 . . . . 1.54 110.234 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 73.8 m -66.44 -23.09 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 1.43 110.531 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.77 -55.06 34.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 1.05 110.491 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.43 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 41.5 mt-30 -61.91 -32.44 72.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.961 -0.563 . . . . 1.63 110.684 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.1 m-20 -72.84 -40.91 65.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 1.46 111.773 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.3 tptp -65.42 -42.41 92.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 2.23 109.69 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 12' ' ' VAL . 72.8 mt -62.36 -38.76 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.433 0.635 . . . . 1.17 110.401 174.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -58.37 -37.1 74.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.85 110.169 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 146' ' ' ASP . 38.9 mt-10 -72.9 -35.14 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.551 -0.75 . . . . 1.5 110.439 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 21.6 mm-40 -67.77 -38.0 82.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 1.74 110.142 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.94 -66.63 2.11 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.463 -0.79 . . . . 1.32 111.684 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.25 81.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.708 0.29 . . . . 2.42 111.478 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -163.13 85.48 0.52 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 2.04 110.329 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 150' ' ' GLU . 36.7 mtmt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.245 -0.883 . . . . 4.65 109.548 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.3 p-10 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.858 -0.115 . . . . 2.1 110.754 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 86.67 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.314 1.045 . . . . 4.04 110.175 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.639 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 11.2 t70 -51.39 -52.47 59.29 Favored Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 123.453 0.471 . . . . 2.78 111.63 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.4 Cg_endo -85.45 -67.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.165 1.244 . . . . 1.83 112.517 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 36.3 p90 -153.37 142.17 21.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.153 -0.684 . . . . 3.98 109.153 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -123.56 136.2 60.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 2.03 111.284 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.0 ttp180 -141.28 141.78 33.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.581 -0.736 . . . . 3.92 110.502 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.703 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.1 133.39 53.07 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.846 -0.798 . . . . 1.16 108.846 173.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 3.8 t -132.91 111.76 11.32 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.399 0.619 . . . . 1.72 110.214 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.489 HG12 ' CG ' ' A' ' 145' ' ' GLN . 2.0 t -123.91 138.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.053 -0.976 . . . . 1.89 111.585 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -96.6 117.04 30.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.251 0.548 . . . . 1.15 109.994 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.697 HG13 HG23 ' A' ' 148' ' ' ILE . 51.4 t -96.48 129.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 1.51 110.081 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.555 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.18 24.9 9.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.967 -0.56 . . . . 1.6 111.845 -173.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.531 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -153.74 33.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.31 0.485 . . . . 1.11 112.31 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 15.8 t70 73.43 165.67 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.904 0.859 . . . . 0.91 112.607 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -65.66 -26.33 67.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.87 -1.059 . . . . 2.19 111.166 -174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.95 -43.69 98.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.122 -0.49 . . . . 3.49 111.09 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.0 p -74.55 -35.76 63.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.888 -0.325 . . . . 1.49 110.361 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 101' ' ' PHE . . . -56.65 -48.16 78.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 1.07 110.444 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.06 -44.47 69.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.43 110.732 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -55.23 -52.33 63.74 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.404 -0.362 . . . . 2.87 110.807 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -67.3 -51.07 57.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.546 -0.297 . . . . 1.21 111.102 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.626 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.0 t80 -65.42 -34.58 78.63 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.059 0.392 . . . . 0.53 112.059 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.575 HD12 HG13 ' A' ' 46' ' ' VAL . 12.9 tp -111.73 -54.42 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.382 -0.527 . . . . 1.23 111.961 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.89 33.7 2.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 1.24 111.705 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.728 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -157.73 34.47 0.53 Allowed Glycine 0 C--O 1.217 -0.908 0 C-N-CA 120.734 -0.746 . . . . 0.83 111.895 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.635 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 t80 -61.58 -51.39 77.19 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 112.264 0.468 . . . . 0.94 112.264 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.665 ' HB3' HD21 ' A' ' 44' ' ' LEU . 93.4 Cg_endo -77.57 15.49 1.23 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.461 2.107 . . . . 0.9 115.058 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.728 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -113.09 -2.31 14.2 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.835 -0.541 . . . . 1.49 111.151 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.826 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 31.2 m0 -72.43 160.13 32.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.329 0.585 . . . . 5.66 111.277 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 58.2 m95 -89.61 -37.01 0.42 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.627 0.973 . . . . 3.41 113.627 175.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.826 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 18.5 Cg_endo -58.18 -84.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.525 2.15 . . . . 1.36 115.448 -163.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.412 ' HB3' HD12 ' A' ' 140' ' ' ILE . 5.6 t30 -110.76 -4.41 15.33 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.776 0.798 . . . . 1.51 109.425 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.808 ' HA ' HG22 ' A' ' 40' ' ' VAL . 1.9 m-20 -86.54 74.39 9.91 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.729 -1.123 . . . . 1.98 111.255 -170.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -154.46 29.09 0.44 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.791 0.663 . . . . 5.13 112.791 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 23.3 mmm180 -135.77 152.63 51.32 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 4.7 111.728 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.3 p -76.17 135.39 39.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.502 -0.317 . . . . 3.11 110.149 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.496 ' H ' ' HB1' ' A' ' 42' ' ' ALA . 1.7 p 50.22 26.04 2.03 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.632 0.729 . . . . 1.89 111.741 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 15.7 ttmm -146.04 71.44 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.165 -0.925 . . . . 3.45 109.1 174.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 34' ' ' ASN . 6.9 m 53.36 29.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.052 -1.431 . . . . 2.3 113.21 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.37 7.35 0.61 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.106 -1.521 . . . . 2.2 114.171 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.802 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . . . -83.1 -171.25 0.29 Allowed Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.517 -0.549 . . . . 1.31 109.517 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.854 ' HG2' ' HB ' ' A' ' 56' ' ' ILE . 18.8 Cg_endo -64.19 74.39 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 120.908 1.072 . . . . 1.94 109.336 161.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.788 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -120.97 -162.44 0.96 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.939 0.875 . . . . 2.23 110.266 -166.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.71 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . 135.68 -115.02 1.28 Allowed Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 113.541 -1.663 . . . . 0.94 110.412 166.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG13 HD12 ' A' ' 24' ' ' LEU . 86.9 t -140.47 136.16 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.69 -0.755 . . . . 1.21 112.297 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.765 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 8.1 t0 -105.77 104.97 14.8 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.343 -1.298 . . . . 1.11 108.071 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' H ' ' HE3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -79.86 -28.69 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.044 0.45 . . . . 3.25 111.008 -174.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -71.49 -29.25 64.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 3.63 111.645 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.6 -25.61 4.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.135 -0.555 . . . . 1.9 112.425 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.39 57.91 1.61 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.158 -0.544 . . . . 0.87 112.803 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.765 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 26.1 ptt180 -146.33 152.73 39.61 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.583 -0.363 . . . . 4.26 111.314 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 32.0 m0 -110.53 113.79 26.69 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.069 -0.715 . . . . 1.52 109.069 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.581 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.7 p90 -151.47 174.03 13.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.101 -1.04 . . . . 2.04 112.786 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.788 ' HG2' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mt-10 -134.05 143.0 47.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.029 -0.532 . . . . 2.12 110.932 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.854 ' HB ' ' HG2' ' A' ' 43' ' ' PRO . 25.4 mm -83.06 103.64 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.373 -0.531 . . . . 1.42 109.785 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' OD1' ' HA ' ' A' ' 61' ' ' GLU . 1.9 p-10 -66.4 -169.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.491 0.662 . . . . 1.97 111.199 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.73 -27.65 22.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.7 1.0 . . . . 2.43 113.7 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.12 -28.64 12.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.658 0.984 . . . . 2.39 113.658 -164.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.96 46.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.268 -1.444 . . . . 2.29 113.782 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.504 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 16.1 mt-10 73.21 73.46 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.119 0.785 . . . . 2.31 113.119 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 11.4 tp10 -123.42 74.41 1.24 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.867 -1.16 . . . . 2.61 107.867 165.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.461 ' CD2' ' HD1' ' A' ' 54' ' ' TYR . 2.0 p80 -113.07 126.36 55.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.549 -1.205 . . . . 4.63 112.143 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.574 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 6.0 m -63.35 135.43 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.123 -1.066 . . . . 2.27 108.123 166.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.7 p90 -123.22 143.99 49.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.539 0.57 . . . . 7.39 112.539 -171.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.52 151.46 41.56 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.041 -1.224 . . . . 1.23 110.041 169.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.794 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -115.6 94.33 4.65 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.043 0.422 . . . . 1.76 111.192 -171.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 71' ' ' VAL . 41.5 mt -74.49 132.49 33.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 1.26 110.354 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 12.8 mmm-85 -103.91 -25.33 13.08 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.716 -0.475 . . . . 2.65 109.716 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 82.6 tttt -145.52 115.52 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 2.03 111.198 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 68' ' ' ILE . 47.6 t -105.01 91.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 109.245 -0.65 . . . . 1.47 109.245 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 1.1 t70 -106.15 100.61 10.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.672 -0.695 . . . . 1.42 109.531 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 17.0 pt-20 -24.79 148.06 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 125.105 1.503 . . . . 0.96 112.542 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.6 Cg_exo -18.55 78.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.839 3.693 . . . . 0.48 114.781 -162.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -164.21 -63.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.844 -1.071 . . . . 0.5 110.614 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -149.69 141.57 23.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.23 0.538 . . . . 1.1 112.284 -175.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.24 115.06 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.354 -0.384 . . . . 1.4 110.037 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 61.7 t -97.25 108.31 21.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.235 -0.654 . . . . 1.31 109.235 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -126.4 130.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.146 -0.479 . . . . 1.48 111.496 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.794 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -84.17 151.71 27.42 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.5 112.397 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.766 ' HZ2' ' HB3' ' A' ' 133' ' ' MET . 27.2 t-105 -82.06 146.13 29.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.836 1.05 . . . . 3.37 113.836 -162.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.733 ' O ' HD13 ' A' ' 83' ' ' LEU . 1.4 ttp180 -139.82 -8.42 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.366 -0.833 . . . . 6.17 111.693 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.733 HD13 ' O ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER 37.07 -160.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.764 1.764 . . . . 2.13 115.764 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 94.7 m-20 -126.26 135.23 51.3 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.116 0.566 . . . . 1.93 109.867 -171.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.58 81.36 0.11 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.201 -0.523 . . . . 2.79 113.402 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -128.21 24.17 5.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.468 . . . . 6.08 110.298 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.09 30.79 2.84 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.334 -1.106 . . . . 2.43 110.334 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.553 ' HD2' ' C ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -97.53 163.41 12.87 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.57 -0.815 . . . . 5.53 112.899 -171.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.7 HG22 ' HE ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -117.22 128.3 74.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.386 -1.279 . . . . 2.42 108.065 159.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.76 136.67 27.58 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.381 -0.6 . . . . 3.18 109.381 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.693 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 53.1 Cg_exo -56.41 -43.36 56.37 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 122.998 2.466 . . . . 2.76 112.185 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 t70 72.09 -28.66 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.947 0.779 . . . . 2.99 112.68 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.3 p30 -124.4 -8.5 7.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.26 0.467 . . . . 3.06 112.26 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 95' ' ' SER . 62.6 p -162.28 -147.67 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.082 -0.247 . . . . 2.11 110.994 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.618 ' OG ' ' HB3' ' A' ' 118' ' ' PHE . 32.7 m 67.73 42.71 1.94 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.734 -0.666 . . . . 1.81 110.5 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.602 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 43.8 mp0 -70.4 139.3 51.84 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.391 -0.822 . . . . 1.81 109.935 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 2.6 p90 -127.37 127.74 44.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.02 0.438 . . . . 0.81 110.271 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.1 m -88.4 110.2 20.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.366 -0.833 . . . . 1.18 110.466 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.635 ' HA ' HG21 ' A' ' 113' ' ' VAL . 65.9 t -82.35 108.9 15.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.949 -0.569 . . . . 1.51 109.681 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 7.0 m -101.54 107.01 18.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.848 0.356 . . . . 1.05 110.774 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.501 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 26.7 m-85 -94.17 111.11 22.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.222 -0.445 . . . . 0.42 110.897 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.24 107.74 19.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.777 -0.453 . . . . 1.26 109.777 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.03 145.36 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 1.13 110.681 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.801 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 4.4 t70 -140.09 107.49 5.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.389 -0.369 . . . . 2.03 110.668 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.27 50.55 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.048 -0.596 . . . . 1.97 113.183 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 58.49 22.42 9.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.32 0.648 . . . . 5.46 111.893 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 43.7 mtmt -141.36 -14.87 0.86 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.187 -0.321 . . . . 3.88 111.212 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.801 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 27.8 tttp -121.49 155.77 34.23 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.501 -0.925 . . . . 2.94 108.501 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 42.4 m -157.25 135.45 11.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.685 0.279 . . . . 1.2 110.333 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 110' ' ' ARG . 8.6 tpt180 -115.12 122.16 45.26 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.035 -0.728 . . . . 3.1 109.035 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.7 p -101.89 136.82 32.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.438 -0.505 . . . . 1.13 110.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -125.47 113.9 18.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 1.38 109.186 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.703 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 3.6 t -95.01 120.82 44.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.317 -0.856 . . . . 1.58 110.78 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.58 111.3 23.63 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.445 -0.798 . . . . 2.31 109.597 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.582 ' O ' HG11 ' A' ' 6' ' ' VAL . 45.4 t60 -123.81 109.51 13.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.351 -0.841 . . . . 2.32 108.843 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.432 HG23 ' HD2' ' A' ' 120' ' ' ARG . 20.2 m -157.42 96.91 1.58 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.143 -0.223 . . . . 3.19 111.231 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.509 ' O ' ' HG3' ' A' ' 121' ' ' MET . 40.5 t60 -162.67 -74.9 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 120.664 0.268 . . . . 2.99 111.196 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 37.5 t80 -85.77 -26.82 25.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.593 0.711 . . . . 4.27 110.089 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.423 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.1 p-10 -68.64 -51.63 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.87 -1.059 . . . . 1.81 110.857 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HD2' HG23 ' A' ' 116' ' ' THR . 7.9 ptm180 -59.02 -19.03 39.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.457 -0.792 . . . . 3.84 112.01 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 94.7 mtp -64.15 -9.85 19.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.948 0.404 . . . . 2.9 110.14 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 55.17 -153.77 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.199 -0.91 . . . . 2.26 114.407 166.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.7 p 44.38 -125.53 0.99 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.29 0.636 . . . . 3.02 111.555 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.49 -23.73 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.652 -0.249 . . . . 4.23 110.911 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.507 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 39.9 m80 -63.47 -51.6 64.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.008 0.432 . . . . 2.7 110.253 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.954 -0.566 . . . . 1.46 110.403 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -63.48 -42.76 98.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.661 . . . . 3.16 111.23 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.7 ' HE ' HG22 ' A' ' 89' ' ' ILE . 11.8 ptm180 -73.84 -31.55 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 2.97 111.501 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.59 -39.57 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.206 0.527 . . . . 1.96 110.643 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.615 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 69.7 ttt180 -62.42 -16.75 56.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.602 -0.726 . . . . 4.34 111.317 -176.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.34 -47.73 62.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.04 0.385 . . . . 2.8 112.04 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.29 -34.98 5.15 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.077 -1.058 . . . . 2.08 113.539 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.766 ' HB3' ' HZ2' ' A' ' 81' ' ' TRP . 23.8 ptm -81.12 -21.84 39.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.904 0.705 . . . . 5.19 112.904 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.615 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 34.1 t70 -54.7 -43.34 72.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.431 0.9 . . . . 2.83 113.431 -168.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -114.13 30.88 6.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.456 0.646 . . . . 4.47 110.331 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.54 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.75 -70.31 0.17 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.493 -0.861 . . . . 1.04 112.124 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.468 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 10.4 t90 -58.19 -52.0 77.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.463 0.542 . . . . 3.78 112.463 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.8 Cg_endo -59.35 -37.74 88.6 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.94 1.76 . . . . 0.77 112.355 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.1 m -70.02 -36.54 75.17 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.746 0.784 . . . . 1.37 109.671 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.688 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 15.3 mt -55.75 -40.24 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.66 -1.155 . . . . 1.32 110.521 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.594 HD13 ' CD2' ' A' ' 8' ' ' HIS . 79.0 mt -61.7 -30.77 70.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.925 0.343 . . . . 1.33 111.925 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.63 -51.29 23.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 1.54 110.193 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.553 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 37.1 m -68.67 -22.76 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.137 -0.483 . . . . 1.43 110.805 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 23' ' ' PHE . 58.9 t80 -61.64 -54.26 45.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 1.05 109.929 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.489 ' CG ' HG12 ' A' ' 10' ' ' VAL . 38.8 mt-30 -57.37 -37.69 73.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.82 -0.627 . . . . 1.63 110.77 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 154' ' ' LYS . 27.3 t70 -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.43 -0.804 . . . . 1.46 111.26 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -67.12 -41.43 86.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.8 0.333 . . . . 2.23 110.414 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.697 HG23 HG13 ' A' ' 12' ' ' VAL . 47.0 mt -62.08 -34.26 62.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 1.17 110.905 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.62 -30.58 68.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.985 -0.552 . . . . 0.85 110.307 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.755 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 64.8 mt-10 -69.09 -43.83 73.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.5 110.03 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -69.53 -17.75 63.61 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.163 -0.926 . . . . 1.74 109.996 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.67 -40.11 6.44 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.407 -0.815 . . . . 1.32 112.62 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -171.95 -26.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.039 0.755 . . . . 2.42 113.039 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.755 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 6.2 ttmt -76.07 72.76 2.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.234 0.54 . . . . 2.04 111.609 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 150' ' ' GLU . 68.2 mttm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.446 -0.787 . . . . 4.65 110.048 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.751 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 17.5 p-10 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.825 0.345 . . . . 2.1 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 54.6 p90 173.26 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.837 -0.619 . . . . 4.04 109.668 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.801 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 32.8 t70 -66.04 -52.31 40.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 2.78 111.041 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.801 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 12.5 Cg_endo -92.44 -70.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.153 1.902 . . . . 1.83 111.605 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -141.25 145.67 35.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 3.98 110.25 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.751 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -118.63 125.72 74.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.419 -0.585 . . . . 2.03 109.419 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 5.9 ttm105 -132.74 143.28 49.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.056 -0.52 . . . . 3.92 112.027 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.511 ' HD1' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -110.0 133.01 53.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.575 -0.898 . . . . 1.16 108.575 170.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.7 m -133.76 111.51 10.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.589 0.709 . . . . 1.72 110.643 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.579 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.7 t -123.5 142.46 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.824 -1.08 . . . . 1.89 110.139 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.6 m -121.92 116.06 23.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 1.15 110.074 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.44 ' HB ' HG22 ' A' ' 148' ' ' ILE . 11.0 m -102.91 163.63 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.509 -0.768 . . . . 1.51 111.028 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.553 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -117.88 26.05 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 1.6 111.661 -171.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 148' ' ' ILE . . . -143.06 23.98 1.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.641 -0.423 . . . . 1.11 111.52 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.825 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 33.8 t70 72.16 173.88 0.3 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.589 -0.732 . . . . 0.91 112.565 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.506 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 9.7 ttp180 -68.03 -26.43 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.14 -0.936 . . . . 2.19 111.321 -172.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -54.44 -48.53 71.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.104 0.478 . . . . 3.49 110.755 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -80.73 -34.17 34.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 1.49 111.046 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -59.58 -45.24 92.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.606 0.241 . . . . 1.07 110.77 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 67.9 t80 -67.99 -45.89 72.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.43 110.516 177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.661 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 29.6 tptp -54.77 -51.84 64.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 2.87 110.452 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.538 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 55.0 m -65.28 -40.4 93.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 1.21 111.539 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 67.5 t80 -71.33 -37.98 71.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.409 -0.36 . . . . 0.53 111.691 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.621 HD11 HG11 ' A' ' 46' ' ' VAL . 9.6 tp -119.44 -55.78 2.1 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.714 0.635 . . . . 1.23 112.714 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.661 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 2.3 mm-40 -87.85 18.33 4.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.542 0.571 . . . . 1.24 112.542 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -151.51 28.44 0.96 Allowed Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.246 -1.142 . . . . 0.83 110.246 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.634 ' HZ ' ' CE1' ' A' ' 65' ' ' PHE . 71.0 t80 -47.54 -51.77 42.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.494 -0.853 . . . . 0.94 113.18 -168.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.4 Cg_endo -96.31 11.39 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.027 1.818 . . . . 0.9 115.445 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -106.31 -6.54 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.306 0.854 . . . . 1.49 113.306 -172.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.782 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 18.2 m95 -92.66 -152.21 0.31 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.2 -0.312 . . . . 5.66 111.75 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.55 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 31.6 m95 -105.77 0.16 0.1 Allowed Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 115.383 1.623 . . . . 3.41 115.383 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.905 ' HB3' ' HA ' ' A' ' 140' ' ' ILE . 27.1 Cg_exo -66.07 -150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 122.54 1.943 . . . . 1.36 114.342 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.594 ' ND2' HG23 ' A' ' 40' ' ' VAL . 63.5 t30 -63.28 -4.35 2.49 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.485 -0.78 . . . . 1.51 111.646 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.945 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 30.8 p30 -83.6 15.64 3.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.807 -0.633 . . . . 1.98 111.975 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.691 ' HD1' ' HG2' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -69.62 3.28 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.167 0.803 . . . . 5.13 113.167 -173.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.691 ' HG2' ' HD1' ' A' ' 35' ' ' PHE . 42.6 mmt-85 -140.13 147.89 40.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.96 0.41 . . . . 4.7 111.541 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -76.1 145.08 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.777 -0.647 . . . . 3.11 111.13 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 57' ' ' ASP . 62.8 p 50.86 16.38 0.32 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.2 1.0 . . . . 1.89 112.279 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.757 ' HD3' HG21 ' A' ' 40' ' ' VAL . 5.8 tmtm? -104.17 -62.88 1.26 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.091 -1.448 . . . . 3.45 107.091 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.945 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 31.3 t -146.95 1.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.108 0.956 . . . . 2.3 108.636 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 28' ' ' PRO . . . -126.73 50.61 0.87 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.538 -0.756 . . . . 2.2 112.461 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.966 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -90.96 168.34 14.0 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.524 . . . . 1.31 109.587 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.675 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 48.4 Cg_endo -69.53 54.97 1.14 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.729 2.286 . . . . 1.94 114.056 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -164.92 -96.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.41 -0.359 . . . . 2.23 110.518 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.605 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 104.85 -59.09 0.45 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.94 112.38 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 24' ' ' LEU . 78.9 t -136.74 141.2 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 122.784 -0.245 . . . . 1.21 110.37 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.755 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 7.1 t70 -112.36 113.38 25.56 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.491 -0.559 . . . . 1.11 109.491 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -79.2 -31.9 43.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.017 0.377 . . . . 3.25 112.017 -175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -83.66 -34.84 24.92 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 3.63 110.9 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.8 -35.87 30.43 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.606 -0.807 . . . . 1.9 111.718 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.429 ' C ' ' HB ' ' A' ' 68' ' ' ILE . . . 85.26 54.24 2.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.429 -0.668 . . . . 0.87 111.429 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -160.65 165.0 31.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 4.26 110.949 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.64 117.82 33.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.756 -0.461 . . . . 1.52 109.756 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.755 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -164.36 152.27 12.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.491 . . . . 2.04 109.99 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.966 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 2.2 mp0 -112.59 160.53 17.76 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.521 -0.548 . . . . 2.12 109.521 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.4 mm -77.14 103.92 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.864 0.364 . . . . 1.42 110.091 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' HA ' HG21 ' A' ' 38' ' ' THR . 4.6 t70 -90.78 170.4 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.97 110.117 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.91 -37.19 64.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.65 0.982 . . . . 2.43 113.65 -165.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.56 ' NE2' ' HB3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -86.6 -0.76 56.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.223 -0.591 . . . . 2.39 111.56 -178.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.79 72.87 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.648 -1.263 . . . . 2.29 114.064 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 53.0 29.7 8.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.491 0.552 . . . . 2.31 112.491 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.56 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 13.7 tp10 -85.73 75.88 10.02 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.404 -0.591 . . . . 2.61 109.404 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HE1' ' O ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -126.96 163.5 23.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.003 -0.544 . . . . 4.63 111.78 177.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.85 HG23 ' HG3' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -134.58 121.26 20.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.734 . . . . 2.27 109.89 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.789 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 3.7 t80 -144.83 -66.7 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 119.787 -0.765 . . . . 7.39 113.057 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' HA3' HD12 ' A' ' 79' ' ' ILE . . . -158.64 165.14 33.9 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.909 -1.615 . . . . 1.23 114.732 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 82' ' ' ARG . 5.6 mp -113.39 107.35 15.74 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.268 0.627 . . . . 1.76 110.342 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.861 HG21 HG22 ' A' ' 71' ' ' VAL . 65.0 mt -70.6 116.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.407 -0.917 . . . . 1.26 110.385 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -90.35 -24.67 20.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.85 -0.613 . . . . 2.65 109.4 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.555 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 65.7 tttt -170.99 123.7 0.61 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.957 -0.565 . . . . 2.03 111.623 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.861 HG22 HG21 ' A' ' 68' ' ' ILE . 95.0 t -106.32 113.5 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.959 -0.756 . . . . 1.47 108.959 169.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -117.6 72.1 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.818 -0.353 . . . . 1.42 110.11 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 45.17 -168.2 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 124.615 1.197 . . . . 0.96 111.9 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.1 Cg_exo -63.33 76.85 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.253 1.302 . . . . 0.48 111.436 166.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.16 -63.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.942 -0.572 . . . . 0.5 110.287 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.441 HG21 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -144.34 139.66 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.482 0.549 . . . . 1.1 112.482 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.96 109.7 6.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 1.4 109.261 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 70' ' ' LYS . 1.2 p -101.5 113.54 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.519 -0.549 . . . . 1.31 109.519 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.51 HD12 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -129.39 141.39 46.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.55 -0.75 . . . . 1.48 110.724 -177.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 96' ' ' GLU . . . -89.5 172.79 39.75 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.951 -0.568 . . . . 0.5 112.859 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.759 ' H ' ' HB2' ' A' ' 95' ' ' SER . 73.0 t-105 -90.22 156.46 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.517 0.199 . . . . 3.37 111.3 -172.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.85 ' HG3' HG23 ' A' ' 64' ' ' THR . 18.1 tpt180 177.86 42.31 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.854 -0.612 . . . . 6.17 110.483 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 84.1 133.35 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.895 0.478 . . . . 2.13 111.135 169.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.589 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 31.2 t30 -93.66 75.35 4.35 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.46 -62.68 3.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.602 -0.809 . . . . 2.79 113.609 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -168.41 138.06 2.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.465 0.174 . . . . 6.08 110.937 -172.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.61 38.1 3.79 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.754 -0.736 . . . . 2.43 114.232 170.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.842 ' NH1' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -148.19 163.32 37.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.372 0.586 . . . . 5.53 111.021 177.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.671 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -122.17 114.59 43.28 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 122.471 0.308 . . . . 2.42 111.357 176.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.842 ' HB3' ' NH1' ' A' ' 88' ' ' ARG . 6.5 t70 -170.22 108.43 0.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 3.18 109.557 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.407 ' HD2' ' CZ ' ' A' ' 128' ' ' ARG . 45.1 Cg_endo -87.66 30.48 0.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.835 2.357 . . . . 2.76 111.466 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.59 ' HB2' HH21 ' A' ' 128' ' ' ARG . 3.4 t70 -84.76 170.62 13.04 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.752 0.787 . . . . 2.99 110.793 -165.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.37 15.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.345 -1.298 . . . . 3.06 109.897 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.478 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 14.8 m -131.67 -78.62 0.51 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.251 -0.886 . . . . 2.11 109.14 170.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.759 ' HB2' ' H ' ' A' ' 81' ' ' TRP . 19.9 m 47.92 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.206 1.002 . . . . 1.81 112.006 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.421 ' H ' ' HA2' ' A' ' 80' ' ' GLY . 49.4 tt0 77.59 112.67 0.07 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 1.81 112.979 163.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.566 ' HB2' HG11 ' A' ' 113' ' ' VAL . 51.0 p90 -127.56 124.26 37.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.81 110.106 167.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 41.8 m -88.16 109.2 19.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.384 -0.826 . . . . 1.18 109.703 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.62 ' HA ' HG22 ' A' ' 113' ' ' VAL . 62.0 t -82.41 110.06 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.395 . . . . 1.51 110.009 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 76' ' ' THR . 28.2 m -103.17 107.31 18.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.518 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.701 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 43.7 m-85 -90.38 111.16 22.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.294 -0.412 . . . . 0.42 110.214 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.3 t -93.04 112.61 26.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.914 -0.402 . . . . 1.26 109.914 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.54 126.98 31.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.306 -0.406 . . . . 1.13 110.607 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 50.7 m-20 -119.17 114.76 22.94 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.367 -0.379 . . . . 2.03 110.49 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.91 -102.84 1.27 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.029 -0.605 . . . . 1.97 112.706 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -145.15 -23.32 0.49 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.807 0.337 . . . . 5.46 110.485 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.825 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 21.6 pttp -142.93 34.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 3.88 111.625 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 56.2 tttm -136.21 148.18 47.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.235 -0.654 . . . . 2.94 109.235 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.3 m -155.33 122.19 5.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.159 0.504 . . . . 1.2 111.499 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -94.38 116.77 29.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.288 -0.869 . . . . 3.1 109.839 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.701 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 p -94.5 134.93 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 109.331 -0.618 . . . . 1.13 109.331 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.13 114.1 13.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.968 -1.015 . . . . 1.38 109.405 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 99' ' ' VAL . 2.4 t -106.87 122.87 61.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.178 -0.919 . . . . 1.58 111.809 -171.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 25.8 mt-10 -98.21 110.76 23.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.248 -0.433 . . . . 2.31 110.067 171.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.618 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.9 t-80 -105.16 103.64 13.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.977 -1.49 . . . . 2.32 106.977 171.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -153.84 96.99 2.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.368 -0.533 . . . . 3.19 110.749 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.605 ' O ' ' HG2' ' A' ' 121' ' ' MET . 1.5 t60 -166.51 -76.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.786 -0.643 . . . . 2.99 109.552 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 94' ' ' SER . 4.4 m-85 -85.45 -23.71 27.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.529 0.937 . . . . 4.27 113.529 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.31 -53.34 59.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.674 0.749 . . . . 1.81 110.69 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.89 -17.46 64.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.662 -1.153 . . . . 3.84 111.446 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 93.6 mmm -73.74 27.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.889 0.7 . . . . 2.9 112.889 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.92 -175.42 21.85 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 118.798 -1.668 . . . . 2.26 114.016 166.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 -53.7 7.74 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.522 -0.839 . . . . 3.02 110.959 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.752 ' HA ' ' HB2' ' A' ' 127' ' ' LYS . 20.3 pttp -89.28 -11.7 42.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.922 0.712 . . . . 4.23 112.922 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.712 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 16.1 m80 -62.45 -53.4 55.36 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.998 -0.681 . . . . 2.7 109.556 167.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 1.46 110.996 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.752 ' HB2' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mttp -66.63 -33.01 74.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 111.94 0.348 . . . . 3.16 111.94 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 27.4 ptt180 -69.89 -52.9 20.83 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.479 -0.488 . . . . 2.97 109.728 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.481 HG12 ' SD ' ' A' ' 133' ' ' MET . 35.0 t -56.48 -33.84 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.206 0.527 . . . . 1.96 111.133 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.36 -16.47 14.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.044 0.938 . . . . 4.34 112.502 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.48 HD21 ' HA ' ' A' ' 88' ' ' ARG . 5.6 t30 -56.06 -40.75 74.02 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.032 0.752 . . . . 2.8 113.032 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.31 19.16 0.23 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.015 -1.564 . . . . 2.08 114.095 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.481 ' SD ' HG12 ' A' ' 129' ' ' VAL . 17.7 ptt? -80.29 -27.66 38.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.667 0.733 . . . . 5.19 109.683 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -80.54 -13.57 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 2.83 111.932 -170.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.597 ' HZ2' ' HB2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -92.88 1.75 57.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.804 0.335 . . . . 4.47 110.539 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.631 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.89 -55.38 0.14 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.123 -1.037 . . . . 1.04 113.048 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.491 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 61.7 t-105 -53.81 -52.76 64.77 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.534 0.568 . . . . 3.78 112.534 -171.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 25.1 Cg_endo -60.97 -45.42 19.99 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.595 1.53 . . . . 0.77 111.768 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.1 m -59.64 -38.7 82.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.652 0.739 . . . . 1.37 110.108 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.905 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 14.0 mt -68.04 -41.67 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.126 -0.943 . . . . 1.32 110.766 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 55.0 mt -63.88 -32.93 74.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 1.33 111.53 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -48.0 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.62 0.248 . . . . 1.54 110.999 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 31.9 m -71.38 -25.9 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.43 110.817 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.52 -55.37 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.672 -0.695 . . . . 1.05 109.941 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.486 ' CG ' HG11 ' A' ' 10' ' ' VAL . 47.3 mt-30 -64.94 -27.6 68.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.905 -0.589 . . . . 1.63 110.522 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 2.8 t70 -67.95 -55.35 13.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 1.46 111.133 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.782 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 16.7 tptm -64.12 -39.87 94.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.267 -0.573 . . . . 2.23 110.638 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.542 HG23 ' HB1' ' A' ' 14' ' ' ALA . 67.7 mt -63.66 -34.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 1.17 110.723 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.553 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 18.4 t70 -66.86 -32.06 73.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.814 -0.439 . . . . 0.85 109.814 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.93 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 35.4 mt-10 -67.84 -33.11 74.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.235 0.54 . . . . 1.5 110.194 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 4.6 mm-40 -79.68 -12.96 59.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.375 -0.83 . . . . 1.74 110.172 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.53 -75.16 1.14 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.713 -0.676 . . . . 1.32 112.862 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -151.24 35.88 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.982 0.391 . . . . 2.42 111.777 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.93 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 12.4 tppt? -75.44 -10.93 59.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.44 0.638 . . . . 2.04 109.642 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.0 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.484 -0.78 . . . . 4.65 109.833 -176.508 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.4 p-10 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.209 -0.293 . . . . 2.1 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 1.2 t80 80.59 -50.71 0.32 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.584 0.552 . . . . 4.04 111.372 172.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.688 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.1 t70 -61.87 -49.41 85.9 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.092 -0.243 . . . . 2.78 111.213 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.0 Cg_endo -92.47 -65.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.964 1.776 . . . . 1.83 111.871 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.31 156.76 44.0 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.182 -1.414 . . . . 3.98 107.182 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.907 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 88.7 t -85.62 124.05 39.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.657 -0.817 . . . . 2.03 109.828 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 14.0 ttp180 -128.82 138.04 51.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.954 0.407 . . . . 3.92 110.865 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.584 ' HD1' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -115.3 132.33 56.65 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.987 -1.116 . . . . 1.16 107.987 170.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 1.0 OUTLIER -136.16 110.47 8.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.746 0.784 . . . . 1.72 109.437 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 145' ' ' GLN . 1.7 t -125.43 142.6 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.434 -1.257 . . . . 1.89 110.966 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -102.33 115.19 30.04 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.279 0.561 . . . . 1.15 109.742 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.695 HG11 HG22 ' A' ' 148' ' ' ILE . 39.6 t -95.07 128.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.824 -0.626 . . . . 1.51 110.316 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.651 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.59 32.79 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 1.6 111.387 -173.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.41 26.87 0.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.586 -0.279 . . . . 1.11 111.666 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.608 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 27.4 t70 73.97 168.42 0.3 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.175 0.512 . . . . 0.91 112.349 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.535 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 12.1 ttp180 -69.12 -33.32 73.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.858 -0.61 . . . . 2.19 111.815 -170.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.608 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 13.7 pttm -59.01 -43.05 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 3.49 110.566 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -72.51 -37.47 68.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.339 -0.391 . . . . 1.49 110.878 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.466 ' HB2' HG13 ' A' ' 12' ' ' VAL . . . -60.23 -46.25 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 1.07 110.429 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -69.42 -45.81 68.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.43 110.607 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.741 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 23.6 tptp -53.47 -50.62 64.94 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.137 -0.483 . . . . 2.87 110.736 176.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -68.61 -50.15 53.7 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.085 -0.246 . . . . 1.21 111.011 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 68.6 t80 -65.45 -39.35 91.92 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.039 0.385 . . . . 0.53 112.039 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.689 HD13 HG11 ' A' ' 46' ' ' VAL . 14.4 tp -109.54 -49.41 3.11 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.021 -0.672 . . . . 1.23 112.035 -176.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.742 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 30.3 mt-10 -87.72 10.79 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.19 0.519 . . . . 1.24 110.598 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.718 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -143.83 26.12 2.08 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.83 110.896 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.516 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 46.8 t80 -49.32 -49.52 70.17 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.41 . . . . 0.94 111.45 -177.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.9 Cg_endo -90.52 25.32 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.106 1.871 . . . . 0.9 114.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.718 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.1 pt-20 -112.12 -9.91 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.785 -0.766 . . . . 1.49 111.753 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.667 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 11.4 m0 -71.84 152.05 42.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.348 0.594 . . . . 5.66 111.163 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.625 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.9 m95 -75.28 -43.58 4.42 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.433 -0.803 . . . . 3.41 113.131 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 143' ' ' SER . 14.3 Cg_endo -53.98 -71.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.019 2.479 . . . . 1.36 114.684 -165.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HB3' HD11 ' A' ' 140' ' ' ILE . 8.9 t30 -117.51 -19.98 9.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.339 0.59 . . . . 1.51 110.294 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.671 ' HA ' HG22 ' A' ' 40' ' ' VAL . 10.0 m120 -92.75 20.2 6.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 1.98 111.806 -169.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -99.16 15.15 26.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.411 0.624 . . . . 5.13 110.137 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -106.29 149.97 26.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.925 -0.58 . . . . 4.7 110.752 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 p -76.74 136.82 39.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.102 -0.332 . . . . 3.11 110.102 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.812 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 43.6 p 66.22 -47.63 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.835 1.254 . . . . 1.89 111.759 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 85.1 tttt -71.11 89.28 0.82 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 122.771 0.429 . . . . 3.45 110.142 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 34' ' ' ASN . 34.5 m 49.07 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.952 1.301 . . . . 2.3 113.031 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.31 17.0 2.71 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.674 -0.774 . . . . 2.2 112.704 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.83 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -74.11 166.84 41.05 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.004 -0.739 . . . . 1.31 109.004 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.9 49.67 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 123.055 2.503 . . . . 1.94 114.011 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.6 tp -162.52 -92.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.586 0.231 . . . . 2.23 110.714 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.75 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.05 -54.62 3.28 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.869 -0.681 . . . . 0.94 112.361 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.689 HG11 HD13 ' A' ' 24' ' ' LEU . 60.3 t -140.34 140.22 34.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 1.21 110.318 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -109.79 110.0 20.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.214 -0.661 . . . . 1.11 109.214 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.742 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 7.8 mtpm? -79.55 -20.48 46.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.068 -0.515 . . . . 3.25 111.689 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -83.64 -44.01 15.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.844 -0.342 . . . . 3.63 110.943 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.7 -30.44 18.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.116 -0.564 . . . . 1.9 112.248 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.64 54.2 2.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.682 . . . . 0.87 112.76 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -142.65 150.2 39.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.507 -0.408 . . . . 4.26 110.661 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.555 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 17.2 m0 -105.38 114.08 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.675 -0.491 . . . . 1.52 109.675 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.34 148.48 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.207 -0.294 . . . . 2.04 110.207 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.83 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 1.6 mp0 -119.58 160.58 22.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.952 -0.759 . . . . 2.12 108.952 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.98 114.05 16.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.955 0.407 . . . . 1.42 110.338 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.679 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.0 t70 -105.15 -170.76 1.8 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.785 -0.643 . . . . 1.97 110.113 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.469 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 12.7 pt-20 -71.84 -38.94 70.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.722 0.638 . . . . 2.43 112.722 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -88.11 4.19 46.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.173 -0.611 . . . . 2.39 110.979 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.69 -106.23 0.41 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.943 -1.122 . . . . 2.29 113.278 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -134.84 21.74 3.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.907 0.384 . . . . 2.31 111.071 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -96.07 77.57 3.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.626 0.727 . . . . 2.61 110.625 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.679 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -122.81 125.7 45.95 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.229 -0.896 . . . . 4.63 110.214 174.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.634 ' HB ' ' HG2' ' A' ' 82' ' ' ARG . 70.2 p 62.03 -66.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.779 1.299 . . . . 2.27 113.363 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 t80 74.26 72.52 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.698 0.799 . . . . 7.39 110.702 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.555 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -83.48 150.48 27.08 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.552 -0.749 . . . . 1.23 112.301 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.466 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -108.1 92.52 4.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.828 0.347 . . . . 1.76 111.563 -172.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 71' ' ' VAL . 25.2 mt -72.04 136.15 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 1.26 110.06 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -110.13 -24.23 10.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 2.65 109.905 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 20.5 ttmm -162.16 119.75 2.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.879 -0.6 . . . . 2.03 111.261 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 68' ' ' ILE . 60.4 t -108.54 96.16 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.472 -0.936 . . . . 1.47 108.472 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -105.41 65.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.928 -0.309 . . . . 1.42 110.53 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 15.5 pt-20 48.07 -170.59 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 O-C-N 124.514 1.134 . . . . 0.96 111.926 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.517 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.1 Cg_exo -64.7 75.98 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.388 1.392 . . . . 0.48 111.545 169.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -160.17 -66.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.312 -0.858 . . . . 0.5 110.214 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 2.4 p -143.85 143.45 31.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.17 0.509 . . . . 1.1 112.277 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.8 mp -133.53 121.84 22.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 1.4 109.831 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 45.5 t -109.57 104.72 17.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.194 -0.669 . . . . 1.31 109.194 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.97 146.22 34.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.554 0.216 . . . . 1.48 111.076 -178.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.76 148.54 18.86 Favored Glycine 0 C--O 1.24 0.486 0 CA-C-N 116.223 -0.444 . . . . 0.5 112.54 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.76 ' HZ2' ' HE1' ' A' ' 133' ' ' MET . 54.4 t-105 -77.06 154.57 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.927 0.491 . . . . 3.37 112.322 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.634 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -153.95 23.22 0.5 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 6.17 109.463 -176.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' A' ' 88' ' ' ARG . 0.2 OUTLIER 79.85 -164.66 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.815 -1.084 . . . . 2.13 109.933 -172.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.599 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 32.7 t30 -137.87 -70.94 0.43 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.492 -0.322 . . . . 1.93 110.524 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 86' ' ' PHE . . . -72.58 -11.27 76.9 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.584 -0.817 . . . . 2.79 113.353 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 85' ' ' GLY . 86.2 t80 71.82 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.485 0.659 . . . . 6.08 110.964 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -27.82 3.54 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.525 -0.761 . . . . 2.43 111.314 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.715 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -94.17 -175.98 3.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 120.907 0.384 . . . . 5.53 110.505 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.72 HD13 ' HE ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -71.53 129.72 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.551 -0.749 . . . . 2.42 111.491 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 p-10 -99.57 121.03 56.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.393 0.616 . . . . 3.18 109.856 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.568 ' HB2' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -84.06 36.42 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.204 2.603 . . . . 2.76 111.556 178.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.73 76.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.806 0.812 . . . . 2.99 111.594 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -143.77 -47.25 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.402 -1.333 . . . . 3.06 107.402 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 m -136.87 -95.3 0.22 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.778 -1.556 . . . . 2.11 108.192 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 91' ' ' PRO . 66.7 m 48.92 23.83 0.76 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.076 0.55 . . . . 1.81 112.409 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 33.4 mt-10 -75.1 138.97 42.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.651 -0.704 . . . . 1.81 109.619 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 79' ' ' ILE . 4.8 p90 -133.26 132.01 40.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.173 0.511 . . . . 0.81 110.543 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 25.8 m -91.4 108.47 19.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.063 -0.971 . . . . 1.18 109.921 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.685 ' HA ' HG22 ' A' ' 113' ' ' VAL . 95.5 t -81.5 108.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 1.51 109.326 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.471 ' HA ' HG23 ' A' ' 76' ' ' THR . 19.3 m -101.68 105.75 16.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.272 -0.422 . . . . 1.05 110.222 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.535 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.3 m-85 -90.28 111.9 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.385 -0.37 . . . . 0.42 110.192 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 109' ' ' THR . 47.8 t -96.21 106.64 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 1.26 109.588 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.41 125.09 28.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.619 . . . . 1.13 110.768 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 28.4 t70 -116.03 114.42 24.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.805 -0.634 . . . . 2.03 110.1 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.47 -114.65 6.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.618 -0.801 . . . . 1.97 111.666 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -146.64 13.5 1.19 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.176 0.512 . . . . 5.46 110.228 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -145.57 -5.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.969 0.729 . . . . 3.88 112.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 29.5 ttpt -123.38 154.01 39.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.602 -0.686 . . . . 2.94 110.304 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 51.8 m -157.56 114.17 2.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.146 0.498 . . . . 1.2 110.973 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -88.3 119.87 29.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.823 -0.626 . . . . 3.1 109.616 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.1 p -96.18 132.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.249 -0.58 . . . . 1.13 109.588 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.54 109.31 12.01 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.561 -0.903 . . . . 1.38 108.561 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 28.6 t -98.83 120.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.029 -0.987 . . . . 1.58 110.991 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.24 119.23 38.46 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.684 0.754 . . . . 2.31 109.431 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.907 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 16.6 t60 -102.74 152.2 21.51 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.595 -1.184 . . . . 2.32 109.016 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.7 t -54.67 169.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.231 1.015 . . . . 3.19 111.604 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -93.92 14.84 18.32 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.503 -1.226 . . . . 2.99 111.124 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.059 0.456 . . . . 4.27 110.09 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -30.51 59.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.142 -0.688 . . . . 1.81 109.142 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 57.5 ttt180 -60.29 -19.82 56.61 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.918 -1.037 . . . . 3.84 111.397 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 87.9 mmm -61.22 -15.44 34.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 2.9 110.271 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.98 -140.38 26.94 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.595 -0.729 . . . . 2.26 113.134 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 16.8 p 36.22 -108.44 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 O-C-N 124.766 0.921 . . . . 3.02 112.813 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -84.81 -34.55 22.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 4.23 111.102 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -63.7 -50.33 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 2.7 110.71 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 -25.79 59.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.495 -0.32 . . . . 1.46 110.667 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 123' ' ' THR . 46.9 tptt -56.51 -52.23 65.53 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.969 0.414 . . . . 3.16 110.403 174.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.72 ' HE ' HD13 ' A' ' 89' ' ' ILE . 9.5 ptm85 -72.24 -30.31 64.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.68 -0.691 . . . . 2.97 111.9 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.5 -39.18 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 1.96 111.589 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -62.79 -16.04 56.37 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.264 -0.425 . . . . 4.34 112.067 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 128' ' ' ARG . 65.5 m-80 -54.99 -24.86 26.2 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.907 0.706 . . . . 2.8 112.907 -175.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -134.74 -24.09 0.61 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.641 -1.266 . . . . 2.08 114.105 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.76 ' HE1' ' HZ2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -73.5 -26.08 60.73 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.431 -0.452 . . . . 5.19 112.0 -172.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.99 -14.63 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.388 . . . . 2.83 110.886 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -115.21 16.38 16.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.734 0.778 . . . . 4.47 109.47 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.68 -91.26 2.21 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.466 -0.788 . . . . 1.04 112.526 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.538 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 20.2 m95 -54.89 -47.58 97.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.681 0.993 . . . . 3.78 113.681 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.2 Cg_endo -52.82 -40.04 75.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.813 1.676 . . . . 0.77 112.446 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 38.9 m -78.15 -43.32 29.11 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.631 0.729 . . . . 1.37 110.102 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.612 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.2 mt -59.79 -51.97 66.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 115.105 -0.952 . . . . 1.32 111.734 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.426 HD12 ' CD2' ' A' ' 8' ' ' HIS . 78.7 mt -58.94 -28.3 66.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.174 0.435 . . . . 1.33 112.174 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -74.24 -51.74 14.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 1.54 110.296 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.642 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 14.9 t -70.52 -23.74 62.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.082 0.468 . . . . 1.43 110.321 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.59 -51.97 66.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 1.05 109.952 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.477 ' CG ' HG11 ' A' ' 10' ' ' VAL . 45.7 mt-30 -66.1 -28.43 68.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.599 -0.728 . . . . 1.63 110.437 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 35.2 t70 -75.78 -43.1 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.698 . . . . 1.46 111.222 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.478 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 58.6 tttm -64.8 -40.12 94.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.065 0.46 . . . . 2.23 110.076 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.695 HG22 HG11 ' A' ' 12' ' ' VAL . 70.8 mt -68.85 -26.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.02 -0.537 . . . . 1.17 110.372 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.93 -37.78 76.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 0.85 109.295 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 34.8 mt-10 -64.65 -46.09 83.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.18 0.991 . . . . 1.5 108.79 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 148' ' ' ILE . 2.4 tp10 -65.64 -43.63 88.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.4 -1.727 . . . . 1.74 110.506 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.35 -70.49 1.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 1.32 112.075 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -161.81 97.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.388 . . . . 2.42 111.28 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.562 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.0 ttmm -137.3 -46.38 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.969 -0.559 . . . . 2.04 109.678 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.543 ' H ' ' HD3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.496 -0.775 . . . . 4.65 111.176 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 25.0 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.17 0.509 . . . . 2.1 110.784 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.817 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 41.9 p90 -168.38 -42.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.155 -0.475 . . . . 4.04 110.647 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.586 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.6 t70 -72.78 -58.67 2.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.613 -0.267 . . . . 2.78 111.526 -173.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.13 -64.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.165 1.243 . . . . 1.83 110.636 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 53.1 p90 -154.66 147.07 23.98 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.958 -0.564 . . . . 3.98 110.135 173.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -110.46 114.47 47.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.796 -1.187 . . . . 2.03 107.796 164.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 28.9 ttm180 -112.67 138.65 49.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.716 -0.674 . . . . 3.92 111.257 -173.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.592 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.57 133.83 52.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.696 -0.853 . . . . 1.16 108.696 172.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 70.0 m -141.61 113.82 8.11 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.131 -0.486 . . . . 1.72 109.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.996 HG22 HG12 ' A' ' 111' ' ' VAL . 1.9 m -122.92 143.48 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 1.89 109.983 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.1 m -98.04 115.8 28.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.431 0.634 . . . . 1.15 110.158 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG11 HG22 ' A' ' 148' ' ' ILE . 33.1 t -103.1 133.8 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.568 -0.742 . . . . 1.51 109.947 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.12 30.2 6.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 1.6 111.886 -174.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.23 35.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 1.11 111.209 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 75.03 173.21 0.26 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-O 122.1 0.952 . . . . 0.91 112.705 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.556 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 19.8 ttp180 -71.79 -24.75 61.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.594 -1.185 . . . . 2.19 110.711 -171.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.14 -48.4 81.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 3.49 110.671 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.2 p -70.9 -38.54 73.01 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.979 -0.288 . . . . 1.49 111.059 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.498 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -56.7 -46.47 81.19 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 120.913 0.387 . . . . 1.07 110.647 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' HZ ' ' HE2' ' A' ' 48' ' ' LYS . 77.3 t80 -71.69 -47.79 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.43 110.872 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.693 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 25.6 tptp -52.33 -46.53 66.09 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 120.966 0.412 . . . . 2.87 111.1 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 m -70.88 -49.04 50.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.192 -0.458 . . . . 1.21 110.349 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.3 t80 -62.39 -41.08 98.38 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.231 0.456 . . . . 0.53 112.231 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.45 ' CD1' HG11 ' A' ' 46' ' ' VAL . 12.5 tp -113.05 -34.24 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.231 -0.588 . . . . 1.23 112.512 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.693 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 35.1 mt-10 -104.82 16.22 26.38 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.234 -0.291 . . . . 1.24 111.419 -173.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.735 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -153.87 38.74 0.69 Allowed Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.754 -0.736 . . . . 0.83 111.482 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.601 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 61.9 t80 -53.66 -54.45 45.94 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 112.806 0.669 . . . . 0.94 112.806 -169.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 36.5 Cg_endo -87.5 13.88 2.53 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.9 114.496 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.7 pt-20 -97.36 -6.49 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.159 -0.616 . . . . 1.49 110.586 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.641 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 26.8 m0 -73.3 176.11 6.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.482 0.658 . . . . 5.66 111.446 -175.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.535 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 35.0 m95 -97.91 -25.19 0.23 Allowed Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 114.136 1.161 . . . . 3.41 114.136 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.641 ' HD2' ' CB ' ' A' ' 30' ' ' TRP . 72.6 Cg_endo -75.2 -151.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.726 1.617 . . . . 1.36 114.281 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.554 ' ND2' HG22 ' A' ' 40' ' ' VAL . 9.5 t30 -44.73 -43.28 8.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.85 -1.068 . . . . 1.51 113.293 -171.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.951 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 2.0 p-10 -79.95 38.95 0.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.395 -0.821 . . . . 1.98 112.323 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -100.35 -6.23 26.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 5.13 110.722 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -89.48 131.07 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.342 -0.39 . . . . 4.7 110.751 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.6 p -76.01 137.38 40.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 3.11 110.881 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.9 p 52.92 24.46 3.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 1.89 111.338 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -121.31 -55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.496 -0.927 . . . . 3.45 108.496 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.951 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 1.6 t -150.47 19.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.222 -0.659 . . . . 2.3 109.222 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.48 41.84 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.584 -1.293 . . . . 2.2 114.135 -166.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -67.95 173.22 3.27 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.247 -0.649 . . . . 1.31 109.247 167.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.821 ' HD2' ' HB2' ' A' ' 42' ' ' ALA . 29.5 Cg_endo -63.44 26.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.049 2.499 . . . . 1.94 115.335 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 42' ' ' ALA . 62.8 tp -142.1 -88.94 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.932 -0.48 . . . . 2.23 110.81 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 95.2 -49.77 1.91 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.766 -0.73 . . . . 0.94 112.766 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.45 HG11 ' CD1' ' A' ' 24' ' ' LEU . 85.8 t -137.12 143.38 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 1.21 110.161 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.824 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 13.6 t70 -104.95 109.1 20.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.206 -0.664 . . . . 1.11 109.206 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' HE2' ' HZ ' ' A' ' 20' ' ' PHE . 22.0 tptp -80.95 -13.64 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.49 -0.777 . . . . 3.25 112.316 -173.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -90.4 -40.05 12.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.665 0.269 . . . . 3.63 111.573 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.68 -32.27 4.23 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.986 -0.846 . . . . 1.9 110.986 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 96.16 79.61 1.47 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.87 111.946 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.824 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 28.6 ptt180 -157.99 165.28 35.51 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.53 -0.544 . . . . 4.26 109.53 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -111.82 117.93 34.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.74 -0.467 . . . . 1.52 109.74 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.9 p90 -164.02 159.03 20.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.282 0.563 . . . . 2.04 111.244 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.904 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 26.2 mt-10 -111.82 153.72 26.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.678 -0.692 . . . . 2.12 110.2 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 60' ' ' GLY . 37.5 mm -81.2 103.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.258 -0.645 . . . . 1.42 109.258 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.672 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.0 t70 -90.25 -170.79 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.258 -0.275 . . . . 1.97 110.258 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 11.4 pt-20 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.883 0.327 . . . . 2.43 111.883 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.581 ' OE1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -84.5 -10.35 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 2.39 110.61 -178.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' HG21 ' A' ' 56' ' ' ILE . . . 145.93 -86.79 0.17 Allowed Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.83 -0.623 . . . . 2.29 112.448 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . 40.0 mt-10 -148.65 37.13 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.539 0.209 . . . . 2.31 111.285 -172.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.45 77.85 1.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.147 0.975 . . . . 2.61 110.84 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -123.22 163.95 19.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.634 -1.166 . . . . 4.63 110.275 172.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 82' ' ' ARG . 7.1 p -57.98 106.22 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 2.27 111.48 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 19.2 p90 -79.61 109.31 13.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 7.39 112.162 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -67.41 136.62 32.15 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.987 -0.845 . . . . 1.23 110.987 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 67' ' ' LEU . 4.0 mp -87.91 86.88 7.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.45 0.125 . . . . 1.76 111.166 -171.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 51' ' ' GLY . 35.5 mt -82.27 116.62 26.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.094 -1.042 . . . . 1.26 109.568 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -103.21 -12.79 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.168 -0.923 . . . . 2.65 110.319 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HD2' HG21 ' A' ' 78' ' ' VAL . 36.9 ttmt -156.81 121.12 4.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 2.03 111.511 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' HA ' HD13 ' A' ' 77' ' ' LEU . 59.3 t -109.86 89.06 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.966 -1.124 . . . . 1.47 107.966 167.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 76' ' ' THR . 38.7 t0 -97.8 71.41 2.22 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.879 -0.328 . . . . 1.42 110.454 -175.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.553 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.3 pt-20 46.42 -169.73 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 124.402 1.064 . . . . 0.96 111.411 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -67.06 74.38 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.107 1.205 . . . . 0.48 110.914 165.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -155.0 -71.35 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.491 -0.322 . . . . 0.5 110.771 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.572 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -142.31 123.94 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.476 0.547 . . . . 1.1 112.476 -175.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -118.73 123.2 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.862 -0.523 . . . . 1.4 110.41 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.573 HG21 ' HD2' ' A' ' 70' ' ' LYS . 58.1 t -103.13 101.72 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 1.31 109.251 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.32 140.92 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.138 -0.483 . . . . 1.48 111.12 -176.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.38 145.9 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.589 -0.732 . . . . 0.5 112.365 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.958 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 72.0 t-105 -72.99 142.62 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.581 0.586 . . . . 3.37 112.581 -174.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.589 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -145.12 44.41 1.33 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.49 -0.777 . . . . 6.17 109.32 177.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.619 HD11 ' N ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 75.95 145.46 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.337 -0.847 . . . . 2.13 111.954 176.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.619 ' N ' HD11 ' A' ' 83' ' ' LEU . 29.1 t30 -83.11 -66.59 0.87 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.047 -0.979 . . . . 1.93 111.306 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 40' ' ' VAL . . . -91.13 29.14 7.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 2.79 113.678 -172.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 63' ' ' HIS . 75.7 t80 67.32 -68.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.23 0.612 . . . . 6.08 112.563 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.77 55.66 4.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.212 -0.518 . . . . 2.43 113.944 -170.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.618 ' HB2' HD13 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -140.53 -175.96 4.46 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.719 -0.845 . . . . 5.53 108.719 170.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -92.44 127.66 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.251 0.548 . . . . 2.42 111.494 -173.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' OD1' ' HD3' ' A' ' 82' ' ' ARG . 3.2 p30 -135.39 158.92 73.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.62 -0.718 . . . . 3.18 109.15 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 93' ' ' ASN . 28.5 Cg_endo -91.0 -29.16 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.346 2.03 . . . . 2.76 114.089 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.17 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.923 1.289 . . . . 2.99 114.418 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 91' ' ' PRO . 10.2 m-80 -79.56 -20.1 47.87 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.718 -0.613 . . . . 3.06 112.211 -174.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 p -155.9 -90.09 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.398 -0.593 . . . . 2.11 109.398 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.958 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.4 m 54.87 25.73 7.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.763 -0.653 . . . . 1.81 111.685 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.633 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 39.2 tt0 -77.63 142.63 38.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 1.81 112.214 -171.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 79' ' ' ILE . 6.6 p90 -139.92 141.06 36.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.81 110.52 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 39.0 m -97.04 112.38 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.686 -0.688 . . . . 1.18 110.387 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 76' ' ' THR . 84.5 t -84.43 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 1.51 109.71 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.446 ' HA ' HG21 ' A' ' 76' ' ' THR . 55.6 m -107.13 106.03 16.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.917 0.389 . . . . 1.05 110.849 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.556 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 46.0 m-85 -85.08 113.38 21.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.401 -0.363 . . . . 0.42 110.05 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.63 109.49 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.645 -0.502 . . . . 1.26 109.645 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.67 124.21 28.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.207 0.527 . . . . 1.13 111.041 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 32.8 m-20 -106.59 125.24 50.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.318 -0.855 . . . . 2.03 109.165 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.86 71.87 0.39 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.131 -0.486 . . . . 1.97 113.9 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 8.7 tt0 -169.6 25.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.055 -1.091 . . . . 5.46 108.055 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 57.38 48.74 14.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.859 0.837 . . . . 3.88 109.317 -169.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 36.1 tttp -130.22 148.8 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.561 -1.199 . . . . 2.94 108.613 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.1 m -155.25 113.68 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.124 0.488 . . . . 1.2 110.904 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.6 tmm_? -100.37 111.5 23.77 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.593 -0.891 . . . . 3.1 108.593 176.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.996 HG12 HG22 ' A' ' 10' ' ' VAL . 13.0 p -85.8 145.51 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.861 -0.336 . . . . 1.13 110.862 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -129.19 117.09 20.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 124.177 0.923 . . . . 1.38 109.578 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.592 ' HB ' ' CD2' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -104.75 128.44 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 110.266 -0.272 . . . . 1.58 110.266 175.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -103.63 114.82 29.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.21 -0.663 . . . . 2.31 109.21 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.641 ' HE2' ' HE2' ' A' ' 118' ' ' PHE . 41.6 t60 -131.98 125.5 31.7 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.997 -1.001 . . . . 2.32 108.864 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.456 ' HB ' ' HA ' ' A' ' 5' ' ' PHE . 5.2 t -176.94 101.86 0.05 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.75 0.786 . . . . 3.19 110.198 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.476 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.6 t-160 -166.81 -67.1 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.573 -0.74 . . . . 2.99 110.302 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.641 ' HE2' ' HE2' ' A' ' 115' ' ' HIS . 1.2 p90 -81.83 -24.74 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.891 -0.595 . . . . 4.27 110.98 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.817 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -75.46 -52.68 10.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.505 0.722 . . . . 1.81 111.352 -176.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.401 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 16.4 ptt180 -65.41 -16.7 63.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.213 -0.903 . . . . 3.84 110.705 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 41.9 tpp -74.51 26.21 0.08 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.192 -0.913 . . . . 2.9 112.721 -169.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.68 172.15 13.09 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.265 -1.445 . . . . 2.26 114.718 166.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 m -58.03 -54.24 49.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.674 -0.763 . . . . 3.02 111.892 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -68.48 -28.64 67.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 4.23 110.875 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.739 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 13.4 m-70 -67.93 -47.85 67.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.207 -0.451 . . . . 2.7 111.278 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.72 -23.42 58.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.359 -0.536 . . . . 1.46 110.468 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -74.6 -38.16 62.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 3.16 110.618 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.739 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 14.5 ptp180 -67.05 -28.35 68.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.738 -0.467 . . . . 2.97 109.738 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.709 ' HA ' ' SD ' ' A' ' 133' ' ' MET . 67.5 t -65.27 -46.33 90.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.013 -0.54 . . . . 1.96 109.808 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.609 ' HA ' ' HB2' ' A' ' 134' ' ' ASP . 65.0 ttt180 -65.91 -16.28 63.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.484 -0.78 . . . . 4.34 110.963 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.66 ' OD1' ' HA ' ' A' ' 128' ' ' ARG . 3.6 m120 -53.76 -55.55 25.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.195 -0.457 . . . . 2.8 111.444 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.06 -7.18 0.1 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.838 -1.172 . . . . 2.08 114.923 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.709 ' SD ' ' HA ' ' A' ' 129' ' ' VAL . 10.8 mtt -80.29 -28.11 38.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.3 -1.0 . . . . 5.19 108.3 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.609 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 12.3 t70 -56.34 -43.44 79.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.941 -1.481 . . . . 2.83 112.567 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -108.99 11.19 26.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 4.47 111.872 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.551 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.12 -65.61 0.7 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.019 -1.086 . . . . 1.04 112.329 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.504 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -57.92 -48.48 97.05 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.818 0.673 . . . . 3.78 112.818 -172.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.4 Cg_endo -58.32 -44.38 38.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.781 1.654 . . . . 0.77 112.02 176.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 m -59.62 -42.81 93.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.559 0.695 . . . . 1.37 109.672 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.609 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.9 mt -59.38 -50.58 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.764 -1.107 . . . . 1.32 111.345 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -34.51 74.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.282 0.475 . . . . 1.33 112.282 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.674 HE21 ' N ' ' A' ' 142' ' ' GLN . 0.0 OUTLIER -68.45 -52.65 30.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.019 0.438 . . . . 1.54 110.542 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.452 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.1 m -68.9 -22.03 64.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.997 -0.547 . . . . 1.43 110.575 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.97 -53.94 42.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 1.05 110.109 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -60.3 -29.31 68.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.844 -0.616 . . . . 1.63 110.046 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.83 -47.19 60.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.116 -0.947 . . . . 1.46 110.367 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -61.83 -34.15 75.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.689 . . . . 2.23 110.424 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.644 HG22 HG11 ' A' ' 12' ' ' VAL . 66.4 mt -80.78 -25.19 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.77 -0.65 . . . . 1.17 110.811 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.576 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 25.7 t0 -63.78 -24.58 67.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.85 109.512 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 45.0 mt-10 -67.17 -26.81 66.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.214 -0.903 . . . . 1.5 110.338 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.07 -7.35 58.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 1.74 109.98 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.15 -80.26 0.67 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.839 -0.618 . . . . 1.32 113.244 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.91 30.79 0.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.08 0.44 . . . . 2.42 112.173 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.576 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 18.0 tppt? -61.53 -38.54 87.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 2.04 111.035 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.405 -0.807 . . . . 4.65 111.119 -177.294 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.7 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 18.4 p-10 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.71 0.29 . . . . 2.1 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.439 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . 6.2 p90 -179.41 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.343 -0.389 . . . . 4.04 110.575 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.885 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.2 t70 -64.85 -62.79 4.36 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.51 -0.314 . . . . 2.78 111.299 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.885 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 10.3 Cg_endo -90.42 -57.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.697 1.598 . . . . 1.83 111.245 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.428 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 49.7 p90 -152.12 167.36 28.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.063 -0.971 . . . . 3.98 108.849 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.7 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 4.3 m -104.57 133.65 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.271 -1.011 . . . . 2.03 108.271 174.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.4 ttp180 -131.1 150.05 52.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.421 0.629 . . . . 3.92 111.041 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.981 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 2.3 t-160 -119.31 132.82 55.94 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.756 -1.202 . . . . 1.16 107.756 170.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.0 t -139.62 114.43 9.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.362 -0.535 . . . . 1.72 110.155 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.55 HG13 ' CG ' ' A' ' 145' ' ' GLN . 2.3 t -131.65 139.73 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.664 -0.698 . . . . 1.89 111.067 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -99.08 115.46 29.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.41 -0.589 . . . . 1.15 109.41 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.659 HG11 HG23 ' A' ' 148' ' ' ILE . 45.8 t -97.14 130.5 45.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.982 -0.554 . . . . 1.51 109.825 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.616 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.76 23.85 12.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 1.6 111.517 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -147.06 29.15 0.99 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.837 -0.345 . . . . 1.11 111.747 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 24.3 t70 72.53 165.28 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.778 0.799 . . . . 0.91 112.566 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.557 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 17.3 ttp180 -66.1 -25.72 67.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.988 -1.006 . . . . 2.19 111.44 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -59.78 -51.13 71.07 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.224 -0.444 . . . . 3.49 110.985 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 42.9 p -72.17 -32.9 67.27 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.579 -0.282 . . . . 1.49 110.62 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.464 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . . . -56.4 -51.07 69.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.07 110.635 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -69.79 -41.5 75.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.43 110.6 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 18' ' ' THR . 4.3 tppp? -53.87 -52.81 59.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.98 -0.554 . . . . 2.87 110.779 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 m -69.63 -48.64 59.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.009 -0.541 . . . . 1.21 110.665 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.859 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 63.1 t80 -62.16 -32.67 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.22 0.452 . . . . 0.53 112.22 -172.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.479 ' CD1' HG12 ' A' ' 46' ' ' VAL . 15.1 tp -117.82 -51.27 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.754 0.65 . . . . 1.23 112.754 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.412 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 38.7 mt-10 -76.82 -20.94 55.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 1.24 111.355 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -118.95 36.24 3.64 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.843 -0.694 . . . . 0.83 111.98 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.504 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 58.4 t80 -53.01 -51.74 71.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.629 0.603 . . . . 0.94 112.629 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 41.1 Cg_endo -87.5 12.39 2.93 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.757 1.638 . . . . 0.9 114.821 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 7.8 pt-20 -102.89 -4.93 24.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.295 -0.562 . . . . 1.49 111.577 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.859 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 34.8 m0 -69.4 168.83 13.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.464 0.65 . . . . 5.66 111.873 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.501 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 56.5 m95 -86.02 -38.03 0.56 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 114.978 -1.01 . . . . 3.41 113.435 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.724 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 58.0 Cg_endo -68.65 -105.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.375 2.05 . . . . 1.36 115.071 -165.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.503 ' ND2' HG22 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -79.65 -42.65 24.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.02 0.438 . . . . 1.51 111.051 -175.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.88 68.03 8.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.535 0.684 . . . . 1.98 111.08 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.01 12.06 4.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.091 -0.959 . . . . 5.13 109.627 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -126.47 137.2 53.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.862 -0.608 . . . . 4.7 111.252 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -77.09 141.19 40.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 3.11 110.89 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.522 HG21 ' HA ' ' A' ' 57' ' ' ASP . 56.0 p 55.47 18.43 2.66 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.84 0.856 . . . . 1.89 112.3 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 45.9 tttp -110.7 -61.85 1.62 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.801 -0.814 . . . . 3.45 108.801 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.628 HG11 ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -157.46 25.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.887 -1.051 . . . . 2.3 110.035 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.36 36.34 0.24 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.305 -0.95 . . . . 2.2 113.27 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.968 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -72.96 170.42 13.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.678 -0.49 . . . . 1.31 109.678 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.25 67.79 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.698 2.265 . . . . 1.94 113.071 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -175.35 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.554 -0.748 . . . . 2.23 110.16 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.504 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 87.05 -58.68 4.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.963 -0.636 . . . . 0.94 112.474 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 24' ' ' LEU . 91.9 t -135.69 137.91 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.926 0.393 . . . . 1.21 110.907 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.633 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 23.7 t70 -103.8 99.36 9.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.749 -0.834 . . . . 1.11 108.749 173.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -80.76 -9.13 59.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.309 -0.859 . . . . 3.25 111.186 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -68.18 -55.58 11.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.984 -0.553 . . . . 3.63 110.583 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.12 -54.08 1.05 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.958 -0.639 . . . . 1.9 111.658 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.13 64.19 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.82 -0.705 . . . . 0.87 112.648 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.732 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 21.4 ptt180 -149.34 140.21 22.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.636 0.255 . . . . 4.26 111.54 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.721 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.4 m0 -97.21 108.23 20.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.67 -0.241 . . . . 1.52 110.591 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.633 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.3 p90 -158.25 176.15 12.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.453 . . . . 2.04 110.966 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.968 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 18.5 mt-10 -130.6 155.19 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 2.12 110.595 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.615 HG21 ' HG2' ' A' ' 61' ' ' GLU . 37.4 mm -78.22 103.0 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.499 -0.926 . . . . 1.42 108.499 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.656 ' OD2' ' HG3' ' A' ' 59' ' ' GLN . 12.5 t70 -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.169 -0.468 . . . . 1.97 109.963 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.18 -6.92 58.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.78 0.659 . . . . 2.43 112.78 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG3' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -90.12 7.3 38.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.473 -0.891 . . . . 2.39 110.471 170.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.42 62.11 0.45 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.953 -0.641 . . . . 2.29 113.76 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.615 ' HG2' HG21 ' A' ' 56' ' ' ILE . 40.0 mt-10 44.74 54.07 6.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.281 0.845 . . . . 2.31 113.281 171.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.77 84.68 2.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.413 0.625 . . . . 2.61 110.143 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -124.54 158.42 32.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.197 -0.91 . . . . 4.63 109.593 172.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -59.65 142.03 53.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.251 -0.648 . . . . 2.27 109.251 170.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.732 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 p90 -121.83 117.48 26.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.097 0.475 . . . . 7.39 111.187 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -57.15 134.28 52.36 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-N 115.235 -0.893 . . . . 1.23 111.754 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.72 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -92.26 88.1 6.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.191 0.52 . . . . 1.76 110.668 -171.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 58.2 mt -74.17 121.32 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.202 0.525 . . . . 1.26 110.382 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -31.09 24.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.603 -0.726 . . . . 2.65 109.539 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -160.21 119.92 2.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 2.03 111.819 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.537 ' CG2' HG23 ' A' ' 68' ' ' ILE . 60.8 t -99.6 100.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.152 -1.055 . . . . 1.47 108.152 167.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -108.48 70.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.768 -0.373 . . . . 1.42 110.96 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 14.0 pt-20 47.03 -170.39 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 124.471 1.107 . . . . 0.96 111.722 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 38.8 Cg_exo -64.23 75.21 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.474 1.449 . . . . 0.48 111.342 166.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -157.35 -62.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.75 -0.659 . . . . 0.5 110.413 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -147.75 148.37 30.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.324 0.49 . . . . 1.1 112.324 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.4 HD21 HD23 ' A' ' 24' ' ' LEU . 1.8 mp -136.59 114.92 11.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 1.4 109.416 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 98' ' ' THR . 36.4 t -101.33 104.9 16.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.897 -0.779 . . . . 1.31 108.897 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.602 HG21 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -128.55 144.7 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.826 0.346 . . . . 1.48 111.293 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.72 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -98.47 159.56 20.46 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.5 112.717 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.865 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -64.56 157.21 27.5 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 112.794 0.664 . . . . 3.37 112.794 -168.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.59 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.2 tmt_? -149.96 -2.19 0.41 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.502 -0.772 . . . . 6.17 110.373 -167.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.711 HD11 ' HB3' ' A' ' 88' ' ' ARG . 3.1 tm? 71.19 133.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.468 -0.787 . . . . 2.13 110.882 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.628 ' OD1' HG11 ' A' ' 40' ' ' VAL . 55.5 t30 -108.15 135.94 48.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.93 110.324 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.552 ' HA2' ' HE3' ' A' ' 39' ' ' LYS . . . 106.08 -17.21 41.57 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.564 -0.827 . . . . 2.79 112.732 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 t80 69.87 -54.62 0.61 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.139 0.575 . . . . 6.08 111.83 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.34 10.78 47.82 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.947 -0.461 . . . . 2.43 111.947 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.711 ' HB3' HD11 ' A' ' 83' ' ' LEU . 1.9 tpp180 -97.33 167.89 10.74 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.559 -1.275 . . . . 5.53 107.559 173.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -113.4 123.22 68.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 119.927 -0.709 . . . . 2.42 112.023 -173.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 16.8 t70 -160.17 131.37 3.87 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 108.35 -0.981 . . . . 3.18 108.35 166.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.516 ' HD3' ' HD3' ' A' ' 128' ' ' ARG . 7.9 Cg_exo -73.63 1.71 6.62 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.749 2.299 . . . . 2.76 113.393 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 60.68 81.17 0.19 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.463 -0.569 . . . . 2.99 109.463 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -126.96 -64.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.219 0.452 . . . . 3.06 112.219 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -124.19 -145.41 0.34 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.22 -0.446 . . . . 2.11 111.24 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.865 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 9.2 t 73.16 67.93 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.28 -0.873 . . . . 1.81 111.385 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.88 98.4 10.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.487 -0.779 . . . . 1.81 109.847 172.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.63 ' HA ' ' HB2' ' A' ' 115' ' ' HIS . 7.5 p90 -104.83 130.98 52.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.168 -0.613 . . . . 0.81 111.323 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.606 HG23 HG23 ' A' ' 78' ' ' VAL . 12.6 m -91.99 110.49 21.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.413 -0.812 . . . . 1.18 110.655 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.659 ' HA ' HG23 ' A' ' 113' ' ' VAL . 60.2 t -82.3 109.27 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.394 -0.595 . . . . 1.51 109.394 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.505 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.1 m -101.57 106.92 18.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.321 -0.399 . . . . 1.05 110.732 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.716 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.4 m-85 -88.94 107.31 18.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.551 -0.537 . . . . 0.42 109.551 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -93.13 108.98 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.494 -0.558 . . . . 1.26 109.494 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.77 141.01 58.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.832 -0.622 . . . . 1.13 111.014 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 7.3 t70 -126.65 92.64 3.59 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.043 -0.526 . . . . 2.03 109.593 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.15 -108.44 2.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.74 -0.743 . . . . 1.97 112.436 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -140.96 -2.43 1.31 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.714 0.265 . . . . 5.46 111.714 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -3.17 1.34 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.758 0.651 . . . . 3.88 112.758 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.725 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 49.1 tttm -127.46 157.08 41.02 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.486 -0.486 . . . . 2.94 109.945 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.1 m -159.18 123.39 3.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.446 -0.343 . . . . 1.2 110.548 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -97.23 118.61 34.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.271 -0.64 . . . . 3.1 109.271 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.716 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 p -99.89 134.53 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.775 -0.454 . . . . 1.13 109.775 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.732 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.2 t70 -138.3 114.43 10.15 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.25 -0.887 . . . . 1.38 109.877 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.981 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 25.6 t -91.39 124.4 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.105 -0.498 . . . . 1.58 110.782 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -107.38 115.95 31.06 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 124.003 0.815 . . . . 2.31 109.621 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.63 ' HB2' ' HA ' ' A' ' 97' ' ' PHE . 25.8 t60 -154.7 143.33 20.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.426 . . . . 2.32 110.744 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 9.7 t -162.36 119.27 2.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.054 0.391 . . . . 3.19 112.054 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' THR . 76.9 t60 169.16 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.541 -0.754 . . . . 2.99 110.788 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -53.23 -50.33 64.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.652 0.612 . . . . 4.27 112.652 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 8.3 t70 -78.69 -39.92 35.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.916 0.388 . . . . 1.81 111.548 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -66.3 -27.45 67.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 3.84 110.856 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 32.9 tpp -98.55 18.34 16.94 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.985 -1.117 . . . . 2.9 107.985 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 125' ' ' HIS . . . -66.22 -88.13 0.06 OUTLIER Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.729 -1.578 . . . . 2.26 114.339 -168.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 28.7 m 57.3 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.703 -0.851 . . . . 3.02 108.703 -165.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.66 -55.07 19.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.266 -0.642 . . . . 4.23 109.266 170.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.629 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 3.0 t-160 -64.51 -48.26 75.79 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.494 -0.775 . . . . 2.7 111.208 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.599 ' HB2' ' HA3' ' A' ' 122' ' ' GLY . . . -58.51 -45.98 87.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.163 -0.472 . . . . 1.46 111.249 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 123' ' ' THR . 5.7 tmtm? -61.76 -47.38 85.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 3.16 110.887 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.656 ' HB2' HG23 ' A' ' 89' ' ' ILE . 7.4 ptp180 -68.3 -35.1 77.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.439 0.533 . . . . 2.97 112.439 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.413 HG13 ' CZ2' ' A' ' 81' ' ' TRP . 91.9 t -80.23 -40.87 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.979 0.419 . . . . 1.96 111.25 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -62.56 -15.03 48.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.745 -0.662 . . . . 4.34 111.171 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.643 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 94.5 m-20 -58.77 -22.68 58.62 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 2.8 112.243 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.18 -31.83 0.07 OUTLIER Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.005 -1.093 . . . . 2.08 114.059 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -65.0 -23.25 67.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.557 -0.378 . . . . 5.19 110.851 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.38 -24.73 66.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.927 -0.579 . . . . 2.83 111.983 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -113.26 -48.03 2.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.882 0.372 . . . . 4.47 110.833 -176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -61.41 -56.73 21.74 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.858 -0.61 . . . . 1.04 113.236 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.586 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -60.38 -48.52 93.61 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.431 0.53 . . . . 3.78 112.431 -173.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 15.6 Cg_endo -58.87 -42.34 53.58 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.648 1.566 . . . . 0.77 112.026 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.8 m -64.53 -35.44 80.96 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.685 0.755 . . . . 1.37 109.387 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.586 ' HB ' ' O ' ' A' ' 137' ' ' TRP . 13.6 mt -54.79 -49.16 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.597 -1.183 . . . . 1.32 110.809 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.0 mt -62.9 -29.11 70.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.295 0.48 . . . . 1.33 112.295 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.19 -57.5 4.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.54 110.318 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.49 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 29.5 m -65.36 -23.4 66.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.103 0.478 . . . . 1.43 110.621 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 148' ' ' ILE . 45.7 t80 -61.56 -54.78 38.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.634 . . . . 1.05 110.233 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.55 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.2 mt-30 -60.49 -31.81 70.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.83 -0.623 . . . . 1.63 110.894 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -42.37 69.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.758 -0.655 . . . . 1.46 111.735 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 18.3 tptm -69.97 -35.04 74.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.492 -0.483 . . . . 2.23 109.723 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.659 HG23 HG11 ' A' ' 12' ' ' VAL . 62.2 mt -66.45 -35.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 1.17 110.393 175.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 154' ' ' LYS . 19.0 t70 -59.14 -40.42 85.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.85 109.044 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.497 ' HA ' ' CB ' ' A' ' 154' ' ' LYS . 43.7 mt-10 -68.38 -35.37 77.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.801 -0.636 . . . . 1.5 110.787 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.82 -43.88 97.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 1.74 111.264 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.22 -66.15 1.68 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.529 -0.843 . . . . 1.32 111.861 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.495 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -173.5 89.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.719 -0.474 . . . . 2.42 109.719 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.564 ' HA ' ' OD2' ' A' ' 149' ' ' ASP . 11.9 tppt? -73.88 134.41 43.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 2.04 110.245 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' A' ' 153' ' ' ALA . 5.0 mptt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.475 -0.774 . . . . 4.65 110.62 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 19.6 p-10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.161 0.505 . . . . 2.1 110.715 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.498 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 46.6 p90 -176.47 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.867 -0.606 . . . . 4.04 110.751 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.991 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.2 t70 -72.57 -64.85 0.85 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.616 -0.266 . . . . 2.78 111.009 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.991 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 27.8 Cg_endo -97.51 -67.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.506 2.137 . . . . 1.83 113.151 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 4' ' ' PRO . 70.8 m-85 -124.72 113.59 18.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.417 -0.356 . . . . 3.98 111.052 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.842 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 46.0 t -90.81 111.91 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.148 -0.686 . . . . 2.03 109.148 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.8 ttp180 -133.22 134.96 44.72 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.043 -0.663 . . . . 3.92 111.174 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.608 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.92 131.75 54.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.886 -0.783 . . . . 1.16 108.886 173.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.3 m -132.93 110.43 10.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.594 -0.73 . . . . 1.72 109.852 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.448 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.2 t -124.63 139.29 51.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.144 -0.934 . . . . 1.89 110.867 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.6 m -103.67 114.61 29.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.71 0.767 . . . . 1.15 109.875 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.667 HG12 HG21 ' A' ' 148' ' ' ILE . 25.1 t -90.77 139.06 18.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.098 -0.955 . . . . 1.51 109.682 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.615 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -111.61 29.25 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.103 0.478 . . . . 1.6 110.871 -176.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.466 ' H ' HG13 ' A' ' 12' ' ' VAL . . . -150.84 29.41 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 1.11 111.635 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 35.3 t70 72.2 162.38 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.749 0.785 . . . . 0.91 112.423 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.536 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 33.6 ttp180 -65.59 -23.65 66.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.133 -0.94 . . . . 2.19 111.036 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HB2' ' HE3' ' A' ' 17' ' ' LYS . 21.1 ttmt -57.29 -44.99 84.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 3.49 110.587 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 68.4 p -80.23 -31.82 38.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.336 -0.393 . . . . 1.49 110.515 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.462 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.41 -47.59 81.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 1.07 110.687 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.555 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 83.0 t80 -67.77 -44.32 77.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.43 110.443 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 18' ' ' THR . 42.3 tttp -52.17 -49.49 63.7 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.839 -0.619 . . . . 2.87 110.488 175.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 29.1 m -68.39 -52.49 32.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.297 -0.41 . . . . 1.21 111.688 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.75 ' HA ' ' HZ ' ' A' ' 144' ' ' PHE . 60.1 t80 -65.36 -30.72 71.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.889 -0.324 . . . . 0.53 111.756 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.608 HD11 HG13 ' A' ' 46' ' ' VAL . 15.6 tp -120.12 -54.15 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.315 0.857 . . . . 1.23 113.315 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' HG2' ' HZ1' ' A' ' 48' ' ' LYS . 22.2 mt-10 -81.37 -23.7 37.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.568 0.581 . . . . 1.24 112.568 -167.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.544 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -110.16 28.98 9.66 Favored Glycine 0 C--N 1.314 -0.665 0 N-CA-C 111.24 -0.744 . . . . 0.83 111.24 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.639 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 41.6 t80 -48.01 -54.32 25.4 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.928 -0.636 . . . . 0.94 112.447 -170.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 8.1 Cg_endo -95.67 38.06 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.051 1.834 . . . . 0.9 115.298 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.9 pt-20 -132.1 -11.11 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.481 -0.888 . . . . 1.49 113.03 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.754 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 11.2 m95 -76.92 172.79 12.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.226 0.536 . . . . 5.66 111.746 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.474 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 m95 -74.6 -47.65 5.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.929 1.085 . . . . 3.41 113.929 -175.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.754 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 27.7 Cg_endo -57.87 -87.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.714 2.276 . . . . 1.36 115.108 -158.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.457 ' HB3' HD13 ' A' ' 140' ' ' ILE . 6.9 t30 -111.12 -3.73 15.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.432 -0.951 . . . . 1.51 108.432 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.598 ' HA ' HG22 ' A' ' 40' ' ' VAL . 15.0 m120 -93.83 22.69 5.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.44 -1.255 . . . . 1.98 112.579 -168.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -134.23 58.3 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.392 0.615 . . . . 5.13 110.416 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 36.9 mmt180 -136.47 145.58 45.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 4.7 109.597 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -75.65 132.43 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.801 -0.359 . . . . 3.11 110.221 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 57' ' ' ASP . 73.0 p 53.69 21.76 2.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.861 0.864 . . . . 1.89 111.798 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' HD3' ' HA3' ' A' ' 85' ' ' GLY . 5.1 mmtp -138.58 79.69 1.75 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.851 -0.613 . . . . 3.45 110.592 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 34' ' ' ASN . 22.2 m 42.61 26.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.5 -1.227 . . . . 2.3 112.982 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.13 16.41 2.55 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.133 -0.556 . . . . 2.2 111.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.93 162.01 66.45 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.991 -0.744 . . . . 1.31 108.991 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.34 50.68 0.17 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 123.263 2.642 . . . . 1.94 114.679 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -166.34 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.708 0.289 . . . . 2.23 110.995 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.639 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.48 -56.59 3.11 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.817 -0.706 . . . . 0.94 112.59 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.608 HG13 HD11 ' A' ' 24' ' ' LEU . 97.3 t -134.47 145.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.014 0.435 . . . . 1.21 111.003 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.963 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.3 t70 -121.28 102.78 8.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.566 -0.743 . . . . 1.11 109.038 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 15.3 mtmt -77.75 -28.45 50.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.213 0.449 . . . . 3.25 112.213 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -72.63 -35.08 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.961 -0.296 . . . . 3.63 111.05 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.72 -42.41 4.47 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.821 -0.704 . . . . 1.9 112.097 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 102.5 45.48 1.67 Allowed Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.913 -0.661 . . . . 0.87 112.921 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -144.06 165.04 28.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.466 -0.432 . . . . 4.26 111.607 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.62 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 18.9 m0 -108.15 123.98 49.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.824 -0.625 . . . . 1.52 109.627 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.963 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 2.7 p90 -163.36 151.43 13.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.954 0.407 . . . . 2.04 110.784 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.6 mp0 -117.95 160.18 21.88 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.488 -0.56 . . . . 2.12 109.488 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.506 HD13 ' HG2' ' A' ' 61' ' ' GLU . 26.8 mm -78.25 103.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.33 -0.395 . . . . 1.42 110.017 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.506 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.9 t70 -84.25 -166.53 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 1.97 110.012 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 1.1 pp20? -83.56 -37.86 22.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.027 0.38 . . . . 2.43 112.027 -172.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.18 23.56 3.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.155 0.503 . . . . 2.39 110.937 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.35 -113.27 0.86 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.875 -1.155 . . . . 2.29 113.011 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.568 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 40.4 mt-10 -149.12 2.06 0.56 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.262 0.467 . . . . 2.31 112.262 -167.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -93.11 90.82 7.04 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.929 0.871 . . . . 2.61 110.683 -168.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.549 ' C ' ' HG1' ' A' ' 64' ' ' THR . 0.1 OUTLIER -121.4 87.78 2.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.382 -1.281 . . . . 4.63 111.028 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.708 HG22 ' HD1' ' A' ' 86' ' ' PHE . 0.8 OUTLIER 54.25 179.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.606 0.717 . . . . 2.27 112.733 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -133.65 99.26 4.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.192 -0.458 . . . . 7.39 110.424 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.681 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.78 119.57 9.14 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.556 -1.418 . . . . 1.23 109.556 173.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -79.91 86.33 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.255 -0.578 . . . . 1.76 110.667 -169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.671 HG22 HG21 ' A' ' 71' ' ' VAL . 19.2 mt -76.43 114.8 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.694 -1.202 . . . . 1.26 109.326 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 18.0 mmm180 -95.54 -25.4 16.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.759 -1.109 . . . . 2.65 109.388 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 81.8 tttt -161.01 115.63 2.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 2.03 111.525 -175.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG21 HG22 ' A' ' 68' ' ' ILE . 89.6 t -107.35 102.01 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.564 -0.902 . . . . 1.47 108.564 168.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 9.1 t0 -112.86 69.23 0.69 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.367 -0.533 . . . . 1.42 110.462 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.8 pt-20 46.12 -169.05 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 O-C-N 124.706 1.254 . . . . 0.96 111.578 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.596 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.0 Cg_exo -64.52 78.47 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.154 1.236 . . . . 0.48 111.408 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.9 t70 -161.96 -66.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.445 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.5 p -140.71 141.41 34.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.141 0.496 . . . . 1.1 112.308 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.461 HD22 HD21 ' A' ' 24' ' ' LEU . 2.7 mp -135.55 122.26 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 1.4 109.717 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 98' ' ' THR . 41.9 t -110.32 106.81 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.423 -0.584 . . . . 1.31 109.423 176.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.99 133.87 62.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.027 0.441 . . . . 1.48 112.137 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.867 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -80.43 156.92 39.74 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.946 -0.57 . . . . 0.5 112.562 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -66.89 144.16 56.42 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.236 0.541 . . . . 3.37 112.347 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.681 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 4.5 ttp180 -136.35 -18.17 1.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.971 -1.013 . . . . 6.17 109.689 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.919 HD21 ' HB2' ' A' ' 88' ' ' ARG . 7.5 tt 80.02 162.08 0.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.271 -0.877 . . . . 2.13 111.311 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.77 97.63 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 1.93 110.817 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.629 ' HA3' ' HD3' ' A' ' 39' ' ' LYS . . . 103.19 -9.49 54.21 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.274 -1.441 . . . . 2.79 115.038 165.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.708 ' HD1' HG22 ' A' ' 64' ' ' THR . 36.0 t80 73.15 -19.22 0.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.823 0.812 . . . . 6.08 112.154 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 85' ' ' GLY . . . -63.76 -17.82 60.96 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.366 -0.445 . . . . 2.43 112.421 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.919 ' HB2' HD21 ' A' ' 83' ' ' LEU . 40.6 mtm105 -108.92 173.61 6.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.408 0.283 . . . . 5.53 110.248 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.58 115.49 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.491 0.662 . . . . 2.42 111.676 -172.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.54 138.96 21.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 3.18 110.224 176.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 93' ' ' ASN . 33.8 Cg_endo -65.2 -38.61 26.62 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.897 2.398 . . . . 2.76 113.481 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 26.3 t70 72.33 -24.3 0.19 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.492 0.663 . . . . 2.99 111.154 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 91' ' ' PRO . 39.7 m-80 -130.78 81.94 2.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.939 -1.504 . . . . 3.06 106.939 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 95' ' ' SER . 2.6 p -107.06 -164.35 0.98 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.665 1.358 . . . . 2.11 114.665 -160.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 1.093 ' HA ' ' HB3' ' A' ' 117' ' ' HIS . 41.3 m -72.87 -45.17 59.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 112.311 -2.222 . . . . 1.81 111.963 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.867 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.1 tt0 70.89 111.39 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.046 0.841 . . . . 1.81 109.793 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.435 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 40.3 p90 -115.06 150.81 35.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.203 0.525 . . . . 0.81 111.589 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.547 HG22 HG22 ' A' ' 78' ' ' VAL . 57.8 m -108.22 114.49 28.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.388 -0.824 . . . . 1.18 110.621 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.675 ' HA ' HG23 ' A' ' 113' ' ' VAL . 90.4 t -88.56 110.49 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.618 . . . . 1.51 110.272 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.434 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.6 m -104.36 105.91 16.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.19 -0.459 . . . . 1.05 110.526 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.548 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.4 m-85 -89.36 109.27 20.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.42 110.283 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' THR . 59.5 t -89.54 107.9 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.813 -0.44 . . . . 1.26 109.813 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.6 33.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.516 . . . . 1.13 110.258 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.7 t70 -125.43 112.96 16.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.92 0.39 . . . . 2.03 110.62 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -112.92 5.02 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.87 -0.681 . . . . 1.97 112.161 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 6.5 tt0 -141.05 -17.97 0.82 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.016 0.436 . . . . 5.46 110.132 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -131.9 24.87 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 3.88 111.799 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.9 ttmp? -140.97 150.87 43.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.27 -0.572 . . . . 2.94 110.916 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.552 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.2 m -158.93 112.29 2.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.878 -0.601 . . . . 1.2 110.372 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.81 110.64 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.582 -0.525 . . . . 3.1 109.582 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -90.59 138.14 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.647 -0.421 . . . . 1.13 110.326 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.459 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 12.0 t70 -128.18 114.67 17.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.895 -0.78 . . . . 1.38 108.895 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 99' ' ' VAL . 25.2 t -104.4 121.24 55.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.32 -0.855 . . . . 1.58 111.345 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -97.59 132.79 42.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 2.31 109.629 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.842 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 4.1 t60 -150.91 110.17 3.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.118 -0.697 . . . . 2.32 109.118 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.59 ' OG1' ' HD2' ' A' ' 120' ' ' ARG . 8.6 t -163.3 97.44 0.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.693 0.759 . . . . 3.19 110.694 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 1.093 ' HB3' ' HA ' ' A' ' 95' ' ' SER . 3.3 t-160 -163.92 -77.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.817 -0.629 . . . . 2.99 111.464 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.13 -39.57 17.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.407 0.521 . . . . 4.27 112.407 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.707 ' HB3' HG22 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -75.43 -34.31 60.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.35 0.595 . . . . 1.81 109.588 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.59 ' HD2' ' OG1' ' A' ' 116' ' ' THR . 40.3 ttt180 -48.21 -21.5 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.439 -1.255 . . . . 3.84 112.075 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -82.06 14.11 3.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 2.9 111.239 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.49 -155.53 4.93 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.764 -0.653 . . . . 2.26 114.18 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 t 38.16 -130.66 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.114 0.966 . . . . 3.02 112.141 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 56.4 tttp -50.77 -43.29 58.44 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 122.962 0.505 . . . . 4.23 112.063 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.506 ' O ' HG23 ' A' ' 129' ' ' VAL . 38.5 m80 -53.69 -52.2 60.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 2.7 111.005 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 2' ' ' TYR . . . -76.86 -29.75 55.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.399 -0.364 . . . . 1.46 110.961 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.03 -52.89 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 3.16 110.479 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 23.6 ptt85 -61.09 -31.86 71.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 2.97 110.842 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.707 HG22 ' HB3' ' A' ' 119' ' ' ASP . 70.6 t -65.84 -41.99 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 120.677 0.275 . . . . 1.96 110.78 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -64.73 -15.97 62.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.366 -0.379 . . . . 4.34 111.557 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.461 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 6.1 m-20 -52.28 -21.55 3.59 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.503 0.557 . . . . 2.8 112.503 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 88' ' ' ARG . . . -169.53 -28.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.021 -1.085 . . . . 2.08 114.274 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -60.97 -40.95 95.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.404 0.602 . . . . 5.19 110.281 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.31 -27.21 45.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.973 -0.558 . . . . 2.83 112.417 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -107.02 -47.23 3.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.003 0.43 . . . . 4.47 111.466 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.641 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -65.39 -54.94 23.62 Favored Glycine 0 C--O 1.223 -0.547 0 CA-C-N 116.021 -0.536 . . . . 1.04 113.226 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t90 -60.74 -51.0 82.68 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.034 0.383 . . . . 3.78 112.034 -171.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 12.5 Cg_endo -57.94 -42.34 59.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.842 1.695 . . . . 0.77 112.111 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.2 m -65.5 -34.99 79.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.336 0.589 . . . . 1.37 110.076 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.754 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 47.7 mt -56.96 -46.07 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.363 -0.835 . . . . 1.32 110.331 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 65.7 mt -62.38 -31.26 71.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 1.33 112.215 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -74.75 -53.8 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.008 -0.277 . . . . 1.54 111.085 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 59.4 m -64.73 -23.42 67.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.11 0.481 . . . . 1.43 110.217 177.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.75 ' HZ ' ' HA ' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -59.1 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 1.05 110.069 173.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.446 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.4 mt-30 -63.54 -25.26 68.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 1.63 111.007 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.83 -49.87 34.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.46 111.195 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.754 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 52.3 tptt -68.02 -34.46 76.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.62 -0.432 . . . . 2.23 110.398 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.667 HG21 HG12 ' A' ' 12' ' ' VAL . 75.5 mt -67.67 -29.43 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.024 0.44 . . . . 1.17 110.378 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.01 -31.34 72.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.549 -0.537 . . . . 0.85 109.549 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 41.0 mt-10 -70.71 -29.89 66.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.581 -0.736 . . . . 1.5 109.928 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -79.34 -23.42 43.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 1.74 110.008 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -97.47 22.97 37.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.634 -0.712 . . . . 1.32 111.427 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.508 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . . . 73.57 85.04 0.11 Allowed 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 124.639 0.846 . . . . 2.42 110.625 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.605 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 13.3 tppt? -73.54 105.16 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.475 -0.784 . . . . 2.04 110.103 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 153' ' ' ALA . 17.5 ptpt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.863 -0.608 . . . . 4.65 110.424 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.777 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 64.7 m-80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.415 -0.217 . . . . 2.1 110.415 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 21.6 p90 168.92 -21.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.036 0.835 . . . . 4.04 109.374 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.986 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -49.54 -59.46 6.65 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.295 -0.866 . . . . 2.78 110.541 -176.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.986 ' HD3' ' HB2' ' A' ' 3' ' ' ASP . 26.3 Cg_endo -97.34 -61.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.375 2.05 . . . . 1.83 111.489 167.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -153.95 171.58 18.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.447 -1.316 . . . . 3.98 107.447 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.777 ' HA ' ' HB3' ' A' ' 1' ' ' ASN . 40.8 t -91.61 138.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 120.651 -0.42 . . . . 2.03 111.155 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.8 ttp180 -134.6 146.58 49.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.163 -0.471 . . . . 3.92 110.96 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.75 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -129.39 134.12 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 1.16 109.844 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 14.4 m -129.15 113.39 15.02 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.191 0.52 . . . . 1.72 110.465 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.776 HG11 ' HG2' ' A' ' 145' ' ' GLN . 1.5 t -126.09 139.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.374 -0.83 . . . . 1.89 111.06 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -97.58 117.14 31.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.184 0.516 . . . . 1.15 109.938 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.657 HG11 HG23 ' A' ' 148' ' ' ILE . 50.8 t -100.65 122.71 52.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.458 0.646 . . . . 1.51 111.323 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.829 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -90.29 13.34 15.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.901 -1.045 . . . . 1.6 112.771 -173.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -146.16 27.69 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.301 0.852 . . . . 1.11 113.301 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.9 t0 76.49 164.78 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.598 0.713 . . . . 0.91 112.358 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.679 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 16.0 ttp180 -69.72 -37.32 76.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.024 -0.989 . . . . 2.19 112.212 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 79.2 mttt -58.29 -49.17 78.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.706 0.765 . . . . 3.49 109.951 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -66.3 -38.74 88.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.302 -1.317 . . . . 1.49 110.909 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.532 ' HB3' HG13 ' A' ' 12' ' ' VAL . . . -57.77 -48.62 79.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.905 0.383 . . . . 1.07 110.479 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.6 t80 -61.25 -45.17 95.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.649 -0.705 . . . . 0.43 110.733 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -58.28 -53.46 58.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 2.87 110.798 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -62.62 -48.74 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.202 0.313 . . . . 1.21 110.835 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.904 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 72.6 t80 -63.18 -43.67 97.57 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.132 0.419 . . . . 0.53 112.132 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.577 HD11 HG12 ' A' ' 46' ' ' VAL . 17.3 tp -101.38 -56.26 2.34 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.519 -0.472 . . . . 1.23 112.119 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -96.2 15.56 20.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.391 0.615 . . . . 1.24 111.404 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.697 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -126.82 24.13 5.51 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.113 -1.195 . . . . 0.83 110.113 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.834 ' HD2' ' HA2' ' A' ' 45' ' ' GLY . 10.3 t80 -52.79 -47.02 96.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.642 -0.779 . . . . 0.94 112.995 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.2 Cg_endo -93.38 19.35 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.793 1.662 . . . . 0.9 115.012 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -110.41 -7.42 14.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.091 -0.643 . . . . 1.49 112.381 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.904 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 19.3 m0 -74.09 169.98 16.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 5.66 111.228 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.628 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 28.0 m95 -90.32 -29.54 0.34 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.639 0.977 . . . . 3.41 113.639 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 36.6 Cg_endo -66.19 -136.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.328 2.019 . . . . 1.36 114.207 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.467 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 25.1 t30 -57.48 -35.97 70.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.104 0.954 . . . . 1.51 111.181 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 1.024 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 3.0 p-10 -89.54 23.3 2.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.703 -1.135 . . . . 1.98 112.678 -169.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.73 -18.99 29.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 5.13 110.683 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.629 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 48.0 mtm105 -88.04 -179.2 6.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.455 0.539 . . . . 4.7 112.455 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.503 HG23 ' HD3' ' A' ' 43' ' ' PRO . 27.9 m -101.18 137.54 39.41 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.621 -0.718 . . . . 3.11 110.009 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.939 ' H ' ' HA ' ' A' ' 42' ' ' ALA . 44.5 p 50.22 28.84 3.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.493 0.717 . . . . 1.89 111.232 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 1.024 ' HD3' ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -67.52 -71.07 0.22 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.717 -1.129 . . . . 3.45 111.21 -177.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.854 ' H ' ' HD2' ' A' ' 39' ' ' LYS . 21.7 m -97.3 -13.01 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 122.217 1.008 . . . . 2.3 108.548 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 38' ' ' THR . . . -168.69 -50.65 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 113.471 -1.695 . . . . 2.2 110.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.939 ' HA ' ' H ' ' A' ' 38' ' ' THR . . . 152.01 -173.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 125.186 1.168 . . . . 1.31 112.195 -172.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.62 ' CD ' ' HB2' ' A' ' 42' ' ' ALA . 20.3 Cg_exo -72.75 74.54 2.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.541 2.16 . . . . 1.94 113.34 167.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 41.7 tp -145.67 -87.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.072 -0.344 . . . . 2.23 110.072 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.834 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 134.58 -92.66 0.24 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.953 -1.118 . . . . 0.94 113.843 170.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG12 HD11 ' A' ' 24' ' ' LEU . 87.9 t -132.99 148.06 31.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.314 0.578 . . . . 1.21 111.821 -168.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.813 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.1 t70 -92.8 110.6 22.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.224 -0.898 . . . . 1.11 109.154 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -80.75 -25.42 38.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.718 -0.674 . . . . 3.25 111.601 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.3 ptpp? -73.97 -38.93 64.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.757 0.28 . . . . 3.63 111.757 -171.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.72 -41.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 1.9 112.154 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 118.52 71.31 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.661 -0.781 . . . . 0.87 112.232 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' A' ' 47' ' ' ASP . 5.4 mpt_? -133.79 157.31 46.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.017 -0.364 . . . . 4.26 110.017 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 29.8 m0 -112.81 117.06 31.12 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.607 -0.886 . . . . 1.52 108.607 168.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.813 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.7 p90 -162.22 155.01 19.9 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.047 0.451 . . . . 2.04 110.06 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.767 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.16 172.73 12.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.119 -0.491 . . . . 2.12 110.586 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.428 HD11 ' HG2' ' A' ' 61' ' ' GLU . 13.7 mm -78.59 99.16 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 1.42 111.395 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 5.5 t70 -96.27 172.87 7.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.627 -0.509 . . . . 1.97 109.627 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.9 pt-20 -58.47 -40.34 82.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.799 1.037 . . . . 2.43 113.799 -167.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -81.54 7.38 12.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.464 -0.494 . . . . 2.39 112.307 -176.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.2 84.11 1.78 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.043 -1.075 . . . . 2.29 114.421 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.428 ' HG2' HD11 ' A' ' 56' ' ' ILE . 43.5 mt-10 55.87 30.89 16.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.772 1.027 . . . . 2.31 113.772 167.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -127.61 92.1 3.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.559 0.695 . . . . 2.61 111.68 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.766 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -120.58 166.46 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.923 -1.035 . . . . 4.63 110.599 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.64 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 9.1 p -47.37 105.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.719 0.637 . . . . 2.27 110.637 171.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 28.8 p90 -90.32 118.02 29.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.138 0.494 . . . . 7.39 111.77 -173.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -67.18 137.5 33.43 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.837 -0.905 . . . . 1.23 110.837 173.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.38 94.13 6.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.201 0.5 . . . . 1.76 111.481 -171.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.596 HG22 HG22 ' A' ' 71' ' ' VAL . 55.4 mt -76.08 123.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.257 0.551 . . . . 1.26 110.158 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -87.72 -34.56 18.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.396 -0.82 . . . . 2.65 109.289 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -147.21 120.83 9.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.028 -0.533 . . . . 2.03 111.54 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 68' ' ' ILE . 32.1 t -102.75 92.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.284 -1.006 . . . . 1.47 108.284 167.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.63 63.28 0.72 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.789 -0.364 . . . . 1.42 110.936 -173.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.629 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.8 pt-20 47.05 -169.37 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 124.476 1.11 . . . . 0.96 112.031 175.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.629 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 33.2 Cg_exo -61.51 76.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.304 1.336 . . . . 0.48 111.798 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.9 -66.6 0.05 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.5 109.754 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.3 p -144.21 143.01 30.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.715 0.635 . . . . 1.1 112.715 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.47 116.19 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.145 -0.687 . . . . 1.4 109.145 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.641 HG23 HG21 ' A' ' 98' ' ' THR . 36.5 t -104.72 110.27 30.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.478 -0.564 . . . . 1.31 109.478 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.98 140.55 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.871 0.367 . . . . 1.48 111.437 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.2 161.1 23.2 Favored Glycine 0 C--O 1.239 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.5 112.639 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 1.058 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 38.9 t-105 -65.04 157.89 27.18 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 113.737 1.014 . . . . 3.37 113.737 -165.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.64 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 2.9 tpt180 -174.41 33.42 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.435 -1.257 . . . . 6.17 108.917 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.932 HD22 ' HB2' ' A' ' 88' ' ' ARG . 13.9 tp 69.55 -133.9 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 2.13 111.857 175.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 59.7 t30 -167.41 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.877 0.37 . . . . 1.93 110.204 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.27 11.02 25.46 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.193 -0.527 . . . . 2.79 114.062 -172.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.5 t80 70.71 -43.37 0.55 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.529 0.731 . . . . 6.08 112.783 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.94 38.41 2.17 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.237 -0.506 . . . . 2.43 113.082 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.932 ' HB2' HD22 ' A' ' 83' ' ' LEU . 4.7 mmp_? -135.09 -175.16 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.52 -0.919 . . . . 5.53 108.52 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.523 HD13 ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -112.32 132.68 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.906 0.384 . . . . 2.42 110.918 -177.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -156.47 107.91 2.02 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.989 -0.551 . . . . 3.18 110.601 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HD3' HD13 ' A' ' 89' ' ' ILE . 1.6 Cg_endo -109.63 18.11 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.127 3.218 . . . . 2.76 110.487 165.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.455 ' OD1' ' HD2' ' A' ' 118' ' ' PHE . 10.5 t70 -79.74 -77.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.366 -0.833 . . . . 2.99 111.294 -159.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 33.9 m-80 76.59 -40.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.218 -0.901 . . . . 3.06 112.359 172.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.775 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . 70.2 m -77.66 -7.57 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.627 0.232 . . . . 2.11 111.627 -176.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 1.058 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 23.1 t -66.55 75.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.074 0.94 . . . . 1.81 109.227 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.53 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.8 tt0 -97.69 123.72 41.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.499 -1.228 . . . . 1.81 110.678 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.796 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 5.4 p90 -120.98 140.28 52.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.468 0.651 . . . . 0.81 111.805 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.641 HG21 HG23 ' A' ' 78' ' ' VAL . 32.4 m -98.7 110.48 23.07 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.475 -1.238 . . . . 1.18 109.721 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.0 t -81.92 108.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.357 -0.608 . . . . 1.51 109.357 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.8 m -102.7 106.7 17.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.086 0.47 . . . . 1.05 111.21 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.679 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 47.9 m-85 -87.4 113.3 22.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 0.42 109.968 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.79 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.604 -0.517 . . . . 1.26 109.604 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.16 124.28 27.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.176 -0.465 . . . . 1.13 111.087 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 23.2 m-20 -106.54 100.36 9.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 2.03 109.111 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.85 -113.37 4.16 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.616 -0.802 . . . . 1.97 111.933 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -147.02 4.89 0.84 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.544 0.211 . . . . 5.46 111.089 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -132.34 -12.23 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.791 0.293 . . . . 3.88 111.791 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 47.6 tttp -121.46 152.65 38.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.794 -0.447 . . . . 2.94 109.794 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.6 m -157.95 119.1 3.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 1.2 111.087 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -94.37 123.54 37.84 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.511 -0.551 . . . . 3.1 109.511 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 10' ' ' VAL . 14.2 p -98.46 135.3 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.112 -0.635 . . . . 1.13 110.391 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 6.3 p-10 -127.87 115.87 19.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.783 0.801 . . . . 1.38 109.197 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 2.1 t -89.71 121.33 39.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.292 -0.867 . . . . 1.58 110.377 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.73 136.25 44.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 124.148 0.905 . . . . 2.31 108.715 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.796 ' HD2' ' HB3' ' A' ' 97' ' ' PHE . 65.6 t-80 -128.46 153.53 47.04 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.78 -0.645 . . . . 2.32 110.716 -171.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 t -64.84 -153.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.55 -0.75 . . . . 3.19 110.248 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -143.47 37.65 1.36 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.127 0.788 . . . . 2.99 113.127 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.775 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 2.4 t80 -71.73 -35.98 70.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.287 0.565 . . . . 4.27 109.704 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.44 ' OD2' ' CE1' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -70.84 -28.89 64.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 1.81 110.477 177.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -54.92 -20.52 9.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.409 -0.814 . . . . 3.84 111.762 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.9 mmt -65.88 -4.52 6.97 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.336 -0.393 . . . . 2.9 110.528 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.26 -141.46 25.92 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.319 -0.855 . . . . 2.26 112.965 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.2 p 42.25 -112.04 0.18 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.663 0.86 . . . . 3.02 112.264 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -77.72 -39.73 43.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.855 -0.612 . . . . 4.23 110.835 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -53.26 59.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.939 0.4 . . . . 2.7 111.079 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -69.61 -33.46 72.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.986 -0.552 . . . . 1.46 111.165 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -70.02 -49.85 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.798 -0.361 . . . . 3.16 111.077 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -66.78 -33.01 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.512 -0.313 . . . . 2.97 111.021 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.7 t -78.55 -30.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 1.96 110.864 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 18.6 ttm180 -56.4 -34.63 66.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 4.34 111.336 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.535 ' CB ' ' HD3' ' A' ' 88' ' ' ARG . 15.7 m-80 -63.59 -25.03 68.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 2.8 110.797 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.537 ' HA2' ' HG3' ' A' ' 88' ' ' ARG . . . -81.2 -106.88 0.33 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.864 -0.684 . . . . 2.08 113.248 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.674 ' HG2' ' HB2' ' A' ' 137' ' ' TRP . 18.2 ttt -79.7 -16.31 55.92 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.599 0.222 . . . . 5.19 111.599 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 25.4 t70 -62.01 -25.91 67.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 2.83 111.722 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 135' ' ' LYS . 33.7 ttpt -91.04 -29.64 17.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.072 0.463 . . . . 4.47 110.905 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -95.17 -32.17 7.21 Favored Glycine 0 C--O 1.217 -0.955 0 CA-C-N 116.155 -0.475 . . . . 1.04 112.368 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.674 ' HB2' ' HG2' ' A' ' 133' ' ' MET . 3.7 t90 -58.03 -47.06 99.54 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 122.512 0.325 . . . . 3.78 111.809 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.81 -32.55 95.62 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.837 1.692 . . . . 0.77 111.666 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.2 m -71.65 -43.17 66.55 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.268 1.032 . . . . 1.37 108.957 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.517 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.6 mt -61.83 -54.44 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.955 -1.475 . . . . 1.32 111.548 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.49 HD13 ' CD2' ' A' ' 8' ' ' HIS . 64.8 mt -58.81 -35.33 72.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 1.33 112.202 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.6 HE21 ' N ' ' A' ' 142' ' ' GLN . 0.0 OUTLIER -67.79 -52.84 32.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.923 -0.311 . . . . 1.54 110.406 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.57 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 12.0 t -69.01 -23.85 64.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 1.43 110.373 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.402 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 22.5 t80 -65.42 -49.85 67.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.609 -0.515 . . . . 1.05 109.609 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.776 ' HG2' HG11 ' A' ' 10' ' ' VAL . 45.5 mt-30 -58.4 -41.93 86.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.331 -0.849 . . . . 1.63 111.251 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 14.2 m-20 -75.46 -37.71 60.13 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.567 -0.453 . . . . 1.46 111.829 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.7 tptp -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.398 -0.593 . . . . 2.23 109.398 174.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.657 HG23 HG11 ' A' ' 12' ' ' VAL . 26.5 mt -62.27 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 1.17 111.109 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.829 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 34.2 t70 -62.38 -30.93 71.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.036 -0.529 . . . . 0.85 110.182 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.509 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 49.3 mt-10 -70.46 -39.53 74.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.994 -0.548 . . . . 1.5 109.798 175.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 16.0 mm-40 -62.33 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.659 -0.7 . . . . 1.74 109.877 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.69 -73.27 0.72 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.458 -0.792 . . . . 1.32 111.219 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -176.01 81.5 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.827 0.346 . . . . 2.42 111.418 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -98.02 -23.93 15.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.046 -0.724 . . . . 2.04 109.046 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.563 ' H ' ' HD3' ' A' ' 155' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.038 -0.983 . . . . 4.65 109.323 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.401 ' O ' HG11 ' A' ' 6' ' ' VAL . 20.9 p-10 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.863 0.364 . . . . 2.1 111.079 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 30.2 p90 -178.12 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.654 -0.703 . . . . 4.04 110.051 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.649 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 28.4 t70 -65.47 -49.74 61.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 2.78 111.782 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 16.3 Cg_endo -87.77 -68.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.142 1.228 . . . . 1.83 110.92 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.74 157.15 37.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 3.98 109.458 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.67 HG21 ' CG ' ' A' ' 115' ' ' HIS . 2.0 m -97.23 113.32 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.523 -0.917 . . . . 2.03 108.523 168.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.555 ' HD3' ' OD2' ' A' ' 112' ' ' ASP . 20.2 ttm180 -104.35 146.59 28.6 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.365 -0.834 . . . . 3.92 112.136 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 1.064 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 9.7 t-160 -112.24 132.84 54.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.614 -1.175 . . . . 1.16 108.667 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 38.3 m -140.32 119.64 12.99 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.839 -0.43 . . . . 1.72 109.839 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.657 HG13 ' HG2' ' A' ' 145' ' ' GLN . 3.9 t -143.7 132.83 19.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.812 -0.631 . . . . 1.89 110.893 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 m -95.97 115.78 27.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.455 -0.572 . . . . 1.15 109.455 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.688 HG13 HG23 ' A' ' 148' ' ' ILE . 24.9 t -95.45 140.54 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.796 -0.638 . . . . 1.51 110.736 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.11 24.22 11.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.47 0.544 . . . . 1.6 112.47 -173.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -155.46 34.92 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.735 0.643 . . . . 1.11 112.735 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 23.7 t70 72.48 166.96 0.31 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.6 0.714 . . . . 0.91 112.377 172.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' NE ' ' HB1' ' A' ' 103' ' ' ALA . 28.3 ttp180 -69.12 -23.68 64.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.42 -0.809 . . . . 2.19 111.425 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -58.89 -49.08 79.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.63 0.252 . . . . 3.49 111.086 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -73.79 -37.76 64.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.702 0.286 . . . . 1.49 110.314 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.33 -45.97 80.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 1.07 111.095 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 70.2 t80 -71.95 -47.94 48.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.407 -0.361 . . . . 0.43 110.893 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.595 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 26.5 tptp -52.9 -52.45 57.62 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.842 -0.617 . . . . 2.87 110.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -50.96 61.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.88 -0.6 . . . . 1.21 111.221 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -62.46 -37.0 84.24 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.246 0.462 . . . . 0.53 112.246 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.521 ' CD1' HG11 ' A' ' 46' ' ' VAL . 13.6 tp -109.02 -53.18 2.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.286 -0.566 . . . . 1.23 112.403 -172.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.595 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 1.4 mm-40 -79.87 -28.64 39.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.105 0.478 . . . . 1.24 111.478 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -100.8 30.58 10.01 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.582 -0.735 . . . . 0.83 111.876 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.488 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 56.4 t80 -48.5 -47.18 70.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.943 0.497 . . . . 0.94 112.279 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 15.6 Cg_endo -98.08 19.35 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.19 1.927 . . . . 0.9 114.409 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 6.6 pt-20 -105.57 -3.87 21.84 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.134 -0.627 . . . . 1.49 111.505 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.74 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 2.9 m0 -80.82 -172.03 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 5.66 111.129 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.539 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 66.4 m95 -102.45 -26.88 0.21 Allowed Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 114.041 1.126 . . . . 3.41 114.041 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.74 ' HD2' ' HB2' ' A' ' 30' ' ' TRP . 65.3 Cg_endo -72.74 -143.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.931 1.754 . . . . 1.36 114.4 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 8.1 t30 -59.29 -14.73 12.3 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.433 0.901 . . . . 1.51 113.433 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.736 HD22 ' HB2' ' A' ' 30' ' ' TRP . 8.0 p30 -76.28 -10.77 59.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.948 0.351 . . . . 1.98 111.948 -174.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -78.01 69.41 4.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 5.13 110.596 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -149.11 151.0 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.636 -0.711 . . . . 4.7 110.571 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 m -87.99 122.75 31.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.916 -0.314 . . . . 3.11 110.375 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.497 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 73.2 p 56.84 16.22 2.63 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.319 0.859 . . . . 1.89 113.319 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -103.53 -47.27 4.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.815 -1.18 . . . . 3.45 107.815 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.61 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -156.21 130.14 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 113.78 -1.555 . . . . 2.3 108.582 171.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' A' ' 55' ' ' GLU . . . 98.91 -72.22 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.54 -0.838 . . . . 2.2 113.291 175.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.751 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . 50.36 -164.65 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 109.813 -0.44 . . . . 1.31 109.813 -169.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.614 ' CD ' ' HB3' ' A' ' 42' ' ' ALA . 23.0 Cg_exo -69.95 16.16 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.324 1.349 . . . . 1.94 113.656 171.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 54' ' ' TYR . 56.0 tp -128.66 -92.11 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.87 -0.518 . . . . 2.23 112.049 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 109.83 -75.01 0.21 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.457 -0.878 . . . . 0.94 113.132 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG11 ' CD1' ' A' ' 24' ' ' LEU . 58.5 t -140.48 135.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 122.723 -0.28 . . . . 1.21 110.799 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.679 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 13.0 t70 -103.64 126.4 50.75 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.411 -0.359 . . . . 1.11 110.405 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HE2' ' HG ' ' A' ' 24' ' ' LEU . 1.3 mmpp? -81.38 -24.07 37.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.539 . . . . 3.25 111.947 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -83.44 -58.7 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 3.63 110.82 -171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -77.95 -22.48 68.75 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.613 -0.803 . . . . 1.9 111.507 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 63.4 2.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.896 -0.669 . . . . 0.87 111.701 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.505 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -156.2 143.74 19.32 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.339 -0.544 . . . . 4.26 111.395 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.566 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 10.5 m0 -87.46 114.26 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.725 -0.843 . . . . 1.52 108.725 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.707 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 3.4 p90 -162.65 171.23 17.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.421 0.629 . . . . 2.04 111.288 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.751 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 8.6 mp0 -127.86 -179.45 4.96 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.288 -1.005 . . . . 2.12 108.288 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.1 103.28 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 119.655 -0.818 . . . . 1.42 110.665 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.497 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 11.6 p-10 -90.55 139.77 30.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.36 0.6 . . . . 1.97 110.189 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.89 -5.13 50.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.681 0.993 . . . . 2.43 113.681 -164.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.689 -0.804 . . . . 2.39 110.659 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.45 49.04 0.45 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.936 -0.65 . . . . 2.29 113.347 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.45 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 45.7 mt-10 60.28 76.68 0.35 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.008 1.114 . . . . 2.31 114.008 172.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 30.4 tt0 -131.37 74.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.59 0.709 . . . . 2.61 110.131 169.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.707 ' CE1' ' HD1' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -120.47 154.24 35.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.326 -0.852 . . . . 4.63 110.305 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 p -64.9 149.34 49.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 2.27 109.146 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 45.8 p90 -123.38 127.45 48.49 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.189 -0.604 . . . . 7.39 111.034 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.38 136.21 28.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.116 -0.793 . . . . 1.23 111.116 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 67' ' ' LEU . 5.8 mp -82.8 87.7 6.79 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 121.092 -0.243 . . . . 1.76 110.499 -173.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 71' ' ' VAL . 43.5 mt -87.69 116.51 29.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 119.417 -0.913 . . . . 1.26 109.718 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -110.19 -10.46 14.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.093 -0.958 . . . . 2.65 110.487 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 37.1 ttmt -145.53 110.4 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.981 -0.554 . . . . 2.03 111.359 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.598 HG22 HG23 ' A' ' 68' ' ' ILE . 38.9 t -102.26 90.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.03 -1.1 . . . . 1.47 108.03 166.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.5 t70 -106.44 59.63 0.64 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.538 -0.465 . . . . 1.42 110.613 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.705 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.7 pt-20 39.71 -160.95 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 124.734 1.271 . . . . 0.96 111.924 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.705 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -62.47 80.5 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 CA-C-N 120.494 1.212 . . . . 0.48 112.118 168.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 13.9 t70 -165.89 -69.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.5 110.66 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.59 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -146.43 130.69 17.52 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.384 0.883 . . . . 1.1 113.384 -174.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -123.75 125.96 45.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.041 -0.412 . . . . 1.4 110.864 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 99.2 t -103.48 109.83 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.77 -0.456 . . . . 1.31 109.77 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.75 126.73 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.385 -0.825 . . . . 1.48 111.616 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.753 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.1 163.99 29.49 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.787 -0.525 . . . . 0.5 111.787 175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.619 ' CZ2' ' HA ' ' A' ' 83' ' ' LEU . 5.3 t-105 -64.31 161.79 16.06 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.563 0.949 . . . . 3.37 113.563 -166.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.464 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 1.6 ttp180 -158.07 -17.69 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.862 -1.063 . . . . 6.17 109.822 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.619 ' HA ' ' CZ2' ' A' ' 81' ' ' TRP . 2.6 tt 79.2 157.35 0.16 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.758 -1.11 . . . . 2.13 111.624 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.493 ' OD1' HG12 ' A' ' 40' ' ' VAL . 49.9 t30 -131.55 147.42 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.561 -0.745 . . . . 1.93 110.265 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 86' ' ' PHE . . . 83.31 1.1 90.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.911 -0.661 . . . . 2.79 113.645 172.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 18.9 t80 177.55 165.91 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.961 0.381 . . . . 6.08 110.479 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.61 69.18 1.24 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.195 -1.562 . . . . 2.43 109.195 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.547 ' HD2' ' HB3' ' A' ' 131' ' ' ASN . 12.9 ttm180 -97.5 -179.92 4.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.186 -0.507 . . . . 5.53 110.242 -168.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.505 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.06 122.5 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.568 0.699 . . . . 2.42 110.1 177.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 3.5 p30 -122.9 147.43 51.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.4 -0.818 . . . . 3.18 111.38 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HG3' ' HD2' ' A' ' 128' ' ' ARG . 3.4 Cg_exo -80.77 -52.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.892 2.395 . . . . 2.76 110.904 168.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 90' ' ' ASP . 5.2 m-20 44.17 42.34 4.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.043 -0.98 . . . . 2.99 113.161 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -140.54 -22.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 122.008 0.908 . . . . 3.06 109.064 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.439 ' HB2' ' CG ' ' A' ' 118' ' ' PHE . 71.1 m -150.67 -141.85 0.11 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.419 -1.264 . . . . 2.11 107.979 173.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.611 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 21.9 t 60.74 37.27 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.368 1.08 . . . . 1.81 108.307 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.753 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 21.4 mt-10 -74.89 144.37 43.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.175 -1.375 . . . . 1.81 110.182 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.776 ' HB3' ' HD1' ' A' ' 115' ' ' HIS . 2.7 p90 -131.56 132.11 43.88 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.229 0.538 . . . . 0.81 110.636 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 35.9 m -95.24 114.31 26.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.207 -0.906 . . . . 1.18 110.209 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.636 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -82.1 108.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.783 -0.644 . . . . 1.51 109.387 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.4 m -101.29 105.52 16.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.126 -0.488 . . . . 1.05 109.881 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.87 110.5 21.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.415 -0.357 . . . . 0.42 110.062 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.67 106.41 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.137 -0.69 . . . . 1.26 109.137 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HB1' ' NE ' ' A' ' 16' ' ' ARG . . . -78.52 124.34 28.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.638 -0.71 . . . . 1.13 111.46 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -108.27 127.89 54.25 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.726 -0.842 . . . . 2.03 108.726 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.95 -18.42 40.22 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.525 -0.761 . . . . 1.97 114.832 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -92.87 39.58 1.04 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.737 0.769 . . . . 5.46 110.812 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.734 ' HB2' ' HZ2' ' A' ' 107' ' ' LYS . 9.7 mtmp? 64.76 33.29 10.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.06 -0.518 . . . . 3.88 110.86 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 1.2 ttmp? -122.0 153.19 38.89 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.227 -0.657 . . . . 2.94 109.227 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.7 m -155.78 113.82 3.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.187 0.518 . . . . 1.2 111.203 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -92.21 111.71 23.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.515 -0.766 . . . . 3.1 109.933 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.575 HG12 ' HB ' ' A' ' 10' ' ' VAL . 13.4 p -87.61 138.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 1.13 110.163 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.555 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 22.7 t70 -133.19 106.93 7.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.302 -0.863 . . . . 1.38 109.008 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 1.064 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 5.3 t -90.61 120.62 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 120.89 -0.324 . . . . 1.58 110.597 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.71 133.1 43.51 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.701 -0.852 . . . . 2.31 108.701 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.776 ' HD1' ' HB3' ' A' ' 97' ' ' PHE . 34.6 t60 -116.61 153.93 31.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.614 -0.721 . . . . 2.32 109.789 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 118' ' ' PHE . 14.2 t -64.1 -165.31 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.613 -0.722 . . . . 3.19 110.415 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.414 ' O ' ' HG2' ' A' ' 121' ' ' MET . 8.4 p-80 -131.82 27.53 4.6 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.708 -0.678 . . . . 2.99 110.571 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.517 ' H ' HG23 ' A' ' 116' ' ' THR . 46.2 t80 -64.48 -24.33 67.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.506 0.67 . . . . 4.27 109.985 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -44.59 66.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.817 -1.083 . . . . 1.81 109.172 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 1.3 tmt_? -58.49 -21.17 50.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.803 -1.09 . . . . 3.84 111.832 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 94.1 mmm -73.52 33.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.991 0.424 . . . . 2.9 112.107 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 130.09 145.26 5.74 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.244 -0.503 . . . . 2.26 111.96 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.9 m -61.15 -27.12 68.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.34 . . . . 3.02 110.855 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.831 ' HG2' HH21 ' A' ' 128' ' ' ARG . 60.4 tttp -66.25 -47.35 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.461 -0.336 . . . . 4.23 110.315 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.649 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 37.0 m80 -65.04 -47.02 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.922 0.391 . . . . 2.7 110.944 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.65 80.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.314 -0.403 . . . . 1.46 111.466 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.38 -44.91 86.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.723 -0.217 . . . . 3.16 110.924 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.831 HH21 ' HG2' ' A' ' 124' ' ' LYS . 19.2 ptp180 -58.29 -34.04 70.11 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 120.796 0.331 . . . . 2.97 110.683 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 81' ' ' TRP . 92.7 t -79.29 -48.71 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.867 0.365 . . . . 1.96 110.719 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.938 ' HA ' ' HG2' ' A' ' 133' ' ' MET . 17.2 mtp180 -61.91 -17.85 58.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.06 -0.518 . . . . 4.34 111.922 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.547 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 4.2 m-80 -51.98 -46.98 65.04 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.493 0.496 . . . . 2.8 111.517 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.01 -15.71 9.74 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.136 -1.031 . . . . 2.08 113.15 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.938 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 21.6 ptm -80.91 -36.88 30.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.48 . . . . 5.19 112.167 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -27.43 62.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.933 0.716 . . . . 2.83 112.933 -163.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -103.29 -15.85 15.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.167 0.508 . . . . 4.47 111.004 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.598 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.2 -55.46 0.77 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.427 -0.892 . . . . 1.04 113.102 -174.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 8' ' ' HIS . 6.9 t90 -56.12 -53.34 64.56 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.674 0.62 . . . . 3.78 112.674 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.25 -45.24 28.26 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.801 1.668 . . . . 0.77 111.714 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 m -60.53 -40.16 90.47 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.573 0.702 . . . . 1.37 110.34 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 136' ' ' GLY . 49.7 mt -55.67 -45.53 79.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 CA-C-N 114.945 -1.025 . . . . 1.32 110.031 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 38.4 mt -59.14 -34.87 72.58 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.45 0.468 . . . . 1.33 111.842 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.98 -56.19 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 1.54 110.636 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.639 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 23.5 m -68.56 -21.16 64.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.518 -0.31 . . . . 1.43 111.161 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.09 -52.14 65.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.941 -0.392 . . . . 1.05 109.941 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.657 ' HG2' HG13 ' A' ' 10' ' ' VAL . 52.6 mt-30 -60.41 -36.07 77.26 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.741 -0.663 . . . . 1.63 110.046 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.62 -40.26 69.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.892 -1.049 . . . . 1.46 111.208 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 37.4 tptt -65.58 -37.71 87.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.216 0.531 . . . . 2.23 109.642 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.688 HG23 HG13 ' A' ' 12' ' ' VAL . 66.0 mt -72.45 -25.66 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 1.17 110.557 176.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.82 -30.9 71.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.554 -0.536 . . . . 0.85 109.554 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.68 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 40.1 mt-10 -70.4 -30.54 67.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.63 -0.714 . . . . 1.5 110.188 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.87 -36.12 62.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.362 -0.836 . . . . 1.74 109.619 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.26 -0.882 . . . . 1.32 111.647 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -167.21 86.66 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.413 . . . . 2.42 110.967 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.68 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.5 ttmm -107.59 -59.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.41 . . . . 2.04 109.914 176.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 3.9 mptp? . . . . . 0 C--O 1.247 0.946 0 O-C-N 123.777 0.673 . . . . 4.65 111.101 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.455 ' ND2' HG11 ' A' ' 6' ' ' VAL . 3.4 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.682 0.277 . . . . 2.1 111.333 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 46.8 p90 -176.78 -42.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.776 -0.647 . . . . 4.04 109.812 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.774 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 21.3 t70 -58.23 -55.37 46.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.13 -0.486 . . . . 2.78 112.099 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.2 Cg_endo -92.39 -65.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.453 2.102 . . . . 1.83 112.275 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HD2' HG21 ' A' ' 116' ' ' THR . 91.7 m-85 -143.1 145.35 32.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.226 -0.443 . . . . 3.98 110.543 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.695 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 45.2 t -104.58 126.54 59.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.88 -0.785 . . . . 2.03 108.88 167.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.2 ttm105 -128.44 135.2 49.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.221 0.534 . . . . 3.92 110.96 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.938 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -109.07 130.51 55.48 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.135 -1.061 . . . . 1.16 108.135 170.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.4 t -136.78 110.5 8.1 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.568 0.699 . . . . 1.72 109.596 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.727 HG11 ' HG2' ' A' ' 145' ' ' GLN . 1.8 t -122.85 134.7 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.601 -1.181 . . . . 1.89 111.038 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -91.75 115.59 28.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.04 -0.527 . . . . 1.15 109.756 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG11 HG23 ' A' ' 148' ' ' ILE . 42.0 t -96.79 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.496 -0.557 . . . . 1.51 109.496 177.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -104.93 33.25 3.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.885 -0.598 . . . . 1.6 111.5 -173.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.53 31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 1.11 111.573 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.706 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 19.8 t70 71.38 166.9 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.054 0.93 . . . . 0.91 112.348 176.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -71.68 -21.91 61.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.111 -0.95 . . . . 2.19 111.68 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.706 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 39.5 mmtm -58.33 -50.84 72.2 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.048 0.452 . . . . 3.49 109.907 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.1 p -72.57 -37.43 68.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.72 -0.673 . . . . 1.49 110.623 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 12' ' ' VAL . . . -55.9 -45.55 78.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.853 0.359 . . . . 1.07 110.732 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 59.9 t80 -74.24 -47.64 33.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.148 -0.478 . . . . 0.43 111.204 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 21' ' ' LYS . 4.4 ttmm -56.92 -52.18 66.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.592 -0.277 . . . . 2.87 111.167 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 m -64.01 -50.63 67.77 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.416 -0.356 . . . . 1.21 110.577 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.866 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.8 t80 -61.09 -36.84 80.73 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.333 0.494 . . . . 0.53 112.333 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.553 ' CD1' HG13 ' A' ' 46' ' ' VAL . 20.0 tp -106.37 -59.73 1.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.333 0.494 . . . . 1.23 112.333 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.16 -44.78 21.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.236 0.541 . . . . 1.24 111.515 -170.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.763 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -85.19 37.45 3.01 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 115.349 -0.841 . . . . 0.83 112.286 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.614 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 23.8 t80 -54.5 -48.91 93.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 112.366 0.506 . . . . 0.94 112.366 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 48.0 Cg_endo -86.84 12.93 2.85 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.203 1.935 . . . . 0.9 114.711 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.763 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -96.08 -4.23 43.27 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.192 -0.603 . . . . 1.49 110.624 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.866 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 17.1 m0 -77.4 -175.58 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.726 0.774 . . . . 5.66 112.045 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.522 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 47.4 m95 -109.42 -33.66 0.15 Allowed Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 114.642 -1.163 . . . . 3.41 113.454 176.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 60.7 Cg_endo -71.03 -129.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.98 1.787 . . . . 1.36 114.345 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.47 ' CG ' HD22 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -59.87 -47.11 87.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.642 0.734 . . . . 1.51 111.279 -172.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.68 ' HA ' HG13 ' A' ' 40' ' ' VAL . 6.1 p-10 -83.61 34.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.345 -1.298 . . . . 1.98 112.062 -171.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -106.09 5.14 29.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.687 0.756 . . . . 5.13 109.404 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -99.53 124.05 44.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 4.7 110.693 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.412 ' C ' ' HG1' ' A' ' 38' ' ' THR . 1.3 p -74.88 131.26 40.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.064 -0.517 . . . . 3.11 111.51 -172.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 30.5 p 54.54 22.77 4.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.249 1.02 . . . . 1.89 111.74 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -114.0 -46.64 3.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.596 -0.89 . . . . 3.45 108.596 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.68 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.6 p -169.43 6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.053 -0.976 . . . . 2.3 110.03 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.55 53.64 0.36 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.915 -0.66 . . . . 2.2 112.274 -176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 1.012 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -70.6 174.28 3.67 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 109.493 -0.558 . . . . 1.31 109.493 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.408 ' CD ' ' HB3' ' A' ' 42' ' ' ALA . 38.7 Cg_exo -63.15 56.43 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.184 2.589 . . . . 1.94 113.774 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -166.95 -84.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.194 0.598 . . . . 2.23 109.62 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.614 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 89.2 -48.93 3.46 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.043 -0.598 . . . . 0.94 113.012 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 24' ' ' LEU . 75.2 t -137.86 144.83 30.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 110.033 -0.358 . . . . 1.21 110.033 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.748 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 29.5 t70 -108.77 116.07 31.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.54 -0.541 . . . . 1.11 109.54 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 11.0 tptm -73.96 -29.8 62.19 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.572 -0.74 . . . . 3.25 112.128 -173.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.68 -54.04 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.021 0.378 . . . . 3.63 112.021 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.03 -22.21 39.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.41 -0.9 . . . . 1.9 112.651 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 87.3 61.91 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.543 -0.837 . . . . 0.87 111.46 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 3.9 mpt_? -133.17 158.97 41.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.224 . . . . 4.26 110.509 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.697 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 17.0 m0 -113.28 106.39 14.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.804 -0.813 . . . . 1.52 108.804 168.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.748 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 8.6 p90 -157.5 167.72 29.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.031 -0.359 . . . . 2.04 110.031 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 1.012 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 4.4 mt-10 -127.89 159.67 34.21 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.488 -0.324 . . . . 2.12 110.335 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.65 102.26 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.373 -0.973 . . . . 1.42 108.373 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.04 163.27 27.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 1.97 109.325 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.84 -22.13 66.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.694 0.283 . . . . 2.43 111.056 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.43 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -86.83 -15.51 38.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 2.39 110.885 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.89 -100.94 0.21 Allowed Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.395 -0.907 . . . . 2.29 112.95 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.66 27.41 2.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.771 0.32 . . . . 2.31 111.432 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.59 82.49 2.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.347 0.594 . . . . 2.61 109.838 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 163.85 20.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.247 -0.888 . . . . 4.63 110.005 174.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.448 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 16.7 p -46.69 120.56 3.02 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.723 -0.473 . . . . 2.27 109.723 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.697 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 18.0 p90 -115.33 116.41 28.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.652 0.739 . . . . 7.39 112.053 -171.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -72.03 152.0 48.05 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.75 -1.113 . . . . 1.23 111.423 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -112.89 92.06 3.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.966 0.412 . . . . 1.76 111.109 -172.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 20.0 mt -85.13 116.53 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.682 -0.488 . . . . 1.26 109.682 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.61 ' HD3' ' OE2' ' A' ' 96' ' ' GLU . 2.4 mpt_? -88.04 -33.09 18.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.885 0.374 . . . . 2.65 110.733 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 58.0 tttp -129.6 98.97 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 2.03 111.294 -174.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 68' ' ' ILE . 44.9 t -98.05 96.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.05 -1.093 . . . . 1.47 108.05 169.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.66 77.47 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.805 -0.358 . . . . 1.42 111.165 -173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.33 -171.64 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 124.367 1.042 . . . . 0.96 112.012 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.533 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -66.41 74.09 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.353 1.369 . . . . 0.48 111.043 166.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -156.55 -64.73 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.806 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -144.48 145.55 31.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.665 0.617 . . . . 1.1 112.665 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 1.1 mp -139.01 116.51 11.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.733 -0.667 . . . . 1.4 109.745 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.586 HG23 HG23 ' A' ' 98' ' ' THR . 61.6 t -101.03 106.69 19.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.02 -0.733 . . . . 1.31 109.02 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -129.1 127.56 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 1.48 111.95 -171.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -90.7 154.92 23.56 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.427 -0.416 . . . . 0.5 112.896 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.744 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 17.4 t-105 -73.19 160.88 31.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 3.37 111.889 -171.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.513 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 11.9 ptt180 -137.2 0.63 2.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.967 -0.561 . . . . 6.17 110.732 -169.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.757 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 2.7 tm? 74.55 133.09 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.985 0.803 . . . . 2.13 110.82 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.526 ' HB2' ' CH2' ' A' ' 81' ' ' TRP . 40.4 t-20 -98.94 121.4 40.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 1.93 110.367 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.83 -9.22 61.84 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.425 -0.893 . . . . 2.79 114.309 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.1 t80 70.98 -42.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.229 0.612 . . . . 6.08 112.238 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.75 7.23 51.01 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.234 -0.508 . . . . 2.43 112.928 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.515 ' HB2' HD22 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -108.17 178.31 4.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.969 -0.752 . . . . 5.53 108.969 177.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -114.54 128.64 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.963 0.411 . . . . 2.42 111.406 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.757 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 29.1 t70 -144.36 142.52 19.74 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.153 -0.684 . . . . 3.18 109.153 168.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HD2' ' OD2' ' A' ' 90' ' ' ASP . 17.3 Cg_endo -58.1 -27.28 79.24 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.948 2.432 . . . . 2.76 113.893 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 3.0 t70 67.38 -0.85 1.7 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.88 0.848 . . . . 2.99 110.853 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.18 -38.68 60.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.682 -0.69 . . . . 3.06 112.191 -171.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.9 m -156.01 -93.46 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.767 -0.197 . . . . 2.11 110.958 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.744 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 4.1 m 50.64 39.78 22.33 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.63 0.581 . . . . 1.81 110.724 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.723 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.7 mm-40 -69.24 144.52 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.34 -0.846 . . . . 1.81 112.221 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.91 127.95 22.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.56 0.695 . . . . 0.81 111.717 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 78' ' ' VAL . 52.9 m -93.26 112.12 23.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.044 -0.98 . . . . 1.18 110.788 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.611 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -89.59 110.11 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.764 -0.653 . . . . 1.51 109.869 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.56 ' HA ' HG23 ' A' ' 76' ' ' THR . 23.4 m -105.4 106.38 16.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 1.05 110.561 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.448 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 29.8 m-85 -88.5 107.59 18.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.42 110.298 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.24 111.22 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.303 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.88 53.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 1.13 110.453 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 8.6 t70 -130.7 118.9 21.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.137 -0.483 . . . . 2.03 110.534 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.16 -98.78 0.52 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.064 -0.588 . . . . 1.97 112.546 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.01 -20.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 5.46 110.259 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -128.14 7.1 5.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 3.88 111.53 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 83.9 tttt -122.7 151.25 41.73 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.584 -0.446 . . . . 2.94 110.425 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -153.76 118.5 4.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.828 -0.624 . . . . 1.2 109.936 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -100.79 115.8 31.18 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.532 -0.758 . . . . 3.1 109.449 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.2 p -91.76 137.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.285 -0.566 . . . . 1.13 110.642 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.4 109.01 11.33 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.156 -0.929 . . . . 1.38 109.049 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.938 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 3.9 t -101.64 124.16 55.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.897 -0.592 . . . . 1.58 111.263 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -102.76 113.7 27.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.437 0.637 . . . . 2.31 109.452 173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.695 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 65.7 t60 -134.2 98.95 4.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.195 -0.911 . . . . 2.32 109.219 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.459 HG21 ' HD2' ' A' ' 5' ' ' PHE . 5.1 t -152.92 97.29 2.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.918 0.866 . . . . 3.19 111.027 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.68 -69.91 0.09 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.334 -0.848 . . . . 2.99 110.0 176.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.648 ' CE1' ' HB3' ' A' ' 125' ' ' HIS . 13.6 t80 -72.28 -48.73 40.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.531 -0.759 . . . . 4.27 111.173 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.97 78.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 1.81 110.097 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 36.4 ttt180 -51.94 -24.94 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.222 -1.354 . . . . 3.84 112.072 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 95.3 mmm -79.9 -8.85 59.54 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.65 0.262 . . . . 2.9 110.706 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 44.43 -135.13 6.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.539 -0.755 . . . . 2.26 113.636 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 124' ' ' LYS . 25.6 p 40.61 -133.07 0.29 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.763 0.825 . . . . 3.02 112.417 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' H ' ' HB ' ' A' ' 123' ' ' THR . 65.0 mttm -57.77 -33.25 68.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 4.23 111.583 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.648 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 11.8 m-70 -66.51 -52.97 40.24 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.38 0.609 . . . . 2.7 110.739 -171.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.73 69.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.637 -0.711 . . . . 1.46 111.054 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -73.7 -28.94 61.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 3.16 111.668 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 31.6 ptt180 -77.35 -36.66 53.57 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.803 -0.359 . . . . 2.97 111.256 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.64 HG22 ' HE2' ' A' ' 118' ' ' PHE . 93.8 t -76.48 -23.86 15.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.356 0.598 . . . . 1.96 110.421 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.504 ' HG3' ' CB ' ' A' ' 134' ' ' ASP . 27.3 ttm180 -58.22 -19.85 36.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 4.34 111.142 174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.03 -22.72 41.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.196 -0.456 . . . . 2.8 111.362 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.434 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -137.41 -47.69 0.07 OUTLIER Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.374 -0.917 . . . . 2.08 113.469 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.46 -25.58 63.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.879 0.34 . . . . 5.19 111.878 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.504 ' CB ' ' HG3' ' A' ' 130' ' ' ARG . 15.0 t70 -59.28 -43.92 92.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 2.83 112.064 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -96.71 5.85 49.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 4.47 111.146 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.509 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -102.41 -62.15 0.73 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.441 -0.885 . . . . 1.04 112.81 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.533 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 1.1 t90 -60.63 -49.25 90.63 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.966 0.728 . . . . 3.78 112.966 -169.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.6 Cg_endo -58.13 -44.86 35.6 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.662 1.575 . . . . 0.77 112.027 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.0 m -59.05 -40.94 86.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.761 -0.654 . . . . 1.37 110.228 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.633 HG21 ' HZ3' ' A' ' 30' ' ' TRP . 45.6 mt -54.69 -51.94 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.928 -1.033 . . . . 1.32 110.894 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.639 HD13 ' CD2' ' A' ' 8' ' ' HIS . 59.5 mt -61.67 -30.57 70.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.048 0.388 . . . . 1.33 112.048 -175.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.0 mm-40 -70.99 -55.51 8.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 1.54 110.524 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.528 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.6 m -68.08 -22.52 64.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.072 -0.513 . . . . 1.43 110.626 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.79 -52.48 64.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.221 0.534 . . . . 1.05 109.771 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.727 ' HG2' HG11 ' A' ' 10' ' ' VAL . 45.9 mt-30 -59.79 -36.25 76.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.155 -0.929 . . . . 1.63 110.765 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.6 -40.29 49.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.748 -0.66 . . . . 1.46 111.462 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.23 -42.46 99.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 2.23 109.884 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.642 HG23 HG11 ' A' ' 12' ' ' VAL . 57.0 mt -64.44 -35.64 74.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 1.17 110.306 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.49 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 21.7 t70 -59.56 -38.71 81.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.61 -0.723 . . . . 0.85 109.716 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.49 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 45.6 mt-10 -66.06 -22.61 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 1.5 111.348 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -73.6 -8.04 54.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.763 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.27 -47.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.576 -1.297 . . . . 1.32 114.14 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.08 58.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.666 0.617 . . . . 2.42 112.666 -170.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.49 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.0 ttmm -69.26 101.23 1.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.226 -0.443 . . . . 2.04 111.539 -173.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.394 -0.821 . . . . 4.65 109.391 176.359 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.559 0.219 . . . . 2.1 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.509 ' HA ' HG21 ' A' ' 6' ' ' VAL . 52.9 p90 173.53 -36.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.652 0.781 . . . . 4.04 109.92 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.769 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 29.9 t70 -67.97 -57.65 9.13 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.411 -0.359 . . . . 2.78 111.525 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 47.7 Cg_endo -83.03 -63.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.248 1.299 . . . . 1.83 111.714 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.51 139.09 16.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.421 -0.354 . . . . 3.98 110.946 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.682 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 79.6 t -89.11 121.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.047 -0.723 . . . . 2.03 109.047 167.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.5 ttt180 -124.88 130.83 53.15 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.3 -0.409 . . . . 3.92 110.428 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.595 ' HD1' HG23 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.79 130.87 55.47 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.807 -0.812 . . . . 1.16 108.807 172.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 11.3 p -134.79 111.04 9.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.94 0.876 . . . . 1.72 110.498 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.579 ' HB ' HG13 ' A' ' 111' ' ' VAL . 2.3 t -120.37 133.35 67.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.269 -1.332 . . . . 1.89 111.637 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.0 m -96.13 115.51 27.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.693 . . . . 1.15 109.782 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.668 HG13 HG23 ' A' ' 148' ' ' ILE . 4.6 t -98.64 140.8 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.696 . . . . 1.51 111.004 -176.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 11.3 mmtp -100.0 9.88 42.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.919 -0.582 . . . . 1.6 112.016 -170.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.453 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -150.09 37.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.149 -0.62 . . . . 1.11 112.452 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 74.08 165.22 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.784 0.802 . . . . 0.91 112.743 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 10.9 ttp180 -63.1 -30.27 71.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.419 -1.264 . . . . 2.19 111.226 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 18' ' ' THR . 61.8 pttt -56.18 -47.18 78.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.117 -0.492 . . . . 3.49 110.405 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.412 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 27.9 m -74.84 -33.65 62.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.874 -0.603 . . . . 1.49 110.605 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.424 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . . . -60.55 -49.59 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 1.07 110.883 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.495 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 52.0 t80 -70.09 -43.37 71.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.236 -0.438 . . . . 0.43 110.773 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.619 ' HB2' ' HZ3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -53.72 -51.46 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 2.87 110.175 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.572 HG23 ' CE2' ' A' ' 30' ' ' TRP . 61.1 m -63.2 -41.38 99.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.982 -0.554 . . . . 1.21 111.282 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HA ' ' HE1' ' A' ' 144' ' ' PHE . 73.8 t80 -70.48 -47.19 61.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.329 0.492 . . . . 0.53 112.329 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 46' ' ' VAL . 11.3 tp -119.27 -11.7 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.119 1.155 . . . . 1.23 114.119 -167.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.593 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 32.9 mt-10 -113.98 -38.92 4.07 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.213 -0.929 . . . . 1.24 111.345 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.19 29.74 7.87 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.373 -0.831 . . . . 0.83 111.342 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.605 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 59.4 t80 -46.48 -55.07 15.24 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 114.504 -0.848 . . . . 0.94 113.054 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.5 Cg_endo -94.37 21.59 0.55 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.13 1.887 . . . . 0.9 115.493 -172.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -120.37 -18.82 7.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.97 1.1 . . . . 1.49 113.97 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.572 ' CE2' HG23 ' A' ' 22' ' ' THR . 25.3 m95 -76.08 -173.09 2.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.391 0.615 . . . . 5.66 112.523 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 143' ' ' SER . 51.7 m95 -77.35 -35.16 1.28 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 115.617 1.71 . . . . 3.41 115.617 -172.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.634 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 74.3 Cg_endo -72.34 -131.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 121.85 1.7 . . . . 1.36 115.02 -161.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.535 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 10.7 t30 -67.31 -8.07 29.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.084 -0.962 . . . . 1.51 110.496 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 1.048 ' HA ' HG22 ' A' ' 40' ' ' VAL . 1.3 m-20 -90.66 18.05 6.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.772 -1.103 . . . . 1.98 110.666 -172.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -104.83 68.17 0.83 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.555 . . . . 5.13 110.603 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -156.66 -178.06 7.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.002 -0.545 . . . . 4.7 109.85 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -110.37 139.16 45.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.522 -0.547 . . . . 3.11 109.522 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.411 ' H ' ' HB1' ' A' ' 42' ' ' ALA . 50.3 p 51.74 28.3 4.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.895 0.855 . . . . 1.89 111.266 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.661 ' HD3' HG23 ' A' ' 40' ' ' VAL . 1.1 tmtp? -149.46 84.01 1.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.324 -1.362 . . . . 3.45 107.324 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 1.048 HG22 ' HA ' ' A' ' 34' ' ' ASN . 34.0 m 45.02 32.36 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.6 1.188 . . . . 2.3 112.589 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.6 11.62 0.21 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.514 -0.851 . . . . 2.2 113.873 -175.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.983 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.87 -178.27 0.65 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.214 0.507 . . . . 1.31 110.591 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 42' ' ' ALA . 31.1 Cg_exo -63.37 20.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.712 2.274 . . . . 1.94 114.303 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.787 ' HG ' ' H ' ' A' ' 45' ' ' GLY . 17.0 tp -161.59 -156.68 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.579 -1.267 . . . . 2.23 107.579 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.787 ' H ' ' HG ' ' A' ' 44' ' ' LEU . . . 163.9 -50.64 0.3 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.919 -1.134 . . . . 0.94 113.019 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 24' ' ' LEU . 78.1 t -142.88 135.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.267 0.534 . . . . 1.21 111.502 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -113.74 124.01 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.415 -0.357 . . . . 1.11 110.562 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.657 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.23 -20.83 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.506 . . . . 3.25 111.343 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -76.26 -57.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.636 -0.256 . . . . 3.63 110.724 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.86 60.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.625 -0.798 . . . . 1.9 111.689 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.0 49.6 5.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.038 -0.601 . . . . 0.87 112.495 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -136.29 154.19 50.95 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.599 -0.354 . . . . 4.26 110.506 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.683 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.8 m0 -98.53 108.35 21.02 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.229 -1.026 . . . . 1.52 108.229 168.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -149.96 144.55 25.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.584 0.707 . . . . 2.04 111.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.983 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.5 mt-10 -111.81 170.69 7.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.627 -1.169 . . . . 2.12 109.154 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 ' HG2' ' A' ' 61' ' ' GLU . 28.6 mm -78.87 105.26 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.16 -0.681 . . . . 1.42 109.16 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.724 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.8 t70 -88.61 -164.93 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.139 -0.319 . . . . 1.97 110.139 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.4 pt-20 -80.13 -35.51 36.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.76 0.281 . . . . 2.43 111.76 -174.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.474 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -96.93 24.09 6.53 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.255 -0.578 . . . . 2.39 111.639 177.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.4 -97.27 0.38 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.658 -0.782 . . . . 2.29 113.08 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' HG2' HD12 ' A' ' 56' ' ' ILE . 34.1 mt-10 -142.53 29.84 1.56 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.634 0.731 . . . . 2.31 109.729 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.51 76.76 10.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.145 -0.934 . . . . 2.61 110.286 -171.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.724 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.66 130.11 52.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.229 -1.351 . . . . 4.63 109.61 175.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' ' 82' ' ' ARG . 2.9 m -69.92 -92.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 2.27 111.761 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 91.9 m-85 51.27 -167.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.291 1.219 . . . . 7.39 114.291 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.4 141.02 42.04 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.035 -0.984 . . . . 1.23 114.931 -165.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.07 99.22 8.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.795 -0.703 . . . . 1.76 109.484 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.571 HG22 HG22 ' A' ' 71' ' ' VAL . 21.0 mt -84.25 138.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 1.26 111.129 -172.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -99.88 -40.21 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.357 -0.383 . . . . 2.65 110.239 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -138.11 122.69 18.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 2.03 111.463 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.571 HG22 HG22 ' A' ' 68' ' ' ILE . 40.5 t -111.08 108.73 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.102 -0.703 . . . . 1.47 109.102 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -115.31 63.64 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.416 -0.514 . . . . 1.42 110.966 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 46.09 -166.45 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.658 1.224 . . . . 0.96 112.086 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 44.5 Cg_exo -60.74 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.638 1.558 . . . . 0.48 112.316 167.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.81 -66.81 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.654 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -144.71 148.62 34.39 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.643 0.609 . . . . 1.1 112.643 -175.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -138.82 129.02 25.52 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.944 -0.571 . . . . 1.4 110.274 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' PHE . 21.9 t -109.28 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.005 -0.739 . . . . 1.31 109.005 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.18 138.23 55.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.138 -0.483 . . . . 1.48 111.811 -170.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.16 149.05 19.65 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.774 -0.53 . . . . 0.5 111.774 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.812 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 76.2 t-105 -86.13 141.26 29.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.126 0.488 . . . . 3.37 112.092 -170.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.722 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 1.8 tmt_? -113.53 -79.47 0.58 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.29 -0.868 . . . . 6.17 109.053 168.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 1.012 HD21 ' HB2' ' A' ' 88' ' ' ARG . 53.8 mt -176.68 -111.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.41 1.1 . . . . 2.13 112.864 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.417 ' HA ' ' HE2' ' A' ' 65' ' ' PHE . 40.1 t-20 176.53 -161.98 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 103.856 -2.646 . . . . 1.93 103.856 -164.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.69 50.25 0.9 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.668 -1.253 . . . . 2.79 112.222 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -140.22 78.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.823 -0.351 . . . . 6.08 111.865 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.22 49.79 74.7 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 115.752 -0.658 . . . . 2.43 112.42 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 1.012 ' HB2' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -129.31 154.12 47.17 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.517 -0.341 . . . . 5.53 111.859 -169.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.628 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -115.32 135.26 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 110.243 -0.28 . . . . 2.42 110.243 177.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.579 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 5.0 p-10 -102.91 144.92 29.6 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-O 120.999 0.428 . . . . 3.18 111.319 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HG3' ' CE2' ' A' ' 118' ' ' PHE . 15.6 Cg_exo -65.39 -48.29 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.683 2.256 . . . . 2.76 110.658 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.579 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 32.2 t70 64.79 29.5 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 2.99 110.367 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -138.88 -55.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 3.06 111.649 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.7 p -135.25 -121.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.61 -0.436 . . . . 2.11 111.567 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.812 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.6 t 55.21 54.23 9.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.922 -0.769 . . . . 1.81 108.922 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 44.7 tt0 -88.21 143.82 26.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.965 -1.016 . . . . 1.81 111.599 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -107.57 148.36 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.81 110.673 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.9 m -112.09 95.81 5.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.384 -0.969 . . . . 1.18 108.384 158.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.622 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.8 t -83.32 110.14 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.818 -0.438 . . . . 1.51 109.818 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.7 m -108.52 107.36 17.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.784 0.326 . . . . 1.05 111.143 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.61 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 59.5 m-85 -87.38 113.75 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.331 -0.395 . . . . 0.42 110.264 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -96.21 115.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.176 -0.465 . . . . 1.26 110.298 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.67 143.73 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 1.13 111.203 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -138.73 103.54 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.03 110.625 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.5 16.58 55.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.99 -0.55 . . . . 1.97 113.864 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 62.69 15.08 7.76 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.182 0.438 . . . . 5.46 112.182 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -134.76 -18.78 1.86 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.01 0.433 . . . . 3.88 110.793 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.725 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.0 ttpm? -122.3 158.02 30.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.074 -0.713 . . . . 2.94 109.074 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.3 m -154.13 122.78 6.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.972 0.415 . . . . 1.2 111.227 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -98.29 108.17 20.8 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.673 -0.694 . . . . 3.1 109.278 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 9' ' ' SER . 14.4 p -83.41 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.976 -0.69 . . . . 1.13 109.334 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -125.65 107.99 11.11 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.675 -0.861 . . . . 1.38 108.675 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 13.0 t -103.61 123.3 57.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.394 -0.821 . . . . 1.58 112.376 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -92.91 111.22 22.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.069 -0.968 . . . . 2.31 108.824 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.682 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 23.6 t-160 -125.32 97.17 5.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.754 -1.202 . . . . 2.32 107.754 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.521 ' HG1' ' C ' ' A' ' 115' ' ' HIS . 28.1 m -153.64 108.31 3.11 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.7 -0.8 . . . . 3.19 112.584 -175.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -174.8 -63.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.456 -0.793 . . . . 2.99 109.647 165.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.581 ' HE2' HG23 ' A' ' 129' ' ' VAL . 77.4 t80 -76.94 -28.13 55.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.743 -0.662 . . . . 4.27 109.784 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -46.8 87.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.164 -0.926 . . . . 1.81 110.01 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 72.9 ttt180 -57.72 -21.3 39.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.676 -1.147 . . . . 3.84 112.094 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.38 -17.7 62.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.173 0.511 . . . . 2.9 110.606 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.03 -118.15 6.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.18 0.832 . . . . 2.26 115.18 165.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 m -37.93 -88.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.973 1.472 . . . . 3.02 114.973 -160.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -77.33 -34.35 55.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.16 0.429 . . . . 4.23 112.16 -168.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 29.6 m170 -66.08 -52.13 51.69 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.864 0.364 . . . . 2.7 110.9 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -67.02 -37.45 84.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 1.46 110.395 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -61.02 -49.76 76.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.655 0.243 . . . . 3.16 111.655 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.14 -29.24 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 2.97 111.186 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.581 HG23 ' HE2' ' A' ' 118' ' ' PHE . 15.7 t -75.51 -41.1 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.404 0.621 . . . . 1.96 110.535 172.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 1.045 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 39.5 ttp180 -63.16 -15.41 56.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.139 -0.937 . . . . 4.34 111.533 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -50.08 -47.02 53.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.354 -0.385 . . . . 2.8 111.433 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.21 -12.9 22.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.435 -0.888 . . . . 2.08 111.952 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.601 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 26.1 ttt -81.23 -35.3 31.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.721 0.267 . . . . 5.19 111.721 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 1.045 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 38.7 t70 -63.86 -37.29 86.84 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.833 0.679 . . . . 2.83 112.833 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 36.0 tptt -106.66 22.19 16.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.932 0.873 . . . . 4.47 109.608 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.636 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.77 -71.36 0.55 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.344 -0.843 . . . . 1.04 111.798 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.434 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.7 t-105 -54.71 -54.1 53.06 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 113.041 0.756 . . . . 3.78 113.041 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 27.0 Cg_endo -61.49 -41.32 41.3 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.8 1.667 . . . . 0.77 112.199 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -63.28 -40.96 98.84 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.334 0.588 . . . . 1.37 109.962 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 136' ' ' GLY . 42.3 mt -58.18 -43.65 86.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 115.271 -0.877 . . . . 1.32 110.645 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.524 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 24.8 mt -60.06 -41.46 92.4 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.166 0.291 . . . . 1.33 111.2 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.192 -0.603 . . . . 1.54 111.121 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.708 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 13.8 m -75.96 -22.38 56.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 1.43 110.594 176.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 63.4 t80 -61.76 -54.87 36.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.528 -0.76 . . . . 1.05 109.336 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.44 -29.37 70.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.01 -0.541 . . . . 1.63 110.272 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.26 -54.23 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 1.46 111.891 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 147' ' ' LYS . 5.9 tmtt? -74.31 -35.01 63.66 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 120.243 -0.583 . . . . 2.23 110.188 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.668 HG23 HG13 ' A' ' 12' ' ' VAL . 18.7 mt -60.96 -34.88 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.135 0.493 . . . . 1.17 110.418 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 27.5 t70 -59.11 -34.95 72.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.85 109.924 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.622 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 30.5 mt-10 -69.62 -19.55 63.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.844 -0.616 . . . . 1.5 111.4 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.85 2.41 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.093 -0.503 . . . . 1.74 110.582 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.51 -70.72 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.193 -1.003 . . . . 1.32 113.897 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.62 -33.06 21.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.617 0.969 . . . . 2.42 113.617 -167.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.69 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 34.5 ttmt -69.51 166.71 18.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.963 -0.384 . . . . 2.04 109.963 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.69 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 C-N-CA 123.941 0.896 . . . . 4.65 111.244 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.958 HD21 ' HB ' ' A' ' 6' ' ' VAL . 19.9 p-10 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 110.276 -0.268 . . . . 2.1 110.276 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.532 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 84.3 m-85 83.31 -63.58 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.79 0.836 . . . . 4.04 111.044 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.768 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -54.83 -50.59 85.17 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.256 -0.429 . . . . 2.78 111.161 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 13.4 Cg_endo -92.58 -72.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.168 1.912 . . . . 1.83 111.77 169.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.674 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 39.5 p90 -153.59 153.61 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.348 -0.612 . . . . 3.98 109.348 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.958 ' HB ' HD21 ' A' ' 1' ' ' ASN . 0.9 OUTLIER -102.35 143.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.93 -1.137 . . . . 2.03 107.93 169.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.6 ttt180 -133.32 143.42 49.0 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.417 -0.513 . . . . 3.92 110.635 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.819 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.51 132.03 54.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.302 -0.999 . . . . 1.16 108.302 170.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.46 ' HB3' ' NH2' ' A' ' 110' ' ' ARG . 21.8 m -130.37 110.41 11.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.329 0.585 . . . . 1.72 109.753 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 2.5 t -134.53 131.12 54.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.153 -0.93 . . . . 1.89 111.588 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -105.65 116.12 31.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 1.15 109.142 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG21 ' HB ' ' A' ' 109' ' ' THR . 1.5 m -98.01 158.14 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.879 -0.601 . . . . 1.51 110.035 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.84 55.86 0.97 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.053 -0.521 . . . . 1.6 111.002 -174.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -167.17 26.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.968 -0.56 . . . . 1.11 111.837 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.0 t70 73.81 167.41 0.3 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.073 0.463 . . . . 0.91 111.797 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 48.4 ttp180 -71.04 -27.31 63.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.987 -0.552 . . . . 2.19 111.162 -173.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -58.19 -52.93 63.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.918 -0.583 . . . . 3.49 110.266 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 69.3 m -71.04 -34.95 71.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.85 -0.614 . . . . 1.49 111.24 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -57.07 -47.02 82.02 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 1.07 110.802 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 69.4 t80 -70.8 -43.49 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.43 110.615 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.653 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 22.8 tptp -51.92 -52.28 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 2.87 110.711 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.3 m -67.64 -52.23 40.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.54 -0.3 . . . . 1.21 110.868 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -59.21 -39.76 83.67 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.452 0.538 . . . . 0.53 112.452 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 77' ' ' LEU . 27.4 tp -114.21 -47.38 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.158 -0.617 . . . . 1.23 112.205 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.653 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 29.4 mt-10 -88.67 17.4 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.765 0.317 . . . . 1.24 111.082 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.663 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -149.46 39.23 0.92 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.798 -0.715 . . . . 0.83 112.067 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.601 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 12.6 t80 -51.56 -48.48 86.61 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 122.019 0.128 . . . . 0.94 111.07 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 30.0 Cg_endo -88.74 24.19 0.7 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.15 1.9 . . . . 0.9 114.907 174.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.8 pt-20 -105.12 -12.2 16.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.866 0.757 . . . . 1.49 111.462 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.479 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 2.7 m0 -83.54 -164.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.031 -0.359 . . . . 5.66 110.031 -174.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.589 ' H ' ' HD3' ' A' ' 32' ' ' PRO . 12.5 p-90 -140.37 19.01 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 114.464 1.283 . . . . 3.41 114.464 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.629 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 54.9 Cg_endo -83.69 -112.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 CA-C-N 121.406 1.538 . . . . 1.36 113.001 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 63.0 t30 -79.41 -13.76 59.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.044 0.926 . . . . 1.51 109.727 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.625 ' HA ' HG22 ' A' ' 40' ' ' VAL . 7.8 m120 -90.17 30.91 1.04 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.627 -1.169 . . . . 1.98 110.251 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -97.34 2.16 50.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 5.13 110.9 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 21.5 mmt180 -114.0 152.07 31.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.294 0.569 . . . . 4.7 112.218 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -81.5 148.31 29.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.776 . . . . 3.11 109.714 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 57' ' ' ASP . 44.5 p 52.55 16.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.343 0.657 . . . . 1.89 111.715 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.67 ' HD3' HG23 ' A' ' 40' ' ' VAL . 1.2 tmtp? -142.44 80.4 1.7 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.658 -0.701 . . . . 3.45 109.263 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.67 HG23 ' HD3' ' A' ' 39' ' ' LYS . 19.1 m 49.33 16.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.148 1.379 . . . . 2.3 113.716 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.72 25.4 2.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.378 -0.915 . . . . 2.2 112.627 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.78 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -85.28 161.71 51.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.367 -0.605 . . . . 1.31 109.367 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 39.2 Cg_exo -43.83 -12.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.966 3.777 . . . . 1.94 116.982 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.926 ' HG ' ' HA ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -111.24 -94.54 0.44 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.574 -0.704 . . . . 2.23 111.125 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.601 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 91.88 -36.81 3.53 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.78 -0.724 . . . . 0.94 112.976 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 24' ' ' LEU . 81.9 t -140.1 140.65 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.846 0.355 . . . . 1.21 111.168 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.65 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 11.0 t70 -109.88 113.2 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.327 -0.99 . . . . 1.11 108.327 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 16.8 ttmt -79.6 -23.24 42.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.822 -0.626 . . . . 3.25 112.286 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -90.08 -36.48 14.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.747 0.308 . . . . 3.63 111.293 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.83 -20.21 31.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.907 -0.663 . . . . 1.9 112.313 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 79.51 56.77 3.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.746 -0.74 . . . . 0.87 111.811 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -133.78 160.92 36.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.785 0.326 . . . . 4.26 111.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.746 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 15.6 m0 -117.31 108.66 15.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.234 -0.654 . . . . 1.52 109.234 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.65 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 11.0 p90 -162.39 146.22 11.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 2.04 110.862 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.926 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -114.3 175.21 5.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.841 -0.618 . . . . 2.12 109.356 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.913 HG12 HD22 ' A' ' 44' ' ' LEU . 20.6 mm -76.07 111.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.645 -0.502 . . . . 1.42 109.645 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.494 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 39.8 t0 -95.64 157.22 15.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 1.97 109.927 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.84 -28.07 62.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.398 0.888 . . . . 2.43 113.398 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.47 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -85.76 9.69 15.77 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.879 -0.728 . . . . 2.39 111.385 -176.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.75 47.68 0.19 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.079 -1.058 . . . . 2.29 113.532 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.71 ' HG2' HG21 ' A' ' 56' ' ' ILE . 27.7 mt-10 54.36 36.88 26.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.396 0.617 . . . . 2.31 111.278 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -120.08 85.35 2.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 2.61 110.462 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -109.79 164.1 12.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.774 -0.648 . . . . 4.63 110.242 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.8 p -57.48 112.29 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.359 -0.382 . . . . 2.27 110.694 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -79.47 102.39 8.75 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.796 0.295 . . . . 7.39 111.796 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.746 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -55.89 137.51 46.31 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.509 -1.036 . . . . 1.23 110.509 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.59 97.71 7.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.379 0.59 . . . . 1.76 111.773 -168.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.522 HG21 ' CG2' ' A' ' 71' ' ' VAL . 46.1 mt -84.08 133.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.835 -0.432 . . . . 1.26 109.835 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -96.11 -33.27 12.14 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.846 -0.428 . . . . 2.65 109.846 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.5 ttpp -155.04 130.11 9.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.303 -0.408 . . . . 2.03 111.745 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.522 ' CG2' HG21 ' A' ' 68' ' ' ILE . 97.6 t -114.6 100.54 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.785 -0.82 . . . . 1.47 108.785 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.0 m-20 -98.15 59.35 1.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 119.489 -0.291 . . . . 1.42 111.173 -173.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.0 pt-20 44.25 -165.19 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 O-C-N 124.252 0.97 . . . . 0.96 111.635 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.9 Cg_exo -61.59 85.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.067 1.178 . . . . 0.48 111.385 165.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.692 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 26.5 t70 -173.16 -65.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.5 110.561 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -145.53 158.97 43.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.919 0.39 . . . . 1.1 111.809 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' CD2' HD22 ' A' ' 24' ' ' LEU . 4.2 mp -145.99 130.56 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 1.4 109.913 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.95 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.26 -0.427 . . . . 1.31 109.909 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.49 144.53 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.526 -0.306 . . . . 1.48 111.215 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -105.46 155.4 16.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.5 112.597 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 75.6 t-105 -78.55 137.44 37.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.5 0.556 . . . . 3.37 112.5 -169.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -148.07 40.59 0.97 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.482 -0.781 . . . . 6.17 109.285 176.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 85.65 166.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.859 1.059 . . . . 2.13 113.859 171.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.462 ' H ' HD13 ' A' ' 83' ' ' LEU . 36.4 t30 -158.1 -37.29 0.07 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 113.925 -1.489 . . . . 1.93 108.475 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.27 10.25 50.16 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.401 -0.818 . . . . 2.79 112.516 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.5 t80 74.4 -74.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.396 0.679 . . . . 6.08 112.008 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.14 71.56 2.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.879 -0.677 . . . . 2.43 113.508 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.901 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 15.6 ttp180 -146.15 179.01 7.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.025 -0.361 . . . . 5.53 110.025 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.901 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -82.23 126.95 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.063 -0.717 . . . . 2.42 109.063 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 30.0 p-10 -96.81 129.1 33.55 Favored Pre-proline 0 C--N 1.317 -0.816 0 O-C-N 121.672 -0.643 . . . . 3.18 110.098 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 93' ' ' ASN . 23.4 Cg_exo -63.37 -40.01 34.11 Favored 'Trans proline' 0 CA--C 1.519 -0.246 0 C-N-CA 122.926 2.417 . . . . 2.76 113.069 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 68.2 -30.88 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.759 0.652 . . . . 2.99 112.759 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.481 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.8 OUTLIER -74.64 -60.15 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.355 0.598 . . . . 3.06 110.365 -173.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 p -155.23 -90.57 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.568 -0.742 . . . . 2.11 111.293 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 49.5 m 54.11 36.72 25.45 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 108.52 -0.919 . . . . 1.81 108.52 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.504 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.6 tt0 -71.7 141.75 49.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.445 -1.707 . . . . 1.81 111.423 -172.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.541 ' HB2' HG13 ' A' ' 113' ' ' VAL . 6.7 p90 -139.07 134.63 33.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.624 -0.716 . . . . 0.81 110.199 174.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -98.87 117.14 32.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.504 -0.771 . . . . 1.18 110.273 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.525 HG12 HG22 ' A' ' 111' ' ' VAL . 85.4 t -82.91 110.63 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 1.51 109.853 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 8.5 m -99.63 105.62 17.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.286 0.366 . . . . 1.05 111.426 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.4 m-85 -96.46 114.17 25.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.42 110.976 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.3 110.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.327 -0.62 . . . . 1.26 109.327 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.09 134.72 41.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 1.13 111.523 -175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 38.2 t70 -120.89 123.16 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.101 -0.954 . . . . 2.03 108.944 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.96 -10.88 28.54 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.929 -0.578 . . . . 1.97 113.64 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.43 49.8 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.942 0.401 . . . . 5.46 110.464 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 60.43 31.84 20.43 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.73 -0.668 . . . . 3.88 111.308 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 3.8 ttmp? -132.6 155.71 48.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.32 -0.4 . . . . 2.94 110.448 -173.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.536 ' HB ' HG21 ' A' ' 12' ' ' VAL . 22.5 m -158.29 125.43 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 1.2 110.768 173.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.46 ' NH2' ' HB3' ' A' ' 9' ' ' SER . 20.4 tpt180 -101.0 126.65 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.432 -0.803 . . . . 3.1 109.556 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 100' ' ' THR . 9.5 p -114.58 136.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.006 0.432 . . . . 1.13 111.063 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.585 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 3.2 p-10 -126.73 120.24 28.89 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.81 0.814 . . . . 1.38 109.381 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.819 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 1.6 t -90.97 120.24 39.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.958 -1.019 . . . . 1.58 110.084 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -96.36 111.3 23.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.808 0.693 . . . . 2.31 109.212 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.946 ' HB3' HG22 ' A' ' 6' ' ' VAL . 51.8 t-80 -125.27 98.93 5.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.38 -0.827 . . . . 2.32 108.769 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.674 ' HB ' ' CB ' ' A' ' 5' ' ' PHE . 5.4 t -151.36 88.1 1.42 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.89 0.852 . . . . 3.19 109.621 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -157.47 -76.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 2.99 110.253 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.591 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 6.4 t80 -73.2 -38.58 66.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.799 -0.815 . . . . 4.27 108.799 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.557 ' OD1' HG11 ' A' ' 6' ' ' VAL . 17.1 p-10 -73.81 -47.59 37.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.413 -0.812 . . . . 1.81 111.353 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.611 ' HD3' ' OG1' ' A' ' 116' ' ' THR . 52.4 ttp180 -56.28 -21.45 23.93 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.35 -0.386 . . . . 3.84 111.634 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 33.9 tpp -72.38 -3.48 24.29 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.95 0.405 . . . . 2.9 110.371 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.3 -164.49 24.31 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 115.036 0.774 . . . . 2.26 115.036 167.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.0 p 39.9 -116.22 0.23 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.394 1.077 . . . . 3.02 113.016 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.14 -25.13 64.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 4.23 111.184 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.591 ' HB3' ' O ' ' A' ' 118' ' ' PHE . 41.9 m-70 -68.53 -53.93 19.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.037 0.446 . . . . 2.7 110.624 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.94 -26.15 63.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 1.46 109.999 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.616 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 87.4 tttt -62.57 -46.44 88.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.102 -0.954 . . . . 3.16 111.388 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 1.6 ptm180 -78.4 -28.6 46.93 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.827 -0.349 . . . . 2.97 111.587 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 125' ' ' HIS . 88.9 t -72.81 -30.91 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.22 0.452 . . . . 1.96 112.22 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 127' ' ' LYS . 31.8 ptt180 -59.58 -30.01 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.809 0.337 . . . . 4.34 111.631 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.736 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.0 m-20 -65.15 -21.17 66.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.434 0.531 . . . . 2.8 112.434 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.495 ' HA3' HH11 ' A' ' 88' ' ' ARG . . . -96.99 -72.08 1.09 Allowed Glycine 0 C--O 1.226 -0.351 0 C-N-CA 119.975 -1.107 . . . . 2.08 114.8 -164.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.669 ' HB2' ' HB2' ' A' ' 137' ' ' TRP . 26.5 ptt? -80.93 -9.59 59.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.441 0.534 . . . . 5.19 112.441 -170.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.58 -49.84 69.44 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.405 0.52 . . . . 2.83 112.405 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -96.96 22.86 7.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.948 0.351 . . . . 4.47 111.948 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.584 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -139.76 -56.26 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.73 -1.224 . . . . 1.04 113.101 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 65.2 t-105 -55.24 -53.31 63.19 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.549 0.574 . . . . 3.78 112.549 -170.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.6 Cg_endo -59.41 -40.64 65.43 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.81 1.674 . . . . 0.77 112.337 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 m -69.21 -38.28 78.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.515 0.674 . . . . 1.37 110.258 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.629 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 29.1 mt -59.58 -42.02 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.218 -0.901 . . . . 1.32 110.817 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 76.6 mt -62.76 -26.95 68.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.904 0.335 . . . . 1.33 111.904 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.18 -54.64 7.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.371 -0.233 . . . . 1.54 110.371 176.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -27.5 68.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 1.43 110.595 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' O ' HG13 ' A' ' 148' ' ' ILE . 47.2 t80 -62.17 -55.06 32.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.45 -0.795 . . . . 1.05 110.485 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.411 ' CG ' HG12 ' A' ' 10' ' ' VAL . 39.0 mt-30 -62.9 -34.61 77.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.32 0.581 . . . . 1.63 110.816 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.483 ' HB3' ' HE1' ' A' ' 31' ' ' TRP . 13.4 t70 -66.12 -44.99 82.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.873 -1.058 . . . . 1.46 110.402 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -69.19 -31.54 70.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.711 -0.677 . . . . 2.23 110.698 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.463 HG21 ' HB ' ' A' ' 12' ' ' VAL . 53.2 mt -71.43 -36.37 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 1.17 110.446 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.451 ' HB3' ' HE3' ' A' ' 154' ' ' LYS . 17.8 t0 -66.11 -28.97 69.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.504 . . . . 0.85 109.675 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.778 ' HB3' ' HZ2' ' A' ' 155' ' ' LYS . 55.7 mt-10 -60.74 -28.56 68.79 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.572 0.701 . . . . 1.5 110.334 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.51 -3.24 58.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.239 -0.891 . . . . 1.74 110.383 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.72 -70.4 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.525 -0.845 . . . . 1.32 113.67 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.28 -46.65 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.066 0.433 . . . . 2.42 111.407 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttpp -81.72 171.15 14.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.356 -0.384 . . . . 2.04 110.013 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.778 ' HZ2' ' HB3' ' A' ' 150' ' ' GLU . 18.1 tppt? . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.352 -0.981 . . . . 4.65 108.352 167.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.507 ' O ' HG21 ' A' ' 6' ' ' VAL . 18.0 p-10 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.65 0.262 . . . . 2.1 110.509 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 24.6 p90 172.14 -35.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.837 0.855 . . . . 4.04 109.108 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.746 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.9 t70 -73.64 -55.35 3.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.523 -0.308 . . . . 2.78 111.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 52.8 Cg_endo -84.31 -68.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.512 1.474 . . . . 1.83 111.94 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.05 142.78 26.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.169 -0.469 . . . . 3.98 110.073 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 76.5 t -98.29 112.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.866 -0.791 . . . . 2.03 108.866 167.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 45.4 ttm-85 -123.62 135.54 54.0 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.537 -0.465 . . . . 3.92 110.97 -177.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.739 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.66 134.38 52.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.829 -0.804 . . . . 1.16 108.829 174.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 22.4 m -143.24 112.23 6.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.154 -0.475 . . . . 1.72 110.455 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.995 HG22 HG11 ' A' ' 111' ' ' VAL . 2.2 m -126.66 140.42 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.125 -0.489 . . . . 1.89 109.77 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -102.48 114.42 28.61 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.512 -0.921 . . . . 1.15 108.512 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.504 HG12 ' HB ' ' A' ' 109' ' ' THR . 0.3 OUTLIER -103.3 162.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.254 -0.43 . . . . 1.51 110.445 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.92 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 9.5 pttt -125.92 35.93 4.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.753 -0.658 . . . . 1.6 112.013 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.27 29.19 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.215 0.45 . . . . 1.11 112.215 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 20.6 t70 75.84 163.37 0.25 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.857 0.837 . . . . 0.91 112.22 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.864 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 40.1 ttp180 -64.68 -27.88 69.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.717 -1.129 . . . . 2.19 110.96 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.675 ' HZ1' ' HB2' ' A' ' 17' ' ' LYS . 4.3 ttmp? -57.67 -48.55 79.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 3.49 110.825 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -77.46 -36.32 52.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 1.49 111.023 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' A' ' 148' ' ' ILE . . . -59.81 -39.59 85.54 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.79 -0.364 . . . . 1.07 110.405 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CG ' ' HA ' ' A' ' 74' ' ' PRO . 55.6 t80 -71.05 -49.97 39.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.43 110.77 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -54.18 -53.0 59.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.083 0.468 . . . . 2.87 110.982 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.428 HG21 ' NE1' ' A' ' 30' ' ' TRP . 14.2 m -63.83 -45.31 90.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.359 -0.837 . . . . 1.21 110.56 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.701 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.3 t80 -63.95 -37.49 87.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.945 0.35 . . . . 0.53 111.945 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.911 HD12 HG13 ' A' ' 46' ' ' VAL . 17.1 tp -99.49 -59.65 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.179 -0.608 . . . . 1.23 112.485 -174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -88.72 -19.47 26.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.149 0.5 . . . . 1.24 111.547 -173.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.535 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -89.77 18.48 46.81 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.645 -0.788 . . . . 0.83 111.17 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.51 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 10.9 t80 -50.39 -51.78 60.85 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.151 0.58 . . . . 0.94 112.256 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.526 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 42.0 Cg_endo -86.13 8.01 4.71 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.298 1.999 . . . . 0.9 115.525 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.7 pt-20 -111.07 -2.36 15.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.851 -0.739 . . . . 1.49 111.999 -175.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.806 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 43.1 m0 -67.64 155.73 38.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.329 0.585 . . . . 5.66 111.111 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.53 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 68.0 m95 -75.1 -43.79 4.61 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.389 -0.823 . . . . 3.41 112.906 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.806 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 29.1 Cg_endo -60.46 -87.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.63 2.22 . . . . 1.36 115.199 -162.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.526 ' ND2' HG12 ' A' ' 40' ' ' VAL . 6.1 t30 -110.98 -17.85 13.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.516 0.674 . . . . 1.51 110.451 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.621 ' HA ' HG13 ' A' ' 40' ' ' VAL . 2.9 m-20 -100.89 27.63 5.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.474 -0.784 . . . . 1.98 112.037 -168.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -104.4 13.31 32.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.687 0.756 . . . . 5.13 109.44 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -104.74 128.26 52.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.718 -0.674 . . . . 4.7 111.066 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -75.61 137.45 40.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 3.11 111.151 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 57' ' ' ASP . 79.8 p 57.09 11.53 1.04 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.61 1.164 . . . . 1.89 112.956 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 83.0 tttt -100.03 -48.81 4.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.477 -0.934 . . . . 3.45 108.477 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.709 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 12.4 p -174.35 -2.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.418 -1.265 . . . . 2.3 109.984 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.59 47.09 1.04 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.623 -0.799 . . . . 2.2 112.638 -177.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 1.002 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -79.91 158.46 72.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.013 -1.106 . . . . 1.31 108.013 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.69 44.85 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 123.803 3.002 . . . . 1.94 114.786 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -149.51 -84.36 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.723 -0.473 . . . . 2.23 109.723 173.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.23 -52.95 3.17 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.926 -0.654 . . . . 0.94 112.781 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.911 HG13 HD12 ' A' ' 24' ' ' LEU . 58.9 t -140.33 138.42 36.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.003 0.43 . . . . 1.21 111.607 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.614 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 22.3 t70 -100.42 107.27 18.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.841 -0.8 . . . . 1.11 108.841 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -9.83 59.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.19 -0.914 . . . . 3.25 111.203 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -75.39 -62.41 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.035 -0.53 . . . . 3.63 110.702 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.45 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -92.59 -39.49 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.562 -0.828 . . . . 1.9 111.662 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 72.46 0.62 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.654 -0.784 . . . . 0.87 112.805 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -154.39 144.33 21.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 4.26 111.172 175.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.597 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 22.7 m0 -96.2 110.98 23.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 1.52 110.515 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.614 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.8 p90 -153.91 152.91 31.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 2.04 110.399 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 1.002 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 6.4 mp0 -119.98 150.71 40.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.115 -0.698 . . . . 2.12 109.115 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD11 ' HG2' ' A' ' 61' ' ' GLU . 45.0 mm -77.0 103.37 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.999 0.428 . . . . 1.42 109.892 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.767 ' HB3' HE22 ' A' ' 59' ' ' GLN . 8.1 t70 -92.84 148.13 22.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.133 -0.692 . . . . 1.97 109.133 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.88 -10.09 59.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.462 0.912 . . . . 2.43 113.462 -166.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.767 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -93.18 10.25 32.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.648 -0.821 . . . . 2.39 110.712 177.166 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.49 50.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.39 -0.91 . . . . 2.29 113.921 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.469 ' HG2' HD11 ' A' ' 56' ' ' ILE . 39.2 mt-10 58.1 24.67 11.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.175 0.435 . . . . 2.31 112.175 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.86 78.05 6.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.499 0.666 . . . . 2.61 110.143 -173.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -123.22 162.74 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.292 -0.867 . . . . 4.63 109.68 176.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.553 ' C ' ' HD2' ' A' ' 82' ' ' ARG . 4.9 p -62.97 148.59 47.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.4 -0.593 . . . . 2.27 109.4 172.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 44.4 p90 -120.4 120.87 37.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.396 -0.522 . . . . 7.39 111.666 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.34 148.17 46.87 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.681 -0.968 . . . . 1.23 110.681 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.527 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -106.0 96.48 6.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.263 0.532 . . . . 1.76 111.26 -171.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.538 HG21 ' CG2' ' A' ' 71' ' ' VAL . 53.8 mt -77.08 125.29 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.271 0.558 . . . . 1.26 109.939 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -96.2 -21.37 17.93 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.399 -0.818 . . . . 2.65 109.786 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -164.64 125.0 2.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.224 -0.443 . . . . 2.03 111.889 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.538 ' CG2' HG21 ' A' ' 68' ' ' ILE . 62.6 t -109.36 107.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.725 -0.843 . . . . 1.47 108.725 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.44 75.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.649 -0.42 . . . . 1.42 111.211 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 10.3 pt-20 47.67 -170.92 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 124.766 1.291 . . . . 0.96 111.961 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.516 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 35.9 Cg_exo -63.48 81.32 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.373 1.382 . . . . 0.48 111.122 166.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.864 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 14.9 t70 -166.69 -68.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.405 -0.816 . . . . 0.5 110.984 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.542 HG21 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -138.67 140.3 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.783 0.66 . . . . 1.1 112.783 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -135.47 116.41 14.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.48 -0.782 . . . . 1.4 108.977 175.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.617 HG21 HG21 ' A' ' 98' ' ' THR . 29.9 t -95.26 111.78 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.687 -0.857 . . . . 1.31 108.687 175.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.21 126.42 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.75 0.31 . . . . 1.48 111.185 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 1.001 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -84.88 146.25 22.06 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.006 -0.837 . . . . 0.5 111.006 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.849 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 68.8 t-105 -73.63 160.18 31.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.585 0.707 . . . . 3.37 112.34 -168.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.553 ' HD2' ' C ' ' A' ' 64' ' ' THR . 19.3 ttp180 -135.52 -72.56 0.46 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.409 -1.269 . . . . 6.17 109.722 -172.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 90' ' ' ASP . 2.5 tm? 170.46 145.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.343 -0.844 . . . . 2.13 109.539 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.67 ' N ' HD13 ' A' ' 83' ' ' LEU . 54.0 t30 -142.6 146.89 35.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.35 -0.611 . . . . 1.93 109.35 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.65 -15.56 31.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.831 -0.699 . . . . 2.79 112.024 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.602 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 71.3 t80 70.39 -63.29 0.41 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.64 0.776 . . . . 6.08 111.207 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.59 44.65 3.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.224 -0.512 . . . . 2.43 112.037 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.69 ' NH1' ' HA ' ' A' ' 129' ' ' VAL . 2.4 tmm_? -133.86 144.24 48.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.033 -0.729 . . . . 5.53 109.033 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.521 ' C ' HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -96.58 131.92 42.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.028 0.442 . . . . 2.42 111.292 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.736 ' HB2' HD23 ' A' ' 83' ' ' LEU . 5.2 t70 -143.66 137.15 14.16 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.482 -0.933 . . . . 3.18 108.482 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.562 ' HG2' ' CZ ' ' A' ' 118' ' ' PHE . 32.0 Cg_exo -58.72 -25.58 76.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.562 2.175 . . . . 2.76 112.72 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.4 t70 56.51 75.29 0.36 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.358 0.599 . . . . 2.99 110.155 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.32 -75.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 3.06 110.767 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.7 m -113.5 -97.93 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.969 -0.56 . . . . 2.11 110.384 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.849 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 13.5 m 50.64 37.77 17.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.938 -0.574 . . . . 1.81 112.086 175.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 1.001 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 27.9 mt-10 -62.65 143.16 57.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.38 -0.373 . . . . 1.81 111.379 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.766 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -136.46 127.66 28.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.939 -0.573 . . . . 0.81 110.749 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.617 HG21 HG21 ' A' ' 78' ' ' VAL . 27.7 m -91.1 115.1 27.75 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.529 -0.759 . . . . 1.18 110.696 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.515 ' HA ' HG23 ' A' ' 113' ' ' VAL . 58.0 t -86.33 109.92 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.872 -0.418 . . . . 1.51 109.872 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.542 ' HA ' HG21 ' A' ' 76' ' ' THR . 26.3 m -107.88 106.52 16.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.424 -0.353 . . . . 1.05 110.761 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.737 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 52.8 m-85 -88.35 117.72 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.556 -0.293 . . . . 0.42 110.346 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.98 112.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.236 -0.283 . . . . 1.26 110.236 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.33 51.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.887 -0.597 . . . . 1.13 111.593 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.8 t70 -137.38 120.31 16.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.595 . . . . 2.03 109.535 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.27 58.64 1.13 Allowed Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.994 -0.548 . . . . 1.97 113.118 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 21.0 tt0 -150.98 13.57 0.7 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.994 . . . . 5.46 108.315 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 59.8 mttp 67.09 33.7 5.49 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.175 -0.92 . . . . 3.88 109.384 -167.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 7.3 ttpm? -121.65 154.43 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.407 -0.59 . . . . 2.94 109.407 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' HG12 ' A' ' 12' ' ' VAL . 18.7 m -161.14 128.63 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.757 0.313 . . . . 1.2 110.728 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.34 114.95 28.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.036 -0.727 . . . . 3.1 109.036 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.995 HG11 HG22 ' A' ' 10' ' ' VAL . 12.7 p -93.2 144.67 8.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 120.994 -0.283 . . . . 1.13 111.199 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.457 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 7.3 t70 -130.26 126.78 38.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.222 -0.899 . . . . 1.38 109.51 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.739 ' HB ' ' CD2' ' A' ' 8' ' ' HIS . 1.2 t -111.44 133.22 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 116.662 -0.245 . . . . 1.58 110.809 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 49.8 mt-10 -104.31 110.73 23.08 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.907 0.754 . . . . 2.31 109.921 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 79.0 t60 -123.38 99.06 6.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.214 -1.032 . . . . 2.32 108.214 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -153.07 91.26 1.51 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.116 0.484 . . . . 3.19 110.129 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -155.6 -75.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.904 -0.589 . . . . 2.99 110.142 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 91' ' ' PRO . 37.1 t80 -82.31 -25.76 33.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.654 -0.703 . . . . 4.27 110.906 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.87 -43.63 53.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.684 -0.689 . . . . 1.81 110.991 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 71.0 ttt180 -53.72 -21.3 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.368 -0.833 . . . . 3.84 112.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 79.1 mmm -78.64 2.14 20.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.428 -0.351 . . . . 2.9 111.113 -177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.31 -144.38 6.71 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.744 -0.662 . . . . 2.26 114.342 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 47.48 -132.61 1.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.302 0.641 . . . . 3.02 110.85 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -77.59 -13.91 59.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.471 -0.143 . . . . 4.23 111.371 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.479 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.8 m170 -72.72 -52.94 13.11 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.472 -0.566 . . . . 2.7 109.472 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.0 70.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.767 -0.651 . . . . 1.46 111.026 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -64.33 -39.47 93.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.478 -0.328 . . . . 3.16 111.098 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 3.1 ptm180 -73.28 -32.9 64.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 2.97 110.336 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.69 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 89.5 t -65.06 -40.49 89.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.385 0.612 . . . . 1.96 110.266 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.478 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 8.5 ttp180 -65.66 -17.25 64.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 4.34 111.904 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.546 ' HB3' ' HG2' ' A' ' 88' ' ' ARG . 65.9 t30 -52.99 -46.47 68.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.727 0.298 . . . . 2.8 111.629 -173.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.476 ' N ' ' HG3' ' A' ' 88' ' ' ARG . . . -120.01 -20.07 3.83 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.145 -1.026 . . . . 2.08 113.031 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 49.6 ttm -79.74 -22.96 42.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.577 -0.366 . . . . 5.19 111.165 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 10.3 t70 -55.65 -49.15 73.66 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.851 0.685 . . . . 2.83 112.851 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -100.42 -39.85 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.984 -0.286 . . . . 4.47 111.335 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -59.41 -59.59 10.36 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 116.46 -0.336 . . . . 1.04 113.324 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.529 ' HH2' HG12 ' A' ' 113' ' ' VAL . 3.4 t90 -59.36 -49.99 89.68 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.63 0.604 . . . . 3.78 112.63 -172.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 28.6 Cg_endo -62.13 -35.54 74.82 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.002 1.801 . . . . 0.77 112.385 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -68.55 -37.04 79.6 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.248 -0.649 . . . . 1.37 109.248 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.672 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 57.8 mt -55.59 -49.35 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.933 -1.031 . . . . 1.32 110.244 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 60.4 mt -58.79 -33.8 70.75 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.363 0.414 . . . . 1.33 112.063 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.51 -57.0 7.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 1.54 110.417 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.626 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 70.1 m -65.89 -23.18 66.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.941 -0.572 . . . . 1.43 110.532 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.448 ' CZ ' HD12 ' A' ' 148' ' ' ILE . 64.7 t80 -63.85 -53.0 57.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 1.05 110.101 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 76.1 mt-30 -58.58 -33.57 70.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.233 0.54 . . . . 1.63 110.34 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.36 -42.15 45.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.46 111.33 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.5 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 10.0 tptt -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.225 0.536 . . . . 2.23 110.442 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 19' ' ' ALA . 66.2 mt -68.49 -30.31 47.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.821 -0.627 . . . . 1.17 110.537 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.92 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 28.1 t0 -61.08 -30.96 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.85 109.898 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.776 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 43.8 mt-10 -65.99 -29.98 70.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 1.5 110.392 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -85.13 -5.14 59.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.419 -0.809 . . . . 1.74 110.173 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.8 -71.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.943 -0.646 . . . . 1.32 113.488 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.64 24.76 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.467 0.543 . . . . 2.42 112.467 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.776 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 14.9 tppt? -62.14 -74.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.431 0.158 . . . . 2.04 110.777 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.745 ' HZ3' ' HB2' ' A' ' 155' ' ' LYS . 6.8 mtmp? . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.322 -0.847 . . . . 4.65 110.392 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 6' ' ' VAL . 31.8 p-10 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 121.028 0.442 . . . . 2.1 110.78 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.411 ' HA ' HG23 ' A' ' 6' ' ' VAL . 92.1 m-85 -162.01 -41.71 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.44 1.096 . . . . 4.04 108.391 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.743 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 20.0 t70 -61.03 -54.73 51.3 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.171 -0.922 . . . . 2.78 112.312 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.2 Cg_endo -91.69 -63.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 1.83 112.493 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.48 ' HA ' HG23 ' A' ' 116' ' ' THR . 30.9 p90 -152.4 142.86 22.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.082 -0.508 . . . . 3.98 109.856 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.671 ' HB ' ' CE1' ' A' ' 115' ' ' HIS . 16.7 t -103.81 108.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.722 -0.473 . . . . 2.03 109.722 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 25.7 ttm180 -109.38 132.92 53.67 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.844 -0.616 . . . . 3.92 111.502 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CD2' HG11 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.21 135.6 50.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.999 -0.741 . . . . 1.16 108.999 173.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.753 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 5.5 p -141.18 112.72 7.55 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.144 0.497 . . . . 1.72 111.488 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.637 HG23 ' CG1' ' A' ' 111' ' ' VAL . 16.1 m -122.93 152.44 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.978 -0.555 . . . . 1.89 111.317 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -102.18 116.04 31.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.509 -0.769 . . . . 1.15 110.152 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.7 HG23 ' HB3' ' A' ' 19' ' ' ALA . 38.4 t -91.37 132.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.019 -0.991 . . . . 1.51 109.974 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.661 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -101.45 23.25 11.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.978 -0.555 . . . . 1.6 112.139 -171.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.478 ' H ' HG13 ' A' ' 12' ' ' VAL . . . -155.35 37.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.244 0.461 . . . . 1.11 112.244 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 22.6 t70 75.39 159.6 0.22 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 122.04 0.924 . . . . 0.91 112.544 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 32.5 ttp180 -63.04 -25.49 68.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.637 -1.165 . . . . 2.19 111.618 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.92 -48.48 79.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.587 -0.279 . . . . 3.49 110.272 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.2 p -74.08 -36.4 64.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.952 -0.299 . . . . 1.49 111.201 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.7 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -59.23 -45.48 91.03 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.414 -0.514 . . . . 1.07 110.574 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CE1' HD23 ' A' ' 77' ' ' LEU . 76.1 t80 -71.49 -44.27 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.363 -0.38 . . . . 0.43 110.616 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -54.97 -54.27 45.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.132 0.491 . . . . 2.87 110.75 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.44 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.0 m -63.79 -48.54 76.48 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.078 -0.964 . . . . 1.21 110.24 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.714 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 61.5 t80 -59.72 -37.78 79.85 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.647 0.592 . . . . 0.53 112.223 -173.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.618 ' HG ' HG13 ' A' ' 46' ' ' VAL . 11.0 tp -112.78 -51.39 2.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.818 0.673 . . . . 1.23 112.818 -173.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.96 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 11.8 mt-10 -82.08 -38.62 24.61 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.799 -0.563 . . . . 1.24 111.988 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.628 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.07 40.53 2.81 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.876 -0.602 . . . . 0.83 112.193 -176.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.596 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 55.0 t80 -61.54 -58.2 20.02 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 112.043 0.386 . . . . 0.94 112.043 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 80.7 Cg_endo -80.11 29.26 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.533 2.155 . . . . 0.9 114.388 -174.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.3 pt-20 -125.46 2.13 7.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.543 -0.463 . . . . 1.49 110.986 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.768 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 24.9 m0 -75.62 157.87 33.18 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.048 0.451 . . . . 5.66 109.908 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.631 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 12.6 m95 -87.4 -34.93 0.45 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.17 0.804 . . . . 3.41 113.17 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.768 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 14.0 Cg_endo -54.43 -86.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.802 2.335 . . . . 1.36 115.295 -165.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.653 HD21 HG13 ' A' ' 40' ' ' VAL . 2.0 t30 -111.23 -34.72 6.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.479 0.657 . . . . 1.51 110.465 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.743 ' HA ' HG11 ' A' ' 40' ' ' VAL . 9.5 p-10 -91.51 33.62 1.0 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.061 -0.972 . . . . 1.98 111.823 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -96.34 -2.14 46.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.794 0.807 . . . . 5.13 109.115 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 8.2 mmt180 -99.34 126.0 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.198 -0.91 . . . . 4.7 110.65 -176.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 p -76.58 135.59 39.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.117 -0.492 . . . . 3.11 110.821 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' 57' ' ' ASP . 61.1 p 57.74 20.08 6.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.38 1.072 . . . . 1.89 111.727 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -111.56 -46.8 3.23 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.771 -1.196 . . . . 3.45 107.771 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 34' ' ' ASN . 14.3 p -174.52 26.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.711 -1.131 . . . . 2.3 109.02 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.97 36.33 0.28 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.641 -0.79 . . . . 2.2 112.93 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.962 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -66.12 164.49 28.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.531 -0.544 . . . . 1.31 109.531 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 56.96 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.352 2.701 . . . . 1.94 114.202 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.18 -83.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.173 0.589 . . . . 2.23 109.495 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.578 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 89.59 -55.68 3.82 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.86 -0.686 . . . . 0.94 113.592 170.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 24' ' ' LEU . 91.3 t -138.73 142.09 35.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.001 0.429 . . . . 1.21 111.693 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.514 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.6 t70 -110.67 110.08 20.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 1.11 108.97 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 3.2 mptt -80.93 -29.55 35.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 3.25 111.872 -172.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -74.68 -42.43 58.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.031 0.382 . . . . 3.63 112.031 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.21 -42.18 3.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.638 -0.791 . . . . 1.9 111.612 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA2' HD13 ' A' ' 68' ' ' ILE . . . 107.35 68.19 0.66 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.86 -0.686 . . . . 0.87 112.745 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 6.8 ptm180 -159.25 139.74 12.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 4.26 111.094 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.728 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -95.23 110.09 22.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.52 . . . . 1.52 110.154 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.514 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.1 p90 -152.09 159.45 43.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.158 0.504 . . . . 2.04 110.876 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.962 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 24.9 mt-10 -117.18 156.06 28.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 2.12 110.89 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 mm -78.17 102.53 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.317 -0.994 . . . . 1.42 108.317 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.621 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 14.9 t70 -87.71 -177.87 5.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 1.97 110.54 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.444 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 10.5 pt-20 -60.95 -40.64 94.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.348 0.499 . . . . 2.43 112.348 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.463 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -100.16 25.12 7.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 2.39 111.039 -178.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.3 -100.66 0.46 Allowed Glycine 0 C--O 1.22 -0.748 0 C-N-CA 120.822 -0.704 . . . . 2.29 111.801 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.621 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -156.02 75.31 0.89 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.357 0.598 . . . . 2.31 110.394 175.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -110.01 74.58 0.89 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.817 -0.808 . . . . 2.61 108.817 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.605 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 2.2 m-70 -124.21 147.47 48.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 4.63 110.549 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 p -57.68 110.27 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.586 0.554 . . . . 2.27 111.141 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.728 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 48.9 p90 -77.05 122.45 24.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.237 0.541 . . . . 7.39 111.553 -175.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 82' ' ' ARG . . . -60.49 134.41 50.0 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.056 -1.218 . . . . 1.23 110.056 170.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.477 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -97.63 87.81 4.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.607 0.703 . . . . 1.76 110.924 -168.116 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 71' ' ' VAL . 51.5 mt -72.99 126.43 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.051 -0.522 . . . . 1.26 109.893 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.451 ' HG3' ' OE2' ' A' ' 96' ' ' GLU . 6.3 mmm180 -94.33 -26.57 16.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.837 -0.619 . . . . 2.65 109.38 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.2 ttpp -166.13 133.83 2.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.619 -0.719 . . . . 2.03 111.386 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 68' ' ' ILE . 90.7 t -115.26 106.28 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.546 -0.909 . . . . 1.47 108.546 174.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.1 m-20 -102.99 59.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.618 -0.265 . . . . 1.42 110.936 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.557 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 10.5 pt-20 46.89 -168.83 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.247 0.967 . . . . 0.96 111.863 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.557 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 37.5 Cg_exo -63.52 80.5 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.422 1.414 . . . . 0.48 111.384 167.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 23.7 t70 -167.73 -66.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.45 -0.796 . . . . 0.5 110.275 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -146.71 159.07 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 1.1 111.358 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.491 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -148.03 126.92 12.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.571 -0.529 . . . . 1.4 109.571 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.28 101.58 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.08 -0.711 . . . . 1.31 109.08 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.491 HG13 HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.86 137.69 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.859 0.362 . . . . 1.48 110.796 -176.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -89.17 145.4 18.51 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.845 -0.616 . . . . 0.5 112.462 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.781 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 73.7 t-105 -64.48 131.24 46.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.036 0.922 . . . . 3.37 113.347 -171.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.458 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 5.8 tpt180 -151.51 94.52 2.02 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.751 -1.944 . . . . 6.17 105.751 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD21 ' O ' ' A' ' 89' ' ' ILE . 1.5 pp -67.72 -170.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.031 -0.532 . . . . 2.13 112.367 -170.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.427 ' OD1' HG23 ' A' ' 40' ' ' VAL . 3.0 m-20 -68.21 76.65 0.25 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.611 -0.885 . . . . 1.93 108.611 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.26 50.94 4.08 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.058 -0.974 . . . . 2.79 113.672 -168.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -132.47 34.66 3.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.828 -1.175 . . . . 6.08 107.828 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.421 ' O ' ' HD3' ' A' ' 88' ' ' ARG . . . 169.9 -26.36 0.11 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.473 -1.239 . . . . 2.43 111.386 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.697 ' HG3' ' HA3' ' A' ' 132' ' ' GLY . 36.6 mmt-85 -117.15 160.8 20.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.198 -0.297 . . . . 5.53 110.198 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.569 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -94.12 119.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.613 0.72 . . . . 2.42 111.168 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -88.76 133.92 34.89 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.292 -0.867 . . . . 3.18 110.07 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.21 -54.71 2.81 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.566 2.177 . . . . 2.76 112.267 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.19 86.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.935 0.772 . . . . 2.99 111.936 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -160.89 -52.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 3.06 109.124 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 95' ' ' SER . 12.4 m -142.91 -84.68 0.16 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.534 -1.284 . . . . 2.11 107.534 172.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.781 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 14.6 m 56.81 23.81 8.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.848 . . . . 1.81 111.662 169.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.74 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 25.2 mt-10 -71.23 139.63 50.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.873 -0.603 . . . . 1.81 111.665 -172.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.979 ' HB3' ' HB3' ' A' ' 115' ' ' HIS . 1.1 p90 -126.94 137.35 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.013 -0.54 . . . . 0.81 110.927 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 41.8 m -91.41 109.11 20.39 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.185 -0.916 . . . . 1.18 109.977 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 113' ' ' VAL . 45.2 t -89.27 108.6 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.626 -0.509 . . . . 1.51 109.626 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.677 ' HA ' HG22 ' A' ' 76' ' ' THR . 42.1 m -104.09 106.57 17.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 1.05 110.563 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.706 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 48.6 m-85 -88.77 107.44 18.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.971 -0.381 . . . . 0.42 109.971 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.45 112.98 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.813 -0.44 . . . . 1.26 109.813 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.39 134.31 52.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.182 -0.463 . . . . 1.13 110.049 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 22.3 t70 -121.86 111.5 17.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.153 -0.476 . . . . 2.03 109.762 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.62 -99.27 0.81 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.859 -0.686 . . . . 1.97 112.48 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.56 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 4.1 pt20 -150.05 -25.23 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.454 0.168 . . . . 5.46 111.454 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.56 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 35.7 pttt -137.56 19.4 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 3.88 111.164 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 12.3 mptt -122.39 158.38 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.121 -0.696 . . . . 2.94 109.121 172.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.7 m -158.07 119.85 3.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.885 0.374 . . . . 1.2 110.813 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -101.66 108.5 20.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.114 -0.698 . . . . 3.1 109.114 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.2 p -90.82 142.32 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 116.322 -0.399 . . . . 1.13 110.245 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.552 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 16.4 t70 -132.54 113.46 13.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.441 -1.254 . . . . 1.38 109.519 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 3.0 t -105.13 124.48 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 116.504 -0.317 . . . . 1.58 111.131 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.61 125.71 54.46 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.987 -0.685 . . . . 2.31 110.04 170.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.979 ' HB3' ' HB3' ' A' ' 97' ' ' PHE . 27.7 p80 -137.35 125.82 23.52 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.822 -0.626 . . . . 2.32 109.737 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 5' ' ' PHE . 23.2 p -135.06 77.78 1.7 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 3.19 110.916 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.627 ' O ' ' HG2' ' A' ' 121' ' ' MET . 2.0 t-160 -158.96 -75.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.828 -0.749 . . . . 2.99 110.759 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.416 ' HE1' HG12 ' A' ' 129' ' ' VAL . 19.0 p90 -71.47 -29.76 65.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.12 -0.491 . . . . 4.27 111.483 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -51.75 19.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.615 0.766 . . . . 1.81 110.867 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.407 ' NH1' ' HB ' ' A' ' 116' ' ' THR . 42.1 ttp180 -58.89 -20.87 55.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.045 -0.98 . . . . 3.84 111.6 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.627 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.8 mmt -64.36 -19.31 65.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.511 0.196 . . . . 2.9 110.955 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.85 -157.54 3.26 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 114.756 0.662 . . . . 2.26 114.756 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 124' ' ' LYS . 11.5 p 40.62 -128.78 0.43 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.032 0.933 . . . . 3.02 112.964 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.587 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 46.4 mmtm -60.08 -38.54 83.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 4.23 111.516 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -60.86 -49.66 76.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 2.7 110.714 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.68 68.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.112 -0.495 . . . . 1.46 110.491 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -72.37 -41.27 66.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 3.16 110.9 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 8.9 ptp180 -68.92 -33.64 74.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.624 0.249 . . . . 2.97 111.252 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.416 HG12 ' HE1' ' A' ' 118' ' ' PHE . 88.9 t -70.46 -45.75 73.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.397 0.618 . . . . 1.96 110.267 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.536 ' CG ' ' HB2' ' A' ' 134' ' ' ASP . 42.6 ttt180 -68.47 -14.58 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.382 -0.826 . . . . 4.34 111.137 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -52.34 -26.88 13.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.036 -0.529 . . . . 2.8 111.841 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.697 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -140.08 -37.43 0.11 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.974 -1.108 . . . . 2.08 113.34 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.672 ' HG3' ' HB2' ' A' ' 137' ' ' TRP . 7.7 tpt -73.06 -10.67 60.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.047 0.423 . . . . 5.19 111.366 -172.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.536 ' HB2' ' CG ' ' A' ' 130' ' ' ARG . 27.8 t70 -62.49 -31.43 72.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.151 0.501 . . . . 2.83 111.277 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -103.0 4.27 37.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.052 0.453 . . . . 4.47 110.485 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.536 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.75 -63.61 0.6 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.738 -0.665 . . . . 1.04 112.471 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.672 ' HB2' ' HG3' ' A' ' 133' ' ' MET . 4.2 t90 -57.96 -51.96 77.98 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.029 0.752 . . . . 3.78 113.029 -170.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.9 Cg_endo -60.96 -38.24 70.5 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.845 1.696 . . . . 0.77 111.916 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.2 m -67.45 -37.19 82.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.637 -0.71 . . . . 1.37 109.503 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.746 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 17.5 mt -57.39 -50.72 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 114.888 -1.051 . . . . 1.32 111.188 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 75.6 mt -57.44 -41.84 81.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.411 0.445 . . . . 1.33 111.209 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.92 -51.59 68.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.118 0.485 . . . . 1.54 110.866 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.69 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 41.7 m -71.65 -21.51 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 1.43 110.955 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 61.7 t80 -63.19 -53.02 59.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.238 -0.653 . . . . 1.05 109.238 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -31.93 69.35 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.868 -0.605 . . . . 1.63 110.51 173.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.05 -40.36 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 1.46 112.04 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -69.46 -39.32 77.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.068 0.461 . . . . 2.23 109.956 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 12' ' ' VAL . 87.0 mt -65.72 -29.58 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 1.17 110.343 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.416 ' OD2' ' HG3' ' A' ' 154' ' ' LYS . 17.9 t0 -64.39 -25.24 67.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.616 -0.72 . . . . 0.85 110.199 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -71.52 -31.01 66.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.639 . . . . 1.5 109.964 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.52 -32.55 48.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.598 -0.728 . . . . 1.74 109.885 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -89.05 22.73 21.1 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.745 -0.661 . . . . 1.32 111.895 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.12 85.03 0.14 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.085 0.554 . . . . 2.42 111.735 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.416 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 34.0 ttmt -79.92 66.3 5.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.732 0.777 . . . . 2.04 109.014 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.69 ' HZ3' ' HB2' ' A' ' 155' ' ' LYS . 7.8 mtmp? . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.607 -1.179 . . . . 4.65 108.586 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 5.9 p30 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.346 -0.242 . . . . 2.1 110.346 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.526 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.8 p90 -169.21 -57.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.99 0.367 . . . . 4.04 111.99 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.68 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.6 t70 -66.55 -57.24 12.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.645 0.609 . . . . 2.78 112.645 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 2.8 Cg_endo -79.69 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.487 1.458 . . . . 1.83 111.971 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -142.3 121.47 13.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.684 0.278 . . . . 3.98 110.581 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.3 t -86.35 113.65 24.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.311 -0.996 . . . . 2.03 108.311 169.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 2.1 ttt180 -141.85 145.99 35.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.181 0.515 . . . . 3.92 111.077 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.574 ' HD1' HG22 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -122.65 131.09 53.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.012 -0.736 . . . . 1.16 109.012 169.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.9 p -134.64 111.54 10.09 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.808 0.813 . . . . 1.72 110.125 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 110' ' ' ARG . 0.9 OUTLIER -125.95 146.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.272 -1.331 . . . . 1.89 111.801 -174.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -104.45 116.67 32.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.013 -0.539 . . . . 1.15 110.473 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 148' ' ' ILE . 5.0 t -97.36 141.13 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.918 -0.583 . . . . 1.51 109.973 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.598 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 15.3 mmtp -106.83 14.84 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.575 -0.284 . . . . 1.6 111.724 -169.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.09 36.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.48 -0.488 . . . . 1.11 111.499 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.573 ' OD1' ' HG3' ' A' ' 17' ' ' LYS . 35.2 t70 71.73 168.45 0.31 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.053 0.93 . . . . 0.91 112.614 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.613 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 11.5 ttp180 -66.48 -23.74 66.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.383 -1.281 . . . . 2.19 111.412 -174.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.573 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 62.6 mttm -60.96 -52.4 65.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 3.49 110.632 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.6 p -68.98 -34.51 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 1.49 110.458 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.461 ' HB2' ' CE1' ' A' ' 101' ' ' PHE . . . -57.4 -51.24 70.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 1.07 110.824 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.3 t80 -67.61 -45.06 76.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.223 -0.444 . . . . 0.43 110.673 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 18.6 ttmt -57.53 -49.16 77.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 2.87 111.18 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.581 HG22 ' CE2' ' A' ' 30' ' ' TRP . 31.1 m -69.72 -33.22 72.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.043 0.449 . . . . 1.21 111.11 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -75.95 -37.15 58.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.922 -0.311 . . . . 0.53 111.169 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.664 ' HG ' HG13 ' A' ' 46' ' ' VAL . 14.1 tp -120.15 -51.86 2.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.513 0.931 . . . . 1.23 113.513 -171.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.652 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 49.8 mt-10 -75.21 -51.81 12.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.463 0.542 . . . . 1.24 112.463 -168.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -88.12 32.23 4.44 Favored Glycine 0 C--N 1.315 -0.628 0 CA-C-N 115.781 -0.645 . . . . 0.83 111.9 -175.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.665 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 62.8 t80 -50.09 -57.84 11.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 123.343 0.657 . . . . 0.94 112.135 -170.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 28.1 Cg_endo -87.81 51.17 2.0 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.945 1.763 . . . . 0.9 114.62 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.6 pt-20 -150.07 -11.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.258 0.836 . . . . 1.49 113.258 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.763 ' CZ3' ' HG2' ' A' ' 147' ' ' LYS . 11.1 m95 -76.41 -172.31 2.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.155 0.502 . . . . 5.66 111.094 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 19.6 m95 -92.56 -26.05 0.28 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 3.41 114.758 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.652 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 93.4 Cg_endo -79.2 -139.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 CA-C-N 120.972 1.383 . . . . 1.36 113.876 -169.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.571 ' ND2' HG23 ' A' ' 40' ' ' VAL . 3.4 t-20 -48.07 -45.78 32.85 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.518 -0.765 . . . . 1.51 111.533 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -76.69 26.07 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.368 0.877 . . . . 1.98 113.368 -170.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -102.07 3.8 39.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 5.13 110.509 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -100.52 120.83 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 4.7 111.411 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 p -76.99 133.86 39.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.823 0.344 . . . . 3.11 111.511 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 p 52.86 27.37 5.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.019 0.928 . . . . 1.89 111.241 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' O ' HG11 ' A' ' 40' ' ' VAL . 48.3 tttp -124.89 -49.27 1.74 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.732 -1.122 . . . . 3.45 108.668 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.608 HG12 ' HD1' ' A' ' 65' ' ' PHE . 1.3 m -166.0 30.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 124.127 0.892 . . . . 2.3 110.693 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -173.08 31.87 0.11 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.813 -1.184 . . . . 2.2 114.159 -171.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.784 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.41 173.94 3.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.299 -0.63 . . . . 1.31 109.299 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 42' ' ' ALA . 34.6 Cg_exo -63.49 41.97 0.1 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 C-N-CA 123.327 2.684 . . . . 1.94 114.71 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -149.11 -80.76 0.13 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.676 -0.49 . . . . 2.23 109.676 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.512 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 88.6 -60.87 3.91 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.887 -0.673 . . . . 0.94 112.689 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.664 HG13 ' HG ' ' A' ' 24' ' ' LEU . 77.9 t -141.26 133.6 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.547 0.213 . . . . 1.21 111.164 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -103.85 113.06 26.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.112 -0.494 . . . . 1.11 110.208 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 5.5 mptt -81.15 -16.15 53.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 3.25 110.847 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -76.36 -62.21 1.69 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.109 -0.496 . . . . 3.63 110.7 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.21 17.86 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 1.9 111.424 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.7 60.37 0.59 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.804 -0.713 . . . . 0.87 112.097 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.39 150.84 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.54 -0.388 . . . . 4.26 111.279 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 65' ' ' PHE . 6.1 m0 -100.24 110.86 23.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.984 -0.747 . . . . 1.52 108.984 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -162.4 174.55 12.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.429 0.633 . . . . 2.04 111.26 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.784 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 25.1 mt-10 -126.8 174.69 8.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.648 -0.705 . . . . 2.12 109.834 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.421 HD13 ' HG2' ' A' ' 61' ' ' GLU . 32.3 mm -100.75 100.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.954 -0.758 . . . . 1.42 108.954 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 2.9 m-20 -67.26 -175.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.574 0.702 . . . . 1.97 112.013 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.28 -25.29 29.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.289 -0.868 . . . . 2.43 110.925 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.593 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 2.4 pm0 -95.66 5.05 52.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 2.39 110.828 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.16 -109.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.235 -0.983 . . . . 2.29 112.56 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HG2' HD13 ' A' ' 56' ' ' ILE . 28.2 mt-10 -147.97 34.54 0.83 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.478 0.311 . . . . 2.31 110.975 -173.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 9.9 pt-20 -97.5 74.43 2.44 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.29 -0.964 . . . . 2.61 111.283 -171.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.9 163.32 20.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.995 . . . . 4.63 111.409 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -131.04 148.67 52.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.411 -0.813 . . . . 2.27 110.534 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 6.6 t80 -165.54 -54.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.587 0.554 . . . . 7.39 109.598 172.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.537 ' HA3' HD13 ' A' ' 79' ' ' ILE . . . -156.12 149.91 21.03 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.186 -1.007 . . . . 1.23 113.415 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.474 HD12 ' CZ ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -114.76 103.92 11.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.625 -0.509 . . . . 1.76 109.625 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.456 HG22 HG21 ' A' ' 71' ' ' VAL . 43.4 mt -79.5 142.1 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.987 0.422 . . . . 1.26 110.839 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.474 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.6 mpt_? -114.04 -25.22 8.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.82 -0.627 . . . . 2.65 110.48 174.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.64 ' HD2' HG23 ' A' ' 78' ' ' VAL . 13.1 ttmm -142.55 106.62 4.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.531 -0.304 . . . . 2.03 111.174 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 HG21 HG22 ' A' ' 68' ' ' ILE . 41.5 t -95.05 92.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.268 -1.012 . . . . 1.47 108.268 167.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -109.5 70.34 0.73 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.661 -0.416 . . . . 1.42 111.12 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.9 pt-20 48.37 -172.59 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.507 1.13 . . . . 0.96 112.018 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 26.2 Cg_exo -65.45 75.35 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.428 1.419 . . . . 0.48 111.1 166.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -157.46 -66.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.5 110.358 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -141.77 143.71 33.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.412 0.625 . . . . 1.1 112.079 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -131.5 112.05 12.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.509 -0.769 . . . . 1.4 109.506 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.64 HG23 ' HD2' ' A' ' 70' ' ' LYS . 86.1 t -90.6 104.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.801 -0.815 . . . . 1.31 108.801 172.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.537 HD13 ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -127.93 122.55 58.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.378 -0.828 . . . . 1.48 111.333 -170.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.927 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -87.25 154.7 26.57 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 111.833 -0.507 . . . . 0.5 111.833 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.758 ' CZ2' ' HA ' ' A' ' 83' ' ' LEU . 68.8 t-105 -91.16 125.93 36.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.466 0.651 . . . . 3.37 111.798 -171.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -124.76 0.27 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 6.17 109.26 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 1.079 HD21 ' HB2' ' A' ' 88' ' ' ARG . 6.8 tt 78.57 154.26 0.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.706 -1.134 . . . . 2.13 113.416 169.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.524 ' HB2' HG13 ' A' ' 40' ' ' VAL . 22.5 p-10 -117.88 -28.0 6.04 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.129 -0.941 . . . . 1.93 112.689 -168.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.47 -29.59 63.84 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-O 119.727 -0.485 . . . . 2.79 113.882 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 73.01 -42.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.412 0.685 . . . . 6.08 110.769 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.88 3.39 70.59 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.101 -0.8 . . . . 2.43 111.101 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 1.079 ' HB2' HD21 ' A' ' 83' ' ' LEU . 69.2 mmt-85 -96.75 173.93 7.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.155 -0.313 . . . . 5.53 110.155 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.852 HD11 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -101.15 119.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.175 0.512 . . . . 2.42 110.319 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 7.6 p-10 -91.24 141.31 26.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.157 0.503 . . . . 3.18 111.556 -175.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 129' ' ' VAL . 10.0 Cg_exo -72.07 -49.97 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.036 2.49 . . . . 2.76 111.538 171.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.462 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 17.4 t70 70.72 -41.93 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.785 0.834 . . . . 2.99 112.911 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.575 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 21.2 m-80 -73.32 -31.24 63.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.384 . . . . 3.06 111.927 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.537 ' HB2' ' HD2' ' A' ' 118' ' ' PHE . 67.6 m -154.19 -126.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.101 -0.239 . . . . 2.11 111.244 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.67 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 58.8 m 57.59 28.67 16.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.454 0.645 . . . . 1.81 110.352 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.927 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 36.5 tt0 -62.08 138.55 58.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.957 -1.02 . . . . 1.81 111.02 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.53 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -133.92 136.92 44.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.149 0.499 . . . . 0.81 110.931 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.8 m -99.17 110.42 22.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 1.18 110.174 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.67 ' HA ' HG21 ' A' ' 113' ' ' VAL . 91.8 t -82.8 109.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.828 -0.624 . . . . 1.51 110.103 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.7 m -103.52 106.13 16.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.379 -0.373 . . . . 1.05 110.67 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.613 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 40.9 m-85 -87.99 112.7 22.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.304 -0.407 . . . . 0.42 110.255 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.13 111.19 25.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.286 -0.415 . . . . 1.26 110.125 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.89 133.76 48.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 1.13 110.833 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.768 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.9 t0 -126.99 100.92 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.174 -0.466 . . . . 2.03 109.833 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.7 49.46 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.708 -0.758 . . . . 1.97 113.404 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 72.22 8.16 5.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.504 0.722 . . . . 5.46 111.973 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -128.06 -11.66 5.29 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.828 -0.545 . . . . 3.88 110.285 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 77.5 tttt -122.48 158.06 30.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.893 -0.781 . . . . 2.94 108.893 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.1 m -157.6 117.64 3.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.95 0.405 . . . . 1.2 110.792 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.4 tmm_? -102.12 116.22 32.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.512 -0.922 . . . . 3.1 108.512 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.9 p -90.73 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.313 -0.403 . . . . 1.13 111.116 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -129.13 112.58 14.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 1.38 108.732 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' A' ' 99' ' ' VAL . 47.0 t -104.71 120.85 55.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.956 -0.566 . . . . 1.58 111.209 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.46 122.82 40.95 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.765 0.666 . . . . 2.31 109.651 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.626 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 2.3 t-160 -131.44 97.75 4.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.799 -0.815 . . . . 2.32 108.799 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.57 HG21 ' HD2' ' A' ' 120' ' ' ARG . 24.5 p -141.78 103.13 4.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.726 -0.215 . . . . 3.19 111.271 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -167.39 -74.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.315 -0.554 . . . . 2.99 112.172 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.575 ' HE2' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -85.75 -42.43 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 4.27 111.391 -168.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.95 73.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.195 -0.911 . . . . 1.81 110.719 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD2' HG21 ' A' ' 116' ' ' THR . 44.1 mtp180 -59.59 -19.32 47.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.424 -0.807 . . . . 3.84 111.923 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.9 ' HA ' ' HE3' ' A' ' 121' ' ' MET . 11.5 mmt -72.4 23.63 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.69 0.996 . . . . 2.9 113.69 -171.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.79 -155.88 15.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.847 -1.168 . . . . 2.26 114.406 168.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 p -61.66 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.32 0.859 . . . . 3.02 113.32 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 48.1 mtpt -70.05 -14.31 62.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 4.23 112.002 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.65 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 40.3 m80 -73.03 -49.92 26.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.461 0.648 . . . . 2.7 109.364 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.89 73.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.024 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.606 ' HB3' ' HA ' ' A' ' 124' ' ' LYS . 2.8 tppp? -71.25 -38.03 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.685 -0.689 . . . . 3.16 111.382 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.852 ' HB2' HD11 ' A' ' 89' ' ' ILE . 15.8 ptm180 -67.69 -30.86 70.49 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.907 -0.317 . . . . 2.97 110.272 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.562 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.4 t -84.61 -30.92 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.319 -0.552 . . . . 1.96 111.605 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.271 -0.422 . . . . 4.34 111.928 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 5.3 p30 -63.56 -33.48 75.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 2.8 111.281 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.89 -71.33 1.28 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.517 -0.849 . . . . 2.08 114.213 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.608 ' HB3' ' CZ2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -77.84 -21.89 50.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.961 0.726 . . . . 5.19 112.961 -165.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.9 -28.15 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 2.83 111.244 -174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.3 mmpt? -101.99 15.24 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 4.47 110.916 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -134.24 -57.25 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.508 -0.853 . . . . 1.04 112.489 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.422 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 1.6 t90 -56.0 -54.43 52.4 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.693 0.627 . . . . 3.78 112.693 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.83 -34.33 40.13 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.708 1.606 . . . . 0.77 111.948 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 -41.0 95.23 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.925 -0.58 . . . . 1.37 109.894 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.652 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 63.2 mt -57.9 -46.43 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 115.334 -0.848 . . . . 1.32 109.843 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 21.6 mt -54.95 -42.9 72.92 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 123.638 0.586 . . . . 1.33 111.385 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -64.02 -46.18 85.6 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.582 -0.447 . . . . 1.54 110.813 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -75.19 -22.19 58.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.027 0.442 . . . . 1.43 110.927 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.463 ' HD2' ' OE1' ' A' ' 145' ' ' GLN . 92.8 t80 -61.18 -55.14 35.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 1.05 109.6 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.463 ' OE1' ' HD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -64.92 -30.7 71.7 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.019 -0.537 . . . . 1.63 110.45 175.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.48 -55.77 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.591 -0.277 . . . . 1.46 111.342 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.763 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 21.9 tptp -68.0 -39.61 83.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.53 -0.468 . . . . 2.23 110.841 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.692 HG22 HG13 ' A' ' 12' ' ' VAL . 47.2 mt -65.9 -37.83 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 1.17 111.894 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.924 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.1 t70 -64.09 -25.53 68.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.377 -0.374 . . . . 0.85 110.333 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.733 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 61.4 mt-10 -69.53 -39.66 77.37 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.38 -20.6 66.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.054 -0.975 . . . . 1.74 108.972 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.95 -82.78 0.9 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.06 -0.973 . . . . 1.32 111.56 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -155.01 12.37 0.37 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.866 0.691 . . . . 2.42 112.866 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.924 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 21.1 ttmm -63.67 -32.48 73.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.942 0.401 . . . . 2.04 111.466 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 119.22 -0.419 . . . . 4.65 110.719 -176.755 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.865 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 32.6 p30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.375 -0.232 . . . . 2.1 110.375 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER 70.26 -31.76 0.22 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.082 1.353 . . . . 4.04 112.172 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.788 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 23.6 t70 -59.34 -53.63 64.17 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.284 -0.265 . . . . 2.78 110.284 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 25.5 Cg_endo -94.64 -64.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.244 1.963 . . . . 1.83 111.348 167.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 38.6 p90 -151.77 171.4 17.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.936 -1.135 . . . . 3.98 107.936 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.934 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 86.0 t -107.58 103.91 16.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.853 -0.339 . . . . 2.03 110.53 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.786 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.1 ttp180 -93.76 130.59 39.69 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.239 -0.584 . . . . 3.92 110.84 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.681 ' HD1' HG22 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -110.53 133.54 53.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 1.16 108.817 173.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.1 t -134.7 111.08 9.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.518 0.675 . . . . 1.72 110.111 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 3.0 t -124.63 137.78 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.675 -1.148 . . . . 1.89 111.652 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.1 m -97.77 116.88 30.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.813 -0.63 . . . . 1.15 110.443 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 148' ' ' ILE . 32.9 t -94.7 142.4 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.46 -0.791 . . . . 1.51 110.868 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -99.23 12.76 35.27 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.25 0.463 . . . . 1.6 112.25 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG13 ' A' ' 12' ' ' VAL . . . -155.4 39.66 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.975 -0.69 . . . . 1.11 112.414 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 14.3 t70 73.12 167.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.811 0.815 . . . . 0.91 111.927 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 25.9 ttp180 -69.43 -23.4 63.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.094 -0.957 . . . . 2.19 110.707 -174.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 15.1 ptpt -60.76 -39.22 87.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 3.49 111.195 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -82.91 -37.86 23.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.928 -0.309 . . . . 1.49 110.594 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' A' ' 12' ' ' VAL . . . -56.27 -43.38 78.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.829 0.347 . . . . 1.07 110.462 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 79.4 t80 -70.93 -46.01 63.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.322 -0.399 . . . . 0.43 110.48 176.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -55.19 -55.0 36.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.037 -0.529 . . . . 2.87 111.382 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.448 HG22 ' NE1' ' A' ' 30' ' ' TRP . 23.6 m -67.23 -46.68 73.07 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.311 -0.859 . . . . 1.21 111.028 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.631 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 66.5 t80 -64.46 -34.89 79.25 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.103 0.409 . . . . 0.53 112.103 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.569 ' CD1' HG12 ' A' ' 46' ' ' VAL . 14.2 tp -108.67 -53.72 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.033 -0.667 . . . . 1.23 112.373 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.63 -39.44 37.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 1.24 111.297 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.692 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -91.4 33.53 4.72 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.65 -0.704 . . . . 0.83 112.336 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.521 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 44.8 t80 -52.54 -48.0 91.71 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.216 0.45 . . . . 0.94 112.216 -173.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -89.64 15.29 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.869 1.713 . . . . 0.9 115.036 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.692 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.0 pt-20 -100.44 -5.03 27.71 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.993 -0.683 . . . . 1.49 110.766 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.631 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 23.9 m0 -75.73 153.75 36.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.488 0.661 . . . . 5.66 111.468 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.629 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 36.8 m95 -80.47 -44.1 1.35 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.908 -1.042 . . . . 3.41 112.855 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 1.083 ' HD3' ' HB2' ' A' ' 143' ' ' SER . 11.3 Cg_endo -52.12 -76.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.062 2.508 . . . . 1.36 114.76 -164.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -120.35 -11.61 9.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 1.51 110.609 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.688 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.4 m-20 -99.14 18.67 16.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.688 . . . . 1.98 111.103 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.55 8.37 43.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.142 0.496 . . . . 5.13 111.023 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -117.73 140.33 49.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 4.7 111.65 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.48 148.03 37.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 3.11 110.921 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 57' ' ' ASP . 63.6 p 57.88 8.02 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.547 1.139 . . . . 1.89 112.843 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.78 -77.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.479 -0.934 . . . . 3.45 108.479 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.8 m -147.21 15.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.588 -0.893 . . . . 2.3 108.588 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.49 55.35 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.72 -1.127 . . . . 2.2 111.876 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.878 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -104.05 169.81 6.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.406 -0.961 . . . . 1.31 108.406 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.19 53.83 0.26 Allowed 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 123.038 2.492 . . . . 1.94 113.77 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.43 HD22 ' CZ ' ' A' ' 54' ' ' TYR . 35.3 tp -170.8 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.745 0.418 . . . . 2.23 110.378 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.649 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 87.76 -57.78 4.38 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.991 -0.623 . . . . 0.94 112.487 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 24' ' ' LEU . 89.0 t -134.81 136.66 51.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.839 0.352 . . . . 1.21 110.67 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.627 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.9 t70 -107.94 122.77 47.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.561 -0.745 . . . . 1.11 109.77 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -33.91 40.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.403 0.52 . . . . 3.25 112.403 -175.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HZ1' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -72.23 -47.22 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.814 0.301 . . . . 3.63 111.814 -172.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.88 -25.39 22.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.655 -0.784 . . . . 1.9 111.784 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.18 60.33 2.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.652 -0.785 . . . . 0.87 111.207 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 8.3 ptm180 -146.39 139.76 25.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.843 0.354 . . . . 4.26 111.118 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.529 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 24.5 m0 -97.99 108.26 20.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 1.52 110.547 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.627 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -153.32 151.71 30.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.997 0.427 . . . . 2.04 110.282 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.878 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 51.6 mp0 -117.79 160.05 22.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 2.12 110.512 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 61' ' ' GLU . 36.8 mm -77.84 103.97 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 1.42 110.062 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 38' ' ' THR . 7.0 t70 -95.43 -178.12 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 1.97 110.476 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -80.92 -7.68 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.798 0.666 . . . . 2.43 112.798 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.51 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -95.98 -4.65 42.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.289 0.566 . . . . 2.39 110.194 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.21 -85.1 0.18 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.505 -0.771 . . . . 2.29 111.816 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.506 ' HG2' HD12 ' A' ' 56' ' ' ILE . 52.6 mt-10 -156.65 18.94 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.717 -0.475 . . . . 2.31 109.717 -177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.86 88.85 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.742 0.782 . . . . 2.61 110.274 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -117.84 163.74 16.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.886 -1.052 . . . . 4.63 110.254 -178.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -52.7 109.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.67 -0.493 . . . . 2.27 109.67 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 30.7 p90 -92.58 130.66 38.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.334 0.588 . . . . 7.39 112.016 -170.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.4 157.55 31.72 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.74 -0.944 . . . . 1.23 110.74 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 93' ' ' ASN . 1.2 pt? -116.01 99.59 7.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.996 0.398 . . . . 1.76 111.261 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.592 HG22 HG23 ' A' ' 71' ' ' VAL . 40.7 mt -79.37 118.6 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.047 -0.661 . . . . 1.26 109.907 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -85.94 -23.25 27.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.841 -1.072 . . . . 2.65 109.818 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 78' ' ' VAL . 58.5 tttp -156.39 105.41 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.732 -0.667 . . . . 2.03 111.266 -174.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG23 HG22 ' A' ' 68' ' ' ILE . 49.8 t -98.92 93.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.652 -0.87 . . . . 1.47 108.652 169.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.02 73.15 0.83 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.535 -0.466 . . . . 1.42 111.648 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.608 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 48.18 -174.12 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 124.827 1.33 . . . . 0.96 112.623 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 39.3 Cg_exo -62.77 82.08 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.504 1.469 . . . . 0.48 110.956 166.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -167.68 -67.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.789 . . . . 0.5 110.506 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 3.6 p -141.91 140.97 32.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.431 0.53 . . . . 1.1 112.431 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' N ' HD11 ' A' ' 77' ' ' LEU . 2.2 mp -136.6 112.93 9.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 1.4 109.621 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 98' ' ' THR . 39.6 t -103.24 109.9 28.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.007 -0.738 . . . . 1.31 109.007 175.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -130.02 138.62 53.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.902 0.382 . . . . 1.48 111.947 -176.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 150.95 21.8 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.816 -0.629 . . . . 0.5 112.791 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.782 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 61.0 t-105 -89.09 148.94 23.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.209 0.604 . . . . 3.37 111.64 -168.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -142.87 23.24 1.91 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.995 -0.548 . . . . 6.17 110.374 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.71 HD12 ' HB3' ' A' ' 88' ' ' ARG . 1.6 tm? 84.63 152.83 0.09 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.177 -0.919 . . . . 2.13 111.081 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 83' ' ' LEU . 42.0 t30 -131.79 -29.99 1.66 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.01 -0.541 . . . . 1.93 111.52 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.7 46.08 2.8 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.304 -0.474 . . . . 2.79 113.81 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.3 t80 58.63 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 6.08 112.307 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.17 39.23 2.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.988 -0.625 . . . . 2.43 112.145 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.766 ' HD2' ' HB3' ' A' ' 131' ' ' ASN . 5.6 tpp180 -97.56 -176.62 3.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.729 -0.471 . . . . 5.53 109.729 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.478 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -94.14 137.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.965 0.412 . . . . 2.42 110.47 -175.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -96.0 137.6 21.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.081 -0.509 . . . . 3.18 111.428 -179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.554 ' HG2' ' HD1' ' A' ' 81' ' ' TRP . 50.2 Cg_exo -57.62 -21.72 48.34 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.17 3.247 . . . . 2.76 113.807 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 32.5 t70 77.25 41.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.381 -0.827 . . . . 2.99 110.596 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.525 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.8 OUTLIER 80.36 36.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.032 -0.986 . . . . 3.06 112.845 158.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 p -122.71 -37.25 2.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.757 -0.377 . . . . 2.11 111.682 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.782 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 20.5 t -55.85 97.06 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.522 -0.763 . . . . 1.81 109.292 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -122.57 136.84 54.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.237 -0.438 . . . . 1.81 110.673 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.489 ' HD1' ' CE1' ' A' ' 115' ' ' HIS . 12.2 p90 -134.48 139.4 45.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.235 0.541 . . . . 0.81 111.855 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.549 HG22 HG21 ' A' ' 78' ' ' VAL . 75.7 m -96.9 109.1 21.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.117 -0.947 . . . . 1.18 110.134 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 113' ' ' VAL . 84.2 t -83.53 109.98 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 1.51 110.077 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.404 ' HA ' HG22 ' A' ' 76' ' ' THR . 25.2 m -106.19 106.56 17.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.646 -0.252 . . . . 1.05 110.636 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.555 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.8 m-85 -88.12 115.8 25.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.657 -0.247 . . . . 0.42 110.498 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.2 112.01 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.907 -0.405 . . . . 1.26 109.907 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.58 133.89 43.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.844 -0.616 . . . . 1.13 111.372 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.734 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -121.93 128.85 52.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 2.03 109.227 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.65 -13.05 29.79 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.343 -0.844 . . . . 1.97 115.176 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -84.21 33.86 0.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.993 0.896 . . . . 5.46 111.685 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 12.3 mmtp 56.5 45.72 21.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.746 0.784 . . . . 3.88 108.947 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 87.9 tttt -133.87 155.03 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.809 -1.087 . . . . 2.94 109.341 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.9 m -155.03 114.63 3.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.139 0.495 . . . . 1.2 110.841 173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.467 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 18.2 tpp85 -91.64 113.98 26.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.543 -0.753 . . . . 3.1 109.697 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -91.04 138.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.768 0.318 . . . . 1.13 110.485 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.512 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 17.8 t70 -127.55 109.98 12.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.491 -0.777 . . . . 1.38 109.213 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 t -102.93 135.67 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.536 -0.756 . . . . 1.58 111.578 -175.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -113.04 111.62 22.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 2.31 109.683 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.934 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -100.77 115.57 30.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.454 -0.794 . . . . 2.32 109.235 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 p -127.99 168.88 14.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.522 -0.471 . . . . 3.19 111.619 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 101.98 -66.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 113.804 -1.544 . . . . 2.99 110.563 162.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.706 ' HE2' HG21 ' A' ' 129' ' ' VAL . 59.5 t80 -86.97 -52.34 5.51 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.029 -0.532 . . . . 4.27 111.996 -175.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 2' ' ' TYR . 1.7 m-20 -54.82 -33.39 61.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 1.81 112.281 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 37.7 ttp180 -62.52 -22.73 66.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 3.84 111.502 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.81 -22.09 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.536 -0.302 . . . . 2.9 110.358 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 126' ' ' ALA . . . 48.82 -154.02 2.09 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.39 -0.823 . . . . 2.26 114.801 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 m 44.76 -101.92 0.05 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.397 1.079 . . . . 3.02 113.112 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.96 -45.16 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.136 -0.32 . . . . 4.23 110.136 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -61.15 -49.8 75.76 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.334 0.588 . . . . 2.7 110.469 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . . . -64.51 -51.24 63.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.549 -0.751 . . . . 1.46 111.222 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -61.91 -34.0 75.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.905 0.335 . . . . 3.16 111.905 -173.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -77.16 -32.94 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.419 -0.513 . . . . 2.97 111.438 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.706 HG21 ' HE2' ' A' ' 118' ' ' PHE . 79.2 t -78.61 -42.3 25.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.374 0.607 . . . . 1.96 110.664 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.889 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 65.9 mtt-85 -68.18 -12.41 60.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.516 -0.766 . . . . 4.34 110.957 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.766 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 45.7 t30 -51.8 -25.09 6.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.568 -0.742 . . . . 2.8 110.004 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.18 -17.92 2.64 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.918 -0.583 . . . . 2.08 112.422 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.821 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 6.4 tpp -80.07 -42.89 22.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.475 0.546 . . . . 5.19 112.475 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.889 ' HB2' ' HB3' ' A' ' 130' ' ' ARG . 7.4 t70 -68.46 -25.92 65.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.975 0.731 . . . . 2.83 112.975 -163.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -115.9 24.19 11.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.586 0.708 . . . . 4.47 109.922 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.96 -74.68 0.64 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.36 -0.836 . . . . 1.04 111.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.528 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 5.5 t90 -58.51 -48.86 96.15 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.76 0.652 . . . . 3.78 112.76 -173.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.0 Cg_endo -59.61 -38.75 80.14 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.189 1.926 . . . . 0.77 112.642 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 m -70.9 -37.11 72.98 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.757 0.789 . . . . 1.37 109.347 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.653 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.6 mt -54.59 -44.74 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.4 -1.273 . . . . 1.32 110.196 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.56 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 68.9 mt -56.68 -33.8 66.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.464 0.478 . . . . 1.33 111.608 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -69.15 -57.71 5.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.18 0.514 . . . . 1.54 111.002 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 1.083 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -71.93 -21.39 61.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.104 -0.498 . . . . 1.43 111.132 -178.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.35 -47.57 85.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 1.05 109.543 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 67.6 mt-30 -61.23 -36.22 79.36 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.549 -0.751 . . . . 1.63 110.356 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.47 -39.75 64.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.492 -0.777 . . . . 1.46 111.506 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -66.56 -35.77 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.934 0.397 . . . . 2.23 110.112 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.728 HG22 HG12 ' A' ' 12' ' ' VAL . 50.4 mt -71.47 -32.68 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.288 0.566 . . . . 1.17 110.375 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.411 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 12.8 t70 -58.88 -32.33 69.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.609 -0.723 . . . . 0.85 109.727 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.828 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 49.6 mt-10 -66.0 -33.22 75.3 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.538 -0.755 . . . . 1.5 110.413 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -82.15 -17.1 47.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.359 -0.837 . . . . 1.74 109.726 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -96.56 -75.89 1.28 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.467 -0.788 . . . . 1.32 112.819 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.55 15.27 1.8 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.697 0.628 . . . . 2.42 112.697 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.828 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttmm -79.62 76.94 6.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.232 0.539 . . . . 2.04 110.087 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--O 1.246 0.901 0 CA-C-N 115.7 -0.682 . . . . 4.65 109.553 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 2' ' ' TYR . 35.2 m-80 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.691 -0.485 . . . . 2.1 109.691 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.477 ' CD1' ' HB1' ' A' ' 126' ' ' ALA . 28.4 p90 172.96 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.62 0.575 . . . . 4.04 110.288 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.888 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.4 t70 -59.98 -56.74 32.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.129 -0.487 . . . . 2.78 111.397 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.888 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 18.9 Cg_endo -96.08 -64.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.392 2.061 . . . . 1.83 111.953 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -149.6 154.97 39.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.667 -1.234 . . . . 3.98 107.667 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.726 ' HB ' ' CB ' ' A' ' 115' ' ' HIS . 27.4 t -85.7 106.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.221 -0.592 . . . . 2.03 109.812 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.8 ttm180 -111.75 135.38 52.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.805 0.812 . . . . 3.92 111.427 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 1.005 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 4.8 t-160 -109.38 132.37 54.19 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.736 -1.209 . . . . 1.16 107.736 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.2 t -146.04 112.02 5.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.944 -0.391 . . . . 1.72 109.944 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 111' ' ' VAL . 10.8 m -138.31 139.21 42.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 1.89 110.819 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m -92.84 116.14 28.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.471 -0.786 . . . . 1.15 109.906 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.697 HG11 HG22 ' A' ' 148' ' ' ILE . 22.4 t -98.47 125.57 51.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.476 -0.784 . . . . 1.51 110.379 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 35.06 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.933 0.397 . . . . 1.6 111.567 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.434 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.39 26.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.434 -0.348 . . . . 1.11 111.039 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.1 t70 72.6 169.21 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 0.91 112.857 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 7.6 ttp180 -63.36 -27.49 69.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.16 -0.927 . . . . 2.19 110.978 -174.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -54.28 -53.36 54.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.721 -0.672 . . . . 3.49 111.405 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -76.56 -33.57 58.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 1.49 111.181 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' A' ' 12' ' ' VAL . . . -60.47 -48.31 82.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 1.07 110.79 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -69.1 -33.78 74.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.43 110.537 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.835 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 5.5 tppp? -61.06 -55.7 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.427 . . . . 2.87 110.262 176.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.544 HG21 ' CE2' ' A' ' 30' ' ' TRP . 31.2 m -66.55 -23.87 66.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 1.21 111.939 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' CE2' HG22 ' A' ' 99' ' ' VAL . 69.4 t80 -87.81 -37.26 16.72 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.722 -0.391 . . . . 0.53 111.467 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.532 ' CD1' HG11 ' A' ' 46' ' ' VAL . 18.9 tp -119.95 -54.89 2.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.51 0.93 . . . . 1.23 113.51 -172.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.835 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 29.0 mt-10 -78.68 -24.72 44.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.378 0.609 . . . . 1.24 110.779 -169.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.418 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.72 93.84 0.54 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.056 -2.017 . . . . 0.83 108.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.848 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 23.0 t80 -95.93 -63.85 0.12 Allowed Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.722 -0.239 . . . . 0.94 111.041 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.848 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 29.9 Cg_endo -96.46 37.53 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.282 1.988 . . . . 0.9 114.677 -174.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -126.97 5.24 6.53 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.409 0.892 . . . . 1.49 113.409 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.837 ' HE3' ' HG3' ' A' ' 147' ' ' LYS . 18.7 m95 -99.07 -160.89 0.83 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.127 -0.358 . . . . 5.66 110.221 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 22.1 m95 -99.05 -8.92 0.12 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.991 1.478 . . . . 3.41 114.991 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HB3' ' HB3' ' A' ' 143' ' ' SER . 92.8 Cg_endo -81.82 -148.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 CA-C-N 122.484 1.923 . . . . 1.36 113.292 -170.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.63 ' ND2' HD22 ' A' ' 84' ' ' ASN . 6.5 t30 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.812 . . . . 1.51 111.025 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.758 ' HA ' HG22 ' A' ' 40' ' ' VAL . 30.9 m-20 -78.87 20.98 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.183 -0.462 . . . . 1.98 110.739 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 33' ' ' ASN . 8.0 t80 -117.83 22.39 12.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 5.13 110.33 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -117.66 146.97 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 4.7 110.108 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.58 135.66 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.023 -0.271 . . . . 3.11 110.854 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.1 p 58.52 14.49 3.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.082 0.953 . . . . 1.89 112.133 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 40' ' ' VAL . 54.2 tttp -132.6 80.35 1.89 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.985 -0.746 . . . . 3.45 108.985 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.758 HG22 ' HA ' ' A' ' 34' ' ' ASN . 5.1 m 54.1 17.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.429 1.091 . . . . 2.3 112.165 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -146.28 26.88 1.7 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.56 -0.828 . . . . 2.2 113.312 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.853 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -77.56 167.14 38.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.45 -0.944 . . . . 1.31 108.45 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.02 59.71 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.751 2.301 . . . . 1.94 113.718 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 53.4 tp -166.03 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 2.23 110.027 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 94.98 -63.88 1.46 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.872 -0.68 . . . . 0.94 113.06 173.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 24' ' ' LEU . 84.8 t -132.75 147.41 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.84 0.353 . . . . 1.21 110.487 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.793 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.6 t0 -123.98 96.32 4.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.853 -0.795 . . . . 1.11 108.853 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 8.5 mtpt -74.06 -22.31 59.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.112 0.482 . . . . 3.25 110.245 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.534 ' HB3' ' HZ2' ' A' ' 49' ' ' LYS . 4.2 ttpm? -64.67 -56.61 12.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 3.63 110.787 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.93 -28.72 33.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.966 -0.635 . . . . 1.9 112.595 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.95 49.42 2.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.696 -0.764 . . . . 0.87 112.169 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.44 161.31 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.735 0.302 . . . . 4.26 111.417 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.452 ' CD1' HD11 ' A' ' 68' ' ' ILE . 14.4 m0 -108.99 120.01 41.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 1.52 109.999 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.793 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -163.91 158.11 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.087 0.47 . . . . 2.04 110.677 175.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.853 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 1.1 mp0 -125.71 166.55 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.486 -0.931 . . . . 2.12 108.486 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG23 ' HG2' ' A' ' 61' ' ' GLU . 43.2 mm -78.34 103.62 5.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.121 0.486 . . . . 1.42 109.958 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.569 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.4 t70 -87.98 145.94 25.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.717 -0.674 . . . . 1.97 110.092 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -61.34 -26.82 68.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.681 0.613 . . . . 2.43 112.354 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.422 ' HB3' ' OD2' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -75.8 -17.99 59.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.951 0.405 . . . . 2.39 111.226 -175.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.15 54.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.175 -1.012 . . . . 2.29 113.211 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 56' ' ' ILE . 43.6 mt-10 56.0 26.26 9.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.157 0.799 . . . . 2.31 113.157 173.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 12.8 tp10 -112.9 95.83 5.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.424 0.63 . . . . 2.61 110.236 -176.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.569 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.22 165.16 16.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.047 -0.978 . . . . 4.63 110.602 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 82' ' ' ARG . 3.2 p -47.82 124.77 7.76 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.627 0.58 . . . . 2.27 111.316 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -89.61 112.46 23.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.743 -0.662 . . . . 7.39 110.943 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.624 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -83.29 127.21 7.89 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.633 -0.987 . . . . 1.23 110.633 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.446 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -100.63 96.11 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.016 0.436 . . . . 1.76 111.316 -171.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.521 HG21 ' CG2' ' A' ' 71' ' ' VAL . 39.5 mt -83.34 124.49 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.122 0.487 . . . . 1.26 110.298 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -104.33 -14.84 15.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.538 -0.755 . . . . 2.65 110.5 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -159.31 118.91 3.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.248 -0.433 . . . . 2.03 111.835 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' CG2' HG21 ' A' ' 68' ' ' ILE . 57.7 t -103.1 92.96 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.076 -1.083 . . . . 1.47 108.076 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 5.7 t0 -101.38 64.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.628 -0.26 . . . . 1.42 111.19 -170.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 7.4 pt-20 48.28 -172.38 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.287 1.035 . . . . 0.96 112.03 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 31.3 Cg_exo -62.64 72.17 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.48 111.774 166.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -156.44 -65.79 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.452 -0.795 . . . . 0.5 110.183 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 100' ' ' THR . 4.0 p -145.57 152.48 39.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 1.1 112.357 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' CD2' HD21 ' A' ' 24' ' ' LEU . 3.1 mp -138.18 126.36 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.676 -0.693 . . . . 1.4 109.526 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.77 105.56 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.59 -0.522 . . . . 1.31 109.59 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.76 137.39 57.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.292 -0.413 . . . . 1.48 111.282 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.09 165.41 26.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.5 111.889 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.952 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 39.6 t-105 -62.17 162.88 8.91 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 114.253 1.205 . . . . 3.37 114.253 -163.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.624 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -158.67 -35.57 0.06 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.608 -1.178 . . . . 6.17 110.023 -169.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.906 ' HG ' ' HA3' ' A' ' 132' ' ' GLY . 4.8 tt 78.11 175.27 0.17 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.753 -0.658 . . . . 2.13 110.599 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.63 HD22 ' ND2' ' A' ' 33' ' ' ASN . 46.7 t-20 -109.12 -76.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.714 0.292 . . . . 1.93 110.416 -173.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.59 0.54 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 120.663 -0.78 . . . . 2.79 111.216 176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -54.48 -6.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.294 0.85 . . . . 6.08 113.294 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.08 -0.89 76.84 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.944 -0.862 . . . . 2.43 110.944 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.597 ' HD3' ' H ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -97.55 152.78 18.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.148 0.499 . . . . 5.53 110.585 178.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -65.51 124.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.203 -0.908 . . . . 2.42 110.477 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 92' ' ' ASP . 4.1 p-10 -101.75 142.81 25.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 121.42 0.628 . . . . 3.18 111.45 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.688 ' HD2' ' HD1' ' A' ' 81' ' ' TRP . 59.8 Cg_endo -97.69 37.46 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.915 3.077 . . . . 2.76 111.868 167.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.614 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -65.78 89.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.155 0.979 . . . . 2.99 111.066 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.0 OUTLIER -167.88 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.437 -1.256 . . . . 3.06 108.368 167.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.769 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 74.6 m -160.96 -143.69 0.1 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.976 -1.465 . . . . 2.11 108.674 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.952 ' HB2' ' HB2' ' A' ' 81' ' ' TRP . 37.9 m 54.63 38.0 29.14 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.477 0.656 . . . . 1.81 111.442 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.648 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 20.2 tt0 -71.77 149.78 45.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.895 -1.048 . . . . 1.81 110.69 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.596 ' HB2' HG13 ' A' ' 113' ' ' VAL . 9.0 p90 -146.37 147.43 31.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.96 0.409 . . . . 0.81 110.866 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 30.5 m -104.36 115.82 31.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.594 -0.73 . . . . 1.18 110.374 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.619 ' HA ' HG21 ' A' ' 113' ' ' VAL . 97.4 t -82.42 109.73 16.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 1.51 109.804 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.489 ' HA ' HG22 ' A' ' 76' ' ' THR . 9.5 m -104.12 105.97 16.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.935 0.397 . . . . 1.05 111.224 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.499 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 52.1 m-85 -89.9 110.91 21.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.357 -0.383 . . . . 0.42 110.138 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.8 t -91.61 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 110.123 -0.325 . . . . 1.26 110.123 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.25 138.07 53.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 1.13 110.393 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -130.12 103.0 6.49 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 2.03 110.75 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.34 -97.89 0.63 Allowed Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.946 -0.645 . . . . 1.97 113.223 171.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -146.68 -20.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.095 0.406 . . . . 5.46 112.095 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -136.26 3.64 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.97 -0.692 . . . . 3.88 112.671 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 26.4 ttpp -127.31 153.96 45.52 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.448 -0.901 . . . . 2.94 110.911 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.7 m -160.9 124.31 3.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.826 -0.624 . . . . 1.2 109.95 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.54 120.25 41.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.79 . . . . 3.1 108.866 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 10' ' ' VAL . 10.0 p -96.55 141.12 16.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.802 -0.359 . . . . 1.13 110.791 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.7 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -129.5 124.23 33.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.08 -0.711 . . . . 1.38 109.08 171.23 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 1.005 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 4.1 t -99.05 121.51 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-N 115.725 -0.671 . . . . 1.58 110.086 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.19 121.34 41.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.893 -0.78 . . . . 2.31 108.893 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.726 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 t-80 -103.03 152.77 20.96 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.285 -0.87 . . . . 2.32 110.114 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.677 HG21 ' HD2' ' A' ' 118' ' ' PHE . 9.0 t -60.13 177.86 0.23 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.12 -0.945 . . . . 3.19 110.944 170.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -108.35 18.94 20.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.854 -0.612 . . . . 2.99 110.438 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.769 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 20.7 m-85 -59.33 -29.07 67.37 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.499 -0.319 . . . . 4.27 111.434 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.6 -49.79 15.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.554 0.692 . . . . 1.81 109.699 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.482 ' C ' ' H ' ' A' ' 122' ' ' GLY . 55.2 ttt180 -58.54 -18.08 26.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.582 -1.19 . . . . 3.84 111.14 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 121' ' ' MET . 24.2 ttt -65.83 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.003 0.921 . . . . 2.9 112.466 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 152.93 151.03 5.57 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.177 -1.011 . . . . 2.26 112.085 172.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.9 m -60.39 -36.2 77.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.28 0.562 . . . . 3.02 109.657 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -71.58 -39.34 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.436 -0.802 . . . . 4.23 110.467 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.569 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 5.3 m170 -63.8 -46.23 86.12 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 121.26 0.552 . . . . 2.7 110.631 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.477 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -66.87 -31.51 72.17 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 1.46 111.262 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.42 -39.38 81.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 3.16 110.639 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.6 ' HB2' HD11 ' A' ' 89' ' ' ILE . 16.8 ptm180 -76.25 -24.95 54.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 2.97 111.737 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 91' ' ' PRO . 61.5 t -83.52 -54.79 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.304 0.853 . . . . 1.96 113.304 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.576 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 35.5 ttt180 -62.66 -23.86 67.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.519 0.563 . . . . 4.34 112.519 -167.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.457 ' CG ' ' HD2' ' A' ' 88' ' ' ARG . 16.7 p30 -55.41 -22.32 19.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.353 -0.385 . . . . 2.8 111.817 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.906 ' HA3' ' HG ' ' A' ' 83' ' ' LEU . . . -100.3 -96.75 2.19 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.456 -0.878 . . . . 2.08 114.038 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.577 ' HB3' ' CH2' ' A' ' 81' ' ' TRP . 54.2 ttm -79.29 -27.44 42.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.844 0.683 . . . . 5.19 112.844 -164.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.576 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 20.9 t70 -65.11 -21.93 66.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.948 0.404 . . . . 2.83 111.482 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.459 ' HA ' ' CE ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -79.46 -15.92 56.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.111 0.411 . . . . 4.47 112.111 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.617 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -117.07 -17.25 5.88 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.351 -0.7 . . . . 1.04 111.351 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.511 ' O ' HD13 ' A' ' 141' ' ' LEU . 38.0 t-105 -55.4 -54.49 50.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 123.061 0.544 . . . . 3.78 111.453 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.59 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 18.7 Cg_endo -60.22 -34.62 93.86 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.837 1.691 . . . . 0.77 111.623 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.1 m -66.29 -49.96 65.3 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 121.733 0.777 . . . . 1.37 110.447 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 136' ' ' GLY . 59.1 mt -55.44 -54.58 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.018 -0.992 . . . . 1.32 110.053 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 137' ' ' TRP . 7.0 mp -56.34 -26.86 53.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.25 0.833 . . . . 1.33 113.25 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 28.4 mm-40 -69.14 -54.33 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.484 -0.561 . . . . 1.54 109.484 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.614 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . 37.3 t -70.16 -23.81 63.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 1.43 110.745 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 64.6 t80 -58.35 -53.15 61.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.479 -0.782 . . . . 1.05 109.489 174.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.93 -22.11 61.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.508 -0.769 . . . . 1.63 110.508 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.12 -52.09 10.85 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.94 -0.573 . . . . 1.46 111.698 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.837 ' HG3' ' HE3' ' A' ' 30' ' ' TRP . 2.4 tmtt? -66.94 -39.78 87.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.508 -0.477 . . . . 2.23 109.962 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.697 HG22 HG11 ' A' ' 12' ' ' VAL . 22.6 mt -57.92 -35.27 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.303 0.573 . . . . 1.17 110.545 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.425 ' OD2' ' HE2' ' A' ' 154' ' ' LYS . 24.1 t0 -61.26 -35.49 77.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.638 -0.71 . . . . 0.85 110.002 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 63.6 mt-10 -68.32 -26.75 65.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.39 0.614 . . . . 1.5 110.809 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 11.1 mm-40 -88.89 5.69 42.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.713 -0.676 . . . . 1.74 110.325 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.29 -78.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.171 -1.014 . . . . 1.32 114.02 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.47 -45.69 10.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.114 0.483 . . . . 2.42 111.652 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 31.5 ttpt -87.74 114.28 24.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.94 -0.573 . . . . 2.04 109.991 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.85 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.791 -0.623 . . . . 4.65 109.719 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.683 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 19.7 p30 . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.801 -0.074 . . . . 2.1 110.801 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.464 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -171.77 -51.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.334 0.494 . . . . 4.04 112.334 176.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.521 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.7 t70 -66.71 -61.85 4.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 112.042 0.386 . . . . 2.78 112.042 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.04 -58.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.115 1.21 . . . . 1.83 112.098 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.683 ' O ' ' HB2' ' A' ' 1' ' ' ASN . 47.0 p90 -154.8 143.63 20.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.566 . . . . 3.98 110.195 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.803 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 95.2 t -103.88 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.138 -1.06 . . . . 2.03 108.138 164.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 58.8 ttp180 -101.04 134.86 43.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.427 0.632 . . . . 3.92 111.939 -170.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.766 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -109.9 131.82 54.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.426 -0.953 . . . . 1.16 108.426 167.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 50.0 m -135.52 110.35 8.73 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.584 -0.735 . . . . 1.72 110.35 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.732 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.3 t -121.46 135.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.824 -1.08 . . . . 1.89 111.032 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -100.95 115.71 31.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.38 0.61 . . . . 1.15 109.546 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.676 HG11 HG23 ' A' ' 148' ' ' ILE . 42.2 t -93.4 127.58 45.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 1.51 111.264 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.963 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -86.91 12.82 10.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.168 -0.924 . . . . 1.6 113.131 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -156.77 41.46 0.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.011 -0.675 . . . . 1.11 112.474 -173.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 11.3 t70 73.32 161.89 0.25 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.252 1.025 . . . . 0.91 113.69 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 1.07 ' HE ' ' HB2' ' A' ' 103' ' ' ALA . 8.0 ttp85 -63.45 -28.11 69.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.28 -1.327 . . . . 2.19 112.422 -172.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 34.1 mttp -66.85 -40.91 88.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.95 -0.3 . . . . 3.49 110.838 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -73.12 -34.86 66.38 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.866 -0.333 . . . . 1.49 110.329 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -56.2 -51.56 67.61 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.131 -0.486 . . . . 1.07 110.325 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 70.7 t80 -69.92 -40.54 75.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.43 110.887 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -55.8 -47.09 77.75 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.228 -0.442 . . . . 2.87 109.854 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.527 ' N ' ' HG3' ' A' ' 21' ' ' LYS . 16.5 m -77.33 -45.4 26.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.411 -0.358 . . . . 1.21 111.01 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.614 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 67.4 t80 -65.08 -28.96 69.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.774 0.287 . . . . 0.53 111.774 -174.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.72 HD23 ' HE3' ' A' ' 48' ' ' LYS . 16.5 tp -115.46 -56.09 2.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.253 -0.579 . . . . 1.23 112.087 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 51.7 mt-10 -91.41 -3.43 56.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.423 . . . . 1.24 111.634 -172.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.65 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -114.91 25.34 10.15 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.693 -0.963 . . . . 0.83 110.693 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.4 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.4 t80 -52.41 -49.37 85.84 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.308 0.484 . . . . 0.94 112.308 -174.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 69.5 Cg_endo -81.37 4.3 7.11 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.154 1.903 . . . . 0.9 115.142 -176.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -103.14 -1.94 28.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.914 -0.714 . . . . 1.49 111.675 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.771 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.5 m0 -72.29 154.18 41.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.546 0.689 . . . . 5.66 111.067 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.572 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 47.5 m95 -83.47 -38.36 0.72 Allowed Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 114.968 -1.015 . . . . 3.41 113.071 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.771 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 20.0 Cg_endo -59.41 -79.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 122.31 2.007 . . . . 1.36 114.414 -165.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.645 ' ND2' HD21 ' A' ' 84' ' ' ASN . 57.3 t30 -106.85 -16.16 14.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.278 0.561 . . . . 1.51 109.864 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.716 ' HA ' HG21 ' A' ' 40' ' ' VAL . 1.8 m-20 -97.8 20.66 11.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.709 . . . . 1.98 111.612 -168.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -79.77 -29.8 40.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.449 . . . . 5.13 111.492 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 36' ' ' ARG . 33.3 mmt180 -90.92 142.97 27.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.538 0.57 . . . . 4.7 112.538 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 39' ' ' LYS . 26.9 p -77.01 151.93 35.4 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 3.11 111.02 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 57' ' ' ASP . 7.0 p 54.48 6.81 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.396 1.078 . . . . 1.89 112.462 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 37' ' ' THR . 72.5 tttt -94.73 -135.45 0.2 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.207 -2.146 . . . . 3.45 105.207 161.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' A' ' 34' ' ' ASN . 17.1 m -93.0 20.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.423 0.63 . . . . 2.3 110.71 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -132.54 39.86 1.69 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.68 -0.691 . . . . 2.2 112.431 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 1.057 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -88.78 160.43 44.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.639 -0.874 . . . . 1.31 108.639 171.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.6 -17.6 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 124.134 3.223 . . . . 1.94 116.14 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 45' ' ' GLY . 48.1 tp -97.42 -97.38 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.874 -0.516 . . . . 2.23 111.184 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.67 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 109.14 -55.97 0.48 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.67 -0.776 . . . . 0.94 112.722 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.634 HG12 HD11 ' A' ' 24' ' ' LEU . 94.2 t -139.9 139.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.078 0.466 . . . . 1.21 111.582 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.691 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 19.4 t70 -105.68 102.71 12.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.422 -0.808 . . . . 1.11 109.431 174.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.72 ' HE3' HD23 ' A' ' 24' ' ' LEU . 25.3 mtpt -80.52 -12.17 59.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 3.25 111.82 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.6 ptpp? -83.86 -43.7 15.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.946 -0.302 . . . . 3.63 111.214 -174.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.9 -32.9 5.71 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.909 -0.662 . . . . 1.9 111.793 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 68' ' ' ILE . . . 102.67 58.4 0.76 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.563 -0.827 . . . . 0.87 112.771 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -144.72 149.54 35.77 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.723 -0.281 . . . . 4.26 110.532 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -100.33 115.27 29.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.258 -0.645 . . . . 1.52 109.258 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.691 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 6.8 p90 -160.97 149.1 15.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.469 . . . . 2.04 110.118 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 1.057 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.3 mp0 -113.06 169.13 9.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.48 -0.563 . . . . 2.12 109.48 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.457 HD11 ' HG2' ' A' ' 61' ' ' GLU . 32.8 mm -77.55 103.3 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.621 -0.511 . . . . 1.42 109.621 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.757 ' HB3' HE22 ' A' ' 59' ' ' GLN . 8.1 t70 -101.75 159.52 15.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 1.97 110.267 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.019 1.118 . . . . 2.43 114.019 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.757 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -86.31 8.16 22.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.102 -0.639 . . . . 2.39 111.441 -175.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.4 62.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.245 -0.978 . . . . 2.29 113.693 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.457 ' HG2' HD11 ' A' ' 56' ' ' ILE . 41.1 mt-10 52.24 35.2 16.28 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.816 0.672 . . . . 2.31 112.816 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -108.11 85.43 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.469 0.652 . . . . 2.61 110.745 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -121.84 158.63 28.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 4.63 110.05 175.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.594 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 3.2 t -134.58 115.41 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.334 -0.393 . . . . 2.27 110.405 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.799 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 37.6 t80 -131.4 -46.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 7.39 111.329 174.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 79' ' ' ILE . . . -157.29 156.6 27.39 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.38 -1.391 . . . . 1.23 113.949 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.469 HD21 ' HD2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -116.89 110.42 18.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.397 -0.594 . . . . 1.76 109.397 177.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.542 HG23 ' CG2' ' A' ' 71' ' ' VAL . 35.5 mt -80.83 136.29 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 1.26 111.228 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -101.94 -34.17 9.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.264 -0.88 . . . . 2.65 109.212 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -149.7 129.27 13.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.687 -0.688 . . . . 2.03 110.97 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 68' ' ' ILE . 44.1 t -112.87 93.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.75 -0.833 . . . . 1.47 108.75 172.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.78 70.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.544 -0.298 . . . . 1.42 111.7 -172.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.619 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 47.27 -173.34 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 124.539 1.15 . . . . 0.96 112.505 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.4 Cg_exo -61.48 82.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.406 1.404 . . . . 0.48 111.195 166.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.47 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 28.2 t70 -168.29 -68.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.606 . . . . 0.5 110.572 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 100' ' ' THR . 1.8 p -144.55 144.86 31.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.22 0.533 . . . . 1.1 112.154 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -135.14 117.33 15.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.672 -0.694 . . . . 1.4 109.29 177.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 t -93.47 105.66 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.42 -0.956 . . . . 1.31 108.42 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -128.58 130.58 69.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.999 -0.546 . . . . 1.48 111.3 -169.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.771 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.44 153.11 20.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.301 -0.476 . . . . 0.5 112.082 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.661 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 65.0 t-105 -85.82 132.81 34.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 3.37 111.532 -172.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.594 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 6.8 ttt180 -137.56 28.68 2.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.687 -0.688 . . . . 6.17 109.644 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.799 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 19.0 tp 77.52 167.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.87 -1.059 . . . . 2.13 112.147 172.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.645 HD21 ' ND2' ' A' ' 33' ' ' ASN . 1.5 m-20 -82.67 5.29 21.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.711 -0.477 . . . . 1.93 109.711 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.98 38.5 92.94 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.691 -0.686 . . . . 2.79 113.049 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -137.95 91.56 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.946 0.403 . . . . 6.08 112.018 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.6 2.35 21.25 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.628 -0.714 . . . . 2.43 114.755 168.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.5 mmp_? -112.76 -176.27 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 117.239 0.519 . . . . 5.53 110.266 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.407 ' O ' HD11 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -101.78 136.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.111 -0.495 . . . . 2.42 110.121 177.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 7.5 p-10 -97.88 140.09 21.71 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.916 0.389 . . . . 3.18 110.403 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 93' ' ' ASN . 36.9 Cg_exo -61.4 -46.02 16.32 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.833 2.355 . . . . 2.76 111.856 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 73.05 -40.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.045 0.841 . . . . 2.99 112.638 173.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 91' ' ' PRO . 7.7 p30 -76.12 -36.37 58.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.839 0.681 . . . . 3.06 112.839 -169.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.5 p -165.79 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.743 -0.383 . . . . 2.11 111.773 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.661 ' CB ' ' HB3' ' A' ' 81' ' ' TRP . 44.3 m 55.37 30.24 14.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.419 0.628 . . . . 1.81 110.671 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.771 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.8 tt0 -62.71 124.32 20.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.855 -1.066 . . . . 1.81 111.275 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.584 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 8.5 p90 -125.9 136.12 52.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.164 0.507 . . . . 0.81 110.738 174.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 31.9 m -89.43 115.49 26.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.578 -0.737 . . . . 1.18 110.266 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.667 ' HA ' HG21 ' A' ' 113' ' ' VAL . 99.2 t -91.0 108.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.283 -0.636 . . . . 1.51 109.283 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.706 ' HA ' HG23 ' A' ' 76' ' ' THR . 15.6 m -106.77 104.96 14.77 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.105 -0.498 . . . . 1.05 110.909 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.634 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.7 m-85 -82.64 102.6 11.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.34 -0.615 . . . . 0.42 109.34 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -91.54 108.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.319 -0.623 . . . . 1.26 109.319 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 1.07 ' HB2' ' HE ' ' A' ' 16' ' ' ARG . . . -57.4 124.45 18.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.944 -0.571 . . . . 1.13 109.967 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.731 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 12.7 t70 -109.15 103.3 12.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.969 -0.752 . . . . 2.03 108.969 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.2 -106.53 1.91 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.854 -0.898 . . . . 1.97 110.854 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.842 ' HA ' HE21 ' A' ' 106' ' ' GLN . 0.0 OUTLIER -153.64 -9.25 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.337 . . . . 5.46 110.969 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -119.99 -0.16 10.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 3.88 110.722 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.731 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 11.6 mptt -127.39 159.98 32.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.969 -0.752 . . . . 2.94 108.969 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 53.4 m -156.26 114.79 3.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.863 0.363 . . . . 1.2 110.211 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -100.66 111.32 23.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.94 -0.763 . . . . 3.1 108.94 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 10.9 p -85.9 138.04 19.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 1.13 110.319 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -127.41 116.13 19.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.845 . . . . 1.38 109.223 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.766 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 4.1 t -108.37 130.84 60.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.983 -1.008 . . . . 1.58 111.189 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.58 111.34 22.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.303 0.573 . . . . 2.31 110.141 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.803 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 82.0 t60 -113.43 97.23 6.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.148 -0.933 . . . . 2.32 108.864 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.566 ' HG1' ' HA ' ' A' ' 5' ' ' PHE . 34.8 m -145.55 94.71 2.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.967 0.413 . . . . 3.19 111.344 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.622 ' O ' ' HG2' ' A' ' 121' ' ' MET . 15.6 t60 -167.16 -73.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.097 -0.501 . . . . 2.99 110.212 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 128' ' ' ARG . 29.4 t80 -64.96 -47.53 77.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.53 -0.759 . . . . 4.27 112.137 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -37.25 67.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.543 0.687 . . . . 1.81 110.35 -174.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -55.91 -20.88 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.754 -1.112 . . . . 3.84 111.945 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.9 mmt -81.18 19.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.06 0.393 . . . . 2.9 112.06 -171.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.68 163.31 11.24 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.015 -1.088 . . . . 2.26 113.007 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.7 p -65.23 -22.51 66.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.593 -0.303 . . . . 3.02 111.432 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -67.68 -52.69 35.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.681 0.277 . . . . 4.23 110.745 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.748 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 33.4 m170 -60.98 -48.84 79.94 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.602 0.715 . . . . 2.7 110.5 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.81 68.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.213 -0.903 . . . . 1.46 111.037 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 130' ' ' ARG . 35.1 ttpt -75.84 -41.86 51.27 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.798 0.296 . . . . 3.16 111.798 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.748 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.9 ptm180 -64.03 -30.58 71.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.915 -0.314 . . . . 2.97 110.68 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.71 -32.13 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 120.423 -0.511 . . . . 1.96 110.593 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 21.9 tpp85 -61.77 -15.17 38.99 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.489 0.716 . . . . 4.34 111.376 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 53.0 m-20 -52.04 -21.67 3.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.643 0.979 . . . . 2.8 113.643 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.07 -39.16 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 119.252 -1.452 . . . . 2.08 114.053 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.507 ' HE3' ' CG ' ' A' ' 88' ' ' ARG . 12.9 mmt -74.24 -9.29 58.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 5.19 111.285 -171.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 16.3 t70 -62.22 -22.75 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.635 -0.712 . . . . 2.83 111.461 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.65 -30.7 12.32 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.886 -0.326 . . . . 4.47 110.857 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -69.65 -50.21 32.22 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.092 -0.575 . . . . 1.04 112.491 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.459 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.6 t-105 -54.85 -52.19 72.74 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.186 0.439 . . . . 3.78 112.186 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -60.25 -36.95 86.03 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.646 1.564 . . . . 0.77 112.069 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.3 m -68.4 -35.52 77.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.514 0.673 . . . . 1.37 109.623 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.64 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 16.5 mt -58.54 -44.63 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.876 -1.057 . . . . 1.32 110.578 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 8' ' ' HIS . 70.9 mt -63.74 -33.23 75.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.187 0.44 . . . . 1.33 112.187 -175.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.53 -54.76 12.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.961 0.41 . . . . 1.54 110.314 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.646 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 48.9 m -65.87 -22.02 66.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 1.43 111.144 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 23' ' ' PHE . 54.5 t80 -65.95 -53.45 38.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.308 0.575 . . . . 1.05 109.559 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.796 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 45.1 mt-30 -61.64 -29.82 70.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.277 -0.874 . . . . 1.63 110.25 176.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.95 -43.75 57.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.853 -1.067 . . . . 1.46 110.529 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' NE1' ' A' ' 31' ' ' TRP . 28.1 tptp -65.79 -43.19 89.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.713 0.292 . . . . 2.23 110.584 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.676 HG23 HG11 ' A' ' 12' ' ' VAL . 57.5 mt -62.37 -40.14 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 1.17 111.368 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.963 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 28.5 t70 -65.53 -27.33 68.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.318 -0.401 . . . . 0.85 110.872 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.5 -39.06 93.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.511 0.672 . . . . 1.5 109.537 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.73 -29.26 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.373 -1.285 . . . . 1.74 108.906 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -74.26 -74.94 0.81 Allowed Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 114.817 -1.083 . . . . 1.32 112.345 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -164.35 23.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.76 0.652 . . . . 2.42 112.76 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -69.9 -75.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.369 -0.532 . . . . 2.04 110.601 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.812 -1.089 . . . . 4.65 110.409 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' ' 7' ' ' ARG . 25.3 p-10 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.883 0.373 . . . . 2.1 110.457 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.598 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 32.1 p90 179.66 -32.84 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 4.04 109.713 -174.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.712 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.0 t70 -73.16 -55.0 4.02 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 111.959 0.355 . . . . 2.78 111.959 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.712 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.5 Cg_endo -93.69 -62.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.172 1.914 . . . . 1.83 112.998 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.424 ' CD2' HG23 ' A' ' 116' ' ' THR . 96.2 m-85 -144.31 118.88 9.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 3.98 110.421 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 1.044 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 97.3 t -85.05 125.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.9 -0.778 . . . . 2.03 108.9 167.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 36.6 ttp85 -132.38 136.72 47.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.026 -0.534 . . . . 3.92 109.787 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 1.059 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 3.2 t-160 -108.38 132.31 53.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.491 -0.929 . . . . 1.16 108.491 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 13.4 m -136.17 118.91 16.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.251 0.548 . . . . 1.72 110.716 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.656 ' HB ' HG11 ' A' ' 111' ' ' VAL . 2.7 t -137.31 134.19 46.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.158 -0.928 . . . . 1.89 111.086 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -101.8 114.98 29.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.435 0.636 . . . . 1.15 109.808 173.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.669 HG11 HG21 ' A' ' 148' ' ' ILE . 38.5 t -95.57 136.27 27.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.296 -0.866 . . . . 1.51 109.726 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 36.05 2.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.726 0.269 . . . . 1.6 111.726 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.84 31.63 0.36 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.93 0.345 . . . . 1.11 111.93 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.8 t70 75.22 164.06 0.27 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.861 0.838 . . . . 0.91 112.732 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 14.6 ttp180 -66.47 -25.72 66.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.686 -1.143 . . . . 2.19 111.544 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.055 -0.258 . . . . 3.49 110.828 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -68.33 -35.14 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.995 -0.282 . . . . 1.49 110.362 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.28 -48.98 75.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 1.07 110.613 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.508 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 84.7 t80 -72.57 -50.6 24.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.43 111.207 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -52.35 -49.7 63.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.03 -0.532 . . . . 2.87 111.158 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 m -67.56 -51.09 54.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.982 -0.554 . . . . 1.21 110.792 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 73.6 t80 -58.93 -40.48 84.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.349 0.5 . . . . 0.53 112.349 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -104.46 -50.39 3.33 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.271 -0.572 . . . . 1.23 112.31 -172.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.775 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 53.9 mt-10 -86.24 -6.94 58.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.76 0.314 . . . . 1.24 111.631 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -117.15 30.1 6.45 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.374 -0.917 . . . . 0.83 112.525 -176.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.469 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -49.31 -53.84 35.73 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.006 0.373 . . . . 0.94 112.006 -172.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 24.9 Cg_endo -90.57 21.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.921 1.747 . . . . 0.9 114.644 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.6 pt-20 -113.64 -15.88 12.43 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.562 -0.855 . . . . 1.49 113.045 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.641 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -79.61 -176.64 5.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.944 -0.702 . . . . 5.66 109.617 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.511 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 10.2 p-90 -115.32 16.9 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 115.36 1.615 . . . . 3.41 115.36 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.641 ' CD ' ' HB2' ' A' ' 30' ' ' TRP . 57.8 Cg_endo -85.03 -134.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 121.984 1.744 . . . . 1.36 113.136 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.505 ' ND2' HD22 ' A' ' 84' ' ' ASN . 9.7 t30 -67.18 -25.7 66.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 1.51 111.047 -175.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.657 ' HA ' HG22 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -85.94 18.72 2.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.469 -0.787 . . . . 1.98 110.997 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -82.69 -4.13 57.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.5 0.667 . . . . 5.13 109.421 174.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -106.62 164.24 12.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.735 . . . . 4.7 110.199 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 42' ' ' ALA . 1.1 p -98.28 147.29 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.538 -0.301 . . . . 3.11 111.272 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.692 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 19.8 p 54.44 25.0 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.799 0.839 . . . . 1.89 111.941 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.613 ' O ' HG13 ' A' ' 40' ' ' VAL . 20.4 mtmt -111.21 -50.54 2.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.708 -1.133 . . . . 3.45 109.146 165.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -177.5 28.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 124.424 1.078 . . . . 2.3 110.256 175.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.06 29.96 0.59 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.843 -1.17 . . . . 2.2 114.253 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.795 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -78.64 170.46 16.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 117.282 0.541 . . . . 1.31 109.617 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 28.0 Cg_endo -63.26 72.28 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.475 2.116 . . . . 1.94 112.753 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 tp -169.19 -90.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.474 -0.785 . . . . 2.23 109.687 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.38 -88.9 0.53 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.334 -0.936 . . . . 0.94 112.46 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 53' ' ' TRP . 57.5 t -139.91 139.89 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.738 0.304 . . . . 1.21 111.114 -172.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.53 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.742 -0.836 . . . . 1.11 108.742 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.775 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 40.3 mtpt -78.93 -18.76 53.27 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.956 0.725 . . . . 3.25 112.956 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -89.2 -45.2 9.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.839 -0.344 . . . . 3.63 110.962 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.39 -38.4 21.57 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.273 -0.731 . . . . 1.9 111.273 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.92 58.31 1.04 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.915 -0.66 . . . . 0.87 112.205 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -159.29 141.07 13.34 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.752 -0.379 . . . . 4.26 110.404 177.058 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.937 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -100.97 135.48 42.36 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.597 -0.441 . . . . 1.52 110.654 177.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.448 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 0.8 OUTLIER -163.02 -179.36 6.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.673 0.608 . . . . 2.04 110.528 179.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.795 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 39.9 mt-10 -132.35 177.64 7.43 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 116.639 -0.255 . . . . 2.12 111.136 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 mm -102.41 102.83 14.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.414 -0.587 . . . . 1.42 109.414 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.692 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-20 -70.27 135.48 48.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.873 0.694 . . . . 1.97 112.873 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.27 -26.57 67.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.854 -1.067 . . . . 2.43 111.151 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.639 HE21 ' HB3' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -82.8 -7.23 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 2.39 111.447 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.92 72.24 0.63 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.554 -0.832 . . . . 2.29 112.598 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 37.6 77.22 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.408 1.262 . . . . 2.31 114.408 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 18.7 mm-40 -129.18 73.16 1.5 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.61 109.929 170.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 1.3 p80 -110.54 157.81 19.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.766 -1.106 . . . . 4.63 111.502 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.763 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 37.6 p -83.66 151.96 25.02 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.726 -0.842 . . . . 2.27 108.726 169.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.5 p90 -108.78 111.72 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.228 -0.589 . . . . 7.39 110.51 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' A' ' 53' ' ' TRP . . . -63.36 129.64 40.3 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.047 -0.821 . . . . 1.23 111.047 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.5 HD13 ' HD3' ' A' ' 82' ' ' ARG . 4.4 mp -78.74 87.57 4.63 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.824 -0.35 . . . . 1.76 110.918 -170.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.681 HG21 HG12 ' A' ' 71' ' ' VAL . 13.7 mt -92.1 115.35 30.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.001 -1.08 . . . . 1.26 109.321 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -104.82 -12.58 16.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.313 -0.858 . . . . 2.65 110.596 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 19.5 ttmm -151.82 107.38 3.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 2.03 111.332 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 68' ' ' ILE . 2.5 m -103.14 85.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 1.47 108.568 167.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.19 72.82 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 1.42 111.08 -172.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 46.96 -171.88 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 124.684 1.24 . . . . 0.96 112.288 175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.3 Cg_exo -64.04 76.05 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.518 1.479 . . . . 0.48 111.411 166.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -159.61 -65.63 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.649 -0.705 . . . . 0.5 110.673 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.459 HG23 ' HA ' ' A' ' 100' ' ' THR . 2.8 p -144.96 143.08 30.34 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.427 0.529 . . . . 1.1 112.427 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.65 120.15 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 1.4 109.668 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 59.0 t -105.73 103.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.474 -0.565 . . . . 1.31 109.474 175.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.732 HG13 ' HE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -129.39 135.07 62.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.973 -0.558 . . . . 1.48 111.701 -174.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.16 147.67 18.69 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.065 -0.814 . . . . 0.5 111.065 174.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.692 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . 52.8 t-105 -78.96 135.65 37.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.237 0.541 . . . . 3.37 111.964 -168.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.763 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.9 tpt180 -130.76 25.93 5.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.423 -0.808 . . . . 6.17 109.641 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.837 HD11 ' HB2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER 81.25 134.78 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.845 -1.07 . . . . 2.13 112.233 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.53 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.1 t30 -108.53 109.67 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.023 -0.99 . . . . 1.93 109.786 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.07 -24.52 8.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.583 -0.818 . . . . 2.79 111.327 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 74.74 -25.71 0.2 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.589 0.756 . . . . 6.08 112.706 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.61 19.11 38.57 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.828 -0.701 . . . . 2.43 113.247 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.837 ' HB2' HD11 ' A' ' 83' ' ' LEU . 41.9 mmt180 -124.88 173.66 8.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.622 -0.51 . . . . 5.53 109.622 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.427 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -74.55 132.12 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.786 0.327 . . . . 2.42 110.73 178.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 10.3 p-10 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 3.18 110.495 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 52.7 Cg_exo -58.25 -37.63 94.47 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.267 2.644 . . . . 2.76 112.597 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER 78.35 -39.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.87 0.731 . . . . 2.99 112.39 169.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -120.06 -30.3 4.71 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.034 0.383 . . . . 3.06 112.034 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.438 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 48.9 m -138.95 -140.89 0.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.926 -0.31 . . . . 2.11 111.832 -175.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.583 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 67.7 m 65.75 24.02 11.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.496 -0.775 . . . . 1.81 109.427 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.796 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.7 tt0 -67.28 136.48 54.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.812 -1.085 . . . . 1.81 110.442 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.635 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 13.9 p90 -137.62 138.03 39.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.273 0.559 . . . . 0.81 110.84 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.559 HG21 HG22 ' A' ' 78' ' ' VAL . 34.1 m -100.26 109.76 21.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.244 -0.889 . . . . 1.18 109.663 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.411 HG12 HG21 ' A' ' 113' ' ' VAL . 1.6 m -87.64 121.6 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 119.591 -0.844 . . . . 1.51 109.122 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.459 ' HA ' HG23 ' A' ' 76' ' ' THR . 27.2 m -102.64 106.84 17.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.345 -0.843 . . . . 1.05 110.339 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.495 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.9 m-85 -82.37 109.82 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.655 -0.498 . . . . 0.42 109.655 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.16 112.52 27.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.572 -0.529 . . . . 1.26 109.572 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 124.38 23.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 1.13 110.568 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.809 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.3 t0 -105.69 103.4 12.9 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.425 -0.954 . . . . 2.03 108.425 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.27 -111.11 3.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.537 -0.84 . . . . 1.97 111.562 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -147.95 -3.93 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.638 0.256 . . . . 5.46 111.255 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.775 ' HB2' ' HZ2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -136.51 8.23 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.288 . . . . 3.88 111.342 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.809 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 36.1 ttmt -126.78 158.15 37.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.999 -0.741 . . . . 2.94 108.999 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.6 m -156.01 130.65 9.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.008 0.433 . . . . 1.2 111.096 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -109.37 112.91 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.82 -0.627 . . . . 3.1 109.741 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.656 HG11 ' HB ' ' A' ' 10' ' ' VAL . 8.7 p -90.95 141.77 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.865 -0.334 . . . . 1.13 110.63 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.7 t70 -135.01 105.72 6.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.354 -0.839 . . . . 1.38 109.857 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 1.059 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 9.5 t -86.3 131.57 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.357 -0.383 . . . . 1.58 111.941 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.82 124.03 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.842 0.714 . . . . 2.31 109.504 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 1.044 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 7.7 t-160 -142.23 102.72 4.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.526 -0.546 . . . . 2.32 109.526 -175.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.424 HG23 ' CD2' ' A' ' 5' ' ' PHE . 8.6 p -149.84 40.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.345 0.498 . . . . 3.19 112.345 -174.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.53 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.1 t-160 -113.37 -65.05 1.22 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.999 -0.68 . . . . 2.99 111.405 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.483 ' HB2' ' H ' ' A' ' 95' ' ' SER . 11.6 t80 -86.18 -49.67 7.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.896 0.379 . . . . 4.27 110.444 -175.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.84 -51.71 68.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.478 -0.783 . . . . 1.81 111.025 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.562 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 5.8 tmm_? -60.89 -19.43 60.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.779 -1.1 . . . . 3.84 111.125 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.53 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 42.3 tpp -80.97 23.07 0.58 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.864 0.364 . . . . 2.9 111.879 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.2 170.42 12.86 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.752 -1.214 . . . . 2.26 114.333 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 t -66.8 -44.48 81.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.894 -0.653 . . . . 3.02 111.676 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -66.13 -39.09 89.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.574 0.226 . . . . 4.23 110.726 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.656 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 10.1 m-70 -61.03 -52.85 63.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 2.7 110.486 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -64.73 -35.95 82.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 1.46 111.025 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -64.03 -46.45 84.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 3.16 111.405 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.656 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 8.3 ptm180 -64.93 -39.57 93.72 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.439 -0.346 . . . . 2.97 111.305 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 125' ' ' HIS . 2.8 p -81.33 -17.83 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.315 0.579 . . . . 1.96 110.987 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 61.7 ttt180 -68.74 -9.73 52.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.155 -0.341 . . . . 4.34 111.43 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.727 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.3 p30 -47.12 -40.06 14.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.561 0.578 . . . . 2.8 112.561 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.463 ' C ' ' HE3' ' A' ' 133' ' ' MET . . . -145.52 -11.24 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.072 -1.061 . . . . 2.08 113.381 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.527 ' SD ' ' HB3' ' A' ' 84' ' ' ASN . 22.6 mmt -79.43 -11.68 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.342 -0.505 . . . . 5.19 110.277 -172.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.66 -39.67 92.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.507 -0.769 . . . . 2.83 110.961 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -104.8 14.07 30.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 4.47 110.552 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -77.57 -78.18 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.925 -0.579 . . . . 1.04 111.828 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.545 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 13.6 m95 -55.62 -47.92 97.6 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 113.58 0.956 . . . . 3.78 113.58 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.9 Cg_endo -50.93 -43.64 46.25 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.839 1.693 . . . . 0.77 112.213 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.1 m -73.22 -45.72 54.54 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.432 0.634 . . . . 1.37 110.639 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 56.5 mt -58.38 -44.99 89.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 115.371 -0.831 . . . . 1.32 111.361 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 51.2 mt -59.86 -38.81 83.21 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.278 0.361 . . . . 1.33 111.054 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.1 mm-40 -61.5 -50.93 70.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.544 -0.462 . . . . 1.54 109.854 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 51.0 m -65.58 -28.4 69.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.604 -0.725 . . . . 1.43 110.817 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 60.0 t80 -68.27 -55.3 12.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 1.05 111.135 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -35.1 73.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.855 0.36 . . . . 1.63 111.076 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.26 -40.96 62.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.916 -0.584 . . . . 1.46 110.673 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.424 ' HE3' ' HG3' ' A' ' 29' ' ' GLU . 29.7 tptp -60.62 -38.52 85.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.361 0.601 . . . . 2.23 109.902 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.669 HG21 HG11 ' A' ' 12' ' ' VAL . 52.2 mt -74.45 -26.82 20.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.497 -0.774 . . . . 1.17 111.082 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.84 -31.22 72.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.477 -0.564 . . . . 0.85 109.477 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.816 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 37.5 mt-10 -66.28 -33.09 74.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 1.5 109.74 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -71.86 -23.46 61.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.081 -0.963 . . . . 1.74 109.646 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -98.89 -88.7 1.95 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.32 112.951 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.8 30.58 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.314 0.487 . . . . 2.42 112.314 -171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.816 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 16.9 tppt? -68.42 -19.63 64.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.491 0.662 . . . . 2.04 110.361 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.171 -0.922 . . . . 4.65 111.243 -176.273 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.919 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.7 p-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.934 -0.395 . . . . 2.1 109.934 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 5.2 p90 69.87 -40.78 0.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.413 1.485 . . . . 4.04 112.684 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.782 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 18.8 t70 -67.06 -54.58 19.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.216 -0.29 . . . . 2.78 110.216 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 32.6 Cg_endo -87.89 -64.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.66 1.573 . . . . 1.83 111.323 169.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.32 152.27 31.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.257 -1.016 . . . . 3.98 108.257 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.919 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -109.58 126.2 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.094 0.473 . . . . 2.03 109.98 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 20.6 ttp85 -130.99 135.17 47.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 3.92 110.453 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.6 ' HD1' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.79 132.42 54.17 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.567 -0.531 . . . . 1.16 109.567 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.723 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.9 p -135.44 116.27 14.05 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.883 -0.599 . . . . 1.72 110.887 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 111' ' ' VAL . 15.5 m -125.02 156.06 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.845 -0.616 . . . . 1.89 110.869 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.7 m -109.82 116.83 32.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.536 -0.756 . . . . 1.15 109.93 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.707 HG23 ' HB2' ' A' ' 19' ' ' ALA . 37.1 t -93.79 138.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.273 -0.876 . . . . 1.51 110.77 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -96.8 7.76 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 1.6 112.256 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.569 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.03 47.09 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.533 -0.467 . . . . 1.11 112.233 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.5 t70 75.07 163.17 0.26 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.075 0.941 . . . . 0.91 112.973 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 27.9 ttp180 -62.34 -25.62 67.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.387 -1.279 . . . . 2.19 110.783 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 17' ' ' LYS . 33.8 ttpt -57.65 -49.47 76.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 3.49 110.988 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.4 p -75.43 -31.93 60.51 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.808 -0.357 . . . . 1.49 110.935 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 12' ' ' VAL . . . -60.98 -46.75 89.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.755 -0.378 . . . . 1.07 110.637 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 73.4 t80 -67.14 -42.32 84.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.43 110.657 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.886 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 19.8 tptm -56.12 -52.8 63.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.45 . . . . 2.87 110.518 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.61 HG23 ' CE2' ' A' ' 30' ' ' TRP . 18.7 m -72.01 -22.58 61.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.952 -0.567 . . . . 1.21 111.553 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -88.99 -36.93 15.56 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.182 -0.324 . . . . 0.53 111.558 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -119.82 -48.88 2.35 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.245 0.832 . . . . 1.23 113.245 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.886 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 20.5 mt-10 -75.08 -29.21 60.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.808 0.813 . . . . 1.24 110.354 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.86 99.15 0.7 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 108.244 -1.942 . . . . 0.83 108.244 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.629 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.6 t80 -96.17 -56.64 0.2 Allowed Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 115.704 -0.248 . . . . 0.94 111.58 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.657 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 40.9 Cg_endo -103.43 39.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.095 2.53 . . . . 0.9 114.493 -172.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.81 -2.86 5.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.905 -0.718 . . . . 1.49 112.894 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.762 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 17.0 m95 -90.6 -155.87 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 5.66 110.748 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.533 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 10.6 m95 -110.91 6.15 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.929 1.455 . . . . 3.41 114.929 -172.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.999 ' HB2' HD13 ' A' ' 140' ' ' ILE . 74.4 Cg_endo -88.32 -140.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 122.108 1.788 . . . . 1.36 112.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.539 ' HB3' HD11 ' A' ' 140' ' ' ILE . 62.7 t30 -67.69 -20.42 65.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.848 0.832 . . . . 1.51 110.004 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.842 ' HA ' HG21 ' A' ' 40' ' ' VAL . 1.2 m-20 -77.05 19.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.567 -1.197 . . . . 1.98 111.675 -171.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.28 -3.85 19.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.937 0.399 . . . . 5.13 110.696 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.87 142.76 27.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.414 . . . . 4.7 110.89 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 m -76.83 138.63 39.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 3.11 111.298 -172.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.2 p 57.06 8.16 0.5 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.731 1.212 . . . . 1.89 113.32 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.83 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 32.4 ttmt -91.48 -73.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.98 -0.748 . . . . 3.45 108.98 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.842 HG21 ' HA ' ' A' ' 34' ' ' ASN . 3.7 m -147.08 18.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.404 -0.816 . . . . 2.3 109.142 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.657 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -140.38 51.02 0.74 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.424 -0.807 . . . . 2.2 113.3 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 1.048 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -94.25 172.8 5.25 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.634 -0.876 . . . . 1.31 108.634 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 32.7 Cg_endo -65.01 62.44 0.3 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.659 2.24 . . . . 1.94 113.475 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 42.3 tp -170.51 -91.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 2.23 110.268 175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.548 ' HA3' ' HB3' ' A' ' 27' ' ' PHE . . . 94.76 -63.62 1.54 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.811 -0.709 . . . . 0.94 112.791 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' A' ' 27' ' ' PHE . 77.1 t -137.87 139.23 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.977 -0.379 . . . . 1.21 109.977 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.617 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 24.6 t70 -105.43 118.33 36.28 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.054 -0.721 . . . . 1.11 109.054 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.661 ' HZ3' ' HG2' ' A' ' 25' ' ' GLU . 14.0 mmmm -80.06 -35.5 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.613 -0.721 . . . . 3.25 111.622 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HZ1' ' HB3' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -76.41 -38.88 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.711 0.263 . . . . 3.63 111.711 -173.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -36.29 6.24 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.765 -0.731 . . . . 1.9 112.118 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 93.33 65.65 1.07 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.664 -0.779 . . . . 0.87 112.155 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HG3' ' CD2' ' A' ' 54' ' ' TYR . 11.9 ptt180 -159.34 148.06 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.647 -0.421 . . . . 4.26 111.574 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.605 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.8 m0 -95.38 108.53 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.52 110.203 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.617 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -158.57 162.48 37.38 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.993 0.425 . . . . 2.04 110.305 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 1.048 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 11.6 mp0 -122.26 165.74 15.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.122 -0.695 . . . . 2.12 109.122 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.556 HG21 ' HG2' ' A' ' 61' ' ' GLU . 47.9 mm -77.37 102.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.937 -0.764 . . . . 1.42 108.937 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.79 144.1 39.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 1.97 110.679 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.11 -27.73 69.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.138 -0.937 . . . . 2.43 111.918 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.497 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -74.91 -22.83 58.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 2.39 111.285 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.11 50.18 0.03 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.004 -1.093 . . . . 2.29 113.919 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.556 ' HG2' HG21 ' A' ' 56' ' ' ILE . 44.9 mt-10 63.02 16.34 9.2 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.368 0.877 . . . . 2.31 113.368 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.497 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 10.1 tp10 -105.34 82.39 1.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.638 0.732 . . . . 2.61 110.389 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -111.08 148.48 32.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.095 -0.957 . . . . 4.63 110.728 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.696 HG23 ' HD3' ' A' ' 82' ' ' ARG . 3.3 t -54.69 140.76 34.63 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.451 -0.944 . . . . 2.27 108.451 167.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.8 p90 -129.89 143.99 51.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.472 0.653 . . . . 7.39 112.394 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 128.22 8.44 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.55 -1.02 . . . . 1.23 110.55 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.564 HD22 ' O ' ' A' ' 93' ' ' ASN . 3.8 mp -85.87 89.23 7.71 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 111.438 0.162 . . . . 1.76 111.438 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.949 HG23 HG12 ' A' ' 71' ' ' VAL . 58.4 mt -80.62 116.16 24.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.014 -0.674 . . . . 1.26 110.024 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 67' ' ' LEU . 4.9 mpt_? -98.59 -25.24 14.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.713 -0.477 . . . . 2.65 109.713 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 72' ' ' ASP . 18.0 ttmm -139.52 121.56 15.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 2.03 111.774 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.949 HG12 HG23 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -111.79 85.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.665 -0.865 . . . . 1.47 108.665 167.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -96.45 70.74 2.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.16 -0.473 . . . . 1.42 110.69 -170.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 8.2 pt-20 49.43 -172.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 124.523 1.139 . . . . 0.96 111.188 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . 35.7 Cg_exo -63.48 77.33 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.294 1.329 . . . . 0.48 111.058 163.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.6 t70 -159.72 -68.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.5 110.549 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -139.42 143.05 37.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.559 0.577 . . . . 1.1 112.559 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.94 117.41 16.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.864 -0.607 . . . . 1.4 109.597 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.486 HG21 HG23 ' A' ' 98' ' ' THR . 41.2 t -104.35 103.18 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.475 . . . . 1.31 109.719 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.574 HG12 ' N ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -129.5 142.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.79 -0.641 . . . . 1.48 112.139 -175.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.574 ' N ' HG12 ' A' ' 79' ' ' ILE . . . -86.5 158.06 30.76 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.56 -0.745 . . . . 0.5 111.523 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -78.78 155.09 29.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.954 0.724 . . . . 3.37 112.954 -170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.696 ' HD3' HG23 ' A' ' 64' ' ' THR . 0.0 OUTLIER -125.43 -78.34 0.6 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.822 -1.081 . . . . 6.17 110.747 -176.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.682 HD21 ' HG2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 172.0 146.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.971 -1.122 . . . . 2.13 107.971 -176.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.624 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 10.1 t30 -117.88 -62.96 1.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.399 0.518 . . . . 1.93 112.399 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.69 -10.6 83.15 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.792 -0.718 . . . . 2.79 114.466 -169.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.83 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 19.6 t80 64.95 14.58 9.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.73 0.776 . . . . 6.08 110.604 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 34.06 2.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.209 -1.156 . . . . 2.43 110.209 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.682 ' HG2' HD21 ' A' ' 83' ' ' LEU . 2.6 ttp180 -137.41 162.21 34.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.889 -0.655 . . . . 5.53 110.878 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.573 ' C ' HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -109.06 127.09 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.509 -0.552 . . . . 2.42 109.509 175.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.582 ' HB2' HD22 ' A' ' 83' ' ' LEU . 6.1 m-20 -144.07 149.96 47.39 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.778 -0.647 . . . . 3.18 109.657 171.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.29 -12.95 34.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.192 2.595 . . . . 2.76 114.322 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 60.88 33.58 19.88 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.459 0.647 . . . . 2.99 109.975 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.564 ' O ' HD22 ' A' ' 67' ' ' LEU . 11.6 m-80 -141.87 -80.68 0.23 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.618 . . . . 3.06 112.603 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 m -78.41 -125.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.401 0.519 . . . . 2.11 112.401 -170.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.634 ' HB3' ' HE1' ' A' ' 115' ' ' HIS . 16.2 m 70.85 -75.29 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.733 -0.667 . . . . 1.81 110.994 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 60.4 116.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.144 0.794 . . . . 1.81 113.144 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.401 ' HB3' ' CG ' ' A' ' 115' ' ' HIS . 18.6 p90 -132.15 129.39 39.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.14 0.495 . . . . 0.81 110.985 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HG21 ' A' ' 78' ' ' VAL . 47.8 m -89.98 107.35 19.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.23 -0.896 . . . . 1.18 109.758 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.672 ' HA ' HG22 ' A' ' 113' ' ' VAL . 98.3 t -81.84 109.73 16.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.866 -0.606 . . . . 1.51 109.961 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.444 ' HA ' HG23 ' A' ' 76' ' ' THR . 27.5 m -105.9 105.95 16.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.835 0.35 . . . . 1.05 110.981 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.607 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 49.7 m-85 -86.0 110.97 19.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.75 -0.463 . . . . 0.42 109.75 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.2 t -91.87 109.35 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.312 -0.625 . . . . 1.26 109.312 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.65 132.62 42.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.46 0.648 . . . . 1.13 111.908 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -108.0 123.16 48.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.402 -0.962 . . . . 2.03 108.402 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.93 -25.48 37.89 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.623 0.609 . . . . 1.97 114.623 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -85.12 39.5 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.453 0.626 . . . . 5.46 110.909 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 42.2 mmtt 58.53 46.74 14.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.996 0.903 . . . . 3.88 110.241 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -135.6 155.39 50.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.224 -1.353 . . . . 2.94 107.853 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 48.3 m -155.13 119.46 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.873 -0.517 . . . . 1.2 111.646 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -95.78 112.71 24.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.512 -0.767 . . . . 3.1 109.705 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.769 HG13 HG23 ' A' ' 10' ' ' VAL . 14.6 p -88.7 136.89 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 120.119 -0.633 . . . . 1.13 109.822 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.432 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 7.4 t70 -126.28 108.35 11.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.426 1.079 . . . . 1.38 108.607 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 99' ' ' VAL . 10.1 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.622 -0.717 . . . . 1.58 111.425 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.69 111.49 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.632 0.583 . . . . 2.31 109.495 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.634 ' HE1' ' HB3' ' A' ' 95' ' ' SER . 6.1 t60 -123.13 118.02 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.482 -0.562 . . . . 2.32 109.482 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 120' ' ' ARG . 85.0 m -158.78 103.68 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.124 -0.23 . . . . 3.19 111.6 -174.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.98 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.865 0.364 . . . . 2.99 111.099 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.465 ' HZ ' ' HD3' ' A' ' 128' ' ' ARG . 50.4 t80 -78.24 -50.36 12.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.092 -0.503 . . . . 4.27 112.139 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -38.42 77.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.411 0.624 . . . . 1.81 110.041 -174.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.804 ' HD2' HG22 ' A' ' 116' ' ' THR . 20.0 ttt180 -63.6 -20.21 65.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 3.84 111.573 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 31.0 tpp -80.11 29.87 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.099 0.777 . . . . 2.9 113.099 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.76 177.42 16.71 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.637 -1.268 . . . . 2.26 114.547 168.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -55.88 -60.55 3.3 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.812 -0.694 . . . . 3.02 112.745 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.9 -35.54 81.48 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 121.057 -0.257 . . . . 4.23 111.306 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.543 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 24.4 m80 -59.51 -50.93 72.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.973 0.416 . . . . 2.7 110.165 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.46 63.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 1.46 111.118 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 89.0 tttt -69.38 -38.96 78.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.099 -0.5 . . . . 3.16 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.42 -31.64 65.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 2.97 109.686 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.589 HG12 ' HG2' ' A' ' 133' ' ' MET . 87.0 t -61.63 -49.72 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 1.96 111.15 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.67 ' HA ' ' HG3' ' A' ' 133' ' ' MET . 0.0 OUTLIER -65.87 -14.54 61.66 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.162 -0.336 . . . . 4.34 111.443 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -52.51 -28.58 21.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.628 0.371 . . . . 2.8 111.843 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -157.76 15.58 0.3 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.99 -1.1 . . . . 2.08 113.857 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.67 ' HG3' ' HA ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -84.22 -26.87 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.899 0.85 . . . . 5.19 111.438 176.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.56 -34.16 77.28 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.962 0.727 . . . . 2.83 112.962 -164.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.38 18.13 22.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.011 0.434 . . . . 4.47 110.579 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.638 ' O ' HD12 ' A' ' 140' ' ' ILE . . . -122.47 -77.34 0.4 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.04 -1.076 . . . . 1.04 112.871 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.467 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 76.0 t-105 -54.33 -51.91 73.8 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.716 0.636 . . . . 3.78 112.716 -169.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.8 -33.29 96.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.809 1.673 . . . . 0.77 111.94 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -76.56 -33.49 58.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.717 -0.674 . . . . 1.37 110.304 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -55.07 -48.16 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 108.596 -0.89 . . . . 1.32 108.596 173.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.0 mt -60.42 -28.36 68.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.261 -0.881 . . . . 1.33 112.002 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 26.4 mm-40 -72.13 -57.4 4.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.154 -0.313 . . . . 1.54 110.154 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.6 m -67.6 -25.93 66.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.12 0.486 . . . . 1.43 110.522 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 10' ' ' VAL . 62.0 t80 -57.8 -55.29 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.422 -0.808 . . . . 1.05 109.956 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.502 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 43.7 mt-30 -68.7 -24.63 64.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.763 -0.653 . . . . 1.63 110.939 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.25 -45.39 40.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.285 . . . . 1.46 111.593 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.762 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 15.2 tptm -70.23 -31.36 68.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.631 -0.828 . . . . 2.23 110.263 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.659 HG22 HG11 ' A' ' 12' ' ' VAL . 49.9 mt -63.43 -37.36 79.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.484 0.659 . . . . 1.17 109.635 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.474 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 11.5 t70 -59.33 -36.97 76.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.174 -0.921 . . . . 0.85 109.494 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 3.9 mm-40 -63.72 -41.04 98.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.507 -0.77 . . . . 1.5 110.673 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 5.7 mm-40 -75.96 -16.01 60.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.899 -1.046 . . . . 1.74 109.839 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -102.0 -75.88 1.14 Allowed Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.409 -0.814 . . . . 1.32 113.235 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.19 13.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.28 0.845 . . . . 2.42 113.28 -169.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 21.9 ttmm -71.47 -39.66 70.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 2.04 109.164 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.775 ' HB3' ' HZ2' ' A' ' 155' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.475 -0.784 . . . . 4.65 110.031 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.609 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 3.5 p-10 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.548 0.214 . . . . 2.1 110.989 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.496 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 54.8 p90 169.96 -30.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 4.04 109.62 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.835 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 31.6 t70 -65.87 -54.26 29.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 2.78 110.927 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.835 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -91.23 -68.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.133 1.889 . . . . 1.83 111.176 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 12.0 p90 -153.69 159.26 41.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.061 -0.518 . . . . 3.98 109.652 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.894 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 79.0 t -97.49 128.63 48.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.965 -0.754 . . . . 2.03 108.965 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 15.9 ttp180 -117.33 142.43 47.11 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.954 -0.698 . . . . 3.92 111.536 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.522 ' CD2' HG11 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -124.04 133.39 53.66 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.387 -0.968 . . . . 1.16 108.387 172.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.751 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 6.6 t -139.8 111.35 7.2 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.881 -0.414 . . . . 1.72 109.881 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.724 HG23 ' CG1' ' A' ' 111' ' ' VAL . 6.3 m -126.2 151.45 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 1.89 110.955 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.8 m -103.38 115.74 31.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.507 -0.769 . . . . 1.15 110.158 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.724 HG23 ' HB2' ' A' ' 19' ' ' ALA . 55.9 t -97.51 125.6 50.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.251 -0.886 . . . . 1.51 110.013 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.648 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.68 23.94 8.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.799 -0.637 . . . . 1.6 111.886 -173.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.23 31.04 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 1.11 111.055 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 37.7 t70 72.32 167.26 0.31 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.13 0.967 . . . . 0.91 113.504 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.545 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 34.3 ttp180 -63.47 -27.79 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.232 -1.349 . . . . 2.19 111.226 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.36 -45.08 84.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 3.49 111.141 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -77.36 -40.59 43.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.798 -0.361 . . . . 1.49 110.739 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.724 ' HB2' HG23 ' A' ' 12' ' ' VAL . . . -56.56 -41.68 77.28 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 120.886 -0.325 . . . . 1.07 110.904 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.31 -47.31 43.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.613 0.244 . . . . 0.43 110.949 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -54.12 -52.53 60.76 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.298 -0.41 . . . . 2.87 110.37 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -65.5 -51.03 62.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.367 -0.379 . . . . 1.21 111.031 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.763 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.4 t80 -61.22 -37.55 83.41 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.406 0.521 . . . . 0.53 112.406 -173.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.677 ' HG ' HG13 ' A' ' 46' ' ' VAL . 14.5 tp -113.02 -50.06 2.9 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.195 -0.602 . . . . 1.23 112.469 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.545 ' HA ' ' CE ' ' A' ' 48' ' ' LYS . 36.6 mt-10 -78.36 -35.28 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.071 0.462 . . . . 1.24 111.15 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.741 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -105.36 35.52 5.01 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 115.642 -0.708 . . . . 0.83 112.084 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.562 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 62.0 t80 -52.56 -51.27 74.73 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.968 0.729 . . . . 0.94 112.968 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.05 -2.01 11.79 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.11 1.873 . . . . 0.9 114.801 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.5 pt-20 -90.75 -5.45 55.68 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.227 -0.589 . . . . 1.49 112.183 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.763 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 9.7 m0 -74.52 -179.07 3.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.397 0.618 . . . . 5.66 111.259 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.52 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 79.2 m95 -96.18 -32.63 0.27 Allowed Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 114.237 1.199 . . . . 3.41 114.237 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.63 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 68.5 Cg_endo -71.54 -123.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.332 2.021 . . . . 1.36 115.244 -165.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.53 HD21 HG22 ' A' ' 40' ' ' VAL . 6.3 t30 -62.33 -22.74 66.31 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.169 -0.469 . . . . 1.51 111.452 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.79 ' HA ' HG23 ' A' ' 40' ' ' VAL . 11.8 p30 -86.91 17.22 4.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.999 -0.546 . . . . 1.98 111.497 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -71.76 -10.22 59.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.377 0.608 . . . . 5.13 110.037 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -104.3 118.88 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 4.7 111.279 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -77.25 151.39 35.14 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.63 -0.714 . . . . 3.11 109.64 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.546 HG21 ' HA ' ' A' ' 57' ' ' ASP . 51.5 p 55.74 25.39 8.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.919 0.866 . . . . 1.89 110.791 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HG2' HG21 ' A' ' 40' ' ' VAL . 16.8 ttmm -127.48 -59.67 1.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.61 -1.177 . . . . 3.45 109.723 166.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.79 HG23 ' HA ' ' A' ' 34' ' ' ASN . 2.8 m -157.72 28.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.955 -0.566 . . . . 2.3 110.492 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.88 18.31 0.85 Allowed Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.934 -1.127 . . . . 2.2 114.178 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.993 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -73.95 162.67 72.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 117.163 0.482 . . . . 1.31 109.974 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -50.05 -5.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 124.645 3.563 . . . . 1.94 116.53 -172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -105.33 -85.31 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.094 -0.379 . . . . 2.23 110.571 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.562 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.37 -48.28 2.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.884 -0.674 . . . . 0.94 112.976 174.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.677 HG13 ' HG ' ' A' ' 24' ' ' LEU . 73.3 t -140.11 141.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 1.21 111.289 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.871 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 20.7 t70 -96.38 115.07 26.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.508 -0.552 . . . . 1.11 109.508 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.545 ' CE ' ' HA ' ' A' ' 25' ' ' GLU . 36.4 mmtm -79.65 -27.99 40.85 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.95 0.781 . . . . 3.25 112.23 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -83.09 -46.84 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.425 0.528 . . . . 3.63 112.425 -170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.66 -32.01 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.446 -0.883 . . . . 1.9 111.954 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.549 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 103.95 71.18 0.84 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.348 -0.93 . . . . 0.87 112.239 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -136.25 162.55 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.929 -0.397 . . . . 4.26 109.929 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.0 m95 -116.75 107.75 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.52 108.886 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.871 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.7 p90 -162.64 159.93 25.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.228 0.537 . . . . 2.04 111.109 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.993 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 23.4 mt-10 -102.23 -176.01 3.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 2.12 110.051 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.402 HG21 ' OE2' ' A' ' 61' ' ' GLU . 43.8 mm -105.22 111.57 35.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.767 -0.827 . . . . 1.42 108.767 157.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.703 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 3.5 t70 -91.65 177.72 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.537 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -84.48 -36.14 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.851 0.686 . . . . 2.43 112.851 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.429 HE22 ' CG ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -88.26 14.68 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.55 -0.46 . . . . 2.39 111.672 -173.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.75 64.02 0.92 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.356 -0.926 . . . . 2.29 112.811 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.681 ' HA ' ' NE2' ' A' ' 63' ' ' HIS . 0.1 OUTLIER 57.35 74.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.817 1.043 . . . . 2.31 113.817 172.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.17 73.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.113 -0.699 . . . . 2.61 109.113 169.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.703 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -125.24 163.31 22.78 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.214 -0.903 . . . . 4.63 110.883 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.629 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 9.0 t -157.09 135.62 11.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.639 0.257 . . . . 2.27 110.602 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.704 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 33.5 t80 -146.93 -58.43 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 7.39 110.558 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA3' HD12 ' A' ' 79' ' ' ILE . . . -155.72 159.68 29.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.53 -1.319 . . . . 1.23 114.25 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -119.01 113.81 21.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.668 -0.766 . . . . 1.76 109.696 177.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.969 HG21 HG13 ' A' ' 71' ' ' VAL . 72.3 mt -77.26 132.28 33.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 1.26 110.858 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -102.87 -24.94 13.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.047 -0.979 . . . . 2.65 109.504 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' HZ1' ' HB2' ' A' ' 72' ' ' ASP . 47.4 tttm -165.79 108.96 0.8 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.559 -0.746 . . . . 2.03 111.192 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.969 HG13 HG21 ' A' ' 68' ' ' ILE . 1.6 m -100.91 115.5 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.362 -0.607 . . . . 1.47 109.362 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB2' ' HZ1' ' A' ' 70' ' ' LYS . 1.1 t70 -122.24 74.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.73 -0.388 . . . . 1.42 110.779 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.15 -170.69 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 124.525 1.14 . . . . 0.96 111.944 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.536 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.7 Cg_exo -64.71 78.26 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.322 1.348 . . . . 0.48 111.093 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 23.5 t70 -161.76 -67.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.5 110.837 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 100' ' ' THR . 2.2 p -142.01 141.97 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.076 0.465 . . . . 1.1 111.805 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.59 126.94 28.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.433 . . . . 1.4 109.845 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 98' ' ' THR . 26.2 t -103.39 109.92 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.629 -0.878 . . . . 1.31 108.629 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.475 HD12 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -127.18 127.12 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.334 -0.394 . . . . 1.48 110.249 -174.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.825 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.56 155.75 23.53 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.5 112.339 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 58.3 t-105 -81.68 138.37 35.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.054 0.39 . . . . 3.37 112.054 -171.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.629 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 34.8 ttt-85 -148.54 23.16 1.02 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.859 -0.61 . . . . 6.17 109.997 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 78.48 145.48 0.09 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.083 -0.962 . . . . 2.13 112.917 172.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.506 ' H ' HD13 ' A' ' 83' ' ' LEU . 8.1 m-20 -77.85 48.47 0.7 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.499 -0.773 . . . . 1.93 111.37 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.22 46.9 43.19 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 116.126 -0.488 . . . . 2.79 113.916 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.402 ' H ' HD11 ' A' ' 83' ' ' LEU . 28.8 m-85 -106.96 1.81 24.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.159 -0.612 . . . . 6.08 111.211 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.42 24.62 76.62 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.53 -0.843 . . . . 2.43 111.603 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HD3' ' HB3' ' A' ' 131' ' ' ASN . 50.3 mtt180 -98.96 -174.28 2.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.41 -0.395 . . . . 5.53 110.637 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.684 ' O ' HD21 ' A' ' 83' ' ' LEU . 1.7 pp -54.74 149.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.845 0.716 . . . . 2.42 111.292 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 p-10 -146.49 135.15 11.01 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 110.0 -0.37 . . . . 3.18 110.0 175.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 81' ' ' TRP . 3.4 Cg_exo -76.58 -37.89 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.446 2.097 . . . . 2.76 111.71 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 70.06 -6.59 1.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.388 -0.824 . . . . 2.99 111.88 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -137.89 -64.69 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 3.06 111.017 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -89.54 -161.49 0.78 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.185 -0.461 . . . . 2.11 111.293 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 3.7 t 67.4 40.0 2.79 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 122.06 0.933 . . . . 1.81 108.605 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.825 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 15.7 mt-10 -81.12 136.76 35.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.359 -1.292 . . . . 1.81 110.012 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -120.23 120.67 36.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.464 0.65 . . . . 0.81 110.563 174.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.513 HG23 HG21 ' A' ' 78' ' ' VAL . 41.7 m -93.35 115.27 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.99 -1.005 . . . . 1.18 110.085 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.467 ' CB ' HG23 ' A' ' 113' ' ' VAL . 2.0 m -94.59 123.82 46.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.349 0.595 . . . . 1.51 109.459 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.444 ' HA ' HG21 ' A' ' 76' ' ' THR . 86.5 m -104.89 106.84 17.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.307 -0.86 . . . . 1.05 109.805 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.682 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.1 m-85 -82.79 110.39 17.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 0.42 109.917 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 109' ' ' THR . 58.8 t -88.17 107.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.759 0.314 . . . . 1.26 110.481 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 129.28 39.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.831 -0.622 . . . . 1.13 110.928 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.751 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 5.9 t0 -128.16 97.3 4.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 2.03 110.476 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.45 69.56 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.913 -0.66 . . . . 1.97 113.977 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 66.67 6.64 4.62 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.887 0.699 . . . . 5.46 112.887 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 41.2 mtmt -136.26 -0.42 2.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 3.88 111.378 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.751 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 42.4 tttt -138.34 157.97 45.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.223 -0.658 . . . . 2.94 109.223 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.525 ' N ' ' HG2' ' A' ' 108' ' ' LYS . 18.1 m -156.67 128.28 7.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.102 0.477 . . . . 1.2 110.99 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -106.33 115.14 29.7 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.763 -0.828 . . . . 3.1 108.763 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -95.17 141.55 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.291 -0.564 . . . . 1.13 111.005 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.557 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 11.5 t70 -128.99 104.1 7.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 124.459 1.099 . . . . 1.38 109.565 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -85.7 139.17 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-N 116.499 -0.319 . . . . 1.58 111.293 178.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 39.8 mt-10 -118.46 110.52 17.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.027 0.83 . . . . 2.31 109.823 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.894 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 3.0 t-160 -91.89 107.26 19.08 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.098 -0.955 . . . . 2.32 108.555 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 22.9 p -118.84 158.59 25.36 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.707 0.765 . . . . 3.19 112.383 -172.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.657 ' O ' ' HG3' ' A' ' 121' ' ' MET . 98.9 m-70 99.22 -78.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.486 -1.688 . . . . 2.99 111.077 164.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.454 ' HZ ' ' NH1' ' A' ' 128' ' ' ARG . 31.6 t80 -72.47 -48.84 37.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.706 -0.679 . . . . 4.27 112.592 -165.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.48 -43.36 99.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.92 0.867 . . . . 1.81 109.5 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 55.2 ttt180 -61.12 -20.71 62.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.194 -1.367 . . . . 3.84 111.931 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.657 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 93.8 mtp -78.08 25.14 0.23 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.461 0.541 . . . . 2.9 112.461 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.4 155.37 8.9 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.722 -1.228 . . . . 2.26 113.293 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 t -51.93 -47.86 64.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.234 -0.483 . . . . 3.02 112.279 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -72.66 -25.27 61.2 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.879 -0.329 . . . . 4.23 111.168 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.529 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 11.5 m170 -68.35 -50.07 55.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.403 0.621 . . . . 2.7 109.569 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' A' ' 2' ' ' TYR . . . -69.9 -30.87 68.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 1.46 111.001 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -68.37 -37.83 80.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 3.16 111.198 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.7 ptm180 -72.67 -36.27 67.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.887 -0.325 . . . . 2.97 110.248 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.0 t -68.75 -33.05 57.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.342 0.591 . . . . 1.96 110.346 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 32.9 ttm180 -57.39 -21.83 38.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.242 -0.89 . . . . 4.34 111.0 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 91.1 m-20 -64.55 -21.35 66.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.8 111.598 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.7 -58.13 0.52 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.007 -1.092 . . . . 2.08 114.155 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -80.53 -9.18 59.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.131 0.789 . . . . 5.19 113.131 -170.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 6.4 p-10 -53.42 -49.4 67.4 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.842 0.682 . . . . 2.83 112.842 -169.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -111.34 -19.88 12.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 4.47 110.955 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -63.27 -57.27 15.92 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.632 -0.587 . . . . 1.04 111.632 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.43 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.6 m0 -55.47 -53.99 56.1 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.052 0.76 . . . . 3.78 113.052 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.3 Cg_endo -56.91 -37.75 97.55 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.747 1.632 . . . . 0.77 112.097 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.9 m -70.16 -45.29 67.06 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.635 0.731 . . . . 1.37 109.958 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 27.0 mt -58.54 -54.18 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.957 -1.019 . . . . 1.32 111.548 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.44 ' HB3' HG13 ' A' ' 10' ' ' VAL . 82.2 mt -62.6 -24.66 67.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.255 0.465 . . . . 1.33 112.255 -173.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -56.56 4.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.952 0.406 . . . . 1.54 110.234 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 73.8 m -66.44 -23.09 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 1.43 110.531 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.77 -55.06 34.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 1.05 110.491 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.43 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 41.5 mt-30 -61.91 -32.44 72.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.961 -0.563 . . . . 1.63 110.684 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.1 m-20 -72.84 -40.91 65.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 1.46 111.773 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.3 tptp -65.42 -42.41 92.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 2.23 109.69 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.677 HG21 HG12 ' A' ' 12' ' ' VAL . 72.8 mt -62.36 -38.76 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.433 0.635 . . . . 1.17 110.401 174.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -58.37 -37.1 74.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.85 110.169 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 146' ' ' ASP . 38.9 mt-10 -72.9 -35.14 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.551 -0.75 . . . . 1.5 110.439 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 21.6 mm-40 -67.77 -38.0 82.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 1.74 110.142 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.94 -66.63 2.11 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.463 -0.79 . . . . 1.32 111.684 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.25 81.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.708 0.29 . . . . 2.42 111.478 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -163.13 85.48 0.52 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 2.04 110.329 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 150' ' ' GLU . 36.7 mtmt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.245 -0.883 . . . . 4.65 109.548 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.3 p-10 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.858 -0.115 . . . . 2.1 110.754 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 86.67 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.314 1.045 . . . . 4.04 110.175 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.639 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 11.2 t70 -51.39 -52.47 59.29 Favored Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 123.453 0.471 . . . . 2.78 111.63 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.4 Cg_endo -85.45 -67.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.165 1.244 . . . . 1.83 112.517 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 36.3 p90 -153.37 142.17 21.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.153 -0.684 . . . . 3.98 109.153 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -123.56 136.2 60.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 2.03 111.284 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.0 ttp180 -141.28 141.78 33.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.581 -0.736 . . . . 3.92 110.502 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.703 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.1 133.39 53.07 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.846 -0.798 . . . . 1.16 108.846 173.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 3.8 t -132.91 111.76 11.32 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.399 0.619 . . . . 1.72 110.214 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.489 HG12 ' CG ' ' A' ' 145' ' ' GLN . 2.0 t -123.91 138.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.053 -0.976 . . . . 1.89 111.585 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -96.6 117.04 30.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.251 0.548 . . . . 1.15 109.994 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.697 HG13 HG23 ' A' ' 148' ' ' ILE . 51.4 t -96.48 129.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 1.51 110.081 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.555 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.18 24.9 9.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.967 -0.56 . . . . 1.6 111.845 -173.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.531 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -153.74 33.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.31 0.485 . . . . 1.11 112.31 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 15.8 t70 73.43 165.67 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.904 0.859 . . . . 0.91 112.607 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -65.66 -26.33 67.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.87 -1.059 . . . . 2.19 111.166 -174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.95 -43.69 98.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.122 -0.49 . . . . 3.49 111.09 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.0 p -74.55 -35.76 63.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.888 -0.325 . . . . 1.49 110.361 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 101' ' ' PHE . . . -56.65 -48.16 78.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 1.07 110.444 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.06 -44.47 69.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.43 110.732 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -55.23 -52.33 63.74 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.404 -0.362 . . . . 2.87 110.807 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -67.3 -51.07 57.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.546 -0.297 . . . . 1.21 111.102 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.626 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.0 t80 -65.42 -34.58 78.63 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.059 0.392 . . . . 0.53 112.059 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.575 HD12 HG13 ' A' ' 46' ' ' VAL . 12.9 tp -111.73 -54.42 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.382 -0.527 . . . . 1.23 111.961 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.89 33.7 2.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 1.24 111.705 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.728 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -157.73 34.47 0.53 Allowed Glycine 0 C--O 1.217 -0.908 0 C-N-CA 120.734 -0.746 . . . . 0.83 111.895 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.635 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 t80 -61.58 -51.39 77.19 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 112.264 0.468 . . . . 0.94 112.264 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.665 ' HB3' HD21 ' A' ' 44' ' ' LEU . 93.4 Cg_endo -77.57 15.49 1.23 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.461 2.107 . . . . 0.9 115.058 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.728 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -113.09 -2.31 14.2 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.835 -0.541 . . . . 1.49 111.151 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.826 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 31.2 m0 -72.43 160.13 32.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.329 0.585 . . . . 5.66 111.277 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 58.2 m95 -89.61 -37.01 0.42 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.627 0.973 . . . . 3.41 113.627 175.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.826 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 18.5 Cg_endo -58.18 -84.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.525 2.15 . . . . 1.36 115.448 -163.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.412 ' HB3' HD12 ' A' ' 140' ' ' ILE . 5.6 t30 -110.76 -4.41 15.33 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.776 0.798 . . . . 1.51 109.425 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.808 ' HA ' HG22 ' A' ' 40' ' ' VAL . 1.9 m-20 -86.54 74.39 9.91 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.729 -1.123 . . . . 1.98 111.255 -170.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -154.46 29.09 0.44 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.791 0.663 . . . . 5.13 112.791 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 23.3 mmm180 -135.77 152.63 51.32 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 4.7 111.728 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.3 p -76.17 135.39 39.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.502 -0.317 . . . . 3.11 110.149 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.496 ' H ' ' HB1' ' A' ' 42' ' ' ALA . 1.7 p 50.22 26.04 2.03 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.632 0.729 . . . . 1.89 111.741 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 15.7 ttmm -146.04 71.44 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.165 -0.925 . . . . 3.45 109.1 174.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 34' ' ' ASN . 6.9 m 53.36 29.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.052 -1.431 . . . . 2.3 113.21 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.37 7.35 0.61 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.106 -1.521 . . . . 2.2 114.171 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.802 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . . . -83.1 -171.25 0.29 Allowed Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.517 -0.549 . . . . 1.31 109.517 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.854 ' HG2' ' HB ' ' A' ' 56' ' ' ILE . 18.8 Cg_endo -64.19 74.39 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 120.908 1.072 . . . . 1.94 109.336 161.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.788 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -120.97 -162.44 0.96 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.939 0.875 . . . . 2.23 110.266 -166.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.71 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . 135.68 -115.02 1.28 Allowed Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 113.541 -1.663 . . . . 0.94 110.412 166.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG13 HD12 ' A' ' 24' ' ' LEU . 86.9 t -140.47 136.16 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.69 -0.755 . . . . 1.21 112.297 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.765 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 8.1 t0 -105.77 104.97 14.8 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.343 -1.298 . . . . 1.11 108.071 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' H ' ' HE3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -79.86 -28.69 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.044 0.45 . . . . 3.25 111.008 -174.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -71.49 -29.25 64.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 3.63 111.645 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.6 -25.61 4.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.135 -0.555 . . . . 1.9 112.425 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.39 57.91 1.61 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.158 -0.544 . . . . 0.87 112.803 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.765 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 26.1 ptt180 -146.33 152.73 39.61 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.583 -0.363 . . . . 4.26 111.314 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.559 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 32.0 m0 -110.53 113.79 26.69 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.069 -0.715 . . . . 1.52 109.069 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.581 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.7 p90 -151.47 174.03 13.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.101 -1.04 . . . . 2.04 112.786 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.788 ' HG2' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mt-10 -134.05 143.0 47.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.029 -0.532 . . . . 2.12 110.932 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.854 ' HB ' ' HG2' ' A' ' 43' ' ' PRO . 25.4 mm -83.06 103.64 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.373 -0.531 . . . . 1.42 109.785 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' OD1' ' HA ' ' A' ' 61' ' ' GLU . 1.9 p-10 -66.4 -169.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.491 0.662 . . . . 1.97 111.199 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.73 -27.65 22.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.7 1.0 . . . . 2.43 113.7 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.12 -28.64 12.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.658 0.984 . . . . 2.39 113.658 -164.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.96 46.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.268 -1.444 . . . . 2.29 113.782 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.504 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 16.1 mt-10 73.21 73.46 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.119 0.785 . . . . 2.31 113.119 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 11.4 tp10 -123.42 74.41 1.24 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.867 -1.16 . . . . 2.61 107.867 165.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.461 ' CD2' ' HD1' ' A' ' 54' ' ' TYR . 2.0 p80 -113.07 126.36 55.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.549 -1.205 . . . . 4.63 112.143 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.574 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 6.0 m -63.35 135.43 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.123 -1.066 . . . . 2.27 108.123 166.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.7 p90 -123.22 143.99 49.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.539 0.57 . . . . 7.39 112.539 -171.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.52 151.46 41.56 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.041 -1.224 . . . . 1.23 110.041 169.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.794 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -115.6 94.33 4.65 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.043 0.422 . . . . 1.76 111.192 -171.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 71' ' ' VAL . 41.5 mt -74.49 132.49 33.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 1.26 110.354 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.528 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 12.8 mmm-85 -103.91 -25.33 13.08 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.716 -0.475 . . . . 2.65 109.716 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 82.6 tttt -145.52 115.52 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 2.03 111.198 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 68' ' ' ILE . 47.6 t -105.01 91.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 109.245 -0.65 . . . . 1.47 109.245 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 1.1 t70 -106.15 100.61 10.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.672 -0.695 . . . . 1.42 109.531 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 17.0 pt-20 -24.79 148.06 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 125.105 1.503 . . . . 0.96 112.542 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.6 Cg_exo -18.55 78.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.839 3.693 . . . . 0.48 114.781 -162.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -164.21 -63.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.844 -1.071 . . . . 0.5 110.614 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -149.69 141.57 23.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.23 0.538 . . . . 1.1 112.284 -175.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.24 115.06 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.354 -0.384 . . . . 1.4 110.037 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 61.7 t -97.25 108.31 21.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.235 -0.654 . . . . 1.31 109.235 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -126.4 130.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.146 -0.479 . . . . 1.48 111.496 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.794 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -84.17 151.71 27.42 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.5 112.397 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.766 ' HZ2' ' HB3' ' A' ' 133' ' ' MET . 27.2 t-105 -82.06 146.13 29.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.836 1.05 . . . . 3.37 113.836 -162.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.733 ' O ' HD13 ' A' ' 83' ' ' LEU . 1.4 ttp180 -139.82 -8.42 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.366 -0.833 . . . . 6.17 111.693 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.733 HD13 ' O ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER 37.07 -160.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.764 1.764 . . . . 2.13 115.764 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 94.7 m-20 -126.26 135.23 51.3 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.116 0.566 . . . . 1.93 109.867 -171.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.58 81.36 0.11 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.201 -0.523 . . . . 2.79 113.402 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -128.21 24.17 5.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.468 . . . . 6.08 110.298 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.09 30.79 2.84 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.334 -1.106 . . . . 2.43 110.334 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.553 ' HD2' ' C ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -97.53 163.41 12.87 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.57 -0.815 . . . . 5.53 112.899 -171.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.7 HG22 ' HE ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -117.22 128.3 74.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.386 -1.279 . . . . 2.42 108.065 159.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.76 136.67 27.58 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.381 -0.6 . . . . 3.18 109.381 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.693 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 53.1 Cg_exo -56.41 -43.36 56.37 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 122.998 2.466 . . . . 2.76 112.185 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 t70 72.09 -28.66 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.947 0.779 . . . . 2.99 112.68 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.3 p30 -124.4 -8.5 7.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.26 0.467 . . . . 3.06 112.26 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 95' ' ' SER . 62.6 p -162.28 -147.67 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.082 -0.247 . . . . 2.11 110.994 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.618 ' OG ' ' HB3' ' A' ' 118' ' ' PHE . 32.7 m 67.73 42.71 1.94 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.734 -0.666 . . . . 1.81 110.5 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.602 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 43.8 mp0 -70.4 139.3 51.84 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.391 -0.822 . . . . 1.81 109.935 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 2.6 p90 -127.37 127.74 44.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.02 0.438 . . . . 0.81 110.271 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.1 m -88.4 110.2 20.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.366 -0.833 . . . . 1.18 110.466 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.635 ' HA ' HG21 ' A' ' 113' ' ' VAL . 65.9 t -82.35 108.9 15.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.949 -0.569 . . . . 1.51 109.681 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 7.0 m -101.54 107.01 18.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.848 0.356 . . . . 1.05 110.774 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.501 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 26.7 m-85 -94.17 111.11 22.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.222 -0.445 . . . . 0.42 110.897 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.24 107.74 19.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.777 -0.453 . . . . 1.26 109.777 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.03 145.36 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 1.13 110.681 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.801 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 4.4 t70 -140.09 107.49 5.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.389 -0.369 . . . . 2.03 110.668 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.27 50.55 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.048 -0.596 . . . . 1.97 113.183 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 58.49 22.42 9.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.32 0.648 . . . . 5.46 111.893 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 43.7 mtmt -141.36 -14.87 0.86 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.187 -0.321 . . . . 3.88 111.212 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.801 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 27.8 tttp -121.49 155.77 34.23 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.501 -0.925 . . . . 2.94 108.501 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 42.4 m -157.25 135.45 11.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.685 0.279 . . . . 1.2 110.333 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 110' ' ' ARG . 8.6 tpt180 -115.12 122.16 45.26 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.035 -0.728 . . . . 3.1 109.035 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.7 p -101.89 136.82 32.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.438 -0.505 . . . . 1.13 110.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -125.47 113.9 18.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 1.38 109.186 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.703 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 3.6 t -95.01 120.82 44.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.317 -0.856 . . . . 1.58 110.78 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.58 111.3 23.63 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.445 -0.798 . . . . 2.31 109.597 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.582 ' O ' HG11 ' A' ' 6' ' ' VAL . 45.4 t60 -123.81 109.51 13.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.351 -0.841 . . . . 2.32 108.843 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.432 HG23 ' HD2' ' A' ' 120' ' ' ARG . 20.2 m -157.42 96.91 1.58 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.143 -0.223 . . . . 3.19 111.231 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.509 ' O ' ' HG3' ' A' ' 121' ' ' MET . 40.5 t60 -162.67 -74.9 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 120.664 0.268 . . . . 2.99 111.196 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 37.5 t80 -85.77 -26.82 25.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.593 0.711 . . . . 4.27 110.089 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.423 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.1 p-10 -68.64 -51.63 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.87 -1.059 . . . . 1.81 110.857 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HD2' HG23 ' A' ' 116' ' ' THR . 7.9 ptm180 -59.02 -19.03 39.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.457 -0.792 . . . . 3.84 112.01 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.509 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 94.7 mtp -64.15 -9.85 19.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.948 0.404 . . . . 2.9 110.14 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 55.17 -153.77 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.199 -0.91 . . . . 2.26 114.407 166.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.7 p 44.38 -125.53 0.99 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.29 0.636 . . . . 3.02 111.555 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.49 -23.73 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.652 -0.249 . . . . 4.23 110.911 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.507 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 39.9 m80 -63.47 -51.6 64.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.008 0.432 . . . . 2.7 110.253 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.954 -0.566 . . . . 1.46 110.403 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -63.48 -42.76 98.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.661 . . . . 3.16 111.23 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.7 ' HE ' HG22 ' A' ' 89' ' ' ILE . 11.8 ptm180 -73.84 -31.55 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 2.97 111.501 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.59 -39.57 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.206 0.527 . . . . 1.96 110.643 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.615 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 69.7 ttt180 -62.42 -16.75 56.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.602 -0.726 . . . . 4.34 111.317 -176.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.34 -47.73 62.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.04 0.385 . . . . 2.8 112.04 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.29 -34.98 5.15 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.077 -1.058 . . . . 2.08 113.539 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.766 ' HB3' ' HZ2' ' A' ' 81' ' ' TRP . 23.8 ptm -81.12 -21.84 39.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.904 0.705 . . . . 5.19 112.904 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.615 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 34.1 t70 -54.7 -43.34 72.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.431 0.9 . . . . 2.83 113.431 -168.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -114.13 30.88 6.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.456 0.646 . . . . 4.47 110.331 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.54 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.75 -70.31 0.17 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.493 -0.861 . . . . 1.04 112.124 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.468 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 10.4 t90 -58.19 -52.0 77.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.463 0.542 . . . . 3.78 112.463 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.8 Cg_endo -59.35 -37.74 88.6 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.94 1.76 . . . . 0.77 112.355 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.1 m -70.02 -36.54 75.17 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.746 0.784 . . . . 1.37 109.671 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.688 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 15.3 mt -55.75 -40.24 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.66 -1.155 . . . . 1.32 110.521 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.594 HD13 ' CD2' ' A' ' 8' ' ' HIS . 79.0 mt -61.7 -30.77 70.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.925 0.343 . . . . 1.33 111.925 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.63 -51.29 23.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 1.54 110.193 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.553 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 37.1 m -68.67 -22.76 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.137 -0.483 . . . . 1.43 110.805 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 23' ' ' PHE . 58.9 t80 -61.64 -54.26 45.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 1.05 109.929 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.489 ' CG ' HG12 ' A' ' 10' ' ' VAL . 38.8 mt-30 -57.37 -37.69 73.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.82 -0.627 . . . . 1.63 110.77 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 154' ' ' LYS . 27.3 t70 -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.43 -0.804 . . . . 1.46 111.26 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -67.12 -41.43 86.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.8 0.333 . . . . 2.23 110.414 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.697 HG23 HG13 ' A' ' 12' ' ' VAL . 47.0 mt -62.08 -34.26 62.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 1.17 110.905 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.62 -30.58 68.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.985 -0.552 . . . . 0.85 110.307 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.755 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 64.8 mt-10 -69.09 -43.83 73.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.5 110.03 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -69.53 -17.75 63.61 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.163 -0.926 . . . . 1.74 109.996 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.67 -40.11 6.44 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.407 -0.815 . . . . 1.32 112.62 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -171.95 -26.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.039 0.755 . . . . 2.42 113.039 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.755 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 6.2 ttmt -76.07 72.76 2.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.234 0.54 . . . . 2.04 111.609 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 150' ' ' GLU . 68.2 mttm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.446 -0.787 . . . . 4.65 110.048 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.751 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 17.5 p-10 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.825 0.345 . . . . 2.1 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 54.6 p90 173.26 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.837 -0.619 . . . . 4.04 109.668 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.801 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 32.8 t70 -66.04 -52.31 40.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 2.78 111.041 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.801 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 12.5 Cg_endo -92.44 -70.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.153 1.902 . . . . 1.83 111.605 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -141.25 145.67 35.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 3.98 110.25 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.751 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -118.63 125.72 74.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.419 -0.585 . . . . 2.03 109.419 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 5.9 ttm105 -132.74 143.28 49.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.056 -0.52 . . . . 3.92 112.027 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' HD1' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -110.0 133.01 53.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.575 -0.898 . . . . 1.16 108.575 170.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.7 m -133.76 111.51 10.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.589 0.709 . . . . 1.72 110.643 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.579 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.7 t -123.5 142.46 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.824 -1.08 . . . . 1.89 110.139 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.6 m -121.92 116.06 23.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 1.15 110.074 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.44 ' HB ' HG22 ' A' ' 148' ' ' ILE . 11.0 m -102.91 163.63 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.509 -0.768 . . . . 1.51 111.028 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.553 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -117.88 26.05 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 1.6 111.661 -171.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 148' ' ' ILE . . . -143.06 23.98 1.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.641 -0.423 . . . . 1.11 111.52 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.825 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 33.8 t70 72.16 173.88 0.3 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.589 -0.732 . . . . 0.91 112.565 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.506 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 9.7 ttp180 -68.03 -26.43 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.14 -0.936 . . . . 2.19 111.321 -172.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -54.44 -48.53 71.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.104 0.478 . . . . 3.49 110.755 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -80.73 -34.17 34.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 1.49 111.046 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -59.58 -45.24 92.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.606 0.241 . . . . 1.07 110.77 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 67.9 t80 -67.99 -45.89 72.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.43 110.516 177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.661 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 29.6 tptp -54.77 -51.84 64.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 2.87 110.452 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.538 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 55.0 m -65.28 -40.4 93.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 1.21 111.539 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 67.5 t80 -71.33 -37.98 71.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.409 -0.36 . . . . 0.53 111.691 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.621 HD11 HG11 ' A' ' 46' ' ' VAL . 9.6 tp -119.44 -55.78 2.1 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.714 0.635 . . . . 1.23 112.714 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.661 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 2.3 mm-40 -87.85 18.33 4.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.542 0.571 . . . . 1.24 112.542 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -151.51 28.44 0.96 Allowed Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.246 -1.142 . . . . 0.83 110.246 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.634 ' HZ ' ' CE1' ' A' ' 65' ' ' PHE . 71.0 t80 -47.54 -51.77 42.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.494 -0.853 . . . . 0.94 113.18 -168.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.4 Cg_endo -96.31 11.39 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.027 1.818 . . . . 0.9 115.445 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -106.31 -6.54 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.306 0.854 . . . . 1.49 113.306 -172.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.782 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 18.2 m95 -92.66 -152.21 0.31 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.2 -0.312 . . . . 5.66 111.75 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.55 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 31.6 m95 -105.77 0.16 0.1 Allowed Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 115.383 1.623 . . . . 3.41 115.383 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.905 ' HB3' ' HA ' ' A' ' 140' ' ' ILE . 27.1 Cg_exo -66.07 -150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 122.54 1.943 . . . . 1.36 114.342 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.594 ' ND2' HG23 ' A' ' 40' ' ' VAL . 63.5 t30 -63.28 -4.35 2.49 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.485 -0.78 . . . . 1.51 111.646 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.945 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 30.8 p30 -83.6 15.64 3.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.807 -0.633 . . . . 1.98 111.975 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.691 ' HD1' ' HG2' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -69.62 3.28 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.167 0.803 . . . . 5.13 113.167 -173.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.691 ' HG2' ' HD1' ' A' ' 35' ' ' PHE . 42.6 mmt-85 -140.13 147.89 40.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.96 0.41 . . . . 4.7 111.541 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -76.1 145.08 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.777 -0.647 . . . . 3.11 111.13 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 57' ' ' ASP . 62.8 p 50.86 16.38 0.32 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.2 1.0 . . . . 1.89 112.279 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.757 ' HD3' HG21 ' A' ' 40' ' ' VAL . 5.8 tmtm? -104.17 -62.88 1.26 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.091 -1.448 . . . . 3.45 107.091 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.945 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 31.3 t -146.95 1.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.108 0.956 . . . . 2.3 108.636 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 28' ' ' PRO . . . -126.73 50.61 0.87 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.538 -0.756 . . . . 2.2 112.461 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.966 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -90.96 168.34 14.0 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.524 . . . . 1.31 109.587 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.675 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 48.4 Cg_endo -69.53 54.97 1.14 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.729 2.286 . . . . 1.94 114.056 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.1 tp -164.92 -96.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.41 -0.359 . . . . 2.23 110.518 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.605 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 104.85 -59.09 0.45 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.94 112.38 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 24' ' ' LEU . 78.9 t -136.74 141.2 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 122.784 -0.245 . . . . 1.21 110.37 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.755 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 7.1 t70 -112.36 113.38 25.56 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.491 -0.559 . . . . 1.11 109.491 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -79.2 -31.9 43.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.017 0.377 . . . . 3.25 112.017 -175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -83.66 -34.84 24.92 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 3.63 110.9 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.8 -35.87 30.43 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.606 -0.807 . . . . 1.9 111.718 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.429 ' C ' ' HB ' ' A' ' 68' ' ' ILE . . . 85.26 54.24 2.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.429 -0.668 . . . . 0.87 111.429 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -160.65 165.0 31.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 4.26 110.949 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.64 117.82 33.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.756 -0.461 . . . . 1.52 109.756 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.755 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -164.36 152.27 12.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.491 . . . . 2.04 109.99 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.966 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 2.2 mp0 -112.59 160.53 17.76 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.521 -0.548 . . . . 2.12 109.521 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.4 mm -77.14 103.92 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.864 0.364 . . . . 1.42 110.091 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' HA ' HG21 ' A' ' 38' ' ' THR . 4.6 t70 -90.78 170.4 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.97 110.117 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.91 -37.19 64.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.65 0.982 . . . . 2.43 113.65 -165.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.56 ' NE2' ' HB3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -86.6 -0.76 56.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.223 -0.591 . . . . 2.39 111.56 -178.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.79 72.87 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.648 -1.263 . . . . 2.29 114.064 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 53.0 29.7 8.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.491 0.552 . . . . 2.31 112.491 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.56 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 13.7 tp10 -85.73 75.88 10.02 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.404 -0.591 . . . . 2.61 109.404 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HE1' ' O ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -126.96 163.5 23.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.003 -0.544 . . . . 4.63 111.78 177.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.85 HG23 ' HG3' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -134.58 121.26 20.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.734 . . . . 2.27 109.89 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.789 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 3.7 t80 -144.83 -66.7 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 119.787 -0.765 . . . . 7.39 113.057 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' HA3' HD12 ' A' ' 79' ' ' ILE . . . -158.64 165.14 33.9 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.909 -1.615 . . . . 1.23 114.732 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 82' ' ' ARG . 5.6 mp -113.39 107.35 15.74 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.268 0.627 . . . . 1.76 110.342 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.861 HG21 HG22 ' A' ' 71' ' ' VAL . 65.0 mt -70.6 116.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.407 -0.917 . . . . 1.26 110.385 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -90.35 -24.67 20.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.85 -0.613 . . . . 2.65 109.4 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.555 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 65.7 tttt -170.99 123.7 0.61 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.957 -0.565 . . . . 2.03 111.623 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.861 HG22 HG21 ' A' ' 68' ' ' ILE . 95.0 t -106.32 113.5 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.959 -0.756 . . . . 1.47 108.959 169.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -117.6 72.1 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.818 -0.353 . . . . 1.42 110.11 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 45.17 -168.2 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 124.615 1.197 . . . . 0.96 111.9 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.1 Cg_exo -63.33 76.85 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.253 1.302 . . . . 0.48 111.436 166.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.16 -63.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.942 -0.572 . . . . 0.5 110.287 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.441 HG21 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -144.34 139.66 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.482 0.549 . . . . 1.1 112.482 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.96 109.7 6.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 1.4 109.261 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 70' ' ' LYS . 1.2 p -101.5 113.54 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.519 -0.549 . . . . 1.31 109.519 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.51 HD12 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -129.39 141.39 46.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.55 -0.75 . . . . 1.48 110.724 -177.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' A' ' 96' ' ' GLU . . . -89.5 172.79 39.75 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.951 -0.568 . . . . 0.5 112.859 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.759 ' H ' ' HB2' ' A' ' 95' ' ' SER . 73.0 t-105 -90.22 156.46 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.517 0.199 . . . . 3.37 111.3 -172.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.85 ' HG3' HG23 ' A' ' 64' ' ' THR . 18.1 tpt180 177.86 42.31 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.854 -0.612 . . . . 6.17 110.483 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 84.1 133.35 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.895 0.478 . . . . 2.13 111.135 169.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.589 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 31.2 t30 -93.66 75.35 4.35 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.46 -62.68 3.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.602 -0.809 . . . . 2.79 113.609 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -168.41 138.06 2.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.465 0.174 . . . . 6.08 110.937 -172.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.61 38.1 3.79 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.754 -0.736 . . . . 2.43 114.232 170.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.842 ' NH1' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -148.19 163.32 37.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.372 0.586 . . . . 5.53 111.021 177.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.671 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -122.17 114.59 43.28 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 122.471 0.308 . . . . 2.42 111.357 176.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.842 ' HB3' ' NH1' ' A' ' 88' ' ' ARG . 6.5 t70 -170.22 108.43 0.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 3.18 109.557 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.407 ' HD2' ' CZ ' ' A' ' 128' ' ' ARG . 45.1 Cg_endo -87.66 30.48 0.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.835 2.357 . . . . 2.76 111.466 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.59 ' HB2' HH21 ' A' ' 128' ' ' ARG . 3.4 t70 -84.76 170.62 13.04 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.752 0.787 . . . . 2.99 110.793 -165.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.37 15.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.345 -1.298 . . . . 3.06 109.897 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.478 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 14.8 m -131.67 -78.62 0.51 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.251 -0.886 . . . . 2.11 109.14 170.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.759 ' HB2' ' H ' ' A' ' 81' ' ' TRP . 19.9 m 47.92 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.206 1.002 . . . . 1.81 112.006 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.421 ' H ' ' HA2' ' A' ' 80' ' ' GLY . 49.4 tt0 77.59 112.67 0.07 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 1.81 112.979 163.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.566 ' HB2' HG11 ' A' ' 113' ' ' VAL . 51.0 p90 -127.56 124.26 37.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.81 110.106 167.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 41.8 m -88.16 109.2 19.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.384 -0.826 . . . . 1.18 109.703 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.62 ' HA ' HG22 ' A' ' 113' ' ' VAL . 62.0 t -82.41 110.06 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.395 . . . . 1.51 110.009 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 76' ' ' THR . 28.2 m -103.17 107.31 18.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.518 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.701 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 43.7 m-85 -90.38 111.16 22.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.294 -0.412 . . . . 0.42 110.214 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.3 t -93.04 112.61 26.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.914 -0.402 . . . . 1.26 109.914 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.54 126.98 31.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.306 -0.406 . . . . 1.13 110.607 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 50.7 m-20 -119.17 114.76 22.94 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.367 -0.379 . . . . 2.03 110.49 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.91 -102.84 1.27 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.029 -0.605 . . . . 1.97 112.706 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -145.15 -23.32 0.49 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.807 0.337 . . . . 5.46 110.485 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.825 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 21.6 pttp -142.93 34.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 3.88 111.625 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 56.2 tttm -136.21 148.18 47.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.235 -0.654 . . . . 2.94 109.235 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.3 m -155.33 122.19 5.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.159 0.504 . . . . 1.2 111.499 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -94.38 116.77 29.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.288 -0.869 . . . . 3.1 109.839 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.701 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 p -94.5 134.93 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 109.331 -0.618 . . . . 1.13 109.331 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.13 114.1 13.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.968 -1.015 . . . . 1.38 109.405 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 99' ' ' VAL . 2.4 t -106.87 122.87 61.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.178 -0.919 . . . . 1.58 111.809 -171.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 25.8 mt-10 -98.21 110.76 23.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.248 -0.433 . . . . 2.31 110.067 171.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.618 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.9 t-80 -105.16 103.64 13.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.977 -1.49 . . . . 2.32 106.977 171.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -153.84 96.99 2.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.368 -0.533 . . . . 3.19 110.749 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.605 ' O ' ' HG2' ' A' ' 121' ' ' MET . 1.5 t60 -166.51 -76.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.786 -0.643 . . . . 2.99 109.552 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 94' ' ' SER . 4.4 m-85 -85.45 -23.71 27.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.529 0.937 . . . . 4.27 113.529 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.31 -53.34 59.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.674 0.749 . . . . 1.81 110.69 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.89 -17.46 64.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.662 -1.153 . . . . 3.84 111.446 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 93.6 mmm -73.74 27.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.889 0.7 . . . . 2.9 112.889 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.92 -175.42 21.85 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 118.798 -1.668 . . . . 2.26 114.016 166.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 -53.7 7.74 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.522 -0.839 . . . . 3.02 110.959 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.752 ' HA ' ' HB2' ' A' ' 127' ' ' LYS . 20.3 pttp -89.28 -11.7 42.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.922 0.712 . . . . 4.23 112.922 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.712 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 16.1 m80 -62.45 -53.4 55.36 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.998 -0.681 . . . . 2.7 109.556 167.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 1.46 110.996 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.752 ' HB2' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mttp -66.63 -33.01 74.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 111.94 0.348 . . . . 3.16 111.94 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.712 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 27.4 ptt180 -69.89 -52.9 20.83 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.479 -0.488 . . . . 2.97 109.728 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.481 HG12 ' SD ' ' A' ' 133' ' ' MET . 35.0 t -56.48 -33.84 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.206 0.527 . . . . 1.96 111.133 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.36 -16.47 14.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.044 0.938 . . . . 4.34 112.502 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.48 HD21 ' HA ' ' A' ' 88' ' ' ARG . 5.6 t30 -56.06 -40.75 74.02 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.032 0.752 . . . . 2.8 113.032 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.31 19.16 0.23 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.015 -1.564 . . . . 2.08 114.095 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.481 ' SD ' HG12 ' A' ' 129' ' ' VAL . 17.7 ptt? -80.29 -27.66 38.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.667 0.733 . . . . 5.19 109.683 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -80.54 -13.57 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 2.83 111.932 -170.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.597 ' HZ2' ' HB2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -92.88 1.75 57.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.804 0.335 . . . . 4.47 110.539 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.631 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.89 -55.38 0.14 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.123 -1.037 . . . . 1.04 113.048 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.491 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 61.7 t-105 -53.81 -52.76 64.77 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.534 0.568 . . . . 3.78 112.534 -171.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 25.1 Cg_endo -60.97 -45.42 19.99 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.595 1.53 . . . . 0.77 111.768 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.1 m -59.64 -38.7 82.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.652 0.739 . . . . 1.37 110.108 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.905 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 14.0 mt -68.04 -41.67 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.126 -0.943 . . . . 1.32 110.766 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 55.0 mt -63.88 -32.93 74.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 1.33 111.53 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -48.0 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.62 0.248 . . . . 1.54 110.999 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 31.9 m -71.38 -25.9 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.43 110.817 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.52 -55.37 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.672 -0.695 . . . . 1.05 109.941 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.486 ' CG ' HG11 ' A' ' 10' ' ' VAL . 47.3 mt-30 -64.94 -27.6 68.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.905 -0.589 . . . . 1.63 110.522 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 2.8 t70 -67.95 -55.35 13.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 1.46 111.133 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.782 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 16.7 tptm -64.12 -39.87 94.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.267 -0.573 . . . . 2.23 110.638 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.542 HG23 ' HB1' ' A' ' 14' ' ' ALA . 67.7 mt -63.66 -34.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 1.17 110.723 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.553 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 18.4 t70 -66.86 -32.06 73.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.814 -0.439 . . . . 0.85 109.814 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.93 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 35.4 mt-10 -67.84 -33.11 74.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.235 0.54 . . . . 1.5 110.194 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 4.6 mm-40 -79.68 -12.96 59.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.375 -0.83 . . . . 1.74 110.172 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.53 -75.16 1.14 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.713 -0.676 . . . . 1.32 112.862 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -151.24 35.88 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.982 0.391 . . . . 2.42 111.777 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.93 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 12.4 tppt? -75.44 -10.93 59.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.44 0.638 . . . . 2.04 109.642 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.0 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.484 -0.78 . . . . 4.65 109.833 -176.508 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.4 p-10 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.209 -0.293 . . . . 2.1 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 1.2 t80 80.59 -50.71 0.32 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.584 0.552 . . . . 4.04 111.372 172.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.688 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.1 t70 -61.87 -49.41 85.9 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.092 -0.243 . . . . 2.78 111.213 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.0 Cg_endo -92.47 -65.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.964 1.776 . . . . 1.83 111.871 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.31 156.76 44.0 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.182 -1.414 . . . . 3.98 107.182 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.907 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 88.7 t -85.62 124.05 39.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.657 -0.817 . . . . 2.03 109.828 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 14.0 ttp180 -128.82 138.04 51.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.954 0.407 . . . . 3.92 110.865 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' HD1' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -115.3 132.33 56.65 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.987 -1.116 . . . . 1.16 107.987 170.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 1.0 OUTLIER -136.16 110.47 8.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.746 0.784 . . . . 1.72 109.437 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 145' ' ' GLN . 1.7 t -125.43 142.6 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.434 -1.257 . . . . 1.89 110.966 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -102.33 115.19 30.04 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.279 0.561 . . . . 1.15 109.742 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.695 HG11 HG22 ' A' ' 148' ' ' ILE . 39.6 t -95.07 128.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.824 -0.626 . . . . 1.51 110.316 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.651 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.59 32.79 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 1.6 111.387 -173.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.41 26.87 0.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.586 -0.279 . . . . 1.11 111.666 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.608 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 27.4 t70 73.97 168.42 0.3 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.175 0.512 . . . . 0.91 112.349 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.535 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 12.1 ttp180 -69.12 -33.32 73.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.858 -0.61 . . . . 2.19 111.815 -170.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.608 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 13.7 pttm -59.01 -43.05 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 3.49 110.566 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -72.51 -37.47 68.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.339 -0.391 . . . . 1.49 110.878 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.466 ' HB2' HG13 ' A' ' 12' ' ' VAL . . . -60.23 -46.25 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 1.07 110.429 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -69.42 -45.81 68.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.43 110.607 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.741 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 23.6 tptp -53.47 -50.62 64.94 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.137 -0.483 . . . . 2.87 110.736 176.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -68.61 -50.15 53.7 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.085 -0.246 . . . . 1.21 111.011 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 68.6 t80 -65.45 -39.35 91.92 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.039 0.385 . . . . 0.53 112.039 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.689 HD13 HG11 ' A' ' 46' ' ' VAL . 14.4 tp -109.54 -49.41 3.11 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.021 -0.672 . . . . 1.23 112.035 -176.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.742 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 30.3 mt-10 -87.72 10.79 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.19 0.519 . . . . 1.24 110.598 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.718 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -143.83 26.12 2.08 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.83 110.896 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.516 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 46.8 t80 -49.32 -49.52 70.17 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.41 . . . . 0.94 111.45 -177.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.9 Cg_endo -90.52 25.32 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.106 1.871 . . . . 0.9 114.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.718 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.1 pt-20 -112.12 -9.91 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.785 -0.766 . . . . 1.49 111.753 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.667 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 11.4 m0 -71.84 152.05 42.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.348 0.594 . . . . 5.66 111.163 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.625 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.9 m95 -75.28 -43.58 4.42 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.433 -0.803 . . . . 3.41 113.131 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 143' ' ' SER . 14.3 Cg_endo -53.98 -71.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.019 2.479 . . . . 1.36 114.684 -165.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HB3' HD11 ' A' ' 140' ' ' ILE . 8.9 t30 -117.51 -19.98 9.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.339 0.59 . . . . 1.51 110.294 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.671 ' HA ' HG22 ' A' ' 40' ' ' VAL . 10.0 m120 -92.75 20.2 6.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 1.98 111.806 -169.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -99.16 15.15 26.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.411 0.624 . . . . 5.13 110.137 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -106.29 149.97 26.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.925 -0.58 . . . . 4.7 110.752 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 p -76.74 136.82 39.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.102 -0.332 . . . . 3.11 110.102 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.812 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 43.6 p 66.22 -47.63 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.835 1.254 . . . . 1.89 111.759 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 85.1 tttt -71.11 89.28 0.82 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 122.771 0.429 . . . . 3.45 110.142 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 34' ' ' ASN . 34.5 m 49.07 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.952 1.301 . . . . 2.3 113.031 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.31 17.0 2.71 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.674 -0.774 . . . . 2.2 112.704 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.83 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -74.11 166.84 41.05 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.004 -0.739 . . . . 1.31 109.004 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.9 49.67 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 123.055 2.503 . . . . 1.94 114.011 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.6 tp -162.52 -92.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.586 0.231 . . . . 2.23 110.714 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.75 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.05 -54.62 3.28 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.869 -0.681 . . . . 0.94 112.361 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.689 HG11 HD13 ' A' ' 24' ' ' LEU . 60.3 t -140.34 140.22 34.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 1.21 110.318 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -109.79 110.0 20.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.214 -0.661 . . . . 1.11 109.214 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.742 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 7.8 mtpm? -79.55 -20.48 46.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.068 -0.515 . . . . 3.25 111.689 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -83.64 -44.01 15.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.844 -0.342 . . . . 3.63 110.943 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.7 -30.44 18.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.116 -0.564 . . . . 1.9 112.248 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.64 54.2 2.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.682 . . . . 0.87 112.76 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -142.65 150.2 39.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.507 -0.408 . . . . 4.26 110.661 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.555 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 17.2 m0 -105.38 114.08 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.675 -0.491 . . . . 1.52 109.675 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.34 148.48 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.207 -0.294 . . . . 2.04 110.207 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.83 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 1.6 mp0 -119.58 160.58 22.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.952 -0.759 . . . . 2.12 108.952 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.98 114.05 16.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.955 0.407 . . . . 1.42 110.338 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.679 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.0 t70 -105.15 -170.76 1.8 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.785 -0.643 . . . . 1.97 110.113 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.469 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 12.7 pt-20 -71.84 -38.94 70.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.722 0.638 . . . . 2.43 112.722 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -88.11 4.19 46.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.173 -0.611 . . . . 2.39 110.979 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.69 -106.23 0.41 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.943 -1.122 . . . . 2.29 113.278 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -134.84 21.74 3.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.907 0.384 . . . . 2.31 111.071 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -96.07 77.57 3.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.626 0.727 . . . . 2.61 110.625 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.679 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -122.81 125.7 45.95 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.229 -0.896 . . . . 4.63 110.214 174.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.634 ' HB ' ' HG2' ' A' ' 82' ' ' ARG . 70.2 p 62.03 -66.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.779 1.299 . . . . 2.27 113.363 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 t80 74.26 72.52 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.698 0.799 . . . . 7.39 110.702 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.555 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -83.48 150.48 27.08 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.552 -0.749 . . . . 1.23 112.301 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.466 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -108.1 92.52 4.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.828 0.347 . . . . 1.76 111.563 -172.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 71' ' ' VAL . 25.2 mt -72.04 136.15 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 1.26 110.06 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -110.13 -24.23 10.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 2.65 109.905 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 20.5 ttmm -162.16 119.75 2.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.879 -0.6 . . . . 2.03 111.261 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 68' ' ' ILE . 60.4 t -108.54 96.16 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.472 -0.936 . . . . 1.47 108.472 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -105.41 65.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.928 -0.309 . . . . 1.42 110.53 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 15.5 pt-20 48.07 -170.59 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 O-C-N 124.514 1.134 . . . . 0.96 111.926 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.517 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.1 Cg_exo -64.7 75.98 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.388 1.392 . . . . 0.48 111.545 169.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -160.17 -66.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.312 -0.858 . . . . 0.5 110.214 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 2.4 p -143.85 143.45 31.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.17 0.509 . . . . 1.1 112.277 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.8 mp -133.53 121.84 22.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 1.4 109.831 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 45.5 t -109.57 104.72 17.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.194 -0.669 . . . . 1.31 109.194 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.485 HG22 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.97 146.22 34.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.554 0.216 . . . . 1.48 111.076 -178.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.76 148.54 18.86 Favored Glycine 0 C--O 1.24 0.486 0 CA-C-N 116.223 -0.444 . . . . 0.5 112.54 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.76 ' HZ2' ' HE1' ' A' ' 133' ' ' MET . 54.4 t-105 -77.06 154.57 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.927 0.491 . . . . 3.37 112.322 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.634 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -153.95 23.22 0.5 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 6.17 109.463 -176.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' A' ' 88' ' ' ARG . 0.2 OUTLIER 79.85 -164.66 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.815 -1.084 . . . . 2.13 109.933 -172.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.599 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 32.7 t30 -137.87 -70.94 0.43 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.492 -0.322 . . . . 1.93 110.524 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 86' ' ' PHE . . . -72.58 -11.27 76.9 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.584 -0.817 . . . . 2.79 113.353 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 85' ' ' GLY . 86.2 t80 71.82 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.485 0.659 . . . . 6.08 110.964 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -27.82 3.54 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.525 -0.761 . . . . 2.43 111.314 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.715 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -94.17 -175.98 3.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 120.907 0.384 . . . . 5.53 110.505 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.72 HD13 ' HE ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -71.53 129.72 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.551 -0.749 . . . . 2.42 111.491 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 p-10 -99.57 121.03 56.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.393 0.616 . . . . 3.18 109.856 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.568 ' HB2' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -84.06 36.42 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.204 2.603 . . . . 2.76 111.556 178.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.73 76.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.806 0.812 . . . . 2.99 111.594 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -143.77 -47.25 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.402 -1.333 . . . . 3.06 107.402 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 m -136.87 -95.3 0.22 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.778 -1.556 . . . . 2.11 108.192 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 91' ' ' PRO . 66.7 m 48.92 23.83 0.76 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.076 0.55 . . . . 1.81 112.409 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 33.4 mt-10 -75.1 138.97 42.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.651 -0.704 . . . . 1.81 109.619 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 79' ' ' ILE . 4.8 p90 -133.26 132.01 40.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.173 0.511 . . . . 0.81 110.543 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 25.8 m -91.4 108.47 19.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.063 -0.971 . . . . 1.18 109.921 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.685 ' HA ' HG22 ' A' ' 113' ' ' VAL . 95.5 t -81.5 108.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 1.51 109.326 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.471 ' HA ' HG23 ' A' ' 76' ' ' THR . 19.3 m -101.68 105.75 16.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.272 -0.422 . . . . 1.05 110.222 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.535 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.3 m-85 -90.28 111.9 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.385 -0.37 . . . . 0.42 110.192 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 109' ' ' THR . 47.8 t -96.21 106.64 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 1.26 109.588 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.41 125.09 28.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.619 . . . . 1.13 110.768 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 28.4 t70 -116.03 114.42 24.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.805 -0.634 . . . . 2.03 110.1 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.47 -114.65 6.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.618 -0.801 . . . . 1.97 111.666 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -146.64 13.5 1.19 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.176 0.512 . . . . 5.46 110.228 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -145.57 -5.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.969 0.729 . . . . 3.88 112.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 29.5 ttpt -123.38 154.01 39.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.602 -0.686 . . . . 2.94 110.304 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 51.8 m -157.56 114.17 2.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.146 0.498 . . . . 1.2 110.973 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -88.3 119.87 29.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.823 -0.626 . . . . 3.1 109.616 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.1 p -96.18 132.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.249 -0.58 . . . . 1.13 109.588 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.54 109.31 12.01 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.561 -0.903 . . . . 1.38 108.561 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 28.6 t -98.83 120.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.029 -0.987 . . . . 1.58 110.991 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.24 119.23 38.46 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.684 0.754 . . . . 2.31 109.431 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.907 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 16.6 t60 -102.74 152.2 21.51 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.595 -1.184 . . . . 2.32 109.016 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.7 t -54.67 169.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.231 1.015 . . . . 3.19 111.604 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -93.92 14.84 18.32 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.503 -1.226 . . . . 2.99 111.124 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.059 0.456 . . . . 4.27 110.09 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -30.51 59.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.142 -0.688 . . . . 1.81 109.142 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 57.5 ttt180 -60.29 -19.82 56.61 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.918 -1.037 . . . . 3.84 111.397 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 87.9 mmm -61.22 -15.44 34.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 2.9 110.271 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.98 -140.38 26.94 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.595 -0.729 . . . . 2.26 113.134 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 16.8 p 36.22 -108.44 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 O-C-N 124.766 0.921 . . . . 3.02 112.813 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -84.81 -34.55 22.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 4.23 111.102 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -63.7 -50.33 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 2.7 110.71 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 -25.79 59.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.495 -0.32 . . . . 1.46 110.667 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 123' ' ' THR . 46.9 tptt -56.51 -52.23 65.53 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.969 0.414 . . . . 3.16 110.403 174.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.72 ' HE ' HD13 ' A' ' 89' ' ' ILE . 9.5 ptm85 -72.24 -30.31 64.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.68 -0.691 . . . . 2.97 111.9 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.5 -39.18 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 1.96 111.589 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -62.79 -16.04 56.37 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.264 -0.425 . . . . 4.34 112.067 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 128' ' ' ARG . 65.5 m-80 -54.99 -24.86 26.2 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.907 0.706 . . . . 2.8 112.907 -175.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -134.74 -24.09 0.61 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.641 -1.266 . . . . 2.08 114.105 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.76 ' HE1' ' HZ2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -73.5 -26.08 60.73 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.431 -0.452 . . . . 5.19 112.0 -172.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.99 -14.63 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.388 . . . . 2.83 110.886 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -115.21 16.38 16.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.734 0.778 . . . . 4.47 109.47 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.68 -91.26 2.21 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.466 -0.788 . . . . 1.04 112.526 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.538 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 20.2 m95 -54.89 -47.58 97.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.681 0.993 . . . . 3.78 113.681 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.2 Cg_endo -52.82 -40.04 75.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.813 1.676 . . . . 0.77 112.446 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 38.9 m -78.15 -43.32 29.11 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.631 0.729 . . . . 1.37 110.102 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.612 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.2 mt -59.79 -51.97 66.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 115.105 -0.952 . . . . 1.32 111.734 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD12 ' CD2' ' A' ' 8' ' ' HIS . 78.7 mt -58.94 -28.3 66.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.174 0.435 . . . . 1.33 112.174 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -74.24 -51.74 14.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 1.54 110.296 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.642 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 14.9 t -70.52 -23.74 62.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.082 0.468 . . . . 1.43 110.321 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.59 -51.97 66.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 1.05 109.952 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.477 ' CG ' HG11 ' A' ' 10' ' ' VAL . 45.7 mt-30 -66.1 -28.43 68.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.599 -0.728 . . . . 1.63 110.437 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 35.2 t70 -75.78 -43.1 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.698 . . . . 1.46 111.222 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.478 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 58.6 tttm -64.8 -40.12 94.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.065 0.46 . . . . 2.23 110.076 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.695 HG22 HG11 ' A' ' 12' ' ' VAL . 70.8 mt -68.85 -26.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.02 -0.537 . . . . 1.17 110.372 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.93 -37.78 76.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 0.85 109.295 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 34.8 mt-10 -64.65 -46.09 83.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.18 0.991 . . . . 1.5 108.79 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 148' ' ' ILE . 2.4 tp10 -65.64 -43.63 88.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.4 -1.727 . . . . 1.74 110.506 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.35 -70.49 1.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 1.32 112.075 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -161.81 97.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.388 . . . . 2.42 111.28 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.562 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.0 ttmm -137.3 -46.38 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.969 -0.559 . . . . 2.04 109.678 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.543 ' H ' ' HD3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.496 -0.775 . . . . 4.65 111.176 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 25.0 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.17 0.509 . . . . 2.1 110.784 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.817 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 41.9 p90 -168.38 -42.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.155 -0.475 . . . . 4.04 110.647 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.586 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.6 t70 -72.78 -58.67 2.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.613 -0.267 . . . . 2.78 111.526 -173.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.13 -64.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.165 1.243 . . . . 1.83 110.636 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 53.1 p90 -154.66 147.07 23.98 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.958 -0.564 . . . . 3.98 110.135 173.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -110.46 114.47 47.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.796 -1.187 . . . . 2.03 107.796 164.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 28.9 ttm180 -112.67 138.65 49.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.716 -0.674 . . . . 3.92 111.257 -173.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.592 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.57 133.83 52.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.696 -0.853 . . . . 1.16 108.696 172.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 70.0 m -141.61 113.82 8.11 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.131 -0.486 . . . . 1.72 109.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.996 HG22 HG12 ' A' ' 111' ' ' VAL . 1.9 m -122.92 143.48 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 1.89 109.983 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.1 m -98.04 115.8 28.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.431 0.634 . . . . 1.15 110.158 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG11 HG22 ' A' ' 148' ' ' ILE . 33.1 t -103.1 133.8 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.568 -0.742 . . . . 1.51 109.947 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.12 30.2 6.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 1.6 111.886 -174.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.23 35.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 1.11 111.209 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 75.03 173.21 0.26 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-O 122.1 0.952 . . . . 0.91 112.705 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.556 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 19.8 ttp180 -71.79 -24.75 61.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.594 -1.185 . . . . 2.19 110.711 -171.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.14 -48.4 81.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 3.49 110.671 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.2 p -70.9 -38.54 73.01 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.979 -0.288 . . . . 1.49 111.059 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.498 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -56.7 -46.47 81.19 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 120.913 0.387 . . . . 1.07 110.647 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' HZ ' ' HE2' ' A' ' 48' ' ' LYS . 77.3 t80 -71.69 -47.79 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.43 110.872 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.693 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 25.6 tptp -52.33 -46.53 66.09 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 120.966 0.412 . . . . 2.87 111.1 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 m -70.88 -49.04 50.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.192 -0.458 . . . . 1.21 110.349 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.3 t80 -62.39 -41.08 98.38 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.231 0.456 . . . . 0.53 112.231 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.45 ' CD1' HG11 ' A' ' 46' ' ' VAL . 12.5 tp -113.05 -34.24 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.231 -0.588 . . . . 1.23 112.512 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.693 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 35.1 mt-10 -104.82 16.22 26.38 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.234 -0.291 . . . . 1.24 111.419 -173.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.735 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -153.87 38.74 0.69 Allowed Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.754 -0.736 . . . . 0.83 111.482 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.601 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 61.9 t80 -53.66 -54.45 45.94 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 112.806 0.669 . . . . 0.94 112.806 -169.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 36.5 Cg_endo -87.5 13.88 2.53 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.9 114.496 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.7 pt-20 -97.36 -6.49 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.159 -0.616 . . . . 1.49 110.586 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.641 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 26.8 m0 -73.3 176.11 6.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.482 0.658 . . . . 5.66 111.446 -175.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 35.0 m95 -97.91 -25.19 0.23 Allowed Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 114.136 1.161 . . . . 3.41 114.136 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.641 ' HD2' ' CB ' ' A' ' 30' ' ' TRP . 72.6 Cg_endo -75.2 -151.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.726 1.617 . . . . 1.36 114.281 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.554 ' ND2' HG22 ' A' ' 40' ' ' VAL . 9.5 t30 -44.73 -43.28 8.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.85 -1.068 . . . . 1.51 113.293 -171.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.951 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 2.0 p-10 -79.95 38.95 0.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.395 -0.821 . . . . 1.98 112.323 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -100.35 -6.23 26.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 5.13 110.722 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -89.48 131.07 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.342 -0.39 . . . . 4.7 110.751 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.6 p -76.01 137.38 40.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 3.11 110.881 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.9 p 52.92 24.46 3.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 1.89 111.338 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -121.31 -55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.496 -0.927 . . . . 3.45 108.496 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.951 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 1.6 t -150.47 19.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.222 -0.659 . . . . 2.3 109.222 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.48 41.84 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.584 -1.293 . . . . 2.2 114.135 -166.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -67.95 173.22 3.27 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.247 -0.649 . . . . 1.31 109.247 167.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.821 ' HD2' ' HB2' ' A' ' 42' ' ' ALA . 29.5 Cg_endo -63.44 26.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.049 2.499 . . . . 1.94 115.335 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 42' ' ' ALA . 62.8 tp -142.1 -88.94 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.932 -0.48 . . . . 2.23 110.81 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 95.2 -49.77 1.91 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.766 -0.73 . . . . 0.94 112.766 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.45 HG11 ' CD1' ' A' ' 24' ' ' LEU . 85.8 t -137.12 143.38 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 1.21 110.161 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.824 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 13.6 t70 -104.95 109.1 20.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.206 -0.664 . . . . 1.11 109.206 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' HE2' ' HZ ' ' A' ' 20' ' ' PHE . 22.0 tptp -80.95 -13.64 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.49 -0.777 . . . . 3.25 112.316 -173.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -90.4 -40.05 12.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.665 0.269 . . . . 3.63 111.573 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.68 -32.27 4.23 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.986 -0.846 . . . . 1.9 110.986 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.605 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 96.16 79.61 1.47 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.87 111.946 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.824 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 28.6 ptt180 -157.99 165.28 35.51 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.53 -0.544 . . . . 4.26 109.53 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -111.82 117.93 34.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.74 -0.467 . . . . 1.52 109.74 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.611 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.9 p90 -164.02 159.03 20.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.282 0.563 . . . . 2.04 111.244 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.904 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 26.2 mt-10 -111.82 153.72 26.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.678 -0.692 . . . . 2.12 110.2 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 60' ' ' GLY . 37.5 mm -81.2 103.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.258 -0.645 . . . . 1.42 109.258 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.672 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.0 t70 -90.25 -170.79 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.258 -0.275 . . . . 1.97 110.258 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 11.4 pt-20 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.883 0.327 . . . . 2.43 111.883 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.581 ' OE1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -84.5 -10.35 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 2.39 110.61 -178.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' HG21 ' A' ' 56' ' ' ILE . . . 145.93 -86.79 0.17 Allowed Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.83 -0.623 . . . . 2.29 112.448 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . 40.0 mt-10 -148.65 37.13 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.539 0.209 . . . . 2.31 111.285 -172.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.45 77.85 1.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.147 0.975 . . . . 2.61 110.84 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -123.22 163.95 19.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.634 -1.166 . . . . 4.63 110.275 172.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' A' ' 82' ' ' ARG . 7.1 p -57.98 106.22 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 2.27 111.48 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 19.2 p90 -79.61 109.31 13.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 7.39 112.162 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -67.41 136.62 32.15 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.987 -0.845 . . . . 1.23 110.987 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 67' ' ' LEU . 4.0 mp -87.91 86.88 7.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.45 0.125 . . . . 1.76 111.166 -171.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 51' ' ' GLY . 35.5 mt -82.27 116.62 26.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.094 -1.042 . . . . 1.26 109.568 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -103.21 -12.79 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.168 -0.923 . . . . 2.65 110.319 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HD2' HG21 ' A' ' 78' ' ' VAL . 36.9 ttmt -156.81 121.12 4.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 2.03 111.511 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' HA ' HD13 ' A' ' 77' ' ' LEU . 59.3 t -109.86 89.06 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.966 -1.124 . . . . 1.47 107.966 167.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 76' ' ' THR . 38.7 t0 -97.8 71.41 2.22 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.879 -0.328 . . . . 1.42 110.454 -175.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.553 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.3 pt-20 46.42 -169.73 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 124.402 1.064 . . . . 0.96 111.411 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -67.06 74.38 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.107 1.205 . . . . 0.48 110.914 165.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -155.0 -71.35 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.491 -0.322 . . . . 0.5 110.771 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.572 ' C ' HD12 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -142.31 123.94 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.476 0.547 . . . . 1.1 112.476 -175.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -118.73 123.2 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.862 -0.523 . . . . 1.4 110.41 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.573 HG21 ' HD2' ' A' ' 70' ' ' LYS . 58.1 t -103.13 101.72 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 1.31 109.251 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.32 140.92 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.138 -0.483 . . . . 1.48 111.12 -176.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.38 145.9 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.589 -0.732 . . . . 0.5 112.365 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.958 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 72.0 t-105 -72.99 142.62 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.581 0.586 . . . . 3.37 112.581 -174.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.589 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -145.12 44.41 1.33 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.49 -0.777 . . . . 6.17 109.32 177.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.619 HD11 ' N ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER 75.95 145.46 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.337 -0.847 . . . . 2.13 111.954 176.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.619 ' N ' HD11 ' A' ' 83' ' ' LEU . 29.1 t30 -83.11 -66.59 0.87 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.047 -0.979 . . . . 1.93 111.306 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 40' ' ' VAL . . . -91.13 29.14 7.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 2.79 113.678 -172.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 63' ' ' HIS . 75.7 t80 67.32 -68.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.23 0.612 . . . . 6.08 112.563 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.77 55.66 4.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.212 -0.518 . . . . 2.43 113.944 -170.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.618 ' HB2' HD13 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -140.53 -175.96 4.46 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.719 -0.845 . . . . 5.53 108.719 170.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.595 HG22 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -92.44 127.66 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.251 0.548 . . . . 2.42 111.494 -173.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' OD1' ' HD3' ' A' ' 82' ' ' ARG . 3.2 p30 -135.39 158.92 73.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.62 -0.718 . . . . 3.18 109.15 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 93' ' ' ASN . 28.5 Cg_endo -91.0 -29.16 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.346 2.03 . . . . 2.76 114.089 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.17 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.923 1.289 . . . . 2.99 114.418 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 91' ' ' PRO . 10.2 m-80 -79.56 -20.1 47.87 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.718 -0.613 . . . . 3.06 112.211 -174.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 p -155.9 -90.09 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.398 -0.593 . . . . 2.11 109.398 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.958 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.4 m 54.87 25.73 7.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.763 -0.653 . . . . 1.81 111.685 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.633 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 39.2 tt0 -77.63 142.63 38.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 1.81 112.214 -171.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 79' ' ' ILE . 6.6 p90 -139.92 141.06 36.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.81 110.52 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 39.0 m -97.04 112.38 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.686 -0.688 . . . . 1.18 110.387 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 76' ' ' THR . 84.5 t -84.43 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 1.51 109.71 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.446 ' HA ' HG21 ' A' ' 76' ' ' THR . 55.6 m -107.13 106.03 16.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.917 0.389 . . . . 1.05 110.849 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.556 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 46.0 m-85 -85.08 113.38 21.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.401 -0.363 . . . . 0.42 110.05 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.63 109.49 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.645 -0.502 . . . . 1.26 109.645 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.67 124.21 28.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.207 0.527 . . . . 1.13 111.041 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 32.8 m-20 -106.59 125.24 50.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.318 -0.855 . . . . 2.03 109.165 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.86 71.87 0.39 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.131 -0.486 . . . . 1.97 113.9 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 8.7 tt0 -169.6 25.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.055 -1.091 . . . . 5.46 108.055 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 57.38 48.74 14.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.859 0.837 . . . . 3.88 109.317 -169.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 36.1 tttp -130.22 148.8 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.561 -1.199 . . . . 2.94 108.613 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.1 m -155.25 113.68 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.124 0.488 . . . . 1.2 110.904 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.6 tmm_? -100.37 111.5 23.77 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.593 -0.891 . . . . 3.1 108.593 176.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.996 HG12 HG22 ' A' ' 10' ' ' VAL . 13.0 p -85.8 145.51 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.861 -0.336 . . . . 1.13 110.862 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -129.19 117.09 20.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 124.177 0.923 . . . . 1.38 109.578 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.592 ' HB ' ' CD2' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -104.75 128.44 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 110.266 -0.272 . . . . 1.58 110.266 175.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -103.63 114.82 29.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.21 -0.663 . . . . 2.31 109.21 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.641 ' HE2' ' HE2' ' A' ' 118' ' ' PHE . 41.6 t60 -131.98 125.5 31.7 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.997 -1.001 . . . . 2.32 108.864 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.456 ' HB ' ' HA ' ' A' ' 5' ' ' PHE . 5.2 t -176.94 101.86 0.05 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.75 0.786 . . . . 3.19 110.198 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.476 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.6 t-160 -166.81 -67.1 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.573 -0.74 . . . . 2.99 110.302 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.641 ' HE2' ' HE2' ' A' ' 115' ' ' HIS . 1.2 p90 -81.83 -24.74 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.891 -0.595 . . . . 4.27 110.98 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.817 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -75.46 -52.68 10.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.505 0.722 . . . . 1.81 111.352 -176.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.401 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 16.4 ptt180 -65.41 -16.7 63.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.213 -0.903 . . . . 3.84 110.705 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 41.9 tpp -74.51 26.21 0.08 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.192 -0.913 . . . . 2.9 112.721 -169.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.68 172.15 13.09 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.265 -1.445 . . . . 2.26 114.718 166.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 m -58.03 -54.24 49.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.674 -0.763 . . . . 3.02 111.892 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -68.48 -28.64 67.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 4.23 110.875 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.739 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 13.4 m-70 -67.93 -47.85 67.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.207 -0.451 . . . . 2.7 111.278 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.72 -23.42 58.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.359 -0.536 . . . . 1.46 110.468 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -74.6 -38.16 62.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 3.16 110.618 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.739 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 14.5 ptp180 -67.05 -28.35 68.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.738 -0.467 . . . . 2.97 109.738 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.709 ' HA ' ' SD ' ' A' ' 133' ' ' MET . 67.5 t -65.27 -46.33 90.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.013 -0.54 . . . . 1.96 109.808 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.609 ' HA ' ' HB2' ' A' ' 134' ' ' ASP . 65.0 ttt180 -65.91 -16.28 63.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.484 -0.78 . . . . 4.34 110.963 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.66 ' OD1' ' HA ' ' A' ' 128' ' ' ARG . 3.6 m120 -53.76 -55.55 25.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.195 -0.457 . . . . 2.8 111.444 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.06 -7.18 0.1 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.838 -1.172 . . . . 2.08 114.923 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.709 ' SD ' ' HA ' ' A' ' 129' ' ' VAL . 10.8 mtt -80.29 -28.11 38.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.3 -1.0 . . . . 5.19 108.3 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.609 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 12.3 t70 -56.34 -43.44 79.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.941 -1.481 . . . . 2.83 112.567 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -108.99 11.19 26.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 4.47 111.872 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.551 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.12 -65.61 0.7 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.019 -1.086 . . . . 1.04 112.329 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.504 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -57.92 -48.48 97.05 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.818 0.673 . . . . 3.78 112.818 -172.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.4 Cg_endo -58.32 -44.38 38.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.781 1.654 . . . . 0.77 112.02 176.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 m -59.62 -42.81 93.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.559 0.695 . . . . 1.37 109.672 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.609 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.9 mt -59.38 -50.58 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.764 -1.107 . . . . 1.32 111.345 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -34.51 74.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.282 0.475 . . . . 1.33 112.282 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.674 HE21 ' N ' ' A' ' 142' ' ' GLN . 0.0 OUTLIER -68.45 -52.65 30.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.019 0.438 . . . . 1.54 110.542 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.452 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.1 m -68.9 -22.03 64.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.997 -0.547 . . . . 1.43 110.575 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.97 -53.94 42.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 1.05 110.109 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -60.3 -29.31 68.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.844 -0.616 . . . . 1.63 110.046 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.83 -47.19 60.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.116 -0.947 . . . . 1.46 110.367 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -61.83 -34.15 75.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.689 . . . . 2.23 110.424 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.644 HG22 HG11 ' A' ' 12' ' ' VAL . 66.4 mt -80.78 -25.19 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.77 -0.65 . . . . 1.17 110.811 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.576 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 25.7 t0 -63.78 -24.58 67.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.85 109.512 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 45.0 mt-10 -67.17 -26.81 66.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.214 -0.903 . . . . 1.5 110.338 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.07 -7.35 58.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 1.74 109.98 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.15 -80.26 0.67 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.839 -0.618 . . . . 1.32 113.244 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.91 30.79 0.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.08 0.44 . . . . 2.42 112.173 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.576 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 18.0 tppt? -61.53 -38.54 87.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 2.04 111.035 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.405 -0.807 . . . . 4.65 111.119 -177.294 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.7 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 18.4 p-10 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.71 0.29 . . . . 2.1 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.439 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . 6.2 p90 -179.41 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.343 -0.389 . . . . 4.04 110.575 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.885 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.2 t70 -64.85 -62.79 4.36 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.51 -0.314 . . . . 2.78 111.299 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.885 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 10.3 Cg_endo -90.42 -57.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.697 1.598 . . . . 1.83 111.245 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.428 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 49.7 p90 -152.12 167.36 28.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.063 -0.971 . . . . 3.98 108.849 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.7 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 4.3 m -104.57 133.65 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.271 -1.011 . . . . 2.03 108.271 174.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.4 ttp180 -131.1 150.05 52.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.421 0.629 . . . . 3.92 111.041 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.981 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 2.3 t-160 -119.31 132.82 55.94 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.756 -1.202 . . . . 1.16 107.756 170.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.0 t -139.62 114.43 9.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.362 -0.535 . . . . 1.72 110.155 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.55 HG13 ' CG ' ' A' ' 145' ' ' GLN . 2.3 t -131.65 139.73 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.664 -0.698 . . . . 1.89 111.067 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -99.08 115.46 29.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.41 -0.589 . . . . 1.15 109.41 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.659 HG11 HG23 ' A' ' 148' ' ' ILE . 45.8 t -97.14 130.5 45.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.982 -0.554 . . . . 1.51 109.825 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.616 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.76 23.85 12.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 1.6 111.517 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -147.06 29.15 0.99 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.837 -0.345 . . . . 1.11 111.747 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 24.3 t70 72.53 165.28 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.778 0.799 . . . . 0.91 112.566 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.557 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 17.3 ttp180 -66.1 -25.72 67.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.988 -1.006 . . . . 2.19 111.44 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -59.78 -51.13 71.07 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.224 -0.444 . . . . 3.49 110.985 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.414 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 42.9 p -72.17 -32.9 67.27 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.579 -0.282 . . . . 1.49 110.62 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.464 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . . . -56.4 -51.07 69.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.07 110.635 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -69.79 -41.5 75.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.43 110.6 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 18' ' ' THR . 4.3 tppp? -53.87 -52.81 59.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.98 -0.554 . . . . 2.87 110.779 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 m -69.63 -48.64 59.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.009 -0.541 . . . . 1.21 110.665 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.859 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 63.1 t80 -62.16 -32.67 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.22 0.452 . . . . 0.53 112.22 -172.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.479 ' CD1' HG12 ' A' ' 46' ' ' VAL . 15.1 tp -117.82 -51.27 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.754 0.65 . . . . 1.23 112.754 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 38.7 mt-10 -76.82 -20.94 55.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 1.24 111.355 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -118.95 36.24 3.64 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.843 -0.694 . . . . 0.83 111.98 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.504 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 58.4 t80 -53.01 -51.74 71.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.629 0.603 . . . . 0.94 112.629 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 41.1 Cg_endo -87.5 12.39 2.93 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.757 1.638 . . . . 0.9 114.821 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 7.8 pt-20 -102.89 -4.93 24.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.295 -0.562 . . . . 1.49 111.577 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.859 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 34.8 m0 -69.4 168.83 13.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.464 0.65 . . . . 5.66 111.873 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.501 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 56.5 m95 -86.02 -38.03 0.56 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 114.978 -1.01 . . . . 3.41 113.435 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.724 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 58.0 Cg_endo -68.65 -105.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.375 2.05 . . . . 1.36 115.071 -165.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.503 ' ND2' HG22 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -79.65 -42.65 24.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.02 0.438 . . . . 1.51 111.051 -175.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.88 68.03 8.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.535 0.684 . . . . 1.98 111.08 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.01 12.06 4.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.091 -0.959 . . . . 5.13 109.627 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -126.47 137.2 53.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.862 -0.608 . . . . 4.7 111.252 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -77.09 141.19 40.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 3.11 110.89 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.522 HG21 ' HA ' ' A' ' 57' ' ' ASP . 56.0 p 55.47 18.43 2.66 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.84 0.856 . . . . 1.89 112.3 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 45.9 tttp -110.7 -61.85 1.62 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.801 -0.814 . . . . 3.45 108.801 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.628 HG11 ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -157.46 25.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.887 -1.051 . . . . 2.3 110.035 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.36 36.34 0.24 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.305 -0.95 . . . . 2.2 113.27 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.968 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -72.96 170.42 13.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.678 -0.49 . . . . 1.31 109.678 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.25 67.79 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.698 2.265 . . . . 1.94 113.071 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -175.35 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.554 -0.748 . . . . 2.23 110.16 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.504 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 87.05 -58.68 4.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.963 -0.636 . . . . 0.94 112.474 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 24' ' ' LEU . 91.9 t -135.69 137.91 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.926 0.393 . . . . 1.21 110.907 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.633 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 23.7 t70 -103.8 99.36 9.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.749 -0.834 . . . . 1.11 108.749 173.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -80.76 -9.13 59.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.309 -0.859 . . . . 3.25 111.186 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -68.18 -55.58 11.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.984 -0.553 . . . . 3.63 110.583 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.12 -54.08 1.05 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.958 -0.639 . . . . 1.9 111.658 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.13 64.19 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.82 -0.705 . . . . 0.87 112.648 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.732 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 21.4 ptt180 -149.34 140.21 22.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.636 0.255 . . . . 4.26 111.54 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.721 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.4 m0 -97.21 108.23 20.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.67 -0.241 . . . . 1.52 110.591 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.633 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.3 p90 -158.25 176.15 12.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.453 . . . . 2.04 110.966 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.968 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 18.5 mt-10 -130.6 155.19 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 2.12 110.595 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.615 HG21 ' HG2' ' A' ' 61' ' ' GLU . 37.4 mm -78.22 103.0 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.499 -0.926 . . . . 1.42 108.499 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.656 ' OD2' ' HG3' ' A' ' 59' ' ' GLN . 12.5 t70 -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.169 -0.468 . . . . 1.97 109.963 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.18 -6.92 58.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.78 0.659 . . . . 2.43 112.78 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.656 ' HG3' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -90.12 7.3 38.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.473 -0.891 . . . . 2.39 110.471 170.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.42 62.11 0.45 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.953 -0.641 . . . . 2.29 113.76 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.615 ' HG2' HG21 ' A' ' 56' ' ' ILE . 40.0 mt-10 44.74 54.07 6.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.281 0.845 . . . . 2.31 113.281 171.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.77 84.68 2.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.413 0.625 . . . . 2.61 110.143 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -124.54 158.42 32.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.197 -0.91 . . . . 4.63 109.593 172.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -59.65 142.03 53.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.251 -0.648 . . . . 2.27 109.251 170.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.732 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 p90 -121.83 117.48 26.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.097 0.475 . . . . 7.39 111.187 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -57.15 134.28 52.36 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-N 115.235 -0.893 . . . . 1.23 111.754 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.72 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -92.26 88.1 6.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.191 0.52 . . . . 1.76 110.668 -171.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 58.2 mt -74.17 121.32 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.202 0.525 . . . . 1.26 110.382 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -31.09 24.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.603 -0.726 . . . . 2.65 109.539 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -160.21 119.92 2.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 2.03 111.819 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.537 ' CG2' HG23 ' A' ' 68' ' ' ILE . 60.8 t -99.6 100.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.152 -1.055 . . . . 1.47 108.152 167.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -108.48 70.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.768 -0.373 . . . . 1.42 110.96 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 14.0 pt-20 47.03 -170.39 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 124.471 1.107 . . . . 0.96 111.722 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 38.8 Cg_exo -64.23 75.21 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.474 1.449 . . . . 0.48 111.342 166.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -157.35 -62.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.75 -0.659 . . . . 0.5 110.413 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -147.75 148.37 30.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.324 0.49 . . . . 1.1 112.324 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 HD21 HD23 ' A' ' 24' ' ' LEU . 1.8 mp -136.59 114.92 11.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 1.4 109.416 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 98' ' ' THR . 36.4 t -101.33 104.9 16.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.897 -0.779 . . . . 1.31 108.897 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.602 HG21 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -128.55 144.7 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.826 0.346 . . . . 1.48 111.293 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.72 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -98.47 159.56 20.46 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.5 112.717 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.865 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -64.56 157.21 27.5 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 112.794 0.664 . . . . 3.37 112.794 -168.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.59 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.2 tmt_? -149.96 -2.19 0.41 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.502 -0.772 . . . . 6.17 110.373 -167.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.711 HD11 ' HB3' ' A' ' 88' ' ' ARG . 3.1 tm? 71.19 133.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.468 -0.787 . . . . 2.13 110.882 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.628 ' OD1' HG11 ' A' ' 40' ' ' VAL . 55.5 t30 -108.15 135.94 48.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.93 110.324 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.552 ' HA2' ' HE3' ' A' ' 39' ' ' LYS . . . 106.08 -17.21 41.57 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.564 -0.827 . . . . 2.79 112.732 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 t80 69.87 -54.62 0.61 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.139 0.575 . . . . 6.08 111.83 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.34 10.78 47.82 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.947 -0.461 . . . . 2.43 111.947 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.711 ' HB3' HD11 ' A' ' 83' ' ' LEU . 1.9 tpp180 -97.33 167.89 10.74 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.559 -1.275 . . . . 5.53 107.559 173.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -113.4 123.22 68.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 119.927 -0.709 . . . . 2.42 112.023 -173.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 16.8 t70 -160.17 131.37 3.87 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 108.35 -0.981 . . . . 3.18 108.35 166.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.516 ' HD3' ' HD3' ' A' ' 128' ' ' ARG . 7.9 Cg_exo -73.63 1.71 6.62 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.749 2.299 . . . . 2.76 113.393 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 60.68 81.17 0.19 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.463 -0.569 . . . . 2.99 109.463 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -126.96 -64.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.219 0.452 . . . . 3.06 112.219 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -124.19 -145.41 0.34 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.22 -0.446 . . . . 2.11 111.24 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.865 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 9.2 t 73.16 67.93 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.28 -0.873 . . . . 1.81 111.385 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.88 98.4 10.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.487 -0.779 . . . . 1.81 109.847 172.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.63 ' HA ' ' HB2' ' A' ' 115' ' ' HIS . 7.5 p90 -104.83 130.98 52.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.168 -0.613 . . . . 0.81 111.323 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.606 HG23 HG23 ' A' ' 78' ' ' VAL . 12.6 m -91.99 110.49 21.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.413 -0.812 . . . . 1.18 110.655 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.659 ' HA ' HG23 ' A' ' 113' ' ' VAL . 60.2 t -82.3 109.27 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.394 -0.595 . . . . 1.51 109.394 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.505 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.1 m -101.57 106.92 18.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.321 -0.399 . . . . 1.05 110.732 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.716 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.4 m-85 -88.94 107.31 18.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.551 -0.537 . . . . 0.42 109.551 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -93.13 108.98 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.494 -0.558 . . . . 1.26 109.494 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.77 141.01 58.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.832 -0.622 . . . . 1.13 111.014 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 7.3 t70 -126.65 92.64 3.59 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.043 -0.526 . . . . 2.03 109.593 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.15 -108.44 2.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.74 -0.743 . . . . 1.97 112.436 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -140.96 -2.43 1.31 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.714 0.265 . . . . 5.46 111.714 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -3.17 1.34 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.758 0.651 . . . . 3.88 112.758 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.725 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 49.1 tttm -127.46 157.08 41.02 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.486 -0.486 . . . . 2.94 109.945 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.1 m -159.18 123.39 3.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.446 -0.343 . . . . 1.2 110.548 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -97.23 118.61 34.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.271 -0.64 . . . . 3.1 109.271 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.716 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 p -99.89 134.53 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.775 -0.454 . . . . 1.13 109.775 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.732 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.2 t70 -138.3 114.43 10.15 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.25 -0.887 . . . . 1.38 109.877 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.981 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 25.6 t -91.39 124.4 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.105 -0.498 . . . . 1.58 110.782 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -107.38 115.95 31.06 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 124.003 0.815 . . . . 2.31 109.621 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.63 ' HB2' ' HA ' ' A' ' 97' ' ' PHE . 25.8 t60 -154.7 143.33 20.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.426 . . . . 2.32 110.744 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 9.7 t -162.36 119.27 2.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.054 0.391 . . . . 3.19 112.054 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' THR . 76.9 t60 169.16 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.541 -0.754 . . . . 2.99 110.788 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -53.23 -50.33 64.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.652 0.612 . . . . 4.27 112.652 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 8.3 t70 -78.69 -39.92 35.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.916 0.388 . . . . 1.81 111.548 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -66.3 -27.45 67.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 3.84 110.856 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 32.9 tpp -98.55 18.34 16.94 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.985 -1.117 . . . . 2.9 107.985 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 125' ' ' HIS . . . -66.22 -88.13 0.06 OUTLIER Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.729 -1.578 . . . . 2.26 114.339 -168.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 28.7 m 57.3 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.703 -0.851 . . . . 3.02 108.703 -165.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.66 -55.07 19.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.266 -0.642 . . . . 4.23 109.266 170.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.629 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 3.0 t-160 -64.51 -48.26 75.79 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.494 -0.775 . . . . 2.7 111.208 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.599 ' HB2' ' HA3' ' A' ' 122' ' ' GLY . . . -58.51 -45.98 87.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.163 -0.472 . . . . 1.46 111.249 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 123' ' ' THR . 5.7 tmtm? -61.76 -47.38 85.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 3.16 110.887 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.656 ' HB2' HG23 ' A' ' 89' ' ' ILE . 7.4 ptp180 -68.3 -35.1 77.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.439 0.533 . . . . 2.97 112.439 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.413 HG13 ' CZ2' ' A' ' 81' ' ' TRP . 91.9 t -80.23 -40.87 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.979 0.419 . . . . 1.96 111.25 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -62.56 -15.03 48.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.745 -0.662 . . . . 4.34 111.171 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.643 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 94.5 m-20 -58.77 -22.68 58.62 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 2.8 112.243 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.18 -31.83 0.07 OUTLIER Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.005 -1.093 . . . . 2.08 114.059 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -65.0 -23.25 67.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.557 -0.378 . . . . 5.19 110.851 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.38 -24.73 66.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.927 -0.579 . . . . 2.83 111.983 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -113.26 -48.03 2.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.882 0.372 . . . . 4.47 110.833 -176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -61.41 -56.73 21.74 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.858 -0.61 . . . . 1.04 113.236 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.586 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -60.38 -48.52 93.61 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.431 0.53 . . . . 3.78 112.431 -173.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 15.6 Cg_endo -58.87 -42.34 53.58 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.648 1.566 . . . . 0.77 112.026 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.8 m -64.53 -35.44 80.96 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.685 0.755 . . . . 1.37 109.387 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.586 ' HB ' ' O ' ' A' ' 137' ' ' TRP . 13.6 mt -54.79 -49.16 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.597 -1.183 . . . . 1.32 110.809 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.0 mt -62.9 -29.11 70.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.295 0.48 . . . . 1.33 112.295 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.19 -57.5 4.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.54 110.318 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.49 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 29.5 m -65.36 -23.4 66.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.103 0.478 . . . . 1.43 110.621 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 148' ' ' ILE . 45.7 t80 -61.56 -54.78 38.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.634 . . . . 1.05 110.233 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.55 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.2 mt-30 -60.49 -31.81 70.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.83 -0.623 . . . . 1.63 110.894 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -42.37 69.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.758 -0.655 . . . . 1.46 111.735 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 18.3 tptm -69.97 -35.04 74.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.492 -0.483 . . . . 2.23 109.723 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.659 HG23 HG11 ' A' ' 12' ' ' VAL . 62.2 mt -66.45 -35.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 1.17 110.393 175.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 154' ' ' LYS . 19.0 t70 -59.14 -40.42 85.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.85 109.044 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.497 ' HA ' ' CB ' ' A' ' 154' ' ' LYS . 43.7 mt-10 -68.38 -35.37 77.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.801 -0.636 . . . . 1.5 110.787 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.82 -43.88 97.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 1.74 111.264 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.22 -66.15 1.68 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.529 -0.843 . . . . 1.32 111.861 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.495 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -173.5 89.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.719 -0.474 . . . . 2.42 109.719 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.564 ' HA ' ' OD2' ' A' ' 149' ' ' ASP . 11.9 tppt? -73.88 134.41 43.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 2.04 110.245 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.495 ' HE3' ' O ' ' A' ' 153' ' ' ALA . 5.0 mptt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.475 -0.774 . . . . 4.65 110.62 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 19.6 p-10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.161 0.505 . . . . 2.1 110.715 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.498 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 46.6 p90 -176.47 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.867 -0.606 . . . . 4.04 110.751 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.991 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.2 t70 -72.57 -64.85 0.85 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.616 -0.266 . . . . 2.78 111.009 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.991 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 27.8 Cg_endo -97.51 -67.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.506 2.137 . . . . 1.83 113.151 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 4' ' ' PRO . 70.8 m-85 -124.72 113.59 18.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.417 -0.356 . . . . 3.98 111.052 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.842 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 46.0 t -90.81 111.91 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.148 -0.686 . . . . 2.03 109.148 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.8 ttp180 -133.22 134.96 44.72 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.043 -0.663 . . . . 3.92 111.174 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.608 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.92 131.75 54.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.886 -0.783 . . . . 1.16 108.886 173.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.3 m -132.93 110.43 10.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.594 -0.73 . . . . 1.72 109.852 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.448 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.2 t -124.63 139.29 51.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.144 -0.934 . . . . 1.89 110.867 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.6 m -103.67 114.61 29.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.71 0.767 . . . . 1.15 109.875 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.667 HG12 HG21 ' A' ' 148' ' ' ILE . 25.1 t -90.77 139.06 18.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.098 -0.955 . . . . 1.51 109.682 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.615 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -111.61 29.25 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.103 0.478 . . . . 1.6 110.871 -176.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.466 ' H ' HG13 ' A' ' 12' ' ' VAL . . . -150.84 29.41 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 1.11 111.635 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 35.3 t70 72.2 162.38 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.749 0.785 . . . . 0.91 112.423 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.536 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 33.6 ttp180 -65.59 -23.65 66.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.133 -0.94 . . . . 2.19 111.036 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HB2' ' HE3' ' A' ' 17' ' ' LYS . 21.1 ttmt -57.29 -44.99 84.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 3.49 110.587 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 68.4 p -80.23 -31.82 38.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.336 -0.393 . . . . 1.49 110.515 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.462 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.41 -47.59 81.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 1.07 110.687 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.555 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 83.0 t80 -67.77 -44.32 77.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.43 110.443 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 18' ' ' THR . 42.3 tttp -52.17 -49.49 63.7 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.839 -0.619 . . . . 2.87 110.488 175.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 29.1 m -68.39 -52.49 32.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.297 -0.41 . . . . 1.21 111.688 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.75 ' HA ' ' HZ ' ' A' ' 144' ' ' PHE . 60.1 t80 -65.36 -30.72 71.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.889 -0.324 . . . . 0.53 111.756 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.608 HD11 HG13 ' A' ' 46' ' ' VAL . 15.6 tp -120.12 -54.15 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.315 0.857 . . . . 1.23 113.315 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' HG2' ' HZ1' ' A' ' 48' ' ' LYS . 22.2 mt-10 -81.37 -23.7 37.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.568 0.581 . . . . 1.24 112.568 -167.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -110.16 28.98 9.66 Favored Glycine 0 C--N 1.314 -0.665 0 N-CA-C 111.24 -0.744 . . . . 0.83 111.24 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.639 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 41.6 t80 -48.01 -54.32 25.4 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.928 -0.636 . . . . 0.94 112.447 -170.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 8.1 Cg_endo -95.67 38.06 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.051 1.834 . . . . 0.9 115.298 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.9 pt-20 -132.1 -11.11 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.481 -0.888 . . . . 1.49 113.03 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.754 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 11.2 m95 -76.92 172.79 12.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.226 0.536 . . . . 5.66 111.746 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.474 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 m95 -74.6 -47.65 5.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.929 1.085 . . . . 3.41 113.929 -175.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.754 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 27.7 Cg_endo -57.87 -87.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.714 2.276 . . . . 1.36 115.108 -158.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.457 ' HB3' HD13 ' A' ' 140' ' ' ILE . 6.9 t30 -111.12 -3.73 15.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.432 -0.951 . . . . 1.51 108.432 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.598 ' HA ' HG22 ' A' ' 40' ' ' VAL . 15.0 m120 -93.83 22.69 5.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.44 -1.255 . . . . 1.98 112.579 -168.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -134.23 58.3 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.392 0.615 . . . . 5.13 110.416 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 36.9 mmt180 -136.47 145.58 45.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 4.7 109.597 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -75.65 132.43 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.801 -0.359 . . . . 3.11 110.221 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 57' ' ' ASP . 73.0 p 53.69 21.76 2.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.861 0.864 . . . . 1.89 111.798 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' HD3' ' HA3' ' A' ' 85' ' ' GLY . 5.1 mmtp -138.58 79.69 1.75 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.851 -0.613 . . . . 3.45 110.592 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 34' ' ' ASN . 22.2 m 42.61 26.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.5 -1.227 . . . . 2.3 112.982 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.13 16.41 2.55 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.133 -0.556 . . . . 2.2 111.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.93 162.01 66.45 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.991 -0.744 . . . . 1.31 108.991 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.34 50.68 0.17 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 123.263 2.642 . . . . 1.94 114.679 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -166.34 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.708 0.289 . . . . 2.23 110.995 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.639 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.48 -56.59 3.11 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.817 -0.706 . . . . 0.94 112.59 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.608 HG13 HD11 ' A' ' 24' ' ' LEU . 97.3 t -134.47 145.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.014 0.435 . . . . 1.21 111.003 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.963 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.3 t70 -121.28 102.78 8.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.566 -0.743 . . . . 1.11 109.038 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 15.3 mtmt -77.75 -28.45 50.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.213 0.449 . . . . 3.25 112.213 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -72.63 -35.08 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.961 -0.296 . . . . 3.63 111.05 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.72 -42.41 4.47 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.821 -0.704 . . . . 1.9 112.097 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 102.5 45.48 1.67 Allowed Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.913 -0.661 . . . . 0.87 112.921 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -144.06 165.04 28.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.466 -0.432 . . . . 4.26 111.607 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.62 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 18.9 m0 -108.15 123.98 49.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.824 -0.625 . . . . 1.52 109.627 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.963 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 2.7 p90 -163.36 151.43 13.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.954 0.407 . . . . 2.04 110.784 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.6 mp0 -117.95 160.18 21.88 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.488 -0.56 . . . . 2.12 109.488 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.506 HD13 ' HG2' ' A' ' 61' ' ' GLU . 26.8 mm -78.25 103.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.33 -0.395 . . . . 1.42 110.017 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.506 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.9 t70 -84.25 -166.53 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 1.97 110.012 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 1.1 pp20? -83.56 -37.86 22.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.027 0.38 . . . . 2.43 112.027 -172.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.18 23.56 3.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.155 0.503 . . . . 2.39 110.937 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.35 -113.27 0.86 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.875 -1.155 . . . . 2.29 113.011 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.568 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 40.4 mt-10 -149.12 2.06 0.56 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.262 0.467 . . . . 2.31 112.262 -167.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -93.11 90.82 7.04 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.929 0.871 . . . . 2.61 110.683 -168.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.549 ' C ' ' HG1' ' A' ' 64' ' ' THR . 0.1 OUTLIER -121.4 87.78 2.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.382 -1.281 . . . . 4.63 111.028 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.708 HG22 ' HD1' ' A' ' 86' ' ' PHE . 0.8 OUTLIER 54.25 179.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.606 0.717 . . . . 2.27 112.733 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -133.65 99.26 4.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.192 -0.458 . . . . 7.39 110.424 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.681 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.78 119.57 9.14 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.556 -1.418 . . . . 1.23 109.556 173.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -79.91 86.33 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.255 -0.578 . . . . 1.76 110.667 -169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.671 HG22 HG21 ' A' ' 71' ' ' VAL . 19.2 mt -76.43 114.8 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.694 -1.202 . . . . 1.26 109.326 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 18.0 mmm180 -95.54 -25.4 16.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.759 -1.109 . . . . 2.65 109.388 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 81.8 tttt -161.01 115.63 2.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 2.03 111.525 -175.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG21 HG22 ' A' ' 68' ' ' ILE . 89.6 t -107.35 102.01 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.564 -0.902 . . . . 1.47 108.564 168.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 9.1 t0 -112.86 69.23 0.69 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.367 -0.533 . . . . 1.42 110.462 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.8 pt-20 46.12 -169.05 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 O-C-N 124.706 1.254 . . . . 0.96 111.578 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.596 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.0 Cg_exo -64.52 78.47 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.154 1.236 . . . . 0.48 111.408 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.9 t70 -161.96 -66.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.445 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.5 p -140.71 141.41 34.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.141 0.496 . . . . 1.1 112.308 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.461 HD22 HD21 ' A' ' 24' ' ' LEU . 2.7 mp -135.55 122.26 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 1.4 109.717 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 98' ' ' THR . 41.9 t -110.32 106.81 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.423 -0.584 . . . . 1.31 109.423 176.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.99 133.87 62.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.027 0.441 . . . . 1.48 112.137 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.867 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -80.43 156.92 39.74 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.946 -0.57 . . . . 0.5 112.562 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -66.89 144.16 56.42 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.236 0.541 . . . . 3.37 112.347 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.681 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 4.5 ttp180 -136.35 -18.17 1.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.971 -1.013 . . . . 6.17 109.689 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.919 HD21 ' HB2' ' A' ' 88' ' ' ARG . 7.5 tt 80.02 162.08 0.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.271 -0.877 . . . . 2.13 111.311 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.77 97.63 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 1.93 110.817 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.629 ' HA3' ' HD3' ' A' ' 39' ' ' LYS . . . 103.19 -9.49 54.21 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.274 -1.441 . . . . 2.79 115.038 165.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.708 ' HD1' HG22 ' A' ' 64' ' ' THR . 36.0 t80 73.15 -19.22 0.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.823 0.812 . . . . 6.08 112.154 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 85' ' ' GLY . . . -63.76 -17.82 60.96 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.366 -0.445 . . . . 2.43 112.421 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.919 ' HB2' HD21 ' A' ' 83' ' ' LEU . 40.6 mtm105 -108.92 173.61 6.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.408 0.283 . . . . 5.53 110.248 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.58 115.49 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.491 0.662 . . . . 2.42 111.676 -172.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.54 138.96 21.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 3.18 110.224 176.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 93' ' ' ASN . 33.8 Cg_endo -65.2 -38.61 26.62 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.897 2.398 . . . . 2.76 113.481 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 26.3 t70 72.33 -24.3 0.19 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.492 0.663 . . . . 2.99 111.154 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 91' ' ' PRO . 39.7 m-80 -130.78 81.94 2.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.939 -1.504 . . . . 3.06 106.939 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 95' ' ' SER . 2.6 p -107.06 -164.35 0.98 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.665 1.358 . . . . 2.11 114.665 -160.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 1.093 ' HA ' ' HB3' ' A' ' 117' ' ' HIS . 41.3 m -72.87 -45.17 59.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 112.311 -2.222 . . . . 1.81 111.963 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.867 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.1 tt0 70.89 111.39 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.046 0.841 . . . . 1.81 109.793 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.435 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 40.3 p90 -115.06 150.81 35.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.203 0.525 . . . . 0.81 111.589 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.547 HG22 HG22 ' A' ' 78' ' ' VAL . 57.8 m -108.22 114.49 28.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.388 -0.824 . . . . 1.18 110.621 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.675 ' HA ' HG23 ' A' ' 113' ' ' VAL . 90.4 t -88.56 110.49 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.618 . . . . 1.51 110.272 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.434 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.6 m -104.36 105.91 16.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.19 -0.459 . . . . 1.05 110.526 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.548 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.4 m-85 -89.36 109.27 20.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.42 110.283 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' THR . 59.5 t -89.54 107.9 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.813 -0.44 . . . . 1.26 109.813 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.6 33.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.516 . . . . 1.13 110.258 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.7 t70 -125.43 112.96 16.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.92 0.39 . . . . 2.03 110.62 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -112.92 5.02 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.87 -0.681 . . . . 1.97 112.161 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 6.5 tt0 -141.05 -17.97 0.82 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.016 0.436 . . . . 5.46 110.132 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -131.9 24.87 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 3.88 111.799 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.9 ttmp? -140.97 150.87 43.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.27 -0.572 . . . . 2.94 110.916 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.552 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.2 m -158.93 112.29 2.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.878 -0.601 . . . . 1.2 110.372 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.81 110.64 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.582 -0.525 . . . . 3.1 109.582 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -90.59 138.14 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.647 -0.421 . . . . 1.13 110.326 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.459 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 12.0 t70 -128.18 114.67 17.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.895 -0.78 . . . . 1.38 108.895 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 99' ' ' VAL . 25.2 t -104.4 121.24 55.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.32 -0.855 . . . . 1.58 111.345 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -97.59 132.79 42.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 2.31 109.629 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.842 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 4.1 t60 -150.91 110.17 3.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.118 -0.697 . . . . 2.32 109.118 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.59 ' OG1' ' HD2' ' A' ' 120' ' ' ARG . 8.6 t -163.3 97.44 0.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.693 0.759 . . . . 3.19 110.694 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 1.093 ' HB3' ' HA ' ' A' ' 95' ' ' SER . 3.3 t-160 -163.92 -77.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.817 -0.629 . . . . 2.99 111.464 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.13 -39.57 17.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.407 0.521 . . . . 4.27 112.407 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.707 ' HB3' HG22 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -75.43 -34.31 60.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.35 0.595 . . . . 1.81 109.588 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.59 ' HD2' ' OG1' ' A' ' 116' ' ' THR . 40.3 ttt180 -48.21 -21.5 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.439 -1.255 . . . . 3.84 112.075 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -82.06 14.11 3.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 2.9 111.239 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.49 -155.53 4.93 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.764 -0.653 . . . . 2.26 114.18 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 t 38.16 -130.66 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.114 0.966 . . . . 3.02 112.141 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 56.4 tttp -50.77 -43.29 58.44 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 122.962 0.505 . . . . 4.23 112.063 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.506 ' O ' HG23 ' A' ' 129' ' ' VAL . 38.5 m80 -53.69 -52.2 60.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 2.7 111.005 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 2' ' ' TYR . . . -76.86 -29.75 55.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.399 -0.364 . . . . 1.46 110.961 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.03 -52.89 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 3.16 110.479 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 23.6 ptt85 -61.09 -31.86 71.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 2.97 110.842 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.707 HG22 ' HB3' ' A' ' 119' ' ' ASP . 70.6 t -65.84 -41.99 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 120.677 0.275 . . . . 1.96 110.78 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -64.73 -15.97 62.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.366 -0.379 . . . . 4.34 111.557 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.461 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 6.1 m-20 -52.28 -21.55 3.59 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.503 0.557 . . . . 2.8 112.503 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 88' ' ' ARG . . . -169.53 -28.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.021 -1.085 . . . . 2.08 114.274 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -60.97 -40.95 95.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.404 0.602 . . . . 5.19 110.281 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.31 -27.21 45.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.973 -0.558 . . . . 2.83 112.417 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -107.02 -47.23 3.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.003 0.43 . . . . 4.47 111.466 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.641 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -65.39 -54.94 23.62 Favored Glycine 0 C--O 1.223 -0.547 0 CA-C-N 116.021 -0.536 . . . . 1.04 113.226 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t90 -60.74 -51.0 82.68 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.034 0.383 . . . . 3.78 112.034 -171.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 12.5 Cg_endo -57.94 -42.34 59.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.842 1.695 . . . . 0.77 112.111 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.2 m -65.5 -34.99 79.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.336 0.589 . . . . 1.37 110.076 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.754 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 47.7 mt -56.96 -46.07 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.363 -0.835 . . . . 1.32 110.331 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 65.7 mt -62.38 -31.26 71.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 1.33 112.215 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -74.75 -53.8 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.008 -0.277 . . . . 1.54 111.085 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 59.4 m -64.73 -23.42 67.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.11 0.481 . . . . 1.43 110.217 177.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.75 ' HZ ' ' HA ' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -59.1 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 1.05 110.069 173.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.446 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.4 mt-30 -63.54 -25.26 68.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 1.63 111.007 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.83 -49.87 34.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.46 111.195 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.754 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 52.3 tptt -68.02 -34.46 76.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.62 -0.432 . . . . 2.23 110.398 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.667 HG21 HG12 ' A' ' 12' ' ' VAL . 75.5 mt -67.67 -29.43 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.024 0.44 . . . . 1.17 110.378 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.01 -31.34 72.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.549 -0.537 . . . . 0.85 109.549 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 41.0 mt-10 -70.71 -29.89 66.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.581 -0.736 . . . . 1.5 109.928 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -79.34 -23.42 43.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 1.74 110.008 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -97.47 22.97 37.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.634 -0.712 . . . . 1.32 111.427 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.508 ' HB2' ' HE3' ' A' ' 155' ' ' LYS . . . 73.57 85.04 0.11 Allowed 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 124.639 0.846 . . . . 2.42 110.625 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.605 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 13.3 tppt? -73.54 105.16 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.475 -0.784 . . . . 2.04 110.103 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 153' ' ' ALA . 17.5 ptpt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.863 -0.608 . . . . 4.65 110.424 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.777 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 64.7 m-80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.415 -0.217 . . . . 2.1 110.415 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 21.6 p90 168.92 -21.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.036 0.835 . . . . 4.04 109.374 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.986 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -49.54 -59.46 6.65 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.295 -0.866 . . . . 2.78 110.541 -176.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.986 ' HD3' ' HB2' ' A' ' 3' ' ' ASP . 26.3 Cg_endo -97.34 -61.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.375 2.05 . . . . 1.83 111.489 167.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -153.95 171.58 18.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.447 -1.316 . . . . 3.98 107.447 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.777 ' HA ' ' HB3' ' A' ' 1' ' ' ASN . 40.8 t -91.61 138.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 120.651 -0.42 . . . . 2.03 111.155 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.8 ttp180 -134.6 146.58 49.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.163 -0.471 . . . . 3.92 110.96 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.75 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -129.39 134.12 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 1.16 109.844 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 14.4 m -129.15 113.39 15.02 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.191 0.52 . . . . 1.72 110.465 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.776 HG11 ' HG2' ' A' ' 145' ' ' GLN . 1.5 t -126.09 139.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.374 -0.83 . . . . 1.89 111.06 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -97.58 117.14 31.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.184 0.516 . . . . 1.15 109.938 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.657 HG11 HG23 ' A' ' 148' ' ' ILE . 50.8 t -100.65 122.71 52.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.458 0.646 . . . . 1.51 111.323 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.829 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -90.29 13.34 15.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.901 -1.045 . . . . 1.6 112.771 -173.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -146.16 27.69 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.301 0.852 . . . . 1.11 113.301 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.9 t0 76.49 164.78 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.598 0.713 . . . . 0.91 112.358 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.679 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 16.0 ttp180 -69.72 -37.32 76.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.024 -0.989 . . . . 2.19 112.212 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 79.2 mttt -58.29 -49.17 78.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.706 0.765 . . . . 3.49 109.951 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -66.3 -38.74 88.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.302 -1.317 . . . . 1.49 110.909 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.532 ' HB3' HG13 ' A' ' 12' ' ' VAL . . . -57.77 -48.62 79.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.905 0.383 . . . . 1.07 110.479 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.6 t80 -61.25 -45.17 95.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.649 -0.705 . . . . 0.43 110.733 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -58.28 -53.46 58.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 2.87 110.798 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -62.62 -48.74 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.202 0.313 . . . . 1.21 110.835 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.904 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 72.6 t80 -63.18 -43.67 97.57 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.132 0.419 . . . . 0.53 112.132 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.577 HD11 HG12 ' A' ' 46' ' ' VAL . 17.3 tp -101.38 -56.26 2.34 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.519 -0.472 . . . . 1.23 112.119 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -96.2 15.56 20.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.391 0.615 . . . . 1.24 111.404 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.697 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -126.82 24.13 5.51 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.113 -1.195 . . . . 0.83 110.113 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.834 ' HD2' ' HA2' ' A' ' 45' ' ' GLY . 10.3 t80 -52.79 -47.02 96.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.642 -0.779 . . . . 0.94 112.995 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.2 Cg_endo -93.38 19.35 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.793 1.662 . . . . 0.9 115.012 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -110.41 -7.42 14.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.091 -0.643 . . . . 1.49 112.381 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.904 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 19.3 m0 -74.09 169.98 16.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 5.66 111.228 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.628 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 28.0 m95 -90.32 -29.54 0.34 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.639 0.977 . . . . 3.41 113.639 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 36.6 Cg_endo -66.19 -136.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.328 2.019 . . . . 1.36 114.207 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.467 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 25.1 t30 -57.48 -35.97 70.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.104 0.954 . . . . 1.51 111.181 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 1.024 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 3.0 p-10 -89.54 23.3 2.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.703 -1.135 . . . . 1.98 112.678 -169.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.73 -18.99 29.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 5.13 110.683 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.629 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 48.0 mtm105 -88.04 -179.2 6.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.455 0.539 . . . . 4.7 112.455 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.503 HG23 ' HD3' ' A' ' 43' ' ' PRO . 27.9 m -101.18 137.54 39.41 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.621 -0.718 . . . . 3.11 110.009 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.939 ' H ' ' HA ' ' A' ' 42' ' ' ALA . 44.5 p 50.22 28.84 3.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.493 0.717 . . . . 1.89 111.232 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 1.024 ' HD3' ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -67.52 -71.07 0.22 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.717 -1.129 . . . . 3.45 111.21 -177.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.854 ' H ' ' HD2' ' A' ' 39' ' ' LYS . 21.7 m -97.3 -13.01 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 122.217 1.008 . . . . 2.3 108.548 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 38' ' ' THR . . . -168.69 -50.65 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 113.471 -1.695 . . . . 2.2 110.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.939 ' HA ' ' H ' ' A' ' 38' ' ' THR . . . 152.01 -173.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 125.186 1.168 . . . . 1.31 112.195 -172.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.62 ' CD ' ' HB2' ' A' ' 42' ' ' ALA . 20.3 Cg_exo -72.75 74.54 2.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.541 2.16 . . . . 1.94 113.34 167.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 41.7 tp -145.67 -87.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.072 -0.344 . . . . 2.23 110.072 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.834 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 134.58 -92.66 0.24 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.953 -1.118 . . . . 0.94 113.843 170.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG12 HD11 ' A' ' 24' ' ' LEU . 87.9 t -132.99 148.06 31.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.314 0.578 . . . . 1.21 111.821 -168.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.813 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.1 t70 -92.8 110.6 22.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.224 -0.898 . . . . 1.11 109.154 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -80.75 -25.42 38.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.718 -0.674 . . . . 3.25 111.601 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.3 ptpp? -73.97 -38.93 64.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.757 0.28 . . . . 3.63 111.757 -171.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.72 -41.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 1.9 112.154 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 118.52 71.31 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.661 -0.781 . . . . 0.87 112.232 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HB2' ' HB3' ' A' ' 47' ' ' ASP . 5.4 mpt_? -133.79 157.31 46.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.017 -0.364 . . . . 4.26 110.017 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 29.8 m0 -112.81 117.06 31.12 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.607 -0.886 . . . . 1.52 108.607 168.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.813 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.7 p90 -162.22 155.01 19.9 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.047 0.451 . . . . 2.04 110.06 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.767 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.16 172.73 12.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.119 -0.491 . . . . 2.12 110.586 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.428 HD11 ' HG2' ' A' ' 61' ' ' GLU . 13.7 mm -78.59 99.16 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 1.42 111.395 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 5.5 t70 -96.27 172.87 7.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.627 -0.509 . . . . 1.97 109.627 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.9 pt-20 -58.47 -40.34 82.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.799 1.037 . . . . 2.43 113.799 -167.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -81.54 7.38 12.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.464 -0.494 . . . . 2.39 112.307 -176.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.2 84.11 1.78 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.043 -1.075 . . . . 2.29 114.421 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.428 ' HG2' HD11 ' A' ' 56' ' ' ILE . 43.5 mt-10 55.87 30.89 16.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.772 1.027 . . . . 2.31 113.772 167.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -127.61 92.1 3.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.559 0.695 . . . . 2.61 111.68 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.766 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -120.58 166.46 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.923 -1.035 . . . . 4.63 110.599 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.64 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 9.1 p -47.37 105.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.719 0.637 . . . . 2.27 110.637 171.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 28.8 p90 -90.32 118.02 29.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.138 0.494 . . . . 7.39 111.77 -173.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -67.18 137.5 33.43 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.837 -0.905 . . . . 1.23 110.837 173.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.38 94.13 6.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.201 0.5 . . . . 1.76 111.481 -171.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.596 HG22 HG22 ' A' ' 71' ' ' VAL . 55.4 mt -76.08 123.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.257 0.551 . . . . 1.26 110.158 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -87.72 -34.56 18.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.396 -0.82 . . . . 2.65 109.289 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -147.21 120.83 9.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.028 -0.533 . . . . 2.03 111.54 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 68' ' ' ILE . 32.1 t -102.75 92.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.284 -1.006 . . . . 1.47 108.284 167.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.63 63.28 0.72 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.789 -0.364 . . . . 1.42 110.936 -173.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.629 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.8 pt-20 47.05 -169.37 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 124.476 1.11 . . . . 0.96 112.031 175.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.629 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 33.2 Cg_exo -61.51 76.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.304 1.336 . . . . 0.48 111.798 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.9 -66.6 0.05 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.5 109.754 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.3 p -144.21 143.01 30.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.715 0.635 . . . . 1.1 112.715 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 mp -132.47 116.19 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.145 -0.687 . . . . 1.4 109.145 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.641 HG23 HG21 ' A' ' 98' ' ' THR . 36.5 t -104.72 110.27 30.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.478 -0.564 . . . . 1.31 109.478 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.98 140.55 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.871 0.367 . . . . 1.48 111.437 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.2 161.1 23.2 Favored Glycine 0 C--O 1.239 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.5 112.639 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 1.058 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 38.9 t-105 -65.04 157.89 27.18 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 113.737 1.014 . . . . 3.37 113.737 -165.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.64 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 2.9 tpt180 -174.41 33.42 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.435 -1.257 . . . . 6.17 108.917 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.932 HD22 ' HB2' ' A' ' 88' ' ' ARG . 13.9 tp 69.55 -133.9 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 2.13 111.857 175.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 59.7 t30 -167.41 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.877 0.37 . . . . 1.93 110.204 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.27 11.02 25.46 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.193 -0.527 . . . . 2.79 114.062 -172.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.5 t80 70.71 -43.37 0.55 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.529 0.731 . . . . 6.08 112.783 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.94 38.41 2.17 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.237 -0.506 . . . . 2.43 113.082 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.932 ' HB2' HD22 ' A' ' 83' ' ' LEU . 4.7 mmp_? -135.09 -175.16 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.52 -0.919 . . . . 5.53 108.52 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.523 HD13 ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -112.32 132.68 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.906 0.384 . . . . 2.42 110.918 -177.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -156.47 107.91 2.02 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.989 -0.551 . . . . 3.18 110.601 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HD3' HD13 ' A' ' 89' ' ' ILE . 1.6 Cg_endo -109.63 18.11 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.127 3.218 . . . . 2.76 110.487 165.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.455 ' OD1' ' HD2' ' A' ' 118' ' ' PHE . 10.5 t70 -79.74 -77.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.366 -0.833 . . . . 2.99 111.294 -159.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 33.9 m-80 76.59 -40.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.218 -0.901 . . . . 3.06 112.359 172.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.775 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . 70.2 m -77.66 -7.57 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.627 0.232 . . . . 2.11 111.627 -176.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 1.058 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 23.1 t -66.55 75.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.074 0.94 . . . . 1.81 109.227 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.53 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.8 tt0 -97.69 123.72 41.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.499 -1.228 . . . . 1.81 110.678 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.796 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 5.4 p90 -120.98 140.28 52.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.468 0.651 . . . . 0.81 111.805 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.641 HG21 HG23 ' A' ' 78' ' ' VAL . 32.4 m -98.7 110.48 23.07 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.475 -1.238 . . . . 1.18 109.721 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.0 t -81.92 108.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.357 -0.608 . . . . 1.51 109.357 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.8 m -102.7 106.7 17.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.086 0.47 . . . . 1.05 111.21 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.679 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 47.9 m-85 -87.4 113.3 22.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 0.42 109.968 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.79 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.604 -0.517 . . . . 1.26 109.604 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.16 124.28 27.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.176 -0.465 . . . . 1.13 111.087 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 23.2 m-20 -106.54 100.36 9.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 2.03 109.111 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.85 -113.37 4.16 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.616 -0.802 . . . . 1.97 111.933 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -147.02 4.89 0.84 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.544 0.211 . . . . 5.46 111.089 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -132.34 -12.23 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.791 0.293 . . . . 3.88 111.791 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 47.6 tttp -121.46 152.65 38.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.794 -0.447 . . . . 2.94 109.794 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.6 m -157.95 119.1 3.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 1.2 111.087 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -94.37 123.54 37.84 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.511 -0.551 . . . . 3.1 109.511 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.57 ' CG1' ' HB ' ' A' ' 10' ' ' VAL . 14.2 p -98.46 135.3 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.112 -0.635 . . . . 1.13 110.391 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 6.3 p-10 -127.87 115.87 19.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.783 0.801 . . . . 1.38 109.197 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 2.1 t -89.71 121.33 39.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.292 -0.867 . . . . 1.58 110.377 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.73 136.25 44.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 124.148 0.905 . . . . 2.31 108.715 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.796 ' HD2' ' HB3' ' A' ' 97' ' ' PHE . 65.6 t-80 -128.46 153.53 47.04 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.78 -0.645 . . . . 2.32 110.716 -171.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 t -64.84 -153.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.55 -0.75 . . . . 3.19 110.248 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -143.47 37.65 1.36 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.127 0.788 . . . . 2.99 113.127 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.775 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 2.4 t80 -71.73 -35.98 70.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.287 0.565 . . . . 4.27 109.704 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.44 ' OD2' ' CE1' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -70.84 -28.89 64.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 1.81 110.477 177.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -54.92 -20.52 9.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.409 -0.814 . . . . 3.84 111.762 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.9 mmt -65.88 -4.52 6.97 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.336 -0.393 . . . . 2.9 110.528 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.26 -141.46 25.92 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.319 -0.855 . . . . 2.26 112.965 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.2 p 42.25 -112.04 0.18 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.663 0.86 . . . . 3.02 112.264 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -77.72 -39.73 43.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.855 -0.612 . . . . 4.23 110.835 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -53.26 59.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.939 0.4 . . . . 2.7 111.079 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -69.61 -33.46 72.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.986 -0.552 . . . . 1.46 111.165 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -70.02 -49.85 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.798 -0.361 . . . . 3.16 111.077 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -66.78 -33.01 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.512 -0.313 . . . . 2.97 111.021 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.7 t -78.55 -30.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 1.96 110.864 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 18.6 ttm180 -56.4 -34.63 66.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 4.34 111.336 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.535 ' CB ' ' HD3' ' A' ' 88' ' ' ARG . 15.7 m-80 -63.59 -25.03 68.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 2.8 110.797 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.537 ' HA2' ' HG3' ' A' ' 88' ' ' ARG . . . -81.2 -106.88 0.33 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.864 -0.684 . . . . 2.08 113.248 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.674 ' HG2' ' HB2' ' A' ' 137' ' ' TRP . 18.2 ttt -79.7 -16.31 55.92 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.599 0.222 . . . . 5.19 111.599 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 25.4 t70 -62.01 -25.91 67.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 2.83 111.722 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 135' ' ' LYS . 33.7 ttpt -91.04 -29.64 17.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.072 0.463 . . . . 4.47 110.905 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -95.17 -32.17 7.21 Favored Glycine 0 C--O 1.217 -0.955 0 CA-C-N 116.155 -0.475 . . . . 1.04 112.368 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.674 ' HB2' ' HG2' ' A' ' 133' ' ' MET . 3.7 t90 -58.03 -47.06 99.54 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 122.512 0.325 . . . . 3.78 111.809 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.81 -32.55 95.62 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.837 1.692 . . . . 0.77 111.666 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.2 m -71.65 -43.17 66.55 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.268 1.032 . . . . 1.37 108.957 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.517 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.6 mt -61.83 -54.44 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.955 -1.475 . . . . 1.32 111.548 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.49 HD13 ' CD2' ' A' ' 8' ' ' HIS . 64.8 mt -58.81 -35.33 72.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 1.33 112.202 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.6 HE21 ' N ' ' A' ' 142' ' ' GLN . 0.0 OUTLIER -67.79 -52.84 32.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.923 -0.311 . . . . 1.54 110.406 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.57 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 12.0 t -69.01 -23.85 64.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 1.43 110.373 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.402 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 22.5 t80 -65.42 -49.85 67.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.609 -0.515 . . . . 1.05 109.609 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.776 ' HG2' HG11 ' A' ' 10' ' ' VAL . 45.5 mt-30 -58.4 -41.93 86.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.331 -0.849 . . . . 1.63 111.251 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 14.2 m-20 -75.46 -37.71 60.13 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.567 -0.453 . . . . 1.46 111.829 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.7 tptp -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.398 -0.593 . . . . 2.23 109.398 174.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.657 HG23 HG11 ' A' ' 12' ' ' VAL . 26.5 mt -62.27 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 1.17 111.109 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.829 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 34.2 t70 -62.38 -30.93 71.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.036 -0.529 . . . . 0.85 110.182 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.509 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 49.3 mt-10 -70.46 -39.53 74.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.994 -0.548 . . . . 1.5 109.798 175.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 16.0 mm-40 -62.33 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.659 -0.7 . . . . 1.74 109.877 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.69 -73.27 0.72 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.458 -0.792 . . . . 1.32 111.219 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -176.01 81.5 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.827 0.346 . . . . 2.42 111.418 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -98.02 -23.93 15.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.046 -0.724 . . . . 2.04 109.046 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.563 ' H ' ' HD3' ' A' ' 155' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.038 -0.983 . . . . 4.65 109.323 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.401 ' O ' HG11 ' A' ' 6' ' ' VAL . 20.9 p-10 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.863 0.364 . . . . 2.1 111.079 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 30.2 p90 -178.12 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.654 -0.703 . . . . 4.04 110.051 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.649 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 28.4 t70 -65.47 -49.74 61.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 2.78 111.782 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 16.3 Cg_endo -87.77 -68.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.142 1.228 . . . . 1.83 110.92 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.74 157.15 37.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 3.98 109.458 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.67 HG21 ' CG ' ' A' ' 115' ' ' HIS . 2.0 m -97.23 113.32 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.523 -0.917 . . . . 2.03 108.523 168.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.555 ' HD3' ' OD2' ' A' ' 112' ' ' ASP . 20.2 ttm180 -104.35 146.59 28.6 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.365 -0.834 . . . . 3.92 112.136 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 1.064 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 9.7 t-160 -112.24 132.84 54.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.614 -1.175 . . . . 1.16 108.667 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 38.3 m -140.32 119.64 12.99 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.839 -0.43 . . . . 1.72 109.839 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.657 HG13 ' HG2' ' A' ' 145' ' ' GLN . 3.9 t -143.7 132.83 19.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.812 -0.631 . . . . 1.89 110.893 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 m -95.97 115.78 27.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.455 -0.572 . . . . 1.15 109.455 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.688 HG13 HG23 ' A' ' 148' ' ' ILE . 24.9 t -95.45 140.54 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.796 -0.638 . . . . 1.51 110.736 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.11 24.22 11.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.47 0.544 . . . . 1.6 112.47 -173.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -155.46 34.92 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.735 0.643 . . . . 1.11 112.735 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 23.7 t70 72.48 166.96 0.31 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.6 0.714 . . . . 0.91 112.377 172.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' NE ' ' HB1' ' A' ' 103' ' ' ALA . 28.3 ttp180 -69.12 -23.68 64.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.42 -0.809 . . . . 2.19 111.425 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -58.89 -49.08 79.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.63 0.252 . . . . 3.49 111.086 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -73.79 -37.76 64.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.702 0.286 . . . . 1.49 110.314 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.33 -45.97 80.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 1.07 111.095 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 70.2 t80 -71.95 -47.94 48.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.407 -0.361 . . . . 0.43 110.893 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.595 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 26.5 tptp -52.9 -52.45 57.62 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.842 -0.617 . . . . 2.87 110.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -50.96 61.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.88 -0.6 . . . . 1.21 111.221 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -62.46 -37.0 84.24 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.246 0.462 . . . . 0.53 112.246 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.521 ' CD1' HG11 ' A' ' 46' ' ' VAL . 13.6 tp -109.02 -53.18 2.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.286 -0.566 . . . . 1.23 112.403 -172.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.595 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 1.4 mm-40 -79.87 -28.64 39.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.105 0.478 . . . . 1.24 111.478 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -100.8 30.58 10.01 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.582 -0.735 . . . . 0.83 111.876 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.488 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 56.4 t80 -48.5 -47.18 70.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.943 0.497 . . . . 0.94 112.279 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 15.6 Cg_endo -98.08 19.35 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.19 1.927 . . . . 0.9 114.409 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 6.6 pt-20 -105.57 -3.87 21.84 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.134 -0.627 . . . . 1.49 111.505 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.74 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 2.9 m0 -80.82 -172.03 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 5.66 111.129 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.539 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 66.4 m95 -102.45 -26.88 0.21 Allowed Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 114.041 1.126 . . . . 3.41 114.041 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.74 ' HD2' ' HB2' ' A' ' 30' ' ' TRP . 65.3 Cg_endo -72.74 -143.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.931 1.754 . . . . 1.36 114.4 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 8.1 t30 -59.29 -14.73 12.3 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.433 0.901 . . . . 1.51 113.433 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.736 HD22 ' HB2' ' A' ' 30' ' ' TRP . 8.0 p30 -76.28 -10.77 59.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.948 0.351 . . . . 1.98 111.948 -174.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -78.01 69.41 4.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 5.13 110.596 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -149.11 151.0 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.636 -0.711 . . . . 4.7 110.571 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.3 m -87.99 122.75 31.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.916 -0.314 . . . . 3.11 110.375 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.497 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 73.2 p 56.84 16.22 2.63 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.319 0.859 . . . . 1.89 113.319 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -103.53 -47.27 4.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.815 -1.18 . . . . 3.45 107.815 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.61 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -156.21 130.14 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 113.78 -1.555 . . . . 2.3 108.582 171.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' A' ' 55' ' ' GLU . . . 98.91 -72.22 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.54 -0.838 . . . . 2.2 113.291 175.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.751 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . 50.36 -164.65 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 109.813 -0.44 . . . . 1.31 109.813 -169.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.614 ' CD ' ' HB3' ' A' ' 42' ' ' ALA . 23.0 Cg_exo -69.95 16.16 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.324 1.349 . . . . 1.94 113.656 171.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 54' ' ' TYR . 56.0 tp -128.66 -92.11 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.87 -0.518 . . . . 2.23 112.049 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 109.83 -75.01 0.21 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.457 -0.878 . . . . 0.94 113.132 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG11 ' CD1' ' A' ' 24' ' ' LEU . 58.5 t -140.48 135.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 122.723 -0.28 . . . . 1.21 110.799 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.679 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 13.0 t70 -103.64 126.4 50.75 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.411 -0.359 . . . . 1.11 110.405 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HE2' ' HG ' ' A' ' 24' ' ' LEU . 1.3 mmpp? -81.38 -24.07 37.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.539 . . . . 3.25 111.947 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -83.44 -58.7 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 3.63 110.82 -171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -77.95 -22.48 68.75 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.613 -0.803 . . . . 1.9 111.507 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 63.4 2.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.896 -0.669 . . . . 0.87 111.701 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.505 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -156.2 143.74 19.32 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.339 -0.544 . . . . 4.26 111.395 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.566 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 10.5 m0 -87.46 114.26 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.725 -0.843 . . . . 1.52 108.725 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.707 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 3.4 p90 -162.65 171.23 17.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.421 0.629 . . . . 2.04 111.288 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.751 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 8.6 mp0 -127.86 -179.45 4.96 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.288 -1.005 . . . . 2.12 108.288 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.1 103.28 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 119.655 -0.818 . . . . 1.42 110.665 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 11.6 p-10 -90.55 139.77 30.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.36 0.6 . . . . 1.97 110.189 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.89 -5.13 50.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.681 0.993 . . . . 2.43 113.681 -164.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.689 -0.804 . . . . 2.39 110.659 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.45 49.04 0.45 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.936 -0.65 . . . . 2.29 113.347 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.45 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 45.7 mt-10 60.28 76.68 0.35 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.008 1.114 . . . . 2.31 114.008 172.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 30.4 tt0 -131.37 74.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.59 0.709 . . . . 2.61 110.131 169.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.707 ' CE1' ' HD1' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -120.47 154.24 35.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.326 -0.852 . . . . 4.63 110.305 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 p -64.9 149.34 49.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 2.27 109.146 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 45.8 p90 -123.38 127.45 48.49 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.189 -0.604 . . . . 7.39 111.034 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.38 136.21 28.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.116 -0.793 . . . . 1.23 111.116 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 67' ' ' LEU . 5.8 mp -82.8 87.7 6.79 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 121.092 -0.243 . . . . 1.76 110.499 -173.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 71' ' ' VAL . 43.5 mt -87.69 116.51 29.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 119.417 -0.913 . . . . 1.26 109.718 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -110.19 -10.46 14.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.093 -0.958 . . . . 2.65 110.487 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 37.1 ttmt -145.53 110.4 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.981 -0.554 . . . . 2.03 111.359 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.598 HG22 HG23 ' A' ' 68' ' ' ILE . 38.9 t -102.26 90.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.03 -1.1 . . . . 1.47 108.03 166.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.5 t70 -106.44 59.63 0.64 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.538 -0.465 . . . . 1.42 110.613 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.705 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.7 pt-20 39.71 -160.95 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 124.734 1.271 . . . . 0.96 111.924 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.705 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -62.47 80.5 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 CA-C-N 120.494 1.212 . . . . 0.48 112.118 168.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 13.9 t70 -165.89 -69.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.5 110.66 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.59 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -146.43 130.69 17.52 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.384 0.883 . . . . 1.1 113.384 -174.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -123.75 125.96 45.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.041 -0.412 . . . . 1.4 110.864 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 99.2 t -103.48 109.83 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.77 -0.456 . . . . 1.31 109.77 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.75 126.73 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.385 -0.825 . . . . 1.48 111.616 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.753 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.1 163.99 29.49 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.787 -0.525 . . . . 0.5 111.787 175.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.619 ' CZ2' ' HA ' ' A' ' 83' ' ' LEU . 5.3 t-105 -64.31 161.79 16.06 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.563 0.949 . . . . 3.37 113.563 -166.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 1.6 ttp180 -158.07 -17.69 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.862 -1.063 . . . . 6.17 109.822 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.619 ' HA ' ' CZ2' ' A' ' 81' ' ' TRP . 2.6 tt 79.2 157.35 0.16 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.758 -1.11 . . . . 2.13 111.624 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.493 ' OD1' HG12 ' A' ' 40' ' ' VAL . 49.9 t30 -131.55 147.42 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.561 -0.745 . . . . 1.93 110.265 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 86' ' ' PHE . . . 83.31 1.1 90.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.911 -0.661 . . . . 2.79 113.645 172.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 18.9 t80 177.55 165.91 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.961 0.381 . . . . 6.08 110.479 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.61 69.18 1.24 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.195 -1.562 . . . . 2.43 109.195 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.547 ' HD2' ' HB3' ' A' ' 131' ' ' ASN . 12.9 ttm180 -97.5 -179.92 4.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.186 -0.507 . . . . 5.53 110.242 -168.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.505 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.06 122.5 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.568 0.699 . . . . 2.42 110.1 177.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 3.5 p30 -122.9 147.43 51.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.4 -0.818 . . . . 3.18 111.38 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HG3' ' HD2' ' A' ' 128' ' ' ARG . 3.4 Cg_exo -80.77 -52.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.892 2.395 . . . . 2.76 110.904 168.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 90' ' ' ASP . 5.2 m-20 44.17 42.34 4.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.043 -0.98 . . . . 2.99 113.161 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -140.54 -22.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 122.008 0.908 . . . . 3.06 109.064 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.439 ' HB2' ' CG ' ' A' ' 118' ' ' PHE . 71.1 m -150.67 -141.85 0.11 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.419 -1.264 . . . . 2.11 107.979 173.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.611 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 21.9 t 60.74 37.27 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.368 1.08 . . . . 1.81 108.307 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.753 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 21.4 mt-10 -74.89 144.37 43.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.175 -1.375 . . . . 1.81 110.182 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.776 ' HB3' ' HD1' ' A' ' 115' ' ' HIS . 2.7 p90 -131.56 132.11 43.88 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.229 0.538 . . . . 0.81 110.636 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 35.9 m -95.24 114.31 26.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.207 -0.906 . . . . 1.18 110.209 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.636 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -82.1 108.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.783 -0.644 . . . . 1.51 109.387 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.4 m -101.29 105.52 16.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.126 -0.488 . . . . 1.05 109.881 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.87 110.5 21.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.415 -0.357 . . . . 0.42 110.062 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.67 106.41 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.137 -0.69 . . . . 1.26 109.137 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HB1' ' NE ' ' A' ' 16' ' ' ARG . . . -78.52 124.34 28.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.638 -0.71 . . . . 1.13 111.46 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -108.27 127.89 54.25 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.726 -0.842 . . . . 2.03 108.726 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.95 -18.42 40.22 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.525 -0.761 . . . . 1.97 114.832 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -92.87 39.58 1.04 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.737 0.769 . . . . 5.46 110.812 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.734 ' HB2' ' HZ2' ' A' ' 107' ' ' LYS . 9.7 mtmp? 64.76 33.29 10.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.06 -0.518 . . . . 3.88 110.86 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 1.2 ttmp? -122.0 153.19 38.89 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.227 -0.657 . . . . 2.94 109.227 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.7 m -155.78 113.82 3.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.187 0.518 . . . . 1.2 111.203 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -92.21 111.71 23.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.515 -0.766 . . . . 3.1 109.933 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.575 HG12 ' HB ' ' A' ' 10' ' ' VAL . 13.4 p -87.61 138.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 1.13 110.163 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.555 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 22.7 t70 -133.19 106.93 7.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.302 -0.863 . . . . 1.38 109.008 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 1.064 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 5.3 t -90.61 120.62 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 120.89 -0.324 . . . . 1.58 110.597 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.71 133.1 43.51 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.701 -0.852 . . . . 2.31 108.701 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.776 ' HD1' ' HB3' ' A' ' 97' ' ' PHE . 34.6 t60 -116.61 153.93 31.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.614 -0.721 . . . . 2.32 109.789 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 118' ' ' PHE . 14.2 t -64.1 -165.31 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.613 -0.722 . . . . 3.19 110.415 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.414 ' O ' ' HG2' ' A' ' 121' ' ' MET . 8.4 p-80 -131.82 27.53 4.6 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.708 -0.678 . . . . 2.99 110.571 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.517 ' H ' HG23 ' A' ' 116' ' ' THR . 46.2 t80 -64.48 -24.33 67.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.506 0.67 . . . . 4.27 109.985 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -44.59 66.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.817 -1.083 . . . . 1.81 109.172 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 1.3 tmt_? -58.49 -21.17 50.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.803 -1.09 . . . . 3.84 111.832 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 94.1 mmm -73.52 33.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.991 0.424 . . . . 2.9 112.107 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 130.09 145.26 5.74 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.244 -0.503 . . . . 2.26 111.96 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.9 m -61.15 -27.12 68.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.34 . . . . 3.02 110.855 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.831 ' HG2' HH21 ' A' ' 128' ' ' ARG . 60.4 tttp -66.25 -47.35 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.461 -0.336 . . . . 4.23 110.315 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.649 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 37.0 m80 -65.04 -47.02 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.922 0.391 . . . . 2.7 110.944 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.65 80.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.314 -0.403 . . . . 1.46 111.466 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.38 -44.91 86.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.723 -0.217 . . . . 3.16 110.924 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.831 HH21 ' HG2' ' A' ' 124' ' ' LYS . 19.2 ptp180 -58.29 -34.04 70.11 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 120.796 0.331 . . . . 2.97 110.683 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 81' ' ' TRP . 92.7 t -79.29 -48.71 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.867 0.365 . . . . 1.96 110.719 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.938 ' HA ' ' HG2' ' A' ' 133' ' ' MET . 17.2 mtp180 -61.91 -17.85 58.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.06 -0.518 . . . . 4.34 111.922 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.547 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 4.2 m-80 -51.98 -46.98 65.04 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.493 0.496 . . . . 2.8 111.517 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.01 -15.71 9.74 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.136 -1.031 . . . . 2.08 113.15 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.938 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 21.6 ptm -80.91 -36.88 30.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.48 . . . . 5.19 112.167 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -27.43 62.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.933 0.716 . . . . 2.83 112.933 -163.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -103.29 -15.85 15.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.167 0.508 . . . . 4.47 111.004 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.598 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.2 -55.46 0.77 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.427 -0.892 . . . . 1.04 113.102 -174.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 8' ' ' HIS . 6.9 t90 -56.12 -53.34 64.56 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.674 0.62 . . . . 3.78 112.674 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.25 -45.24 28.26 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.801 1.668 . . . . 0.77 111.714 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 m -60.53 -40.16 90.47 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.573 0.702 . . . . 1.37 110.34 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 136' ' ' GLY . 49.7 mt -55.67 -45.53 79.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 CA-C-N 114.945 -1.025 . . . . 1.32 110.031 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 38.4 mt -59.14 -34.87 72.58 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.45 0.468 . . . . 1.33 111.842 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.98 -56.19 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 1.54 110.636 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.639 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 23.5 m -68.56 -21.16 64.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.518 -0.31 . . . . 1.43 111.161 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.09 -52.14 65.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.941 -0.392 . . . . 1.05 109.941 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.657 ' HG2' HG13 ' A' ' 10' ' ' VAL . 52.6 mt-30 -60.41 -36.07 77.26 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.741 -0.663 . . . . 1.63 110.046 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.62 -40.26 69.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.892 -1.049 . . . . 1.46 111.208 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 37.4 tptt -65.58 -37.71 87.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.216 0.531 . . . . 2.23 109.642 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.688 HG23 HG13 ' A' ' 12' ' ' VAL . 66.0 mt -72.45 -25.66 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 1.17 110.557 176.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.82 -30.9 71.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.554 -0.536 . . . . 0.85 109.554 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.68 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 40.1 mt-10 -70.4 -30.54 67.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.63 -0.714 . . . . 1.5 110.188 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.87 -36.12 62.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.362 -0.836 . . . . 1.74 109.619 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.26 -0.882 . . . . 1.32 111.647 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -167.21 86.66 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.413 . . . . 2.42 110.967 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.68 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.5 ttmm -107.59 -59.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.41 . . . . 2.04 109.914 176.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 3.9 mptp? . . . . . 0 C--O 1.247 0.946 0 O-C-N 123.777 0.673 . . . . 4.65 111.101 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.455 ' ND2' HG11 ' A' ' 6' ' ' VAL . 3.4 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.682 0.277 . . . . 2.1 111.333 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 46.8 p90 -176.78 -42.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.776 -0.647 . . . . 4.04 109.812 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.774 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 21.3 t70 -58.23 -55.37 46.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.13 -0.486 . . . . 2.78 112.099 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.2 Cg_endo -92.39 -65.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.453 2.102 . . . . 1.83 112.275 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HD2' HG21 ' A' ' 116' ' ' THR . 91.7 m-85 -143.1 145.35 32.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.226 -0.443 . . . . 3.98 110.543 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.695 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 45.2 t -104.58 126.54 59.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.88 -0.785 . . . . 2.03 108.88 167.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.2 ttm105 -128.44 135.2 49.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.221 0.534 . . . . 3.92 110.96 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.938 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -109.07 130.51 55.48 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.135 -1.061 . . . . 1.16 108.135 170.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.4 t -136.78 110.5 8.1 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.568 0.699 . . . . 1.72 109.596 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.727 HG11 ' HG2' ' A' ' 145' ' ' GLN . 1.8 t -122.85 134.7 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.601 -1.181 . . . . 1.89 111.038 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -91.75 115.59 28.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.04 -0.527 . . . . 1.15 109.756 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG11 HG23 ' A' ' 148' ' ' ILE . 42.0 t -96.79 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.496 -0.557 . . . . 1.51 109.496 177.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -104.93 33.25 3.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.885 -0.598 . . . . 1.6 111.5 -173.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.53 31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 1.11 111.573 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.706 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 19.8 t70 71.38 166.9 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.054 0.93 . . . . 0.91 112.348 176.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -71.68 -21.91 61.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.111 -0.95 . . . . 2.19 111.68 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.706 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 39.5 mmtm -58.33 -50.84 72.2 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.048 0.452 . . . . 3.49 109.907 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.1 p -72.57 -37.43 68.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.72 -0.673 . . . . 1.49 110.623 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 12' ' ' VAL . . . -55.9 -45.55 78.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.853 0.359 . . . . 1.07 110.732 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 59.9 t80 -74.24 -47.64 33.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.148 -0.478 . . . . 0.43 111.204 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 21' ' ' LYS . 4.4 ttmm -56.92 -52.18 66.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.592 -0.277 . . . . 2.87 111.167 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 m -64.01 -50.63 67.77 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.416 -0.356 . . . . 1.21 110.577 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.866 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.8 t80 -61.09 -36.84 80.73 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.333 0.494 . . . . 0.53 112.333 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.553 ' CD1' HG13 ' A' ' 46' ' ' VAL . 20.0 tp -106.37 -59.73 1.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.333 0.494 . . . . 1.23 112.333 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.16 -44.78 21.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.236 0.541 . . . . 1.24 111.515 -170.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.763 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -85.19 37.45 3.01 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 115.349 -0.841 . . . . 0.83 112.286 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.614 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 23.8 t80 -54.5 -48.91 93.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 112.366 0.506 . . . . 0.94 112.366 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 48.0 Cg_endo -86.84 12.93 2.85 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.203 1.935 . . . . 0.9 114.711 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.763 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -96.08 -4.23 43.27 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.192 -0.603 . . . . 1.49 110.624 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.866 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 17.1 m0 -77.4 -175.58 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.726 0.774 . . . . 5.66 112.045 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.522 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 47.4 m95 -109.42 -33.66 0.15 Allowed Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 114.642 -1.163 . . . . 3.41 113.454 176.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 60.7 Cg_endo -71.03 -129.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.98 1.787 . . . . 1.36 114.345 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.47 ' CG ' HD22 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -59.87 -47.11 87.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.642 0.734 . . . . 1.51 111.279 -172.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.68 ' HA ' HG13 ' A' ' 40' ' ' VAL . 6.1 p-10 -83.61 34.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.345 -1.298 . . . . 1.98 112.062 -171.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -106.09 5.14 29.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.687 0.756 . . . . 5.13 109.404 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -99.53 124.05 44.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 4.7 110.693 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.412 ' C ' ' HG1' ' A' ' 38' ' ' THR . 1.3 p -74.88 131.26 40.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.064 -0.517 . . . . 3.11 111.51 -172.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 30.5 p 54.54 22.77 4.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.249 1.02 . . . . 1.89 111.74 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -114.0 -46.64 3.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.596 -0.89 . . . . 3.45 108.596 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.68 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.6 p -169.43 6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.053 -0.976 . . . . 2.3 110.03 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.55 53.64 0.36 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.915 -0.66 . . . . 2.2 112.274 -176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 1.012 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -70.6 174.28 3.67 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 109.493 -0.558 . . . . 1.31 109.493 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.408 ' CD ' ' HB3' ' A' ' 42' ' ' ALA . 38.7 Cg_exo -63.15 56.43 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.184 2.589 . . . . 1.94 113.774 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -166.95 -84.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.194 0.598 . . . . 2.23 109.62 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.614 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 89.2 -48.93 3.46 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.043 -0.598 . . . . 0.94 113.012 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 24' ' ' LEU . 75.2 t -137.86 144.83 30.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 110.033 -0.358 . . . . 1.21 110.033 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.748 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 29.5 t70 -108.77 116.07 31.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.54 -0.541 . . . . 1.11 109.54 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 11.0 tptm -73.96 -29.8 62.19 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.572 -0.74 . . . . 3.25 112.128 -173.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.68 -54.04 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.021 0.378 . . . . 3.63 112.021 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.03 -22.21 39.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.41 -0.9 . . . . 1.9 112.651 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 87.3 61.91 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.543 -0.837 . . . . 0.87 111.46 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 3.9 mpt_? -133.17 158.97 41.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.224 . . . . 4.26 110.509 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.697 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 17.0 m0 -113.28 106.39 14.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.804 -0.813 . . . . 1.52 108.804 168.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.748 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 8.6 p90 -157.5 167.72 29.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.031 -0.359 . . . . 2.04 110.031 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 1.012 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 4.4 mt-10 -127.89 159.67 34.21 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.488 -0.324 . . . . 2.12 110.335 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.65 102.26 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.373 -0.973 . . . . 1.42 108.373 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.04 163.27 27.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 1.97 109.325 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.84 -22.13 66.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.694 0.283 . . . . 2.43 111.056 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.43 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -86.83 -15.51 38.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 2.39 110.885 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.89 -100.94 0.21 Allowed Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.395 -0.907 . . . . 2.29 112.95 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.66 27.41 2.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.771 0.32 . . . . 2.31 111.432 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.59 82.49 2.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.347 0.594 . . . . 2.61 109.838 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 163.85 20.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.247 -0.888 . . . . 4.63 110.005 174.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.448 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 16.7 p -46.69 120.56 3.02 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.723 -0.473 . . . . 2.27 109.723 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.697 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 18.0 p90 -115.33 116.41 28.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.652 0.739 . . . . 7.39 112.053 -171.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -72.03 152.0 48.05 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.75 -1.113 . . . . 1.23 111.423 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -112.89 92.06 3.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.966 0.412 . . . . 1.76 111.109 -172.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 20.0 mt -85.13 116.53 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.682 -0.488 . . . . 1.26 109.682 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.61 ' HD3' ' OE2' ' A' ' 96' ' ' GLU . 2.4 mpt_? -88.04 -33.09 18.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.885 0.374 . . . . 2.65 110.733 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 58.0 tttp -129.6 98.97 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 2.03 111.294 -174.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 68' ' ' ILE . 44.9 t -98.05 96.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.05 -1.093 . . . . 1.47 108.05 169.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.66 77.47 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.805 -0.358 . . . . 1.42 111.165 -173.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.533 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.33 -171.64 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 124.367 1.042 . . . . 0.96 112.012 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.533 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -66.41 74.09 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.353 1.369 . . . . 0.48 111.043 166.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -156.55 -64.73 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.806 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -144.48 145.55 31.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.665 0.617 . . . . 1.1 112.665 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 1.1 mp -139.01 116.51 11.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.733 -0.667 . . . . 1.4 109.745 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.586 HG23 HG23 ' A' ' 98' ' ' THR . 61.6 t -101.03 106.69 19.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.02 -0.733 . . . . 1.31 109.02 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -129.1 127.56 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 1.48 111.95 -171.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -90.7 154.92 23.56 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.427 -0.416 . . . . 0.5 112.896 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.744 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 17.4 t-105 -73.19 160.88 31.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 3.37 111.889 -171.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.513 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 11.9 ptt180 -137.2 0.63 2.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.967 -0.561 . . . . 6.17 110.732 -169.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.757 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 2.7 tm? 74.55 133.09 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.985 0.803 . . . . 2.13 110.82 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.526 ' HB2' ' CH2' ' A' ' 81' ' ' TRP . 40.4 t-20 -98.94 121.4 40.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 1.93 110.367 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.83 -9.22 61.84 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.425 -0.893 . . . . 2.79 114.309 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.1 t80 70.98 -42.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.229 0.612 . . . . 6.08 112.238 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.75 7.23 51.01 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.234 -0.508 . . . . 2.43 112.928 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.515 ' HB2' HD22 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -108.17 178.31 4.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.969 -0.752 . . . . 5.53 108.969 177.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -114.54 128.64 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.963 0.411 . . . . 2.42 111.406 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.757 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 29.1 t70 -144.36 142.52 19.74 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.153 -0.684 . . . . 3.18 109.153 168.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HD2' ' OD2' ' A' ' 90' ' ' ASP . 17.3 Cg_endo -58.1 -27.28 79.24 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.948 2.432 . . . . 2.76 113.893 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 3.0 t70 67.38 -0.85 1.7 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.88 0.848 . . . . 2.99 110.853 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.18 -38.68 60.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.682 -0.69 . . . . 3.06 112.191 -171.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.9 m -156.01 -93.46 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.767 -0.197 . . . . 2.11 110.958 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.744 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 4.1 m 50.64 39.78 22.33 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.63 0.581 . . . . 1.81 110.724 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.723 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.7 mm-40 -69.24 144.52 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.34 -0.846 . . . . 1.81 112.221 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.91 127.95 22.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.56 0.695 . . . . 0.81 111.717 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.586 HG23 HG23 ' A' ' 78' ' ' VAL . 52.9 m -93.26 112.12 23.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.044 -0.98 . . . . 1.18 110.788 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.611 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -89.59 110.11 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.764 -0.653 . . . . 1.51 109.869 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.56 ' HA ' HG23 ' A' ' 76' ' ' THR . 23.4 m -105.4 106.38 16.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 1.05 110.561 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.448 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 29.8 m-85 -88.5 107.59 18.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.42 110.298 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.24 111.22 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.324 -0.398 . . . . 1.26 110.303 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.88 53.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 1.13 110.453 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 8.6 t70 -130.7 118.9 21.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.137 -0.483 . . . . 2.03 110.534 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.16 -98.78 0.52 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.064 -0.588 . . . . 1.97 112.546 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.01 -20.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 5.46 110.259 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -128.14 7.1 5.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 3.88 111.53 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 83.9 tttt -122.7 151.25 41.73 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.584 -0.446 . . . . 2.94 110.425 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -153.76 118.5 4.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.828 -0.624 . . . . 1.2 109.936 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -100.79 115.8 31.18 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.532 -0.758 . . . . 3.1 109.449 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.2 p -91.76 137.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.285 -0.566 . . . . 1.13 110.642 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.4 109.01 11.33 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.156 -0.929 . . . . 1.38 109.049 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.938 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 3.9 t -101.64 124.16 55.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.897 -0.592 . . . . 1.58 111.263 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -102.76 113.7 27.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.437 0.637 . . . . 2.31 109.452 173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.695 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 65.7 t60 -134.2 98.95 4.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.195 -0.911 . . . . 2.32 109.219 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.459 HG21 ' HD2' ' A' ' 5' ' ' PHE . 5.1 t -152.92 97.29 2.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.918 0.866 . . . . 3.19 111.027 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.68 -69.91 0.09 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.334 -0.848 . . . . 2.99 110.0 176.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.648 ' CE1' ' HB3' ' A' ' 125' ' ' HIS . 13.6 t80 -72.28 -48.73 40.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.531 -0.759 . . . . 4.27 111.173 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.97 78.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 1.81 110.097 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 36.4 ttt180 -51.94 -24.94 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.222 -1.354 . . . . 3.84 112.072 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 95.3 mmm -79.9 -8.85 59.54 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.65 0.262 . . . . 2.9 110.706 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 44.43 -135.13 6.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.539 -0.755 . . . . 2.26 113.636 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 124' ' ' LYS . 25.6 p 40.61 -133.07 0.29 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.763 0.825 . . . . 3.02 112.417 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' H ' ' HB ' ' A' ' 123' ' ' THR . 65.0 mttm -57.77 -33.25 68.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 4.23 111.583 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.648 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 11.8 m-70 -66.51 -52.97 40.24 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.38 0.609 . . . . 2.7 110.739 -171.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.73 69.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.637 -0.711 . . . . 1.46 111.054 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -73.7 -28.94 61.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 3.16 111.668 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 31.6 ptt180 -77.35 -36.66 53.57 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.803 -0.359 . . . . 2.97 111.256 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.64 HG22 ' HE2' ' A' ' 118' ' ' PHE . 93.8 t -76.48 -23.86 15.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.356 0.598 . . . . 1.96 110.421 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.504 ' HG3' ' CB ' ' A' ' 134' ' ' ASP . 27.3 ttm180 -58.22 -19.85 36.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 4.34 111.142 174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.03 -22.72 41.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.196 -0.456 . . . . 2.8 111.362 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.434 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -137.41 -47.69 0.07 OUTLIER Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.374 -0.917 . . . . 2.08 113.469 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.46 -25.58 63.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.879 0.34 . . . . 5.19 111.878 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.504 ' CB ' ' HG3' ' A' ' 130' ' ' ARG . 15.0 t70 -59.28 -43.92 92.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 2.83 112.064 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -96.71 5.85 49.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 4.47 111.146 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.509 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -102.41 -62.15 0.73 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.441 -0.885 . . . . 1.04 112.81 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.533 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 1.1 t90 -60.63 -49.25 90.63 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.966 0.728 . . . . 3.78 112.966 -169.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.6 Cg_endo -58.13 -44.86 35.6 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.662 1.575 . . . . 0.77 112.027 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.0 m -59.05 -40.94 86.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.761 -0.654 . . . . 1.37 110.228 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.633 HG21 ' HZ3' ' A' ' 30' ' ' TRP . 45.6 mt -54.69 -51.94 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.928 -1.033 . . . . 1.32 110.894 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.639 HD13 ' CD2' ' A' ' 8' ' ' HIS . 59.5 mt -61.67 -30.57 70.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.048 0.388 . . . . 1.33 112.048 -175.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.0 mm-40 -70.99 -55.51 8.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 1.54 110.524 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.528 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.6 m -68.08 -22.52 64.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.072 -0.513 . . . . 1.43 110.626 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.79 -52.48 64.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.221 0.534 . . . . 1.05 109.771 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.727 ' HG2' HG11 ' A' ' 10' ' ' VAL . 45.9 mt-30 -59.79 -36.25 76.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.155 -0.929 . . . . 1.63 110.765 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.6 -40.29 49.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.748 -0.66 . . . . 1.46 111.462 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.23 -42.46 99.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 2.23 109.884 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.642 HG23 HG11 ' A' ' 12' ' ' VAL . 57.0 mt -64.44 -35.64 74.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 1.17 110.306 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.49 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 21.7 t70 -59.56 -38.71 81.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.61 -0.723 . . . . 0.85 109.716 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.49 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 45.6 mt-10 -66.06 -22.61 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 1.5 111.348 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -73.6 -8.04 54.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.763 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.27 -47.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.576 -1.297 . . . . 1.32 114.14 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.08 58.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.666 0.617 . . . . 2.42 112.666 -170.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.49 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.0 ttmm -69.26 101.23 1.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.226 -0.443 . . . . 2.04 111.539 -173.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.394 -0.821 . . . . 4.65 109.391 176.359 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.559 0.219 . . . . 2.1 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.509 ' HA ' HG21 ' A' ' 6' ' ' VAL . 52.9 p90 173.53 -36.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.652 0.781 . . . . 4.04 109.92 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.769 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 29.9 t70 -67.97 -57.65 9.13 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.411 -0.359 . . . . 2.78 111.525 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 47.7 Cg_endo -83.03 -63.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.248 1.299 . . . . 1.83 111.714 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.51 139.09 16.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.421 -0.354 . . . . 3.98 110.946 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.682 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 79.6 t -89.11 121.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.047 -0.723 . . . . 2.03 109.047 167.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.5 ttt180 -124.88 130.83 53.15 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.3 -0.409 . . . . 3.92 110.428 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' HD1' HG23 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.79 130.87 55.47 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.807 -0.812 . . . . 1.16 108.807 172.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 11.3 p -134.79 111.04 9.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.94 0.876 . . . . 1.72 110.498 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.579 ' HB ' HG13 ' A' ' 111' ' ' VAL . 2.3 t -120.37 133.35 67.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.269 -1.332 . . . . 1.89 111.637 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.0 m -96.13 115.51 27.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.693 . . . . 1.15 109.782 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.668 HG13 HG23 ' A' ' 148' ' ' ILE . 4.6 t -98.64 140.8 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.696 . . . . 1.51 111.004 -176.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 11.3 mmtp -100.0 9.88 42.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.919 -0.582 . . . . 1.6 112.016 -170.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -150.09 37.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.149 -0.62 . . . . 1.11 112.452 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 74.08 165.22 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.784 0.802 . . . . 0.91 112.743 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 10.9 ttp180 -63.1 -30.27 71.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.419 -1.264 . . . . 2.19 111.226 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 18' ' ' THR . 61.8 pttt -56.18 -47.18 78.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.117 -0.492 . . . . 3.49 110.405 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.412 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 27.9 m -74.84 -33.65 62.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.874 -0.603 . . . . 1.49 110.605 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.424 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . . . -60.55 -49.59 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 1.07 110.883 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.495 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 52.0 t80 -70.09 -43.37 71.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.236 -0.438 . . . . 0.43 110.773 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.619 ' HB2' ' HZ3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -53.72 -51.46 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 2.87 110.175 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.572 HG23 ' CE2' ' A' ' 30' ' ' TRP . 61.1 m -63.2 -41.38 99.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.982 -0.554 . . . . 1.21 111.282 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HA ' ' HE1' ' A' ' 144' ' ' PHE . 73.8 t80 -70.48 -47.19 61.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.329 0.492 . . . . 0.53 112.329 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 46' ' ' VAL . 11.3 tp -119.27 -11.7 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.119 1.155 . . . . 1.23 114.119 -167.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.593 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 32.9 mt-10 -113.98 -38.92 4.07 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.213 -0.929 . . . . 1.24 111.345 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.19 29.74 7.87 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.373 -0.831 . . . . 0.83 111.342 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.605 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 59.4 t80 -46.48 -55.07 15.24 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 114.504 -0.848 . . . . 0.94 113.054 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.5 Cg_endo -94.37 21.59 0.55 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.13 1.887 . . . . 0.9 115.493 -172.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -120.37 -18.82 7.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.97 1.1 . . . . 1.49 113.97 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.572 ' CE2' HG23 ' A' ' 22' ' ' THR . 25.3 m95 -76.08 -173.09 2.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.391 0.615 . . . . 5.66 112.523 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 143' ' ' SER . 51.7 m95 -77.35 -35.16 1.28 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 115.617 1.71 . . . . 3.41 115.617 -172.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.634 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 74.3 Cg_endo -72.34 -131.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 121.85 1.7 . . . . 1.36 115.02 -161.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.535 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 10.7 t30 -67.31 -8.07 29.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.084 -0.962 . . . . 1.51 110.496 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 1.048 ' HA ' HG22 ' A' ' 40' ' ' VAL . 1.3 m-20 -90.66 18.05 6.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.772 -1.103 . . . . 1.98 110.666 -172.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -104.83 68.17 0.83 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.555 . . . . 5.13 110.603 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -156.66 -178.06 7.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.002 -0.545 . . . . 4.7 109.85 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -110.37 139.16 45.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.522 -0.547 . . . . 3.11 109.522 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.411 ' H ' ' HB1' ' A' ' 42' ' ' ALA . 50.3 p 51.74 28.3 4.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.895 0.855 . . . . 1.89 111.266 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.661 ' HD3' HG23 ' A' ' 40' ' ' VAL . 1.1 tmtp? -149.46 84.01 1.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.324 -1.362 . . . . 3.45 107.324 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 1.048 HG22 ' HA ' ' A' ' 34' ' ' ASN . 34.0 m 45.02 32.36 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.6 1.188 . . . . 2.3 112.589 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.6 11.62 0.21 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.514 -0.851 . . . . 2.2 113.873 -175.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.983 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.87 -178.27 0.65 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.214 0.507 . . . . 1.31 110.591 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 42' ' ' ALA . 31.1 Cg_exo -63.37 20.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.712 2.274 . . . . 1.94 114.303 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.787 ' HG ' ' H ' ' A' ' 45' ' ' GLY . 17.0 tp -161.59 -156.68 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.579 -1.267 . . . . 2.23 107.579 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.787 ' H ' ' HG ' ' A' ' 44' ' ' LEU . . . 163.9 -50.64 0.3 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.919 -1.134 . . . . 0.94 113.019 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 24' ' ' LEU . 78.1 t -142.88 135.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.267 0.534 . . . . 1.21 111.502 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -113.74 124.01 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.415 -0.357 . . . . 1.11 110.562 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.657 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.23 -20.83 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.506 . . . . 3.25 111.343 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -76.26 -57.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.636 -0.256 . . . . 3.63 110.724 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.86 60.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.625 -0.798 . . . . 1.9 111.689 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.0 49.6 5.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.038 -0.601 . . . . 0.87 112.495 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -136.29 154.19 50.95 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.599 -0.354 . . . . 4.26 110.506 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.683 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.8 m0 -98.53 108.35 21.02 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.229 -1.026 . . . . 1.52 108.229 168.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -149.96 144.55 25.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.584 0.707 . . . . 2.04 111.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.983 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.5 mt-10 -111.81 170.69 7.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.627 -1.169 . . . . 2.12 109.154 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 ' HG2' ' A' ' 61' ' ' GLU . 28.6 mm -78.87 105.26 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.16 -0.681 . . . . 1.42 109.16 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.724 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.8 t70 -88.61 -164.93 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.139 -0.319 . . . . 1.97 110.139 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.4 pt-20 -80.13 -35.51 36.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.76 0.281 . . . . 2.43 111.76 -174.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.474 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -96.93 24.09 6.53 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.255 -0.578 . . . . 2.39 111.639 177.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.4 -97.27 0.38 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.658 -0.782 . . . . 2.29 113.08 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' HG2' HD12 ' A' ' 56' ' ' ILE . 34.1 mt-10 -142.53 29.84 1.56 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.634 0.731 . . . . 2.31 109.729 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.51 76.76 10.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.145 -0.934 . . . . 2.61 110.286 -171.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.724 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.66 130.11 52.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.229 -1.351 . . . . 4.63 109.61 175.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' ' 82' ' ' ARG . 2.9 m -69.92 -92.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 2.27 111.761 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 91.9 m-85 51.27 -167.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.291 1.219 . . . . 7.39 114.291 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.4 141.02 42.04 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.035 -0.984 . . . . 1.23 114.931 -165.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.07 99.22 8.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.795 -0.703 . . . . 1.76 109.484 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.571 HG22 HG22 ' A' ' 71' ' ' VAL . 21.0 mt -84.25 138.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 1.26 111.129 -172.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -99.88 -40.21 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.357 -0.383 . . . . 2.65 110.239 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -138.11 122.69 18.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 2.03 111.463 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.571 HG22 HG22 ' A' ' 68' ' ' ILE . 40.5 t -111.08 108.73 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.102 -0.703 . . . . 1.47 109.102 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -115.31 63.64 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.416 -0.514 . . . . 1.42 110.966 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 46.09 -166.45 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.658 1.224 . . . . 0.96 112.086 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 44.5 Cg_exo -60.74 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.638 1.558 . . . . 0.48 112.316 167.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.81 -66.81 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.654 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -144.71 148.62 34.39 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.643 0.609 . . . . 1.1 112.643 -175.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -138.82 129.02 25.52 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.944 -0.571 . . . . 1.4 110.274 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 97' ' ' PHE . 21.9 t -109.28 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.005 -0.739 . . . . 1.31 109.005 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.18 138.23 55.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.138 -0.483 . . . . 1.48 111.811 -170.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.16 149.05 19.65 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.774 -0.53 . . . . 0.5 111.774 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.812 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 76.2 t-105 -86.13 141.26 29.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.126 0.488 . . . . 3.37 112.092 -170.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.722 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 1.8 tmt_? -113.53 -79.47 0.58 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.29 -0.868 . . . . 6.17 109.053 168.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 1.012 HD21 ' HB2' ' A' ' 88' ' ' ARG . 53.8 mt -176.68 -111.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.41 1.1 . . . . 2.13 112.864 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.417 ' HA ' ' HE2' ' A' ' 65' ' ' PHE . 40.1 t-20 176.53 -161.98 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 103.856 -2.646 . . . . 1.93 103.856 -164.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.69 50.25 0.9 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.668 -1.253 . . . . 2.79 112.222 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -140.22 78.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.823 -0.351 . . . . 6.08 111.865 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.22 49.79 74.7 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 115.752 -0.658 . . . . 2.43 112.42 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 1.012 ' HB2' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -129.31 154.12 47.17 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.517 -0.341 . . . . 5.53 111.859 -169.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.628 ' O ' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -115.32 135.26 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 110.243 -0.28 . . . . 2.42 110.243 177.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.579 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 5.0 p-10 -102.91 144.92 29.6 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-O 120.999 0.428 . . . . 3.18 111.319 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HG3' ' CE2' ' A' ' 118' ' ' PHE . 15.6 Cg_exo -65.39 -48.29 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.683 2.256 . . . . 2.76 110.658 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.579 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 32.2 t70 64.79 29.5 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 2.99 110.367 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -138.88 -55.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 3.06 111.649 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.7 p -135.25 -121.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.61 -0.436 . . . . 2.11 111.567 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.812 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.6 t 55.21 54.23 9.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.922 -0.769 . . . . 1.81 108.922 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 44.7 tt0 -88.21 143.82 26.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.965 -1.016 . . . . 1.81 111.599 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -107.57 148.36 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.81 110.673 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.9 m -112.09 95.81 5.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.384 -0.969 . . . . 1.18 108.384 158.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.622 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.8 t -83.32 110.14 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.818 -0.438 . . . . 1.51 109.818 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.7 m -108.52 107.36 17.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.784 0.326 . . . . 1.05 111.143 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.61 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 59.5 m-85 -87.38 113.75 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.331 -0.395 . . . . 0.42 110.264 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -96.21 115.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.176 -0.465 . . . . 1.26 110.298 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.67 143.73 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 1.13 111.203 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -138.73 103.54 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.03 110.625 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.5 16.58 55.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.99 -0.55 . . . . 1.97 113.864 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 62.69 15.08 7.76 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.182 0.438 . . . . 5.46 112.182 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -134.76 -18.78 1.86 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.01 0.433 . . . . 3.88 110.793 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.725 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.0 ttpm? -122.3 158.02 30.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.074 -0.713 . . . . 2.94 109.074 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.3 m -154.13 122.78 6.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.972 0.415 . . . . 1.2 111.227 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -98.29 108.17 20.8 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.673 -0.694 . . . . 3.1 109.278 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 9' ' ' SER . 14.4 p -83.41 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.976 -0.69 . . . . 1.13 109.334 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -125.65 107.99 11.11 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.675 -0.861 . . . . 1.38 108.675 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 13.0 t -103.61 123.3 57.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.394 -0.821 . . . . 1.58 112.376 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -92.91 111.22 22.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.069 -0.968 . . . . 2.31 108.824 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.682 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 23.6 t-160 -125.32 97.17 5.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.754 -1.202 . . . . 2.32 107.754 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.521 ' HG1' ' C ' ' A' ' 115' ' ' HIS . 28.1 m -153.64 108.31 3.11 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.7 -0.8 . . . . 3.19 112.584 -175.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -174.8 -63.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.456 -0.793 . . . . 2.99 109.647 165.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.581 ' HE2' HG23 ' A' ' 129' ' ' VAL . 77.4 t80 -76.94 -28.13 55.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.743 -0.662 . . . . 4.27 109.784 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -46.8 87.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.164 -0.926 . . . . 1.81 110.01 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 72.9 ttt180 -57.72 -21.3 39.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.676 -1.147 . . . . 3.84 112.094 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.38 -17.7 62.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.173 0.511 . . . . 2.9 110.606 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.03 -118.15 6.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.18 0.832 . . . . 2.26 115.18 165.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 m -37.93 -88.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.973 1.472 . . . . 3.02 114.973 -160.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -77.33 -34.35 55.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.16 0.429 . . . . 4.23 112.16 -168.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 29.6 m170 -66.08 -52.13 51.69 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.864 0.364 . . . . 2.7 110.9 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -67.02 -37.45 84.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 1.46 110.395 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -61.02 -49.76 76.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.655 0.243 . . . . 3.16 111.655 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.14 -29.24 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 2.97 111.186 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.581 HG23 ' HE2' ' A' ' 118' ' ' PHE . 15.7 t -75.51 -41.1 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.404 0.621 . . . . 1.96 110.535 172.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 1.045 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 39.5 ttp180 -63.16 -15.41 56.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.139 -0.937 . . . . 4.34 111.533 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -50.08 -47.02 53.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.354 -0.385 . . . . 2.8 111.433 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.21 -12.9 22.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.435 -0.888 . . . . 2.08 111.952 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.601 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 26.1 ttt -81.23 -35.3 31.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.721 0.267 . . . . 5.19 111.721 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 1.045 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 38.7 t70 -63.86 -37.29 86.84 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.833 0.679 . . . . 2.83 112.833 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 36.0 tptt -106.66 22.19 16.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.932 0.873 . . . . 4.47 109.608 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.636 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.77 -71.36 0.55 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.344 -0.843 . . . . 1.04 111.798 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.434 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.7 t-105 -54.71 -54.1 53.06 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 113.041 0.756 . . . . 3.78 113.041 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 27.0 Cg_endo -61.49 -41.32 41.3 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.8 1.667 . . . . 0.77 112.199 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -63.28 -40.96 98.84 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.334 0.588 . . . . 1.37 109.962 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 136' ' ' GLY . 42.3 mt -58.18 -43.65 86.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 115.271 -0.877 . . . . 1.32 110.645 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.524 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 24.8 mt -60.06 -41.46 92.4 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.166 0.291 . . . . 1.33 111.2 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.192 -0.603 . . . . 1.54 111.121 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.708 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 13.8 m -75.96 -22.38 56.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 1.43 110.594 176.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 63.4 t80 -61.76 -54.87 36.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.528 -0.76 . . . . 1.05 109.336 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.44 -29.37 70.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.01 -0.541 . . . . 1.63 110.272 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.26 -54.23 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 1.46 111.891 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 147' ' ' LYS . 5.9 tmtt? -74.31 -35.01 63.66 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 120.243 -0.583 . . . . 2.23 110.188 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.668 HG23 HG13 ' A' ' 12' ' ' VAL . 18.7 mt -60.96 -34.88 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.135 0.493 . . . . 1.17 110.418 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 27.5 t70 -59.11 -34.95 72.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.85 109.924 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.622 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 30.5 mt-10 -69.62 -19.55 63.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.844 -0.616 . . . . 1.5 111.4 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.85 2.41 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.093 -0.503 . . . . 1.74 110.582 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.51 -70.72 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.193 -1.003 . . . . 1.32 113.897 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.62 -33.06 21.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.617 0.969 . . . . 2.42 113.617 -167.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.69 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 34.5 ttmt -69.51 166.71 18.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.963 -0.384 . . . . 2.04 109.963 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.69 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 C-N-CA 123.941 0.896 . . . . 4.65 111.244 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.958 HD21 ' HB ' ' A' ' 6' ' ' VAL . 19.9 p-10 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 110.276 -0.268 . . . . 2.1 110.276 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.532 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 84.3 m-85 83.31 -63.58 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.79 0.836 . . . . 4.04 111.044 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.768 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -54.83 -50.59 85.17 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.256 -0.429 . . . . 2.78 111.161 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 13.4 Cg_endo -92.58 -72.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.168 1.912 . . . . 1.83 111.77 169.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.674 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 39.5 p90 -153.59 153.61 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.348 -0.612 . . . . 3.98 109.348 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.958 ' HB ' HD21 ' A' ' 1' ' ' ASN . 0.9 OUTLIER -102.35 143.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.93 -1.137 . . . . 2.03 107.93 169.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.6 ttt180 -133.32 143.42 49.0 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.417 -0.513 . . . . 3.92 110.635 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.819 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.51 132.03 54.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.302 -0.999 . . . . 1.16 108.302 170.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.46 ' HB3' ' NH2' ' A' ' 110' ' ' ARG . 21.8 m -130.37 110.41 11.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.329 0.585 . . . . 1.72 109.753 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 2.5 t -134.53 131.12 54.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.153 -0.93 . . . . 1.89 111.588 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -105.65 116.12 31.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 1.15 109.142 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG21 ' HB ' ' A' ' 109' ' ' THR . 1.5 m -98.01 158.14 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.879 -0.601 . . . . 1.51 110.035 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.84 55.86 0.97 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.053 -0.521 . . . . 1.6 111.002 -174.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -167.17 26.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.968 -0.56 . . . . 1.11 111.837 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.0 t70 73.81 167.41 0.3 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.073 0.463 . . . . 0.91 111.797 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 48.4 ttp180 -71.04 -27.31 63.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.987 -0.552 . . . . 2.19 111.162 -173.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -58.19 -52.93 63.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.918 -0.583 . . . . 3.49 110.266 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 69.3 m -71.04 -34.95 71.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.85 -0.614 . . . . 1.49 111.24 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.52 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -57.07 -47.02 82.02 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 1.07 110.802 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 69.4 t80 -70.8 -43.49 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.43 110.615 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.653 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 22.8 tptp -51.92 -52.28 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 2.87 110.711 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.3 m -67.64 -52.23 40.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.54 -0.3 . . . . 1.21 110.868 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -59.21 -39.76 83.67 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.452 0.538 . . . . 0.53 112.452 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD22 ' CD2' ' A' ' 77' ' ' LEU . 27.4 tp -114.21 -47.38 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.158 -0.617 . . . . 1.23 112.205 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.653 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 29.4 mt-10 -88.67 17.4 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.765 0.317 . . . . 1.24 111.082 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.663 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -149.46 39.23 0.92 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.798 -0.715 . . . . 0.83 112.067 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.601 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 12.6 t80 -51.56 -48.48 86.61 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 122.019 0.128 . . . . 0.94 111.07 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 30.0 Cg_endo -88.74 24.19 0.7 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.15 1.9 . . . . 0.9 114.907 174.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.8 pt-20 -105.12 -12.2 16.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.866 0.757 . . . . 1.49 111.462 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.479 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 2.7 m0 -83.54 -164.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.031 -0.359 . . . . 5.66 110.031 -174.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.589 ' H ' ' HD3' ' A' ' 32' ' ' PRO . 12.5 p-90 -140.37 19.01 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 114.464 1.283 . . . . 3.41 114.464 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.629 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 54.9 Cg_endo -83.69 -112.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 CA-C-N 121.406 1.538 . . . . 1.36 113.001 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 63.0 t30 -79.41 -13.76 59.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.044 0.926 . . . . 1.51 109.727 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.625 ' HA ' HG22 ' A' ' 40' ' ' VAL . 7.8 m120 -90.17 30.91 1.04 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.627 -1.169 . . . . 1.98 110.251 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -97.34 2.16 50.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 5.13 110.9 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 21.5 mmt180 -114.0 152.07 31.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.294 0.569 . . . . 4.7 112.218 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -81.5 148.31 29.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.776 . . . . 3.11 109.714 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 57' ' ' ASP . 44.5 p 52.55 16.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.343 0.657 . . . . 1.89 111.715 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.67 ' HD3' HG23 ' A' ' 40' ' ' VAL . 1.2 tmtp? -142.44 80.4 1.7 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.658 -0.701 . . . . 3.45 109.263 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.67 HG23 ' HD3' ' A' ' 39' ' ' LYS . 19.1 m 49.33 16.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.148 1.379 . . . . 2.3 113.716 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.72 25.4 2.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.378 -0.915 . . . . 2.2 112.627 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.78 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -85.28 161.71 51.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.367 -0.605 . . . . 1.31 109.367 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 39.2 Cg_exo -43.83 -12.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.966 3.777 . . . . 1.94 116.982 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.926 ' HG ' ' HA ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -111.24 -94.54 0.44 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.574 -0.704 . . . . 2.23 111.125 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.601 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 91.88 -36.81 3.53 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.78 -0.724 . . . . 0.94 112.976 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 24' ' ' LEU . 81.9 t -140.1 140.65 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.846 0.355 . . . . 1.21 111.168 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.65 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 11.0 t70 -109.88 113.2 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.327 -0.99 . . . . 1.11 108.327 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 16.8 ttmt -79.6 -23.24 42.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.822 -0.626 . . . . 3.25 112.286 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -90.08 -36.48 14.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.747 0.308 . . . . 3.63 111.293 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.83 -20.21 31.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.907 -0.663 . . . . 1.9 112.313 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 79.51 56.77 3.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.746 -0.74 . . . . 0.87 111.811 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -133.78 160.92 36.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.785 0.326 . . . . 4.26 111.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.746 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 15.6 m0 -117.31 108.66 15.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.234 -0.654 . . . . 1.52 109.234 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.65 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 11.0 p90 -162.39 146.22 11.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 2.04 110.862 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.926 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -114.3 175.21 5.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.841 -0.618 . . . . 2.12 109.356 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.913 HG12 HD22 ' A' ' 44' ' ' LEU . 20.6 mm -76.07 111.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.645 -0.502 . . . . 1.42 109.645 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.494 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 39.8 t0 -95.64 157.22 15.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 1.97 109.927 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.84 -28.07 62.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.398 0.888 . . . . 2.43 113.398 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.47 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -85.76 9.69 15.77 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.879 -0.728 . . . . 2.39 111.385 -176.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.75 47.68 0.19 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.079 -1.058 . . . . 2.29 113.532 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.71 ' HG2' HG21 ' A' ' 56' ' ' ILE . 27.7 mt-10 54.36 36.88 26.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.396 0.617 . . . . 2.31 111.278 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -120.08 85.35 2.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 2.61 110.462 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -109.79 164.1 12.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.774 -0.648 . . . . 4.63 110.242 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.8 p -57.48 112.29 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.359 -0.382 . . . . 2.27 110.694 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -79.47 102.39 8.75 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.796 0.295 . . . . 7.39 111.796 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.746 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -55.89 137.51 46.31 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.509 -1.036 . . . . 1.23 110.509 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.59 97.71 7.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.379 0.59 . . . . 1.76 111.773 -168.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.522 HG21 ' CG2' ' A' ' 71' ' ' VAL . 46.1 mt -84.08 133.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.835 -0.432 . . . . 1.26 109.835 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -96.11 -33.27 12.14 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.846 -0.428 . . . . 2.65 109.846 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.5 ttpp -155.04 130.11 9.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.303 -0.408 . . . . 2.03 111.745 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.522 ' CG2' HG21 ' A' ' 68' ' ' ILE . 97.6 t -114.6 100.54 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.785 -0.82 . . . . 1.47 108.785 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.0 m-20 -98.15 59.35 1.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 119.489 -0.291 . . . . 1.42 111.173 -173.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.0 pt-20 44.25 -165.19 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 O-C-N 124.252 0.97 . . . . 0.96 111.635 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.9 Cg_exo -61.59 85.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.067 1.178 . . . . 0.48 111.385 165.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.692 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 26.5 t70 -173.16 -65.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.5 110.561 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -145.53 158.97 43.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.919 0.39 . . . . 1.1 111.809 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' CD2' HD22 ' A' ' 24' ' ' LEU . 4.2 mp -145.99 130.56 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 1.4 109.913 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.95 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.26 -0.427 . . . . 1.31 109.909 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.49 144.53 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.526 -0.306 . . . . 1.48 111.215 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -105.46 155.4 16.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.5 112.597 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 75.6 t-105 -78.55 137.44 37.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.5 0.556 . . . . 3.37 112.5 -169.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -148.07 40.59 0.97 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.482 -0.781 . . . . 6.17 109.285 176.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 85.65 166.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.859 1.059 . . . . 2.13 113.859 171.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.462 ' H ' HD13 ' A' ' 83' ' ' LEU . 36.4 t30 -158.1 -37.29 0.07 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 113.925 -1.489 . . . . 1.93 108.475 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.27 10.25 50.16 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.401 -0.818 . . . . 2.79 112.516 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.5 t80 74.4 -74.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.396 0.679 . . . . 6.08 112.008 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.14 71.56 2.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.879 -0.677 . . . . 2.43 113.508 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.901 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 15.6 ttp180 -146.15 179.01 7.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.025 -0.361 . . . . 5.53 110.025 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.901 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -82.23 126.95 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.063 -0.717 . . . . 2.42 109.063 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 30.0 p-10 -96.81 129.1 33.55 Favored Pre-proline 0 C--N 1.317 -0.816 0 O-C-N 121.672 -0.643 . . . . 3.18 110.098 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 93' ' ' ASN . 23.4 Cg_exo -63.37 -40.01 34.11 Favored 'Trans proline' 0 CA--C 1.519 -0.246 0 C-N-CA 122.926 2.417 . . . . 2.76 113.069 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 68.2 -30.88 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.759 0.652 . . . . 2.99 112.759 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.481 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.8 OUTLIER -74.64 -60.15 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.355 0.598 . . . . 3.06 110.365 -173.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 p -155.23 -90.57 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.568 -0.742 . . . . 2.11 111.293 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 49.5 m 54.11 36.72 25.45 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 108.52 -0.919 . . . . 1.81 108.52 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.504 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.6 tt0 -71.7 141.75 49.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.445 -1.707 . . . . 1.81 111.423 -172.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.541 ' HB2' HG13 ' A' ' 113' ' ' VAL . 6.7 p90 -139.07 134.63 33.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.624 -0.716 . . . . 0.81 110.199 174.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -98.87 117.14 32.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.504 -0.771 . . . . 1.18 110.273 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.525 HG12 HG22 ' A' ' 111' ' ' VAL . 85.4 t -82.91 110.63 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 1.51 109.853 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.678 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 8.5 m -99.63 105.62 17.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.286 0.366 . . . . 1.05 111.426 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.533 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.4 m-85 -96.46 114.17 25.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.42 110.976 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.3 110.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.327 -0.62 . . . . 1.26 109.327 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.09 134.72 41.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 1.13 111.523 -175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 38.2 t70 -120.89 123.16 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.101 -0.954 . . . . 2.03 108.944 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.96 -10.88 28.54 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.929 -0.578 . . . . 1.97 113.64 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.43 49.8 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.942 0.401 . . . . 5.46 110.464 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 60.43 31.84 20.43 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.73 -0.668 . . . . 3.88 111.308 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 3.8 ttmp? -132.6 155.71 48.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.32 -0.4 . . . . 2.94 110.448 -173.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.536 ' HB ' HG21 ' A' ' 12' ' ' VAL . 22.5 m -158.29 125.43 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 1.2 110.768 173.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.46 ' NH2' ' HB3' ' A' ' 9' ' ' SER . 20.4 tpt180 -101.0 126.65 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.432 -0.803 . . . . 3.1 109.556 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 100' ' ' THR . 9.5 p -114.58 136.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.006 0.432 . . . . 1.13 111.063 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.585 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 3.2 p-10 -126.73 120.24 28.89 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.81 0.814 . . . . 1.38 109.381 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.819 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 1.6 t -90.97 120.24 39.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.958 -1.019 . . . . 1.58 110.084 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -96.36 111.3 23.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.808 0.693 . . . . 2.31 109.212 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.946 ' HB3' HG22 ' A' ' 6' ' ' VAL . 51.8 t-80 -125.27 98.93 5.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.38 -0.827 . . . . 2.32 108.769 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.674 ' HB ' ' CB ' ' A' ' 5' ' ' PHE . 5.4 t -151.36 88.1 1.42 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.89 0.852 . . . . 3.19 109.621 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -157.47 -76.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 2.99 110.253 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.591 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 6.4 t80 -73.2 -38.58 66.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.799 -0.815 . . . . 4.27 108.799 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.557 ' OD1' HG11 ' A' ' 6' ' ' VAL . 17.1 p-10 -73.81 -47.59 37.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.413 -0.812 . . . . 1.81 111.353 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.611 ' HD3' ' OG1' ' A' ' 116' ' ' THR . 52.4 ttp180 -56.28 -21.45 23.93 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.35 -0.386 . . . . 3.84 111.634 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 33.9 tpp -72.38 -3.48 24.29 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.95 0.405 . . . . 2.9 110.371 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.3 -164.49 24.31 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 115.036 0.774 . . . . 2.26 115.036 167.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.0 p 39.9 -116.22 0.23 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.394 1.077 . . . . 3.02 113.016 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.14 -25.13 64.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 4.23 111.184 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.591 ' HB3' ' O ' ' A' ' 118' ' ' PHE . 41.9 m-70 -68.53 -53.93 19.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.037 0.446 . . . . 2.7 110.624 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.94 -26.15 63.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 1.46 109.999 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.616 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 87.4 tttt -62.57 -46.44 88.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.102 -0.954 . . . . 3.16 111.388 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 1.6 ptm180 -78.4 -28.6 46.93 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.827 -0.349 . . . . 2.97 111.587 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 125' ' ' HIS . 88.9 t -72.81 -30.91 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.22 0.452 . . . . 1.96 112.22 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 127' ' ' LYS . 31.8 ptt180 -59.58 -30.01 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.809 0.337 . . . . 4.34 111.631 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.736 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.0 m-20 -65.15 -21.17 66.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.434 0.531 . . . . 2.8 112.434 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.495 ' HA3' HH11 ' A' ' 88' ' ' ARG . . . -96.99 -72.08 1.09 Allowed Glycine 0 C--O 1.226 -0.351 0 C-N-CA 119.975 -1.107 . . . . 2.08 114.8 -164.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.669 ' HB2' ' HB2' ' A' ' 137' ' ' TRP . 26.5 ptt? -80.93 -9.59 59.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.441 0.534 . . . . 5.19 112.441 -170.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.58 -49.84 69.44 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.405 0.52 . . . . 2.83 112.405 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -96.96 22.86 7.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.948 0.351 . . . . 4.47 111.948 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.584 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -139.76 -56.26 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.73 -1.224 . . . . 1.04 113.101 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 65.2 t-105 -55.24 -53.31 63.19 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.549 0.574 . . . . 3.78 112.549 -170.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.6 Cg_endo -59.41 -40.64 65.43 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.81 1.674 . . . . 0.77 112.337 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 m -69.21 -38.28 78.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.515 0.674 . . . . 1.37 110.258 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.629 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 29.1 mt -59.58 -42.02 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.218 -0.901 . . . . 1.32 110.817 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 76.6 mt -62.76 -26.95 68.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.904 0.335 . . . . 1.33 111.904 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.18 -54.64 7.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.371 -0.233 . . . . 1.54 110.371 176.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -27.5 68.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 1.43 110.595 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' O ' HG13 ' A' ' 148' ' ' ILE . 47.2 t80 -62.17 -55.06 32.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.45 -0.795 . . . . 1.05 110.485 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.411 ' CG ' HG12 ' A' ' 10' ' ' VAL . 39.0 mt-30 -62.9 -34.61 77.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.32 0.581 . . . . 1.63 110.816 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.483 ' HB3' ' HE1' ' A' ' 31' ' ' TRP . 13.4 t70 -66.12 -44.99 82.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.873 -1.058 . . . . 1.46 110.402 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -69.19 -31.54 70.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.711 -0.677 . . . . 2.23 110.698 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.463 HG21 ' HB ' ' A' ' 12' ' ' VAL . 53.2 mt -71.43 -36.37 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 1.17 110.446 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.451 ' HB3' ' HE3' ' A' ' 154' ' ' LYS . 17.8 t0 -66.11 -28.97 69.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.504 . . . . 0.85 109.675 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.778 ' HB3' ' HZ2' ' A' ' 155' ' ' LYS . 55.7 mt-10 -60.74 -28.56 68.79 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.572 0.701 . . . . 1.5 110.334 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.51 -3.24 58.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.239 -0.891 . . . . 1.74 110.383 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.72 -70.4 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.525 -0.845 . . . . 1.32 113.67 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.28 -46.65 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.066 0.433 . . . . 2.42 111.407 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttpp -81.72 171.15 14.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.356 -0.384 . . . . 2.04 110.013 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.778 ' HZ2' ' HB3' ' A' ' 150' ' ' GLU . 18.1 tppt? . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.352 -0.981 . . . . 4.65 108.352 167.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.507 ' O ' HG21 ' A' ' 6' ' ' VAL . 18.0 p-10 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.65 0.262 . . . . 2.1 110.509 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 24.6 p90 172.14 -35.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.837 0.855 . . . . 4.04 109.108 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.746 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.9 t70 -73.64 -55.35 3.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.523 -0.308 . . . . 2.78 111.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 52.8 Cg_endo -84.31 -68.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.512 1.474 . . . . 1.83 111.94 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.05 142.78 26.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.169 -0.469 . . . . 3.98 110.073 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 76.5 t -98.29 112.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.866 -0.791 . . . . 2.03 108.866 167.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 45.4 ttm-85 -123.62 135.54 54.0 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.537 -0.465 . . . . 3.92 110.97 -177.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.739 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.66 134.38 52.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.829 -0.804 . . . . 1.16 108.829 174.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 22.4 m -143.24 112.23 6.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.154 -0.475 . . . . 1.72 110.455 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.995 HG22 HG11 ' A' ' 111' ' ' VAL . 2.2 m -126.66 140.42 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.125 -0.489 . . . . 1.89 109.77 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -102.48 114.42 28.61 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.512 -0.921 . . . . 1.15 108.512 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.504 HG12 ' HB ' ' A' ' 109' ' ' THR . 0.3 OUTLIER -103.3 162.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.254 -0.43 . . . . 1.51 110.445 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.92 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 9.5 pttt -125.92 35.93 4.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.753 -0.658 . . . . 1.6 112.013 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.27 29.19 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.215 0.45 . . . . 1.11 112.215 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 20.6 t70 75.84 163.37 0.25 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.857 0.837 . . . . 0.91 112.22 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.864 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 40.1 ttp180 -64.68 -27.88 69.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.717 -1.129 . . . . 2.19 110.96 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.675 ' HZ1' ' HB2' ' A' ' 17' ' ' LYS . 4.3 ttmp? -57.67 -48.55 79.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 3.49 110.825 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -77.46 -36.32 52.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 1.49 111.023 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' A' ' 148' ' ' ILE . . . -59.81 -39.59 85.54 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.79 -0.364 . . . . 1.07 110.405 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CG ' ' HA ' ' A' ' 74' ' ' PRO . 55.6 t80 -71.05 -49.97 39.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.43 110.77 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -54.18 -53.0 59.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.083 0.468 . . . . 2.87 110.982 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.428 HG21 ' NE1' ' A' ' 30' ' ' TRP . 14.2 m -63.83 -45.31 90.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.359 -0.837 . . . . 1.21 110.56 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.701 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.3 t80 -63.95 -37.49 87.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.945 0.35 . . . . 0.53 111.945 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.911 HD12 HG13 ' A' ' 46' ' ' VAL . 17.1 tp -99.49 -59.65 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.179 -0.608 . . . . 1.23 112.485 -174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -88.72 -19.47 26.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.149 0.5 . . . . 1.24 111.547 -173.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -89.77 18.48 46.81 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.645 -0.788 . . . . 0.83 111.17 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.51 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 10.9 t80 -50.39 -51.78 60.85 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.151 0.58 . . . . 0.94 112.256 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.526 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 42.0 Cg_endo -86.13 8.01 4.71 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.298 1.999 . . . . 0.9 115.525 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.7 pt-20 -111.07 -2.36 15.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.851 -0.739 . . . . 1.49 111.999 -175.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.806 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 43.1 m0 -67.64 155.73 38.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.329 0.585 . . . . 5.66 111.111 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.53 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 68.0 m95 -75.1 -43.79 4.61 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.389 -0.823 . . . . 3.41 112.906 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.806 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 29.1 Cg_endo -60.46 -87.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.63 2.22 . . . . 1.36 115.199 -162.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.526 ' ND2' HG12 ' A' ' 40' ' ' VAL . 6.1 t30 -110.98 -17.85 13.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.516 0.674 . . . . 1.51 110.451 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.621 ' HA ' HG13 ' A' ' 40' ' ' VAL . 2.9 m-20 -100.89 27.63 5.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.474 -0.784 . . . . 1.98 112.037 -168.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -104.4 13.31 32.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.687 0.756 . . . . 5.13 109.44 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -104.74 128.26 52.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.718 -0.674 . . . . 4.7 111.066 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -75.61 137.45 40.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 3.11 111.151 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.533 HG22 ' HA ' ' A' ' 57' ' ' ASP . 79.8 p 57.09 11.53 1.04 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.61 1.164 . . . . 1.89 112.956 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 83.0 tttt -100.03 -48.81 4.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.477 -0.934 . . . . 3.45 108.477 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.709 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 12.4 p -174.35 -2.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.418 -1.265 . . . . 2.3 109.984 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.59 47.09 1.04 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.623 -0.799 . . . . 2.2 112.638 -177.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 1.002 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -79.91 158.46 72.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.013 -1.106 . . . . 1.31 108.013 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.69 44.85 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 123.803 3.002 . . . . 1.94 114.786 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -149.51 -84.36 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.723 -0.473 . . . . 2.23 109.723 173.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.23 -52.95 3.17 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.926 -0.654 . . . . 0.94 112.781 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.911 HG13 HD12 ' A' ' 24' ' ' LEU . 58.9 t -140.33 138.42 36.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.003 0.43 . . . . 1.21 111.607 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.614 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 22.3 t70 -100.42 107.27 18.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.841 -0.8 . . . . 1.11 108.841 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -9.83 59.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.19 -0.914 . . . . 3.25 111.203 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -75.39 -62.41 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.035 -0.53 . . . . 3.63 110.702 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.45 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -92.59 -39.49 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.562 -0.828 . . . . 1.9 111.662 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 72.46 0.62 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.654 -0.784 . . . . 0.87 112.805 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -154.39 144.33 21.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 4.26 111.172 175.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.597 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 22.7 m0 -96.2 110.98 23.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 1.52 110.515 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.614 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.8 p90 -153.91 152.91 31.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 2.04 110.399 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 1.002 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 6.4 mp0 -119.98 150.71 40.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.115 -0.698 . . . . 2.12 109.115 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD11 ' HG2' ' A' ' 61' ' ' GLU . 45.0 mm -77.0 103.37 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.999 0.428 . . . . 1.42 109.892 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.767 ' HB3' HE22 ' A' ' 59' ' ' GLN . 8.1 t70 -92.84 148.13 22.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.133 -0.692 . . . . 1.97 109.133 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.88 -10.09 59.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.462 0.912 . . . . 2.43 113.462 -166.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.767 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -93.18 10.25 32.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.648 -0.821 . . . . 2.39 110.712 177.166 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.49 50.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.39 -0.91 . . . . 2.29 113.921 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.469 ' HG2' HD11 ' A' ' 56' ' ' ILE . 39.2 mt-10 58.1 24.67 11.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.175 0.435 . . . . 2.31 112.175 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.86 78.05 6.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.499 0.666 . . . . 2.61 110.143 -173.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -123.22 162.74 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.292 -0.867 . . . . 4.63 109.68 176.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.553 ' C ' ' HD2' ' A' ' 82' ' ' ARG . 4.9 p -62.97 148.59 47.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.4 -0.593 . . . . 2.27 109.4 172.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 44.4 p90 -120.4 120.87 37.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.396 -0.522 . . . . 7.39 111.666 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.34 148.17 46.87 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.681 -0.968 . . . . 1.23 110.681 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.527 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -106.0 96.48 6.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.263 0.532 . . . . 1.76 111.26 -171.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.538 HG21 ' CG2' ' A' ' 71' ' ' VAL . 53.8 mt -77.08 125.29 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.271 0.558 . . . . 1.26 109.939 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -96.2 -21.37 17.93 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.399 -0.818 . . . . 2.65 109.786 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -164.64 125.0 2.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.224 -0.443 . . . . 2.03 111.889 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.538 ' CG2' HG21 ' A' ' 68' ' ' ILE . 62.6 t -109.36 107.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.725 -0.843 . . . . 1.47 108.725 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.44 75.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.649 -0.42 . . . . 1.42 111.211 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 10.3 pt-20 47.67 -170.92 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 124.766 1.291 . . . . 0.96 111.961 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.516 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 35.9 Cg_exo -63.48 81.32 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.373 1.382 . . . . 0.48 111.122 166.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.864 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 14.9 t70 -166.69 -68.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.405 -0.816 . . . . 0.5 110.984 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.542 HG21 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -138.67 140.3 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.783 0.66 . . . . 1.1 112.783 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -135.47 116.41 14.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.48 -0.782 . . . . 1.4 108.977 175.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.617 HG21 HG21 ' A' ' 98' ' ' THR . 29.9 t -95.26 111.78 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.687 -0.857 . . . . 1.31 108.687 175.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.21 126.42 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.75 0.31 . . . . 1.48 111.185 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 1.001 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -84.88 146.25 22.06 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.006 -0.837 . . . . 0.5 111.006 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.849 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 68.8 t-105 -73.63 160.18 31.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.585 0.707 . . . . 3.37 112.34 -168.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.553 ' HD2' ' C ' ' A' ' 64' ' ' THR . 19.3 ttp180 -135.52 -72.56 0.46 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.409 -1.269 . . . . 6.17 109.722 -172.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 90' ' ' ASP . 2.5 tm? 170.46 145.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.343 -0.844 . . . . 2.13 109.539 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.67 ' N ' HD13 ' A' ' 83' ' ' LEU . 54.0 t30 -142.6 146.89 35.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.35 -0.611 . . . . 1.93 109.35 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.65 -15.56 31.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.831 -0.699 . . . . 2.79 112.024 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.602 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 71.3 t80 70.39 -63.29 0.41 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.64 0.776 . . . . 6.08 111.207 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.59 44.65 3.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.224 -0.512 . . . . 2.43 112.037 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.69 ' NH1' ' HA ' ' A' ' 129' ' ' VAL . 2.4 tmm_? -133.86 144.24 48.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.033 -0.729 . . . . 5.53 109.033 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.521 ' C ' HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -96.58 131.92 42.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.028 0.442 . . . . 2.42 111.292 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.736 ' HB2' HD23 ' A' ' 83' ' ' LEU . 5.2 t70 -143.66 137.15 14.16 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.482 -0.933 . . . . 3.18 108.482 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.562 ' HG2' ' CZ ' ' A' ' 118' ' ' PHE . 32.0 Cg_exo -58.72 -25.58 76.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.562 2.175 . . . . 2.76 112.72 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.4 t70 56.51 75.29 0.36 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.358 0.599 . . . . 2.99 110.155 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.32 -75.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 3.06 110.767 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.7 m -113.5 -97.93 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.969 -0.56 . . . . 2.11 110.384 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.849 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 13.5 m 50.64 37.77 17.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.938 -0.574 . . . . 1.81 112.086 175.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 1.001 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 27.9 mt-10 -62.65 143.16 57.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.38 -0.373 . . . . 1.81 111.379 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.766 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -136.46 127.66 28.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.939 -0.573 . . . . 0.81 110.749 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.617 HG21 HG21 ' A' ' 78' ' ' VAL . 27.7 m -91.1 115.1 27.75 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.529 -0.759 . . . . 1.18 110.696 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.515 ' HA ' HG23 ' A' ' 113' ' ' VAL . 58.0 t -86.33 109.92 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.872 -0.418 . . . . 1.51 109.872 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.542 ' HA ' HG21 ' A' ' 76' ' ' THR . 26.3 m -107.88 106.52 16.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.424 -0.353 . . . . 1.05 110.761 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.737 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 52.8 m-85 -88.35 117.72 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.556 -0.293 . . . . 0.42 110.346 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.98 112.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.236 -0.283 . . . . 1.26 110.236 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.33 51.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.887 -0.597 . . . . 1.13 111.593 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.8 t70 -137.38 120.31 16.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.595 . . . . 2.03 109.535 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.27 58.64 1.13 Allowed Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.994 -0.548 . . . . 1.97 113.118 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 21.0 tt0 -150.98 13.57 0.7 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.994 . . . . 5.46 108.315 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 59.8 mttp 67.09 33.7 5.49 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.175 -0.92 . . . . 3.88 109.384 -167.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 7.3 ttpm? -121.65 154.43 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.407 -0.59 . . . . 2.94 109.407 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' HG12 ' A' ' 12' ' ' VAL . 18.7 m -161.14 128.63 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.757 0.313 . . . . 1.2 110.728 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.34 114.95 28.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.036 -0.727 . . . . 3.1 109.036 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.995 HG11 HG22 ' A' ' 10' ' ' VAL . 12.7 p -93.2 144.67 8.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 120.994 -0.283 . . . . 1.13 111.199 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.457 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 7.3 t70 -130.26 126.78 38.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.222 -0.899 . . . . 1.38 109.51 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.739 ' HB ' ' CD2' ' A' ' 8' ' ' HIS . 1.2 t -111.44 133.22 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 116.662 -0.245 . . . . 1.58 110.809 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 49.8 mt-10 -104.31 110.73 23.08 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.907 0.754 . . . . 2.31 109.921 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 79.0 t60 -123.38 99.06 6.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.214 -1.032 . . . . 2.32 108.214 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -153.07 91.26 1.51 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.116 0.484 . . . . 3.19 110.129 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -155.6 -75.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.904 -0.589 . . . . 2.99 110.142 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.562 ' CZ ' ' HG2' ' A' ' 91' ' ' PRO . 37.1 t80 -82.31 -25.76 33.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.654 -0.703 . . . . 4.27 110.906 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.87 -43.63 53.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.684 -0.689 . . . . 1.81 110.991 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 71.0 ttt180 -53.72 -21.3 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.368 -0.833 . . . . 3.84 112.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 79.1 mmm -78.64 2.14 20.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.428 -0.351 . . . . 2.9 111.113 -177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.31 -144.38 6.71 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.744 -0.662 . . . . 2.26 114.342 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 47.48 -132.61 1.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.302 0.641 . . . . 3.02 110.85 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -77.59 -13.91 59.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.471 -0.143 . . . . 4.23 111.371 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.479 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.8 m170 -72.72 -52.94 13.11 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.472 -0.566 . . . . 2.7 109.472 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.0 70.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.767 -0.651 . . . . 1.46 111.026 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -64.33 -39.47 93.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.478 -0.328 . . . . 3.16 111.098 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 3.1 ptm180 -73.28 -32.9 64.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 2.97 110.336 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.69 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 89.5 t -65.06 -40.49 89.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.385 0.612 . . . . 1.96 110.266 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.478 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 8.5 ttp180 -65.66 -17.25 64.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 4.34 111.904 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.546 ' HB3' ' HG2' ' A' ' 88' ' ' ARG . 65.9 t30 -52.99 -46.47 68.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.727 0.298 . . . . 2.8 111.629 -173.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.476 ' N ' ' HG3' ' A' ' 88' ' ' ARG . . . -120.01 -20.07 3.83 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.145 -1.026 . . . . 2.08 113.031 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 49.6 ttm -79.74 -22.96 42.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.577 -0.366 . . . . 5.19 111.165 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 10.3 t70 -55.65 -49.15 73.66 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.851 0.685 . . . . 2.83 112.851 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -100.42 -39.85 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.984 -0.286 . . . . 4.47 111.335 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -59.41 -59.59 10.36 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 116.46 -0.336 . . . . 1.04 113.324 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.529 ' HH2' HG12 ' A' ' 113' ' ' VAL . 3.4 t90 -59.36 -49.99 89.68 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.63 0.604 . . . . 3.78 112.63 -172.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 28.6 Cg_endo -62.13 -35.54 74.82 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.002 1.801 . . . . 0.77 112.385 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -68.55 -37.04 79.6 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.248 -0.649 . . . . 1.37 109.248 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.672 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 57.8 mt -55.59 -49.35 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.933 -1.031 . . . . 1.32 110.244 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 60.4 mt -58.79 -33.8 70.75 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.363 0.414 . . . . 1.33 112.063 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.51 -57.0 7.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 1.54 110.417 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.626 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 70.1 m -65.89 -23.18 66.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.941 -0.572 . . . . 1.43 110.532 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.448 ' CZ ' HD12 ' A' ' 148' ' ' ILE . 64.7 t80 -63.85 -53.0 57.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 1.05 110.101 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 76.1 mt-30 -58.58 -33.57 70.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.233 0.54 . . . . 1.63 110.34 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.36 -42.15 45.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.46 111.33 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.5 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 10.0 tptt -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.225 0.536 . . . . 2.23 110.442 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 19' ' ' ALA . 66.2 mt -68.49 -30.31 47.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.821 -0.627 . . . . 1.17 110.537 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.92 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 28.1 t0 -61.08 -30.96 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.85 109.898 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.776 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 43.8 mt-10 -65.99 -29.98 70.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 1.5 110.392 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -85.13 -5.14 59.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.419 -0.809 . . . . 1.74 110.173 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.8 -71.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.943 -0.646 . . . . 1.32 113.488 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.64 24.76 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.467 0.543 . . . . 2.42 112.467 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.776 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 14.9 tppt? -62.14 -74.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.431 0.158 . . . . 2.04 110.777 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.745 ' HZ3' ' HB2' ' A' ' 155' ' ' LYS . 6.8 mtmp? . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.322 -0.847 . . . . 4.65 110.392 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 6' ' ' VAL . 31.8 p-10 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 121.028 0.442 . . . . 2.1 110.78 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.411 ' HA ' HG23 ' A' ' 6' ' ' VAL . 92.1 m-85 -162.01 -41.71 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.44 1.096 . . . . 4.04 108.391 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.743 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 20.0 t70 -61.03 -54.73 51.3 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.171 -0.922 . . . . 2.78 112.312 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.2 Cg_endo -91.69 -63.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 1.83 112.493 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.48 ' HA ' HG23 ' A' ' 116' ' ' THR . 30.9 p90 -152.4 142.86 22.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.082 -0.508 . . . . 3.98 109.856 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.671 ' HB ' ' CE1' ' A' ' 115' ' ' HIS . 16.7 t -103.81 108.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.722 -0.473 . . . . 2.03 109.722 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 25.7 ttm180 -109.38 132.92 53.67 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.844 -0.616 . . . . 3.92 111.502 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CD2' HG11 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.21 135.6 50.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.999 -0.741 . . . . 1.16 108.999 173.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.753 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 5.5 p -141.18 112.72 7.55 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.144 0.497 . . . . 1.72 111.488 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.637 HG23 ' CG1' ' A' ' 111' ' ' VAL . 16.1 m -122.93 152.44 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.978 -0.555 . . . . 1.89 111.317 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -102.18 116.04 31.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.509 -0.769 . . . . 1.15 110.152 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.7 HG23 ' HB3' ' A' ' 19' ' ' ALA . 38.4 t -91.37 132.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.019 -0.991 . . . . 1.51 109.974 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.661 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -101.45 23.25 11.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.978 -0.555 . . . . 1.6 112.139 -171.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.478 ' H ' HG13 ' A' ' 12' ' ' VAL . . . -155.35 37.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.244 0.461 . . . . 1.11 112.244 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 22.6 t70 75.39 159.6 0.22 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 122.04 0.924 . . . . 0.91 112.544 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 32.5 ttp180 -63.04 -25.49 68.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.637 -1.165 . . . . 2.19 111.618 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.92 -48.48 79.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.587 -0.279 . . . . 3.49 110.272 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.2 p -74.08 -36.4 64.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.952 -0.299 . . . . 1.49 111.201 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.7 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -59.23 -45.48 91.03 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.414 -0.514 . . . . 1.07 110.574 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CE1' HD23 ' A' ' 77' ' ' LEU . 76.1 t80 -71.49 -44.27 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.363 -0.38 . . . . 0.43 110.616 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -54.97 -54.27 45.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.132 0.491 . . . . 2.87 110.75 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.44 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.0 m -63.79 -48.54 76.48 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.078 -0.964 . . . . 1.21 110.24 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.714 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 61.5 t80 -59.72 -37.78 79.85 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.647 0.592 . . . . 0.53 112.223 -173.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' HG ' HG13 ' A' ' 46' ' ' VAL . 11.0 tp -112.78 -51.39 2.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.818 0.673 . . . . 1.23 112.818 -173.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.96 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 11.8 mt-10 -82.08 -38.62 24.61 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.799 -0.563 . . . . 1.24 111.988 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.628 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.07 40.53 2.81 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.876 -0.602 . . . . 0.83 112.193 -176.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.596 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 55.0 t80 -61.54 -58.2 20.02 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 112.043 0.386 . . . . 0.94 112.043 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 80.7 Cg_endo -80.11 29.26 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.533 2.155 . . . . 0.9 114.388 -174.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.3 pt-20 -125.46 2.13 7.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.543 -0.463 . . . . 1.49 110.986 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.768 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 24.9 m0 -75.62 157.87 33.18 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.048 0.451 . . . . 5.66 109.908 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.631 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 12.6 m95 -87.4 -34.93 0.45 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.17 0.804 . . . . 3.41 113.17 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.768 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 14.0 Cg_endo -54.43 -86.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.802 2.335 . . . . 1.36 115.295 -165.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.653 HD21 HG13 ' A' ' 40' ' ' VAL . 2.0 t30 -111.23 -34.72 6.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.479 0.657 . . . . 1.51 110.465 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.743 ' HA ' HG11 ' A' ' 40' ' ' VAL . 9.5 p-10 -91.51 33.62 1.0 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.061 -0.972 . . . . 1.98 111.823 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -96.34 -2.14 46.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.794 0.807 . . . . 5.13 109.115 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 8.2 mmt180 -99.34 126.0 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.198 -0.91 . . . . 4.7 110.65 -176.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 p -76.58 135.59 39.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.117 -0.492 . . . . 3.11 110.821 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' 57' ' ' ASP . 61.1 p 57.74 20.08 6.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.38 1.072 . . . . 1.89 111.727 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -111.56 -46.8 3.23 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.771 -1.196 . . . . 3.45 107.771 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 34' ' ' ASN . 14.3 p -174.52 26.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.711 -1.131 . . . . 2.3 109.02 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.97 36.33 0.28 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.641 -0.79 . . . . 2.2 112.93 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.962 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -66.12 164.49 28.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.531 -0.544 . . . . 1.31 109.531 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 56.96 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.352 2.701 . . . . 1.94 114.202 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.18 -83.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.173 0.589 . . . . 2.23 109.495 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.578 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 89.59 -55.68 3.82 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.86 -0.686 . . . . 0.94 113.592 170.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 24' ' ' LEU . 91.3 t -138.73 142.09 35.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.001 0.429 . . . . 1.21 111.693 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.514 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.6 t70 -110.67 110.08 20.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 1.11 108.97 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 3.2 mptt -80.93 -29.55 35.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 3.25 111.872 -172.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -74.68 -42.43 58.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.031 0.382 . . . . 3.63 112.031 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.21 -42.18 3.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.638 -0.791 . . . . 1.9 111.612 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA2' HD13 ' A' ' 68' ' ' ILE . . . 107.35 68.19 0.66 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.86 -0.686 . . . . 0.87 112.745 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 6.8 ptm180 -159.25 139.74 12.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 4.26 111.094 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.728 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -95.23 110.09 22.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.52 . . . . 1.52 110.154 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.1 p90 -152.09 159.45 43.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.158 0.504 . . . . 2.04 110.876 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.962 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 24.9 mt-10 -117.18 156.06 28.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 2.12 110.89 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 mm -78.17 102.53 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.317 -0.994 . . . . 1.42 108.317 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.621 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 14.9 t70 -87.71 -177.87 5.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 1.97 110.54 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.444 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 10.5 pt-20 -60.95 -40.64 94.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.348 0.499 . . . . 2.43 112.348 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.463 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -100.16 25.12 7.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 2.39 111.039 -178.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.3 -100.66 0.46 Allowed Glycine 0 C--O 1.22 -0.748 0 C-N-CA 120.822 -0.704 . . . . 2.29 111.801 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.621 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -156.02 75.31 0.89 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.357 0.598 . . . . 2.31 110.394 175.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -110.01 74.58 0.89 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.817 -0.808 . . . . 2.61 108.817 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.605 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 2.2 m-70 -124.21 147.47 48.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 4.63 110.549 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 p -57.68 110.27 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.586 0.554 . . . . 2.27 111.141 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.728 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 48.9 p90 -77.05 122.45 24.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.237 0.541 . . . . 7.39 111.553 -175.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 82' ' ' ARG . . . -60.49 134.41 50.0 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.056 -1.218 . . . . 1.23 110.056 170.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.477 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -97.63 87.81 4.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.607 0.703 . . . . 1.76 110.924 -168.116 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 71' ' ' VAL . 51.5 mt -72.99 126.43 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.051 -0.522 . . . . 1.26 109.893 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.451 ' HG3' ' OE2' ' A' ' 96' ' ' GLU . 6.3 mmm180 -94.33 -26.57 16.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.837 -0.619 . . . . 2.65 109.38 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.2 ttpp -166.13 133.83 2.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.619 -0.719 . . . . 2.03 111.386 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 68' ' ' ILE . 90.7 t -115.26 106.28 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.546 -0.909 . . . . 1.47 108.546 174.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.1 m-20 -102.99 59.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.618 -0.265 . . . . 1.42 110.936 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.557 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 10.5 pt-20 46.89 -168.83 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.247 0.967 . . . . 0.96 111.863 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.557 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 37.5 Cg_exo -63.52 80.5 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.422 1.414 . . . . 0.48 111.384 167.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 23.7 t70 -167.73 -66.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.45 -0.796 . . . . 0.5 110.275 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -146.71 159.07 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 1.1 111.358 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.491 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -148.03 126.92 12.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.571 -0.529 . . . . 1.4 109.571 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.28 101.58 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.08 -0.711 . . . . 1.31 109.08 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.491 HG13 HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.86 137.69 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.859 0.362 . . . . 1.48 110.796 -176.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -89.17 145.4 18.51 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.845 -0.616 . . . . 0.5 112.462 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.781 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 73.7 t-105 -64.48 131.24 46.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.036 0.922 . . . . 3.37 113.347 -171.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.458 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 5.8 tpt180 -151.51 94.52 2.02 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.751 -1.944 . . . . 6.17 105.751 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD21 ' O ' ' A' ' 89' ' ' ILE . 1.5 pp -67.72 -170.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.031 -0.532 . . . . 2.13 112.367 -170.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.427 ' OD1' HG23 ' A' ' 40' ' ' VAL . 3.0 m-20 -68.21 76.65 0.25 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.611 -0.885 . . . . 1.93 108.611 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.26 50.94 4.08 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.058 -0.974 . . . . 2.79 113.672 -168.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -132.47 34.66 3.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.828 -1.175 . . . . 6.08 107.828 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.421 ' O ' ' HD3' ' A' ' 88' ' ' ARG . . . 169.9 -26.36 0.11 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.473 -1.239 . . . . 2.43 111.386 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.697 ' HG3' ' HA3' ' A' ' 132' ' ' GLY . 36.6 mmt-85 -117.15 160.8 20.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.198 -0.297 . . . . 5.53 110.198 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.569 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -94.12 119.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.613 0.72 . . . . 2.42 111.168 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -88.76 133.92 34.89 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.292 -0.867 . . . . 3.18 110.07 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.21 -54.71 2.81 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.566 2.177 . . . . 2.76 112.267 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.19 86.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.935 0.772 . . . . 2.99 111.936 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -160.89 -52.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 3.06 109.124 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 95' ' ' SER . 12.4 m -142.91 -84.68 0.16 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.534 -1.284 . . . . 2.11 107.534 172.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.781 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 14.6 m 56.81 23.81 8.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.848 . . . . 1.81 111.662 169.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.74 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 25.2 mt-10 -71.23 139.63 50.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.873 -0.603 . . . . 1.81 111.665 -172.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.979 ' HB3' ' HB3' ' A' ' 115' ' ' HIS . 1.1 p90 -126.94 137.35 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.013 -0.54 . . . . 0.81 110.927 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 41.8 m -91.41 109.11 20.39 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.185 -0.916 . . . . 1.18 109.977 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 113' ' ' VAL . 45.2 t -89.27 108.6 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.626 -0.509 . . . . 1.51 109.626 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.677 ' HA ' HG22 ' A' ' 76' ' ' THR . 42.1 m -104.09 106.57 17.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 1.05 110.563 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.706 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 48.6 m-85 -88.77 107.44 18.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.971 -0.381 . . . . 0.42 109.971 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.45 112.98 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.813 -0.44 . . . . 1.26 109.813 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.39 134.31 52.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.182 -0.463 . . . . 1.13 110.049 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 22.3 t70 -121.86 111.5 17.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.153 -0.476 . . . . 2.03 109.762 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.62 -99.27 0.81 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.859 -0.686 . . . . 1.97 112.48 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.56 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 4.1 pt20 -150.05 -25.23 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.454 0.168 . . . . 5.46 111.454 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.56 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 35.7 pttt -137.56 19.4 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 3.88 111.164 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 12.3 mptt -122.39 158.38 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.121 -0.696 . . . . 2.94 109.121 172.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.7 m -158.07 119.85 3.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.885 0.374 . . . . 1.2 110.813 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -101.66 108.5 20.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.114 -0.698 . . . . 3.1 109.114 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.2 p -90.82 142.32 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 116.322 -0.399 . . . . 1.13 110.245 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.552 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 16.4 t70 -132.54 113.46 13.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.441 -1.254 . . . . 1.38 109.519 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 3.0 t -105.13 124.48 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 116.504 -0.317 . . . . 1.58 111.131 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.61 125.71 54.46 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.987 -0.685 . . . . 2.31 110.04 170.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.979 ' HB3' ' HB3' ' A' ' 97' ' ' PHE . 27.7 p80 -137.35 125.82 23.52 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.822 -0.626 . . . . 2.32 109.737 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 5' ' ' PHE . 23.2 p -135.06 77.78 1.7 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 3.19 110.916 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.627 ' O ' ' HG2' ' A' ' 121' ' ' MET . 2.0 t-160 -158.96 -75.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.828 -0.749 . . . . 2.99 110.759 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.416 ' HE1' HG12 ' A' ' 129' ' ' VAL . 19.0 p90 -71.47 -29.76 65.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.12 -0.491 . . . . 4.27 111.483 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -51.75 19.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.615 0.766 . . . . 1.81 110.867 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.407 ' NH1' ' HB ' ' A' ' 116' ' ' THR . 42.1 ttp180 -58.89 -20.87 55.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.045 -0.98 . . . . 3.84 111.6 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.627 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.8 mmt -64.36 -19.31 65.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.511 0.196 . . . . 2.9 110.955 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.85 -157.54 3.26 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 114.756 0.662 . . . . 2.26 114.756 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 124' ' ' LYS . 11.5 p 40.62 -128.78 0.43 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.032 0.933 . . . . 3.02 112.964 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.587 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 46.4 mmtm -60.08 -38.54 83.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 4.23 111.516 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -60.86 -49.66 76.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 2.7 110.714 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.68 68.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.112 -0.495 . . . . 1.46 110.491 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -72.37 -41.27 66.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 3.16 110.9 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 8.9 ptp180 -68.92 -33.64 74.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.624 0.249 . . . . 2.97 111.252 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.416 HG12 ' HE1' ' A' ' 118' ' ' PHE . 88.9 t -70.46 -45.75 73.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.397 0.618 . . . . 1.96 110.267 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.536 ' CG ' ' HB2' ' A' ' 134' ' ' ASP . 42.6 ttt180 -68.47 -14.58 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.382 -0.826 . . . . 4.34 111.137 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -52.34 -26.88 13.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.036 -0.529 . . . . 2.8 111.841 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.697 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -140.08 -37.43 0.11 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.974 -1.108 . . . . 2.08 113.34 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.672 ' HG3' ' HB2' ' A' ' 137' ' ' TRP . 7.7 tpt -73.06 -10.67 60.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.047 0.423 . . . . 5.19 111.366 -172.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.536 ' HB2' ' CG ' ' A' ' 130' ' ' ARG . 27.8 t70 -62.49 -31.43 72.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.151 0.501 . . . . 2.83 111.277 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -103.0 4.27 37.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.052 0.453 . . . . 4.47 110.485 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.536 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.75 -63.61 0.6 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.738 -0.665 . . . . 1.04 112.471 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.672 ' HB2' ' HG3' ' A' ' 133' ' ' MET . 4.2 t90 -57.96 -51.96 77.98 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.029 0.752 . . . . 3.78 113.029 -170.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.9 Cg_endo -60.96 -38.24 70.5 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.845 1.696 . . . . 0.77 111.916 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.2 m -67.45 -37.19 82.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.637 -0.71 . . . . 1.37 109.503 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.746 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 17.5 mt -57.39 -50.72 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 114.888 -1.051 . . . . 1.32 111.188 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 75.6 mt -57.44 -41.84 81.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.411 0.445 . . . . 1.33 111.209 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.92 -51.59 68.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.118 0.485 . . . . 1.54 110.866 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.69 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 41.7 m -71.65 -21.51 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 1.43 110.955 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 61.7 t80 -63.19 -53.02 59.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.238 -0.653 . . . . 1.05 109.238 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -31.93 69.35 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.868 -0.605 . . . . 1.63 110.51 173.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.05 -40.36 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 1.46 112.04 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -69.46 -39.32 77.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.068 0.461 . . . . 2.23 109.956 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 12' ' ' VAL . 87.0 mt -65.72 -29.58 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 1.17 110.343 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.416 ' OD2' ' HG3' ' A' ' 154' ' ' LYS . 17.9 t0 -64.39 -25.24 67.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.616 -0.72 . . . . 0.85 110.199 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -71.52 -31.01 66.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.639 . . . . 1.5 109.964 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.52 -32.55 48.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.598 -0.728 . . . . 1.74 109.885 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -89.05 22.73 21.1 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.745 -0.661 . . . . 1.32 111.895 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.12 85.03 0.14 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.085 0.554 . . . . 2.42 111.735 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.416 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 34.0 ttmt -79.92 66.3 5.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.732 0.777 . . . . 2.04 109.014 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.69 ' HZ3' ' HB2' ' A' ' 155' ' ' LYS . 7.8 mtmp? . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.607 -1.179 . . . . 4.65 108.586 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 5.9 p30 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.346 -0.242 . . . . 2.1 110.346 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.526 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.8 p90 -169.21 -57.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.99 0.367 . . . . 4.04 111.99 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.68 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.6 t70 -66.55 -57.24 12.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.645 0.609 . . . . 2.78 112.645 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 2.8 Cg_endo -79.69 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.487 1.458 . . . . 1.83 111.971 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -142.3 121.47 13.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.684 0.278 . . . . 3.98 110.581 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.3 t -86.35 113.65 24.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.311 -0.996 . . . . 2.03 108.311 169.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 2.1 ttt180 -141.85 145.99 35.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.181 0.515 . . . . 3.92 111.077 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' HD1' HG22 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -122.65 131.09 53.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.012 -0.736 . . . . 1.16 109.012 169.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.9 p -134.64 111.54 10.09 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.808 0.813 . . . . 1.72 110.125 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 110' ' ' ARG . 0.9 OUTLIER -125.95 146.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.272 -1.331 . . . . 1.89 111.801 -174.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -104.45 116.67 32.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.013 -0.539 . . . . 1.15 110.473 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 148' ' ' ILE . 5.0 t -97.36 141.13 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.918 -0.583 . . . . 1.51 109.973 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.598 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 15.3 mmtp -106.83 14.84 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.575 -0.284 . . . . 1.6 111.724 -169.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.09 36.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.48 -0.488 . . . . 1.11 111.499 -174.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.573 ' OD1' ' HG3' ' A' ' 17' ' ' LYS . 35.2 t70 71.73 168.45 0.31 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.053 0.93 . . . . 0.91 112.614 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.613 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 11.5 ttp180 -66.48 -23.74 66.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.383 -1.281 . . . . 2.19 111.412 -174.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.573 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 62.6 mttm -60.96 -52.4 65.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 3.49 110.632 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.6 p -68.98 -34.51 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 1.49 110.458 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.461 ' HB2' ' CE1' ' A' ' 101' ' ' PHE . . . -57.4 -51.24 70.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 1.07 110.824 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.3 t80 -67.61 -45.06 76.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.223 -0.444 . . . . 0.43 110.673 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 18.6 ttmt -57.53 -49.16 77.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 2.87 111.18 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.581 HG22 ' CE2' ' A' ' 30' ' ' TRP . 31.1 m -69.72 -33.22 72.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.043 0.449 . . . . 1.21 111.11 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -75.95 -37.15 58.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.922 -0.311 . . . . 0.53 111.169 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.664 ' HG ' HG13 ' A' ' 46' ' ' VAL . 14.1 tp -120.15 -51.86 2.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.513 0.931 . . . . 1.23 113.513 -171.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.652 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 49.8 mt-10 -75.21 -51.81 12.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.463 0.542 . . . . 1.24 112.463 -168.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -88.12 32.23 4.44 Favored Glycine 0 C--N 1.315 -0.628 0 CA-C-N 115.781 -0.645 . . . . 0.83 111.9 -175.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.665 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 62.8 t80 -50.09 -57.84 11.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 123.343 0.657 . . . . 0.94 112.135 -170.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 28.1 Cg_endo -87.81 51.17 2.0 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.945 1.763 . . . . 0.9 114.62 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.6 pt-20 -150.07 -11.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.258 0.836 . . . . 1.49 113.258 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.763 ' CZ3' ' HG2' ' A' ' 147' ' ' LYS . 11.1 m95 -76.41 -172.31 2.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.155 0.502 . . . . 5.66 111.094 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 19.6 m95 -92.56 -26.05 0.28 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 3.41 114.758 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.652 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 93.4 Cg_endo -79.2 -139.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 CA-C-N 120.972 1.383 . . . . 1.36 113.876 -169.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.571 ' ND2' HG23 ' A' ' 40' ' ' VAL . 3.4 t-20 -48.07 -45.78 32.85 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.518 -0.765 . . . . 1.51 111.533 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -76.69 26.07 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.368 0.877 . . . . 1.98 113.368 -170.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -102.07 3.8 39.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 5.13 110.509 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -100.52 120.83 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 4.7 111.411 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 p -76.99 133.86 39.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.823 0.344 . . . . 3.11 111.511 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 p 52.86 27.37 5.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.019 0.928 . . . . 1.89 111.241 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' O ' HG11 ' A' ' 40' ' ' VAL . 48.3 tttp -124.89 -49.27 1.74 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.732 -1.122 . . . . 3.45 108.668 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.608 HG12 ' HD1' ' A' ' 65' ' ' PHE . 1.3 m -166.0 30.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 124.127 0.892 . . . . 2.3 110.693 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -173.08 31.87 0.11 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.813 -1.184 . . . . 2.2 114.159 -171.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.784 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.41 173.94 3.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.299 -0.63 . . . . 1.31 109.299 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 42' ' ' ALA . 34.6 Cg_exo -63.49 41.97 0.1 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 C-N-CA 123.327 2.684 . . . . 1.94 114.71 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -149.11 -80.76 0.13 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.676 -0.49 . . . . 2.23 109.676 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.512 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 88.6 -60.87 3.91 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.887 -0.673 . . . . 0.94 112.689 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.664 HG13 ' HG ' ' A' ' 24' ' ' LEU . 77.9 t -141.26 133.6 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.547 0.213 . . . . 1.21 111.164 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -103.85 113.06 26.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.112 -0.494 . . . . 1.11 110.208 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 5.5 mptt -81.15 -16.15 53.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 3.25 110.847 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -76.36 -62.21 1.69 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.109 -0.496 . . . . 3.63 110.7 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.21 17.86 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 1.9 111.424 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.7 60.37 0.59 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.804 -0.713 . . . . 0.87 112.097 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.39 150.84 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.54 -0.388 . . . . 4.26 111.279 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 65' ' ' PHE . 6.1 m0 -100.24 110.86 23.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.984 -0.747 . . . . 1.52 108.984 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -162.4 174.55 12.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.429 0.633 . . . . 2.04 111.26 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.784 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 25.1 mt-10 -126.8 174.69 8.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.648 -0.705 . . . . 2.12 109.834 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.421 HD13 ' HG2' ' A' ' 61' ' ' GLU . 32.3 mm -100.75 100.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.954 -0.758 . . . . 1.42 108.954 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 2.9 m-20 -67.26 -175.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.574 0.702 . . . . 1.97 112.013 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.28 -25.29 29.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.289 -0.868 . . . . 2.43 110.925 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.593 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 2.4 pm0 -95.66 5.05 52.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 2.39 110.828 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.16 -109.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.235 -0.983 . . . . 2.29 112.56 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HG2' HD13 ' A' ' 56' ' ' ILE . 28.2 mt-10 -147.97 34.54 0.83 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.478 0.311 . . . . 2.31 110.975 -173.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 9.9 pt-20 -97.5 74.43 2.44 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.29 -0.964 . . . . 2.61 111.283 -171.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.9 163.32 20.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.995 . . . . 4.63 111.409 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -131.04 148.67 52.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.411 -0.813 . . . . 2.27 110.534 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 6.6 t80 -165.54 -54.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.587 0.554 . . . . 7.39 109.598 172.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.537 ' HA3' HD13 ' A' ' 79' ' ' ILE . . . -156.12 149.91 21.03 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.186 -1.007 . . . . 1.23 113.415 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.474 HD12 ' CZ ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -114.76 103.92 11.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.625 -0.509 . . . . 1.76 109.625 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.456 HG22 HG21 ' A' ' 71' ' ' VAL . 43.4 mt -79.5 142.1 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.987 0.422 . . . . 1.26 110.839 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.6 mpt_? -114.04 -25.22 8.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.82 -0.627 . . . . 2.65 110.48 174.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.64 ' HD2' HG23 ' A' ' 78' ' ' VAL . 13.1 ttmm -142.55 106.62 4.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.531 -0.304 . . . . 2.03 111.174 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.456 HG21 HG22 ' A' ' 68' ' ' ILE . 41.5 t -95.05 92.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.268 -1.012 . . . . 1.47 108.268 167.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -109.5 70.34 0.73 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.661 -0.416 . . . . 1.42 111.12 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.9 pt-20 48.37 -172.59 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.507 1.13 . . . . 0.96 112.018 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 26.2 Cg_exo -65.45 75.35 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.428 1.419 . . . . 0.48 111.1 166.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -157.46 -66.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.5 110.358 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -141.77 143.71 33.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.412 0.625 . . . . 1.1 112.079 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -131.5 112.05 12.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.509 -0.769 . . . . 1.4 109.506 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.64 HG23 ' HD2' ' A' ' 70' ' ' LYS . 86.1 t -90.6 104.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.801 -0.815 . . . . 1.31 108.801 172.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.537 HD13 ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -127.93 122.55 58.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.378 -0.828 . . . . 1.48 111.333 -170.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.927 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -87.25 154.7 26.57 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 111.833 -0.507 . . . . 0.5 111.833 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.758 ' CZ2' ' HA ' ' A' ' 83' ' ' LEU . 68.8 t-105 -91.16 125.93 36.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.466 0.651 . . . . 3.37 111.798 -171.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -124.76 0.27 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 6.17 109.26 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 1.079 HD21 ' HB2' ' A' ' 88' ' ' ARG . 6.8 tt 78.57 154.26 0.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.706 -1.134 . . . . 2.13 113.416 169.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.524 ' HB2' HG13 ' A' ' 40' ' ' VAL . 22.5 p-10 -117.88 -28.0 6.04 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.129 -0.941 . . . . 1.93 112.689 -168.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.47 -29.59 63.84 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-O 119.727 -0.485 . . . . 2.79 113.882 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 73.01 -42.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.412 0.685 . . . . 6.08 110.769 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.88 3.39 70.59 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.101 -0.8 . . . . 2.43 111.101 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 1.079 ' HB2' HD21 ' A' ' 83' ' ' LEU . 69.2 mmt-85 -96.75 173.93 7.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.155 -0.313 . . . . 5.53 110.155 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.852 HD11 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -101.15 119.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.175 0.512 . . . . 2.42 110.319 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 7.6 p-10 -91.24 141.31 26.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.157 0.503 . . . . 3.18 111.556 -175.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 129' ' ' VAL . 10.0 Cg_exo -72.07 -49.97 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.036 2.49 . . . . 2.76 111.538 171.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.462 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 17.4 t70 70.72 -41.93 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.785 0.834 . . . . 2.99 112.911 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.575 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 21.2 m-80 -73.32 -31.24 63.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.384 . . . . 3.06 111.927 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.537 ' HB2' ' HD2' ' A' ' 118' ' ' PHE . 67.6 m -154.19 -126.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.101 -0.239 . . . . 2.11 111.244 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.67 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 58.8 m 57.59 28.67 16.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.454 0.645 . . . . 1.81 110.352 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.927 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 36.5 tt0 -62.08 138.55 58.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.957 -1.02 . . . . 1.81 111.02 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.53 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -133.92 136.92 44.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.149 0.499 . . . . 0.81 110.931 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.8 m -99.17 110.42 22.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 1.18 110.174 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.67 ' HA ' HG21 ' A' ' 113' ' ' VAL . 91.8 t -82.8 109.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.828 -0.624 . . . . 1.51 110.103 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.7 m -103.52 106.13 16.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.379 -0.373 . . . . 1.05 110.67 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.613 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 40.9 m-85 -87.99 112.7 22.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.304 -0.407 . . . . 0.42 110.255 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.13 111.19 25.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.286 -0.415 . . . . 1.26 110.125 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.89 133.76 48.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 1.13 110.833 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.768 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.9 t0 -126.99 100.92 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.174 -0.466 . . . . 2.03 109.833 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.7 49.46 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.708 -0.758 . . . . 1.97 113.404 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 72.22 8.16 5.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.504 0.722 . . . . 5.46 111.973 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -128.06 -11.66 5.29 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.828 -0.545 . . . . 3.88 110.285 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 77.5 tttt -122.48 158.06 30.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.893 -0.781 . . . . 2.94 108.893 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.1 m -157.6 117.64 3.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.95 0.405 . . . . 1.2 110.792 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.4 tmm_? -102.12 116.22 32.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.512 -0.922 . . . . 3.1 108.512 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.9 p -90.73 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.313 -0.403 . . . . 1.13 111.116 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -129.13 112.58 14.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 1.38 108.732 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' A' ' 99' ' ' VAL . 47.0 t -104.71 120.85 55.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.956 -0.566 . . . . 1.58 111.209 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.46 122.82 40.95 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.765 0.666 . . . . 2.31 109.651 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.626 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 2.3 t-160 -131.44 97.75 4.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.799 -0.815 . . . . 2.32 108.799 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.57 HG21 ' HD2' ' A' ' 120' ' ' ARG . 24.5 p -141.78 103.13 4.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.726 -0.215 . . . . 3.19 111.271 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -167.39 -74.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.315 -0.554 . . . . 2.99 112.172 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.575 ' HE2' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -85.75 -42.43 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 4.27 111.391 -168.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.95 73.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.195 -0.911 . . . . 1.81 110.719 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD2' HG21 ' A' ' 116' ' ' THR . 44.1 mtp180 -59.59 -19.32 47.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.424 -0.807 . . . . 3.84 111.923 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.9 ' HA ' ' HE3' ' A' ' 121' ' ' MET . 11.5 mmt -72.4 23.63 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.69 0.996 . . . . 2.9 113.69 -171.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.79 -155.88 15.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.847 -1.168 . . . . 2.26 114.406 168.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 p -61.66 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.32 0.859 . . . . 3.02 113.32 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 48.1 mtpt -70.05 -14.31 62.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 4.23 112.002 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.65 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 40.3 m80 -73.03 -49.92 26.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.461 0.648 . . . . 2.7 109.364 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.89 73.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.024 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.606 ' HB3' ' HA ' ' A' ' 124' ' ' LYS . 2.8 tppp? -71.25 -38.03 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.685 -0.689 . . . . 3.16 111.382 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.852 ' HB2' HD11 ' A' ' 89' ' ' ILE . 15.8 ptm180 -67.69 -30.86 70.49 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.907 -0.317 . . . . 2.97 110.272 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.562 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.4 t -84.61 -30.92 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.319 -0.552 . . . . 1.96 111.605 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.271 -0.422 . . . . 4.34 111.928 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 5.3 p30 -63.56 -33.48 75.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 2.8 111.281 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.89 -71.33 1.28 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.517 -0.849 . . . . 2.08 114.213 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.608 ' HB3' ' CZ2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -77.84 -21.89 50.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.961 0.726 . . . . 5.19 112.961 -165.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.9 -28.15 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 2.83 111.244 -174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.3 mmpt? -101.99 15.24 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 4.47 110.916 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -134.24 -57.25 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.508 -0.853 . . . . 1.04 112.489 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.422 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 1.6 t90 -56.0 -54.43 52.4 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.693 0.627 . . . . 3.78 112.693 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.83 -34.33 40.13 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.708 1.606 . . . . 0.77 111.948 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 -41.0 95.23 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.925 -0.58 . . . . 1.37 109.894 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.652 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 63.2 mt -57.9 -46.43 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 115.334 -0.848 . . . . 1.32 109.843 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 21.6 mt -54.95 -42.9 72.92 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 123.638 0.586 . . . . 1.33 111.385 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -64.02 -46.18 85.6 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.582 -0.447 . . . . 1.54 110.813 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -75.19 -22.19 58.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.027 0.442 . . . . 1.43 110.927 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.463 ' HD2' ' OE1' ' A' ' 145' ' ' GLN . 92.8 t80 -61.18 -55.14 35.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 1.05 109.6 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.463 ' OE1' ' HD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -64.92 -30.7 71.7 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.019 -0.537 . . . . 1.63 110.45 175.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.48 -55.77 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.591 -0.277 . . . . 1.46 111.342 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.763 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 21.9 tptp -68.0 -39.61 83.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.53 -0.468 . . . . 2.23 110.841 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.692 HG22 HG13 ' A' ' 12' ' ' VAL . 47.2 mt -65.9 -37.83 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 1.17 111.894 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.924 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.1 t70 -64.09 -25.53 68.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.377 -0.374 . . . . 0.85 110.333 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.733 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 61.4 mt-10 -69.53 -39.66 77.37 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.38 -20.6 66.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.054 -0.975 . . . . 1.74 108.972 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.95 -82.78 0.9 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.06 -0.973 . . . . 1.32 111.56 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -155.01 12.37 0.37 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.866 0.691 . . . . 2.42 112.866 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.924 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 21.1 ttmm -63.67 -32.48 73.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.942 0.401 . . . . 2.04 111.466 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 119.22 -0.419 . . . . 4.65 110.719 -176.755 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.865 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 32.6 p30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.375 -0.232 . . . . 2.1 110.375 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER 70.26 -31.76 0.22 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.082 1.353 . . . . 4.04 112.172 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.788 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 23.6 t70 -59.34 -53.63 64.17 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.284 -0.265 . . . . 2.78 110.284 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 25.5 Cg_endo -94.64 -64.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.244 1.963 . . . . 1.83 111.348 167.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 38.6 p90 -151.77 171.4 17.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.936 -1.135 . . . . 3.98 107.936 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.934 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 86.0 t -107.58 103.91 16.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.853 -0.339 . . . . 2.03 110.53 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.786 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.1 ttp180 -93.76 130.59 39.69 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.239 -0.584 . . . . 3.92 110.84 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.681 ' HD1' HG22 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -110.53 133.54 53.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 1.16 108.817 173.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.1 t -134.7 111.08 9.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.518 0.675 . . . . 1.72 110.111 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 3.0 t -124.63 137.78 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.675 -1.148 . . . . 1.89 111.652 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.1 m -97.77 116.88 30.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.813 -0.63 . . . . 1.15 110.443 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 148' ' ' ILE . 32.9 t -94.7 142.4 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.46 -0.791 . . . . 1.51 110.868 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -99.23 12.76 35.27 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.25 0.463 . . . . 1.6 112.25 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG13 ' A' ' 12' ' ' VAL . . . -155.4 39.66 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.975 -0.69 . . . . 1.11 112.414 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 14.3 t70 73.12 167.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.811 0.815 . . . . 0.91 111.927 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 25.9 ttp180 -69.43 -23.4 63.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.094 -0.957 . . . . 2.19 110.707 -174.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 15.1 ptpt -60.76 -39.22 87.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 3.49 111.195 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -82.91 -37.86 23.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.928 -0.309 . . . . 1.49 110.594 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB1' HG11 ' A' ' 12' ' ' VAL . . . -56.27 -43.38 78.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.829 0.347 . . . . 1.07 110.462 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 79.4 t80 -70.93 -46.01 63.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.322 -0.399 . . . . 0.43 110.48 176.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -55.19 -55.0 36.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.037 -0.529 . . . . 2.87 111.382 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.448 HG22 ' NE1' ' A' ' 30' ' ' TRP . 23.6 m -67.23 -46.68 73.07 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.311 -0.859 . . . . 1.21 111.028 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.631 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 66.5 t80 -64.46 -34.89 79.25 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.103 0.409 . . . . 0.53 112.103 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.569 ' CD1' HG12 ' A' ' 46' ' ' VAL . 14.2 tp -108.67 -53.72 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.033 -0.667 . . . . 1.23 112.373 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.63 -39.44 37.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 1.24 111.297 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.692 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -91.4 33.53 4.72 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.65 -0.704 . . . . 0.83 112.336 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.521 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 44.8 t80 -52.54 -48.0 91.71 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.216 0.45 . . . . 0.94 112.216 -173.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -89.64 15.29 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.869 1.713 . . . . 0.9 115.036 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.692 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.0 pt-20 -100.44 -5.03 27.71 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.993 -0.683 . . . . 1.49 110.766 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.631 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 23.9 m0 -75.73 153.75 36.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.488 0.661 . . . . 5.66 111.468 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.629 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 36.8 m95 -80.47 -44.1 1.35 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.908 -1.042 . . . . 3.41 112.855 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 1.083 ' HD3' ' HB2' ' A' ' 143' ' ' SER . 11.3 Cg_endo -52.12 -76.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.062 2.508 . . . . 1.36 114.76 -164.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -120.35 -11.61 9.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 1.51 110.609 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.688 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.4 m-20 -99.14 18.67 16.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.688 . . . . 1.98 111.103 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.55 8.37 43.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.142 0.496 . . . . 5.13 111.023 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -117.73 140.33 49.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 4.7 111.65 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.48 148.03 37.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 3.11 110.921 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 57' ' ' ASP . 63.6 p 57.88 8.02 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.547 1.139 . . . . 1.89 112.843 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.78 -77.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.479 -0.934 . . . . 3.45 108.479 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.8 m -147.21 15.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.588 -0.893 . . . . 2.3 108.588 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.49 55.35 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.72 -1.127 . . . . 2.2 111.876 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.878 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -104.05 169.81 6.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.406 -0.961 . . . . 1.31 108.406 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.19 53.83 0.26 Allowed 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 123.038 2.492 . . . . 1.94 113.77 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.43 HD22 ' CZ ' ' A' ' 54' ' ' TYR . 35.3 tp -170.8 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.745 0.418 . . . . 2.23 110.378 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.649 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 87.76 -57.78 4.38 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.991 -0.623 . . . . 0.94 112.487 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 24' ' ' LEU . 89.0 t -134.81 136.66 51.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.839 0.352 . . . . 1.21 110.67 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.627 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.9 t70 -107.94 122.77 47.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.561 -0.745 . . . . 1.11 109.77 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -33.91 40.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.403 0.52 . . . . 3.25 112.403 -175.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HZ1' ' HB2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -72.23 -47.22 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.814 0.301 . . . . 3.63 111.814 -172.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.88 -25.39 22.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.655 -0.784 . . . . 1.9 111.784 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.18 60.33 2.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.652 -0.785 . . . . 0.87 111.207 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 8.3 ptm180 -146.39 139.76 25.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.843 0.354 . . . . 4.26 111.118 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.529 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 24.5 m0 -97.99 108.26 20.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 1.52 110.547 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.627 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -153.32 151.71 30.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.997 0.427 . . . . 2.04 110.282 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.878 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 51.6 mp0 -117.79 160.05 22.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 2.12 110.512 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 61' ' ' GLU . 36.8 mm -77.84 103.97 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 1.42 110.062 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 38' ' ' THR . 7.0 t70 -95.43 -178.12 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 1.97 110.476 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -80.92 -7.68 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.798 0.666 . . . . 2.43 112.798 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.51 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -95.98 -4.65 42.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.289 0.566 . . . . 2.39 110.194 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.21 -85.1 0.18 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.505 -0.771 . . . . 2.29 111.816 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.506 ' HG2' HD12 ' A' ' 56' ' ' ILE . 52.6 mt-10 -156.65 18.94 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.717 -0.475 . . . . 2.31 109.717 -177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.86 88.85 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.742 0.782 . . . . 2.61 110.274 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -117.84 163.74 16.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.886 -1.052 . . . . 4.63 110.254 -178.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -52.7 109.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.67 -0.493 . . . . 2.27 109.67 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 30.7 p90 -92.58 130.66 38.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.334 0.588 . . . . 7.39 112.016 -170.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.4 157.55 31.72 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.74 -0.944 . . . . 1.23 110.74 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 93' ' ' ASN . 1.2 pt? -116.01 99.59 7.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.996 0.398 . . . . 1.76 111.261 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.592 HG22 HG23 ' A' ' 71' ' ' VAL . 40.7 mt -79.37 118.6 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.047 -0.661 . . . . 1.26 109.907 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -85.94 -23.25 27.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.841 -1.072 . . . . 2.65 109.818 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 78' ' ' VAL . 58.5 tttp -156.39 105.41 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.732 -0.667 . . . . 2.03 111.266 -174.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG23 HG22 ' A' ' 68' ' ' ILE . 49.8 t -98.92 93.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.652 -0.87 . . . . 1.47 108.652 169.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.02 73.15 0.83 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.535 -0.466 . . . . 1.42 111.648 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.608 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 48.18 -174.12 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 124.827 1.33 . . . . 0.96 112.623 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.608 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 39.3 Cg_exo -62.77 82.08 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.504 1.469 . . . . 0.48 110.956 166.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -167.68 -67.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.789 . . . . 0.5 110.506 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 3.6 p -141.91 140.97 32.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.431 0.53 . . . . 1.1 112.431 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' N ' HD11 ' A' ' 77' ' ' LEU . 2.2 mp -136.6 112.93 9.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 1.4 109.621 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 98' ' ' THR . 39.6 t -103.24 109.9 28.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.007 -0.738 . . . . 1.31 109.007 175.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -130.02 138.62 53.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.902 0.382 . . . . 1.48 111.947 -176.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 150.95 21.8 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.816 -0.629 . . . . 0.5 112.791 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.782 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 61.0 t-105 -89.09 148.94 23.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.209 0.604 . . . . 3.37 111.64 -168.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -142.87 23.24 1.91 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.995 -0.548 . . . . 6.17 110.374 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.71 HD12 ' HB3' ' A' ' 88' ' ' ARG . 1.6 tm? 84.63 152.83 0.09 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.177 -0.919 . . . . 2.13 111.081 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 83' ' ' LEU . 42.0 t30 -131.79 -29.99 1.66 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.01 -0.541 . . . . 1.93 111.52 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.7 46.08 2.8 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.304 -0.474 . . . . 2.79 113.81 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.3 t80 58.63 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 6.08 112.307 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.17 39.23 2.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.988 -0.625 . . . . 2.43 112.145 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.766 ' HD2' ' HB3' ' A' ' 131' ' ' ASN . 5.6 tpp180 -97.56 -176.62 3.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.729 -0.471 . . . . 5.53 109.729 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.478 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -94.14 137.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.965 0.412 . . . . 2.42 110.47 -175.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -96.0 137.6 21.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.081 -0.509 . . . . 3.18 111.428 -179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.554 ' HG2' ' HD1' ' A' ' 81' ' ' TRP . 50.2 Cg_exo -57.62 -21.72 48.34 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.17 3.247 . . . . 2.76 113.807 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 32.5 t70 77.25 41.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.381 -0.827 . . . . 2.99 110.596 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.525 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.8 OUTLIER 80.36 36.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.032 -0.986 . . . . 3.06 112.845 158.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 p -122.71 -37.25 2.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.757 -0.377 . . . . 2.11 111.682 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.782 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 20.5 t -55.85 97.06 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.522 -0.763 . . . . 1.81 109.292 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -122.57 136.84 54.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.237 -0.438 . . . . 1.81 110.673 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.489 ' HD1' ' CE1' ' A' ' 115' ' ' HIS . 12.2 p90 -134.48 139.4 45.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.235 0.541 . . . . 0.81 111.855 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.549 HG22 HG21 ' A' ' 78' ' ' VAL . 75.7 m -96.9 109.1 21.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.117 -0.947 . . . . 1.18 110.134 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 113' ' ' VAL . 84.2 t -83.53 109.98 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 1.51 110.077 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.404 ' HA ' HG22 ' A' ' 76' ' ' THR . 25.2 m -106.19 106.56 17.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.646 -0.252 . . . . 1.05 110.636 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.555 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.8 m-85 -88.12 115.8 25.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.657 -0.247 . . . . 0.42 110.498 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.2 112.01 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.907 -0.405 . . . . 1.26 109.907 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.58 133.89 43.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.844 -0.616 . . . . 1.13 111.372 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.734 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -121.93 128.85 52.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 2.03 109.227 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.65 -13.05 29.79 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.343 -0.844 . . . . 1.97 115.176 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -84.21 33.86 0.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.993 0.896 . . . . 5.46 111.685 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 12.3 mmtp 56.5 45.72 21.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.746 0.784 . . . . 3.88 108.947 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 87.9 tttt -133.87 155.03 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.809 -1.087 . . . . 2.94 109.341 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.9 m -155.03 114.63 3.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.139 0.495 . . . . 1.2 110.841 173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.467 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 18.2 tpp85 -91.64 113.98 26.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.543 -0.753 . . . . 3.1 109.697 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -91.04 138.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.768 0.318 . . . . 1.13 110.485 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.512 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 17.8 t70 -127.55 109.98 12.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.491 -0.777 . . . . 1.38 109.213 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 t -102.93 135.67 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.536 -0.756 . . . . 1.58 111.578 -175.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -113.04 111.62 22.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 2.31 109.683 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.934 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -100.77 115.57 30.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.454 -0.794 . . . . 2.32 109.235 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 p -127.99 168.88 14.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.522 -0.471 . . . . 3.19 111.619 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 101.98 -66.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 113.804 -1.544 . . . . 2.99 110.563 162.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.706 ' HE2' HG21 ' A' ' 129' ' ' VAL . 59.5 t80 -86.97 -52.34 5.51 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.029 -0.532 . . . . 4.27 111.996 -175.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 2' ' ' TYR . 1.7 m-20 -54.82 -33.39 61.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 1.81 112.281 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 37.7 ttp180 -62.52 -22.73 66.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 3.84 111.502 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.81 -22.09 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.536 -0.302 . . . . 2.9 110.358 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 126' ' ' ALA . . . 48.82 -154.02 2.09 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.39 -0.823 . . . . 2.26 114.801 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 m 44.76 -101.92 0.05 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.397 1.079 . . . . 3.02 113.112 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.96 -45.16 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.136 -0.32 . . . . 4.23 110.136 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -61.15 -49.8 75.76 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.334 0.588 . . . . 2.7 110.469 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . . . -64.51 -51.24 63.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.549 -0.751 . . . . 1.46 111.222 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -61.91 -34.0 75.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.905 0.335 . . . . 3.16 111.905 -173.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -77.16 -32.94 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.419 -0.513 . . . . 2.97 111.438 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.706 HG21 ' HE2' ' A' ' 118' ' ' PHE . 79.2 t -78.61 -42.3 25.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.374 0.607 . . . . 1.96 110.664 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.889 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 65.9 mtt-85 -68.18 -12.41 60.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.516 -0.766 . . . . 4.34 110.957 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.766 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 45.7 t30 -51.8 -25.09 6.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.568 -0.742 . . . . 2.8 110.004 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.18 -17.92 2.64 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.918 -0.583 . . . . 2.08 112.422 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.821 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 6.4 tpp -80.07 -42.89 22.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.475 0.546 . . . . 5.19 112.475 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.889 ' HB2' ' HB3' ' A' ' 130' ' ' ARG . 7.4 t70 -68.46 -25.92 65.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.975 0.731 . . . . 2.83 112.975 -163.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -115.9 24.19 11.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.586 0.708 . . . . 4.47 109.922 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.96 -74.68 0.64 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.36 -0.836 . . . . 1.04 111.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.528 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 5.5 t90 -58.51 -48.86 96.15 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.76 0.652 . . . . 3.78 112.76 -173.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.0 Cg_endo -59.61 -38.75 80.14 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.189 1.926 . . . . 0.77 112.642 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 m -70.9 -37.11 72.98 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.757 0.789 . . . . 1.37 109.347 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.653 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.6 mt -54.59 -44.74 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.4 -1.273 . . . . 1.32 110.196 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.56 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 68.9 mt -56.68 -33.8 66.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.464 0.478 . . . . 1.33 111.608 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -69.15 -57.71 5.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.18 0.514 . . . . 1.54 111.002 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 1.083 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -71.93 -21.39 61.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.104 -0.498 . . . . 1.43 111.132 -178.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.35 -47.57 85.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 1.05 109.543 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 67.6 mt-30 -61.23 -36.22 79.36 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.549 -0.751 . . . . 1.63 110.356 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.47 -39.75 64.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.492 -0.777 . . . . 1.46 111.506 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -66.56 -35.77 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.934 0.397 . . . . 2.23 110.112 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.728 HG22 HG12 ' A' ' 12' ' ' VAL . 50.4 mt -71.47 -32.68 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.288 0.566 . . . . 1.17 110.375 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.411 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 12.8 t70 -58.88 -32.33 69.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.609 -0.723 . . . . 0.85 109.727 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.828 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 49.6 mt-10 -66.0 -33.22 75.3 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.538 -0.755 . . . . 1.5 110.413 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -82.15 -17.1 47.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.359 -0.837 . . . . 1.74 109.726 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -96.56 -75.89 1.28 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.467 -0.788 . . . . 1.32 112.819 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.55 15.27 1.8 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.697 0.628 . . . . 2.42 112.697 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.828 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttmm -79.62 76.94 6.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.232 0.539 . . . . 2.04 110.087 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--O 1.246 0.901 0 CA-C-N 115.7 -0.682 . . . . 4.65 109.553 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 2' ' ' TYR . 35.2 m-80 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.691 -0.485 . . . . 2.1 109.691 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.477 ' CD1' ' HB1' ' A' ' 126' ' ' ALA . 28.4 p90 172.96 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.62 0.575 . . . . 4.04 110.288 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.888 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.4 t70 -59.98 -56.74 32.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.129 -0.487 . . . . 2.78 111.397 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.888 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 18.9 Cg_endo -96.08 -64.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.392 2.061 . . . . 1.83 111.953 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -149.6 154.97 39.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.667 -1.234 . . . . 3.98 107.667 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.726 ' HB ' ' CB ' ' A' ' 115' ' ' HIS . 27.4 t -85.7 106.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.221 -0.592 . . . . 2.03 109.812 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.8 ttm180 -111.75 135.38 52.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.805 0.812 . . . . 3.92 111.427 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 1.005 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 4.8 t-160 -109.38 132.37 54.19 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.736 -1.209 . . . . 1.16 107.736 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.2 t -146.04 112.02 5.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.944 -0.391 . . . . 1.72 109.944 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 111' ' ' VAL . 10.8 m -138.31 139.21 42.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 1.89 110.819 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m -92.84 116.14 28.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.471 -0.786 . . . . 1.15 109.906 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.697 HG11 HG22 ' A' ' 148' ' ' ILE . 22.4 t -98.47 125.57 51.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.476 -0.784 . . . . 1.51 110.379 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 35.06 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.933 0.397 . . . . 1.6 111.567 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.434 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.39 26.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.434 -0.348 . . . . 1.11 111.039 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.1 t70 72.6 169.21 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 0.91 112.857 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 7.6 ttp180 -63.36 -27.49 69.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.16 -0.927 . . . . 2.19 110.978 -174.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -54.28 -53.36 54.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.721 -0.672 . . . . 3.49 111.405 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -76.56 -33.57 58.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 1.49 111.181 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' A' ' 12' ' ' VAL . . . -60.47 -48.31 82.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 1.07 110.79 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -69.1 -33.78 74.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.43 110.537 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.835 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 5.5 tppp? -61.06 -55.7 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.427 . . . . 2.87 110.262 176.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.544 HG21 ' CE2' ' A' ' 30' ' ' TRP . 31.2 m -66.55 -23.87 66.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 1.21 111.939 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' CE2' HG22 ' A' ' 99' ' ' VAL . 69.4 t80 -87.81 -37.26 16.72 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.722 -0.391 . . . . 0.53 111.467 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.532 ' CD1' HG11 ' A' ' 46' ' ' VAL . 18.9 tp -119.95 -54.89 2.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.51 0.93 . . . . 1.23 113.51 -172.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.835 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 29.0 mt-10 -78.68 -24.72 44.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.378 0.609 . . . . 1.24 110.779 -169.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.418 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.72 93.84 0.54 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.056 -2.017 . . . . 0.83 108.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.848 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 23.0 t80 -95.93 -63.85 0.12 Allowed Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.722 -0.239 . . . . 0.94 111.041 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.848 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 29.9 Cg_endo -96.46 37.53 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.282 1.988 . . . . 0.9 114.677 -174.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -126.97 5.24 6.53 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.409 0.892 . . . . 1.49 113.409 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.837 ' HE3' ' HG3' ' A' ' 147' ' ' LYS . 18.7 m95 -99.07 -160.89 0.83 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.127 -0.358 . . . . 5.66 110.221 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 22.1 m95 -99.05 -8.92 0.12 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.991 1.478 . . . . 3.41 114.991 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.614 ' HB3' ' HB3' ' A' ' 143' ' ' SER . 92.8 Cg_endo -81.82 -148.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 CA-C-N 122.484 1.923 . . . . 1.36 113.292 -170.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.63 ' ND2' HD22 ' A' ' 84' ' ' ASN . 6.5 t30 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.812 . . . . 1.51 111.025 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.758 ' HA ' HG22 ' A' ' 40' ' ' VAL . 30.9 m-20 -78.87 20.98 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.183 -0.462 . . . . 1.98 110.739 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 33' ' ' ASN . 8.0 t80 -117.83 22.39 12.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 5.13 110.33 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -117.66 146.97 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 4.7 110.108 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.58 135.66 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.023 -0.271 . . . . 3.11 110.854 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.1 p 58.52 14.49 3.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.082 0.953 . . . . 1.89 112.133 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.501 ' O ' HG23 ' A' ' 40' ' ' VAL . 54.2 tttp -132.6 80.35 1.89 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.985 -0.746 . . . . 3.45 108.985 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.758 HG22 ' HA ' ' A' ' 34' ' ' ASN . 5.1 m 54.1 17.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.429 1.091 . . . . 2.3 112.165 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -146.28 26.88 1.7 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.56 -0.828 . . . . 2.2 113.312 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.853 ' HB1' ' HB3' ' A' ' 55' ' ' GLU . . . -77.56 167.14 38.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.45 -0.944 . . . . 1.31 108.45 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.02 59.71 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.751 2.301 . . . . 1.94 113.718 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 53.4 tp -166.03 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 2.23 110.027 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 94.98 -63.88 1.46 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.872 -0.68 . . . . 0.94 113.06 173.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 24' ' ' LEU . 84.8 t -132.75 147.41 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.84 0.353 . . . . 1.21 110.487 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.793 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.6 t0 -123.98 96.32 4.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.853 -0.795 . . . . 1.11 108.853 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 8.5 mtpt -74.06 -22.31 59.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.112 0.482 . . . . 3.25 110.245 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.534 ' HB3' ' HZ2' ' A' ' 49' ' ' LYS . 4.2 ttpm? -64.67 -56.61 12.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 3.63 110.787 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.93 -28.72 33.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.966 -0.635 . . . . 1.9 112.595 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.95 49.42 2.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.696 -0.764 . . . . 0.87 112.169 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.44 161.31 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.735 0.302 . . . . 4.26 111.417 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.452 ' CD1' HD11 ' A' ' 68' ' ' ILE . 14.4 m0 -108.99 120.01 41.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 1.52 109.999 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.793 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -163.91 158.11 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.087 0.47 . . . . 2.04 110.677 175.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.853 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 1.1 mp0 -125.71 166.55 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.486 -0.931 . . . . 2.12 108.486 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG23 ' HG2' ' A' ' 61' ' ' GLU . 43.2 mm -78.34 103.62 5.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.121 0.486 . . . . 1.42 109.958 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.569 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.4 t70 -87.98 145.94 25.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.717 -0.674 . . . . 1.97 110.092 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -61.34 -26.82 68.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.681 0.613 . . . . 2.43 112.354 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.422 ' HB3' ' OD2' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -75.8 -17.99 59.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.951 0.405 . . . . 2.39 111.226 -175.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.15 54.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.175 -1.012 . . . . 2.29 113.211 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 56' ' ' ILE . 43.6 mt-10 56.0 26.26 9.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.157 0.799 . . . . 2.31 113.157 173.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 12.8 tp10 -112.9 95.83 5.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.424 0.63 . . . . 2.61 110.236 -176.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.569 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.22 165.16 16.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.047 -0.978 . . . . 4.63 110.602 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 82' ' ' ARG . 3.2 p -47.82 124.77 7.76 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.627 0.58 . . . . 2.27 111.316 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -89.61 112.46 23.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.743 -0.662 . . . . 7.39 110.943 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.624 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -83.29 127.21 7.89 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.633 -0.987 . . . . 1.23 110.633 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.446 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -100.63 96.11 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.016 0.436 . . . . 1.76 111.316 -171.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.521 HG21 ' CG2' ' A' ' 71' ' ' VAL . 39.5 mt -83.34 124.49 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.122 0.487 . . . . 1.26 110.298 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -104.33 -14.84 15.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.538 -0.755 . . . . 2.65 110.5 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -159.31 118.91 3.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.248 -0.433 . . . . 2.03 111.835 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' CG2' HG21 ' A' ' 68' ' ' ILE . 57.7 t -103.1 92.96 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.076 -1.083 . . . . 1.47 108.076 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 5.7 t0 -101.38 64.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.628 -0.26 . . . . 1.42 111.19 -170.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 7.4 pt-20 48.28 -172.38 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.287 1.035 . . . . 0.96 112.03 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 31.3 Cg_exo -62.64 72.17 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.48 111.774 166.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -156.44 -65.79 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.452 -0.795 . . . . 0.5 110.183 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 100' ' ' THR . 4.0 p -145.57 152.48 39.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 1.1 112.357 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' CD2' HD21 ' A' ' 24' ' ' LEU . 3.1 mp -138.18 126.36 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.676 -0.693 . . . . 1.4 109.526 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.77 105.56 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.59 -0.522 . . . . 1.31 109.59 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.76 137.39 57.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.292 -0.413 . . . . 1.48 111.282 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.09 165.41 26.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.5 111.889 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.952 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 39.6 t-105 -62.17 162.88 8.91 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 114.253 1.205 . . . . 3.37 114.253 -163.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.624 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -158.67 -35.57 0.06 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.608 -1.178 . . . . 6.17 110.023 -169.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.906 ' HG ' ' HA3' ' A' ' 132' ' ' GLY . 4.8 tt 78.11 175.27 0.17 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.753 -0.658 . . . . 2.13 110.599 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.63 HD22 ' ND2' ' A' ' 33' ' ' ASN . 46.7 t-20 -109.12 -76.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.714 0.292 . . . . 1.93 110.416 -173.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.59 0.54 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 120.663 -0.78 . . . . 2.79 111.216 176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -54.48 -6.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.294 0.85 . . . . 6.08 113.294 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.08 -0.89 76.84 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.944 -0.862 . . . . 2.43 110.944 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.597 ' HD3' ' H ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -97.55 152.78 18.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.148 0.499 . . . . 5.53 110.585 178.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -65.51 124.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.203 -0.908 . . . . 2.42 110.477 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.614 ' OD2' ' HB3' ' A' ' 92' ' ' ASP . 4.1 p-10 -101.75 142.81 25.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 121.42 0.628 . . . . 3.18 111.45 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.688 ' HD2' ' HD1' ' A' ' 81' ' ' TRP . 59.8 Cg_endo -97.69 37.46 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.915 3.077 . . . . 2.76 111.868 167.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.614 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -65.78 89.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.155 0.979 . . . . 2.99 111.066 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.0 OUTLIER -167.88 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.437 -1.256 . . . . 3.06 108.368 167.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.769 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 74.6 m -160.96 -143.69 0.1 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.976 -1.465 . . . . 2.11 108.674 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.952 ' HB2' ' HB2' ' A' ' 81' ' ' TRP . 37.9 m 54.63 38.0 29.14 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.477 0.656 . . . . 1.81 111.442 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.648 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 20.2 tt0 -71.77 149.78 45.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.895 -1.048 . . . . 1.81 110.69 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.596 ' HB2' HG13 ' A' ' 113' ' ' VAL . 9.0 p90 -146.37 147.43 31.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.96 0.409 . . . . 0.81 110.866 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 30.5 m -104.36 115.82 31.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.594 -0.73 . . . . 1.18 110.374 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.619 ' HA ' HG21 ' A' ' 113' ' ' VAL . 97.4 t -82.42 109.73 16.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 1.51 109.804 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.489 ' HA ' HG22 ' A' ' 76' ' ' THR . 9.5 m -104.12 105.97 16.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.935 0.397 . . . . 1.05 111.224 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.499 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 52.1 m-85 -89.9 110.91 21.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.357 -0.383 . . . . 0.42 110.138 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.8 t -91.61 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 110.123 -0.325 . . . . 1.26 110.123 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.25 138.07 53.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 1.13 110.393 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -130.12 103.0 6.49 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 2.03 110.75 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.34 -97.89 0.63 Allowed Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.946 -0.645 . . . . 1.97 113.223 171.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -146.68 -20.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.095 0.406 . . . . 5.46 112.095 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -136.26 3.64 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.97 -0.692 . . . . 3.88 112.671 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 26.4 ttpp -127.31 153.96 45.52 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.448 -0.901 . . . . 2.94 110.911 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.7 m -160.9 124.31 3.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.826 -0.624 . . . . 1.2 109.95 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.54 120.25 41.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.79 . . . . 3.1 108.866 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 10' ' ' VAL . 10.0 p -96.55 141.12 16.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.802 -0.359 . . . . 1.13 110.791 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.7 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -129.5 124.23 33.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.08 -0.711 . . . . 1.38 109.08 171.23 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 1.005 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 4.1 t -99.05 121.51 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-N 115.725 -0.671 . . . . 1.58 110.086 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.19 121.34 41.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.893 -0.78 . . . . 2.31 108.893 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.726 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 t-80 -103.03 152.77 20.96 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.285 -0.87 . . . . 2.32 110.114 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.677 HG21 ' HD2' ' A' ' 118' ' ' PHE . 9.0 t -60.13 177.86 0.23 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.12 -0.945 . . . . 3.19 110.944 170.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -108.35 18.94 20.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.854 -0.612 . . . . 2.99 110.438 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.769 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 20.7 m-85 -59.33 -29.07 67.37 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.499 -0.319 . . . . 4.27 111.434 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.6 -49.79 15.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.554 0.692 . . . . 1.81 109.699 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.482 ' C ' ' H ' ' A' ' 122' ' ' GLY . 55.2 ttt180 -58.54 -18.08 26.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.582 -1.19 . . . . 3.84 111.14 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 121' ' ' MET . 24.2 ttt -65.83 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.003 0.921 . . . . 2.9 112.466 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 152.93 151.03 5.57 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.177 -1.011 . . . . 2.26 112.085 172.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.9 m -60.39 -36.2 77.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.28 0.562 . . . . 3.02 109.657 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -71.58 -39.34 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.436 -0.802 . . . . 4.23 110.467 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.569 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 5.3 m170 -63.8 -46.23 86.12 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 121.26 0.552 . . . . 2.7 110.631 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.477 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -66.87 -31.51 72.17 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 1.46 111.262 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.42 -39.38 81.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 3.16 110.639 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.6 ' HB2' HD11 ' A' ' 89' ' ' ILE . 16.8 ptm180 -76.25 -24.95 54.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 2.97 111.737 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 91' ' ' PRO . 61.5 t -83.52 -54.79 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.304 0.853 . . . . 1.96 113.304 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.576 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 35.5 ttt180 -62.66 -23.86 67.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.519 0.563 . . . . 4.34 112.519 -167.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.457 ' CG ' ' HD2' ' A' ' 88' ' ' ARG . 16.7 p30 -55.41 -22.32 19.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.353 -0.385 . . . . 2.8 111.817 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.906 ' HA3' ' HG ' ' A' ' 83' ' ' LEU . . . -100.3 -96.75 2.19 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.456 -0.878 . . . . 2.08 114.038 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.577 ' HB3' ' CH2' ' A' ' 81' ' ' TRP . 54.2 ttm -79.29 -27.44 42.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.844 0.683 . . . . 5.19 112.844 -164.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.576 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 20.9 t70 -65.11 -21.93 66.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.948 0.404 . . . . 2.83 111.482 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.459 ' HA ' ' CE ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -79.46 -15.92 56.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.111 0.411 . . . . 4.47 112.111 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.617 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -117.07 -17.25 5.88 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.351 -0.7 . . . . 1.04 111.351 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.511 ' O ' HD13 ' A' ' 141' ' ' LEU . 38.0 t-105 -55.4 -54.49 50.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 123.061 0.544 . . . . 3.78 111.453 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.59 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 18.7 Cg_endo -60.22 -34.62 93.86 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.837 1.691 . . . . 0.77 111.623 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.1 m -66.29 -49.96 65.3 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 121.733 0.777 . . . . 1.37 110.447 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 136' ' ' GLY . 59.1 mt -55.44 -54.58 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.018 -0.992 . . . . 1.32 110.053 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 137' ' ' TRP . 7.0 mp -56.34 -26.86 53.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.25 0.833 . . . . 1.33 113.25 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 28.4 mm-40 -69.14 -54.33 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.484 -0.561 . . . . 1.54 109.484 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.614 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . 37.3 t -70.16 -23.81 63.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 1.43 110.745 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 64.6 t80 -58.35 -53.15 61.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.479 -0.782 . . . . 1.05 109.489 174.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.93 -22.11 61.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.508 -0.769 . . . . 1.63 110.508 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.12 -52.09 10.85 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.94 -0.573 . . . . 1.46 111.698 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.837 ' HG3' ' HE3' ' A' ' 30' ' ' TRP . 2.4 tmtt? -66.94 -39.78 87.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.508 -0.477 . . . . 2.23 109.962 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.697 HG22 HG11 ' A' ' 12' ' ' VAL . 22.6 mt -57.92 -35.27 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.303 0.573 . . . . 1.17 110.545 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.425 ' OD2' ' HE2' ' A' ' 154' ' ' LYS . 24.1 t0 -61.26 -35.49 77.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.638 -0.71 . . . . 0.85 110.002 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 63.6 mt-10 -68.32 -26.75 65.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.39 0.614 . . . . 1.5 110.809 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 11.1 mm-40 -88.89 5.69 42.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.713 -0.676 . . . . 1.74 110.325 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.29 -78.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.171 -1.014 . . . . 1.32 114.02 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.47 -45.69 10.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.114 0.483 . . . . 2.42 111.652 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 31.5 ttpt -87.74 114.28 24.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.94 -0.573 . . . . 2.04 109.991 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.85 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.791 -0.623 . . . . 4.65 109.719 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.683 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 19.7 p30 . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.801 -0.074 . . . . 2.1 110.801 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.464 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -171.77 -51.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.334 0.494 . . . . 4.04 112.334 176.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.521 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.7 t70 -66.71 -61.85 4.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 112.042 0.386 . . . . 2.78 112.042 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.04 -58.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.115 1.21 . . . . 1.83 112.098 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.683 ' O ' ' HB2' ' A' ' 1' ' ' ASN . 47.0 p90 -154.8 143.63 20.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.566 . . . . 3.98 110.195 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.803 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 95.2 t -103.88 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.138 -1.06 . . . . 2.03 108.138 164.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 58.8 ttp180 -101.04 134.86 43.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.427 0.632 . . . . 3.92 111.939 -170.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.766 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -109.9 131.82 54.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.426 -0.953 . . . . 1.16 108.426 167.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 50.0 m -135.52 110.35 8.73 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.584 -0.735 . . . . 1.72 110.35 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.732 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.3 t -121.46 135.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.824 -1.08 . . . . 1.89 111.032 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -100.95 115.71 31.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.38 0.61 . . . . 1.15 109.546 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.676 HG11 HG23 ' A' ' 148' ' ' ILE . 42.2 t -93.4 127.58 45.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 1.51 111.264 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.963 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -86.91 12.82 10.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.168 -0.924 . . . . 1.6 113.131 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -156.77 41.46 0.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.011 -0.675 . . . . 1.11 112.474 -173.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 11.3 t70 73.32 161.89 0.25 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.252 1.025 . . . . 0.91 113.69 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 1.07 ' HE ' ' HB2' ' A' ' 103' ' ' ALA . 8.0 ttp85 -63.45 -28.11 69.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.28 -1.327 . . . . 2.19 112.422 -172.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 34.1 mttp -66.85 -40.91 88.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.95 -0.3 . . . . 3.49 110.838 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -73.12 -34.86 66.38 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.866 -0.333 . . . . 1.49 110.329 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -56.2 -51.56 67.61 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.131 -0.486 . . . . 1.07 110.325 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 70.7 t80 -69.92 -40.54 75.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.43 110.887 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -55.8 -47.09 77.75 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.228 -0.442 . . . . 2.87 109.854 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.527 ' N ' ' HG3' ' A' ' 21' ' ' LYS . 16.5 m -77.33 -45.4 26.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.411 -0.358 . . . . 1.21 111.01 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.614 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 67.4 t80 -65.08 -28.96 69.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.774 0.287 . . . . 0.53 111.774 -174.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.72 HD23 ' HE3' ' A' ' 48' ' ' LYS . 16.5 tp -115.46 -56.09 2.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.253 -0.579 . . . . 1.23 112.087 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 51.7 mt-10 -91.41 -3.43 56.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.423 . . . . 1.24 111.634 -172.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.65 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -114.91 25.34 10.15 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.693 -0.963 . . . . 0.83 110.693 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.4 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.4 t80 -52.41 -49.37 85.84 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.308 0.484 . . . . 0.94 112.308 -174.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 69.5 Cg_endo -81.37 4.3 7.11 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.154 1.903 . . . . 0.9 115.142 -176.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -103.14 -1.94 28.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.914 -0.714 . . . . 1.49 111.675 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.771 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.5 m0 -72.29 154.18 41.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.546 0.689 . . . . 5.66 111.067 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.572 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 47.5 m95 -83.47 -38.36 0.72 Allowed Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 114.968 -1.015 . . . . 3.41 113.071 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.771 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 20.0 Cg_endo -59.41 -79.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 122.31 2.007 . . . . 1.36 114.414 -165.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.645 ' ND2' HD21 ' A' ' 84' ' ' ASN . 57.3 t30 -106.85 -16.16 14.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.278 0.561 . . . . 1.51 109.864 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.716 ' HA ' HG21 ' A' ' 40' ' ' VAL . 1.8 m-20 -97.8 20.66 11.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.709 . . . . 1.98 111.612 -168.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -79.77 -29.8 40.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.449 . . . . 5.13 111.492 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 36' ' ' ARG . 33.3 mmt180 -90.92 142.97 27.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.538 0.57 . . . . 4.7 112.538 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 39' ' ' LYS . 26.9 p -77.01 151.93 35.4 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 3.11 111.02 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 57' ' ' ASP . 7.0 p 54.48 6.81 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.396 1.078 . . . . 1.89 112.462 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 37' ' ' THR . 72.5 tttt -94.73 -135.45 0.2 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.207 -2.146 . . . . 3.45 105.207 161.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' A' ' 34' ' ' ASN . 17.1 m -93.0 20.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.423 0.63 . . . . 2.3 110.71 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -132.54 39.86 1.69 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.68 -0.691 . . . . 2.2 112.431 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 1.057 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -88.78 160.43 44.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.639 -0.874 . . . . 1.31 108.639 171.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.6 -17.6 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 124.134 3.223 . . . . 1.94 116.14 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 45' ' ' GLY . 48.1 tp -97.42 -97.38 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.874 -0.516 . . . . 2.23 111.184 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.67 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 109.14 -55.97 0.48 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.67 -0.776 . . . . 0.94 112.722 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.634 HG12 HD11 ' A' ' 24' ' ' LEU . 94.2 t -139.9 139.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.078 0.466 . . . . 1.21 111.582 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.691 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 19.4 t70 -105.68 102.71 12.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.422 -0.808 . . . . 1.11 109.431 174.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.72 ' HE3' HD23 ' A' ' 24' ' ' LEU . 25.3 mtpt -80.52 -12.17 59.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 3.25 111.82 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.6 ptpp? -83.86 -43.7 15.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.946 -0.302 . . . . 3.63 111.214 -174.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.9 -32.9 5.71 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.909 -0.662 . . . . 1.9 111.793 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 68' ' ' ILE . . . 102.67 58.4 0.76 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.563 -0.827 . . . . 0.87 112.771 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -144.72 149.54 35.77 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.723 -0.281 . . . . 4.26 110.532 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -100.33 115.27 29.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.258 -0.645 . . . . 1.52 109.258 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.691 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 6.8 p90 -160.97 149.1 15.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.469 . . . . 2.04 110.118 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 1.057 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.3 mp0 -113.06 169.13 9.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.48 -0.563 . . . . 2.12 109.48 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.457 HD11 ' HG2' ' A' ' 61' ' ' GLU . 32.8 mm -77.55 103.3 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.621 -0.511 . . . . 1.42 109.621 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.757 ' HB3' HE22 ' A' ' 59' ' ' GLN . 8.1 t70 -101.75 159.52 15.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 1.97 110.267 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.019 1.118 . . . . 2.43 114.019 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.757 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -86.31 8.16 22.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.102 -0.639 . . . . 2.39 111.441 -175.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.4 62.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.245 -0.978 . . . . 2.29 113.693 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.457 ' HG2' HD11 ' A' ' 56' ' ' ILE . 41.1 mt-10 52.24 35.2 16.28 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.816 0.672 . . . . 2.31 112.816 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -108.11 85.43 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.469 0.652 . . . . 2.61 110.745 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -121.84 158.63 28.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 4.63 110.05 175.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.594 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 3.2 t -134.58 115.41 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.334 -0.393 . . . . 2.27 110.405 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.799 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 37.6 t80 -131.4 -46.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 7.39 111.329 174.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.516 ' HA3' HD13 ' A' ' 79' ' ' ILE . . . -157.29 156.6 27.39 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.38 -1.391 . . . . 1.23 113.949 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 HD21 ' HD2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -116.89 110.42 18.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.397 -0.594 . . . . 1.76 109.397 177.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.542 HG23 ' CG2' ' A' ' 71' ' ' VAL . 35.5 mt -80.83 136.29 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 1.26 111.228 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -101.94 -34.17 9.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.264 -0.88 . . . . 2.65 109.212 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -149.7 129.27 13.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.687 -0.688 . . . . 2.03 110.97 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 68' ' ' ILE . 44.1 t -112.87 93.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.75 -0.833 . . . . 1.47 108.75 172.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.78 70.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.544 -0.298 . . . . 1.42 111.7 -172.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.619 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 47.27 -173.34 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 124.539 1.15 . . . . 0.96 112.505 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.4 Cg_exo -61.48 82.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.406 1.404 . . . . 0.48 111.195 166.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.47 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 28.2 t70 -168.29 -68.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.606 . . . . 0.5 110.572 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.706 HG23 ' HA ' ' A' ' 100' ' ' THR . 1.8 p -144.55 144.86 31.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.22 0.533 . . . . 1.1 112.154 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -135.14 117.33 15.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.672 -0.694 . . . . 1.4 109.29 177.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 t -93.47 105.66 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.42 -0.956 . . . . 1.31 108.42 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.516 HD13 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -128.58 130.58 69.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.999 -0.546 . . . . 1.48 111.3 -169.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.771 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.44 153.11 20.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.301 -0.476 . . . . 0.5 112.082 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.661 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 65.0 t-105 -85.82 132.81 34.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 3.37 111.532 -172.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.594 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 6.8 ttt180 -137.56 28.68 2.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.687 -0.688 . . . . 6.17 109.644 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.799 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 19.0 tp 77.52 167.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.87 -1.059 . . . . 2.13 112.147 172.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.645 HD21 ' ND2' ' A' ' 33' ' ' ASN . 1.5 m-20 -82.67 5.29 21.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.711 -0.477 . . . . 1.93 109.711 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.98 38.5 92.94 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.691 -0.686 . . . . 2.79 113.049 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -137.95 91.56 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.946 0.403 . . . . 6.08 112.018 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.6 2.35 21.25 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.628 -0.714 . . . . 2.43 114.755 168.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.5 mmp_? -112.76 -176.27 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 117.239 0.519 . . . . 5.53 110.266 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.407 ' O ' HD11 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -101.78 136.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.111 -0.495 . . . . 2.42 110.121 177.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 7.5 p-10 -97.88 140.09 21.71 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.916 0.389 . . . . 3.18 110.403 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 93' ' ' ASN . 36.9 Cg_exo -61.4 -46.02 16.32 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.833 2.355 . . . . 2.76 111.856 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 73.05 -40.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.045 0.841 . . . . 2.99 112.638 173.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 91' ' ' PRO . 7.7 p30 -76.12 -36.37 58.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.839 0.681 . . . . 3.06 112.839 -169.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.5 p -165.79 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.743 -0.383 . . . . 2.11 111.773 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.661 ' CB ' ' HB3' ' A' ' 81' ' ' TRP . 44.3 m 55.37 30.24 14.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.419 0.628 . . . . 1.81 110.671 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.771 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.8 tt0 -62.71 124.32 20.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.855 -1.066 . . . . 1.81 111.275 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.584 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 8.5 p90 -125.9 136.12 52.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.164 0.507 . . . . 0.81 110.738 174.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 31.9 m -89.43 115.49 26.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.578 -0.737 . . . . 1.18 110.266 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.667 ' HA ' HG21 ' A' ' 113' ' ' VAL . 99.2 t -91.0 108.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.283 -0.636 . . . . 1.51 109.283 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.706 ' HA ' HG23 ' A' ' 76' ' ' THR . 15.6 m -106.77 104.96 14.77 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.105 -0.498 . . . . 1.05 110.909 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.634 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.7 m-85 -82.64 102.6 11.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.34 -0.615 . . . . 0.42 109.34 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -91.54 108.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.319 -0.623 . . . . 1.26 109.319 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 1.07 ' HB2' ' HE ' ' A' ' 16' ' ' ARG . . . -57.4 124.45 18.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.944 -0.571 . . . . 1.13 109.967 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.731 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 12.7 t70 -109.15 103.3 12.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.969 -0.752 . . . . 2.03 108.969 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.2 -106.53 1.91 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.854 -0.898 . . . . 1.97 110.854 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.842 ' HA ' HE21 ' A' ' 106' ' ' GLN . 0.0 OUTLIER -153.64 -9.25 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.337 . . . . 5.46 110.969 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -119.99 -0.16 10.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 3.88 110.722 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.731 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 11.6 mptt -127.39 159.98 32.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.969 -0.752 . . . . 2.94 108.969 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 53.4 m -156.26 114.79 3.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.863 0.363 . . . . 1.2 110.211 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -100.66 111.32 23.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.94 -0.763 . . . . 3.1 108.94 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 10.9 p -85.9 138.04 19.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 1.13 110.319 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -127.41 116.13 19.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.845 . . . . 1.38 109.223 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.766 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 4.1 t -108.37 130.84 60.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.983 -1.008 . . . . 1.58 111.189 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.58 111.34 22.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.303 0.573 . . . . 2.31 110.141 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.803 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 82.0 t60 -113.43 97.23 6.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.148 -0.933 . . . . 2.32 108.864 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.566 ' HG1' ' HA ' ' A' ' 5' ' ' PHE . 34.8 m -145.55 94.71 2.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.967 0.413 . . . . 3.19 111.344 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.622 ' O ' ' HG2' ' A' ' 121' ' ' MET . 15.6 t60 -167.16 -73.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.097 -0.501 . . . . 2.99 110.212 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 128' ' ' ARG . 29.4 t80 -64.96 -47.53 77.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.53 -0.759 . . . . 4.27 112.137 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -37.25 67.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.543 0.687 . . . . 1.81 110.35 -174.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -55.91 -20.88 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.754 -1.112 . . . . 3.84 111.945 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.9 mmt -81.18 19.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.06 0.393 . . . . 2.9 112.06 -171.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.68 163.31 11.24 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.015 -1.088 . . . . 2.26 113.007 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.7 p -65.23 -22.51 66.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.593 -0.303 . . . . 3.02 111.432 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -67.68 -52.69 35.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.681 0.277 . . . . 4.23 110.745 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.748 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 33.4 m170 -60.98 -48.84 79.94 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.602 0.715 . . . . 2.7 110.5 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.81 68.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.213 -0.903 . . . . 1.46 111.037 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 130' ' ' ARG . 35.1 ttpt -75.84 -41.86 51.27 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.798 0.296 . . . . 3.16 111.798 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.748 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.9 ptm180 -64.03 -30.58 71.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.915 -0.314 . . . . 2.97 110.68 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.71 -32.13 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 120.423 -0.511 . . . . 1.96 110.593 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 21.9 tpp85 -61.77 -15.17 38.99 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.489 0.716 . . . . 4.34 111.376 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 53.0 m-20 -52.04 -21.67 3.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.643 0.979 . . . . 2.8 113.643 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.07 -39.16 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 119.252 -1.452 . . . . 2.08 114.053 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.507 ' HE3' ' CG ' ' A' ' 88' ' ' ARG . 12.9 mmt -74.24 -9.29 58.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 5.19 111.285 -171.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 16.3 t70 -62.22 -22.75 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.635 -0.712 . . . . 2.83 111.461 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.65 -30.7 12.32 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.886 -0.326 . . . . 4.47 110.857 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -69.65 -50.21 32.22 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.092 -0.575 . . . . 1.04 112.491 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.459 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.6 t-105 -54.85 -52.19 72.74 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.186 0.439 . . . . 3.78 112.186 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -60.25 -36.95 86.03 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.646 1.564 . . . . 0.77 112.069 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.3 m -68.4 -35.52 77.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.514 0.673 . . . . 1.37 109.623 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.64 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 16.5 mt -58.54 -44.63 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.876 -1.057 . . . . 1.32 110.578 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.558 HD13 ' CD2' ' A' ' 8' ' ' HIS . 70.9 mt -63.74 -33.23 75.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.187 0.44 . . . . 1.33 112.187 -175.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.53 -54.76 12.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.961 0.41 . . . . 1.54 110.314 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.646 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 48.9 m -65.87 -22.02 66.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 1.43 111.144 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 23' ' ' PHE . 54.5 t80 -65.95 -53.45 38.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.308 0.575 . . . . 1.05 109.559 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.796 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 45.1 mt-30 -61.64 -29.82 70.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.277 -0.874 . . . . 1.63 110.25 176.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.95 -43.75 57.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.853 -1.067 . . . . 1.46 110.529 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HD3' ' NE1' ' A' ' 31' ' ' TRP . 28.1 tptp -65.79 -43.19 89.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.713 0.292 . . . . 2.23 110.584 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.676 HG23 HG11 ' A' ' 12' ' ' VAL . 57.5 mt -62.37 -40.14 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 1.17 111.368 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.963 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 28.5 t70 -65.53 -27.33 68.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.318 -0.401 . . . . 0.85 110.872 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -64.5 -39.06 93.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.511 0.672 . . . . 1.5 109.537 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -74.73 -29.26 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.373 -1.285 . . . . 1.74 108.906 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -74.26 -74.94 0.81 Allowed Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 114.817 -1.083 . . . . 1.32 112.345 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -164.35 23.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.76 0.652 . . . . 2.42 112.76 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -69.9 -75.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.369 -0.532 . . . . 2.04 110.601 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.812 -1.089 . . . . 4.65 110.409 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' ' 7' ' ' ARG . 25.3 p-10 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.883 0.373 . . . . 2.1 110.457 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.598 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 32.1 p90 179.66 -32.84 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 4.04 109.713 -174.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.712 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.0 t70 -73.16 -55.0 4.02 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 111.959 0.355 . . . . 2.78 111.959 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.712 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.5 Cg_endo -93.69 -62.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.172 1.914 . . . . 1.83 112.998 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.424 ' CD2' HG23 ' A' ' 116' ' ' THR . 96.2 m-85 -144.31 118.88 9.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 3.98 110.421 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 1.044 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 97.3 t -85.05 125.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.9 -0.778 . . . . 2.03 108.9 167.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 36.6 ttp85 -132.38 136.72 47.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.026 -0.534 . . . . 3.92 109.787 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 1.059 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 3.2 t-160 -108.38 132.31 53.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.491 -0.929 . . . . 1.16 108.491 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 13.4 m -136.17 118.91 16.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.251 0.548 . . . . 1.72 110.716 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.656 ' HB ' HG11 ' A' ' 111' ' ' VAL . 2.7 t -137.31 134.19 46.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.158 -0.928 . . . . 1.89 111.086 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -101.8 114.98 29.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.435 0.636 . . . . 1.15 109.808 173.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.669 HG11 HG21 ' A' ' 148' ' ' ILE . 38.5 t -95.57 136.27 27.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.296 -0.866 . . . . 1.51 109.726 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 36.05 2.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.726 0.269 . . . . 1.6 111.726 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.84 31.63 0.36 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.93 0.345 . . . . 1.11 111.93 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.8 t70 75.22 164.06 0.27 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.861 0.838 . . . . 0.91 112.732 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 14.6 ttp180 -66.47 -25.72 66.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.686 -1.143 . . . . 2.19 111.544 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.055 -0.258 . . . . 3.49 110.828 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -68.33 -35.14 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.995 -0.282 . . . . 1.49 110.362 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.28 -48.98 75.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 1.07 110.613 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.508 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 84.7 t80 -72.57 -50.6 24.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.43 111.207 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -52.35 -49.7 63.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.03 -0.532 . . . . 2.87 111.158 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 m -67.56 -51.09 54.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.982 -0.554 . . . . 1.21 110.792 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 73.6 t80 -58.93 -40.48 84.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.349 0.5 . . . . 0.53 112.349 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -104.46 -50.39 3.33 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.271 -0.572 . . . . 1.23 112.31 -172.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.775 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 53.9 mt-10 -86.24 -6.94 58.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.76 0.314 . . . . 1.24 111.631 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -117.15 30.1 6.45 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.374 -0.917 . . . . 0.83 112.525 -176.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.469 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -49.31 -53.84 35.73 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.006 0.373 . . . . 0.94 112.006 -172.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 24.9 Cg_endo -90.57 21.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.921 1.747 . . . . 0.9 114.644 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.6 pt-20 -113.64 -15.88 12.43 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.562 -0.855 . . . . 1.49 113.045 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.641 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -79.61 -176.64 5.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.944 -0.702 . . . . 5.66 109.617 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.511 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 10.2 p-90 -115.32 16.9 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 115.36 1.615 . . . . 3.41 115.36 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.641 ' CD ' ' HB2' ' A' ' 30' ' ' TRP . 57.8 Cg_endo -85.03 -134.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 121.984 1.744 . . . . 1.36 113.136 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.505 ' ND2' HD22 ' A' ' 84' ' ' ASN . 9.7 t30 -67.18 -25.7 66.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 1.51 111.047 -175.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.657 ' HA ' HG22 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -85.94 18.72 2.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.469 -0.787 . . . . 1.98 110.997 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -82.69 -4.13 57.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.5 0.667 . . . . 5.13 109.421 174.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -106.62 164.24 12.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.735 . . . . 4.7 110.199 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 42' ' ' ALA . 1.1 p -98.28 147.29 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.538 -0.301 . . . . 3.11 111.272 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.692 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 19.8 p 54.44 25.0 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.799 0.839 . . . . 1.89 111.941 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.613 ' O ' HG13 ' A' ' 40' ' ' VAL . 20.4 mtmt -111.21 -50.54 2.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.708 -1.133 . . . . 3.45 109.146 165.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -177.5 28.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 124.424 1.078 . . . . 2.3 110.256 175.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.06 29.96 0.59 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.843 -1.17 . . . . 2.2 114.253 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.795 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . . . -78.64 170.46 16.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 117.282 0.541 . . . . 1.31 109.617 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 28.0 Cg_endo -63.26 72.28 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.475 2.116 . . . . 1.94 112.753 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 tp -169.19 -90.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.474 -0.785 . . . . 2.23 109.687 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.38 -88.9 0.53 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.334 -0.936 . . . . 0.94 112.46 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 53' ' ' TRP . 57.5 t -139.91 139.89 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.738 0.304 . . . . 1.21 111.114 -172.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.53 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.742 -0.836 . . . . 1.11 108.742 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.775 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 40.3 mtpt -78.93 -18.76 53.27 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.956 0.725 . . . . 3.25 112.956 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -89.2 -45.2 9.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.839 -0.344 . . . . 3.63 110.962 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.39 -38.4 21.57 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.273 -0.731 . . . . 1.9 111.273 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.92 58.31 1.04 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.915 -0.66 . . . . 0.87 112.205 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -159.29 141.07 13.34 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.752 -0.379 . . . . 4.26 110.404 177.058 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.937 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -100.97 135.48 42.36 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.597 -0.441 . . . . 1.52 110.654 177.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.448 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 0.8 OUTLIER -163.02 -179.36 6.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.673 0.608 . . . . 2.04 110.528 179.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.795 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 39.9 mt-10 -132.35 177.64 7.43 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 116.639 -0.255 . . . . 2.12 111.136 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 mm -102.41 102.83 14.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.414 -0.587 . . . . 1.42 109.414 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.692 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-20 -70.27 135.48 48.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.873 0.694 . . . . 1.97 112.873 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.27 -26.57 67.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.854 -1.067 . . . . 2.43 111.151 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.639 HE21 ' HB3' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -82.8 -7.23 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 2.39 111.447 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.92 72.24 0.63 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.554 -0.832 . . . . 2.29 112.598 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 37.6 77.22 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.408 1.262 . . . . 2.31 114.408 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 18.7 mm-40 -129.18 73.16 1.5 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.61 109.929 170.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 1.3 p80 -110.54 157.81 19.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.766 -1.106 . . . . 4.63 111.502 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.763 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 37.6 p -83.66 151.96 25.02 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.726 -0.842 . . . . 2.27 108.726 169.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.5 p90 -108.78 111.72 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.228 -0.589 . . . . 7.39 110.51 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' A' ' 53' ' ' TRP . . . -63.36 129.64 40.3 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.047 -0.821 . . . . 1.23 111.047 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.5 HD13 ' HD3' ' A' ' 82' ' ' ARG . 4.4 mp -78.74 87.57 4.63 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.824 -0.35 . . . . 1.76 110.918 -170.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.681 HG21 HG12 ' A' ' 71' ' ' VAL . 13.7 mt -92.1 115.35 30.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.001 -1.08 . . . . 1.26 109.321 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -104.82 -12.58 16.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.313 -0.858 . . . . 2.65 110.596 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 19.5 ttmm -151.82 107.38 3.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 2.03 111.332 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 68' ' ' ILE . 2.5 m -103.14 85.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 1.47 108.568 167.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.19 72.82 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 1.42 111.08 -172.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 46.96 -171.88 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 124.684 1.24 . . . . 0.96 112.288 175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.3 Cg_exo -64.04 76.05 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.518 1.479 . . . . 0.48 111.411 166.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -159.61 -65.63 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.649 -0.705 . . . . 0.5 110.673 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.459 HG23 ' HA ' ' A' ' 100' ' ' THR . 2.8 p -144.96 143.08 30.34 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.427 0.529 . . . . 1.1 112.427 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.65 120.15 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 1.4 109.668 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 59.0 t -105.73 103.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.474 -0.565 . . . . 1.31 109.474 175.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.732 HG13 ' HE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -129.39 135.07 62.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.973 -0.558 . . . . 1.48 111.701 -174.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.16 147.67 18.69 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.065 -0.814 . . . . 0.5 111.065 174.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.692 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . 52.8 t-105 -78.96 135.65 37.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.237 0.541 . . . . 3.37 111.964 -168.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.763 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.9 tpt180 -130.76 25.93 5.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.423 -0.808 . . . . 6.17 109.641 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.837 HD11 ' HB2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER 81.25 134.78 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.845 -1.07 . . . . 2.13 112.233 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.53 ' N ' HD12 ' A' ' 83' ' ' LEU . 5.1 t30 -108.53 109.67 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.023 -0.99 . . . . 1.93 109.786 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.07 -24.52 8.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.583 -0.818 . . . . 2.79 111.327 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 74.74 -25.71 0.2 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.589 0.756 . . . . 6.08 112.706 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.61 19.11 38.57 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.828 -0.701 . . . . 2.43 113.247 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.837 ' HB2' HD11 ' A' ' 83' ' ' LEU . 41.9 mmt180 -124.88 173.66 8.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.622 -0.51 . . . . 5.53 109.622 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.427 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -74.55 132.12 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.786 0.327 . . . . 2.42 110.73 178.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 10.3 p-10 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 3.18 110.495 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 52.7 Cg_exo -58.25 -37.63 94.47 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.267 2.644 . . . . 2.76 112.597 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER 78.35 -39.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.87 0.731 . . . . 2.99 112.39 169.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -120.06 -30.3 4.71 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.034 0.383 . . . . 3.06 112.034 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.438 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 48.9 m -138.95 -140.89 0.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.926 -0.31 . . . . 2.11 111.832 -175.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.583 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 67.7 m 65.75 24.02 11.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.496 -0.775 . . . . 1.81 109.427 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.796 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.7 tt0 -67.28 136.48 54.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.812 -1.085 . . . . 1.81 110.442 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.635 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 13.9 p90 -137.62 138.03 39.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.273 0.559 . . . . 0.81 110.84 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.559 HG21 HG22 ' A' ' 78' ' ' VAL . 34.1 m -100.26 109.76 21.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.244 -0.889 . . . . 1.18 109.663 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.411 HG12 HG21 ' A' ' 113' ' ' VAL . 1.6 m -87.64 121.6 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 119.591 -0.844 . . . . 1.51 109.122 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.459 ' HA ' HG23 ' A' ' 76' ' ' THR . 27.2 m -102.64 106.84 17.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.345 -0.843 . . . . 1.05 110.339 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.495 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.9 m-85 -82.37 109.82 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.655 -0.498 . . . . 0.42 109.655 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.16 112.52 27.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.572 -0.529 . . . . 1.26 109.572 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 124.38 23.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 1.13 110.568 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.809 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.3 t0 -105.69 103.4 12.9 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.425 -0.954 . . . . 2.03 108.425 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.27 -111.11 3.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.537 -0.84 . . . . 1.97 111.562 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -147.95 -3.93 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.638 0.256 . . . . 5.46 111.255 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.775 ' HB2' ' HZ2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -136.51 8.23 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.288 . . . . 3.88 111.342 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.809 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 36.1 ttmt -126.78 158.15 37.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.999 -0.741 . . . . 2.94 108.999 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.6 m -156.01 130.65 9.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.008 0.433 . . . . 1.2 111.096 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -109.37 112.91 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.82 -0.627 . . . . 3.1 109.741 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.656 HG11 ' HB ' ' A' ' 10' ' ' VAL . 8.7 p -90.95 141.77 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.865 -0.334 . . . . 1.13 110.63 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.7 t70 -135.01 105.72 6.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.354 -0.839 . . . . 1.38 109.857 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 1.059 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 9.5 t -86.3 131.57 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.357 -0.383 . . . . 1.58 111.941 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.82 124.03 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.842 0.714 . . . . 2.31 109.504 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 1.044 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 7.7 t-160 -142.23 102.72 4.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.526 -0.546 . . . . 2.32 109.526 -175.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.424 HG23 ' CD2' ' A' ' 5' ' ' PHE . 8.6 p -149.84 40.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.345 0.498 . . . . 3.19 112.345 -174.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.53 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.1 t-160 -113.37 -65.05 1.22 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.999 -0.68 . . . . 2.99 111.405 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.483 ' HB2' ' H ' ' A' ' 95' ' ' SER . 11.6 t80 -86.18 -49.67 7.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.896 0.379 . . . . 4.27 110.444 -175.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.84 -51.71 68.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.478 -0.783 . . . . 1.81 111.025 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.562 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 5.8 tmm_? -60.89 -19.43 60.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.779 -1.1 . . . . 3.84 111.125 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.53 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 42.3 tpp -80.97 23.07 0.58 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.864 0.364 . . . . 2.9 111.879 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.2 170.42 12.86 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.752 -1.214 . . . . 2.26 114.333 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 t -66.8 -44.48 81.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.894 -0.653 . . . . 3.02 111.676 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -66.13 -39.09 89.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.574 0.226 . . . . 4.23 110.726 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.656 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 10.1 m-70 -61.03 -52.85 63.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 2.7 110.486 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -64.73 -35.95 82.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 1.46 111.025 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -64.03 -46.45 84.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 3.16 111.405 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.656 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 8.3 ptm180 -64.93 -39.57 93.72 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.439 -0.346 . . . . 2.97 111.305 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 125' ' ' HIS . 2.8 p -81.33 -17.83 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.315 0.579 . . . . 1.96 110.987 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 61.7 ttt180 -68.74 -9.73 52.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.155 -0.341 . . . . 4.34 111.43 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.727 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.3 p30 -47.12 -40.06 14.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.561 0.578 . . . . 2.8 112.561 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.463 ' C ' ' HE3' ' A' ' 133' ' ' MET . . . -145.52 -11.24 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.072 -1.061 . . . . 2.08 113.381 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.527 ' SD ' ' HB3' ' A' ' 84' ' ' ASN . 22.6 mmt -79.43 -11.68 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.342 -0.505 . . . . 5.19 110.277 -172.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.66 -39.67 92.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.507 -0.769 . . . . 2.83 110.961 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -104.8 14.07 30.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 4.47 110.552 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -77.57 -78.18 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.925 -0.579 . . . . 1.04 111.828 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.545 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 13.6 m95 -55.62 -47.92 97.6 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 113.58 0.956 . . . . 3.78 113.58 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.9 Cg_endo -50.93 -43.64 46.25 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.839 1.693 . . . . 0.77 112.213 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.1 m -73.22 -45.72 54.54 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.432 0.634 . . . . 1.37 110.639 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 56.5 mt -58.38 -44.99 89.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 115.371 -0.831 . . . . 1.32 111.361 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 51.2 mt -59.86 -38.81 83.21 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.278 0.361 . . . . 1.33 111.054 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.1 mm-40 -61.5 -50.93 70.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.544 -0.462 . . . . 1.54 109.854 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 51.0 m -65.58 -28.4 69.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.604 -0.725 . . . . 1.43 110.817 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 60.0 t80 -68.27 -55.3 12.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 1.05 111.135 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -35.1 73.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.855 0.36 . . . . 1.63 111.076 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.26 -40.96 62.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.916 -0.584 . . . . 1.46 110.673 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.424 ' HE3' ' HG3' ' A' ' 29' ' ' GLU . 29.7 tptp -60.62 -38.52 85.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.361 0.601 . . . . 2.23 109.902 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.669 HG21 HG11 ' A' ' 12' ' ' VAL . 52.2 mt -74.45 -26.82 20.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.497 -0.774 . . . . 1.17 111.082 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.84 -31.22 72.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.477 -0.564 . . . . 0.85 109.477 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.816 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 37.5 mt-10 -66.28 -33.09 74.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 1.5 109.74 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -71.86 -23.46 61.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.081 -0.963 . . . . 1.74 109.646 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -98.89 -88.7 1.95 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.32 112.951 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.8 30.58 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.314 0.487 . . . . 2.42 112.314 -171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.816 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 16.9 tppt? -68.42 -19.63 64.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.491 0.662 . . . . 2.04 110.361 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.171 -0.922 . . . . 4.65 111.243 -176.273 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.97 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.7 p-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.934 -0.395 . . . . 1.66 109.934 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.548 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 p90 69.87 -40.78 0.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.413 1.485 . . . . 3.73 112.684 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.796 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 18.8 t70 -67.06 -54.58 19.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.216 -0.29 . . . . 2.78 110.216 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 32.6 Cg_endo -87.89 -64.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.66 1.573 . . . . 1.63 111.323 169.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.32 152.27 31.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.257 -1.016 . . . . 3.21 108.257 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.97 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -109.58 126.2 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.094 0.473 . . . . 1.44 109.98 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 20.6 ttp85 -130.99 135.17 47.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 3.37 110.453 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.585 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.79 132.42 54.17 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.567 -0.531 . . . . 0.79 109.567 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.9 p -135.44 116.27 14.05 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.883 -0.599 . . . . 1.28 110.887 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 111' ' ' VAL . 15.5 m -125.02 156.06 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.845 -0.616 . . . . 1.27 110.869 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.7 m -109.82 116.83 32.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.536 -0.756 . . . . 0.57 109.93 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.921 HG13 HG21 ' A' ' 148' ' ' ILE . 37.1 t -93.79 138.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.273 -0.876 . . . . 0.91 110.77 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -96.8 7.76 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.98 112.256 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.03 47.09 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.533 -0.467 . . . . 0.36 112.233 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.5 t70 75.07 163.17 0.26 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.075 0.941 . . . . 0.91 112.973 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.571 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 27.9 ttp180 -62.34 -25.62 67.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.387 -1.279 . . . . 1.88 110.783 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 17' ' ' LYS . 33.8 ttpt -57.65 -49.47 76.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 3.05 110.988 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.4 p -75.43 -31.93 60.51 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.808 -0.357 . . . . 1.11 110.935 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.836 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -60.98 -46.75 89.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.755 -0.378 . . . . 0.32 110.637 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.423 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 73.4 t80 -67.14 -42.32 84.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.38 110.657 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.917 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 19.8 tptm -56.12 -52.8 63.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.45 . . . . 2.39 110.518 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.603 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 18.7 m -72.01 -22.58 61.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.952 -0.567 . . . . 0.68 111.553 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -88.99 -36.93 15.56 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.182 -0.324 . . . . 0.48 111.558 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -119.82 -48.88 2.35 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.245 0.832 . . . . 0.5 113.245 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.917 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 20.5 mt-10 -75.08 -29.21 60.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.808 0.813 . . . . 1.24 110.354 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.86 99.15 0.7 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 108.244 -1.942 . . . . 0.83 108.244 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.632 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.6 t80 -96.17 -56.64 0.2 Allowed Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 115.704 -0.248 . . . . 0.74 111.58 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.675 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 40.9 Cg_endo -103.43 39.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.095 2.53 . . . . 0.76 114.493 -172.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.81 -2.86 5.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.905 -0.718 . . . . 1.49 112.894 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.778 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 17.0 m95 -90.6 -155.87 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 4.62 110.748 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 10.6 m95 -110.91 6.15 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.929 1.455 . . . . 2.78 114.929 -172.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.999 ' HB2' HD12 ' A' ' 140' ' ' ILE . 74.4 Cg_endo -88.32 -140.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 122.108 1.788 . . . . 1.36 112.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HB3' HD11 ' A' ' 140' ' ' ILE . 62.7 t30 -67.69 -20.42 65.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.848 0.832 . . . . 1.51 110.004 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.865 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.2 m-20 -77.05 19.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.567 -1.197 . . . . 1.79 111.675 -171.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.28 -3.85 19.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.937 0.399 . . . . 4.45 110.696 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.87 142.76 27.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.414 . . . . 4.14 110.89 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 m -76.83 138.63 39.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 2.68 111.298 -172.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.2 p 57.06 8.16 0.5 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.731 1.212 . . . . 1.42 113.32 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.857 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 32.4 ttmt -91.48 -73.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.98 -0.748 . . . . 2.9 108.98 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.865 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.7 m -147.08 18.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.404 -0.816 . . . . 1.83 109.142 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -140.38 51.02 0.74 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.424 -0.807 . . . . 2.17 113.3 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.089 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -94.25 172.8 5.25 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.634 -0.876 . . . . 1.12 108.634 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 32.7 Cg_endo -65.01 62.44 0.3 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.659 2.24 . . . . 1.48 113.475 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 42.3 tp -170.51 -91.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 1.75 110.268 175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 27' ' ' PHE . . . 94.76 -63.62 1.54 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.811 -0.709 . . . . 0.75 112.791 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 27' ' ' PHE . 77.1 t -137.87 139.23 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.977 -0.379 . . . . 0.6 109.977 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.678 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 24.6 t70 -105.43 118.33 36.28 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.054 -0.721 . . . . 1.11 109.054 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -80.06 -35.5 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.613 -0.721 . . . . 2.81 111.622 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.41 -38.88 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.711 0.263 . . . . 3.17 111.711 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -36.29 6.24 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.765 -0.731 . . . . 1.53 112.118 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 93.33 65.65 1.07 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.664 -0.779 . . . . 0.77 112.155 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' CD2' ' A' ' 54' ' ' TYR . 11.9 ptt180 -159.34 148.06 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.647 -0.421 . . . . 3.72 111.574 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.8 m0 -95.38 108.53 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.28 110.203 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.678 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -158.57 162.48 37.38 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.993 0.425 . . . . 1.66 110.305 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.089 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 11.6 mp0 -122.26 165.74 15.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.122 -0.695 . . . . 2.12 109.122 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.593 HG23 ' HG2' ' A' ' 61' ' ' GLU . 47.9 mm -77.37 102.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.937 -0.764 . . . . 0.92 108.937 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.79 144.1 39.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 1.97 110.679 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.11 -27.73 69.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.138 -0.937 . . . . 2.43 111.918 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -74.91 -22.83 58.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 2.39 111.285 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.11 50.18 0.03 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.004 -1.093 . . . . 2.29 113.919 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.593 ' HG2' HG23 ' A' ' 56' ' ' ILE . 44.9 mt-10 63.02 16.34 9.2 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.368 0.877 . . . . 2.31 113.368 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 10.1 tp10 -105.34 82.39 1.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.638 0.732 . . . . 2.61 110.389 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -111.08 148.48 32.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.095 -0.957 . . . . 3.72 110.728 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.706 HG23 ' HD3' ' A' ' 82' ' ' ARG . 3.3 t -54.69 140.76 34.63 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.451 -0.944 . . . . 2.27 108.451 167.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.8 p90 -129.89 143.99 51.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.472 0.653 . . . . 6.48 112.394 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 128.22 8.44 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.55 -1.02 . . . . 1.23 110.55 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 67' ' ' LEU . 3.8 mp -85.87 89.23 7.71 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 111.438 0.162 . . . . 1.17 111.438 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.963 HG21 HG13 ' A' ' 71' ' ' VAL . 58.4 mt -80.62 116.16 24.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.014 -0.674 . . . . 0.61 110.024 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 67' ' ' LEU . 4.9 mpt_? -98.59 -25.24 14.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.713 -0.477 . . . . 2.0 109.713 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HD3' ' HB2' ' A' ' 72' ' ' ASP . 18.0 ttmm -139.52 121.56 15.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 1.53 111.774 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.963 HG13 HG21 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -111.79 85.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.665 -0.865 . . . . 0.88 108.665 167.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -96.45 70.74 2.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.16 -0.473 . . . . 1.42 110.69 -170.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 8.2 pt-20 49.43 -172.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 124.523 1.139 . . . . 0.96 111.188 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 35.7 Cg_exo -63.48 77.33 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.294 1.329 . . . . 0.38 111.058 163.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.6 t70 -159.72 -68.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.5 110.549 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.2 p -139.42 143.05 37.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.559 0.577 . . . . 0.35 112.559 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.94 117.41 16.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.864 -0.607 . . . . 0.74 109.597 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 98' ' ' THR . 41.2 t -104.35 103.18 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.475 . . . . 0.67 109.719 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.579 HG12 ' N ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -129.5 142.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.79 -0.641 . . . . 0.75 112.139 -175.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.579 ' N ' HG12 ' A' ' 79' ' ' ILE . . . -86.5 158.06 30.76 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.56 -0.745 . . . . 0.5 111.523 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.422 ' H ' ' HB2' ' A' ' 95' ' ' SER . 70.9 t-105 -78.78 155.09 29.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.954 0.724 . . . . 2.79 112.954 -170.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.706 ' HD3' HG23 ' A' ' 64' ' ' THR . 0.0 OUTLIER -125.43 -78.34 0.6 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.822 -1.081 . . . . 5.46 110.747 -176.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.639 HD21 ' HG2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 172.0 146.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.971 -1.122 . . . . 1.55 107.971 -176.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.575 ' H ' HD13 ' A' ' 83' ' ' LEU . 25.3 t-20 -117.88 -62.96 1.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.399 0.518 . . . . 1.93 112.399 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.69 -10.6 83.15 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.792 -0.718 . . . . 2.4 114.466 -169.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.857 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 19.6 t80 64.95 14.58 9.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.73 0.776 . . . . 5.38 110.604 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 34.06 2.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.209 -1.156 . . . . 2.3 110.209 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HG2' HD21 ' A' ' 83' ' ' LEU . 2.6 ttp180 -137.41 162.21 34.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.889 -0.655 . . . . 4.77 110.878 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.575 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -109.06 127.09 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.509 -0.552 . . . . 1.86 109.509 175.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.628 ' HB2' HD23 ' A' ' 83' ' ' LEU . 6.1 m-20 -144.07 149.96 47.39 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.778 -0.647 . . . . 3.18 109.657 171.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 16.0 Cg_exo -69.29 -12.95 34.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.192 2.595 . . . . 2.36 114.322 -171.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 60.88 33.58 19.88 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.459 0.647 . . . . 2.99 109.975 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' HA ' HD21 ' A' ' 67' ' ' LEU . 11.6 m-80 -141.87 -80.68 0.23 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.618 . . . . 3.06 112.603 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 m -78.41 -125.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.401 0.519 . . . . 1.85 112.401 -170.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.645 ' HB3' ' HE1' ' A' ' 115' ' ' HIS . 16.2 m 70.85 -75.29 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.733 -0.667 . . . . 1.44 110.994 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 60.4 116.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.144 0.794 . . . . 1.81 113.144 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HB3' ' CG ' ' A' ' 115' ' ' HIS . 18.6 p90 -132.15 129.39 39.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.14 0.495 . . . . 0.64 110.985 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.502 HG23 HG22 ' A' ' 78' ' ' VAL . 47.8 m -89.98 107.35 19.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.23 -0.896 . . . . 0.43 109.758 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.754 ' HA ' HG22 ' A' ' 113' ' ' VAL . 98.3 t -81.84 109.73 16.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.866 -0.606 . . . . 0.87 109.961 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.474 ' HA ' HG22 ' A' ' 76' ' ' THR . 27.5 m -105.9 105.95 16.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.835 0.35 . . . . 0.45 110.981 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.612 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 49.7 m-85 -86.0 110.97 19.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.75 -0.463 . . . . 0.34 109.75 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.2 t -91.87 109.35 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.312 -0.625 . . . . 0.54 109.312 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.65 132.62 42.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.46 0.648 . . . . 0.44 111.908 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -108.0 123.16 48.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.402 -0.962 . . . . 2.03 108.402 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.93 -25.48 37.89 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.623 0.609 . . . . 1.97 114.623 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -85.12 39.5 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.453 0.626 . . . . 4.93 110.909 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 42.2 mmtt 58.53 46.74 14.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.996 0.903 . . . . 3.53 110.241 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.9 tttm -135.6 155.39 50.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.224 -1.353 . . . . 2.44 107.853 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 48.3 m -155.13 119.46 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.873 -0.517 . . . . 0.42 111.646 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -95.78 112.71 24.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.512 -0.767 . . . . 2.59 109.705 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.762 HG12 HG22 ' A' ' 10' ' ' VAL . 14.6 p -88.7 136.89 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 120.119 -0.633 . . . . 0.4 109.822 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.432 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 7.4 t70 -126.28 108.35 11.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.426 1.079 . . . . 1.38 108.607 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 99' ' ' VAL . 10.1 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.622 -0.717 . . . . 0.91 111.425 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.69 111.49 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.632 0.583 . . . . 2.31 109.495 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.645 ' HE1' ' HB3' ' A' ' 95' ' ' SER . 6.1 t60 -123.13 118.02 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.482 -0.562 . . . . 1.64 109.482 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.82 HG23 ' HD2' ' A' ' 120' ' ' ARG . 85.0 m -158.78 103.68 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.124 -0.23 . . . . 2.67 111.6 -174.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.98 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.865 0.364 . . . . 2.63 111.099 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.483 ' HZ ' ' HD3' ' A' ' 128' ' ' ARG . 50.4 t80 -78.24 -50.36 12.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.092 -0.503 . . . . 3.54 112.139 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.67 -38.42 77.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.411 0.624 . . . . 1.81 110.041 -174.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.82 ' HD2' HG23 ' A' ' 116' ' ' THR . 20.0 ttt180 -63.6 -20.21 65.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 3.38 111.573 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 31.0 tpp -80.11 29.87 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.099 0.777 . . . . 2.43 113.099 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.76 177.42 16.71 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.637 -1.268 . . . . 1.61 114.547 168.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -55.88 -60.55 3.3 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.812 -0.694 . . . . 2.58 112.745 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.9 -35.54 81.48 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 121.057 -0.257 . . . . 3.8 111.306 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.545 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 24.4 m80 -59.51 -50.93 72.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.973 0.416 . . . . 2.14 110.165 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.46 63.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 0.92 111.118 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 89.0 tttt -69.38 -38.96 78.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.099 -0.5 . . . . 2.83 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.42 -31.64 65.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 2.59 109.686 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.612 HG12 ' HG2' ' A' ' 133' ' ' MET . 87.0 t -61.63 -49.72 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 1.48 111.15 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.693 ' HA ' ' HG3' ' A' ' 133' ' ' MET . 0.0 OUTLIER -65.87 -14.54 61.66 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.162 -0.336 . . . . 3.83 111.443 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -52.51 -28.58 21.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.628 0.371 . . . . 2.48 111.843 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.411 ' H ' ' HD3' ' A' ' 88' ' ' ARG . . . -157.76 15.58 0.3 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.99 -1.1 . . . . 1.61 113.857 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.693 ' HG3' ' HA ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -84.22 -26.87 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.899 0.85 . . . . 4.83 111.438 176.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.56 -34.16 77.28 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.962 0.727 . . . . 2.83 112.962 -164.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.38 18.13 22.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.011 0.434 . . . . 4.15 110.579 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 140' ' ' ILE . . . -122.47 -77.34 0.4 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.04 -1.076 . . . . 1.04 112.871 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.474 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 76.0 t-105 -54.33 -51.91 73.8 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.716 0.636 . . . . 2.78 112.716 -169.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.8 -33.29 96.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.809 1.673 . . . . 0.68 111.94 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -76.56 -33.49 58.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.717 -0.674 . . . . 0.87 110.304 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -55.07 -48.16 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 108.596 -0.89 . . . . 0.72 108.596 173.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.0 mt -60.42 -28.36 68.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.261 -0.881 . . . . 0.69 112.002 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 26.4 mm-40 -72.13 -57.4 4.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.154 -0.313 . . . . 1.49 110.154 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.6 m -67.6 -25.93 66.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.12 0.486 . . . . 1.15 110.522 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 10' ' ' VAL . 62.0 t80 -57.8 -55.29 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.422 -0.808 . . . . 0.8 109.956 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.509 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 43.7 mt-30 -68.7 -24.63 64.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.763 -0.653 . . . . 1.63 110.939 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.25 -45.39 40.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.285 . . . . 1.46 111.593 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.778 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 15.2 tptm -70.23 -31.36 68.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.631 -0.828 . . . . 1.74 110.263 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.921 HG21 HG13 ' A' ' 12' ' ' VAL . 49.9 mt -63.43 -37.36 79.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.484 0.659 . . . . 0.5 109.635 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.482 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 11.5 t70 -59.33 -36.97 76.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.174 -0.921 . . . . 0.85 109.494 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 3.9 mm-40 -63.72 -41.04 98.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.507 -0.77 . . . . 1.5 110.673 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 5.7 mm-40 -75.96 -16.01 60.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.899 -1.046 . . . . 1.74 109.839 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -102.0 -75.88 1.14 Allowed Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.409 -0.814 . . . . 1.32 113.235 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.19 13.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.28 0.845 . . . . 1.92 113.28 -169.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 21.9 ttmm -71.47 -39.66 70.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 2.04 109.164 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' A' ' 155' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.475 -0.784 . . . . 4.22 110.031 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.643 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 2.8 p30 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.548 0.214 . . . . 1.66 110.989 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.498 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 54.8 p90 169.96 -30.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 3.73 109.62 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.835 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 31.6 t70 -65.87 -54.26 29.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 2.78 110.927 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.835 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -91.23 -68.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.133 1.889 . . . . 1.63 111.176 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 12.0 p90 -153.69 159.26 41.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.061 -0.518 . . . . 3.21 109.652 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.931 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 79.0 t -97.49 128.63 48.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.965 -0.754 . . . . 1.44 108.965 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 15.9 ttp180 -117.33 142.43 47.11 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.954 -0.698 . . . . 3.37 111.536 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.522 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -124.04 133.39 53.66 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.387 -0.968 . . . . 0.79 108.387 172.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.766 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 6.6 t -139.8 111.35 7.2 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.881 -0.414 . . . . 1.28 109.881 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.744 HG22 ' CG1' ' A' ' 111' ' ' VAL . 6.3 m -126.2 151.45 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 1.27 110.955 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.8 m -103.38 115.74 31.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.507 -0.769 . . . . 0.57 110.158 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.819 HG21 ' HB2' ' A' ' 19' ' ' ALA . 55.9 t -97.51 125.6 50.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.251 -0.886 . . . . 0.91 110.013 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.682 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.68 23.94 8.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.799 -0.637 . . . . 0.98 111.886 -173.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -148.23 31.04 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.36 111.055 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 37.7 t70 72.32 167.26 0.31 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.13 0.967 . . . . 0.91 113.504 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.547 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 34.3 ttp180 -63.47 -27.79 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.232 -1.349 . . . . 1.88 111.226 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.36 -45.08 84.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 3.05 111.141 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -77.36 -40.59 43.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.798 -0.361 . . . . 1.11 110.739 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.819 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.56 -41.68 77.28 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 120.886 -0.325 . . . . 0.32 110.904 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.31 -47.31 43.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.613 0.244 . . . . 0.38 110.949 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -54.12 -52.53 60.76 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.298 -0.41 . . . . 2.39 110.37 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -65.5 -51.03 62.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.367 -0.379 . . . . 0.68 111.031 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.784 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.4 t80 -61.22 -37.55 83.41 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.406 0.521 . . . . 0.48 112.406 -173.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.663 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -113.02 -50.06 2.9 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.195 -0.602 . . . . 0.5 112.469 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HA ' ' CE ' ' A' ' 48' ' ' LYS . 36.6 mt-10 -78.36 -35.28 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.071 0.462 . . . . 1.24 111.15 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.756 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -105.36 35.52 5.01 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 115.642 -0.708 . . . . 0.83 112.084 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.578 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 62.0 t80 -52.56 -51.27 74.73 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.968 0.729 . . . . 0.74 112.968 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.05 -2.01 11.79 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.11 1.873 . . . . 0.76 114.801 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.756 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.5 pt-20 -90.75 -5.45 55.68 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.227 -0.589 . . . . 1.49 112.183 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.784 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 9.7 m0 -74.52 -179.07 3.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.397 0.618 . . . . 4.62 111.259 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.52 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 79.2 m95 -96.18 -32.63 0.27 Allowed Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 114.237 1.199 . . . . 2.78 114.237 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.643 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 68.5 Cg_endo -71.54 -123.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.332 2.021 . . . . 1.36 115.244 -165.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.598 HD22 HG21 ' A' ' 40' ' ' VAL . 6.3 t30 -62.33 -22.74 66.31 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.169 -0.469 . . . . 1.51 111.452 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.799 ' HA ' HG23 ' A' ' 40' ' ' VAL . 11.8 p30 -86.91 17.22 4.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.999 -0.546 . . . . 1.79 111.497 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -71.76 -10.22 59.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.377 0.608 . . . . 4.45 110.037 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -104.3 118.88 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 4.14 111.279 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -77.25 151.39 35.14 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.63 -0.714 . . . . 2.68 109.64 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 57' ' ' ASP . 51.5 p 55.74 25.39 8.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.919 0.866 . . . . 1.42 110.791 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.566 ' HG2' HG22 ' A' ' 40' ' ' VAL . 16.8 ttmm -127.48 -59.67 1.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.61 -1.177 . . . . 2.9 109.723 166.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 34' ' ' ASN . 2.8 m -157.72 28.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.955 -0.566 . . . . 1.83 110.492 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.88 18.31 0.85 Allowed Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.934 -1.127 . . . . 2.17 114.178 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.006 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -73.95 162.67 72.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 117.163 0.482 . . . . 1.12 109.974 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 96.1 Cg_exo -50.05 -5.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 124.645 3.563 . . . . 1.48 116.53 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -105.33 -85.31 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.094 -0.379 . . . . 1.75 110.571 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.578 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.37 -48.28 2.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.884 -0.674 . . . . 0.75 112.976 174.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.663 HG11 ' HG ' ' A' ' 24' ' ' LEU . 73.3 t -140.11 141.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.6 111.289 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.875 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 20.7 t70 -96.38 115.07 26.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.508 -0.552 . . . . 1.11 109.508 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.556 ' CE ' ' HA ' ' A' ' 25' ' ' GLU . 36.4 mmtm -79.65 -27.99 40.85 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.95 0.781 . . . . 2.81 112.23 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -83.09 -46.84 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.425 0.528 . . . . 3.17 112.425 -170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.66 -32.01 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.446 -0.883 . . . . 1.53 111.954 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.553 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 103.95 71.18 0.84 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.348 -0.93 . . . . 0.77 112.239 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -136.25 162.55 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.929 -0.397 . . . . 3.72 109.929 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.0 m95 -116.75 107.75 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.28 108.886 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.875 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.7 p90 -162.64 159.93 25.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.228 0.537 . . . . 1.66 111.109 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 23.4 mt-10 -102.23 -176.01 3.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 2.12 110.051 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.8 mm -105.22 111.57 35.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.767 -0.827 . . . . 0.92 108.767 157.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.713 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 3.5 t70 -91.65 177.72 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.537 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -84.48 -36.14 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.851 0.686 . . . . 2.43 112.851 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -88.26 14.68 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.55 -0.46 . . . . 2.39 111.672 -173.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.75 64.02 0.92 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.356 -0.926 . . . . 2.29 112.811 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.683 ' HA ' ' NE2' ' A' ' 63' ' ' HIS . 0.1 OUTLIER 57.35 74.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.817 1.043 . . . . 2.31 113.817 172.087 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.17 73.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.113 -0.699 . . . . 2.61 109.113 169.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.713 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -125.24 163.31 22.78 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.214 -0.903 . . . . 3.72 110.883 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.609 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 9.0 t -157.09 135.62 11.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.639 0.257 . . . . 2.27 110.602 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.712 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 33.5 t80 -146.93 -58.43 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 6.48 110.558 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.525 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -155.72 159.68 29.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.53 -1.319 . . . . 1.23 114.25 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -119.01 113.81 21.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.668 -0.766 . . . . 1.17 109.696 177.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.004 HG21 HG13 ' A' ' 71' ' ' VAL . 72.3 mt -77.26 132.28 33.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 0.61 110.858 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -102.87 -24.94 13.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.047 -0.979 . . . . 2.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 47.4 tttm -165.79 108.96 0.8 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.559 -0.746 . . . . 1.53 111.192 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.004 HG13 HG21 ' A' ' 68' ' ' ILE . 1.6 m -100.91 115.5 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.362 -0.607 . . . . 0.88 109.362 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.24 74.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.73 -0.388 . . . . 1.42 110.779 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.15 -170.69 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 124.525 1.14 . . . . 0.96 111.944 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 30.7 Cg_exo -64.71 78.26 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.322 1.348 . . . . 0.38 111.093 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 23.5 t70 -161.76 -67.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.5 110.837 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.2 p -142.01 141.97 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.076 0.465 . . . . 0.35 111.805 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.59 126.94 28.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.433 . . . . 0.74 109.845 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 98' ' ' THR . 26.2 t -103.39 109.92 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.629 -0.878 . . . . 0.67 108.629 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.525 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -127.18 127.12 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.334 -0.394 . . . . 0.75 110.249 -174.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.84 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.56 155.75 23.53 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.5 112.339 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 58.3 t-105 -81.68 138.37 35.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.054 0.39 . . . . 2.79 112.054 -171.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 34.8 ttt-85 -148.54 23.16 1.02 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.859 -0.61 . . . . 5.46 109.997 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 78.48 145.48 0.09 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.083 -0.962 . . . . 1.55 112.917 172.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.551 ' H ' HD13 ' A' ' 83' ' ' LEU . 8.1 m-20 -77.85 48.47 0.7 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.499 -0.773 . . . . 1.93 111.37 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.22 46.9 43.19 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 116.126 -0.488 . . . . 2.4 113.916 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.471 ' H ' HD12 ' A' ' 83' ' ' LEU . 28.8 m-85 -106.96 1.81 24.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.159 -0.612 . . . . 5.38 111.211 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.42 24.62 76.62 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.53 -0.843 . . . . 2.3 111.603 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HD3' ' HB3' ' A' ' 131' ' ' ASN . 50.3 mtt180 -98.96 -174.28 2.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.41 -0.395 . . . . 4.77 110.637 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.67 ' O ' HD23 ' A' ' 83' ' ' LEU . 1.7 pp -54.74 149.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.845 0.716 . . . . 1.86 111.292 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 p-10 -146.49 135.15 11.01 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 110.0 -0.37 . . . . 3.18 110.0 175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 81' ' ' TRP . 3.4 Cg_exo -76.58 -37.89 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.446 2.097 . . . . 2.36 111.71 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 70.06 -6.59 1.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.388 -0.824 . . . . 2.99 111.88 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -137.89 -64.69 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 3.06 111.017 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -89.54 -161.49 0.78 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.185 -0.461 . . . . 1.85 111.293 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 3.7 t 67.4 40.0 2.79 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 122.06 0.933 . . . . 1.44 108.605 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.84 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 15.7 mt-10 -81.12 136.76 35.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.359 -1.292 . . . . 1.81 110.012 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -120.23 120.67 36.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.464 0.65 . . . . 0.64 110.563 174.082 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.536 HG23 HG22 ' A' ' 78' ' ' VAL . 41.7 m -93.35 115.27 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.99 -1.005 . . . . 0.43 110.085 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.472 ' CB ' HG23 ' A' ' 113' ' ' VAL . 2.0 m -94.59 123.82 46.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.349 0.595 . . . . 0.87 109.459 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' HG22 ' A' ' 76' ' ' THR . 86.5 m -104.89 106.84 17.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.307 -0.86 . . . . 0.45 109.805 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.691 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.1 m-85 -82.79 110.39 17.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 0.34 109.917 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 109' ' ' THR . 58.8 t -88.17 107.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.759 0.314 . . . . 0.54 110.481 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 129.28 39.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.928 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 5.9 t0 -128.16 97.3 4.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 2.03 110.476 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.45 69.56 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.913 -0.66 . . . . 1.97 113.977 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 66.67 6.64 4.62 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.887 0.699 . . . . 4.93 112.887 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 41.2 mtmt -136.26 -0.42 2.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 3.53 111.378 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 42.4 tttt -138.34 157.97 45.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.223 -0.658 . . . . 2.44 109.223 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.532 ' N ' ' HG2' ' A' ' 108' ' ' LYS . 18.1 m -156.67 128.28 7.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.102 0.477 . . . . 0.42 110.99 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 110' ' ' ARG . 8.5 tpt180 -106.33 115.14 29.7 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.763 -0.828 . . . . 2.59 108.763 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -95.17 141.55 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.291 -0.564 . . . . 0.4 111.005 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.563 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 11.5 t70 -128.99 104.1 7.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 124.459 1.099 . . . . 1.38 109.565 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -85.7 139.17 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-N 116.499 -0.319 . . . . 0.91 111.293 178.008 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 39.8 mt-10 -118.46 110.52 17.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.027 0.83 . . . . 2.31 109.823 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.931 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 3.0 t-160 -91.89 107.26 19.08 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.098 -0.955 . . . . 1.64 108.555 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 22.9 p -118.84 158.59 25.36 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.707 0.765 . . . . 2.67 112.383 -172.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.658 ' O ' ' HG3' ' A' ' 121' ' ' MET . 63.9 m80 99.22 -78.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.486 -1.688 . . . . 2.63 111.077 164.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.454 ' HZ ' ' NH1' ' A' ' 128' ' ' ARG . 31.6 t80 -72.47 -48.84 37.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.706 -0.679 . . . . 3.54 112.592 -165.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.48 -43.36 99.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.92 0.867 . . . . 1.81 109.5 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 55.2 ttt180 -61.12 -20.71 62.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.194 -1.367 . . . . 3.38 111.931 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.658 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 93.8 mtp -78.08 25.14 0.23 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.461 0.541 . . . . 2.43 112.461 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.4 155.37 8.9 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.722 -1.228 . . . . 1.61 113.293 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 t -51.93 -47.86 64.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.234 -0.483 . . . . 2.58 112.279 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -72.66 -25.27 61.2 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.879 -0.329 . . . . 3.8 111.168 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.554 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 11.5 m170 -68.35 -50.07 55.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.403 0.621 . . . . 2.14 109.569 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 2' ' ' TYR . . . -69.9 -30.87 68.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 0.92 111.001 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -68.37 -37.83 80.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 2.83 111.198 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.7 ptm180 -72.67 -36.27 67.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.887 -0.325 . . . . 2.59 110.248 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 81' ' ' TRP . 93.0 t -68.75 -33.05 57.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.342 0.591 . . . . 1.48 110.346 175.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 32.9 ttm180 -57.39 -21.83 38.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.242 -0.89 . . . . 3.83 111.0 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 91.1 m-20 -64.55 -21.35 66.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.48 111.598 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.7 -58.13 0.52 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.007 -1.092 . . . . 1.61 114.155 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -80.53 -9.18 59.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.131 0.789 . . . . 4.83 113.131 -170.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 6.4 p-10 -53.42 -49.4 67.4 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.842 0.682 . . . . 2.83 112.842 -169.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -111.34 -19.88 12.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 4.15 110.955 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -63.27 -57.27 15.92 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.632 -0.587 . . . . 1.04 111.632 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.433 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.6 m0 -55.47 -53.99 56.1 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.052 0.76 . . . . 2.78 113.052 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.3 Cg_endo -56.91 -37.75 97.55 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.747 1.632 . . . . 0.68 112.097 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.9 m -70.16 -45.29 67.06 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.635 0.731 . . . . 0.87 109.958 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.643 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 27.0 mt -58.54 -54.18 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.957 -1.019 . . . . 0.72 111.548 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HB3' HG11 ' A' ' 10' ' ' VAL . 82.2 mt -62.6 -24.66 67.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.255 0.465 . . . . 0.69 112.255 -173.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -56.56 4.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.952 0.406 . . . . 1.49 110.234 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 73.8 m -66.44 -23.09 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 1.15 110.531 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.77 -55.06 34.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 0.8 110.491 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.445 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 41.5 mt-30 -61.91 -32.44 72.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.961 -0.563 . . . . 1.63 110.684 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.1 m-20 -72.84 -40.91 65.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 1.46 111.773 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.3 tptp -65.42 -42.41 92.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 1.74 109.69 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.816 HG21 HG13 ' A' ' 12' ' ' VAL . 72.8 mt -62.36 -38.76 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.433 0.635 . . . . 0.5 110.401 174.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -58.37 -37.1 74.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.85 110.169 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 146' ' ' ASP . 38.9 mt-10 -72.9 -35.14 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.551 -0.75 . . . . 1.5 110.439 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 21.6 mm-40 -67.77 -38.0 82.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 1.74 110.142 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.94 -66.63 2.11 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.463 -0.79 . . . . 1.32 111.684 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.25 81.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.708 0.29 . . . . 1.92 111.478 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -163.13 85.48 0.52 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 2.04 110.329 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 150' ' ' GLU . 36.7 mtmt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.245 -0.883 . . . . 4.22 109.548 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.786 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.3 p-10 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.858 -0.115 . . . . 1.66 110.754 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 86.67 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.314 1.045 . . . . 3.73 110.175 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.653 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 11.2 t70 -51.39 -52.47 59.29 Favored Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 123.453 0.471 . . . . 2.78 111.63 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.4 Cg_endo -85.45 -67.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.165 1.244 . . . . 1.63 112.517 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 36.3 p90 -153.37 142.17 21.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.153 -0.684 . . . . 3.21 109.153 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.786 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -123.56 136.2 60.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 1.44 111.284 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.0 ttp180 -141.28 141.78 33.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.581 -0.736 . . . . 3.37 110.502 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.716 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.1 133.39 53.07 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.846 -0.798 . . . . 0.79 108.846 173.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 3.8 t -132.91 111.76 11.32 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.399 0.619 . . . . 1.28 110.214 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.0 t -123.91 138.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.053 -0.976 . . . . 1.27 111.585 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -96.6 117.04 30.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.251 0.548 . . . . 0.57 109.994 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.869 HG13 HG21 ' A' ' 148' ' ' ILE . 51.4 t -96.48 129.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.91 110.081 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.609 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.18 24.9 9.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.967 -0.56 . . . . 0.98 111.845 -173.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -153.74 33.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.31 0.485 . . . . 0.36 112.31 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 15.8 t70 73.43 165.67 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.904 0.859 . . . . 0.91 112.607 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -65.66 -26.33 67.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.87 -1.059 . . . . 1.88 111.166 -174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.95 -43.69 98.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.122 -0.49 . . . . 3.05 111.09 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.0 p -74.55 -35.76 63.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.888 -0.325 . . . . 1.11 110.361 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.65 -48.16 78.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.32 110.444 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.06 -44.47 69.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.38 110.732 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -55.23 -52.33 63.74 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.404 -0.362 . . . . 2.39 110.807 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -67.3 -51.07 57.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.546 -0.297 . . . . 0.68 111.102 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.646 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.0 t80 -65.42 -34.58 78.63 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.059 0.392 . . . . 0.48 112.059 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD11 HG11 ' A' ' 46' ' ' VAL . 12.9 tp -111.73 -54.42 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.382 -0.527 . . . . 0.5 111.961 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.89 33.7 2.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 1.24 111.705 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.747 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -157.73 34.47 0.53 Allowed Glycine 0 C--O 1.217 -0.908 0 C-N-CA 120.734 -0.746 . . . . 0.83 111.895 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.61 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 t80 -61.58 -51.39 77.19 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 112.264 0.468 . . . . 0.74 112.264 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.676 ' HB3' HD23 ' A' ' 44' ' ' LEU . 93.4 Cg_endo -77.57 15.49 1.23 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.461 2.107 . . . . 0.76 115.058 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -113.09 -2.31 14.2 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.835 -0.541 . . . . 1.49 111.151 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.864 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 31.2 m0 -72.43 160.13 32.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.329 0.585 . . . . 4.62 111.277 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 58.2 m95 -89.61 -37.01 0.42 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.627 0.973 . . . . 2.78 113.627 175.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 18.5 Cg_endo -58.18 -84.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.525 2.15 . . . . 1.36 115.448 -163.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HB3' HD11 ' A' ' 140' ' ' ILE . 12.2 t-20 -110.76 -4.41 15.33 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.776 0.798 . . . . 1.51 109.425 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.847 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.9 m-20 -86.54 74.39 9.91 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.729 -1.123 . . . . 1.79 111.255 -170.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -154.46 29.09 0.44 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.791 0.663 . . . . 4.45 112.791 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 23.3 mmm180 -135.77 152.63 51.32 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 4.14 111.728 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.3 p -76.17 135.39 39.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.502 -0.317 . . . . 2.68 110.149 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 57' ' ' ASP . 1.7 p 50.22 26.04 2.03 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.632 0.729 . . . . 1.42 111.741 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 15.7 ttmm -146.04 71.44 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.165 -0.925 . . . . 2.9 109.1 174.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.847 HG23 ' HA ' ' A' ' 34' ' ' ASN . 6.9 m 53.36 29.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.052 -1.431 . . . . 1.83 113.21 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.37 7.35 0.61 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.106 -1.521 . . . . 2.17 114.171 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 43' ' ' PRO . . . -83.1 -171.25 0.29 Allowed Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.517 -0.549 . . . . 1.12 109.517 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.876 ' HG2' ' HB ' ' A' ' 56' ' ' ILE . 18.8 Cg_endo -64.19 74.39 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 120.908 1.072 . . . . 1.48 109.336 161.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.81 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -120.97 -162.44 0.96 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.939 0.875 . . . . 1.75 110.266 -166.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.734 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . 135.68 -115.02 1.28 Allowed Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 113.541 -1.663 . . . . 0.75 110.412 166.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.582 HG11 HD11 ' A' ' 24' ' ' LEU . 86.9 t -140.47 136.16 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.69 -0.755 . . . . 0.6 112.297 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.799 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 8.1 t0 -105.77 104.97 14.8 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.343 -1.298 . . . . 1.11 108.071 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.62 ' H ' ' HE3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -79.86 -28.69 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.044 0.45 . . . . 2.81 111.008 -174.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 50.6 pttt -71.49 -29.25 64.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 3.17 111.645 -175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.6 -25.61 4.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.135 -0.555 . . . . 1.53 112.425 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.39 57.91 1.61 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.158 -0.544 . . . . 0.77 112.803 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.799 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 26.1 ptt180 -146.33 152.73 39.61 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.583 -0.363 . . . . 3.72 111.314 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 32.0 m0 -110.53 113.79 26.69 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.069 -0.715 . . . . 1.28 109.069 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.585 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.7 p90 -151.47 174.03 13.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.101 -1.04 . . . . 1.66 112.786 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.81 ' HG2' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mt-10 -134.05 143.0 47.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.029 -0.532 . . . . 2.12 110.932 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.876 ' HB ' ' HG2' ' A' ' 43' ' ' PRO . 25.4 mm -83.06 103.64 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.373 -0.531 . . . . 0.92 109.785 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 61' ' ' GLU . 1.9 p-10 -66.4 -169.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.491 0.662 . . . . 1.97 111.199 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.73 -27.65 22.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.7 1.0 . . . . 2.43 113.7 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.12 -28.64 12.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.658 0.984 . . . . 2.39 113.658 -164.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.96 46.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.268 -1.444 . . . . 2.29 113.782 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 16.1 mt-10 73.21 73.46 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.119 0.785 . . . . 2.31 113.119 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 11.4 tp10 -123.42 74.41 1.24 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.867 -1.16 . . . . 2.61 107.867 165.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.463 ' CD2' ' HD1' ' A' ' 54' ' ' TYR . 2.0 p80 -113.07 126.36 55.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.549 -1.205 . . . . 3.72 112.143 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.592 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 6.0 m -63.35 135.43 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.123 -1.066 . . . . 2.27 108.123 166.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.7 p90 -123.22 143.99 49.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.539 0.57 . . . . 6.48 112.539 -171.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -75.52 151.46 41.56 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.041 -1.224 . . . . 1.23 110.041 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.779 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -115.6 94.33 4.65 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.043 0.422 . . . . 1.17 111.192 -171.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 71' ' ' VAL . 41.5 mt -74.49 132.49 33.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.61 110.354 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.565 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 12.8 mmm-85 -103.91 -25.33 13.08 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.716 -0.475 . . . . 2.0 109.716 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 82.6 tttt -145.52 115.52 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.53 111.198 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 68' ' ' ILE . 47.6 t -105.01 91.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 109.245 -0.65 . . . . 0.88 109.245 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 1.1 t70 -106.15 100.61 10.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.672 -0.695 . . . . 1.42 109.531 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 17.0 pt-20 -24.79 148.06 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 125.105 1.503 . . . . 0.96 112.542 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.6 Cg_exo -18.55 78.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.839 3.693 . . . . 0.38 114.781 -162.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -164.21 -63.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.844 -1.071 . . . . 0.5 110.614 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -149.69 141.57 23.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.23 0.538 . . . . 0.35 112.284 -175.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 77' ' ' LEU . 1.7 mp -134.24 115.06 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.354 -0.384 . . . . 0.74 110.037 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 61.7 t -97.25 108.31 21.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.235 -0.654 . . . . 0.67 109.235 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -126.4 130.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.146 -0.479 . . . . 0.75 111.496 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.779 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -84.17 151.71 27.42 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.5 112.397 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.792 ' HZ2' ' HB3' ' A' ' 133' ' ' MET . 27.2 t-105 -82.06 146.13 29.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.836 1.05 . . . . 2.79 113.836 -162.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.74 ' O ' HD12 ' A' ' 83' ' ' LEU . 1.4 ttp180 -139.82 -8.42 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.366 -0.833 . . . . 5.46 111.693 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER 37.07 -160.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.764 1.764 . . . . 1.55 115.764 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 94.7 m-20 -126.26 135.23 51.3 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.116 0.566 . . . . 1.93 109.867 -171.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.58 81.36 0.11 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.201 -0.523 . . . . 2.4 113.402 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -128.21 24.17 5.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.468 . . . . 5.38 110.298 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.09 30.79 2.84 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.334 -1.106 . . . . 2.3 110.334 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.541 ' HD2' ' C ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -97.53 163.41 12.87 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.57 -0.815 . . . . 4.77 112.899 -171.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.774 HG21 ' HE ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -117.22 128.3 74.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.386 -1.279 . . . . 1.86 108.065 159.246 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.76 136.67 27.58 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.381 -0.6 . . . . 3.18 109.381 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.694 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 53.1 Cg_exo -56.41 -43.36 56.37 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 122.998 2.466 . . . . 2.36 112.185 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 t70 72.09 -28.66 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.947 0.779 . . . . 2.99 112.68 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -124.4 -8.5 7.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.26 0.467 . . . . 3.06 112.26 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 95' ' ' SER . 62.6 p -162.28 -147.67 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.082 -0.247 . . . . 1.85 110.994 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.628 ' OG ' ' HB3' ' A' ' 118' ' ' PHE . 32.7 m 67.73 42.71 1.94 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.734 -0.666 . . . . 1.44 110.5 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.615 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 43.8 mp0 -70.4 139.3 51.84 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.391 -0.822 . . . . 1.81 109.935 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.488 ' HB2' HG13 ' A' ' 113' ' ' VAL . 2.6 p90 -127.37 127.74 44.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.02 0.438 . . . . 0.64 110.271 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.1 m -88.4 110.2 20.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.366 -0.833 . . . . 0.43 110.466 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.722 ' HA ' HG22 ' A' ' 113' ' ' VAL . 65.9 t -82.35 108.9 15.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.949 -0.569 . . . . 0.87 109.681 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 7.0 m -101.54 107.01 18.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.848 0.356 . . . . 0.45 110.774 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 26.7 m-85 -94.17 111.11 22.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.222 -0.445 . . . . 0.34 110.897 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.24 107.74 19.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.777 -0.453 . . . . 0.54 109.777 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.03 145.36 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.681 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.824 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 4.4 t70 -140.09 107.49 5.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.389 -0.369 . . . . 2.03 110.668 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.27 50.55 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.048 -0.596 . . . . 1.97 113.183 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 58.49 22.42 9.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.32 0.648 . . . . 4.93 111.893 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 43.7 mtmt -141.36 -14.87 0.86 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.187 -0.321 . . . . 3.53 111.212 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.824 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 27.8 tttp -121.49 155.77 34.23 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.501 -0.925 . . . . 2.44 108.501 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.551 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 42.4 m -157.25 135.45 11.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.685 0.279 . . . . 0.42 110.333 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -115.12 122.16 45.26 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.035 -0.728 . . . . 2.59 109.035 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.7 p -101.89 136.82 32.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.438 -0.505 . . . . 0.4 110.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -125.47 113.9 18.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 1.38 109.186 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.722 HG22 ' HA ' ' A' ' 99' ' ' VAL . 3.6 t -95.01 120.82 44.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.317 -0.856 . . . . 0.91 110.78 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.58 111.3 23.63 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.445 -0.798 . . . . 2.31 109.597 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.603 ' O ' HG13 ' A' ' 6' ' ' VAL . 45.4 t60 -123.81 109.51 13.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.351 -0.841 . . . . 1.64 108.843 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 120' ' ' ARG . 20.2 m -157.42 96.91 1.58 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.143 -0.223 . . . . 2.67 111.231 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.518 ' O ' ' HG3' ' A' ' 121' ' ' MET . 40.5 t60 -162.67 -74.9 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 120.664 0.268 . . . . 2.63 111.196 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.628 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 37.5 t80 -85.77 -26.82 25.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.593 0.711 . . . . 3.54 110.089 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.1 p-10 -68.64 -51.63 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.87 -1.059 . . . . 1.81 110.857 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD2' HG22 ' A' ' 116' ' ' THR . 7.9 ptm180 -59.02 -19.03 39.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.457 -0.792 . . . . 3.38 112.01 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 94.7 mtp -64.15 -9.85 19.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.948 0.404 . . . . 2.43 110.14 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 55.17 -153.77 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.199 -0.91 . . . . 1.61 114.407 166.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.7 p 44.38 -125.53 0.99 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.29 0.636 . . . . 2.58 111.555 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.49 -23.73 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.652 -0.249 . . . . 3.8 110.911 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.527 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 39.9 m80 -63.47 -51.6 64.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.008 0.432 . . . . 2.14 110.253 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.954 -0.566 . . . . 0.92 110.403 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -63.48 -42.76 98.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.661 . . . . 2.83 111.23 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.774 ' HE ' HG21 ' A' ' 89' ' ' ILE . 11.8 ptm180 -73.84 -31.55 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 2.59 111.501 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.59 -39.57 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.206 0.527 . . . . 1.48 110.643 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.638 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 69.7 ttt180 -62.42 -16.75 56.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.602 -0.726 . . . . 3.83 111.317 -176.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.34 -47.73 62.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.04 0.385 . . . . 2.48 112.04 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.29 -34.98 5.15 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.077 -1.058 . . . . 1.61 113.539 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.792 ' HB3' ' HZ2' ' A' ' 81' ' ' TRP . 23.8 ptm -81.12 -21.84 39.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.904 0.705 . . . . 4.83 112.904 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.638 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 34.1 t70 -54.7 -43.34 72.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.431 0.9 . . . . 2.83 113.431 -168.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -114.13 30.88 6.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.456 0.646 . . . . 4.15 110.331 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.75 -70.31 0.17 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.493 -0.861 . . . . 1.04 112.124 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.471 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 10.4 t90 -58.19 -52.0 77.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.463 0.542 . . . . 2.78 112.463 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.8 Cg_endo -59.35 -37.74 88.6 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.94 1.76 . . . . 0.68 112.355 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.1 m -70.02 -36.54 75.17 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.746 0.784 . . . . 0.87 109.671 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.7 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 15.3 mt -55.75 -40.24 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.66 -1.155 . . . . 0.72 110.521 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 8' ' ' HIS . 79.0 mt -61.7 -30.77 70.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.925 0.343 . . . . 0.69 111.925 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.63 -51.29 23.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 1.49 110.193 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.531 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 37.1 m -68.67 -22.76 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.137 -0.483 . . . . 1.15 110.805 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 58.9 t80 -61.64 -54.26 45.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 0.8 109.929 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.495 ' CG ' HG13 ' A' ' 10' ' ' VAL . 38.8 mt-30 -57.37 -37.69 73.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.82 -0.627 . . . . 1.63 110.77 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.43 -0.804 . . . . 1.46 111.26 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -67.12 -41.43 86.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.8 0.333 . . . . 1.74 110.414 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.869 HG21 HG13 ' A' ' 12' ' ' VAL . 47.0 mt -62.08 -34.26 62.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.5 110.905 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.62 -30.58 68.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.985 -0.552 . . . . 0.85 110.307 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.784 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 64.8 mt-10 -69.09 -43.83 73.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.5 110.03 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -69.53 -17.75 63.61 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.163 -0.926 . . . . 1.74 109.996 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.67 -40.11 6.44 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.407 -0.815 . . . . 1.32 112.62 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -171.95 -26.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.039 0.755 . . . . 1.92 113.039 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.784 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 6.2 ttmt -76.07 72.76 2.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.234 0.54 . . . . 2.04 111.609 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 150' ' ' GLU . 68.2 mttm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.446 -0.787 . . . . 4.22 110.048 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.803 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 17.5 p-10 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.825 0.345 . . . . 1.66 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 54.6 p90 173.26 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.837 -0.619 . . . . 3.73 109.668 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.804 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 32.8 t70 -66.04 -52.31 40.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 2.78 111.041 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 12.5 Cg_endo -92.44 -70.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.153 1.902 . . . . 1.63 111.605 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -141.25 145.67 35.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 3.21 110.25 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.803 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -118.63 125.72 74.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.419 -0.585 . . . . 1.44 109.419 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 5.9 ttm105 -132.74 143.28 49.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.056 -0.52 . . . . 3.37 112.027 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HE2' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.0 133.01 53.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.575 -0.898 . . . . 0.79 108.575 170.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.7 m -133.76 111.51 10.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.589 0.709 . . . . 1.28 110.643 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.596 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.7 t -123.5 142.46 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.824 -1.08 . . . . 1.27 110.139 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.6 m -121.92 116.06 23.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.57 110.074 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.659 ' HB ' HG21 ' A' ' 148' ' ' ILE . 11.0 m -102.91 163.63 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.509 -0.768 . . . . 0.91 111.028 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.566 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -117.88 26.05 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.98 111.661 -171.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB3' HG23 ' A' ' 148' ' ' ILE . . . -143.06 23.98 1.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.641 -0.423 . . . . 0.36 111.52 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 33.8 t70 72.16 173.88 0.3 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.589 -0.732 . . . . 0.91 112.565 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 9.7 ttp180 -68.03 -26.43 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.14 -0.936 . . . . 1.88 111.321 -172.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -54.44 -48.53 71.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.104 0.478 . . . . 3.05 110.755 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -80.73 -34.17 34.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 1.11 111.046 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -59.58 -45.24 92.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.606 0.241 . . . . 0.32 110.77 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -67.99 -45.89 72.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.38 110.516 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.701 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 29.6 tptp -54.77 -51.84 64.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 2.39 110.452 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.551 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 55.0 m -65.28 -40.4 93.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.68 111.539 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 67.5 t80 -71.33 -37.98 71.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.409 -0.36 . . . . 0.48 111.691 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 46' ' ' VAL . 9.6 tp -119.44 -55.78 2.1 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.714 0.635 . . . . 0.5 112.714 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.701 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 2.3 mm-40 -87.85 18.33 4.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.542 0.571 . . . . 1.24 112.542 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -151.51 28.44 0.96 Allowed Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.246 -1.142 . . . . 0.83 110.246 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.623 ' HZ ' ' CE1' ' A' ' 65' ' ' PHE . 71.0 t80 -47.54 -51.77 42.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.494 -0.853 . . . . 0.74 113.18 -168.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.4 Cg_endo -96.31 11.39 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.027 1.818 . . . . 0.76 115.445 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -106.31 -6.54 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.306 0.854 . . . . 1.49 113.306 -172.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.793 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 18.2 m95 -92.66 -152.21 0.31 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.2 -0.312 . . . . 4.62 111.75 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.58 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 31.6 m95 -105.77 0.16 0.1 Allowed Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 115.383 1.623 . . . . 2.78 115.383 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.902 ' HB3' ' HA ' ' A' ' 140' ' ' ILE . 27.1 Cg_exo -66.07 -150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 122.54 1.943 . . . . 1.36 114.342 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.601 ' ND2' HG21 ' A' ' 40' ' ' VAL . 63.5 t30 -63.28 -4.35 2.49 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.485 -0.78 . . . . 1.51 111.646 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.967 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 30.8 p30 -83.6 15.64 3.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.807 -0.633 . . . . 1.79 111.975 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.699 ' HD1' ' HG2' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -69.62 3.28 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.167 0.803 . . . . 4.45 113.167 -173.047 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.699 ' HG2' ' HD1' ' A' ' 35' ' ' PHE . 42.6 mmt-85 -140.13 147.89 40.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.96 0.41 . . . . 4.14 111.541 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -76.1 145.08 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.777 -0.647 . . . . 2.68 111.13 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 57' ' ' ASP . 62.8 p 50.86 16.38 0.32 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.2 1.0 . . . . 1.42 112.279 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.795 ' HD3' HG23 ' A' ' 40' ' ' VAL . 5.8 tmtm? -104.17 -62.88 1.26 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.091 -1.448 . . . . 2.9 107.091 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.967 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 31.3 t -146.95 1.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.108 0.956 . . . . 1.83 108.636 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 28' ' ' PRO . . . -126.73 50.61 0.87 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.538 -0.756 . . . . 2.17 112.461 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -90.96 168.34 14.0 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.524 . . . . 1.12 109.587 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 48.4 Cg_endo -69.53 54.97 1.14 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.729 2.286 . . . . 1.48 114.056 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HB2' HG12 ' A' ' 56' ' ' ILE . 55.1 tp -164.92 -96.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.41 -0.359 . . . . 1.75 110.518 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.625 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 104.85 -59.09 0.45 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.75 112.38 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 24' ' ' LEU . 78.9 t -136.74 141.2 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 122.784 -0.245 . . . . 0.6 110.37 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.77 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 7.1 t70 -112.36 113.38 25.56 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.491 -0.559 . . . . 1.11 109.491 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -79.2 -31.9 43.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.017 0.377 . . . . 2.81 112.017 -175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -83.66 -34.84 24.92 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 3.17 110.9 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.8 -35.87 30.43 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.606 -0.807 . . . . 1.53 111.718 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' HB ' ' A' ' 68' ' ' ILE . . . 85.26 54.24 2.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.429 -0.668 . . . . 0.77 111.429 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -160.65 165.0 31.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 3.72 110.949 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.64 117.82 33.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.756 -0.461 . . . . 1.28 109.756 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.77 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -164.36 152.27 12.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.491 . . . . 1.66 109.99 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 2.2 mp0 -112.59 160.53 17.76 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.521 -0.548 . . . . 2.12 109.521 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 44' ' ' LEU . 44.4 mm -77.14 103.92 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.864 0.364 . . . . 0.92 110.091 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 38' ' ' THR . 4.6 t70 -90.78 170.4 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.97 110.117 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.91 -37.19 64.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.65 0.982 . . . . 2.43 113.65 -165.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.41 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -86.6 -0.76 56.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.223 -0.591 . . . . 2.39 111.56 -178.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.79 72.87 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.648 -1.263 . . . . 2.29 114.064 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 53.0 29.7 8.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.491 0.552 . . . . 2.31 112.491 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 13.7 tp10 -85.73 75.88 10.02 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.404 -0.591 . . . . 2.61 109.404 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HE1' ' O ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -126.96 163.5 23.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.003 -0.544 . . . . 3.72 111.78 177.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.853 HG22 ' HG3' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -134.58 121.26 20.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.734 . . . . 2.27 109.89 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.803 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 3.7 t80 -144.83 -66.7 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 119.787 -0.765 . . . . 6.48 113.057 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -158.64 165.14 33.9 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.909 -1.615 . . . . 1.23 114.732 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 82' ' ' ARG . 5.6 mp -113.39 107.35 15.74 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.268 0.627 . . . . 1.17 110.342 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.863 HG21 HG23 ' A' ' 71' ' ' VAL . 65.0 mt -70.6 116.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.407 -0.917 . . . . 0.61 110.385 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -90.35 -24.67 20.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.85 -0.613 . . . . 2.0 109.4 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 65.7 tttt -170.99 123.7 0.61 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.957 -0.565 . . . . 1.53 111.623 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 68' ' ' ILE . 95.0 t -106.32 113.5 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.959 -0.756 . . . . 0.88 108.959 169.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -117.6 72.1 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.818 -0.353 . . . . 1.42 110.11 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 45.17 -168.2 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 124.615 1.197 . . . . 0.96 111.9 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.1 Cg_exo -63.33 76.85 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.253 1.302 . . . . 0.38 111.436 166.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.16 -63.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.942 -0.572 . . . . 0.5 110.287 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -144.34 139.66 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.482 0.549 . . . . 0.35 112.482 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.96 109.7 6.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.74 109.261 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 70' ' ' LYS . 1.2 p -101.5 113.54 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.519 -0.549 . . . . 0.67 109.519 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.535 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -129.39 141.39 46.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.55 -0.75 . . . . 0.75 110.724 -177.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.528 ' HA2' ' H ' ' A' ' 96' ' ' GLU . . . -89.5 172.79 39.75 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.951 -0.568 . . . . 0.5 112.859 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.816 ' H ' ' HB2' ' A' ' 95' ' ' SER . 73.0 t-105 -90.22 156.46 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.517 0.199 . . . . 2.79 111.3 -172.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.853 ' HG3' HG22 ' A' ' 64' ' ' THR . 18.1 tpt180 177.86 42.31 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.854 -0.612 . . . . 5.46 110.483 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.803 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 84.1 133.35 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.895 0.478 . . . . 1.55 111.135 169.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.497 ' N ' HD13 ' A' ' 83' ' ' LEU . 3.2 t-20 -93.66 75.35 4.35 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.46 -62.68 3.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.602 -0.809 . . . . 2.4 113.609 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -168.41 138.06 2.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.465 0.174 . . . . 5.38 110.937 -172.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.61 38.1 3.79 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.754 -0.736 . . . . 2.3 114.232 170.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.842 ' NH1' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -148.19 163.32 37.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.372 0.586 . . . . 4.77 111.021 177.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.592 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -122.17 114.59 43.28 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 122.471 0.308 . . . . 1.86 111.357 176.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.842 ' HB3' ' NH1' ' A' ' 88' ' ' ARG . 6.5 t70 -170.22 108.43 0.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 3.18 109.557 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD2' ' CZ ' ' A' ' 128' ' ' ARG . 45.1 Cg_endo -87.66 30.48 0.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.835 2.357 . . . . 2.36 111.466 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.586 ' HB2' HH21 ' A' ' 128' ' ' ARG . 3.4 t70 -84.76 170.62 13.04 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.752 0.787 . . . . 2.99 110.793 -165.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.37 15.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.345 -1.298 . . . . 3.06 109.897 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.48 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 14.8 m -131.67 -78.62 0.51 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.251 -0.886 . . . . 1.85 109.14 170.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.816 ' HB2' ' H ' ' A' ' 81' ' ' TRP . 19.9 m 47.92 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.206 1.002 . . . . 1.44 112.006 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.528 ' H ' ' HA2' ' A' ' 80' ' ' GLY . 49.4 tt0 77.59 112.67 0.07 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 1.81 112.979 163.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.575 ' HB2' HG13 ' A' ' 113' ' ' VAL . 51.0 p90 -127.56 124.26 37.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.64 110.106 167.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.473 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 41.8 m -88.16 109.2 19.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.384 -0.826 . . . . 0.43 109.703 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 113' ' ' VAL . 62.0 t -82.41 110.06 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.395 . . . . 0.87 110.009 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.488 ' HA ' HG22 ' A' ' 76' ' ' THR . 28.2 m -103.17 107.31 18.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.45 110.518 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.712 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 43.7 m-85 -90.38 111.16 22.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.294 -0.412 . . . . 0.34 110.214 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.3 t -93.04 112.61 26.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.914 -0.402 . . . . 0.54 109.914 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.54 126.98 31.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.306 -0.406 . . . . 0.44 110.607 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 50.7 m-20 -119.17 114.76 22.94 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.367 -0.379 . . . . 2.03 110.49 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.91 -102.84 1.27 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.029 -0.605 . . . . 1.97 112.706 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -145.15 -23.32 0.49 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.807 0.337 . . . . 4.93 110.485 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 21.6 pttp -142.93 34.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 3.53 111.625 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 56.2 tttm -136.21 148.18 47.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.235 -0.654 . . . . 2.44 109.235 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.3 m -155.33 122.19 5.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.159 0.504 . . . . 0.42 111.499 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -94.38 116.77 29.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.288 -0.869 . . . . 2.59 109.839 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.712 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 p -94.5 134.93 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 109.331 -0.618 . . . . 0.4 109.331 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.13 114.1 13.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.968 -1.015 . . . . 1.38 109.405 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 99' ' ' VAL . 2.4 t -106.87 122.87 61.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.178 -0.919 . . . . 0.91 111.809 -171.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 25.8 mt-10 -98.21 110.76 23.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.248 -0.433 . . . . 2.31 110.067 171.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.579 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.9 t-80 -105.16 103.64 13.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.977 -1.49 . . . . 1.64 106.977 171.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -153.84 96.99 2.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.368 -0.533 . . . . 2.67 110.749 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.628 ' O ' ' HG2' ' A' ' 121' ' ' MET . 1.5 t60 -166.51 -76.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.786 -0.643 . . . . 2.63 109.552 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 94' ' ' SER . 4.4 m-85 -85.45 -23.71 27.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.529 0.937 . . . . 3.54 113.529 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.31 -53.34 59.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.674 0.749 . . . . 1.81 110.69 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.89 -17.46 64.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.662 -1.153 . . . . 3.38 111.446 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 93.6 mmm -73.74 27.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.889 0.7 . . . . 2.43 112.889 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.92 -175.42 21.85 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 118.798 -1.668 . . . . 1.61 114.016 166.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 -53.7 7.74 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.522 -0.839 . . . . 2.58 110.959 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.768 ' HA ' ' HB2' ' A' ' 127' ' ' LYS . 20.3 pttp -89.28 -11.7 42.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.922 0.712 . . . . 3.8 112.922 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.727 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 16.1 m80 -62.45 -53.4 55.36 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.998 -0.681 . . . . 2.14 109.556 167.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.92 110.996 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.768 ' HB2' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mttp -66.63 -33.01 74.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 111.94 0.348 . . . . 2.83 111.94 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 27.4 ptt180 -69.89 -52.9 20.83 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.479 -0.488 . . . . 2.59 109.728 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.508 HG12 ' SD ' ' A' ' 133' ' ' MET . 35.0 t -56.48 -33.84 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.206 0.527 . . . . 1.48 111.133 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.36 -16.47 14.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.044 0.938 . . . . 3.83 112.502 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 88' ' ' ARG . 11.3 t-20 -56.06 -40.75 74.02 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.032 0.752 . . . . 2.48 113.032 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.31 19.16 0.23 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.015 -1.564 . . . . 1.61 114.095 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.508 ' SD ' HG12 ' A' ' 129' ' ' VAL . 17.7 ptt? -80.29 -27.66 38.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.667 0.733 . . . . 4.83 109.683 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -80.54 -13.57 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 2.83 111.932 -170.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HB2' ' NZ ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -92.88 1.75 57.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.804 0.335 . . . . 4.15 110.539 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.635 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.89 -55.38 0.14 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.123 -1.037 . . . . 1.04 113.048 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.503 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 61.7 t-105 -53.81 -52.76 64.77 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.534 0.568 . . . . 2.78 112.534 -171.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 25.1 Cg_endo -60.97 -45.42 19.99 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.595 1.53 . . . . 0.68 111.768 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.1 m -59.64 -38.7 82.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.652 0.739 . . . . 0.87 110.108 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.902 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 14.0 mt -68.04 -41.67 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.126 -0.943 . . . . 0.72 110.766 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 55.0 mt -63.88 -32.93 74.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.69 111.53 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -48.0 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.62 0.248 . . . . 1.49 110.999 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 31.9 m -71.38 -25.9 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.15 110.817 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.52 -55.37 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.672 -0.695 . . . . 0.8 109.941 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.458 ' CG ' HG13 ' A' ' 10' ' ' VAL . 47.3 mt-30 -64.94 -27.6 68.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.905 -0.589 . . . . 1.63 110.522 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 2.8 t70 -67.95 -55.35 13.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 1.46 111.133 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.793 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 16.7 tptm -64.12 -39.87 94.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.267 -0.573 . . . . 1.74 110.638 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.659 HG21 ' HB ' ' A' ' 12' ' ' VAL . 67.7 mt -63.66 -34.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.5 110.723 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.566 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 18.4 t70 -66.86 -32.06 73.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.814 -0.439 . . . . 0.85 109.814 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.961 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 35.4 mt-10 -67.84 -33.11 74.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.235 0.54 . . . . 1.5 110.194 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 4.6 mm-40 -79.68 -12.96 59.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.375 -0.83 . . . . 1.74 110.172 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.53 -75.16 1.14 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.713 -0.676 . . . . 1.32 112.862 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -151.24 35.88 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.982 0.391 . . . . 1.92 111.777 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.961 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 12.4 tppt? -75.44 -10.93 59.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.44 0.638 . . . . 2.04 109.642 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.0 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.484 -0.78 . . . . 4.22 109.833 -176.508 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.4 p-10 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.209 -0.293 . . . . 1.66 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 1.2 t80 80.59 -50.71 0.32 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.584 0.552 . . . . 3.73 111.372 172.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.686 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.1 t70 -61.87 -49.41 85.9 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.092 -0.243 . . . . 2.78 111.213 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.0 Cg_endo -92.47 -65.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.964 1.776 . . . . 1.63 111.871 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.31 156.76 44.0 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.182 -1.414 . . . . 3.21 107.182 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.924 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 88.7 t -85.62 124.05 39.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.657 -0.817 . . . . 1.44 109.828 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 14.0 ttp180 -128.82 138.04 51.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.954 0.407 . . . . 3.37 110.865 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.526 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -115.3 132.33 56.65 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.987 -1.116 . . . . 0.79 107.987 170.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 1.0 OUTLIER -136.16 110.47 8.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.746 0.784 . . . . 1.28 109.437 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.469 HG13 ' CG ' ' A' ' 145' ' ' GLN . 1.7 t -125.43 142.6 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.434 -1.257 . . . . 1.27 110.966 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -102.33 115.19 30.04 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.279 0.561 . . . . 0.57 109.742 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.817 HG13 HG21 ' A' ' 148' ' ' ILE . 39.6 t -95.07 128.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.824 -0.626 . . . . 0.91 110.316 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.678 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.59 32.79 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.98 111.387 -173.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.41 26.87 0.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.586 -0.279 . . . . 0.36 111.666 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.618 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 27.4 t70 73.97 168.42 0.3 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.175 0.512 . . . . 0.91 112.349 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 12.1 ttp180 -69.12 -33.32 73.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.858 -0.61 . . . . 1.88 111.815 -170.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.618 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 13.7 pttm -59.01 -43.05 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 3.05 110.566 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -72.51 -37.47 68.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.339 -0.391 . . . . 1.11 110.878 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -60.23 -46.25 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.32 110.429 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -69.42 -45.81 68.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.38 110.607 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.774 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 23.6 tptp -53.47 -50.62 64.94 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.137 -0.483 . . . . 2.39 110.736 176.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -68.61 -50.15 53.7 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.085 -0.246 . . . . 0.68 111.011 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.684 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 68.6 t80 -65.45 -39.35 91.92 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.039 0.385 . . . . 0.48 112.039 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 46' ' ' VAL . 14.4 tp -109.54 -49.41 3.11 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.021 -0.672 . . . . 0.5 112.035 -176.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.776 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 30.3 mt-10 -87.72 10.79 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.19 0.519 . . . . 1.24 110.598 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.73 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -143.83 26.12 2.08 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.83 110.896 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 46.8 t80 -49.32 -49.52 70.17 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.41 . . . . 0.74 111.45 -177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.9 Cg_endo -90.52 25.32 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.106 1.871 . . . . 0.76 114.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.1 pt-20 -112.12 -9.91 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.785 -0.766 . . . . 1.49 111.753 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.684 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 11.4 m0 -71.84 152.05 42.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.348 0.594 . . . . 4.62 111.163 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.637 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.9 m95 -75.28 -43.58 4.42 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.433 -0.803 . . . . 2.78 113.131 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 31' ' ' TRP . 14.3 Cg_endo -53.98 -71.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.019 2.479 . . . . 1.36 114.684 -165.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' HB3' HD11 ' A' ' 140' ' ' ILE . 22.6 t-20 -117.51 -19.98 9.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.339 0.59 . . . . 1.51 110.294 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.674 ' HA ' HG23 ' A' ' 40' ' ' VAL . 10.0 m120 -92.75 20.2 6.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 1.79 111.806 -169.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -99.16 15.15 26.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.411 0.624 . . . . 4.45 110.137 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -106.29 149.97 26.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.925 -0.58 . . . . 4.14 110.752 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 p -76.74 136.82 39.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.102 -0.332 . . . . 2.68 110.102 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.841 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 43.6 p 66.22 -47.63 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.835 1.254 . . . . 1.42 111.759 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 85.1 tttt -71.11 89.28 0.82 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 122.771 0.429 . . . . 2.9 110.142 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.674 HG23 ' HA ' ' A' ' 34' ' ' ASN . 34.5 m 49.07 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.952 1.301 . . . . 1.83 113.031 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.31 17.0 2.71 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.674 -0.774 . . . . 2.17 112.704 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.85 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -74.11 166.84 41.05 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.004 -0.739 . . . . 1.12 109.004 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.9 49.67 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 123.055 2.503 . . . . 1.48 114.011 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.6 tp -162.52 -92.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.586 0.231 . . . . 1.75 110.714 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.768 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.05 -54.62 3.28 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.869 -0.681 . . . . 0.75 112.361 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 24' ' ' LEU . 60.3 t -140.34 140.22 34.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.6 110.318 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -109.79 110.0 20.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.214 -0.661 . . . . 1.11 109.214 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.776 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 7.8 mtpm? -79.55 -20.48 46.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.068 -0.515 . . . . 2.81 111.689 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -83.64 -44.01 15.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.844 -0.342 . . . . 3.17 110.943 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.7 -30.44 18.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.116 -0.564 . . . . 1.53 112.248 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.64 54.2 2.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.682 . . . . 0.77 112.76 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -142.65 150.2 39.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.507 -0.408 . . . . 3.72 110.661 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.558 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 17.2 m0 -105.38 114.08 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.675 -0.491 . . . . 1.28 109.675 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.34 148.48 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.207 -0.294 . . . . 1.66 110.207 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.6 mp0 -119.58 160.58 22.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.952 -0.759 . . . . 2.12 108.952 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.98 114.05 16.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.955 0.407 . . . . 0.92 110.338 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.668 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.0 t70 -105.15 -170.76 1.8 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.785 -0.643 . . . . 1.97 110.113 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 12.7 pt-20 -71.84 -38.94 70.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.722 0.638 . . . . 2.43 112.722 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.11 4.19 46.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.173 -0.611 . . . . 2.39 110.979 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.69 -106.23 0.41 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.943 -1.122 . . . . 2.29 113.278 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -134.84 21.74 3.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.907 0.384 . . . . 2.31 111.071 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -96.07 77.57 3.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.626 0.727 . . . . 2.61 110.625 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.668 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -122.81 125.7 45.95 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.229 -0.896 . . . . 3.72 110.214 174.277 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.668 ' HB ' ' HG2' ' A' ' 82' ' ' ARG . 70.2 p 62.03 -66.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.779 1.299 . . . . 2.27 113.363 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 t80 74.26 72.52 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.698 0.799 . . . . 6.48 110.702 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -83.48 150.48 27.08 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.552 -0.749 . . . . 1.23 112.301 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -108.1 92.52 4.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.828 0.347 . . . . 1.17 111.563 -172.437 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 71' ' ' VAL . 25.2 mt -72.04 136.15 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.61 110.06 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -110.13 -24.23 10.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 2.0 109.905 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 20.5 ttmm -162.16 119.75 2.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.879 -0.6 . . . . 1.53 111.261 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 68' ' ' ILE . 60.4 t -108.54 96.16 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.472 -0.936 . . . . 0.88 108.472 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -105.41 65.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.928 -0.309 . . . . 1.42 110.53 -174.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 15.5 pt-20 48.07 -170.59 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 O-C-N 124.514 1.134 . . . . 0.96 111.926 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.513 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.1 Cg_exo -64.7 75.98 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.388 1.392 . . . . 0.38 111.545 169.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.3 t70 -160.17 -66.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.312 -0.858 . . . . 0.5 110.214 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.4 p -143.85 143.45 31.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.17 0.509 . . . . 0.35 112.277 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.8 mp -133.53 121.84 22.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.74 109.831 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 45.5 t -109.57 104.72 17.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.194 -0.669 . . . . 0.67 109.194 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.493 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.97 146.22 34.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.554 0.216 . . . . 0.75 111.076 -178.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.76 148.54 18.86 Favored Glycine 0 C--O 1.24 0.486 0 CA-C-N 116.223 -0.444 . . . . 0.5 112.54 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -77.06 154.57 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.927 0.491 . . . . 2.79 112.322 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.668 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -153.95 23.22 0.5 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 5.46 109.463 -176.069 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 79.85 -164.66 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.815 -1.084 . . . . 1.55 109.933 -172.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.627 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 32.7 t30 -137.87 -70.94 0.43 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.492 -0.322 . . . . 1.93 110.524 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' PHE . . . -72.58 -11.27 76.9 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.584 -0.817 . . . . 2.4 113.353 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 85' ' ' GLY . 86.2 t80 71.82 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.485 0.659 . . . . 5.38 110.964 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -27.82 3.54 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.525 -0.761 . . . . 2.3 111.314 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.69 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -94.17 -175.98 3.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 120.907 0.384 . . . . 4.77 110.505 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.775 HD13 ' HE ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -71.53 129.72 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.551 -0.749 . . . . 1.86 111.491 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 p-10 -99.57 121.03 56.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.393 0.616 . . . . 3.18 109.856 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HB2' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -84.06 36.42 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.204 2.603 . . . . 2.36 111.556 178.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.73 76.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.806 0.812 . . . . 2.99 111.594 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -143.77 -47.25 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.402 -1.333 . . . . 3.06 107.402 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 m -136.87 -95.3 0.22 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.778 -1.556 . . . . 1.85 108.192 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' A' ' 91' ' ' PRO . 66.7 m 48.92 23.83 0.76 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.076 0.55 . . . . 1.44 112.409 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 33.4 mt-10 -75.1 138.97 42.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.651 -0.704 . . . . 1.81 109.619 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CE2' HG23 ' A' ' 79' ' ' ILE . 4.8 p90 -133.26 132.01 40.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.173 0.511 . . . . 0.64 110.543 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 25.8 m -91.4 108.47 19.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.063 -0.971 . . . . 0.43 109.921 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.828 ' HA ' HG22 ' A' ' 113' ' ' VAL . 95.5 t -81.5 108.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 0.87 109.326 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.517 ' HA ' HG22 ' A' ' 76' ' ' THR . 19.3 m -101.68 105.75 16.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.272 -0.422 . . . . 0.45 110.222 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.548 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.3 m-85 -90.28 111.9 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.385 -0.37 . . . . 0.34 110.192 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.21 106.64 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 0.54 109.588 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.41 125.09 28.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.619 . . . . 0.44 110.768 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 28.4 t70 -116.03 114.42 24.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.805 -0.634 . . . . 2.03 110.1 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.47 -114.65 6.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.618 -0.801 . . . . 1.97 111.666 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -146.64 13.5 1.19 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.176 0.512 . . . . 4.93 110.228 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -145.57 -5.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.969 0.729 . . . . 3.53 112.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 29.5 ttpt -123.38 154.01 39.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.602 -0.686 . . . . 2.44 110.304 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.8 m -157.56 114.17 2.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.146 0.498 . . . . 0.42 110.973 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -88.3 119.87 29.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.823 -0.626 . . . . 2.59 109.616 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.1 p -96.18 132.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.249 -0.58 . . . . 0.4 109.588 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.54 109.31 12.01 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.561 -0.903 . . . . 1.38 108.561 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 99' ' ' VAL . 28.6 t -98.83 120.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.029 -0.987 . . . . 0.91 110.991 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.24 119.23 38.46 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.684 0.754 . . . . 2.31 109.431 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.924 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 16.6 t60 -102.74 152.2 21.51 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.595 -1.184 . . . . 1.64 109.016 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 118' ' ' PHE . 11.7 t -54.67 169.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.231 1.015 . . . . 2.67 111.604 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -93.92 14.84 18.32 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.503 -1.226 . . . . 2.63 111.124 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.506 ' H ' HG23 ' A' ' 116' ' ' THR . 16.2 t80 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.059 0.456 . . . . 3.54 110.09 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -30.51 59.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.142 -0.688 . . . . 1.81 109.142 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 57.5 ttt180 -60.29 -19.82 56.61 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.918 -1.037 . . . . 3.38 111.397 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 87.9 mmm -61.22 -15.44 34.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 2.43 110.271 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.98 -140.38 26.94 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.595 -0.729 . . . . 1.61 113.134 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 16.8 p 36.22 -108.44 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 O-C-N 124.766 0.921 . . . . 2.58 112.813 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -84.81 -34.55 22.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 3.8 111.102 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -63.7 -50.33 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 2.14 110.71 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 -25.79 59.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.495 -0.32 . . . . 0.92 110.667 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' THR . 46.9 tptt -56.51 -52.23 65.53 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.969 0.414 . . . . 2.83 110.403 174.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.775 ' HE ' HD13 ' A' ' 89' ' ' ILE . 9.5 ptm85 -72.24 -30.31 64.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.68 -0.691 . . . . 2.59 111.9 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.5 -39.18 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 1.48 111.589 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -62.79 -16.04 56.37 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.264 -0.425 . . . . 3.83 112.067 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -54.99 -24.86 26.2 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.907 0.706 . . . . 2.48 112.907 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -134.74 -24.09 0.61 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.641 -1.266 . . . . 1.61 114.105 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.438 ' SD ' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -73.5 -26.08 60.73 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.431 -0.452 . . . . 4.83 112.0 -172.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.99 -14.63 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.388 . . . . 2.83 110.886 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -115.21 16.38 16.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.734 0.778 . . . . 4.15 109.47 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.68 -91.26 2.21 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.466 -0.788 . . . . 1.04 112.526 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 20.2 m95 -54.89 -47.58 97.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.681 0.993 . . . . 2.78 113.681 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.2 Cg_endo -52.82 -40.04 75.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.813 1.676 . . . . 0.68 112.446 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 38.9 m -78.15 -43.32 29.11 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.631 0.729 . . . . 0.87 110.102 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.624 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.2 mt -59.79 -51.97 66.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 115.105 -0.952 . . . . 0.72 111.734 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 78.7 mt -58.94 -28.3 66.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.174 0.435 . . . . 0.69 112.174 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.3 mm-40 -74.24 -51.74 14.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 1.49 110.296 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 14.9 t -70.52 -23.74 62.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.082 0.468 . . . . 1.15 110.321 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.59 -51.97 66.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 0.8 109.952 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.469 ' CG ' HG13 ' A' ' 10' ' ' VAL . 45.7 mt-30 -66.1 -28.43 68.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.599 -0.728 . . . . 1.63 110.437 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 35.2 t70 -75.78 -43.1 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.698 . . . . 1.46 111.222 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.492 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 58.6 tttm -64.8 -40.12 94.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.065 0.46 . . . . 1.74 110.076 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.817 HG21 HG13 ' A' ' 12' ' ' VAL . 70.8 mt -68.85 -26.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.02 -0.537 . . . . 0.5 110.372 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.93 -37.78 76.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 0.85 109.295 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.589 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 34.8 mt-10 -64.65 -46.09 83.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.18 0.991 . . . . 1.5 108.79 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 148' ' ' ILE . 2.4 tp10 -65.64 -43.63 88.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.4 -1.727 . . . . 1.74 110.506 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.35 -70.49 1.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 1.32 112.075 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -161.81 97.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.388 . . . . 1.92 111.28 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.0 ttmm -137.3 -46.38 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.969 -0.559 . . . . 2.04 109.678 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.496 -0.775 . . . . 4.22 111.176 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 25.0 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.17 0.509 . . . . 1.66 110.784 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.844 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 41.9 p90 -168.38 -42.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.155 -0.475 . . . . 3.73 110.647 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.606 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.6 t70 -72.78 -58.67 2.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.613 -0.267 . . . . 2.78 111.526 -173.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.13 -64.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.165 1.243 . . . . 1.63 110.636 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 53.1 p90 -154.66 147.07 23.98 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.958 -0.564 . . . . 3.21 110.135 173.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -110.46 114.47 47.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.796 -1.187 . . . . 1.44 107.796 164.38 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 28.9 ttm180 -112.67 138.65 49.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.716 -0.674 . . . . 3.37 111.257 -173.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.579 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.57 133.83 52.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.696 -0.853 . . . . 0.79 108.696 172.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.807 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 70.0 m -141.61 113.82 8.11 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.131 -0.486 . . . . 1.28 109.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.967 HG22 HG12 ' A' ' 111' ' ' VAL . 1.9 m -122.92 143.48 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 1.27 109.983 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.1 m -98.04 115.8 28.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.431 0.634 . . . . 0.57 110.158 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.813 HG13 HG21 ' A' ' 148' ' ' ILE . 33.1 t -103.1 133.8 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.568 -0.742 . . . . 0.91 109.947 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.12 30.2 6.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 0.98 111.886 -174.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -154.23 35.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.36 111.209 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 75.03 173.21 0.26 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-O 122.1 0.952 . . . . 0.91 112.705 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.558 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 19.8 ttp180 -71.79 -24.75 61.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.594 -1.185 . . . . 1.88 110.711 -171.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 19.6 tptm -61.14 -48.4 81.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 3.05 110.671 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.2 p -70.9 -38.54 73.01 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.979 -0.288 . . . . 1.11 111.059 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.7 -46.47 81.19 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 120.913 0.387 . . . . 0.32 110.647 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -71.69 -47.79 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.872 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 25.6 tptp -52.33 -46.53 66.09 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 120.966 0.412 . . . . 2.39 111.1 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 m -70.88 -49.04 50.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.192 -0.458 . . . . 0.68 110.349 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.55 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.3 t80 -62.39 -41.08 98.38 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.231 0.456 . . . . 0.48 112.231 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 46' ' ' VAL . 12.5 tp -113.05 -34.24 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.231 -0.588 . . . . 0.5 112.512 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.712 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 35.1 mt-10 -104.82 16.22 26.38 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.234 -0.291 . . . . 1.24 111.419 -173.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.747 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -153.87 38.74 0.69 Allowed Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.754 -0.736 . . . . 0.83 111.482 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.615 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 61.9 t80 -53.66 -54.45 45.94 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 112.806 0.669 . . . . 0.74 112.806 -169.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 36.5 Cg_endo -87.5 13.88 2.53 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.76 114.496 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.7 pt-20 -97.36 -6.49 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.159 -0.616 . . . . 1.49 110.586 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.661 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 26.8 m0 -73.3 176.11 6.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.482 0.658 . . . . 4.62 111.446 -175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.535 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 35.0 m95 -97.91 -25.19 0.23 Allowed Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 114.136 1.161 . . . . 2.78 114.136 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 30' ' ' TRP . 72.6 Cg_endo -75.2 -151.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.726 1.617 . . . . 1.36 114.281 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.478 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 25.5 t-20 -44.73 -43.28 8.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.85 -1.068 . . . . 1.51 113.293 -171.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.941 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 2.0 p-10 -79.95 38.95 0.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.395 -0.821 . . . . 1.79 112.323 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -100.35 -6.23 26.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 4.45 110.722 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 12.4 mmm180 -89.48 131.07 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.342 -0.39 . . . . 4.14 110.751 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.6 p -76.01 137.38 40.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 2.68 110.881 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.9 p 52.92 24.46 3.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 1.42 111.338 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 3.0 tmtp? -121.31 -55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.496 -0.927 . . . . 2.9 108.496 174.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.941 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 1.6 t -150.47 19.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.222 -0.659 . . . . 1.83 109.222 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.48 41.84 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.584 -1.293 . . . . 2.17 114.135 -166.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.925 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -67.95 173.22 3.27 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.247 -0.649 . . . . 1.12 109.247 167.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 29.5 Cg_endo -63.44 26.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.049 2.499 . . . . 1.48 115.335 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -142.1 -88.94 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.932 -0.48 . . . . 1.75 110.81 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 95.2 -49.77 1.91 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.766 -0.73 . . . . 0.75 112.766 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 24' ' ' LEU . 85.8 t -137.12 143.38 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.6 110.161 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.854 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 13.6 t70 -104.95 109.1 20.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.206 -0.664 . . . . 1.11 109.206 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -80.95 -13.64 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.49 -0.777 . . . . 2.81 112.316 -173.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -90.4 -40.05 12.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.665 0.269 . . . . 3.17 111.573 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.68 -32.27 4.23 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.986 -0.846 . . . . 1.53 110.986 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 96.16 79.61 1.47 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.77 111.946 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.854 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 28.6 ptt180 -157.99 165.28 35.51 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.53 -0.544 . . . . 3.72 109.53 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.677 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -111.82 117.93 34.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.74 -0.467 . . . . 1.28 109.74 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.612 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.9 p90 -164.02 159.03 20.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.282 0.563 . . . . 1.66 111.244 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.925 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 26.2 mt-10 -111.82 153.72 26.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.678 -0.692 . . . . 2.12 110.2 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 mm -81.2 103.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.258 -0.645 . . . . 0.92 109.258 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.678 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.0 t70 -90.25 -170.79 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.258 -0.275 . . . . 1.97 110.258 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 11.4 pt-20 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.883 0.327 . . . . 2.43 111.883 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.588 ' OE1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -84.5 -10.35 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 2.39 110.61 -178.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -86.79 0.17 Allowed Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.83 -0.623 . . . . 2.29 112.448 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . 40.0 mt-10 -148.65 37.13 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.539 0.209 . . . . 2.31 111.285 -172.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.45 77.85 1.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.147 0.975 . . . . 2.61 110.84 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.678 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -123.22 163.95 19.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.634 -1.166 . . . . 3.72 110.275 172.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.604 ' HB ' ' HD2' ' A' ' 82' ' ' ARG . 7.1 p -57.98 106.22 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 2.27 111.48 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 19.2 p90 -79.61 109.31 13.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 6.48 112.162 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -67.41 136.62 32.15 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.987 -0.845 . . . . 1.23 110.987 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 67' ' ' LEU . 4.0 mp -87.91 86.88 7.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.45 0.125 . . . . 1.17 111.166 -171.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 51' ' ' GLY . 35.5 mt -82.27 116.62 26.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.094 -1.042 . . . . 0.61 109.568 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -103.21 -12.79 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.168 -0.923 . . . . 2.0 110.319 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 36.9 ttmt -156.81 121.12 4.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 1.53 111.511 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 77' ' ' LEU . 59.3 t -109.86 89.06 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.966 -1.124 . . . . 0.88 107.966 167.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 76' ' ' THR . 38.7 t0 -97.8 71.41 2.22 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.879 -0.328 . . . . 1.42 110.454 -175.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.559 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 pt-20 46.42 -169.73 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 124.402 1.064 . . . . 0.96 111.411 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -67.06 74.38 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.107 1.205 . . . . 0.38 110.914 165.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -155.0 -71.35 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.491 -0.322 . . . . 0.5 110.771 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.581 ' C ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -142.31 123.94 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.476 0.547 . . . . 0.35 112.476 -175.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD13 ' C ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -118.73 123.2 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.862 -0.523 . . . . 0.74 110.41 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 58.1 t -103.13 101.72 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.67 109.251 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.32 140.92 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.138 -0.483 . . . . 0.75 111.12 -176.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.38 145.9 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.589 -0.732 . . . . 0.5 112.365 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 1.002 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 72.0 t-105 -72.99 142.62 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.581 0.586 . . . . 2.79 112.581 -174.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.604 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -145.12 44.41 1.33 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.49 -0.777 . . . . 5.46 109.32 177.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 75.95 145.46 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.337 -0.847 . . . . 1.55 111.954 176.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.629 ' N ' HD13 ' A' ' 83' ' ' LEU . 2.5 t-20 -83.11 -66.59 0.87 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.047 -0.979 . . . . 1.93 111.306 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 40' ' ' VAL . . . -91.13 29.14 7.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 2.4 113.678 -172.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 63' ' ' HIS . 75.7 t80 67.32 -68.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.23 0.612 . . . . 5.38 112.563 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.77 55.66 4.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.212 -0.518 . . . . 2.3 113.944 -170.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.648 ' HB2' HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -140.53 -175.96 4.46 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.719 -0.845 . . . . 4.77 108.719 170.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -92.44 127.66 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.251 0.548 . . . . 1.86 111.494 -173.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' OD1' ' HD3' ' A' ' 82' ' ' ARG . 3.2 p30 -135.39 158.92 73.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.62 -0.718 . . . . 3.18 109.15 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -91.0 -29.16 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.346 2.03 . . . . 2.36 114.089 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.17 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.923 1.289 . . . . 2.99 114.418 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -79.56 -20.1 47.87 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.718 -0.613 . . . . 3.06 112.211 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 p -155.9 -90.09 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.398 -0.593 . . . . 1.85 109.398 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 1.002 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.4 m 54.87 25.73 7.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.763 -0.653 . . . . 1.44 111.685 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.646 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 39.2 tt0 -77.63 142.63 38.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 1.81 112.214 -171.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 79' ' ' ILE . 6.6 p90 -139.92 141.06 36.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.64 110.52 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 39.0 m -97.04 112.38 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.686 -0.688 . . . . 0.43 110.387 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' THR . 84.5 t -84.43 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.87 109.71 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.469 ' HA ' HG22 ' A' ' 76' ' ' THR . 55.6 m -107.13 106.03 16.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.917 0.389 . . . . 0.45 110.849 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.558 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 46.0 m-85 -85.08 113.38 21.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.401 -0.363 . . . . 0.34 110.05 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.63 109.49 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.645 -0.502 . . . . 0.54 109.645 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.67 124.21 28.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.207 0.527 . . . . 0.44 111.041 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 32.8 m-20 -106.59 125.24 50.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.318 -0.855 . . . . 2.03 109.165 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.86 71.87 0.39 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.131 -0.486 . . . . 1.97 113.9 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 46.0 tt0 -169.6 25.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.055 -1.091 . . . . 4.93 108.055 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 57.38 48.74 14.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.859 0.837 . . . . 3.53 109.317 -169.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 36.1 tttp -130.22 148.8 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.561 -1.199 . . . . 2.44 108.613 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.1 m -155.25 113.68 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.124 0.488 . . . . 0.42 110.904 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.6 tmm_? -100.37 111.5 23.77 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.593 -0.891 . . . . 2.59 108.593 176.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.967 HG12 HG22 ' A' ' 10' ' ' VAL . 13.0 p -85.8 145.51 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.861 -0.336 . . . . 0.4 110.862 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -129.19 117.09 20.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 124.177 0.923 . . . . 1.38 109.578 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -104.75 128.44 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 110.266 -0.272 . . . . 0.91 110.266 175.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -103.63 114.82 29.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.21 -0.663 . . . . 2.31 109.21 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.6 t60 -131.98 125.5 31.7 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.997 -1.001 . . . . 1.64 108.864 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 5' ' ' PHE . 5.2 t -176.94 101.86 0.05 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.75 0.786 . . . . 2.67 110.198 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.6 t-160 -166.81 -67.1 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.573 -0.74 . . . . 2.63 110.302 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.6 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 1.2 p90 -81.83 -24.74 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.891 -0.595 . . . . 3.54 110.98 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.844 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -75.46 -52.68 10.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.505 0.722 . . . . 1.81 111.352 -176.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 16.4 ptt180 -65.41 -16.7 63.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.213 -0.903 . . . . 3.38 110.705 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 41.9 tpp -74.51 26.21 0.08 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.192 -0.913 . . . . 2.43 112.721 -169.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.68 172.15 13.09 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.265 -1.445 . . . . 1.61 114.718 166.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 m -58.03 -54.24 49.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.674 -0.763 . . . . 2.58 111.892 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 124' ' ' LYS . 45.4 mtpt -68.48 -28.64 67.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 3.8 110.875 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.764 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 13.4 m-70 -67.93 -47.85 67.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.207 -0.451 . . . . 2.14 111.278 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.72 -23.42 58.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.359 -0.536 . . . . 0.92 110.468 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -74.6 -38.16 62.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 2.83 110.618 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.764 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 14.5 ptp180 -67.05 -28.35 68.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.738 -0.467 . . . . 2.59 109.738 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.719 ' HA ' ' SD ' ' A' ' 133' ' ' MET . 67.5 t -65.27 -46.33 90.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.013 -0.54 . . . . 1.48 109.808 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.645 ' HA ' ' HB2' ' A' ' 134' ' ' ASP . 65.0 ttt180 -65.91 -16.28 63.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.484 -0.78 . . . . 3.83 110.963 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.655 ' OD1' ' HA ' ' A' ' 128' ' ' ARG . 3.6 m120 -53.76 -55.55 25.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.444 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.06 -7.18 0.1 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.838 -1.172 . . . . 1.61 114.923 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 129' ' ' VAL . 10.8 mtt -80.29 -28.11 38.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.3 -1.0 . . . . 4.83 108.3 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.645 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 12.3 t70 -56.34 -43.44 79.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.941 -1.481 . . . . 2.83 112.567 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -108.99 11.19 26.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 4.15 111.872 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.548 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.12 -65.61 0.7 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.019 -1.086 . . . . 1.04 112.329 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.51 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -57.92 -48.48 97.05 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.818 0.673 . . . . 2.78 112.818 -172.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.4 Cg_endo -58.32 -44.38 38.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.781 1.654 . . . . 0.68 112.02 176.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 m -59.62 -42.81 93.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.559 0.695 . . . . 0.87 109.672 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.623 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.9 mt -59.38 -50.58 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.764 -1.107 . . . . 0.72 111.345 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -34.51 74.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.282 0.475 . . . . 0.69 112.282 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -52.65 30.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.019 0.438 . . . . 1.49 110.542 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.449 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.1 m -68.9 -22.03 64.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.997 -0.547 . . . . 1.15 110.575 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.97 -53.94 42.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.8 110.109 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -60.3 -29.31 68.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.844 -0.616 . . . . 1.63 110.046 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.83 -47.19 60.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.116 -0.947 . . . . 1.46 110.367 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -61.83 -34.15 75.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.689 . . . . 1.74 110.424 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.813 HG21 HG13 ' A' ' 12' ' ' VAL . 66.4 mt -80.78 -25.19 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.77 -0.65 . . . . 0.5 110.811 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.591 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 25.7 t0 -63.78 -24.58 67.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.85 109.512 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 45.0 mt-10 -67.17 -26.81 66.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.214 -0.903 . . . . 1.5 110.338 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.07 -7.35 58.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 1.74 109.98 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.15 -80.26 0.67 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.839 -0.618 . . . . 1.32 113.244 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.91 30.79 0.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.08 0.44 . . . . 1.92 112.173 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 18.0 tppt? -61.53 -38.54 87.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 2.04 111.035 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.405 -0.807 . . . . 4.22 111.119 -177.294 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 18.4 p-10 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.71 0.29 . . . . 1.66 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.444 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . 6.2 p90 -179.41 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.343 -0.389 . . . . 3.73 110.575 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.878 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.2 t70 -64.85 -62.79 4.36 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.51 -0.314 . . . . 2.78 111.299 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 10.3 Cg_endo -90.42 -57.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.697 1.598 . . . . 1.63 111.245 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 49.7 p90 -152.12 167.36 28.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.063 -0.971 . . . . 3.21 108.849 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 4.3 m -104.57 133.65 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.271 -1.011 . . . . 1.44 108.271 174.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.4 ttp180 -131.1 150.05 52.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.421 0.629 . . . . 3.37 111.041 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.995 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 2.3 t-160 -119.31 132.82 55.94 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.756 -1.202 . . . . 0.79 107.756 170.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.0 t -139.62 114.43 9.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.362 -0.535 . . . . 1.28 110.155 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.3 t -131.65 139.73 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.664 -0.698 . . . . 1.27 111.067 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -99.08 115.46 29.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.41 -0.589 . . . . 0.57 109.41 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.829 HG13 HG21 ' A' ' 148' ' ' ILE . 45.8 t -97.14 130.5 45.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.982 -0.554 . . . . 0.91 109.825 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.658 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.76 23.85 12.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.98 111.517 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -147.06 29.15 0.99 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.837 -0.345 . . . . 0.36 111.747 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 24.3 t70 72.53 165.28 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.778 0.799 . . . . 0.91 112.566 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 17.3 ttp180 -66.1 -25.72 67.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.988 -1.006 . . . . 1.88 111.44 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -59.78 -51.13 71.07 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.224 -0.444 . . . . 3.05 110.985 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 42.9 p -72.17 -32.9 67.27 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.579 -0.282 . . . . 1.11 110.62 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.4 -51.07 69.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.32 110.635 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -69.79 -41.5 75.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.38 110.6 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 4.3 tppp? -53.87 -52.81 59.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.98 -0.554 . . . . 2.39 110.779 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.424 HG22 ' NE1' ' A' ' 30' ' ' TRP . 6.5 m -69.63 -48.64 59.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.009 -0.541 . . . . 0.68 110.665 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.876 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 63.1 t80 -62.16 -32.67 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.22 0.452 . . . . 0.48 112.22 -172.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' A' ' 46' ' ' VAL . 15.1 tp -117.82 -51.27 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.754 0.65 . . . . 0.5 112.754 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.443 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 38.7 mt-10 -76.82 -20.94 55.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 1.24 111.355 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.667 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -118.95 36.24 3.64 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.843 -0.694 . . . . 0.83 111.98 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.517 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 58.4 t80 -53.01 -51.74 71.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.629 0.603 . . . . 0.74 112.629 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 41.1 Cg_endo -87.5 12.39 2.93 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.757 1.638 . . . . 0.76 114.821 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 7.8 pt-20 -102.89 -4.93 24.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.295 -0.562 . . . . 1.49 111.577 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.876 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 34.8 m0 -69.4 168.83 13.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.464 0.65 . . . . 4.62 111.873 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.501 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 56.5 m95 -86.02 -38.03 0.56 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 114.978 -1.01 . . . . 2.78 113.435 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.765 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 58.0 Cg_endo -68.65 -105.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.375 2.05 . . . . 1.36 115.071 -165.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' ND2' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -79.65 -42.65 24.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.02 0.438 . . . . 1.51 111.051 -175.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -81.88 68.03 8.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.535 0.684 . . . . 1.79 111.08 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.01 12.06 4.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.091 -0.959 . . . . 4.45 109.627 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -126.47 137.2 53.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.862 -0.608 . . . . 4.14 111.252 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -77.09 141.19 40.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 2.68 110.89 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 56.0 p 55.47 18.43 2.66 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.84 0.856 . . . . 1.42 112.3 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.563 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 45.9 tttp -110.7 -61.85 1.62 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.801 -0.814 . . . . 2.9 108.801 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.634 HG11 ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -157.46 25.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.887 -1.051 . . . . 1.83 110.035 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.36 36.34 0.24 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.305 -0.95 . . . . 2.17 113.27 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.006 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.96 170.42 13.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.678 -0.49 . . . . 1.12 109.678 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.25 67.79 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.698 2.265 . . . . 1.48 113.071 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -175.35 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.554 -0.748 . . . . 1.75 110.16 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.517 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 87.05 -58.68 4.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.963 -0.636 . . . . 0.75 112.474 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 24' ' ' LEU . 91.9 t -135.69 137.91 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.926 0.393 . . . . 0.6 110.907 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.651 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 23.7 t70 -103.8 99.36 9.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.749 -0.834 . . . . 1.11 108.749 173.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -80.76 -9.13 59.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.309 -0.859 . . . . 2.81 111.186 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -68.18 -55.58 11.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.984 -0.553 . . . . 3.17 110.583 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.12 -54.08 1.05 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.958 -0.639 . . . . 1.53 111.658 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 132.13 64.19 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.82 -0.705 . . . . 0.77 112.648 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.76 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 21.4 ptt180 -149.34 140.21 22.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.636 0.255 . . . . 3.72 111.54 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.736 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.4 m0 -97.21 108.23 20.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.67 -0.241 . . . . 1.28 110.591 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.651 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.3 p90 -158.25 176.15 12.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.453 . . . . 1.66 110.966 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 18.5 mt-10 -130.6 155.19 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 2.12 110.595 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.648 HG23 ' HG2' ' A' ' 61' ' ' GLU . 37.4 mm -78.22 103.0 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.499 -0.926 . . . . 0.92 108.499 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.659 ' OD2' ' HG3' ' A' ' 59' ' ' GLN . 12.5 t70 -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.169 -0.468 . . . . 1.97 109.963 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.18 -6.92 58.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.78 0.659 . . . . 2.43 112.78 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.659 ' HG3' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -90.12 7.3 38.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.473 -0.891 . . . . 2.39 110.471 170.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.42 62.11 0.45 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.953 -0.641 . . . . 2.29 113.76 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.648 ' HG2' HG23 ' A' ' 56' ' ' ILE . 40.0 mt-10 44.74 54.07 6.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.281 0.845 . . . . 2.31 113.281 171.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' H ' HE22 ' A' ' 59' ' ' GLN . 0.8 OUTLIER -127.77 84.68 2.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.413 0.625 . . . . 2.61 110.143 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -124.54 158.42 32.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.197 -0.91 . . . . 3.72 109.593 172.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -59.65 142.03 53.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.251 -0.648 . . . . 2.27 109.251 170.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.76 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 p90 -121.83 117.48 26.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.097 0.475 . . . . 6.48 111.187 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -57.15 134.28 52.36 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-N 115.235 -0.893 . . . . 1.23 111.754 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.69 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -92.26 88.1 6.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.191 0.52 . . . . 1.17 110.668 -171.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 58.2 mt -74.17 121.32 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.202 0.525 . . . . 0.61 110.382 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -31.09 24.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.603 -0.726 . . . . 2.0 109.539 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -160.21 119.92 2.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 1.53 111.819 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 68' ' ' ILE . 60.8 t -99.6 100.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.152 -1.055 . . . . 0.88 108.152 167.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -108.48 70.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.768 -0.373 . . . . 1.42 110.96 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 pt-20 47.03 -170.39 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 124.471 1.107 . . . . 0.96 111.722 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.8 Cg_exo -64.23 75.21 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.474 1.449 . . . . 0.38 111.342 166.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -157.35 -62.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.75 -0.659 . . . . 0.5 110.413 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -147.75 148.37 30.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.324 0.49 . . . . 0.35 112.324 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 mp -136.59 114.92 11.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.74 109.416 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.623 HG22 HG23 ' A' ' 98' ' ' THR . 36.4 t -101.33 104.9 16.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.897 -0.779 . . . . 0.67 108.897 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -128.55 144.7 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.826 0.346 . . . . 0.75 111.293 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.69 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -98.47 159.56 20.46 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.5 112.717 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.9 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -64.56 157.21 27.5 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 112.794 0.664 . . . . 2.79 112.794 -168.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.2 tmt_? -149.96 -2.19 0.41 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.502 -0.772 . . . . 5.46 110.373 -167.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 88' ' ' ARG . 3.1 tm? 71.19 133.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.468 -0.787 . . . . 1.55 110.882 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.634 ' OD1' HG11 ' A' ' 40' ' ' VAL . 55.5 t30 -108.15 135.94 48.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.93 110.324 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.563 ' HA2' ' HE3' ' A' ' 39' ' ' LYS . . . 106.08 -17.21 41.57 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.564 -0.827 . . . . 2.4 112.732 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 t80 69.87 -54.62 0.61 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.139 0.575 . . . . 5.38 111.83 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.34 10.78 47.82 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.947 -0.461 . . . . 2.3 111.947 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.696 ' HB3' HD11 ' A' ' 83' ' ' LEU . 1.9 tpp180 -97.33 167.89 10.74 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.559 -1.275 . . . . 4.77 107.559 173.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.687 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -113.4 123.22 68.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 119.927 -0.709 . . . . 1.86 112.023 -173.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 16.8 t70 -160.17 131.37 3.87 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 108.35 -0.981 . . . . 3.18 108.35 166.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 128' ' ' ARG . 7.9 Cg_exo -73.63 1.71 6.62 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.749 2.299 . . . . 2.36 113.393 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 60.68 81.17 0.19 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.463 -0.569 . . . . 2.99 109.463 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.96 -64.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.219 0.452 . . . . 3.06 112.219 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -124.19 -145.41 0.34 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.22 -0.446 . . . . 1.85 111.24 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.9 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 9.2 t 73.16 67.93 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.28 -0.873 . . . . 1.44 111.385 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.88 98.4 10.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.487 -0.779 . . . . 1.81 109.847 172.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HA ' ' HB2' ' A' ' 115' ' ' HIS . 7.5 p90 -104.83 130.98 52.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.168 -0.613 . . . . 0.64 111.323 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.623 HG23 HG22 ' A' ' 78' ' ' VAL . 12.6 m -91.99 110.49 21.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.413 -0.812 . . . . 0.43 110.655 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.764 ' HA ' HG22 ' A' ' 113' ' ' VAL . 60.2 t -82.3 109.27 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.394 -0.595 . . . . 0.87 109.394 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.545 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.1 m -101.57 106.92 18.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.321 -0.399 . . . . 0.45 110.732 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.722 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.4 m-85 -88.94 107.31 18.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.551 -0.537 . . . . 0.34 109.551 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -93.13 108.98 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.494 -0.558 . . . . 0.54 109.494 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.77 141.01 58.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.832 -0.622 . . . . 0.44 111.014 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.711 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 7.3 t70 -126.65 92.64 3.59 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.043 -0.526 . . . . 2.03 109.593 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.15 -108.44 2.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.74 -0.743 . . . . 1.97 112.436 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -140.96 -2.43 1.31 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.714 0.265 . . . . 4.93 111.714 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -3.17 1.34 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.758 0.651 . . . . 3.53 112.758 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 49.1 tttm -127.46 157.08 41.02 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.486 -0.486 . . . . 2.44 109.945 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.1 m -159.18 123.39 3.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.446 -0.343 . . . . 0.42 110.548 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -97.23 118.61 34.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.271 -0.64 . . . . 2.59 109.271 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.722 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 p -99.89 134.53 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.775 -0.454 . . . . 0.4 109.775 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.752 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.2 t70 -138.3 114.43 10.15 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.25 -0.887 . . . . 1.38 109.877 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.995 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 25.6 t -91.39 124.4 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.105 -0.498 . . . . 0.91 110.782 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -107.38 115.95 31.06 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 124.003 0.815 . . . . 2.31 109.621 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 97' ' ' PHE . 25.8 t60 -154.7 143.33 20.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.426 . . . . 1.64 110.744 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 9.7 t -162.36 119.27 2.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.054 0.391 . . . . 2.67 112.054 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' THR . 76.9 t60 169.16 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.541 -0.754 . . . . 2.63 110.788 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -53.23 -50.33 64.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.652 0.612 . . . . 3.54 112.652 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 8.3 t70 -78.69 -39.92 35.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.916 0.388 . . . . 1.81 111.548 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -66.3 -27.45 67.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 3.38 110.856 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 32.9 tpp -98.55 18.34 16.94 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.985 -1.117 . . . . 2.43 107.985 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.651 ' HA2' ' HB3' ' A' ' 125' ' ' HIS . . . -66.22 -88.13 0.06 OUTLIER Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.729 -1.578 . . . . 1.61 114.339 -168.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 28.7 m 57.3 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.703 -0.851 . . . . 2.58 108.703 -165.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.66 -55.07 19.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.266 -0.642 . . . . 3.8 109.266 170.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.651 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 3.0 t-160 -64.51 -48.26 75.79 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.494 -0.775 . . . . 2.14 111.208 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.566 ' HB2' ' HA3' ' A' ' 122' ' ' GLY . . . -58.51 -45.98 87.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.163 -0.472 . . . . 0.92 111.249 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 123' ' ' THR . 5.7 tmtm? -61.76 -47.38 85.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 2.83 110.887 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.687 ' HB2' HG23 ' A' ' 89' ' ' ILE . 7.4 ptp180 -68.3 -35.1 77.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.439 0.533 . . . . 2.59 112.439 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.408 HG13 ' CZ2' ' A' ' 81' ' ' TRP . 91.9 t -80.23 -40.87 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.979 0.419 . . . . 1.48 111.25 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -62.56 -15.03 48.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.745 -0.662 . . . . 3.83 111.171 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.68 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 94.5 m-20 -58.77 -22.68 58.62 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 2.48 112.243 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.18 -31.83 0.07 OUTLIER Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.005 -1.093 . . . . 1.61 114.059 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -65.0 -23.25 67.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.557 -0.378 . . . . 4.83 110.851 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.38 -24.73 66.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.927 -0.579 . . . . 2.83 111.983 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -113.26 -48.03 2.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.882 0.372 . . . . 4.15 110.833 -176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -61.41 -56.73 21.74 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.858 -0.61 . . . . 1.04 113.236 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.589 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -60.38 -48.52 93.61 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.431 0.53 . . . . 2.78 112.431 -173.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 15.6 Cg_endo -58.87 -42.34 53.58 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.648 1.566 . . . . 0.68 112.026 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.8 m -64.53 -35.44 80.96 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.685 0.755 . . . . 0.87 109.387 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 137' ' ' TRP . 13.6 mt -54.79 -49.16 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.597 -1.183 . . . . 0.72 110.809 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.0 mt -62.9 -29.11 70.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.295 0.48 . . . . 0.69 112.295 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.19 -57.5 4.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.49 110.318 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.474 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 29.5 m -65.36 -23.4 66.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.103 0.478 . . . . 1.15 110.621 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 45.7 t80 -61.56 -54.78 38.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.634 . . . . 0.8 110.233 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.558 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.2 mt-30 -60.49 -31.81 70.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.83 -0.623 . . . . 1.63 110.894 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -42.37 69.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.758 -0.655 . . . . 1.46 111.735 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 18.3 tptm -69.97 -35.04 74.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.492 -0.483 . . . . 1.74 109.723 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.829 HG21 HG13 ' A' ' 12' ' ' VAL . 62.2 mt -66.45 -35.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.5 110.393 175.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 154' ' ' LYS . 19.0 t70 -59.14 -40.42 85.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.85 109.044 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 154' ' ' LYS . 43.7 mt-10 -68.38 -35.37 77.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.801 -0.636 . . . . 1.5 110.787 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.82 -43.88 97.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 1.74 111.264 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.22 -66.15 1.68 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.529 -0.843 . . . . 1.32 111.861 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.482 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -173.5 89.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.719 -0.474 . . . . 1.92 109.719 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 149' ' ' ASP . 11.9 tppt? -73.88 134.41 43.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 2.04 110.245 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 153' ' ' ALA . 5.0 mptt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.475 -0.774 . . . . 4.22 110.62 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 19.6 p-10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.161 0.505 . . . . 1.66 110.715 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.505 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 46.6 p90 -176.47 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.867 -0.606 . . . . 3.73 110.751 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.985 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.2 t70 -72.57 -64.85 0.85 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.616 -0.266 . . . . 2.78 111.009 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.985 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 27.8 Cg_endo -97.51 -67.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.506 2.137 . . . . 1.63 113.151 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 4' ' ' PRO . 70.8 m-85 -124.72 113.59 18.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.417 -0.356 . . . . 3.21 111.052 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.823 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 46.0 t -90.81 111.91 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.148 -0.686 . . . . 1.44 109.148 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.667 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.8 ttp180 -133.22 134.96 44.72 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.043 -0.663 . . . . 3.37 111.174 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.584 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.92 131.75 54.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.886 -0.783 . . . . 0.79 108.886 173.021 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.3 m -132.93 110.43 10.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.594 -0.73 . . . . 1.28 109.852 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.2 t -124.63 139.29 51.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.144 -0.934 . . . . 1.27 110.867 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.6 m -103.67 114.61 29.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.71 0.767 . . . . 0.57 109.875 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.809 HG13 HG21 ' A' ' 148' ' ' ILE . 25.1 t -90.77 139.06 18.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.098 -0.955 . . . . 0.91 109.682 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.641 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -111.61 29.25 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.103 0.478 . . . . 0.98 110.871 -176.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.629 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.84 29.41 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.36 111.635 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 35.3 t70 72.2 162.38 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.749 0.785 . . . . 0.91 112.423 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 33.6 ttp180 -65.59 -23.65 66.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.133 -0.94 . . . . 1.88 111.036 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HB2' ' HE3' ' A' ' 17' ' ' LYS . 21.1 ttmt -57.29 -44.99 84.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 3.05 110.587 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 68.4 p -80.23 -31.82 38.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.336 -0.393 . . . . 1.11 110.515 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.41 -47.59 81.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.32 110.687 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 83.0 t80 -67.77 -44.32 77.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.38 110.443 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 18' ' ' THR . 42.3 tttp -52.17 -49.49 63.7 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.839 -0.619 . . . . 2.39 110.488 175.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 29.1 m -68.39 -52.49 32.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.297 -0.41 . . . . 0.68 111.688 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.761 ' HA ' ' HZ ' ' A' ' 144' ' ' PHE . 60.1 t80 -65.36 -30.72 71.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.889 -0.324 . . . . 0.48 111.756 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' CD1' HG11 ' A' ' 46' ' ' VAL . 15.6 tp -120.12 -54.15 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.315 0.857 . . . . 0.5 113.315 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -81.37 -23.7 37.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.568 0.581 . . . . 1.24 112.568 -167.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -110.16 28.98 9.66 Favored Glycine 0 C--N 1.314 -0.665 0 N-CA-C 111.24 -0.744 . . . . 0.83 111.24 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.657 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 41.6 t80 -48.01 -54.32 25.4 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.928 -0.636 . . . . 0.74 112.447 -170.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 8.1 Cg_endo -95.67 38.06 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.051 1.834 . . . . 0.76 115.298 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.9 pt-20 -132.1 -11.11 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.481 -0.888 . . . . 1.49 113.03 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.773 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 11.2 m95 -76.92 172.79 12.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.226 0.536 . . . . 4.62 111.746 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.486 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 m95 -74.6 -47.65 5.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.929 1.085 . . . . 2.78 113.929 -175.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.766 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 27.7 Cg_endo -57.87 -87.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.714 2.276 . . . . 1.36 115.108 -158.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' HB3' HD11 ' A' ' 140' ' ' ILE . 12.8 t-20 -111.12 -3.73 15.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.432 -0.951 . . . . 1.51 108.432 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.618 ' HA ' HG23 ' A' ' 40' ' ' VAL . 15.0 m120 -93.83 22.69 5.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.44 -1.255 . . . . 1.79 112.579 -168.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -134.23 58.3 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.392 0.615 . . . . 4.45 110.416 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 36.9 mmt180 -136.47 145.58 45.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 4.14 109.597 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -75.65 132.43 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.801 -0.359 . . . . 2.68 110.221 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 57' ' ' ASP . 73.0 p 53.69 21.76 2.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.861 0.864 . . . . 1.42 111.798 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' HD3' ' HA3' ' A' ' 85' ' ' GLY . 5.1 mmtp -138.58 79.69 1.75 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.851 -0.613 . . . . 2.9 110.592 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.618 HG23 ' HA ' ' A' ' 34' ' ' ASN . 22.2 m 42.61 26.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.5 -1.227 . . . . 1.83 112.982 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.13 16.41 2.55 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.133 -0.556 . . . . 2.17 111.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.93 162.01 66.45 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.991 -0.744 . . . . 1.12 108.991 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.34 50.68 0.17 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 123.263 2.642 . . . . 1.48 114.679 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -166.34 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.708 0.289 . . . . 1.75 110.995 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.657 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.48 -56.59 3.11 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.817 -0.706 . . . . 0.75 112.59 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.593 HG11 ' CD1' ' A' ' 24' ' ' LEU . 97.3 t -134.47 145.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.014 0.435 . . . . 0.6 111.003 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 1.028 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.3 t70 -121.28 102.78 8.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.566 -0.743 . . . . 1.11 109.038 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 15.3 mtmt -77.75 -28.45 50.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.213 0.449 . . . . 2.81 112.213 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -72.63 -35.08 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.961 -0.296 . . . . 3.17 111.05 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.72 -42.41 4.47 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.821 -0.704 . . . . 1.53 112.097 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 102.5 45.48 1.67 Allowed Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.913 -0.661 . . . . 0.77 112.921 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -144.06 165.04 28.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.466 -0.432 . . . . 3.72 111.607 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.618 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 18.9 m0 -108.15 123.98 49.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.824 -0.625 . . . . 1.28 109.627 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 1.028 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 2.7 p90 -163.36 151.43 13.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.954 0.407 . . . . 1.66 110.784 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.6 mp0 -117.95 160.18 21.88 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.488 -0.56 . . . . 2.12 109.488 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' HG2' ' A' ' 61' ' ' GLU . 26.8 mm -78.25 103.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.33 -0.395 . . . . 0.92 110.017 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.507 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.9 t70 -84.25 -166.53 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 1.97 110.012 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.56 -37.86 22.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.027 0.38 . . . . 2.43 112.027 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.18 23.56 3.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.155 0.503 . . . . 2.39 110.937 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.35 -113.27 0.86 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.875 -1.155 . . . . 2.29 113.011 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.568 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 40.4 mt-10 -149.12 2.06 0.56 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.262 0.467 . . . . 2.31 112.262 -167.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -93.11 90.82 7.04 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.929 0.871 . . . . 2.61 110.683 -168.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -121.4 87.78 2.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.382 -1.281 . . . . 3.72 111.028 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.735 HG23 ' HD1' ' A' ' 86' ' ' PHE . 0.8 OUTLIER 54.25 179.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.606 0.717 . . . . 2.27 112.733 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -133.65 99.26 4.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.192 -0.458 . . . . 6.48 110.424 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.704 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.78 119.57 9.14 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.556 -1.418 . . . . 1.23 109.556 173.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 67' ' ' LEU . 3.8 mp -79.91 86.33 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.255 -0.578 . . . . 1.17 110.667 -169.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.67 HG21 HG23 ' A' ' 71' ' ' VAL . 19.2 mt -76.43 114.8 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.694 -1.202 . . . . 0.61 109.326 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 18.0 mmm180 -95.54 -25.4 16.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.759 -1.109 . . . . 2.0 109.388 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 81.8 tttt -161.01 115.63 2.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 1.53 111.525 -175.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.67 HG23 HG21 ' A' ' 68' ' ' ILE . 89.6 t -107.35 102.01 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.564 -0.902 . . . . 0.88 108.564 168.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 9.1 t0 -112.86 69.23 0.69 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.367 -0.533 . . . . 1.42 110.462 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.8 pt-20 46.12 -169.05 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 O-C-N 124.706 1.254 . . . . 0.96 111.578 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.596 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.0 Cg_exo -64.52 78.47 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.154 1.236 . . . . 0.38 111.408 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.9 t70 -161.96 -66.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.445 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.5 p -140.71 141.41 34.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.141 0.496 . . . . 0.35 112.308 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' CD2' HD22 ' A' ' 24' ' ' LEU . 2.7 mp -135.55 122.26 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.74 109.717 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 98' ' ' THR . 41.9 t -110.32 106.81 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.423 -0.584 . . . . 0.67 109.423 176.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -130.99 133.87 62.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.027 0.441 . . . . 0.75 112.137 -178.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.837 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -80.43 156.92 39.74 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.946 -0.57 . . . . 0.5 112.562 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -66.89 144.16 56.42 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.236 0.541 . . . . 2.79 112.347 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.704 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 4.5 ttp180 -136.35 -18.17 1.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.971 -1.013 . . . . 5.46 109.689 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.91 HD21 ' HB2' ' A' ' 88' ' ' ARG . 7.5 tt 80.02 162.08 0.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.271 -0.877 . . . . 1.55 111.311 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.77 97.63 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 1.93 110.817 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.633 ' HA3' ' HD3' ' A' ' 39' ' ' LYS . . . 103.19 -9.49 54.21 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.274 -1.441 . . . . 2.4 115.038 165.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.735 ' HD1' HG23 ' A' ' 64' ' ' THR . 36.0 t80 73.15 -19.22 0.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.823 0.812 . . . . 5.38 112.154 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.76 -17.82 60.96 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.366 -0.445 . . . . 2.3 112.421 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.91 ' HB2' HD21 ' A' ' 83' ' ' LEU . 40.6 mtm105 -108.92 173.61 6.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.408 0.283 . . . . 4.77 110.248 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -78.58 115.49 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.491 0.662 . . . . 1.86 111.676 -172.006 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.54 138.96 21.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 3.18 110.224 176.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 93' ' ' ASN . 33.8 Cg_endo -65.2 -38.61 26.62 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.897 2.398 . . . . 2.36 113.481 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 26.3 t70 72.33 -24.3 0.19 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.492 0.663 . . . . 2.99 111.154 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 91' ' ' PRO . 39.7 m-80 -130.78 81.94 2.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.939 -1.504 . . . . 3.06 106.939 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 95' ' ' SER . 2.6 p -107.06 -164.35 0.98 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.665 1.358 . . . . 1.85 114.665 -160.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . 1.099 ' HA ' ' HB3' ' A' ' 117' ' ' HIS . 41.3 m -72.87 -45.17 59.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 112.311 -2.222 . . . . 1.44 111.963 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.837 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.1 tt0 70.89 111.39 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.046 0.841 . . . . 1.81 109.793 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.439 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 40.3 p90 -115.06 150.81 35.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.203 0.525 . . . . 0.64 111.589 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.561 HG23 HG22 ' A' ' 78' ' ' VAL . 57.8 m -108.22 114.49 28.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.388 -0.824 . . . . 0.43 110.621 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.753 ' HA ' HG22 ' A' ' 113' ' ' VAL . 90.4 t -88.56 110.49 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.618 . . . . 0.87 110.272 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.456 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.6 m -104.36 105.91 16.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.19 -0.459 . . . . 0.45 110.526 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.4 m-85 -89.36 109.27 20.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.34 110.283 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' THR . 59.5 t -89.54 107.9 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.813 -0.44 . . . . 0.54 109.813 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.6 33.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.516 . . . . 0.44 110.258 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.7 t70 -125.43 112.96 16.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.92 0.39 . . . . 2.03 110.62 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -112.92 5.02 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.87 -0.681 . . . . 1.97 112.161 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 49.3 tt0 -141.05 -17.97 0.82 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.016 0.436 . . . . 4.93 110.132 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -131.9 24.87 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 3.53 111.799 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.9 ttmp? -140.97 150.87 43.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.27 -0.572 . . . . 2.44 110.916 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.583 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.2 m -158.93 112.29 2.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.878 -0.601 . . . . 0.42 110.372 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.81 110.64 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.582 -0.525 . . . . 2.59 109.582 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -90.59 138.14 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.647 -0.421 . . . . 0.4 110.326 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 12.0 t70 -128.18 114.67 17.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.895 -0.78 . . . . 1.38 108.895 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 99' ' ' VAL . 25.2 t -104.4 121.24 55.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.32 -0.855 . . . . 0.91 111.345 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -97.59 132.79 42.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 2.31 109.629 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.823 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 4.1 t60 -150.91 110.17 3.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.118 -0.697 . . . . 1.64 109.118 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.609 ' OG1' ' HD2' ' A' ' 120' ' ' ARG . 8.6 t -163.3 97.44 0.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.693 0.759 . . . . 2.67 110.694 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 1.099 ' HB3' ' HA ' ' A' ' 95' ' ' SER . 5.1 t-80 -163.92 -77.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.817 -0.629 . . . . 2.63 111.464 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.13 -39.57 17.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.407 0.521 . . . . 3.54 112.407 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.722 ' HB3' HG21 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -75.43 -34.31 60.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.35 0.595 . . . . 1.81 109.588 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.609 ' HD2' ' OG1' ' A' ' 116' ' ' THR . 40.3 ttt180 -48.21 -21.5 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.439 -1.255 . . . . 3.38 112.075 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -82.06 14.11 3.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 2.43 111.239 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.49 -155.53 4.93 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.764 -0.653 . . . . 1.61 114.18 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 t 38.16 -130.66 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.114 0.966 . . . . 2.58 112.141 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 56.4 tttp -50.77 -43.29 58.44 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 122.962 0.505 . . . . 3.8 112.063 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 129' ' ' VAL . 38.5 m80 -53.69 -52.2 60.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 2.14 111.005 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -76.86 -29.75 55.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.399 -0.364 . . . . 0.92 110.961 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.03 -52.89 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 2.83 110.479 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 23.6 ptt85 -61.09 -31.86 71.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 2.59 110.842 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 119' ' ' ASP . 70.6 t -65.84 -41.99 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 120.677 0.275 . . . . 1.48 110.78 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -64.73 -15.97 62.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.366 -0.379 . . . . 3.83 111.557 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.511 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 6.1 m-20 -52.28 -21.55 3.59 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.503 0.557 . . . . 2.48 112.503 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 88' ' ' ARG . . . -169.53 -28.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.021 -1.085 . . . . 1.61 114.274 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.407 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 12.7 tmm? -60.97 -40.95 95.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.404 0.602 . . . . 4.83 110.281 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.31 -27.21 45.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.973 -0.558 . . . . 2.83 112.417 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -107.02 -47.23 3.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.003 0.43 . . . . 4.15 111.466 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.645 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -65.39 -54.94 23.62 Favored Glycine 0 C--O 1.223 -0.547 0 CA-C-N 116.021 -0.536 . . . . 1.04 113.226 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t90 -60.74 -51.0 82.68 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.034 0.383 . . . . 2.78 112.034 -171.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 12.5 Cg_endo -57.94 -42.34 59.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.842 1.695 . . . . 0.68 112.111 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.2 m -65.5 -34.99 79.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.336 0.589 . . . . 0.87 110.076 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.766 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 47.7 mt -56.96 -46.07 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.72 110.331 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 65.7 mt -62.38 -31.26 71.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.69 112.215 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -74.75 -53.8 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.008 -0.277 . . . . 1.49 111.085 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 59.4 m -64.73 -23.42 67.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.11 0.481 . . . . 1.15 110.217 177.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.761 ' HZ ' ' HA ' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -59.1 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 0.8 110.069 173.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.424 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.4 mt-30 -63.54 -25.26 68.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 1.63 111.007 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.83 -49.87 34.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.46 111.195 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.773 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 52.3 tptt -68.02 -34.46 76.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.62 -0.432 . . . . 1.74 110.398 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.809 HG21 HG13 ' A' ' 12' ' ' VAL . 75.5 mt -67.67 -29.43 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.024 0.44 . . . . 0.5 110.378 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.01 -31.34 72.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.549 -0.537 . . . . 0.85 109.549 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 41.0 mt-10 -70.71 -29.89 66.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.581 -0.736 . . . . 1.5 109.928 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -79.34 -23.42 43.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 1.74 110.008 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -97.47 22.97 37.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.634 -0.712 . . . . 1.32 111.427 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.592 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . 73.57 85.04 0.11 Allowed 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 124.639 0.846 . . . . 1.92 110.625 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.631 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 13.3 tppt? -73.54 105.16 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.475 -0.784 . . . . 2.04 110.103 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HE3' ' HB1' ' A' ' 153' ' ' ALA . 17.5 ptpt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.863 -0.608 . . . . 4.22 110.424 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.807 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 64.7 m-80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.415 -0.217 . . . . 1.66 110.415 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 21.6 p90 168.92 -21.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.036 0.835 . . . . 3.73 109.374 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.983 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -49.54 -59.46 6.65 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.295 -0.866 . . . . 2.78 110.541 -176.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.983 ' HD3' ' HB2' ' A' ' 3' ' ' ASP . 26.3 Cg_endo -97.34 -61.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.375 2.05 . . . . 1.63 111.489 167.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -153.95 171.58 18.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.447 -1.316 . . . . 3.21 107.447 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.807 ' HA ' ' HB3' ' A' ' 1' ' ' ASN . 40.8 t -91.61 138.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 120.651 -0.42 . . . . 1.44 111.155 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.8 ttp180 -134.6 146.58 49.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.163 -0.471 . . . . 3.37 110.96 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.763 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -129.39 134.12 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 0.79 109.844 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 14.4 m -129.15 113.39 15.02 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.191 0.52 . . . . 1.28 110.465 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.819 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.5 t -126.09 139.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.374 -0.83 . . . . 1.27 111.06 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -97.58 117.14 31.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.184 0.516 . . . . 0.57 109.938 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.938 HG13 HG21 ' A' ' 148' ' ' ILE . 50.8 t -100.65 122.71 52.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.458 0.646 . . . . 0.91 111.323 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.821 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -90.29 13.34 15.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.901 -1.045 . . . . 0.98 112.771 -173.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -146.16 27.69 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.301 0.852 . . . . 0.36 113.301 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.9 t0 76.49 164.78 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.598 0.713 . . . . 0.91 112.358 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 16.0 ttp180 -69.72 -37.32 76.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.024 -0.989 . . . . 1.88 112.212 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 79.2 mttt -58.29 -49.17 78.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.706 0.765 . . . . 3.05 109.951 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -66.3 -38.74 88.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.302 -1.317 . . . . 1.11 110.909 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.764 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -57.77 -48.62 79.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.32 110.479 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.6 t80 -61.25 -45.17 95.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.649 -0.705 . . . . 0.38 110.733 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 4.2 tppp? -58.28 -53.46 58.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 2.39 110.798 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -62.62 -48.74 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.202 0.313 . . . . 0.68 110.835 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.901 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 72.6 t80 -63.18 -43.67 97.57 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.132 0.419 . . . . 0.48 112.132 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.606 HD11 HG11 ' A' ' 46' ' ' VAL . 17.3 tp -101.38 -56.26 2.34 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.519 -0.472 . . . . 0.5 112.119 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 51.6 mt-10 -96.2 15.56 20.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.391 0.615 . . . . 1.24 111.404 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.711 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -126.82 24.13 5.51 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.113 -1.195 . . . . 0.83 110.113 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.841 ' HD2' ' HA2' ' A' ' 45' ' ' GLY . 10.3 t80 -52.79 -47.02 96.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.642 -0.779 . . . . 0.74 112.995 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.2 Cg_endo -93.38 19.35 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.793 1.662 . . . . 0.76 115.012 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.711 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -110.41 -7.42 14.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.091 -0.643 . . . . 1.49 112.381 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.901 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 19.3 m0 -74.09 169.98 16.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 4.62 111.228 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.644 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 28.0 m95 -90.32 -29.54 0.34 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.639 0.977 . . . . 2.78 113.639 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.724 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 36.6 Cg_endo -66.19 -136.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.328 2.019 . . . . 1.36 114.207 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 25.1 t30 -57.48 -35.97 70.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.104 0.954 . . . . 1.51 111.181 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 1.006 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 3.0 p-10 -89.54 23.3 2.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.703 -1.135 . . . . 1.79 112.678 -169.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.73 -18.99 29.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 4.45 110.683 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.647 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 48.0 mtm105 -88.04 -179.2 6.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.455 0.539 . . . . 4.14 112.455 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.529 HG23 ' HD3' ' A' ' 43' ' ' PRO . 27.9 m -101.18 137.54 39.41 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.621 -0.718 . . . . 2.68 110.009 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 1.012 ' H ' ' HA ' ' A' ' 42' ' ' ALA . 44.5 p 50.22 28.84 3.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.493 0.717 . . . . 1.42 111.232 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 1.006 ' HD3' ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -67.52 -71.07 0.22 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.717 -1.129 . . . . 2.9 111.21 -177.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.861 ' H ' ' HD2' ' A' ' 39' ' ' LYS . 21.7 m -97.3 -13.01 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 122.217 1.008 . . . . 1.83 108.548 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.759 ' HA2' ' CD2' ' A' ' 63' ' ' HIS . . . -168.69 -50.65 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 113.471 -1.695 . . . . 2.17 110.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.012 ' HA ' ' H ' ' A' ' 38' ' ' THR . . . 152.01 -173.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 125.186 1.168 . . . . 1.12 112.195 -172.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.638 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 20.3 Cg_exo -72.75 74.54 2.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.541 2.16 . . . . 1.48 113.34 167.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.79 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 41.7 tp -145.67 -87.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.072 -0.344 . . . . 1.75 110.072 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.841 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 134.58 -92.66 0.24 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.953 -1.118 . . . . 0.75 113.843 170.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 24' ' ' LEU . 87.9 t -132.99 148.06 31.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.314 0.578 . . . . 0.6 111.821 -168.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.824 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.1 t70 -92.8 110.6 22.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.224 -0.898 . . . . 1.11 109.154 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 17.8 tptm -80.75 -25.42 38.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.718 -0.674 . . . . 2.81 111.601 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.3 ptpp? -73.97 -38.93 64.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.757 0.28 . . . . 3.17 111.757 -171.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.72 -41.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 1.53 112.154 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.491 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 118.52 71.31 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.661 -0.781 . . . . 0.77 112.232 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 47' ' ' ASP . 5.4 mpt_? -133.79 157.31 46.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.017 -0.364 . . . . 3.72 110.017 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 29.8 m0 -112.81 117.06 31.12 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.607 -0.886 . . . . 1.28 108.607 168.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.824 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.7 p90 -162.22 155.01 19.9 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.047 0.451 . . . . 1.66 110.06 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.79 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.16 172.73 12.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.119 -0.491 . . . . 2.12 110.586 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' HG2' ' A' ' 61' ' ' GLU . 13.7 mm -78.59 99.16 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.92 111.395 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 58' ' ' GLU . 5.5 t70 -96.27 172.87 7.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.627 -0.509 . . . . 1.97 109.627 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.498 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.9 pt-20 -58.47 -40.34 82.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.799 1.037 . . . . 2.43 113.799 -167.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.54 7.38 12.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.464 -0.494 . . . . 2.39 112.307 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.2 84.11 1.78 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.043 -1.075 . . . . 2.29 114.421 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 56' ' ' ILE . 43.5 mt-10 55.87 30.89 16.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.772 1.027 . . . . 2.31 113.772 167.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -127.61 92.1 3.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.559 0.695 . . . . 2.61 111.68 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.759 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 1.0 OUTLIER -120.58 166.46 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.923 -1.035 . . . . 3.72 110.599 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.681 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 9.1 p -47.37 105.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.719 0.637 . . . . 2.27 110.637 171.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 28.8 p90 -90.32 118.02 29.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.138 0.494 . . . . 6.48 111.77 -173.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -67.18 137.5 33.43 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.837 -0.905 . . . . 1.23 110.837 173.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -100.38 94.13 6.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.201 0.5 . . . . 1.17 111.481 -171.287 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.609 HG21 HG22 ' A' ' 71' ' ' VAL . 55.4 mt -76.08 123.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.257 0.551 . . . . 0.61 110.158 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 10.5 mmm180 -87.72 -34.56 18.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.396 -0.82 . . . . 2.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -147.21 120.83 9.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.028 -0.533 . . . . 1.53 111.54 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 68' ' ' ILE . 32.1 t -102.75 92.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.284 -1.006 . . . . 0.88 108.284 167.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.63 63.28 0.72 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.789 -0.364 . . . . 1.42 110.936 -173.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.654 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.8 pt-20 47.05 -169.37 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 124.476 1.11 . . . . 0.96 112.031 175.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 33.2 Cg_exo -61.51 76.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.304 1.336 . . . . 0.38 111.798 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.9 -66.6 0.05 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.5 109.754 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.3 p -144.21 143.01 30.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.715 0.635 . . . . 0.35 112.715 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 77' ' ' LEU . 2.0 mp -132.47 116.19 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.145 -0.687 . . . . 0.74 109.145 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 98' ' ' THR . 36.5 t -104.72 110.27 30.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.478 -0.564 . . . . 0.67 109.478 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.98 140.55 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.871 0.367 . . . . 0.75 111.437 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.2 161.1 23.2 Favored Glycine 0 C--O 1.239 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.5 112.639 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 1.073 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 38.9 t-105 -65.04 157.89 27.18 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 113.737 1.014 . . . . 2.79 113.737 -165.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.681 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 2.9 tpt180 -174.41 33.42 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.435 -1.257 . . . . 5.46 108.917 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 88' ' ' ARG . 13.9 tp 69.55 -133.9 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 1.55 111.857 175.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 59.7 t30 -167.41 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.877 0.37 . . . . 1.93 110.204 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.27 11.02 25.46 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.193 -0.527 . . . . 2.4 114.062 -172.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.5 t80 70.71 -43.37 0.55 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.529 0.731 . . . . 5.38 112.783 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.94 38.41 2.17 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.237 -0.506 . . . . 2.3 113.082 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.001 ' HB2' HD21 ' A' ' 83' ' ' LEU . 4.7 mmp_? -135.09 -175.16 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.52 -0.919 . . . . 4.77 108.52 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.606 HD13 ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -112.32 132.68 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.906 0.384 . . . . 1.86 110.918 -177.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -156.47 107.91 2.02 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.989 -0.551 . . . . 3.18 110.601 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.606 ' HD3' HD13 ' A' ' 89' ' ' ILE . 1.6 Cg_endo -109.63 18.11 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.127 3.218 . . . . 2.36 110.487 165.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' A' ' 118' ' ' PHE . 10.5 t70 -79.74 -77.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.366 -0.833 . . . . 2.99 111.294 -159.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 33.9 m-80 76.59 -40.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.218 -0.901 . . . . 3.06 112.359 172.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.785 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . 70.2 m -77.66 -7.57 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.627 0.232 . . . . 1.85 111.627 -176.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 1.073 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 23.1 t -66.55 75.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.074 0.94 . . . . 1.44 109.227 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.8 tt0 -97.69 123.72 41.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.499 -1.228 . . . . 1.81 110.678 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.793 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 5.4 p90 -120.98 140.28 52.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.468 0.651 . . . . 0.64 111.805 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.661 HG23 HG22 ' A' ' 78' ' ' VAL . 32.4 m -98.7 110.48 23.07 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.475 -1.238 . . . . 0.43 109.721 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.0 t -81.92 108.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.357 -0.608 . . . . 0.87 109.357 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.639 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.8 m -102.7 106.7 17.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.086 0.47 . . . . 0.45 111.21 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.692 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 47.9 m-85 -87.4 113.3 22.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 0.34 109.968 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.79 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.604 -0.517 . . . . 0.54 109.604 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.16 124.28 27.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.087 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 23.2 m-20 -106.54 100.36 9.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 2.03 109.111 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.85 -113.37 4.16 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.616 -0.802 . . . . 1.97 111.933 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.409 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 3.1 pt20 -147.02 4.89 0.84 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.544 0.211 . . . . 4.93 111.089 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 47.6 mmtm -132.34 -12.23 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.791 0.293 . . . . 3.53 111.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 47.6 tttp -121.46 152.65 38.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.794 -0.447 . . . . 2.44 109.794 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.6 m -157.95 119.1 3.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 0.42 111.087 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -94.37 123.54 37.84 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.511 -0.551 . . . . 2.59 109.511 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.599 ' CG1' ' HB ' ' A' ' 10' ' ' VAL . 14.2 p -98.46 135.3 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.112 -0.635 . . . . 0.4 110.391 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 6.3 p-10 -127.87 115.87 19.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.783 0.801 . . . . 1.38 109.197 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.763 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 2.1 t -89.71 121.33 39.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.292 -0.867 . . . . 0.91 110.377 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.73 136.25 44.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 124.148 0.905 . . . . 2.31 108.715 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 97' ' ' PHE . 65.6 t-80 -128.46 153.53 47.04 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.78 -0.645 . . . . 1.64 110.716 -171.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 t -64.84 -153.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.55 -0.75 . . . . 2.67 110.248 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -143.47 37.65 1.36 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.127 0.788 . . . . 2.63 113.127 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 2.4 t80 -71.73 -35.98 70.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.287 0.565 . . . . 3.54 109.704 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.44 ' OD2' ' CE1' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -70.84 -28.89 64.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 1.81 110.477 177.244 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -54.92 -20.52 9.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.409 -0.814 . . . . 3.38 111.762 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.9 mmt -65.88 -4.52 6.97 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.336 -0.393 . . . . 2.43 110.528 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.26 -141.46 25.92 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.319 -0.855 . . . . 1.61 112.965 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.2 p 42.25 -112.04 0.18 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.663 0.86 . . . . 2.58 112.264 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -77.72 -39.73 43.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.855 -0.612 . . . . 3.8 110.835 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -53.26 59.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.939 0.4 . . . . 2.14 111.079 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -69.61 -33.46 72.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.986 -0.552 . . . . 0.92 111.165 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -70.02 -49.85 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.798 -0.361 . . . . 2.83 111.077 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -66.78 -33.01 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.512 -0.313 . . . . 2.59 111.021 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.7 t -78.55 -30.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 1.48 110.864 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.501 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 18.6 ttm180 -56.4 -34.63 66.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 3.83 111.336 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.556 ' CB ' ' HD3' ' A' ' 88' ' ' ARG . 15.7 m-80 -63.59 -25.03 68.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 2.48 110.797 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.545 ' HA2' ' HG3' ' A' ' 88' ' ' ARG . . . -81.2 -106.88 0.33 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.864 -0.684 . . . . 1.61 113.248 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.682 ' HB3' ' HH2' ' A' ' 81' ' ' TRP . 18.2 ttt -79.7 -16.31 55.92 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.599 0.222 . . . . 4.83 111.599 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 25.4 t70 -62.01 -25.91 67.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 2.83 111.722 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -91.04 -29.64 17.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.072 0.463 . . . . 4.15 110.905 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -95.17 -32.17 7.21 Favored Glycine 0 C--O 1.217 -0.955 0 CA-C-N 116.155 -0.475 . . . . 1.04 112.368 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.669 ' HB2' ' HG2' ' A' ' 133' ' ' MET . 3.7 t90 -58.03 -47.06 99.54 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 122.512 0.325 . . . . 2.78 111.809 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.81 -32.55 95.62 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.837 1.692 . . . . 0.68 111.666 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.2 m -71.65 -43.17 66.55 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.268 1.032 . . . . 0.87 108.957 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.6 mt -61.83 -54.44 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.955 -1.475 . . . . 0.72 111.548 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 8' ' ' HIS . 64.8 mt -58.81 -35.33 72.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.69 112.202 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -52.84 32.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.923 -0.311 . . . . 1.49 110.406 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.553 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 12.0 t -69.01 -23.85 64.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 1.15 110.373 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.422 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 22.5 t80 -65.42 -49.85 67.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.609 -0.515 . . . . 0.8 109.609 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.819 ' HG2' HG13 ' A' ' 10' ' ' VAL . 45.5 mt-30 -58.4 -41.93 86.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.331 -0.849 . . . . 1.63 111.251 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 14.2 m-20 -75.46 -37.71 60.13 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.567 -0.453 . . . . 1.46 111.829 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.7 tptp -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.398 -0.593 . . . . 1.74 109.398 174.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.938 HG21 HG13 ' A' ' 12' ' ' VAL . 26.5 mt -62.27 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.5 111.109 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.821 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 34.2 t70 -62.38 -30.93 71.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.036 -0.529 . . . . 0.85 110.182 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.526 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 49.3 mt-10 -70.46 -39.53 74.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.994 -0.548 . . . . 1.5 109.798 175.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 16.0 mm-40 -62.33 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.659 -0.7 . . . . 1.74 109.877 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.69 -73.27 0.72 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.458 -0.792 . . . . 1.32 111.219 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -176.01 81.5 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.827 0.346 . . . . 1.92 111.418 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -98.02 -23.93 15.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.046 -0.724 . . . . 2.04 109.046 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.648 ' H ' ' HD3' ' A' ' 155' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.038 -0.983 . . . . 4.22 109.323 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.863 0.364 . . . . 1.66 111.079 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 30.2 p90 -178.12 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.654 -0.703 . . . . 3.73 110.051 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.652 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 28.4 t70 -65.47 -49.74 61.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 2.78 111.782 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 16.3 Cg_endo -87.77 -68.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.142 1.228 . . . . 1.63 110.92 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.74 157.15 37.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 3.21 109.458 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.673 HG22 ' CG ' ' A' ' 115' ' ' HIS . 2.0 m -97.23 113.32 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.523 -0.917 . . . . 1.44 108.523 168.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.555 ' HD3' ' OD2' ' A' ' 112' ' ' ASP . 20.2 ttm180 -104.35 146.59 28.6 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.365 -0.834 . . . . 3.37 112.136 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 1.046 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 9.7 t-160 -112.24 132.84 54.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.614 -1.175 . . . . 0.79 108.667 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 38.3 m -140.32 119.64 12.99 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.839 -0.43 . . . . 1.28 109.839 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 145' ' ' GLN . 3.9 t -143.7 132.83 19.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.812 -0.631 . . . . 1.27 110.893 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 m -95.97 115.78 27.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.455 -0.572 . . . . 0.57 109.455 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.878 HG13 HG21 ' A' ' 148' ' ' ILE . 24.9 t -95.45 140.54 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.796 -0.638 . . . . 0.91 110.736 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.11 24.22 11.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.47 0.544 . . . . 0.98 112.47 -173.235 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.46 34.92 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.735 0.643 . . . . 0.36 112.735 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 23.7 t70 72.48 166.96 0.31 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.6 0.714 . . . . 0.91 112.377 172.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NE ' ' HB2' ' A' ' 103' ' ' ALA . 28.3 ttp180 -69.12 -23.68 64.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.42 -0.809 . . . . 1.88 111.425 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -58.89 -49.08 79.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.63 0.252 . . . . 3.05 111.086 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -73.79 -37.76 64.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.702 0.286 . . . . 1.11 110.314 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.33 -45.97 80.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.32 111.095 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.503 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 70.2 t80 -71.95 -47.94 48.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.407 -0.361 . . . . 0.38 110.893 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.629 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 26.5 tptp -52.9 -52.45 57.62 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.842 -0.617 . . . . 2.39 110.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -50.96 61.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.68 111.221 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -62.46 -37.0 84.24 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.246 0.462 . . . . 0.48 112.246 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' HG11 ' A' ' 46' ' ' VAL . 13.6 tp -109.02 -53.18 2.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.286 -0.566 . . . . 0.5 112.403 -172.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.629 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 1.4 mm-40 -79.87 -28.64 39.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.105 0.478 . . . . 1.24 111.478 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -100.8 30.58 10.01 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.582 -0.735 . . . . 0.83 111.876 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.499 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 56.4 t80 -48.5 -47.18 70.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.943 0.497 . . . . 0.74 112.279 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.611 ' HA ' HD21 ' A' ' 34' ' ' ASN . 15.6 Cg_endo -98.08 19.35 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.19 1.927 . . . . 0.76 114.409 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 6.6 pt-20 -105.57 -3.87 21.84 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.134 -0.627 . . . . 1.49 111.505 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.761 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 2.9 m0 -80.82 -172.03 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 4.62 111.129 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.539 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 66.4 m95 -102.45 -26.88 0.21 Allowed Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 114.041 1.126 . . . . 2.78 114.041 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.761 ' HD2' ' HB2' ' A' ' 30' ' ' TRP . 65.3 Cg_endo -72.74 -143.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.931 1.754 . . . . 1.36 114.4 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 15.3 t-20 -59.29 -14.73 12.3 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.433 0.901 . . . . 1.51 113.433 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.611 HD21 ' HA ' ' A' ' 28' ' ' PRO . 2.6 p-10 -76.28 -10.77 59.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.948 0.351 . . . . 1.79 111.948 -174.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -78.01 69.41 4.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 4.45 110.596 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -149.11 151.0 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.636 -0.711 . . . . 4.14 110.571 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 38' ' ' THR . 7.3 m -87.99 122.75 31.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.916 -0.314 . . . . 2.68 110.375 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 73.2 p 56.84 16.22 2.63 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.319 0.859 . . . . 1.42 113.319 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -103.53 -47.27 4.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.815 -1.18 . . . . 2.9 107.815 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.598 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -156.21 130.14 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 113.78 -1.555 . . . . 1.83 108.582 171.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 55' ' ' GLU . . . 98.91 -72.22 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.54 -0.838 . . . . 2.17 113.291 175.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . 50.36 -164.65 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 109.813 -0.44 . . . . 1.12 109.813 -169.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.649 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 23.0 Cg_exo -69.95 16.16 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.324 1.349 . . . . 1.48 113.656 171.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.475 HD21 ' CE2' ' A' ' 54' ' ' TYR . 56.0 tp -128.66 -92.11 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.87 -0.518 . . . . 1.75 112.049 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 109.83 -75.01 0.21 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.457 -0.878 . . . . 0.75 113.132 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 24' ' ' LEU . 58.5 t -140.48 135.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 122.723 -0.28 . . . . 0.6 110.799 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.702 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 13.0 t70 -103.64 126.4 50.75 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.411 -0.359 . . . . 1.11 110.405 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HE2' ' HG ' ' A' ' 24' ' ' LEU . 1.3 mmpp? -81.38 -24.07 37.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.539 . . . . 2.81 111.947 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -83.44 -58.7 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 3.17 110.82 -171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.514 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -77.95 -22.48 68.75 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.613 -0.803 . . . . 1.53 111.507 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 63.4 2.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.896 -0.669 . . . . 0.77 111.701 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -156.2 143.74 19.32 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.339 -0.544 . . . . 3.72 111.395 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.574 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 10.5 m0 -87.46 114.26 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.725 -0.843 . . . . 1.28 108.725 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.708 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 3.4 p90 -162.65 171.23 17.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.421 0.629 . . . . 1.66 111.288 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 8.6 mp0 -127.86 -179.45 4.96 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.288 -1.005 . . . . 2.12 108.288 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.1 103.28 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 119.655 -0.818 . . . . 0.92 110.665 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 11.6 p-10 -90.55 139.77 30.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.36 0.6 . . . . 1.97 110.189 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.89 -5.13 50.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.681 0.993 . . . . 2.43 113.681 -164.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.689 -0.804 . . . . 2.39 110.659 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.45 49.04 0.45 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.936 -0.65 . . . . 2.29 113.347 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.493 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 45.7 mt-10 60.28 76.68 0.35 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.008 1.114 . . . . 2.31 114.008 172.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.46 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 30.4 tt0 -131.37 74.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.59 0.709 . . . . 2.61 110.131 169.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.708 ' CE1' ' HD1' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -120.47 154.24 35.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.326 -0.852 . . . . 3.72 110.305 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 p -64.9 149.34 49.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 2.27 109.146 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 45.8 p90 -123.38 127.45 48.49 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.189 -0.604 . . . . 6.48 111.034 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.38 136.21 28.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.116 -0.793 . . . . 1.23 111.116 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 67' ' ' LEU . 5.8 mp -82.8 87.7 6.79 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 121.092 -0.243 . . . . 1.17 110.499 -173.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 71' ' ' VAL . 43.5 mt -87.69 116.51 29.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 119.417 -0.913 . . . . 0.61 109.718 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -110.19 -10.46 14.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.093 -0.958 . . . . 2.0 110.487 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 37.1 ttmt -145.53 110.4 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.981 -0.554 . . . . 1.53 111.359 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 68' ' ' ILE . 38.9 t -102.26 90.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.03 -1.1 . . . . 0.88 108.03 166.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.5 t70 -106.44 59.63 0.64 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.538 -0.465 . . . . 1.42 110.613 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.705 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.7 pt-20 39.71 -160.95 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 124.734 1.271 . . . . 0.96 111.924 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.705 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -62.47 80.5 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 CA-C-N 120.494 1.212 . . . . 0.38 112.118 168.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.459 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 13.9 t70 -165.89 -69.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.5 110.66 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.615 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -146.43 130.69 17.52 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.384 0.883 . . . . 0.35 113.384 -174.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -123.75 125.96 45.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.041 -0.412 . . . . 0.74 110.864 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 99.2 t -103.48 109.83 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.77 -0.456 . . . . 0.67 109.77 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.75 126.73 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.385 -0.825 . . . . 0.75 111.616 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.1 163.99 29.49 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.787 -0.525 . . . . 0.5 111.787 175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 5.3 t-105 -64.31 161.79 16.06 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.563 0.949 . . . . 2.79 113.563 -166.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.481 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 1.6 ttp180 -158.07 -17.69 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.862 -1.063 . . . . 5.46 109.822 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.618 ' HA ' ' CZ2' ' A' ' 81' ' ' TRP . 2.6 tt 79.2 157.35 0.16 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.758 -1.11 . . . . 1.55 111.624 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.504 ' OD1' HG11 ' A' ' 40' ' ' VAL . 49.9 t30 -131.55 147.42 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.561 -0.745 . . . . 1.93 110.265 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' PHE . . . 83.31 1.1 90.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.911 -0.661 . . . . 2.4 113.645 172.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 18.9 t80 177.55 165.91 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.961 0.381 . . . . 5.38 110.479 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.61 69.18 1.24 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.195 -1.562 . . . . 2.3 109.195 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 131' ' ' ASN . 12.9 ttm180 -97.5 -179.92 4.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.186 -0.507 . . . . 4.77 110.242 -168.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.512 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.06 122.5 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.568 0.699 . . . . 1.86 110.1 177.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.53 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 3.5 p30 -122.9 147.43 51.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.4 -0.818 . . . . 3.18 111.38 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' ' HD2' ' A' ' 128' ' ' ARG . 3.4 Cg_exo -80.77 -52.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.892 2.395 . . . . 2.36 110.904 168.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 90' ' ' ASP . 5.2 m-20 44.17 42.34 4.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.043 -0.98 . . . . 2.99 113.161 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.405 ' H ' ' H ' ' A' ' 94' ' ' SER . 10.3 p30 -140.54 -22.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 122.008 0.908 . . . . 3.06 109.064 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.463 ' HB2' ' CG ' ' A' ' 118' ' ' PHE . 71.1 m -150.67 -141.85 0.11 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.419 -1.264 . . . . 1.85 107.979 173.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 21.9 t 60.74 37.27 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.368 1.08 . . . . 1.44 108.307 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.76 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 21.4 mt-10 -74.89 144.37 43.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.175 -1.375 . . . . 1.81 110.182 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.57 ' HB2' ' CG1' ' A' ' 113' ' ' VAL . 2.7 p90 -131.56 132.11 43.88 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.229 0.538 . . . . 0.64 110.636 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 35.9 m -95.24 114.31 26.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.207 -0.906 . . . . 0.43 110.209 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.707 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -82.1 108.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.783 -0.644 . . . . 0.87 109.387 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.4 m -101.29 105.52 16.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.126 -0.488 . . . . 0.45 109.881 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.87 110.5 21.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.415 -0.357 . . . . 0.34 110.062 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.67 106.41 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.137 -0.69 . . . . 0.54 109.137 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.503 ' HB2' ' NE ' ' A' ' 16' ' ' ARG . . . -78.52 124.34 28.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.638 -0.71 . . . . 0.44 111.46 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -108.27 127.89 54.25 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.726 -0.842 . . . . 2.03 108.726 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.95 -18.42 40.22 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.525 -0.761 . . . . 1.97 114.832 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -92.87 39.58 1.04 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.737 0.769 . . . . 4.93 110.812 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.551 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . 9.7 mtmp? 64.76 33.29 10.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.06 -0.518 . . . . 3.53 110.86 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 1.2 ttmp? -122.0 153.19 38.89 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.227 -0.657 . . . . 2.44 109.227 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.7 m -155.78 113.82 3.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.187 0.518 . . . . 0.42 111.203 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -92.21 111.71 23.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.515 -0.766 . . . . 2.59 109.933 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.589 HG12 ' HB ' ' A' ' 10' ' ' VAL . 13.4 p -87.61 138.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.4 110.163 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.555 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 22.7 t70 -133.19 106.93 7.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.302 -0.863 . . . . 1.38 109.008 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.046 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 5.3 t -90.61 120.62 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 120.89 -0.324 . . . . 0.91 110.597 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.71 133.1 43.51 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.701 -0.852 . . . . 2.31 108.701 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.673 ' CG ' HG22 ' A' ' 6' ' ' VAL . 34.6 t60 -116.61 153.93 31.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.614 -0.721 . . . . 1.64 109.789 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 118' ' ' PHE . 14.2 t -64.1 -165.31 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.613 -0.722 . . . . 2.67 110.415 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' A' ' 121' ' ' MET . 8.4 p-80 -131.82 27.53 4.6 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.708 -0.678 . . . . 2.63 110.571 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' H ' HG23 ' A' ' 116' ' ' THR . 46.2 t80 -64.48 -24.33 67.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.506 0.67 . . . . 3.54 109.985 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -44.59 66.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.817 -1.083 . . . . 1.81 109.172 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 2' ' ' TYR . 1.3 tmt_? -58.49 -21.17 50.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.803 -1.09 . . . . 3.38 111.832 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 94.1 mmm -73.52 33.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.991 0.424 . . . . 2.43 112.107 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 130.09 145.26 5.74 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.244 -0.503 . . . . 1.61 111.96 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.9 m -61.15 -27.12 68.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.34 . . . . 2.58 110.855 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.836 ' HG2' HH21 ' A' ' 128' ' ' ARG . 60.4 tttp -66.25 -47.35 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.461 -0.336 . . . . 3.8 110.315 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.671 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 37.0 m80 -65.04 -47.02 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.922 0.391 . . . . 2.14 110.944 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.65 80.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.314 -0.403 . . . . 0.92 111.466 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.38 -44.91 86.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.723 -0.217 . . . . 2.83 110.924 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.836 HH21 ' HG2' ' A' ' 124' ' ' LYS . 19.2 ptp180 -58.29 -34.04 70.11 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 120.796 0.331 . . . . 2.59 110.683 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.5 HG12 ' SD ' ' A' ' 133' ' ' MET . 92.7 t -79.29 -48.71 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.867 0.365 . . . . 1.48 110.719 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.975 ' HA ' ' HG2' ' A' ' 133' ' ' MET . 17.2 mtp180 -61.91 -17.85 58.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.06 -0.518 . . . . 3.83 111.922 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 4.2 m-80 -51.98 -46.98 65.04 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.493 0.496 . . . . 2.48 111.517 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.01 -15.71 9.74 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.136 -1.031 . . . . 1.61 113.15 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.975 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 21.6 ptm -80.91 -36.88 30.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.48 . . . . 4.83 112.167 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -27.43 62.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.933 0.716 . . . . 2.83 112.933 -163.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -103.29 -15.85 15.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.167 0.508 . . . . 4.15 111.004 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.597 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.2 -55.46 0.77 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.427 -0.892 . . . . 1.04 113.102 -174.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 8' ' ' HIS . 6.9 t90 -56.12 -53.34 64.56 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.674 0.62 . . . . 2.78 112.674 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.25 -45.24 28.26 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.801 1.668 . . . . 0.68 111.714 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 m -60.53 -40.16 90.47 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.573 0.702 . . . . 0.87 110.34 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 136' ' ' GLY . 49.7 mt -55.67 -45.53 79.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 CA-C-N 114.945 -1.025 . . . . 0.72 110.031 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 38.4 mt -59.14 -34.87 72.58 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.45 0.468 . . . . 0.69 111.842 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.98 -56.19 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 1.49 110.636 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.668 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 23.5 m -68.56 -21.16 64.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.518 -0.31 . . . . 1.15 111.161 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.09 -52.14 65.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.941 -0.392 . . . . 0.8 109.941 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.692 ' HG2' HG13 ' A' ' 10' ' ' VAL . 21.1 mt-30 -60.41 -36.07 77.26 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.741 -0.663 . . . . 1.63 110.046 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.62 -40.26 69.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.892 -1.049 . . . . 1.46 111.208 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 37.4 tptt -65.58 -37.71 87.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.216 0.531 . . . . 1.74 109.642 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.878 HG21 HG13 ' A' ' 12' ' ' VAL . 66.0 mt -72.45 -25.66 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.5 110.557 176.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.82 -30.9 71.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.554 -0.536 . . . . 0.85 109.554 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.696 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 40.1 mt-10 -70.4 -30.54 67.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.63 -0.714 . . . . 1.5 110.188 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.87 -36.12 62.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.362 -0.836 . . . . 1.74 109.619 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.26 -0.882 . . . . 1.32 111.647 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -167.21 86.66 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.413 . . . . 1.92 110.967 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.696 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.5 ttmm -107.59 -59.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.41 . . . . 2.04 109.914 176.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 3.9 mptp? . . . . . 0 C--O 1.247 0.946 0 O-C-N 123.777 0.673 . . . . 4.22 111.101 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 2.7 p30 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.682 0.277 . . . . 1.66 111.333 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 46.8 p90 -176.78 -42.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.776 -0.647 . . . . 3.73 109.812 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.768 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 21.3 t70 -58.23 -55.37 46.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.13 -0.486 . . . . 2.78 112.099 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.2 Cg_endo -92.39 -65.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.453 2.102 . . . . 1.63 112.275 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.473 ' HD2' HG21 ' A' ' 116' ' ' THR . 91.7 m-85 -143.1 145.35 32.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.226 -0.443 . . . . 3.21 110.543 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 45.2 t -104.58 126.54 59.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.88 -0.785 . . . . 1.44 108.88 167.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.2 ttm105 -128.44 135.2 49.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.221 0.534 . . . . 3.37 110.96 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.952 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -109.07 130.51 55.48 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.135 -1.061 . . . . 0.79 108.135 170.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.4 t -136.78 110.5 8.1 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.568 0.699 . . . . 1.28 109.596 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.8 t -122.85 134.7 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.601 -1.181 . . . . 1.27 111.038 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -91.75 115.59 28.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.04 -0.527 . . . . 0.57 109.756 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.768 HG13 HG21 ' A' ' 148' ' ' ILE . 42.0 t -96.79 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.496 -0.557 . . . . 0.91 109.496 177.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -104.93 33.25 3.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.885 -0.598 . . . . 0.98 111.5 -173.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -153.53 31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 0.36 111.573 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.71 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 19.8 t70 71.38 166.9 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.054 0.93 . . . . 0.91 112.348 176.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -71.68 -21.91 61.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.111 -0.95 . . . . 1.88 111.68 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.71 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 39.5 mmtm -58.33 -50.84 72.2 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.048 0.452 . . . . 3.05 109.907 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.1 p -72.57 -37.43 68.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.72 -0.673 . . . . 1.11 110.623 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -55.9 -45.55 78.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.853 0.359 . . . . 0.32 110.732 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.432 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 59.9 t80 -74.24 -47.64 33.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.148 -0.478 . . . . 0.38 111.204 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 21' ' ' LYS . 4.4 ttmm -56.92 -52.18 66.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.592 -0.277 . . . . 2.39 111.167 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 m -64.01 -50.63 67.77 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.416 -0.356 . . . . 0.68 110.577 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.882 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.8 t80 -61.09 -36.84 80.73 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.333 0.494 . . . . 0.48 112.333 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.557 ' CD1' HG11 ' A' ' 46' ' ' VAL . 20.0 tp -106.37 -59.73 1.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.333 0.494 . . . . 0.5 112.333 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.16 -44.78 21.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.236 0.541 . . . . 1.24 111.515 -170.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.779 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -85.19 37.45 3.01 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 115.349 -0.841 . . . . 0.83 112.286 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.627 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 23.8 t80 -54.5 -48.91 93.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 112.366 0.506 . . . . 0.74 112.366 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 48.0 Cg_endo -86.84 12.93 2.85 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.203 1.935 . . . . 0.76 114.711 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.779 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -96.08 -4.23 43.27 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.192 -0.603 . . . . 1.49 110.624 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.882 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 17.1 m0 -77.4 -175.58 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.726 0.774 . . . . 4.62 112.045 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.522 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 47.4 m95 -109.42 -33.66 0.15 Allowed Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 114.642 -1.163 . . . . 2.78 113.454 176.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.851 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 60.7 Cg_endo -71.03 -129.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.98 1.787 . . . . 1.36 114.345 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.502 ' CG ' HD21 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -59.87 -47.11 87.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.642 0.734 . . . . 1.51 111.279 -172.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.691 ' HA ' HG13 ' A' ' 40' ' ' VAL . 6.1 p-10 -83.61 34.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.345 -1.298 . . . . 1.79 112.062 -171.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -106.09 5.14 29.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.687 0.756 . . . . 4.45 109.404 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -99.53 124.05 44.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 4.14 110.693 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -74.88 131.26 40.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.064 -0.517 . . . . 2.68 111.51 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.651 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 30.5 p 54.54 22.77 4.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.249 1.02 . . . . 1.42 111.74 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -114.0 -46.64 3.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.596 -0.89 . . . . 2.9 108.596 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.691 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.6 p -169.43 6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.053 -0.976 . . . . 1.83 110.03 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -159.55 53.64 0.36 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.915 -0.66 . . . . 2.17 112.274 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.023 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.6 174.28 3.67 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 109.493 -0.558 . . . . 1.12 109.493 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 38.7 Cg_exo -63.15 56.43 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.184 2.589 . . . . 1.48 113.774 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -166.95 -84.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.194 0.598 . . . . 1.75 109.62 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.627 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 89.2 -48.93 3.46 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.043 -0.598 . . . . 0.75 113.012 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG11 ' CD1' ' A' ' 24' ' ' LEU . 75.2 t -137.86 144.83 30.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 110.033 -0.358 . . . . 0.6 110.033 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.753 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 29.5 t70 -108.77 116.07 31.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.54 -0.541 . . . . 1.11 109.54 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -73.96 -29.8 62.19 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.572 -0.74 . . . . 2.81 112.128 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.68 -54.04 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.021 0.378 . . . . 3.17 112.021 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.03 -22.21 39.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.41 -0.9 . . . . 1.53 112.651 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.486 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 87.3 61.91 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.543 -0.837 . . . . 0.77 111.46 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 3.9 mpt_? -133.17 158.97 41.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.224 . . . . 3.72 110.509 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.712 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 17.0 m0 -113.28 106.39 14.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.804 -0.813 . . . . 1.28 108.804 168.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.753 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 8.6 p90 -157.5 167.72 29.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.031 -0.359 . . . . 1.66 110.031 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.023 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 4.4 mt-10 -127.89 159.67 34.21 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.488 -0.324 . . . . 2.12 110.335 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.65 102.26 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.373 -0.973 . . . . 0.92 108.373 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.04 163.27 27.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 1.97 109.325 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.84 -22.13 66.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.694 0.283 . . . . 2.43 111.056 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -86.83 -15.51 38.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 2.39 110.885 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.89 -100.94 0.21 Allowed Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.395 -0.907 . . . . 2.29 112.95 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.66 27.41 2.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.771 0.32 . . . . 2.31 111.432 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.59 82.49 2.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.347 0.594 . . . . 2.61 109.838 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 163.85 20.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.247 -0.888 . . . . 3.72 110.005 174.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 16.7 p -46.69 120.56 3.02 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.723 -0.473 . . . . 2.27 109.723 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 18.0 p90 -115.33 116.41 28.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.652 0.739 . . . . 6.48 112.053 -171.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -72.03 152.0 48.05 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.75 -1.113 . . . . 1.23 111.423 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -112.89 92.06 3.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.966 0.412 . . . . 1.17 111.109 -172.248 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 71' ' ' VAL . 20.0 mt -85.13 116.53 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.682 -0.488 . . . . 0.61 109.682 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.611 ' HD3' ' OE2' ' A' ' 96' ' ' GLU . 2.4 mpt_? -88.04 -33.09 18.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.885 0.374 . . . . 2.0 110.733 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 58.0 tttp -129.6 98.97 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 1.53 111.294 -174.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 68' ' ' ILE . 44.9 t -98.05 96.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.05 -1.093 . . . . 0.88 108.05 169.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -115.66 77.47 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.805 -0.358 . . . . 1.42 111.165 -173.11 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.33 -171.64 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 124.367 1.042 . . . . 0.96 112.012 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -66.41 74.09 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.353 1.369 . . . . 0.38 111.043 166.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 22.3 t70 -156.55 -64.73 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.806 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.611 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -144.48 145.55 31.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.665 0.617 . . . . 0.35 112.665 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 1.1 mp -139.01 116.51 11.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.733 -0.667 . . . . 0.74 109.745 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 98' ' ' THR . 61.6 t -101.03 106.69 19.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.02 -0.733 . . . . 0.67 109.02 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -129.1 127.56 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.75 111.95 -171.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -90.7 154.92 23.56 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.427 -0.416 . . . . 0.5 112.896 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 17.4 t-105 -73.19 160.88 31.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 2.79 111.889 -171.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.54 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 11.9 ptt180 -137.2 0.63 2.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.967 -0.561 . . . . 5.46 110.732 -169.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.781 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 2.7 tm? 74.55 133.09 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.985 0.803 . . . . 1.55 110.82 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.541 ' HB2' ' CH2' ' A' ' 81' ' ' TRP . 40.4 t-20 -98.94 121.4 40.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 1.93 110.367 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.83 -9.22 61.84 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.425 -0.893 . . . . 2.4 114.309 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.1 t80 70.98 -42.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.229 0.612 . . . . 5.38 112.238 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.75 7.23 51.01 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.234 -0.508 . . . . 2.3 112.928 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HB2' HD21 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -108.17 178.31 4.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.969 -0.752 . . . . 4.77 108.969 177.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.519 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -114.54 128.64 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.963 0.411 . . . . 1.86 111.406 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.781 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 29.1 t70 -144.36 142.52 19.74 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.153 -0.684 . . . . 3.18 109.153 168.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.555 ' HD2' ' OD2' ' A' ' 90' ' ' ASP . 17.3 Cg_endo -58.1 -27.28 79.24 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.948 2.432 . . . . 2.36 113.893 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 3.0 t70 67.38 -0.85 1.7 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.88 0.848 . . . . 2.99 110.853 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.18 -38.68 60.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.682 -0.69 . . . . 3.06 112.191 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.9 m -156.01 -93.46 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.767 -0.197 . . . . 1.85 110.958 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.779 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 4.1 m 50.64 39.78 22.33 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.63 0.581 . . . . 1.44 110.724 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.763 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.7 mm-40 -69.24 144.52 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.34 -0.846 . . . . 1.81 112.221 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.91 127.95 22.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.56 0.695 . . . . 0.64 111.717 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.6 HG23 HG22 ' A' ' 78' ' ' VAL . 52.9 m -93.26 112.12 23.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.044 -0.98 . . . . 0.43 110.788 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -89.59 110.11 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.764 -0.653 . . . . 0.87 109.869 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.611 ' HA ' HG22 ' A' ' 76' ' ' THR . 23.4 m -105.4 106.38 16.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 0.45 110.561 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 29.8 m-85 -88.5 107.59 18.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.34 110.298 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.24 111.22 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.324 -0.398 . . . . 0.54 110.303 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.88 53.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.44 110.453 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.781 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 8.6 t70 -130.7 118.9 21.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.137 -0.483 . . . . 2.03 110.534 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.16 -98.78 0.52 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.064 -0.588 . . . . 1.97 112.546 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.01 -20.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 4.93 110.259 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -128.14 7.1 5.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 3.53 111.53 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.781 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 83.9 tttt -122.7 151.25 41.73 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.584 -0.446 . . . . 2.44 110.425 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -153.76 118.5 4.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.828 -0.624 . . . . 0.42 109.936 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -100.79 115.8 31.18 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.532 -0.758 . . . . 2.59 109.449 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.2 p -91.76 137.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.285 -0.566 . . . . 0.4 110.642 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.4 109.01 11.33 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.156 -0.929 . . . . 1.38 109.049 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.952 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 3.9 t -101.64 124.16 55.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.897 -0.592 . . . . 0.91 111.263 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -102.76 113.7 27.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.437 0.637 . . . . 2.31 109.452 173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.703 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 65.7 t60 -134.2 98.95 4.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.195 -0.911 . . . . 1.64 109.219 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.473 HG21 ' HD2' ' A' ' 5' ' ' PHE . 5.1 t -152.92 97.29 2.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.918 0.866 . . . . 2.67 111.027 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.68 -69.91 0.09 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.334 -0.848 . . . . 2.63 110.0 176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.652 ' CE1' ' HB3' ' A' ' 125' ' ' HIS . 13.6 t80 -72.28 -48.73 40.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.531 -0.759 . . . . 3.54 111.173 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.97 78.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 1.81 110.097 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 36.4 ttt180 -51.94 -24.94 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.222 -1.354 . . . . 3.38 112.072 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 95.3 mmm -79.9 -8.85 59.54 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.65 0.262 . . . . 2.43 110.706 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 44.43 -135.13 6.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.539 -0.755 . . . . 1.61 113.636 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.6 p 40.61 -133.07 0.29 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.763 0.825 . . . . 2.58 112.417 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -57.77 -33.25 68.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 3.8 111.583 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.652 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 12.5 m80 -66.51 -52.97 40.24 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.38 0.609 . . . . 2.14 110.739 -171.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.73 69.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.637 -0.711 . . . . 0.92 111.054 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -73.7 -28.94 61.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 2.83 111.668 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 31.6 ptt180 -77.35 -36.66 53.57 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.803 -0.359 . . . . 2.59 111.256 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.638 HG21 ' HE2' ' A' ' 118' ' ' PHE . 93.8 t -76.48 -23.86 15.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.356 0.598 . . . . 1.48 110.421 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.51 ' HG3' ' CB ' ' A' ' 134' ' ' ASP . 27.3 ttm180 -58.22 -19.85 36.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 3.83 111.142 174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.03 -22.72 41.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.196 -0.456 . . . . 2.48 111.362 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -137.41 -47.69 0.07 OUTLIER Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.374 -0.917 . . . . 1.61 113.469 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.46 -25.58 63.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.879 0.34 . . . . 4.83 111.878 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.51 ' CB ' ' HG3' ' A' ' 130' ' ' ARG . 15.0 t70 -59.28 -43.92 92.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 2.83 112.064 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -96.71 5.85 49.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 4.15 111.146 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -102.41 -62.15 0.73 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.441 -0.885 . . . . 1.04 112.81 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.54 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 1.1 t90 -60.63 -49.25 90.63 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.966 0.728 . . . . 2.78 112.966 -169.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.6 Cg_endo -58.13 -44.86 35.6 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.662 1.575 . . . . 0.68 112.027 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.0 m -59.05 -40.94 86.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.761 -0.654 . . . . 0.87 110.228 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.641 HG23 ' HZ3' ' A' ' 30' ' ' TRP . 45.6 mt -54.69 -51.94 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.928 -1.033 . . . . 0.72 110.894 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 8' ' ' HIS . 59.5 mt -61.67 -30.57 70.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.048 0.388 . . . . 0.69 112.048 -175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.0 mm-40 -70.99 -55.51 8.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 1.49 110.524 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.536 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.6 m -68.08 -22.52 64.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.072 -0.513 . . . . 1.15 110.626 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.79 -52.48 64.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.221 0.534 . . . . 0.8 109.771 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.744 ' HG2' HG13 ' A' ' 10' ' ' VAL . 45.9 mt-30 -59.79 -36.25 76.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.155 -0.929 . . . . 1.63 110.765 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.6 -40.29 49.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.748 -0.66 . . . . 1.46 111.462 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.23 -42.46 99.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 1.74 109.884 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.768 HG21 HG13 ' A' ' 12' ' ' VAL . 57.0 mt -64.44 -35.64 74.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.5 110.306 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.493 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 21.7 t70 -59.56 -38.71 81.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.61 -0.723 . . . . 0.85 109.716 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.509 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 45.6 mt-10 -66.06 -22.61 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 1.5 111.348 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -73.6 -8.04 54.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.763 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.27 -47.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.576 -1.297 . . . . 1.32 114.14 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.08 58.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.666 0.617 . . . . 1.92 112.666 -170.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.509 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.0 ttmm -69.26 101.23 1.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.226 -0.443 . . . . 2.04 111.539 -173.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 29.9 mmtp . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.394 -0.821 . . . . 4.22 109.391 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.559 0.219 . . . . 1.66 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.527 ' HA ' HG23 ' A' ' 6' ' ' VAL . 52.9 p90 173.53 -36.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.652 0.781 . . . . 3.73 109.92 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.786 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 29.9 t70 -67.97 -57.65 9.13 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.411 -0.359 . . . . 2.78 111.525 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 47.7 Cg_endo -83.03 -63.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.248 1.299 . . . . 1.63 111.714 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.51 139.09 16.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.421 -0.354 . . . . 3.21 110.946 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.69 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 79.6 t -89.11 121.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.047 -0.723 . . . . 1.44 109.047 167.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.5 ttt180 -124.88 130.83 53.15 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.3 -0.409 . . . . 3.37 110.428 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.79 130.87 55.47 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.807 -0.812 . . . . 0.79 108.807 172.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 11.3 p -134.79 111.04 9.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.94 0.876 . . . . 1.28 110.498 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.3 t -120.37 133.35 67.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.269 -1.332 . . . . 1.27 111.637 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.0 m -96.13 115.51 27.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.693 . . . . 0.57 109.782 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG13 HG21 ' A' ' 148' ' ' ILE . 4.6 t -98.64 140.8 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.91 111.004 -176.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 11.3 mmtp -100.0 9.88 42.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.919 -0.582 . . . . 0.98 112.016 -170.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.497 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.09 37.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.149 -0.62 . . . . 0.36 112.452 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 74.08 165.22 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.784 0.802 . . . . 0.91 112.743 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.616 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 10.9 ttp180 -63.1 -30.27 71.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.419 -1.264 . . . . 1.88 111.226 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 18' ' ' THR . 61.8 pttt -56.18 -47.18 78.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.117 -0.492 . . . . 3.05 110.405 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 27.9 m -74.84 -33.65 62.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.874 -0.603 . . . . 1.11 110.605 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -60.55 -49.59 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.32 110.883 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 52.0 t80 -70.09 -43.37 71.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.236 -0.438 . . . . 0.38 110.773 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -53.72 -51.46 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 2.39 110.175 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' CE2' ' A' ' 30' ' ' TRP . 61.1 m -63.2 -41.38 99.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.982 -0.554 . . . . 0.68 111.282 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HA ' ' HE1' ' A' ' 144' ' ' PHE . 73.8 t80 -70.48 -47.19 61.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.329 0.492 . . . . 0.48 112.329 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 46' ' ' VAL . 11.3 tp -119.27 -11.7 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.119 1.155 . . . . 0.5 114.119 -167.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.622 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 32.9 mt-10 -113.98 -38.92 4.07 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.213 -0.929 . . . . 1.24 111.345 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.19 29.74 7.87 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.373 -0.831 . . . . 0.83 111.342 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.614 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 59.4 t80 -46.48 -55.07 15.24 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 114.504 -0.848 . . . . 0.74 113.054 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.5 Cg_endo -94.37 21.59 0.55 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.13 1.887 . . . . 0.76 115.493 -172.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -120.37 -18.82 7.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.97 1.1 . . . . 1.49 113.97 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CE2' HG23 ' A' ' 22' ' ' THR . 25.3 m95 -76.08 -173.09 2.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.391 0.615 . . . . 4.62 112.523 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.732 ' HB2' ' HB3' ' A' ' 143' ' ' SER . 51.7 m95 -77.35 -35.16 1.28 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 115.617 1.71 . . . . 2.78 115.617 -172.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.645 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 74.3 Cg_endo -72.34 -131.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 121.85 1.7 . . . . 1.36 115.02 -161.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 29.3 t-20 -67.31 -8.07 29.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.084 -0.962 . . . . 1.51 110.496 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 1.058 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.3 m-20 -90.66 18.05 6.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.772 -1.103 . . . . 1.79 110.666 -172.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -104.83 68.17 0.83 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.555 . . . . 4.45 110.603 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -156.66 -178.06 7.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.002 -0.545 . . . . 4.14 109.85 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -110.37 139.16 45.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.522 -0.547 . . . . 2.68 109.522 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.539 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 50.3 p 51.74 28.3 4.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.895 0.855 . . . . 1.42 111.266 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HD3' HG22 ' A' ' 40' ' ' VAL . 1.1 tmtp? -149.46 84.01 1.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.324 -1.362 . . . . 2.9 107.324 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.058 HG23 ' HA ' ' A' ' 34' ' ' ASN . 34.0 m 45.02 32.36 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.6 1.188 . . . . 1.83 112.589 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.6 11.62 0.21 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.514 -0.851 . . . . 2.17 113.873 -175.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.042 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.87 -178.27 0.65 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.214 0.507 . . . . 1.12 110.591 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.553 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 31.1 Cg_exo -63.37 20.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.712 2.274 . . . . 1.48 114.303 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.824 ' HG ' ' H ' ' A' ' 45' ' ' GLY . 17.0 tp -161.59 -156.68 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.579 -1.267 . . . . 1.75 107.579 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.824 ' H ' ' HG ' ' A' ' 44' ' ' LEU . . . 163.9 -50.64 0.3 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.919 -1.134 . . . . 0.75 113.019 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.785 HG11 ' HG ' ' A' ' 24' ' ' LEU . 78.1 t -142.88 135.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.267 0.534 . . . . 0.6 111.502 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -113.74 124.01 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.415 -0.357 . . . . 1.11 110.562 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.673 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.23 -20.83 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.506 . . . . 2.81 111.343 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -76.26 -57.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.636 -0.256 . . . . 3.17 110.724 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.86 60.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.625 -0.798 . . . . 1.53 111.689 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 81.0 49.6 5.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.038 -0.601 . . . . 0.77 112.495 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 7.2 mpt_? -136.29 154.19 50.95 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.599 -0.354 . . . . 3.72 110.506 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.695 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.8 m0 -98.53 108.35 21.02 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.229 -1.026 . . . . 1.28 108.229 168.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -149.96 144.55 25.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.584 0.707 . . . . 1.66 111.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.042 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.5 mt-10 -111.81 170.69 7.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.627 -1.169 . . . . 2.12 109.154 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' A' ' 61' ' ' GLU . 28.6 mm -78.87 105.26 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.16 -0.681 . . . . 0.92 109.16 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.714 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.8 t70 -88.61 -164.93 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.139 -0.319 . . . . 1.97 110.139 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.4 pt-20 -80.13 -35.51 36.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.76 0.281 . . . . 2.43 111.76 -174.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.93 24.09 6.53 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.255 -0.578 . . . . 2.39 111.639 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.4 -97.27 0.38 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.658 -0.782 . . . . 2.29 113.08 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG2' HD13 ' A' ' 56' ' ' ILE . 34.1 mt-10 -142.53 29.84 1.56 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.634 0.731 . . . . 2.31 109.729 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.51 76.76 10.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.145 -0.934 . . . . 2.61 110.286 -171.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.714 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.66 130.11 52.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.229 -1.351 . . . . 3.72 109.61 175.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.616 HG22 ' HG3' ' A' ' 82' ' ' ARG . 2.9 m -69.92 -92.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 2.27 111.761 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.695 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 91.9 m-85 51.27 -167.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.291 1.219 . . . . 6.48 114.291 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.4 141.02 42.04 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.035 -0.984 . . . . 1.23 114.931 -165.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -111.07 99.22 8.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.795 -0.703 . . . . 1.17 109.484 177.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.58 HG21 HG22 ' A' ' 71' ' ' VAL . 21.0 mt -84.25 138.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.61 111.129 -172.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -99.88 -40.21 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.357 -0.383 . . . . 2.0 110.239 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -138.11 122.69 18.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 1.53 111.463 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.58 HG22 HG21 ' A' ' 68' ' ' ILE . 40.5 t -111.08 108.73 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.102 -0.703 . . . . 0.88 109.102 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -115.31 63.64 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.416 -0.514 . . . . 1.42 110.966 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.673 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 46.09 -166.45 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.658 1.224 . . . . 0.96 112.086 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 44.5 Cg_exo -60.74 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.638 1.558 . . . . 0.38 112.316 167.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.81 -66.81 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.654 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -144.71 148.62 34.39 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.643 0.609 . . . . 0.35 112.643 -175.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -138.82 129.02 25.52 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.74 110.274 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 97' ' ' PHE . 21.9 t -109.28 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.005 -0.739 . . . . 0.67 109.005 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.18 138.23 55.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.75 111.811 -170.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.16 149.05 19.65 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.774 -0.53 . . . . 0.5 111.774 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.83 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 76.2 t-105 -86.13 141.26 29.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.126 0.488 . . . . 2.79 112.092 -170.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.727 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 1.8 tmt_? -113.53 -79.47 0.58 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.29 -0.868 . . . . 5.46 109.053 168.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.015 HD22 ' HB2' ' A' ' 88' ' ' ARG . 53.8 mt -176.68 -111.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.41 1.1 . . . . 1.55 112.864 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 176.53 -161.98 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 103.856 -2.646 . . . . 1.93 103.856 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.69 50.25 0.9 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.668 -1.253 . . . . 2.4 112.222 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -140.22 78.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.823 -0.351 . . . . 5.38 111.865 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.22 49.79 74.7 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 115.752 -0.658 . . . . 2.3 112.42 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.015 ' HB2' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -129.31 154.12 47.17 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.517 -0.341 . . . . 4.77 111.859 -169.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.632 ' O ' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -115.32 135.26 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 110.243 -0.28 . . . . 1.86 110.243 177.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.594 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 5.0 p-10 -102.91 144.92 29.6 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-O 120.999 0.428 . . . . 3.18 111.319 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.566 ' HG3' ' CE2' ' A' ' 118' ' ' PHE . 15.6 Cg_exo -65.39 -48.29 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.683 2.256 . . . . 2.36 110.658 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.594 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 32.2 t70 64.79 29.5 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 2.99 110.367 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -138.88 -55.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 3.06 111.649 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.7 p -135.25 -121.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.61 -0.436 . . . . 1.85 111.567 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.83 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.6 t 55.21 54.23 9.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.922 -0.769 . . . . 1.44 108.922 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.445 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 44.7 tt0 -88.21 143.82 26.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.965 -1.016 . . . . 1.81 111.599 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -107.57 148.36 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.64 110.673 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.9 m -112.09 95.81 5.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.384 -0.969 . . . . 0.43 108.384 158.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.646 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.8 t -83.32 110.14 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.818 -0.438 . . . . 0.87 109.818 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.7 m -108.52 107.36 17.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.784 0.326 . . . . 0.45 111.143 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.616 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 59.5 m-85 -87.38 113.75 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.331 -0.395 . . . . 0.34 110.264 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -96.21 115.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.176 -0.465 . . . . 0.54 110.298 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.67 143.73 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.203 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.709 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -138.73 103.54 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.03 110.625 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.5 16.58 55.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.99 -0.55 . . . . 1.97 113.864 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 62.69 15.08 7.76 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.182 0.438 . . . . 4.93 112.182 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -134.76 -18.78 1.86 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.01 0.433 . . . . 3.53 110.793 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.0 ttpm? -122.3 158.02 30.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.074 -0.713 . . . . 2.44 109.074 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.3 m -154.13 122.78 6.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.972 0.415 . . . . 0.42 111.227 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -98.29 108.17 20.8 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.673 -0.694 . . . . 2.59 109.278 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 9' ' ' SER . 14.4 p -83.41 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.976 -0.69 . . . . 0.4 109.334 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -125.65 107.99 11.11 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.675 -0.861 . . . . 1.38 108.675 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 99' ' ' VAL . 13.0 t -103.61 123.3 57.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.394 -0.821 . . . . 0.91 112.376 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -92.91 111.22 22.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.069 -0.968 . . . . 2.31 108.824 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.69 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 23.6 t-160 -125.32 97.17 5.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.754 -1.202 . . . . 1.64 107.754 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.1 m -153.64 108.31 3.11 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.7 -0.8 . . . . 2.67 112.584 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -174.8 -63.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.456 -0.793 . . . . 2.63 109.647 165.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 129' ' ' VAL . 77.4 t80 -76.94 -28.13 55.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.743 -0.662 . . . . 3.54 109.784 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -46.8 87.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.164 -0.926 . . . . 1.81 110.01 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 72.9 ttt180 -57.72 -21.3 39.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.676 -1.147 . . . . 3.38 112.094 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.38 -17.7 62.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.173 0.511 . . . . 2.43 110.606 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 2' ' ' TYR . . . 73.03 -118.15 6.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.18 0.832 . . . . 1.61 115.18 165.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 m -37.93 -88.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.973 1.472 . . . . 2.58 114.973 -160.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -77.33 -34.35 55.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.16 0.429 . . . . 3.8 112.16 -168.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 29.6 m170 -66.08 -52.13 51.69 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.864 0.364 . . . . 2.14 110.9 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -67.02 -37.45 84.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.92 110.395 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -61.02 -49.76 76.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.655 0.243 . . . . 2.83 111.655 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.14 -29.24 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 2.59 111.186 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.569 HG21 ' HE2' ' A' ' 118' ' ' PHE . 15.7 t -75.51 -41.1 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.404 0.621 . . . . 1.48 110.535 172.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 1.033 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 39.5 ttp180 -63.16 -15.41 56.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.139 -0.937 . . . . 3.83 111.533 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -50.08 -47.02 53.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.354 -0.385 . . . . 2.48 111.433 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.21 -12.9 22.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.435 -0.888 . . . . 1.61 111.952 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.631 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 26.1 ttt -81.23 -35.3 31.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.721 0.267 . . . . 4.83 111.721 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 1.033 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 38.7 t70 -63.86 -37.29 86.84 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.833 0.679 . . . . 2.83 112.833 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 36.0 tptt -106.66 22.19 16.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.932 0.873 . . . . 4.15 109.608 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.64 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.77 -71.36 0.55 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.344 -0.843 . . . . 1.04 111.798 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.443 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.7 t-105 -54.71 -54.1 53.06 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 113.041 0.756 . . . . 2.78 113.041 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 27.0 Cg_endo -61.49 -41.32 41.3 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.8 1.667 . . . . 0.68 112.199 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -63.28 -40.96 98.84 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.334 0.588 . . . . 0.87 109.962 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 42.3 mt -58.18 -43.65 86.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 115.271 -0.877 . . . . 0.72 110.645 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.538 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 24.8 mt -60.06 -41.46 92.4 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.166 0.291 . . . . 0.69 111.2 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.192 -0.603 . . . . 1.49 111.121 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.732 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 13.8 m -75.96 -22.38 56.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 1.15 110.594 176.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 63.4 t80 -61.76 -54.87 36.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.528 -0.76 . . . . 0.8 109.336 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.44 -29.37 70.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.01 -0.541 . . . . 1.63 110.272 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.26 -54.23 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 1.46 111.891 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 147' ' ' LYS . 5.9 tmtt? -74.31 -35.01 63.66 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 120.243 -0.583 . . . . 1.74 110.188 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.735 HG21 HG13 ' A' ' 12' ' ' VAL . 18.7 mt -60.96 -34.88 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.135 0.493 . . . . 0.5 110.418 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 27.5 t70 -59.11 -34.95 72.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.85 109.924 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.646 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 30.5 mt-10 -69.62 -19.55 63.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.844 -0.616 . . . . 1.5 111.4 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.85 2.41 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.093 -0.503 . . . . 1.74 110.582 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.51 -70.72 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.193 -1.003 . . . . 1.32 113.897 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.62 -33.06 21.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.617 0.969 . . . . 1.92 113.617 -167.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.689 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 34.5 ttmt -69.51 166.71 18.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.963 -0.384 . . . . 2.04 109.963 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 C-N-CA 123.941 0.896 . . . . 4.22 111.244 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 1.004 HD22 ' HB ' ' A' ' 6' ' ' VAL . 19.9 p-10 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 110.276 -0.268 . . . . 1.66 110.276 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 84.3 m-85 83.31 -63.58 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.79 0.836 . . . . 3.73 111.044 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.774 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -54.83 -50.59 85.17 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.256 -0.429 . . . . 2.78 111.161 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 13.4 Cg_endo -92.58 -72.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.168 1.912 . . . . 1.63 111.77 169.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.677 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 39.5 p90 -153.59 153.61 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.348 -0.612 . . . . 3.21 109.348 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.004 ' HB ' HD22 ' A' ' 1' ' ' ASN . 0.9 OUTLIER -102.35 143.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.93 -1.137 . . . . 1.44 107.93 169.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.6 ttt180 -133.32 143.42 49.0 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.417 -0.513 . . . . 3.37 110.635 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.832 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.51 132.03 54.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.302 -0.999 . . . . 0.79 108.302 170.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' ' NH2' ' A' ' 110' ' ' ARG . 21.8 m -130.37 110.41 11.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.329 0.585 . . . . 1.28 109.753 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 2.5 t -134.53 131.12 54.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.153 -0.93 . . . . 1.27 111.588 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -105.65 116.12 31.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.57 109.142 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 19' ' ' ALA . 1.5 m -98.01 158.14 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.879 -0.601 . . . . 0.91 110.035 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.84 55.86 0.97 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.053 -0.521 . . . . 0.98 111.002 -174.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -167.17 26.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.968 -0.56 . . . . 0.36 111.837 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.0 t70 73.81 167.41 0.3 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.073 0.463 . . . . 0.91 111.797 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.703 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 48.4 ttp180 -71.04 -27.31 63.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.987 -0.552 . . . . 1.88 111.162 -173.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -58.19 -52.93 63.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.918 -0.583 . . . . 3.05 110.266 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 69.3 m -71.04 -34.95 71.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.85 -0.614 . . . . 1.11 111.24 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -57.07 -47.02 82.02 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.32 110.802 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 69.4 t80 -70.8 -43.49 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.38 110.615 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.677 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 22.8 tptp -51.92 -52.28 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 2.39 110.711 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.3 m -67.64 -52.23 40.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.54 -0.3 . . . . 0.68 110.868 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -59.21 -39.76 83.67 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.452 0.538 . . . . 0.48 112.452 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 77' ' ' LEU . 27.4 tp -114.21 -47.38 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.158 -0.617 . . . . 0.5 112.205 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.677 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 29.4 mt-10 -88.67 17.4 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.765 0.317 . . . . 1.24 111.082 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.67 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -149.46 39.23 0.92 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.798 -0.715 . . . . 0.83 112.067 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.617 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 12.6 t80 -51.56 -48.48 86.61 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 122.019 0.128 . . . . 0.74 111.07 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 30.0 Cg_endo -88.74 24.19 0.7 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.15 1.9 . . . . 0.76 114.907 174.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.8 pt-20 -105.12 -12.2 16.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.866 0.757 . . . . 1.49 111.462 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.504 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 2.7 m0 -83.54 -164.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.031 -0.359 . . . . 4.62 110.031 -174.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.653 ' H ' ' HD3' ' A' ' 32' ' ' PRO . 12.5 p-90 -140.37 19.01 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 114.464 1.283 . . . . 2.78 114.464 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.653 ' HD3' ' H ' ' A' ' 31' ' ' TRP . 54.9 Cg_endo -83.69 -112.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 CA-C-N 121.406 1.538 . . . . 1.36 113.001 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 6.8 t-20 -79.41 -13.76 59.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.044 0.926 . . . . 1.51 109.727 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.63 ' HA ' HG23 ' A' ' 40' ' ' VAL . 7.8 m120 -90.17 30.91 1.04 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.627 -1.169 . . . . 1.79 110.251 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -97.34 2.16 50.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 4.45 110.9 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 21.5 mmt180 -114.0 152.07 31.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.294 0.569 . . . . 4.14 112.218 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -81.5 148.31 29.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.776 . . . . 2.68 109.714 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 56' ' ' ILE . 44.5 p 52.55 16.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.343 0.657 . . . . 1.42 111.715 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.706 ' HD3' HG22 ' A' ' 40' ' ' VAL . 1.2 tmtp? -142.44 80.4 1.7 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.658 -0.701 . . . . 2.9 109.263 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.706 HG22 ' HD3' ' A' ' 39' ' ' LYS . 19.1 m 49.33 16.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.148 1.379 . . . . 1.83 113.716 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.72 25.4 2.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.378 -0.915 . . . . 2.17 112.627 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.795 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -85.28 161.71 51.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.367 -0.605 . . . . 1.12 109.367 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 39.2 Cg_exo -43.83 -12.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.966 3.777 . . . . 1.48 116.982 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.933 HD21 HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -111.24 -94.54 0.44 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.574 -0.704 . . . . 1.75 111.125 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.617 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 91.88 -36.81 3.53 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.78 -0.724 . . . . 0.75 112.976 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 24' ' ' LEU . 81.9 t -140.1 140.65 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.846 0.355 . . . . 0.6 111.168 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.702 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 11.0 t70 -109.88 113.2 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.327 -0.99 . . . . 1.11 108.327 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 16.8 ttmt -79.6 -23.24 42.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.822 -0.626 . . . . 2.81 112.286 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -90.08 -36.48 14.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.747 0.308 . . . . 3.17 111.293 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.83 -20.21 31.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.907 -0.663 . . . . 1.53 112.313 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 79.51 56.77 3.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.746 -0.74 . . . . 0.77 111.811 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -133.78 160.92 36.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.785 0.326 . . . . 3.72 111.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.746 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 15.6 m0 -117.31 108.66 15.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.234 -0.654 . . . . 1.28 109.234 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.702 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 11.0 p90 -162.39 146.22 11.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 1.66 110.862 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.909 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -114.3 175.21 5.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.841 -0.618 . . . . 2.12 109.356 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.933 HG12 HD21 ' A' ' 44' ' ' LEU . 20.6 mm -76.07 111.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.645 -0.502 . . . . 0.92 109.645 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 39.8 t0 -95.64 157.22 15.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 1.97 109.927 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.84 -28.07 62.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.398 0.888 . . . . 2.43 113.398 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.76 9.69 15.77 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.879 -0.728 . . . . 2.39 111.385 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.75 47.68 0.19 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.079 -1.058 . . . . 2.29 113.532 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.731 ' HG2' HG23 ' A' ' 56' ' ' ILE . 27.7 mt-10 54.36 36.88 26.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.396 0.617 . . . . 2.31 111.278 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -120.08 85.35 2.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 2.61 110.462 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -109.79 164.1 12.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.774 -0.648 . . . . 3.72 110.242 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.8 p -57.48 112.29 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.359 -0.382 . . . . 2.27 110.694 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -79.47 102.39 8.75 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.796 0.295 . . . . 6.48 111.796 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.746 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -55.89 137.51 46.31 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.509 -1.036 . . . . 1.23 110.509 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -108.59 97.71 7.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.379 0.59 . . . . 1.17 111.773 -168.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.533 HG21 ' CG2' ' A' ' 71' ' ' VAL . 46.1 mt -84.08 133.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.835 -0.432 . . . . 0.61 109.835 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -96.11 -33.27 12.14 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.846 -0.428 . . . . 2.0 109.846 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.5 ttpp -155.04 130.11 9.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.303 -0.408 . . . . 1.53 111.745 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.533 ' CG2' HG21 ' A' ' 68' ' ' ILE . 97.6 t -114.6 100.54 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.785 -0.82 . . . . 0.88 108.785 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.6 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.0 m-20 -98.15 59.35 1.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 119.489 -0.291 . . . . 1.42 111.173 -173.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.0 pt-20 44.25 -165.19 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 O-C-N 124.252 0.97 . . . . 0.96 111.635 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.9 Cg_exo -61.59 85.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.067 1.178 . . . . 0.38 111.385 165.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.703 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 26.5 t70 -173.16 -65.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.5 110.561 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -145.53 158.97 43.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.919 0.39 . . . . 0.35 111.809 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' CD2' HD22 ' A' ' 24' ' ' LEU . 4.2 mp -145.99 130.56 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 0.74 109.913 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.95 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.26 -0.427 . . . . 0.67 109.909 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.49 144.53 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.526 -0.306 . . . . 0.75 111.215 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -105.46 155.4 16.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.5 112.597 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 75.6 t-105 -78.55 137.44 37.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.5 0.556 . . . . 2.79 112.5 -169.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -148.07 40.59 0.97 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.482 -0.781 . . . . 5.46 109.285 176.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 85.65 166.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.859 1.059 . . . . 1.55 113.859 171.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.486 ' H ' HD13 ' A' ' 83' ' ' LEU . 36.4 t30 -158.1 -37.29 0.07 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 113.925 -1.489 . . . . 1.93 108.475 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.27 10.25 50.16 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.401 -0.818 . . . . 2.4 112.516 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.5 t80 74.4 -74.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.396 0.679 . . . . 5.38 112.008 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.14 71.56 2.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.879 -0.677 . . . . 2.3 113.508 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.883 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 15.6 ttp180 -146.15 179.01 7.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.025 -0.361 . . . . 4.77 110.025 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.883 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -82.23 126.95 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.063 -0.717 . . . . 1.86 109.063 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 30.0 p-10 -96.81 129.1 33.55 Favored Pre-proline 0 C--N 1.317 -0.816 0 O-C-N 121.672 -0.643 . . . . 3.18 110.098 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' ASN . 23.4 Cg_exo -63.37 -40.01 34.11 Favored 'Trans proline' 0 CA--C 1.519 -0.246 0 C-N-CA 122.926 2.417 . . . . 2.36 113.069 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 68.2 -30.88 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.759 0.652 . . . . 2.99 112.759 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' PRO . 3.6 m-20 -74.64 -60.15 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.355 0.598 . . . . 3.06 110.365 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 p -155.23 -90.57 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.568 -0.742 . . . . 1.85 111.293 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 49.5 m 54.11 36.72 25.45 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 108.52 -0.919 . . . . 1.44 108.52 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.6 tt0 -71.7 141.75 49.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.445 -1.707 . . . . 1.81 111.423 -172.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.598 ' HB2' HG13 ' A' ' 113' ' ' VAL . 6.7 p90 -139.07 134.63 33.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.624 -0.716 . . . . 0.64 110.199 174.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -98.87 117.14 32.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.504 -0.771 . . . . 0.43 110.273 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 111' ' ' VAL . 85.4 t -82.91 110.63 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 0.87 109.853 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 8.5 m -99.63 105.62 17.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.286 0.366 . . . . 0.45 111.426 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.4 m-85 -96.46 114.17 25.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.34 110.976 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.3 110.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.327 -0.62 . . . . 0.54 109.327 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.09 134.72 41.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.44 111.523 -175.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 38.2 t70 -120.89 123.16 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.101 -0.954 . . . . 2.03 108.944 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.96 -10.88 28.54 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.929 -0.578 . . . . 1.97 113.64 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.43 49.8 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.942 0.401 . . . . 4.93 110.464 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 60.43 31.84 20.43 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.73 -0.668 . . . . 3.53 111.308 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.644 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 3.8 ttmp? -132.6 155.71 48.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.32 -0.4 . . . . 2.44 110.448 -173.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.555 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.5 m -158.29 125.43 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.42 110.768 173.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.474 ' NH2' ' HB3' ' A' ' 9' ' ' SER . 20.4 tpt180 -101.0 126.65 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.432 -0.803 . . . . 2.59 109.556 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 100' ' ' THR . 9.5 p -114.58 136.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.006 0.432 . . . . 0.4 111.063 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.588 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 3.2 p-10 -126.73 120.24 28.89 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.81 0.814 . . . . 1.38 109.381 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.832 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 1.6 t -90.97 120.24 39.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.958 -1.019 . . . . 0.91 110.084 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -96.36 111.3 23.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.808 0.693 . . . . 2.31 109.212 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.947 ' HB3' HG22 ' A' ' 6' ' ' VAL . 51.8 t-80 -125.27 98.93 5.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.38 -0.827 . . . . 1.64 108.769 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.677 ' HB ' ' CB ' ' A' ' 5' ' ' PHE . 5.4 t -151.36 88.1 1.42 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.89 0.852 . . . . 2.67 109.621 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -157.47 -76.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 2.63 110.253 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.605 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 6.4 t80 -73.2 -38.58 66.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.799 -0.815 . . . . 3.54 108.799 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.558 ' OD1' HG13 ' A' ' 6' ' ' VAL . 17.1 p-10 -73.81 -47.59 37.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.413 -0.812 . . . . 1.81 111.353 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HD3' ' OG1' ' A' ' 116' ' ' THR . 52.4 ttp180 -56.28 -21.45 23.93 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.35 -0.386 . . . . 3.38 111.634 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 33.9 tpp -72.38 -3.48 24.29 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.95 0.405 . . . . 2.43 110.371 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.3 -164.49 24.31 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 115.036 0.774 . . . . 1.61 115.036 167.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.0 p 39.9 -116.22 0.23 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.394 1.077 . . . . 2.58 113.016 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.14 -25.13 64.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.8 111.184 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.605 ' HB3' ' O ' ' A' ' 118' ' ' PHE . 41.9 m-70 -68.53 -53.93 19.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.037 0.446 . . . . 2.14 110.624 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.94 -26.15 63.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.92 109.999 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 87.4 tttt -62.57 -46.44 88.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.102 -0.954 . . . . 2.83 111.388 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 1.6 ptm180 -78.4 -28.6 46.93 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.827 -0.349 . . . . 2.59 111.587 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 125' ' ' HIS . 88.9 t -72.81 -30.91 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.22 0.452 . . . . 1.48 112.22 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 127' ' ' LYS . 31.8 ptt180 -59.58 -30.01 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.809 0.337 . . . . 3.83 111.631 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.761 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.0 m-20 -65.15 -21.17 66.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.434 0.531 . . . . 2.48 112.434 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.5 ' HA3' HH11 ' A' ' 88' ' ' ARG . . . -96.99 -72.08 1.09 Allowed Glycine 0 C--O 1.226 -0.351 0 C-N-CA 119.975 -1.107 . . . . 1.61 114.8 -164.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.693 ' HB2' ' HB2' ' A' ' 137' ' ' TRP . 26.5 ptt? -80.93 -9.59 59.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.441 0.534 . . . . 4.83 112.441 -170.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.58 -49.84 69.44 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.405 0.52 . . . . 2.83 112.405 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -96.96 22.86 7.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.948 0.351 . . . . 4.15 111.948 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.585 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -139.76 -56.26 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.73 -1.224 . . . . 1.04 113.101 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.693 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 65.2 t-105 -55.24 -53.31 63.19 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.549 0.574 . . . . 2.78 112.549 -170.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.6 Cg_endo -59.41 -40.64 65.43 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.81 1.674 . . . . 0.68 112.337 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 m -69.21 -38.28 78.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.515 0.674 . . . . 0.87 110.258 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.642 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 29.1 mt -59.58 -42.02 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.218 -0.901 . . . . 0.72 110.817 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 76.6 mt -62.76 -26.95 68.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.904 0.335 . . . . 0.69 111.904 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.18 -54.64 7.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.371 -0.233 . . . . 1.49 110.371 176.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -27.5 68.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 1.15 110.595 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 47.2 t80 -62.17 -55.06 32.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.45 -0.795 . . . . 0.8 110.485 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.447 ' CG ' HG13 ' A' ' 10' ' ' VAL . 39.0 mt-30 -62.9 -34.61 77.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.32 0.581 . . . . 1.63 110.816 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.513 ' HB3' ' HE1' ' A' ' 31' ' ' TRP . 13.4 t70 -66.12 -44.99 82.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.873 -1.058 . . . . 1.46 110.402 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -69.19 -31.54 70.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.711 -0.677 . . . . 1.74 110.698 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.529 HG21 ' HB ' ' A' ' 12' ' ' VAL . 53.2 mt -71.43 -36.37 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.5 110.446 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.473 ' HB3' ' HE3' ' A' ' 154' ' ' LYS . 17.8 t0 -66.11 -28.97 69.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.504 . . . . 0.85 109.675 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 55.7 mt-10 -60.74 -28.56 68.79 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.572 0.701 . . . . 1.5 110.334 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.51 -3.24 58.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.239 -0.891 . . . . 1.74 110.383 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.72 -70.4 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.525 -0.845 . . . . 1.32 113.67 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.28 -46.65 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.066 0.433 . . . . 1.92 111.407 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttpp -81.72 171.15 14.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.356 -0.384 . . . . 2.04 110.013 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.555 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 18.1 tppt? . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.352 -0.981 . . . . 4.22 108.352 167.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.0 p-10 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.65 0.262 . . . . 1.66 110.509 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 24.6 p90 172.14 -35.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.837 0.855 . . . . 3.73 109.108 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.76 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.9 t70 -73.64 -55.35 3.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.523 -0.308 . . . . 2.78 111.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 52.8 Cg_endo -84.31 -68.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.512 1.474 . . . . 1.63 111.94 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.05 142.78 26.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.169 -0.469 . . . . 3.21 110.073 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.638 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 76.5 t -98.29 112.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.866 -0.791 . . . . 1.44 108.866 167.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 45.4 ttm-85 -123.62 135.54 54.0 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.537 -0.465 . . . . 3.37 110.97 -177.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.725 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.66 134.38 52.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.829 -0.804 . . . . 0.79 108.829 174.119 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 22.4 m -143.24 112.23 6.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.154 -0.475 . . . . 1.28 110.455 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.948 HG22 HG12 ' A' ' 111' ' ' VAL . 2.2 m -126.66 140.42 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.125 -0.489 . . . . 1.27 109.77 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -102.48 114.42 28.61 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.512 -0.921 . . . . 0.57 108.512 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' HB ' ' A' ' 109' ' ' THR . 0.3 OUTLIER -103.3 162.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.254 -0.43 . . . . 0.91 110.445 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.922 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 9.5 pttt -125.92 35.93 4.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.753 -0.658 . . . . 0.98 112.013 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.27 29.19 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.215 0.45 . . . . 0.36 112.215 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 20.6 t70 75.84 163.37 0.25 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.857 0.837 . . . . 0.91 112.22 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.881 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 40.1 ttp180 -64.68 -27.88 69.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.717 -1.129 . . . . 1.88 110.96 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 4.3 ttmp? -57.67 -48.55 79.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 3.05 110.825 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -77.46 -36.32 52.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 1.11 111.023 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.622 ' HA ' HD13 ' A' ' 148' ' ' ILE . . . -59.81 -39.59 85.54 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.79 -0.364 . . . . 0.32 110.405 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CG ' ' HA ' ' A' ' 74' ' ' PRO . 55.6 t80 -71.05 -49.97 39.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.38 110.77 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -54.18 -53.0 59.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.083 0.468 . . . . 2.39 110.982 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.475 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.2 m -63.83 -45.31 90.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.359 -0.837 . . . . 0.68 110.56 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.719 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.3 t80 -63.95 -37.49 87.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.945 0.35 . . . . 0.48 111.945 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.87 HD11 HG11 ' A' ' 46' ' ' VAL . 17.1 tp -99.49 -59.65 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.179 -0.608 . . . . 0.5 112.485 -174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -88.72 -19.47 26.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.149 0.5 . . . . 1.24 111.547 -173.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -89.77 18.48 46.81 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.645 -0.788 . . . . 0.83 111.17 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.534 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 10.9 t80 -50.39 -51.78 60.85 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.151 0.58 . . . . 0.74 112.256 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 42.0 Cg_endo -86.13 8.01 4.71 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.298 1.999 . . . . 0.76 115.525 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.7 pt-20 -111.07 -2.36 15.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.851 -0.739 . . . . 1.49 111.999 -175.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.818 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 43.1 m0 -67.64 155.73 38.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.329 0.585 . . . . 4.62 111.111 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.547 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 68.0 m95 -75.1 -43.79 4.61 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.389 -0.823 . . . . 2.78 112.906 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 29.1 Cg_endo -60.46 -87.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.63 2.22 . . . . 1.36 115.199 -162.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -110.98 -17.85 13.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.516 0.674 . . . . 1.51 110.451 -173.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.627 ' HA ' HG13 ' A' ' 40' ' ' VAL . 2.9 m-20 -100.89 27.63 5.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.474 -0.784 . . . . 1.79 112.037 -168.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -104.4 13.31 32.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.687 0.756 . . . . 4.45 109.44 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -104.74 128.26 52.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.718 -0.674 . . . . 4.14 111.066 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -75.61 137.45 40.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 2.68 111.151 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 57' ' ' ASP . 79.8 p 57.09 11.53 1.04 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.61 1.164 . . . . 1.42 112.956 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.642 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 83.0 tttt -100.03 -48.81 4.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.477 -0.934 . . . . 2.9 108.477 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.717 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 12.4 p -174.35 -2.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.418 -1.265 . . . . 1.83 109.984 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -127.59 47.09 1.04 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.623 -0.799 . . . . 2.17 112.638 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.037 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -79.91 158.46 72.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.013 -1.106 . . . . 1.12 108.013 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.69 44.85 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 123.803 3.002 . . . . 1.48 114.786 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -149.51 -84.36 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.723 -0.473 . . . . 1.75 109.723 173.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.434 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.23 -52.95 3.17 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.926 -0.654 . . . . 0.75 112.781 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.87 HG11 HD11 ' A' ' 24' ' ' LEU . 58.9 t -140.33 138.42 36.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.003 0.43 . . . . 0.6 111.607 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.647 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 22.3 t70 -100.42 107.27 18.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.841 -0.8 . . . . 1.11 108.841 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -9.83 59.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.19 -0.914 . . . . 2.81 111.203 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -75.39 -62.41 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.035 -0.53 . . . . 3.17 110.702 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -92.59 -39.49 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.562 -0.828 . . . . 1.53 111.662 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 72.46 0.62 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.654 -0.784 . . . . 0.77 112.805 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -154.39 144.33 21.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 3.72 111.172 175.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.608 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 22.7 m0 -96.2 110.98 23.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 1.28 110.515 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.647 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.8 p90 -153.91 152.91 31.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 1.66 110.399 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 6.4 mp0 -119.98 150.71 40.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.115 -0.698 . . . . 2.12 109.115 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.507 HD12 ' HG2' ' A' ' 61' ' ' GLU . 45.0 mm -77.0 103.37 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.999 0.428 . . . . 0.92 109.892 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' HA ' HG22 ' A' ' 38' ' ' THR . 8.1 t70 -92.84 148.13 22.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.133 -0.692 . . . . 1.97 109.133 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.88 -10.09 59.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.462 0.912 . . . . 2.43 113.462 -166.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.18 10.25 32.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.648 -0.821 . . . . 2.39 110.712 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.49 50.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.39 -0.91 . . . . 2.29 113.921 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.507 ' HG2' HD12 ' A' ' 56' ' ' ILE . 39.2 mt-10 58.1 24.67 11.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.175 0.435 . . . . 2.31 112.175 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.86 78.05 6.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.499 0.666 . . . . 2.61 110.143 -173.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.508 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -123.22 162.74 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.292 -0.867 . . . . 3.72 109.68 176.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.566 ' C ' ' HD2' ' A' ' 82' ' ' ARG . 4.9 p -62.97 148.59 47.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.4 -0.593 . . . . 2.27 109.4 172.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 44.4 p90 -120.4 120.87 37.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.396 -0.522 . . . . 6.48 111.666 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.34 148.17 46.87 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.681 -0.968 . . . . 1.23 110.681 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.491 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -106.0 96.48 6.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.263 0.532 . . . . 1.17 111.26 -171.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.545 HG21 ' CG2' ' A' ' 71' ' ' VAL . 53.8 mt -77.08 125.29 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.271 0.558 . . . . 0.61 109.939 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -96.2 -21.37 17.93 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.399 -0.818 . . . . 2.0 109.786 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -164.64 125.0 2.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.224 -0.443 . . . . 1.53 111.889 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' CG2' HG21 ' A' ' 68' ' ' ILE . 62.6 t -109.36 107.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.725 -0.843 . . . . 0.88 108.725 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.44 75.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.649 -0.42 . . . . 1.42 111.211 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.3 pt-20 47.67 -170.92 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 124.766 1.291 . . . . 0.96 111.961 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 35.9 Cg_exo -63.48 81.32 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.373 1.382 . . . . 0.38 111.122 166.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.881 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 14.9 t70 -166.69 -68.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.405 -0.816 . . . . 0.5 110.984 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -138.67 140.3 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.783 0.66 . . . . 0.35 112.783 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -135.47 116.41 14.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.48 -0.782 . . . . 0.74 108.977 175.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 98' ' ' THR . 29.9 t -95.26 111.78 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.687 -0.857 . . . . 0.67 108.687 175.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.21 126.42 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.75 0.31 . . . . 0.75 111.185 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 1.01 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -84.88 146.25 22.06 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.006 -0.837 . . . . 0.5 111.006 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.89 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 68.8 t-105 -73.63 160.18 31.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.585 0.707 . . . . 2.79 112.34 -168.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.568 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 19.3 ttp180 -135.52 -72.56 0.46 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.409 -1.269 . . . . 5.46 109.722 -172.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.769 HD23 ' HB2' ' A' ' 90' ' ' ASP . 2.5 tm? 170.46 145.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.343 -0.844 . . . . 1.55 109.539 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.679 ' N ' HD13 ' A' ' 83' ' ' LEU . 54.0 t30 -142.6 146.89 35.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.35 -0.611 . . . . 1.93 109.35 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.65 -15.56 31.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.831 -0.699 . . . . 2.4 112.024 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.642 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 71.3 t80 70.39 -63.29 0.41 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.64 0.776 . . . . 5.38 111.207 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.59 44.65 3.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.224 -0.512 . . . . 2.3 112.037 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.694 ' NH1' ' HA ' ' A' ' 129' ' ' VAL . 2.4 tmm_? -133.86 144.24 48.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.033 -0.729 . . . . 4.77 109.033 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.512 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -96.58 131.92 42.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.028 0.442 . . . . 1.86 111.292 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.769 ' HB2' HD23 ' A' ' 83' ' ' LEU . 5.2 t70 -143.66 137.15 14.16 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.482 -0.933 . . . . 3.18 108.482 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HG2' ' CZ ' ' A' ' 118' ' ' PHE . 32.0 Cg_exo -58.72 -25.58 76.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.562 2.175 . . . . 2.36 112.72 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.4 t70 56.51 75.29 0.36 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.358 0.599 . . . . 2.99 110.155 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -134.32 -75.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 3.06 110.767 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.7 m -113.5 -97.93 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.969 -0.56 . . . . 1.85 110.384 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.89 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 13.5 m 50.64 37.77 17.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.938 -0.574 . . . . 1.44 112.086 175.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 1.01 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 27.9 mt-10 -62.65 143.16 57.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.38 -0.373 . . . . 1.81 111.379 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.776 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -136.46 127.66 28.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.939 -0.573 . . . . 0.64 110.749 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.63 HG23 HG22 ' A' ' 78' ' ' VAL . 27.7 m -91.1 115.1 27.75 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.43 110.696 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 113' ' ' VAL . 58.0 t -86.33 109.92 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.872 -0.418 . . . . 0.87 109.872 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.3 m -107.88 106.52 16.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.424 -0.353 . . . . 0.45 110.761 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.74 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 52.8 m-85 -88.35 117.72 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.346 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.98 112.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.236 -0.283 . . . . 0.54 110.236 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.33 51.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.887 -0.597 . . . . 0.44 111.593 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.8 t70 -137.38 120.31 16.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.595 . . . . 2.03 109.535 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.27 58.64 1.13 Allowed Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.994 -0.548 . . . . 1.97 113.118 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 21.0 tt0 -150.98 13.57 0.7 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.994 . . . . 4.93 108.315 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 59.8 mttp 67.09 33.7 5.49 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.175 -0.92 . . . . 3.53 109.384 -167.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 7.3 ttpm? -121.65 154.43 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.407 -0.59 . . . . 2.44 109.407 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.584 ' HB ' HG12 ' A' ' 12' ' ' VAL . 18.7 m -161.14 128.63 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.757 0.313 . . . . 0.42 110.728 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.34 114.95 28.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.036 -0.727 . . . . 2.59 109.036 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.948 HG12 HG22 ' A' ' 10' ' ' VAL . 12.7 p -93.2 144.67 8.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 120.994 -0.283 . . . . 0.4 111.199 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.47 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 7.3 t70 -130.26 126.78 38.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.222 -0.899 . . . . 1.38 109.51 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.725 ' HB ' ' CD2' ' A' ' 8' ' ' HIS . 1.2 t -111.44 133.22 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 116.662 -0.245 . . . . 0.91 110.809 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 49.8 mt-10 -104.31 110.73 23.08 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.907 0.754 . . . . 2.31 109.921 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.776 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 46.7 t-80 -123.38 99.06 6.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.214 -1.032 . . . . 1.64 108.214 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -153.07 91.26 1.51 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.116 0.484 . . . . 2.67 110.129 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -155.6 -75.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.904 -0.589 . . . . 2.63 110.142 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.575 ' CZ ' ' HG2' ' A' ' 91' ' ' PRO . 37.1 t80 -82.31 -25.76 33.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.654 -0.703 . . . . 3.54 110.906 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.87 -43.63 53.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.684 -0.689 . . . . 1.81 110.991 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 71.0 ttt180 -53.72 -21.3 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.368 -0.833 . . . . 3.38 112.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 79.1 mmm -78.64 2.14 20.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.428 -0.351 . . . . 2.43 111.113 -177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.31 -144.38 6.71 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.744 -0.662 . . . . 1.61 114.342 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 47.48 -132.61 1.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.302 0.641 . . . . 2.58 110.85 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -77.59 -13.91 59.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.471 -0.143 . . . . 3.8 111.371 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.8 m170 -72.72 -52.94 13.11 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.472 -0.566 . . . . 2.14 109.472 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.0 70.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.767 -0.651 . . . . 0.92 111.026 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -64.33 -39.47 93.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.478 -0.328 . . . . 2.83 111.098 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.452 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 3.1 ptm180 -73.28 -32.9 64.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 2.59 110.336 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.694 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 89.5 t -65.06 -40.49 89.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.385 0.612 . . . . 1.48 110.266 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.52 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 8.5 ttp180 -65.66 -17.25 64.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 3.83 111.904 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 88' ' ' ARG . 65.9 t30 -52.99 -46.47 68.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.727 0.298 . . . . 2.48 111.629 -173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' HG3' ' A' ' 88' ' ' ARG . . . -120.01 -20.07 3.83 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.145 -1.026 . . . . 1.61 113.031 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 49.6 ttm -79.74 -22.96 42.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.577 -0.366 . . . . 4.83 111.165 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 10.3 t70 -55.65 -49.15 73.66 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.851 0.685 . . . . 2.83 112.851 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -100.42 -39.85 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.984 -0.286 . . . . 4.15 111.335 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -59.41 -59.59 10.36 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 116.46 -0.336 . . . . 1.04 113.324 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.541 ' HH2' HG11 ' A' ' 113' ' ' VAL . 3.4 t90 -59.36 -49.99 89.68 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.63 0.604 . . . . 2.78 112.63 -172.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 28.6 Cg_endo -62.13 -35.54 74.82 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.002 1.801 . . . . 0.68 112.385 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -68.55 -37.04 79.6 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.248 -0.649 . . . . 0.87 109.248 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.687 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 57.8 mt -55.59 -49.35 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.933 -1.031 . . . . 0.72 110.244 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 60.4 mt -58.79 -33.8 70.75 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.363 0.414 . . . . 0.69 112.063 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.51 -57.0 7.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 1.49 110.417 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.611 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 70.1 m -65.89 -23.18 66.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.941 -0.572 . . . . 1.15 110.532 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.462 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 64.7 t80 -63.85 -53.0 57.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 0.8 110.101 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 76.1 mt-30 -58.58 -33.57 70.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.233 0.54 . . . . 1.63 110.34 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.36 -42.15 45.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.46 111.33 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.509 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 10.0 tptt -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.225 0.536 . . . . 1.74 110.442 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 19' ' ' ALA . 66.2 mt -68.49 -30.31 47.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.821 -0.627 . . . . 0.5 110.537 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.922 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 28.1 t0 -61.08 -30.96 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.85 109.898 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.803 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 43.8 mt-10 -65.99 -29.98 70.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 1.5 110.392 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -85.13 -5.14 59.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.419 -0.809 . . . . 1.74 110.173 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.8 -71.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.943 -0.646 . . . . 1.32 113.488 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.64 24.76 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.467 0.543 . . . . 1.92 112.467 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.803 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 14.9 tppt? -62.14 -74.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.431 0.158 . . . . 2.04 110.777 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 155' ' ' LYS . 6.8 mtmp? . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.322 -0.847 . . . . 4.22 110.392 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.57 ' O ' HG22 ' A' ' 6' ' ' VAL . 31.8 p-10 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 121.028 0.442 . . . . 1.66 110.78 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.437 ' HA ' HG22 ' A' ' 6' ' ' VAL . 92.1 m-85 -162.01 -41.71 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.44 1.096 . . . . 3.73 108.391 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.745 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 20.0 t70 -61.03 -54.73 51.3 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.171 -0.922 . . . . 2.78 112.312 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.2 Cg_endo -91.69 -63.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 1.63 112.493 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HA ' HG22 ' A' ' 116' ' ' THR . 30.9 p90 -152.4 142.86 22.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.082 -0.508 . . . . 3.21 109.856 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.682 ' HB ' ' CE1' ' A' ' 115' ' ' HIS . 16.7 t -103.81 108.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.722 -0.473 . . . . 1.44 109.722 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.817 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 25.7 ttm180 -109.38 132.92 53.67 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.844 -0.616 . . . . 3.37 111.502 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.21 135.6 50.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.999 -0.741 . . . . 0.79 108.999 173.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.778 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 5.5 p -141.18 112.72 7.55 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.144 0.497 . . . . 1.28 111.488 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.675 HG22 ' CG1' ' A' ' 111' ' ' VAL . 16.1 m -122.93 152.44 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.978 -0.555 . . . . 1.27 111.317 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -102.18 116.04 31.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.509 -0.769 . . . . 0.57 110.152 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.968 HG13 HG21 ' A' ' 148' ' ' ILE . 38.4 t -91.37 132.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.019 -0.991 . . . . 0.91 109.974 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.716 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -101.45 23.25 11.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.978 -0.555 . . . . 0.98 112.139 -171.541 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.35 37.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.244 0.461 . . . . 0.36 112.244 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 22.6 t70 75.39 159.6 0.22 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 122.04 0.924 . . . . 0.91 112.544 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 32.5 ttp180 -63.04 -25.49 68.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.637 -1.165 . . . . 1.88 111.618 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.92 -48.48 79.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.587 -0.279 . . . . 3.05 110.272 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.2 p -74.08 -36.4 64.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.952 -0.299 . . . . 1.11 111.201 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.85 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -59.23 -45.48 91.03 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.414 -0.514 . . . . 0.32 110.574 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CE1' HD21 ' A' ' 77' ' ' LEU . 76.1 t80 -71.49 -44.27 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.363 -0.38 . . . . 0.38 110.616 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -54.97 -54.27 45.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.132 0.491 . . . . 2.39 110.75 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.454 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.0 m -63.79 -48.54 76.48 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.078 -0.964 . . . . 0.68 110.24 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.728 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 61.5 t80 -59.72 -37.78 79.85 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.647 0.592 . . . . 0.48 112.223 -173.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.605 ' HG ' HG11 ' A' ' 46' ' ' VAL . 11.0 tp -112.78 -51.39 2.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.818 0.673 . . . . 0.5 112.818 -173.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.985 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 11.8 mt-10 -82.08 -38.62 24.61 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.799 -0.563 . . . . 1.24 111.988 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.651 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.07 40.53 2.81 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.876 -0.602 . . . . 0.83 112.193 -176.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.613 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 55.0 t80 -61.54 -58.2 20.02 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 112.043 0.386 . . . . 0.74 112.043 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 80.7 Cg_endo -80.11 29.26 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.533 2.155 . . . . 0.76 114.388 -174.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.3 pt-20 -125.46 2.13 7.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.543 -0.463 . . . . 1.49 110.986 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.782 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 24.9 m0 -75.62 157.87 33.18 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.048 0.451 . . . . 4.62 109.908 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.646 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 12.6 m95 -87.4 -34.93 0.45 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.17 0.804 . . . . 2.78 113.17 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 14.0 Cg_endo -54.43 -86.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.802 2.335 . . . . 1.36 115.295 -165.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -111.23 -34.72 6.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.479 0.657 . . . . 1.51 110.465 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.748 ' HA ' HG13 ' A' ' 40' ' ' VAL . 9.5 p-10 -91.51 33.62 1.0 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.061 -0.972 . . . . 1.79 111.823 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -96.34 -2.14 46.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.794 0.807 . . . . 4.45 109.115 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 8.2 mmt180 -99.34 126.0 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.198 -0.91 . . . . 4.14 110.65 -176.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 p -76.58 135.59 39.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.117 -0.492 . . . . 2.68 110.821 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 57' ' ' ASP . 61.1 p 57.74 20.08 6.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.38 1.072 . . . . 1.42 111.727 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -111.56 -46.8 3.23 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.771 -1.196 . . . . 2.9 107.771 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.748 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.3 p -174.52 26.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.711 -1.131 . . . . 1.83 109.02 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.97 36.33 0.28 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.641 -0.79 . . . . 2.17 112.93 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -66.12 164.49 28.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.531 -0.544 . . . . 1.12 109.531 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 56.96 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.352 2.701 . . . . 1.48 114.202 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.18 -83.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.173 0.589 . . . . 1.75 109.495 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.575 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 89.59 -55.68 3.82 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.86 -0.686 . . . . 0.75 113.592 170.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.605 HG11 ' HG ' ' A' ' 24' ' ' LEU . 91.3 t -138.73 142.09 35.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.001 0.429 . . . . 0.6 111.693 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.529 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.6 t70 -110.67 110.08 20.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 1.11 108.97 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.985 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 3.2 mptt -80.93 -29.55 35.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 2.81 111.872 -172.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -74.68 -42.43 58.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.031 0.382 . . . . 3.17 112.031 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.21 -42.18 3.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.638 -0.791 . . . . 1.53 111.612 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 107.35 68.19 0.66 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.86 -0.686 . . . . 0.77 112.745 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 6.8 ptm180 -159.25 139.74 12.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 3.72 111.094 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.737 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -95.23 110.09 22.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.52 . . . . 1.28 110.154 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.529 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.1 p90 -152.09 159.45 43.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.158 0.504 . . . . 1.66 110.876 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.993 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 24.9 mt-10 -117.18 156.06 28.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 2.12 110.89 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 mm -78.17 102.53 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.317 -0.994 . . . . 0.92 108.317 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.678 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 14.9 t70 -87.71 -177.87 5.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 1.97 110.54 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.45 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 10.5 pt-20 -60.95 -40.64 94.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.348 0.499 . . . . 2.43 112.348 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.16 25.12 7.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 2.39 111.039 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.3 -100.66 0.46 Allowed Glycine 0 C--O 1.22 -0.748 0 C-N-CA 120.822 -0.704 . . . . 2.29 111.801 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.678 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -156.02 75.31 0.89 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.357 0.598 . . . . 2.31 110.394 175.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -110.01 74.58 0.89 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.817 -0.808 . . . . 2.61 108.817 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 2.2 m-70 -124.21 147.47 48.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 3.72 110.549 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 p -57.68 110.27 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.586 0.554 . . . . 2.27 111.141 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.737 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 48.9 p90 -77.05 122.45 24.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.237 0.541 . . . . 6.48 111.553 -175.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 82' ' ' ARG . . . -60.49 134.41 50.0 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.056 -1.218 . . . . 1.23 110.056 170.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -97.63 87.81 4.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.607 0.703 . . . . 1.17 110.924 -168.116 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.53 HG12 HG13 ' A' ' 79' ' ' ILE . 51.5 mt -72.99 126.43 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.051 -0.522 . . . . 0.61 109.893 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' OE2' ' A' ' 96' ' ' GLU . 6.3 mmm180 -94.33 -26.57 16.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.837 -0.619 . . . . 2.0 109.38 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.2 ttpp -166.13 133.83 2.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.619 -0.719 . . . . 1.53 111.386 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.527 HG23 HG21 ' A' ' 68' ' ' ILE . 90.7 t -115.26 106.28 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.546 -0.909 . . . . 0.88 108.546 174.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.1 m-20 -102.99 59.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.618 -0.265 . . . . 1.42 110.936 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.5 pt-20 46.89 -168.83 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.247 0.967 . . . . 0.96 111.863 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.5 Cg_exo -63.52 80.5 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.422 1.414 . . . . 0.38 111.384 167.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 23.7 t70 -167.73 -66.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.45 -0.796 . . . . 0.5 110.275 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -146.71 159.07 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 0.35 111.358 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.466 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -148.03 126.92 12.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.571 -0.529 . . . . 0.74 109.571 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.28 101.58 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.08 -0.711 . . . . 0.67 109.08 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.53 HG13 HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.86 137.69 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.859 0.362 . . . . 0.75 110.796 -176.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.755 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -89.17 145.4 18.51 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.845 -0.616 . . . . 0.5 112.462 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.825 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 73.7 t-105 -64.48 131.24 46.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.036 0.922 . . . . 2.79 113.347 -171.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.464 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 5.8 tpt180 -151.51 94.52 2.02 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.751 -1.944 . . . . 5.46 105.751 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 89' ' ' ILE . 1.5 pp -67.72 -170.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.031 -0.532 . . . . 1.55 112.367 -170.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' OD1' HG21 ' A' ' 40' ' ' VAL . 3.0 m-20 -68.21 76.65 0.25 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.611 -0.885 . . . . 1.93 108.611 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.26 50.94 4.08 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.058 -0.974 . . . . 2.4 113.672 -168.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -132.47 34.66 3.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.828 -1.175 . . . . 5.38 107.828 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 88' ' ' ARG . . . 169.9 -26.36 0.11 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.473 -1.239 . . . . 2.3 111.386 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.713 ' HG3' ' HA3' ' A' ' 132' ' ' GLY . 36.6 mmt-85 -117.15 160.8 20.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.198 -0.297 . . . . 4.77 110.198 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.585 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -94.12 119.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.613 0.72 . . . . 1.86 111.168 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -88.76 133.92 34.89 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.292 -0.867 . . . . 3.18 110.07 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.21 -54.71 2.81 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.566 2.177 . . . . 2.36 112.267 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.19 86.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.935 0.772 . . . . 2.99 111.936 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -160.89 -52.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 3.06 109.124 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.4 m -142.91 -84.68 0.16 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.534 -1.284 . . . . 1.85 107.534 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.825 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 14.6 m 56.81 23.81 8.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.848 . . . . 1.44 111.662 169.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.755 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 25.2 mt-10 -71.23 139.63 50.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.873 -0.603 . . . . 1.81 111.665 -172.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.996 ' HB3' ' HB3' ' A' ' 115' ' ' HIS . 1.1 p90 -126.94 137.35 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.013 -0.54 . . . . 0.64 110.927 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 41.8 m -91.41 109.11 20.39 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.43 109.977 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.664 ' HA ' HG22 ' A' ' 113' ' ' VAL . 45.2 t -89.27 108.6 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.626 -0.509 . . . . 0.87 109.626 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.704 ' HA ' HG22 ' A' ' 76' ' ' THR . 42.1 m -104.09 106.57 17.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.45 110.563 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.711 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 48.6 m-85 -88.77 107.44 18.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.971 -0.381 . . . . 0.34 109.971 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.45 112.98 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.813 -0.44 . . . . 0.54 109.813 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.39 134.31 52.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.049 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 22.3 t70 -121.86 111.5 17.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.153 -0.476 . . . . 2.03 109.762 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.62 -99.27 0.81 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.859 -0.686 . . . . 1.97 112.48 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.573 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 4.1 pt20 -150.05 -25.23 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.454 0.168 . . . . 4.93 111.454 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.573 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 35.7 pttt -137.56 19.4 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 3.53 111.164 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.77 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 12.3 mptt -122.39 158.38 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.121 -0.696 . . . . 2.44 109.121 172.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.7 m -158.07 119.85 3.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.885 0.374 . . . . 0.42 110.813 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -101.66 108.5 20.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.114 -0.698 . . . . 2.59 109.114 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.2 p -90.82 142.32 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.4 110.245 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.564 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 16.4 t70 -132.54 113.46 13.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.441 -1.254 . . . . 1.38 109.519 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 3.0 t -105.13 124.48 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 116.504 -0.317 . . . . 0.91 111.131 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.61 125.71 54.46 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.987 -0.685 . . . . 2.31 110.04 170.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.996 ' HB3' ' HB3' ' A' ' 97' ' ' PHE . 27.7 p80 -137.35 125.82 23.52 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.822 -0.626 . . . . 1.64 109.737 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 5' ' ' PHE . 23.2 p -135.06 77.78 1.7 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 2.67 110.916 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.64 ' O ' ' HG2' ' A' ' 121' ' ' MET . 2.0 t-160 -158.96 -75.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.828 -0.749 . . . . 2.63 110.759 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.438 ' HE1' HG11 ' A' ' 129' ' ' VAL . 19.0 p90 -71.47 -29.76 65.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.12 -0.491 . . . . 3.54 111.483 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -51.75 19.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.615 0.766 . . . . 1.81 110.867 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' NH1' ' HB ' ' A' ' 116' ' ' THR . 42.1 ttp180 -58.89 -20.87 55.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.045 -0.98 . . . . 3.38 111.6 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.64 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.8 mmt -64.36 -19.31 65.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.511 0.196 . . . . 2.43 110.955 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.85 -157.54 3.26 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 114.756 0.662 . . . . 1.61 114.756 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 p 40.62 -128.78 0.43 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.032 0.933 . . . . 2.58 112.964 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 46.4 mmtm -60.08 -38.54 83.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 3.8 111.516 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -60.86 -49.66 76.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 2.14 110.714 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.68 68.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.112 -0.495 . . . . 0.92 110.491 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -72.37 -41.27 66.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 2.83 110.9 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 8.9 ptp180 -68.92 -33.64 74.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.624 0.249 . . . . 2.59 111.252 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.438 HG11 ' HE1' ' A' ' 118' ' ' PHE . 88.9 t -70.46 -45.75 73.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.397 0.618 . . . . 1.48 110.267 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.537 ' CG ' ' HB2' ' A' ' 134' ' ' ASP . 42.6 ttt180 -68.47 -14.58 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.382 -0.826 . . . . 3.83 111.137 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -52.34 -26.88 13.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.036 -0.529 . . . . 2.48 111.841 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.713 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -140.08 -37.43 0.11 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.974 -1.108 . . . . 1.61 113.34 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.71 ' HG3' ' HB2' ' A' ' 137' ' ' TRP . 7.7 tpt -73.06 -10.67 60.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.047 0.423 . . . . 4.83 111.366 -172.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.537 ' HB2' ' CG ' ' A' ' 130' ' ' ARG . 27.8 t70 -62.49 -31.43 72.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.151 0.501 . . . . 2.83 111.277 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -103.0 4.27 37.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.052 0.453 . . . . 4.15 110.485 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.539 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.75 -63.61 0.6 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.738 -0.665 . . . . 1.04 112.471 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.71 ' HB2' ' HG3' ' A' ' 133' ' ' MET . 4.2 t90 -57.96 -51.96 77.98 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.029 0.752 . . . . 2.78 113.029 -170.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.9 Cg_endo -60.96 -38.24 70.5 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.845 1.696 . . . . 0.68 111.916 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.2 m -67.45 -37.19 82.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.637 -0.71 . . . . 0.87 109.503 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.759 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 17.5 mt -57.39 -50.72 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 114.888 -1.051 . . . . 0.72 111.188 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 75.6 mt -57.44 -41.84 81.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.411 0.445 . . . . 0.69 111.209 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.92 -51.59 68.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.118 0.485 . . . . 1.49 110.866 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.694 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 41.7 m -71.65 -21.51 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 1.15 110.955 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 61.7 t80 -63.19 -53.02 59.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.238 -0.653 . . . . 0.8 109.238 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -31.93 69.35 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.868 -0.605 . . . . 1.63 110.51 173.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.05 -40.36 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 1.46 112.04 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -69.46 -39.32 77.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.068 0.461 . . . . 1.74 109.956 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.968 HG21 HG13 ' A' ' 12' ' ' VAL . 87.0 mt -65.72 -29.58 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.5 110.343 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.408 ' OD2' ' HG3' ' A' ' 154' ' ' LYS . 17.9 t0 -64.39 -25.24 67.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.616 -0.72 . . . . 0.85 110.199 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -71.52 -31.01 66.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.639 . . . . 1.5 109.964 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.52 -32.55 48.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.598 -0.728 . . . . 1.74 109.885 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -89.05 22.73 21.1 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.745 -0.661 . . . . 1.32 111.895 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.12 85.03 0.14 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.085 0.554 . . . . 1.92 111.735 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 34.0 ttmt -79.92 66.3 5.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.732 0.777 . . . . 2.04 109.014 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 155' ' ' LYS . 7.8 mtmp? . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.607 -1.179 . . . . 4.22 108.586 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 5.9 p30 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.346 -0.242 . . . . 1.66 110.346 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.8 p90 -169.21 -57.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.99 0.367 . . . . 3.73 111.99 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.6 t70 -66.55 -57.24 12.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.645 0.609 . . . . 2.78 112.645 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 2.8 Cg_endo -79.69 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.487 1.458 . . . . 1.63 111.971 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -142.3 121.47 13.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.684 0.278 . . . . 3.21 110.581 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.3 t -86.35 113.65 24.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.311 -0.996 . . . . 1.44 108.311 169.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 2.1 ttt180 -141.85 145.99 35.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.181 0.515 . . . . 3.37 111.077 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HE2' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -122.65 131.09 53.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.012 -0.736 . . . . 0.79 109.012 169.319 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.9 p -134.64 111.54 10.09 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.808 0.813 . . . . 1.28 110.125 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.547 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -125.95 146.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.272 -1.331 . . . . 1.27 111.801 -174.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -104.45 116.67 32.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.57 110.473 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.775 HG13 HG21 ' A' ' 148' ' ' ILE . 5.0 t -97.36 141.13 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.918 -0.583 . . . . 0.91 109.973 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.606 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 15.3 mmtp -106.83 14.84 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.575 -0.284 . . . . 0.98 111.724 -169.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.09 36.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.48 -0.488 . . . . 0.36 111.499 -174.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.567 ' OD1' ' HG3' ' A' ' 17' ' ' LYS . 35.2 t70 71.73 168.45 0.31 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.053 0.93 . . . . 0.91 112.614 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.623 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 11.5 ttp180 -66.48 -23.74 66.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.383 -1.281 . . . . 1.88 111.412 -174.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 62.6 mttm -60.96 -52.4 65.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 3.05 110.632 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.6 p -68.98 -34.51 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 1.11 110.458 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.4 -51.24 70.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.32 110.824 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.3 t80 -67.61 -45.06 76.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.223 -0.444 . . . . 0.38 110.673 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 18.6 ttmt -57.53 -49.16 77.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 2.39 111.18 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.562 HG23 ' CE2' ' A' ' 30' ' ' TRP . 31.1 m -69.72 -33.22 72.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.043 0.449 . . . . 0.68 111.11 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -75.95 -37.15 58.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.922 -0.311 . . . . 0.48 111.169 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.1 tp -120.15 -51.86 2.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.513 0.931 . . . . 0.5 113.513 -171.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.649 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 49.8 mt-10 -75.21 -51.81 12.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.463 0.542 . . . . 1.24 112.463 -168.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -88.12 32.23 4.44 Favored Glycine 0 C--N 1.315 -0.628 0 CA-C-N 115.781 -0.645 . . . . 0.83 111.9 -175.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.683 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 62.8 t80 -50.09 -57.84 11.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 123.343 0.657 . . . . 0.74 112.135 -170.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 28.1 Cg_endo -87.81 51.17 2.0 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.945 1.763 . . . . 0.76 114.62 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.6 pt-20 -150.07 -11.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.258 0.836 . . . . 1.49 113.258 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.774 ' CZ3' ' HG2' ' A' ' 147' ' ' LYS . 11.1 m95 -76.41 -172.31 2.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.155 0.502 . . . . 4.62 111.094 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 19.6 m95 -92.56 -26.05 0.28 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 2.78 114.758 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 93.4 Cg_endo -79.2 -139.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 CA-C-N 120.972 1.383 . . . . 1.36 113.876 -169.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' ND2' HG21 ' A' ' 40' ' ' VAL . 3.4 t-20 -48.07 -45.78 32.85 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.518 -0.765 . . . . 1.51 111.533 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -76.69 26.07 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.368 0.877 . . . . 1.79 113.368 -170.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -102.07 3.8 39.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 4.45 110.509 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -100.52 120.83 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 4.14 111.411 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 p -76.99 133.86 39.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.823 0.344 . . . . 2.68 111.511 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.474 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 6.3 p 52.86 27.37 5.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.019 0.928 . . . . 1.42 111.241 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 40' ' ' VAL . 48.3 tttp -124.89 -49.27 1.74 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.732 -1.122 . . . . 2.9 108.668 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.609 HG12 ' HD1' ' A' ' 65' ' ' PHE . 1.3 m -166.0 30.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 124.127 0.892 . . . . 1.83 110.693 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -173.08 31.87 0.11 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.813 -1.184 . . . . 2.17 114.159 -171.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.801 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.41 173.94 3.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.299 -0.63 . . . . 1.12 109.299 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.441 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 34.6 Cg_exo -63.49 41.97 0.1 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 C-N-CA 123.327 2.684 . . . . 1.48 114.71 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -149.11 -80.76 0.13 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.676 -0.49 . . . . 1.75 109.676 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.528 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 88.6 -60.87 3.91 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.887 -0.673 . . . . 0.75 112.689 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.646 HG11 ' HG ' ' A' ' 24' ' ' LEU . 77.9 t -141.26 133.6 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.547 0.213 . . . . 0.6 111.164 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -103.85 113.06 26.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.112 -0.494 . . . . 1.11 110.208 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 5.5 mptt -81.15 -16.15 53.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 2.81 110.847 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -76.36 -62.21 1.69 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.109 -0.496 . . . . 3.17 110.7 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.21 17.86 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 1.53 111.424 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.7 60.37 0.59 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.804 -0.713 . . . . 0.77 112.097 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.39 150.84 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.54 -0.388 . . . . 3.72 111.279 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 65' ' ' PHE . 6.1 m0 -100.24 110.86 23.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.984 -0.747 . . . . 1.28 108.984 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -162.4 174.55 12.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.429 0.633 . . . . 1.66 111.26 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.801 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 25.1 mt-10 -126.8 174.69 8.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.648 -0.705 . . . . 2.12 109.834 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' HG2' ' A' ' 61' ' ' GLU . 32.3 mm -100.75 100.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.954 -0.758 . . . . 0.92 108.954 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.603 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 2.9 m-20 -67.26 -175.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.574 0.702 . . . . 1.97 112.013 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.28 -25.29 29.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.289 -0.868 . . . . 2.43 110.925 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 2.4 pm0 -95.66 5.05 52.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 2.39 110.828 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.16 -109.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.235 -0.983 . . . . 2.29 112.56 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.422 ' HG2' HD12 ' A' ' 56' ' ' ILE . 28.2 mt-10 -147.97 34.54 0.83 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.478 0.311 . . . . 2.31 110.975 -173.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 9.9 pt-20 -97.5 74.43 2.44 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.29 -0.964 . . . . 2.61 111.283 -171.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.9 163.32 20.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.995 . . . . 3.72 111.409 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -131.04 148.67 52.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.411 -0.813 . . . . 2.27 110.534 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 6.6 t80 -165.54 -54.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.587 0.554 . . . . 6.48 109.598 172.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -156.12 149.91 21.03 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.186 -1.007 . . . . 1.23 113.415 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.494 HD12 ' CZ ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -114.76 103.92 11.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.625 -0.509 . . . . 1.17 109.625 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.467 HG21 HG22 ' A' ' 71' ' ' VAL . 43.4 mt -79.5 142.1 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.987 0.422 . . . . 0.61 110.839 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.6 mpt_? -114.04 -25.22 8.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.48 174.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.665 ' HD2' HG23 ' A' ' 78' ' ' VAL . 13.1 ttmm -142.55 106.62 4.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.531 -0.304 . . . . 1.53 111.174 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 68' ' ' ILE . 41.5 t -95.05 92.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.268 -1.012 . . . . 0.88 108.268 167.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -109.5 70.34 0.73 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.661 -0.416 . . . . 1.42 111.12 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.9 pt-20 48.37 -172.59 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.507 1.13 . . . . 0.96 112.018 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 26.2 Cg_exo -65.45 75.35 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.428 1.419 . . . . 0.38 111.1 166.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -157.46 -66.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.5 110.358 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -141.77 143.71 33.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.412 0.625 . . . . 0.35 112.079 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -131.5 112.05 12.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.509 -0.769 . . . . 0.74 109.506 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.665 HG23 ' HD2' ' A' ' 70' ' ' LYS . 86.1 t -90.6 104.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.801 -0.815 . . . . 0.67 108.801 172.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.593 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -127.93 122.55 58.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.378 -0.828 . . . . 0.75 111.333 -170.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.924 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -87.25 154.7 26.57 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 111.833 -0.507 . . . . 0.5 111.833 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.767 ' CZ2' ' HA ' ' A' ' 83' ' ' LEU . 68.8 t-105 -91.16 125.93 36.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.466 0.651 . . . . 2.79 111.798 -171.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -124.76 0.27 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 5.46 109.26 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.052 HD21 ' HB2' ' A' ' 88' ' ' ARG . 6.8 tt 78.57 154.26 0.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.706 -1.134 . . . . 1.55 113.416 169.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.551 ' HB2' HG11 ' A' ' 40' ' ' VAL . 22.5 p-10 -117.88 -28.0 6.04 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.129 -0.941 . . . . 1.93 112.689 -168.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.47 -29.59 63.84 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-O 119.727 -0.485 . . . . 2.4 113.882 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 73.01 -42.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.412 0.685 . . . . 5.38 110.769 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.88 3.39 70.59 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.101 -0.8 . . . . 2.3 111.101 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.052 ' HB2' HD21 ' A' ' 83' ' ' LEU . 69.2 mmt-85 -96.75 173.93 7.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.155 -0.313 . . . . 4.77 110.155 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.879 HD12 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -101.15 119.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.175 0.512 . . . . 1.86 110.319 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 7.6 p-10 -91.24 141.31 26.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.157 0.503 . . . . 3.18 111.556 -175.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.602 ' HG3' HG22 ' A' ' 129' ' ' VAL . 10.0 Cg_exo -72.07 -49.97 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.036 2.49 . . . . 2.36 111.538 171.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.48 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 17.4 t70 70.72 -41.93 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.785 0.834 . . . . 2.99 112.911 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.591 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 21.2 m-80 -73.32 -31.24 63.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.384 . . . . 3.06 111.927 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.521 ' HB2' ' HD2' ' A' ' 118' ' ' PHE . 67.6 m -154.19 -126.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.101 -0.239 . . . . 1.85 111.244 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.706 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 58.8 m 57.59 28.67 16.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.454 0.645 . . . . 1.44 110.352 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.924 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 36.5 tt0 -62.08 138.55 58.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.957 -1.02 . . . . 1.81 111.02 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -133.92 136.92 44.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.149 0.499 . . . . 0.64 110.931 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.8 m -99.17 110.42 22.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.43 110.174 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.724 ' HA ' HG22 ' A' ' 113' ' ' VAL . 91.8 t -82.8 109.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.828 -0.624 . . . . 0.87 110.103 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.7 m -103.52 106.13 16.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.379 -0.373 . . . . 0.45 110.67 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.623 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 40.9 m-85 -87.99 112.7 22.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.304 -0.407 . . . . 0.34 110.255 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.13 111.19 25.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.286 -0.415 . . . . 0.54 110.125 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.89 133.76 48.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.833 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.9 t0 -126.99 100.92 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.174 -0.466 . . . . 2.03 109.833 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.7 49.46 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.708 -0.758 . . . . 1.97 113.404 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 72.22 8.16 5.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.504 0.722 . . . . 4.93 111.973 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -128.06 -11.66 5.29 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.828 -0.545 . . . . 3.53 110.285 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 77.5 tttt -122.48 158.06 30.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.893 -0.781 . . . . 2.44 108.893 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.1 m -157.6 117.64 3.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.95 0.405 . . . . 0.42 110.792 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.4 tmm_? -102.12 116.22 32.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.512 -0.922 . . . . 2.59 108.512 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.9 p -90.73 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.313 -0.403 . . . . 0.4 111.116 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -129.13 112.58 14.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 1.38 108.732 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 99' ' ' VAL . 47.0 t -104.71 120.85 55.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.956 -0.566 . . . . 0.91 111.209 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.46 122.82 40.95 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.765 0.666 . . . . 2.31 109.651 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 2.3 t-160 -131.44 97.75 4.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.799 -0.815 . . . . 1.64 108.799 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.577 HG22 ' HD2' ' A' ' 120' ' ' ARG . 24.5 p -141.78 103.13 4.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.726 -0.215 . . . . 2.67 111.271 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -167.39 -74.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.315 -0.554 . . . . 2.63 112.172 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -85.75 -42.43 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 3.54 111.391 -168.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.95 73.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.195 -0.911 . . . . 1.81 110.719 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.577 ' HD2' HG22 ' A' ' 116' ' ' THR . 44.1 mtp180 -59.59 -19.32 47.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.424 -0.807 . . . . 3.38 111.923 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.521 ' HA ' ' CE ' ' A' ' 121' ' ' MET . 11.5 mmt -72.4 23.63 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.69 0.996 . . . . 2.43 113.69 -171.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.79 -155.88 15.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.847 -1.168 . . . . 1.61 114.406 168.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 p -61.66 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.32 0.859 . . . . 2.58 113.32 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 48.1 mtpt -70.05 -14.31 62.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 3.8 112.002 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.67 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 40.3 m80 -73.03 -49.92 26.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.461 0.648 . . . . 2.14 109.364 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.89 73.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.92 110.024 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.639 ' HB3' ' HA ' ' A' ' 124' ' ' LYS . 2.8 tppp? -71.25 -38.03 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.685 -0.689 . . . . 2.83 111.382 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.879 ' HB2' HD12 ' A' ' 89' ' ' ILE . 15.8 ptm180 -67.69 -30.86 70.49 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.907 -0.317 . . . . 2.59 110.272 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.4 t -84.61 -30.92 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.319 -0.552 . . . . 1.48 111.605 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.271 -0.422 . . . . 3.83 111.928 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 5.3 p30 -63.56 -33.48 75.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 2.48 111.281 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.89 -71.33 1.28 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.517 -0.849 . . . . 1.61 114.213 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.614 ' HB3' ' CZ2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -77.84 -21.89 50.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.961 0.726 . . . . 4.83 112.961 -165.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.9 -28.15 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 2.83 111.244 -174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.822 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.3 mmpt? -101.99 15.24 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 4.15 110.916 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.631 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -134.24 -57.25 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.508 -0.853 . . . . 1.04 112.489 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.433 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 1.6 t90 -56.0 -54.43 52.4 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.693 0.627 . . . . 2.78 112.693 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 34.9 Cg_endo -65.83 -34.33 40.13 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.708 1.606 . . . . 0.68 111.948 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 -41.0 95.23 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.925 -0.58 . . . . 0.87 109.894 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.667 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 63.2 mt -57.9 -46.43 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 115.334 -0.848 . . . . 0.72 109.843 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 21.6 mt -54.95 -42.9 72.92 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 123.638 0.586 . . . . 0.69 111.385 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -64.02 -46.18 85.6 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.582 -0.447 . . . . 1.49 110.813 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -75.19 -22.19 58.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.027 0.442 . . . . 1.15 110.927 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 92.8 t80 -61.18 -55.14 35.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.8 109.6 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.464 ' OE1' ' HD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -64.92 -30.7 71.7 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.019 -0.537 . . . . 1.63 110.45 175.026 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.48 -55.77 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.591 -0.277 . . . . 1.46 111.342 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.774 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 21.9 tptp -68.0 -39.61 83.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.53 -0.468 . . . . 1.74 110.841 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.775 HG21 HG13 ' A' ' 12' ' ' VAL . 47.2 mt -65.9 -37.83 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.5 111.894 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.936 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.1 t70 -64.09 -25.53 68.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.377 -0.374 . . . . 0.85 110.333 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.777 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 61.4 mt-10 -69.53 -39.66 77.37 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.38 -20.6 66.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.054 -0.975 . . . . 1.74 108.972 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.95 -82.78 0.9 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.06 -0.973 . . . . 1.32 111.56 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -155.01 12.37 0.37 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.866 0.691 . . . . 1.92 112.866 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.936 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 21.1 ttmm -63.67 -32.48 73.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.942 0.401 . . . . 2.04 111.466 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 119.22 -0.419 . . . . 4.22 110.719 -176.755 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.9 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 32.6 p30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.375 -0.232 . . . . 1.66 110.375 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER 70.26 -31.76 0.22 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.082 1.353 . . . . 3.73 112.172 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.79 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 23.6 t70 -59.34 -53.63 64.17 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.284 -0.265 . . . . 2.78 110.284 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 25.5 Cg_endo -94.64 -64.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.244 1.963 . . . . 1.63 111.348 167.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 38.6 p90 -151.77 171.4 17.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.936 -1.135 . . . . 3.21 107.936 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.964 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 86.0 t -107.58 103.91 16.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.853 -0.339 . . . . 1.44 110.53 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.1 ttp180 -93.76 130.59 39.69 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.239 -0.584 . . . . 3.37 110.84 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.646 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -110.53 133.54 53.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.79 108.817 173.104 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.677 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.1 t -134.7 111.08 9.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.518 0.675 . . . . 1.28 110.111 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 3.0 t -124.63 137.78 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.675 -1.148 . . . . 1.27 111.652 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.1 m -97.77 116.88 30.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.813 -0.63 . . . . 0.57 110.443 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.904 HG13 HG21 ' A' ' 148' ' ' ILE . 32.9 t -94.7 142.4 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.46 -0.791 . . . . 0.91 110.868 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -99.23 12.76 35.27 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.25 0.463 . . . . 0.98 112.25 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.485 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.4 39.66 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.975 -0.69 . . . . 0.36 112.414 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.572 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 14.3 t70 73.12 167.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.811 0.815 . . . . 0.91 111.927 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 25.9 ttp180 -69.43 -23.4 63.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.094 -0.957 . . . . 1.88 110.707 -174.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 15.1 ptpt -60.76 -39.22 87.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 3.05 111.195 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -82.91 -37.86 23.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.928 -0.309 . . . . 1.11 110.594 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -56.27 -43.38 78.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.829 0.347 . . . . 0.32 110.462 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 79.4 t80 -70.93 -46.01 63.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.322 -0.399 . . . . 0.38 110.48 176.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -55.19 -55.0 36.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.037 -0.529 . . . . 2.39 111.382 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.444 HG22 ' NE1' ' A' ' 30' ' ' TRP . 23.6 m -67.23 -46.68 73.07 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.311 -0.859 . . . . 0.68 111.028 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.647 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 66.5 t80 -64.46 -34.89 79.25 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.103 0.409 . . . . 0.48 112.103 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.57 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.2 tp -108.67 -53.72 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.033 -0.667 . . . . 0.5 112.373 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.63 -39.44 37.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 1.24 111.297 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.709 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -91.4 33.53 4.72 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.65 -0.704 . . . . 0.83 112.336 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.541 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 44.8 t80 -52.54 -48.0 91.71 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.216 0.45 . . . . 0.74 112.216 -173.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -89.64 15.29 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.869 1.713 . . . . 0.76 115.036 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.0 pt-20 -100.44 -5.03 27.71 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.993 -0.683 . . . . 1.49 110.766 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.647 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 23.9 m0 -75.73 153.75 36.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.488 0.661 . . . . 4.62 111.468 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.647 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 36.8 m95 -80.47 -44.1 1.35 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.908 -1.042 . . . . 2.78 112.855 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 1.105 ' HD3' ' HB2' ' A' ' 143' ' ' SER . 11.3 Cg_endo -52.12 -76.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.062 2.508 . . . . 1.36 114.76 -164.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -120.35 -11.61 9.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 1.51 110.609 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.703 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.4 m-20 -99.14 18.67 16.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.688 . . . . 1.79 111.103 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.55 8.37 43.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.142 0.496 . . . . 4.45 111.023 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -117.73 140.33 49.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 4.14 111.65 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.48 148.03 37.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 2.68 110.921 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 57' ' ' ASP . 63.6 p 57.88 8.02 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.547 1.139 . . . . 1.42 112.843 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.78 -77.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.479 -0.934 . . . . 2.9 108.479 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.703 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.8 m -147.21 15.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.588 -0.893 . . . . 1.83 108.588 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.49 55.35 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.72 -1.127 . . . . 2.17 111.876 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -104.05 169.81 6.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.406 -0.961 . . . . 1.12 108.406 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.19 53.83 0.26 Allowed 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 123.038 2.492 . . . . 1.48 113.77 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD21 ' CZ ' ' A' ' 54' ' ' TYR . 35.3 tp -170.8 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.745 0.418 . . . . 1.75 110.378 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.664 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 87.76 -57.78 4.38 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.991 -0.623 . . . . 0.75 112.487 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 24' ' ' LEU . 89.0 t -134.81 136.66 51.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.839 0.352 . . . . 0.6 110.67 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.648 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.9 t70 -107.94 122.77 47.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.561 -0.745 . . . . 1.11 109.77 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -33.91 40.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.403 0.52 . . . . 2.81 112.403 -175.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -47.22 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.814 0.301 . . . . 3.17 111.814 -172.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.88 -25.39 22.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.655 -0.784 . . . . 1.53 111.784 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 82.18 60.33 2.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.652 -0.785 . . . . 0.77 111.207 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 8.3 ptm180 -146.39 139.76 25.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.843 0.354 . . . . 3.72 111.118 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 24.5 m0 -97.99 108.26 20.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 1.28 110.547 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.648 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -153.32 151.71 30.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.997 0.427 . . . . 1.66 110.282 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 51.6 mp0 -117.79 160.05 22.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 2.12 110.512 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.51 HD12 ' HG2' ' A' ' 61' ' ' GLU . 36.8 mm -77.84 103.97 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 0.92 110.062 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.0 t70 -95.43 -178.12 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 1.97 110.476 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -80.92 -7.68 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.798 0.666 . . . . 2.43 112.798 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.511 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -95.98 -4.65 42.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.289 0.566 . . . . 2.39 110.194 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.21 -85.1 0.18 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.505 -0.771 . . . . 2.29 111.816 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.51 ' HG2' HD12 ' A' ' 56' ' ' ILE . 52.6 mt-10 -156.65 18.94 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.717 -0.475 . . . . 2.31 109.717 -177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.86 88.85 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.742 0.782 . . . . 2.61 110.274 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -117.84 163.74 16.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.886 -1.052 . . . . 3.72 110.254 -178.426 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -52.7 109.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.67 -0.493 . . . . 2.27 109.67 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 30.7 p90 -92.58 130.66 38.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.334 0.588 . . . . 6.48 112.016 -170.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.4 157.55 31.72 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.74 -0.944 . . . . 1.23 110.74 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.2 pt? -116.01 99.59 7.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.996 0.398 . . . . 1.17 111.261 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 71' ' ' VAL . 40.7 mt -79.37 118.6 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.047 -0.661 . . . . 0.61 109.907 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -85.94 -23.25 27.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.841 -1.072 . . . . 2.0 109.818 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 78' ' ' VAL . 58.5 tttp -156.39 105.41 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.732 -0.667 . . . . 1.53 111.266 -174.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 68' ' ' ILE . 49.8 t -98.92 93.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.652 -0.87 . . . . 0.88 108.652 169.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.02 73.15 0.83 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.535 -0.466 . . . . 1.42 111.648 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 48.18 -174.12 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 124.827 1.33 . . . . 0.96 112.623 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 39.3 Cg_exo -62.77 82.08 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.504 1.469 . . . . 0.38 110.956 166.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -167.68 -67.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.789 . . . . 0.5 110.506 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 100' ' ' THR . 3.6 p -141.91 140.97 32.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.431 0.53 . . . . 0.35 112.431 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 77' ' ' LEU . 2.2 mp -136.6 112.93 9.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 0.74 109.621 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 98' ' ' THR . 39.6 t -103.24 109.9 28.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.007 -0.738 . . . . 0.67 109.007 175.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 138.62 53.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.902 0.382 . . . . 0.75 111.947 -176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 150.95 21.8 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.816 -0.629 . . . . 0.5 112.791 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.81 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 61.0 t-105 -89.09 148.94 23.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.209 0.604 . . . . 2.79 111.64 -168.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -142.87 23.24 1.91 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.995 -0.548 . . . . 5.46 110.374 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.72 HD11 ' HB3' ' A' ' 88' ' ' ARG . 1.6 tm? 84.63 152.83 0.09 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.177 -0.919 . . . . 1.55 111.081 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.554 ' N ' HD13 ' A' ' 83' ' ' LEU . 42.0 t30 -131.79 -29.99 1.66 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.01 -0.541 . . . . 1.93 111.52 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.7 46.08 2.8 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.304 -0.474 . . . . 2.4 113.81 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.3 t80 58.63 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 5.38 112.307 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.17 39.23 2.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.988 -0.625 . . . . 2.3 112.145 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.763 ' HD2' ' ND2' ' A' ' 131' ' ' ASN . 5.6 tpp180 -97.56 -176.62 3.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.729 -0.471 . . . . 4.77 109.729 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.457 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -94.14 137.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.965 0.412 . . . . 1.86 110.47 -175.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -96.0 137.6 21.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.081 -0.509 . . . . 3.18 111.428 -179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HG2' ' HD1' ' A' ' 81' ' ' TRP . 50.2 Cg_exo -57.62 -21.72 48.34 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.17 3.247 . . . . 2.36 113.807 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.5 t70 77.25 41.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.381 -0.827 . . . . 2.99 110.596 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.43 ' HA ' HD21 ' A' ' 67' ' ' LEU . 4.6 m-20 80.36 36.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.032 -0.986 . . . . 3.06 112.845 158.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 p -122.71 -37.25 2.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.757 -0.377 . . . . 1.85 111.682 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.81 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 20.5 t -55.85 97.06 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.522 -0.763 . . . . 1.44 109.292 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -122.57 136.84 54.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.237 -0.438 . . . . 1.81 110.673 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.487 ' HD1' ' CE1' ' A' ' 115' ' ' HIS . 12.2 p90 -134.48 139.4 45.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.235 0.541 . . . . 0.64 111.855 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 78' ' ' VAL . 75.7 m -96.9 109.1 21.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.117 -0.947 . . . . 0.43 110.134 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.788 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.2 t -83.53 109.98 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.87 110.077 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 ' HA ' HG22 ' A' ' 76' ' ' THR . 25.2 m -106.19 106.56 17.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.646 -0.252 . . . . 0.45 110.636 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.565 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.8 m-85 -88.12 115.8 25.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.657 -0.247 . . . . 0.34 110.498 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.2 112.01 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.907 -0.405 . . . . 0.54 109.907 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.58 133.89 43.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.844 -0.616 . . . . 0.44 111.372 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -121.93 128.85 52.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 2.03 109.227 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.65 -13.05 29.79 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.343 -0.844 . . . . 1.97 115.176 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -84.21 33.86 0.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.993 0.896 . . . . 4.93 111.685 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 12.3 mmtp 56.5 45.72 21.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.746 0.784 . . . . 3.53 108.947 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 87.9 tttt -133.87 155.03 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.809 -1.087 . . . . 2.44 109.341 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.441 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 25.9 m -155.03 114.63 3.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.139 0.495 . . . . 0.42 110.841 173.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.481 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 18.2 tpp85 -91.64 113.98 26.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.543 -0.753 . . . . 2.59 109.697 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -91.04 138.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.768 0.318 . . . . 0.4 110.485 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 17.8 t70 -127.55 109.98 12.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.491 -0.777 . . . . 1.38 109.213 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 t -102.93 135.67 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.536 -0.756 . . . . 0.91 111.578 -175.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -113.04 111.62 22.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 2.31 109.683 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.964 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -100.77 115.57 30.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.454 -0.794 . . . . 1.64 109.235 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 p -127.99 168.88 14.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.522 -0.471 . . . . 2.67 111.619 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 101.98 -66.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 113.804 -1.544 . . . . 2.63 110.563 162.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.838 ' HE2' HG21 ' A' ' 129' ' ' VAL . 59.5 t80 -86.97 -52.34 5.51 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.029 -0.532 . . . . 3.54 111.996 -175.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 2' ' ' TYR . 1.7 m-20 -54.82 -33.39 61.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 1.81 112.281 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 37.7 ttp180 -62.52 -22.73 66.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 3.38 111.502 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.81 -22.09 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.536 -0.302 . . . . 2.43 110.358 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 126' ' ' ALA . . . 48.82 -154.02 2.09 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.39 -0.823 . . . . 1.61 114.801 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 m 44.76 -101.92 0.05 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.397 1.079 . . . . 2.58 113.112 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.96 -45.16 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.136 -0.32 . . . . 3.8 110.136 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -61.15 -49.8 75.76 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.334 0.588 . . . . 2.14 110.469 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . . . -64.51 -51.24 63.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.549 -0.751 . . . . 0.92 111.222 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -61.91 -34.0 75.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.905 0.335 . . . . 2.83 111.905 -173.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -77.16 -32.94 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.419 -0.513 . . . . 2.59 111.438 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.838 HG21 ' HE2' ' A' ' 118' ' ' PHE . 79.2 t -78.61 -42.3 25.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.374 0.607 . . . . 1.48 110.664 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.901 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 65.9 mtt-85 -68.18 -12.41 60.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.516 -0.766 . . . . 3.83 110.957 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.763 ' ND2' ' HD2' ' A' ' 88' ' ' ARG . 45.7 t30 -51.8 -25.09 6.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.568 -0.742 . . . . 2.48 110.004 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.18 -17.92 2.64 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.918 -0.583 . . . . 1.61 112.422 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.811 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 6.4 tpp -80.07 -42.89 22.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.475 0.546 . . . . 4.83 112.475 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.901 ' HB2' ' HB3' ' A' ' 130' ' ' ARG . 7.4 t70 -68.46 -25.92 65.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.975 0.731 . . . . 2.83 112.975 -163.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -115.9 24.19 11.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.586 0.708 . . . . 4.15 109.922 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.96 -74.68 0.64 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.36 -0.836 . . . . 1.04 111.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 5.5 t90 -58.51 -48.86 96.15 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.76 0.652 . . . . 2.78 112.76 -173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.0 Cg_endo -59.61 -38.75 80.14 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.189 1.926 . . . . 0.68 112.642 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 m -70.9 -37.11 72.98 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.757 0.789 . . . . 0.87 109.347 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.666 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.6 mt -54.59 -44.74 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.4 -1.273 . . . . 0.72 110.196 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.563 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 68.9 mt -56.68 -33.8 66.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.464 0.478 . . . . 0.69 111.608 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -69.15 -57.71 5.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.18 0.514 . . . . 1.49 111.002 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 1.105 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -71.93 -21.39 61.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.104 -0.498 . . . . 1.15 111.132 -178.134 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.35 -47.57 85.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.8 109.543 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 26.4 mt-30 -61.23 -36.22 79.36 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.549 -0.751 . . . . 1.63 110.356 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.47 -39.75 64.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.492 -0.777 . . . . 1.46 111.506 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -66.56 -35.77 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.934 0.397 . . . . 1.74 110.112 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.904 HG21 HG13 ' A' ' 12' ' ' VAL . 50.4 mt -71.47 -32.68 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.288 0.566 . . . . 0.5 110.375 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.425 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 12.8 t70 -58.88 -32.33 69.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.609 -0.723 . . . . 0.85 109.727 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.85 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 49.6 mt-10 -66.0 -33.22 75.3 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.538 -0.755 . . . . 1.5 110.413 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -82.15 -17.1 47.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.359 -0.837 . . . . 1.74 109.726 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -96.56 -75.89 1.28 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.467 -0.788 . . . . 1.32 112.819 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.55 15.27 1.8 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.697 0.628 . . . . 1.92 112.697 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.85 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttmm -79.62 76.94 6.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.232 0.539 . . . . 2.04 110.087 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--O 1.246 0.901 0 CA-C-N 115.7 -0.682 . . . . 4.22 109.553 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 35.2 m-80 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.691 -0.485 . . . . 1.66 109.691 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 28.4 p90 172.96 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.62 0.575 . . . . 3.73 110.288 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.899 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.4 t70 -59.98 -56.74 32.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.129 -0.487 . . . . 2.78 111.397 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.899 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 18.9 Cg_endo -96.08 -64.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.392 2.061 . . . . 1.63 111.953 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -149.6 154.97 39.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.667 -1.234 . . . . 3.21 107.667 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.734 ' HB ' ' CB ' ' A' ' 115' ' ' HIS . 27.4 t -85.7 106.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.221 -0.592 . . . . 1.44 109.812 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.8 ttm180 -111.75 135.38 52.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.805 0.812 . . . . 3.37 111.427 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 1.025 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.38 132.37 54.19 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.736 -1.209 . . . . 0.79 107.736 174.016 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.2 t -146.04 112.02 5.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.944 -0.391 . . . . 1.28 109.944 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.808 HG22 HG12 ' A' ' 111' ' ' VAL . 10.8 m -138.31 139.21 42.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 1.27 110.819 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m -92.84 116.14 28.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.471 -0.786 . . . . 0.57 109.906 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.778 HG13 HG21 ' A' ' 148' ' ' ILE . 22.4 t -98.47 125.57 51.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.476 -0.784 . . . . 0.91 110.379 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 35.06 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.933 0.397 . . . . 0.98 111.567 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.548 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.39 26.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.434 -0.348 . . . . 0.36 111.039 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.1 t70 72.6 169.21 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 0.91 112.857 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.497 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 7.6 ttp180 -63.36 -27.49 69.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.16 -0.927 . . . . 1.88 110.978 -174.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -54.28 -53.36 54.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.721 -0.672 . . . . 3.05 111.405 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -76.56 -33.57 58.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 1.11 111.181 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.621 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -60.47 -48.31 82.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.32 110.79 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -69.1 -33.78 74.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.38 110.537 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.863 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 5.5 tppp? -61.06 -55.7 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.427 . . . . 2.39 110.262 176.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.544 HG23 ' CE2' ' A' ' 30' ' ' TRP . 31.2 m -66.55 -23.87 66.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.68 111.939 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 99' ' ' VAL . 69.4 t80 -87.81 -37.26 16.72 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.722 -0.391 . . . . 0.48 111.467 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.54 HD23 ' HE3' ' A' ' 48' ' ' LYS . 18.9 tp -119.95 -54.89 2.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.51 0.93 . . . . 0.5 113.51 -172.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.863 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 29.0 mt-10 -78.68 -24.72 44.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.378 0.609 . . . . 1.24 110.779 -169.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.418 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.72 93.84 0.54 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.056 -2.017 . . . . 0.83 108.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.863 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 23.0 t80 -95.93 -63.85 0.12 Allowed Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.722 -0.239 . . . . 0.74 111.041 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 29.9 Cg_endo -96.46 37.53 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.282 1.988 . . . . 0.76 114.677 -174.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -126.97 5.24 6.53 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.409 0.892 . . . . 1.49 113.409 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' HE3' ' HG3' ' A' ' 147' ' ' LYS . 18.7 m95 -99.07 -160.89 0.83 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.127 -0.358 . . . . 4.62 110.221 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 22.1 m95 -99.05 -8.92 0.12 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.991 1.478 . . . . 2.78 114.991 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HB3' ' HB3' ' A' ' 143' ' ' SER . 92.8 Cg_endo -81.82 -148.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 CA-C-N 122.484 1.923 . . . . 1.36 113.292 -170.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.663 HD22 ' HE3' ' A' ' 39' ' ' LYS . 25.6 t-20 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.812 . . . . 1.51 111.025 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.784 ' HA ' HG23 ' A' ' 40' ' ' VAL . 30.9 m-20 -78.87 20.98 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.183 -0.462 . . . . 1.79 110.739 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -117.83 22.39 12.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 4.45 110.33 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -117.66 146.97 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 4.14 110.108 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.58 135.66 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.023 -0.271 . . . . 2.68 110.854 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.1 p 58.52 14.49 3.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.082 0.953 . . . . 1.42 112.133 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.663 ' HE3' HD22 ' A' ' 33' ' ' ASN . 54.2 tttp -132.6 80.35 1.89 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.985 -0.746 . . . . 2.9 108.985 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.784 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.1 m 54.1 17.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.429 1.091 . . . . 1.83 112.165 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -146.28 26.88 1.7 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.56 -0.828 . . . . 2.17 113.312 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.892 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -77.56 167.14 38.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.45 -0.944 . . . . 1.12 108.45 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.02 59.71 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.751 2.301 . . . . 1.48 113.718 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 53.4 tp -166.03 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.75 110.027 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.45 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 94.98 -63.88 1.46 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.872 -0.68 . . . . 0.75 113.06 173.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 24' ' ' LEU . 84.8 t -132.75 147.41 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.84 0.353 . . . . 0.6 110.487 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.83 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.6 t0 -123.98 96.32 4.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.853 -0.795 . . . . 1.11 108.853 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 8.5 mtpt -74.06 -22.31 59.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.112 0.482 . . . . 2.81 110.245 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 49' ' ' LYS . 4.2 ttpm? -64.67 -56.61 12.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 3.17 110.787 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.93 -28.72 33.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.966 -0.635 . . . . 1.53 112.595 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.95 49.42 2.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.696 -0.764 . . . . 0.77 112.169 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.44 161.31 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.735 0.302 . . . . 3.72 111.417 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD1' HD11 ' A' ' 68' ' ' ILE . 14.4 m0 -108.99 120.01 41.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 1.28 109.999 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.83 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -163.91 158.11 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.087 0.47 . . . . 1.66 110.677 175.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.892 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.1 mp0 -125.71 166.55 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.486 -0.931 . . . . 2.12 108.486 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 61' ' ' GLU . 43.2 mm -78.34 103.62 5.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.121 0.486 . . . . 0.92 109.958 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.4 t70 -87.98 145.94 25.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.717 -0.674 . . . . 1.97 110.092 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -61.34 -26.82 68.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.681 0.613 . . . . 2.43 112.354 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.427 ' HB3' ' OD2' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -75.8 -17.99 59.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.951 0.405 . . . . 2.39 111.226 -175.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.15 54.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.175 -1.012 . . . . 2.29 113.211 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 56' ' ' ILE . 43.6 mt-10 56.0 26.26 9.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.157 0.799 . . . . 2.31 113.157 173.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.419 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 12.8 tp10 -112.9 95.83 5.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.424 0.63 . . . . 2.61 110.236 -176.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.22 165.16 16.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.047 -0.978 . . . . 3.72 110.602 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 82' ' ' ARG . 3.2 p -47.82 124.77 7.76 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.627 0.58 . . . . 2.27 111.316 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -89.61 112.46 23.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.743 -0.662 . . . . 6.48 110.943 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.647 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -83.29 127.21 7.89 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.633 -0.987 . . . . 1.23 110.633 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -100.63 96.11 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.016 0.436 . . . . 1.17 111.316 -171.536 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.531 HG21 ' CG2' ' A' ' 71' ' ' VAL . 39.5 mt -83.34 124.49 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.122 0.487 . . . . 0.61 110.298 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -104.33 -14.84 15.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.538 -0.755 . . . . 2.0 110.5 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -159.31 118.91 3.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.248 -0.433 . . . . 1.53 111.835 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' A' ' 68' ' ' ILE . 57.7 t -103.1 92.96 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.076 -1.083 . . . . 0.88 108.076 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 5.7 t0 -101.38 64.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.628 -0.26 . . . . 1.42 111.19 -170.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 7.4 pt-20 48.28 -172.38 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.287 1.035 . . . . 0.96 112.03 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 31.3 Cg_exo -62.64 72.17 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.38 111.774 166.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -156.44 -65.79 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.452 -0.795 . . . . 0.5 110.183 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 100' ' ' THR . 4.0 p -145.57 152.48 39.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.35 112.357 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.1 mp -138.18 126.36 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.676 -0.693 . . . . 0.74 109.526 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.77 105.56 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.59 -0.522 . . . . 0.67 109.59 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.76 137.39 57.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.292 -0.413 . . . . 0.75 111.282 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.09 165.41 26.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.5 111.889 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.978 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 39.6 t-105 -62.17 162.88 8.91 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 114.253 1.205 . . . . 2.79 114.253 -163.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.647 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -158.67 -35.57 0.06 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.608 -1.178 . . . . 5.46 110.023 -169.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.904 ' HG ' ' HA3' ' A' ' 132' ' ' GLY . 4.8 tt 78.11 175.27 0.17 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.753 -0.658 . . . . 1.55 110.599 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 133' ' ' MET . 46.7 t-20 -109.12 -76.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.714 0.292 . . . . 1.93 110.416 -173.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.59 0.54 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 120.663 -0.78 . . . . 2.4 111.216 176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -54.48 -6.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.294 0.85 . . . . 5.38 113.294 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.08 -0.89 76.84 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.944 -0.862 . . . . 2.3 110.944 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HD3' ' H ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -97.55 152.78 18.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.148 0.499 . . . . 4.77 110.585 178.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -65.51 124.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.203 -0.908 . . . . 1.86 110.477 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.626 ' OD2' ' HB3' ' A' ' 92' ' ' ASP . 4.1 p-10 -101.75 142.81 25.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 121.42 0.628 . . . . 3.18 111.45 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.69 ' HD2' ' HD1' ' A' ' 81' ' ' TRP . 59.8 Cg_endo -97.69 37.46 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.915 3.077 . . . . 2.36 111.868 167.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.626 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -65.78 89.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.155 0.979 . . . . 2.99 111.066 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.428 ' H ' ' H ' ' A' ' 94' ' ' SER . 18.9 p-10 -167.88 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.437 -1.256 . . . . 3.06 108.368 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.77 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 74.6 m -160.96 -143.69 0.1 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.976 -1.465 . . . . 1.85 108.674 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.978 ' HB2' ' HB2' ' A' ' 81' ' ' TRP . 37.9 m 54.63 38.0 29.14 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.477 0.656 . . . . 1.44 111.442 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.636 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 20.2 tt0 -71.77 149.78 45.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.895 -1.048 . . . . 1.81 110.69 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.606 ' HB2' HG13 ' A' ' 113' ' ' VAL . 9.0 p90 -146.37 147.43 31.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.96 0.409 . . . . 0.64 110.866 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 30.5 m -104.36 115.82 31.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.43 110.374 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.661 ' HA ' HG22 ' A' ' 113' ' ' VAL . 97.4 t -82.42 109.73 16.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.87 109.804 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.532 ' HA ' HG22 ' A' ' 76' ' ' THR . 9.5 m -104.12 105.97 16.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.935 0.397 . . . . 0.45 111.224 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.502 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 52.1 m-85 -89.9 110.91 21.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.357 -0.383 . . . . 0.34 110.138 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.8 t -91.61 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 110.123 -0.325 . . . . 0.54 110.123 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.25 138.07 53.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.393 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -130.12 103.0 6.49 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 2.03 110.75 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.34 -97.89 0.63 Allowed Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.946 -0.645 . . . . 1.97 113.223 171.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -146.68 -20.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.095 0.406 . . . . 4.93 112.095 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -136.26 3.64 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.97 -0.692 . . . . 3.53 112.671 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 26.4 ttpp -127.31 153.96 45.52 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.448 -0.901 . . . . 2.44 110.911 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.7 m -160.9 124.31 3.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.826 -0.624 . . . . 0.42 109.95 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -109.54 120.25 41.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.79 . . . . 2.59 108.866 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 10' ' ' VAL . 10.0 p -96.55 141.12 16.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.802 -0.359 . . . . 0.4 110.791 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -129.5 124.23 33.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.08 -0.711 . . . . 1.38 109.08 171.23 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 4.1 t -99.05 121.51 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-N 115.725 -0.671 . . . . 0.91 110.086 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.19 121.34 41.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.893 -0.78 . . . . 2.31 108.893 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.734 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 t-80 -103.03 152.77 20.96 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.285 -0.87 . . . . 1.64 110.114 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.686 HG21 ' HD2' ' A' ' 118' ' ' PHE . 9.0 t -60.13 177.86 0.23 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.12 -0.945 . . . . 2.67 110.944 170.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -108.35 18.94 20.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.854 -0.612 . . . . 2.63 110.438 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.77 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 20.7 m-85 -59.33 -29.07 67.37 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.499 -0.319 . . . . 3.54 111.434 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.6 -49.79 15.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.554 0.692 . . . . 1.81 109.699 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' C ' ' H ' ' A' ' 122' ' ' GLY . 55.2 ttt180 -58.54 -18.08 26.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.582 -1.19 . . . . 3.38 111.14 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 121' ' ' MET . 24.2 ttt -65.83 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.003 0.921 . . . . 2.43 112.466 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 152.93 151.03 5.57 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.177 -1.011 . . . . 1.61 112.085 172.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.9 m -60.39 -36.2 77.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.28 0.562 . . . . 2.58 109.657 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -71.58 -39.34 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.436 -0.802 . . . . 3.8 110.467 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 5.3 m170 -63.8 -46.23 86.12 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 121.26 0.552 . . . . 2.14 110.631 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -66.87 -31.51 72.17 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.92 111.262 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.42 -39.38 81.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 2.83 110.639 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.625 ' HB2' HD12 ' A' ' 89' ' ' ILE . 16.8 ptm180 -76.25 -24.95 54.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 2.59 111.737 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.645 HG22 ' HG3' ' A' ' 91' ' ' PRO . 61.5 t -83.52 -54.79 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.304 0.853 . . . . 1.48 113.304 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 35.5 ttt180 -62.66 -23.86 67.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.519 0.563 . . . . 3.83 112.519 -167.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.437 ' CG ' ' HD2' ' A' ' 88' ' ' ARG . 16.7 p30 -55.41 -22.32 19.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.353 -0.385 . . . . 2.48 111.817 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.904 ' HA3' ' HG ' ' A' ' 83' ' ' LEU . . . -100.3 -96.75 2.19 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.456 -0.878 . . . . 1.61 114.038 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.589 ' HB3' ' CH2' ' A' ' 81' ' ' TRP . 54.2 ttm -79.29 -27.44 42.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.844 0.683 . . . . 4.83 112.844 -164.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 20.9 t70 -65.11 -21.93 66.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.948 0.404 . . . . 2.83 111.482 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -79.46 -15.92 56.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.111 0.411 . . . . 4.15 112.111 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.623 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -117.07 -17.25 5.88 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.351 -0.7 . . . . 1.04 111.351 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.562 ' O ' HD13 ' A' ' 141' ' ' LEU . 38.0 t-105 -55.4 -54.49 50.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 123.061 0.544 . . . . 2.78 111.453 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.601 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 18.7 Cg_endo -60.22 -34.62 93.86 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.837 1.691 . . . . 0.68 111.623 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.1 m -66.29 -49.96 65.3 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 121.733 0.777 . . . . 0.87 110.447 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 136' ' ' GLY . 59.1 mt -55.44 -54.58 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.018 -0.992 . . . . 0.72 110.053 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 137' ' ' TRP . 7.0 mp -56.34 -26.86 53.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.25 0.833 . . . . 0.69 113.25 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 28.4 mm-40 -69.14 -54.33 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.484 -0.561 . . . . 1.49 109.484 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . 37.3 t -70.16 -23.81 63.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 1.15 110.745 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 64.6 t80 -58.35 -53.15 61.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.479 -0.782 . . . . 0.8 109.489 174.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.93 -22.11 61.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.508 -0.769 . . . . 1.63 110.508 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.12 -52.09 10.85 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.94 -0.573 . . . . 1.46 111.698 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.841 ' HG3' ' HE3' ' A' ' 30' ' ' TRP . 2.4 tmtt? -66.94 -39.78 87.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.508 -0.477 . . . . 1.74 109.962 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.778 HG21 HG13 ' A' ' 12' ' ' VAL . 22.6 mt -57.92 -35.27 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.303 0.573 . . . . 0.5 110.545 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.423 ' OD2' ' HE2' ' A' ' 154' ' ' LYS . 24.1 t0 -61.26 -35.49 77.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.638 -0.71 . . . . 0.85 110.002 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 63.6 mt-10 -68.32 -26.75 65.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.39 0.614 . . . . 1.5 110.809 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 11.1 mm-40 -88.89 5.69 42.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.713 -0.676 . . . . 1.74 110.325 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.29 -78.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.171 -1.014 . . . . 1.32 114.02 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.47 -45.69 10.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.114 0.483 . . . . 1.92 111.652 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 31.5 ttpt -87.74 114.28 24.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.94 -0.573 . . . . 2.04 109.991 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.883 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.791 -0.623 . . . . 4.22 109.719 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.697 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 19.7 p30 . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.801 -0.074 . . . . 1.66 110.801 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.484 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -171.77 -51.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.334 0.494 . . . . 3.73 112.334 176.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.535 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.7 t70 -66.71 -61.85 4.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 112.042 0.386 . . . . 2.78 112.042 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.04 -58.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.115 1.21 . . . . 1.63 112.098 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.697 ' O ' ' HB2' ' A' ' 1' ' ' ASN . 47.0 p90 -154.8 143.63 20.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.566 . . . . 3.21 110.195 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.809 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 95.2 t -103.88 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.138 -1.06 . . . . 1.44 108.138 164.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 58.8 ttp180 -101.04 134.86 43.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.427 0.632 . . . . 3.37 111.939 -170.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.789 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -109.9 131.82 54.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.426 -0.953 . . . . 0.79 108.426 167.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 50.0 m -135.52 110.35 8.73 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.584 -0.735 . . . . 1.28 110.35 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.3 t -121.46 135.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.824 -1.08 . . . . 1.27 111.032 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -100.95 115.71 31.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.38 0.61 . . . . 0.57 109.546 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 148' ' ' ILE . 42.2 t -93.4 127.58 45.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.91 111.264 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.953 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -86.91 12.82 10.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.168 -0.924 . . . . 0.98 113.131 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.564 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.77 41.46 0.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.011 -0.675 . . . . 0.36 112.474 -173.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 11.3 t70 73.32 161.89 0.25 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.252 1.025 . . . . 0.91 113.69 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 1.108 ' HE ' ' HB2' ' A' ' 103' ' ' ALA . 8.0 ttp85 -63.45 -28.11 69.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.28 -1.327 . . . . 1.88 112.422 -172.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 34.1 mttp -66.85 -40.91 88.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.95 -0.3 . . . . 3.05 110.838 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -73.12 -34.86 66.38 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.866 -0.333 . . . . 1.11 110.329 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.2 -51.56 67.61 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.131 -0.486 . . . . 0.32 110.325 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 70.7 t80 -69.92 -40.54 75.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.38 110.887 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -55.8 -47.09 77.75 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.228 -0.442 . . . . 2.39 109.854 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.512 ' N ' ' HG3' ' A' ' 21' ' ' LYS . 16.5 m -77.33 -45.4 26.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.411 -0.358 . . . . 0.68 111.01 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 67.4 t80 -65.08 -28.96 69.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.774 0.287 . . . . 0.48 111.774 -174.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.767 HD23 ' HE3' ' A' ' 48' ' ' LYS . 16.5 tp -115.46 -56.09 2.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.253 -0.579 . . . . 0.5 112.087 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 51.7 mt-10 -91.41 -3.43 56.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.423 . . . . 1.24 111.634 -172.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.669 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -114.91 25.34 10.15 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.693 -0.963 . . . . 0.83 110.693 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.424 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.4 t80 -52.41 -49.37 85.84 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.308 0.484 . . . . 0.74 112.308 -174.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 69.5 Cg_endo -81.37 4.3 7.11 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.154 1.903 . . . . 0.76 115.142 -176.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -103.14 -1.94 28.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.914 -0.714 . . . . 1.49 111.675 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.804 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.5 m0 -72.29 154.18 41.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.546 0.689 . . . . 4.62 111.067 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.593 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 47.5 m95 -83.47 -38.36 0.72 Allowed Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 114.968 -1.015 . . . . 2.78 113.071 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 20.0 Cg_endo -59.41 -79.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 122.31 2.007 . . . . 1.36 114.414 -165.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' HD11 ' A' ' 140' ' ' ILE . 8.3 t-20 -106.85 -16.16 14.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.278 0.561 . . . . 1.51 109.864 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.696 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.8 m-20 -97.8 20.66 11.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.709 . . . . 1.79 111.612 -168.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -79.77 -29.8 40.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.449 . . . . 4.45 111.492 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 36' ' ' ARG . 33.3 mmt180 -90.92 142.97 27.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.538 0.57 . . . . 4.14 112.538 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 39' ' ' LYS . 26.9 p -77.01 151.93 35.4 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 2.68 111.02 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 57' ' ' ASP . 7.0 p 54.48 6.81 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.396 1.078 . . . . 1.42 112.462 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 37' ' ' THR . 72.5 tttt -94.73 -135.45 0.2 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.207 -2.146 . . . . 2.9 105.207 161.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 34' ' ' ASN . 17.1 m -93.0 20.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.423 0.63 . . . . 1.83 110.71 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -132.54 39.86 1.69 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.68 -0.691 . . . . 2.17 112.431 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.051 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -88.78 160.43 44.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.639 -0.874 . . . . 1.12 108.639 171.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.6 -17.6 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 124.134 3.223 . . . . 1.48 116.14 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 45' ' ' GLY . 48.1 tp -97.42 -97.38 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.874 -0.516 . . . . 1.75 111.184 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.682 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 109.14 -55.97 0.48 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.67 -0.776 . . . . 0.75 112.722 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.615 HG11 HD11 ' A' ' 24' ' ' LEU . 94.2 t -139.9 139.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.078 0.466 . . . . 0.6 111.582 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.703 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 19.4 t70 -105.68 102.71 12.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.422 -0.808 . . . . 1.11 109.431 174.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.767 ' HE3' HD23 ' A' ' 24' ' ' LEU . 25.3 mtpt -80.52 -12.17 59.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 2.81 111.82 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.46 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.6 ptpp? -83.86 -43.7 15.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.946 -0.302 . . . . 3.17 111.214 -174.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.9 -32.9 5.71 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.909 -0.662 . . . . 1.53 111.793 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 102.67 58.4 0.76 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.563 -0.827 . . . . 0.77 112.771 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -144.72 149.54 35.77 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.723 -0.281 . . . . 3.72 110.532 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -100.33 115.27 29.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.258 -0.645 . . . . 1.28 109.258 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.703 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 6.8 p90 -160.97 149.1 15.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.469 . . . . 1.66 110.118 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.051 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.3 mp0 -113.06 169.13 9.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.48 -0.563 . . . . 2.12 109.48 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.457 HD12 ' HG2' ' A' ' 61' ' ' GLU . 32.8 mm -77.55 103.3 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.621 -0.511 . . . . 0.92 109.621 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 38' ' ' THR . 8.1 t70 -101.75 159.52 15.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 1.97 110.267 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.019 1.118 . . . . 2.43 114.019 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.31 8.16 22.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.102 -0.639 . . . . 2.39 111.441 -175.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.4 62.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.245 -0.978 . . . . 2.29 113.693 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.457 ' HG2' HD12 ' A' ' 56' ' ' ILE . 41.1 mt-10 52.24 35.2 16.28 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.816 0.672 . . . . 2.31 112.816 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -108.11 85.43 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.469 0.652 . . . . 2.61 110.745 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.533 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -121.84 158.63 28.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 3.72 110.05 175.389 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 3.2 t -134.58 115.41 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.334 -0.393 . . . . 2.27 110.405 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.807 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 37.6 t80 -131.4 -46.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 6.48 111.329 174.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.543 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -157.29 156.6 27.39 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.38 -1.391 . . . . 1.23 113.949 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.466 HD22 ' HD2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -116.89 110.42 18.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.397 -0.594 . . . . 1.17 109.397 177.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.543 HG21 ' CG2' ' A' ' 71' ' ' VAL . 35.5 mt -80.83 136.29 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 0.61 111.228 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -101.94 -34.17 9.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.264 -0.88 . . . . 2.0 109.212 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -149.7 129.27 13.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.687 -0.688 . . . . 1.53 110.97 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 68' ' ' ILE . 44.1 t -112.87 93.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.75 -0.833 . . . . 0.88 108.75 172.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.78 70.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.544 -0.298 . . . . 1.42 111.7 -172.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.643 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 47.27 -173.34 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 124.539 1.15 . . . . 0.96 112.505 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.4 Cg_exo -61.48 82.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.406 1.404 . . . . 0.38 111.195 166.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.488 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 28.2 t70 -168.29 -68.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.606 . . . . 0.5 110.572 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.8 p -144.55 144.86 31.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.22 0.533 . . . . 0.35 112.154 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -135.14 117.33 15.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.672 -0.694 . . . . 0.74 109.29 177.312 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 t -93.47 105.66 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.42 -0.956 . . . . 0.67 108.42 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.543 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -128.58 130.58 69.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.999 -0.546 . . . . 0.75 111.3 -169.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.791 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.44 153.11 20.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.301 -0.476 . . . . 0.5 112.082 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.685 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 65.0 t-105 -85.82 132.81 34.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 2.79 111.532 -172.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.583 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 6.8 ttt180 -137.56 28.68 2.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.687 -0.688 . . . . 5.46 109.644 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.807 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 19.0 tp 77.52 167.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.87 -1.059 . . . . 1.55 112.147 172.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.644 ' HB2' ' HE3' ' A' ' 133' ' ' MET . 1.5 m-20 -82.67 5.29 21.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.711 -0.477 . . . . 1.93 109.711 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.98 38.5 92.94 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.691 -0.686 . . . . 2.4 113.049 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -137.95 91.56 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.946 0.403 . . . . 5.38 112.018 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.6 2.35 21.25 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.628 -0.714 . . . . 2.3 114.755 168.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.627 ' HB2' HD11 ' A' ' 83' ' ' LEU . 1.5 mmp_? -112.76 -176.27 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 117.239 0.519 . . . . 4.77 110.266 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.402 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -101.78 136.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.111 -0.495 . . . . 1.86 110.121 177.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 7.5 p-10 -97.88 140.09 21.71 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.916 0.389 . . . . 3.18 110.403 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 36.9 Cg_exo -61.4 -46.02 16.32 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.833 2.355 . . . . 2.36 111.856 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 73.05 -40.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.045 0.841 . . . . 2.99 112.638 173.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.12 -36.37 58.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.839 0.681 . . . . 3.06 112.839 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.5 p -165.79 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.743 -0.383 . . . . 1.85 111.773 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.685 ' CB ' ' HB3' ' A' ' 81' ' ' TRP . 44.3 m 55.37 30.24 14.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.419 0.628 . . . . 1.44 110.671 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.791 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.8 tt0 -62.71 124.32 20.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.855 -1.066 . . . . 1.81 111.275 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.587 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 8.5 p90 -125.9 136.12 52.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.164 0.507 . . . . 0.64 110.738 174.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 31.9 m -89.43 115.49 26.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.578 -0.737 . . . . 0.43 110.266 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 113' ' ' VAL . 99.2 t -91.0 108.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.283 -0.636 . . . . 0.87 109.283 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.758 ' HA ' HG22 ' A' ' 76' ' ' THR . 15.6 m -106.77 104.96 14.77 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.105 -0.498 . . . . 0.45 110.909 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.641 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.7 m-85 -82.64 102.6 11.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.34 -0.615 . . . . 0.34 109.34 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -91.54 108.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.319 -0.623 . . . . 0.54 109.319 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.108 ' HB2' ' HE ' ' A' ' 16' ' ' ARG . . . -57.4 124.45 18.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.44 109.967 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.766 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 12.7 t70 -109.15 103.3 12.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.969 -0.752 . . . . 2.03 108.969 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.2 -106.53 1.91 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.854 -0.898 . . . . 1.97 110.854 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -153.64 -9.25 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.337 . . . . 4.93 110.969 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -119.99 -0.16 10.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 3.53 110.722 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 11.6 mptt -127.39 159.98 32.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.969 -0.752 . . . . 2.44 108.969 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.437 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 53.4 m -156.26 114.79 3.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.863 0.363 . . . . 0.42 110.211 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -100.66 111.32 23.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.94 -0.763 . . . . 2.59 108.94 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.641 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 10.9 p -85.9 138.04 19.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 0.4 110.319 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -127.41 116.13 19.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.845 . . . . 1.38 109.223 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 99' ' ' VAL . 4.1 t -108.37 130.84 60.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.983 -1.008 . . . . 0.91 111.189 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.58 111.34 22.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.303 0.573 . . . . 2.31 110.141 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.809 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 82.0 t60 -113.43 97.23 6.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.148 -0.933 . . . . 1.64 108.864 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.564 ' OG1' ' HA ' ' A' ' 5' ' ' PHE . 34.8 m -145.55 94.71 2.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.967 0.413 . . . . 2.67 111.344 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.632 ' O ' ' HG2' ' A' ' 121' ' ' MET . 15.6 t60 -167.16 -73.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.097 -0.501 . . . . 2.63 110.212 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.427 ' CZ ' ' HD3' ' A' ' 128' ' ' ARG . 29.4 t80 -64.96 -47.53 77.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.53 -0.759 . . . . 3.54 112.137 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -37.25 67.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.543 0.687 . . . . 1.81 110.35 -174.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -55.91 -20.88 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.754 -1.112 . . . . 3.38 111.945 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.632 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.9 mmt -81.18 19.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.06 0.393 . . . . 2.43 112.06 -171.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.68 163.31 11.24 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.015 -1.088 . . . . 1.61 113.007 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.7 p -65.23 -22.51 66.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.593 -0.303 . . . . 2.58 111.432 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -67.68 -52.69 35.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.681 0.277 . . . . 3.8 110.745 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.761 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 33.4 m170 -60.98 -48.84 79.94 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.602 0.715 . . . . 2.14 110.5 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.81 68.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.213 -0.903 . . . . 0.92 111.037 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 130' ' ' ARG . 35.1 ttpt -75.84 -41.86 51.27 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.798 0.296 . . . . 2.83 111.798 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.761 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.9 ptm180 -64.03 -30.58 71.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.915 -0.314 . . . . 2.59 110.68 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.71 -32.13 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 120.423 -0.511 . . . . 1.48 110.593 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.555 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 21.9 tpp85 -61.77 -15.17 38.99 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.489 0.716 . . . . 3.83 111.376 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 53.0 m-20 -52.04 -21.67 3.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.643 0.979 . . . . 2.48 113.643 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.07 -39.16 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 119.252 -1.452 . . . . 1.61 114.053 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.644 ' HE3' ' HB2' ' A' ' 84' ' ' ASN . 12.9 mmt -74.24 -9.29 58.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 4.83 111.285 -171.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 16.3 t70 -62.22 -22.75 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.635 -0.712 . . . . 2.83 111.461 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.65 -30.7 12.32 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.886 -0.326 . . . . 4.15 110.857 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.565 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -69.65 -50.21 32.22 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.092 -0.575 . . . . 1.04 112.491 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.6 t-105 -54.85 -52.19 72.74 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.186 0.439 . . . . 2.78 112.186 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -60.25 -36.95 86.03 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.646 1.564 . . . . 0.68 112.069 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.3 m -68.4 -35.52 77.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.514 0.673 . . . . 0.87 109.623 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.652 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 16.5 mt -58.54 -44.63 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.876 -1.057 . . . . 0.72 110.578 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 8' ' ' HIS . 70.9 mt -63.74 -33.23 75.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.187 0.44 . . . . 0.69 112.187 -175.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.53 -54.76 12.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.961 0.41 . . . . 1.49 110.314 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.63 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 48.9 m -65.87 -22.02 66.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 1.15 111.144 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 23' ' ' PHE . 54.5 t80 -65.95 -53.45 38.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.308 0.575 . . . . 0.8 109.559 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.815 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 45.1 mt-30 -61.64 -29.82 70.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.277 -0.874 . . . . 1.63 110.25 176.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 143' ' ' SER . 31.9 t70 -73.95 -43.75 57.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.853 -1.067 . . . . 1.46 110.529 -175.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.462 ' HD3' ' NE1' ' A' ' 31' ' ' TRP . 28.1 tptp -65.79 -43.19 89.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.713 0.292 . . . . 1.74 110.584 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.814 HG21 HG13 ' A' ' 12' ' ' VAL . 57.5 mt -62.37 -40.14 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.5 111.368 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.953 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 28.5 t70 -65.53 -27.33 68.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.318 -0.401 . . . . 0.85 110.872 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 50.7 mt-10 -64.5 -39.06 93.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.511 0.672 . . . . 1.5 109.537 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 10.7 mm-40 -74.73 -29.26 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.373 -1.285 . . . . 1.74 108.906 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -74.26 -74.94 0.81 Allowed Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 114.817 -1.083 . . . . 1.32 112.345 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -164.35 23.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.76 0.652 . . . . 1.92 112.76 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 32.0 ttmt -69.9 -75.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.369 -0.532 . . . . 2.04 110.601 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.812 -1.089 . . . . 4.22 110.409 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 7' ' ' ARG . 25.3 p-10 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.883 0.373 . . . . 1.66 110.457 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.617 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 32.1 p90 179.66 -32.84 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 3.73 109.713 -174.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.711 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.0 t70 -73.16 -55.0 4.02 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 111.959 0.355 . . . . 2.78 111.959 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.5 Cg_endo -93.69 -62.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.172 1.914 . . . . 1.63 112.998 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.433 ' CD2' HG21 ' A' ' 116' ' ' THR . 96.2 m-85 -144.31 118.88 9.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 3.21 110.421 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.039 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 97.3 t -85.05 125.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.9 -0.778 . . . . 1.44 108.9 167.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 36.6 ttp85 -132.38 136.72 47.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.026 -0.534 . . . . 3.37 109.787 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 1.112 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 3.2 t-160 -108.38 132.31 53.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.491 -0.929 . . . . 0.79 108.491 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 13.4 m -136.17 118.91 16.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.251 0.548 . . . . 1.28 110.716 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 111' ' ' VAL . 2.7 t -137.31 134.19 46.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.158 -0.928 . . . . 1.27 111.086 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -101.8 114.98 29.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.435 0.636 . . . . 0.57 109.808 173.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.819 HG13 HG21 ' A' ' 148' ' ' ILE . 38.5 t -95.57 136.27 27.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.296 -0.866 . . . . 0.91 109.726 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 36.05 2.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.726 0.269 . . . . 0.98 111.726 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.84 31.63 0.36 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.93 0.345 . . . . 0.36 111.93 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.8 t70 75.22 164.06 0.27 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.861 0.838 . . . . 0.91 112.732 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 14.6 ttp180 -66.47 -25.72 66.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.686 -1.143 . . . . 1.88 111.544 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.055 -0.258 . . . . 3.05 110.828 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -68.33 -35.14 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.995 -0.282 . . . . 1.11 110.362 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.28 -48.98 75.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.32 110.613 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.507 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 84.7 t80 -72.57 -50.6 24.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.38 111.207 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -52.35 -49.7 63.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.03 -0.532 . . . . 2.39 111.158 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 m -67.56 -51.09 54.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.982 -0.554 . . . . 0.68 110.792 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 73.6 t80 -58.93 -40.48 84.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.349 0.5 . . . . 0.48 112.349 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -104.46 -50.39 3.33 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.271 -0.572 . . . . 0.5 112.31 -172.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.809 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 53.9 mt-10 -86.24 -6.94 58.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.76 0.314 . . . . 1.24 111.631 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.642 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -117.15 30.1 6.45 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.374 -0.917 . . . . 0.83 112.525 -176.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -49.31 -53.84 35.73 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.006 0.373 . . . . 0.74 112.006 -172.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 24.9 Cg_endo -90.57 21.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.921 1.747 . . . . 0.76 114.644 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.6 pt-20 -113.64 -15.88 12.43 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.562 -0.855 . . . . 1.49 113.045 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -79.61 -176.64 5.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.944 -0.702 . . . . 4.62 109.617 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.511 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 10.2 p-90 -115.32 16.9 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 115.36 1.615 . . . . 2.78 115.36 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 30' ' ' TRP . 57.8 Cg_endo -85.03 -134.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 121.984 1.744 . . . . 1.36 113.136 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.487 ' ND2' HD21 ' A' ' 84' ' ' ASN . 9.7 t30 -67.18 -25.7 66.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 1.51 111.047 -175.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.659 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -85.94 18.72 2.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.469 -0.787 . . . . 1.79 110.997 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -82.69 -4.13 57.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.5 0.667 . . . . 4.45 109.421 174.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -106.62 164.24 12.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.735 . . . . 4.14 110.199 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 42' ' ' ALA . 1.1 p -98.28 147.29 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.538 -0.301 . . . . 2.68 111.272 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.7 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 19.8 p 54.44 25.0 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.799 0.839 . . . . 1.42 111.941 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' O ' HG13 ' A' ' 40' ' ' VAL . 20.4 mtmt -111.21 -50.54 2.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.708 -1.133 . . . . 2.9 109.146 165.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -177.5 28.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 124.424 1.078 . . . . 1.83 110.256 175.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.06 29.96 0.59 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.843 -1.17 . . . . 2.17 114.253 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.845 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.64 170.46 16.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 117.282 0.541 . . . . 1.12 109.617 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.686 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 28.0 Cg_endo -63.26 72.28 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.475 2.116 . . . . 1.48 112.753 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 tp -169.19 -90.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.474 -0.785 . . . . 1.75 109.687 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.38 -88.9 0.53 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.334 -0.936 . . . . 0.75 112.46 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 53' ' ' TRP . 57.5 t -139.91 139.89 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.738 0.304 . . . . 0.6 111.114 -172.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.53 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.742 -0.836 . . . . 1.11 108.742 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.809 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 40.3 mtpt -78.93 -18.76 53.27 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.956 0.725 . . . . 2.81 112.956 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -89.2 -45.2 9.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.839 -0.344 . . . . 3.17 110.962 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.39 -38.4 21.57 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.273 -0.731 . . . . 1.53 111.273 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.92 58.31 1.04 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.915 -0.66 . . . . 0.77 112.205 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -159.29 141.07 13.34 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.752 -0.379 . . . . 3.72 110.404 177.058 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.956 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -100.97 135.48 42.36 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.597 -0.441 . . . . 1.28 110.654 177.649 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 0.8 OUTLIER -163.02 -179.36 6.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.673 0.608 . . . . 1.66 110.528 179.192 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 39.9 mt-10 -132.35 177.64 7.43 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 116.639 -0.255 . . . . 2.12 111.136 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 mm -102.41 102.83 14.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.414 -0.587 . . . . 0.92 109.414 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.7 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-20 -70.27 135.48 48.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.873 0.694 . . . . 1.97 112.873 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.27 -26.57 67.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.854 -1.067 . . . . 2.43 111.151 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.636 HE21 ' HB3' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -82.8 -7.23 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 2.39 111.447 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.92 72.24 0.63 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.554 -0.832 . . . . 2.29 112.598 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 37.6 77.22 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.408 1.262 . . . . 2.31 114.408 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.487 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 18.7 mm-40 -129.18 73.16 1.5 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.61 109.929 170.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 1.3 p80 -110.54 157.81 19.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.766 -1.106 . . . . 3.72 111.502 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.794 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 37.6 p -83.66 151.96 25.02 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.726 -0.842 . . . . 2.27 108.726 169.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.5 p90 -108.78 111.72 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.228 -0.589 . . . . 6.48 110.51 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.718 ' HA3' ' CE2' ' A' ' 53' ' ' TRP . . . -63.36 129.64 40.3 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.047 -0.821 . . . . 1.23 111.047 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 82' ' ' ARG . 4.4 mp -78.74 87.57 4.63 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.824 -0.35 . . . . 1.17 110.918 -170.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 71' ' ' VAL . 13.7 mt -92.1 115.35 30.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.001 -1.08 . . . . 0.61 109.321 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -104.82 -12.58 16.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.596 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 19.5 ttmm -151.82 107.38 3.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 1.53 111.332 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 68' ' ' ILE . 2.5 m -103.14 85.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.88 108.568 167.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.19 72.82 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 1.42 111.08 -172.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.594 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 46.96 -171.88 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 124.684 1.24 . . . . 0.96 112.288 175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.3 Cg_exo -64.04 76.05 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.518 1.479 . . . . 0.38 111.411 166.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -159.61 -65.63 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.649 -0.705 . . . . 0.5 110.673 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.8 p -144.96 143.08 30.34 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.427 0.529 . . . . 0.35 112.427 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.65 120.15 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.74 109.668 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 59.0 t -105.73 103.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.474 -0.565 . . . . 0.67 109.474 175.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.766 HG13 ' HE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -129.39 135.07 62.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.973 -0.558 . . . . 0.75 111.701 -174.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.793 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.16 147.67 18.69 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.065 -0.814 . . . . 0.5 111.065 174.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.685 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . 52.8 t-105 -78.96 135.65 37.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.237 0.541 . . . . 2.79 111.964 -168.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.794 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.9 tpt180 -130.76 25.93 5.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.423 -0.808 . . . . 5.46 109.641 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.824 HD11 ' HB2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER 81.25 134.78 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.845 -1.07 . . . . 1.55 112.233 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.536 ' HB3' ' SD ' ' A' ' 133' ' ' MET . 5.1 t30 -108.53 109.67 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.023 -0.99 . . . . 1.93 109.786 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.07 -24.52 8.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.583 -0.818 . . . . 2.4 111.327 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.437 ' H ' HD12 ' A' ' 83' ' ' LEU . 3.3 m-30 74.74 -25.71 0.2 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.589 0.756 . . . . 5.38 112.706 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.61 19.11 38.57 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.828 -0.701 . . . . 2.3 113.247 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.824 ' HB2' HD11 ' A' ' 83' ' ' LEU . 41.9 mmt180 -124.88 173.66 8.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.622 -0.51 . . . . 4.77 109.622 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -74.55 132.12 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.786 0.327 . . . . 1.86 110.73 178.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 10.3 p-10 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 3.18 110.495 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.685 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 52.7 Cg_exo -58.25 -37.63 94.47 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.267 2.644 . . . . 2.36 112.597 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER 78.35 -39.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.87 0.731 . . . . 2.99 112.39 169.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -120.06 -30.3 4.71 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.034 0.383 . . . . 3.06 112.034 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.45 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 48.9 m -138.95 -140.89 0.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.926 -0.31 . . . . 1.85 111.832 -175.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 67.7 m 65.75 24.02 11.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.496 -0.775 . . . . 1.44 109.427 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.793 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.7 tt0 -67.28 136.48 54.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.812 -1.085 . . . . 1.81 110.442 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.636 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 13.9 p90 -137.62 138.03 39.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.273 0.559 . . . . 0.64 110.84 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.575 HG23 HG22 ' A' ' 78' ' ' VAL . 34.1 m -100.26 109.76 21.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.244 -0.889 . . . . 0.43 109.663 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.442 HG12 HG22 ' A' ' 113' ' ' VAL . 1.6 m -87.64 121.6 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 119.591 -0.844 . . . . 0.87 109.122 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.512 ' HA ' HG22 ' A' ' 76' ' ' THR . 27.2 m -102.64 106.84 17.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.345 -0.843 . . . . 0.45 110.339 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.498 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.9 m-85 -82.37 109.82 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.655 -0.498 . . . . 0.34 109.655 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.16 112.52 27.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.572 -0.529 . . . . 0.54 109.572 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 124.38 23.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.44 110.568 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.3 t0 -105.69 103.4 12.9 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.425 -0.954 . . . . 2.03 108.425 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.27 -111.11 3.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.537 -0.84 . . . . 1.97 111.562 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -147.95 -3.93 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.638 0.256 . . . . 4.93 111.255 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -136.51 8.23 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.288 . . . . 3.53 111.342 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.797 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 36.1 ttmt -126.78 158.15 37.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.999 -0.741 . . . . 2.44 108.999 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.6 m -156.01 130.65 9.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.008 0.433 . . . . 0.42 111.096 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -109.37 112.91 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.82 -0.627 . . . . 2.59 109.741 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 10' ' ' VAL . 8.7 p -90.95 141.77 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.865 -0.334 . . . . 0.4 110.63 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.7 t70 -135.01 105.72 6.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.354 -0.839 . . . . 1.38 109.857 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.112 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 9.5 t -86.3 131.57 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.91 111.941 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.82 124.03 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.842 0.714 . . . . 2.31 109.504 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 1.039 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 7.7 t-160 -142.23 102.72 4.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.526 -0.546 . . . . 1.64 109.526 -175.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.433 HG21 ' CD2' ' A' ' 5' ' ' PHE . 8.6 p -149.84 40.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.345 0.498 . . . . 2.67 112.345 -174.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.548 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.1 t-160 -113.37 -65.05 1.22 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.999 -0.68 . . . . 2.63 111.405 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.524 ' HB2' ' H ' ' A' ' 95' ' ' SER . 11.6 t80 -86.18 -49.67 7.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.896 0.379 . . . . 3.54 110.444 -175.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.84 -51.71 68.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.478 -0.783 . . . . 1.81 111.025 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.561 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 5.8 tmm_? -60.89 -19.43 60.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.779 -1.1 . . . . 3.38 111.125 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.548 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 42.3 tpp -80.97 23.07 0.58 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.864 0.364 . . . . 2.43 111.879 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.2 170.42 12.86 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.752 -1.214 . . . . 1.61 114.333 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 t -66.8 -44.48 81.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.894 -0.653 . . . . 2.58 111.676 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 124' ' ' LYS . 16.4 tptm -66.13 -39.09 89.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.574 0.226 . . . . 3.8 110.726 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.669 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 10.1 m-70 -61.03 -52.85 63.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 2.14 110.486 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -64.73 -35.95 82.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.92 111.025 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -64.03 -46.45 84.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 2.83 111.405 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 8.3 ptm180 -64.93 -39.57 93.72 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.439 -0.346 . . . . 2.59 111.305 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 125' ' ' HIS . 2.8 p -81.33 -17.83 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.315 0.579 . . . . 1.48 110.987 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 61.7 ttt180 -68.74 -9.73 52.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.155 -0.341 . . . . 3.83 111.43 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.711 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.3 p30 -47.12 -40.06 14.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.561 0.578 . . . . 2.48 112.561 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -145.52 -11.24 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.072 -1.061 . . . . 1.61 113.381 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 84' ' ' ASN . 22.6 mmt -79.43 -11.68 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.342 -0.505 . . . . 4.83 110.277 -172.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.66 -39.67 92.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.507 -0.769 . . . . 2.83 110.961 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -104.8 14.07 30.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 4.15 110.552 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -77.57 -78.18 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.925 -0.579 . . . . 1.04 111.828 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 13.6 m95 -55.62 -47.92 97.6 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 113.58 0.956 . . . . 2.78 113.58 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.9 Cg_endo -50.93 -43.64 46.25 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.839 1.693 . . . . 0.68 112.213 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.1 m -73.22 -45.72 54.54 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.432 0.634 . . . . 0.87 110.639 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.627 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 56.5 mt -58.38 -44.99 89.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 115.371 -0.831 . . . . 0.72 111.361 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 51.2 mt -59.86 -38.81 83.21 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.278 0.361 . . . . 0.69 111.054 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.1 mm-40 -61.5 -50.93 70.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.544 -0.462 . . . . 1.49 109.854 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 51.0 m -65.58 -28.4 69.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.604 -0.725 . . . . 1.15 110.817 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 60.0 t80 -68.27 -55.3 12.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.8 111.135 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -35.1 73.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.855 0.36 . . . . 1.63 111.076 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.26 -40.96 62.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.916 -0.584 . . . . 1.46 110.673 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.43 ' HE3' ' HG3' ' A' ' 29' ' ' GLU . 29.7 tptp -60.62 -38.52 85.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.361 0.601 . . . . 1.74 109.902 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.819 HG21 HG13 ' A' ' 12' ' ' VAL . 52.2 mt -74.45 -26.82 20.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.497 -0.774 . . . . 0.5 111.082 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.4 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.0 t70 -64.84 -31.22 72.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.477 -0.564 . . . . 0.85 109.477 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.843 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 37.5 mt-10 -66.28 -33.09 74.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 1.5 109.74 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -71.86 -23.46 61.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.081 -0.963 . . . . 1.74 109.646 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -98.89 -88.7 1.95 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.32 112.951 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.8 30.58 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.314 0.487 . . . . 1.92 112.314 -171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.843 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 16.9 tppt? -68.42 -19.63 64.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.491 0.662 . . . . 2.04 110.361 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 11.2 ptpt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.171 -0.922 . . . . 4.22 111.243 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.97 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.7 p-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.934 -0.395 . . . . 1.66 109.934 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.548 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 p90 69.87 -40.78 0.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.413 1.485 . . . . 3.73 112.684 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.796 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 18.8 t70 -67.06 -54.58 19.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.216 -0.29 . . . . 2.78 110.216 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 32.6 Cg_endo -87.89 -64.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.66 1.573 . . . . 1.63 111.323 169.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.32 152.27 31.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.257 -1.016 . . . . 3.21 108.257 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.97 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -109.58 126.2 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.094 0.473 . . . . 1.44 109.98 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 20.6 ttp85 -130.99 135.17 47.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 3.37 110.453 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.585 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.79 132.42 54.17 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.567 -0.531 . . . . 0.79 109.567 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.9 p -135.44 116.27 14.05 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.883 -0.599 . . . . 1.28 110.887 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 111' ' ' VAL . 15.5 m -125.02 156.06 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.845 -0.616 . . . . 1.27 110.869 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.7 m -109.82 116.83 32.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.536 -0.756 . . . . 0.57 109.93 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.921 HG13 HG21 ' A' ' 148' ' ' ILE . 37.1 t -93.79 138.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.273 -0.876 . . . . 0.91 110.77 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -96.8 7.76 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.98 112.256 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.03 47.09 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.533 -0.467 . . . . 0.36 112.233 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.5 t70 75.07 163.17 0.26 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.075 0.941 . . . . 0.91 112.973 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.571 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 27.9 ttp180 -62.34 -25.62 67.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.387 -1.279 . . . . 1.88 110.783 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 17' ' ' LYS . 33.8 ttpt -57.65 -49.47 76.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 3.05 110.988 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.4 p -75.43 -31.93 60.51 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.808 -0.357 . . . . 1.11 110.935 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.836 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -60.98 -46.75 89.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.755 -0.378 . . . . 0.32 110.637 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 73.4 t80 -67.14 -42.32 84.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.38 110.657 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.917 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 19.8 tptm -56.12 -52.8 63.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.45 . . . . 2.39 110.518 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.603 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 18.7 m -72.01 -22.58 61.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.952 -0.567 . . . . 0.68 111.553 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -88.99 -36.93 15.56 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.182 -0.324 . . . . 0.48 111.558 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -119.82 -48.88 2.35 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.245 0.832 . . . . 0.5 113.245 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.917 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 20.5 mt-10 -75.08 -29.21 60.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.808 0.813 . . . . 1.24 110.354 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.86 99.15 0.7 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 108.244 -1.942 . . . . 0.83 108.244 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.632 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.6 t80 -96.17 -56.64 0.2 Allowed Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 115.704 -0.248 . . . . 0.74 111.58 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.675 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 40.9 Cg_endo -103.43 39.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.095 2.53 . . . . 0.76 114.493 -172.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.81 -2.86 5.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.905 -0.718 . . . . 1.49 112.894 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.778 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 17.0 m95 -90.6 -155.87 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 4.62 110.748 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 10.6 m95 -110.91 6.15 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.929 1.455 . . . . 2.78 114.929 -172.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.999 ' HB2' HD12 ' A' ' 140' ' ' ILE . 74.4 Cg_endo -88.32 -140.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 122.108 1.788 . . . . 1.36 112.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HB3' HD11 ' A' ' 140' ' ' ILE . 62.7 t30 -67.69 -20.42 65.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.848 0.832 . . . . 1.51 110.004 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.865 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.2 m-20 -77.05 19.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.567 -1.197 . . . . 1.79 111.675 -171.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.28 -3.85 19.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.937 0.399 . . . . 4.45 110.696 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.87 142.76 27.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.414 . . . . 4.14 110.89 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 m -76.83 138.63 39.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 2.68 111.298 -172.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.2 p 57.06 8.16 0.5 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.731 1.212 . . . . 1.42 113.32 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.857 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 32.4 ttmt -91.48 -73.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.98 -0.748 . . . . 2.9 108.98 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.865 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.7 m -147.08 18.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.404 -0.816 . . . . 1.83 109.142 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -140.38 51.02 0.74 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.424 -0.807 . . . . 2.17 113.3 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.089 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -94.25 172.8 5.25 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.634 -0.876 . . . . 1.12 108.634 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 32.7 Cg_endo -65.01 62.44 0.3 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.659 2.24 . . . . 1.48 113.475 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 42.3 tp -170.51 -91.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 1.75 110.268 175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 27' ' ' PHE . . . 94.76 -63.62 1.54 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.811 -0.709 . . . . 0.75 112.791 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 27' ' ' PHE . 77.1 t -137.87 139.23 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.977 -0.379 . . . . 0.6 109.977 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.678 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 24.6 t70 -105.43 118.33 36.28 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.054 -0.721 . . . . 1.11 109.054 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -80.06 -35.5 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.613 -0.721 . . . . 2.81 111.622 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.41 -38.88 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.711 0.263 . . . . 3.17 111.711 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -36.29 6.24 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.765 -0.731 . . . . 1.53 112.118 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 93.33 65.65 1.07 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.664 -0.779 . . . . 0.77 112.155 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' CD2' ' A' ' 54' ' ' TYR . 11.9 ptt180 -159.34 148.06 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.647 -0.421 . . . . 3.72 111.574 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.8 m0 -95.38 108.53 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.28 110.203 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.678 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -158.57 162.48 37.38 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.993 0.425 . . . . 1.66 110.305 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.089 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 11.6 mp0 -122.26 165.74 15.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.122 -0.695 . . . . 2.12 109.122 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.593 HG23 ' HG2' ' A' ' 61' ' ' GLU . 47.9 mm -77.37 102.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.937 -0.764 . . . . 0.92 108.937 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.79 144.1 39.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 1.97 110.679 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.11 -27.73 69.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.138 -0.937 . . . . 2.43 111.918 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -74.91 -22.83 58.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 2.39 111.285 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.11 50.18 0.03 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.004 -1.093 . . . . 2.29 113.919 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.593 ' HG2' HG23 ' A' ' 56' ' ' ILE . 44.9 mt-10 63.02 16.34 9.2 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.368 0.877 . . . . 2.31 113.368 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 10.1 tp10 -105.34 82.39 1.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.638 0.732 . . . . 2.61 110.389 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -111.08 148.48 32.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.095 -0.957 . . . . 3.72 110.728 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.706 HG23 ' HD3' ' A' ' 82' ' ' ARG . 3.3 t -54.69 140.76 34.63 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.451 -0.944 . . . . 2.27 108.451 167.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.8 p90 -129.89 143.99 51.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.472 0.653 . . . . 6.48 112.394 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 128.22 8.44 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.55 -1.02 . . . . 1.23 110.55 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 67' ' ' LEU . 3.8 mp -85.87 89.23 7.71 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 111.438 0.162 . . . . 1.17 111.438 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.963 HG21 HG13 ' A' ' 71' ' ' VAL . 58.4 mt -80.62 116.16 24.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.014 -0.674 . . . . 0.61 110.024 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 67' ' ' LEU . 4.9 mpt_? -98.59 -25.24 14.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.713 -0.477 . . . . 2.0 109.713 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HD3' ' HB2' ' A' ' 72' ' ' ASP . 18.0 ttmm -139.52 121.56 15.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 1.53 111.774 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.963 HG13 HG21 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -111.79 85.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.665 -0.865 . . . . 0.88 108.665 167.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -96.45 70.74 2.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.16 -0.473 . . . . 1.42 110.69 -170.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 8.2 pt-20 49.43 -172.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 124.523 1.139 . . . . 0.96 111.188 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 35.7 Cg_exo -63.48 77.33 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.294 1.329 . . . . 0.38 111.058 163.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.6 t70 -159.72 -68.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.5 110.549 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.2 p -139.42 143.05 37.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.559 0.577 . . . . 0.35 112.559 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.94 117.41 16.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.864 -0.607 . . . . 0.74 109.597 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 98' ' ' THR . 41.2 t -104.35 103.18 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.475 . . . . 0.67 109.719 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.579 HG12 ' N ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -129.5 142.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.79 -0.641 . . . . 0.75 112.139 -175.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.579 ' N ' HG12 ' A' ' 79' ' ' ILE . . . -86.5 158.06 30.76 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.56 -0.745 . . . . 0.5 111.523 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.422 ' H ' ' HB2' ' A' ' 95' ' ' SER . 70.9 t-105 -78.78 155.09 29.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.954 0.724 . . . . 2.79 112.954 -170.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.706 ' HD3' HG23 ' A' ' 64' ' ' THR . 0.0 OUTLIER -125.43 -78.34 0.6 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.822 -1.081 . . . . 5.46 110.747 -176.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.639 HD21 ' HG2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 172.0 146.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.971 -1.122 . . . . 1.55 107.971 -176.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.575 ' H ' HD13 ' A' ' 83' ' ' LEU . 25.3 t-20 -117.88 -62.96 1.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.399 0.518 . . . . 1.93 112.399 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.69 -10.6 83.15 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.792 -0.718 . . . . 2.4 114.466 -169.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.857 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 19.6 t80 64.95 14.58 9.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.73 0.776 . . . . 5.38 110.604 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 34.06 2.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.209 -1.156 . . . . 2.3 110.209 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HG2' HD21 ' A' ' 83' ' ' LEU . 2.6 ttp180 -137.41 162.21 34.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.889 -0.655 . . . . 4.77 110.878 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.575 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -109.06 127.09 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.509 -0.552 . . . . 1.86 109.509 175.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.628 ' HB2' HD23 ' A' ' 83' ' ' LEU . 6.1 m-20 -144.07 149.96 47.39 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.778 -0.647 . . . . 3.18 109.657 171.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 16.0 Cg_exo -69.29 -12.95 34.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.192 2.595 . . . . 2.36 114.322 -171.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 60.88 33.58 19.88 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.459 0.647 . . . . 2.99 109.975 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' HA ' HD21 ' A' ' 67' ' ' LEU . 11.6 m-80 -141.87 -80.68 0.23 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.618 . . . . 3.06 112.603 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 m -78.41 -125.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.401 0.519 . . . . 1.85 112.401 -170.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.645 ' HB3' ' HE1' ' A' ' 115' ' ' HIS . 16.2 m 70.85 -75.29 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.733 -0.667 . . . . 1.44 110.994 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 60.4 116.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.144 0.794 . . . . 1.81 113.144 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HB3' ' CG ' ' A' ' 115' ' ' HIS . 18.6 p90 -132.15 129.39 39.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.14 0.495 . . . . 0.64 110.985 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.502 HG23 HG22 ' A' ' 78' ' ' VAL . 47.8 m -89.98 107.35 19.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.23 -0.896 . . . . 0.43 109.758 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.754 ' HA ' HG22 ' A' ' 113' ' ' VAL . 98.3 t -81.84 109.73 16.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.866 -0.606 . . . . 0.87 109.961 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.474 ' HA ' HG22 ' A' ' 76' ' ' THR . 27.5 m -105.9 105.95 16.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.835 0.35 . . . . 0.45 110.981 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.612 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 49.7 m-85 -86.0 110.97 19.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.75 -0.463 . . . . 0.34 109.75 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.2 t -91.87 109.35 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.312 -0.625 . . . . 0.54 109.312 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.65 132.62 42.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.46 0.648 . . . . 0.44 111.908 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -108.0 123.16 48.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.402 -0.962 . . . . 2.03 108.402 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.93 -25.48 37.89 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.623 0.609 . . . . 1.97 114.623 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -85.12 39.5 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.453 0.626 . . . . 4.93 110.909 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 42.2 mmtt 58.53 46.74 14.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.996 0.903 . . . . 3.53 110.241 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.9 tttm -135.6 155.39 50.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.224 -1.353 . . . . 2.44 107.853 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 48.3 m -155.13 119.46 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.873 -0.517 . . . . 0.42 111.646 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -95.78 112.71 24.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.512 -0.767 . . . . 2.59 109.705 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.762 HG12 HG22 ' A' ' 10' ' ' VAL . 14.6 p -88.7 136.89 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 120.119 -0.633 . . . . 0.4 109.822 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.432 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 7.4 t70 -126.28 108.35 11.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.426 1.079 . . . . 1.38 108.607 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 99' ' ' VAL . 10.1 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.622 -0.717 . . . . 0.91 111.425 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.69 111.49 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.632 0.583 . . . . 2.31 109.495 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.645 ' HE1' ' HB3' ' A' ' 95' ' ' SER . 6.1 t60 -123.13 118.02 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.482 -0.562 . . . . 1.64 109.482 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.82 HG23 ' HD2' ' A' ' 120' ' ' ARG . 85.0 m -158.78 103.68 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.124 -0.23 . . . . 2.67 111.6 -174.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.98 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.865 0.364 . . . . 2.63 111.099 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.483 ' HZ ' ' HD3' ' A' ' 128' ' ' ARG . 50.4 t80 -78.24 -50.36 12.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.092 -0.503 . . . . 3.54 112.139 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.67 -38.42 77.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.411 0.624 . . . . 1.81 110.041 -174.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.82 ' HD2' HG23 ' A' ' 116' ' ' THR . 20.0 ttt180 -63.6 -20.21 65.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 3.38 111.573 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 31.0 tpp -80.11 29.87 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.099 0.777 . . . . 2.43 113.099 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.76 177.42 16.71 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.637 -1.268 . . . . 1.61 114.547 168.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -55.88 -60.55 3.3 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.812 -0.694 . . . . 2.58 112.745 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.9 -35.54 81.48 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 121.057 -0.257 . . . . 3.8 111.306 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.545 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 24.4 m80 -59.51 -50.93 72.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.973 0.416 . . . . 2.14 110.165 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.46 63.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 0.92 111.118 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 89.0 tttt -69.38 -38.96 78.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.099 -0.5 . . . . 2.83 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.42 -31.64 65.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 2.59 109.686 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.612 HG12 ' HG2' ' A' ' 133' ' ' MET . 87.0 t -61.63 -49.72 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 1.48 111.15 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.693 ' HA ' ' HG3' ' A' ' 133' ' ' MET . 0.0 OUTLIER -65.87 -14.54 61.66 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.162 -0.336 . . . . 3.83 111.443 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -52.51 -28.58 21.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.628 0.371 . . . . 2.48 111.843 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.411 ' H ' ' HD3' ' A' ' 88' ' ' ARG . . . -157.76 15.58 0.3 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.99 -1.1 . . . . 1.61 113.857 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.693 ' HG3' ' HA ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -84.22 -26.87 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.899 0.85 . . . . 4.83 111.438 176.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.56 -34.16 77.28 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.962 0.727 . . . . 2.83 112.962 -164.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.38 18.13 22.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.011 0.434 . . . . 4.15 110.579 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 140' ' ' ILE . . . -122.47 -77.34 0.4 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.04 -1.076 . . . . 1.04 112.871 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.474 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 76.0 t-105 -54.33 -51.91 73.8 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.716 0.636 . . . . 2.78 112.716 -169.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.8 -33.29 96.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.809 1.673 . . . . 0.68 111.94 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -76.56 -33.49 58.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.717 -0.674 . . . . 0.87 110.304 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -55.07 -48.16 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 108.596 -0.89 . . . . 0.72 108.596 173.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.0 mt -60.42 -28.36 68.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.261 -0.881 . . . . 0.69 112.002 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 26.4 mm-40 -72.13 -57.4 4.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.154 -0.313 . . . . 1.49 110.154 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.6 m -67.6 -25.93 66.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.12 0.486 . . . . 1.15 110.522 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 10' ' ' VAL . 62.0 t80 -57.8 -55.29 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.422 -0.808 . . . . 0.8 109.956 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.509 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 43.7 mt-30 -68.7 -24.63 64.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.763 -0.653 . . . . 1.63 110.939 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.25 -45.39 40.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.285 . . . . 1.46 111.593 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.778 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 15.2 tptm -70.23 -31.36 68.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.631 -0.828 . . . . 1.74 110.263 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.921 HG21 HG13 ' A' ' 12' ' ' VAL . 49.9 mt -63.43 -37.36 79.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.484 0.659 . . . . 0.5 109.635 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.482 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 11.5 t70 -59.33 -36.97 76.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.174 -0.921 . . . . 0.85 109.494 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 3.9 mm-40 -63.72 -41.04 98.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.507 -0.77 . . . . 1.5 110.673 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 5.7 mm-40 -75.96 -16.01 60.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.899 -1.046 . . . . 1.74 109.839 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -102.0 -75.88 1.14 Allowed Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.409 -0.814 . . . . 1.32 113.235 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.19 13.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.28 0.845 . . . . 1.92 113.28 -169.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 21.9 ttmm -71.47 -39.66 70.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 2.04 109.164 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' A' ' 155' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.475 -0.784 . . . . 4.22 110.031 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.643 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 2.8 p30 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.548 0.214 . . . . 1.66 110.989 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.498 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 54.8 p90 169.96 -30.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 3.73 109.62 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.835 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 31.6 t70 -65.87 -54.26 29.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 2.78 110.927 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.835 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -91.23 -68.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.133 1.889 . . . . 1.63 111.176 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 12.0 p90 -153.69 159.26 41.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.061 -0.518 . . . . 3.21 109.652 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.931 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 79.0 t -97.49 128.63 48.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.965 -0.754 . . . . 1.44 108.965 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 15.9 ttp180 -117.33 142.43 47.11 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.954 -0.698 . . . . 3.37 111.536 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.522 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -124.04 133.39 53.66 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.387 -0.968 . . . . 0.79 108.387 172.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.766 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 6.6 t -139.8 111.35 7.2 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.881 -0.414 . . . . 1.28 109.881 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.744 HG22 ' CG1' ' A' ' 111' ' ' VAL . 6.3 m -126.2 151.45 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 1.27 110.955 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.8 m -103.38 115.74 31.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.507 -0.769 . . . . 0.57 110.158 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.819 HG21 ' HB2' ' A' ' 19' ' ' ALA . 55.9 t -97.51 125.6 50.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.251 -0.886 . . . . 0.91 110.013 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.682 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.68 23.94 8.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.799 -0.637 . . . . 0.98 111.886 -173.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -148.23 31.04 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.36 111.055 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 37.7 t70 72.32 167.26 0.31 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.13 0.967 . . . . 0.91 113.504 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.547 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 34.3 ttp180 -63.47 -27.79 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.232 -1.349 . . . . 1.88 111.226 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.36 -45.08 84.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 3.05 111.141 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -77.36 -40.59 43.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.798 -0.361 . . . . 1.11 110.739 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.819 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.56 -41.68 77.28 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 120.886 -0.325 . . . . 0.32 110.904 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.31 -47.31 43.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.613 0.244 . . . . 0.38 110.949 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -54.12 -52.53 60.76 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.298 -0.41 . . . . 2.39 110.37 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -65.5 -51.03 62.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.367 -0.379 . . . . 0.68 111.031 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.784 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.4 t80 -61.22 -37.55 83.41 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.406 0.521 . . . . 0.48 112.406 -173.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.663 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -113.02 -50.06 2.9 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.195 -0.602 . . . . 0.5 112.469 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HA ' ' CE ' ' A' ' 48' ' ' LYS . 36.6 mt-10 -78.36 -35.28 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.071 0.462 . . . . 1.24 111.15 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.756 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -105.36 35.52 5.01 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 115.642 -0.708 . . . . 0.83 112.084 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.578 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 62.0 t80 -52.56 -51.27 74.73 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.968 0.729 . . . . 0.74 112.968 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.05 -2.01 11.79 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.11 1.873 . . . . 0.76 114.801 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.756 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.5 pt-20 -90.75 -5.45 55.68 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.227 -0.589 . . . . 1.49 112.183 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.784 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 9.7 m0 -74.52 -179.07 3.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.397 0.618 . . . . 4.62 111.259 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.52 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 79.2 m95 -96.18 -32.63 0.27 Allowed Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 114.237 1.199 . . . . 2.78 114.237 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.643 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 68.5 Cg_endo -71.54 -123.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.332 2.021 . . . . 1.36 115.244 -165.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.598 HD22 HG21 ' A' ' 40' ' ' VAL . 6.3 t30 -62.33 -22.74 66.31 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.169 -0.469 . . . . 1.51 111.452 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.799 ' HA ' HG23 ' A' ' 40' ' ' VAL . 11.8 p30 -86.91 17.22 4.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.999 -0.546 . . . . 1.79 111.497 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -71.76 -10.22 59.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.377 0.608 . . . . 4.45 110.037 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -104.3 118.88 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 4.14 111.279 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -77.25 151.39 35.14 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.63 -0.714 . . . . 2.68 109.64 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 57' ' ' ASP . 51.5 p 55.74 25.39 8.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.919 0.866 . . . . 1.42 110.791 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.566 ' HG2' HG22 ' A' ' 40' ' ' VAL . 16.8 ttmm -127.48 -59.67 1.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.61 -1.177 . . . . 2.9 109.723 166.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 34' ' ' ASN . 2.8 m -157.72 28.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.955 -0.566 . . . . 1.83 110.492 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.88 18.31 0.85 Allowed Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.934 -1.127 . . . . 2.17 114.178 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.006 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -73.95 162.67 72.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 117.163 0.482 . . . . 1.12 109.974 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 96.1 Cg_exo -50.05 -5.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 124.645 3.563 . . . . 1.48 116.53 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -105.33 -85.31 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.094 -0.379 . . . . 1.75 110.571 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.578 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.37 -48.28 2.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.884 -0.674 . . . . 0.75 112.976 174.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.663 HG11 ' HG ' ' A' ' 24' ' ' LEU . 73.3 t -140.11 141.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.6 111.289 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.875 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 20.7 t70 -96.38 115.07 26.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.508 -0.552 . . . . 1.11 109.508 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' CE ' ' HA ' ' A' ' 25' ' ' GLU . 36.4 mmtm -79.65 -27.99 40.85 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.95 0.781 . . . . 2.81 112.23 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -83.09 -46.84 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.425 0.528 . . . . 3.17 112.425 -170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.66 -32.01 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.446 -0.883 . . . . 1.53 111.954 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.553 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 103.95 71.18 0.84 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.348 -0.93 . . . . 0.77 112.239 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -136.25 162.55 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.929 -0.397 . . . . 3.72 109.929 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.0 m95 -116.75 107.75 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.28 108.886 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.875 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.7 p90 -162.64 159.93 25.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.228 0.537 . . . . 1.66 111.109 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 23.4 mt-10 -102.23 -176.01 3.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 2.12 110.051 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.8 mm -105.22 111.57 35.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.767 -0.827 . . . . 0.92 108.767 157.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.713 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 3.5 t70 -91.65 177.72 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.537 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -84.48 -36.14 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.851 0.686 . . . . 2.43 112.851 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -88.26 14.68 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.55 -0.46 . . . . 2.39 111.672 -173.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.75 64.02 0.92 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.356 -0.926 . . . . 2.29 112.811 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.683 ' HA ' ' NE2' ' A' ' 63' ' ' HIS . 0.1 OUTLIER 57.35 74.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.817 1.043 . . . . 2.31 113.817 172.087 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.17 73.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.113 -0.699 . . . . 2.61 109.113 169.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.713 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -125.24 163.31 22.78 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.214 -0.903 . . . . 3.72 110.883 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.609 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 9.0 t -157.09 135.62 11.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.639 0.257 . . . . 2.27 110.602 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.712 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 33.5 t80 -146.93 -58.43 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 6.48 110.558 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.525 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -155.72 159.68 29.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.53 -1.319 . . . . 1.23 114.25 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -119.01 113.81 21.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.668 -0.766 . . . . 1.17 109.696 177.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.004 HG21 HG13 ' A' ' 71' ' ' VAL . 72.3 mt -77.26 132.28 33.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 0.61 110.858 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -102.87 -24.94 13.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.047 -0.979 . . . . 2.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 47.4 tttm -165.79 108.96 0.8 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.559 -0.746 . . . . 1.53 111.192 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.004 HG13 HG21 ' A' ' 68' ' ' ILE . 1.6 m -100.91 115.5 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.362 -0.607 . . . . 0.88 109.362 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.24 74.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.73 -0.388 . . . . 1.42 110.779 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.15 -170.69 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 124.525 1.14 . . . . 0.96 111.944 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 30.7 Cg_exo -64.71 78.26 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.322 1.348 . . . . 0.38 111.093 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 23.5 t70 -161.76 -67.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.5 110.837 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.2 p -142.01 141.97 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.076 0.465 . . . . 0.35 111.805 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.59 126.94 28.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.433 . . . . 0.74 109.845 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 98' ' ' THR . 26.2 t -103.39 109.92 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.629 -0.878 . . . . 0.67 108.629 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.525 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -127.18 127.12 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.334 -0.394 . . . . 0.75 110.249 -174.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.84 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.56 155.75 23.53 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.5 112.339 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 58.3 t-105 -81.68 138.37 35.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.054 0.39 . . . . 2.79 112.054 -171.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 34.8 ttt-85 -148.54 23.16 1.02 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.859 -0.61 . . . . 5.46 109.997 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 78.48 145.48 0.09 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.083 -0.962 . . . . 1.55 112.917 172.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.551 ' H ' HD13 ' A' ' 83' ' ' LEU . 8.1 m-20 -77.85 48.47 0.7 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.499 -0.773 . . . . 1.93 111.37 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.22 46.9 43.19 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 116.126 -0.488 . . . . 2.4 113.916 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.471 ' H ' HD12 ' A' ' 83' ' ' LEU . 28.8 m-85 -106.96 1.81 24.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.159 -0.612 . . . . 5.38 111.211 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.42 24.62 76.62 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.53 -0.843 . . . . 2.3 111.603 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HD3' ' HB3' ' A' ' 131' ' ' ASN . 50.3 mtt180 -98.96 -174.28 2.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.41 -0.395 . . . . 4.77 110.637 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.67 ' O ' HD23 ' A' ' 83' ' ' LEU . 1.7 pp -54.74 149.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.845 0.716 . . . . 1.86 111.292 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 p-10 -146.49 135.15 11.01 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 110.0 -0.37 . . . . 3.18 110.0 175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 81' ' ' TRP . 3.4 Cg_exo -76.58 -37.89 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.446 2.097 . . . . 2.36 111.71 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 70.06 -6.59 1.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.388 -0.824 . . . . 2.99 111.88 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -137.89 -64.69 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 3.06 111.017 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -89.54 -161.49 0.78 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.185 -0.461 . . . . 1.85 111.293 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 3.7 t 67.4 40.0 2.79 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 122.06 0.933 . . . . 1.44 108.605 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.84 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 15.7 mt-10 -81.12 136.76 35.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.359 -1.292 . . . . 1.81 110.012 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -120.23 120.67 36.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.464 0.65 . . . . 0.64 110.563 174.082 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.536 HG23 HG22 ' A' ' 78' ' ' VAL . 41.7 m -93.35 115.27 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.99 -1.005 . . . . 0.43 110.085 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.472 ' CB ' HG23 ' A' ' 113' ' ' VAL . 2.0 m -94.59 123.82 46.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.349 0.595 . . . . 0.87 109.459 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' HG22 ' A' ' 76' ' ' THR . 86.5 m -104.89 106.84 17.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.307 -0.86 . . . . 0.45 109.805 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.691 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.1 m-85 -82.79 110.39 17.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 0.34 109.917 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 109' ' ' THR . 58.8 t -88.17 107.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.759 0.314 . . . . 0.54 110.481 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 129.28 39.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.928 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 5.9 t0 -128.16 97.3 4.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 2.03 110.476 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.45 69.56 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.913 -0.66 . . . . 1.97 113.977 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 66.67 6.64 4.62 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.887 0.699 . . . . 4.93 112.887 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 41.2 mtmt -136.26 -0.42 2.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 3.53 111.378 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 42.4 tttt -138.34 157.97 45.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.223 -0.658 . . . . 2.44 109.223 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.532 ' N ' ' HG2' ' A' ' 108' ' ' LYS . 18.1 m -156.67 128.28 7.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.102 0.477 . . . . 0.42 110.99 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 110' ' ' ARG . 8.5 tpt180 -106.33 115.14 29.7 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.763 -0.828 . . . . 2.59 108.763 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -95.17 141.55 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.291 -0.564 . . . . 0.4 111.005 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.563 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 11.5 t70 -128.99 104.1 7.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 124.459 1.099 . . . . 1.38 109.565 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -85.7 139.17 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-N 116.499 -0.319 . . . . 0.91 111.293 178.008 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 39.8 mt-10 -118.46 110.52 17.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.027 0.83 . . . . 2.31 109.823 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.931 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 3.0 t-160 -91.89 107.26 19.08 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.098 -0.955 . . . . 1.64 108.555 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 22.9 p -118.84 158.59 25.36 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.707 0.765 . . . . 2.67 112.383 -172.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.658 ' O ' ' HG3' ' A' ' 121' ' ' MET . 63.9 m80 99.22 -78.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.486 -1.688 . . . . 2.63 111.077 164.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.454 ' HZ ' ' NH1' ' A' ' 128' ' ' ARG . 31.6 t80 -72.47 -48.84 37.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.706 -0.679 . . . . 3.54 112.592 -165.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.48 -43.36 99.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.92 0.867 . . . . 1.81 109.5 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 55.2 ttt180 -61.12 -20.71 62.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.194 -1.367 . . . . 3.38 111.931 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.658 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 93.8 mtp -78.08 25.14 0.23 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.461 0.541 . . . . 2.43 112.461 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.4 155.37 8.9 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.722 -1.228 . . . . 1.61 113.293 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 t -51.93 -47.86 64.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.234 -0.483 . . . . 2.58 112.279 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -72.66 -25.27 61.2 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.879 -0.329 . . . . 3.8 111.168 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.554 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 11.5 m170 -68.35 -50.07 55.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.403 0.621 . . . . 2.14 109.569 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 2' ' ' TYR . . . -69.9 -30.87 68.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 0.92 111.001 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -68.37 -37.83 80.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 2.83 111.198 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.7 ptm180 -72.67 -36.27 67.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.887 -0.325 . . . . 2.59 110.248 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 81' ' ' TRP . 93.0 t -68.75 -33.05 57.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.342 0.591 . . . . 1.48 110.346 175.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 32.9 ttm180 -57.39 -21.83 38.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.242 -0.89 . . . . 3.83 111.0 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 91.1 m-20 -64.55 -21.35 66.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.48 111.598 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.7 -58.13 0.52 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.007 -1.092 . . . . 1.61 114.155 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -80.53 -9.18 59.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.131 0.789 . . . . 4.83 113.131 -170.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 6.4 p-10 -53.42 -49.4 67.4 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.842 0.682 . . . . 2.83 112.842 -169.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -111.34 -19.88 12.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 4.15 110.955 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -63.27 -57.27 15.92 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.632 -0.587 . . . . 1.04 111.632 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.433 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.6 m0 -55.47 -53.99 56.1 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.052 0.76 . . . . 2.78 113.052 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.3 Cg_endo -56.91 -37.75 97.55 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.747 1.632 . . . . 0.68 112.097 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.9 m -70.16 -45.29 67.06 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.635 0.731 . . . . 0.87 109.958 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.643 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 27.0 mt -58.54 -54.18 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.957 -1.019 . . . . 0.72 111.548 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HB3' HG11 ' A' ' 10' ' ' VAL . 82.2 mt -62.6 -24.66 67.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.255 0.465 . . . . 0.69 112.255 -173.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -56.56 4.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.952 0.406 . . . . 1.49 110.234 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 73.8 m -66.44 -23.09 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 1.15 110.531 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.77 -55.06 34.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 0.8 110.491 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.445 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 41.5 mt-30 -61.91 -32.44 72.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.961 -0.563 . . . . 1.63 110.684 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.1 m-20 -72.84 -40.91 65.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 1.46 111.773 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.3 tptp -65.42 -42.41 92.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 1.74 109.69 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.816 HG21 HG13 ' A' ' 12' ' ' VAL . 72.8 mt -62.36 -38.76 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.433 0.635 . . . . 0.5 110.401 174.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -58.37 -37.1 74.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.85 110.169 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 146' ' ' ASP . 38.9 mt-10 -72.9 -35.14 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.551 -0.75 . . . . 1.5 110.439 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 21.6 mm-40 -67.77 -38.0 82.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 1.74 110.142 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.94 -66.63 2.11 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.463 -0.79 . . . . 1.32 111.684 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.25 81.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.708 0.29 . . . . 1.92 111.478 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -163.13 85.48 0.52 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 2.04 110.329 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 150' ' ' GLU . 36.7 mtmt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.245 -0.883 . . . . 4.22 109.548 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.786 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.3 p-10 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.858 -0.115 . . . . 1.66 110.754 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 86.67 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.314 1.045 . . . . 3.73 110.175 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.653 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 11.2 t70 -51.39 -52.47 59.29 Favored Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 123.453 0.471 . . . . 2.78 111.63 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.4 Cg_endo -85.45 -67.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.165 1.244 . . . . 1.63 112.517 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 36.3 p90 -153.37 142.17 21.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.153 -0.684 . . . . 3.21 109.153 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.786 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -123.56 136.2 60.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 1.44 111.284 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.0 ttp180 -141.28 141.78 33.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.581 -0.736 . . . . 3.37 110.502 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.716 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.1 133.39 53.07 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.846 -0.798 . . . . 0.79 108.846 173.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 3.8 t -132.91 111.76 11.32 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.399 0.619 . . . . 1.28 110.214 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.0 t -123.91 138.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.053 -0.976 . . . . 1.27 111.585 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -96.6 117.04 30.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.251 0.548 . . . . 0.57 109.994 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.869 HG13 HG21 ' A' ' 148' ' ' ILE . 51.4 t -96.48 129.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.91 110.081 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.609 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.18 24.9 9.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.967 -0.56 . . . . 0.98 111.845 -173.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -153.74 33.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.31 0.485 . . . . 0.36 112.31 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 15.8 t70 73.43 165.67 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.904 0.859 . . . . 0.91 112.607 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -65.66 -26.33 67.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.87 -1.059 . . . . 1.88 111.166 -174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.95 -43.69 98.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.122 -0.49 . . . . 3.05 111.09 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.0 p -74.55 -35.76 63.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.888 -0.325 . . . . 1.11 110.361 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.65 -48.16 78.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.32 110.444 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.06 -44.47 69.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.38 110.732 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -55.23 -52.33 63.74 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.404 -0.362 . . . . 2.39 110.807 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -67.3 -51.07 57.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.546 -0.297 . . . . 0.68 111.102 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.646 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.0 t80 -65.42 -34.58 78.63 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.059 0.392 . . . . 0.48 112.059 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD11 HG11 ' A' ' 46' ' ' VAL . 12.9 tp -111.73 -54.42 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.382 -0.527 . . . . 0.5 111.961 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.89 33.7 2.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 1.24 111.705 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.747 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -157.73 34.47 0.53 Allowed Glycine 0 C--O 1.217 -0.908 0 C-N-CA 120.734 -0.746 . . . . 0.83 111.895 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.61 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 t80 -61.58 -51.39 77.19 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 112.264 0.468 . . . . 0.74 112.264 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.676 ' HB3' HD23 ' A' ' 44' ' ' LEU . 93.4 Cg_endo -77.57 15.49 1.23 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.461 2.107 . . . . 0.76 115.058 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -113.09 -2.31 14.2 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.835 -0.541 . . . . 1.49 111.151 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.864 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 31.2 m0 -72.43 160.13 32.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.329 0.585 . . . . 4.62 111.277 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 58.2 m95 -89.61 -37.01 0.42 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.627 0.973 . . . . 2.78 113.627 175.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 18.5 Cg_endo -58.18 -84.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.525 2.15 . . . . 1.36 115.448 -163.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HB3' HD11 ' A' ' 140' ' ' ILE . 12.2 t-20 -110.76 -4.41 15.33 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.776 0.798 . . . . 1.51 109.425 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.847 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.9 m-20 -86.54 74.39 9.91 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.729 -1.123 . . . . 1.79 111.255 -170.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -154.46 29.09 0.44 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.791 0.663 . . . . 4.45 112.791 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 23.3 mmm180 -135.77 152.63 51.32 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 4.14 111.728 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.3 p -76.17 135.39 39.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.502 -0.317 . . . . 2.68 110.149 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 57' ' ' ASP . 1.7 p 50.22 26.04 2.03 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.632 0.729 . . . . 1.42 111.741 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 15.7 ttmm -146.04 71.44 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.165 -0.925 . . . . 2.9 109.1 174.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.847 HG23 ' HA ' ' A' ' 34' ' ' ASN . 6.9 m 53.36 29.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.052 -1.431 . . . . 1.83 113.21 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.37 7.35 0.61 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.106 -1.521 . . . . 2.17 114.171 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 43' ' ' PRO . . . -83.1 -171.25 0.29 Allowed Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.517 -0.549 . . . . 1.12 109.517 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.876 ' HG2' ' HB ' ' A' ' 56' ' ' ILE . 18.8 Cg_endo -64.19 74.39 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 120.908 1.072 . . . . 1.48 109.336 161.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.81 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -120.97 -162.44 0.96 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.939 0.875 . . . . 1.75 110.266 -166.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.734 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . 135.68 -115.02 1.28 Allowed Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 113.541 -1.663 . . . . 0.75 110.412 166.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.582 HG11 HD11 ' A' ' 24' ' ' LEU . 86.9 t -140.47 136.16 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.69 -0.755 . . . . 0.6 112.297 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.799 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 8.1 t0 -105.77 104.97 14.8 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.343 -1.298 . . . . 1.11 108.071 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.62 ' H ' ' HE3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -79.86 -28.69 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.044 0.45 . . . . 2.81 111.008 -174.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 50.6 pttt -71.49 -29.25 64.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 3.17 111.645 -175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.6 -25.61 4.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.135 -0.555 . . . . 1.53 112.425 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.39 57.91 1.61 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.158 -0.544 . . . . 0.77 112.803 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.799 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 26.1 ptt180 -146.33 152.73 39.61 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.583 -0.363 . . . . 3.72 111.314 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 32.0 m0 -110.53 113.79 26.69 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.069 -0.715 . . . . 1.28 109.069 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.585 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.7 p90 -151.47 174.03 13.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.101 -1.04 . . . . 1.66 112.786 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.81 ' HG2' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mt-10 -134.05 143.0 47.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.029 -0.532 . . . . 2.12 110.932 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.876 ' HB ' ' HG2' ' A' ' 43' ' ' PRO . 25.4 mm -83.06 103.64 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.373 -0.531 . . . . 0.92 109.785 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 61' ' ' GLU . 1.9 p-10 -66.4 -169.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.491 0.662 . . . . 1.97 111.199 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.73 -27.65 22.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.7 1.0 . . . . 2.43 113.7 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.12 -28.64 12.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.658 0.984 . . . . 2.39 113.658 -164.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.96 46.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.268 -1.444 . . . . 2.29 113.782 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 16.1 mt-10 73.21 73.46 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.119 0.785 . . . . 2.31 113.119 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 11.4 tp10 -123.42 74.41 1.24 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.867 -1.16 . . . . 2.61 107.867 165.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.463 ' CD2' ' HD1' ' A' ' 54' ' ' TYR . 2.0 p80 -113.07 126.36 55.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.549 -1.205 . . . . 3.72 112.143 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.592 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 6.0 m -63.35 135.43 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.123 -1.066 . . . . 2.27 108.123 166.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.7 p90 -123.22 143.99 49.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.539 0.57 . . . . 6.48 112.539 -171.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -75.52 151.46 41.56 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.041 -1.224 . . . . 1.23 110.041 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.779 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -115.6 94.33 4.65 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.043 0.422 . . . . 1.17 111.192 -171.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 71' ' ' VAL . 41.5 mt -74.49 132.49 33.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.61 110.354 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.565 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 12.8 mmm-85 -103.91 -25.33 13.08 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.716 -0.475 . . . . 2.0 109.716 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 82.6 tttt -145.52 115.52 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.53 111.198 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 68' ' ' ILE . 47.6 t -105.01 91.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 109.245 -0.65 . . . . 0.88 109.245 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 1.1 t70 -106.15 100.61 10.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.672 -0.695 . . . . 1.42 109.531 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 17.0 pt-20 -24.79 148.06 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 125.105 1.503 . . . . 0.96 112.542 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.6 Cg_exo -18.55 78.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.839 3.693 . . . . 0.38 114.781 -162.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -164.21 -63.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.844 -1.071 . . . . 0.5 110.614 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -149.69 141.57 23.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.23 0.538 . . . . 0.35 112.284 -175.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 77' ' ' LEU . 1.7 mp -134.24 115.06 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.354 -0.384 . . . . 0.74 110.037 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 61.7 t -97.25 108.31 21.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.235 -0.654 . . . . 0.67 109.235 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -126.4 130.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.146 -0.479 . . . . 0.75 111.496 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.779 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -84.17 151.71 27.42 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.5 112.397 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.792 ' HZ2' ' HB3' ' A' ' 133' ' ' MET . 27.2 t-105 -82.06 146.13 29.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.836 1.05 . . . . 2.79 113.836 -162.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.74 ' O ' HD12 ' A' ' 83' ' ' LEU . 1.4 ttp180 -139.82 -8.42 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.366 -0.833 . . . . 5.46 111.693 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER 37.07 -160.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.764 1.764 . . . . 1.55 115.764 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 94.7 m-20 -126.26 135.23 51.3 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.116 0.566 . . . . 1.93 109.867 -171.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.58 81.36 0.11 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.201 -0.523 . . . . 2.4 113.402 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -128.21 24.17 5.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.468 . . . . 5.38 110.298 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.09 30.79 2.84 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.334 -1.106 . . . . 2.3 110.334 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.541 ' HD2' ' C ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -97.53 163.41 12.87 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.57 -0.815 . . . . 4.77 112.899 -171.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.774 HG21 ' HE ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -117.22 128.3 74.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.386 -1.279 . . . . 1.86 108.065 159.246 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.76 136.67 27.58 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.381 -0.6 . . . . 3.18 109.381 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.694 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 53.1 Cg_exo -56.41 -43.36 56.37 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 122.998 2.466 . . . . 2.36 112.185 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 t70 72.09 -28.66 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.947 0.779 . . . . 2.99 112.68 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -124.4 -8.5 7.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.26 0.467 . . . . 3.06 112.26 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 95' ' ' SER . 62.6 p -162.28 -147.67 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.082 -0.247 . . . . 1.85 110.994 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.628 ' OG ' ' HB3' ' A' ' 118' ' ' PHE . 32.7 m 67.73 42.71 1.94 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.734 -0.666 . . . . 1.44 110.5 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.615 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 43.8 mp0 -70.4 139.3 51.84 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.391 -0.822 . . . . 1.81 109.935 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.488 ' HB2' HG13 ' A' ' 113' ' ' VAL . 2.6 p90 -127.37 127.74 44.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.02 0.438 . . . . 0.64 110.271 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.1 m -88.4 110.2 20.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.366 -0.833 . . . . 0.43 110.466 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.722 ' HA ' HG22 ' A' ' 113' ' ' VAL . 65.9 t -82.35 108.9 15.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.949 -0.569 . . . . 0.87 109.681 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 7.0 m -101.54 107.01 18.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.848 0.356 . . . . 0.45 110.774 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 26.7 m-85 -94.17 111.11 22.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.222 -0.445 . . . . 0.34 110.897 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.24 107.74 19.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.777 -0.453 . . . . 0.54 109.777 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.03 145.36 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.681 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.824 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 4.4 t70 -140.09 107.49 5.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.389 -0.369 . . . . 2.03 110.668 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.27 50.55 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.048 -0.596 . . . . 1.97 113.183 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 58.49 22.42 9.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.32 0.648 . . . . 4.93 111.893 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 43.7 mtmt -141.36 -14.87 0.86 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.187 -0.321 . . . . 3.53 111.212 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.824 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 27.8 tttp -121.49 155.77 34.23 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.501 -0.925 . . . . 2.44 108.501 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.551 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 42.4 m -157.25 135.45 11.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.685 0.279 . . . . 0.42 110.333 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -115.12 122.16 45.26 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.035 -0.728 . . . . 2.59 109.035 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.7 p -101.89 136.82 32.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.438 -0.505 . . . . 0.4 110.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -125.47 113.9 18.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 1.38 109.186 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.722 HG22 ' HA ' ' A' ' 99' ' ' VAL . 3.6 t -95.01 120.82 44.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.317 -0.856 . . . . 0.91 110.78 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.58 111.3 23.63 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.445 -0.798 . . . . 2.31 109.597 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.603 ' O ' HG13 ' A' ' 6' ' ' VAL . 45.4 t60 -123.81 109.51 13.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.351 -0.841 . . . . 1.64 108.843 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 120' ' ' ARG . 20.2 m -157.42 96.91 1.58 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.143 -0.223 . . . . 2.67 111.231 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.518 ' O ' ' HG3' ' A' ' 121' ' ' MET . 40.5 t60 -162.67 -74.9 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 120.664 0.268 . . . . 2.63 111.196 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.628 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 37.5 t80 -85.77 -26.82 25.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.593 0.711 . . . . 3.54 110.089 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.1 p-10 -68.64 -51.63 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.87 -1.059 . . . . 1.81 110.857 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD2' HG22 ' A' ' 116' ' ' THR . 7.9 ptm180 -59.02 -19.03 39.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.457 -0.792 . . . . 3.38 112.01 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 94.7 mtp -64.15 -9.85 19.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.948 0.404 . . . . 2.43 110.14 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 55.17 -153.77 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.199 -0.91 . . . . 1.61 114.407 166.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.7 p 44.38 -125.53 0.99 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.29 0.636 . . . . 2.58 111.555 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.49 -23.73 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.652 -0.249 . . . . 3.8 110.911 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.527 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 39.9 m80 -63.47 -51.6 64.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.008 0.432 . . . . 2.14 110.253 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.954 -0.566 . . . . 0.92 110.403 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -63.48 -42.76 98.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.661 . . . . 2.83 111.23 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.774 ' HE ' HG21 ' A' ' 89' ' ' ILE . 11.8 ptm180 -73.84 -31.55 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 2.59 111.501 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.59 -39.57 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.206 0.527 . . . . 1.48 110.643 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.638 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 69.7 ttt180 -62.42 -16.75 56.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.602 -0.726 . . . . 3.83 111.317 -176.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.34 -47.73 62.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.04 0.385 . . . . 2.48 112.04 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.29 -34.98 5.15 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.077 -1.058 . . . . 1.61 113.539 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.792 ' HB3' ' HZ2' ' A' ' 81' ' ' TRP . 23.8 ptm -81.12 -21.84 39.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.904 0.705 . . . . 4.83 112.904 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.638 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 34.1 t70 -54.7 -43.34 72.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.431 0.9 . . . . 2.83 113.431 -168.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -114.13 30.88 6.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.456 0.646 . . . . 4.15 110.331 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.75 -70.31 0.17 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.493 -0.861 . . . . 1.04 112.124 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.471 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 10.4 t90 -58.19 -52.0 77.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.463 0.542 . . . . 2.78 112.463 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.8 Cg_endo -59.35 -37.74 88.6 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.94 1.76 . . . . 0.68 112.355 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.1 m -70.02 -36.54 75.17 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.746 0.784 . . . . 0.87 109.671 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.7 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 15.3 mt -55.75 -40.24 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.66 -1.155 . . . . 0.72 110.521 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 8' ' ' HIS . 79.0 mt -61.7 -30.77 70.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.925 0.343 . . . . 0.69 111.925 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.63 -51.29 23.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 1.49 110.193 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.531 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 37.1 m -68.67 -22.76 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.137 -0.483 . . . . 1.15 110.805 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 58.9 t80 -61.64 -54.26 45.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 0.8 109.929 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.495 ' CG ' HG13 ' A' ' 10' ' ' VAL . 38.8 mt-30 -57.37 -37.69 73.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.82 -0.627 . . . . 1.63 110.77 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.43 -0.804 . . . . 1.46 111.26 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -67.12 -41.43 86.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.8 0.333 . . . . 1.74 110.414 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.869 HG21 HG13 ' A' ' 12' ' ' VAL . 47.0 mt -62.08 -34.26 62.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.5 110.905 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.62 -30.58 68.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.985 -0.552 . . . . 0.85 110.307 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.784 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 64.8 mt-10 -69.09 -43.83 73.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.5 110.03 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -69.53 -17.75 63.61 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.163 -0.926 . . . . 1.74 109.996 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.67 -40.11 6.44 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.407 -0.815 . . . . 1.32 112.62 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -171.95 -26.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.039 0.755 . . . . 1.92 113.039 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.784 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 6.2 ttmt -76.07 72.76 2.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.234 0.54 . . . . 2.04 111.609 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 150' ' ' GLU . 68.2 mttm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.446 -0.787 . . . . 4.22 110.048 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.803 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 17.5 p-10 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.825 0.345 . . . . 1.66 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 54.6 p90 173.26 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.837 -0.619 . . . . 3.73 109.668 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.804 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 32.8 t70 -66.04 -52.31 40.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 2.78 111.041 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 12.5 Cg_endo -92.44 -70.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.153 1.902 . . . . 1.63 111.605 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -141.25 145.67 35.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 3.21 110.25 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.803 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -118.63 125.72 74.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.419 -0.585 . . . . 1.44 109.419 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 5.9 ttm105 -132.74 143.28 49.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.056 -0.52 . . . . 3.37 112.027 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HE2' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.0 133.01 53.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.575 -0.898 . . . . 0.79 108.575 170.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.7 m -133.76 111.51 10.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.589 0.709 . . . . 1.28 110.643 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.596 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.7 t -123.5 142.46 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.824 -1.08 . . . . 1.27 110.139 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.6 m -121.92 116.06 23.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.57 110.074 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.659 ' HB ' HG21 ' A' ' 148' ' ' ILE . 11.0 m -102.91 163.63 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.509 -0.768 . . . . 0.91 111.028 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.566 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -117.88 26.05 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.98 111.661 -171.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB3' HG23 ' A' ' 148' ' ' ILE . . . -143.06 23.98 1.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.641 -0.423 . . . . 0.36 111.52 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 33.8 t70 72.16 173.88 0.3 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.589 -0.732 . . . . 0.91 112.565 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 9.7 ttp180 -68.03 -26.43 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.14 -0.936 . . . . 1.88 111.321 -172.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -54.44 -48.53 71.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.104 0.478 . . . . 3.05 110.755 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -80.73 -34.17 34.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 1.11 111.046 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -59.58 -45.24 92.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.606 0.241 . . . . 0.32 110.77 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -67.99 -45.89 72.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.38 110.516 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.701 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 29.6 tptp -54.77 -51.84 64.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 2.39 110.452 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.551 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 55.0 m -65.28 -40.4 93.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.68 111.539 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 67.5 t80 -71.33 -37.98 71.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.409 -0.36 . . . . 0.48 111.691 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 46' ' ' VAL . 9.6 tp -119.44 -55.78 2.1 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.714 0.635 . . . . 0.5 112.714 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.701 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 2.3 mm-40 -87.85 18.33 4.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.542 0.571 . . . . 1.24 112.542 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -151.51 28.44 0.96 Allowed Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.246 -1.142 . . . . 0.83 110.246 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.623 ' HZ ' ' CE1' ' A' ' 65' ' ' PHE . 71.0 t80 -47.54 -51.77 42.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.494 -0.853 . . . . 0.74 113.18 -168.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.4 Cg_endo -96.31 11.39 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.027 1.818 . . . . 0.76 115.445 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -106.31 -6.54 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.306 0.854 . . . . 1.49 113.306 -172.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.793 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 18.2 m95 -92.66 -152.21 0.31 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.2 -0.312 . . . . 4.62 111.75 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.58 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 31.6 m95 -105.77 0.16 0.1 Allowed Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 115.383 1.623 . . . . 2.78 115.383 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.902 ' HB3' ' HA ' ' A' ' 140' ' ' ILE . 27.1 Cg_exo -66.07 -150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 122.54 1.943 . . . . 1.36 114.342 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.601 ' ND2' HG21 ' A' ' 40' ' ' VAL . 63.5 t30 -63.28 -4.35 2.49 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.485 -0.78 . . . . 1.51 111.646 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.967 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 30.8 p30 -83.6 15.64 3.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.807 -0.633 . . . . 1.79 111.975 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.699 ' HD1' ' HG2' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -69.62 3.28 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.167 0.803 . . . . 4.45 113.167 -173.047 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.699 ' HG2' ' HD1' ' A' ' 35' ' ' PHE . 42.6 mmt-85 -140.13 147.89 40.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.96 0.41 . . . . 4.14 111.541 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -76.1 145.08 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.777 -0.647 . . . . 2.68 111.13 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 57' ' ' ASP . 62.8 p 50.86 16.38 0.32 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.2 1.0 . . . . 1.42 112.279 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.795 ' HD3' HG23 ' A' ' 40' ' ' VAL . 5.8 tmtm? -104.17 -62.88 1.26 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.091 -1.448 . . . . 2.9 107.091 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.967 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 31.3 t -146.95 1.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.108 0.956 . . . . 1.83 108.636 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 28' ' ' PRO . . . -126.73 50.61 0.87 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.538 -0.756 . . . . 2.17 112.461 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -90.96 168.34 14.0 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.524 . . . . 1.12 109.587 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 48.4 Cg_endo -69.53 54.97 1.14 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.729 2.286 . . . . 1.48 114.056 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HB2' HG12 ' A' ' 56' ' ' ILE . 55.1 tp -164.92 -96.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.41 -0.359 . . . . 1.75 110.518 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.625 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 104.85 -59.09 0.45 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.75 112.38 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 24' ' ' LEU . 78.9 t -136.74 141.2 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 122.784 -0.245 . . . . 0.6 110.37 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.77 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 7.1 t70 -112.36 113.38 25.56 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.491 -0.559 . . . . 1.11 109.491 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -79.2 -31.9 43.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.017 0.377 . . . . 2.81 112.017 -175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -83.66 -34.84 24.92 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 3.17 110.9 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.8 -35.87 30.43 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.606 -0.807 . . . . 1.53 111.718 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' HB ' ' A' ' 68' ' ' ILE . . . 85.26 54.24 2.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.429 -0.668 . . . . 0.77 111.429 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -160.65 165.0 31.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 3.72 110.949 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.64 117.82 33.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.756 -0.461 . . . . 1.28 109.756 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.77 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -164.36 152.27 12.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.491 . . . . 1.66 109.99 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 2.2 mp0 -112.59 160.53 17.76 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.521 -0.548 . . . . 2.12 109.521 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 44' ' ' LEU . 44.4 mm -77.14 103.92 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.864 0.364 . . . . 0.92 110.091 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 38' ' ' THR . 4.6 t70 -90.78 170.4 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.97 110.117 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.91 -37.19 64.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.65 0.982 . . . . 2.43 113.65 -165.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -86.6 -0.76 56.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.223 -0.591 . . . . 2.39 111.56 -178.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.79 72.87 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.648 -1.263 . . . . 2.29 114.064 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 53.0 29.7 8.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.491 0.552 . . . . 2.31 112.491 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 13.7 tp10 -85.73 75.88 10.02 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.404 -0.591 . . . . 2.61 109.404 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HE1' ' O ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -126.96 163.5 23.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.003 -0.544 . . . . 3.72 111.78 177.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.853 HG22 ' HG3' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -134.58 121.26 20.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.734 . . . . 2.27 109.89 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.803 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 3.7 t80 -144.83 -66.7 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 119.787 -0.765 . . . . 6.48 113.057 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -158.64 165.14 33.9 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.909 -1.615 . . . . 1.23 114.732 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 82' ' ' ARG . 5.6 mp -113.39 107.35 15.74 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.268 0.627 . . . . 1.17 110.342 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.863 HG21 HG23 ' A' ' 71' ' ' VAL . 65.0 mt -70.6 116.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.407 -0.917 . . . . 0.61 110.385 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -90.35 -24.67 20.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.85 -0.613 . . . . 2.0 109.4 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 65.7 tttt -170.99 123.7 0.61 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.957 -0.565 . . . . 1.53 111.623 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 68' ' ' ILE . 95.0 t -106.32 113.5 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.959 -0.756 . . . . 0.88 108.959 169.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -117.6 72.1 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.818 -0.353 . . . . 1.42 110.11 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 45.17 -168.2 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 124.615 1.197 . . . . 0.96 111.9 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.1 Cg_exo -63.33 76.85 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.253 1.302 . . . . 0.38 111.436 166.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.16 -63.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.942 -0.572 . . . . 0.5 110.287 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -144.34 139.66 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.482 0.549 . . . . 0.35 112.482 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.96 109.7 6.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.74 109.261 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 70' ' ' LYS . 1.2 p -101.5 113.54 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.519 -0.549 . . . . 0.67 109.519 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.535 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -129.39 141.39 46.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.55 -0.75 . . . . 0.75 110.724 -177.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.528 ' HA2' ' H ' ' A' ' 96' ' ' GLU . . . -89.5 172.79 39.75 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.951 -0.568 . . . . 0.5 112.859 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.816 ' H ' ' HB2' ' A' ' 95' ' ' SER . 73.0 t-105 -90.22 156.46 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.517 0.199 . . . . 2.79 111.3 -172.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.853 ' HG3' HG22 ' A' ' 64' ' ' THR . 18.1 tpt180 177.86 42.31 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.854 -0.612 . . . . 5.46 110.483 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.803 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 84.1 133.35 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.895 0.478 . . . . 1.55 111.135 169.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' N ' HD13 ' A' ' 83' ' ' LEU . 3.2 t-20 -93.66 75.35 4.35 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.46 -62.68 3.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.602 -0.809 . . . . 2.4 113.609 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -168.41 138.06 2.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.465 0.174 . . . . 5.38 110.937 -172.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.61 38.1 3.79 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.754 -0.736 . . . . 2.3 114.232 170.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.842 ' NH1' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -148.19 163.32 37.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.372 0.586 . . . . 4.77 111.021 177.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.592 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -122.17 114.59 43.28 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 122.471 0.308 . . . . 1.86 111.357 176.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.842 ' HB3' ' NH1' ' A' ' 88' ' ' ARG . 6.5 t70 -170.22 108.43 0.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 3.18 109.557 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD2' ' CZ ' ' A' ' 128' ' ' ARG . 45.1 Cg_endo -87.66 30.48 0.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.835 2.357 . . . . 2.36 111.466 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.586 ' HB2' HH21 ' A' ' 128' ' ' ARG . 3.4 t70 -84.76 170.62 13.04 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.752 0.787 . . . . 2.99 110.793 -165.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.37 15.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.345 -1.298 . . . . 3.06 109.897 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.48 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 14.8 m -131.67 -78.62 0.51 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.251 -0.886 . . . . 1.85 109.14 170.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.816 ' HB2' ' H ' ' A' ' 81' ' ' TRP . 19.9 m 47.92 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.206 1.002 . . . . 1.44 112.006 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' H ' ' HA2' ' A' ' 80' ' ' GLY . 49.4 tt0 77.59 112.67 0.07 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 1.81 112.979 163.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.575 ' HB2' HG13 ' A' ' 113' ' ' VAL . 51.0 p90 -127.56 124.26 37.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.64 110.106 167.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.473 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 41.8 m -88.16 109.2 19.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.384 -0.826 . . . . 0.43 109.703 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 113' ' ' VAL . 62.0 t -82.41 110.06 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.395 . . . . 0.87 110.009 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.488 ' HA ' HG22 ' A' ' 76' ' ' THR . 28.2 m -103.17 107.31 18.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.45 110.518 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.712 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 43.7 m-85 -90.38 111.16 22.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.294 -0.412 . . . . 0.34 110.214 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.3 t -93.04 112.61 26.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.914 -0.402 . . . . 0.54 109.914 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.54 126.98 31.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.306 -0.406 . . . . 0.44 110.607 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 50.7 m-20 -119.17 114.76 22.94 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.367 -0.379 . . . . 2.03 110.49 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.91 -102.84 1.27 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.029 -0.605 . . . . 1.97 112.706 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -145.15 -23.32 0.49 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.807 0.337 . . . . 4.93 110.485 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 21.6 pttp -142.93 34.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 3.53 111.625 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 56.2 tttm -136.21 148.18 47.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.235 -0.654 . . . . 2.44 109.235 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.3 m -155.33 122.19 5.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.159 0.504 . . . . 0.42 111.499 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -94.38 116.77 29.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.288 -0.869 . . . . 2.59 109.839 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.712 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 p -94.5 134.93 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 109.331 -0.618 . . . . 0.4 109.331 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.13 114.1 13.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.968 -1.015 . . . . 1.38 109.405 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 99' ' ' VAL . 2.4 t -106.87 122.87 61.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.178 -0.919 . . . . 0.91 111.809 -171.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 25.8 mt-10 -98.21 110.76 23.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.248 -0.433 . . . . 2.31 110.067 171.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.579 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.9 t-80 -105.16 103.64 13.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.977 -1.49 . . . . 1.64 106.977 171.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -153.84 96.99 2.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.368 -0.533 . . . . 2.67 110.749 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.628 ' O ' ' HG2' ' A' ' 121' ' ' MET . 1.5 t60 -166.51 -76.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.786 -0.643 . . . . 2.63 109.552 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 94' ' ' SER . 4.4 m-85 -85.45 -23.71 27.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.529 0.937 . . . . 3.54 113.529 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.31 -53.34 59.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.674 0.749 . . . . 1.81 110.69 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.89 -17.46 64.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.662 -1.153 . . . . 3.38 111.446 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 93.6 mmm -73.74 27.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.889 0.7 . . . . 2.43 112.889 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.92 -175.42 21.85 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 118.798 -1.668 . . . . 1.61 114.016 166.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 -53.7 7.74 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.522 -0.839 . . . . 2.58 110.959 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.768 ' HA ' ' HB2' ' A' ' 127' ' ' LYS . 20.3 pttp -89.28 -11.7 42.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.922 0.712 . . . . 3.8 112.922 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.727 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 16.1 m80 -62.45 -53.4 55.36 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.998 -0.681 . . . . 2.14 109.556 167.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.92 110.996 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.768 ' HB2' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mttp -66.63 -33.01 74.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 111.94 0.348 . . . . 2.83 111.94 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 27.4 ptt180 -69.89 -52.9 20.83 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.479 -0.488 . . . . 2.59 109.728 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.508 HG12 ' SD ' ' A' ' 133' ' ' MET . 35.0 t -56.48 -33.84 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.206 0.527 . . . . 1.48 111.133 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.36 -16.47 14.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.044 0.938 . . . . 3.83 112.502 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 88' ' ' ARG . 11.3 t-20 -56.06 -40.75 74.02 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.032 0.752 . . . . 2.48 113.032 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.31 19.16 0.23 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.015 -1.564 . . . . 1.61 114.095 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.508 ' SD ' HG12 ' A' ' 129' ' ' VAL . 17.7 ptt? -80.29 -27.66 38.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.667 0.733 . . . . 4.83 109.683 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -80.54 -13.57 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 2.83 111.932 -170.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HB2' ' NZ ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -92.88 1.75 57.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.804 0.335 . . . . 4.15 110.539 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.635 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.89 -55.38 0.14 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.123 -1.037 . . . . 1.04 113.048 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.503 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 61.7 t-105 -53.81 -52.76 64.77 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.534 0.568 . . . . 2.78 112.534 -171.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 25.1 Cg_endo -60.97 -45.42 19.99 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.595 1.53 . . . . 0.68 111.768 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.1 m -59.64 -38.7 82.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.652 0.739 . . . . 0.87 110.108 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.902 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 14.0 mt -68.04 -41.67 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.126 -0.943 . . . . 0.72 110.766 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 55.0 mt -63.88 -32.93 74.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.69 111.53 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -48.0 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.62 0.248 . . . . 1.49 110.999 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 31.9 m -71.38 -25.9 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.15 110.817 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.52 -55.37 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.672 -0.695 . . . . 0.8 109.941 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.458 ' CG ' HG13 ' A' ' 10' ' ' VAL . 47.3 mt-30 -64.94 -27.6 68.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.905 -0.589 . . . . 1.63 110.522 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 2.8 t70 -67.95 -55.35 13.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 1.46 111.133 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.793 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 16.7 tptm -64.12 -39.87 94.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.267 -0.573 . . . . 1.74 110.638 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.659 HG21 ' HB ' ' A' ' 12' ' ' VAL . 67.7 mt -63.66 -34.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.5 110.723 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.566 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 18.4 t70 -66.86 -32.06 73.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.814 -0.439 . . . . 0.85 109.814 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.961 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 35.4 mt-10 -67.84 -33.11 74.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.235 0.54 . . . . 1.5 110.194 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 4.6 mm-40 -79.68 -12.96 59.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.375 -0.83 . . . . 1.74 110.172 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.53 -75.16 1.14 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.713 -0.676 . . . . 1.32 112.862 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -151.24 35.88 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.982 0.391 . . . . 1.92 111.777 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.961 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 12.4 tppt? -75.44 -10.93 59.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.44 0.638 . . . . 2.04 109.642 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.0 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.484 -0.78 . . . . 4.22 109.833 -176.508 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.4 p-10 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.209 -0.293 . . . . 1.66 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 1.2 t80 80.59 -50.71 0.32 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.584 0.552 . . . . 3.73 111.372 172.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.686 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.1 t70 -61.87 -49.41 85.9 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.092 -0.243 . . . . 2.78 111.213 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.0 Cg_endo -92.47 -65.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.964 1.776 . . . . 1.63 111.871 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.31 156.76 44.0 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.182 -1.414 . . . . 3.21 107.182 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.924 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 88.7 t -85.62 124.05 39.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.657 -0.817 . . . . 1.44 109.828 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 14.0 ttp180 -128.82 138.04 51.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.954 0.407 . . . . 3.37 110.865 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.526 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -115.3 132.33 56.65 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.987 -1.116 . . . . 0.79 107.987 170.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 1.0 OUTLIER -136.16 110.47 8.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.746 0.784 . . . . 1.28 109.437 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.469 HG13 ' CG ' ' A' ' 145' ' ' GLN . 1.7 t -125.43 142.6 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.434 -1.257 . . . . 1.27 110.966 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -102.33 115.19 30.04 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.279 0.561 . . . . 0.57 109.742 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.817 HG13 HG21 ' A' ' 148' ' ' ILE . 39.6 t -95.07 128.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.824 -0.626 . . . . 0.91 110.316 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.678 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.59 32.79 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.98 111.387 -173.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.41 26.87 0.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.586 -0.279 . . . . 0.36 111.666 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.618 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 27.4 t70 73.97 168.42 0.3 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.175 0.512 . . . . 0.91 112.349 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 12.1 ttp180 -69.12 -33.32 73.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.858 -0.61 . . . . 1.88 111.815 -170.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.618 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 13.7 pttm -59.01 -43.05 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 3.05 110.566 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -72.51 -37.47 68.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.339 -0.391 . . . . 1.11 110.878 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -60.23 -46.25 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.32 110.429 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -69.42 -45.81 68.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.38 110.607 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.774 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 23.6 tptp -53.47 -50.62 64.94 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.137 -0.483 . . . . 2.39 110.736 176.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -68.61 -50.15 53.7 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.085 -0.246 . . . . 0.68 111.011 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.684 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 68.6 t80 -65.45 -39.35 91.92 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.039 0.385 . . . . 0.48 112.039 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 46' ' ' VAL . 14.4 tp -109.54 -49.41 3.11 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.021 -0.672 . . . . 0.5 112.035 -176.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.776 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 30.3 mt-10 -87.72 10.79 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.19 0.519 . . . . 1.24 110.598 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.73 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -143.83 26.12 2.08 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.83 110.896 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 46.8 t80 -49.32 -49.52 70.17 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.41 . . . . 0.74 111.45 -177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.9 Cg_endo -90.52 25.32 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.106 1.871 . . . . 0.76 114.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.1 pt-20 -112.12 -9.91 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.785 -0.766 . . . . 1.49 111.753 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.684 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 11.4 m0 -71.84 152.05 42.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.348 0.594 . . . . 4.62 111.163 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.637 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.9 m95 -75.28 -43.58 4.42 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.433 -0.803 . . . . 2.78 113.131 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 31' ' ' TRP . 14.3 Cg_endo -53.98 -71.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.019 2.479 . . . . 1.36 114.684 -165.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' HB3' HD11 ' A' ' 140' ' ' ILE . 22.6 t-20 -117.51 -19.98 9.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.339 0.59 . . . . 1.51 110.294 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.674 ' HA ' HG23 ' A' ' 40' ' ' VAL . 10.0 m120 -92.75 20.2 6.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 1.79 111.806 -169.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -99.16 15.15 26.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.411 0.624 . . . . 4.45 110.137 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -106.29 149.97 26.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.925 -0.58 . . . . 4.14 110.752 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 p -76.74 136.82 39.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.102 -0.332 . . . . 2.68 110.102 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.841 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 43.6 p 66.22 -47.63 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.835 1.254 . . . . 1.42 111.759 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 85.1 tttt -71.11 89.28 0.82 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 122.771 0.429 . . . . 2.9 110.142 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.674 HG23 ' HA ' ' A' ' 34' ' ' ASN . 34.5 m 49.07 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.952 1.301 . . . . 1.83 113.031 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.31 17.0 2.71 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.674 -0.774 . . . . 2.17 112.704 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.85 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -74.11 166.84 41.05 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.004 -0.739 . . . . 1.12 109.004 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.9 49.67 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 123.055 2.503 . . . . 1.48 114.011 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.6 tp -162.52 -92.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.586 0.231 . . . . 1.75 110.714 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.768 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.05 -54.62 3.28 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.869 -0.681 . . . . 0.75 112.361 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 24' ' ' LEU . 60.3 t -140.34 140.22 34.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.6 110.318 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -109.79 110.0 20.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.214 -0.661 . . . . 1.11 109.214 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.776 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 7.8 mtpm? -79.55 -20.48 46.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.068 -0.515 . . . . 2.81 111.689 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -83.64 -44.01 15.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.844 -0.342 . . . . 3.17 110.943 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.7 -30.44 18.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.116 -0.564 . . . . 1.53 112.248 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.64 54.2 2.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.682 . . . . 0.77 112.76 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -142.65 150.2 39.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.507 -0.408 . . . . 3.72 110.661 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.558 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 17.2 m0 -105.38 114.08 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.675 -0.491 . . . . 1.28 109.675 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.34 148.48 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.207 -0.294 . . . . 1.66 110.207 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.6 mp0 -119.58 160.58 22.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.952 -0.759 . . . . 2.12 108.952 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.98 114.05 16.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.955 0.407 . . . . 0.92 110.338 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.668 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.0 t70 -105.15 -170.76 1.8 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.785 -0.643 . . . . 1.97 110.113 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 12.7 pt-20 -71.84 -38.94 70.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.722 0.638 . . . . 2.43 112.722 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.11 4.19 46.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.173 -0.611 . . . . 2.39 110.979 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.69 -106.23 0.41 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.943 -1.122 . . . . 2.29 113.278 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -134.84 21.74 3.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.907 0.384 . . . . 2.31 111.071 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -96.07 77.57 3.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.626 0.727 . . . . 2.61 110.625 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.668 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -122.81 125.7 45.95 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.229 -0.896 . . . . 3.72 110.214 174.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.668 ' HB ' ' HG2' ' A' ' 82' ' ' ARG . 70.2 p 62.03 -66.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.779 1.299 . . . . 2.27 113.363 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 t80 74.26 72.52 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.698 0.799 . . . . 6.48 110.702 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -83.48 150.48 27.08 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.552 -0.749 . . . . 1.23 112.301 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -108.1 92.52 4.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.828 0.347 . . . . 1.17 111.563 -172.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 71' ' ' VAL . 25.2 mt -72.04 136.15 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.61 110.06 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -110.13 -24.23 10.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 2.0 109.905 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 20.5 ttmm -162.16 119.75 2.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.879 -0.6 . . . . 1.53 111.261 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 68' ' ' ILE . 60.4 t -108.54 96.16 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.472 -0.936 . . . . 0.88 108.472 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -105.41 65.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.928 -0.309 . . . . 1.42 110.53 -174.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 15.5 pt-20 48.07 -170.59 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 O-C-N 124.514 1.134 . . . . 0.96 111.926 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.513 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.1 Cg_exo -64.7 75.98 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.388 1.392 . . . . 0.38 111.545 169.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.3 t70 -160.17 -66.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.312 -0.858 . . . . 0.5 110.214 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.4 p -143.85 143.45 31.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.17 0.509 . . . . 0.35 112.277 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.8 mp -133.53 121.84 22.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.74 109.831 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 45.5 t -109.57 104.72 17.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.194 -0.669 . . . . 0.67 109.194 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.493 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.97 146.22 34.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.554 0.216 . . . . 0.75 111.076 -178.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.76 148.54 18.86 Favored Glycine 0 C--O 1.24 0.486 0 CA-C-N 116.223 -0.444 . . . . 0.5 112.54 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -77.06 154.57 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.927 0.491 . . . . 2.79 112.322 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.668 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -153.95 23.22 0.5 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 5.46 109.463 -176.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 79.85 -164.66 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.815 -1.084 . . . . 1.55 109.933 -172.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.627 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 32.7 t30 -137.87 -70.94 0.43 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.492 -0.322 . . . . 1.93 110.524 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' PHE . . . -72.58 -11.27 76.9 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.584 -0.817 . . . . 2.4 113.353 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 85' ' ' GLY . 86.2 t80 71.82 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.485 0.659 . . . . 5.38 110.964 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -27.82 3.54 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.525 -0.761 . . . . 2.3 111.314 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.69 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -94.17 -175.98 3.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 120.907 0.384 . . . . 4.77 110.505 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.775 HD13 ' HE ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -71.53 129.72 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.551 -0.749 . . . . 1.86 111.491 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 p-10 -99.57 121.03 56.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.393 0.616 . . . . 3.18 109.856 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HB2' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -84.06 36.42 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.204 2.603 . . . . 2.36 111.556 178.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.73 76.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.806 0.812 . . . . 2.99 111.594 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -143.77 -47.25 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.402 -1.333 . . . . 3.06 107.402 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 m -136.87 -95.3 0.22 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.778 -1.556 . . . . 1.85 108.192 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' A' ' 91' ' ' PRO . 66.7 m 48.92 23.83 0.76 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.076 0.55 . . . . 1.44 112.409 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 33.4 mt-10 -75.1 138.97 42.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.651 -0.704 . . . . 1.81 109.619 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CE2' HG23 ' A' ' 79' ' ' ILE . 4.8 p90 -133.26 132.01 40.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.173 0.511 . . . . 0.64 110.543 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 25.8 m -91.4 108.47 19.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.063 -0.971 . . . . 0.43 109.921 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.828 ' HA ' HG22 ' A' ' 113' ' ' VAL . 95.5 t -81.5 108.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 0.87 109.326 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.517 ' HA ' HG22 ' A' ' 76' ' ' THR . 19.3 m -101.68 105.75 16.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.272 -0.422 . . . . 0.45 110.222 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.548 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.3 m-85 -90.28 111.9 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.385 -0.37 . . . . 0.34 110.192 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.21 106.64 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 0.54 109.588 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.41 125.09 28.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.619 . . . . 0.44 110.768 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 28.4 t70 -116.03 114.42 24.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.805 -0.634 . . . . 2.03 110.1 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.47 -114.65 6.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.618 -0.801 . . . . 1.97 111.666 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -146.64 13.5 1.19 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.176 0.512 . . . . 4.93 110.228 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -145.57 -5.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.969 0.729 . . . . 3.53 112.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 29.5 ttpt -123.38 154.01 39.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.602 -0.686 . . . . 2.44 110.304 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.8 m -157.56 114.17 2.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.146 0.498 . . . . 0.42 110.973 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -88.3 119.87 29.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.823 -0.626 . . . . 2.59 109.616 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.1 p -96.18 132.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.249 -0.58 . . . . 0.4 109.588 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.54 109.31 12.01 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.561 -0.903 . . . . 1.38 108.561 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 99' ' ' VAL . 28.6 t -98.83 120.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.029 -0.987 . . . . 0.91 110.991 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.24 119.23 38.46 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.684 0.754 . . . . 2.31 109.431 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.924 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 16.6 t60 -102.74 152.2 21.51 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.595 -1.184 . . . . 1.64 109.016 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 118' ' ' PHE . 11.7 t -54.67 169.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.231 1.015 . . . . 2.67 111.604 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -93.92 14.84 18.32 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.503 -1.226 . . . . 2.63 111.124 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.506 ' H ' HG23 ' A' ' 116' ' ' THR . 16.2 t80 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.059 0.456 . . . . 3.54 110.09 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -30.51 59.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.142 -0.688 . . . . 1.81 109.142 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 57.5 ttt180 -60.29 -19.82 56.61 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.918 -1.037 . . . . 3.38 111.397 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 87.9 mmm -61.22 -15.44 34.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 2.43 110.271 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.98 -140.38 26.94 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.595 -0.729 . . . . 1.61 113.134 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 16.8 p 36.22 -108.44 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 O-C-N 124.766 0.921 . . . . 2.58 112.813 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -84.81 -34.55 22.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 3.8 111.102 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -63.7 -50.33 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 2.14 110.71 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 -25.79 59.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.495 -0.32 . . . . 0.92 110.667 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' THR . 46.9 tptt -56.51 -52.23 65.53 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.969 0.414 . . . . 2.83 110.403 174.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.775 ' HE ' HD13 ' A' ' 89' ' ' ILE . 9.5 ptm85 -72.24 -30.31 64.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.68 -0.691 . . . . 2.59 111.9 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.5 -39.18 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 1.48 111.589 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -62.79 -16.04 56.37 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.264 -0.425 . . . . 3.83 112.067 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -54.99 -24.86 26.2 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.907 0.706 . . . . 2.48 112.907 -175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -134.74 -24.09 0.61 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.641 -1.266 . . . . 1.61 114.105 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.438 ' SD ' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -73.5 -26.08 60.73 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.431 -0.452 . . . . 4.83 112.0 -172.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.99 -14.63 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.388 . . . . 2.83 110.886 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -115.21 16.38 16.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.734 0.778 . . . . 4.15 109.47 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.68 -91.26 2.21 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.466 -0.788 . . . . 1.04 112.526 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 20.2 m95 -54.89 -47.58 97.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.681 0.993 . . . . 2.78 113.681 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.2 Cg_endo -52.82 -40.04 75.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.813 1.676 . . . . 0.68 112.446 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 38.9 m -78.15 -43.32 29.11 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.631 0.729 . . . . 0.87 110.102 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.624 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.2 mt -59.79 -51.97 66.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 115.105 -0.952 . . . . 0.72 111.734 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 78.7 mt -58.94 -28.3 66.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.174 0.435 . . . . 0.69 112.174 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.3 mm-40 -74.24 -51.74 14.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 1.49 110.296 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 14.9 t -70.52 -23.74 62.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.082 0.468 . . . . 1.15 110.321 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.59 -51.97 66.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 0.8 109.952 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.469 ' CG ' HG13 ' A' ' 10' ' ' VAL . 45.7 mt-30 -66.1 -28.43 68.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.599 -0.728 . . . . 1.63 110.437 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 35.2 t70 -75.78 -43.1 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.698 . . . . 1.46 111.222 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.492 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 58.6 tttm -64.8 -40.12 94.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.065 0.46 . . . . 1.74 110.076 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.817 HG21 HG13 ' A' ' 12' ' ' VAL . 70.8 mt -68.85 -26.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.02 -0.537 . . . . 0.5 110.372 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.93 -37.78 76.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 0.85 109.295 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.589 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 34.8 mt-10 -64.65 -46.09 83.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.18 0.991 . . . . 1.5 108.79 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 148' ' ' ILE . 2.4 tp10 -65.64 -43.63 88.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.4 -1.727 . . . . 1.74 110.506 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.35 -70.49 1.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 1.32 112.075 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -161.81 97.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.388 . . . . 1.92 111.28 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.0 ttmm -137.3 -46.38 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.969 -0.559 . . . . 2.04 109.678 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.496 -0.775 . . . . 4.22 111.176 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 25.0 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.17 0.509 . . . . 1.66 110.784 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.844 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 41.9 p90 -168.38 -42.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.155 -0.475 . . . . 3.73 110.647 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.606 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.6 t70 -72.78 -58.67 2.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.613 -0.267 . . . . 2.78 111.526 -173.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.13 -64.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.165 1.243 . . . . 1.63 110.636 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 53.1 p90 -154.66 147.07 23.98 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.958 -0.564 . . . . 3.21 110.135 173.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -110.46 114.47 47.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.796 -1.187 . . . . 1.44 107.796 164.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 28.9 ttm180 -112.67 138.65 49.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.716 -0.674 . . . . 3.37 111.257 -173.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.579 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.57 133.83 52.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.696 -0.853 . . . . 0.79 108.696 172.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.807 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 70.0 m -141.61 113.82 8.11 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.131 -0.486 . . . . 1.28 109.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.967 HG22 HG12 ' A' ' 111' ' ' VAL . 1.9 m -122.92 143.48 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 1.27 109.983 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.1 m -98.04 115.8 28.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.431 0.634 . . . . 0.57 110.158 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.813 HG13 HG21 ' A' ' 148' ' ' ILE . 33.1 t -103.1 133.8 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.568 -0.742 . . . . 0.91 109.947 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.12 30.2 6.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 0.98 111.886 -174.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -154.23 35.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.36 111.209 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 75.03 173.21 0.26 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-O 122.1 0.952 . . . . 0.91 112.705 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.558 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 19.8 ttp180 -71.79 -24.75 61.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.594 -1.185 . . . . 1.88 110.711 -171.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 19.6 tptm -61.14 -48.4 81.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 3.05 110.671 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.2 p -70.9 -38.54 73.01 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.979 -0.288 . . . . 1.11 111.059 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.7 -46.47 81.19 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 120.913 0.387 . . . . 0.32 110.647 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -71.69 -47.79 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.872 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 25.6 tptp -52.33 -46.53 66.09 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 120.966 0.412 . . . . 2.39 111.1 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 m -70.88 -49.04 50.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.192 -0.458 . . . . 0.68 110.349 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.55 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.3 t80 -62.39 -41.08 98.38 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.231 0.456 . . . . 0.48 112.231 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 46' ' ' VAL . 12.5 tp -113.05 -34.24 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.231 -0.588 . . . . 0.5 112.512 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.712 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 35.1 mt-10 -104.82 16.22 26.38 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.234 -0.291 . . . . 1.24 111.419 -173.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.747 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -153.87 38.74 0.69 Allowed Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.754 -0.736 . . . . 0.83 111.482 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.615 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 61.9 t80 -53.66 -54.45 45.94 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 112.806 0.669 . . . . 0.74 112.806 -169.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 36.5 Cg_endo -87.5 13.88 2.53 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.76 114.496 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.7 pt-20 -97.36 -6.49 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.159 -0.616 . . . . 1.49 110.586 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.661 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 26.8 m0 -73.3 176.11 6.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.482 0.658 . . . . 4.62 111.446 -175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 35.0 m95 -97.91 -25.19 0.23 Allowed Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 114.136 1.161 . . . . 2.78 114.136 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 30' ' ' TRP . 72.6 Cg_endo -75.2 -151.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.726 1.617 . . . . 1.36 114.281 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.478 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 25.5 t-20 -44.73 -43.28 8.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.85 -1.068 . . . . 1.51 113.293 -171.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.941 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 2.0 p-10 -79.95 38.95 0.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.395 -0.821 . . . . 1.79 112.323 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -100.35 -6.23 26.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 4.45 110.722 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 12.4 mmm180 -89.48 131.07 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.342 -0.39 . . . . 4.14 110.751 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.6 p -76.01 137.38 40.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 2.68 110.881 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.9 p 52.92 24.46 3.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 1.42 111.338 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 3.0 tmtp? -121.31 -55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.496 -0.927 . . . . 2.9 108.496 174.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.941 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 1.6 t -150.47 19.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.222 -0.659 . . . . 1.83 109.222 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.48 41.84 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.584 -1.293 . . . . 2.17 114.135 -166.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.925 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -67.95 173.22 3.27 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.247 -0.649 . . . . 1.12 109.247 167.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 29.5 Cg_endo -63.44 26.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.049 2.499 . . . . 1.48 115.335 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -142.1 -88.94 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.932 -0.48 . . . . 1.75 110.81 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.531 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 95.2 -49.77 1.91 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.766 -0.73 . . . . 0.75 112.766 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 24' ' ' LEU . 85.8 t -137.12 143.38 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.6 110.161 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.854 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 13.6 t70 -104.95 109.1 20.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.206 -0.664 . . . . 1.11 109.206 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -80.95 -13.64 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.49 -0.777 . . . . 2.81 112.316 -173.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -90.4 -40.05 12.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.665 0.269 . . . . 3.17 111.573 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.68 -32.27 4.23 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.986 -0.846 . . . . 1.53 110.986 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 96.16 79.61 1.47 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.77 111.946 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.854 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 28.6 ptt180 -157.99 165.28 35.51 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.53 -0.544 . . . . 3.72 109.53 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.677 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -111.82 117.93 34.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.74 -0.467 . . . . 1.28 109.74 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.612 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.9 p90 -164.02 159.03 20.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.282 0.563 . . . . 1.66 111.244 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.925 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 26.2 mt-10 -111.82 153.72 26.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.678 -0.692 . . . . 2.12 110.2 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 mm -81.2 103.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.258 -0.645 . . . . 0.92 109.258 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.678 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.0 t70 -90.25 -170.79 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.258 -0.275 . . . . 1.97 110.258 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 11.4 pt-20 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.883 0.327 . . . . 2.43 111.883 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.588 ' OE1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -84.5 -10.35 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 2.39 110.61 -178.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -86.79 0.17 Allowed Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.83 -0.623 . . . . 2.29 112.448 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . 40.0 mt-10 -148.65 37.13 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.539 0.209 . . . . 2.31 111.285 -172.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.45 77.85 1.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.147 0.975 . . . . 2.61 110.84 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.678 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -123.22 163.95 19.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.634 -1.166 . . . . 3.72 110.275 172.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.604 ' HB ' ' HD2' ' A' ' 82' ' ' ARG . 7.1 p -57.98 106.22 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 2.27 111.48 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 19.2 p90 -79.61 109.31 13.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 6.48 112.162 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -67.41 136.62 32.15 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.987 -0.845 . . . . 1.23 110.987 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 67' ' ' LEU . 4.0 mp -87.91 86.88 7.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.45 0.125 . . . . 1.17 111.166 -171.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 51' ' ' GLY . 35.5 mt -82.27 116.62 26.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.094 -1.042 . . . . 0.61 109.568 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -103.21 -12.79 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.168 -0.923 . . . . 2.0 110.319 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 36.9 ttmt -156.81 121.12 4.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 1.53 111.511 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 77' ' ' LEU . 59.3 t -109.86 89.06 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.966 -1.124 . . . . 0.88 107.966 167.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 76' ' ' THR . 38.7 t0 -97.8 71.41 2.22 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.879 -0.328 . . . . 1.42 110.454 -175.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.559 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 pt-20 46.42 -169.73 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 124.402 1.064 . . . . 0.96 111.411 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -67.06 74.38 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.107 1.205 . . . . 0.38 110.914 165.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -155.0 -71.35 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.491 -0.322 . . . . 0.5 110.771 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.581 ' C ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -142.31 123.94 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.476 0.547 . . . . 0.35 112.476 -175.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD13 ' C ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -118.73 123.2 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.862 -0.523 . . . . 0.74 110.41 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 58.1 t -103.13 101.72 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.67 109.251 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.32 140.92 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.138 -0.483 . . . . 0.75 111.12 -176.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.38 145.9 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.589 -0.732 . . . . 0.5 112.365 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 1.002 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 72.0 t-105 -72.99 142.62 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.581 0.586 . . . . 2.79 112.581 -174.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.604 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -145.12 44.41 1.33 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.49 -0.777 . . . . 5.46 109.32 177.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 75.95 145.46 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.337 -0.847 . . . . 1.55 111.954 176.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.629 ' N ' HD13 ' A' ' 83' ' ' LEU . 2.5 t-20 -83.11 -66.59 0.87 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.047 -0.979 . . . . 1.93 111.306 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 40' ' ' VAL . . . -91.13 29.14 7.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 2.4 113.678 -172.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 63' ' ' HIS . 75.7 t80 67.32 -68.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.23 0.612 . . . . 5.38 112.563 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.77 55.66 4.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.212 -0.518 . . . . 2.3 113.944 -170.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.648 ' HB2' HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -140.53 -175.96 4.46 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.719 -0.845 . . . . 4.77 108.719 170.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -92.44 127.66 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.251 0.548 . . . . 1.86 111.494 -173.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' OD1' ' HD3' ' A' ' 82' ' ' ARG . 3.2 p30 -135.39 158.92 73.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.62 -0.718 . . . . 3.18 109.15 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -91.0 -29.16 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.346 2.03 . . . . 2.36 114.089 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.17 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.923 1.289 . . . . 2.99 114.418 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -79.56 -20.1 47.87 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.718 -0.613 . . . . 3.06 112.211 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 p -155.9 -90.09 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.398 -0.593 . . . . 1.85 109.398 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 1.002 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.4 m 54.87 25.73 7.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.763 -0.653 . . . . 1.44 111.685 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.646 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 39.2 tt0 -77.63 142.63 38.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 1.81 112.214 -171.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 79' ' ' ILE . 6.6 p90 -139.92 141.06 36.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.64 110.52 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 39.0 m -97.04 112.38 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.686 -0.688 . . . . 0.43 110.387 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' THR . 84.5 t -84.43 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.87 109.71 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.469 ' HA ' HG22 ' A' ' 76' ' ' THR . 55.6 m -107.13 106.03 16.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.917 0.389 . . . . 0.45 110.849 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.558 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 46.0 m-85 -85.08 113.38 21.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.401 -0.363 . . . . 0.34 110.05 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.63 109.49 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.645 -0.502 . . . . 0.54 109.645 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.67 124.21 28.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.207 0.527 . . . . 0.44 111.041 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 32.8 m-20 -106.59 125.24 50.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.318 -0.855 . . . . 2.03 109.165 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.86 71.87 0.39 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.131 -0.486 . . . . 1.97 113.9 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 46.0 tt0 -169.6 25.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.055 -1.091 . . . . 4.93 108.055 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 57.38 48.74 14.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.859 0.837 . . . . 3.53 109.317 -169.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 36.1 tttp -130.22 148.8 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.561 -1.199 . . . . 2.44 108.613 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.1 m -155.25 113.68 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.124 0.488 . . . . 0.42 110.904 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.6 tmm_? -100.37 111.5 23.77 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.593 -0.891 . . . . 2.59 108.593 176.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.967 HG12 HG22 ' A' ' 10' ' ' VAL . 13.0 p -85.8 145.51 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.861 -0.336 . . . . 0.4 110.862 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -129.19 117.09 20.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 124.177 0.923 . . . . 1.38 109.578 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -104.75 128.44 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 110.266 -0.272 . . . . 0.91 110.266 175.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -103.63 114.82 29.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.21 -0.663 . . . . 2.31 109.21 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.6 t60 -131.98 125.5 31.7 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.997 -1.001 . . . . 1.64 108.864 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 5' ' ' PHE . 5.2 t -176.94 101.86 0.05 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.75 0.786 . . . . 2.67 110.198 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.6 t-160 -166.81 -67.1 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.573 -0.74 . . . . 2.63 110.302 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.6 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 1.2 p90 -81.83 -24.74 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.891 -0.595 . . . . 3.54 110.98 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.844 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -75.46 -52.68 10.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.505 0.722 . . . . 1.81 111.352 -176.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 16.4 ptt180 -65.41 -16.7 63.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.213 -0.903 . . . . 3.38 110.705 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 41.9 tpp -74.51 26.21 0.08 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.192 -0.913 . . . . 2.43 112.721 -169.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.68 172.15 13.09 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.265 -1.445 . . . . 1.61 114.718 166.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 m -58.03 -54.24 49.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.674 -0.763 . . . . 2.58 111.892 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 124' ' ' LYS . 45.4 mtpt -68.48 -28.64 67.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 3.8 110.875 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.764 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 13.4 m-70 -67.93 -47.85 67.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.207 -0.451 . . . . 2.14 111.278 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.72 -23.42 58.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.359 -0.536 . . . . 0.92 110.468 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -74.6 -38.16 62.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 2.83 110.618 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.764 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 14.5 ptp180 -67.05 -28.35 68.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.738 -0.467 . . . . 2.59 109.738 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.719 ' HA ' ' SD ' ' A' ' 133' ' ' MET . 67.5 t -65.27 -46.33 90.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.013 -0.54 . . . . 1.48 109.808 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.645 ' HA ' ' HB2' ' A' ' 134' ' ' ASP . 65.0 ttt180 -65.91 -16.28 63.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.484 -0.78 . . . . 3.83 110.963 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.655 ' OD1' ' HA ' ' A' ' 128' ' ' ARG . 3.6 m120 -53.76 -55.55 25.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.444 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.06 -7.18 0.1 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.838 -1.172 . . . . 1.61 114.923 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 129' ' ' VAL . 10.8 mtt -80.29 -28.11 38.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.3 -1.0 . . . . 4.83 108.3 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.645 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 12.3 t70 -56.34 -43.44 79.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.941 -1.481 . . . . 2.83 112.567 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -108.99 11.19 26.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 4.15 111.872 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.548 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.12 -65.61 0.7 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.019 -1.086 . . . . 1.04 112.329 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.51 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -57.92 -48.48 97.05 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.818 0.673 . . . . 2.78 112.818 -172.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.4 Cg_endo -58.32 -44.38 38.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.781 1.654 . . . . 0.68 112.02 176.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 m -59.62 -42.81 93.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.559 0.695 . . . . 0.87 109.672 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.623 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.9 mt -59.38 -50.58 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.764 -1.107 . . . . 0.72 111.345 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -34.51 74.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.282 0.475 . . . . 0.69 112.282 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -52.65 30.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.019 0.438 . . . . 1.49 110.542 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.449 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.1 m -68.9 -22.03 64.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.997 -0.547 . . . . 1.15 110.575 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.97 -53.94 42.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.8 110.109 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -60.3 -29.31 68.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.844 -0.616 . . . . 1.63 110.046 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.83 -47.19 60.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.116 -0.947 . . . . 1.46 110.367 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -61.83 -34.15 75.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.689 . . . . 1.74 110.424 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.813 HG21 HG13 ' A' ' 12' ' ' VAL . 66.4 mt -80.78 -25.19 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.77 -0.65 . . . . 0.5 110.811 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.591 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 25.7 t0 -63.78 -24.58 67.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.85 109.512 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 45.0 mt-10 -67.17 -26.81 66.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.214 -0.903 . . . . 1.5 110.338 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.07 -7.35 58.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 1.74 109.98 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.15 -80.26 0.67 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.839 -0.618 . . . . 1.32 113.244 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.91 30.79 0.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.08 0.44 . . . . 1.92 112.173 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 18.0 tppt? -61.53 -38.54 87.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 2.04 111.035 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.405 -0.807 . . . . 4.22 111.119 -177.294 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 18.4 p-10 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.71 0.29 . . . . 1.66 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.444 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . 6.2 p90 -179.41 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.343 -0.389 . . . . 3.73 110.575 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.878 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.2 t70 -64.85 -62.79 4.36 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.51 -0.314 . . . . 2.78 111.299 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 10.3 Cg_endo -90.42 -57.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.697 1.598 . . . . 1.63 111.245 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 49.7 p90 -152.12 167.36 28.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.063 -0.971 . . . . 3.21 108.849 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 4.3 m -104.57 133.65 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.271 -1.011 . . . . 1.44 108.271 174.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.4 ttp180 -131.1 150.05 52.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.421 0.629 . . . . 3.37 111.041 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.995 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 2.3 t-160 -119.31 132.82 55.94 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.756 -1.202 . . . . 0.79 107.756 170.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.0 t -139.62 114.43 9.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.362 -0.535 . . . . 1.28 110.155 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.3 t -131.65 139.73 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.664 -0.698 . . . . 1.27 111.067 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -99.08 115.46 29.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.41 -0.589 . . . . 0.57 109.41 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.829 HG13 HG21 ' A' ' 148' ' ' ILE . 45.8 t -97.14 130.5 45.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.982 -0.554 . . . . 0.91 109.825 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.658 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.76 23.85 12.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.98 111.517 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -147.06 29.15 0.99 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.837 -0.345 . . . . 0.36 111.747 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 24.3 t70 72.53 165.28 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.778 0.799 . . . . 0.91 112.566 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 17.3 ttp180 -66.1 -25.72 67.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.988 -1.006 . . . . 1.88 111.44 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -59.78 -51.13 71.07 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.224 -0.444 . . . . 3.05 110.985 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 42.9 p -72.17 -32.9 67.27 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.579 -0.282 . . . . 1.11 110.62 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.4 -51.07 69.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.32 110.635 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -69.79 -41.5 75.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.38 110.6 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 4.3 tppp? -53.87 -52.81 59.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.98 -0.554 . . . . 2.39 110.779 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.424 HG22 ' NE1' ' A' ' 30' ' ' TRP . 6.5 m -69.63 -48.64 59.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.009 -0.541 . . . . 0.68 110.665 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.876 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 63.1 t80 -62.16 -32.67 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.22 0.452 . . . . 0.48 112.22 -172.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' A' ' 46' ' ' VAL . 15.1 tp -117.82 -51.27 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.754 0.65 . . . . 0.5 112.754 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.443 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 38.7 mt-10 -76.82 -20.94 55.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 1.24 111.355 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.667 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -118.95 36.24 3.64 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.843 -0.694 . . . . 0.83 111.98 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.517 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 58.4 t80 -53.01 -51.74 71.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.629 0.603 . . . . 0.74 112.629 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 41.1 Cg_endo -87.5 12.39 2.93 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.757 1.638 . . . . 0.76 114.821 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 7.8 pt-20 -102.89 -4.93 24.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.295 -0.562 . . . . 1.49 111.577 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.876 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 34.8 m0 -69.4 168.83 13.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.464 0.65 . . . . 4.62 111.873 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.501 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 56.5 m95 -86.02 -38.03 0.56 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 114.978 -1.01 . . . . 2.78 113.435 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.765 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 58.0 Cg_endo -68.65 -105.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.375 2.05 . . . . 1.36 115.071 -165.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' ND2' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -79.65 -42.65 24.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.02 0.438 . . . . 1.51 111.051 -175.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -81.88 68.03 8.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.535 0.684 . . . . 1.79 111.08 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.01 12.06 4.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.091 -0.959 . . . . 4.45 109.627 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -126.47 137.2 53.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.862 -0.608 . . . . 4.14 111.252 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -77.09 141.19 40.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 2.68 110.89 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 56.0 p 55.47 18.43 2.66 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.84 0.856 . . . . 1.42 112.3 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.563 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 45.9 tttp -110.7 -61.85 1.62 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.801 -0.814 . . . . 2.9 108.801 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.634 HG11 ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -157.46 25.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.887 -1.051 . . . . 1.83 110.035 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.36 36.34 0.24 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.305 -0.95 . . . . 2.17 113.27 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.006 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.96 170.42 13.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.678 -0.49 . . . . 1.12 109.678 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.25 67.79 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.698 2.265 . . . . 1.48 113.071 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -175.35 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.554 -0.748 . . . . 1.75 110.16 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.517 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 87.05 -58.68 4.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.963 -0.636 . . . . 0.75 112.474 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 24' ' ' LEU . 91.9 t -135.69 137.91 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.926 0.393 . . . . 0.6 110.907 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.651 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 23.7 t70 -103.8 99.36 9.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.749 -0.834 . . . . 1.11 108.749 173.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -80.76 -9.13 59.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.309 -0.859 . . . . 2.81 111.186 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -68.18 -55.58 11.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.984 -0.553 . . . . 3.17 110.583 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.12 -54.08 1.05 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.958 -0.639 . . . . 1.53 111.658 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 132.13 64.19 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.82 -0.705 . . . . 0.77 112.648 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.76 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 21.4 ptt180 -149.34 140.21 22.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.636 0.255 . . . . 3.72 111.54 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.736 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.4 m0 -97.21 108.23 20.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.67 -0.241 . . . . 1.28 110.591 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.651 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.3 p90 -158.25 176.15 12.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.453 . . . . 1.66 110.966 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 18.5 mt-10 -130.6 155.19 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 2.12 110.595 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.648 HG23 ' HG2' ' A' ' 61' ' ' GLU . 37.4 mm -78.22 103.0 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.499 -0.926 . . . . 0.92 108.499 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.659 ' OD2' ' HG3' ' A' ' 59' ' ' GLN . 12.5 t70 -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.169 -0.468 . . . . 1.97 109.963 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.18 -6.92 58.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.78 0.659 . . . . 2.43 112.78 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.659 ' HG3' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -90.12 7.3 38.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.473 -0.891 . . . . 2.39 110.471 170.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.42 62.11 0.45 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.953 -0.641 . . . . 2.29 113.76 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.648 ' HG2' HG23 ' A' ' 56' ' ' ILE . 40.0 mt-10 44.74 54.07 6.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.281 0.845 . . . . 2.31 113.281 171.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' H ' HE22 ' A' ' 59' ' ' GLN . 0.8 OUTLIER -127.77 84.68 2.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.413 0.625 . . . . 2.61 110.143 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -124.54 158.42 32.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.197 -0.91 . . . . 3.72 109.593 172.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -59.65 142.03 53.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.251 -0.648 . . . . 2.27 109.251 170.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.76 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 p90 -121.83 117.48 26.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.097 0.475 . . . . 6.48 111.187 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -57.15 134.28 52.36 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-N 115.235 -0.893 . . . . 1.23 111.754 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.69 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -92.26 88.1 6.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.191 0.52 . . . . 1.17 110.668 -171.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 58.2 mt -74.17 121.32 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.202 0.525 . . . . 0.61 110.382 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -31.09 24.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.603 -0.726 . . . . 2.0 109.539 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -160.21 119.92 2.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 1.53 111.819 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 68' ' ' ILE . 60.8 t -99.6 100.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.152 -1.055 . . . . 0.88 108.152 167.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -108.48 70.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.768 -0.373 . . . . 1.42 110.96 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 pt-20 47.03 -170.39 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 124.471 1.107 . . . . 0.96 111.722 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.8 Cg_exo -64.23 75.21 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.474 1.449 . . . . 0.38 111.342 166.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -157.35 -62.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.75 -0.659 . . . . 0.5 110.413 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -147.75 148.37 30.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.324 0.49 . . . . 0.35 112.324 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 mp -136.59 114.92 11.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.74 109.416 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.623 HG22 HG23 ' A' ' 98' ' ' THR . 36.4 t -101.33 104.9 16.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.897 -0.779 . . . . 0.67 108.897 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -128.55 144.7 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.826 0.346 . . . . 0.75 111.293 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.69 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -98.47 159.56 20.46 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.5 112.717 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.9 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -64.56 157.21 27.5 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 112.794 0.664 . . . . 2.79 112.794 -168.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.2 tmt_? -149.96 -2.19 0.41 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.502 -0.772 . . . . 5.46 110.373 -167.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 88' ' ' ARG . 3.1 tm? 71.19 133.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.468 -0.787 . . . . 1.55 110.882 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.634 ' OD1' HG11 ' A' ' 40' ' ' VAL . 55.5 t30 -108.15 135.94 48.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.93 110.324 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.563 ' HA2' ' HE3' ' A' ' 39' ' ' LYS . . . 106.08 -17.21 41.57 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.564 -0.827 . . . . 2.4 112.732 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 t80 69.87 -54.62 0.61 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.139 0.575 . . . . 5.38 111.83 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.34 10.78 47.82 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.947 -0.461 . . . . 2.3 111.947 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.696 ' HB3' HD11 ' A' ' 83' ' ' LEU . 1.9 tpp180 -97.33 167.89 10.74 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.559 -1.275 . . . . 4.77 107.559 173.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.687 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -113.4 123.22 68.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 119.927 -0.709 . . . . 1.86 112.023 -173.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 16.8 t70 -160.17 131.37 3.87 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 108.35 -0.981 . . . . 3.18 108.35 166.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 128' ' ' ARG . 7.9 Cg_exo -73.63 1.71 6.62 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.749 2.299 . . . . 2.36 113.393 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 60.68 81.17 0.19 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.463 -0.569 . . . . 2.99 109.463 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.96 -64.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.219 0.452 . . . . 3.06 112.219 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -124.19 -145.41 0.34 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.22 -0.446 . . . . 1.85 111.24 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.9 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 9.2 t 73.16 67.93 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.28 -0.873 . . . . 1.44 111.385 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.88 98.4 10.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.487 -0.779 . . . . 1.81 109.847 172.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HA ' ' HB2' ' A' ' 115' ' ' HIS . 7.5 p90 -104.83 130.98 52.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.168 -0.613 . . . . 0.64 111.323 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.623 HG23 HG22 ' A' ' 78' ' ' VAL . 12.6 m -91.99 110.49 21.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.413 -0.812 . . . . 0.43 110.655 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.764 ' HA ' HG22 ' A' ' 113' ' ' VAL . 60.2 t -82.3 109.27 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.394 -0.595 . . . . 0.87 109.394 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.545 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.1 m -101.57 106.92 18.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.321 -0.399 . . . . 0.45 110.732 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.722 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.4 m-85 -88.94 107.31 18.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.551 -0.537 . . . . 0.34 109.551 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -93.13 108.98 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.494 -0.558 . . . . 0.54 109.494 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.77 141.01 58.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.832 -0.622 . . . . 0.44 111.014 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.711 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 7.3 t70 -126.65 92.64 3.59 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.043 -0.526 . . . . 2.03 109.593 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.15 -108.44 2.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.74 -0.743 . . . . 1.97 112.436 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -140.96 -2.43 1.31 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.714 0.265 . . . . 4.93 111.714 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -3.17 1.34 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.758 0.651 . . . . 3.53 112.758 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 49.1 tttm -127.46 157.08 41.02 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.486 -0.486 . . . . 2.44 109.945 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.1 m -159.18 123.39 3.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.446 -0.343 . . . . 0.42 110.548 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -97.23 118.61 34.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.271 -0.64 . . . . 2.59 109.271 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.722 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 p -99.89 134.53 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.775 -0.454 . . . . 0.4 109.775 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.752 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.2 t70 -138.3 114.43 10.15 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.25 -0.887 . . . . 1.38 109.877 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.995 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 25.6 t -91.39 124.4 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.105 -0.498 . . . . 0.91 110.782 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -107.38 115.95 31.06 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 124.003 0.815 . . . . 2.31 109.621 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 97' ' ' PHE . 25.8 t60 -154.7 143.33 20.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.426 . . . . 1.64 110.744 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 9.7 t -162.36 119.27 2.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.054 0.391 . . . . 2.67 112.054 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' THR . 76.9 t60 169.16 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.541 -0.754 . . . . 2.63 110.788 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -53.23 -50.33 64.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.652 0.612 . . . . 3.54 112.652 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 8.3 t70 -78.69 -39.92 35.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.916 0.388 . . . . 1.81 111.548 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -66.3 -27.45 67.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 3.38 110.856 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 32.9 tpp -98.55 18.34 16.94 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.985 -1.117 . . . . 2.43 107.985 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.651 ' HA2' ' HB3' ' A' ' 125' ' ' HIS . . . -66.22 -88.13 0.06 OUTLIER Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.729 -1.578 . . . . 1.61 114.339 -168.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 28.7 m 57.3 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.703 -0.851 . . . . 2.58 108.703 -165.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.66 -55.07 19.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.266 -0.642 . . . . 3.8 109.266 170.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.651 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 3.0 t-160 -64.51 -48.26 75.79 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.494 -0.775 . . . . 2.14 111.208 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.566 ' HB2' ' HA3' ' A' ' 122' ' ' GLY . . . -58.51 -45.98 87.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.163 -0.472 . . . . 0.92 111.249 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 123' ' ' THR . 5.7 tmtm? -61.76 -47.38 85.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 2.83 110.887 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.687 ' HB2' HG23 ' A' ' 89' ' ' ILE . 7.4 ptp180 -68.3 -35.1 77.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.439 0.533 . . . . 2.59 112.439 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.408 HG13 ' CZ2' ' A' ' 81' ' ' TRP . 91.9 t -80.23 -40.87 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.979 0.419 . . . . 1.48 111.25 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -62.56 -15.03 48.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.745 -0.662 . . . . 3.83 111.171 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.68 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 94.5 m-20 -58.77 -22.68 58.62 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 2.48 112.243 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.18 -31.83 0.07 OUTLIER Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.005 -1.093 . . . . 1.61 114.059 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -65.0 -23.25 67.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.557 -0.378 . . . . 4.83 110.851 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.38 -24.73 66.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.927 -0.579 . . . . 2.83 111.983 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -113.26 -48.03 2.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.882 0.372 . . . . 4.15 110.833 -176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -61.41 -56.73 21.74 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.858 -0.61 . . . . 1.04 113.236 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.589 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -60.38 -48.52 93.61 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.431 0.53 . . . . 2.78 112.431 -173.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 15.6 Cg_endo -58.87 -42.34 53.58 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.648 1.566 . . . . 0.68 112.026 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.8 m -64.53 -35.44 80.96 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.685 0.755 . . . . 0.87 109.387 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 137' ' ' TRP . 13.6 mt -54.79 -49.16 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.597 -1.183 . . . . 0.72 110.809 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.0 mt -62.9 -29.11 70.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.295 0.48 . . . . 0.69 112.295 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.19 -57.5 4.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.49 110.318 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.474 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 29.5 m -65.36 -23.4 66.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.103 0.478 . . . . 1.15 110.621 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 45.7 t80 -61.56 -54.78 38.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.634 . . . . 0.8 110.233 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.558 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.2 mt-30 -60.49 -31.81 70.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.83 -0.623 . . . . 1.63 110.894 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -42.37 69.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.758 -0.655 . . . . 1.46 111.735 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 18.3 tptm -69.97 -35.04 74.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.492 -0.483 . . . . 1.74 109.723 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.829 HG21 HG13 ' A' ' 12' ' ' VAL . 62.2 mt -66.45 -35.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.5 110.393 175.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 154' ' ' LYS . 19.0 t70 -59.14 -40.42 85.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.85 109.044 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 154' ' ' LYS . 43.7 mt-10 -68.38 -35.37 77.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.801 -0.636 . . . . 1.5 110.787 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.82 -43.88 97.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 1.74 111.264 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.22 -66.15 1.68 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.529 -0.843 . . . . 1.32 111.861 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.482 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -173.5 89.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.719 -0.474 . . . . 1.92 109.719 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 149' ' ' ASP . 11.9 tppt? -73.88 134.41 43.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 2.04 110.245 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 153' ' ' ALA . 5.0 mptt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.475 -0.774 . . . . 4.22 110.62 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 19.6 p-10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.161 0.505 . . . . 1.66 110.715 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.505 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 46.6 p90 -176.47 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.867 -0.606 . . . . 3.73 110.751 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.985 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.2 t70 -72.57 -64.85 0.85 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.616 -0.266 . . . . 2.78 111.009 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.985 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 27.8 Cg_endo -97.51 -67.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.506 2.137 . . . . 1.63 113.151 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 4' ' ' PRO . 70.8 m-85 -124.72 113.59 18.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.417 -0.356 . . . . 3.21 111.052 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.823 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 46.0 t -90.81 111.91 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.148 -0.686 . . . . 1.44 109.148 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.667 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.8 ttp180 -133.22 134.96 44.72 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.043 -0.663 . . . . 3.37 111.174 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.92 131.75 54.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.886 -0.783 . . . . 0.79 108.886 173.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.3 m -132.93 110.43 10.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.594 -0.73 . . . . 1.28 109.852 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.2 t -124.63 139.29 51.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.144 -0.934 . . . . 1.27 110.867 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.6 m -103.67 114.61 29.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.71 0.767 . . . . 0.57 109.875 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.809 HG13 HG21 ' A' ' 148' ' ' ILE . 25.1 t -90.77 139.06 18.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.098 -0.955 . . . . 0.91 109.682 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.641 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -111.61 29.25 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.103 0.478 . . . . 0.98 110.871 -176.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.629 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.84 29.41 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.36 111.635 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 35.3 t70 72.2 162.38 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.749 0.785 . . . . 0.91 112.423 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 33.6 ttp180 -65.59 -23.65 66.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.133 -0.94 . . . . 1.88 111.036 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HB2' ' HE3' ' A' ' 17' ' ' LYS . 21.1 ttmt -57.29 -44.99 84.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 3.05 110.587 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 68.4 p -80.23 -31.82 38.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.336 -0.393 . . . . 1.11 110.515 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.41 -47.59 81.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.32 110.687 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 83.0 t80 -67.77 -44.32 77.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.38 110.443 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 18' ' ' THR . 42.3 tttp -52.17 -49.49 63.7 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.839 -0.619 . . . . 2.39 110.488 175.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 29.1 m -68.39 -52.49 32.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.297 -0.41 . . . . 0.68 111.688 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.761 ' HA ' ' HZ ' ' A' ' 144' ' ' PHE . 60.1 t80 -65.36 -30.72 71.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.889 -0.324 . . . . 0.48 111.756 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' CD1' HG11 ' A' ' 46' ' ' VAL . 15.6 tp -120.12 -54.15 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.315 0.857 . . . . 0.5 113.315 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -81.37 -23.7 37.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.568 0.581 . . . . 1.24 112.568 -167.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -110.16 28.98 9.66 Favored Glycine 0 C--N 1.314 -0.665 0 N-CA-C 111.24 -0.744 . . . . 0.83 111.24 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.657 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 41.6 t80 -48.01 -54.32 25.4 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.928 -0.636 . . . . 0.74 112.447 -170.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 8.1 Cg_endo -95.67 38.06 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.051 1.834 . . . . 0.76 115.298 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.9 pt-20 -132.1 -11.11 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.481 -0.888 . . . . 1.49 113.03 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.773 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 11.2 m95 -76.92 172.79 12.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.226 0.536 . . . . 4.62 111.746 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.486 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 m95 -74.6 -47.65 5.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.929 1.085 . . . . 2.78 113.929 -175.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.766 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 27.7 Cg_endo -57.87 -87.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.714 2.276 . . . . 1.36 115.108 -158.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' HB3' HD11 ' A' ' 140' ' ' ILE . 12.8 t-20 -111.12 -3.73 15.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.432 -0.951 . . . . 1.51 108.432 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.618 ' HA ' HG23 ' A' ' 40' ' ' VAL . 15.0 m120 -93.83 22.69 5.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.44 -1.255 . . . . 1.79 112.579 -168.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -134.23 58.3 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.392 0.615 . . . . 4.45 110.416 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 36.9 mmt180 -136.47 145.58 45.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 4.14 109.597 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -75.65 132.43 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.801 -0.359 . . . . 2.68 110.221 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 57' ' ' ASP . 73.0 p 53.69 21.76 2.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.861 0.864 . . . . 1.42 111.798 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' HD3' ' HA3' ' A' ' 85' ' ' GLY . 5.1 mmtp -138.58 79.69 1.75 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.851 -0.613 . . . . 2.9 110.592 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.618 HG23 ' HA ' ' A' ' 34' ' ' ASN . 22.2 m 42.61 26.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.5 -1.227 . . . . 1.83 112.982 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.13 16.41 2.55 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.133 -0.556 . . . . 2.17 111.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.93 162.01 66.45 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.991 -0.744 . . . . 1.12 108.991 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.34 50.68 0.17 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 123.263 2.642 . . . . 1.48 114.679 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -166.34 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.708 0.289 . . . . 1.75 110.995 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.657 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.48 -56.59 3.11 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.817 -0.706 . . . . 0.75 112.59 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.593 HG11 ' CD1' ' A' ' 24' ' ' LEU . 97.3 t -134.47 145.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.014 0.435 . . . . 0.6 111.003 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 1.028 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.3 t70 -121.28 102.78 8.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.566 -0.743 . . . . 1.11 109.038 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 15.3 mtmt -77.75 -28.45 50.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.213 0.449 . . . . 2.81 112.213 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -72.63 -35.08 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.961 -0.296 . . . . 3.17 111.05 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.72 -42.41 4.47 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.821 -0.704 . . . . 1.53 112.097 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 102.5 45.48 1.67 Allowed Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.913 -0.661 . . . . 0.77 112.921 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -144.06 165.04 28.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.466 -0.432 . . . . 3.72 111.607 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.618 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 18.9 m0 -108.15 123.98 49.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.824 -0.625 . . . . 1.28 109.627 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 1.028 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 2.7 p90 -163.36 151.43 13.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.954 0.407 . . . . 1.66 110.784 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.6 mp0 -117.95 160.18 21.88 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.488 -0.56 . . . . 2.12 109.488 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' HG2' ' A' ' 61' ' ' GLU . 26.8 mm -78.25 103.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.33 -0.395 . . . . 0.92 110.017 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.507 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.9 t70 -84.25 -166.53 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 1.97 110.012 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.56 -37.86 22.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.027 0.38 . . . . 2.43 112.027 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -92.18 23.56 3.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.155 0.503 . . . . 2.39 110.937 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.35 -113.27 0.86 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.875 -1.155 . . . . 2.29 113.011 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.568 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 40.4 mt-10 -149.12 2.06 0.56 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.262 0.467 . . . . 2.31 112.262 -167.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -93.11 90.82 7.04 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.929 0.871 . . . . 2.61 110.683 -168.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -121.4 87.78 2.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.382 -1.281 . . . . 3.72 111.028 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.735 HG23 ' HD1' ' A' ' 86' ' ' PHE . 0.8 OUTLIER 54.25 179.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.606 0.717 . . . . 2.27 112.733 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -133.65 99.26 4.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.192 -0.458 . . . . 6.48 110.424 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.704 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.78 119.57 9.14 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.556 -1.418 . . . . 1.23 109.556 173.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 67' ' ' LEU . 3.8 mp -79.91 86.33 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.255 -0.578 . . . . 1.17 110.667 -169.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.67 HG21 HG23 ' A' ' 71' ' ' VAL . 19.2 mt -76.43 114.8 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.694 -1.202 . . . . 0.61 109.326 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 18.0 mmm180 -95.54 -25.4 16.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.759 -1.109 . . . . 2.0 109.388 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 81.8 tttt -161.01 115.63 2.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 1.53 111.525 -175.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.67 HG23 HG21 ' A' ' 68' ' ' ILE . 89.6 t -107.35 102.01 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.564 -0.902 . . . . 0.88 108.564 168.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 9.1 t0 -112.86 69.23 0.69 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.367 -0.533 . . . . 1.42 110.462 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.8 pt-20 46.12 -169.05 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 O-C-N 124.706 1.254 . . . . 0.96 111.578 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.596 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.0 Cg_exo -64.52 78.47 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.154 1.236 . . . . 0.38 111.408 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.9 t70 -161.96 -66.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.445 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.5 p -140.71 141.41 34.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.141 0.496 . . . . 0.35 112.308 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' CD2' HD22 ' A' ' 24' ' ' LEU . 2.7 mp -135.55 122.26 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.74 109.717 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 98' ' ' THR . 41.9 t -110.32 106.81 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.423 -0.584 . . . . 0.67 109.423 176.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -130.99 133.87 62.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.027 0.441 . . . . 0.75 112.137 -178.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.837 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -80.43 156.92 39.74 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.946 -0.57 . . . . 0.5 112.562 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -66.89 144.16 56.42 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.236 0.541 . . . . 2.79 112.347 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.704 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 4.5 ttp180 -136.35 -18.17 1.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.971 -1.013 . . . . 5.46 109.689 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.91 HD21 ' HB2' ' A' ' 88' ' ' ARG . 7.5 tt 80.02 162.08 0.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.271 -0.877 . . . . 1.55 111.311 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.77 97.63 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 1.93 110.817 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.633 ' HA3' ' HD3' ' A' ' 39' ' ' LYS . . . 103.19 -9.49 54.21 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.274 -1.441 . . . . 2.4 115.038 165.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.735 ' HD1' HG23 ' A' ' 64' ' ' THR . 36.0 t80 73.15 -19.22 0.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.823 0.812 . . . . 5.38 112.154 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.76 -17.82 60.96 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.366 -0.445 . . . . 2.3 112.421 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.91 ' HB2' HD21 ' A' ' 83' ' ' LEU . 40.6 mtm105 -108.92 173.61 6.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.408 0.283 . . . . 4.77 110.248 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -78.58 115.49 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.491 0.662 . . . . 1.86 111.676 -172.006 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.54 138.96 21.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 3.18 110.224 176.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 93' ' ' ASN . 33.8 Cg_endo -65.2 -38.61 26.62 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.897 2.398 . . . . 2.36 113.481 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 26.3 t70 72.33 -24.3 0.19 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.492 0.663 . . . . 2.99 111.154 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 91' ' ' PRO . 39.7 m-80 -130.78 81.94 2.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.939 -1.504 . . . . 3.06 106.939 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 95' ' ' SER . 2.6 p -107.06 -164.35 0.98 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.665 1.358 . . . . 1.85 114.665 -160.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 1.099 ' HA ' ' HB3' ' A' ' 117' ' ' HIS . 41.3 m -72.87 -45.17 59.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 112.311 -2.222 . . . . 1.44 111.963 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.837 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.1 tt0 70.89 111.39 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.046 0.841 . . . . 1.81 109.793 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.439 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 40.3 p90 -115.06 150.81 35.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.203 0.525 . . . . 0.64 111.589 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.561 HG23 HG22 ' A' ' 78' ' ' VAL . 57.8 m -108.22 114.49 28.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.388 -0.824 . . . . 0.43 110.621 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.753 ' HA ' HG22 ' A' ' 113' ' ' VAL . 90.4 t -88.56 110.49 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.618 . . . . 0.87 110.272 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.456 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.6 m -104.36 105.91 16.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.19 -0.459 . . . . 0.45 110.526 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.4 m-85 -89.36 109.27 20.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.34 110.283 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' THR . 59.5 t -89.54 107.9 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.813 -0.44 . . . . 0.54 109.813 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.6 33.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.516 . . . . 0.44 110.258 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.7 t70 -125.43 112.96 16.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.92 0.39 . . . . 2.03 110.62 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -112.92 5.02 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.87 -0.681 . . . . 1.97 112.161 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 49.3 tt0 -141.05 -17.97 0.82 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.016 0.436 . . . . 4.93 110.132 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -131.9 24.87 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 3.53 111.799 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.9 ttmp? -140.97 150.87 43.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.27 -0.572 . . . . 2.44 110.916 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.583 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.2 m -158.93 112.29 2.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.878 -0.601 . . . . 0.42 110.372 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.81 110.64 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.582 -0.525 . . . . 2.59 109.582 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -90.59 138.14 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.647 -0.421 . . . . 0.4 110.326 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 12.0 t70 -128.18 114.67 17.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.895 -0.78 . . . . 1.38 108.895 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 99' ' ' VAL . 25.2 t -104.4 121.24 55.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.32 -0.855 . . . . 0.91 111.345 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -97.59 132.79 42.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 2.31 109.629 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.823 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 4.1 t60 -150.91 110.17 3.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.118 -0.697 . . . . 1.64 109.118 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.609 ' OG1' ' HD2' ' A' ' 120' ' ' ARG . 8.6 t -163.3 97.44 0.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.693 0.759 . . . . 2.67 110.694 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 1.099 ' HB3' ' HA ' ' A' ' 95' ' ' SER . 5.1 t-80 -163.92 -77.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.817 -0.629 . . . . 2.63 111.464 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.13 -39.57 17.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.407 0.521 . . . . 3.54 112.407 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.722 ' HB3' HG21 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -75.43 -34.31 60.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.35 0.595 . . . . 1.81 109.588 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.609 ' HD2' ' OG1' ' A' ' 116' ' ' THR . 40.3 ttt180 -48.21 -21.5 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.439 -1.255 . . . . 3.38 112.075 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -82.06 14.11 3.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 2.43 111.239 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.49 -155.53 4.93 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.764 -0.653 . . . . 1.61 114.18 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 t 38.16 -130.66 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.114 0.966 . . . . 2.58 112.141 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 56.4 tttp -50.77 -43.29 58.44 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 122.962 0.505 . . . . 3.8 112.063 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 129' ' ' VAL . 38.5 m80 -53.69 -52.2 60.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 2.14 111.005 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -76.86 -29.75 55.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.399 -0.364 . . . . 0.92 110.961 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.03 -52.89 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 2.83 110.479 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 23.6 ptt85 -61.09 -31.86 71.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 2.59 110.842 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 119' ' ' ASP . 70.6 t -65.84 -41.99 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 120.677 0.275 . . . . 1.48 110.78 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -64.73 -15.97 62.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.366 -0.379 . . . . 3.83 111.557 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.511 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 6.1 m-20 -52.28 -21.55 3.59 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.503 0.557 . . . . 2.48 112.503 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 88' ' ' ARG . . . -169.53 -28.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.021 -1.085 . . . . 1.61 114.274 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.407 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 12.7 tmm? -60.97 -40.95 95.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.404 0.602 . . . . 4.83 110.281 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.31 -27.21 45.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.973 -0.558 . . . . 2.83 112.417 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -107.02 -47.23 3.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.003 0.43 . . . . 4.15 111.466 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.645 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -65.39 -54.94 23.62 Favored Glycine 0 C--O 1.223 -0.547 0 CA-C-N 116.021 -0.536 . . . . 1.04 113.226 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t90 -60.74 -51.0 82.68 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.034 0.383 . . . . 2.78 112.034 -171.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 12.5 Cg_endo -57.94 -42.34 59.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.842 1.695 . . . . 0.68 112.111 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.2 m -65.5 -34.99 79.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.336 0.589 . . . . 0.87 110.076 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.766 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 47.7 mt -56.96 -46.07 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.72 110.331 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 65.7 mt -62.38 -31.26 71.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.69 112.215 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -74.75 -53.8 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.008 -0.277 . . . . 1.49 111.085 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 59.4 m -64.73 -23.42 67.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.11 0.481 . . . . 1.15 110.217 177.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.761 ' HZ ' ' HA ' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -59.1 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 0.8 110.069 173.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.424 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.4 mt-30 -63.54 -25.26 68.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 1.63 111.007 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.83 -49.87 34.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.46 111.195 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.773 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 52.3 tptt -68.02 -34.46 76.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.62 -0.432 . . . . 1.74 110.398 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.809 HG21 HG13 ' A' ' 12' ' ' VAL . 75.5 mt -67.67 -29.43 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.024 0.44 . . . . 0.5 110.378 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.01 -31.34 72.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.549 -0.537 . . . . 0.85 109.549 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 41.0 mt-10 -70.71 -29.89 66.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.581 -0.736 . . . . 1.5 109.928 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -79.34 -23.42 43.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 1.74 110.008 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -97.47 22.97 37.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.634 -0.712 . . . . 1.32 111.427 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.592 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . 73.57 85.04 0.11 Allowed 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 124.639 0.846 . . . . 1.92 110.625 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.631 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 13.3 tppt? -73.54 105.16 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.475 -0.784 . . . . 2.04 110.103 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HE3' ' HB1' ' A' ' 153' ' ' ALA . 17.5 ptpt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.863 -0.608 . . . . 4.22 110.424 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.807 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 64.7 m-80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.415 -0.217 . . . . 1.66 110.415 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 21.6 p90 168.92 -21.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.036 0.835 . . . . 3.73 109.374 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.983 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -49.54 -59.46 6.65 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.295 -0.866 . . . . 2.78 110.541 -176.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.983 ' HD3' ' HB2' ' A' ' 3' ' ' ASP . 26.3 Cg_endo -97.34 -61.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.375 2.05 . . . . 1.63 111.489 167.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -153.95 171.58 18.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.447 -1.316 . . . . 3.21 107.447 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.807 ' HA ' ' HB3' ' A' ' 1' ' ' ASN . 40.8 t -91.61 138.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 120.651 -0.42 . . . . 1.44 111.155 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.8 ttp180 -134.6 146.58 49.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.163 -0.471 . . . . 3.37 110.96 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.763 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -129.39 134.12 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 0.79 109.844 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 14.4 m -129.15 113.39 15.02 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.191 0.52 . . . . 1.28 110.465 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.819 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.5 t -126.09 139.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.374 -0.83 . . . . 1.27 111.06 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -97.58 117.14 31.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.184 0.516 . . . . 0.57 109.938 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.938 HG13 HG21 ' A' ' 148' ' ' ILE . 50.8 t -100.65 122.71 52.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.458 0.646 . . . . 0.91 111.323 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.821 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -90.29 13.34 15.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.901 -1.045 . . . . 0.98 112.771 -173.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -146.16 27.69 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.301 0.852 . . . . 0.36 113.301 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.9 t0 76.49 164.78 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.598 0.713 . . . . 0.91 112.358 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 16.0 ttp180 -69.72 -37.32 76.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.024 -0.989 . . . . 1.88 112.212 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 79.2 mttt -58.29 -49.17 78.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.706 0.765 . . . . 3.05 109.951 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -66.3 -38.74 88.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.302 -1.317 . . . . 1.11 110.909 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.764 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -57.77 -48.62 79.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.32 110.479 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.6 t80 -61.25 -45.17 95.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.649 -0.705 . . . . 0.38 110.733 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 4.2 tppp? -58.28 -53.46 58.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 2.39 110.798 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -62.62 -48.74 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.202 0.313 . . . . 0.68 110.835 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.901 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 72.6 t80 -63.18 -43.67 97.57 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.132 0.419 . . . . 0.48 112.132 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.606 HD11 HG11 ' A' ' 46' ' ' VAL . 17.3 tp -101.38 -56.26 2.34 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.519 -0.472 . . . . 0.5 112.119 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 51.6 mt-10 -96.2 15.56 20.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.391 0.615 . . . . 1.24 111.404 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.711 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -126.82 24.13 5.51 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.113 -1.195 . . . . 0.83 110.113 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.841 ' HD2' ' HA2' ' A' ' 45' ' ' GLY . 10.3 t80 -52.79 -47.02 96.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.642 -0.779 . . . . 0.74 112.995 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.2 Cg_endo -93.38 19.35 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.793 1.662 . . . . 0.76 115.012 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.711 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -110.41 -7.42 14.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.091 -0.643 . . . . 1.49 112.381 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.901 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 19.3 m0 -74.09 169.98 16.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 4.62 111.228 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.644 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 28.0 m95 -90.32 -29.54 0.34 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.639 0.977 . . . . 2.78 113.639 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.724 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 36.6 Cg_endo -66.19 -136.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.328 2.019 . . . . 1.36 114.207 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 25.1 t30 -57.48 -35.97 70.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.104 0.954 . . . . 1.51 111.181 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.006 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 3.0 p-10 -89.54 23.3 2.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.703 -1.135 . . . . 1.79 112.678 -169.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.73 -18.99 29.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 4.45 110.683 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.647 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 48.0 mtm105 -88.04 -179.2 6.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.455 0.539 . . . . 4.14 112.455 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.529 HG23 ' HD3' ' A' ' 43' ' ' PRO . 27.9 m -101.18 137.54 39.41 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.621 -0.718 . . . . 2.68 110.009 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 1.012 ' H ' ' HA ' ' A' ' 42' ' ' ALA . 44.5 p 50.22 28.84 3.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.493 0.717 . . . . 1.42 111.232 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 1.006 ' HD3' ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -67.52 -71.07 0.22 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.717 -1.129 . . . . 2.9 111.21 -177.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.861 ' H ' ' HD2' ' A' ' 39' ' ' LYS . 21.7 m -97.3 -13.01 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 122.217 1.008 . . . . 1.83 108.548 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.759 ' HA2' ' CD2' ' A' ' 63' ' ' HIS . . . -168.69 -50.65 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 113.471 -1.695 . . . . 2.17 110.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.012 ' HA ' ' H ' ' A' ' 38' ' ' THR . . . 152.01 -173.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 125.186 1.168 . . . . 1.12 112.195 -172.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.638 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 20.3 Cg_exo -72.75 74.54 2.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.541 2.16 . . . . 1.48 113.34 167.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.79 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 41.7 tp -145.67 -87.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.072 -0.344 . . . . 1.75 110.072 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.841 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 134.58 -92.66 0.24 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.953 -1.118 . . . . 0.75 113.843 170.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 24' ' ' LEU . 87.9 t -132.99 148.06 31.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.314 0.578 . . . . 0.6 111.821 -168.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.824 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.1 t70 -92.8 110.6 22.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.224 -0.898 . . . . 1.11 109.154 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 17.8 tptm -80.75 -25.42 38.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.718 -0.674 . . . . 2.81 111.601 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.3 ptpp? -73.97 -38.93 64.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.757 0.28 . . . . 3.17 111.757 -171.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.72 -41.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 1.53 112.154 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.491 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 118.52 71.31 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.661 -0.781 . . . . 0.77 112.232 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 47' ' ' ASP . 5.4 mpt_? -133.79 157.31 46.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.017 -0.364 . . . . 3.72 110.017 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 29.8 m0 -112.81 117.06 31.12 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.607 -0.886 . . . . 1.28 108.607 168.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.824 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.7 p90 -162.22 155.01 19.9 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.047 0.451 . . . . 1.66 110.06 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.79 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.16 172.73 12.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.119 -0.491 . . . . 2.12 110.586 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' HG2' ' A' ' 61' ' ' GLU . 13.7 mm -78.59 99.16 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.92 111.395 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 58' ' ' GLU . 5.5 t70 -96.27 172.87 7.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.627 -0.509 . . . . 1.97 109.627 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.498 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.9 pt-20 -58.47 -40.34 82.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.799 1.037 . . . . 2.43 113.799 -167.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.54 7.38 12.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.464 -0.494 . . . . 2.39 112.307 -176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.2 84.11 1.78 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.043 -1.075 . . . . 2.29 114.421 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 56' ' ' ILE . 43.5 mt-10 55.87 30.89 16.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.772 1.027 . . . . 2.31 113.772 167.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -127.61 92.1 3.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.559 0.695 . . . . 2.61 111.68 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.759 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 1.0 OUTLIER -120.58 166.46 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.923 -1.035 . . . . 3.72 110.599 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.681 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 9.1 p -47.37 105.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.719 0.637 . . . . 2.27 110.637 171.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 28.8 p90 -90.32 118.02 29.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.138 0.494 . . . . 6.48 111.77 -173.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -67.18 137.5 33.43 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.837 -0.905 . . . . 1.23 110.837 173.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -100.38 94.13 6.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.201 0.5 . . . . 1.17 111.481 -171.287 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.609 HG21 HG22 ' A' ' 71' ' ' VAL . 55.4 mt -76.08 123.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.257 0.551 . . . . 0.61 110.158 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 10.5 mmm180 -87.72 -34.56 18.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.396 -0.82 . . . . 2.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -147.21 120.83 9.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.028 -0.533 . . . . 1.53 111.54 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 68' ' ' ILE . 32.1 t -102.75 92.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.284 -1.006 . . . . 0.88 108.284 167.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.63 63.28 0.72 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.789 -0.364 . . . . 1.42 110.936 -173.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.654 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.8 pt-20 47.05 -169.37 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 124.476 1.11 . . . . 0.96 112.031 175.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 33.2 Cg_exo -61.51 76.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.304 1.336 . . . . 0.38 111.798 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.9 -66.6 0.05 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.5 109.754 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.3 p -144.21 143.01 30.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.715 0.635 . . . . 0.35 112.715 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 77' ' ' LEU . 2.0 mp -132.47 116.19 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.145 -0.687 . . . . 0.74 109.145 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 98' ' ' THR . 36.5 t -104.72 110.27 30.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.478 -0.564 . . . . 0.67 109.478 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.98 140.55 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.871 0.367 . . . . 0.75 111.437 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.2 161.1 23.2 Favored Glycine 0 C--O 1.239 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.5 112.639 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 1.073 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 38.9 t-105 -65.04 157.89 27.18 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 113.737 1.014 . . . . 2.79 113.737 -165.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.681 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 2.9 tpt180 -174.41 33.42 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.435 -1.257 . . . . 5.46 108.917 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 88' ' ' ARG . 13.9 tp 69.55 -133.9 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 1.55 111.857 175.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 59.7 t30 -167.41 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.877 0.37 . . . . 1.93 110.204 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.27 11.02 25.46 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.193 -0.527 . . . . 2.4 114.062 -172.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.5 t80 70.71 -43.37 0.55 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.529 0.731 . . . . 5.38 112.783 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.94 38.41 2.17 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.237 -0.506 . . . . 2.3 113.082 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.001 ' HB2' HD21 ' A' ' 83' ' ' LEU . 4.7 mmp_? -135.09 -175.16 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.52 -0.919 . . . . 4.77 108.52 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.606 HD13 ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -112.32 132.68 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.906 0.384 . . . . 1.86 110.918 -177.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -156.47 107.91 2.02 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.989 -0.551 . . . . 3.18 110.601 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.606 ' HD3' HD13 ' A' ' 89' ' ' ILE . 1.6 Cg_endo -109.63 18.11 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.127 3.218 . . . . 2.36 110.487 165.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' A' ' 118' ' ' PHE . 10.5 t70 -79.74 -77.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.366 -0.833 . . . . 2.99 111.294 -159.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 33.9 m-80 76.59 -40.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.218 -0.901 . . . . 3.06 112.359 172.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.785 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . 70.2 m -77.66 -7.57 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.627 0.232 . . . . 1.85 111.627 -176.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 1.073 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 23.1 t -66.55 75.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.074 0.94 . . . . 1.44 109.227 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.8 tt0 -97.69 123.72 41.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.499 -1.228 . . . . 1.81 110.678 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.793 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 5.4 p90 -120.98 140.28 52.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.468 0.651 . . . . 0.64 111.805 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.661 HG23 HG22 ' A' ' 78' ' ' VAL . 32.4 m -98.7 110.48 23.07 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.475 -1.238 . . . . 0.43 109.721 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.0 t -81.92 108.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.357 -0.608 . . . . 0.87 109.357 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.639 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.8 m -102.7 106.7 17.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.086 0.47 . . . . 0.45 111.21 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.692 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 47.9 m-85 -87.4 113.3 22.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 0.34 109.968 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.79 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.604 -0.517 . . . . 0.54 109.604 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.16 124.28 27.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.087 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 23.2 m-20 -106.54 100.36 9.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 2.03 109.111 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.85 -113.37 4.16 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.616 -0.802 . . . . 1.97 111.933 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.409 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 3.1 pt20 -147.02 4.89 0.84 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.544 0.211 . . . . 4.93 111.089 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 47.6 mmtm -132.34 -12.23 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.791 0.293 . . . . 3.53 111.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 47.6 tttp -121.46 152.65 38.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.794 -0.447 . . . . 2.44 109.794 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.6 m -157.95 119.1 3.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 0.42 111.087 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -94.37 123.54 37.84 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.511 -0.551 . . . . 2.59 109.511 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.599 ' CG1' ' HB ' ' A' ' 10' ' ' VAL . 14.2 p -98.46 135.3 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.112 -0.635 . . . . 0.4 110.391 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 6.3 p-10 -127.87 115.87 19.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.783 0.801 . . . . 1.38 109.197 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.763 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 2.1 t -89.71 121.33 39.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.292 -0.867 . . . . 0.91 110.377 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.73 136.25 44.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 124.148 0.905 . . . . 2.31 108.715 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 97' ' ' PHE . 65.6 t-80 -128.46 153.53 47.04 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.78 -0.645 . . . . 1.64 110.716 -171.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 t -64.84 -153.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.55 -0.75 . . . . 2.67 110.248 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -143.47 37.65 1.36 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.127 0.788 . . . . 2.63 113.127 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 2.4 t80 -71.73 -35.98 70.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.287 0.565 . . . . 3.54 109.704 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.44 ' OD2' ' CE1' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -70.84 -28.89 64.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 1.81 110.477 177.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -54.92 -20.52 9.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.409 -0.814 . . . . 3.38 111.762 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.9 mmt -65.88 -4.52 6.97 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.336 -0.393 . . . . 2.43 110.528 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.26 -141.46 25.92 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.319 -0.855 . . . . 1.61 112.965 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.2 p 42.25 -112.04 0.18 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.663 0.86 . . . . 2.58 112.264 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -77.72 -39.73 43.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.855 -0.612 . . . . 3.8 110.835 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -53.26 59.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.939 0.4 . . . . 2.14 111.079 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -69.61 -33.46 72.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.986 -0.552 . . . . 0.92 111.165 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -70.02 -49.85 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.798 -0.361 . . . . 2.83 111.077 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -66.78 -33.01 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.512 -0.313 . . . . 2.59 111.021 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.7 t -78.55 -30.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 1.48 110.864 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.501 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 18.6 ttm180 -56.4 -34.63 66.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 3.83 111.336 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.556 ' CB ' ' HD3' ' A' ' 88' ' ' ARG . 15.7 m-80 -63.59 -25.03 68.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 2.48 110.797 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.545 ' HA2' ' HG3' ' A' ' 88' ' ' ARG . . . -81.2 -106.88 0.33 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.864 -0.684 . . . . 1.61 113.248 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.682 ' HB3' ' HH2' ' A' ' 81' ' ' TRP . 18.2 ttt -79.7 -16.31 55.92 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.599 0.222 . . . . 4.83 111.599 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 25.4 t70 -62.01 -25.91 67.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 2.83 111.722 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -91.04 -29.64 17.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.072 0.463 . . . . 4.15 110.905 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -95.17 -32.17 7.21 Favored Glycine 0 C--O 1.217 -0.955 0 CA-C-N 116.155 -0.475 . . . . 1.04 112.368 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.669 ' HB2' ' HG2' ' A' ' 133' ' ' MET . 3.7 t90 -58.03 -47.06 99.54 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 122.512 0.325 . . . . 2.78 111.809 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.81 -32.55 95.62 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.837 1.692 . . . . 0.68 111.666 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.2 m -71.65 -43.17 66.55 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.268 1.032 . . . . 0.87 108.957 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.6 mt -61.83 -54.44 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.955 -1.475 . . . . 0.72 111.548 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 8' ' ' HIS . 64.8 mt -58.81 -35.33 72.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.69 112.202 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -52.84 32.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.923 -0.311 . . . . 1.49 110.406 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.553 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 12.0 t -69.01 -23.85 64.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 1.15 110.373 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.422 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 22.5 t80 -65.42 -49.85 67.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.609 -0.515 . . . . 0.8 109.609 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.819 ' HG2' HG13 ' A' ' 10' ' ' VAL . 45.5 mt-30 -58.4 -41.93 86.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.331 -0.849 . . . . 1.63 111.251 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 14.2 m-20 -75.46 -37.71 60.13 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.567 -0.453 . . . . 1.46 111.829 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.7 tptp -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.398 -0.593 . . . . 1.74 109.398 174.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.938 HG21 HG13 ' A' ' 12' ' ' VAL . 26.5 mt -62.27 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.5 111.109 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.821 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 34.2 t70 -62.38 -30.93 71.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.036 -0.529 . . . . 0.85 110.182 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.526 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 49.3 mt-10 -70.46 -39.53 74.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.994 -0.548 . . . . 1.5 109.798 175.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 16.0 mm-40 -62.33 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.659 -0.7 . . . . 1.74 109.877 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.69 -73.27 0.72 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.458 -0.792 . . . . 1.32 111.219 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -176.01 81.5 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.827 0.346 . . . . 1.92 111.418 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -98.02 -23.93 15.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.046 -0.724 . . . . 2.04 109.046 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.648 ' H ' ' HD3' ' A' ' 155' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.038 -0.983 . . . . 4.22 109.323 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.863 0.364 . . . . 1.66 111.079 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 30.2 p90 -178.12 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.654 -0.703 . . . . 3.73 110.051 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.652 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 28.4 t70 -65.47 -49.74 61.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 2.78 111.782 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 16.3 Cg_endo -87.77 -68.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.142 1.228 . . . . 1.63 110.92 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.74 157.15 37.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 3.21 109.458 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.673 HG22 ' CG ' ' A' ' 115' ' ' HIS . 2.0 m -97.23 113.32 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.523 -0.917 . . . . 1.44 108.523 168.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.555 ' HD3' ' OD2' ' A' ' 112' ' ' ASP . 20.2 ttm180 -104.35 146.59 28.6 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.365 -0.834 . . . . 3.37 112.136 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 1.046 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 9.7 t-160 -112.24 132.84 54.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.614 -1.175 . . . . 0.79 108.667 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 38.3 m -140.32 119.64 12.99 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.839 -0.43 . . . . 1.28 109.839 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 145' ' ' GLN . 3.9 t -143.7 132.83 19.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.812 -0.631 . . . . 1.27 110.893 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 m -95.97 115.78 27.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.455 -0.572 . . . . 0.57 109.455 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.878 HG13 HG21 ' A' ' 148' ' ' ILE . 24.9 t -95.45 140.54 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.796 -0.638 . . . . 0.91 110.736 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.11 24.22 11.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.47 0.544 . . . . 0.98 112.47 -173.235 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.46 34.92 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.735 0.643 . . . . 0.36 112.735 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 23.7 t70 72.48 166.96 0.31 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.6 0.714 . . . . 0.91 112.377 172.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NE ' ' HB2' ' A' ' 103' ' ' ALA . 28.3 ttp180 -69.12 -23.68 64.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.42 -0.809 . . . . 1.88 111.425 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -58.89 -49.08 79.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.63 0.252 . . . . 3.05 111.086 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -73.79 -37.76 64.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.702 0.286 . . . . 1.11 110.314 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.33 -45.97 80.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.32 111.095 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.503 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 70.2 t80 -71.95 -47.94 48.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.407 -0.361 . . . . 0.38 110.893 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.629 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 26.5 tptp -52.9 -52.45 57.62 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.842 -0.617 . . . . 2.39 110.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -50.96 61.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.68 111.221 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -62.46 -37.0 84.24 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.246 0.462 . . . . 0.48 112.246 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' HG11 ' A' ' 46' ' ' VAL . 13.6 tp -109.02 -53.18 2.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.286 -0.566 . . . . 0.5 112.403 -172.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.629 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 1.4 mm-40 -79.87 -28.64 39.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.105 0.478 . . . . 1.24 111.478 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -100.8 30.58 10.01 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.582 -0.735 . . . . 0.83 111.876 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.499 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 56.4 t80 -48.5 -47.18 70.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.943 0.497 . . . . 0.74 112.279 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.611 ' HA ' HD21 ' A' ' 34' ' ' ASN . 15.6 Cg_endo -98.08 19.35 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.19 1.927 . . . . 0.76 114.409 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 6.6 pt-20 -105.57 -3.87 21.84 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.134 -0.627 . . . . 1.49 111.505 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.761 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 2.9 m0 -80.82 -172.03 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 4.62 111.129 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.539 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 66.4 m95 -102.45 -26.88 0.21 Allowed Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 114.041 1.126 . . . . 2.78 114.041 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.761 ' HD2' ' HB2' ' A' ' 30' ' ' TRP . 65.3 Cg_endo -72.74 -143.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.931 1.754 . . . . 1.36 114.4 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 15.3 t-20 -59.29 -14.73 12.3 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.433 0.901 . . . . 1.51 113.433 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.611 HD21 ' HA ' ' A' ' 28' ' ' PRO . 2.6 p-10 -76.28 -10.77 59.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.948 0.351 . . . . 1.79 111.948 -174.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -78.01 69.41 4.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 4.45 110.596 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -149.11 151.0 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.636 -0.711 . . . . 4.14 110.571 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 38' ' ' THR . 7.3 m -87.99 122.75 31.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.916 -0.314 . . . . 2.68 110.375 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 73.2 p 56.84 16.22 2.63 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.319 0.859 . . . . 1.42 113.319 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -103.53 -47.27 4.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.815 -1.18 . . . . 2.9 107.815 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.598 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -156.21 130.14 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 113.78 -1.555 . . . . 1.83 108.582 171.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 55' ' ' GLU . . . 98.91 -72.22 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.54 -0.838 . . . . 2.17 113.291 175.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . 50.36 -164.65 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 109.813 -0.44 . . . . 1.12 109.813 -169.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.649 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 23.0 Cg_exo -69.95 16.16 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.324 1.349 . . . . 1.48 113.656 171.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.475 HD21 ' CE2' ' A' ' 54' ' ' TYR . 56.0 tp -128.66 -92.11 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.87 -0.518 . . . . 1.75 112.049 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 109.83 -75.01 0.21 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.457 -0.878 . . . . 0.75 113.132 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 24' ' ' LEU . 58.5 t -140.48 135.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 122.723 -0.28 . . . . 0.6 110.799 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.702 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 13.0 t70 -103.64 126.4 50.75 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.411 -0.359 . . . . 1.11 110.405 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HE2' ' HG ' ' A' ' 24' ' ' LEU . 1.3 mmpp? -81.38 -24.07 37.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.539 . . . . 2.81 111.947 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -83.44 -58.7 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 3.17 110.82 -171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.514 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -77.95 -22.48 68.75 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.613 -0.803 . . . . 1.53 111.507 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 63.4 2.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.896 -0.669 . . . . 0.77 111.701 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -156.2 143.74 19.32 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.339 -0.544 . . . . 3.72 111.395 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.574 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 10.5 m0 -87.46 114.26 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.725 -0.843 . . . . 1.28 108.725 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.708 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 3.4 p90 -162.65 171.23 17.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.421 0.629 . . . . 1.66 111.288 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 8.6 mp0 -127.86 -179.45 4.96 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.288 -1.005 . . . . 2.12 108.288 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.1 103.28 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 119.655 -0.818 . . . . 0.92 110.665 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 11.6 p-10 -90.55 139.77 30.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.36 0.6 . . . . 1.97 110.189 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.89 -5.13 50.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.681 0.993 . . . . 2.43 113.681 -164.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.689 -0.804 . . . . 2.39 110.659 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.45 49.04 0.45 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.936 -0.65 . . . . 2.29 113.347 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.493 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 45.7 mt-10 60.28 76.68 0.35 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.008 1.114 . . . . 2.31 114.008 172.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.46 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 30.4 tt0 -131.37 74.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.59 0.709 . . . . 2.61 110.131 169.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.708 ' CE1' ' HD1' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -120.47 154.24 35.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.326 -0.852 . . . . 3.72 110.305 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 p -64.9 149.34 49.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 2.27 109.146 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 45.8 p90 -123.38 127.45 48.49 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.189 -0.604 . . . . 6.48 111.034 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.38 136.21 28.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.116 -0.793 . . . . 1.23 111.116 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 67' ' ' LEU . 5.8 mp -82.8 87.7 6.79 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 121.092 -0.243 . . . . 1.17 110.499 -173.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 71' ' ' VAL . 43.5 mt -87.69 116.51 29.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 119.417 -0.913 . . . . 0.61 109.718 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -110.19 -10.46 14.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.093 -0.958 . . . . 2.0 110.487 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 37.1 ttmt -145.53 110.4 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.981 -0.554 . . . . 1.53 111.359 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 68' ' ' ILE . 38.9 t -102.26 90.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.03 -1.1 . . . . 0.88 108.03 166.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.5 t70 -106.44 59.63 0.64 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.538 -0.465 . . . . 1.42 110.613 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.705 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.7 pt-20 39.71 -160.95 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 124.734 1.271 . . . . 0.96 111.924 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.705 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -62.47 80.5 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 CA-C-N 120.494 1.212 . . . . 0.38 112.118 168.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.459 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 13.9 t70 -165.89 -69.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.5 110.66 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.615 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -146.43 130.69 17.52 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.384 0.883 . . . . 0.35 113.384 -174.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -123.75 125.96 45.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.041 -0.412 . . . . 0.74 110.864 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 99.2 t -103.48 109.83 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.77 -0.456 . . . . 0.67 109.77 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.75 126.73 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.385 -0.825 . . . . 0.75 111.616 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.1 163.99 29.49 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.787 -0.525 . . . . 0.5 111.787 175.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 5.3 t-105 -64.31 161.79 16.06 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.563 0.949 . . . . 2.79 113.563 -166.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.481 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 1.6 ttp180 -158.07 -17.69 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.862 -1.063 . . . . 5.46 109.822 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.618 ' HA ' ' CZ2' ' A' ' 81' ' ' TRP . 2.6 tt 79.2 157.35 0.16 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.758 -1.11 . . . . 1.55 111.624 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.504 ' OD1' HG11 ' A' ' 40' ' ' VAL . 49.9 t30 -131.55 147.42 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.561 -0.745 . . . . 1.93 110.265 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' PHE . . . 83.31 1.1 90.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.911 -0.661 . . . . 2.4 113.645 172.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 18.9 t80 177.55 165.91 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.961 0.381 . . . . 5.38 110.479 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.61 69.18 1.24 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.195 -1.562 . . . . 2.3 109.195 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 131' ' ' ASN . 12.9 ttm180 -97.5 -179.92 4.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.186 -0.507 . . . . 4.77 110.242 -168.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.512 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.06 122.5 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.568 0.699 . . . . 1.86 110.1 177.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 3.5 p30 -122.9 147.43 51.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.4 -0.818 . . . . 3.18 111.38 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' ' HD2' ' A' ' 128' ' ' ARG . 3.4 Cg_exo -80.77 -52.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.892 2.395 . . . . 2.36 110.904 168.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 90' ' ' ASP . 5.2 m-20 44.17 42.34 4.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.043 -0.98 . . . . 2.99 113.161 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.405 ' H ' ' H ' ' A' ' 94' ' ' SER . 10.3 p30 -140.54 -22.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 122.008 0.908 . . . . 3.06 109.064 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.463 ' HB2' ' CG ' ' A' ' 118' ' ' PHE . 71.1 m -150.67 -141.85 0.11 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.419 -1.264 . . . . 1.85 107.979 173.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 21.9 t 60.74 37.27 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.368 1.08 . . . . 1.44 108.307 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.76 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 21.4 mt-10 -74.89 144.37 43.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.175 -1.375 . . . . 1.81 110.182 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.57 ' HB2' ' CG1' ' A' ' 113' ' ' VAL . 2.7 p90 -131.56 132.11 43.88 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.229 0.538 . . . . 0.64 110.636 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 35.9 m -95.24 114.31 26.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.207 -0.906 . . . . 0.43 110.209 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.707 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -82.1 108.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.783 -0.644 . . . . 0.87 109.387 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.4 m -101.29 105.52 16.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.126 -0.488 . . . . 0.45 109.881 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.87 110.5 21.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.415 -0.357 . . . . 0.34 110.062 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.67 106.41 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.137 -0.69 . . . . 0.54 109.137 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.503 ' HB2' ' NE ' ' A' ' 16' ' ' ARG . . . -78.52 124.34 28.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.638 -0.71 . . . . 0.44 111.46 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -108.27 127.89 54.25 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.726 -0.842 . . . . 2.03 108.726 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.95 -18.42 40.22 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.525 -0.761 . . . . 1.97 114.832 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -92.87 39.58 1.04 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.737 0.769 . . . . 4.93 110.812 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.551 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . 9.7 mtmp? 64.76 33.29 10.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.06 -0.518 . . . . 3.53 110.86 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 1.2 ttmp? -122.0 153.19 38.89 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.227 -0.657 . . . . 2.44 109.227 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.7 m -155.78 113.82 3.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.187 0.518 . . . . 0.42 111.203 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -92.21 111.71 23.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.515 -0.766 . . . . 2.59 109.933 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.589 HG12 ' HB ' ' A' ' 10' ' ' VAL . 13.4 p -87.61 138.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.4 110.163 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.555 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 22.7 t70 -133.19 106.93 7.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.302 -0.863 . . . . 1.38 109.008 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.046 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 5.3 t -90.61 120.62 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 120.89 -0.324 . . . . 0.91 110.597 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.71 133.1 43.51 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.701 -0.852 . . . . 2.31 108.701 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.673 ' CG ' HG22 ' A' ' 6' ' ' VAL . 34.6 t60 -116.61 153.93 31.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.614 -0.721 . . . . 1.64 109.789 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 118' ' ' PHE . 14.2 t -64.1 -165.31 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.613 -0.722 . . . . 2.67 110.415 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' A' ' 121' ' ' MET . 8.4 p-80 -131.82 27.53 4.6 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.708 -0.678 . . . . 2.63 110.571 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' H ' HG23 ' A' ' 116' ' ' THR . 46.2 t80 -64.48 -24.33 67.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.506 0.67 . . . . 3.54 109.985 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -44.59 66.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.817 -1.083 . . . . 1.81 109.172 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 2' ' ' TYR . 1.3 tmt_? -58.49 -21.17 50.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.803 -1.09 . . . . 3.38 111.832 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 94.1 mmm -73.52 33.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.991 0.424 . . . . 2.43 112.107 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 130.09 145.26 5.74 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.244 -0.503 . . . . 1.61 111.96 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.9 m -61.15 -27.12 68.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.34 . . . . 2.58 110.855 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.836 ' HG2' HH21 ' A' ' 128' ' ' ARG . 60.4 tttp -66.25 -47.35 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.461 -0.336 . . . . 3.8 110.315 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.671 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 37.0 m80 -65.04 -47.02 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.922 0.391 . . . . 2.14 110.944 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.65 80.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.314 -0.403 . . . . 0.92 111.466 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.38 -44.91 86.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.723 -0.217 . . . . 2.83 110.924 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.836 HH21 ' HG2' ' A' ' 124' ' ' LYS . 19.2 ptp180 -58.29 -34.04 70.11 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 120.796 0.331 . . . . 2.59 110.683 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.5 HG12 ' SD ' ' A' ' 133' ' ' MET . 92.7 t -79.29 -48.71 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.867 0.365 . . . . 1.48 110.719 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.975 ' HA ' ' HG2' ' A' ' 133' ' ' MET . 17.2 mtp180 -61.91 -17.85 58.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.06 -0.518 . . . . 3.83 111.922 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 4.2 m-80 -51.98 -46.98 65.04 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.493 0.496 . . . . 2.48 111.517 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.01 -15.71 9.74 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.136 -1.031 . . . . 1.61 113.15 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.975 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 21.6 ptm -80.91 -36.88 30.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.48 . . . . 4.83 112.167 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -27.43 62.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.933 0.716 . . . . 2.83 112.933 -163.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -103.29 -15.85 15.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.167 0.508 . . . . 4.15 111.004 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.597 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.2 -55.46 0.77 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.427 -0.892 . . . . 1.04 113.102 -174.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 8' ' ' HIS . 6.9 t90 -56.12 -53.34 64.56 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.674 0.62 . . . . 2.78 112.674 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.25 -45.24 28.26 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.801 1.668 . . . . 0.68 111.714 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 m -60.53 -40.16 90.47 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.573 0.702 . . . . 0.87 110.34 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 136' ' ' GLY . 49.7 mt -55.67 -45.53 79.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 CA-C-N 114.945 -1.025 . . . . 0.72 110.031 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 38.4 mt -59.14 -34.87 72.58 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.45 0.468 . . . . 0.69 111.842 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.98 -56.19 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 1.49 110.636 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.668 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 23.5 m -68.56 -21.16 64.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.518 -0.31 . . . . 1.15 111.161 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.09 -52.14 65.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.941 -0.392 . . . . 0.8 109.941 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.692 ' HG2' HG13 ' A' ' 10' ' ' VAL . 21.1 mt-30 -60.41 -36.07 77.26 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.741 -0.663 . . . . 1.63 110.046 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.62 -40.26 69.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.892 -1.049 . . . . 1.46 111.208 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 37.4 tptt -65.58 -37.71 87.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.216 0.531 . . . . 1.74 109.642 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.878 HG21 HG13 ' A' ' 12' ' ' VAL . 66.0 mt -72.45 -25.66 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.5 110.557 176.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.82 -30.9 71.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.554 -0.536 . . . . 0.85 109.554 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.696 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 40.1 mt-10 -70.4 -30.54 67.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.63 -0.714 . . . . 1.5 110.188 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.87 -36.12 62.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.362 -0.836 . . . . 1.74 109.619 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.26 -0.882 . . . . 1.32 111.647 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -167.21 86.66 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.413 . . . . 1.92 110.967 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.696 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.5 ttmm -107.59 -59.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.41 . . . . 2.04 109.914 176.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 3.9 mptp? . . . . . 0 C--O 1.247 0.946 0 O-C-N 123.777 0.673 . . . . 4.22 111.101 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 2.7 p30 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.682 0.277 . . . . 1.66 111.333 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 46.8 p90 -176.78 -42.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.776 -0.647 . . . . 3.73 109.812 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.768 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 21.3 t70 -58.23 -55.37 46.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.13 -0.486 . . . . 2.78 112.099 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.2 Cg_endo -92.39 -65.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.453 2.102 . . . . 1.63 112.275 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.473 ' HD2' HG21 ' A' ' 116' ' ' THR . 91.7 m-85 -143.1 145.35 32.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.226 -0.443 . . . . 3.21 110.543 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 45.2 t -104.58 126.54 59.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.88 -0.785 . . . . 1.44 108.88 167.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.2 ttm105 -128.44 135.2 49.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.221 0.534 . . . . 3.37 110.96 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.952 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -109.07 130.51 55.48 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.135 -1.061 . . . . 0.79 108.135 170.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.4 t -136.78 110.5 8.1 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.568 0.699 . . . . 1.28 109.596 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.8 t -122.85 134.7 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.601 -1.181 . . . . 1.27 111.038 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -91.75 115.59 28.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.04 -0.527 . . . . 0.57 109.756 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.768 HG13 HG21 ' A' ' 148' ' ' ILE . 42.0 t -96.79 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.496 -0.557 . . . . 0.91 109.496 177.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -104.93 33.25 3.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.885 -0.598 . . . . 0.98 111.5 -173.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -153.53 31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 0.36 111.573 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.71 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 19.8 t70 71.38 166.9 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.054 0.93 . . . . 0.91 112.348 176.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -71.68 -21.91 61.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.111 -0.95 . . . . 1.88 111.68 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.71 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 39.5 mmtm -58.33 -50.84 72.2 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.048 0.452 . . . . 3.05 109.907 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.1 p -72.57 -37.43 68.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.72 -0.673 . . . . 1.11 110.623 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -55.9 -45.55 78.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.853 0.359 . . . . 0.32 110.732 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.432 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 59.9 t80 -74.24 -47.64 33.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.148 -0.478 . . . . 0.38 111.204 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 21' ' ' LYS . 4.4 ttmm -56.92 -52.18 66.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.592 -0.277 . . . . 2.39 111.167 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 m -64.01 -50.63 67.77 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.416 -0.356 . . . . 0.68 110.577 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.882 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.8 t80 -61.09 -36.84 80.73 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.333 0.494 . . . . 0.48 112.333 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 ' CD1' HG11 ' A' ' 46' ' ' VAL . 20.0 tp -106.37 -59.73 1.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.333 0.494 . . . . 0.5 112.333 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.16 -44.78 21.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.236 0.541 . . . . 1.24 111.515 -170.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.779 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -85.19 37.45 3.01 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 115.349 -0.841 . . . . 0.83 112.286 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.627 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 23.8 t80 -54.5 -48.91 93.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 112.366 0.506 . . . . 0.74 112.366 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 48.0 Cg_endo -86.84 12.93 2.85 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.203 1.935 . . . . 0.76 114.711 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.779 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -96.08 -4.23 43.27 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.192 -0.603 . . . . 1.49 110.624 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.882 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 17.1 m0 -77.4 -175.58 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.726 0.774 . . . . 4.62 112.045 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.522 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 47.4 m95 -109.42 -33.66 0.15 Allowed Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 114.642 -1.163 . . . . 2.78 113.454 176.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.851 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 60.7 Cg_endo -71.03 -129.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.98 1.787 . . . . 1.36 114.345 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.502 ' CG ' HD21 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -59.87 -47.11 87.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.642 0.734 . . . . 1.51 111.279 -172.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.691 ' HA ' HG13 ' A' ' 40' ' ' VAL . 6.1 p-10 -83.61 34.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.345 -1.298 . . . . 1.79 112.062 -171.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -106.09 5.14 29.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.687 0.756 . . . . 4.45 109.404 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -99.53 124.05 44.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 4.14 110.693 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -74.88 131.26 40.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.064 -0.517 . . . . 2.68 111.51 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.651 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 30.5 p 54.54 22.77 4.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.249 1.02 . . . . 1.42 111.74 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -114.0 -46.64 3.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.596 -0.89 . . . . 2.9 108.596 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.691 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.6 p -169.43 6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.053 -0.976 . . . . 1.83 110.03 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -159.55 53.64 0.36 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.915 -0.66 . . . . 2.17 112.274 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.023 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.6 174.28 3.67 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 109.493 -0.558 . . . . 1.12 109.493 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 38.7 Cg_exo -63.15 56.43 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.184 2.589 . . . . 1.48 113.774 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -166.95 -84.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.194 0.598 . . . . 1.75 109.62 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.627 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 89.2 -48.93 3.46 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.043 -0.598 . . . . 0.75 113.012 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG11 ' CD1' ' A' ' 24' ' ' LEU . 75.2 t -137.86 144.83 30.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 110.033 -0.358 . . . . 0.6 110.033 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.753 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 29.5 t70 -108.77 116.07 31.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.54 -0.541 . . . . 1.11 109.54 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -73.96 -29.8 62.19 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.572 -0.74 . . . . 2.81 112.128 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.68 -54.04 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.021 0.378 . . . . 3.17 112.021 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.03 -22.21 39.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.41 -0.9 . . . . 1.53 112.651 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.486 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 87.3 61.91 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.543 -0.837 . . . . 0.77 111.46 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 3.9 mpt_? -133.17 158.97 41.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.224 . . . . 3.72 110.509 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.712 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 17.0 m0 -113.28 106.39 14.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.804 -0.813 . . . . 1.28 108.804 168.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.753 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 8.6 p90 -157.5 167.72 29.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.031 -0.359 . . . . 1.66 110.031 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.023 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 4.4 mt-10 -127.89 159.67 34.21 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.488 -0.324 . . . . 2.12 110.335 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.65 102.26 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.373 -0.973 . . . . 0.92 108.373 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.04 163.27 27.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 1.97 109.325 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.84 -22.13 66.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.694 0.283 . . . . 2.43 111.056 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -86.83 -15.51 38.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 2.39 110.885 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.89 -100.94 0.21 Allowed Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.395 -0.907 . . . . 2.29 112.95 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.66 27.41 2.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.771 0.32 . . . . 2.31 111.432 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.59 82.49 2.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.347 0.594 . . . . 2.61 109.838 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 163.85 20.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.247 -0.888 . . . . 3.72 110.005 174.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 16.7 p -46.69 120.56 3.02 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.723 -0.473 . . . . 2.27 109.723 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 18.0 p90 -115.33 116.41 28.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.652 0.739 . . . . 6.48 112.053 -171.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -72.03 152.0 48.05 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.75 -1.113 . . . . 1.23 111.423 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -112.89 92.06 3.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.966 0.412 . . . . 1.17 111.109 -172.248 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 71' ' ' VAL . 20.0 mt -85.13 116.53 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.682 -0.488 . . . . 0.61 109.682 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.611 ' HD3' ' OE2' ' A' ' 96' ' ' GLU . 2.4 mpt_? -88.04 -33.09 18.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.885 0.374 . . . . 2.0 110.733 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 58.0 tttp -129.6 98.97 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 1.53 111.294 -174.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 68' ' ' ILE . 44.9 t -98.05 96.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.05 -1.093 . . . . 0.88 108.05 169.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -115.66 77.47 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.805 -0.358 . . . . 1.42 111.165 -173.11 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.33 -171.64 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 124.367 1.042 . . . . 0.96 112.012 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -66.41 74.09 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.353 1.369 . . . . 0.38 111.043 166.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 22.3 t70 -156.55 -64.73 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.806 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.611 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -144.48 145.55 31.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.665 0.617 . . . . 0.35 112.665 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 1.1 mp -139.01 116.51 11.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.733 -0.667 . . . . 0.74 109.745 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 98' ' ' THR . 61.6 t -101.03 106.69 19.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.02 -0.733 . . . . 0.67 109.02 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -129.1 127.56 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.75 111.95 -171.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -90.7 154.92 23.56 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.427 -0.416 . . . . 0.5 112.896 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 17.4 t-105 -73.19 160.88 31.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 2.79 111.889 -171.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.54 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 11.9 ptt180 -137.2 0.63 2.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.967 -0.561 . . . . 5.46 110.732 -169.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.781 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 2.7 tm? 74.55 133.09 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.985 0.803 . . . . 1.55 110.82 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.541 ' HB2' ' CH2' ' A' ' 81' ' ' TRP . 40.4 t-20 -98.94 121.4 40.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 1.93 110.367 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.83 -9.22 61.84 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.425 -0.893 . . . . 2.4 114.309 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.1 t80 70.98 -42.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.229 0.612 . . . . 5.38 112.238 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.75 7.23 51.01 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.234 -0.508 . . . . 2.3 112.928 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HB2' HD21 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -108.17 178.31 4.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.969 -0.752 . . . . 4.77 108.969 177.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.519 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -114.54 128.64 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.963 0.411 . . . . 1.86 111.406 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.781 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 29.1 t70 -144.36 142.52 19.74 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.153 -0.684 . . . . 3.18 109.153 168.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.555 ' HD2' ' OD2' ' A' ' 90' ' ' ASP . 17.3 Cg_endo -58.1 -27.28 79.24 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.948 2.432 . . . . 2.36 113.893 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 3.0 t70 67.38 -0.85 1.7 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.88 0.848 . . . . 2.99 110.853 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.18 -38.68 60.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.682 -0.69 . . . . 3.06 112.191 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.9 m -156.01 -93.46 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.767 -0.197 . . . . 1.85 110.958 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.779 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 4.1 m 50.64 39.78 22.33 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.63 0.581 . . . . 1.44 110.724 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.763 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.7 mm-40 -69.24 144.52 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.34 -0.846 . . . . 1.81 112.221 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.91 127.95 22.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.56 0.695 . . . . 0.64 111.717 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.6 HG23 HG22 ' A' ' 78' ' ' VAL . 52.9 m -93.26 112.12 23.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.044 -0.98 . . . . 0.43 110.788 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -89.59 110.11 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.764 -0.653 . . . . 0.87 109.869 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.611 ' HA ' HG22 ' A' ' 76' ' ' THR . 23.4 m -105.4 106.38 16.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 0.45 110.561 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 29.8 m-85 -88.5 107.59 18.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.34 110.298 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.24 111.22 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.324 -0.398 . . . . 0.54 110.303 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.88 53.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.44 110.453 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.781 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 8.6 t70 -130.7 118.9 21.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.137 -0.483 . . . . 2.03 110.534 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.16 -98.78 0.52 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.064 -0.588 . . . . 1.97 112.546 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.01 -20.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 4.93 110.259 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -128.14 7.1 5.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 3.53 111.53 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.781 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 83.9 tttt -122.7 151.25 41.73 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.584 -0.446 . . . . 2.44 110.425 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -153.76 118.5 4.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.828 -0.624 . . . . 0.42 109.936 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -100.79 115.8 31.18 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.532 -0.758 . . . . 2.59 109.449 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.2 p -91.76 137.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.285 -0.566 . . . . 0.4 110.642 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.4 109.01 11.33 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.156 -0.929 . . . . 1.38 109.049 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.952 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 3.9 t -101.64 124.16 55.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.897 -0.592 . . . . 0.91 111.263 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -102.76 113.7 27.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.437 0.637 . . . . 2.31 109.452 173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.703 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 65.7 t60 -134.2 98.95 4.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.195 -0.911 . . . . 1.64 109.219 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.473 HG21 ' HD2' ' A' ' 5' ' ' PHE . 5.1 t -152.92 97.29 2.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.918 0.866 . . . . 2.67 111.027 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.68 -69.91 0.09 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.334 -0.848 . . . . 2.63 110.0 176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.652 ' CE1' ' HB3' ' A' ' 125' ' ' HIS . 13.6 t80 -72.28 -48.73 40.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.531 -0.759 . . . . 3.54 111.173 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.97 78.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 1.81 110.097 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 36.4 ttt180 -51.94 -24.94 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.222 -1.354 . . . . 3.38 112.072 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 95.3 mmm -79.9 -8.85 59.54 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.65 0.262 . . . . 2.43 110.706 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 44.43 -135.13 6.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.539 -0.755 . . . . 1.61 113.636 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.6 p 40.61 -133.07 0.29 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.763 0.825 . . . . 2.58 112.417 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -57.77 -33.25 68.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 3.8 111.583 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.652 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 12.5 m80 -66.51 -52.97 40.24 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.38 0.609 . . . . 2.14 110.739 -171.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.73 69.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.637 -0.711 . . . . 0.92 111.054 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -73.7 -28.94 61.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 2.83 111.668 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 31.6 ptt180 -77.35 -36.66 53.57 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.803 -0.359 . . . . 2.59 111.256 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.638 HG21 ' HE2' ' A' ' 118' ' ' PHE . 93.8 t -76.48 -23.86 15.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.356 0.598 . . . . 1.48 110.421 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.51 ' HG3' ' CB ' ' A' ' 134' ' ' ASP . 27.3 ttm180 -58.22 -19.85 36.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 3.83 111.142 174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.03 -22.72 41.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.196 -0.456 . . . . 2.48 111.362 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -137.41 -47.69 0.07 OUTLIER Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.374 -0.917 . . . . 1.61 113.469 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.46 -25.58 63.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.879 0.34 . . . . 4.83 111.878 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.51 ' CB ' ' HG3' ' A' ' 130' ' ' ARG . 15.0 t70 -59.28 -43.92 92.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 2.83 112.064 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -96.71 5.85 49.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 4.15 111.146 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -102.41 -62.15 0.73 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.441 -0.885 . . . . 1.04 112.81 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.54 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 1.1 t90 -60.63 -49.25 90.63 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.966 0.728 . . . . 2.78 112.966 -169.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.6 Cg_endo -58.13 -44.86 35.6 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.662 1.575 . . . . 0.68 112.027 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.0 m -59.05 -40.94 86.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.761 -0.654 . . . . 0.87 110.228 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.641 HG23 ' HZ3' ' A' ' 30' ' ' TRP . 45.6 mt -54.69 -51.94 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.928 -1.033 . . . . 0.72 110.894 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 8' ' ' HIS . 59.5 mt -61.67 -30.57 70.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.048 0.388 . . . . 0.69 112.048 -175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.0 mm-40 -70.99 -55.51 8.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 1.49 110.524 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.536 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.6 m -68.08 -22.52 64.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.072 -0.513 . . . . 1.15 110.626 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.79 -52.48 64.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.221 0.534 . . . . 0.8 109.771 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.744 ' HG2' HG13 ' A' ' 10' ' ' VAL . 45.9 mt-30 -59.79 -36.25 76.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.155 -0.929 . . . . 1.63 110.765 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.6 -40.29 49.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.748 -0.66 . . . . 1.46 111.462 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.23 -42.46 99.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 1.74 109.884 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.768 HG21 HG13 ' A' ' 12' ' ' VAL . 57.0 mt -64.44 -35.64 74.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.5 110.306 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.493 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 21.7 t70 -59.56 -38.71 81.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.61 -0.723 . . . . 0.85 109.716 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.509 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 45.6 mt-10 -66.06 -22.61 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 1.5 111.348 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -73.6 -8.04 54.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.763 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.27 -47.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.576 -1.297 . . . . 1.32 114.14 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.08 58.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.666 0.617 . . . . 1.92 112.666 -170.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.509 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.0 ttmm -69.26 101.23 1.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.226 -0.443 . . . . 2.04 111.539 -173.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 29.9 mmtp . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.394 -0.821 . . . . 4.22 109.391 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.559 0.219 . . . . 1.66 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.527 ' HA ' HG23 ' A' ' 6' ' ' VAL . 52.9 p90 173.53 -36.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.652 0.781 . . . . 3.73 109.92 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.786 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 29.9 t70 -67.97 -57.65 9.13 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.411 -0.359 . . . . 2.78 111.525 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 47.7 Cg_endo -83.03 -63.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.248 1.299 . . . . 1.63 111.714 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.51 139.09 16.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.421 -0.354 . . . . 3.21 110.946 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.69 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 79.6 t -89.11 121.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.047 -0.723 . . . . 1.44 109.047 167.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.5 ttt180 -124.88 130.83 53.15 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.3 -0.409 . . . . 3.37 110.428 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.79 130.87 55.47 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.807 -0.812 . . . . 0.79 108.807 172.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 11.3 p -134.79 111.04 9.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.94 0.876 . . . . 1.28 110.498 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.3 t -120.37 133.35 67.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.269 -1.332 . . . . 1.27 111.637 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.0 m -96.13 115.51 27.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.693 . . . . 0.57 109.782 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG13 HG21 ' A' ' 148' ' ' ILE . 4.6 t -98.64 140.8 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.91 111.004 -176.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 11.3 mmtp -100.0 9.88 42.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.919 -0.582 . . . . 0.98 112.016 -170.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.497 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.09 37.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.149 -0.62 . . . . 0.36 112.452 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 74.08 165.22 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.784 0.802 . . . . 0.91 112.743 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.616 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 10.9 ttp180 -63.1 -30.27 71.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.419 -1.264 . . . . 1.88 111.226 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 18' ' ' THR . 61.8 pttt -56.18 -47.18 78.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.117 -0.492 . . . . 3.05 110.405 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 27.9 m -74.84 -33.65 62.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.874 -0.603 . . . . 1.11 110.605 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -60.55 -49.59 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.32 110.883 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 52.0 t80 -70.09 -43.37 71.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.236 -0.438 . . . . 0.38 110.773 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -53.72 -51.46 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 2.39 110.175 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' CE2' ' A' ' 30' ' ' TRP . 61.1 m -63.2 -41.38 99.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.982 -0.554 . . . . 0.68 111.282 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HA ' ' HE1' ' A' ' 144' ' ' PHE . 73.8 t80 -70.48 -47.19 61.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.329 0.492 . . . . 0.48 112.329 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 46' ' ' VAL . 11.3 tp -119.27 -11.7 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.119 1.155 . . . . 0.5 114.119 -167.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.622 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 32.9 mt-10 -113.98 -38.92 4.07 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.213 -0.929 . . . . 1.24 111.345 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.19 29.74 7.87 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.373 -0.831 . . . . 0.83 111.342 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.614 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 59.4 t80 -46.48 -55.07 15.24 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 114.504 -0.848 . . . . 0.74 113.054 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.5 Cg_endo -94.37 21.59 0.55 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.13 1.887 . . . . 0.76 115.493 -172.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -120.37 -18.82 7.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.97 1.1 . . . . 1.49 113.97 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CE2' HG23 ' A' ' 22' ' ' THR . 25.3 m95 -76.08 -173.09 2.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.391 0.615 . . . . 4.62 112.523 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.732 ' HB2' ' HB3' ' A' ' 143' ' ' SER . 51.7 m95 -77.35 -35.16 1.28 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 115.617 1.71 . . . . 2.78 115.617 -172.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.645 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 74.3 Cg_endo -72.34 -131.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 121.85 1.7 . . . . 1.36 115.02 -161.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 29.3 t-20 -67.31 -8.07 29.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.084 -0.962 . . . . 1.51 110.496 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.058 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.3 m-20 -90.66 18.05 6.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.772 -1.103 . . . . 1.79 110.666 -172.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -104.83 68.17 0.83 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.555 . . . . 4.45 110.603 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -156.66 -178.06 7.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.002 -0.545 . . . . 4.14 109.85 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -110.37 139.16 45.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.522 -0.547 . . . . 2.68 109.522 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.539 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 50.3 p 51.74 28.3 4.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.895 0.855 . . . . 1.42 111.266 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HD3' HG22 ' A' ' 40' ' ' VAL . 1.1 tmtp? -149.46 84.01 1.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.324 -1.362 . . . . 2.9 107.324 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.058 HG23 ' HA ' ' A' ' 34' ' ' ASN . 34.0 m 45.02 32.36 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.6 1.188 . . . . 1.83 112.589 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.6 11.62 0.21 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.514 -0.851 . . . . 2.17 113.873 -175.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.042 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.87 -178.27 0.65 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.214 0.507 . . . . 1.12 110.591 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.553 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 31.1 Cg_exo -63.37 20.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.712 2.274 . . . . 1.48 114.303 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.824 ' HG ' ' H ' ' A' ' 45' ' ' GLY . 17.0 tp -161.59 -156.68 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.579 -1.267 . . . . 1.75 107.579 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.824 ' H ' ' HG ' ' A' ' 44' ' ' LEU . . . 163.9 -50.64 0.3 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.919 -1.134 . . . . 0.75 113.019 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.785 HG11 ' HG ' ' A' ' 24' ' ' LEU . 78.1 t -142.88 135.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.267 0.534 . . . . 0.6 111.502 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -113.74 124.01 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.415 -0.357 . . . . 1.11 110.562 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.673 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.23 -20.83 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.506 . . . . 2.81 111.343 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -76.26 -57.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.636 -0.256 . . . . 3.17 110.724 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.86 60.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.625 -0.798 . . . . 1.53 111.689 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 81.0 49.6 5.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.038 -0.601 . . . . 0.77 112.495 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 7.2 mpt_? -136.29 154.19 50.95 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.599 -0.354 . . . . 3.72 110.506 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.695 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.8 m0 -98.53 108.35 21.02 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.229 -1.026 . . . . 1.28 108.229 168.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -149.96 144.55 25.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.584 0.707 . . . . 1.66 111.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.042 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.5 mt-10 -111.81 170.69 7.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.627 -1.169 . . . . 2.12 109.154 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' A' ' 61' ' ' GLU . 28.6 mm -78.87 105.26 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.16 -0.681 . . . . 0.92 109.16 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.714 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.8 t70 -88.61 -164.93 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.139 -0.319 . . . . 1.97 110.139 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.4 pt-20 -80.13 -35.51 36.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.76 0.281 . . . . 2.43 111.76 -174.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.93 24.09 6.53 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.255 -0.578 . . . . 2.39 111.639 177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.4 -97.27 0.38 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.658 -0.782 . . . . 2.29 113.08 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG2' HD13 ' A' ' 56' ' ' ILE . 34.1 mt-10 -142.53 29.84 1.56 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.634 0.731 . . . . 2.31 109.729 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.51 76.76 10.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.145 -0.934 . . . . 2.61 110.286 -171.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.714 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.66 130.11 52.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.229 -1.351 . . . . 3.72 109.61 175.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.616 HG22 ' HG3' ' A' ' 82' ' ' ARG . 2.9 m -69.92 -92.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 2.27 111.761 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.695 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 91.9 m-85 51.27 -167.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.291 1.219 . . . . 6.48 114.291 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.4 141.02 42.04 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.035 -0.984 . . . . 1.23 114.931 -165.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -111.07 99.22 8.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.795 -0.703 . . . . 1.17 109.484 177.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.58 HG21 HG22 ' A' ' 71' ' ' VAL . 21.0 mt -84.25 138.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.61 111.129 -172.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -99.88 -40.21 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.357 -0.383 . . . . 2.0 110.239 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -138.11 122.69 18.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 1.53 111.463 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.58 HG22 HG21 ' A' ' 68' ' ' ILE . 40.5 t -111.08 108.73 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.102 -0.703 . . . . 0.88 109.102 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -115.31 63.64 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.416 -0.514 . . . . 1.42 110.966 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.673 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 46.09 -166.45 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.658 1.224 . . . . 0.96 112.086 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 44.5 Cg_exo -60.74 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.638 1.558 . . . . 0.38 112.316 167.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.81 -66.81 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.654 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -144.71 148.62 34.39 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.643 0.609 . . . . 0.35 112.643 -175.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -138.82 129.02 25.52 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.74 110.274 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 97' ' ' PHE . 21.9 t -109.28 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.005 -0.739 . . . . 0.67 109.005 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.18 138.23 55.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.75 111.811 -170.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.16 149.05 19.65 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.774 -0.53 . . . . 0.5 111.774 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.83 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 76.2 t-105 -86.13 141.26 29.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.126 0.488 . . . . 2.79 112.092 -170.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.727 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 1.8 tmt_? -113.53 -79.47 0.58 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.29 -0.868 . . . . 5.46 109.053 168.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.015 HD22 ' HB2' ' A' ' 88' ' ' ARG . 53.8 mt -176.68 -111.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.41 1.1 . . . . 1.55 112.864 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 176.53 -161.98 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 103.856 -2.646 . . . . 1.93 103.856 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.69 50.25 0.9 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.668 -1.253 . . . . 2.4 112.222 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -140.22 78.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.823 -0.351 . . . . 5.38 111.865 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.22 49.79 74.7 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 115.752 -0.658 . . . . 2.3 112.42 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.015 ' HB2' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -129.31 154.12 47.17 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.517 -0.341 . . . . 4.77 111.859 -169.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.632 ' O ' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -115.32 135.26 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 110.243 -0.28 . . . . 1.86 110.243 177.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.594 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 5.0 p-10 -102.91 144.92 29.6 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-O 120.999 0.428 . . . . 3.18 111.319 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.566 ' HG3' ' CE2' ' A' ' 118' ' ' PHE . 15.6 Cg_exo -65.39 -48.29 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.683 2.256 . . . . 2.36 110.658 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.594 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 32.2 t70 64.79 29.5 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 2.99 110.367 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -138.88 -55.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 3.06 111.649 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.7 p -135.25 -121.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.61 -0.436 . . . . 1.85 111.567 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.83 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.6 t 55.21 54.23 9.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.922 -0.769 . . . . 1.44 108.922 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.445 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 44.7 tt0 -88.21 143.82 26.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.965 -1.016 . . . . 1.81 111.599 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -107.57 148.36 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.64 110.673 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.9 m -112.09 95.81 5.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.384 -0.969 . . . . 0.43 108.384 158.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.646 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.8 t -83.32 110.14 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.818 -0.438 . . . . 0.87 109.818 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.7 m -108.52 107.36 17.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.784 0.326 . . . . 0.45 111.143 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.616 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 59.5 m-85 -87.38 113.75 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.331 -0.395 . . . . 0.34 110.264 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -96.21 115.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.176 -0.465 . . . . 0.54 110.298 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.67 143.73 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.203 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.709 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -138.73 103.54 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.03 110.625 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.5 16.58 55.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.99 -0.55 . . . . 1.97 113.864 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 62.69 15.08 7.76 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.182 0.438 . . . . 4.93 112.182 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -134.76 -18.78 1.86 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.01 0.433 . . . . 3.53 110.793 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.0 ttpm? -122.3 158.02 30.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.074 -0.713 . . . . 2.44 109.074 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.3 m -154.13 122.78 6.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.972 0.415 . . . . 0.42 111.227 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -98.29 108.17 20.8 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.673 -0.694 . . . . 2.59 109.278 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 9' ' ' SER . 14.4 p -83.41 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.976 -0.69 . . . . 0.4 109.334 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -125.65 107.99 11.11 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.675 -0.861 . . . . 1.38 108.675 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 99' ' ' VAL . 13.0 t -103.61 123.3 57.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.394 -0.821 . . . . 0.91 112.376 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -92.91 111.22 22.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.069 -0.968 . . . . 2.31 108.824 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.69 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 23.6 t-160 -125.32 97.17 5.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.754 -1.202 . . . . 1.64 107.754 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.1 m -153.64 108.31 3.11 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.7 -0.8 . . . . 2.67 112.584 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -174.8 -63.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.456 -0.793 . . . . 2.63 109.647 165.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 129' ' ' VAL . 77.4 t80 -76.94 -28.13 55.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.743 -0.662 . . . . 3.54 109.784 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -46.8 87.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.164 -0.926 . . . . 1.81 110.01 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 72.9 ttt180 -57.72 -21.3 39.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.676 -1.147 . . . . 3.38 112.094 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.38 -17.7 62.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.173 0.511 . . . . 2.43 110.606 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 2' ' ' TYR . . . 73.03 -118.15 6.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.18 0.832 . . . . 1.61 115.18 165.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 m -37.93 -88.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.973 1.472 . . . . 2.58 114.973 -160.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -77.33 -34.35 55.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.16 0.429 . . . . 3.8 112.16 -168.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 29.6 m170 -66.08 -52.13 51.69 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.864 0.364 . . . . 2.14 110.9 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -67.02 -37.45 84.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.92 110.395 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -61.02 -49.76 76.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.655 0.243 . . . . 2.83 111.655 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.14 -29.24 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 2.59 111.186 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.569 HG21 ' HE2' ' A' ' 118' ' ' PHE . 15.7 t -75.51 -41.1 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.404 0.621 . . . . 1.48 110.535 172.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 1.033 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 39.5 ttp180 -63.16 -15.41 56.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.139 -0.937 . . . . 3.83 111.533 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -50.08 -47.02 53.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.354 -0.385 . . . . 2.48 111.433 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.21 -12.9 22.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.435 -0.888 . . . . 1.61 111.952 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.631 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 26.1 ttt -81.23 -35.3 31.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.721 0.267 . . . . 4.83 111.721 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 1.033 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 38.7 t70 -63.86 -37.29 86.84 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.833 0.679 . . . . 2.83 112.833 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 36.0 tptt -106.66 22.19 16.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.932 0.873 . . . . 4.15 109.608 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.64 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.77 -71.36 0.55 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.344 -0.843 . . . . 1.04 111.798 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.443 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.7 t-105 -54.71 -54.1 53.06 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 113.041 0.756 . . . . 2.78 113.041 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 27.0 Cg_endo -61.49 -41.32 41.3 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.8 1.667 . . . . 0.68 112.199 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -63.28 -40.96 98.84 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.334 0.588 . . . . 0.87 109.962 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 42.3 mt -58.18 -43.65 86.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 115.271 -0.877 . . . . 0.72 110.645 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.538 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 24.8 mt -60.06 -41.46 92.4 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.166 0.291 . . . . 0.69 111.2 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.192 -0.603 . . . . 1.49 111.121 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.732 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 13.8 m -75.96 -22.38 56.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 1.15 110.594 176.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 63.4 t80 -61.76 -54.87 36.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.528 -0.76 . . . . 0.8 109.336 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.44 -29.37 70.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.01 -0.541 . . . . 1.63 110.272 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.26 -54.23 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 1.46 111.891 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 147' ' ' LYS . 5.9 tmtt? -74.31 -35.01 63.66 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 120.243 -0.583 . . . . 1.74 110.188 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.735 HG21 HG13 ' A' ' 12' ' ' VAL . 18.7 mt -60.96 -34.88 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.135 0.493 . . . . 0.5 110.418 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 27.5 t70 -59.11 -34.95 72.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.85 109.924 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.646 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 30.5 mt-10 -69.62 -19.55 63.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.844 -0.616 . . . . 1.5 111.4 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.85 2.41 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.093 -0.503 . . . . 1.74 110.582 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.51 -70.72 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.193 -1.003 . . . . 1.32 113.897 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.62 -33.06 21.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.617 0.969 . . . . 1.92 113.617 -167.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.689 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 34.5 ttmt -69.51 166.71 18.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.963 -0.384 . . . . 2.04 109.963 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 C-N-CA 123.941 0.896 . . . . 4.22 111.244 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 1.004 HD22 ' HB ' ' A' ' 6' ' ' VAL . 19.9 p-10 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 110.276 -0.268 . . . . 1.66 110.276 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 84.3 m-85 83.31 -63.58 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.79 0.836 . . . . 3.73 111.044 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.774 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -54.83 -50.59 85.17 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.256 -0.429 . . . . 2.78 111.161 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 13.4 Cg_endo -92.58 -72.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.168 1.912 . . . . 1.63 111.77 169.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.677 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 39.5 p90 -153.59 153.61 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.348 -0.612 . . . . 3.21 109.348 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.004 ' HB ' HD22 ' A' ' 1' ' ' ASN . 0.9 OUTLIER -102.35 143.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.93 -1.137 . . . . 1.44 107.93 169.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.6 ttt180 -133.32 143.42 49.0 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.417 -0.513 . . . . 3.37 110.635 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.832 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.51 132.03 54.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.302 -0.999 . . . . 0.79 108.302 170.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' ' NH2' ' A' ' 110' ' ' ARG . 21.8 m -130.37 110.41 11.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.329 0.585 . . . . 1.28 109.753 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 2.5 t -134.53 131.12 54.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.153 -0.93 . . . . 1.27 111.588 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -105.65 116.12 31.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.57 109.142 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 19' ' ' ALA . 1.5 m -98.01 158.14 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.879 -0.601 . . . . 0.91 110.035 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.84 55.86 0.97 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.053 -0.521 . . . . 0.98 111.002 -174.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -167.17 26.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.968 -0.56 . . . . 0.36 111.837 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.0 t70 73.81 167.41 0.3 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.073 0.463 . . . . 0.91 111.797 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.703 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 48.4 ttp180 -71.04 -27.31 63.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.987 -0.552 . . . . 1.88 111.162 -173.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -58.19 -52.93 63.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.918 -0.583 . . . . 3.05 110.266 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 69.3 m -71.04 -34.95 71.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.85 -0.614 . . . . 1.11 111.24 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -57.07 -47.02 82.02 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.32 110.802 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 69.4 t80 -70.8 -43.49 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.38 110.615 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.677 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 22.8 tptp -51.92 -52.28 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 2.39 110.711 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.3 m -67.64 -52.23 40.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.54 -0.3 . . . . 0.68 110.868 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -59.21 -39.76 83.67 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.452 0.538 . . . . 0.48 112.452 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 77' ' ' LEU . 27.4 tp -114.21 -47.38 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.158 -0.617 . . . . 0.5 112.205 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.677 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 29.4 mt-10 -88.67 17.4 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.765 0.317 . . . . 1.24 111.082 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.67 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -149.46 39.23 0.92 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.798 -0.715 . . . . 0.83 112.067 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.617 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 12.6 t80 -51.56 -48.48 86.61 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 122.019 0.128 . . . . 0.74 111.07 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 30.0 Cg_endo -88.74 24.19 0.7 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.15 1.9 . . . . 0.76 114.907 174.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.8 pt-20 -105.12 -12.2 16.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.866 0.757 . . . . 1.49 111.462 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.504 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 2.7 m0 -83.54 -164.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.031 -0.359 . . . . 4.62 110.031 -174.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.653 ' H ' ' HD3' ' A' ' 32' ' ' PRO . 12.5 p-90 -140.37 19.01 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 114.464 1.283 . . . . 2.78 114.464 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.653 ' HD3' ' H ' ' A' ' 31' ' ' TRP . 54.9 Cg_endo -83.69 -112.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 CA-C-N 121.406 1.538 . . . . 1.36 113.001 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 6.8 t-20 -79.41 -13.76 59.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.044 0.926 . . . . 1.51 109.727 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.63 ' HA ' HG23 ' A' ' 40' ' ' VAL . 7.8 m120 -90.17 30.91 1.04 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.627 -1.169 . . . . 1.79 110.251 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -97.34 2.16 50.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 4.45 110.9 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 21.5 mmt180 -114.0 152.07 31.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.294 0.569 . . . . 4.14 112.218 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -81.5 148.31 29.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.776 . . . . 2.68 109.714 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 56' ' ' ILE . 44.5 p 52.55 16.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.343 0.657 . . . . 1.42 111.715 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.706 ' HD3' HG22 ' A' ' 40' ' ' VAL . 1.2 tmtp? -142.44 80.4 1.7 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.658 -0.701 . . . . 2.9 109.263 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.706 HG22 ' HD3' ' A' ' 39' ' ' LYS . 19.1 m 49.33 16.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.148 1.379 . . . . 1.83 113.716 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.72 25.4 2.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.378 -0.915 . . . . 2.17 112.627 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.795 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -85.28 161.71 51.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.367 -0.605 . . . . 1.12 109.367 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 39.2 Cg_exo -43.83 -12.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.966 3.777 . . . . 1.48 116.982 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.933 HD21 HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -111.24 -94.54 0.44 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.574 -0.704 . . . . 1.75 111.125 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.617 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 91.88 -36.81 3.53 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.78 -0.724 . . . . 0.75 112.976 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 24' ' ' LEU . 81.9 t -140.1 140.65 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.846 0.355 . . . . 0.6 111.168 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.702 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 11.0 t70 -109.88 113.2 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.327 -0.99 . . . . 1.11 108.327 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 16.8 ttmt -79.6 -23.24 42.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.822 -0.626 . . . . 2.81 112.286 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -90.08 -36.48 14.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.747 0.308 . . . . 3.17 111.293 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.83 -20.21 31.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.907 -0.663 . . . . 1.53 112.313 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 79.51 56.77 3.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.746 -0.74 . . . . 0.77 111.811 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -133.78 160.92 36.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.785 0.326 . . . . 3.72 111.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.746 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 15.6 m0 -117.31 108.66 15.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.234 -0.654 . . . . 1.28 109.234 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.702 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 11.0 p90 -162.39 146.22 11.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 1.66 110.862 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.909 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -114.3 175.21 5.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.841 -0.618 . . . . 2.12 109.356 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.933 HG12 HD21 ' A' ' 44' ' ' LEU . 20.6 mm -76.07 111.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.645 -0.502 . . . . 0.92 109.645 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 39.8 t0 -95.64 157.22 15.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 1.97 109.927 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.84 -28.07 62.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.398 0.888 . . . . 2.43 113.398 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.76 9.69 15.77 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.879 -0.728 . . . . 2.39 111.385 -176.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.75 47.68 0.19 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.079 -1.058 . . . . 2.29 113.532 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.731 ' HG2' HG23 ' A' ' 56' ' ' ILE . 27.7 mt-10 54.36 36.88 26.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.396 0.617 . . . . 2.31 111.278 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -120.08 85.35 2.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 2.61 110.462 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -109.79 164.1 12.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.774 -0.648 . . . . 3.72 110.242 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.8 p -57.48 112.29 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.359 -0.382 . . . . 2.27 110.694 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -79.47 102.39 8.75 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.796 0.295 . . . . 6.48 111.796 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.746 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -55.89 137.51 46.31 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.509 -1.036 . . . . 1.23 110.509 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -108.59 97.71 7.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.379 0.59 . . . . 1.17 111.773 -168.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.533 HG21 ' CG2' ' A' ' 71' ' ' VAL . 46.1 mt -84.08 133.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.835 -0.432 . . . . 0.61 109.835 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -96.11 -33.27 12.14 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.846 -0.428 . . . . 2.0 109.846 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.5 ttpp -155.04 130.11 9.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.303 -0.408 . . . . 1.53 111.745 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.533 ' CG2' HG21 ' A' ' 68' ' ' ILE . 97.6 t -114.6 100.54 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.785 -0.82 . . . . 0.88 108.785 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.6 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.0 m-20 -98.15 59.35 1.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 119.489 -0.291 . . . . 1.42 111.173 -173.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.0 pt-20 44.25 -165.19 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 O-C-N 124.252 0.97 . . . . 0.96 111.635 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.9 Cg_exo -61.59 85.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.067 1.178 . . . . 0.38 111.385 165.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.703 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 26.5 t70 -173.16 -65.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.5 110.561 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -145.53 158.97 43.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.919 0.39 . . . . 0.35 111.809 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' CD2' HD22 ' A' ' 24' ' ' LEU . 4.2 mp -145.99 130.56 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 0.74 109.913 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.95 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.26 -0.427 . . . . 0.67 109.909 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.49 144.53 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.526 -0.306 . . . . 0.75 111.215 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -105.46 155.4 16.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.5 112.597 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 75.6 t-105 -78.55 137.44 37.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.5 0.556 . . . . 2.79 112.5 -169.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -148.07 40.59 0.97 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.482 -0.781 . . . . 5.46 109.285 176.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 85.65 166.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.859 1.059 . . . . 1.55 113.859 171.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.486 ' H ' HD13 ' A' ' 83' ' ' LEU . 36.4 t30 -158.1 -37.29 0.07 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 113.925 -1.489 . . . . 1.93 108.475 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.27 10.25 50.16 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.401 -0.818 . . . . 2.4 112.516 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.5 t80 74.4 -74.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.396 0.679 . . . . 5.38 112.008 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.14 71.56 2.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.879 -0.677 . . . . 2.3 113.508 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.883 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 15.6 ttp180 -146.15 179.01 7.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.025 -0.361 . . . . 4.77 110.025 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.883 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -82.23 126.95 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.063 -0.717 . . . . 1.86 109.063 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 30.0 p-10 -96.81 129.1 33.55 Favored Pre-proline 0 C--N 1.317 -0.816 0 O-C-N 121.672 -0.643 . . . . 3.18 110.098 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' ASN . 23.4 Cg_exo -63.37 -40.01 34.11 Favored 'Trans proline' 0 CA--C 1.519 -0.246 0 C-N-CA 122.926 2.417 . . . . 2.36 113.069 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 68.2 -30.88 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.759 0.652 . . . . 2.99 112.759 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' PRO . 3.6 m-20 -74.64 -60.15 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.355 0.598 . . . . 3.06 110.365 -173.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 p -155.23 -90.57 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.568 -0.742 . . . . 1.85 111.293 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 49.5 m 54.11 36.72 25.45 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 108.52 -0.919 . . . . 1.44 108.52 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.6 tt0 -71.7 141.75 49.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.445 -1.707 . . . . 1.81 111.423 -172.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.598 ' HB2' HG13 ' A' ' 113' ' ' VAL . 6.7 p90 -139.07 134.63 33.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.624 -0.716 . . . . 0.64 110.199 174.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -98.87 117.14 32.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.504 -0.771 . . . . 0.43 110.273 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 111' ' ' VAL . 85.4 t -82.91 110.63 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 0.87 109.853 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 8.5 m -99.63 105.62 17.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.286 0.366 . . . . 0.45 111.426 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.4 m-85 -96.46 114.17 25.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.34 110.976 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.3 110.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.327 -0.62 . . . . 0.54 109.327 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.09 134.72 41.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.44 111.523 -175.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 38.2 t70 -120.89 123.16 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.101 -0.954 . . . . 2.03 108.944 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.96 -10.88 28.54 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.929 -0.578 . . . . 1.97 113.64 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.43 49.8 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.942 0.401 . . . . 4.93 110.464 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 60.43 31.84 20.43 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.73 -0.668 . . . . 3.53 111.308 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.644 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 3.8 ttmp? -132.6 155.71 48.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.32 -0.4 . . . . 2.44 110.448 -173.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.555 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.5 m -158.29 125.43 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.42 110.768 173.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.474 ' NH2' ' HB3' ' A' ' 9' ' ' SER . 20.4 tpt180 -101.0 126.65 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.432 -0.803 . . . . 2.59 109.556 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 100' ' ' THR . 9.5 p -114.58 136.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.006 0.432 . . . . 0.4 111.063 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.588 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 3.2 p-10 -126.73 120.24 28.89 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.81 0.814 . . . . 1.38 109.381 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.832 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 1.6 t -90.97 120.24 39.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.958 -1.019 . . . . 0.91 110.084 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -96.36 111.3 23.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.808 0.693 . . . . 2.31 109.212 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.947 ' HB3' HG22 ' A' ' 6' ' ' VAL . 51.8 t-80 -125.27 98.93 5.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.38 -0.827 . . . . 1.64 108.769 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.677 ' HB ' ' CB ' ' A' ' 5' ' ' PHE . 5.4 t -151.36 88.1 1.42 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.89 0.852 . . . . 2.67 109.621 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -157.47 -76.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 2.63 110.253 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.605 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 6.4 t80 -73.2 -38.58 66.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.799 -0.815 . . . . 3.54 108.799 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.558 ' OD1' HG13 ' A' ' 6' ' ' VAL . 17.1 p-10 -73.81 -47.59 37.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.413 -0.812 . . . . 1.81 111.353 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HD3' ' OG1' ' A' ' 116' ' ' THR . 52.4 ttp180 -56.28 -21.45 23.93 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.35 -0.386 . . . . 3.38 111.634 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 33.9 tpp -72.38 -3.48 24.29 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.95 0.405 . . . . 2.43 110.371 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.3 -164.49 24.31 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 115.036 0.774 . . . . 1.61 115.036 167.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.0 p 39.9 -116.22 0.23 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.394 1.077 . . . . 2.58 113.016 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.14 -25.13 64.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.8 111.184 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.605 ' HB3' ' O ' ' A' ' 118' ' ' PHE . 41.9 m-70 -68.53 -53.93 19.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.037 0.446 . . . . 2.14 110.624 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.94 -26.15 63.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.92 109.999 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 87.4 tttt -62.57 -46.44 88.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.102 -0.954 . . . . 2.83 111.388 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 1.6 ptm180 -78.4 -28.6 46.93 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.827 -0.349 . . . . 2.59 111.587 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 125' ' ' HIS . 88.9 t -72.81 -30.91 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.22 0.452 . . . . 1.48 112.22 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 127' ' ' LYS . 31.8 ptt180 -59.58 -30.01 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.809 0.337 . . . . 3.83 111.631 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.761 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.0 m-20 -65.15 -21.17 66.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.434 0.531 . . . . 2.48 112.434 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' HA3' HH11 ' A' ' 88' ' ' ARG . . . -96.99 -72.08 1.09 Allowed Glycine 0 C--O 1.226 -0.351 0 C-N-CA 119.975 -1.107 . . . . 1.61 114.8 -164.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.693 ' HB2' ' HB2' ' A' ' 137' ' ' TRP . 26.5 ptt? -80.93 -9.59 59.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.441 0.534 . . . . 4.83 112.441 -170.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.58 -49.84 69.44 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.405 0.52 . . . . 2.83 112.405 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -96.96 22.86 7.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.948 0.351 . . . . 4.15 111.948 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.585 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -139.76 -56.26 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.73 -1.224 . . . . 1.04 113.101 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.693 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 65.2 t-105 -55.24 -53.31 63.19 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.549 0.574 . . . . 2.78 112.549 -170.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.6 Cg_endo -59.41 -40.64 65.43 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.81 1.674 . . . . 0.68 112.337 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 m -69.21 -38.28 78.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.515 0.674 . . . . 0.87 110.258 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.642 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 29.1 mt -59.58 -42.02 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.218 -0.901 . . . . 0.72 110.817 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 76.6 mt -62.76 -26.95 68.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.904 0.335 . . . . 0.69 111.904 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.18 -54.64 7.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.371 -0.233 . . . . 1.49 110.371 176.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -27.5 68.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 1.15 110.595 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 47.2 t80 -62.17 -55.06 32.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.45 -0.795 . . . . 0.8 110.485 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.447 ' CG ' HG13 ' A' ' 10' ' ' VAL . 39.0 mt-30 -62.9 -34.61 77.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.32 0.581 . . . . 1.63 110.816 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.513 ' HB3' ' HE1' ' A' ' 31' ' ' TRP . 13.4 t70 -66.12 -44.99 82.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.873 -1.058 . . . . 1.46 110.402 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -69.19 -31.54 70.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.711 -0.677 . . . . 1.74 110.698 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.529 HG21 ' HB ' ' A' ' 12' ' ' VAL . 53.2 mt -71.43 -36.37 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.5 110.446 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.473 ' HB3' ' HE3' ' A' ' 154' ' ' LYS . 17.8 t0 -66.11 -28.97 69.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.504 . . . . 0.85 109.675 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 55.7 mt-10 -60.74 -28.56 68.79 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.572 0.701 . . . . 1.5 110.334 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.51 -3.24 58.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.239 -0.891 . . . . 1.74 110.383 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.72 -70.4 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.525 -0.845 . . . . 1.32 113.67 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.28 -46.65 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.066 0.433 . . . . 1.92 111.407 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttpp -81.72 171.15 14.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.356 -0.384 . . . . 2.04 110.013 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.555 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 18.1 tppt? . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.352 -0.981 . . . . 4.22 108.352 167.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.0 p-10 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.65 0.262 . . . . 1.66 110.509 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 24.6 p90 172.14 -35.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.837 0.855 . . . . 3.73 109.108 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.76 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.9 t70 -73.64 -55.35 3.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.523 -0.308 . . . . 2.78 111.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 52.8 Cg_endo -84.31 -68.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.512 1.474 . . . . 1.63 111.94 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.05 142.78 26.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.169 -0.469 . . . . 3.21 110.073 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.638 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 76.5 t -98.29 112.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.866 -0.791 . . . . 1.44 108.866 167.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 45.4 ttm-85 -123.62 135.54 54.0 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.537 -0.465 . . . . 3.37 110.97 -177.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.725 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.66 134.38 52.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.829 -0.804 . . . . 0.79 108.829 174.119 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 22.4 m -143.24 112.23 6.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.154 -0.475 . . . . 1.28 110.455 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.948 HG22 HG12 ' A' ' 111' ' ' VAL . 2.2 m -126.66 140.42 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.125 -0.489 . . . . 1.27 109.77 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -102.48 114.42 28.61 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.512 -0.921 . . . . 0.57 108.512 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' HB ' ' A' ' 109' ' ' THR . 0.3 OUTLIER -103.3 162.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.254 -0.43 . . . . 0.91 110.445 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.922 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 9.5 pttt -125.92 35.93 4.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.753 -0.658 . . . . 0.98 112.013 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.27 29.19 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.215 0.45 . . . . 0.36 112.215 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 20.6 t70 75.84 163.37 0.25 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.857 0.837 . . . . 0.91 112.22 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.881 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 40.1 ttp180 -64.68 -27.88 69.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.717 -1.129 . . . . 1.88 110.96 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 4.3 ttmp? -57.67 -48.55 79.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 3.05 110.825 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -77.46 -36.32 52.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 1.11 111.023 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.622 ' HA ' HD13 ' A' ' 148' ' ' ILE . . . -59.81 -39.59 85.54 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.79 -0.364 . . . . 0.32 110.405 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CG ' ' HA ' ' A' ' 74' ' ' PRO . 55.6 t80 -71.05 -49.97 39.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.38 110.77 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -54.18 -53.0 59.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.083 0.468 . . . . 2.39 110.982 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.475 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.2 m -63.83 -45.31 90.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.359 -0.837 . . . . 0.68 110.56 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.719 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.3 t80 -63.95 -37.49 87.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.945 0.35 . . . . 0.48 111.945 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.87 HD11 HG11 ' A' ' 46' ' ' VAL . 17.1 tp -99.49 -59.65 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.179 -0.608 . . . . 0.5 112.485 -174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -88.72 -19.47 26.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.149 0.5 . . . . 1.24 111.547 -173.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -89.77 18.48 46.81 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.645 -0.788 . . . . 0.83 111.17 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.534 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 10.9 t80 -50.39 -51.78 60.85 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.151 0.58 . . . . 0.74 112.256 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 42.0 Cg_endo -86.13 8.01 4.71 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.298 1.999 . . . . 0.76 115.525 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.7 pt-20 -111.07 -2.36 15.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.851 -0.739 . . . . 1.49 111.999 -175.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.818 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 43.1 m0 -67.64 155.73 38.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.329 0.585 . . . . 4.62 111.111 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.547 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 68.0 m95 -75.1 -43.79 4.61 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.389 -0.823 . . . . 2.78 112.906 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 29.1 Cg_endo -60.46 -87.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.63 2.22 . . . . 1.36 115.199 -162.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -110.98 -17.85 13.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.516 0.674 . . . . 1.51 110.451 -173.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.627 ' HA ' HG13 ' A' ' 40' ' ' VAL . 2.9 m-20 -100.89 27.63 5.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.474 -0.784 . . . . 1.79 112.037 -168.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -104.4 13.31 32.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.687 0.756 . . . . 4.45 109.44 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -104.74 128.26 52.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.718 -0.674 . . . . 4.14 111.066 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -75.61 137.45 40.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 2.68 111.151 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 57' ' ' ASP . 79.8 p 57.09 11.53 1.04 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.61 1.164 . . . . 1.42 112.956 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.642 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 83.0 tttt -100.03 -48.81 4.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.477 -0.934 . . . . 2.9 108.477 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.717 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 12.4 p -174.35 -2.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.418 -1.265 . . . . 1.83 109.984 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -127.59 47.09 1.04 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.623 -0.799 . . . . 2.17 112.638 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.037 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -79.91 158.46 72.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.013 -1.106 . . . . 1.12 108.013 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.69 44.85 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 123.803 3.002 . . . . 1.48 114.786 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -149.51 -84.36 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.723 -0.473 . . . . 1.75 109.723 173.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.434 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.23 -52.95 3.17 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.926 -0.654 . . . . 0.75 112.781 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.87 HG11 HD11 ' A' ' 24' ' ' LEU . 58.9 t -140.33 138.42 36.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.003 0.43 . . . . 0.6 111.607 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.647 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 22.3 t70 -100.42 107.27 18.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.841 -0.8 . . . . 1.11 108.841 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -9.83 59.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.19 -0.914 . . . . 2.81 111.203 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -75.39 -62.41 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.035 -0.53 . . . . 3.17 110.702 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -92.59 -39.49 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.562 -0.828 . . . . 1.53 111.662 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 72.46 0.62 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.654 -0.784 . . . . 0.77 112.805 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -154.39 144.33 21.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 3.72 111.172 175.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.608 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 22.7 m0 -96.2 110.98 23.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 1.28 110.515 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.647 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.8 p90 -153.91 152.91 31.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 1.66 110.399 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 6.4 mp0 -119.98 150.71 40.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.115 -0.698 . . . . 2.12 109.115 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.507 HD12 ' HG2' ' A' ' 61' ' ' GLU . 45.0 mm -77.0 103.37 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.999 0.428 . . . . 0.92 109.892 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' HA ' HG22 ' A' ' 38' ' ' THR . 8.1 t70 -92.84 148.13 22.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.133 -0.692 . . . . 1.97 109.133 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.88 -10.09 59.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.462 0.912 . . . . 2.43 113.462 -166.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.18 10.25 32.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.648 -0.821 . . . . 2.39 110.712 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.49 50.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.39 -0.91 . . . . 2.29 113.921 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.507 ' HG2' HD12 ' A' ' 56' ' ' ILE . 39.2 mt-10 58.1 24.67 11.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.175 0.435 . . . . 2.31 112.175 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.86 78.05 6.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.499 0.666 . . . . 2.61 110.143 -173.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.508 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -123.22 162.74 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.292 -0.867 . . . . 3.72 109.68 176.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.566 ' C ' ' HD2' ' A' ' 82' ' ' ARG . 4.9 p -62.97 148.59 47.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.4 -0.593 . . . . 2.27 109.4 172.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 44.4 p90 -120.4 120.87 37.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.396 -0.522 . . . . 6.48 111.666 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.34 148.17 46.87 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.681 -0.968 . . . . 1.23 110.681 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.491 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -106.0 96.48 6.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.263 0.532 . . . . 1.17 111.26 -171.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.545 HG21 ' CG2' ' A' ' 71' ' ' VAL . 53.8 mt -77.08 125.29 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.271 0.558 . . . . 0.61 109.939 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -96.2 -21.37 17.93 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.399 -0.818 . . . . 2.0 109.786 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -164.64 125.0 2.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.224 -0.443 . . . . 1.53 111.889 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' CG2' HG21 ' A' ' 68' ' ' ILE . 62.6 t -109.36 107.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.725 -0.843 . . . . 0.88 108.725 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.44 75.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.649 -0.42 . . . . 1.42 111.211 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.3 pt-20 47.67 -170.92 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 124.766 1.291 . . . . 0.96 111.961 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 35.9 Cg_exo -63.48 81.32 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.373 1.382 . . . . 0.38 111.122 166.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.881 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 14.9 t70 -166.69 -68.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.405 -0.816 . . . . 0.5 110.984 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -138.67 140.3 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.783 0.66 . . . . 0.35 112.783 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -135.47 116.41 14.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.48 -0.782 . . . . 0.74 108.977 175.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 98' ' ' THR . 29.9 t -95.26 111.78 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.687 -0.857 . . . . 0.67 108.687 175.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.21 126.42 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.75 0.31 . . . . 0.75 111.185 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 1.01 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -84.88 146.25 22.06 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.006 -0.837 . . . . 0.5 111.006 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.89 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 68.8 t-105 -73.63 160.18 31.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.585 0.707 . . . . 2.79 112.34 -168.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.568 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 19.3 ttp180 -135.52 -72.56 0.46 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.409 -1.269 . . . . 5.46 109.722 -172.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.769 HD23 ' HB2' ' A' ' 90' ' ' ASP . 2.5 tm? 170.46 145.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.343 -0.844 . . . . 1.55 109.539 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.679 ' N ' HD13 ' A' ' 83' ' ' LEU . 54.0 t30 -142.6 146.89 35.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.35 -0.611 . . . . 1.93 109.35 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.65 -15.56 31.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.831 -0.699 . . . . 2.4 112.024 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.642 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 71.3 t80 70.39 -63.29 0.41 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.64 0.776 . . . . 5.38 111.207 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.59 44.65 3.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.224 -0.512 . . . . 2.3 112.037 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.694 ' NH1' ' HA ' ' A' ' 129' ' ' VAL . 2.4 tmm_? -133.86 144.24 48.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.033 -0.729 . . . . 4.77 109.033 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.512 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -96.58 131.92 42.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.028 0.442 . . . . 1.86 111.292 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.769 ' HB2' HD23 ' A' ' 83' ' ' LEU . 5.2 t70 -143.66 137.15 14.16 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.482 -0.933 . . . . 3.18 108.482 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HG2' ' CZ ' ' A' ' 118' ' ' PHE . 32.0 Cg_exo -58.72 -25.58 76.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.562 2.175 . . . . 2.36 112.72 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.4 t70 56.51 75.29 0.36 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.358 0.599 . . . . 2.99 110.155 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -134.32 -75.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 3.06 110.767 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.7 m -113.5 -97.93 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.969 -0.56 . . . . 1.85 110.384 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.89 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 13.5 m 50.64 37.77 17.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.938 -0.574 . . . . 1.44 112.086 175.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 1.01 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 27.9 mt-10 -62.65 143.16 57.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.38 -0.373 . . . . 1.81 111.379 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.776 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -136.46 127.66 28.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.939 -0.573 . . . . 0.64 110.749 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.63 HG23 HG22 ' A' ' 78' ' ' VAL . 27.7 m -91.1 115.1 27.75 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.43 110.696 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 113' ' ' VAL . 58.0 t -86.33 109.92 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.872 -0.418 . . . . 0.87 109.872 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.3 m -107.88 106.52 16.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.424 -0.353 . . . . 0.45 110.761 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.74 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 52.8 m-85 -88.35 117.72 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.346 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.98 112.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.236 -0.283 . . . . 0.54 110.236 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.33 51.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.887 -0.597 . . . . 0.44 111.593 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.8 t70 -137.38 120.31 16.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.595 . . . . 2.03 109.535 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.27 58.64 1.13 Allowed Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.994 -0.548 . . . . 1.97 113.118 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 21.0 tt0 -150.98 13.57 0.7 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.994 . . . . 4.93 108.315 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 59.8 mttp 67.09 33.7 5.49 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.175 -0.92 . . . . 3.53 109.384 -167.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 7.3 ttpm? -121.65 154.43 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.407 -0.59 . . . . 2.44 109.407 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.584 ' HB ' HG12 ' A' ' 12' ' ' VAL . 18.7 m -161.14 128.63 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.757 0.313 . . . . 0.42 110.728 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.34 114.95 28.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.036 -0.727 . . . . 2.59 109.036 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.948 HG12 HG22 ' A' ' 10' ' ' VAL . 12.7 p -93.2 144.67 8.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 120.994 -0.283 . . . . 0.4 111.199 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.47 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 7.3 t70 -130.26 126.78 38.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.222 -0.899 . . . . 1.38 109.51 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.725 ' HB ' ' CD2' ' A' ' 8' ' ' HIS . 1.2 t -111.44 133.22 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 116.662 -0.245 . . . . 0.91 110.809 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 49.8 mt-10 -104.31 110.73 23.08 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.907 0.754 . . . . 2.31 109.921 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.776 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 46.7 t-80 -123.38 99.06 6.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.214 -1.032 . . . . 1.64 108.214 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -153.07 91.26 1.51 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.116 0.484 . . . . 2.67 110.129 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -155.6 -75.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.904 -0.589 . . . . 2.63 110.142 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.575 ' CZ ' ' HG2' ' A' ' 91' ' ' PRO . 37.1 t80 -82.31 -25.76 33.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.654 -0.703 . . . . 3.54 110.906 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.87 -43.63 53.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.684 -0.689 . . . . 1.81 110.991 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 71.0 ttt180 -53.72 -21.3 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.368 -0.833 . . . . 3.38 112.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 79.1 mmm -78.64 2.14 20.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.428 -0.351 . . . . 2.43 111.113 -177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.31 -144.38 6.71 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.744 -0.662 . . . . 1.61 114.342 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 47.48 -132.61 1.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.302 0.641 . . . . 2.58 110.85 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -77.59 -13.91 59.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.471 -0.143 . . . . 3.8 111.371 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.8 m170 -72.72 -52.94 13.11 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.472 -0.566 . . . . 2.14 109.472 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.0 70.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.767 -0.651 . . . . 0.92 111.026 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -64.33 -39.47 93.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.478 -0.328 . . . . 2.83 111.098 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.452 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 3.1 ptm180 -73.28 -32.9 64.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 2.59 110.336 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.694 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 89.5 t -65.06 -40.49 89.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.385 0.612 . . . . 1.48 110.266 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.52 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 8.5 ttp180 -65.66 -17.25 64.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 3.83 111.904 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 88' ' ' ARG . 65.9 t30 -52.99 -46.47 68.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.727 0.298 . . . . 2.48 111.629 -173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' HG3' ' A' ' 88' ' ' ARG . . . -120.01 -20.07 3.83 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.145 -1.026 . . . . 1.61 113.031 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 49.6 ttm -79.74 -22.96 42.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.577 -0.366 . . . . 4.83 111.165 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 10.3 t70 -55.65 -49.15 73.66 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.851 0.685 . . . . 2.83 112.851 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -100.42 -39.85 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.984 -0.286 . . . . 4.15 111.335 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -59.41 -59.59 10.36 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 116.46 -0.336 . . . . 1.04 113.324 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.541 ' HH2' HG11 ' A' ' 113' ' ' VAL . 3.4 t90 -59.36 -49.99 89.68 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.63 0.604 . . . . 2.78 112.63 -172.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 28.6 Cg_endo -62.13 -35.54 74.82 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.002 1.801 . . . . 0.68 112.385 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -68.55 -37.04 79.6 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.248 -0.649 . . . . 0.87 109.248 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.687 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 57.8 mt -55.59 -49.35 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.933 -1.031 . . . . 0.72 110.244 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 60.4 mt -58.79 -33.8 70.75 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.363 0.414 . . . . 0.69 112.063 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.51 -57.0 7.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 1.49 110.417 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.611 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 70.1 m -65.89 -23.18 66.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.941 -0.572 . . . . 1.15 110.532 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.462 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 64.7 t80 -63.85 -53.0 57.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 0.8 110.101 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 76.1 mt-30 -58.58 -33.57 70.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.233 0.54 . . . . 1.63 110.34 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.36 -42.15 45.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.46 111.33 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.509 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 10.0 tptt -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.225 0.536 . . . . 1.74 110.442 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 19' ' ' ALA . 66.2 mt -68.49 -30.31 47.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.821 -0.627 . . . . 0.5 110.537 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.922 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 28.1 t0 -61.08 -30.96 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.85 109.898 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.803 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 43.8 mt-10 -65.99 -29.98 70.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 1.5 110.392 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -85.13 -5.14 59.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.419 -0.809 . . . . 1.74 110.173 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.8 -71.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.943 -0.646 . . . . 1.32 113.488 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.64 24.76 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.467 0.543 . . . . 1.92 112.467 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.803 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 14.9 tppt? -62.14 -74.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.431 0.158 . . . . 2.04 110.777 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 155' ' ' LYS . 6.8 mtmp? . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.322 -0.847 . . . . 4.22 110.392 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.57 ' O ' HG22 ' A' ' 6' ' ' VAL . 31.8 p-10 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 121.028 0.442 . . . . 1.66 110.78 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.437 ' HA ' HG22 ' A' ' 6' ' ' VAL . 92.1 m-85 -162.01 -41.71 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.44 1.096 . . . . 3.73 108.391 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.745 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 20.0 t70 -61.03 -54.73 51.3 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.171 -0.922 . . . . 2.78 112.312 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.2 Cg_endo -91.69 -63.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 1.63 112.493 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HA ' HG22 ' A' ' 116' ' ' THR . 30.9 p90 -152.4 142.86 22.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.082 -0.508 . . . . 3.21 109.856 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.682 ' HB ' ' CE1' ' A' ' 115' ' ' HIS . 16.7 t -103.81 108.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.722 -0.473 . . . . 1.44 109.722 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.817 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 25.7 ttm180 -109.38 132.92 53.67 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.844 -0.616 . . . . 3.37 111.502 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.21 135.6 50.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.999 -0.741 . . . . 0.79 108.999 173.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.778 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 5.5 p -141.18 112.72 7.55 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.144 0.497 . . . . 1.28 111.488 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.675 HG22 ' CG1' ' A' ' 111' ' ' VAL . 16.1 m -122.93 152.44 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.978 -0.555 . . . . 1.27 111.317 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -102.18 116.04 31.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.509 -0.769 . . . . 0.57 110.152 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.968 HG13 HG21 ' A' ' 148' ' ' ILE . 38.4 t -91.37 132.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.019 -0.991 . . . . 0.91 109.974 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.716 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -101.45 23.25 11.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.978 -0.555 . . . . 0.98 112.139 -171.541 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.35 37.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.244 0.461 . . . . 0.36 112.244 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 22.6 t70 75.39 159.6 0.22 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 122.04 0.924 . . . . 0.91 112.544 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 32.5 ttp180 -63.04 -25.49 68.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.637 -1.165 . . . . 1.88 111.618 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.92 -48.48 79.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.587 -0.279 . . . . 3.05 110.272 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.2 p -74.08 -36.4 64.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.952 -0.299 . . . . 1.11 111.201 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.85 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -59.23 -45.48 91.03 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.414 -0.514 . . . . 0.32 110.574 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CE1' HD21 ' A' ' 77' ' ' LEU . 76.1 t80 -71.49 -44.27 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.363 -0.38 . . . . 0.38 110.616 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -54.97 -54.27 45.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.132 0.491 . . . . 2.39 110.75 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.454 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.0 m -63.79 -48.54 76.48 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.078 -0.964 . . . . 0.68 110.24 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.728 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 61.5 t80 -59.72 -37.78 79.85 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.647 0.592 . . . . 0.48 112.223 -173.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.605 ' HG ' HG11 ' A' ' 46' ' ' VAL . 11.0 tp -112.78 -51.39 2.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.818 0.673 . . . . 0.5 112.818 -173.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.985 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 11.8 mt-10 -82.08 -38.62 24.61 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.799 -0.563 . . . . 1.24 111.988 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.651 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.07 40.53 2.81 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.876 -0.602 . . . . 0.83 112.193 -176.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.613 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 55.0 t80 -61.54 -58.2 20.02 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 112.043 0.386 . . . . 0.74 112.043 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 80.7 Cg_endo -80.11 29.26 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.533 2.155 . . . . 0.76 114.388 -174.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.3 pt-20 -125.46 2.13 7.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.543 -0.463 . . . . 1.49 110.986 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.782 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 24.9 m0 -75.62 157.87 33.18 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.048 0.451 . . . . 4.62 109.908 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.646 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 12.6 m95 -87.4 -34.93 0.45 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.17 0.804 . . . . 2.78 113.17 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 14.0 Cg_endo -54.43 -86.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.802 2.335 . . . . 1.36 115.295 -165.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -111.23 -34.72 6.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.479 0.657 . . . . 1.51 110.465 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.748 ' HA ' HG13 ' A' ' 40' ' ' VAL . 9.5 p-10 -91.51 33.62 1.0 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.061 -0.972 . . . . 1.79 111.823 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -96.34 -2.14 46.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.794 0.807 . . . . 4.45 109.115 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 8.2 mmt180 -99.34 126.0 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.198 -0.91 . . . . 4.14 110.65 -176.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 p -76.58 135.59 39.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.117 -0.492 . . . . 2.68 110.821 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 57' ' ' ASP . 61.1 p 57.74 20.08 6.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.38 1.072 . . . . 1.42 111.727 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -111.56 -46.8 3.23 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.771 -1.196 . . . . 2.9 107.771 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.748 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.3 p -174.52 26.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.711 -1.131 . . . . 1.83 109.02 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.97 36.33 0.28 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.641 -0.79 . . . . 2.17 112.93 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -66.12 164.49 28.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.531 -0.544 . . . . 1.12 109.531 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 56.96 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.352 2.701 . . . . 1.48 114.202 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.18 -83.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.173 0.589 . . . . 1.75 109.495 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.575 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 89.59 -55.68 3.82 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.86 -0.686 . . . . 0.75 113.592 170.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.605 HG11 ' HG ' ' A' ' 24' ' ' LEU . 91.3 t -138.73 142.09 35.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.001 0.429 . . . . 0.6 111.693 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.6 t70 -110.67 110.08 20.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 1.11 108.97 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.985 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 3.2 mptt -80.93 -29.55 35.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 2.81 111.872 -172.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -74.68 -42.43 58.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.031 0.382 . . . . 3.17 112.031 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.21 -42.18 3.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.638 -0.791 . . . . 1.53 111.612 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 107.35 68.19 0.66 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.86 -0.686 . . . . 0.77 112.745 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 6.8 ptm180 -159.25 139.74 12.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 3.72 111.094 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.737 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -95.23 110.09 22.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.52 . . . . 1.28 110.154 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.529 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.1 p90 -152.09 159.45 43.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.158 0.504 . . . . 1.66 110.876 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.993 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 24.9 mt-10 -117.18 156.06 28.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 2.12 110.89 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 mm -78.17 102.53 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.317 -0.994 . . . . 0.92 108.317 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.678 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 14.9 t70 -87.71 -177.87 5.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 1.97 110.54 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.45 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 10.5 pt-20 -60.95 -40.64 94.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.348 0.499 . . . . 2.43 112.348 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.16 25.12 7.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 2.39 111.039 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.3 -100.66 0.46 Allowed Glycine 0 C--O 1.22 -0.748 0 C-N-CA 120.822 -0.704 . . . . 2.29 111.801 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.678 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -156.02 75.31 0.89 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.357 0.598 . . . . 2.31 110.394 175.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -110.01 74.58 0.89 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.817 -0.808 . . . . 2.61 108.817 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 2.2 m-70 -124.21 147.47 48.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 3.72 110.549 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 p -57.68 110.27 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.586 0.554 . . . . 2.27 111.141 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.737 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 48.9 p90 -77.05 122.45 24.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.237 0.541 . . . . 6.48 111.553 -175.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 82' ' ' ARG . . . -60.49 134.41 50.0 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.056 -1.218 . . . . 1.23 110.056 170.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -97.63 87.81 4.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.607 0.703 . . . . 1.17 110.924 -168.116 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.53 HG12 HG13 ' A' ' 79' ' ' ILE . 51.5 mt -72.99 126.43 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.051 -0.522 . . . . 0.61 109.893 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' OE2' ' A' ' 96' ' ' GLU . 6.3 mmm180 -94.33 -26.57 16.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.837 -0.619 . . . . 2.0 109.38 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.2 ttpp -166.13 133.83 2.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.619 -0.719 . . . . 1.53 111.386 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.527 HG23 HG21 ' A' ' 68' ' ' ILE . 90.7 t -115.26 106.28 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.546 -0.909 . . . . 0.88 108.546 174.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.1 m-20 -102.99 59.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.618 -0.265 . . . . 1.42 110.936 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.5 pt-20 46.89 -168.83 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.247 0.967 . . . . 0.96 111.863 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.5 Cg_exo -63.52 80.5 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.422 1.414 . . . . 0.38 111.384 167.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 23.7 t70 -167.73 -66.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.45 -0.796 . . . . 0.5 110.275 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -146.71 159.07 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 0.35 111.358 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -148.03 126.92 12.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.571 -0.529 . . . . 0.74 109.571 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.28 101.58 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.08 -0.711 . . . . 0.67 109.08 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.53 HG13 HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.86 137.69 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.859 0.362 . . . . 0.75 110.796 -176.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.755 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -89.17 145.4 18.51 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.845 -0.616 . . . . 0.5 112.462 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.825 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 73.7 t-105 -64.48 131.24 46.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.036 0.922 . . . . 2.79 113.347 -171.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 5.8 tpt180 -151.51 94.52 2.02 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.751 -1.944 . . . . 5.46 105.751 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 89' ' ' ILE . 1.5 pp -67.72 -170.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.031 -0.532 . . . . 1.55 112.367 -170.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' OD1' HG21 ' A' ' 40' ' ' VAL . 3.0 m-20 -68.21 76.65 0.25 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.611 -0.885 . . . . 1.93 108.611 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.26 50.94 4.08 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.058 -0.974 . . . . 2.4 113.672 -168.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -132.47 34.66 3.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.828 -1.175 . . . . 5.38 107.828 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 88' ' ' ARG . . . 169.9 -26.36 0.11 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.473 -1.239 . . . . 2.3 111.386 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.713 ' HG3' ' HA3' ' A' ' 132' ' ' GLY . 36.6 mmt-85 -117.15 160.8 20.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.198 -0.297 . . . . 4.77 110.198 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.585 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -94.12 119.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.613 0.72 . . . . 1.86 111.168 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -88.76 133.92 34.89 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.292 -0.867 . . . . 3.18 110.07 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.21 -54.71 2.81 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.566 2.177 . . . . 2.36 112.267 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.19 86.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.935 0.772 . . . . 2.99 111.936 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -160.89 -52.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 3.06 109.124 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.4 m -142.91 -84.68 0.16 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.534 -1.284 . . . . 1.85 107.534 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.825 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 14.6 m 56.81 23.81 8.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.848 . . . . 1.44 111.662 169.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.755 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 25.2 mt-10 -71.23 139.63 50.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.873 -0.603 . . . . 1.81 111.665 -172.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.996 ' HB3' ' HB3' ' A' ' 115' ' ' HIS . 1.1 p90 -126.94 137.35 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.013 -0.54 . . . . 0.64 110.927 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 41.8 m -91.41 109.11 20.39 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.43 109.977 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.664 ' HA ' HG22 ' A' ' 113' ' ' VAL . 45.2 t -89.27 108.6 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.626 -0.509 . . . . 0.87 109.626 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.704 ' HA ' HG22 ' A' ' 76' ' ' THR . 42.1 m -104.09 106.57 17.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.45 110.563 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.711 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 48.6 m-85 -88.77 107.44 18.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.971 -0.381 . . . . 0.34 109.971 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.45 112.98 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.813 -0.44 . . . . 0.54 109.813 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.39 134.31 52.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.049 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 22.3 t70 -121.86 111.5 17.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.153 -0.476 . . . . 2.03 109.762 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.62 -99.27 0.81 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.859 -0.686 . . . . 1.97 112.48 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.573 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 4.1 pt20 -150.05 -25.23 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.454 0.168 . . . . 4.93 111.454 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.573 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 35.7 pttt -137.56 19.4 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 3.53 111.164 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.77 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 12.3 mptt -122.39 158.38 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.121 -0.696 . . . . 2.44 109.121 172.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.7 m -158.07 119.85 3.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.885 0.374 . . . . 0.42 110.813 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -101.66 108.5 20.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.114 -0.698 . . . . 2.59 109.114 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.2 p -90.82 142.32 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.4 110.245 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.564 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 16.4 t70 -132.54 113.46 13.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.441 -1.254 . . . . 1.38 109.519 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 3.0 t -105.13 124.48 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 116.504 -0.317 . . . . 0.91 111.131 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.61 125.71 54.46 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.987 -0.685 . . . . 2.31 110.04 170.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.996 ' HB3' ' HB3' ' A' ' 97' ' ' PHE . 27.7 p80 -137.35 125.82 23.52 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.822 -0.626 . . . . 1.64 109.737 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 5' ' ' PHE . 23.2 p -135.06 77.78 1.7 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 2.67 110.916 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.64 ' O ' ' HG2' ' A' ' 121' ' ' MET . 2.0 t-160 -158.96 -75.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.828 -0.749 . . . . 2.63 110.759 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.438 ' HE1' HG11 ' A' ' 129' ' ' VAL . 19.0 p90 -71.47 -29.76 65.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.12 -0.491 . . . . 3.54 111.483 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -51.75 19.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.615 0.766 . . . . 1.81 110.867 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.413 ' NH1' ' HB ' ' A' ' 116' ' ' THR . 42.1 ttp180 -58.89 -20.87 55.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.045 -0.98 . . . . 3.38 111.6 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.64 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.8 mmt -64.36 -19.31 65.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.511 0.196 . . . . 2.43 110.955 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.85 -157.54 3.26 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 114.756 0.662 . . . . 1.61 114.756 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 p 40.62 -128.78 0.43 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.032 0.933 . . . . 2.58 112.964 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 46.4 mmtm -60.08 -38.54 83.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 3.8 111.516 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -60.86 -49.66 76.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 2.14 110.714 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.68 68.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.112 -0.495 . . . . 0.92 110.491 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -72.37 -41.27 66.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 2.83 110.9 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 8.9 ptp180 -68.92 -33.64 74.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.624 0.249 . . . . 2.59 111.252 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.438 HG11 ' HE1' ' A' ' 118' ' ' PHE . 88.9 t -70.46 -45.75 73.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.397 0.618 . . . . 1.48 110.267 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.537 ' CG ' ' HB2' ' A' ' 134' ' ' ASP . 42.6 ttt180 -68.47 -14.58 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.382 -0.826 . . . . 3.83 111.137 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -52.34 -26.88 13.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.036 -0.529 . . . . 2.48 111.841 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.713 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -140.08 -37.43 0.11 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.974 -1.108 . . . . 1.61 113.34 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.71 ' HG3' ' HB2' ' A' ' 137' ' ' TRP . 7.7 tpt -73.06 -10.67 60.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.047 0.423 . . . . 4.83 111.366 -172.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' HB2' ' CG ' ' A' ' 130' ' ' ARG . 27.8 t70 -62.49 -31.43 72.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.151 0.501 . . . . 2.83 111.277 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -103.0 4.27 37.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.052 0.453 . . . . 4.15 110.485 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.539 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.75 -63.61 0.6 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.738 -0.665 . . . . 1.04 112.471 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.71 ' HB2' ' HG3' ' A' ' 133' ' ' MET . 4.2 t90 -57.96 -51.96 77.98 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.029 0.752 . . . . 2.78 113.029 -170.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.9 Cg_endo -60.96 -38.24 70.5 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.845 1.696 . . . . 0.68 111.916 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.2 m -67.45 -37.19 82.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.637 -0.71 . . . . 0.87 109.503 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.759 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 17.5 mt -57.39 -50.72 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 114.888 -1.051 . . . . 0.72 111.188 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 75.6 mt -57.44 -41.84 81.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.411 0.445 . . . . 0.69 111.209 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.92 -51.59 68.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.118 0.485 . . . . 1.49 110.866 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.694 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 41.7 m -71.65 -21.51 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 1.15 110.955 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 61.7 t80 -63.19 -53.02 59.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.238 -0.653 . . . . 0.8 109.238 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -31.93 69.35 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.868 -0.605 . . . . 1.63 110.51 173.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.05 -40.36 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 1.46 112.04 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -69.46 -39.32 77.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.068 0.461 . . . . 1.74 109.956 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.968 HG21 HG13 ' A' ' 12' ' ' VAL . 87.0 mt -65.72 -29.58 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.5 110.343 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.408 ' OD2' ' HG3' ' A' ' 154' ' ' LYS . 17.9 t0 -64.39 -25.24 67.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.616 -0.72 . . . . 0.85 110.199 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -71.52 -31.01 66.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.639 . . . . 1.5 109.964 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.52 -32.55 48.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.598 -0.728 . . . . 1.74 109.885 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -89.05 22.73 21.1 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.745 -0.661 . . . . 1.32 111.895 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.12 85.03 0.14 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.085 0.554 . . . . 1.92 111.735 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 34.0 ttmt -79.92 66.3 5.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.732 0.777 . . . . 2.04 109.014 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 155' ' ' LYS . 7.8 mtmp? . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.607 -1.179 . . . . 4.22 108.586 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 5.9 p30 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.346 -0.242 . . . . 1.66 110.346 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.8 p90 -169.21 -57.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.99 0.367 . . . . 3.73 111.99 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.6 t70 -66.55 -57.24 12.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.645 0.609 . . . . 2.78 112.645 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 2.8 Cg_endo -79.69 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.487 1.458 . . . . 1.63 111.971 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -142.3 121.47 13.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.684 0.278 . . . . 3.21 110.581 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.3 t -86.35 113.65 24.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.311 -0.996 . . . . 1.44 108.311 169.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 2.1 ttt180 -141.85 145.99 35.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.181 0.515 . . . . 3.37 111.077 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HE2' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -122.65 131.09 53.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.012 -0.736 . . . . 0.79 109.012 169.319 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.9 p -134.64 111.54 10.09 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.808 0.813 . . . . 1.28 110.125 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -125.95 146.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.272 -1.331 . . . . 1.27 111.801 -174.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -104.45 116.67 32.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.57 110.473 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.775 HG13 HG21 ' A' ' 148' ' ' ILE . 5.0 t -97.36 141.13 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.918 -0.583 . . . . 0.91 109.973 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.606 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 15.3 mmtp -106.83 14.84 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.575 -0.284 . . . . 0.98 111.724 -169.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.09 36.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.48 -0.488 . . . . 0.36 111.499 -174.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' OD1' ' HG3' ' A' ' 17' ' ' LYS . 35.2 t70 71.73 168.45 0.31 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.053 0.93 . . . . 0.91 112.614 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.623 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 11.5 ttp180 -66.48 -23.74 66.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.383 -1.281 . . . . 1.88 111.412 -174.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 62.6 mttm -60.96 -52.4 65.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 3.05 110.632 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.6 p -68.98 -34.51 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 1.11 110.458 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.4 -51.24 70.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.32 110.824 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.3 t80 -67.61 -45.06 76.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.223 -0.444 . . . . 0.38 110.673 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 18.6 ttmt -57.53 -49.16 77.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 2.39 111.18 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.562 HG23 ' CE2' ' A' ' 30' ' ' TRP . 31.1 m -69.72 -33.22 72.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.043 0.449 . . . . 0.68 111.11 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -75.95 -37.15 58.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.922 -0.311 . . . . 0.48 111.169 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.1 tp -120.15 -51.86 2.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.513 0.931 . . . . 0.5 113.513 -171.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.649 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 49.8 mt-10 -75.21 -51.81 12.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.463 0.542 . . . . 1.24 112.463 -168.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -88.12 32.23 4.44 Favored Glycine 0 C--N 1.315 -0.628 0 CA-C-N 115.781 -0.645 . . . . 0.83 111.9 -175.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.683 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 62.8 t80 -50.09 -57.84 11.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 123.343 0.657 . . . . 0.74 112.135 -170.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 28.1 Cg_endo -87.81 51.17 2.0 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.945 1.763 . . . . 0.76 114.62 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.6 pt-20 -150.07 -11.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.258 0.836 . . . . 1.49 113.258 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.774 ' CZ3' ' HG2' ' A' ' 147' ' ' LYS . 11.1 m95 -76.41 -172.31 2.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.155 0.502 . . . . 4.62 111.094 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 19.6 m95 -92.56 -26.05 0.28 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 2.78 114.758 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 93.4 Cg_endo -79.2 -139.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 CA-C-N 120.972 1.383 . . . . 1.36 113.876 -169.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' ND2' HG21 ' A' ' 40' ' ' VAL . 3.4 t-20 -48.07 -45.78 32.85 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.518 -0.765 . . . . 1.51 111.533 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -76.69 26.07 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.368 0.877 . . . . 1.79 113.368 -170.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -102.07 3.8 39.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 4.45 110.509 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -100.52 120.83 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 4.14 111.411 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 p -76.99 133.86 39.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.823 0.344 . . . . 2.68 111.511 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.474 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 6.3 p 52.86 27.37 5.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.019 0.928 . . . . 1.42 111.241 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 40' ' ' VAL . 48.3 tttp -124.89 -49.27 1.74 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.732 -1.122 . . . . 2.9 108.668 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.609 HG12 ' HD1' ' A' ' 65' ' ' PHE . 1.3 m -166.0 30.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 124.127 0.892 . . . . 1.83 110.693 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -173.08 31.87 0.11 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.813 -1.184 . . . . 2.17 114.159 -171.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.801 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.41 173.94 3.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.299 -0.63 . . . . 1.12 109.299 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.441 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 34.6 Cg_exo -63.49 41.97 0.1 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 C-N-CA 123.327 2.684 . . . . 1.48 114.71 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -149.11 -80.76 0.13 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.676 -0.49 . . . . 1.75 109.676 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.528 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 88.6 -60.87 3.91 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.887 -0.673 . . . . 0.75 112.689 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG11 ' HG ' ' A' ' 24' ' ' LEU . 77.9 t -141.26 133.6 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.547 0.213 . . . . 0.6 111.164 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -103.85 113.06 26.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.112 -0.494 . . . . 1.11 110.208 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 5.5 mptt -81.15 -16.15 53.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 2.81 110.847 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -76.36 -62.21 1.69 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.109 -0.496 . . . . 3.17 110.7 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.21 17.86 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 1.53 111.424 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.7 60.37 0.59 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.804 -0.713 . . . . 0.77 112.097 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.39 150.84 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.54 -0.388 . . . . 3.72 111.279 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 65' ' ' PHE . 6.1 m0 -100.24 110.86 23.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.984 -0.747 . . . . 1.28 108.984 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -162.4 174.55 12.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.429 0.633 . . . . 1.66 111.26 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.801 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 25.1 mt-10 -126.8 174.69 8.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.648 -0.705 . . . . 2.12 109.834 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' HG2' ' A' ' 61' ' ' GLU . 32.3 mm -100.75 100.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.954 -0.758 . . . . 0.92 108.954 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.603 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 2.9 m-20 -67.26 -175.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.574 0.702 . . . . 1.97 112.013 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.28 -25.29 29.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.289 -0.868 . . . . 2.43 110.925 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 2.4 pm0 -95.66 5.05 52.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 2.39 110.828 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.16 -109.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.235 -0.983 . . . . 2.29 112.56 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' HG2' HD12 ' A' ' 56' ' ' ILE . 28.2 mt-10 -147.97 34.54 0.83 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.478 0.311 . . . . 2.31 110.975 -173.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 9.9 pt-20 -97.5 74.43 2.44 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.29 -0.964 . . . . 2.61 111.283 -171.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.9 163.32 20.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.995 . . . . 3.72 111.409 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -131.04 148.67 52.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.411 -0.813 . . . . 2.27 110.534 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 6.6 t80 -165.54 -54.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.587 0.554 . . . . 6.48 109.598 172.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -156.12 149.91 21.03 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.186 -1.007 . . . . 1.23 113.415 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.494 HD12 ' CZ ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -114.76 103.92 11.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.625 -0.509 . . . . 1.17 109.625 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.467 HG21 HG22 ' A' ' 71' ' ' VAL . 43.4 mt -79.5 142.1 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.987 0.422 . . . . 0.61 110.839 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.6 mpt_? -114.04 -25.22 8.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.48 174.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.665 ' HD2' HG23 ' A' ' 78' ' ' VAL . 13.1 ttmm -142.55 106.62 4.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.531 -0.304 . . . . 1.53 111.174 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 68' ' ' ILE . 41.5 t -95.05 92.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.268 -1.012 . . . . 0.88 108.268 167.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -109.5 70.34 0.73 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.661 -0.416 . . . . 1.42 111.12 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.9 pt-20 48.37 -172.59 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.507 1.13 . . . . 0.96 112.018 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 26.2 Cg_exo -65.45 75.35 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.428 1.419 . . . . 0.38 111.1 166.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -157.46 -66.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.5 110.358 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -141.77 143.71 33.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.412 0.625 . . . . 0.35 112.079 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -131.5 112.05 12.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.509 -0.769 . . . . 0.74 109.506 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.665 HG23 ' HD2' ' A' ' 70' ' ' LYS . 86.1 t -90.6 104.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.801 -0.815 . . . . 0.67 108.801 172.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.593 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -127.93 122.55 58.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.378 -0.828 . . . . 0.75 111.333 -170.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.924 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -87.25 154.7 26.57 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 111.833 -0.507 . . . . 0.5 111.833 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.767 ' CZ2' ' HA ' ' A' ' 83' ' ' LEU . 68.8 t-105 -91.16 125.93 36.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.466 0.651 . . . . 2.79 111.798 -171.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -124.76 0.27 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 5.46 109.26 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.052 HD21 ' HB2' ' A' ' 88' ' ' ARG . 6.8 tt 78.57 154.26 0.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.706 -1.134 . . . . 1.55 113.416 169.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.551 ' HB2' HG11 ' A' ' 40' ' ' VAL . 22.5 p-10 -117.88 -28.0 6.04 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.129 -0.941 . . . . 1.93 112.689 -168.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.47 -29.59 63.84 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-O 119.727 -0.485 . . . . 2.4 113.882 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 73.01 -42.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.412 0.685 . . . . 5.38 110.769 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.88 3.39 70.59 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.101 -0.8 . . . . 2.3 111.101 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.052 ' HB2' HD21 ' A' ' 83' ' ' LEU . 69.2 mmt-85 -96.75 173.93 7.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.155 -0.313 . . . . 4.77 110.155 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.879 HD12 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -101.15 119.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.175 0.512 . . . . 1.86 110.319 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 7.6 p-10 -91.24 141.31 26.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.157 0.503 . . . . 3.18 111.556 -175.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.602 ' HG3' HG22 ' A' ' 129' ' ' VAL . 10.0 Cg_exo -72.07 -49.97 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.036 2.49 . . . . 2.36 111.538 171.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.48 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 17.4 t70 70.72 -41.93 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.785 0.834 . . . . 2.99 112.911 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.591 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 21.2 m-80 -73.32 -31.24 63.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.384 . . . . 3.06 111.927 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.521 ' HB2' ' HD2' ' A' ' 118' ' ' PHE . 67.6 m -154.19 -126.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.101 -0.239 . . . . 1.85 111.244 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.706 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 58.8 m 57.59 28.67 16.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.454 0.645 . . . . 1.44 110.352 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.924 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 36.5 tt0 -62.08 138.55 58.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.957 -1.02 . . . . 1.81 111.02 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -133.92 136.92 44.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.149 0.499 . . . . 0.64 110.931 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.8 m -99.17 110.42 22.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.43 110.174 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.724 ' HA ' HG22 ' A' ' 113' ' ' VAL . 91.8 t -82.8 109.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.828 -0.624 . . . . 0.87 110.103 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.7 m -103.52 106.13 16.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.379 -0.373 . . . . 0.45 110.67 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.623 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 40.9 m-85 -87.99 112.7 22.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.304 -0.407 . . . . 0.34 110.255 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.13 111.19 25.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.286 -0.415 . . . . 0.54 110.125 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.89 133.76 48.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.833 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.9 t0 -126.99 100.92 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.174 -0.466 . . . . 2.03 109.833 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.7 49.46 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.708 -0.758 . . . . 1.97 113.404 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 72.22 8.16 5.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.504 0.722 . . . . 4.93 111.973 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -128.06 -11.66 5.29 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.828 -0.545 . . . . 3.53 110.285 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 77.5 tttt -122.48 158.06 30.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.893 -0.781 . . . . 2.44 108.893 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.1 m -157.6 117.64 3.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.95 0.405 . . . . 0.42 110.792 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.4 tmm_? -102.12 116.22 32.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.512 -0.922 . . . . 2.59 108.512 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.9 p -90.73 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.313 -0.403 . . . . 0.4 111.116 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -129.13 112.58 14.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 1.38 108.732 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 99' ' ' VAL . 47.0 t -104.71 120.85 55.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.956 -0.566 . . . . 0.91 111.209 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.46 122.82 40.95 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.765 0.666 . . . . 2.31 109.651 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 2.3 t-160 -131.44 97.75 4.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.799 -0.815 . . . . 1.64 108.799 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.577 HG22 ' HD2' ' A' ' 120' ' ' ARG . 24.5 p -141.78 103.13 4.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.726 -0.215 . . . . 2.67 111.271 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -167.39 -74.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.315 -0.554 . . . . 2.63 112.172 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -85.75 -42.43 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 3.54 111.391 -168.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.95 73.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.195 -0.911 . . . . 1.81 110.719 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.577 ' HD2' HG22 ' A' ' 116' ' ' THR . 44.1 mtp180 -59.59 -19.32 47.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.424 -0.807 . . . . 3.38 111.923 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.521 ' HA ' ' CE ' ' A' ' 121' ' ' MET . 11.5 mmt -72.4 23.63 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.69 0.996 . . . . 2.43 113.69 -171.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.79 -155.88 15.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.847 -1.168 . . . . 1.61 114.406 168.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 p -61.66 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.32 0.859 . . . . 2.58 113.32 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 48.1 mtpt -70.05 -14.31 62.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 3.8 112.002 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.67 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 40.3 m80 -73.03 -49.92 26.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.461 0.648 . . . . 2.14 109.364 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.89 73.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.92 110.024 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.639 ' HB3' ' HA ' ' A' ' 124' ' ' LYS . 2.8 tppp? -71.25 -38.03 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.685 -0.689 . . . . 2.83 111.382 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.879 ' HB2' HD12 ' A' ' 89' ' ' ILE . 15.8 ptm180 -67.69 -30.86 70.49 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.907 -0.317 . . . . 2.59 110.272 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.4 t -84.61 -30.92 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.319 -0.552 . . . . 1.48 111.605 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.271 -0.422 . . . . 3.83 111.928 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 5.3 p30 -63.56 -33.48 75.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 2.48 111.281 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.89 -71.33 1.28 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.517 -0.849 . . . . 1.61 114.213 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.614 ' HB3' ' CZ2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -77.84 -21.89 50.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.961 0.726 . . . . 4.83 112.961 -165.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.9 -28.15 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 2.83 111.244 -174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.822 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.3 mmpt? -101.99 15.24 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 4.15 110.916 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.631 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -134.24 -57.25 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.508 -0.853 . . . . 1.04 112.489 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.433 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 1.6 t90 -56.0 -54.43 52.4 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.693 0.627 . . . . 2.78 112.693 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 34.9 Cg_endo -65.83 -34.33 40.13 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.708 1.606 . . . . 0.68 111.948 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 -41.0 95.23 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.925 -0.58 . . . . 0.87 109.894 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.667 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 63.2 mt -57.9 -46.43 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 115.334 -0.848 . . . . 0.72 109.843 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 21.6 mt -54.95 -42.9 72.92 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 123.638 0.586 . . . . 0.69 111.385 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -64.02 -46.18 85.6 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.582 -0.447 . . . . 1.49 110.813 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -75.19 -22.19 58.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.027 0.442 . . . . 1.15 110.927 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 92.8 t80 -61.18 -55.14 35.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.8 109.6 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.464 ' OE1' ' HD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -64.92 -30.7 71.7 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.019 -0.537 . . . . 1.63 110.45 175.026 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.48 -55.77 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.591 -0.277 . . . . 1.46 111.342 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.774 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 21.9 tptp -68.0 -39.61 83.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.53 -0.468 . . . . 1.74 110.841 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.775 HG21 HG13 ' A' ' 12' ' ' VAL . 47.2 mt -65.9 -37.83 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.5 111.894 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.936 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.1 t70 -64.09 -25.53 68.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.377 -0.374 . . . . 0.85 110.333 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.777 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 61.4 mt-10 -69.53 -39.66 77.37 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.38 -20.6 66.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.054 -0.975 . . . . 1.74 108.972 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.95 -82.78 0.9 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.06 -0.973 . . . . 1.32 111.56 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -155.01 12.37 0.37 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.866 0.691 . . . . 1.92 112.866 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.936 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 21.1 ttmm -63.67 -32.48 73.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.942 0.401 . . . . 2.04 111.466 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 119.22 -0.419 . . . . 4.22 110.719 -176.755 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.9 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 32.6 p30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.375 -0.232 . . . . 1.66 110.375 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER 70.26 -31.76 0.22 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.082 1.353 . . . . 3.73 112.172 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.79 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 23.6 t70 -59.34 -53.63 64.17 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.284 -0.265 . . . . 2.78 110.284 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 25.5 Cg_endo -94.64 -64.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.244 1.963 . . . . 1.63 111.348 167.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 38.6 p90 -151.77 171.4 17.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.936 -1.135 . . . . 3.21 107.936 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.964 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 86.0 t -107.58 103.91 16.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.853 -0.339 . . . . 1.44 110.53 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.1 ttp180 -93.76 130.59 39.69 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.239 -0.584 . . . . 3.37 110.84 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.646 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -110.53 133.54 53.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.79 108.817 173.104 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.677 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.1 t -134.7 111.08 9.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.518 0.675 . . . . 1.28 110.111 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 3.0 t -124.63 137.78 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.675 -1.148 . . . . 1.27 111.652 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.1 m -97.77 116.88 30.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.813 -0.63 . . . . 0.57 110.443 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.904 HG13 HG21 ' A' ' 148' ' ' ILE . 32.9 t -94.7 142.4 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.46 -0.791 . . . . 0.91 110.868 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -99.23 12.76 35.27 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.25 0.463 . . . . 0.98 112.25 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.4 39.66 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.975 -0.69 . . . . 0.36 112.414 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.572 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 14.3 t70 73.12 167.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.811 0.815 . . . . 0.91 111.927 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 25.9 ttp180 -69.43 -23.4 63.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.094 -0.957 . . . . 1.88 110.707 -174.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 15.1 ptpt -60.76 -39.22 87.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 3.05 111.195 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -82.91 -37.86 23.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.928 -0.309 . . . . 1.11 110.594 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -56.27 -43.38 78.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.829 0.347 . . . . 0.32 110.462 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 79.4 t80 -70.93 -46.01 63.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.322 -0.399 . . . . 0.38 110.48 176.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -55.19 -55.0 36.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.037 -0.529 . . . . 2.39 111.382 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.444 HG22 ' NE1' ' A' ' 30' ' ' TRP . 23.6 m -67.23 -46.68 73.07 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.311 -0.859 . . . . 0.68 111.028 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.647 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 66.5 t80 -64.46 -34.89 79.25 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.103 0.409 . . . . 0.48 112.103 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.2 tp -108.67 -53.72 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.033 -0.667 . . . . 0.5 112.373 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.63 -39.44 37.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 1.24 111.297 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.709 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -91.4 33.53 4.72 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.65 -0.704 . . . . 0.83 112.336 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.541 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 44.8 t80 -52.54 -48.0 91.71 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.216 0.45 . . . . 0.74 112.216 -173.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -89.64 15.29 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.869 1.713 . . . . 0.76 115.036 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.0 pt-20 -100.44 -5.03 27.71 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.993 -0.683 . . . . 1.49 110.766 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.647 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 23.9 m0 -75.73 153.75 36.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.488 0.661 . . . . 4.62 111.468 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.647 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 36.8 m95 -80.47 -44.1 1.35 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.908 -1.042 . . . . 2.78 112.855 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 1.105 ' HD3' ' HB2' ' A' ' 143' ' ' SER . 11.3 Cg_endo -52.12 -76.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.062 2.508 . . . . 1.36 114.76 -164.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -120.35 -11.61 9.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 1.51 110.609 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.703 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.4 m-20 -99.14 18.67 16.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.688 . . . . 1.79 111.103 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.55 8.37 43.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.142 0.496 . . . . 4.45 111.023 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -117.73 140.33 49.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 4.14 111.65 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.48 148.03 37.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 2.68 110.921 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 57' ' ' ASP . 63.6 p 57.88 8.02 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.547 1.139 . . . . 1.42 112.843 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.78 -77.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.479 -0.934 . . . . 2.9 108.479 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.703 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.8 m -147.21 15.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.588 -0.893 . . . . 1.83 108.588 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.49 55.35 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.72 -1.127 . . . . 2.17 111.876 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -104.05 169.81 6.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.406 -0.961 . . . . 1.12 108.406 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.19 53.83 0.26 Allowed 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 123.038 2.492 . . . . 1.48 113.77 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD21 ' CZ ' ' A' ' 54' ' ' TYR . 35.3 tp -170.8 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.745 0.418 . . . . 1.75 110.378 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.664 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 87.76 -57.78 4.38 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.991 -0.623 . . . . 0.75 112.487 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 24' ' ' LEU . 89.0 t -134.81 136.66 51.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.839 0.352 . . . . 0.6 110.67 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.648 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.9 t70 -107.94 122.77 47.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.561 -0.745 . . . . 1.11 109.77 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -33.91 40.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.403 0.52 . . . . 2.81 112.403 -175.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -47.22 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.814 0.301 . . . . 3.17 111.814 -172.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.88 -25.39 22.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.655 -0.784 . . . . 1.53 111.784 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 82.18 60.33 2.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.652 -0.785 . . . . 0.77 111.207 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 8.3 ptm180 -146.39 139.76 25.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.843 0.354 . . . . 3.72 111.118 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 24.5 m0 -97.99 108.26 20.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 1.28 110.547 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.648 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -153.32 151.71 30.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.997 0.427 . . . . 1.66 110.282 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 51.6 mp0 -117.79 160.05 22.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 2.12 110.512 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.51 HD12 ' HG2' ' A' ' 61' ' ' GLU . 36.8 mm -77.84 103.97 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 0.92 110.062 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.0 t70 -95.43 -178.12 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 1.97 110.476 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -80.92 -7.68 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.798 0.666 . . . . 2.43 112.798 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.511 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -95.98 -4.65 42.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.289 0.566 . . . . 2.39 110.194 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.21 -85.1 0.18 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.505 -0.771 . . . . 2.29 111.816 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.51 ' HG2' HD12 ' A' ' 56' ' ' ILE . 52.6 mt-10 -156.65 18.94 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.717 -0.475 . . . . 2.31 109.717 -177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.86 88.85 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.742 0.782 . . . . 2.61 110.274 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -117.84 163.74 16.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.886 -1.052 . . . . 3.72 110.254 -178.426 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -52.7 109.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.67 -0.493 . . . . 2.27 109.67 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 30.7 p90 -92.58 130.66 38.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.334 0.588 . . . . 6.48 112.016 -170.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.4 157.55 31.72 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.74 -0.944 . . . . 1.23 110.74 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.2 pt? -116.01 99.59 7.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.996 0.398 . . . . 1.17 111.261 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 71' ' ' VAL . 40.7 mt -79.37 118.6 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.047 -0.661 . . . . 0.61 109.907 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -85.94 -23.25 27.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.841 -1.072 . . . . 2.0 109.818 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 78' ' ' VAL . 58.5 tttp -156.39 105.41 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.732 -0.667 . . . . 1.53 111.266 -174.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 68' ' ' ILE . 49.8 t -98.92 93.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.652 -0.87 . . . . 0.88 108.652 169.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.02 73.15 0.83 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.535 -0.466 . . . . 1.42 111.648 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 48.18 -174.12 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 124.827 1.33 . . . . 0.96 112.623 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 39.3 Cg_exo -62.77 82.08 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.504 1.469 . . . . 0.38 110.956 166.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -167.68 -67.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.789 . . . . 0.5 110.506 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 100' ' ' THR . 3.6 p -141.91 140.97 32.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.431 0.53 . . . . 0.35 112.431 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 77' ' ' LEU . 2.2 mp -136.6 112.93 9.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 0.74 109.621 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 98' ' ' THR . 39.6 t -103.24 109.9 28.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.007 -0.738 . . . . 0.67 109.007 175.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 138.62 53.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.902 0.382 . . . . 0.75 111.947 -176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 150.95 21.8 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.816 -0.629 . . . . 0.5 112.791 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.81 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 61.0 t-105 -89.09 148.94 23.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.209 0.604 . . . . 2.79 111.64 -168.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -142.87 23.24 1.91 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.995 -0.548 . . . . 5.46 110.374 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.72 HD11 ' HB3' ' A' ' 88' ' ' ARG . 1.6 tm? 84.63 152.83 0.09 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.177 -0.919 . . . . 1.55 111.081 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.554 ' N ' HD13 ' A' ' 83' ' ' LEU . 42.0 t30 -131.79 -29.99 1.66 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.01 -0.541 . . . . 1.93 111.52 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.7 46.08 2.8 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.304 -0.474 . . . . 2.4 113.81 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.3 t80 58.63 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 5.38 112.307 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.17 39.23 2.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.988 -0.625 . . . . 2.3 112.145 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.763 ' HD2' ' ND2' ' A' ' 131' ' ' ASN . 5.6 tpp180 -97.56 -176.62 3.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.729 -0.471 . . . . 4.77 109.729 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.457 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -94.14 137.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.965 0.412 . . . . 1.86 110.47 -175.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -96.0 137.6 21.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.081 -0.509 . . . . 3.18 111.428 -179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HG2' ' HD1' ' A' ' 81' ' ' TRP . 50.2 Cg_exo -57.62 -21.72 48.34 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.17 3.247 . . . . 2.36 113.807 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.5 t70 77.25 41.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.381 -0.827 . . . . 2.99 110.596 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.43 ' HA ' HD21 ' A' ' 67' ' ' LEU . 4.6 m-20 80.36 36.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.032 -0.986 . . . . 3.06 112.845 158.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 p -122.71 -37.25 2.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.757 -0.377 . . . . 1.85 111.682 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.81 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 20.5 t -55.85 97.06 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.522 -0.763 . . . . 1.44 109.292 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -122.57 136.84 54.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.237 -0.438 . . . . 1.81 110.673 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.487 ' HD1' ' CE1' ' A' ' 115' ' ' HIS . 12.2 p90 -134.48 139.4 45.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.235 0.541 . . . . 0.64 111.855 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 78' ' ' VAL . 75.7 m -96.9 109.1 21.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.117 -0.947 . . . . 0.43 110.134 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.788 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.2 t -83.53 109.98 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.87 110.077 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 ' HA ' HG22 ' A' ' 76' ' ' THR . 25.2 m -106.19 106.56 17.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.646 -0.252 . . . . 0.45 110.636 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.565 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.8 m-85 -88.12 115.8 25.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.657 -0.247 . . . . 0.34 110.498 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.2 112.01 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.907 -0.405 . . . . 0.54 109.907 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.58 133.89 43.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.844 -0.616 . . . . 0.44 111.372 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -121.93 128.85 52.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 2.03 109.227 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.65 -13.05 29.79 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.343 -0.844 . . . . 1.97 115.176 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -84.21 33.86 0.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.993 0.896 . . . . 4.93 111.685 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 12.3 mmtp 56.5 45.72 21.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.746 0.784 . . . . 3.53 108.947 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 87.9 tttt -133.87 155.03 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.809 -1.087 . . . . 2.44 109.341 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.441 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 25.9 m -155.03 114.63 3.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.139 0.495 . . . . 0.42 110.841 173.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.481 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 18.2 tpp85 -91.64 113.98 26.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.543 -0.753 . . . . 2.59 109.697 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -91.04 138.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.768 0.318 . . . . 0.4 110.485 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 17.8 t70 -127.55 109.98 12.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.491 -0.777 . . . . 1.38 109.213 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 t -102.93 135.67 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.536 -0.756 . . . . 0.91 111.578 -175.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -113.04 111.62 22.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 2.31 109.683 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.964 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -100.77 115.57 30.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.454 -0.794 . . . . 1.64 109.235 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 p -127.99 168.88 14.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.522 -0.471 . . . . 2.67 111.619 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 101.98 -66.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 113.804 -1.544 . . . . 2.63 110.563 162.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.838 ' HE2' HG21 ' A' ' 129' ' ' VAL . 59.5 t80 -86.97 -52.34 5.51 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.029 -0.532 . . . . 3.54 111.996 -175.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 2' ' ' TYR . 1.7 m-20 -54.82 -33.39 61.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 1.81 112.281 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 37.7 ttp180 -62.52 -22.73 66.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 3.38 111.502 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.81 -22.09 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.536 -0.302 . . . . 2.43 110.358 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 126' ' ' ALA . . . 48.82 -154.02 2.09 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.39 -0.823 . . . . 1.61 114.801 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 m 44.76 -101.92 0.05 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.397 1.079 . . . . 2.58 113.112 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.96 -45.16 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.136 -0.32 . . . . 3.8 110.136 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -61.15 -49.8 75.76 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.334 0.588 . . . . 2.14 110.469 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . . . -64.51 -51.24 63.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.549 -0.751 . . . . 0.92 111.222 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -61.91 -34.0 75.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.905 0.335 . . . . 2.83 111.905 -173.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -77.16 -32.94 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.419 -0.513 . . . . 2.59 111.438 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.838 HG21 ' HE2' ' A' ' 118' ' ' PHE . 79.2 t -78.61 -42.3 25.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.374 0.607 . . . . 1.48 110.664 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.901 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 65.9 mtt-85 -68.18 -12.41 60.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.516 -0.766 . . . . 3.83 110.957 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.763 ' ND2' ' HD2' ' A' ' 88' ' ' ARG . 45.7 t30 -51.8 -25.09 6.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.568 -0.742 . . . . 2.48 110.004 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.18 -17.92 2.64 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.918 -0.583 . . . . 1.61 112.422 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.811 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 6.4 tpp -80.07 -42.89 22.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.475 0.546 . . . . 4.83 112.475 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.901 ' HB2' ' HB3' ' A' ' 130' ' ' ARG . 7.4 t70 -68.46 -25.92 65.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.975 0.731 . . . . 2.83 112.975 -163.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -115.9 24.19 11.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.586 0.708 . . . . 4.15 109.922 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.96 -74.68 0.64 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.36 -0.836 . . . . 1.04 111.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 5.5 t90 -58.51 -48.86 96.15 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.76 0.652 . . . . 2.78 112.76 -173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.0 Cg_endo -59.61 -38.75 80.14 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.189 1.926 . . . . 0.68 112.642 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 m -70.9 -37.11 72.98 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.757 0.789 . . . . 0.87 109.347 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.666 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.6 mt -54.59 -44.74 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.4 -1.273 . . . . 0.72 110.196 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.563 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 68.9 mt -56.68 -33.8 66.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.464 0.478 . . . . 0.69 111.608 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -69.15 -57.71 5.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.18 0.514 . . . . 1.49 111.002 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 1.105 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -71.93 -21.39 61.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.104 -0.498 . . . . 1.15 111.132 -178.134 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.35 -47.57 85.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.8 109.543 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 26.4 mt-30 -61.23 -36.22 79.36 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.549 -0.751 . . . . 1.63 110.356 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.47 -39.75 64.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.492 -0.777 . . . . 1.46 111.506 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -66.56 -35.77 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.934 0.397 . . . . 1.74 110.112 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.904 HG21 HG13 ' A' ' 12' ' ' VAL . 50.4 mt -71.47 -32.68 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.288 0.566 . . . . 0.5 110.375 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.425 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 12.8 t70 -58.88 -32.33 69.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.609 -0.723 . . . . 0.85 109.727 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.85 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 49.6 mt-10 -66.0 -33.22 75.3 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.538 -0.755 . . . . 1.5 110.413 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -82.15 -17.1 47.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.359 -0.837 . . . . 1.74 109.726 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -96.56 -75.89 1.28 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.467 -0.788 . . . . 1.32 112.819 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.55 15.27 1.8 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.697 0.628 . . . . 1.92 112.697 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.85 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttmm -79.62 76.94 6.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.232 0.539 . . . . 2.04 110.087 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--O 1.246 0.901 0 CA-C-N 115.7 -0.682 . . . . 4.22 109.553 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 35.2 m-80 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.691 -0.485 . . . . 1.66 109.691 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 28.4 p90 172.96 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.62 0.575 . . . . 3.73 110.288 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.899 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.4 t70 -59.98 -56.74 32.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.129 -0.487 . . . . 2.78 111.397 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.899 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 18.9 Cg_endo -96.08 -64.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.392 2.061 . . . . 1.63 111.953 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -149.6 154.97 39.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.667 -1.234 . . . . 3.21 107.667 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.734 ' HB ' ' CB ' ' A' ' 115' ' ' HIS . 27.4 t -85.7 106.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.221 -0.592 . . . . 1.44 109.812 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.8 ttm180 -111.75 135.38 52.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.805 0.812 . . . . 3.37 111.427 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 1.025 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.38 132.37 54.19 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.736 -1.209 . . . . 0.79 107.736 174.016 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.2 t -146.04 112.02 5.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.944 -0.391 . . . . 1.28 109.944 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.808 HG22 HG12 ' A' ' 111' ' ' VAL . 10.8 m -138.31 139.21 42.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 1.27 110.819 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m -92.84 116.14 28.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.471 -0.786 . . . . 0.57 109.906 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.778 HG13 HG21 ' A' ' 148' ' ' ILE . 22.4 t -98.47 125.57 51.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.476 -0.784 . . . . 0.91 110.379 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 35.06 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.933 0.397 . . . . 0.98 111.567 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.548 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.39 26.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.434 -0.348 . . . . 0.36 111.039 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.1 t70 72.6 169.21 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 0.91 112.857 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.497 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 7.6 ttp180 -63.36 -27.49 69.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.16 -0.927 . . . . 1.88 110.978 -174.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -54.28 -53.36 54.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.721 -0.672 . . . . 3.05 111.405 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -76.56 -33.57 58.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 1.11 111.181 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.621 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -60.47 -48.31 82.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.32 110.79 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -69.1 -33.78 74.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.38 110.537 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.863 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 5.5 tppp? -61.06 -55.7 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.427 . . . . 2.39 110.262 176.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.544 HG23 ' CE2' ' A' ' 30' ' ' TRP . 31.2 m -66.55 -23.87 66.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.68 111.939 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 99' ' ' VAL . 69.4 t80 -87.81 -37.26 16.72 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.722 -0.391 . . . . 0.48 111.467 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.54 HD23 ' HE3' ' A' ' 48' ' ' LYS . 18.9 tp -119.95 -54.89 2.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.51 0.93 . . . . 0.5 113.51 -172.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.863 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 29.0 mt-10 -78.68 -24.72 44.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.378 0.609 . . . . 1.24 110.779 -169.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.418 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.72 93.84 0.54 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.056 -2.017 . . . . 0.83 108.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.863 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 23.0 t80 -95.93 -63.85 0.12 Allowed Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.722 -0.239 . . . . 0.74 111.041 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 29.9 Cg_endo -96.46 37.53 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.282 1.988 . . . . 0.76 114.677 -174.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -126.97 5.24 6.53 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.409 0.892 . . . . 1.49 113.409 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' HE3' ' HG3' ' A' ' 147' ' ' LYS . 18.7 m95 -99.07 -160.89 0.83 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.127 -0.358 . . . . 4.62 110.221 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 22.1 m95 -99.05 -8.92 0.12 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.991 1.478 . . . . 2.78 114.991 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HB3' ' HB3' ' A' ' 143' ' ' SER . 92.8 Cg_endo -81.82 -148.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 CA-C-N 122.484 1.923 . . . . 1.36 113.292 -170.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.663 HD22 ' HE3' ' A' ' 39' ' ' LYS . 25.6 t-20 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.812 . . . . 1.51 111.025 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.784 ' HA ' HG23 ' A' ' 40' ' ' VAL . 30.9 m-20 -78.87 20.98 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.183 -0.462 . . . . 1.79 110.739 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -117.83 22.39 12.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 4.45 110.33 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -117.66 146.97 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 4.14 110.108 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.58 135.66 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.023 -0.271 . . . . 2.68 110.854 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.1 p 58.52 14.49 3.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.082 0.953 . . . . 1.42 112.133 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.663 ' HE3' HD22 ' A' ' 33' ' ' ASN . 54.2 tttp -132.6 80.35 1.89 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.985 -0.746 . . . . 2.9 108.985 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.784 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.1 m 54.1 17.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.429 1.091 . . . . 1.83 112.165 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -146.28 26.88 1.7 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.56 -0.828 . . . . 2.17 113.312 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.892 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -77.56 167.14 38.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.45 -0.944 . . . . 1.12 108.45 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.02 59.71 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.751 2.301 . . . . 1.48 113.718 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 53.4 tp -166.03 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.75 110.027 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.45 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 94.98 -63.88 1.46 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.872 -0.68 . . . . 0.75 113.06 173.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 24' ' ' LEU . 84.8 t -132.75 147.41 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.84 0.353 . . . . 0.6 110.487 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.83 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.6 t0 -123.98 96.32 4.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.853 -0.795 . . . . 1.11 108.853 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 8.5 mtpt -74.06 -22.31 59.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.112 0.482 . . . . 2.81 110.245 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 49' ' ' LYS . 4.2 ttpm? -64.67 -56.61 12.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 3.17 110.787 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.93 -28.72 33.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.966 -0.635 . . . . 1.53 112.595 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.95 49.42 2.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.696 -0.764 . . . . 0.77 112.169 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.44 161.31 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.735 0.302 . . . . 3.72 111.417 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD1' HD11 ' A' ' 68' ' ' ILE . 14.4 m0 -108.99 120.01 41.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 1.28 109.999 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.83 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -163.91 158.11 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.087 0.47 . . . . 1.66 110.677 175.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.892 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.1 mp0 -125.71 166.55 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.486 -0.931 . . . . 2.12 108.486 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 61' ' ' GLU . 43.2 mm -78.34 103.62 5.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.121 0.486 . . . . 0.92 109.958 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.4 t70 -87.98 145.94 25.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.717 -0.674 . . . . 1.97 110.092 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -61.34 -26.82 68.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.681 0.613 . . . . 2.43 112.354 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.427 ' HB3' ' OD2' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -75.8 -17.99 59.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.951 0.405 . . . . 2.39 111.226 -175.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.15 54.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.175 -1.012 . . . . 2.29 113.211 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 56' ' ' ILE . 43.6 mt-10 56.0 26.26 9.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.157 0.799 . . . . 2.31 113.157 173.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 12.8 tp10 -112.9 95.83 5.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.424 0.63 . . . . 2.61 110.236 -176.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.22 165.16 16.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.047 -0.978 . . . . 3.72 110.602 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 82' ' ' ARG . 3.2 p -47.82 124.77 7.76 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.627 0.58 . . . . 2.27 111.316 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -89.61 112.46 23.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.743 -0.662 . . . . 6.48 110.943 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.647 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -83.29 127.21 7.89 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.633 -0.987 . . . . 1.23 110.633 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -100.63 96.11 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.016 0.436 . . . . 1.17 111.316 -171.536 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.531 HG21 ' CG2' ' A' ' 71' ' ' VAL . 39.5 mt -83.34 124.49 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.122 0.487 . . . . 0.61 110.298 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -104.33 -14.84 15.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.538 -0.755 . . . . 2.0 110.5 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -159.31 118.91 3.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.248 -0.433 . . . . 1.53 111.835 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' A' ' 68' ' ' ILE . 57.7 t -103.1 92.96 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.076 -1.083 . . . . 0.88 108.076 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 5.7 t0 -101.38 64.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.628 -0.26 . . . . 1.42 111.19 -170.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 7.4 pt-20 48.28 -172.38 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.287 1.035 . . . . 0.96 112.03 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 31.3 Cg_exo -62.64 72.17 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.38 111.774 166.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -156.44 -65.79 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.452 -0.795 . . . . 0.5 110.183 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 100' ' ' THR . 4.0 p -145.57 152.48 39.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.35 112.357 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.1 mp -138.18 126.36 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.676 -0.693 . . . . 0.74 109.526 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.77 105.56 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.59 -0.522 . . . . 0.67 109.59 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.76 137.39 57.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.292 -0.413 . . . . 0.75 111.282 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.09 165.41 26.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.5 111.889 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.978 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 39.6 t-105 -62.17 162.88 8.91 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 114.253 1.205 . . . . 2.79 114.253 -163.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.647 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -158.67 -35.57 0.06 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.608 -1.178 . . . . 5.46 110.023 -169.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.904 ' HG ' ' HA3' ' A' ' 132' ' ' GLY . 4.8 tt 78.11 175.27 0.17 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.753 -0.658 . . . . 1.55 110.599 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 133' ' ' MET . 46.7 t-20 -109.12 -76.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.714 0.292 . . . . 1.93 110.416 -173.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.59 0.54 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 120.663 -0.78 . . . . 2.4 111.216 176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -54.48 -6.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.294 0.85 . . . . 5.38 113.294 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.08 -0.89 76.84 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.944 -0.862 . . . . 2.3 110.944 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HD3' ' H ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -97.55 152.78 18.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.148 0.499 . . . . 4.77 110.585 178.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -65.51 124.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.203 -0.908 . . . . 1.86 110.477 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.626 ' OD2' ' HB3' ' A' ' 92' ' ' ASP . 4.1 p-10 -101.75 142.81 25.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 121.42 0.628 . . . . 3.18 111.45 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.69 ' HD2' ' HD1' ' A' ' 81' ' ' TRP . 59.8 Cg_endo -97.69 37.46 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.915 3.077 . . . . 2.36 111.868 167.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.626 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -65.78 89.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.155 0.979 . . . . 2.99 111.066 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' H ' ' H ' ' A' ' 94' ' ' SER . 18.9 p-10 -167.88 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.437 -1.256 . . . . 3.06 108.368 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.77 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 74.6 m -160.96 -143.69 0.1 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.976 -1.465 . . . . 1.85 108.674 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.978 ' HB2' ' HB2' ' A' ' 81' ' ' TRP . 37.9 m 54.63 38.0 29.14 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.477 0.656 . . . . 1.44 111.442 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.636 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 20.2 tt0 -71.77 149.78 45.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.895 -1.048 . . . . 1.81 110.69 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.606 ' HB2' HG13 ' A' ' 113' ' ' VAL . 9.0 p90 -146.37 147.43 31.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.96 0.409 . . . . 0.64 110.866 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 30.5 m -104.36 115.82 31.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.43 110.374 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.661 ' HA ' HG22 ' A' ' 113' ' ' VAL . 97.4 t -82.42 109.73 16.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.87 109.804 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.532 ' HA ' HG22 ' A' ' 76' ' ' THR . 9.5 m -104.12 105.97 16.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.935 0.397 . . . . 0.45 111.224 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.502 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 52.1 m-85 -89.9 110.91 21.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.357 -0.383 . . . . 0.34 110.138 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.8 t -91.61 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 110.123 -0.325 . . . . 0.54 110.123 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.25 138.07 53.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.393 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -130.12 103.0 6.49 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 2.03 110.75 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.34 -97.89 0.63 Allowed Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.946 -0.645 . . . . 1.97 113.223 171.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -146.68 -20.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.095 0.406 . . . . 4.93 112.095 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -136.26 3.64 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.97 -0.692 . . . . 3.53 112.671 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 26.4 ttpp -127.31 153.96 45.52 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.448 -0.901 . . . . 2.44 110.911 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.7 m -160.9 124.31 3.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.826 -0.624 . . . . 0.42 109.95 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -109.54 120.25 41.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.79 . . . . 2.59 108.866 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 10' ' ' VAL . 10.0 p -96.55 141.12 16.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.802 -0.359 . . . . 0.4 110.791 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -129.5 124.23 33.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.08 -0.711 . . . . 1.38 109.08 171.23 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 4.1 t -99.05 121.51 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-N 115.725 -0.671 . . . . 0.91 110.086 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.19 121.34 41.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.893 -0.78 . . . . 2.31 108.893 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.734 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 t-80 -103.03 152.77 20.96 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.285 -0.87 . . . . 1.64 110.114 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.686 HG21 ' HD2' ' A' ' 118' ' ' PHE . 9.0 t -60.13 177.86 0.23 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.12 -0.945 . . . . 2.67 110.944 170.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -108.35 18.94 20.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.854 -0.612 . . . . 2.63 110.438 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.77 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 20.7 m-85 -59.33 -29.07 67.37 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.499 -0.319 . . . . 3.54 111.434 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.6 -49.79 15.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.554 0.692 . . . . 1.81 109.699 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' C ' ' H ' ' A' ' 122' ' ' GLY . 55.2 ttt180 -58.54 -18.08 26.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.582 -1.19 . . . . 3.38 111.14 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 121' ' ' MET . 24.2 ttt -65.83 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.003 0.921 . . . . 2.43 112.466 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 152.93 151.03 5.57 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.177 -1.011 . . . . 1.61 112.085 172.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.9 m -60.39 -36.2 77.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.28 0.562 . . . . 2.58 109.657 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -71.58 -39.34 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.436 -0.802 . . . . 3.8 110.467 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 5.3 m170 -63.8 -46.23 86.12 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 121.26 0.552 . . . . 2.14 110.631 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -66.87 -31.51 72.17 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.92 111.262 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.42 -39.38 81.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 2.83 110.639 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.625 ' HB2' HD12 ' A' ' 89' ' ' ILE . 16.8 ptm180 -76.25 -24.95 54.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 2.59 111.737 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.645 HG22 ' HG3' ' A' ' 91' ' ' PRO . 61.5 t -83.52 -54.79 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.304 0.853 . . . . 1.48 113.304 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 35.5 ttt180 -62.66 -23.86 67.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.519 0.563 . . . . 3.83 112.519 -167.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.437 ' CG ' ' HD2' ' A' ' 88' ' ' ARG . 16.7 p30 -55.41 -22.32 19.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.353 -0.385 . . . . 2.48 111.817 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.904 ' HA3' ' HG ' ' A' ' 83' ' ' LEU . . . -100.3 -96.75 2.19 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.456 -0.878 . . . . 1.61 114.038 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.589 ' HB3' ' CH2' ' A' ' 81' ' ' TRP . 54.2 ttm -79.29 -27.44 42.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.844 0.683 . . . . 4.83 112.844 -164.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 20.9 t70 -65.11 -21.93 66.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.948 0.404 . . . . 2.83 111.482 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -79.46 -15.92 56.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.111 0.411 . . . . 4.15 112.111 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.623 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -117.07 -17.25 5.88 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.351 -0.7 . . . . 1.04 111.351 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.562 ' O ' HD13 ' A' ' 141' ' ' LEU . 38.0 t-105 -55.4 -54.49 50.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 123.061 0.544 . . . . 2.78 111.453 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.601 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 18.7 Cg_endo -60.22 -34.62 93.86 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.837 1.691 . . . . 0.68 111.623 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.1 m -66.29 -49.96 65.3 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 121.733 0.777 . . . . 0.87 110.447 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 136' ' ' GLY . 59.1 mt -55.44 -54.58 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.018 -0.992 . . . . 0.72 110.053 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 137' ' ' TRP . 7.0 mp -56.34 -26.86 53.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.25 0.833 . . . . 0.69 113.25 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 28.4 mm-40 -69.14 -54.33 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.484 -0.561 . . . . 1.49 109.484 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . 37.3 t -70.16 -23.81 63.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 1.15 110.745 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 64.6 t80 -58.35 -53.15 61.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.479 -0.782 . . . . 0.8 109.489 174.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.93 -22.11 61.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.508 -0.769 . . . . 1.63 110.508 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.12 -52.09 10.85 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.94 -0.573 . . . . 1.46 111.698 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.841 ' HG3' ' HE3' ' A' ' 30' ' ' TRP . 2.4 tmtt? -66.94 -39.78 87.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.508 -0.477 . . . . 1.74 109.962 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.778 HG21 HG13 ' A' ' 12' ' ' VAL . 22.6 mt -57.92 -35.27 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.303 0.573 . . . . 0.5 110.545 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.423 ' OD2' ' HE2' ' A' ' 154' ' ' LYS . 24.1 t0 -61.26 -35.49 77.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.638 -0.71 . . . . 0.85 110.002 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 63.6 mt-10 -68.32 -26.75 65.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.39 0.614 . . . . 1.5 110.809 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 11.1 mm-40 -88.89 5.69 42.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.713 -0.676 . . . . 1.74 110.325 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.29 -78.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.171 -1.014 . . . . 1.32 114.02 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.47 -45.69 10.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.114 0.483 . . . . 1.92 111.652 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 31.5 ttpt -87.74 114.28 24.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.94 -0.573 . . . . 2.04 109.991 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.883 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.791 -0.623 . . . . 4.22 109.719 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.697 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 19.7 p30 . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.801 -0.074 . . . . 1.66 110.801 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.484 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -171.77 -51.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.334 0.494 . . . . 3.73 112.334 176.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.535 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.7 t70 -66.71 -61.85 4.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 112.042 0.386 . . . . 2.78 112.042 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.04 -58.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.115 1.21 . . . . 1.63 112.098 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.697 ' O ' ' HB2' ' A' ' 1' ' ' ASN . 47.0 p90 -154.8 143.63 20.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.566 . . . . 3.21 110.195 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.809 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 95.2 t -103.88 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.138 -1.06 . . . . 1.44 108.138 164.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 58.8 ttp180 -101.04 134.86 43.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.427 0.632 . . . . 3.37 111.939 -170.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.789 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -109.9 131.82 54.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.426 -0.953 . . . . 0.79 108.426 167.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 50.0 m -135.52 110.35 8.73 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.584 -0.735 . . . . 1.28 110.35 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.3 t -121.46 135.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.824 -1.08 . . . . 1.27 111.032 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -100.95 115.71 31.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.38 0.61 . . . . 0.57 109.546 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 148' ' ' ILE . 42.2 t -93.4 127.58 45.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.91 111.264 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.953 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -86.91 12.82 10.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.168 -0.924 . . . . 0.98 113.131 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.564 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.77 41.46 0.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.011 -0.675 . . . . 0.36 112.474 -173.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 11.3 t70 73.32 161.89 0.25 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.252 1.025 . . . . 0.91 113.69 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.108 ' HE ' ' HB2' ' A' ' 103' ' ' ALA . 8.0 ttp85 -63.45 -28.11 69.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.28 -1.327 . . . . 1.88 112.422 -172.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 34.1 mttp -66.85 -40.91 88.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.95 -0.3 . . . . 3.05 110.838 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -73.12 -34.86 66.38 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.866 -0.333 . . . . 1.11 110.329 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.2 -51.56 67.61 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.131 -0.486 . . . . 0.32 110.325 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 70.7 t80 -69.92 -40.54 75.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.38 110.887 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -55.8 -47.09 77.75 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.228 -0.442 . . . . 2.39 109.854 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.512 ' N ' ' HG3' ' A' ' 21' ' ' LYS . 16.5 m -77.33 -45.4 26.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.411 -0.358 . . . . 0.68 111.01 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 67.4 t80 -65.08 -28.96 69.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.774 0.287 . . . . 0.48 111.774 -174.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.767 HD23 ' HE3' ' A' ' 48' ' ' LYS . 16.5 tp -115.46 -56.09 2.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.253 -0.579 . . . . 0.5 112.087 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 51.7 mt-10 -91.41 -3.43 56.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.423 . . . . 1.24 111.634 -172.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.669 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -114.91 25.34 10.15 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.693 -0.963 . . . . 0.83 110.693 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.4 t80 -52.41 -49.37 85.84 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.308 0.484 . . . . 0.74 112.308 -174.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 69.5 Cg_endo -81.37 4.3 7.11 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.154 1.903 . . . . 0.76 115.142 -176.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -103.14 -1.94 28.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.914 -0.714 . . . . 1.49 111.675 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.804 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.5 m0 -72.29 154.18 41.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.546 0.689 . . . . 4.62 111.067 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.593 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 47.5 m95 -83.47 -38.36 0.72 Allowed Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 114.968 -1.015 . . . . 2.78 113.071 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 20.0 Cg_endo -59.41 -79.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 122.31 2.007 . . . . 1.36 114.414 -165.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' HD11 ' A' ' 140' ' ' ILE . 8.3 t-20 -106.85 -16.16 14.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.278 0.561 . . . . 1.51 109.864 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.696 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.8 m-20 -97.8 20.66 11.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.709 . . . . 1.79 111.612 -168.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -79.77 -29.8 40.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.449 . . . . 4.45 111.492 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 36' ' ' ARG . 33.3 mmt180 -90.92 142.97 27.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.538 0.57 . . . . 4.14 112.538 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 39' ' ' LYS . 26.9 p -77.01 151.93 35.4 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 2.68 111.02 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 57' ' ' ASP . 7.0 p 54.48 6.81 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.396 1.078 . . . . 1.42 112.462 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 37' ' ' THR . 72.5 tttt -94.73 -135.45 0.2 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.207 -2.146 . . . . 2.9 105.207 161.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 34' ' ' ASN . 17.1 m -93.0 20.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.423 0.63 . . . . 1.83 110.71 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -132.54 39.86 1.69 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.68 -0.691 . . . . 2.17 112.431 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.051 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -88.78 160.43 44.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.639 -0.874 . . . . 1.12 108.639 171.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.6 -17.6 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 124.134 3.223 . . . . 1.48 116.14 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 45' ' ' GLY . 48.1 tp -97.42 -97.38 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.874 -0.516 . . . . 1.75 111.184 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.682 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 109.14 -55.97 0.48 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.67 -0.776 . . . . 0.75 112.722 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.615 HG11 HD11 ' A' ' 24' ' ' LEU . 94.2 t -139.9 139.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.078 0.466 . . . . 0.6 111.582 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.703 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 19.4 t70 -105.68 102.71 12.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.422 -0.808 . . . . 1.11 109.431 174.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.767 ' HE3' HD23 ' A' ' 24' ' ' LEU . 25.3 mtpt -80.52 -12.17 59.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 2.81 111.82 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.46 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.6 ptpp? -83.86 -43.7 15.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.946 -0.302 . . . . 3.17 111.214 -174.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.9 -32.9 5.71 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.909 -0.662 . . . . 1.53 111.793 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 102.67 58.4 0.76 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.563 -0.827 . . . . 0.77 112.771 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -144.72 149.54 35.77 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.723 -0.281 . . . . 3.72 110.532 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -100.33 115.27 29.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.258 -0.645 . . . . 1.28 109.258 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.703 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 6.8 p90 -160.97 149.1 15.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.469 . . . . 1.66 110.118 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.051 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.3 mp0 -113.06 169.13 9.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.48 -0.563 . . . . 2.12 109.48 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.457 HD12 ' HG2' ' A' ' 61' ' ' GLU . 32.8 mm -77.55 103.3 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.621 -0.511 . . . . 0.92 109.621 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.579 ' HA ' HG22 ' A' ' 38' ' ' THR . 8.1 t70 -101.75 159.52 15.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 1.97 110.267 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.019 1.118 . . . . 2.43 114.019 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.31 8.16 22.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.102 -0.639 . . . . 2.39 111.441 -175.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.4 62.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.245 -0.978 . . . . 2.29 113.693 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.457 ' HG2' HD12 ' A' ' 56' ' ' ILE . 41.1 mt-10 52.24 35.2 16.28 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.816 0.672 . . . . 2.31 112.816 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -108.11 85.43 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.469 0.652 . . . . 2.61 110.745 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.533 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -121.84 158.63 28.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 3.72 110.05 175.389 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 3.2 t -134.58 115.41 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.334 -0.393 . . . . 2.27 110.405 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.807 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 37.6 t80 -131.4 -46.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 6.48 111.329 174.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.543 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -157.29 156.6 27.39 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.38 -1.391 . . . . 1.23 113.949 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.466 HD22 ' HD2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -116.89 110.42 18.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.397 -0.594 . . . . 1.17 109.397 177.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.543 HG21 ' CG2' ' A' ' 71' ' ' VAL . 35.5 mt -80.83 136.29 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 0.61 111.228 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -101.94 -34.17 9.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.264 -0.88 . . . . 2.0 109.212 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -149.7 129.27 13.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.687 -0.688 . . . . 1.53 110.97 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 68' ' ' ILE . 44.1 t -112.87 93.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.75 -0.833 . . . . 0.88 108.75 172.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.78 70.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.544 -0.298 . . . . 1.42 111.7 -172.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.643 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 47.27 -173.34 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 124.539 1.15 . . . . 0.96 112.505 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.4 Cg_exo -61.48 82.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.406 1.404 . . . . 0.38 111.195 166.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.488 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 28.2 t70 -168.29 -68.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.606 . . . . 0.5 110.572 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.8 p -144.55 144.86 31.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.22 0.533 . . . . 0.35 112.154 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -135.14 117.33 15.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.672 -0.694 . . . . 0.74 109.29 177.312 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 t -93.47 105.66 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.42 -0.956 . . . . 0.67 108.42 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.543 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -128.58 130.58 69.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.999 -0.546 . . . . 0.75 111.3 -169.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.791 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.44 153.11 20.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.301 -0.476 . . . . 0.5 112.082 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.685 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 65.0 t-105 -85.82 132.81 34.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 2.79 111.532 -172.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.583 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 6.8 ttt180 -137.56 28.68 2.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.687 -0.688 . . . . 5.46 109.644 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.807 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 19.0 tp 77.52 167.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.87 -1.059 . . . . 1.55 112.147 172.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.644 ' HB2' ' HE3' ' A' ' 133' ' ' MET . 1.5 m-20 -82.67 5.29 21.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.711 -0.477 . . . . 1.93 109.711 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.98 38.5 92.94 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.691 -0.686 . . . . 2.4 113.049 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -137.95 91.56 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.946 0.403 . . . . 5.38 112.018 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.6 2.35 21.25 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.628 -0.714 . . . . 2.3 114.755 168.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.627 ' HB2' HD11 ' A' ' 83' ' ' LEU . 1.5 mmp_? -112.76 -176.27 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 117.239 0.519 . . . . 4.77 110.266 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.402 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -101.78 136.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.111 -0.495 . . . . 1.86 110.121 177.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 7.5 p-10 -97.88 140.09 21.71 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.916 0.389 . . . . 3.18 110.403 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 36.9 Cg_exo -61.4 -46.02 16.32 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.833 2.355 . . . . 2.36 111.856 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 73.05 -40.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.045 0.841 . . . . 2.99 112.638 173.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.12 -36.37 58.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.839 0.681 . . . . 3.06 112.839 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.5 p -165.79 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.743 -0.383 . . . . 1.85 111.773 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.685 ' CB ' ' HB3' ' A' ' 81' ' ' TRP . 44.3 m 55.37 30.24 14.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.419 0.628 . . . . 1.44 110.671 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.791 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.8 tt0 -62.71 124.32 20.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.855 -1.066 . . . . 1.81 111.275 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.587 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 8.5 p90 -125.9 136.12 52.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.164 0.507 . . . . 0.64 110.738 174.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 31.9 m -89.43 115.49 26.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.578 -0.737 . . . . 0.43 110.266 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 113' ' ' VAL . 99.2 t -91.0 108.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.283 -0.636 . . . . 0.87 109.283 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.758 ' HA ' HG22 ' A' ' 76' ' ' THR . 15.6 m -106.77 104.96 14.77 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.105 -0.498 . . . . 0.45 110.909 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.641 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.7 m-85 -82.64 102.6 11.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.34 -0.615 . . . . 0.34 109.34 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -91.54 108.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.319 -0.623 . . . . 0.54 109.319 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.108 ' HB2' ' HE ' ' A' ' 16' ' ' ARG . . . -57.4 124.45 18.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.44 109.967 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.766 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 12.7 t70 -109.15 103.3 12.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.969 -0.752 . . . . 2.03 108.969 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.2 -106.53 1.91 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.854 -0.898 . . . . 1.97 110.854 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -153.64 -9.25 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.337 . . . . 4.93 110.969 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -119.99 -0.16 10.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 3.53 110.722 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 11.6 mptt -127.39 159.98 32.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.969 -0.752 . . . . 2.44 108.969 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.437 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 53.4 m -156.26 114.79 3.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.863 0.363 . . . . 0.42 110.211 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -100.66 111.32 23.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.94 -0.763 . . . . 2.59 108.94 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.641 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 10.9 p -85.9 138.04 19.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 0.4 110.319 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -127.41 116.13 19.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.845 . . . . 1.38 109.223 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 99' ' ' VAL . 4.1 t -108.37 130.84 60.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.983 -1.008 . . . . 0.91 111.189 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.58 111.34 22.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.303 0.573 . . . . 2.31 110.141 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.809 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 82.0 t60 -113.43 97.23 6.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.148 -0.933 . . . . 1.64 108.864 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.564 ' OG1' ' HA ' ' A' ' 5' ' ' PHE . 34.8 m -145.55 94.71 2.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.967 0.413 . . . . 2.67 111.344 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.632 ' O ' ' HG2' ' A' ' 121' ' ' MET . 15.6 t60 -167.16 -73.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.097 -0.501 . . . . 2.63 110.212 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.427 ' CZ ' ' HD3' ' A' ' 128' ' ' ARG . 29.4 t80 -64.96 -47.53 77.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.53 -0.759 . . . . 3.54 112.137 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -37.25 67.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.543 0.687 . . . . 1.81 110.35 -174.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -55.91 -20.88 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.754 -1.112 . . . . 3.38 111.945 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.632 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.9 mmt -81.18 19.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.06 0.393 . . . . 2.43 112.06 -171.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.68 163.31 11.24 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.015 -1.088 . . . . 1.61 113.007 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.7 p -65.23 -22.51 66.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.593 -0.303 . . . . 2.58 111.432 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -67.68 -52.69 35.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.681 0.277 . . . . 3.8 110.745 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.761 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 33.4 m170 -60.98 -48.84 79.94 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.602 0.715 . . . . 2.14 110.5 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.81 68.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.213 -0.903 . . . . 0.92 111.037 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 130' ' ' ARG . 35.1 ttpt -75.84 -41.86 51.27 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.798 0.296 . . . . 2.83 111.798 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.761 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.9 ptm180 -64.03 -30.58 71.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.915 -0.314 . . . . 2.59 110.68 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.71 -32.13 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 120.423 -0.511 . . . . 1.48 110.593 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.555 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 21.9 tpp85 -61.77 -15.17 38.99 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.489 0.716 . . . . 3.83 111.376 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 53.0 m-20 -52.04 -21.67 3.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.643 0.979 . . . . 2.48 113.643 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.07 -39.16 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 119.252 -1.452 . . . . 1.61 114.053 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.644 ' HE3' ' HB2' ' A' ' 84' ' ' ASN . 12.9 mmt -74.24 -9.29 58.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 4.83 111.285 -171.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 16.3 t70 -62.22 -22.75 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.635 -0.712 . . . . 2.83 111.461 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.65 -30.7 12.32 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.886 -0.326 . . . . 4.15 110.857 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.565 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -69.65 -50.21 32.22 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.092 -0.575 . . . . 1.04 112.491 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.6 t-105 -54.85 -52.19 72.74 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.186 0.439 . . . . 2.78 112.186 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -60.25 -36.95 86.03 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.646 1.564 . . . . 0.68 112.069 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.3 m -68.4 -35.52 77.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.514 0.673 . . . . 0.87 109.623 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.652 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 16.5 mt -58.54 -44.63 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.876 -1.057 . . . . 0.72 110.578 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 8' ' ' HIS . 70.9 mt -63.74 -33.23 75.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.187 0.44 . . . . 0.69 112.187 -175.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.53 -54.76 12.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.961 0.41 . . . . 1.49 110.314 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.63 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 48.9 m -65.87 -22.02 66.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 1.15 111.144 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 23' ' ' PHE . 54.5 t80 -65.95 -53.45 38.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.308 0.575 . . . . 0.8 109.559 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.815 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 45.1 mt-30 -61.64 -29.82 70.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.277 -0.874 . . . . 1.63 110.25 176.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 143' ' ' SER . 31.9 t70 -73.95 -43.75 57.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.853 -1.067 . . . . 1.46 110.529 -175.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.462 ' HD3' ' NE1' ' A' ' 31' ' ' TRP . 28.1 tptp -65.79 -43.19 89.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.713 0.292 . . . . 1.74 110.584 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.814 HG21 HG13 ' A' ' 12' ' ' VAL . 57.5 mt -62.37 -40.14 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.5 111.368 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.953 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 28.5 t70 -65.53 -27.33 68.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.318 -0.401 . . . . 0.85 110.872 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 50.7 mt-10 -64.5 -39.06 93.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.511 0.672 . . . . 1.5 109.537 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 10.7 mm-40 -74.73 -29.26 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.373 -1.285 . . . . 1.74 108.906 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -74.26 -74.94 0.81 Allowed Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 114.817 -1.083 . . . . 1.32 112.345 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -164.35 23.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.76 0.652 . . . . 1.92 112.76 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 32.0 ttmt -69.9 -75.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.369 -0.532 . . . . 2.04 110.601 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.812 -1.089 . . . . 4.22 110.409 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 7' ' ' ARG . 25.3 p-10 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.883 0.373 . . . . 1.66 110.457 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.617 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 32.1 p90 179.66 -32.84 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 3.73 109.713 -174.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.711 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.0 t70 -73.16 -55.0 4.02 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 111.959 0.355 . . . . 2.78 111.959 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.5 Cg_endo -93.69 -62.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.172 1.914 . . . . 1.63 112.998 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.433 ' CD2' HG21 ' A' ' 116' ' ' THR . 96.2 m-85 -144.31 118.88 9.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 3.21 110.421 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.039 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 97.3 t -85.05 125.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.9 -0.778 . . . . 1.44 108.9 167.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 36.6 ttp85 -132.38 136.72 47.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.026 -0.534 . . . . 3.37 109.787 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 1.112 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 3.2 t-160 -108.38 132.31 53.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.491 -0.929 . . . . 0.79 108.491 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 13.4 m -136.17 118.91 16.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.251 0.548 . . . . 1.28 110.716 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 111' ' ' VAL . 2.7 t -137.31 134.19 46.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.158 -0.928 . . . . 1.27 111.086 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -101.8 114.98 29.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.435 0.636 . . . . 0.57 109.808 173.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.819 HG13 HG21 ' A' ' 148' ' ' ILE . 38.5 t -95.57 136.27 27.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.296 -0.866 . . . . 0.91 109.726 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 36.05 2.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.726 0.269 . . . . 0.98 111.726 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.84 31.63 0.36 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.93 0.345 . . . . 0.36 111.93 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.8 t70 75.22 164.06 0.27 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.861 0.838 . . . . 0.91 112.732 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 14.6 ttp180 -66.47 -25.72 66.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.686 -1.143 . . . . 1.88 111.544 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.055 -0.258 . . . . 3.05 110.828 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -68.33 -35.14 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.995 -0.282 . . . . 1.11 110.362 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.28 -48.98 75.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.32 110.613 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.507 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 84.7 t80 -72.57 -50.6 24.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.38 111.207 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -52.35 -49.7 63.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.03 -0.532 . . . . 2.39 111.158 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 m -67.56 -51.09 54.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.982 -0.554 . . . . 0.68 110.792 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 73.6 t80 -58.93 -40.48 84.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.349 0.5 . . . . 0.48 112.349 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -104.46 -50.39 3.33 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.271 -0.572 . . . . 0.5 112.31 -172.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.809 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 53.9 mt-10 -86.24 -6.94 58.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.76 0.314 . . . . 1.24 111.631 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.642 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -117.15 30.1 6.45 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.374 -0.917 . . . . 0.83 112.525 -176.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -49.31 -53.84 35.73 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.006 0.373 . . . . 0.74 112.006 -172.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 24.9 Cg_endo -90.57 21.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.921 1.747 . . . . 0.76 114.644 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.6 pt-20 -113.64 -15.88 12.43 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.562 -0.855 . . . . 1.49 113.045 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -79.61 -176.64 5.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.944 -0.702 . . . . 4.62 109.617 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.511 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 10.2 p-90 -115.32 16.9 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 115.36 1.615 . . . . 2.78 115.36 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 30' ' ' TRP . 57.8 Cg_endo -85.03 -134.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 121.984 1.744 . . . . 1.36 113.136 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.487 ' ND2' HD21 ' A' ' 84' ' ' ASN . 9.7 t30 -67.18 -25.7 66.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 1.51 111.047 -175.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.659 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -85.94 18.72 2.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.469 -0.787 . . . . 1.79 110.997 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -82.69 -4.13 57.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.5 0.667 . . . . 4.45 109.421 174.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -106.62 164.24 12.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.735 . . . . 4.14 110.199 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 42' ' ' ALA . 1.1 p -98.28 147.29 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.538 -0.301 . . . . 2.68 111.272 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.7 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 19.8 p 54.44 25.0 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.799 0.839 . . . . 1.42 111.941 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' O ' HG13 ' A' ' 40' ' ' VAL . 20.4 mtmt -111.21 -50.54 2.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.708 -1.133 . . . . 2.9 109.146 165.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -177.5 28.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 124.424 1.078 . . . . 1.83 110.256 175.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.06 29.96 0.59 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.843 -1.17 . . . . 2.17 114.253 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.845 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.64 170.46 16.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 117.282 0.541 . . . . 1.12 109.617 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.686 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 28.0 Cg_endo -63.26 72.28 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.475 2.116 . . . . 1.48 112.753 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 tp -169.19 -90.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.474 -0.785 . . . . 1.75 109.687 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.38 -88.9 0.53 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.334 -0.936 . . . . 0.75 112.46 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 53' ' ' TRP . 57.5 t -139.91 139.89 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.738 0.304 . . . . 0.6 111.114 -172.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.53 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.742 -0.836 . . . . 1.11 108.742 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.809 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 40.3 mtpt -78.93 -18.76 53.27 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.956 0.725 . . . . 2.81 112.956 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -89.2 -45.2 9.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.839 -0.344 . . . . 3.17 110.962 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.39 -38.4 21.57 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.273 -0.731 . . . . 1.53 111.273 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.92 58.31 1.04 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.915 -0.66 . . . . 0.77 112.205 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -159.29 141.07 13.34 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.752 -0.379 . . . . 3.72 110.404 177.058 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.956 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -100.97 135.48 42.36 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.597 -0.441 . . . . 1.28 110.654 177.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 0.8 OUTLIER -163.02 -179.36 6.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.673 0.608 . . . . 1.66 110.528 179.192 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 39.9 mt-10 -132.35 177.64 7.43 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 116.639 -0.255 . . . . 2.12 111.136 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 mm -102.41 102.83 14.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.414 -0.587 . . . . 0.92 109.414 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.7 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-20 -70.27 135.48 48.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.873 0.694 . . . . 1.97 112.873 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.27 -26.57 67.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.854 -1.067 . . . . 2.43 111.151 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.636 HE21 ' HB3' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -82.8 -7.23 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 2.39 111.447 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.92 72.24 0.63 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.554 -0.832 . . . . 2.29 112.598 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 37.6 77.22 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.408 1.262 . . . . 2.31 114.408 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.487 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 18.7 mm-40 -129.18 73.16 1.5 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.61 109.929 170.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 1.3 p80 -110.54 157.81 19.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.766 -1.106 . . . . 3.72 111.502 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.794 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 37.6 p -83.66 151.96 25.02 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.726 -0.842 . . . . 2.27 108.726 169.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.5 p90 -108.78 111.72 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.228 -0.589 . . . . 6.48 110.51 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.718 ' HA3' ' CE2' ' A' ' 53' ' ' TRP . . . -63.36 129.64 40.3 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.047 -0.821 . . . . 1.23 111.047 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 82' ' ' ARG . 4.4 mp -78.74 87.57 4.63 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.824 -0.35 . . . . 1.17 110.918 -170.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 71' ' ' VAL . 13.7 mt -92.1 115.35 30.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.001 -1.08 . . . . 0.61 109.321 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -104.82 -12.58 16.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.596 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 19.5 ttmm -151.82 107.38 3.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 1.53 111.332 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 68' ' ' ILE . 2.5 m -103.14 85.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.88 108.568 167.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.19 72.82 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 1.42 111.08 -172.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.594 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 46.96 -171.88 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 124.684 1.24 . . . . 0.96 112.288 175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.3 Cg_exo -64.04 76.05 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.518 1.479 . . . . 0.38 111.411 166.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -159.61 -65.63 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.649 -0.705 . . . . 0.5 110.673 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.8 p -144.96 143.08 30.34 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.427 0.529 . . . . 0.35 112.427 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.65 120.15 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.74 109.668 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 59.0 t -105.73 103.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.474 -0.565 . . . . 0.67 109.474 175.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.766 HG13 ' HE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -129.39 135.07 62.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.973 -0.558 . . . . 0.75 111.701 -174.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.793 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.16 147.67 18.69 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.065 -0.814 . . . . 0.5 111.065 174.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.685 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . 52.8 t-105 -78.96 135.65 37.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.237 0.541 . . . . 2.79 111.964 -168.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.794 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.9 tpt180 -130.76 25.93 5.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.423 -0.808 . . . . 5.46 109.641 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.824 HD11 ' HB2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER 81.25 134.78 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.845 -1.07 . . . . 1.55 112.233 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.536 ' HB3' ' SD ' ' A' ' 133' ' ' MET . 5.1 t30 -108.53 109.67 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.023 -0.99 . . . . 1.93 109.786 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.07 -24.52 8.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.583 -0.818 . . . . 2.4 111.327 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.437 ' H ' HD12 ' A' ' 83' ' ' LEU . 3.3 m-30 74.74 -25.71 0.2 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.589 0.756 . . . . 5.38 112.706 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.61 19.11 38.57 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.828 -0.701 . . . . 2.3 113.247 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.824 ' HB2' HD11 ' A' ' 83' ' ' LEU . 41.9 mmt180 -124.88 173.66 8.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.622 -0.51 . . . . 4.77 109.622 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -74.55 132.12 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.786 0.327 . . . . 1.86 110.73 178.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 10.3 p-10 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 3.18 110.495 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.685 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 52.7 Cg_exo -58.25 -37.63 94.47 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.267 2.644 . . . . 2.36 112.597 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER 78.35 -39.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.87 0.731 . . . . 2.99 112.39 169.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -120.06 -30.3 4.71 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.034 0.383 . . . . 3.06 112.034 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.45 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 48.9 m -138.95 -140.89 0.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.926 -0.31 . . . . 1.85 111.832 -175.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 67.7 m 65.75 24.02 11.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.496 -0.775 . . . . 1.44 109.427 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.793 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.7 tt0 -67.28 136.48 54.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.812 -1.085 . . . . 1.81 110.442 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.636 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 13.9 p90 -137.62 138.03 39.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.273 0.559 . . . . 0.64 110.84 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.575 HG23 HG22 ' A' ' 78' ' ' VAL . 34.1 m -100.26 109.76 21.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.244 -0.889 . . . . 0.43 109.663 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.442 HG12 HG22 ' A' ' 113' ' ' VAL . 1.6 m -87.64 121.6 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 119.591 -0.844 . . . . 0.87 109.122 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.512 ' HA ' HG22 ' A' ' 76' ' ' THR . 27.2 m -102.64 106.84 17.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.345 -0.843 . . . . 0.45 110.339 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.498 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.9 m-85 -82.37 109.82 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.655 -0.498 . . . . 0.34 109.655 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.16 112.52 27.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.572 -0.529 . . . . 0.54 109.572 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 124.38 23.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.44 110.568 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.3 t0 -105.69 103.4 12.9 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.425 -0.954 . . . . 2.03 108.425 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.27 -111.11 3.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.537 -0.84 . . . . 1.97 111.562 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -147.95 -3.93 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.638 0.256 . . . . 4.93 111.255 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -136.51 8.23 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.288 . . . . 3.53 111.342 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.797 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 36.1 ttmt -126.78 158.15 37.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.999 -0.741 . . . . 2.44 108.999 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.6 m -156.01 130.65 9.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.008 0.433 . . . . 0.42 111.096 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -109.37 112.91 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.82 -0.627 . . . . 2.59 109.741 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 10' ' ' VAL . 8.7 p -90.95 141.77 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.865 -0.334 . . . . 0.4 110.63 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.7 t70 -135.01 105.72 6.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.354 -0.839 . . . . 1.38 109.857 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.112 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 9.5 t -86.3 131.57 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.91 111.941 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.82 124.03 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.842 0.714 . . . . 2.31 109.504 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 1.039 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 7.7 t-160 -142.23 102.72 4.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.526 -0.546 . . . . 1.64 109.526 -175.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.433 HG21 ' CD2' ' A' ' 5' ' ' PHE . 8.6 p -149.84 40.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.345 0.498 . . . . 2.67 112.345 -174.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.548 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.1 t-160 -113.37 -65.05 1.22 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.999 -0.68 . . . . 2.63 111.405 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.524 ' HB2' ' H ' ' A' ' 95' ' ' SER . 11.6 t80 -86.18 -49.67 7.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.896 0.379 . . . . 3.54 110.444 -175.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.84 -51.71 68.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.478 -0.783 . . . . 1.81 111.025 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.561 ' O ' ' HD2' ' A' ' 120' ' ' ARG . 5.8 tmm_? -60.89 -19.43 60.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.779 -1.1 . . . . 3.38 111.125 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.548 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 42.3 tpp -80.97 23.07 0.58 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.864 0.364 . . . . 2.43 111.879 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.2 170.42 12.86 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.752 -1.214 . . . . 1.61 114.333 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 t -66.8 -44.48 81.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.894 -0.653 . . . . 2.58 111.676 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 124' ' ' LYS . 16.4 tptm -66.13 -39.09 89.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.574 0.226 . . . . 3.8 110.726 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.669 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 10.1 m-70 -61.03 -52.85 63.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 2.14 110.486 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -64.73 -35.95 82.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.92 111.025 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -64.03 -46.45 84.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 2.83 111.405 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 8.3 ptm180 -64.93 -39.57 93.72 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.439 -0.346 . . . . 2.59 111.305 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 125' ' ' HIS . 2.8 p -81.33 -17.83 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.315 0.579 . . . . 1.48 110.987 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 61.7 ttt180 -68.74 -9.73 52.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.155 -0.341 . . . . 3.83 111.43 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.711 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.3 p30 -47.12 -40.06 14.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.561 0.578 . . . . 2.48 112.561 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -145.52 -11.24 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.072 -1.061 . . . . 1.61 113.381 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 84' ' ' ASN . 22.6 mmt -79.43 -11.68 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.342 -0.505 . . . . 4.83 110.277 -172.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.66 -39.67 92.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.507 -0.769 . . . . 2.83 110.961 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -104.8 14.07 30.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 4.15 110.552 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -77.57 -78.18 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.925 -0.579 . . . . 1.04 111.828 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 13.6 m95 -55.62 -47.92 97.6 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 113.58 0.956 . . . . 2.78 113.58 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.9 Cg_endo -50.93 -43.64 46.25 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.839 1.693 . . . . 0.68 112.213 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.1 m -73.22 -45.72 54.54 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.432 0.634 . . . . 0.87 110.639 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.627 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 56.5 mt -58.38 -44.99 89.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 115.371 -0.831 . . . . 0.72 111.361 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 51.2 mt -59.86 -38.81 83.21 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.278 0.361 . . . . 0.69 111.054 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.1 mm-40 -61.5 -50.93 70.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.544 -0.462 . . . . 1.49 109.854 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 51.0 m -65.58 -28.4 69.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.604 -0.725 . . . . 1.15 110.817 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 60.0 t80 -68.27 -55.3 12.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.8 111.135 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -35.1 73.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.855 0.36 . . . . 1.63 111.076 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.26 -40.96 62.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.916 -0.584 . . . . 1.46 110.673 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.43 ' HE3' ' HG3' ' A' ' 29' ' ' GLU . 29.7 tptp -60.62 -38.52 85.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.361 0.601 . . . . 1.74 109.902 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.819 HG21 HG13 ' A' ' 12' ' ' VAL . 52.2 mt -74.45 -26.82 20.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.497 -0.774 . . . . 0.5 111.082 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.4 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.0 t70 -64.84 -31.22 72.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.477 -0.564 . . . . 0.85 109.477 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.843 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 37.5 mt-10 -66.28 -33.09 74.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 1.5 109.74 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -71.86 -23.46 61.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.081 -0.963 . . . . 1.74 109.646 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -98.89 -88.7 1.95 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.32 112.951 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.8 30.58 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.314 0.487 . . . . 1.92 112.314 -171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.843 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 16.9 tppt? -68.42 -19.63 64.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.491 0.662 . . . . 2.04 110.361 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 11.2 ptpt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.171 -0.922 . . . . 4.22 111.243 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.97 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.7 p-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.934 -0.395 . . . . 1.6599999999999999 109.934 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.548 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 p90 69.87 -40.78 0.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.413 1.485 . . . . 3.73 112.684 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.796 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 18.8 t70 -67.06 -54.58 19.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.216 -0.29 . . . . 2.7799999999999998 110.216 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 32.6 Cg_endo -87.89 -64.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.66 1.573 . . . . 1.6299999999999999 111.323 169.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.32 152.27 31.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.257 -1.016 . . . . 3.21 108.257 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.97 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -109.58 126.2 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.094 0.473 . . . . 1.4399999999999999 109.98 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 20.6 ttp85 -130.99 135.17 47.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 3.3700000000000001 110.453 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.585 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.79 132.42 54.17 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.567 -0.531 . . . . 0.79000000000000004 109.567 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.9 p -135.44 116.27 14.05 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.883 -0.599 . . . . 1.28 110.887 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 111' ' ' VAL . 15.5 m -125.02 156.06 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.845 -0.616 . . . . 1.27 110.869 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.7 m -109.82 116.83 32.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.536 -0.756 . . . . 0.56999999999999995 109.93 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.921 HG13 HG21 ' A' ' 148' ' ' ILE . 37.1 t -93.79 138.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.273 -0.876 . . . . 0.91000000000000003 110.77 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -96.8 7.76 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.97999999999999998 112.256 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.03 47.09 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.533 -0.467 . . . . 0.35999999999999999 112.233 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.5 t70 75.07 163.17 0.26 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.075 0.941 . . . . 0.91000000000000003 112.973 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.571 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 27.9 ttp180 -62.34 -25.62 67.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.387 -1.279 . . . . 1.8799999999999999 110.783 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 17' ' ' LYS . 33.8 ttpt -57.65 -49.47 76.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 3.0499999999999998 110.988 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.4 p -75.43 -31.93 60.51 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.808 -0.357 . . . . 1.1100000000000001 110.935 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.836 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -60.98 -46.75 89.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.755 -0.378 . . . . 0.32000000000000001 110.637 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.423 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 73.4 t80 -67.14 -42.32 84.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.38 110.657 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.917 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 19.8 tptm -56.12 -52.8 63.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.45 . . . . 2.3900000000000001 110.518 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.603 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 18.7 m -72.01 -22.58 61.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.952 -0.567 . . . . 0.68000000000000005 111.553 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -88.99 -36.93 15.56 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.182 -0.324 . . . . 0.47999999999999998 111.558 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -119.82 -48.88 2.35 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.245 0.832 . . . . 0.5 113.245 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.917 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 20.5 mt-10 -75.08 -29.21 60.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.808 0.813 . . . . 1.24 110.354 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.86 99.15 0.7 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 108.244 -1.942 . . . . 0.82999999999999996 108.244 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.632 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.6 t80 -96.17 -56.64 0.2 Allowed Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 115.704 -0.248 . . . . 0.73999999999999999 111.58 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.675 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 40.9 Cg_endo -103.43 39.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.095 2.53 . . . . 0.76000000000000001 114.493 -172.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.81 -2.86 5.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.905 -0.718 . . . . 1.49 112.894 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.778 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 17.0 m95 -90.6 -155.87 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 4.6200000000000001 110.748 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 10.6 m95 -110.91 6.15 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.929 1.455 . . . . 2.7799999999999998 114.929 -172.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.999 ' HB2' HD12 ' A' ' 140' ' ' ILE . 74.4 Cg_endo -88.32 -140.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 122.108 1.788 . . . . 1.3600000000000001 112.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HB3' HD11 ' A' ' 140' ' ' ILE . 62.7 t30 -67.69 -20.42 65.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.848 0.832 . . . . 1.51 110.004 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.865 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.2 m-20 -77.05 19.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.567 -1.197 . . . . 1.79 111.675 -171.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.28 -3.85 19.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.937 0.399 . . . . 4.4500000000000002 110.696 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.87 142.76 27.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.414 . . . . 4.1399999999999997 110.89 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 m -76.83 138.63 39.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 2.6800000000000002 111.298 -172.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.2 p 57.06 8.16 0.5 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.731 1.212 . . . . 1.4199999999999999 113.32 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.857 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 32.4 ttmt -91.48 -73.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.98 -0.748 . . . . 2.8999999999999999 108.98 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.865 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.7 m -147.08 18.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.404 -0.816 . . . . 1.8300000000000001 109.142 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -140.38 51.02 0.74 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.424 -0.807 . . . . 2.1699999999999999 113.3 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.089 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -94.25 172.8 5.25 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.634 -0.876 . . . . 1.1200000000000001 108.634 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 32.7 Cg_endo -65.01 62.44 0.3 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.659 2.24 . . . . 1.48 113.475 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 42.3 tp -170.51 -91.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 1.75 110.268 175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 27' ' ' PHE . . . 94.76 -63.62 1.54 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.811 -0.709 . . . . 0.75 112.791 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 27' ' ' PHE . 77.1 t -137.87 139.23 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.977 -0.379 . . . . 0.59999999999999998 109.977 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.678 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 24.6 t70 -105.43 118.33 36.28 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.054 -0.721 . . . . 1.1100000000000001 109.054 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -80.06 -35.5 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.613 -0.721 . . . . 2.8100000000000001 111.622 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.41 -38.88 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.711 0.263 . . . . 3.1699999999999999 111.711 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -36.29 6.24 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.765 -0.731 . . . . 1.53 112.118 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 93.33 65.65 1.07 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.664 -0.779 . . . . 0.77000000000000002 112.155 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' CD2' ' A' ' 54' ' ' TYR . 11.9 ptt180 -159.34 148.06 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.647 -0.421 . . . . 3.7200000000000002 111.574 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.8 m0 -95.38 108.53 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.28 110.203 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.678 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -158.57 162.48 37.38 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.993 0.425 . . . . 1.6599999999999999 110.305 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.089 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 11.6 mp0 -122.26 165.74 15.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.122 -0.695 . . . . 2.1200000000000001 109.122 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.593 HG23 ' HG2' ' A' ' 61' ' ' GLU . 47.9 mm -77.37 102.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.937 -0.764 . . . . 0.92000000000000004 108.937 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.79 144.1 39.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 1.97 110.679 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.11 -27.73 69.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.138 -0.937 . . . . 2.4300000000000002 111.918 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -74.91 -22.83 58.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 2.3900000000000001 111.285 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.11 50.18 0.03 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.004 -1.093 . . . . 2.29 113.919 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.593 ' HG2' HG23 ' A' ' 56' ' ' ILE . 44.9 mt-10 63.02 16.34 9.2 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.368 0.877 . . . . 2.3100000000000001 113.368 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 10.1 tp10 -105.34 82.39 1.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.638 0.732 . . . . 2.6099999999999999 110.389 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -111.08 148.48 32.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.095 -0.957 . . . . 3.7200000000000002 110.728 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.706 HG23 ' HD3' ' A' ' 82' ' ' ARG . 3.3 t -54.69 140.76 34.63 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.451 -0.944 . . . . 2.27 108.451 167.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.8 p90 -129.89 143.99 51.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.472 0.653 . . . . 6.4800000000000004 112.394 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 128.22 8.44 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.55 -1.02 . . . . 1.23 110.55 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.8 mp -85.87 89.23 7.71 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 111.438 0.162 . . . . 1.1699999999999999 111.438 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.963 HG21 HG13 ' A' ' 71' ' ' VAL . 58.4 mt -80.62 116.16 24.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.014 -0.674 . . . . 0.60999999999999999 110.024 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 67' ' ' LEU . 4.9 mpt_? -98.59 -25.24 14.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.713 -0.477 . . . . 2.0 109.713 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HD3' ' HB2' ' A' ' 72' ' ' ASP . 18.0 ttmm -139.52 121.56 15.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 1.53 111.774 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.963 HG13 HG21 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -111.79 85.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.665 -0.865 . . . . 0.88 108.665 167.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -96.45 70.74 2.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.16 -0.473 . . . . 1.4199999999999999 110.69 -170.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 8.2 pt-20 49.43 -172.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 124.523 1.139 . . . . 0.95999999999999996 111.188 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 35.7 Cg_exo -63.48 77.33 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.294 1.329 . . . . 0.38 111.058 163.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.6 t70 -159.72 -68.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.5 110.549 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.2 p -139.42 143.05 37.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.559 0.577 . . . . 0.34999999999999998 112.559 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.94 117.41 16.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.864 -0.607 . . . . 0.73999999999999999 109.597 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 98' ' ' THR . 41.2 t -104.35 103.18 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.475 . . . . 0.67000000000000004 109.719 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.579 HG12 ' N ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -129.5 142.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.79 -0.641 . . . . 0.75 112.139 -175.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.579 ' N ' HG12 ' A' ' 79' ' ' ILE . . . -86.5 158.06 30.76 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.56 -0.745 . . . . 0.5 111.523 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.422 ' H ' ' HB2' ' A' ' 95' ' ' SER . 70.9 t-105 -78.78 155.09 29.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.954 0.724 . . . . 2.79 112.954 -170.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.706 ' HD3' HG23 ' A' ' 64' ' ' THR . 0.0 OUTLIER -125.43 -78.34 0.6 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.822 -1.081 . . . . 5.46 110.747 -176.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.639 HD21 ' HG2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 172.0 146.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.971 -1.122 . . . . 1.55 107.971 -176.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.632 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 10.1 t30 -117.88 -62.96 1.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.399 0.518 . . . . 1.9299999999999999 112.399 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.69 -10.6 83.15 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.792 -0.718 . . . . 2.3999999999999999 114.466 -169.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.857 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 19.6 t80 64.95 14.58 9.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.73 0.776 . . . . 5.3799999999999999 110.604 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 34.06 2.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.209 -1.156 . . . . 2.2999999999999998 110.209 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HG2' HD21 ' A' ' 83' ' ' LEU . 2.6 ttp180 -137.41 162.21 34.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.889 -0.655 . . . . 4.7699999999999996 110.878 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.575 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -109.06 127.09 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.509 -0.552 . . . . 1.8600000000000001 109.509 175.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.628 ' HB2' HD23 ' A' ' 83' ' ' LEU . 6.1 m-20 -144.07 149.96 47.39 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.778 -0.647 . . . . 3.1800000000000002 109.657 171.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 16.0 Cg_exo -69.29 -12.95 34.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.192 2.595 . . . . 2.3599999999999999 114.322 -171.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 60.88 33.58 19.88 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.459 0.647 . . . . 2.9900000000000002 109.975 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' HA ' HD21 ' A' ' 67' ' ' LEU . 11.6 m-80 -141.87 -80.68 0.23 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.618 . . . . 3.0600000000000001 112.603 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 m -78.41 -125.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.401 0.519 . . . . 1.8500000000000001 112.401 -170.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.645 ' HB3' ' HE1' ' A' ' 115' ' ' HIS . 16.2 m 70.85 -75.29 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.733 -0.667 . . . . 1.4399999999999999 110.994 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 60.4 116.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.144 0.794 . . . . 1.8100000000000001 113.144 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HB3' ' CG ' ' A' ' 115' ' ' HIS . 18.6 p90 -132.15 129.39 39.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.14 0.495 . . . . 0.64000000000000001 110.985 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.502 HG23 HG22 ' A' ' 78' ' ' VAL . 47.8 m -89.98 107.35 19.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.23 -0.896 . . . . 0.42999999999999999 109.758 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.754 ' HA ' HG22 ' A' ' 113' ' ' VAL . 98.3 t -81.84 109.73 16.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.866 -0.606 . . . . 0.87 109.961 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.474 ' HA ' HG22 ' A' ' 76' ' ' THR . 27.5 m -105.9 105.95 16.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.835 0.35 . . . . 0.45000000000000001 110.981 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.612 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 49.7 m-85 -86.0 110.97 19.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.75 -0.463 . . . . 0.34000000000000002 109.75 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.2 t -91.87 109.35 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.312 -0.625 . . . . 0.54000000000000004 109.312 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.65 132.62 42.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.46 0.648 . . . . 0.44 111.908 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -108.0 123.16 48.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.402 -0.962 . . . . 2.0299999999999998 108.402 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.93 -25.48 37.89 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.623 0.609 . . . . 1.97 114.623 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -85.12 39.5 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.453 0.626 . . . . 4.9299999999999997 110.909 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 42.2 mmtt 58.53 46.74 14.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.996 0.903 . . . . 3.5299999999999998 110.241 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.9 tttm -135.6 155.39 50.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.224 -1.353 . . . . 2.4399999999999999 107.853 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 48.3 m -155.13 119.46 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.873 -0.517 . . . . 0.41999999999999998 111.646 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -95.78 112.71 24.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.512 -0.767 . . . . 2.5899999999999999 109.705 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.762 HG12 HG22 ' A' ' 10' ' ' VAL . 14.6 p -88.7 136.89 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 120.119 -0.633 . . . . 0.40000000000000002 109.822 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.432 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 7.4 t70 -126.28 108.35 11.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.426 1.079 . . . . 1.3799999999999999 108.607 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 99' ' ' VAL . 10.1 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.622 -0.717 . . . . 0.91000000000000003 111.425 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.69 111.49 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.632 0.583 . . . . 2.3100000000000001 109.495 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.645 ' HE1' ' HB3' ' A' ' 95' ' ' SER . 6.1 t60 -123.13 118.02 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.482 -0.562 . . . . 1.6399999999999999 109.482 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.82 HG23 ' HD2' ' A' ' 120' ' ' ARG . 85.0 m -158.78 103.68 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.124 -0.23 . . . . 2.6699999999999999 111.6 -174.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.98 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.865 0.364 . . . . 2.6299999999999999 111.099 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.483 ' HZ ' ' HD3' ' A' ' 128' ' ' ARG . 50.4 t80 -78.24 -50.36 12.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.092 -0.503 . . . . 3.54 112.139 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.67 -38.42 77.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.411 0.624 . . . . 1.8100000000000001 110.041 -174.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.82 ' HD2' HG23 ' A' ' 116' ' ' THR . 20.0 ttt180 -63.6 -20.21 65.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 3.3799999999999999 111.573 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 31.0 tpp -80.11 29.87 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.099 0.777 . . . . 2.4300000000000002 113.099 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.76 177.42 16.71 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.637 -1.268 . . . . 1.6100000000000001 114.547 168.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -55.88 -60.55 3.3 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.812 -0.694 . . . . 2.5800000000000001 112.745 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.9 -35.54 81.48 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 121.057 -0.257 . . . . 3.7999999999999998 111.306 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.545 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 24.4 m80 -59.51 -50.93 72.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.973 0.416 . . . . 2.1400000000000001 110.165 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.46 63.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 0.92000000000000004 111.118 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 89.0 tttt -69.38 -38.96 78.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.099 -0.5 . . . . 2.8300000000000001 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.42 -31.64 65.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 2.5899999999999999 109.686 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.612 HG12 ' HG2' ' A' ' 133' ' ' MET . 87.0 t -61.63 -49.72 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 1.48 111.15 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.693 ' HA ' ' HG3' ' A' ' 133' ' ' MET . 0.0 OUTLIER -65.87 -14.54 61.66 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.162 -0.336 . . . . 3.8300000000000001 111.443 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -52.51 -28.58 21.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.628 0.371 . . . . 2.48 111.843 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.411 ' H ' ' HD3' ' A' ' 88' ' ' ARG . . . -157.76 15.58 0.3 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.99 -1.1 . . . . 1.6100000000000001 113.857 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.693 ' HG3' ' HA ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -84.22 -26.87 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.899 0.85 . . . . 4.8300000000000001 111.438 176.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.56 -34.16 77.28 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.962 0.727 . . . . 2.8300000000000001 112.962 -164.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.38 18.13 22.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.011 0.434 . . . . 4.1500000000000004 110.579 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 140' ' ' ILE . . . -122.47 -77.34 0.4 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.04 -1.076 . . . . 1.04 112.871 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.474 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 76.0 t-105 -54.33 -51.91 73.8 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.716 0.636 . . . . 2.7799999999999998 112.716 -169.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.8 -33.29 96.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.809 1.673 . . . . 0.68000000000000005 111.94 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -76.56 -33.49 58.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.717 -0.674 . . . . 0.87 110.304 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -55.07 -48.16 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 108.596 -0.89 . . . . 0.71999999999999997 108.596 173.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.0 mt -60.42 -28.36 68.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.261 -0.881 . . . . 0.68999999999999995 112.002 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 26.4 mm-40 -72.13 -57.4 4.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.154 -0.313 . . . . 1.49 110.154 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.6 m -67.6 -25.93 66.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.12 0.486 . . . . 1.1499999999999999 110.522 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 10' ' ' VAL . 62.0 t80 -57.8 -55.29 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.422 -0.808 . . . . 0.80000000000000004 109.956 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.509 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 43.7 mt-30 -68.7 -24.63 64.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.763 -0.653 . . . . 1.6299999999999999 110.939 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.25 -45.39 40.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.285 . . . . 1.46 111.593 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.778 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 15.2 tptm -70.23 -31.36 68.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.631 -0.828 . . . . 1.74 110.263 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.921 HG21 HG13 ' A' ' 12' ' ' VAL . 49.9 mt -63.43 -37.36 79.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.484 0.659 . . . . 0.5 109.635 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.482 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 11.5 t70 -59.33 -36.97 76.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.174 -0.921 . . . . 0.84999999999999998 109.494 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 3.9 mm-40 -63.72 -41.04 98.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.507 -0.77 . . . . 1.5 110.673 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 5.7 mm-40 -75.96 -16.01 60.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.899 -1.046 . . . . 1.74 109.839 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -102.0 -75.88 1.14 Allowed Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.409 -0.814 . . . . 1.3200000000000001 113.235 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.19 13.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.28 0.845 . . . . 1.9199999999999999 113.28 -169.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 21.9 ttmm -71.47 -39.66 70.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 2.04 109.164 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HB3' ' NZ ' ' A' ' 155' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.475 -0.784 . . . . 4.2199999999999998 110.031 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.643 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 3.5 p-10 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.548 0.214 . . . . 1.6599999999999999 110.989 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.498 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 54.8 p90 169.96 -30.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 3.73 109.62 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.835 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 31.6 t70 -65.87 -54.26 29.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 2.7799999999999998 110.927 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.835 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -91.23 -68.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.133 1.889 . . . . 1.6299999999999999 111.176 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 12.0 p90 -153.69 159.26 41.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.061 -0.518 . . . . 3.21 109.652 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.931 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 79.0 t -97.49 128.63 48.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.965 -0.754 . . . . 1.4399999999999999 108.965 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 15.9 ttp180 -117.33 142.43 47.11 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.954 -0.698 . . . . 3.3700000000000001 111.536 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.522 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -124.04 133.39 53.66 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.387 -0.968 . . . . 0.79000000000000004 108.387 172.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.766 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 6.6 t -139.8 111.35 7.2 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.881 -0.414 . . . . 1.28 109.881 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.744 HG22 ' CG1' ' A' ' 111' ' ' VAL . 6.3 m -126.2 151.45 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 1.27 110.955 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.8 m -103.38 115.74 31.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.507 -0.769 . . . . 0.56999999999999995 110.158 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.819 HG21 ' HB2' ' A' ' 19' ' ' ALA . 55.9 t -97.51 125.6 50.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.251 -0.886 . . . . 0.91000000000000003 110.013 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.682 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.68 23.94 8.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.799 -0.637 . . . . 0.97999999999999998 111.886 -173.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -148.23 31.04 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.35999999999999999 111.055 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 37.7 t70 72.32 167.26 0.31 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.13 0.967 . . . . 0.91000000000000003 113.504 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.547 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 34.3 ttp180 -63.47 -27.79 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.232 -1.349 . . . . 1.8799999999999999 111.226 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.36 -45.08 84.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 3.0499999999999998 111.141 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -77.36 -40.59 43.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.798 -0.361 . . . . 1.1100000000000001 110.739 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.819 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.56 -41.68 77.28 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 120.886 -0.325 . . . . 0.32000000000000001 110.904 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.31 -47.31 43.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.613 0.244 . . . . 0.38 110.949 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -54.12 -52.53 60.76 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.298 -0.41 . . . . 2.3900000000000001 110.37 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -65.5 -51.03 62.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.367 -0.379 . . . . 0.68000000000000005 111.031 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.784 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.4 t80 -61.22 -37.55 83.41 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.406 0.521 . . . . 0.47999999999999998 112.406 -173.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.663 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -113.02 -50.06 2.9 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.195 -0.602 . . . . 0.5 112.469 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HA ' ' CE ' ' A' ' 48' ' ' LYS . 36.6 mt-10 -78.36 -35.28 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.071 0.462 . . . . 1.24 111.15 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.756 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -105.36 35.52 5.01 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 115.642 -0.708 . . . . 0.82999999999999996 112.084 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.578 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 62.0 t80 -52.56 -51.27 74.73 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.968 0.729 . . . . 0.73999999999999999 112.968 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.05 -2.01 11.79 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.11 1.873 . . . . 0.76000000000000001 114.801 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.756 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.5 pt-20 -90.75 -5.45 55.68 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.227 -0.589 . . . . 1.49 112.183 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.784 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 9.7 m0 -74.52 -179.07 3.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.397 0.618 . . . . 4.6200000000000001 111.259 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.52 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 79.2 m95 -96.18 -32.63 0.27 Allowed Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 114.237 1.199 . . . . 2.7799999999999998 114.237 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.643 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 68.5 Cg_endo -71.54 -123.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.332 2.021 . . . . 1.3600000000000001 115.244 -165.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.598 HD22 HG21 ' A' ' 40' ' ' VAL . 6.3 t30 -62.33 -22.74 66.31 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.169 -0.469 . . . . 1.51 111.452 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.799 ' HA ' HG23 ' A' ' 40' ' ' VAL . 11.8 p30 -86.91 17.22 4.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.999 -0.546 . . . . 1.79 111.497 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -71.76 -10.22 59.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.377 0.608 . . . . 4.4500000000000002 110.037 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -104.3 118.88 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 4.1399999999999997 111.279 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -77.25 151.39 35.14 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.63 -0.714 . . . . 2.6800000000000002 109.64 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 57' ' ' ASP . 51.5 p 55.74 25.39 8.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.919 0.866 . . . . 1.4199999999999999 110.791 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.566 ' HG2' HG22 ' A' ' 40' ' ' VAL . 16.8 ttmm -127.48 -59.67 1.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.61 -1.177 . . . . 2.8999999999999999 109.723 166.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 34' ' ' ASN . 2.8 m -157.72 28.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.955 -0.566 . . . . 1.8300000000000001 110.492 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.88 18.31 0.85 Allowed Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.934 -1.127 . . . . 2.1699999999999999 114.178 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.006 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -73.95 162.67 72.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 117.163 0.482 . . . . 1.1200000000000001 109.974 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 96.1 Cg_exo -50.05 -5.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 124.645 3.563 . . . . 1.48 116.53 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -105.33 -85.31 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.094 -0.379 . . . . 1.75 110.571 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.578 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.37 -48.28 2.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.884 -0.674 . . . . 0.75 112.976 174.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.663 HG11 ' HG ' ' A' ' 24' ' ' LEU . 73.3 t -140.11 141.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.59999999999999998 111.289 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.875 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 20.7 t70 -96.38 115.07 26.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.508 -0.552 . . . . 1.1100000000000001 109.508 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.556 ' CE ' ' HA ' ' A' ' 25' ' ' GLU . 36.4 mmtm -79.65 -27.99 40.85 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.95 0.781 . . . . 2.8100000000000001 112.23 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -83.09 -46.84 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.425 0.528 . . . . 3.1699999999999999 112.425 -170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.66 -32.01 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.446 -0.883 . . . . 1.53 111.954 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.553 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 103.95 71.18 0.84 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.348 -0.93 . . . . 0.77000000000000002 112.239 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -136.25 162.55 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.929 -0.397 . . . . 3.7200000000000002 109.929 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.0 m95 -116.75 107.75 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.28 108.886 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.875 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.7 p90 -162.64 159.93 25.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.228 0.537 . . . . 1.6599999999999999 111.109 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 23.4 mt-10 -102.23 -176.01 3.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 2.1200000000000001 110.051 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.8 mm -105.22 111.57 35.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.767 -0.827 . . . . 0.92000000000000004 108.767 157.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.713 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 3.5 t70 -91.65 177.72 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.537 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -84.48 -36.14 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.851 0.686 . . . . 2.4300000000000002 112.851 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.453 HE22 ' CG ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -88.26 14.68 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.55 -0.46 . . . . 2.3900000000000001 111.672 -173.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.75 64.02 0.92 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.356 -0.926 . . . . 2.29 112.811 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.683 ' HA ' ' NE2' ' A' ' 63' ' ' HIS . 0.1 OUTLIER 57.35 74.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.817 1.043 . . . . 2.3100000000000001 113.817 172.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.17 73.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.113 -0.699 . . . . 2.6099999999999999 109.113 169.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.713 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -125.24 163.31 22.78 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.214 -0.903 . . . . 3.7200000000000002 110.883 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.609 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 9.0 t -157.09 135.62 11.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.639 0.257 . . . . 2.27 110.602 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.712 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 33.5 t80 -146.93 -58.43 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 6.4800000000000004 110.558 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.525 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -155.72 159.68 29.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.53 -1.319 . . . . 1.23 114.25 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -119.01 113.81 21.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.668 -0.766 . . . . 1.1699999999999999 109.696 177.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.004 HG21 HG13 ' A' ' 71' ' ' VAL . 72.3 mt -77.26 132.28 33.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 0.60999999999999999 110.858 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -102.87 -24.94 13.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.047 -0.979 . . . . 2.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 47.4 tttm -165.79 108.96 0.8 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.559 -0.746 . . . . 1.53 111.192 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.004 HG13 HG21 ' A' ' 68' ' ' ILE . 1.6 m -100.91 115.5 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.362 -0.607 . . . . 0.88 109.362 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.24 74.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.73 -0.388 . . . . 1.4199999999999999 110.779 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.15 -170.69 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 124.525 1.14 . . . . 0.95999999999999996 111.944 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 30.7 Cg_exo -64.71 78.26 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.322 1.348 . . . . 0.38 111.093 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 23.5 t70 -161.76 -67.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.5 110.837 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.2 p -142.01 141.97 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.076 0.465 . . . . 0.34999999999999998 111.805 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.59 126.94 28.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.433 . . . . 0.73999999999999999 109.845 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 98' ' ' THR . 26.2 t -103.39 109.92 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.629 -0.878 . . . . 0.67000000000000004 108.629 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.525 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -127.18 127.12 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.334 -0.394 . . . . 0.75 110.249 -174.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.84 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.56 155.75 23.53 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.5 112.339 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 58.3 t-105 -81.68 138.37 35.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.054 0.39 . . . . 2.79 112.054 -171.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 34.8 ttt-85 -148.54 23.16 1.02 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.859 -0.61 . . . . 5.46 109.997 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 78.48 145.48 0.09 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.083 -0.962 . . . . 1.55 112.917 172.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.551 ' H ' HD13 ' A' ' 83' ' ' LEU . 8.1 m-20 -77.85 48.47 0.7 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.499 -0.773 . . . . 1.9299999999999999 111.37 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.22 46.9 43.19 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 116.126 -0.488 . . . . 2.3999999999999999 113.916 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.471 ' H ' HD12 ' A' ' 83' ' ' LEU . 28.8 m-85 -106.96 1.81 24.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.159 -0.612 . . . . 5.3799999999999999 111.211 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.42 24.62 76.62 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.53 -0.843 . . . . 2.2999999999999998 111.603 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HD3' ' HB3' ' A' ' 131' ' ' ASN . 50.3 mtt180 -98.96 -174.28 2.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.41 -0.395 . . . . 4.7699999999999996 110.637 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.67 ' O ' HD23 ' A' ' 83' ' ' LEU . 1.7 pp -54.74 149.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.845 0.716 . . . . 1.8600000000000001 111.292 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 p-10 -146.49 135.15 11.01 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 110.0 -0.37 . . . . 3.1800000000000002 110.0 175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 81' ' ' TRP . 3.4 Cg_exo -76.58 -37.89 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.446 2.097 . . . . 2.3599999999999999 111.71 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 70.06 -6.59 1.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.388 -0.824 . . . . 2.9900000000000002 111.88 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -137.89 -64.69 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 3.0600000000000001 111.017 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -89.54 -161.49 0.78 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.185 -0.461 . . . . 1.8500000000000001 111.293 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 3.7 t 67.4 40.0 2.79 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 122.06 0.933 . . . . 1.4399999999999999 108.605 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.84 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 15.7 mt-10 -81.12 136.76 35.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.359 -1.292 . . . . 1.8100000000000001 110.012 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -120.23 120.67 36.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.464 0.65 . . . . 0.64000000000000001 110.563 174.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.536 HG23 HG22 ' A' ' 78' ' ' VAL . 41.7 m -93.35 115.27 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.99 -1.005 . . . . 0.42999999999999999 110.085 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.472 ' CB ' HG23 ' A' ' 113' ' ' VAL . 2.0 m -94.59 123.82 46.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.349 0.595 . . . . 0.87 109.459 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' HG22 ' A' ' 76' ' ' THR . 86.5 m -104.89 106.84 17.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.307 -0.86 . . . . 0.45000000000000001 109.805 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.691 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.1 m-85 -82.79 110.39 17.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 0.34000000000000002 109.917 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 109' ' ' THR . 58.8 t -88.17 107.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.759 0.314 . . . . 0.54000000000000004 110.481 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 129.28 39.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.928 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 5.9 t0 -128.16 97.3 4.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 2.0299999999999998 110.476 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.45 69.56 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.913 -0.66 . . . . 1.97 113.977 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 66.67 6.64 4.62 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.887 0.699 . . . . 4.9299999999999997 112.887 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 41.2 mtmt -136.26 -0.42 2.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 3.5299999999999998 111.378 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 42.4 tttt -138.34 157.97 45.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.223 -0.658 . . . . 2.4399999999999999 109.223 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.532 ' N ' ' HG2' ' A' ' 108' ' ' LYS . 18.1 m -156.67 128.28 7.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.102 0.477 . . . . 0.41999999999999998 110.99 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 110' ' ' ARG . 8.5 tpt180 -106.33 115.14 29.7 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.763 -0.828 . . . . 2.5899999999999999 108.763 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -95.17 141.55 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.291 -0.564 . . . . 0.40000000000000002 111.005 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.563 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 11.5 t70 -128.99 104.1 7.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 124.459 1.099 . . . . 1.3799999999999999 109.565 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -85.7 139.17 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-N 116.499 -0.319 . . . . 0.91000000000000003 111.293 178.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 39.8 mt-10 -118.46 110.52 17.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.027 0.83 . . . . 2.3100000000000001 109.823 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.931 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 3.0 t-160 -91.89 107.26 19.08 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.098 -0.955 . . . . 1.6399999999999999 108.555 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 22.9 p -118.84 158.59 25.36 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.707 0.765 . . . . 2.6699999999999999 112.383 -172.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.658 ' O ' ' HG3' ' A' ' 121' ' ' MET . 98.9 m-70 99.22 -78.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.486 -1.688 . . . . 2.6299999999999999 111.077 164.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.454 ' HZ ' ' NH1' ' A' ' 128' ' ' ARG . 31.6 t80 -72.47 -48.84 37.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.706 -0.679 . . . . 3.54 112.592 -165.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.48 -43.36 99.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.92 0.867 . . . . 1.8100000000000001 109.5 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 55.2 ttt180 -61.12 -20.71 62.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.194 -1.367 . . . . 3.3799999999999999 111.931 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.658 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 93.8 mtp -78.08 25.14 0.23 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.461 0.541 . . . . 2.4300000000000002 112.461 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.4 155.37 8.9 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.722 -1.228 . . . . 1.6100000000000001 113.293 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 t -51.93 -47.86 64.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.234 -0.483 . . . . 2.5800000000000001 112.279 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -72.66 -25.27 61.2 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.879 -0.329 . . . . 3.7999999999999998 111.168 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.554 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 11.5 m170 -68.35 -50.07 55.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.403 0.621 . . . . 2.1400000000000001 109.569 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 2' ' ' TYR . . . -69.9 -30.87 68.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 0.92000000000000004 111.001 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -68.37 -37.83 80.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 2.8300000000000001 111.198 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.7 ptm180 -72.67 -36.27 67.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.887 -0.325 . . . . 2.5899999999999999 110.248 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 81' ' ' TRP . 93.0 t -68.75 -33.05 57.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.342 0.591 . . . . 1.48 110.346 175.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 32.9 ttm180 -57.39 -21.83 38.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.242 -0.89 . . . . 3.8300000000000001 111.0 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 91.1 m-20 -64.55 -21.35 66.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.48 111.598 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.7 -58.13 0.52 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.007 -1.092 . . . . 1.6100000000000001 114.155 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -80.53 -9.18 59.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.131 0.789 . . . . 4.8300000000000001 113.131 -170.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 6.4 p-10 -53.42 -49.4 67.4 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.842 0.682 . . . . 2.8300000000000001 112.842 -169.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -111.34 -19.88 12.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 4.1500000000000004 110.955 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -63.27 -57.27 15.92 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.632 -0.587 . . . . 1.04 111.632 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.433 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.6 m0 -55.47 -53.99 56.1 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.052 0.76 . . . . 2.7799999999999998 113.052 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.3 Cg_endo -56.91 -37.75 97.55 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.747 1.632 . . . . 0.68000000000000005 112.097 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.9 m -70.16 -45.29 67.06 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.635 0.731 . . . . 0.87 109.958 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.643 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 27.0 mt -58.54 -54.18 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.957 -1.019 . . . . 0.71999999999999997 111.548 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HB3' HG11 ' A' ' 10' ' ' VAL . 82.2 mt -62.6 -24.66 67.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.255 0.465 . . . . 0.68999999999999995 112.255 -173.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -56.56 4.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.952 0.406 . . . . 1.49 110.234 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 73.8 m -66.44 -23.09 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 1.1499999999999999 110.531 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.77 -55.06 34.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 0.80000000000000004 110.491 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.445 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 41.5 mt-30 -61.91 -32.44 72.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.961 -0.563 . . . . 1.6299999999999999 110.684 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.1 m-20 -72.84 -40.91 65.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 1.46 111.773 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.3 tptp -65.42 -42.41 92.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 1.74 109.69 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.816 HG21 HG13 ' A' ' 12' ' ' VAL . 72.8 mt -62.36 -38.76 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.433 0.635 . . . . 0.5 110.401 174.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -58.37 -37.1 74.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.84999999999999998 110.169 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 146' ' ' ASP . 38.9 mt-10 -72.9 -35.14 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.551 -0.75 . . . . 1.5 110.439 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 21.6 mm-40 -67.77 -38.0 82.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 1.74 110.142 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.94 -66.63 2.11 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.463 -0.79 . . . . 1.3200000000000001 111.684 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.25 81.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.708 0.29 . . . . 1.9199999999999999 111.478 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -163.13 85.48 0.52 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 2.04 110.329 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 150' ' ' GLU . 36.7 mtmt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.245 -0.883 . . . . 4.2199999999999998 109.548 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.786 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.3 p-10 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.858 -0.115 . . . . 1.6599999999999999 110.754 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 86.67 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.314 1.045 . . . . 3.73 110.175 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.653 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 11.2 t70 -51.39 -52.47 59.29 Favored Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 123.453 0.471 . . . . 2.7799999999999998 111.63 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.4 Cg_endo -85.45 -67.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.165 1.244 . . . . 1.6299999999999999 112.517 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 36.3 p90 -153.37 142.17 21.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.153 -0.684 . . . . 3.21 109.153 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.786 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -123.56 136.2 60.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 1.4399999999999999 111.284 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.0 ttp180 -141.28 141.78 33.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.581 -0.736 . . . . 3.3700000000000001 110.502 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.716 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.1 133.39 53.07 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.846 -0.798 . . . . 0.79000000000000004 108.846 173.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 3.8 t -132.91 111.76 11.32 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.399 0.619 . . . . 1.28 110.214 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.0 t -123.91 138.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.053 -0.976 . . . . 1.27 111.585 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -96.6 117.04 30.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.251 0.548 . . . . 0.56999999999999995 109.994 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.869 HG13 HG21 ' A' ' 148' ' ' ILE . 51.4 t -96.48 129.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.91000000000000003 110.081 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.18 24.9 9.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.967 -0.56 . . . . 0.97999999999999998 111.845 -173.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -153.74 33.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.31 0.485 . . . . 0.35999999999999999 112.31 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 15.8 t70 73.43 165.67 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.904 0.859 . . . . 0.91000000000000003 112.607 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -65.66 -26.33 67.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.87 -1.059 . . . . 1.8799999999999999 111.166 -174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.95 -43.69 98.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.122 -0.49 . . . . 3.0499999999999998 111.09 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.0 p -74.55 -35.76 63.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.888 -0.325 . . . . 1.1100000000000001 110.361 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.65 -48.16 78.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.32000000000000001 110.444 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.06 -44.47 69.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.38 110.732 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -55.23 -52.33 63.74 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.404 -0.362 . . . . 2.3900000000000001 110.807 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -67.3 -51.07 57.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.546 -0.297 . . . . 0.68000000000000005 111.102 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.646 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.0 t80 -65.42 -34.58 78.63 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.059 0.392 . . . . 0.47999999999999998 112.059 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD11 HG11 ' A' ' 46' ' ' VAL . 12.9 tp -111.73 -54.42 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.382 -0.527 . . . . 0.5 111.961 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.89 33.7 2.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 1.24 111.705 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.747 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -157.73 34.47 0.53 Allowed Glycine 0 C--O 1.217 -0.908 0 C-N-CA 120.734 -0.746 . . . . 0.82999999999999996 111.895 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.61 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 t80 -61.58 -51.39 77.19 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 112.264 0.468 . . . . 0.73999999999999999 112.264 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.676 ' HB3' HD23 ' A' ' 44' ' ' LEU . 93.4 Cg_endo -77.57 15.49 1.23 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.461 2.107 . . . . 0.76000000000000001 115.058 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -113.09 -2.31 14.2 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.835 -0.541 . . . . 1.49 111.151 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.864 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 31.2 m0 -72.43 160.13 32.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.329 0.585 . . . . 4.6200000000000001 111.277 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 58.2 m95 -89.61 -37.01 0.42 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.627 0.973 . . . . 2.7799999999999998 113.627 175.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 18.5 Cg_endo -58.18 -84.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.525 2.15 . . . . 1.3600000000000001 115.448 -163.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HB3' HD11 ' A' ' 140' ' ' ILE . 5.6 t30 -110.76 -4.41 15.33 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.776 0.798 . . . . 1.51 109.425 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.847 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.9 m-20 -86.54 74.39 9.91 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.729 -1.123 . . . . 1.79 111.255 -170.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -154.46 29.09 0.44 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.791 0.663 . . . . 4.4500000000000002 112.791 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 23.3 mmm180 -135.77 152.63 51.32 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 4.1399999999999997 111.728 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.3 p -76.17 135.39 39.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.502 -0.317 . . . . 2.6800000000000002 110.149 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 57' ' ' ASP . 1.7 p 50.22 26.04 2.03 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.632 0.729 . . . . 1.4199999999999999 111.741 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 15.7 ttmm -146.04 71.44 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.165 -0.925 . . . . 2.8999999999999999 109.1 174.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.847 HG23 ' HA ' ' A' ' 34' ' ' ASN . 6.9 m 53.36 29.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.052 -1.431 . . . . 1.8300000000000001 113.21 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.37 7.35 0.61 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.106 -1.521 . . . . 2.1699999999999999 114.171 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 43' ' ' PRO . . . -83.1 -171.25 0.29 Allowed Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.517 -0.549 . . . . 1.1200000000000001 109.517 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.876 ' HG2' ' HB ' ' A' ' 56' ' ' ILE . 18.8 Cg_endo -64.19 74.39 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 120.908 1.072 . . . . 1.48 109.336 161.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.81 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -120.97 -162.44 0.96 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.939 0.875 . . . . 1.75 110.266 -166.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.734 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . 135.68 -115.02 1.28 Allowed Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 113.541 -1.663 . . . . 0.75 110.412 166.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.582 HG11 HD11 ' A' ' 24' ' ' LEU . 86.9 t -140.47 136.16 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.69 -0.755 . . . . 0.59999999999999998 112.297 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.799 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 8.1 t0 -105.77 104.97 14.8 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.343 -1.298 . . . . 1.1100000000000001 108.071 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.62 ' H ' ' HE3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -79.86 -28.69 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.044 0.45 . . . . 2.8100000000000001 111.008 -174.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 50.6 pttt -71.49 -29.25 64.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 3.1699999999999999 111.645 -175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.6 -25.61 4.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.135 -0.555 . . . . 1.53 112.425 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.39 57.91 1.61 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.158 -0.544 . . . . 0.77000000000000002 112.803 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.799 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 26.1 ptt180 -146.33 152.73 39.61 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.583 -0.363 . . . . 3.7200000000000002 111.314 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 32.0 m0 -110.53 113.79 26.69 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.069 -0.715 . . . . 1.28 109.069 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.585 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.7 p90 -151.47 174.03 13.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.101 -1.04 . . . . 1.6599999999999999 112.786 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.81 ' HG2' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mt-10 -134.05 143.0 47.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.029 -0.532 . . . . 2.1200000000000001 110.932 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.876 ' HB ' ' HG2' ' A' ' 43' ' ' PRO . 25.4 mm -83.06 103.64 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.373 -0.531 . . . . 0.92000000000000004 109.785 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 61' ' ' GLU . 1.9 p-10 -66.4 -169.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.491 0.662 . . . . 1.97 111.199 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.73 -27.65 22.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.7 1.0 . . . . 2.4300000000000002 113.7 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.12 -28.64 12.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.658 0.984 . . . . 2.3900000000000001 113.658 -164.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.96 46.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.268 -1.444 . . . . 2.29 113.782 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 16.1 mt-10 73.21 73.46 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.119 0.785 . . . . 2.3100000000000001 113.119 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 11.4 tp10 -123.42 74.41 1.24 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.867 -1.16 . . . . 2.6099999999999999 107.867 165.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.463 ' CD2' ' HD1' ' A' ' 54' ' ' TYR . 2.0 p80 -113.07 126.36 55.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.549 -1.205 . . . . 3.7200000000000002 112.143 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.592 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 6.0 m -63.35 135.43 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.123 -1.066 . . . . 2.27 108.123 166.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.7 p90 -123.22 143.99 49.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.539 0.57 . . . . 6.4800000000000004 112.539 -171.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -75.52 151.46 41.56 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.041 -1.224 . . . . 1.23 110.041 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.779 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -115.6 94.33 4.65 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.043 0.422 . . . . 1.1699999999999999 111.192 -171.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 71' ' ' VAL . 41.5 mt -74.49 132.49 33.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.60999999999999999 110.354 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.565 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 12.8 mmm-85 -103.91 -25.33 13.08 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.716 -0.475 . . . . 2.0 109.716 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 82.6 tttt -145.52 115.52 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.53 111.198 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 68' ' ' ILE . 47.6 t -105.01 91.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 109.245 -0.65 . . . . 0.88 109.245 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 1.1 t70 -106.15 100.61 10.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.672 -0.695 . . . . 1.4199999999999999 109.531 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 17.0 pt-20 -24.79 148.06 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 125.105 1.503 . . . . 0.95999999999999996 112.542 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.6 Cg_exo -18.55 78.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.839 3.693 . . . . 0.38 114.781 -162.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -164.21 -63.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.844 -1.071 . . . . 0.5 110.614 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -149.69 141.57 23.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.23 0.538 . . . . 0.34999999999999998 112.284 -175.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 77' ' ' LEU . 1.7 mp -134.24 115.06 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.354 -0.384 . . . . 0.73999999999999999 110.037 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 61.7 t -97.25 108.31 21.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.235 -0.654 . . . . 0.67000000000000004 109.235 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -126.4 130.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.146 -0.479 . . . . 0.75 111.496 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.779 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -84.17 151.71 27.42 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.5 112.397 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.792 ' HZ2' ' HB3' ' A' ' 133' ' ' MET . 27.2 t-105 -82.06 146.13 29.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.836 1.05 . . . . 2.79 113.836 -162.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.74 ' O ' HD12 ' A' ' 83' ' ' LEU . 1.4 ttp180 -139.82 -8.42 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.366 -0.833 . . . . 5.46 111.693 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER 37.07 -160.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.764 1.764 . . . . 1.55 115.764 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 94.7 m-20 -126.26 135.23 51.3 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.116 0.566 . . . . 1.9299999999999999 109.867 -171.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.58 81.36 0.11 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.201 -0.523 . . . . 2.3999999999999999 113.402 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -128.21 24.17 5.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.468 . . . . 5.3799999999999999 110.298 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.09 30.79 2.84 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.334 -1.106 . . . . 2.2999999999999998 110.334 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.541 ' HD2' ' C ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -97.53 163.41 12.87 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.57 -0.815 . . . . 4.7699999999999996 112.899 -171.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.774 HG21 ' HE ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -117.22 128.3 74.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.386 -1.279 . . . . 1.8600000000000001 108.065 159.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.76 136.67 27.58 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.381 -0.6 . . . . 3.1800000000000002 109.381 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.694 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 53.1 Cg_exo -56.41 -43.36 56.37 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 122.998 2.466 . . . . 2.3599999999999999 112.185 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 t70 72.09 -28.66 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.947 0.779 . . . . 2.9900000000000002 112.68 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -124.4 -8.5 7.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.26 0.467 . . . . 3.0600000000000001 112.26 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 95' ' ' SER . 62.6 p -162.28 -147.67 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.082 -0.247 . . . . 1.8500000000000001 110.994 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.628 ' OG ' ' HB3' ' A' ' 118' ' ' PHE . 32.7 m 67.73 42.71 1.94 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.734 -0.666 . . . . 1.4399999999999999 110.5 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.615 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 43.8 mp0 -70.4 139.3 51.84 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.391 -0.822 . . . . 1.8100000000000001 109.935 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.488 ' HB2' HG13 ' A' ' 113' ' ' VAL . 2.6 p90 -127.37 127.74 44.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.02 0.438 . . . . 0.64000000000000001 110.271 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.1 m -88.4 110.2 20.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.366 -0.833 . . . . 0.42999999999999999 110.466 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.722 ' HA ' HG22 ' A' ' 113' ' ' VAL . 65.9 t -82.35 108.9 15.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.949 -0.569 . . . . 0.87 109.681 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 7.0 m -101.54 107.01 18.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.848 0.356 . . . . 0.45000000000000001 110.774 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 26.7 m-85 -94.17 111.11 22.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.222 -0.445 . . . . 0.34000000000000002 110.897 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.24 107.74 19.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.777 -0.453 . . . . 0.54000000000000004 109.777 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.03 145.36 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.681 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.824 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 4.4 t70 -140.09 107.49 5.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.389 -0.369 . . . . 2.0299999999999998 110.668 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.27 50.55 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.048 -0.596 . . . . 1.97 113.183 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 58.49 22.42 9.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.32 0.648 . . . . 4.9299999999999997 111.893 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 43.7 mtmt -141.36 -14.87 0.86 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.187 -0.321 . . . . 3.5299999999999998 111.212 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.824 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 27.8 tttp -121.49 155.77 34.23 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.501 -0.925 . . . . 2.4399999999999999 108.501 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.551 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 42.4 m -157.25 135.45 11.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.685 0.279 . . . . 0.41999999999999998 110.333 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -115.12 122.16 45.26 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.035 -0.728 . . . . 2.5899999999999999 109.035 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.7 p -101.89 136.82 32.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.438 -0.505 . . . . 0.40000000000000002 110.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -125.47 113.9 18.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 1.3799999999999999 109.186 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.722 HG22 ' HA ' ' A' ' 99' ' ' VAL . 3.6 t -95.01 120.82 44.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.317 -0.856 . . . . 0.91000000000000003 110.78 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.58 111.3 23.63 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.445 -0.798 . . . . 2.3100000000000001 109.597 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.603 ' O ' HG13 ' A' ' 6' ' ' VAL . 45.4 t60 -123.81 109.51 13.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.351 -0.841 . . . . 1.6399999999999999 108.843 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 120' ' ' ARG . 20.2 m -157.42 96.91 1.58 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.143 -0.223 . . . . 2.6699999999999999 111.231 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.518 ' O ' ' HG3' ' A' ' 121' ' ' MET . 40.5 t60 -162.67 -74.9 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 120.664 0.268 . . . . 2.6299999999999999 111.196 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.628 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 37.5 t80 -85.77 -26.82 25.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.593 0.711 . . . . 3.54 110.089 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.1 p-10 -68.64 -51.63 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.87 -1.059 . . . . 1.8100000000000001 110.857 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD2' HG22 ' A' ' 116' ' ' THR . 7.9 ptm180 -59.02 -19.03 39.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.457 -0.792 . . . . 3.3799999999999999 112.01 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 94.7 mtp -64.15 -9.85 19.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.948 0.404 . . . . 2.4300000000000002 110.14 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 55.17 -153.77 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.199 -0.91 . . . . 1.6100000000000001 114.407 166.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.7 p 44.38 -125.53 0.99 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.29 0.636 . . . . 2.5800000000000001 111.555 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.49 -23.73 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.652 -0.249 . . . . 3.7999999999999998 110.911 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.527 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 39.9 m80 -63.47 -51.6 64.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.008 0.432 . . . . 2.1400000000000001 110.253 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.954 -0.566 . . . . 0.92000000000000004 110.403 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -63.48 -42.76 98.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.661 . . . . 2.8300000000000001 111.23 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.774 ' HE ' HG21 ' A' ' 89' ' ' ILE . 11.8 ptm180 -73.84 -31.55 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 2.5899999999999999 111.501 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.59 -39.57 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.206 0.527 . . . . 1.48 110.643 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.638 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 69.7 ttt180 -62.42 -16.75 56.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.602 -0.726 . . . . 3.8300000000000001 111.317 -176.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.34 -47.73 62.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.04 0.385 . . . . 2.48 112.04 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.29 -34.98 5.15 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.077 -1.058 . . . . 1.6100000000000001 113.539 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.792 ' HB3' ' HZ2' ' A' ' 81' ' ' TRP . 23.8 ptm -81.12 -21.84 39.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.904 0.705 . . . . 4.8300000000000001 112.904 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.638 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 34.1 t70 -54.7 -43.34 72.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.431 0.9 . . . . 2.8300000000000001 113.431 -168.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -114.13 30.88 6.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.456 0.646 . . . . 4.1500000000000004 110.331 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.75 -70.31 0.17 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.493 -0.861 . . . . 1.04 112.124 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.471 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 10.4 t90 -58.19 -52.0 77.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.463 0.542 . . . . 2.7799999999999998 112.463 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.8 Cg_endo -59.35 -37.74 88.6 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.94 1.76 . . . . 0.68000000000000005 112.355 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.1 m -70.02 -36.54 75.17 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.746 0.784 . . . . 0.87 109.671 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.7 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 15.3 mt -55.75 -40.24 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.66 -1.155 . . . . 0.71999999999999997 110.521 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 8' ' ' HIS . 79.0 mt -61.7 -30.77 70.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.925 0.343 . . . . 0.68999999999999995 111.925 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.63 -51.29 23.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 1.49 110.193 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.531 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 37.1 m -68.67 -22.76 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.137 -0.483 . . . . 1.1499999999999999 110.805 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 58.9 t80 -61.64 -54.26 45.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 0.80000000000000004 109.929 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.495 ' CG ' HG13 ' A' ' 10' ' ' VAL . 38.8 mt-30 -57.37 -37.69 73.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.82 -0.627 . . . . 1.6299999999999999 110.77 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.43 -0.804 . . . . 1.46 111.26 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -67.12 -41.43 86.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.8 0.333 . . . . 1.74 110.414 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.869 HG21 HG13 ' A' ' 12' ' ' VAL . 47.0 mt -62.08 -34.26 62.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.5 110.905 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.62 -30.58 68.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.985 -0.552 . . . . 0.84999999999999998 110.307 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.784 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 64.8 mt-10 -69.09 -43.83 73.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.5 110.03 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -69.53 -17.75 63.61 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.163 -0.926 . . . . 1.74 109.996 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.67 -40.11 6.44 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.407 -0.815 . . . . 1.3200000000000001 112.62 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -171.95 -26.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.039 0.755 . . . . 1.9199999999999999 113.039 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.784 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 6.2 ttmt -76.07 72.76 2.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.234 0.54 . . . . 2.04 111.609 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 150' ' ' GLU . 68.2 mttm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.446 -0.787 . . . . 4.2199999999999998 110.048 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.803 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 17.5 p-10 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.825 0.345 . . . . 1.6599999999999999 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 54.6 p90 173.26 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.837 -0.619 . . . . 3.73 109.668 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.804 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 32.8 t70 -66.04 -52.31 40.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 2.7799999999999998 111.041 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 12.5 Cg_endo -92.44 -70.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.153 1.902 . . . . 1.6299999999999999 111.605 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -141.25 145.67 35.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 3.21 110.25 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.803 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -118.63 125.72 74.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.419 -0.585 . . . . 1.4399999999999999 109.419 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 5.9 ttm105 -132.74 143.28 49.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.056 -0.52 . . . . 3.3700000000000001 112.027 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HE2' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.0 133.01 53.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.575 -0.898 . . . . 0.79000000000000004 108.575 170.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.7 m -133.76 111.51 10.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.589 0.709 . . . . 1.28 110.643 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.596 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.7 t -123.5 142.46 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.824 -1.08 . . . . 1.27 110.139 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.6 m -121.92 116.06 23.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.56999999999999995 110.074 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.659 ' HB ' HG21 ' A' ' 148' ' ' ILE . 11.0 m -102.91 163.63 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.509 -0.768 . . . . 0.91000000000000003 111.028 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.566 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -117.88 26.05 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.97999999999999998 111.661 -171.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB3' HG23 ' A' ' 148' ' ' ILE . . . -143.06 23.98 1.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.641 -0.423 . . . . 0.35999999999999999 111.52 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 33.8 t70 72.16 173.88 0.3 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.589 -0.732 . . . . 0.91000000000000003 112.565 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 9.7 ttp180 -68.03 -26.43 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.14 -0.936 . . . . 1.8799999999999999 111.321 -172.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -54.44 -48.53 71.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.104 0.478 . . . . 3.0499999999999998 110.755 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -80.73 -34.17 34.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 1.1100000000000001 111.046 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -59.58 -45.24 92.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.606 0.241 . . . . 0.32000000000000001 110.77 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -67.99 -45.89 72.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.38 110.516 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.701 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 29.6 tptp -54.77 -51.84 64.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 2.3900000000000001 110.452 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.551 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 55.0 m -65.28 -40.4 93.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.68000000000000005 111.539 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 67.5 t80 -71.33 -37.98 71.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.409 -0.36 . . . . 0.47999999999999998 111.691 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 46' ' ' VAL . 9.6 tp -119.44 -55.78 2.1 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.714 0.635 . . . . 0.5 112.714 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.701 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 2.3 mm-40 -87.85 18.33 4.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.542 0.571 . . . . 1.24 112.542 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -151.51 28.44 0.96 Allowed Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.246 -1.142 . . . . 0.82999999999999996 110.246 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.623 ' HZ ' ' CE1' ' A' ' 65' ' ' PHE . 71.0 t80 -47.54 -51.77 42.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.494 -0.853 . . . . 0.73999999999999999 113.18 -168.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.4 Cg_endo -96.31 11.39 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.027 1.818 . . . . 0.76000000000000001 115.445 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -106.31 -6.54 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.306 0.854 . . . . 1.49 113.306 -172.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.793 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 18.2 m95 -92.66 -152.21 0.31 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.2 -0.312 . . . . 4.6200000000000001 111.75 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.58 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 31.6 m95 -105.77 0.16 0.1 Allowed Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 115.383 1.623 . . . . 2.7799999999999998 115.383 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.902 ' HB3' ' HA ' ' A' ' 140' ' ' ILE . 27.1 Cg_exo -66.07 -150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 122.54 1.943 . . . . 1.3600000000000001 114.342 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.601 ' ND2' HG21 ' A' ' 40' ' ' VAL . 63.5 t30 -63.28 -4.35 2.49 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.485 -0.78 . . . . 1.51 111.646 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.967 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 30.8 p30 -83.6 15.64 3.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.807 -0.633 . . . . 1.79 111.975 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.699 ' HD1' ' HG2' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -69.62 3.28 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.167 0.803 . . . . 4.4500000000000002 113.167 -173.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.699 ' HG2' ' HD1' ' A' ' 35' ' ' PHE . 42.6 mmt-85 -140.13 147.89 40.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.96 0.41 . . . . 4.1399999999999997 111.541 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -76.1 145.08 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.777 -0.647 . . . . 2.6800000000000002 111.13 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 57' ' ' ASP . 62.8 p 50.86 16.38 0.32 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.2 1.0 . . . . 1.4199999999999999 112.279 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.795 ' HD3' HG23 ' A' ' 40' ' ' VAL . 5.8 tmtm? -104.17 -62.88 1.26 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.091 -1.448 . . . . 2.8999999999999999 107.091 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.967 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 31.3 t -146.95 1.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.108 0.956 . . . . 1.8300000000000001 108.636 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 28' ' ' PRO . . . -126.73 50.61 0.87 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.538 -0.756 . . . . 2.1699999999999999 112.461 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -90.96 168.34 14.0 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.524 . . . . 1.1200000000000001 109.587 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 48.4 Cg_endo -69.53 54.97 1.14 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.729 2.286 . . . . 1.48 114.056 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HB2' HG12 ' A' ' 56' ' ' ILE . 55.1 tp -164.92 -96.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.41 -0.359 . . . . 1.75 110.518 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.625 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 104.85 -59.09 0.45 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.75 112.38 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 24' ' ' LEU . 78.9 t -136.74 141.2 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 122.784 -0.245 . . . . 0.59999999999999998 110.37 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.77 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 7.1 t70 -112.36 113.38 25.56 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.491 -0.559 . . . . 1.1100000000000001 109.491 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -79.2 -31.9 43.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.017 0.377 . . . . 2.8100000000000001 112.017 -175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -83.66 -34.84 24.92 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 3.1699999999999999 110.9 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.8 -35.87 30.43 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.606 -0.807 . . . . 1.53 111.718 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' HB ' ' A' ' 68' ' ' ILE . . . 85.26 54.24 2.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.429 -0.668 . . . . 0.77000000000000002 111.429 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -160.65 165.0 31.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 3.7200000000000002 110.949 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.64 117.82 33.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.756 -0.461 . . . . 1.28 109.756 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.77 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -164.36 152.27 12.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.491 . . . . 1.6599999999999999 109.99 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 2.2 mp0 -112.59 160.53 17.76 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.521 -0.548 . . . . 2.1200000000000001 109.521 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 44' ' ' LEU . 44.4 mm -77.14 103.92 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.864 0.364 . . . . 0.92000000000000004 110.091 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 38' ' ' THR . 4.6 t70 -90.78 170.4 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.97 110.117 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.91 -37.19 64.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.65 0.982 . . . . 2.4300000000000002 113.65 -165.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.617 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.3 OUTLIER -86.6 -0.76 56.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.223 -0.591 . . . . 2.3900000000000001 111.56 -178.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.79 72.87 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.648 -1.263 . . . . 2.29 114.064 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 53.0 29.7 8.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.491 0.552 . . . . 2.3100000000000001 112.491 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.574 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 13.7 tp10 -85.73 75.88 10.02 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.404 -0.591 . . . . 2.6099999999999999 109.404 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HE1' ' O ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -126.96 163.5 23.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.003 -0.544 . . . . 3.7200000000000002 111.78 177.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.853 HG22 ' HG3' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -134.58 121.26 20.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.734 . . . . 2.27 109.89 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.803 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 3.7 t80 -144.83 -66.7 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 119.787 -0.765 . . . . 6.4800000000000004 113.057 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -158.64 165.14 33.9 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.909 -1.615 . . . . 1.23 114.732 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 82' ' ' ARG . 5.6 mp -113.39 107.35 15.74 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.268 0.627 . . . . 1.1699999999999999 110.342 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.863 HG21 HG23 ' A' ' 71' ' ' VAL . 65.0 mt -70.6 116.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.407 -0.917 . . . . 0.60999999999999999 110.385 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -90.35 -24.67 20.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.85 -0.613 . . . . 2.0 109.4 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 65.7 tttt -170.99 123.7 0.61 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.957 -0.565 . . . . 1.53 111.623 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 68' ' ' ILE . 95.0 t -106.32 113.5 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.959 -0.756 . . . . 0.88 108.959 169.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -117.6 72.1 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.818 -0.353 . . . . 1.4199999999999999 110.11 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 45.17 -168.2 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 124.615 1.197 . . . . 0.95999999999999996 111.9 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.1 Cg_exo -63.33 76.85 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.253 1.302 . . . . 0.38 111.436 166.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.16 -63.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.942 -0.572 . . . . 0.5 110.287 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -144.34 139.66 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.482 0.549 . . . . 0.34999999999999998 112.482 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.96 109.7 6.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.73999999999999999 109.261 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 70' ' ' LYS . 1.2 p -101.5 113.54 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.519 -0.549 . . . . 0.67000000000000004 109.519 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.535 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -129.39 141.39 46.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.55 -0.75 . . . . 0.75 110.724 -177.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.528 ' HA2' ' H ' ' A' ' 96' ' ' GLU . . . -89.5 172.79 39.75 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.951 -0.568 . . . . 0.5 112.859 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.816 ' H ' ' HB2' ' A' ' 95' ' ' SER . 73.0 t-105 -90.22 156.46 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.517 0.199 . . . . 2.79 111.3 -172.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.853 ' HG3' HG22 ' A' ' 64' ' ' THR . 18.1 tpt180 177.86 42.31 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.854 -0.612 . . . . 5.46 110.483 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.803 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 84.1 133.35 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.895 0.478 . . . . 1.55 111.135 169.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.601 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 31.2 t30 -93.66 75.35 4.35 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.588 -0.523 . . . . 1.9299999999999999 109.588 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.46 -62.68 3.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.602 -0.809 . . . . 2.3999999999999999 113.609 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -168.41 138.06 2.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.465 0.174 . . . . 5.3799999999999999 110.937 -172.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.61 38.1 3.79 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.754 -0.736 . . . . 2.2999999999999998 114.232 170.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.842 ' NH1' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -148.19 163.32 37.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.372 0.586 . . . . 4.7699999999999996 111.021 177.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.592 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -122.17 114.59 43.28 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 122.471 0.308 . . . . 1.8600000000000001 111.357 176.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.842 ' HB3' ' NH1' ' A' ' 88' ' ' ARG . 6.5 t70 -170.22 108.43 0.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 3.1800000000000002 109.557 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD2' ' CZ ' ' A' ' 128' ' ' ARG . 45.1 Cg_endo -87.66 30.48 0.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.835 2.357 . . . . 2.3599999999999999 111.466 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.586 ' HB2' HH21 ' A' ' 128' ' ' ARG . 3.4 t70 -84.76 170.62 13.04 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.752 0.787 . . . . 2.9900000000000002 110.793 -165.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.37 15.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.345 -1.298 . . . . 3.0600000000000001 109.897 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.48 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 14.8 m -131.67 -78.62 0.51 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.251 -0.886 . . . . 1.8500000000000001 109.14 170.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.816 ' HB2' ' H ' ' A' ' 81' ' ' TRP . 19.9 m 47.92 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.206 1.002 . . . . 1.4399999999999999 112.006 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.528 ' H ' ' HA2' ' A' ' 80' ' ' GLY . 49.4 tt0 77.59 112.67 0.07 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 1.8100000000000001 112.979 163.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.575 ' HB2' HG13 ' A' ' 113' ' ' VAL . 51.0 p90 -127.56 124.26 37.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.64000000000000001 110.106 167.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.473 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 41.8 m -88.16 109.2 19.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.384 -0.826 . . . . 0.42999999999999999 109.703 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 113' ' ' VAL . 62.0 t -82.41 110.06 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.395 . . . . 0.87 110.009 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.488 ' HA ' HG22 ' A' ' 76' ' ' THR . 28.2 m -103.17 107.31 18.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.45000000000000001 110.518 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.712 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 43.7 m-85 -90.38 111.16 22.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.294 -0.412 . . . . 0.34000000000000002 110.214 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.3 t -93.04 112.61 26.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.914 -0.402 . . . . 0.54000000000000004 109.914 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.54 126.98 31.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.306 -0.406 . . . . 0.44 110.607 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 50.7 m-20 -119.17 114.76 22.94 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.367 -0.379 . . . . 2.0299999999999998 110.49 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.91 -102.84 1.27 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.029 -0.605 . . . . 1.97 112.706 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -145.15 -23.32 0.49 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.807 0.337 . . . . 4.9299999999999997 110.485 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 21.6 pttp -142.93 34.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 3.5299999999999998 111.625 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 56.2 tttm -136.21 148.18 47.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.235 -0.654 . . . . 2.4399999999999999 109.235 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.3 m -155.33 122.19 5.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.159 0.504 . . . . 0.41999999999999998 111.499 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -94.38 116.77 29.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.288 -0.869 . . . . 2.5899999999999999 109.839 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.712 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 p -94.5 134.93 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 109.331 -0.618 . . . . 0.40000000000000002 109.331 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.13 114.1 13.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.968 -1.015 . . . . 1.3799999999999999 109.405 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 99' ' ' VAL . 2.4 t -106.87 122.87 61.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.178 -0.919 . . . . 0.91000000000000003 111.809 -171.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 25.8 mt-10 -98.21 110.76 23.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.248 -0.433 . . . . 2.3100000000000001 110.067 171.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.579 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.9 t-80 -105.16 103.64 13.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.977 -1.49 . . . . 1.6399999999999999 106.977 171.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -153.84 96.99 2.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.368 -0.533 . . . . 2.6699999999999999 110.749 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.628 ' O ' ' HG2' ' A' ' 121' ' ' MET . 1.5 t60 -166.51 -76.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.786 -0.643 . . . . 2.6299999999999999 109.552 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 94' ' ' SER . 4.4 m-85 -85.45 -23.71 27.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.529 0.937 . . . . 3.54 113.529 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.31 -53.34 59.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.674 0.749 . . . . 1.8100000000000001 110.69 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.89 -17.46 64.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.662 -1.153 . . . . 3.3799999999999999 111.446 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 93.6 mmm -73.74 27.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.889 0.7 . . . . 2.4300000000000002 112.889 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.92 -175.42 21.85 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 118.798 -1.668 . . . . 1.6100000000000001 114.016 166.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 -53.7 7.74 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.522 -0.839 . . . . 2.5800000000000001 110.959 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.768 ' HA ' ' HB2' ' A' ' 127' ' ' LYS . 20.3 pttp -89.28 -11.7 42.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.922 0.712 . . . . 3.7999999999999998 112.922 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.727 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 16.1 m80 -62.45 -53.4 55.36 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.998 -0.681 . . . . 2.1400000000000001 109.556 167.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.92000000000000004 110.996 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.768 ' HB2' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mttp -66.63 -33.01 74.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 111.94 0.348 . . . . 2.8300000000000001 111.94 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 27.4 ptt180 -69.89 -52.9 20.83 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.479 -0.488 . . . . 2.5899999999999999 109.728 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.508 HG12 ' SD ' ' A' ' 133' ' ' MET . 35.0 t -56.48 -33.84 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.206 0.527 . . . . 1.48 111.133 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.36 -16.47 14.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.044 0.938 . . . . 3.8300000000000001 112.502 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.483 HD22 ' HA ' ' A' ' 88' ' ' ARG . 5.6 t30 -56.06 -40.75 74.02 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.032 0.752 . . . . 2.48 113.032 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.31 19.16 0.23 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.015 -1.564 . . . . 1.6100000000000001 114.095 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.508 ' SD ' HG12 ' A' ' 129' ' ' VAL . 17.7 ptt? -80.29 -27.66 38.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.667 0.733 . . . . 4.8300000000000001 109.683 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -80.54 -13.57 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 2.8300000000000001 111.932 -170.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.463 ' NZ ' ' HB2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -92.88 1.75 57.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.804 0.335 . . . . 4.1500000000000004 110.539 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.635 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.89 -55.38 0.14 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.123 -1.037 . . . . 1.04 113.048 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.503 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 61.7 t-105 -53.81 -52.76 64.77 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.534 0.568 . . . . 2.7799999999999998 112.534 -171.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 25.1 Cg_endo -60.97 -45.42 19.99 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.595 1.53 . . . . 0.68000000000000005 111.768 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.1 m -59.64 -38.7 82.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.652 0.739 . . . . 0.87 110.108 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.902 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 14.0 mt -68.04 -41.67 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.126 -0.943 . . . . 0.71999999999999997 110.766 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 55.0 mt -63.88 -32.93 74.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.68999999999999995 111.53 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -48.0 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.62 0.248 . . . . 1.49 110.999 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 31.9 m -71.38 -25.9 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.1499999999999999 110.817 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.52 -55.37 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.672 -0.695 . . . . 0.80000000000000004 109.941 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.458 ' CG ' HG13 ' A' ' 10' ' ' VAL . 47.3 mt-30 -64.94 -27.6 68.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.905 -0.589 . . . . 1.6299999999999999 110.522 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 2.8 t70 -67.95 -55.35 13.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 1.46 111.133 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.793 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 16.7 tptm -64.12 -39.87 94.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.267 -0.573 . . . . 1.74 110.638 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.659 HG21 ' HB ' ' A' ' 12' ' ' VAL . 67.7 mt -63.66 -34.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.5 110.723 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.566 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 18.4 t70 -66.86 -32.06 73.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.814 -0.439 . . . . 0.84999999999999998 109.814 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.961 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 35.4 mt-10 -67.84 -33.11 74.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.235 0.54 . . . . 1.5 110.194 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 4.6 mm-40 -79.68 -12.96 59.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.375 -0.83 . . . . 1.74 110.172 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.53 -75.16 1.14 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.713 -0.676 . . . . 1.3200000000000001 112.862 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -151.24 35.88 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.982 0.391 . . . . 1.9199999999999999 111.777 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.961 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 12.4 tppt? -75.44 -10.93 59.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.44 0.638 . . . . 2.04 109.642 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.0 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.484 -0.78 . . . . 4.2199999999999998 109.833 -176.508 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.4 p-10 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.209 -0.293 . . . . 1.6599999999999999 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 1.2 t80 80.59 -50.71 0.32 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.584 0.552 . . . . 3.73 111.372 172.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.686 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.1 t70 -61.87 -49.41 85.9 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.092 -0.243 . . . . 2.7799999999999998 111.213 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.0 Cg_endo -92.47 -65.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.964 1.776 . . . . 1.6299999999999999 111.871 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.31 156.76 44.0 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.182 -1.414 . . . . 3.21 107.182 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.924 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 88.7 t -85.62 124.05 39.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.657 -0.817 . . . . 1.4399999999999999 109.828 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 14.0 ttp180 -128.82 138.04 51.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.954 0.407 . . . . 3.3700000000000001 110.865 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.526 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -115.3 132.33 56.65 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.987 -1.116 . . . . 0.79000000000000004 107.987 170.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 1.0 OUTLIER -136.16 110.47 8.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.746 0.784 . . . . 1.28 109.437 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.469 HG13 ' CG ' ' A' ' 145' ' ' GLN . 1.7 t -125.43 142.6 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.434 -1.257 . . . . 1.27 110.966 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -102.33 115.19 30.04 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.279 0.561 . . . . 0.56999999999999995 109.742 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.817 HG13 HG21 ' A' ' 148' ' ' ILE . 39.6 t -95.07 128.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.824 -0.626 . . . . 0.91000000000000003 110.316 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.678 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.59 32.79 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.97999999999999998 111.387 -173.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.41 26.87 0.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.586 -0.279 . . . . 0.35999999999999999 111.666 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.618 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 27.4 t70 73.97 168.42 0.3 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.175 0.512 . . . . 0.91000000000000003 112.349 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 12.1 ttp180 -69.12 -33.32 73.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.858 -0.61 . . . . 1.8799999999999999 111.815 -170.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.618 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 13.7 pttm -59.01 -43.05 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 3.0499999999999998 110.566 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -72.51 -37.47 68.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.339 -0.391 . . . . 1.1100000000000001 110.878 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -60.23 -46.25 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.32000000000000001 110.429 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -69.42 -45.81 68.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.38 110.607 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.774 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 23.6 tptp -53.47 -50.62 64.94 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.137 -0.483 . . . . 2.3900000000000001 110.736 176.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -68.61 -50.15 53.7 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.085 -0.246 . . . . 0.68000000000000005 111.011 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.684 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 68.6 t80 -65.45 -39.35 91.92 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.039 0.385 . . . . 0.47999999999999998 112.039 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 46' ' ' VAL . 14.4 tp -109.54 -49.41 3.11 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.021 -0.672 . . . . 0.5 112.035 -176.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.776 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 30.3 mt-10 -87.72 10.79 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.19 0.519 . . . . 1.24 110.598 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.73 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -143.83 26.12 2.08 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.82999999999999996 110.896 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 46.8 t80 -49.32 -49.52 70.17 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.41 . . . . 0.73999999999999999 111.45 -177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.9 Cg_endo -90.52 25.32 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.106 1.871 . . . . 0.76000000000000001 114.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.1 pt-20 -112.12 -9.91 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.785 -0.766 . . . . 1.49 111.753 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.684 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 11.4 m0 -71.84 152.05 42.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.348 0.594 . . . . 4.6200000000000001 111.163 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.637 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.9 m95 -75.28 -43.58 4.42 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.433 -0.803 . . . . 2.7799999999999998 113.131 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 31' ' ' TRP . 14.3 Cg_endo -53.98 -71.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.019 2.479 . . . . 1.3600000000000001 114.684 -165.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' HB3' HD11 ' A' ' 140' ' ' ILE . 8.9 t30 -117.51 -19.98 9.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.339 0.59 . . . . 1.51 110.294 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.674 ' HA ' HG23 ' A' ' 40' ' ' VAL . 10.0 m120 -92.75 20.2 6.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 1.79 111.806 -169.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -99.16 15.15 26.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.411 0.624 . . . . 4.4500000000000002 110.137 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -106.29 149.97 26.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.925 -0.58 . . . . 4.1399999999999997 110.752 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 p -76.74 136.82 39.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.102 -0.332 . . . . 2.6800000000000002 110.102 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.841 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 43.6 p 66.22 -47.63 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.835 1.254 . . . . 1.4199999999999999 111.759 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 85.1 tttt -71.11 89.28 0.82 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 122.771 0.429 . . . . 2.8999999999999999 110.142 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.674 HG23 ' HA ' ' A' ' 34' ' ' ASN . 34.5 m 49.07 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.952 1.301 . . . . 1.8300000000000001 113.031 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.31 17.0 2.71 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.674 -0.774 . . . . 2.1699999999999999 112.704 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.85 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -74.11 166.84 41.05 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.004 -0.739 . . . . 1.1200000000000001 109.004 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.9 49.67 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 123.055 2.503 . . . . 1.48 114.011 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.6 tp -162.52 -92.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.586 0.231 . . . . 1.75 110.714 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.768 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.05 -54.62 3.28 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.869 -0.681 . . . . 0.75 112.361 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 24' ' ' LEU . 60.3 t -140.34 140.22 34.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.59999999999999998 110.318 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -109.79 110.0 20.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.214 -0.661 . . . . 1.1100000000000001 109.214 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.776 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 7.8 mtpm? -79.55 -20.48 46.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.068 -0.515 . . . . 2.8100000000000001 111.689 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -83.64 -44.01 15.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.844 -0.342 . . . . 3.1699999999999999 110.943 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.7 -30.44 18.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.116 -0.564 . . . . 1.53 112.248 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.64 54.2 2.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.682 . . . . 0.77000000000000002 112.76 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -142.65 150.2 39.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.507 -0.408 . . . . 3.7200000000000002 110.661 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.558 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 17.2 m0 -105.38 114.08 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.675 -0.491 . . . . 1.28 109.675 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.34 148.48 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.207 -0.294 . . . . 1.6599999999999999 110.207 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.6 mp0 -119.58 160.58 22.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.952 -0.759 . . . . 2.1200000000000001 108.952 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.98 114.05 16.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.955 0.407 . . . . 0.92000000000000004 110.338 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.668 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.0 t70 -105.15 -170.76 1.8 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.785 -0.643 . . . . 1.97 110.113 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 12.7 pt-20 -71.84 -38.94 70.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.722 0.638 . . . . 2.4300000000000002 112.722 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -88.11 4.19 46.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.173 -0.611 . . . . 2.3900000000000001 110.979 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.69 -106.23 0.41 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.943 -1.122 . . . . 2.29 113.278 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -134.84 21.74 3.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.907 0.384 . . . . 2.3100000000000001 111.071 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -96.07 77.57 3.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.626 0.727 . . . . 2.6099999999999999 110.625 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.668 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -122.81 125.7 45.95 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.229 -0.896 . . . . 3.7200000000000002 110.214 174.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.668 ' HB ' ' HG2' ' A' ' 82' ' ' ARG . 70.2 p 62.03 -66.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.779 1.299 . . . . 2.27 113.363 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 t80 74.26 72.52 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.698 0.799 . . . . 6.4800000000000004 110.702 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -83.48 150.48 27.08 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.552 -0.749 . . . . 1.23 112.301 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -108.1 92.52 4.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.828 0.347 . . . . 1.1699999999999999 111.563 -172.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 71' ' ' VAL . 25.2 mt -72.04 136.15 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.60999999999999999 110.06 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -110.13 -24.23 10.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 2.0 109.905 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 20.5 ttmm -162.16 119.75 2.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.879 -0.6 . . . . 1.53 111.261 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 68' ' ' ILE . 60.4 t -108.54 96.16 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.472 -0.936 . . . . 0.88 108.472 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -105.41 65.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.928 -0.309 . . . . 1.4199999999999999 110.53 -174.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 15.5 pt-20 48.07 -170.59 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 O-C-N 124.514 1.134 . . . . 0.95999999999999996 111.926 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.513 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.1 Cg_exo -64.7 75.98 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.388 1.392 . . . . 0.38 111.545 169.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.3 t70 -160.17 -66.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.312 -0.858 . . . . 0.5 110.214 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.4 p -143.85 143.45 31.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.17 0.509 . . . . 0.34999999999999998 112.277 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.8 mp -133.53 121.84 22.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.73999999999999999 109.831 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 45.5 t -109.57 104.72 17.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.194 -0.669 . . . . 0.67000000000000004 109.194 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.493 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.97 146.22 34.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.554 0.216 . . . . 0.75 111.076 -178.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.76 148.54 18.86 Favored Glycine 0 C--O 1.24 0.486 0 CA-C-N 116.223 -0.444 . . . . 0.5 112.54 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -77.06 154.57 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.927 0.491 . . . . 2.79 112.322 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.668 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -153.95 23.22 0.5 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 5.46 109.463 -176.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 79.85 -164.66 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.815 -1.084 . . . . 1.55 109.933 -172.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.627 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 32.7 t30 -137.87 -70.94 0.43 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.492 -0.322 . . . . 1.9299999999999999 110.524 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' PHE . . . -72.58 -11.27 76.9 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.584 -0.817 . . . . 2.3999999999999999 113.353 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 85' ' ' GLY . 86.2 t80 71.82 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.485 0.659 . . . . 5.3799999999999999 110.964 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -27.82 3.54 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.525 -0.761 . . . . 2.2999999999999998 111.314 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.69 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -94.17 -175.98 3.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 120.907 0.384 . . . . 4.7699999999999996 110.505 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.775 HD13 ' HE ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -71.53 129.72 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.551 -0.749 . . . . 1.8600000000000001 111.491 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 p-10 -99.57 121.03 56.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.393 0.616 . . . . 3.1800000000000002 109.856 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HB2' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -84.06 36.42 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.204 2.603 . . . . 2.3599999999999999 111.556 178.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.73 76.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.806 0.812 . . . . 2.9900000000000002 111.594 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -143.77 -47.25 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.402 -1.333 . . . . 3.0600000000000001 107.402 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 m -136.87 -95.3 0.22 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.778 -1.556 . . . . 1.8500000000000001 108.192 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' A' ' 91' ' ' PRO . 66.7 m 48.92 23.83 0.76 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.076 0.55 . . . . 1.4399999999999999 112.409 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 33.4 mt-10 -75.1 138.97 42.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.651 -0.704 . . . . 1.8100000000000001 109.619 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CE2' HG23 ' A' ' 79' ' ' ILE . 4.8 p90 -133.26 132.01 40.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.173 0.511 . . . . 0.64000000000000001 110.543 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 25.8 m -91.4 108.47 19.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.063 -0.971 . . . . 0.42999999999999999 109.921 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.828 ' HA ' HG22 ' A' ' 113' ' ' VAL . 95.5 t -81.5 108.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 0.87 109.326 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.517 ' HA ' HG22 ' A' ' 76' ' ' THR . 19.3 m -101.68 105.75 16.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.272 -0.422 . . . . 0.45000000000000001 110.222 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.548 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.3 m-85 -90.28 111.9 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.385 -0.37 . . . . 0.34000000000000002 110.192 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.21 106.64 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 0.54000000000000004 109.588 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.41 125.09 28.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.619 . . . . 0.44 110.768 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 28.4 t70 -116.03 114.42 24.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.805 -0.634 . . . . 2.0299999999999998 110.1 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.47 -114.65 6.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.618 -0.801 . . . . 1.97 111.666 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -146.64 13.5 1.19 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.176 0.512 . . . . 4.9299999999999997 110.228 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -145.57 -5.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.969 0.729 . . . . 3.5299999999999998 112.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 29.5 ttpt -123.38 154.01 39.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.602 -0.686 . . . . 2.4399999999999999 110.304 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.8 m -157.56 114.17 2.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.146 0.498 . . . . 0.41999999999999998 110.973 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -88.3 119.87 29.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.823 -0.626 . . . . 2.5899999999999999 109.616 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.1 p -96.18 132.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.249 -0.58 . . . . 0.40000000000000002 109.588 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.54 109.31 12.01 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.561 -0.903 . . . . 1.3799999999999999 108.561 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 99' ' ' VAL . 28.6 t -98.83 120.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.029 -0.987 . . . . 0.91000000000000003 110.991 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.24 119.23 38.46 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.684 0.754 . . . . 2.3100000000000001 109.431 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.924 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 16.6 t60 -102.74 152.2 21.51 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.595 -1.184 . . . . 1.6399999999999999 109.016 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 118' ' ' PHE . 11.7 t -54.67 169.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.231 1.015 . . . . 2.6699999999999999 111.604 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -93.92 14.84 18.32 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.503 -1.226 . . . . 2.6299999999999999 111.124 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.506 ' H ' HG23 ' A' ' 116' ' ' THR . 16.2 t80 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.059 0.456 . . . . 3.54 110.09 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -30.51 59.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.142 -0.688 . . . . 1.8100000000000001 109.142 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 57.5 ttt180 -60.29 -19.82 56.61 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.918 -1.037 . . . . 3.3799999999999999 111.397 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 87.9 mmm -61.22 -15.44 34.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 2.4300000000000002 110.271 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.98 -140.38 26.94 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.595 -0.729 . . . . 1.6100000000000001 113.134 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 16.8 p 36.22 -108.44 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 O-C-N 124.766 0.921 . . . . 2.5800000000000001 112.813 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -84.81 -34.55 22.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 3.7999999999999998 111.102 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -63.7 -50.33 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 2.1400000000000001 110.71 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 -25.79 59.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.495 -0.32 . . . . 0.92000000000000004 110.667 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' THR . 46.9 tptt -56.51 -52.23 65.53 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.969 0.414 . . . . 2.8300000000000001 110.403 174.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.775 ' HE ' HD13 ' A' ' 89' ' ' ILE . 9.5 ptm85 -72.24 -30.31 64.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.68 -0.691 . . . . 2.5899999999999999 111.9 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.5 -39.18 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 1.48 111.589 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -62.79 -16.04 56.37 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.264 -0.425 . . . . 3.8300000000000001 112.067 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 128' ' ' ARG . 65.5 m-80 -54.99 -24.86 26.2 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.907 0.706 . . . . 2.48 112.907 -175.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -134.74 -24.09 0.61 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.641 -1.266 . . . . 1.6100000000000001 114.105 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.438 ' SD ' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -73.5 -26.08 60.73 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.431 -0.452 . . . . 4.8300000000000001 112.0 -172.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.99 -14.63 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.388 . . . . 2.8300000000000001 110.886 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -115.21 16.38 16.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.734 0.778 . . . . 4.1500000000000004 109.47 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.68 -91.26 2.21 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.466 -0.788 . . . . 1.04 112.526 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 20.2 m95 -54.89 -47.58 97.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.681 0.993 . . . . 2.7799999999999998 113.681 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.2 Cg_endo -52.82 -40.04 75.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.813 1.676 . . . . 0.68000000000000005 112.446 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 38.9 m -78.15 -43.32 29.11 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.631 0.729 . . . . 0.87 110.102 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.624 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.2 mt -59.79 -51.97 66.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 115.105 -0.952 . . . . 0.71999999999999997 111.734 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 78.7 mt -58.94 -28.3 66.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.174 0.435 . . . . 0.68999999999999995 112.174 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.3 mm-40 -74.24 -51.74 14.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 1.49 110.296 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 14.9 t -70.52 -23.74 62.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.082 0.468 . . . . 1.1499999999999999 110.321 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.59 -51.97 66.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 0.80000000000000004 109.952 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.469 ' CG ' HG13 ' A' ' 10' ' ' VAL . 45.7 mt-30 -66.1 -28.43 68.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.599 -0.728 . . . . 1.6299999999999999 110.437 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 35.2 t70 -75.78 -43.1 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.698 . . . . 1.46 111.222 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.492 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 58.6 tttm -64.8 -40.12 94.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.065 0.46 . . . . 1.74 110.076 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.817 HG21 HG13 ' A' ' 12' ' ' VAL . 70.8 mt -68.85 -26.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.02 -0.537 . . . . 0.5 110.372 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.93 -37.78 76.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 0.84999999999999998 109.295 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.589 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 34.8 mt-10 -64.65 -46.09 83.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.18 0.991 . . . . 1.5 108.79 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 148' ' ' ILE . 2.4 tp10 -65.64 -43.63 88.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.4 -1.727 . . . . 1.74 110.506 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.35 -70.49 1.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 1.3200000000000001 112.075 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -161.81 97.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.388 . . . . 1.9199999999999999 111.28 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.0 ttmm -137.3 -46.38 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.969 -0.559 . . . . 2.04 109.678 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HD3' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.496 -0.775 . . . . 4.2199999999999998 111.176 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 25.0 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.17 0.509 . . . . 1.6599999999999999 110.784 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.844 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 41.9 p90 -168.38 -42.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.155 -0.475 . . . . 3.73 110.647 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.606 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.6 t70 -72.78 -58.67 2.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.613 -0.267 . . . . 2.7799999999999998 111.526 -173.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.13 -64.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.165 1.243 . . . . 1.6299999999999999 110.636 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 53.1 p90 -154.66 147.07 23.98 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.958 -0.564 . . . . 3.21 110.135 173.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -110.46 114.47 47.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.796 -1.187 . . . . 1.4399999999999999 107.796 164.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 28.9 ttm180 -112.67 138.65 49.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.716 -0.674 . . . . 3.3700000000000001 111.257 -173.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.579 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.57 133.83 52.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.696 -0.853 . . . . 0.79000000000000004 108.696 172.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.807 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 70.0 m -141.61 113.82 8.11 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.131 -0.486 . . . . 1.28 109.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.967 HG22 HG12 ' A' ' 111' ' ' VAL . 1.9 m -122.92 143.48 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 1.27 109.983 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.1 m -98.04 115.8 28.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.431 0.634 . . . . 0.56999999999999995 110.158 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.813 HG13 HG21 ' A' ' 148' ' ' ILE . 33.1 t -103.1 133.8 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.568 -0.742 . . . . 0.91000000000000003 109.947 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.55 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.12 30.2 6.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 0.97999999999999998 111.886 -174.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -154.23 35.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.35999999999999999 111.209 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 75.03 173.21 0.26 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-O 122.1 0.952 . . . . 0.91000000000000003 112.705 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.558 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 19.8 ttp180 -71.79 -24.75 61.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.594 -1.185 . . . . 1.8799999999999999 110.711 -171.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 19.6 tptm -61.14 -48.4 81.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 3.0499999999999998 110.671 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.2 p -70.9 -38.54 73.01 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.979 -0.288 . . . . 1.1100000000000001 111.059 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.7 -46.47 81.19 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 120.913 0.387 . . . . 0.32000000000000001 110.647 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -71.69 -47.79 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.872 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 25.6 tptp -52.33 -46.53 66.09 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 120.966 0.412 . . . . 2.3900000000000001 111.1 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 m -70.88 -49.04 50.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.192 -0.458 . . . . 0.68000000000000005 110.349 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.55 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.3 t80 -62.39 -41.08 98.38 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.231 0.456 . . . . 0.47999999999999998 112.231 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 46' ' ' VAL . 12.5 tp -113.05 -34.24 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.231 -0.588 . . . . 0.5 112.512 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.712 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 35.1 mt-10 -104.82 16.22 26.38 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.234 -0.291 . . . . 1.24 111.419 -173.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.747 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -153.87 38.74 0.69 Allowed Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.754 -0.736 . . . . 0.82999999999999996 111.482 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.615 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 61.9 t80 -53.66 -54.45 45.94 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 112.806 0.669 . . . . 0.73999999999999999 112.806 -169.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 36.5 Cg_endo -87.5 13.88 2.53 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.76000000000000001 114.496 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.7 pt-20 -97.36 -6.49 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.159 -0.616 . . . . 1.49 110.586 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.661 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 26.8 m0 -73.3 176.11 6.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.482 0.658 . . . . 4.6200000000000001 111.446 -175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.535 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 35.0 m95 -97.91 -25.19 0.23 Allowed Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 114.136 1.161 . . . . 2.7799999999999998 114.136 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 30' ' ' TRP . 72.6 Cg_endo -75.2 -151.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.726 1.617 . . . . 1.3600000000000001 114.281 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.566 ' ND2' HG21 ' A' ' 40' ' ' VAL . 9.5 t30 -44.73 -43.28 8.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.85 -1.068 . . . . 1.51 113.293 -171.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.941 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 2.0 p-10 -79.95 38.95 0.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.395 -0.821 . . . . 1.79 112.323 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -100.35 -6.23 26.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 4.4500000000000002 110.722 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 12.4 mmm180 -89.48 131.07 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.342 -0.39 . . . . 4.1399999999999997 110.751 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.6 p -76.01 137.38 40.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 2.6800000000000002 110.881 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.9 p 52.92 24.46 3.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 1.4199999999999999 111.338 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 3.0 tmtp? -121.31 -55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.496 -0.927 . . . . 2.8999999999999999 108.496 174.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.941 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 1.6 t -150.47 19.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.222 -0.659 . . . . 1.8300000000000001 109.222 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.48 41.84 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.584 -1.293 . . . . 2.1699999999999999 114.135 -166.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.925 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -67.95 173.22 3.27 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.247 -0.649 . . . . 1.1200000000000001 109.247 167.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 29.5 Cg_endo -63.44 26.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.049 2.499 . . . . 1.48 115.335 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -142.1 -88.94 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.932 -0.48 . . . . 1.75 110.81 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 95.2 -49.77 1.91 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.766 -0.73 . . . . 0.75 112.766 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 24' ' ' LEU . 85.8 t -137.12 143.38 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.59999999999999998 110.161 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.854 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 13.6 t70 -104.95 109.1 20.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.206 -0.664 . . . . 1.1100000000000001 109.206 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -80.95 -13.64 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.49 -0.777 . . . . 2.8100000000000001 112.316 -173.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -90.4 -40.05 12.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.665 0.269 . . . . 3.1699999999999999 111.573 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.68 -32.27 4.23 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.986 -0.846 . . . . 1.53 110.986 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 96.16 79.61 1.47 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.77000000000000002 111.946 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.854 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 28.6 ptt180 -157.99 165.28 35.51 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.53 -0.544 . . . . 3.7200000000000002 109.53 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.677 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -111.82 117.93 34.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.74 -0.467 . . . . 1.28 109.74 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.612 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.9 p90 -164.02 159.03 20.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.282 0.563 . . . . 1.6599999999999999 111.244 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.925 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 26.2 mt-10 -111.82 153.72 26.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.678 -0.692 . . . . 2.1200000000000001 110.2 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 mm -81.2 103.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.258 -0.645 . . . . 0.92000000000000004 109.258 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.678 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.0 t70 -90.25 -170.79 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.258 -0.275 . . . . 1.97 110.258 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 11.4 pt-20 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.883 0.327 . . . . 2.4300000000000002 111.883 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.588 ' OE1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -84.5 -10.35 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 2.3900000000000001 110.61 -178.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -86.79 0.17 Allowed Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.83 -0.623 . . . . 2.29 112.448 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . 40.0 mt-10 -148.65 37.13 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.539 0.209 . . . . 2.3100000000000001 111.285 -172.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.45 77.85 1.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.147 0.975 . . . . 2.6099999999999999 110.84 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.678 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -123.22 163.95 19.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.634 -1.166 . . . . 3.7200000000000002 110.275 172.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.604 ' HB ' ' HD2' ' A' ' 82' ' ' ARG . 7.1 p -57.98 106.22 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 2.27 111.48 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 19.2 p90 -79.61 109.31 13.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 6.4800000000000004 112.162 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -67.41 136.62 32.15 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.987 -0.845 . . . . 1.23 110.987 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.0 mp -87.91 86.88 7.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.45 0.125 . . . . 1.1699999999999999 111.166 -171.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 51' ' ' GLY . 35.5 mt -82.27 116.62 26.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.094 -1.042 . . . . 0.60999999999999999 109.568 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -103.21 -12.79 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.168 -0.923 . . . . 2.0 110.319 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 36.9 ttmt -156.81 121.12 4.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 1.53 111.511 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 77' ' ' LEU . 59.3 t -109.86 89.06 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.966 -1.124 . . . . 0.88 107.966 167.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 76' ' ' THR . 38.7 t0 -97.8 71.41 2.22 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.879 -0.328 . . . . 1.4199999999999999 110.454 -175.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.559 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 pt-20 46.42 -169.73 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 124.402 1.064 . . . . 0.95999999999999996 111.411 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -67.06 74.38 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.107 1.205 . . . . 0.38 110.914 165.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -155.0 -71.35 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.491 -0.322 . . . . 0.5 110.771 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.581 ' C ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -142.31 123.94 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.476 0.547 . . . . 0.34999999999999998 112.476 -175.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD13 ' C ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -118.73 123.2 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.862 -0.523 . . . . 0.73999999999999999 110.41 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 58.1 t -103.13 101.72 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.67000000000000004 109.251 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.32 140.92 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.138 -0.483 . . . . 0.75 111.12 -176.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.38 145.9 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.589 -0.732 . . . . 0.5 112.365 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 1.002 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 72.0 t-105 -72.99 142.62 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.581 0.586 . . . . 2.79 112.581 -174.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.604 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -145.12 44.41 1.33 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.49 -0.777 . . . . 5.46 109.32 177.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 75.95 145.46 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.337 -0.847 . . . . 1.55 111.954 176.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.629 ' N ' HD13 ' A' ' 83' ' ' LEU . 29.1 t30 -83.11 -66.59 0.87 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.047 -0.979 . . . . 1.9299999999999999 111.306 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 40' ' ' VAL . . . -91.13 29.14 7.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 2.3999999999999999 113.678 -172.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 63' ' ' HIS . 75.7 t80 67.32 -68.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.23 0.612 . . . . 5.3799999999999999 112.563 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.77 55.66 4.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.212 -0.518 . . . . 2.2999999999999998 113.944 -170.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.648 ' HB2' HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -140.53 -175.96 4.46 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.719 -0.845 . . . . 4.7699999999999996 108.719 170.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -92.44 127.66 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.251 0.548 . . . . 1.8600000000000001 111.494 -173.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' OD1' ' HD3' ' A' ' 82' ' ' ARG . 3.2 p30 -135.39 158.92 73.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.62 -0.718 . . . . 3.1800000000000002 109.15 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -91.0 -29.16 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.346 2.03 . . . . 2.3599999999999999 114.089 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.17 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.923 1.289 . . . . 2.9900000000000002 114.418 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -79.56 -20.1 47.87 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.718 -0.613 . . . . 3.0600000000000001 112.211 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 p -155.9 -90.09 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.398 -0.593 . . . . 1.8500000000000001 109.398 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 1.002 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.4 m 54.87 25.73 7.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.763 -0.653 . . . . 1.4399999999999999 111.685 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.646 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 39.2 tt0 -77.63 142.63 38.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 1.8100000000000001 112.214 -171.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 79' ' ' ILE . 6.6 p90 -139.92 141.06 36.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.64000000000000001 110.52 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 39.0 m -97.04 112.38 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.686 -0.688 . . . . 0.42999999999999999 110.387 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' THR . 84.5 t -84.43 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.87 109.71 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.469 ' HA ' HG22 ' A' ' 76' ' ' THR . 55.6 m -107.13 106.03 16.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.917 0.389 . . . . 0.45000000000000001 110.849 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.558 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 46.0 m-85 -85.08 113.38 21.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.401 -0.363 . . . . 0.34000000000000002 110.05 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.63 109.49 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.645 -0.502 . . . . 0.54000000000000004 109.645 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.67 124.21 28.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.207 0.527 . . . . 0.44 111.041 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 32.8 m-20 -106.59 125.24 50.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.318 -0.855 . . . . 2.0299999999999998 109.165 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.86 71.87 0.39 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.131 -0.486 . . . . 1.97 113.9 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 8.7 tt0 -169.6 25.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.055 -1.091 . . . . 4.9299999999999997 108.055 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 57.38 48.74 14.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.859 0.837 . . . . 3.5299999999999998 109.317 -169.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 36.1 tttp -130.22 148.8 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.561 -1.199 . . . . 2.4399999999999999 108.613 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.1 m -155.25 113.68 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.124 0.488 . . . . 0.41999999999999998 110.904 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.6 tmm_? -100.37 111.5 23.77 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.593 -0.891 . . . . 2.5899999999999999 108.593 176.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.967 HG12 HG22 ' A' ' 10' ' ' VAL . 13.0 p -85.8 145.51 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.861 -0.336 . . . . 0.40000000000000002 110.862 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -129.19 117.09 20.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 124.177 0.923 . . . . 1.3799999999999999 109.578 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -104.75 128.44 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 110.266 -0.272 . . . . 0.91000000000000003 110.266 175.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -103.63 114.82 29.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.21 -0.663 . . . . 2.3100000000000001 109.21 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.6 t60 -131.98 125.5 31.7 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.997 -1.001 . . . . 1.6399999999999999 108.864 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 5' ' ' PHE . 5.2 t -176.94 101.86 0.05 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.75 0.786 . . . . 2.6699999999999999 110.198 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.6 t-160 -166.81 -67.1 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.573 -0.74 . . . . 2.6299999999999999 110.302 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.6 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 1.2 p90 -81.83 -24.74 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.891 -0.595 . . . . 3.54 110.98 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.844 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -75.46 -52.68 10.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.505 0.722 . . . . 1.8100000000000001 111.352 -176.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 16.4 ptt180 -65.41 -16.7 63.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.213 -0.903 . . . . 3.3799999999999999 110.705 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 41.9 tpp -74.51 26.21 0.08 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.192 -0.913 . . . . 2.4300000000000002 112.721 -169.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.68 172.15 13.09 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.265 -1.445 . . . . 1.6100000000000001 114.718 166.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 m -58.03 -54.24 49.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.674 -0.763 . . . . 2.5800000000000001 111.892 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 124' ' ' LYS . 45.4 mtpt -68.48 -28.64 67.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 3.7999999999999998 110.875 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.764 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 13.4 m-70 -67.93 -47.85 67.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.207 -0.451 . . . . 2.1400000000000001 111.278 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.72 -23.42 58.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.359 -0.536 . . . . 0.92000000000000004 110.468 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -74.6 -38.16 62.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 2.8300000000000001 110.618 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.764 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 14.5 ptp180 -67.05 -28.35 68.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.738 -0.467 . . . . 2.5899999999999999 109.738 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.719 ' HA ' ' SD ' ' A' ' 133' ' ' MET . 67.5 t -65.27 -46.33 90.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.013 -0.54 . . . . 1.48 109.808 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.645 ' HA ' ' HB2' ' A' ' 134' ' ' ASP . 65.0 ttt180 -65.91 -16.28 63.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.484 -0.78 . . . . 3.8300000000000001 110.963 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.655 ' OD1' ' HA ' ' A' ' 128' ' ' ARG . 3.6 m120 -53.76 -55.55 25.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.444 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.06 -7.18 0.1 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.838 -1.172 . . . . 1.6100000000000001 114.923 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 129' ' ' VAL . 10.8 mtt -80.29 -28.11 38.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.3 -1.0 . . . . 4.8300000000000001 108.3 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.645 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 12.3 t70 -56.34 -43.44 79.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.941 -1.481 . . . . 2.8300000000000001 112.567 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -108.99 11.19 26.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 4.1500000000000004 111.872 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.548 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.12 -65.61 0.7 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.019 -1.086 . . . . 1.04 112.329 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.51 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -57.92 -48.48 97.05 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.818 0.673 . . . . 2.7799999999999998 112.818 -172.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.4 Cg_endo -58.32 -44.38 38.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.781 1.654 . . . . 0.68000000000000005 112.02 176.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 m -59.62 -42.81 93.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.559 0.695 . . . . 0.87 109.672 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.623 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.9 mt -59.38 -50.58 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.764 -1.107 . . . . 0.71999999999999997 111.345 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -34.51 74.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.282 0.475 . . . . 0.68999999999999995 112.282 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.711 ' N ' HE21 ' A' ' 142' ' ' GLN . 0.0 OUTLIER -68.45 -52.65 30.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.019 0.438 . . . . 1.49 110.542 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.449 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.1 m -68.9 -22.03 64.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.997 -0.547 . . . . 1.1499999999999999 110.575 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.97 -53.94 42.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.80000000000000004 110.109 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -60.3 -29.31 68.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.844 -0.616 . . . . 1.6299999999999999 110.046 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.83 -47.19 60.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.116 -0.947 . . . . 1.46 110.367 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -61.83 -34.15 75.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.689 . . . . 1.74 110.424 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.813 HG21 HG13 ' A' ' 12' ' ' VAL . 66.4 mt -80.78 -25.19 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.77 -0.65 . . . . 0.5 110.811 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.591 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 25.7 t0 -63.78 -24.58 67.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.84999999999999998 109.512 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 45.0 mt-10 -67.17 -26.81 66.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.214 -0.903 . . . . 1.5 110.338 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.07 -7.35 58.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 1.74 109.98 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.15 -80.26 0.67 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.839 -0.618 . . . . 1.3200000000000001 113.244 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.91 30.79 0.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.08 0.44 . . . . 1.9199999999999999 112.173 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 18.0 tppt? -61.53 -38.54 87.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 2.04 111.035 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.405 -0.807 . . . . 4.2199999999999998 111.119 -177.294 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 18.4 p-10 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.71 0.29 . . . . 1.6599999999999999 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.444 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . 6.2 p90 -179.41 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.343 -0.389 . . . . 3.73 110.575 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.878 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.2 t70 -64.85 -62.79 4.36 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.51 -0.314 . . . . 2.7799999999999998 111.299 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 10.3 Cg_endo -90.42 -57.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.697 1.598 . . . . 1.6299999999999999 111.245 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 49.7 p90 -152.12 167.36 28.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.063 -0.971 . . . . 3.21 108.849 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 4.3 m -104.57 133.65 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.271 -1.011 . . . . 1.4399999999999999 108.271 174.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.4 ttp180 -131.1 150.05 52.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.421 0.629 . . . . 3.3700000000000001 111.041 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.995 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 2.3 t-160 -119.31 132.82 55.94 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.756 -1.202 . . . . 0.79000000000000004 107.756 170.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.0 t -139.62 114.43 9.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.362 -0.535 . . . . 1.28 110.155 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.3 t -131.65 139.73 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.664 -0.698 . . . . 1.27 111.067 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -99.08 115.46 29.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.41 -0.589 . . . . 0.56999999999999995 109.41 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.829 HG13 HG21 ' A' ' 148' ' ' ILE . 45.8 t -97.14 130.5 45.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.982 -0.554 . . . . 0.91000000000000003 109.825 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.658 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.76 23.85 12.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.97999999999999998 111.517 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -147.06 29.15 0.99 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.837 -0.345 . . . . 0.35999999999999999 111.747 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 24.3 t70 72.53 165.28 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.778 0.799 . . . . 0.91000000000000003 112.566 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 17.3 ttp180 -66.1 -25.72 67.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.988 -1.006 . . . . 1.8799999999999999 111.44 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -59.78 -51.13 71.07 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.224 -0.444 . . . . 3.0499999999999998 110.985 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 42.9 p -72.17 -32.9 67.27 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.579 -0.282 . . . . 1.1100000000000001 110.62 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.4 -51.07 69.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.32000000000000001 110.635 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -69.79 -41.5 75.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.38 110.6 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 4.3 tppp? -53.87 -52.81 59.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.98 -0.554 . . . . 2.3900000000000001 110.779 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.424 HG22 ' NE1' ' A' ' 30' ' ' TRP . 6.5 m -69.63 -48.64 59.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.009 -0.541 . . . . 0.68000000000000005 110.665 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.876 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 63.1 t80 -62.16 -32.67 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.22 0.452 . . . . 0.47999999999999998 112.22 -172.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' A' ' 46' ' ' VAL . 15.1 tp -117.82 -51.27 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.754 0.65 . . . . 0.5 112.754 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.443 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 38.7 mt-10 -76.82 -20.94 55.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 1.24 111.355 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.667 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -118.95 36.24 3.64 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.843 -0.694 . . . . 0.82999999999999996 111.98 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.517 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 58.4 t80 -53.01 -51.74 71.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.629 0.603 . . . . 0.73999999999999999 112.629 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 41.1 Cg_endo -87.5 12.39 2.93 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.757 1.638 . . . . 0.76000000000000001 114.821 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 7.8 pt-20 -102.89 -4.93 24.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.295 -0.562 . . . . 1.49 111.577 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.876 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 34.8 m0 -69.4 168.83 13.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.464 0.65 . . . . 4.6200000000000001 111.873 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.501 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 56.5 m95 -86.02 -38.03 0.56 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 114.978 -1.01 . . . . 2.7799999999999998 113.435 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.765 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 58.0 Cg_endo -68.65 -105.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.375 2.05 . . . . 1.3600000000000001 115.071 -165.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' ND2' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -79.65 -42.65 24.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.02 0.438 . . . . 1.51 111.051 -175.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -81.88 68.03 8.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.535 0.684 . . . . 1.79 111.08 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.01 12.06 4.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.091 -0.959 . . . . 4.4500000000000002 109.627 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.445 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -126.47 137.2 53.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.862 -0.608 . . . . 4.1399999999999997 111.252 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -77.09 141.19 40.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 2.6800000000000002 110.89 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 56.0 p 55.47 18.43 2.66 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.84 0.856 . . . . 1.4199999999999999 112.3 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.563 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 45.9 tttp -110.7 -61.85 1.62 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.801 -0.814 . . . . 2.8999999999999999 108.801 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.634 HG11 ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -157.46 25.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.887 -1.051 . . . . 1.8300000000000001 110.035 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.36 36.34 0.24 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.305 -0.95 . . . . 2.1699999999999999 113.27 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.006 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.96 170.42 13.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.678 -0.49 . . . . 1.1200000000000001 109.678 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.25 67.79 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.698 2.265 . . . . 1.48 113.071 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -175.35 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.554 -0.748 . . . . 1.75 110.16 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.517 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 87.05 -58.68 4.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.963 -0.636 . . . . 0.75 112.474 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 24' ' ' LEU . 91.9 t -135.69 137.91 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.926 0.393 . . . . 0.59999999999999998 110.907 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.651 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 23.7 t70 -103.8 99.36 9.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.749 -0.834 . . . . 1.1100000000000001 108.749 173.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -80.76 -9.13 59.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.309 -0.859 . . . . 2.8100000000000001 111.186 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -68.18 -55.58 11.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.984 -0.553 . . . . 3.1699999999999999 110.583 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.12 -54.08 1.05 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.958 -0.639 . . . . 1.53 111.658 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 132.13 64.19 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.82 -0.705 . . . . 0.77000000000000002 112.648 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.76 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 21.4 ptt180 -149.34 140.21 22.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.636 0.255 . . . . 3.7200000000000002 111.54 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.736 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.4 m0 -97.21 108.23 20.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.67 -0.241 . . . . 1.28 110.591 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.651 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.3 p90 -158.25 176.15 12.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.453 . . . . 1.6599999999999999 110.966 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 18.5 mt-10 -130.6 155.19 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 2.1200000000000001 110.595 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.648 HG23 ' HG2' ' A' ' 61' ' ' GLU . 37.4 mm -78.22 103.0 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.499 -0.926 . . . . 0.92000000000000004 108.499 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.659 ' OD2' ' HG3' ' A' ' 59' ' ' GLN . 12.5 t70 -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.169 -0.468 . . . . 1.97 109.963 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.18 -6.92 58.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.78 0.659 . . . . 2.4300000000000002 112.78 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.659 ' HG3' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -90.12 7.3 38.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.473 -0.891 . . . . 2.3900000000000001 110.471 170.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.42 62.11 0.45 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.953 -0.641 . . . . 2.29 113.76 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.648 ' HG2' HG23 ' A' ' 56' ' ' ILE . 40.0 mt-10 44.74 54.07 6.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.281 0.845 . . . . 2.3100000000000001 113.281 171.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' H ' HE22 ' A' ' 59' ' ' GLN . 0.8 OUTLIER -127.77 84.68 2.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.413 0.625 . . . . 2.6099999999999999 110.143 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -124.54 158.42 32.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.197 -0.91 . . . . 3.7200000000000002 109.593 172.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -59.65 142.03 53.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.251 -0.648 . . . . 2.27 109.251 170.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.76 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 p90 -121.83 117.48 26.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.097 0.475 . . . . 6.4800000000000004 111.187 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -57.15 134.28 52.36 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-N 115.235 -0.893 . . . . 1.23 111.754 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.69 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -92.26 88.1 6.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.191 0.52 . . . . 1.1699999999999999 110.668 -171.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 58.2 mt -74.17 121.32 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.202 0.525 . . . . 0.60999999999999999 110.382 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -31.09 24.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.603 -0.726 . . . . 2.0 109.539 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -160.21 119.92 2.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 1.53 111.819 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 68' ' ' ILE . 60.8 t -99.6 100.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.152 -1.055 . . . . 0.88 108.152 167.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -108.48 70.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.768 -0.373 . . . . 1.4199999999999999 110.96 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 pt-20 47.03 -170.39 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 124.471 1.107 . . . . 0.95999999999999996 111.722 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.8 Cg_exo -64.23 75.21 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.474 1.449 . . . . 0.38 111.342 166.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -157.35 -62.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.75 -0.659 . . . . 0.5 110.413 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -147.75 148.37 30.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.324 0.49 . . . . 0.34999999999999998 112.324 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 mp -136.59 114.92 11.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.73999999999999999 109.416 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.623 HG22 HG23 ' A' ' 98' ' ' THR . 36.4 t -101.33 104.9 16.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.897 -0.779 . . . . 0.67000000000000004 108.897 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -128.55 144.7 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.826 0.346 . . . . 0.75 111.293 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.69 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -98.47 159.56 20.46 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.5 112.717 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.9 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -64.56 157.21 27.5 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 112.794 0.664 . . . . 2.79 112.794 -168.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.2 tmt_? -149.96 -2.19 0.41 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.502 -0.772 . . . . 5.46 110.373 -167.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 88' ' ' ARG . 3.1 tm? 71.19 133.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.468 -0.787 . . . . 1.55 110.882 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.634 ' OD1' HG11 ' A' ' 40' ' ' VAL . 55.5 t30 -108.15 135.94 48.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.9299999999999999 110.324 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.563 ' HA2' ' HE3' ' A' ' 39' ' ' LYS . . . 106.08 -17.21 41.57 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.564 -0.827 . . . . 2.3999999999999999 112.732 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 t80 69.87 -54.62 0.61 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.139 0.575 . . . . 5.3799999999999999 111.83 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.34 10.78 47.82 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.947 -0.461 . . . . 2.2999999999999998 111.947 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.696 ' HB3' HD11 ' A' ' 83' ' ' LEU . 1.9 tpp180 -97.33 167.89 10.74 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.559 -1.275 . . . . 4.7699999999999996 107.559 173.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.687 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -113.4 123.22 68.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 119.927 -0.709 . . . . 1.8600000000000001 112.023 -173.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 16.8 t70 -160.17 131.37 3.87 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 108.35 -0.981 . . . . 3.1800000000000002 108.35 166.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 128' ' ' ARG . 7.9 Cg_exo -73.63 1.71 6.62 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.749 2.299 . . . . 2.3599999999999999 113.393 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 60.68 81.17 0.19 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.463 -0.569 . . . . 2.9900000000000002 109.463 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -126.96 -64.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.219 0.452 . . . . 3.0600000000000001 112.219 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -124.19 -145.41 0.34 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.22 -0.446 . . . . 1.8500000000000001 111.24 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.9 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 9.2 t 73.16 67.93 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.28 -0.873 . . . . 1.4399999999999999 111.385 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.88 98.4 10.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.487 -0.779 . . . . 1.8100000000000001 109.847 172.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HA ' ' HB2' ' A' ' 115' ' ' HIS . 7.5 p90 -104.83 130.98 52.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.168 -0.613 . . . . 0.64000000000000001 111.323 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.623 HG23 HG22 ' A' ' 78' ' ' VAL . 12.6 m -91.99 110.49 21.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.413 -0.812 . . . . 0.42999999999999999 110.655 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.764 ' HA ' HG22 ' A' ' 113' ' ' VAL . 60.2 t -82.3 109.27 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.394 -0.595 . . . . 0.87 109.394 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.545 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.1 m -101.57 106.92 18.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.321 -0.399 . . . . 0.45000000000000001 110.732 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.722 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.4 m-85 -88.94 107.31 18.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.551 -0.537 . . . . 0.34000000000000002 109.551 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -93.13 108.98 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.494 -0.558 . . . . 0.54000000000000004 109.494 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.77 141.01 58.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.832 -0.622 . . . . 0.44 111.014 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.711 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 7.3 t70 -126.65 92.64 3.59 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.043 -0.526 . . . . 2.0299999999999998 109.593 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.15 -108.44 2.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.74 -0.743 . . . . 1.97 112.436 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -140.96 -2.43 1.31 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.714 0.265 . . . . 4.9299999999999997 111.714 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -3.17 1.34 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.758 0.651 . . . . 3.5299999999999998 112.758 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 49.1 tttm -127.46 157.08 41.02 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.486 -0.486 . . . . 2.4399999999999999 109.945 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.1 m -159.18 123.39 3.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.446 -0.343 . . . . 0.41999999999999998 110.548 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -97.23 118.61 34.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.271 -0.64 . . . . 2.5899999999999999 109.271 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.722 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 p -99.89 134.53 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.775 -0.454 . . . . 0.40000000000000002 109.775 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.752 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.2 t70 -138.3 114.43 10.15 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.25 -0.887 . . . . 1.3799999999999999 109.877 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.995 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 25.6 t -91.39 124.4 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.105 -0.498 . . . . 0.91000000000000003 110.782 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -107.38 115.95 31.06 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 124.003 0.815 . . . . 2.3100000000000001 109.621 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 97' ' ' PHE . 25.8 t60 -154.7 143.33 20.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.426 . . . . 1.6399999999999999 110.744 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 9.7 t -162.36 119.27 2.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.054 0.391 . . . . 2.6699999999999999 112.054 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' THR . 76.9 t60 169.16 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.541 -0.754 . . . . 2.6299999999999999 110.788 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -53.23 -50.33 64.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.652 0.612 . . . . 3.54 112.652 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 8.3 t70 -78.69 -39.92 35.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.916 0.388 . . . . 1.8100000000000001 111.548 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -66.3 -27.45 67.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 3.3799999999999999 110.856 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 32.9 tpp -98.55 18.34 16.94 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.985 -1.117 . . . . 2.4300000000000002 107.985 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.651 ' HA2' ' HB3' ' A' ' 125' ' ' HIS . . . -66.22 -88.13 0.06 OUTLIER Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.729 -1.578 . . . . 1.6100000000000001 114.339 -168.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 28.7 m 57.3 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.703 -0.851 . . . . 2.5800000000000001 108.703 -165.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.66 -55.07 19.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.266 -0.642 . . . . 3.7999999999999998 109.266 170.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.651 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 3.0 t-160 -64.51 -48.26 75.79 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.494 -0.775 . . . . 2.1400000000000001 111.208 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.566 ' HB2' ' HA3' ' A' ' 122' ' ' GLY . . . -58.51 -45.98 87.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.163 -0.472 . . . . 0.92000000000000004 111.249 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 123' ' ' THR . 5.7 tmtm? -61.76 -47.38 85.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 2.8300000000000001 110.887 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.687 ' HB2' HG23 ' A' ' 89' ' ' ILE . 7.4 ptp180 -68.3 -35.1 77.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.439 0.533 . . . . 2.5899999999999999 112.439 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.408 HG13 ' CZ2' ' A' ' 81' ' ' TRP . 91.9 t -80.23 -40.87 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.979 0.419 . . . . 1.48 111.25 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -62.56 -15.03 48.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.745 -0.662 . . . . 3.8300000000000001 111.171 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.68 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 94.5 m-20 -58.77 -22.68 58.62 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 2.48 112.243 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.18 -31.83 0.07 OUTLIER Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.005 -1.093 . . . . 1.6100000000000001 114.059 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -65.0 -23.25 67.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.557 -0.378 . . . . 4.8300000000000001 110.851 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.38 -24.73 66.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.927 -0.579 . . . . 2.8300000000000001 111.983 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -113.26 -48.03 2.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.882 0.372 . . . . 4.1500000000000004 110.833 -176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -61.41 -56.73 21.74 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.858 -0.61 . . . . 1.04 113.236 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.589 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -60.38 -48.52 93.61 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.431 0.53 . . . . 2.7799999999999998 112.431 -173.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 15.6 Cg_endo -58.87 -42.34 53.58 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.648 1.566 . . . . 0.68000000000000005 112.026 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.8 m -64.53 -35.44 80.96 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.685 0.755 . . . . 0.87 109.387 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 137' ' ' TRP . 13.6 mt -54.79 -49.16 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.597 -1.183 . . . . 0.71999999999999997 110.809 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.0 mt -62.9 -29.11 70.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.295 0.48 . . . . 0.68999999999999995 112.295 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.19 -57.5 4.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.49 110.318 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.474 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 29.5 m -65.36 -23.4 66.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.103 0.478 . . . . 1.1499999999999999 110.621 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 45.7 t80 -61.56 -54.78 38.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.634 . . . . 0.80000000000000004 110.233 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.558 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.2 mt-30 -60.49 -31.81 70.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.83 -0.623 . . . . 1.6299999999999999 110.894 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -42.37 69.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.758 -0.655 . . . . 1.46 111.735 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 18.3 tptm -69.97 -35.04 74.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.492 -0.483 . . . . 1.74 109.723 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.829 HG21 HG13 ' A' ' 12' ' ' VAL . 62.2 mt -66.45 -35.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.5 110.393 175.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 154' ' ' LYS . 19.0 t70 -59.14 -40.42 85.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.84999999999999998 109.044 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 154' ' ' LYS . 43.7 mt-10 -68.38 -35.37 77.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.801 -0.636 . . . . 1.5 110.787 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.82 -43.88 97.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 1.74 111.264 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.22 -66.15 1.68 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.529 -0.843 . . . . 1.3200000000000001 111.861 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.482 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -173.5 89.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.719 -0.474 . . . . 1.9199999999999999 109.719 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 149' ' ' ASP . 11.9 tppt? -73.88 134.41 43.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 2.04 110.245 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 153' ' ' ALA . 5.0 mptt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.475 -0.774 . . . . 4.2199999999999998 110.62 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 19.6 p-10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.161 0.505 . . . . 1.6599999999999999 110.715 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.505 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 46.6 p90 -176.47 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.867 -0.606 . . . . 3.73 110.751 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.985 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.2 t70 -72.57 -64.85 0.85 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.616 -0.266 . . . . 2.7799999999999998 111.009 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.985 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 27.8 Cg_endo -97.51 -67.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.506 2.137 . . . . 1.6299999999999999 113.151 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 4' ' ' PRO . 70.8 m-85 -124.72 113.59 18.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.417 -0.356 . . . . 3.21 111.052 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.823 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 46.0 t -90.81 111.91 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.148 -0.686 . . . . 1.4399999999999999 109.148 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.667 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.8 ttp180 -133.22 134.96 44.72 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.043 -0.663 . . . . 3.3700000000000001 111.174 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.584 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.92 131.75 54.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.886 -0.783 . . . . 0.79000000000000004 108.886 173.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.3 m -132.93 110.43 10.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.594 -0.73 . . . . 1.28 109.852 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.2 t -124.63 139.29 51.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.144 -0.934 . . . . 1.27 110.867 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.6 m -103.67 114.61 29.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.71 0.767 . . . . 0.56999999999999995 109.875 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.809 HG13 HG21 ' A' ' 148' ' ' ILE . 25.1 t -90.77 139.06 18.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.098 -0.955 . . . . 0.91000000000000003 109.682 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.641 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -111.61 29.25 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.103 0.478 . . . . 0.97999999999999998 110.871 -176.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.629 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.84 29.41 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.35999999999999999 111.635 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 35.3 t70 72.2 162.38 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.749 0.785 . . . . 0.91000000000000003 112.423 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 33.6 ttp180 -65.59 -23.65 66.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.133 -0.94 . . . . 1.8799999999999999 111.036 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 17' ' ' LYS . 21.1 ttmt -57.29 -44.99 84.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 3.0499999999999998 110.587 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 68.4 p -80.23 -31.82 38.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.336 -0.393 . . . . 1.1100000000000001 110.515 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.41 -47.59 81.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.32000000000000001 110.687 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 83.0 t80 -67.77 -44.32 77.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.38 110.443 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 18' ' ' THR . 42.3 tttp -52.17 -49.49 63.7 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.839 -0.619 . . . . 2.3900000000000001 110.488 175.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 29.1 m -68.39 -52.49 32.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.297 -0.41 . . . . 0.68000000000000005 111.688 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.761 ' HA ' ' HZ ' ' A' ' 144' ' ' PHE . 60.1 t80 -65.36 -30.72 71.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.889 -0.324 . . . . 0.47999999999999998 111.756 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' CD1' HG11 ' A' ' 46' ' ' VAL . 15.6 tp -120.12 -54.15 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.315 0.857 . . . . 0.5 113.315 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -81.37 -23.7 37.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.568 0.581 . . . . 1.24 112.568 -167.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -110.16 28.98 9.66 Favored Glycine 0 C--N 1.314 -0.665 0 N-CA-C 111.24 -0.744 . . . . 0.82999999999999996 111.24 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.657 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 41.6 t80 -48.01 -54.32 25.4 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.928 -0.636 . . . . 0.73999999999999999 112.447 -170.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 8.1 Cg_endo -95.67 38.06 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.051 1.834 . . . . 0.76000000000000001 115.298 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.9 pt-20 -132.1 -11.11 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.481 -0.888 . . . . 1.49 113.03 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.773 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 11.2 m95 -76.92 172.79 12.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.226 0.536 . . . . 4.6200000000000001 111.746 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.486 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 m95 -74.6 -47.65 5.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.929 1.085 . . . . 2.7799999999999998 113.929 -175.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.766 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 27.7 Cg_endo -57.87 -87.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.714 2.276 . . . . 1.3600000000000001 115.108 -158.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' HB3' HD11 ' A' ' 140' ' ' ILE . 6.9 t30 -111.12 -3.73 15.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.432 -0.951 . . . . 1.51 108.432 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.618 ' HA ' HG23 ' A' ' 40' ' ' VAL . 15.0 m120 -93.83 22.69 5.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.44 -1.255 . . . . 1.79 112.579 -168.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -134.23 58.3 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.392 0.615 . . . . 4.4500000000000002 110.416 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 36.9 mmt180 -136.47 145.58 45.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 4.1399999999999997 109.597 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -75.65 132.43 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.801 -0.359 . . . . 2.6800000000000002 110.221 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 57' ' ' ASP . 73.0 p 53.69 21.76 2.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.861 0.864 . . . . 1.4199999999999999 111.798 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' HD3' ' HA3' ' A' ' 85' ' ' GLY . 5.1 mmtp -138.58 79.69 1.75 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.851 -0.613 . . . . 2.8999999999999999 110.592 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.618 HG23 ' HA ' ' A' ' 34' ' ' ASN . 22.2 m 42.61 26.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.5 -1.227 . . . . 1.8300000000000001 112.982 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.13 16.41 2.55 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.133 -0.556 . . . . 2.1699999999999999 111.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.93 162.01 66.45 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.991 -0.744 . . . . 1.1200000000000001 108.991 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.34 50.68 0.17 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 123.263 2.642 . . . . 1.48 114.679 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -166.34 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.708 0.289 . . . . 1.75 110.995 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.657 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.48 -56.59 3.11 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.817 -0.706 . . . . 0.75 112.59 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.593 HG11 ' CD1' ' A' ' 24' ' ' LEU . 97.3 t -134.47 145.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.014 0.435 . . . . 0.59999999999999998 111.003 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 1.028 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.3 t70 -121.28 102.78 8.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.566 -0.743 . . . . 1.1100000000000001 109.038 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 15.3 mtmt -77.75 -28.45 50.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.213 0.449 . . . . 2.8100000000000001 112.213 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -72.63 -35.08 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.961 -0.296 . . . . 3.1699999999999999 111.05 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.72 -42.41 4.47 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.821 -0.704 . . . . 1.53 112.097 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 102.5 45.48 1.67 Allowed Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.913 -0.661 . . . . 0.77000000000000002 112.921 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -144.06 165.04 28.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.466 -0.432 . . . . 3.7200000000000002 111.607 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.618 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 18.9 m0 -108.15 123.98 49.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.824 -0.625 . . . . 1.28 109.627 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 1.028 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 2.7 p90 -163.36 151.43 13.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.954 0.407 . . . . 1.6599999999999999 110.784 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.6 mp0 -117.95 160.18 21.88 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.488 -0.56 . . . . 2.1200000000000001 109.488 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' HG2' ' A' ' 61' ' ' GLU . 26.8 mm -78.25 103.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.33 -0.395 . . . . 0.92000000000000004 110.017 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.507 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.9 t70 -84.25 -166.53 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 1.97 110.012 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.56 -37.86 22.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.027 0.38 . . . . 2.4300000000000002 112.027 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.464 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.9 OUTLIER -92.18 23.56 3.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.155 0.503 . . . . 2.3900000000000001 110.937 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.35 -113.27 0.86 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.875 -1.155 . . . . 2.29 113.011 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.568 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 40.4 mt-10 -149.12 2.06 0.56 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.262 0.467 . . . . 2.3100000000000001 112.262 -167.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -93.11 90.82 7.04 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.929 0.871 . . . . 2.6099999999999999 110.683 -168.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -121.4 87.78 2.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.382 -1.281 . . . . 3.7200000000000002 111.028 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.735 HG23 ' HD1' ' A' ' 86' ' ' PHE . 0.8 OUTLIER 54.25 179.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.606 0.717 . . . . 2.27 112.733 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -133.65 99.26 4.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.192 -0.458 . . . . 6.4800000000000004 110.424 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.704 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.78 119.57 9.14 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.556 -1.418 . . . . 1.23 109.556 173.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 67' ' ' LEU . 3.8 mp -79.91 86.33 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.255 -0.578 . . . . 1.1699999999999999 110.667 -169.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.67 HG21 HG23 ' A' ' 71' ' ' VAL . 19.2 mt -76.43 114.8 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.694 -1.202 . . . . 0.60999999999999999 109.326 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 18.0 mmm180 -95.54 -25.4 16.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.759 -1.109 . . . . 2.0 109.388 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 81.8 tttt -161.01 115.63 2.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 1.53 111.525 -175.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.67 HG23 HG21 ' A' ' 68' ' ' ILE . 89.6 t -107.35 102.01 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.564 -0.902 . . . . 0.88 108.564 168.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 9.1 t0 -112.86 69.23 0.69 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.367 -0.533 . . . . 1.4199999999999999 110.462 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.8 pt-20 46.12 -169.05 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 O-C-N 124.706 1.254 . . . . 0.95999999999999996 111.578 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.596 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.0 Cg_exo -64.52 78.47 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.154 1.236 . . . . 0.38 111.408 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.9 t70 -161.96 -66.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.445 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.5 p -140.71 141.41 34.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.141 0.496 . . . . 0.34999999999999998 112.308 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD23 HD22 ' A' ' 24' ' ' LEU . 2.7 mp -135.55 122.26 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.73999999999999999 109.717 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 98' ' ' THR . 41.9 t -110.32 106.81 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.423 -0.584 . . . . 0.67000000000000004 109.423 176.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -130.99 133.87 62.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.027 0.441 . . . . 0.75 112.137 -178.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.837 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -80.43 156.92 39.74 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.946 -0.57 . . . . 0.5 112.562 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -66.89 144.16 56.42 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.236 0.541 . . . . 2.79 112.347 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.704 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 4.5 ttp180 -136.35 -18.17 1.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.971 -1.013 . . . . 5.46 109.689 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.91 HD21 ' HB2' ' A' ' 88' ' ' ARG . 7.5 tt 80.02 162.08 0.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.271 -0.877 . . . . 1.55 111.311 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.77 97.63 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 1.9299999999999999 110.817 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.633 ' HA3' ' HD3' ' A' ' 39' ' ' LYS . . . 103.19 -9.49 54.21 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.274 -1.441 . . . . 2.3999999999999999 115.038 165.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.735 ' HD1' HG23 ' A' ' 64' ' ' THR . 36.0 t80 73.15 -19.22 0.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.823 0.812 . . . . 5.3799999999999999 112.154 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.76 -17.82 60.96 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.366 -0.445 . . . . 2.2999999999999998 112.421 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.91 ' HB2' HD21 ' A' ' 83' ' ' LEU . 40.6 mtm105 -108.92 173.61 6.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.408 0.283 . . . . 4.7699999999999996 110.248 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -78.58 115.49 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.491 0.662 . . . . 1.8600000000000001 111.676 -172.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.54 138.96 21.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 3.1800000000000002 110.224 176.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 93' ' ' ASN . 33.8 Cg_endo -65.2 -38.61 26.62 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.897 2.398 . . . . 2.3599999999999999 113.481 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 26.3 t70 72.33 -24.3 0.19 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.492 0.663 . . . . 2.9900000000000002 111.154 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 91' ' ' PRO . 39.7 m-80 -130.78 81.94 2.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.939 -1.504 . . . . 3.0600000000000001 106.939 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 95' ' ' SER . 2.6 p -107.06 -164.35 0.98 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.665 1.358 . . . . 1.8500000000000001 114.665 -160.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 1.099 ' HA ' ' HB3' ' A' ' 117' ' ' HIS . 41.3 m -72.87 -45.17 59.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 112.311 -2.222 . . . . 1.4399999999999999 111.963 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.837 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.1 tt0 70.89 111.39 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.046 0.841 . . . . 1.8100000000000001 109.793 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.439 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 40.3 p90 -115.06 150.81 35.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.203 0.525 . . . . 0.64000000000000001 111.589 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.561 HG23 HG22 ' A' ' 78' ' ' VAL . 57.8 m -108.22 114.49 28.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.388 -0.824 . . . . 0.42999999999999999 110.621 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.753 ' HA ' HG22 ' A' ' 113' ' ' VAL . 90.4 t -88.56 110.49 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.618 . . . . 0.87 110.272 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.456 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.6 m -104.36 105.91 16.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.19 -0.459 . . . . 0.45000000000000001 110.526 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.4 m-85 -89.36 109.27 20.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.34000000000000002 110.283 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' THR . 59.5 t -89.54 107.9 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.813 -0.44 . . . . 0.54000000000000004 109.813 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.6 33.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.516 . . . . 0.44 110.258 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.7 t70 -125.43 112.96 16.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.92 0.39 . . . . 2.0299999999999998 110.62 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -112.92 5.02 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.87 -0.681 . . . . 1.97 112.161 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 6.5 tt0 -141.05 -17.97 0.82 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.016 0.436 . . . . 4.9299999999999997 110.132 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -131.9 24.87 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 3.5299999999999998 111.799 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.9 ttmp? -140.97 150.87 43.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.27 -0.572 . . . . 2.4399999999999999 110.916 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.583 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.2 m -158.93 112.29 2.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.878 -0.601 . . . . 0.41999999999999998 110.372 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.81 110.64 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.582 -0.525 . . . . 2.5899999999999999 109.582 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -90.59 138.14 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.647 -0.421 . . . . 0.40000000000000002 110.326 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 12.0 t70 -128.18 114.67 17.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.895 -0.78 . . . . 1.3799999999999999 108.895 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 99' ' ' VAL . 25.2 t -104.4 121.24 55.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.32 -0.855 . . . . 0.91000000000000003 111.345 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -97.59 132.79 42.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 2.3100000000000001 109.629 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.823 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 4.1 t60 -150.91 110.17 3.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.118 -0.697 . . . . 1.6399999999999999 109.118 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.609 ' OG1' ' HD2' ' A' ' 120' ' ' ARG . 8.6 t -163.3 97.44 0.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.693 0.759 . . . . 2.6699999999999999 110.694 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 1.099 ' HB3' ' HA ' ' A' ' 95' ' ' SER . 3.3 t-160 -163.92 -77.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.817 -0.629 . . . . 2.6299999999999999 111.464 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.13 -39.57 17.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.407 0.521 . . . . 3.54 112.407 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.722 ' HB3' HG21 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -75.43 -34.31 60.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.35 0.595 . . . . 1.8100000000000001 109.588 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.609 ' HD2' ' OG1' ' A' ' 116' ' ' THR . 40.3 ttt180 -48.21 -21.5 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.439 -1.255 . . . . 3.3799999999999999 112.075 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -82.06 14.11 3.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 2.4300000000000002 111.239 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.49 -155.53 4.93 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.764 -0.653 . . . . 1.6100000000000001 114.18 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 t 38.16 -130.66 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.114 0.966 . . . . 2.5800000000000001 112.141 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 56.4 tttp -50.77 -43.29 58.44 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 122.962 0.505 . . . . 3.7999999999999998 112.063 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 129' ' ' VAL . 38.5 m80 -53.69 -52.2 60.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 2.1400000000000001 111.005 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -76.86 -29.75 55.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.399 -0.364 . . . . 0.92000000000000004 110.961 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.03 -52.89 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 2.8300000000000001 110.479 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 23.6 ptt85 -61.09 -31.86 71.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 2.5899999999999999 110.842 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 119' ' ' ASP . 70.6 t -65.84 -41.99 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 120.677 0.275 . . . . 1.48 110.78 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -64.73 -15.97 62.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.366 -0.379 . . . . 3.8300000000000001 111.557 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.511 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 6.1 m-20 -52.28 -21.55 3.59 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.503 0.557 . . . . 2.48 112.503 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 88' ' ' ARG . . . -169.53 -28.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.021 -1.085 . . . . 1.6100000000000001 114.274 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.407 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 12.7 tmm? -60.97 -40.95 95.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.404 0.602 . . . . 4.8300000000000001 110.281 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.31 -27.21 45.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.973 -0.558 . . . . 2.8300000000000001 112.417 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -107.02 -47.23 3.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.003 0.43 . . . . 4.1500000000000004 111.466 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.645 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -65.39 -54.94 23.62 Favored Glycine 0 C--O 1.223 -0.547 0 CA-C-N 116.021 -0.536 . . . . 1.04 113.226 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t90 -60.74 -51.0 82.68 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.034 0.383 . . . . 2.7799999999999998 112.034 -171.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 12.5 Cg_endo -57.94 -42.34 59.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.842 1.695 . . . . 0.68000000000000005 112.111 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.2 m -65.5 -34.99 79.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.336 0.589 . . . . 0.87 110.076 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.766 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 47.7 mt -56.96 -46.07 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.71999999999999997 110.331 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 65.7 mt -62.38 -31.26 71.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.68999999999999995 112.215 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -74.75 -53.8 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.008 -0.277 . . . . 1.49 111.085 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 59.4 m -64.73 -23.42 67.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.11 0.481 . . . . 1.1499999999999999 110.217 177.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.761 ' HZ ' ' HA ' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -59.1 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 0.80000000000000004 110.069 173.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.424 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.4 mt-30 -63.54 -25.26 68.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 1.6299999999999999 111.007 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.83 -49.87 34.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.46 111.195 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.773 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 52.3 tptt -68.02 -34.46 76.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.62 -0.432 . . . . 1.74 110.398 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.809 HG21 HG13 ' A' ' 12' ' ' VAL . 75.5 mt -67.67 -29.43 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.024 0.44 . . . . 0.5 110.378 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.01 -31.34 72.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.549 -0.537 . . . . 0.84999999999999998 109.549 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 41.0 mt-10 -70.71 -29.89 66.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.581 -0.736 . . . . 1.5 109.928 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -79.34 -23.42 43.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 1.74 110.008 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -97.47 22.97 37.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.634 -0.712 . . . . 1.3200000000000001 111.427 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.592 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . 73.57 85.04 0.11 Allowed 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 124.639 0.846 . . . . 1.9199999999999999 110.625 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.631 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 13.3 tppt? -73.54 105.16 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.475 -0.784 . . . . 2.04 110.103 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HE3' ' HB1' ' A' ' 153' ' ' ALA . 17.5 ptpt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.863 -0.608 . . . . 4.2199999999999998 110.424 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.807 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 64.7 m-80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.415 -0.217 . . . . 1.6599999999999999 110.415 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 21.6 p90 168.92 -21.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.036 0.835 . . . . 3.73 109.374 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.983 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -49.54 -59.46 6.65 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.295 -0.866 . . . . 2.7799999999999998 110.541 -176.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.983 ' HD3' ' HB2' ' A' ' 3' ' ' ASP . 26.3 Cg_endo -97.34 -61.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.375 2.05 . . . . 1.6299999999999999 111.489 167.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -153.95 171.58 18.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.447 -1.316 . . . . 3.21 107.447 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.807 ' HA ' ' HB3' ' A' ' 1' ' ' ASN . 40.8 t -91.61 138.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 120.651 -0.42 . . . . 1.4399999999999999 111.155 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.8 ttp180 -134.6 146.58 49.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.163 -0.471 . . . . 3.3700000000000001 110.96 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.763 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -129.39 134.12 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 0.79000000000000004 109.844 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 14.4 m -129.15 113.39 15.02 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.191 0.52 . . . . 1.28 110.465 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.819 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.5 t -126.09 139.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.374 -0.83 . . . . 1.27 111.06 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -97.58 117.14 31.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.184 0.516 . . . . 0.56999999999999995 109.938 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.938 HG13 HG21 ' A' ' 148' ' ' ILE . 50.8 t -100.65 122.71 52.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.458 0.646 . . . . 0.91000000000000003 111.323 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.821 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -90.29 13.34 15.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.901 -1.045 . . . . 0.97999999999999998 112.771 -173.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -146.16 27.69 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.301 0.852 . . . . 0.35999999999999999 113.301 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.9 t0 76.49 164.78 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.598 0.713 . . . . 0.91000000000000003 112.358 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 16.0 ttp180 -69.72 -37.32 76.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.024 -0.989 . . . . 1.8799999999999999 112.212 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 79.2 mttt -58.29 -49.17 78.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.706 0.765 . . . . 3.0499999999999998 109.951 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -66.3 -38.74 88.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.302 -1.317 . . . . 1.1100000000000001 110.909 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.764 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -57.77 -48.62 79.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.32000000000000001 110.479 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.6 t80 -61.25 -45.17 95.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.649 -0.705 . . . . 0.38 110.733 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 4.2 tppp? -58.28 -53.46 58.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 2.3900000000000001 110.798 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -62.62 -48.74 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.202 0.313 . . . . 0.68000000000000005 110.835 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.901 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 72.6 t80 -63.18 -43.67 97.57 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.132 0.419 . . . . 0.47999999999999998 112.132 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.606 HD11 HG11 ' A' ' 46' ' ' VAL . 17.3 tp -101.38 -56.26 2.34 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.519 -0.472 . . . . 0.5 112.119 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 51.6 mt-10 -96.2 15.56 20.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.391 0.615 . . . . 1.24 111.404 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.711 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -126.82 24.13 5.51 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.113 -1.195 . . . . 0.82999999999999996 110.113 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.841 ' HD2' ' HA2' ' A' ' 45' ' ' GLY . 10.3 t80 -52.79 -47.02 96.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.642 -0.779 . . . . 0.73999999999999999 112.995 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.2 Cg_endo -93.38 19.35 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.793 1.662 . . . . 0.76000000000000001 115.012 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.711 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -110.41 -7.42 14.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.091 -0.643 . . . . 1.49 112.381 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.901 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 19.3 m0 -74.09 169.98 16.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 4.6200000000000001 111.228 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.644 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 28.0 m95 -90.32 -29.54 0.34 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.639 0.977 . . . . 2.7799999999999998 113.639 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.724 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 36.6 Cg_endo -66.19 -136.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.328 2.019 . . . . 1.3600000000000001 114.207 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 25.1 t30 -57.48 -35.97 70.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.104 0.954 . . . . 1.51 111.181 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 1.006 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 3.0 p-10 -89.54 23.3 2.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.703 -1.135 . . . . 1.79 112.678 -169.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.73 -18.99 29.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 4.4500000000000002 110.683 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.647 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 48.0 mtm105 -88.04 -179.2 6.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.455 0.539 . . . . 4.1399999999999997 112.455 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.529 HG23 ' HD3' ' A' ' 43' ' ' PRO . 27.9 m -101.18 137.54 39.41 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.621 -0.718 . . . . 2.6800000000000002 110.009 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 1.012 ' H ' ' HA ' ' A' ' 42' ' ' ALA . 44.5 p 50.22 28.84 3.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.493 0.717 . . . . 1.4199999999999999 111.232 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 1.006 ' HD3' ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -67.52 -71.07 0.22 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.717 -1.129 . . . . 2.8999999999999999 111.21 -177.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.861 ' H ' ' HD2' ' A' ' 39' ' ' LYS . 21.7 m -97.3 -13.01 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 122.217 1.008 . . . . 1.8300000000000001 108.548 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 38' ' ' THR . . . -168.69 -50.65 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 113.471 -1.695 . . . . 2.1699999999999999 110.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.012 ' HA ' ' H ' ' A' ' 38' ' ' THR . . . 152.01 -173.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 125.186 1.168 . . . . 1.1200000000000001 112.195 -172.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.638 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 20.3 Cg_exo -72.75 74.54 2.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.541 2.16 . . . . 1.48 113.34 167.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.79 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 41.7 tp -145.67 -87.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.072 -0.344 . . . . 1.75 110.072 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.841 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 134.58 -92.66 0.24 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.953 -1.118 . . . . 0.75 113.843 170.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 24' ' ' LEU . 87.9 t -132.99 148.06 31.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.314 0.578 . . . . 0.59999999999999998 111.821 -168.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.824 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.1 t70 -92.8 110.6 22.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.224 -0.898 . . . . 1.1100000000000001 109.154 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 17.8 tptm -80.75 -25.42 38.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.718 -0.674 . . . . 2.8100000000000001 111.601 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.3 ptpp? -73.97 -38.93 64.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.757 0.28 . . . . 3.1699999999999999 111.757 -171.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.72 -41.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 1.53 112.154 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.491 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 118.52 71.31 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.661 -0.781 . . . . 0.77000000000000002 112.232 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 47' ' ' ASP . 5.4 mpt_? -133.79 157.31 46.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.017 -0.364 . . . . 3.7200000000000002 110.017 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 29.8 m0 -112.81 117.06 31.12 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.607 -0.886 . . . . 1.28 108.607 168.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.824 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.7 p90 -162.22 155.01 19.9 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.047 0.451 . . . . 1.6599999999999999 110.06 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.79 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.16 172.73 12.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.119 -0.491 . . . . 2.1200000000000001 110.586 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' HG2' ' A' ' 61' ' ' GLU . 13.7 mm -78.59 99.16 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.92000000000000004 111.395 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.767 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 5.5 t70 -96.27 172.87 7.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.627 -0.509 . . . . 1.97 109.627 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.498 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.9 pt-20 -58.47 -40.34 82.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.799 1.037 . . . . 2.4300000000000002 113.799 -167.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.708 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -81.54 7.38 12.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.464 -0.494 . . . . 2.3900000000000001 112.307 -176.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.2 84.11 1.78 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.043 -1.075 . . . . 2.29 114.421 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 56' ' ' ILE . 43.5 mt-10 55.87 30.89 16.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.772 1.027 . . . . 2.3100000000000001 113.772 167.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -127.61 92.1 3.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.559 0.695 . . . . 2.6099999999999999 111.68 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.767 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -120.58 166.46 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.923 -1.035 . . . . 3.7200000000000002 110.599 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.681 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 9.1 p -47.37 105.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.719 0.637 . . . . 2.27 110.637 171.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 28.8 p90 -90.32 118.02 29.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.138 0.494 . . . . 6.4800000000000004 111.77 -173.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -67.18 137.5 33.43 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.837 -0.905 . . . . 1.23 110.837 173.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -100.38 94.13 6.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.201 0.5 . . . . 1.1699999999999999 111.481 -171.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.609 HG21 HG22 ' A' ' 71' ' ' VAL . 55.4 mt -76.08 123.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.257 0.551 . . . . 0.60999999999999999 110.158 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 10.5 mmm180 -87.72 -34.56 18.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.396 -0.82 . . . . 2.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -147.21 120.83 9.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.028 -0.533 . . . . 1.53 111.54 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 68' ' ' ILE . 32.1 t -102.75 92.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.284 -1.006 . . . . 0.88 108.284 167.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.63 63.28 0.72 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.789 -0.364 . . . . 1.4199999999999999 110.936 -173.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.654 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.8 pt-20 47.05 -169.37 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 124.476 1.11 . . . . 0.95999999999999996 112.031 175.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 33.2 Cg_exo -61.51 76.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.304 1.336 . . . . 0.38 111.798 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.9 -66.6 0.05 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.5 109.754 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.3 p -144.21 143.01 30.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.715 0.635 . . . . 0.34999999999999998 112.715 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.0 mp -132.47 116.19 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.145 -0.687 . . . . 0.73999999999999999 109.145 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 98' ' ' THR . 36.5 t -104.72 110.27 30.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.478 -0.564 . . . . 0.67000000000000004 109.478 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.98 140.55 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.871 0.367 . . . . 0.75 111.437 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.2 161.1 23.2 Favored Glycine 0 C--O 1.239 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.5 112.639 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 1.073 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 38.9 t-105 -65.04 157.89 27.18 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 113.737 1.014 . . . . 2.79 113.737 -165.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.681 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 2.9 tpt180 -174.41 33.42 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.435 -1.257 . . . . 5.46 108.917 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 88' ' ' ARG . 13.9 tp 69.55 -133.9 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 1.55 111.857 175.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 59.7 t30 -167.41 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.877 0.37 . . . . 1.9299999999999999 110.204 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.27 11.02 25.46 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.193 -0.527 . . . . 2.3999999999999999 114.062 -172.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.5 t80 70.71 -43.37 0.55 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.529 0.731 . . . . 5.3799999999999999 112.783 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.94 38.41 2.17 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.237 -0.506 . . . . 2.2999999999999998 113.082 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.001 ' HB2' HD21 ' A' ' 83' ' ' LEU . 4.7 mmp_? -135.09 -175.16 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.52 -0.919 . . . . 4.7699999999999996 108.52 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.606 HD13 ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -112.32 132.68 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.906 0.384 . . . . 1.8600000000000001 110.918 -177.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -156.47 107.91 2.02 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.989 -0.551 . . . . 3.1800000000000002 110.601 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.606 ' HD3' HD13 ' A' ' 89' ' ' ILE . 1.6 Cg_endo -109.63 18.11 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.127 3.218 . . . . 2.3599999999999999 110.487 165.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' A' ' 118' ' ' PHE . 10.5 t70 -79.74 -77.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.366 -0.833 . . . . 2.9900000000000002 111.294 -159.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 33.9 m-80 76.59 -40.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.218 -0.901 . . . . 3.0600000000000001 112.359 172.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.785 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . 70.2 m -77.66 -7.57 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.627 0.232 . . . . 1.8500000000000001 111.627 -176.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 1.073 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 23.1 t -66.55 75.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.074 0.94 . . . . 1.4399999999999999 109.227 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.8 tt0 -97.69 123.72 41.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.499 -1.228 . . . . 1.8100000000000001 110.678 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.793 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 5.4 p90 -120.98 140.28 52.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.468 0.651 . . . . 0.64000000000000001 111.805 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.661 HG23 HG22 ' A' ' 78' ' ' VAL . 32.4 m -98.7 110.48 23.07 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.475 -1.238 . . . . 0.42999999999999999 109.721 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.0 t -81.92 108.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.357 -0.608 . . . . 0.87 109.357 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.639 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.8 m -102.7 106.7 17.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.086 0.47 . . . . 0.45000000000000001 111.21 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.692 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 47.9 m-85 -87.4 113.3 22.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 0.34000000000000002 109.968 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.79 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.604 -0.517 . . . . 0.54000000000000004 109.604 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.16 124.28 27.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.087 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 23.2 m-20 -106.54 100.36 9.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 2.0299999999999998 109.111 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.85 -113.37 4.16 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.616 -0.802 . . . . 1.97 111.933 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.409 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 3.1 pt20 -147.02 4.89 0.84 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.544 0.211 . . . . 4.9299999999999997 111.089 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 47.6 mmtm -132.34 -12.23 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.791 0.293 . . . . 3.5299999999999998 111.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 47.6 tttp -121.46 152.65 38.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.794 -0.447 . . . . 2.4399999999999999 109.794 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.6 m -157.95 119.1 3.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 0.41999999999999998 111.087 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -94.37 123.54 37.84 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.511 -0.551 . . . . 2.5899999999999999 109.511 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.599 ' CG1' ' HB ' ' A' ' 10' ' ' VAL . 14.2 p -98.46 135.3 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.112 -0.635 . . . . 0.40000000000000002 110.391 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 6.3 p-10 -127.87 115.87 19.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.783 0.801 . . . . 1.3799999999999999 109.197 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.763 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 2.1 t -89.71 121.33 39.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.292 -0.867 . . . . 0.91000000000000003 110.377 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.73 136.25 44.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 124.148 0.905 . . . . 2.3100000000000001 108.715 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 97' ' ' PHE . 65.6 t-80 -128.46 153.53 47.04 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.78 -0.645 . . . . 1.6399999999999999 110.716 -171.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 t -64.84 -153.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.55 -0.75 . . . . 2.6699999999999999 110.248 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -143.47 37.65 1.36 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.127 0.788 . . . . 2.6299999999999999 113.127 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 2.4 t80 -71.73 -35.98 70.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.287 0.565 . . . . 3.54 109.704 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.44 ' OD2' ' CE1' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -70.84 -28.89 64.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 1.8100000000000001 110.477 177.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -54.92 -20.52 9.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.409 -0.814 . . . . 3.3799999999999999 111.762 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.9 mmt -65.88 -4.52 6.97 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.336 -0.393 . . . . 2.4300000000000002 110.528 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.26 -141.46 25.92 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.319 -0.855 . . . . 1.6100000000000001 112.965 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.2 p 42.25 -112.04 0.18 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.663 0.86 . . . . 2.5800000000000001 112.264 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -77.72 -39.73 43.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.855 -0.612 . . . . 3.7999999999999998 110.835 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -53.26 59.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.939 0.4 . . . . 2.1400000000000001 111.079 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -69.61 -33.46 72.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.986 -0.552 . . . . 0.92000000000000004 111.165 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -70.02 -49.85 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.798 -0.361 . . . . 2.8300000000000001 111.077 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -66.78 -33.01 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.512 -0.313 . . . . 2.5899999999999999 111.021 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.7 t -78.55 -30.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 1.48 110.864 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.501 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 18.6 ttm180 -56.4 -34.63 66.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 3.8300000000000001 111.336 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.556 ' CB ' ' HD3' ' A' ' 88' ' ' ARG . 15.7 m-80 -63.59 -25.03 68.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 2.48 110.797 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.545 ' HA2' ' HG3' ' A' ' 88' ' ' ARG . . . -81.2 -106.88 0.33 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.864 -0.684 . . . . 1.6100000000000001 113.248 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.682 ' HB3' ' HH2' ' A' ' 81' ' ' TRP . 18.2 ttt -79.7 -16.31 55.92 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.599 0.222 . . . . 4.8300000000000001 111.599 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 25.4 t70 -62.01 -25.91 67.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 2.8300000000000001 111.722 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -91.04 -29.64 17.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.072 0.463 . . . . 4.1500000000000004 110.905 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -95.17 -32.17 7.21 Favored Glycine 0 C--O 1.217 -0.955 0 CA-C-N 116.155 -0.475 . . . . 1.04 112.368 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.669 ' HB2' ' HG2' ' A' ' 133' ' ' MET . 3.7 t90 -58.03 -47.06 99.54 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 122.512 0.325 . . . . 2.7799999999999998 111.809 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.81 -32.55 95.62 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.837 1.692 . . . . 0.68000000000000005 111.666 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.2 m -71.65 -43.17 66.55 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.268 1.032 . . . . 0.87 108.957 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.6 mt -61.83 -54.44 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.955 -1.475 . . . . 0.71999999999999997 111.548 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 8' ' ' HIS . 64.8 mt -58.81 -35.33 72.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.68999999999999995 112.202 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.639 ' N ' HE21 ' A' ' 142' ' ' GLN . 0.0 OUTLIER -67.79 -52.84 32.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.923 -0.311 . . . . 1.49 110.406 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.553 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 12.0 t -69.01 -23.85 64.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 1.1499999999999999 110.373 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.422 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 22.5 t80 -65.42 -49.85 67.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.609 -0.515 . . . . 0.80000000000000004 109.609 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.819 ' HG2' HG13 ' A' ' 10' ' ' VAL . 45.5 mt-30 -58.4 -41.93 86.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.331 -0.849 . . . . 1.6299999999999999 111.251 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 14.2 m-20 -75.46 -37.71 60.13 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.567 -0.453 . . . . 1.46 111.829 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.7 tptp -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.398 -0.593 . . . . 1.74 109.398 174.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.938 HG21 HG13 ' A' ' 12' ' ' VAL . 26.5 mt -62.27 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.5 111.109 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.821 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 34.2 t70 -62.38 -30.93 71.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.036 -0.529 . . . . 0.84999999999999998 110.182 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.526 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 49.3 mt-10 -70.46 -39.53 74.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.994 -0.548 . . . . 1.5 109.798 175.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 16.0 mm-40 -62.33 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.659 -0.7 . . . . 1.74 109.877 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.69 -73.27 0.72 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.458 -0.792 . . . . 1.3200000000000001 111.219 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -176.01 81.5 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.827 0.346 . . . . 1.9199999999999999 111.418 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -98.02 -23.93 15.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.046 -0.724 . . . . 2.04 109.046 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.038 -0.983 . . . . 4.2199999999999998 109.323 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.863 0.364 . . . . 1.6599999999999999 111.079 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 30.2 p90 -178.12 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.654 -0.703 . . . . 3.73 110.051 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.652 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 28.4 t70 -65.47 -49.74 61.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 2.7799999999999998 111.782 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 16.3 Cg_endo -87.77 -68.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.142 1.228 . . . . 1.6299999999999999 110.92 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.74 157.15 37.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 3.21 109.458 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.673 HG22 ' CG ' ' A' ' 115' ' ' HIS . 2.0 m -97.23 113.32 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.523 -0.917 . . . . 1.4399999999999999 108.523 168.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.555 ' HD3' ' OD2' ' A' ' 112' ' ' ASP . 20.2 ttm180 -104.35 146.59 28.6 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.365 -0.834 . . . . 3.3700000000000001 112.136 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 1.046 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 9.7 t-160 -112.24 132.84 54.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.614 -1.175 . . . . 0.79000000000000004 108.667 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 38.3 m -140.32 119.64 12.99 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.839 -0.43 . . . . 1.28 109.839 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 145' ' ' GLN . 3.9 t -143.7 132.83 19.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.812 -0.631 . . . . 1.27 110.893 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 m -95.97 115.78 27.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.455 -0.572 . . . . 0.56999999999999995 109.455 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.878 HG13 HG21 ' A' ' 148' ' ' ILE . 24.9 t -95.45 140.54 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.796 -0.638 . . . . 0.91000000000000003 110.736 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.11 24.22 11.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.47 0.544 . . . . 0.97999999999999998 112.47 -173.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.46 34.92 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.735 0.643 . . . . 0.35999999999999999 112.735 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 23.7 t70 72.48 166.96 0.31 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.6 0.714 . . . . 0.91000000000000003 112.377 172.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NE ' ' HB2' ' A' ' 103' ' ' ALA . 28.3 ttp180 -69.12 -23.68 64.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.42 -0.809 . . . . 1.8799999999999999 111.425 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -58.89 -49.08 79.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.63 0.252 . . . . 3.0499999999999998 111.086 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -73.79 -37.76 64.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.702 0.286 . . . . 1.1100000000000001 110.314 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.33 -45.97 80.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.32000000000000001 111.095 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.503 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 70.2 t80 -71.95 -47.94 48.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.407 -0.361 . . . . 0.38 110.893 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.629 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 26.5 tptp -52.9 -52.45 57.62 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.842 -0.617 . . . . 2.3900000000000001 110.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -50.96 61.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.68000000000000005 111.221 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -62.46 -37.0 84.24 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.246 0.462 . . . . 0.47999999999999998 112.246 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' HG11 ' A' ' 46' ' ' VAL . 13.6 tp -109.02 -53.18 2.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.286 -0.566 . . . . 0.5 112.403 -172.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.629 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 1.4 mm-40 -79.87 -28.64 39.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.105 0.478 . . . . 1.24 111.478 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -100.8 30.58 10.01 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.582 -0.735 . . . . 0.82999999999999996 111.876 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.499 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 56.4 t80 -48.5 -47.18 70.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.943 0.497 . . . . 0.73999999999999999 112.279 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 15.6 Cg_endo -98.08 19.35 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.19 1.927 . . . . 0.76000000000000001 114.409 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 6.6 pt-20 -105.57 -3.87 21.84 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.134 -0.627 . . . . 1.49 111.505 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.801 ' HB2' HD21 ' A' ' 34' ' ' ASN . 2.9 m0 -80.82 -172.03 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 4.6200000000000001 111.129 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.539 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 66.4 m95 -102.45 -26.88 0.21 Allowed Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 114.041 1.126 . . . . 2.7799999999999998 114.041 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.761 ' HD2' ' HB2' ' A' ' 30' ' ' TRP . 65.3 Cg_endo -72.74 -143.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.931 1.754 . . . . 1.3600000000000001 114.4 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.483 HD21 ' HA2' ' A' ' 85' ' ' GLY . 8.1 t30 -59.29 -14.73 12.3 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.433 0.901 . . . . 1.51 113.433 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.801 HD21 ' HB2' ' A' ' 30' ' ' TRP . 8.0 p30 -76.28 -10.77 59.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.948 0.351 . . . . 1.79 111.948 -174.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -78.01 69.41 4.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 4.4500000000000002 110.596 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -149.11 151.0 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.636 -0.711 . . . . 4.1399999999999997 110.571 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 38' ' ' THR . 7.3 m -87.99 122.75 31.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.916 -0.314 . . . . 2.6800000000000002 110.375 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 73.2 p 56.84 16.22 2.63 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.319 0.859 . . . . 1.4199999999999999 113.319 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -103.53 -47.27 4.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.815 -1.18 . . . . 2.8999999999999999 107.815 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.598 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -156.21 130.14 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 113.78 -1.555 . . . . 1.8300000000000001 108.582 171.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 55' ' ' GLU . . . 98.91 -72.22 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.54 -0.838 . . . . 2.1699999999999999 113.291 175.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . 50.36 -164.65 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 109.813 -0.44 . . . . 1.1200000000000001 109.813 -169.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.649 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 23.0 Cg_exo -69.95 16.16 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.324 1.349 . . . . 1.48 113.656 171.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.475 HD21 ' CE2' ' A' ' 54' ' ' TYR . 56.0 tp -128.66 -92.11 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.87 -0.518 . . . . 1.75 112.049 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 109.83 -75.01 0.21 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.457 -0.878 . . . . 0.75 113.132 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 24' ' ' LEU . 58.5 t -140.48 135.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 122.723 -0.28 . . . . 0.59999999999999998 110.799 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.702 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 13.0 t70 -103.64 126.4 50.75 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.411 -0.359 . . . . 1.1100000000000001 110.405 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HE2' ' HG ' ' A' ' 24' ' ' LEU . 1.3 mmpp? -81.38 -24.07 37.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.539 . . . . 2.8100000000000001 111.947 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -83.44 -58.7 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 3.1699999999999999 110.82 -171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.514 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -77.95 -22.48 68.75 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.613 -0.803 . . . . 1.53 111.507 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 63.4 2.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.896 -0.669 . . . . 0.77000000000000002 111.701 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -156.2 143.74 19.32 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.339 -0.544 . . . . 3.7200000000000002 111.395 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.574 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 10.5 m0 -87.46 114.26 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.725 -0.843 . . . . 1.28 108.725 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.708 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 3.4 p90 -162.65 171.23 17.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.421 0.629 . . . . 1.6599999999999999 111.288 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 8.6 mp0 -127.86 -179.45 4.96 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.288 -1.005 . . . . 2.1200000000000001 108.288 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.1 103.28 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 119.655 -0.818 . . . . 0.92000000000000004 110.665 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 11.6 p-10 -90.55 139.77 30.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.36 0.6 . . . . 1.97 110.189 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.89 -5.13 50.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.681 0.993 . . . . 2.4300000000000002 113.681 -164.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.689 -0.804 . . . . 2.3900000000000001 110.659 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.45 49.04 0.45 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.936 -0.65 . . . . 2.29 113.347 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.493 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 45.7 mt-10 60.28 76.68 0.35 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.008 1.114 . . . . 2.3100000000000001 114.008 172.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.46 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 30.4 tt0 -131.37 74.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.59 0.709 . . . . 2.6099999999999999 110.131 169.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.708 ' CE1' ' HD1' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -120.47 154.24 35.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.326 -0.852 . . . . 3.7200000000000002 110.305 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 p -64.9 149.34 49.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 2.27 109.146 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 45.8 p90 -123.38 127.45 48.49 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.189 -0.604 . . . . 6.4800000000000004 111.034 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.38 136.21 28.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.116 -0.793 . . . . 1.23 111.116 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -82.8 87.7 6.79 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 121.092 -0.243 . . . . 1.1699999999999999 110.499 -173.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 71' ' ' VAL . 43.5 mt -87.69 116.51 29.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 119.417 -0.913 . . . . 0.60999999999999999 109.718 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -110.19 -10.46 14.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.093 -0.958 . . . . 2.0 110.487 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 37.1 ttmt -145.53 110.4 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.981 -0.554 . . . . 1.53 111.359 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 68' ' ' ILE . 38.9 t -102.26 90.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.03 -1.1 . . . . 0.88 108.03 166.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.5 t70 -106.44 59.63 0.64 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.538 -0.465 . . . . 1.4199999999999999 110.613 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.705 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.7 pt-20 39.71 -160.95 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 124.734 1.271 . . . . 0.95999999999999996 111.924 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.705 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -62.47 80.5 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 CA-C-N 120.494 1.212 . . . . 0.38 112.118 168.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.459 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 13.9 t70 -165.89 -69.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.5 110.66 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.615 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -146.43 130.69 17.52 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.384 0.883 . . . . 0.34999999999999998 113.384 -174.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -123.75 125.96 45.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.041 -0.412 . . . . 0.73999999999999999 110.864 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 99.2 t -103.48 109.83 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.77 -0.456 . . . . 0.67000000000000004 109.77 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.75 126.73 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.385 -0.825 . . . . 0.75 111.616 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.1 163.99 29.49 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.787 -0.525 . . . . 0.5 111.787 175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 5.3 t-105 -64.31 161.79 16.06 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.563 0.949 . . . . 2.79 113.563 -166.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.481 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 1.6 ttp180 -158.07 -17.69 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.862 -1.063 . . . . 5.46 109.822 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.618 ' HA ' ' CZ2' ' A' ' 81' ' ' TRP . 2.6 tt 79.2 157.35 0.16 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.758 -1.11 . . . . 1.55 111.624 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.504 ' OD1' HG11 ' A' ' 40' ' ' VAL . 49.9 t30 -131.55 147.42 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.561 -0.745 . . . . 1.9299999999999999 110.265 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.483 ' HA2' HD21 ' A' ' 33' ' ' ASN . . . 83.31 1.1 90.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.911 -0.661 . . . . 2.3999999999999999 113.645 172.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 18.9 t80 177.55 165.91 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.961 0.381 . . . . 5.3799999999999999 110.479 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.61 69.18 1.24 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.195 -1.562 . . . . 2.2999999999999998 109.195 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 131' ' ' ASN . 12.9 ttm180 -97.5 -179.92 4.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.186 -0.507 . . . . 4.7699999999999996 110.242 -168.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.512 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.06 122.5 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.568 0.699 . . . . 1.8600000000000001 110.1 177.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.53 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 3.5 p30 -122.9 147.43 51.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.4 -0.818 . . . . 3.1800000000000002 111.38 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' ' HD2' ' A' ' 128' ' ' ARG . 3.4 Cg_exo -80.77 -52.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.892 2.395 . . . . 2.3599999999999999 110.904 168.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 90' ' ' ASP . 5.2 m-20 44.17 42.34 4.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.043 -0.98 . . . . 2.9900000000000002 113.161 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.405 ' H ' ' H ' ' A' ' 94' ' ' SER . 10.3 p30 -140.54 -22.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 122.008 0.908 . . . . 3.0600000000000001 109.064 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.463 ' HB2' ' CG ' ' A' ' 118' ' ' PHE . 71.1 m -150.67 -141.85 0.11 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.419 -1.264 . . . . 1.8500000000000001 107.979 173.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 21.9 t 60.74 37.27 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.368 1.08 . . . . 1.4399999999999999 108.307 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.76 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 21.4 mt-10 -74.89 144.37 43.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.175 -1.375 . . . . 1.8100000000000001 110.182 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.57 ' HB2' ' CG1' ' A' ' 113' ' ' VAL . 2.7 p90 -131.56 132.11 43.88 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.229 0.538 . . . . 0.64000000000000001 110.636 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 35.9 m -95.24 114.31 26.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.207 -0.906 . . . . 0.42999999999999999 110.209 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.707 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -82.1 108.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.783 -0.644 . . . . 0.87 109.387 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.4 m -101.29 105.52 16.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.126 -0.488 . . . . 0.45000000000000001 109.881 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.87 110.5 21.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.415 -0.357 . . . . 0.34000000000000002 110.062 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.67 106.41 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.137 -0.69 . . . . 0.54000000000000004 109.137 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.503 ' HB2' ' NE ' ' A' ' 16' ' ' ARG . . . -78.52 124.34 28.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.638 -0.71 . . . . 0.44 111.46 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -108.27 127.89 54.25 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.726 -0.842 . . . . 2.0299999999999998 108.726 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.95 -18.42 40.22 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.525 -0.761 . . . . 1.97 114.832 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -92.87 39.58 1.04 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.737 0.769 . . . . 4.9299999999999997 110.812 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.551 ' NZ ' ' HB2' ' A' ' 107' ' ' LYS . 9.7 mtmp? 64.76 33.29 10.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.06 -0.518 . . . . 3.5299999999999998 110.86 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 1.2 ttmp? -122.0 153.19 38.89 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.227 -0.657 . . . . 2.4399999999999999 109.227 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.7 m -155.78 113.82 3.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.187 0.518 . . . . 0.41999999999999998 111.203 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -92.21 111.71 23.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.515 -0.766 . . . . 2.5899999999999999 109.933 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.589 HG12 ' HB ' ' A' ' 10' ' ' VAL . 13.4 p -87.61 138.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.40000000000000002 110.163 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.555 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 22.7 t70 -133.19 106.93 7.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.302 -0.863 . . . . 1.3799999999999999 109.008 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.046 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 5.3 t -90.61 120.62 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 120.89 -0.324 . . . . 0.91000000000000003 110.597 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.71 133.1 43.51 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.701 -0.852 . . . . 2.3100000000000001 108.701 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.673 ' CG ' HG22 ' A' ' 6' ' ' VAL . 34.6 t60 -116.61 153.93 31.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.614 -0.721 . . . . 1.6399999999999999 109.789 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 118' ' ' PHE . 14.2 t -64.1 -165.31 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.613 -0.722 . . . . 2.6699999999999999 110.415 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' A' ' 121' ' ' MET . 8.4 p-80 -131.82 27.53 4.6 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.708 -0.678 . . . . 2.6299999999999999 110.571 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' H ' HG23 ' A' ' 116' ' ' THR . 46.2 t80 -64.48 -24.33 67.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.506 0.67 . . . . 3.54 109.985 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -44.59 66.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.817 -1.083 . . . . 1.8100000000000001 109.172 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 2' ' ' TYR . 1.3 tmt_? -58.49 -21.17 50.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.803 -1.09 . . . . 3.3799999999999999 111.832 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 94.1 mmm -73.52 33.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.991 0.424 . . . . 2.4300000000000002 112.107 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 130.09 145.26 5.74 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.244 -0.503 . . . . 1.6100000000000001 111.96 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.9 m -61.15 -27.12 68.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.34 . . . . 2.5800000000000001 110.855 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.836 ' HG2' HH21 ' A' ' 128' ' ' ARG . 60.4 tttp -66.25 -47.35 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.461 -0.336 . . . . 3.7999999999999998 110.315 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.671 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 37.0 m80 -65.04 -47.02 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.922 0.391 . . . . 2.1400000000000001 110.944 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.65 80.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.314 -0.403 . . . . 0.92000000000000004 111.466 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.38 -44.91 86.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.723 -0.217 . . . . 2.8300000000000001 110.924 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.836 HH21 ' HG2' ' A' ' 124' ' ' LYS . 19.2 ptp180 -58.29 -34.04 70.11 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 120.796 0.331 . . . . 2.5899999999999999 110.683 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.5 HG12 ' SD ' ' A' ' 133' ' ' MET . 92.7 t -79.29 -48.71 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.867 0.365 . . . . 1.48 110.719 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.975 ' HA ' ' HG2' ' A' ' 133' ' ' MET . 17.2 mtp180 -61.91 -17.85 58.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.06 -0.518 . . . . 3.8300000000000001 111.922 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 4.2 m-80 -51.98 -46.98 65.04 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.493 0.496 . . . . 2.48 111.517 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.01 -15.71 9.74 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.136 -1.031 . . . . 1.6100000000000001 113.15 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.975 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 21.6 ptm -80.91 -36.88 30.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.48 . . . . 4.8300000000000001 112.167 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -27.43 62.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.933 0.716 . . . . 2.8300000000000001 112.933 -163.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -103.29 -15.85 15.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.167 0.508 . . . . 4.1500000000000004 111.004 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.597 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.2 -55.46 0.77 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.427 -0.892 . . . . 1.04 113.102 -174.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 8' ' ' HIS . 6.9 t90 -56.12 -53.34 64.56 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.674 0.62 . . . . 2.7799999999999998 112.674 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.25 -45.24 28.26 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.801 1.668 . . . . 0.68000000000000005 111.714 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 m -60.53 -40.16 90.47 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.573 0.702 . . . . 0.87 110.34 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 136' ' ' GLY . 49.7 mt -55.67 -45.53 79.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 CA-C-N 114.945 -1.025 . . . . 0.71999999999999997 110.031 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 38.4 mt -59.14 -34.87 72.58 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.45 0.468 . . . . 0.68999999999999995 111.842 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.98 -56.19 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 1.49 110.636 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.668 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 23.5 m -68.56 -21.16 64.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.518 -0.31 . . . . 1.1499999999999999 111.161 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.09 -52.14 65.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.941 -0.392 . . . . 0.80000000000000004 109.941 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.692 ' HG2' HG13 ' A' ' 10' ' ' VAL . 52.6 mt-30 -60.41 -36.07 77.26 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.741 -0.663 . . . . 1.6299999999999999 110.046 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.62 -40.26 69.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.892 -1.049 . . . . 1.46 111.208 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 37.4 tptt -65.58 -37.71 87.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.216 0.531 . . . . 1.74 109.642 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.878 HG21 HG13 ' A' ' 12' ' ' VAL . 66.0 mt -72.45 -25.66 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.5 110.557 176.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.82 -30.9 71.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.554 -0.536 . . . . 0.84999999999999998 109.554 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.696 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 40.1 mt-10 -70.4 -30.54 67.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.63 -0.714 . . . . 1.5 110.188 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.87 -36.12 62.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.362 -0.836 . . . . 1.74 109.619 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.26 -0.882 . . . . 1.3200000000000001 111.647 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -167.21 86.66 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.413 . . . . 1.9199999999999999 110.967 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.696 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.5 ttmm -107.59 -59.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.41 . . . . 2.04 109.914 176.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 3.9 mptp? . . . . . 0 C--O 1.247 0.946 0 O-C-N 123.777 0.673 . . . . 4.2199999999999998 111.101 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.5 ' ND2' HG13 ' A' ' 6' ' ' VAL . 3.4 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.682 0.277 . . . . 1.6599999999999999 111.333 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 46.8 p90 -176.78 -42.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.776 -0.647 . . . . 3.73 109.812 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.768 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 21.3 t70 -58.23 -55.37 46.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.13 -0.486 . . . . 2.7799999999999998 112.099 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.2 Cg_endo -92.39 -65.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.453 2.102 . . . . 1.6299999999999999 112.275 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.473 ' HD2' HG21 ' A' ' 116' ' ' THR . 91.7 m-85 -143.1 145.35 32.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.226 -0.443 . . . . 3.21 110.543 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 45.2 t -104.58 126.54 59.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.88 -0.785 . . . . 1.4399999999999999 108.88 167.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.2 ttm105 -128.44 135.2 49.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.221 0.534 . . . . 3.3700000000000001 110.96 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.952 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -109.07 130.51 55.48 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.135 -1.061 . . . . 0.79000000000000004 108.135 170.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.4 t -136.78 110.5 8.1 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.568 0.699 . . . . 1.28 109.596 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.8 t -122.85 134.7 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.601 -1.181 . . . . 1.27 111.038 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -91.75 115.59 28.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.04 -0.527 . . . . 0.56999999999999995 109.756 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.768 HG13 HG21 ' A' ' 148' ' ' ILE . 42.0 t -96.79 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.496 -0.557 . . . . 0.91000000000000003 109.496 177.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -104.93 33.25 3.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.885 -0.598 . . . . 0.97999999999999998 111.5 -173.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -153.53 31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 0.35999999999999999 111.573 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.71 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 19.8 t70 71.38 166.9 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.054 0.93 . . . . 0.91000000000000003 112.348 176.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -71.68 -21.91 61.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.111 -0.95 . . . . 1.8799999999999999 111.68 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.71 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 39.5 mmtm -58.33 -50.84 72.2 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.048 0.452 . . . . 3.0499999999999998 109.907 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.1 p -72.57 -37.43 68.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.72 -0.673 . . . . 1.1100000000000001 110.623 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.508 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -55.9 -45.55 78.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.853 0.359 . . . . 0.32000000000000001 110.732 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.432 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 59.9 t80 -74.24 -47.64 33.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.148 -0.478 . . . . 0.38 111.204 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 21' ' ' LYS . 4.4 ttmm -56.92 -52.18 66.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.592 -0.277 . . . . 2.3900000000000001 111.167 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 m -64.01 -50.63 67.77 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.416 -0.356 . . . . 0.68000000000000005 110.577 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.882 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.8 t80 -61.09 -36.84 80.73 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.333 0.494 . . . . 0.47999999999999998 112.333 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.557 ' CD1' HG11 ' A' ' 46' ' ' VAL . 20.0 tp -106.37 -59.73 1.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.333 0.494 . . . . 0.5 112.333 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.16 -44.78 21.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.236 0.541 . . . . 1.24 111.515 -170.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.779 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -85.19 37.45 3.01 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 115.349 -0.841 . . . . 0.82999999999999996 112.286 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.627 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 23.8 t80 -54.5 -48.91 93.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 112.366 0.506 . . . . 0.73999999999999999 112.366 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 48.0 Cg_endo -86.84 12.93 2.85 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.203 1.935 . . . . 0.76000000000000001 114.711 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.779 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -96.08 -4.23 43.27 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.192 -0.603 . . . . 1.49 110.624 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.882 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 17.1 m0 -77.4 -175.58 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.726 0.774 . . . . 4.6200000000000001 112.045 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.522 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 47.4 m95 -109.42 -33.66 0.15 Allowed Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 114.642 -1.163 . . . . 2.7799999999999998 113.454 176.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.851 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 60.7 Cg_endo -71.03 -129.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.98 1.787 . . . . 1.3600000000000001 114.345 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.502 ' CG ' HD21 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -59.87 -47.11 87.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.642 0.734 . . . . 1.51 111.279 -172.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.691 ' HA ' HG13 ' A' ' 40' ' ' VAL . 6.1 p-10 -83.61 34.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.345 -1.298 . . . . 1.79 112.062 -171.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -106.09 5.14 29.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.687 0.756 . . . . 4.4500000000000002 109.404 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -99.53 124.05 44.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 4.1399999999999997 110.693 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -74.88 131.26 40.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.064 -0.517 . . . . 2.6800000000000002 111.51 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.651 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 30.5 p 54.54 22.77 4.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.249 1.02 . . . . 1.4199999999999999 111.74 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -114.0 -46.64 3.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.596 -0.89 . . . . 2.8999999999999999 108.596 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.691 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.6 p -169.43 6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.053 -0.976 . . . . 1.8300000000000001 110.03 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -159.55 53.64 0.36 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.915 -0.66 . . . . 2.1699999999999999 112.274 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.023 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.6 174.28 3.67 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 109.493 -0.558 . . . . 1.1200000000000001 109.493 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 38.7 Cg_exo -63.15 56.43 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.184 2.589 . . . . 1.48 113.774 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -166.95 -84.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.194 0.598 . . . . 1.75 109.62 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.627 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 89.2 -48.93 3.46 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.043 -0.598 . . . . 0.75 113.012 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG11 ' CD1' ' A' ' 24' ' ' LEU . 75.2 t -137.86 144.83 30.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 110.033 -0.358 . . . . 0.59999999999999998 110.033 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.753 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 29.5 t70 -108.77 116.07 31.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.54 -0.541 . . . . 1.1100000000000001 109.54 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -73.96 -29.8 62.19 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.572 -0.74 . . . . 2.8100000000000001 112.128 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.68 -54.04 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.021 0.378 . . . . 3.1699999999999999 112.021 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.03 -22.21 39.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.41 -0.9 . . . . 1.53 112.651 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.486 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 87.3 61.91 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.543 -0.837 . . . . 0.77000000000000002 111.46 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 3.9 mpt_? -133.17 158.97 41.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.224 . . . . 3.7200000000000002 110.509 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.712 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 17.0 m0 -113.28 106.39 14.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.804 -0.813 . . . . 1.28 108.804 168.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.753 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 8.6 p90 -157.5 167.72 29.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.031 -0.359 . . . . 1.6599999999999999 110.031 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.023 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 4.4 mt-10 -127.89 159.67 34.21 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.488 -0.324 . . . . 2.1200000000000001 110.335 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.65 102.26 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.373 -0.973 . . . . 0.92000000000000004 108.373 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.04 163.27 27.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 1.97 109.325 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.84 -22.13 66.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.694 0.283 . . . . 2.4300000000000002 111.056 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -86.83 -15.51 38.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 2.3900000000000001 110.885 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.89 -100.94 0.21 Allowed Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.395 -0.907 . . . . 2.29 112.95 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.66 27.41 2.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.771 0.32 . . . . 2.3100000000000001 111.432 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.59 82.49 2.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.347 0.594 . . . . 2.6099999999999999 109.838 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 163.85 20.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.247 -0.888 . . . . 3.7200000000000002 110.005 174.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 16.7 p -46.69 120.56 3.02 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.723 -0.473 . . . . 2.27 109.723 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 18.0 p90 -115.33 116.41 28.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.652 0.739 . . . . 6.4800000000000004 112.053 -171.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -72.03 152.0 48.05 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.75 -1.113 . . . . 1.23 111.423 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -112.89 92.06 3.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.966 0.412 . . . . 1.1699999999999999 111.109 -172.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 71' ' ' VAL . 20.0 mt -85.13 116.53 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.682 -0.488 . . . . 0.60999999999999999 109.682 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.611 ' HD3' ' OE2' ' A' ' 96' ' ' GLU . 2.4 mpt_? -88.04 -33.09 18.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.885 0.374 . . . . 2.0 110.733 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 58.0 tttp -129.6 98.97 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 1.53 111.294 -174.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 68' ' ' ILE . 44.9 t -98.05 96.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.05 -1.093 . . . . 0.88 108.05 169.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -115.66 77.47 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.805 -0.358 . . . . 1.4199999999999999 111.165 -173.11 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.33 -171.64 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 124.367 1.042 . . . . 0.95999999999999996 112.012 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -66.41 74.09 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.353 1.369 . . . . 0.38 111.043 166.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 22.3 t70 -156.55 -64.73 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.806 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.611 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -144.48 145.55 31.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.665 0.617 . . . . 0.34999999999999998 112.665 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 1.1 mp -139.01 116.51 11.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.733 -0.667 . . . . 0.73999999999999999 109.745 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 98' ' ' THR . 61.6 t -101.03 106.69 19.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.02 -0.733 . . . . 0.67000000000000004 109.02 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -129.1 127.56 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.75 111.95 -171.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -90.7 154.92 23.56 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.427 -0.416 . . . . 0.5 112.896 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 17.4 t-105 -73.19 160.88 31.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 2.79 111.889 -171.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.54 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 11.9 ptt180 -137.2 0.63 2.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.967 -0.561 . . . . 5.46 110.732 -169.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.781 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 2.7 tm? 74.55 133.09 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.985 0.803 . . . . 1.55 110.82 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.541 ' HB2' ' CH2' ' A' ' 81' ' ' TRP . 40.4 t-20 -98.94 121.4 40.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 1.9299999999999999 110.367 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.83 -9.22 61.84 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.425 -0.893 . . . . 2.3999999999999999 114.309 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.1 t80 70.98 -42.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.229 0.612 . . . . 5.3799999999999999 112.238 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.75 7.23 51.01 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.234 -0.508 . . . . 2.2999999999999998 112.928 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HB2' HD21 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -108.17 178.31 4.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.969 -0.752 . . . . 4.7699999999999996 108.969 177.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.519 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -114.54 128.64 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.963 0.411 . . . . 1.8600000000000001 111.406 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.781 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 29.1 t70 -144.36 142.52 19.74 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.153 -0.684 . . . . 3.1800000000000002 109.153 168.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.555 ' HD2' ' OD2' ' A' ' 90' ' ' ASP . 17.3 Cg_endo -58.1 -27.28 79.24 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.948 2.432 . . . . 2.3599999999999999 113.893 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 3.0 t70 67.38 -0.85 1.7 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.88 0.848 . . . . 2.9900000000000002 110.853 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.18 -38.68 60.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.682 -0.69 . . . . 3.0600000000000001 112.191 -171.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.9 m -156.01 -93.46 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.767 -0.197 . . . . 1.8500000000000001 110.958 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.779 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 4.1 m 50.64 39.78 22.33 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.63 0.581 . . . . 1.4399999999999999 110.724 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.763 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.7 mm-40 -69.24 144.52 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.34 -0.846 . . . . 1.8100000000000001 112.221 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.91 127.95 22.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.56 0.695 . . . . 0.64000000000000001 111.717 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.6 HG23 HG22 ' A' ' 78' ' ' VAL . 52.9 m -93.26 112.12 23.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.044 -0.98 . . . . 0.42999999999999999 110.788 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -89.59 110.11 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.764 -0.653 . . . . 0.87 109.869 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.611 ' HA ' HG22 ' A' ' 76' ' ' THR . 23.4 m -105.4 106.38 16.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 0.45000000000000001 110.561 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 29.8 m-85 -88.5 107.59 18.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.34000000000000002 110.298 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.24 111.22 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.324 -0.398 . . . . 0.54000000000000004 110.303 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.88 53.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.44 110.453 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.781 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 8.6 t70 -130.7 118.9 21.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.137 -0.483 . . . . 2.0299999999999998 110.534 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.16 -98.78 0.52 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.064 -0.588 . . . . 1.97 112.546 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.01 -20.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 4.9299999999999997 110.259 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -128.14 7.1 5.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 3.5299999999999998 111.53 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.781 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 83.9 tttt -122.7 151.25 41.73 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.584 -0.446 . . . . 2.4399999999999999 110.425 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -153.76 118.5 4.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.828 -0.624 . . . . 0.41999999999999998 109.936 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -100.79 115.8 31.18 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.532 -0.758 . . . . 2.5899999999999999 109.449 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.2 p -91.76 137.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.285 -0.566 . . . . 0.40000000000000002 110.642 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.4 109.01 11.33 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.156 -0.929 . . . . 1.3799999999999999 109.049 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.952 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 3.9 t -101.64 124.16 55.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.897 -0.592 . . . . 0.91000000000000003 111.263 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -102.76 113.7 27.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.437 0.637 . . . . 2.3100000000000001 109.452 173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.703 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 65.7 t60 -134.2 98.95 4.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.195 -0.911 . . . . 1.6399999999999999 109.219 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.473 HG21 ' HD2' ' A' ' 5' ' ' PHE . 5.1 t -152.92 97.29 2.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.918 0.866 . . . . 2.6699999999999999 111.027 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.68 -69.91 0.09 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.334 -0.848 . . . . 2.6299999999999999 110.0 176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.652 ' CE1' ' HB3' ' A' ' 125' ' ' HIS . 13.6 t80 -72.28 -48.73 40.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.531 -0.759 . . . . 3.54 111.173 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.97 78.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 1.8100000000000001 110.097 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 36.4 ttt180 -51.94 -24.94 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.222 -1.354 . . . . 3.3799999999999999 112.072 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 95.3 mmm -79.9 -8.85 59.54 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.65 0.262 . . . . 2.4300000000000002 110.706 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 44.43 -135.13 6.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.539 -0.755 . . . . 1.6100000000000001 113.636 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.6 p 40.61 -133.07 0.29 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.763 0.825 . . . . 2.5800000000000001 112.417 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -57.77 -33.25 68.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 3.7999999999999998 111.583 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.652 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 11.8 m-70 -66.51 -52.97 40.24 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.38 0.609 . . . . 2.1400000000000001 110.739 -171.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.73 69.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.637 -0.711 . . . . 0.92000000000000004 111.054 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -73.7 -28.94 61.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 2.8300000000000001 111.668 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 31.6 ptt180 -77.35 -36.66 53.57 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.803 -0.359 . . . . 2.5899999999999999 111.256 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.638 HG21 ' HE2' ' A' ' 118' ' ' PHE . 93.8 t -76.48 -23.86 15.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.356 0.598 . . . . 1.48 110.421 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.51 ' HG3' ' CB ' ' A' ' 134' ' ' ASP . 27.3 ttm180 -58.22 -19.85 36.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 3.8300000000000001 111.142 174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.03 -22.72 41.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.196 -0.456 . . . . 2.48 111.362 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -137.41 -47.69 0.07 OUTLIER Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.374 -0.917 . . . . 1.6100000000000001 113.469 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.46 -25.58 63.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.879 0.34 . . . . 4.8300000000000001 111.878 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.51 ' CB ' ' HG3' ' A' ' 130' ' ' ARG . 15.0 t70 -59.28 -43.92 92.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 2.8300000000000001 112.064 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -96.71 5.85 49.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 4.1500000000000004 111.146 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -102.41 -62.15 0.73 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.441 -0.885 . . . . 1.04 112.81 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.54 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 1.1 t90 -60.63 -49.25 90.63 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.966 0.728 . . . . 2.7799999999999998 112.966 -169.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.6 Cg_endo -58.13 -44.86 35.6 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.662 1.575 . . . . 0.68000000000000005 112.027 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.0 m -59.05 -40.94 86.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.761 -0.654 . . . . 0.87 110.228 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.641 HG23 ' HZ3' ' A' ' 30' ' ' TRP . 45.6 mt -54.69 -51.94 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.928 -1.033 . . . . 0.71999999999999997 110.894 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 8' ' ' HIS . 59.5 mt -61.67 -30.57 70.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.048 0.388 . . . . 0.68999999999999995 112.048 -175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.0 mm-40 -70.99 -55.51 8.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 1.49 110.524 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.536 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.6 m -68.08 -22.52 64.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.072 -0.513 . . . . 1.1499999999999999 110.626 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.79 -52.48 64.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.221 0.534 . . . . 0.80000000000000004 109.771 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.744 ' HG2' HG13 ' A' ' 10' ' ' VAL . 45.9 mt-30 -59.79 -36.25 76.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.155 -0.929 . . . . 1.6299999999999999 110.765 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.6 -40.29 49.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.748 -0.66 . . . . 1.46 111.462 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.23 -42.46 99.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 1.74 109.884 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.768 HG21 HG13 ' A' ' 12' ' ' VAL . 57.0 mt -64.44 -35.64 74.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.5 110.306 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.493 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 21.7 t70 -59.56 -38.71 81.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.61 -0.723 . . . . 0.84999999999999998 109.716 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.509 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 45.6 mt-10 -66.06 -22.61 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 1.5 111.348 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -73.6 -8.04 54.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.763 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.27 -47.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.576 -1.297 . . . . 1.3200000000000001 114.14 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.08 58.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.666 0.617 . . . . 1.9199999999999999 112.666 -170.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.509 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.0 ttmm -69.26 101.23 1.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.226 -0.443 . . . . 2.04 111.539 -173.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 29.9 mmtp . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.394 -0.821 . . . . 4.2199999999999998 109.391 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.559 0.219 . . . . 1.6599999999999999 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.527 ' HA ' HG23 ' A' ' 6' ' ' VAL . 52.9 p90 173.53 -36.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.652 0.781 . . . . 3.73 109.92 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.786 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 29.9 t70 -67.97 -57.65 9.13 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.411 -0.359 . . . . 2.7799999999999998 111.525 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 47.7 Cg_endo -83.03 -63.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.248 1.299 . . . . 1.6299999999999999 111.714 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.51 139.09 16.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.421 -0.354 . . . . 3.21 110.946 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.69 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 79.6 t -89.11 121.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.047 -0.723 . . . . 1.4399999999999999 109.047 167.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.5 ttt180 -124.88 130.83 53.15 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.3 -0.409 . . . . 3.3700000000000001 110.428 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.79 130.87 55.47 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.807 -0.812 . . . . 0.79000000000000004 108.807 172.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 11.3 p -134.79 111.04 9.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.94 0.876 . . . . 1.28 110.498 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.3 t -120.37 133.35 67.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.269 -1.332 . . . . 1.27 111.637 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.0 m -96.13 115.51 27.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.693 . . . . 0.56999999999999995 109.782 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG13 HG21 ' A' ' 148' ' ' ILE . 4.6 t -98.64 140.8 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.91000000000000003 111.004 -176.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 11.3 mmtp -100.0 9.88 42.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.919 -0.582 . . . . 0.97999999999999998 112.016 -170.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.497 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.09 37.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.149 -0.62 . . . . 0.35999999999999999 112.452 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 74.08 165.22 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.784 0.802 . . . . 0.91000000000000003 112.743 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.616 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 10.9 ttp180 -63.1 -30.27 71.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.419 -1.264 . . . . 1.8799999999999999 111.226 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 18' ' ' THR . 61.8 pttt -56.18 -47.18 78.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.117 -0.492 . . . . 3.0499999999999998 110.405 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 27.9 m -74.84 -33.65 62.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.874 -0.603 . . . . 1.1100000000000001 110.605 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -60.55 -49.59 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.32000000000000001 110.883 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 52.0 t80 -70.09 -43.37 71.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.236 -0.438 . . . . 0.38 110.773 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -53.72 -51.46 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 2.3900000000000001 110.175 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' CE2' ' A' ' 30' ' ' TRP . 61.1 m -63.2 -41.38 99.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.982 -0.554 . . . . 0.68000000000000005 111.282 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HA ' ' HE1' ' A' ' 144' ' ' PHE . 73.8 t80 -70.48 -47.19 61.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.329 0.492 . . . . 0.47999999999999998 112.329 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 46' ' ' VAL . 11.3 tp -119.27 -11.7 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.119 1.155 . . . . 0.5 114.119 -167.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.622 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 32.9 mt-10 -113.98 -38.92 4.07 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.213 -0.929 . . . . 1.24 111.345 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.19 29.74 7.87 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.373 -0.831 . . . . 0.82999999999999996 111.342 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.614 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 59.4 t80 -46.48 -55.07 15.24 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 114.504 -0.848 . . . . 0.73999999999999999 113.054 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.5 Cg_endo -94.37 21.59 0.55 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.13 1.887 . . . . 0.76000000000000001 115.493 -172.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -120.37 -18.82 7.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.97 1.1 . . . . 1.49 113.97 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CE2' HG23 ' A' ' 22' ' ' THR . 25.3 m95 -76.08 -173.09 2.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.391 0.615 . . . . 4.6200000000000001 112.523 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.732 ' HB2' ' HB3' ' A' ' 143' ' ' SER . 51.7 m95 -77.35 -35.16 1.28 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 115.617 1.71 . . . . 2.7799999999999998 115.617 -172.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.645 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 74.3 Cg_endo -72.34 -131.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 121.85 1.7 . . . . 1.3600000000000001 115.02 -161.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 10.7 t30 -67.31 -8.07 29.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.084 -0.962 . . . . 1.51 110.496 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 1.058 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.3 m-20 -90.66 18.05 6.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.772 -1.103 . . . . 1.79 110.666 -172.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -104.83 68.17 0.83 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.555 . . . . 4.4500000000000002 110.603 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -156.66 -178.06 7.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.002 -0.545 . . . . 4.1399999999999997 109.85 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -110.37 139.16 45.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.522 -0.547 . . . . 2.6800000000000002 109.522 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.539 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 50.3 p 51.74 28.3 4.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.895 0.855 . . . . 1.4199999999999999 111.266 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HD3' HG22 ' A' ' 40' ' ' VAL . 1.1 tmtp? -149.46 84.01 1.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.324 -1.362 . . . . 2.8999999999999999 107.324 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.058 HG23 ' HA ' ' A' ' 34' ' ' ASN . 34.0 m 45.02 32.36 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.6 1.188 . . . . 1.8300000000000001 112.589 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.6 11.62 0.21 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.514 -0.851 . . . . 2.1699999999999999 113.873 -175.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.042 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.87 -178.27 0.65 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.214 0.507 . . . . 1.1200000000000001 110.591 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.553 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 31.1 Cg_exo -63.37 20.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.712 2.274 . . . . 1.48 114.303 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.824 ' HG ' ' H ' ' A' ' 45' ' ' GLY . 17.0 tp -161.59 -156.68 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.579 -1.267 . . . . 1.75 107.579 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.824 ' H ' ' HG ' ' A' ' 44' ' ' LEU . . . 163.9 -50.64 0.3 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.919 -1.134 . . . . 0.75 113.019 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.785 HG11 ' HG ' ' A' ' 24' ' ' LEU . 78.1 t -142.88 135.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.267 0.534 . . . . 0.59999999999999998 111.502 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -113.74 124.01 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.415 -0.357 . . . . 1.1100000000000001 110.562 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.673 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.23 -20.83 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.506 . . . . 2.8100000000000001 111.343 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -76.26 -57.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.636 -0.256 . . . . 3.1699999999999999 110.724 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.86 60.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.625 -0.798 . . . . 1.53 111.689 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 81.0 49.6 5.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.038 -0.601 . . . . 0.77000000000000002 112.495 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 7.2 mpt_? -136.29 154.19 50.95 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.599 -0.354 . . . . 3.7200000000000002 110.506 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.695 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.8 m0 -98.53 108.35 21.02 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.229 -1.026 . . . . 1.28 108.229 168.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -149.96 144.55 25.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.584 0.707 . . . . 1.6599999999999999 111.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.042 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.5 mt-10 -111.81 170.69 7.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.627 -1.169 . . . . 2.1200000000000001 109.154 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' A' ' 61' ' ' GLU . 28.6 mm -78.87 105.26 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.16 -0.681 . . . . 0.92000000000000004 109.16 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.714 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.8 t70 -88.61 -164.93 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.139 -0.319 . . . . 1.97 110.139 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.4 pt-20 -80.13 -35.51 36.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.76 0.281 . . . . 2.4300000000000002 111.76 -174.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.554 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -96.93 24.09 6.53 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.255 -0.578 . . . . 2.3900000000000001 111.639 177.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.4 -97.27 0.38 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.658 -0.782 . . . . 2.29 113.08 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG2' HD13 ' A' ' 56' ' ' ILE . 34.1 mt-10 -142.53 29.84 1.56 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.634 0.731 . . . . 2.3100000000000001 109.729 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.51 76.76 10.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.145 -0.934 . . . . 2.6099999999999999 110.286 -171.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.714 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.66 130.11 52.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.229 -1.351 . . . . 3.7200000000000002 109.61 175.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.616 HG22 ' HG3' ' A' ' 82' ' ' ARG . 2.9 m -69.92 -92.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 2.27 111.761 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.695 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 91.9 m-85 51.27 -167.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.291 1.219 . . . . 6.4800000000000004 114.291 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.4 141.02 42.04 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.035 -0.984 . . . . 1.23 114.931 -165.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -111.07 99.22 8.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.795 -0.703 . . . . 1.1699999999999999 109.484 177.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.58 HG21 HG22 ' A' ' 71' ' ' VAL . 21.0 mt -84.25 138.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.60999999999999999 111.129 -172.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -99.88 -40.21 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.357 -0.383 . . . . 2.0 110.239 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -138.11 122.69 18.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 1.53 111.463 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.58 HG22 HG21 ' A' ' 68' ' ' ILE . 40.5 t -111.08 108.73 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.102 -0.703 . . . . 0.88 109.102 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -115.31 63.64 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.416 -0.514 . . . . 1.4199999999999999 110.966 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.673 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 46.09 -166.45 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.658 1.224 . . . . 0.95999999999999996 112.086 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 44.5 Cg_exo -60.74 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.638 1.558 . . . . 0.38 112.316 167.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.81 -66.81 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.654 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -144.71 148.62 34.39 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.643 0.609 . . . . 0.34999999999999998 112.643 -175.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -138.82 129.02 25.52 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.73999999999999999 110.274 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 97' ' ' PHE . 21.9 t -109.28 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.005 -0.739 . . . . 0.67000000000000004 109.005 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.18 138.23 55.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.75 111.811 -170.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.16 149.05 19.65 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.774 -0.53 . . . . 0.5 111.774 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.83 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 76.2 t-105 -86.13 141.26 29.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.126 0.488 . . . . 2.79 112.092 -170.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.727 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 1.8 tmt_? -113.53 -79.47 0.58 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.29 -0.868 . . . . 5.46 109.053 168.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.015 HD22 ' HB2' ' A' ' 88' ' ' ARG . 53.8 mt -176.68 -111.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.41 1.1 . . . . 1.55 112.864 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 176.53 -161.98 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 103.856 -2.646 . . . . 1.9299999999999999 103.856 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.69 50.25 0.9 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.668 -1.253 . . . . 2.3999999999999999 112.222 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -140.22 78.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.823 -0.351 . . . . 5.3799999999999999 111.865 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.22 49.79 74.7 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 115.752 -0.658 . . . . 2.2999999999999998 112.42 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.015 ' HB2' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -129.31 154.12 47.17 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.517 -0.341 . . . . 4.7699999999999996 111.859 -169.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.632 ' O ' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -115.32 135.26 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 110.243 -0.28 . . . . 1.8600000000000001 110.243 177.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.594 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 5.0 p-10 -102.91 144.92 29.6 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-O 120.999 0.428 . . . . 3.1800000000000002 111.319 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.566 ' HG3' ' CE2' ' A' ' 118' ' ' PHE . 15.6 Cg_exo -65.39 -48.29 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.683 2.256 . . . . 2.3599999999999999 110.658 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.594 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 32.2 t70 64.79 29.5 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 2.9900000000000002 110.367 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -138.88 -55.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 3.0600000000000001 111.649 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.7 p -135.25 -121.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.61 -0.436 . . . . 1.8500000000000001 111.567 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.83 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.6 t 55.21 54.23 9.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.922 -0.769 . . . . 1.4399999999999999 108.922 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.445 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 44.7 tt0 -88.21 143.82 26.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.965 -1.016 . . . . 1.8100000000000001 111.599 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -107.57 148.36 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.64000000000000001 110.673 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.9 m -112.09 95.81 5.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.384 -0.969 . . . . 0.42999999999999999 108.384 158.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.646 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.8 t -83.32 110.14 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.818 -0.438 . . . . 0.87 109.818 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.7 m -108.52 107.36 17.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.784 0.326 . . . . 0.45000000000000001 111.143 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.616 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 59.5 m-85 -87.38 113.75 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.331 -0.395 . . . . 0.34000000000000002 110.264 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -96.21 115.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.176 -0.465 . . . . 0.54000000000000004 110.298 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.67 143.73 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.203 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.709 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -138.73 103.54 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.0299999999999998 110.625 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.5 16.58 55.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.99 -0.55 . . . . 1.97 113.864 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 62.69 15.08 7.76 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.182 0.438 . . . . 4.9299999999999997 112.182 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -134.76 -18.78 1.86 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.01 0.433 . . . . 3.5299999999999998 110.793 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.0 ttpm? -122.3 158.02 30.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.074 -0.713 . . . . 2.4399999999999999 109.074 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.3 m -154.13 122.78 6.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.972 0.415 . . . . 0.41999999999999998 111.227 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -98.29 108.17 20.8 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.673 -0.694 . . . . 2.5899999999999999 109.278 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 9' ' ' SER . 14.4 p -83.41 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.976 -0.69 . . . . 0.40000000000000002 109.334 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -125.65 107.99 11.11 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.675 -0.861 . . . . 1.3799999999999999 108.675 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 99' ' ' VAL . 13.0 t -103.61 123.3 57.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.394 -0.821 . . . . 0.91000000000000003 112.376 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -92.91 111.22 22.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.069 -0.968 . . . . 2.3100000000000001 108.824 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.69 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 23.6 t-160 -125.32 97.17 5.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.754 -1.202 . . . . 1.6399999999999999 107.754 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.1 m -153.64 108.31 3.11 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.7 -0.8 . . . . 2.6699999999999999 112.584 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -174.8 -63.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.456 -0.793 . . . . 2.6299999999999999 109.647 165.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 129' ' ' VAL . 77.4 t80 -76.94 -28.13 55.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.743 -0.662 . . . . 3.54 109.784 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -46.8 87.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.164 -0.926 . . . . 1.8100000000000001 110.01 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 72.9 ttt180 -57.72 -21.3 39.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.676 -1.147 . . . . 3.3799999999999999 112.094 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.38 -17.7 62.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.173 0.511 . . . . 2.4300000000000002 110.606 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 2' ' ' TYR . . . 73.03 -118.15 6.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.18 0.832 . . . . 1.6100000000000001 115.18 165.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 m -37.93 -88.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.973 1.472 . . . . 2.5800000000000001 114.973 -160.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -77.33 -34.35 55.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.16 0.429 . . . . 3.7999999999999998 112.16 -168.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 29.6 m170 -66.08 -52.13 51.69 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.864 0.364 . . . . 2.1400000000000001 110.9 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -67.02 -37.45 84.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.92000000000000004 110.395 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -61.02 -49.76 76.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.655 0.243 . . . . 2.8300000000000001 111.655 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.14 -29.24 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 2.5899999999999999 111.186 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.569 HG21 ' HE2' ' A' ' 118' ' ' PHE . 15.7 t -75.51 -41.1 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.404 0.621 . . . . 1.48 110.535 172.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 1.033 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 39.5 ttp180 -63.16 -15.41 56.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.139 -0.937 . . . . 3.8300000000000001 111.533 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -50.08 -47.02 53.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.354 -0.385 . . . . 2.48 111.433 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.21 -12.9 22.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.435 -0.888 . . . . 1.6100000000000001 111.952 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.631 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 26.1 ttt -81.23 -35.3 31.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.721 0.267 . . . . 4.8300000000000001 111.721 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 1.033 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 38.7 t70 -63.86 -37.29 86.84 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.833 0.679 . . . . 2.8300000000000001 112.833 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 36.0 tptt -106.66 22.19 16.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.932 0.873 . . . . 4.1500000000000004 109.608 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.64 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.77 -71.36 0.55 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.344 -0.843 . . . . 1.04 111.798 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.443 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.7 t-105 -54.71 -54.1 53.06 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 113.041 0.756 . . . . 2.7799999999999998 113.041 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 27.0 Cg_endo -61.49 -41.32 41.3 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.8 1.667 . . . . 0.68000000000000005 112.199 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -63.28 -40.96 98.84 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.334 0.588 . . . . 0.87 109.962 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 42.3 mt -58.18 -43.65 86.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 115.271 -0.877 . . . . 0.71999999999999997 110.645 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.538 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 24.8 mt -60.06 -41.46 92.4 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.166 0.291 . . . . 0.68999999999999995 111.2 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.192 -0.603 . . . . 1.49 111.121 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.732 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 13.8 m -75.96 -22.38 56.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 1.1499999999999999 110.594 176.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 63.4 t80 -61.76 -54.87 36.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.528 -0.76 . . . . 0.80000000000000004 109.336 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.44 -29.37 70.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.01 -0.541 . . . . 1.6299999999999999 110.272 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.26 -54.23 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 1.46 111.891 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 147' ' ' LYS . 5.9 tmtt? -74.31 -35.01 63.66 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 120.243 -0.583 . . . . 1.74 110.188 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.735 HG21 HG13 ' A' ' 12' ' ' VAL . 18.7 mt -60.96 -34.88 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.135 0.493 . . . . 0.5 110.418 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 27.5 t70 -59.11 -34.95 72.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.84999999999999998 109.924 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.646 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 30.5 mt-10 -69.62 -19.55 63.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.844 -0.616 . . . . 1.5 111.4 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.85 2.41 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.093 -0.503 . . . . 1.74 110.582 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.51 -70.72 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.193 -1.003 . . . . 1.3200000000000001 113.897 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.62 -33.06 21.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.617 0.969 . . . . 1.9199999999999999 113.617 -167.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.689 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 34.5 ttmt -69.51 166.71 18.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.963 -0.384 . . . . 2.04 109.963 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 C-N-CA 123.941 0.896 . . . . 4.2199999999999998 111.244 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 1.004 HD22 ' HB ' ' A' ' 6' ' ' VAL . 19.9 p-10 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 110.276 -0.268 . . . . 1.6599999999999999 110.276 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 84.3 m-85 83.31 -63.58 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.79 0.836 . . . . 3.73 111.044 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.774 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -54.83 -50.59 85.17 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.256 -0.429 . . . . 2.7799999999999998 111.161 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 13.4 Cg_endo -92.58 -72.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.168 1.912 . . . . 1.6299999999999999 111.77 169.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.677 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 39.5 p90 -153.59 153.61 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.348 -0.612 . . . . 3.21 109.348 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.004 ' HB ' HD22 ' A' ' 1' ' ' ASN . 0.9 OUTLIER -102.35 143.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.93 -1.137 . . . . 1.4399999999999999 107.93 169.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.6 ttt180 -133.32 143.42 49.0 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.417 -0.513 . . . . 3.3700000000000001 110.635 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.832 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.51 132.03 54.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.302 -0.999 . . . . 0.79000000000000004 108.302 170.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' ' NH2' ' A' ' 110' ' ' ARG . 21.8 m -130.37 110.41 11.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.329 0.585 . . . . 1.28 109.753 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 2.5 t -134.53 131.12 54.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.153 -0.93 . . . . 1.27 111.588 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -105.65 116.12 31.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.56999999999999995 109.142 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 19' ' ' ALA . 1.5 m -98.01 158.14 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.879 -0.601 . . . . 0.91000000000000003 110.035 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.84 55.86 0.97 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.053 -0.521 . . . . 0.97999999999999998 111.002 -174.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -167.17 26.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.968 -0.56 . . . . 0.35999999999999999 111.837 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.0 t70 73.81 167.41 0.3 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.073 0.463 . . . . 0.91000000000000003 111.797 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.703 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 48.4 ttp180 -71.04 -27.31 63.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.987 -0.552 . . . . 1.8799999999999999 111.162 -173.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -58.19 -52.93 63.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.918 -0.583 . . . . 3.0499999999999998 110.266 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 69.3 m -71.04 -34.95 71.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.85 -0.614 . . . . 1.1100000000000001 111.24 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -57.07 -47.02 82.02 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.32000000000000001 110.802 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 69.4 t80 -70.8 -43.49 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.38 110.615 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.677 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 22.8 tptp -51.92 -52.28 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 2.3900000000000001 110.711 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.3 m -67.64 -52.23 40.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.54 -0.3 . . . . 0.68000000000000005 110.868 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -59.21 -39.76 83.67 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.452 0.538 . . . . 0.47999999999999998 112.452 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 77' ' ' LEU . 27.4 tp -114.21 -47.38 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.158 -0.617 . . . . 0.5 112.205 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.677 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 29.4 mt-10 -88.67 17.4 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.765 0.317 . . . . 1.24 111.082 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.67 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -149.46 39.23 0.92 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.798 -0.715 . . . . 0.82999999999999996 112.067 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.617 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 12.6 t80 -51.56 -48.48 86.61 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 122.019 0.128 . . . . 0.73999999999999999 111.07 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 30.0 Cg_endo -88.74 24.19 0.7 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.15 1.9 . . . . 0.76000000000000001 114.907 174.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.8 pt-20 -105.12 -12.2 16.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.866 0.757 . . . . 1.49 111.462 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.504 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 2.7 m0 -83.54 -164.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.031 -0.359 . . . . 4.6200000000000001 110.031 -174.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.653 ' H ' ' HD3' ' A' ' 32' ' ' PRO . 12.5 p-90 -140.37 19.01 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 114.464 1.283 . . . . 2.7799999999999998 114.464 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.653 ' HD3' ' H ' ' A' ' 31' ' ' TRP . 54.9 Cg_endo -83.69 -112.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 CA-C-N 121.406 1.538 . . . . 1.3600000000000001 113.001 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 63.0 t30 -79.41 -13.76 59.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.044 0.926 . . . . 1.51 109.727 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.63 ' HA ' HG23 ' A' ' 40' ' ' VAL . 7.8 m120 -90.17 30.91 1.04 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.627 -1.169 . . . . 1.79 110.251 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -97.34 2.16 50.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 4.4500000000000002 110.9 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 21.5 mmt180 -114.0 152.07 31.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.294 0.569 . . . . 4.1399999999999997 112.218 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -81.5 148.31 29.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.776 . . . . 2.6800000000000002 109.714 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 56' ' ' ILE . 44.5 p 52.55 16.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.343 0.657 . . . . 1.4199999999999999 111.715 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.706 ' HD3' HG22 ' A' ' 40' ' ' VAL . 1.2 tmtp? -142.44 80.4 1.7 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.658 -0.701 . . . . 2.8999999999999999 109.263 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.706 HG22 ' HD3' ' A' ' 39' ' ' LYS . 19.1 m 49.33 16.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.148 1.379 . . . . 1.8300000000000001 113.716 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.72 25.4 2.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.378 -0.915 . . . . 2.1699999999999999 112.627 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.795 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -85.28 161.71 51.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.367 -0.605 . . . . 1.1200000000000001 109.367 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 39.2 Cg_exo -43.83 -12.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.966 3.777 . . . . 1.48 116.982 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.933 HD21 HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -111.24 -94.54 0.44 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.574 -0.704 . . . . 1.75 111.125 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.617 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 91.88 -36.81 3.53 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.78 -0.724 . . . . 0.75 112.976 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 24' ' ' LEU . 81.9 t -140.1 140.65 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.846 0.355 . . . . 0.59999999999999998 111.168 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.702 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 11.0 t70 -109.88 113.2 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.327 -0.99 . . . . 1.1100000000000001 108.327 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.541 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 16.8 ttmt -79.6 -23.24 42.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.822 -0.626 . . . . 2.8100000000000001 112.286 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -90.08 -36.48 14.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.747 0.308 . . . . 3.1699999999999999 111.293 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.83 -20.21 31.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.907 -0.663 . . . . 1.53 112.313 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 79.51 56.77 3.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.746 -0.74 . . . . 0.77000000000000002 111.811 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -133.78 160.92 36.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.785 0.326 . . . . 3.7200000000000002 111.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.746 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 15.6 m0 -117.31 108.66 15.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.234 -0.654 . . . . 1.28 109.234 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.702 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 11.0 p90 -162.39 146.22 11.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 1.6599999999999999 110.862 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.909 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -114.3 175.21 5.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.841 -0.618 . . . . 2.1200000000000001 109.356 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.933 HG12 HD21 ' A' ' 44' ' ' LEU . 20.6 mm -76.07 111.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.645 -0.502 . . . . 0.92000000000000004 109.645 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 39.8 t0 -95.64 157.22 15.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 1.97 109.927 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.84 -28.07 62.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.398 0.888 . . . . 2.4300000000000002 113.398 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.51 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -85.76 9.69 15.77 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.879 -0.728 . . . . 2.3900000000000001 111.385 -176.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.75 47.68 0.19 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.079 -1.058 . . . . 2.29 113.532 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.731 ' HG2' HG23 ' A' ' 56' ' ' ILE . 27.7 mt-10 54.36 36.88 26.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.396 0.617 . . . . 2.3100000000000001 111.278 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -120.08 85.35 2.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 2.6099999999999999 110.462 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -109.79 164.1 12.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.774 -0.648 . . . . 3.7200000000000002 110.242 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.8 p -57.48 112.29 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.359 -0.382 . . . . 2.27 110.694 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -79.47 102.39 8.75 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.796 0.295 . . . . 6.4800000000000004 111.796 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.746 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -55.89 137.51 46.31 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.509 -1.036 . . . . 1.23 110.509 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -108.59 97.71 7.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.379 0.59 . . . . 1.1699999999999999 111.773 -168.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.533 HG21 ' CG2' ' A' ' 71' ' ' VAL . 46.1 mt -84.08 133.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.835 -0.432 . . . . 0.60999999999999999 109.835 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -96.11 -33.27 12.14 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.846 -0.428 . . . . 2.0 109.846 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.5 ttpp -155.04 130.11 9.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.303 -0.408 . . . . 1.53 111.745 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.533 ' CG2' HG21 ' A' ' 68' ' ' ILE . 97.6 t -114.6 100.54 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.785 -0.82 . . . . 0.88 108.785 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.6 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.0 m-20 -98.15 59.35 1.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 119.489 -0.291 . . . . 1.4199999999999999 111.173 -173.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.0 pt-20 44.25 -165.19 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 O-C-N 124.252 0.97 . . . . 0.95999999999999996 111.635 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.9 Cg_exo -61.59 85.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.067 1.178 . . . . 0.38 111.385 165.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.703 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 26.5 t70 -173.16 -65.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.5 110.561 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -145.53 158.97 43.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.919 0.39 . . . . 0.34999999999999998 111.809 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' CD2' HD22 ' A' ' 24' ' ' LEU . 4.2 mp -145.99 130.56 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 0.73999999999999999 109.913 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.95 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.26 -0.427 . . . . 0.67000000000000004 109.909 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.49 144.53 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.526 -0.306 . . . . 0.75 111.215 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -105.46 155.4 16.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.5 112.597 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 75.6 t-105 -78.55 137.44 37.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.5 0.556 . . . . 2.79 112.5 -169.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -148.07 40.59 0.97 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.482 -0.781 . . . . 5.46 109.285 176.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 85.65 166.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.859 1.059 . . . . 1.55 113.859 171.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.486 ' H ' HD13 ' A' ' 83' ' ' LEU . 36.4 t30 -158.1 -37.29 0.07 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 113.925 -1.489 . . . . 1.9299999999999999 108.475 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.27 10.25 50.16 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.401 -0.818 . . . . 2.3999999999999999 112.516 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.5 t80 74.4 -74.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.396 0.679 . . . . 5.3799999999999999 112.008 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.14 71.56 2.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.879 -0.677 . . . . 2.2999999999999998 113.508 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.883 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 15.6 ttp180 -146.15 179.01 7.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.025 -0.361 . . . . 4.7699999999999996 110.025 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.883 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -82.23 126.95 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.063 -0.717 . . . . 1.8600000000000001 109.063 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 30.0 p-10 -96.81 129.1 33.55 Favored Pre-proline 0 C--N 1.317 -0.816 0 O-C-N 121.672 -0.643 . . . . 3.1800000000000002 110.098 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' ASN . 23.4 Cg_exo -63.37 -40.01 34.11 Favored 'Trans proline' 0 CA--C 1.519 -0.246 0 C-N-CA 122.926 2.417 . . . . 2.3599999999999999 113.069 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 68.2 -30.88 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.759 0.652 . . . . 2.9900000000000002 112.759 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER -74.64 -60.15 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.355 0.598 . . . . 3.0600000000000001 110.365 -173.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 p -155.23 -90.57 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.568 -0.742 . . . . 1.8500000000000001 111.293 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 49.5 m 54.11 36.72 25.45 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 108.52 -0.919 . . . . 1.4399999999999999 108.52 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.6 tt0 -71.7 141.75 49.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.445 -1.707 . . . . 1.8100000000000001 111.423 -172.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.598 ' HB2' HG13 ' A' ' 113' ' ' VAL . 6.7 p90 -139.07 134.63 33.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.624 -0.716 . . . . 0.64000000000000001 110.199 174.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -98.87 117.14 32.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.504 -0.771 . . . . 0.42999999999999999 110.273 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 111' ' ' VAL . 85.4 t -82.91 110.63 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 0.87 109.853 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 8.5 m -99.63 105.62 17.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.286 0.366 . . . . 0.45000000000000001 111.426 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.4 m-85 -96.46 114.17 25.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.34000000000000002 110.976 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.3 110.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.327 -0.62 . . . . 0.54000000000000004 109.327 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.09 134.72 41.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.44 111.523 -175.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 38.2 t70 -120.89 123.16 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.101 -0.954 . . . . 2.0299999999999998 108.944 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.96 -10.88 28.54 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.929 -0.578 . . . . 1.97 113.64 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.43 49.8 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.942 0.401 . . . . 4.9299999999999997 110.464 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 60.43 31.84 20.43 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.73 -0.668 . . . . 3.5299999999999998 111.308 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.644 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 3.8 ttmp? -132.6 155.71 48.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.32 -0.4 . . . . 2.4399999999999999 110.448 -173.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.555 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.5 m -158.29 125.43 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.41999999999999998 110.768 173.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.474 ' NH2' ' HB3' ' A' ' 9' ' ' SER . 20.4 tpt180 -101.0 126.65 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.432 -0.803 . . . . 2.5899999999999999 109.556 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 100' ' ' THR . 9.5 p -114.58 136.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.006 0.432 . . . . 0.40000000000000002 111.063 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.588 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 3.2 p-10 -126.73 120.24 28.89 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.81 0.814 . . . . 1.3799999999999999 109.381 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.832 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 1.6 t -90.97 120.24 39.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.958 -1.019 . . . . 0.91000000000000003 110.084 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -96.36 111.3 23.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.808 0.693 . . . . 2.3100000000000001 109.212 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.947 ' HB3' HG22 ' A' ' 6' ' ' VAL . 51.8 t-80 -125.27 98.93 5.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.38 -0.827 . . . . 1.6399999999999999 108.769 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.677 ' HB ' ' CB ' ' A' ' 5' ' ' PHE . 5.4 t -151.36 88.1 1.42 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.89 0.852 . . . . 2.6699999999999999 109.621 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -157.47 -76.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 2.6299999999999999 110.253 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.605 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 6.4 t80 -73.2 -38.58 66.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.799 -0.815 . . . . 3.54 108.799 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.558 ' OD1' HG13 ' A' ' 6' ' ' VAL . 17.1 p-10 -73.81 -47.59 37.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.413 -0.812 . . . . 1.8100000000000001 111.353 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HD3' ' OG1' ' A' ' 116' ' ' THR . 52.4 ttp180 -56.28 -21.45 23.93 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.35 -0.386 . . . . 3.3799999999999999 111.634 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 33.9 tpp -72.38 -3.48 24.29 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.95 0.405 . . . . 2.4300000000000002 110.371 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.3 -164.49 24.31 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 115.036 0.774 . . . . 1.6100000000000001 115.036 167.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.0 p 39.9 -116.22 0.23 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.394 1.077 . . . . 2.5800000000000001 113.016 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.14 -25.13 64.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.7999999999999998 111.184 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.605 ' HB3' ' O ' ' A' ' 118' ' ' PHE . 41.9 m-70 -68.53 -53.93 19.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.037 0.446 . . . . 2.1400000000000001 110.624 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.94 -26.15 63.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.92000000000000004 109.999 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 87.4 tttt -62.57 -46.44 88.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.102 -0.954 . . . . 2.8300000000000001 111.388 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 1.6 ptm180 -78.4 -28.6 46.93 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.827 -0.349 . . . . 2.5899999999999999 111.587 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 125' ' ' HIS . 88.9 t -72.81 -30.91 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.22 0.452 . . . . 1.48 112.22 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 127' ' ' LYS . 31.8 ptt180 -59.58 -30.01 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.809 0.337 . . . . 3.8300000000000001 111.631 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.761 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.0 m-20 -65.15 -21.17 66.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.434 0.531 . . . . 2.48 112.434 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.5 ' HA3' HH11 ' A' ' 88' ' ' ARG . . . -96.99 -72.08 1.09 Allowed Glycine 0 C--O 1.226 -0.351 0 C-N-CA 119.975 -1.107 . . . . 1.6100000000000001 114.8 -164.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.693 ' HB2' ' HB2' ' A' ' 137' ' ' TRP . 26.5 ptt? -80.93 -9.59 59.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.441 0.534 . . . . 4.8300000000000001 112.441 -170.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.58 -49.84 69.44 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.405 0.52 . . . . 2.8300000000000001 112.405 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -96.96 22.86 7.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.948 0.351 . . . . 4.1500000000000004 111.948 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.585 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -139.76 -56.26 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.73 -1.224 . . . . 1.04 113.101 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.693 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 65.2 t-105 -55.24 -53.31 63.19 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.549 0.574 . . . . 2.7799999999999998 112.549 -170.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.6 Cg_endo -59.41 -40.64 65.43 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.81 1.674 . . . . 0.68000000000000005 112.337 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 m -69.21 -38.28 78.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.515 0.674 . . . . 0.87 110.258 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.642 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 29.1 mt -59.58 -42.02 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.218 -0.901 . . . . 0.71999999999999997 110.817 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 76.6 mt -62.76 -26.95 68.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.904 0.335 . . . . 0.68999999999999995 111.904 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.18 -54.64 7.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.371 -0.233 . . . . 1.49 110.371 176.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -27.5 68.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 1.1499999999999999 110.595 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 47.2 t80 -62.17 -55.06 32.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.45 -0.795 . . . . 0.80000000000000004 110.485 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.447 ' CG ' HG13 ' A' ' 10' ' ' VAL . 39.0 mt-30 -62.9 -34.61 77.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.32 0.581 . . . . 1.6299999999999999 110.816 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.513 ' HB3' ' HE1' ' A' ' 31' ' ' TRP . 13.4 t70 -66.12 -44.99 82.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.873 -1.058 . . . . 1.46 110.402 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -69.19 -31.54 70.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.711 -0.677 . . . . 1.74 110.698 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.529 HG21 ' HB ' ' A' ' 12' ' ' VAL . 53.2 mt -71.43 -36.37 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.5 110.446 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.473 ' HB3' ' HE3' ' A' ' 154' ' ' LYS . 17.8 t0 -66.11 -28.97 69.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.504 . . . . 0.84999999999999998 109.675 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 55.7 mt-10 -60.74 -28.56 68.79 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.572 0.701 . . . . 1.5 110.334 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.51 -3.24 58.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.239 -0.891 . . . . 1.74 110.383 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.72 -70.4 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.525 -0.845 . . . . 1.3200000000000001 113.67 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.28 -46.65 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.066 0.433 . . . . 1.9199999999999999 111.407 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttpp -81.72 171.15 14.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.356 -0.384 . . . . 2.04 110.013 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.555 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 18.1 tppt? . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.352 -0.981 . . . . 4.2199999999999998 108.352 167.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.0 p-10 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.65 0.262 . . . . 1.6599999999999999 110.509 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 24.6 p90 172.14 -35.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.837 0.855 . . . . 3.73 109.108 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.76 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.9 t70 -73.64 -55.35 3.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.523 -0.308 . . . . 2.7799999999999998 111.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 52.8 Cg_endo -84.31 -68.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.512 1.474 . . . . 1.6299999999999999 111.94 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.05 142.78 26.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.169 -0.469 . . . . 3.21 110.073 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.638 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 76.5 t -98.29 112.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.866 -0.791 . . . . 1.4399999999999999 108.866 167.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 45.4 ttm-85 -123.62 135.54 54.0 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.537 -0.465 . . . . 3.3700000000000001 110.97 -177.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.725 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.66 134.38 52.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.829 -0.804 . . . . 0.79000000000000004 108.829 174.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 22.4 m -143.24 112.23 6.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.154 -0.475 . . . . 1.28 110.455 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.948 HG22 HG12 ' A' ' 111' ' ' VAL . 2.2 m -126.66 140.42 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.125 -0.489 . . . . 1.27 109.77 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -102.48 114.42 28.61 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.512 -0.921 . . . . 0.56999999999999995 108.512 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' HB ' ' A' ' 109' ' ' THR . 0.3 OUTLIER -103.3 162.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.254 -0.43 . . . . 0.91000000000000003 110.445 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.922 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 9.5 pttt -125.92 35.93 4.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.753 -0.658 . . . . 0.97999999999999998 112.013 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.27 29.19 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.215 0.45 . . . . 0.35999999999999999 112.215 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 20.6 t70 75.84 163.37 0.25 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.857 0.837 . . . . 0.91000000000000003 112.22 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.881 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 40.1 ttp180 -64.68 -27.88 69.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.717 -1.129 . . . . 1.8799999999999999 110.96 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 4.3 ttmp? -57.67 -48.55 79.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 3.0499999999999998 110.825 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -77.46 -36.32 52.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 1.1100000000000001 111.023 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.622 ' HA ' HD13 ' A' ' 148' ' ' ILE . . . -59.81 -39.59 85.54 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.79 -0.364 . . . . 0.32000000000000001 110.405 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CG ' ' HA ' ' A' ' 74' ' ' PRO . 55.6 t80 -71.05 -49.97 39.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.38 110.77 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -54.18 -53.0 59.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.083 0.468 . . . . 2.3900000000000001 110.982 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.475 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.2 m -63.83 -45.31 90.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.359 -0.837 . . . . 0.68000000000000005 110.56 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.719 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.3 t80 -63.95 -37.49 87.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.945 0.35 . . . . 0.47999999999999998 111.945 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.87 HD11 HG11 ' A' ' 46' ' ' VAL . 17.1 tp -99.49 -59.65 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.179 -0.608 . . . . 0.5 112.485 -174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -88.72 -19.47 26.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.149 0.5 . . . . 1.24 111.547 -173.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -89.77 18.48 46.81 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.645 -0.788 . . . . 0.82999999999999996 111.17 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.534 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 10.9 t80 -50.39 -51.78 60.85 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.151 0.58 . . . . 0.73999999999999999 112.256 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 42.0 Cg_endo -86.13 8.01 4.71 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.298 1.999 . . . . 0.76000000000000001 115.525 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.7 pt-20 -111.07 -2.36 15.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.851 -0.739 . . . . 1.49 111.999 -175.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.818 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 43.1 m0 -67.64 155.73 38.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.329 0.585 . . . . 4.6200000000000001 111.111 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.547 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 68.0 m95 -75.1 -43.79 4.61 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.389 -0.823 . . . . 2.7799999999999998 112.906 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 29.1 Cg_endo -60.46 -87.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.63 2.22 . . . . 1.3600000000000001 115.199 -162.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.532 ' ND2' HG11 ' A' ' 40' ' ' VAL . 6.1 t30 -110.98 -17.85 13.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.516 0.674 . . . . 1.51 110.451 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.627 ' HA ' HG13 ' A' ' 40' ' ' VAL . 2.9 m-20 -100.89 27.63 5.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.474 -0.784 . . . . 1.79 112.037 -168.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -104.4 13.31 32.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.687 0.756 . . . . 4.4500000000000002 109.44 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -104.74 128.26 52.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.718 -0.674 . . . . 4.1399999999999997 111.066 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -75.61 137.45 40.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 2.6800000000000002 111.151 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 57' ' ' ASP . 79.8 p 57.09 11.53 1.04 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.61 1.164 . . . . 1.4199999999999999 112.956 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.642 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 83.0 tttt -100.03 -48.81 4.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.477 -0.934 . . . . 2.8999999999999999 108.477 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.717 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 12.4 p -174.35 -2.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.418 -1.265 . . . . 1.8300000000000001 109.984 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -127.59 47.09 1.04 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.623 -0.799 . . . . 2.1699999999999999 112.638 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.037 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -79.91 158.46 72.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.013 -1.106 . . . . 1.1200000000000001 108.013 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.69 44.85 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 123.803 3.002 . . . . 1.48 114.786 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -149.51 -84.36 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.723 -0.473 . . . . 1.75 109.723 173.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.434 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.23 -52.95 3.17 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.926 -0.654 . . . . 0.75 112.781 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.87 HG11 HD11 ' A' ' 24' ' ' LEU . 58.9 t -140.33 138.42 36.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.003 0.43 . . . . 0.59999999999999998 111.607 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.647 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 22.3 t70 -100.42 107.27 18.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.841 -0.8 . . . . 1.1100000000000001 108.841 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -9.83 59.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.19 -0.914 . . . . 2.8100000000000001 111.203 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -75.39 -62.41 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.035 -0.53 . . . . 3.1699999999999999 110.702 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -92.59 -39.49 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.562 -0.828 . . . . 1.53 111.662 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 72.46 0.62 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.654 -0.784 . . . . 0.77000000000000002 112.805 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -154.39 144.33 21.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 3.7200000000000002 111.172 175.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.608 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 22.7 m0 -96.2 110.98 23.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 1.28 110.515 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.647 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.8 p90 -153.91 152.91 31.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 1.6599999999999999 110.399 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 6.4 mp0 -119.98 150.71 40.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.115 -0.698 . . . . 2.1200000000000001 109.115 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.507 HD12 ' HG2' ' A' ' 61' ' ' GLU . 45.0 mm -77.0 103.37 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.999 0.428 . . . . 0.92000000000000004 109.892 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.814 ' HB3' HE22 ' A' ' 59' ' ' GLN . 8.1 t70 -92.84 148.13 22.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.133 -0.692 . . . . 1.97 109.133 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.88 -10.09 59.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.462 0.912 . . . . 2.4300000000000002 113.462 -166.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.814 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -93.18 10.25 32.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.648 -0.821 . . . . 2.3900000000000001 110.712 177.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.49 50.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.39 -0.91 . . . . 2.29 113.921 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.507 ' HG2' HD12 ' A' ' 56' ' ' ILE . 39.2 mt-10 58.1 24.67 11.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.175 0.435 . . . . 2.3100000000000001 112.175 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 25.5 tt0 -90.86 78.05 6.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.499 0.666 . . . . 2.6099999999999999 110.143 -173.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.508 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -123.22 162.74 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.292 -0.867 . . . . 3.7200000000000002 109.68 176.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.566 ' C ' ' HD2' ' A' ' 82' ' ' ARG . 4.9 p -62.97 148.59 47.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.4 -0.593 . . . . 2.27 109.4 172.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 44.4 p90 -120.4 120.87 37.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.396 -0.522 . . . . 6.4800000000000004 111.666 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.34 148.17 46.87 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.681 -0.968 . . . . 1.23 110.681 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.491 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -106.0 96.48 6.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.263 0.532 . . . . 1.1699999999999999 111.26 -171.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.545 HG21 ' CG2' ' A' ' 71' ' ' VAL . 53.8 mt -77.08 125.29 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.271 0.558 . . . . 0.60999999999999999 109.939 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -96.2 -21.37 17.93 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.399 -0.818 . . . . 2.0 109.786 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -164.64 125.0 2.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.224 -0.443 . . . . 1.53 111.889 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' CG2' HG21 ' A' ' 68' ' ' ILE . 62.6 t -109.36 107.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.725 -0.843 . . . . 0.88 108.725 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.44 75.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.649 -0.42 . . . . 1.4199999999999999 111.211 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.3 pt-20 47.67 -170.92 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 124.766 1.291 . . . . 0.95999999999999996 111.961 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 35.9 Cg_exo -63.48 81.32 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.373 1.382 . . . . 0.38 111.122 166.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.881 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 14.9 t70 -166.69 -68.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.405 -0.816 . . . . 0.5 110.984 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -138.67 140.3 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.783 0.66 . . . . 0.34999999999999998 112.783 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -135.47 116.41 14.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.48 -0.782 . . . . 0.73999999999999999 108.977 175.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 98' ' ' THR . 29.9 t -95.26 111.78 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.687 -0.857 . . . . 0.67000000000000004 108.687 175.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.21 126.42 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.75 0.31 . . . . 0.75 111.185 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 1.01 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -84.88 146.25 22.06 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.006 -0.837 . . . . 0.5 111.006 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.89 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 68.8 t-105 -73.63 160.18 31.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.585 0.707 . . . . 2.79 112.34 -168.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.568 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 19.3 ttp180 -135.52 -72.56 0.46 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.409 -1.269 . . . . 5.46 109.722 -172.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.769 HD23 ' HB2' ' A' ' 90' ' ' ASP . 2.5 tm? 170.46 145.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.343 -0.844 . . . . 1.55 109.539 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.679 ' N ' HD13 ' A' ' 83' ' ' LEU . 54.0 t30 -142.6 146.89 35.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.35 -0.611 . . . . 1.9299999999999999 109.35 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.65 -15.56 31.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.831 -0.699 . . . . 2.3999999999999999 112.024 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.642 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 71.3 t80 70.39 -63.29 0.41 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.64 0.776 . . . . 5.3799999999999999 111.207 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.59 44.65 3.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.224 -0.512 . . . . 2.2999999999999998 112.037 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.694 ' NH1' ' HA ' ' A' ' 129' ' ' VAL . 2.4 tmm_? -133.86 144.24 48.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.033 -0.729 . . . . 4.7699999999999996 109.033 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.512 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -96.58 131.92 42.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.028 0.442 . . . . 1.8600000000000001 111.292 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.769 ' HB2' HD23 ' A' ' 83' ' ' LEU . 5.2 t70 -143.66 137.15 14.16 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.482 -0.933 . . . . 3.1800000000000002 108.482 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HG2' ' CZ ' ' A' ' 118' ' ' PHE . 32.0 Cg_exo -58.72 -25.58 76.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.562 2.175 . . . . 2.3599999999999999 112.72 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.4 t70 56.51 75.29 0.36 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.358 0.599 . . . . 2.9900000000000002 110.155 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.32 -75.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 3.0600000000000001 110.767 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.7 m -113.5 -97.93 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.969 -0.56 . . . . 1.8500000000000001 110.384 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.89 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 13.5 m 50.64 37.77 17.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.938 -0.574 . . . . 1.4399999999999999 112.086 175.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 1.01 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 27.9 mt-10 -62.65 143.16 57.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.38 -0.373 . . . . 1.8100000000000001 111.379 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.776 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -136.46 127.66 28.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.939 -0.573 . . . . 0.64000000000000001 110.749 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.63 HG23 HG22 ' A' ' 78' ' ' VAL . 27.7 m -91.1 115.1 27.75 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.42999999999999999 110.696 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 113' ' ' VAL . 58.0 t -86.33 109.92 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.872 -0.418 . . . . 0.87 109.872 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.3 m -107.88 106.52 16.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.424 -0.353 . . . . 0.45000000000000001 110.761 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.74 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 52.8 m-85 -88.35 117.72 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.556 -0.293 . . . . 0.34000000000000002 110.346 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.98 112.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.236 -0.283 . . . . 0.54000000000000004 110.236 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.33 51.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.887 -0.597 . . . . 0.44 111.593 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.8 t70 -137.38 120.31 16.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.595 . . . . 2.0299999999999998 109.535 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.27 58.64 1.13 Allowed Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.994 -0.548 . . . . 1.97 113.118 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 21.0 tt0 -150.98 13.57 0.7 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.994 . . . . 4.9299999999999997 108.315 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 59.8 mttp 67.09 33.7 5.49 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.175 -0.92 . . . . 3.5299999999999998 109.384 -167.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 7.3 ttpm? -121.65 154.43 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.407 -0.59 . . . . 2.4399999999999999 109.407 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.584 ' HB ' HG12 ' A' ' 12' ' ' VAL . 18.7 m -161.14 128.63 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.757 0.313 . . . . 0.41999999999999998 110.728 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.34 114.95 28.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.036 -0.727 . . . . 2.5899999999999999 109.036 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.948 HG12 HG22 ' A' ' 10' ' ' VAL . 12.7 p -93.2 144.67 8.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 120.994 -0.283 . . . . 0.40000000000000002 111.199 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.47 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 7.3 t70 -130.26 126.78 38.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.222 -0.899 . . . . 1.3799999999999999 109.51 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.725 ' HB ' ' CD2' ' A' ' 8' ' ' HIS . 1.2 t -111.44 133.22 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 116.662 -0.245 . . . . 0.91000000000000003 110.809 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 49.8 mt-10 -104.31 110.73 23.08 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.907 0.754 . . . . 2.3100000000000001 109.921 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.776 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 79.0 t60 -123.38 99.06 6.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.214 -1.032 . . . . 1.6399999999999999 108.214 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -153.07 91.26 1.51 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.116 0.484 . . . . 2.6699999999999999 110.129 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -155.6 -75.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.904 -0.589 . . . . 2.6299999999999999 110.142 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.575 ' CZ ' ' HG2' ' A' ' 91' ' ' PRO . 37.1 t80 -82.31 -25.76 33.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.654 -0.703 . . . . 3.54 110.906 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.87 -43.63 53.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.684 -0.689 . . . . 1.8100000000000001 110.991 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 71.0 ttt180 -53.72 -21.3 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.368 -0.833 . . . . 3.3799999999999999 112.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 79.1 mmm -78.64 2.14 20.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.428 -0.351 . . . . 2.4300000000000002 111.113 -177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.31 -144.38 6.71 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.744 -0.662 . . . . 1.6100000000000001 114.342 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 47.48 -132.61 1.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.302 0.641 . . . . 2.5800000000000001 110.85 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -77.59 -13.91 59.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.471 -0.143 . . . . 3.7999999999999998 111.371 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.8 m170 -72.72 -52.94 13.11 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.472 -0.566 . . . . 2.1400000000000001 109.472 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.0 70.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.767 -0.651 . . . . 0.92000000000000004 111.026 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -64.33 -39.47 93.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.478 -0.328 . . . . 2.8300000000000001 111.098 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.452 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 3.1 ptm180 -73.28 -32.9 64.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 2.5899999999999999 110.336 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.694 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 89.5 t -65.06 -40.49 89.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.385 0.612 . . . . 1.48 110.266 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.52 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 8.5 ttp180 -65.66 -17.25 64.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 3.8300000000000001 111.904 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 88' ' ' ARG . 65.9 t30 -52.99 -46.47 68.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.727 0.298 . . . . 2.48 111.629 -173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' HG3' ' A' ' 88' ' ' ARG . . . -120.01 -20.07 3.83 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.145 -1.026 . . . . 1.6100000000000001 113.031 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 49.6 ttm -79.74 -22.96 42.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.577 -0.366 . . . . 4.8300000000000001 111.165 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 10.3 t70 -55.65 -49.15 73.66 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.851 0.685 . . . . 2.8300000000000001 112.851 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -100.42 -39.85 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.984 -0.286 . . . . 4.1500000000000004 111.335 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -59.41 -59.59 10.36 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 116.46 -0.336 . . . . 1.04 113.324 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.541 ' HH2' HG11 ' A' ' 113' ' ' VAL . 3.4 t90 -59.36 -49.99 89.68 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.63 0.604 . . . . 2.7799999999999998 112.63 -172.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 28.6 Cg_endo -62.13 -35.54 74.82 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.002 1.801 . . . . 0.68000000000000005 112.385 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -68.55 -37.04 79.6 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.248 -0.649 . . . . 0.87 109.248 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.687 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 57.8 mt -55.59 -49.35 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.933 -1.031 . . . . 0.71999999999999997 110.244 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 60.4 mt -58.79 -33.8 70.75 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.363 0.414 . . . . 0.68999999999999995 112.063 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.51 -57.0 7.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 1.49 110.417 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.611 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 70.1 m -65.89 -23.18 66.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.941 -0.572 . . . . 1.1499999999999999 110.532 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.462 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 64.7 t80 -63.85 -53.0 57.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 0.80000000000000004 110.101 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 76.1 mt-30 -58.58 -33.57 70.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.233 0.54 . . . . 1.6299999999999999 110.34 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.36 -42.15 45.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.46 111.33 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.509 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 10.0 tptt -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.225 0.536 . . . . 1.74 110.442 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 19' ' ' ALA . 66.2 mt -68.49 -30.31 47.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.821 -0.627 . . . . 0.5 110.537 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.922 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 28.1 t0 -61.08 -30.96 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.84999999999999998 109.898 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.803 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 43.8 mt-10 -65.99 -29.98 70.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 1.5 110.392 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -85.13 -5.14 59.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.419 -0.809 . . . . 1.74 110.173 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.8 -71.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.943 -0.646 . . . . 1.3200000000000001 113.488 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.64 24.76 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.467 0.543 . . . . 1.9199999999999999 112.467 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.803 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 14.9 tppt? -62.14 -74.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.431 0.158 . . . . 2.04 110.777 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 155' ' ' LYS . 6.8 mtmp? . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.322 -0.847 . . . . 4.2199999999999998 110.392 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.57 ' O ' HG22 ' A' ' 6' ' ' VAL . 31.8 p-10 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 121.028 0.442 . . . . 1.6599999999999999 110.78 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.437 ' HA ' HG22 ' A' ' 6' ' ' VAL . 92.1 m-85 -162.01 -41.71 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.44 1.096 . . . . 3.73 108.391 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.745 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 20.0 t70 -61.03 -54.73 51.3 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.171 -0.922 . . . . 2.7799999999999998 112.312 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.2 Cg_endo -91.69 -63.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 1.6299999999999999 112.493 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HA ' HG22 ' A' ' 116' ' ' THR . 30.9 p90 -152.4 142.86 22.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.082 -0.508 . . . . 3.21 109.856 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.682 ' HB ' ' CE1' ' A' ' 115' ' ' HIS . 16.7 t -103.81 108.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.722 -0.473 . . . . 1.4399999999999999 109.722 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.817 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 25.7 ttm180 -109.38 132.92 53.67 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.844 -0.616 . . . . 3.3700000000000001 111.502 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.21 135.6 50.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.999 -0.741 . . . . 0.79000000000000004 108.999 173.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.778 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 5.5 p -141.18 112.72 7.55 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.144 0.497 . . . . 1.28 111.488 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.675 HG22 ' CG1' ' A' ' 111' ' ' VAL . 16.1 m -122.93 152.44 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.978 -0.555 . . . . 1.27 111.317 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -102.18 116.04 31.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.509 -0.769 . . . . 0.56999999999999995 110.152 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.968 HG13 HG21 ' A' ' 148' ' ' ILE . 38.4 t -91.37 132.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.019 -0.991 . . . . 0.91000000000000003 109.974 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.716 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -101.45 23.25 11.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.978 -0.555 . . . . 0.97999999999999998 112.139 -171.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.35 37.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.244 0.461 . . . . 0.35999999999999999 112.244 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 22.6 t70 75.39 159.6 0.22 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 122.04 0.924 . . . . 0.91000000000000003 112.544 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 32.5 ttp180 -63.04 -25.49 68.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.637 -1.165 . . . . 1.8799999999999999 111.618 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.92 -48.48 79.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.587 -0.279 . . . . 3.0499999999999998 110.272 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.2 p -74.08 -36.4 64.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.952 -0.299 . . . . 1.1100000000000001 111.201 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.85 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -59.23 -45.48 91.03 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.414 -0.514 . . . . 0.32000000000000001 110.574 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CE1' HD21 ' A' ' 77' ' ' LEU . 76.1 t80 -71.49 -44.27 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.363 -0.38 . . . . 0.38 110.616 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -54.97 -54.27 45.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.132 0.491 . . . . 2.3900000000000001 110.75 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.454 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.0 m -63.79 -48.54 76.48 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.078 -0.964 . . . . 0.68000000000000005 110.24 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.728 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 61.5 t80 -59.72 -37.78 79.85 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.647 0.592 . . . . 0.47999999999999998 112.223 -173.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.605 ' HG ' HG11 ' A' ' 46' ' ' VAL . 11.0 tp -112.78 -51.39 2.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.818 0.673 . . . . 0.5 112.818 -173.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.985 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 11.8 mt-10 -82.08 -38.62 24.61 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.799 -0.563 . . . . 1.24 111.988 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.651 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.07 40.53 2.81 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.876 -0.602 . . . . 0.82999999999999996 112.193 -176.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.613 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 55.0 t80 -61.54 -58.2 20.02 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 112.043 0.386 . . . . 0.73999999999999999 112.043 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 80.7 Cg_endo -80.11 29.26 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.533 2.155 . . . . 0.76000000000000001 114.388 -174.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.3 pt-20 -125.46 2.13 7.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.543 -0.463 . . . . 1.49 110.986 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.782 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 24.9 m0 -75.62 157.87 33.18 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.048 0.451 . . . . 4.6200000000000001 109.908 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.646 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 12.6 m95 -87.4 -34.93 0.45 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.17 0.804 . . . . 2.7799999999999998 113.17 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 14.0 Cg_endo -54.43 -86.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.802 2.335 . . . . 1.3600000000000001 115.295 -165.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.71 HD22 HG11 ' A' ' 40' ' ' VAL . 2.0 t30 -111.23 -34.72 6.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.479 0.657 . . . . 1.51 110.465 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.748 ' HA ' HG13 ' A' ' 40' ' ' VAL . 9.5 p-10 -91.51 33.62 1.0 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.061 -0.972 . . . . 1.79 111.823 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -96.34 -2.14 46.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.794 0.807 . . . . 4.4500000000000002 109.115 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 8.2 mmt180 -99.34 126.0 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.198 -0.91 . . . . 4.1399999999999997 110.65 -176.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 p -76.58 135.59 39.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.117 -0.492 . . . . 2.6800000000000002 110.821 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 57' ' ' ASP . 61.1 p 57.74 20.08 6.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.38 1.072 . . . . 1.4199999999999999 111.727 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -111.56 -46.8 3.23 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.771 -1.196 . . . . 2.8999999999999999 107.771 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.748 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.3 p -174.52 26.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.711 -1.131 . . . . 1.8300000000000001 109.02 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.97 36.33 0.28 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.641 -0.79 . . . . 2.1699999999999999 112.93 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -66.12 164.49 28.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.531 -0.544 . . . . 1.1200000000000001 109.531 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 56.96 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.352 2.701 . . . . 1.48 114.202 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.18 -83.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.173 0.589 . . . . 1.75 109.495 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.575 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 89.59 -55.68 3.82 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.86 -0.686 . . . . 0.75 113.592 170.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.605 HG11 ' HG ' ' A' ' 24' ' ' LEU . 91.3 t -138.73 142.09 35.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.001 0.429 . . . . 0.59999999999999998 111.693 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.529 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.6 t70 -110.67 110.08 20.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 1.1100000000000001 108.97 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.985 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 3.2 mptt -80.93 -29.55 35.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 2.8100000000000001 111.872 -172.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -74.68 -42.43 58.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.031 0.382 . . . . 3.1699999999999999 112.031 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.21 -42.18 3.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.638 -0.791 . . . . 1.53 111.612 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 107.35 68.19 0.66 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.86 -0.686 . . . . 0.77000000000000002 112.745 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 6.8 ptm180 -159.25 139.74 12.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 3.7200000000000002 111.094 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.737 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -95.23 110.09 22.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.52 . . . . 1.28 110.154 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.529 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.1 p90 -152.09 159.45 43.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.158 0.504 . . . . 1.6599999999999999 110.876 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.993 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 24.9 mt-10 -117.18 156.06 28.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 2.1200000000000001 110.89 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 mm -78.17 102.53 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.317 -0.994 . . . . 0.92000000000000004 108.317 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.678 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 14.9 t70 -87.71 -177.87 5.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 1.97 110.54 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.45 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 10.5 pt-20 -60.95 -40.64 94.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.348 0.499 . . . . 2.4300000000000002 112.348 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -100.16 25.12 7.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 2.3900000000000001 111.039 -178.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.3 -100.66 0.46 Allowed Glycine 0 C--O 1.22 -0.748 0 C-N-CA 120.822 -0.704 . . . . 2.29 111.801 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.678 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -156.02 75.31 0.89 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.357 0.598 . . . . 2.3100000000000001 110.394 175.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -110.01 74.58 0.89 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.817 -0.808 . . . . 2.6099999999999999 108.817 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 2.2 m-70 -124.21 147.47 48.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 3.7200000000000002 110.549 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 p -57.68 110.27 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.586 0.554 . . . . 2.27 111.141 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.737 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 48.9 p90 -77.05 122.45 24.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.237 0.541 . . . . 6.4800000000000004 111.553 -175.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 82' ' ' ARG . . . -60.49 134.41 50.0 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.056 -1.218 . . . . 1.23 110.056 170.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -97.63 87.81 4.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.607 0.703 . . . . 1.1699999999999999 110.924 -168.116 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.53 HG12 HG13 ' A' ' 79' ' ' ILE . 51.5 mt -72.99 126.43 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.051 -0.522 . . . . 0.60999999999999999 109.893 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' OE2' ' A' ' 96' ' ' GLU . 6.3 mmm180 -94.33 -26.57 16.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.837 -0.619 . . . . 2.0 109.38 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.2 ttpp -166.13 133.83 2.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.619 -0.719 . . . . 1.53 111.386 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.527 HG23 HG21 ' A' ' 68' ' ' ILE . 90.7 t -115.26 106.28 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.546 -0.909 . . . . 0.88 108.546 174.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.1 m-20 -102.99 59.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.618 -0.265 . . . . 1.4199999999999999 110.936 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.5 pt-20 46.89 -168.83 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.247 0.967 . . . . 0.95999999999999996 111.863 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.5 Cg_exo -63.52 80.5 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.422 1.414 . . . . 0.38 111.384 167.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 23.7 t70 -167.73 -66.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.45 -0.796 . . . . 0.5 110.275 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -146.71 159.07 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 0.34999999999999998 111.358 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.466 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -148.03 126.92 12.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.571 -0.529 . . . . 0.73999999999999999 109.571 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.28 101.58 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.08 -0.711 . . . . 0.67000000000000004 109.08 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.53 HG13 HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.86 137.69 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.859 0.362 . . . . 0.75 110.796 -176.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.755 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -89.17 145.4 18.51 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.845 -0.616 . . . . 0.5 112.462 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.825 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 73.7 t-105 -64.48 131.24 46.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.036 0.922 . . . . 2.79 113.347 -171.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.464 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 5.8 tpt180 -151.51 94.52 2.02 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.751 -1.944 . . . . 5.46 105.751 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 89' ' ' ILE . 1.5 pp -67.72 -170.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.031 -0.532 . . . . 1.55 112.367 -170.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' OD1' HG21 ' A' ' 40' ' ' VAL . 3.0 m-20 -68.21 76.65 0.25 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.611 -0.885 . . . . 1.9299999999999999 108.611 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.26 50.94 4.08 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.058 -0.974 . . . . 2.3999999999999999 113.672 -168.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -132.47 34.66 3.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.828 -1.175 . . . . 5.3799999999999999 107.828 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 88' ' ' ARG . . . 169.9 -26.36 0.11 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.473 -1.239 . . . . 2.2999999999999998 111.386 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.713 ' HG3' ' HA3' ' A' ' 132' ' ' GLY . 36.6 mmt-85 -117.15 160.8 20.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.198 -0.297 . . . . 4.7699999999999996 110.198 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.585 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -94.12 119.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.613 0.72 . . . . 1.8600000000000001 111.168 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -88.76 133.92 34.89 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.292 -0.867 . . . . 3.1800000000000002 110.07 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.21 -54.71 2.81 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.566 2.177 . . . . 2.3599999999999999 112.267 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.19 86.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.935 0.772 . . . . 2.9900000000000002 111.936 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -160.89 -52.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 3.0600000000000001 109.124 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.4 m -142.91 -84.68 0.16 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.534 -1.284 . . . . 1.8500000000000001 107.534 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.825 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 14.6 m 56.81 23.81 8.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.848 . . . . 1.4399999999999999 111.662 169.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.755 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 25.2 mt-10 -71.23 139.63 50.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.873 -0.603 . . . . 1.8100000000000001 111.665 -172.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.996 ' HB3' ' HB3' ' A' ' 115' ' ' HIS . 1.1 p90 -126.94 137.35 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.013 -0.54 . . . . 0.64000000000000001 110.927 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 41.8 m -91.41 109.11 20.39 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.42999999999999999 109.977 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.664 ' HA ' HG22 ' A' ' 113' ' ' VAL . 45.2 t -89.27 108.6 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.626 -0.509 . . . . 0.87 109.626 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.704 ' HA ' HG22 ' A' ' 76' ' ' THR . 42.1 m -104.09 106.57 17.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.45000000000000001 110.563 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.711 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 48.6 m-85 -88.77 107.44 18.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.971 -0.381 . . . . 0.34000000000000002 109.971 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.45 112.98 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.813 -0.44 . . . . 0.54000000000000004 109.813 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.39 134.31 52.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.049 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 22.3 t70 -121.86 111.5 17.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.153 -0.476 . . . . 2.0299999999999998 109.762 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.62 -99.27 0.81 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.859 -0.686 . . . . 1.97 112.48 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.573 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 4.1 pt20 -150.05 -25.23 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.454 0.168 . . . . 4.9299999999999997 111.454 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.573 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 35.7 pttt -137.56 19.4 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 3.5299999999999998 111.164 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.77 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 12.3 mptt -122.39 158.38 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.121 -0.696 . . . . 2.4399999999999999 109.121 172.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.7 m -158.07 119.85 3.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.885 0.374 . . . . 0.41999999999999998 110.813 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -101.66 108.5 20.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.114 -0.698 . . . . 2.5899999999999999 109.114 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.2 p -90.82 142.32 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.40000000000000002 110.245 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.564 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 16.4 t70 -132.54 113.46 13.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.441 -1.254 . . . . 1.3799999999999999 109.519 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 3.0 t -105.13 124.48 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 116.504 -0.317 . . . . 0.91000000000000003 111.131 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.61 125.71 54.46 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.987 -0.685 . . . . 2.3100000000000001 110.04 170.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.996 ' HB3' ' HB3' ' A' ' 97' ' ' PHE . 27.7 p80 -137.35 125.82 23.52 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.822 -0.626 . . . . 1.6399999999999999 109.737 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 5' ' ' PHE . 23.2 p -135.06 77.78 1.7 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 2.6699999999999999 110.916 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.64 ' O ' ' HG2' ' A' ' 121' ' ' MET . 2.0 t-160 -158.96 -75.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.828 -0.749 . . . . 2.6299999999999999 110.759 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.438 ' HE1' HG11 ' A' ' 129' ' ' VAL . 19.0 p90 -71.47 -29.76 65.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.12 -0.491 . . . . 3.54 111.483 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -51.75 19.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.615 0.766 . . . . 1.8100000000000001 110.867 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' NH1' ' HB ' ' A' ' 116' ' ' THR . 42.1 ttp180 -58.89 -20.87 55.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.045 -0.98 . . . . 3.3799999999999999 111.6 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.64 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.8 mmt -64.36 -19.31 65.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.511 0.196 . . . . 2.4300000000000002 110.955 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.85 -157.54 3.26 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 114.756 0.662 . . . . 1.6100000000000001 114.756 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 p 40.62 -128.78 0.43 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.032 0.933 . . . . 2.5800000000000001 112.964 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 46.4 mmtm -60.08 -38.54 83.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 3.7999999999999998 111.516 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -60.86 -49.66 76.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 2.1400000000000001 110.714 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.68 68.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.112 -0.495 . . . . 0.92000000000000004 110.491 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -72.37 -41.27 66.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 2.8300000000000001 110.9 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 8.9 ptp180 -68.92 -33.64 74.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.624 0.249 . . . . 2.5899999999999999 111.252 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.438 HG11 ' HE1' ' A' ' 118' ' ' PHE . 88.9 t -70.46 -45.75 73.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.397 0.618 . . . . 1.48 110.267 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.537 ' CG ' ' HB2' ' A' ' 134' ' ' ASP . 42.6 ttt180 -68.47 -14.58 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.382 -0.826 . . . . 3.8300000000000001 111.137 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -52.34 -26.88 13.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.036 -0.529 . . . . 2.48 111.841 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.713 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -140.08 -37.43 0.11 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.974 -1.108 . . . . 1.6100000000000001 113.34 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.71 ' HG3' ' HB2' ' A' ' 137' ' ' TRP . 7.7 tpt -73.06 -10.67 60.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.047 0.423 . . . . 4.8300000000000001 111.366 -172.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.537 ' HB2' ' CG ' ' A' ' 130' ' ' ARG . 27.8 t70 -62.49 -31.43 72.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.151 0.501 . . . . 2.8300000000000001 111.277 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -103.0 4.27 37.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.052 0.453 . . . . 4.1500000000000004 110.485 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.539 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.75 -63.61 0.6 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.738 -0.665 . . . . 1.04 112.471 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.71 ' HB2' ' HG3' ' A' ' 133' ' ' MET . 4.2 t90 -57.96 -51.96 77.98 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.029 0.752 . . . . 2.7799999999999998 113.029 -170.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.9 Cg_endo -60.96 -38.24 70.5 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.845 1.696 . . . . 0.68000000000000005 111.916 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.2 m -67.45 -37.19 82.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.637 -0.71 . . . . 0.87 109.503 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.759 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 17.5 mt -57.39 -50.72 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 114.888 -1.051 . . . . 0.71999999999999997 111.188 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 75.6 mt -57.44 -41.84 81.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.411 0.445 . . . . 0.68999999999999995 111.209 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.92 -51.59 68.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.118 0.485 . . . . 1.49 110.866 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.694 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 41.7 m -71.65 -21.51 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 1.1499999999999999 110.955 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 61.7 t80 -63.19 -53.02 59.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.238 -0.653 . . . . 0.80000000000000004 109.238 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -31.93 69.35 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.868 -0.605 . . . . 1.6299999999999999 110.51 173.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.05 -40.36 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 1.46 112.04 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -69.46 -39.32 77.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.068 0.461 . . . . 1.74 109.956 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.968 HG21 HG13 ' A' ' 12' ' ' VAL . 87.0 mt -65.72 -29.58 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.5 110.343 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.408 ' OD2' ' HG3' ' A' ' 154' ' ' LYS . 17.9 t0 -64.39 -25.24 67.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.616 -0.72 . . . . 0.84999999999999998 110.199 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -71.52 -31.01 66.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.639 . . . . 1.5 109.964 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.52 -32.55 48.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.598 -0.728 . . . . 1.74 109.885 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -89.05 22.73 21.1 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.745 -0.661 . . . . 1.3200000000000001 111.895 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.12 85.03 0.14 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.085 0.554 . . . . 1.9199999999999999 111.735 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 34.0 ttmt -79.92 66.3 5.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.732 0.777 . . . . 2.04 109.014 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 155' ' ' LYS . 7.8 mtmp? . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.607 -1.179 . . . . 4.2199999999999998 108.586 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 5.9 p30 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.346 -0.242 . . . . 1.6599999999999999 110.346 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.8 p90 -169.21 -57.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.99 0.367 . . . . 3.73 111.99 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.6 t70 -66.55 -57.24 12.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.645 0.609 . . . . 2.7799999999999998 112.645 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 2.8 Cg_endo -79.69 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.487 1.458 . . . . 1.6299999999999999 111.971 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -142.3 121.47 13.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.684 0.278 . . . . 3.21 110.581 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.3 t -86.35 113.65 24.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.311 -0.996 . . . . 1.4399999999999999 108.311 169.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 2.1 ttt180 -141.85 145.99 35.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.181 0.515 . . . . 3.3700000000000001 111.077 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HE2' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -122.65 131.09 53.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.012 -0.736 . . . . 0.79000000000000004 109.012 169.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.9 p -134.64 111.54 10.09 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.808 0.813 . . . . 1.28 110.125 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.547 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -125.95 146.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.272 -1.331 . . . . 1.27 111.801 -174.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -104.45 116.67 32.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.56999999999999995 110.473 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.775 HG13 HG21 ' A' ' 148' ' ' ILE . 5.0 t -97.36 141.13 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.918 -0.583 . . . . 0.91000000000000003 109.973 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.606 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 15.3 mmtp -106.83 14.84 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.575 -0.284 . . . . 0.97999999999999998 111.724 -169.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.09 36.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.48 -0.488 . . . . 0.35999999999999999 111.499 -174.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.567 ' OD1' ' HG3' ' A' ' 17' ' ' LYS . 35.2 t70 71.73 168.45 0.31 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.053 0.93 . . . . 0.91000000000000003 112.614 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.623 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 11.5 ttp180 -66.48 -23.74 66.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.383 -1.281 . . . . 1.8799999999999999 111.412 -174.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 62.6 mttm -60.96 -52.4 65.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 3.0499999999999998 110.632 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.6 p -68.98 -34.51 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 1.1100000000000001 110.458 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.4 -51.24 70.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.32000000000000001 110.824 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.3 t80 -67.61 -45.06 76.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.223 -0.444 . . . . 0.38 110.673 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 18.6 ttmt -57.53 -49.16 77.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 2.3900000000000001 111.18 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.562 HG23 ' CE2' ' A' ' 30' ' ' TRP . 31.1 m -69.72 -33.22 72.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.043 0.449 . . . . 0.68000000000000005 111.11 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -75.95 -37.15 58.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.922 -0.311 . . . . 0.47999999999999998 111.169 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.1 tp -120.15 -51.86 2.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.513 0.931 . . . . 0.5 113.513 -171.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.649 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 49.8 mt-10 -75.21 -51.81 12.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.463 0.542 . . . . 1.24 112.463 -168.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -88.12 32.23 4.44 Favored Glycine 0 C--N 1.315 -0.628 0 CA-C-N 115.781 -0.645 . . . . 0.82999999999999996 111.9 -175.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.683 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 62.8 t80 -50.09 -57.84 11.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 123.343 0.657 . . . . 0.73999999999999999 112.135 -170.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 28.1 Cg_endo -87.81 51.17 2.0 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.945 1.763 . . . . 0.76000000000000001 114.62 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.6 pt-20 -150.07 -11.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.258 0.836 . . . . 1.49 113.258 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.774 ' CZ3' ' HG2' ' A' ' 147' ' ' LYS . 11.1 m95 -76.41 -172.31 2.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.155 0.502 . . . . 4.6200000000000001 111.094 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 19.6 m95 -92.56 -26.05 0.28 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 2.7799999999999998 114.758 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 93.4 Cg_endo -79.2 -139.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 CA-C-N 120.972 1.383 . . . . 1.3600000000000001 113.876 -169.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' ND2' HG21 ' A' ' 40' ' ' VAL . 3.4 t-20 -48.07 -45.78 32.85 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.518 -0.765 . . . . 1.51 111.533 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -76.69 26.07 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.368 0.877 . . . . 1.79 113.368 -170.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -102.07 3.8 39.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 4.4500000000000002 110.509 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -100.52 120.83 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 4.1399999999999997 111.411 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 p -76.99 133.86 39.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.823 0.344 . . . . 2.6800000000000002 111.511 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.474 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 6.3 p 52.86 27.37 5.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.019 0.928 . . . . 1.4199999999999999 111.241 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 40' ' ' VAL . 48.3 tttp -124.89 -49.27 1.74 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.732 -1.122 . . . . 2.8999999999999999 108.668 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.609 HG12 ' HD1' ' A' ' 65' ' ' PHE . 1.3 m -166.0 30.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 124.127 0.892 . . . . 1.8300000000000001 110.693 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -173.08 31.87 0.11 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.813 -1.184 . . . . 2.1699999999999999 114.159 -171.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.801 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.41 173.94 3.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.299 -0.63 . . . . 1.1200000000000001 109.299 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.441 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 34.6 Cg_exo -63.49 41.97 0.1 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 C-N-CA 123.327 2.684 . . . . 1.48 114.71 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -149.11 -80.76 0.13 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.676 -0.49 . . . . 1.75 109.676 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.528 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 88.6 -60.87 3.91 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.887 -0.673 . . . . 0.75 112.689 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.646 HG11 ' HG ' ' A' ' 24' ' ' LEU . 77.9 t -141.26 133.6 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.547 0.213 . . . . 0.59999999999999998 111.164 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -103.85 113.06 26.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.112 -0.494 . . . . 1.1100000000000001 110.208 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 5.5 mptt -81.15 -16.15 53.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 2.8100000000000001 110.847 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -76.36 -62.21 1.69 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.109 -0.496 . . . . 3.1699999999999999 110.7 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.21 17.86 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 1.53 111.424 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.7 60.37 0.59 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.804 -0.713 . . . . 0.77000000000000002 112.097 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.39 150.84 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.54 -0.388 . . . . 3.7200000000000002 111.279 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 65' ' ' PHE . 6.1 m0 -100.24 110.86 23.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.984 -0.747 . . . . 1.28 108.984 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -162.4 174.55 12.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.429 0.633 . . . . 1.6599999999999999 111.26 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.801 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 25.1 mt-10 -126.8 174.69 8.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.648 -0.705 . . . . 2.1200000000000001 109.834 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' HG2' ' A' ' 61' ' ' GLU . 32.3 mm -100.75 100.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.954 -0.758 . . . . 0.92000000000000004 108.954 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.603 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 2.9 m-20 -67.26 -175.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.574 0.702 . . . . 1.97 112.013 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.28 -25.29 29.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.289 -0.868 . . . . 2.4300000000000002 110.925 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 2.4 pm0 -95.66 5.05 52.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 2.3900000000000001 110.828 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.16 -109.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.235 -0.983 . . . . 2.29 112.56 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.422 ' HG2' HD12 ' A' ' 56' ' ' ILE . 28.2 mt-10 -147.97 34.54 0.83 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.478 0.311 . . . . 2.3100000000000001 110.975 -173.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 9.9 pt-20 -97.5 74.43 2.44 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.29 -0.964 . . . . 2.6099999999999999 111.283 -171.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.9 163.32 20.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.995 . . . . 3.7200000000000002 111.409 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -131.04 148.67 52.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.411 -0.813 . . . . 2.27 110.534 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 6.6 t80 -165.54 -54.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.587 0.554 . . . . 6.4800000000000004 109.598 172.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -156.12 149.91 21.03 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.186 -1.007 . . . . 1.23 113.415 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.494 HD12 ' CZ ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -114.76 103.92 11.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.625 -0.509 . . . . 1.1699999999999999 109.625 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.467 HG21 HG22 ' A' ' 71' ' ' VAL . 43.4 mt -79.5 142.1 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.987 0.422 . . . . 0.60999999999999999 110.839 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.6 mpt_? -114.04 -25.22 8.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.48 174.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.665 ' HD2' HG23 ' A' ' 78' ' ' VAL . 13.1 ttmm -142.55 106.62 4.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.531 -0.304 . . . . 1.53 111.174 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 68' ' ' ILE . 41.5 t -95.05 92.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.268 -1.012 . . . . 0.88 108.268 167.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -109.5 70.34 0.73 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.661 -0.416 . . . . 1.4199999999999999 111.12 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.9 pt-20 48.37 -172.59 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.507 1.13 . . . . 0.95999999999999996 112.018 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 26.2 Cg_exo -65.45 75.35 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.428 1.419 . . . . 0.38 111.1 166.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -157.46 -66.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.5 110.358 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -141.77 143.71 33.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.412 0.625 . . . . 0.34999999999999998 112.079 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.3 mp -131.5 112.05 12.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.509 -0.769 . . . . 0.73999999999999999 109.506 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.665 HG23 ' HD2' ' A' ' 70' ' ' LYS . 86.1 t -90.6 104.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.801 -0.815 . . . . 0.67000000000000004 108.801 172.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.593 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -127.93 122.55 58.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.378 -0.828 . . . . 0.75 111.333 -170.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.924 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -87.25 154.7 26.57 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 111.833 -0.507 . . . . 0.5 111.833 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.767 ' CZ2' ' HA ' ' A' ' 83' ' ' LEU . 68.8 t-105 -91.16 125.93 36.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.466 0.651 . . . . 2.79 111.798 -171.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -124.76 0.27 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 5.46 109.26 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.052 HD21 ' HB2' ' A' ' 88' ' ' ARG . 6.8 tt 78.57 154.26 0.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.706 -1.134 . . . . 1.55 113.416 169.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.551 ' HB2' HG11 ' A' ' 40' ' ' VAL . 22.5 p-10 -117.88 -28.0 6.04 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.129 -0.941 . . . . 1.9299999999999999 112.689 -168.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.47 -29.59 63.84 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-O 119.727 -0.485 . . . . 2.3999999999999999 113.882 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 73.01 -42.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.412 0.685 . . . . 5.3799999999999999 110.769 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.88 3.39 70.59 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.101 -0.8 . . . . 2.2999999999999998 111.101 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.052 ' HB2' HD21 ' A' ' 83' ' ' LEU . 69.2 mmt-85 -96.75 173.93 7.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.155 -0.313 . . . . 4.7699999999999996 110.155 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.879 HD12 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -101.15 119.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.175 0.512 . . . . 1.8600000000000001 110.319 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 7.6 p-10 -91.24 141.31 26.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.157 0.503 . . . . 3.1800000000000002 111.556 -175.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.602 ' HG3' HG22 ' A' ' 129' ' ' VAL . 10.0 Cg_exo -72.07 -49.97 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.036 2.49 . . . . 2.3599999999999999 111.538 171.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.48 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 17.4 t70 70.72 -41.93 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.785 0.834 . . . . 2.9900000000000002 112.911 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.591 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 21.2 m-80 -73.32 -31.24 63.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.384 . . . . 3.0600000000000001 111.927 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.521 ' HB2' ' HD2' ' A' ' 118' ' ' PHE . 67.6 m -154.19 -126.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.101 -0.239 . . . . 1.8500000000000001 111.244 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.706 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 58.8 m 57.59 28.67 16.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.454 0.645 . . . . 1.4399999999999999 110.352 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.924 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 36.5 tt0 -62.08 138.55 58.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.957 -1.02 . . . . 1.8100000000000001 111.02 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -133.92 136.92 44.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.149 0.499 . . . . 0.64000000000000001 110.931 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.8 m -99.17 110.42 22.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.42999999999999999 110.174 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.724 ' HA ' HG22 ' A' ' 113' ' ' VAL . 91.8 t -82.8 109.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.828 -0.624 . . . . 0.87 110.103 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.7 m -103.52 106.13 16.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.379 -0.373 . . . . 0.45000000000000001 110.67 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.623 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 40.9 m-85 -87.99 112.7 22.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.304 -0.407 . . . . 0.34000000000000002 110.255 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.13 111.19 25.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.286 -0.415 . . . . 0.54000000000000004 110.125 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.89 133.76 48.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.833 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.9 t0 -126.99 100.92 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.174 -0.466 . . . . 2.0299999999999998 109.833 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.7 49.46 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.708 -0.758 . . . . 1.97 113.404 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 72.22 8.16 5.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.504 0.722 . . . . 4.9299999999999997 111.973 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -128.06 -11.66 5.29 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.828 -0.545 . . . . 3.5299999999999998 110.285 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 77.5 tttt -122.48 158.06 30.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.893 -0.781 . . . . 2.4399999999999999 108.893 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.1 m -157.6 117.64 3.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.95 0.405 . . . . 0.41999999999999998 110.792 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.4 tmm_? -102.12 116.22 32.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.512 -0.922 . . . . 2.5899999999999999 108.512 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.9 p -90.73 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.313 -0.403 . . . . 0.40000000000000002 111.116 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -129.13 112.58 14.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 1.3799999999999999 108.732 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 99' ' ' VAL . 47.0 t -104.71 120.85 55.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.956 -0.566 . . . . 0.91000000000000003 111.209 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.46 122.82 40.95 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.765 0.666 . . . . 2.3100000000000001 109.651 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 2.3 t-160 -131.44 97.75 4.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.799 -0.815 . . . . 1.6399999999999999 108.799 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.577 HG22 ' HD2' ' A' ' 120' ' ' ARG . 24.5 p -141.78 103.13 4.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.726 -0.215 . . . . 2.6699999999999999 111.271 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -167.39 -74.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.315 -0.554 . . . . 2.6299999999999999 112.172 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -85.75 -42.43 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 3.54 111.391 -168.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.95 73.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.195 -0.911 . . . . 1.8100000000000001 110.719 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.577 ' HD2' HG22 ' A' ' 116' ' ' THR . 44.1 mtp180 -59.59 -19.32 47.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.424 -0.807 . . . . 3.3799999999999999 111.923 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.521 ' HA ' ' CE ' ' A' ' 121' ' ' MET . 11.5 mmt -72.4 23.63 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.69 0.996 . . . . 2.4300000000000002 113.69 -171.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.79 -155.88 15.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.847 -1.168 . . . . 1.6100000000000001 114.406 168.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 p -61.66 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.32 0.859 . . . . 2.5800000000000001 113.32 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 48.1 mtpt -70.05 -14.31 62.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 3.7999999999999998 112.002 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.67 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 40.3 m80 -73.03 -49.92 26.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.461 0.648 . . . . 2.1400000000000001 109.364 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.89 73.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.92000000000000004 110.024 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.639 ' HB3' ' HA ' ' A' ' 124' ' ' LYS . 2.8 tppp? -71.25 -38.03 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.685 -0.689 . . . . 2.8300000000000001 111.382 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.879 ' HB2' HD12 ' A' ' 89' ' ' ILE . 15.8 ptm180 -67.69 -30.86 70.49 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.907 -0.317 . . . . 2.5899999999999999 110.272 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.4 t -84.61 -30.92 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.319 -0.552 . . . . 1.48 111.605 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.271 -0.422 . . . . 3.8300000000000001 111.928 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 5.3 p30 -63.56 -33.48 75.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 2.48 111.281 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.89 -71.33 1.28 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.517 -0.849 . . . . 1.6100000000000001 114.213 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.614 ' HB3' ' CZ2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -77.84 -21.89 50.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.961 0.726 . . . . 4.8300000000000001 112.961 -165.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.9 -28.15 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 2.8300000000000001 111.244 -174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.822 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.3 mmpt? -101.99 15.24 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 4.1500000000000004 110.916 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.631 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -134.24 -57.25 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.508 -0.853 . . . . 1.04 112.489 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.433 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 1.6 t90 -56.0 -54.43 52.4 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.693 0.627 . . . . 2.7799999999999998 112.693 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 34.9 Cg_endo -65.83 -34.33 40.13 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.708 1.606 . . . . 0.68000000000000005 111.948 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 -41.0 95.23 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.925 -0.58 . . . . 0.87 109.894 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.667 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 63.2 mt -57.9 -46.43 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 115.334 -0.848 . . . . 0.71999999999999997 109.843 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 21.6 mt -54.95 -42.9 72.92 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 123.638 0.586 . . . . 0.68999999999999995 111.385 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -64.02 -46.18 85.6 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.582 -0.447 . . . . 1.49 110.813 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -75.19 -22.19 58.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.027 0.442 . . . . 1.1499999999999999 110.927 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 92.8 t80 -61.18 -55.14 35.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.80000000000000004 109.6 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.464 ' OE1' ' HD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -64.92 -30.7 71.7 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.019 -0.537 . . . . 1.6299999999999999 110.45 175.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.48 -55.77 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.591 -0.277 . . . . 1.46 111.342 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.774 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 21.9 tptp -68.0 -39.61 83.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.53 -0.468 . . . . 1.74 110.841 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.775 HG21 HG13 ' A' ' 12' ' ' VAL . 47.2 mt -65.9 -37.83 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.5 111.894 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.936 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.1 t70 -64.09 -25.53 68.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.377 -0.374 . . . . 0.84999999999999998 110.333 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.777 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 61.4 mt-10 -69.53 -39.66 77.37 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.38 -20.6 66.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.054 -0.975 . . . . 1.74 108.972 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.95 -82.78 0.9 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.06 -0.973 . . . . 1.3200000000000001 111.56 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -155.01 12.37 0.37 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.866 0.691 . . . . 1.9199999999999999 112.866 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.936 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 21.1 ttmm -63.67 -32.48 73.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.942 0.401 . . . . 2.04 111.466 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 119.22 -0.419 . . . . 4.2199999999999998 110.719 -176.755 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.9 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 32.6 p30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.375 -0.232 . . . . 1.6599999999999999 110.375 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER 70.26 -31.76 0.22 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.082 1.353 . . . . 3.73 112.172 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.79 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 23.6 t70 -59.34 -53.63 64.17 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.284 -0.265 . . . . 2.7799999999999998 110.284 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 25.5 Cg_endo -94.64 -64.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.244 1.963 . . . . 1.6299999999999999 111.348 167.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 38.6 p90 -151.77 171.4 17.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.936 -1.135 . . . . 3.21 107.936 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.964 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 86.0 t -107.58 103.91 16.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.853 -0.339 . . . . 1.4399999999999999 110.53 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.1 ttp180 -93.76 130.59 39.69 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.239 -0.584 . . . . 3.3700000000000001 110.84 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.646 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -110.53 133.54 53.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.79000000000000004 108.817 173.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.677 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.1 t -134.7 111.08 9.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.518 0.675 . . . . 1.28 110.111 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG22 HE21 ' A' ' 145' ' ' GLN . 3.0 t -124.63 137.78 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.675 -1.148 . . . . 1.27 111.652 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.1 m -97.77 116.88 30.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.813 -0.63 . . . . 0.56999999999999995 110.443 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.904 HG13 HG21 ' A' ' 148' ' ' ILE . 32.9 t -94.7 142.4 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.46 -0.791 . . . . 0.91000000000000003 110.868 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -99.23 12.76 35.27 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.25 0.463 . . . . 0.97999999999999998 112.25 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.485 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.4 39.66 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.975 -0.69 . . . . 0.35999999999999999 112.414 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.572 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 14.3 t70 73.12 167.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.811 0.815 . . . . 0.91000000000000003 111.927 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 25.9 ttp180 -69.43 -23.4 63.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.094 -0.957 . . . . 1.8799999999999999 110.707 -174.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 15.1 ptpt -60.76 -39.22 87.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 3.0499999999999998 111.195 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -82.91 -37.86 23.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.928 -0.309 . . . . 1.1100000000000001 110.594 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -56.27 -43.38 78.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.829 0.347 . . . . 0.32000000000000001 110.462 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 79.4 t80 -70.93 -46.01 63.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.322 -0.399 . . . . 0.38 110.48 176.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -55.19 -55.0 36.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.037 -0.529 . . . . 2.3900000000000001 111.382 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.444 HG22 ' NE1' ' A' ' 30' ' ' TRP . 23.6 m -67.23 -46.68 73.07 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.311 -0.859 . . . . 0.68000000000000005 111.028 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.647 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 66.5 t80 -64.46 -34.89 79.25 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.103 0.409 . . . . 0.47999999999999998 112.103 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.57 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.2 tp -108.67 -53.72 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.033 -0.667 . . . . 0.5 112.373 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.63 -39.44 37.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 1.24 111.297 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.709 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -91.4 33.53 4.72 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.65 -0.704 . . . . 0.82999999999999996 112.336 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.541 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 44.8 t80 -52.54 -48.0 91.71 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.216 0.45 . . . . 0.73999999999999999 112.216 -173.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -89.64 15.29 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.869 1.713 . . . . 0.76000000000000001 115.036 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.0 pt-20 -100.44 -5.03 27.71 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.993 -0.683 . . . . 1.49 110.766 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.647 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 23.9 m0 -75.73 153.75 36.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.488 0.661 . . . . 4.6200000000000001 111.468 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.647 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 36.8 m95 -80.47 -44.1 1.35 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.908 -1.042 . . . . 2.7799999999999998 112.855 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 1.105 ' HD3' ' HB2' ' A' ' 143' ' ' SER . 11.3 Cg_endo -52.12 -76.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.062 2.508 . . . . 1.3600000000000001 114.76 -164.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -120.35 -11.61 9.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 1.51 110.609 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.703 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.4 m-20 -99.14 18.67 16.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.688 . . . . 1.79 111.103 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.55 8.37 43.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.142 0.496 . . . . 4.4500000000000002 111.023 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -117.73 140.33 49.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 4.1399999999999997 111.65 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.48 148.03 37.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 2.6800000000000002 110.921 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 57' ' ' ASP . 63.6 p 57.88 8.02 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.547 1.139 . . . . 1.4199999999999999 112.843 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.78 -77.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.479 -0.934 . . . . 2.8999999999999999 108.479 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.703 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.8 m -147.21 15.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.588 -0.893 . . . . 1.8300000000000001 108.588 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.49 55.35 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.72 -1.127 . . . . 2.1699999999999999 111.876 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -104.05 169.81 6.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.406 -0.961 . . . . 1.1200000000000001 108.406 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.19 53.83 0.26 Allowed 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 123.038 2.492 . . . . 1.48 113.77 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD21 ' CZ ' ' A' ' 54' ' ' TYR . 35.3 tp -170.8 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.745 0.418 . . . . 1.75 110.378 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.664 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 87.76 -57.78 4.38 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.991 -0.623 . . . . 0.75 112.487 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 24' ' ' LEU . 89.0 t -134.81 136.66 51.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.839 0.352 . . . . 0.59999999999999998 110.67 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.648 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.9 t70 -107.94 122.77 47.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.561 -0.745 . . . . 1.1100000000000001 109.77 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -33.91 40.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.403 0.52 . . . . 2.8100000000000001 112.403 -175.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -47.22 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.814 0.301 . . . . 3.1699999999999999 111.814 -172.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.88 -25.39 22.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.655 -0.784 . . . . 1.53 111.784 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 82.18 60.33 2.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.652 -0.785 . . . . 0.77000000000000002 111.207 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 8.3 ptm180 -146.39 139.76 25.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.843 0.354 . . . . 3.7200000000000002 111.118 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 24.5 m0 -97.99 108.26 20.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 1.28 110.547 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.648 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -153.32 151.71 30.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.997 0.427 . . . . 1.6599999999999999 110.282 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 51.6 mp0 -117.79 160.05 22.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 2.1200000000000001 110.512 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.51 HD12 ' HG2' ' A' ' 61' ' ' GLU . 36.8 mm -77.84 103.97 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 0.92000000000000004 110.062 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.0 t70 -95.43 -178.12 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 1.97 110.476 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -80.92 -7.68 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.798 0.666 . . . . 2.4300000000000002 112.798 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.511 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -95.98 -4.65 42.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.289 0.566 . . . . 2.3900000000000001 110.194 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.21 -85.1 0.18 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.505 -0.771 . . . . 2.29 111.816 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.51 ' HG2' HD12 ' A' ' 56' ' ' ILE . 52.6 mt-10 -156.65 18.94 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.717 -0.475 . . . . 2.3100000000000001 109.717 -177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.86 88.85 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.742 0.782 . . . . 2.6099999999999999 110.274 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -117.84 163.74 16.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.886 -1.052 . . . . 3.7200000000000002 110.254 -178.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -52.7 109.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.67 -0.493 . . . . 2.27 109.67 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 30.7 p90 -92.58 130.66 38.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.334 0.588 . . . . 6.4800000000000004 112.016 -170.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.4 157.55 31.72 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.74 -0.944 . . . . 1.23 110.74 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.2 pt? -116.01 99.59 7.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.996 0.398 . . . . 1.1699999999999999 111.261 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 71' ' ' VAL . 40.7 mt -79.37 118.6 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.047 -0.661 . . . . 0.60999999999999999 109.907 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -85.94 -23.25 27.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.841 -1.072 . . . . 2.0 109.818 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 78' ' ' VAL . 58.5 tttp -156.39 105.41 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.732 -0.667 . . . . 1.53 111.266 -174.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 68' ' ' ILE . 49.8 t -98.92 93.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.652 -0.87 . . . . 0.88 108.652 169.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.02 73.15 0.83 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.535 -0.466 . . . . 1.4199999999999999 111.648 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 48.18 -174.12 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 124.827 1.33 . . . . 0.95999999999999996 112.623 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 39.3 Cg_exo -62.77 82.08 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.504 1.469 . . . . 0.38 110.956 166.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -167.68 -67.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.789 . . . . 0.5 110.506 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 100' ' ' THR . 3.6 p -141.91 140.97 32.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.431 0.53 . . . . 0.34999999999999998 112.431 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.2 mp -136.6 112.93 9.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 0.73999999999999999 109.621 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 98' ' ' THR . 39.6 t -103.24 109.9 28.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.007 -0.738 . . . . 0.67000000000000004 109.007 175.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 138.62 53.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.902 0.382 . . . . 0.75 111.947 -176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 150.95 21.8 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.816 -0.629 . . . . 0.5 112.791 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.81 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 61.0 t-105 -89.09 148.94 23.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.209 0.604 . . . . 2.79 111.64 -168.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -142.87 23.24 1.91 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.995 -0.548 . . . . 5.46 110.374 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.72 HD11 ' HB3' ' A' ' 88' ' ' ARG . 1.6 tm? 84.63 152.83 0.09 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.177 -0.919 . . . . 1.55 111.081 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.554 ' N ' HD13 ' A' ' 83' ' ' LEU . 42.0 t30 -131.79 -29.99 1.66 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.01 -0.541 . . . . 1.9299999999999999 111.52 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.7 46.08 2.8 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.304 -0.474 . . . . 2.3999999999999999 113.81 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.3 t80 58.63 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 5.3799999999999999 112.307 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.17 39.23 2.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.988 -0.625 . . . . 2.2999999999999998 112.145 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.763 ' HD2' ' ND2' ' A' ' 131' ' ' ASN . 5.6 tpp180 -97.56 -176.62 3.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.729 -0.471 . . . . 4.7699999999999996 109.729 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.457 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -94.14 137.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.965 0.412 . . . . 1.8600000000000001 110.47 -175.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -96.0 137.6 21.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.081 -0.509 . . . . 3.1800000000000002 111.428 -179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HG2' ' HD1' ' A' ' 81' ' ' TRP . 50.2 Cg_exo -57.62 -21.72 48.34 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.17 3.247 . . . . 2.3599999999999999 113.807 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.5 t70 77.25 41.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.381 -0.827 . . . . 2.9900000000000002 110.596 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.536 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 80.36 36.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.032 -0.986 . . . . 3.0600000000000001 112.845 158.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 p -122.71 -37.25 2.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.757 -0.377 . . . . 1.8500000000000001 111.682 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.81 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 20.5 t -55.85 97.06 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.522 -0.763 . . . . 1.4399999999999999 109.292 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -122.57 136.84 54.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.237 -0.438 . . . . 1.8100000000000001 110.673 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.487 ' HD1' ' CE1' ' A' ' 115' ' ' HIS . 12.2 p90 -134.48 139.4 45.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.235 0.541 . . . . 0.64000000000000001 111.855 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 78' ' ' VAL . 75.7 m -96.9 109.1 21.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.117 -0.947 . . . . 0.42999999999999999 110.134 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.788 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.2 t -83.53 109.98 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.87 110.077 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 ' HA ' HG22 ' A' ' 76' ' ' THR . 25.2 m -106.19 106.56 17.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.646 -0.252 . . . . 0.45000000000000001 110.636 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.565 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.8 m-85 -88.12 115.8 25.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.657 -0.247 . . . . 0.34000000000000002 110.498 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.2 112.01 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.907 -0.405 . . . . 0.54000000000000004 109.907 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.58 133.89 43.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.844 -0.616 . . . . 0.44 111.372 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -121.93 128.85 52.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 2.0299999999999998 109.227 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.65 -13.05 29.79 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.343 -0.844 . . . . 1.97 115.176 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -84.21 33.86 0.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.993 0.896 . . . . 4.9299999999999997 111.685 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 12.3 mmtp 56.5 45.72 21.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.746 0.784 . . . . 3.5299999999999998 108.947 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 87.9 tttt -133.87 155.03 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.809 -1.087 . . . . 2.4399999999999999 109.341 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.441 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 25.9 m -155.03 114.63 3.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.139 0.495 . . . . 0.41999999999999998 110.841 173.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.481 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 18.2 tpp85 -91.64 113.98 26.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.543 -0.753 . . . . 2.5899999999999999 109.697 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -91.04 138.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.768 0.318 . . . . 0.40000000000000002 110.485 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 17.8 t70 -127.55 109.98 12.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.491 -0.777 . . . . 1.3799999999999999 109.213 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 t -102.93 135.67 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.536 -0.756 . . . . 0.91000000000000003 111.578 -175.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -113.04 111.62 22.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 2.3100000000000001 109.683 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.964 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -100.77 115.57 30.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.454 -0.794 . . . . 1.6399999999999999 109.235 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 p -127.99 168.88 14.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.522 -0.471 . . . . 2.6699999999999999 111.619 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 101.98 -66.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 113.804 -1.544 . . . . 2.6299999999999999 110.563 162.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.838 ' HE2' HG21 ' A' ' 129' ' ' VAL . 59.5 t80 -86.97 -52.34 5.51 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.029 -0.532 . . . . 3.54 111.996 -175.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 2' ' ' TYR . 1.7 m-20 -54.82 -33.39 61.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 1.8100000000000001 112.281 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 37.7 ttp180 -62.52 -22.73 66.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 3.3799999999999999 111.502 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.81 -22.09 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.536 -0.302 . . . . 2.4300000000000002 110.358 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 126' ' ' ALA . . . 48.82 -154.02 2.09 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.39 -0.823 . . . . 1.6100000000000001 114.801 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 m 44.76 -101.92 0.05 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.397 1.079 . . . . 2.5800000000000001 113.112 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.96 -45.16 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.136 -0.32 . . . . 3.7999999999999998 110.136 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -61.15 -49.8 75.76 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.334 0.588 . . . . 2.1400000000000001 110.469 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . . . -64.51 -51.24 63.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.549 -0.751 . . . . 0.92000000000000004 111.222 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -61.91 -34.0 75.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.905 0.335 . . . . 2.8300000000000001 111.905 -173.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -77.16 -32.94 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.419 -0.513 . . . . 2.5899999999999999 111.438 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.838 HG21 ' HE2' ' A' ' 118' ' ' PHE . 79.2 t -78.61 -42.3 25.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.374 0.607 . . . . 1.48 110.664 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.901 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 65.9 mtt-85 -68.18 -12.41 60.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.516 -0.766 . . . . 3.8300000000000001 110.957 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.763 ' ND2' ' HD2' ' A' ' 88' ' ' ARG . 45.7 t30 -51.8 -25.09 6.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.568 -0.742 . . . . 2.48 110.004 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.18 -17.92 2.64 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.918 -0.583 . . . . 1.6100000000000001 112.422 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.811 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 6.4 tpp -80.07 -42.89 22.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.475 0.546 . . . . 4.8300000000000001 112.475 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.901 ' HB2' ' HB3' ' A' ' 130' ' ' ARG . 7.4 t70 -68.46 -25.92 65.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.975 0.731 . . . . 2.8300000000000001 112.975 -163.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -115.9 24.19 11.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.586 0.708 . . . . 4.1500000000000004 109.922 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.96 -74.68 0.64 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.36 -0.836 . . . . 1.04 111.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 5.5 t90 -58.51 -48.86 96.15 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.76 0.652 . . . . 2.7799999999999998 112.76 -173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.0 Cg_endo -59.61 -38.75 80.14 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.189 1.926 . . . . 0.68000000000000005 112.642 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 m -70.9 -37.11 72.98 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.757 0.789 . . . . 0.87 109.347 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.666 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.6 mt -54.59 -44.74 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.4 -1.273 . . . . 0.71999999999999997 110.196 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.563 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 68.9 mt -56.68 -33.8 66.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.464 0.478 . . . . 0.68999999999999995 111.608 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -69.15 -57.71 5.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.18 0.514 . . . . 1.49 111.002 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 1.105 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -71.93 -21.39 61.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.104 -0.498 . . . . 1.1499999999999999 111.132 -178.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.35 -47.57 85.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.80000000000000004 109.543 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 67.6 mt-30 -61.23 -36.22 79.36 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.549 -0.751 . . . . 1.6299999999999999 110.356 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.47 -39.75 64.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.492 -0.777 . . . . 1.46 111.506 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -66.56 -35.77 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.934 0.397 . . . . 1.74 110.112 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.904 HG21 HG13 ' A' ' 12' ' ' VAL . 50.4 mt -71.47 -32.68 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.288 0.566 . . . . 0.5 110.375 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.425 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 12.8 t70 -58.88 -32.33 69.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.609 -0.723 . . . . 0.84999999999999998 109.727 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.85 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 49.6 mt-10 -66.0 -33.22 75.3 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.538 -0.755 . . . . 1.5 110.413 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -82.15 -17.1 47.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.359 -0.837 . . . . 1.74 109.726 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -96.56 -75.89 1.28 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.467 -0.788 . . . . 1.3200000000000001 112.819 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.55 15.27 1.8 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.697 0.628 . . . . 1.9199999999999999 112.697 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.85 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttmm -79.62 76.94 6.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.232 0.539 . . . . 2.04 110.087 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--O 1.246 0.901 0 CA-C-N 115.7 -0.682 . . . . 4.2199999999999998 109.553 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 35.2 m-80 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.691 -0.485 . . . . 1.6599999999999999 109.691 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 28.4 p90 172.96 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.62 0.575 . . . . 3.73 110.288 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.899 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.4 t70 -59.98 -56.74 32.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.129 -0.487 . . . . 2.7799999999999998 111.397 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.899 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 18.9 Cg_endo -96.08 -64.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.392 2.061 . . . . 1.6299999999999999 111.953 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -149.6 154.97 39.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.667 -1.234 . . . . 3.21 107.667 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.734 ' HB ' ' CB ' ' A' ' 115' ' ' HIS . 27.4 t -85.7 106.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.221 -0.592 . . . . 1.4399999999999999 109.812 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.8 ttm180 -111.75 135.38 52.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.805 0.812 . . . . 3.3700000000000001 111.427 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 1.025 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 4.8 t-160 -109.38 132.37 54.19 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.736 -1.209 . . . . 0.79000000000000004 107.736 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.2 t -146.04 112.02 5.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.944 -0.391 . . . . 1.28 109.944 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.808 HG22 HG12 ' A' ' 111' ' ' VAL . 10.8 m -138.31 139.21 42.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 1.27 110.819 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m -92.84 116.14 28.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.471 -0.786 . . . . 0.56999999999999995 109.906 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.778 HG13 HG21 ' A' ' 148' ' ' ILE . 22.4 t -98.47 125.57 51.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.476 -0.784 . . . . 0.91000000000000003 110.379 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 35.06 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.933 0.397 . . . . 0.97999999999999998 111.567 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.548 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.39 26.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.434 -0.348 . . . . 0.35999999999999999 111.039 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.1 t70 72.6 169.21 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 0.91000000000000003 112.857 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.497 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 7.6 ttp180 -63.36 -27.49 69.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.16 -0.927 . . . . 1.8799999999999999 110.978 -174.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -54.28 -53.36 54.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.721 -0.672 . . . . 3.0499999999999998 111.405 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -76.56 -33.57 58.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 1.1100000000000001 111.181 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.621 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -60.47 -48.31 82.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.32000000000000001 110.79 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -69.1 -33.78 74.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.38 110.537 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.863 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 5.5 tppp? -61.06 -55.7 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.427 . . . . 2.3900000000000001 110.262 176.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.544 HG23 ' CE2' ' A' ' 30' ' ' TRP . 31.2 m -66.55 -23.87 66.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.68000000000000005 111.939 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 99' ' ' VAL . 69.4 t80 -87.81 -37.26 16.72 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.722 -0.391 . . . . 0.47999999999999998 111.467 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.54 HD23 ' HE3' ' A' ' 48' ' ' LYS . 18.9 tp -119.95 -54.89 2.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.51 0.93 . . . . 0.5 113.51 -172.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.863 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 29.0 mt-10 -78.68 -24.72 44.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.378 0.609 . . . . 1.24 110.779 -169.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.418 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.72 93.84 0.54 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.056 -2.017 . . . . 0.82999999999999996 108.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.863 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 23.0 t80 -95.93 -63.85 0.12 Allowed Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.722 -0.239 . . . . 0.73999999999999999 111.041 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 29.9 Cg_endo -96.46 37.53 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.282 1.988 . . . . 0.76000000000000001 114.677 -174.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -126.97 5.24 6.53 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.409 0.892 . . . . 1.49 113.409 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.841 ' HE3' ' HG3' ' A' ' 147' ' ' LYS . 18.7 m95 -99.07 -160.89 0.83 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.127 -0.358 . . . . 4.6200000000000001 110.221 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 22.1 m95 -99.05 -8.92 0.12 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.991 1.478 . . . . 2.7799999999999998 114.991 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HB3' ' HB3' ' A' ' 143' ' ' SER . 92.8 Cg_endo -81.82 -148.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 CA-C-N 122.484 1.923 . . . . 1.3600000000000001 113.292 -170.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.643 ' ND2' HD21 ' A' ' 84' ' ' ASN . 6.5 t30 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.812 . . . . 1.51 111.025 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.784 ' HA ' HG23 ' A' ' 40' ' ' VAL . 30.9 m-20 -78.87 20.98 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.183 -0.462 . . . . 1.79 110.739 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -117.83 22.39 12.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 4.4500000000000002 110.33 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -117.66 146.97 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 4.1399999999999997 110.108 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.58 135.66 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.023 -0.271 . . . . 2.6800000000000002 110.854 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.1 p 58.52 14.49 3.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.082 0.953 . . . . 1.4199999999999999 112.133 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' O ' HG22 ' A' ' 40' ' ' VAL . 54.2 tttp -132.6 80.35 1.89 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.985 -0.746 . . . . 2.8999999999999999 108.985 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.784 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.1 m 54.1 17.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.429 1.091 . . . . 1.8300000000000001 112.165 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -146.28 26.88 1.7 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.56 -0.828 . . . . 2.1699999999999999 113.312 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.892 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -77.56 167.14 38.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.45 -0.944 . . . . 1.1200000000000001 108.45 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.02 59.71 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.751 2.301 . . . . 1.48 113.718 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 53.4 tp -166.03 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.75 110.027 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.45 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 94.98 -63.88 1.46 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.872 -0.68 . . . . 0.75 113.06 173.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 24' ' ' LEU . 84.8 t -132.75 147.41 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.84 0.353 . . . . 0.59999999999999998 110.487 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.83 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.6 t0 -123.98 96.32 4.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.853 -0.795 . . . . 1.1100000000000001 108.853 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 8.5 mtpt -74.06 -22.31 59.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.112 0.482 . . . . 2.8100000000000001 110.245 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' NZ ' ' HB3' ' A' ' 49' ' ' LYS . 4.2 ttpm? -64.67 -56.61 12.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 3.1699999999999999 110.787 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.93 -28.72 33.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.966 -0.635 . . . . 1.53 112.595 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.95 49.42 2.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.696 -0.764 . . . . 0.77000000000000002 112.169 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.44 161.31 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.735 0.302 . . . . 3.7200000000000002 111.417 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD1' HD11 ' A' ' 68' ' ' ILE . 14.4 m0 -108.99 120.01 41.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 1.28 109.999 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.83 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -163.91 158.11 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.087 0.47 . . . . 1.6599999999999999 110.677 175.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.892 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.1 mp0 -125.71 166.55 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.486 -0.931 . . . . 2.1200000000000001 108.486 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 61' ' ' GLU . 43.2 mm -78.34 103.62 5.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.121 0.486 . . . . 0.92000000000000004 109.958 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.4 t70 -87.98 145.94 25.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.717 -0.674 . . . . 1.97 110.092 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -61.34 -26.82 68.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.681 0.613 . . . . 2.4300000000000002 112.354 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.427 ' HB3' ' OD2' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -75.8 -17.99 59.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.951 0.405 . . . . 2.3900000000000001 111.226 -175.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.15 54.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.175 -1.012 . . . . 2.29 113.211 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 56' ' ' ILE . 43.6 mt-10 56.0 26.26 9.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.157 0.799 . . . . 2.3100000000000001 113.157 173.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.419 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 12.8 tp10 -112.9 95.83 5.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.424 0.63 . . . . 2.6099999999999999 110.236 -176.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.22 165.16 16.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.047 -0.978 . . . . 3.7200000000000002 110.602 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 82' ' ' ARG . 3.2 p -47.82 124.77 7.76 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.627 0.58 . . . . 2.27 111.316 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -89.61 112.46 23.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.743 -0.662 . . . . 6.4800000000000004 110.943 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.647 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -83.29 127.21 7.89 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.633 -0.987 . . . . 1.23 110.633 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -100.63 96.11 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.016 0.436 . . . . 1.1699999999999999 111.316 -171.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.531 HG21 ' CG2' ' A' ' 71' ' ' VAL . 39.5 mt -83.34 124.49 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.122 0.487 . . . . 0.60999999999999999 110.298 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -104.33 -14.84 15.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.538 -0.755 . . . . 2.0 110.5 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -159.31 118.91 3.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.248 -0.433 . . . . 1.53 111.835 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' A' ' 68' ' ' ILE . 57.7 t -103.1 92.96 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.076 -1.083 . . . . 0.88 108.076 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 5.7 t0 -101.38 64.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.628 -0.26 . . . . 1.4199999999999999 111.19 -170.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 7.4 pt-20 48.28 -172.38 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.287 1.035 . . . . 0.95999999999999996 112.03 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 31.3 Cg_exo -62.64 72.17 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.38 111.774 166.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -156.44 -65.79 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.452 -0.795 . . . . 0.5 110.183 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 100' ' ' THR . 4.0 p -145.57 152.48 39.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.34999999999999998 112.357 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.1 mp -138.18 126.36 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.676 -0.693 . . . . 0.73999999999999999 109.526 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.77 105.56 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.59 -0.522 . . . . 0.67000000000000004 109.59 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.76 137.39 57.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.292 -0.413 . . . . 0.75 111.282 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.09 165.41 26.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.5 111.889 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.978 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 39.6 t-105 -62.17 162.88 8.91 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 114.253 1.205 . . . . 2.79 114.253 -163.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.647 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -158.67 -35.57 0.06 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.608 -1.178 . . . . 5.46 110.023 -169.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.904 ' HG ' ' HA3' ' A' ' 132' ' ' GLY . 4.8 tt 78.11 175.27 0.17 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.753 -0.658 . . . . 1.55 110.599 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.643 HD21 ' ND2' ' A' ' 33' ' ' ASN . 46.7 t-20 -109.12 -76.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.714 0.292 . . . . 1.9299999999999999 110.416 -173.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.59 0.54 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 120.663 -0.78 . . . . 2.3999999999999999 111.216 176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -54.48 -6.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.294 0.85 . . . . 5.3799999999999999 113.294 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.08 -0.89 76.84 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.944 -0.862 . . . . 2.2999999999999998 110.944 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HD3' ' H ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -97.55 152.78 18.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.148 0.499 . . . . 4.7699999999999996 110.585 178.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -65.51 124.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.203 -0.908 . . . . 1.8600000000000001 110.477 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.626 ' OD2' ' HB3' ' A' ' 92' ' ' ASP . 4.1 p-10 -101.75 142.81 25.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 121.42 0.628 . . . . 3.1800000000000002 111.45 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.69 ' HD2' ' HD1' ' A' ' 81' ' ' TRP . 59.8 Cg_endo -97.69 37.46 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.915 3.077 . . . . 2.3599999999999999 111.868 167.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.626 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -65.78 89.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.155 0.979 . . . . 2.9900000000000002 111.066 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -167.88 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.437 -1.256 . . . . 3.0600000000000001 108.368 167.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.77 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 74.6 m -160.96 -143.69 0.1 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.976 -1.465 . . . . 1.8500000000000001 108.674 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.978 ' HB2' ' HB2' ' A' ' 81' ' ' TRP . 37.9 m 54.63 38.0 29.14 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.477 0.656 . . . . 1.4399999999999999 111.442 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.636 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 20.2 tt0 -71.77 149.78 45.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.895 -1.048 . . . . 1.8100000000000001 110.69 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.606 ' HB2' HG13 ' A' ' 113' ' ' VAL . 9.0 p90 -146.37 147.43 31.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.96 0.409 . . . . 0.64000000000000001 110.866 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 30.5 m -104.36 115.82 31.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.42999999999999999 110.374 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.661 ' HA ' HG22 ' A' ' 113' ' ' VAL . 97.4 t -82.42 109.73 16.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.87 109.804 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.532 ' HA ' HG22 ' A' ' 76' ' ' THR . 9.5 m -104.12 105.97 16.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.935 0.397 . . . . 0.45000000000000001 111.224 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.502 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 52.1 m-85 -89.9 110.91 21.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.357 -0.383 . . . . 0.34000000000000002 110.138 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.8 t -91.61 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 110.123 -0.325 . . . . 0.54000000000000004 110.123 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.25 138.07 53.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.393 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -130.12 103.0 6.49 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 2.0299999999999998 110.75 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.34 -97.89 0.63 Allowed Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.946 -0.645 . . . . 1.97 113.223 171.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -146.68 -20.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.095 0.406 . . . . 4.9299999999999997 112.095 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -136.26 3.64 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.97 -0.692 . . . . 3.5299999999999998 112.671 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 26.4 ttpp -127.31 153.96 45.52 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.448 -0.901 . . . . 2.4399999999999999 110.911 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.7 m -160.9 124.31 3.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.826 -0.624 . . . . 0.41999999999999998 109.95 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -109.54 120.25 41.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.79 . . . . 2.5899999999999999 108.866 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 10' ' ' VAL . 10.0 p -96.55 141.12 16.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.802 -0.359 . . . . 0.40000000000000002 110.791 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -129.5 124.23 33.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.08 -0.711 . . . . 1.3799999999999999 109.08 171.23 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 4.1 t -99.05 121.51 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-N 115.725 -0.671 . . . . 0.91000000000000003 110.086 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.19 121.34 41.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.893 -0.78 . . . . 2.3100000000000001 108.893 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.734 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 t-80 -103.03 152.77 20.96 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.285 -0.87 . . . . 1.6399999999999999 110.114 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.686 HG21 ' HD2' ' A' ' 118' ' ' PHE . 9.0 t -60.13 177.86 0.23 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.12 -0.945 . . . . 2.6699999999999999 110.944 170.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -108.35 18.94 20.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.854 -0.612 . . . . 2.6299999999999999 110.438 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.77 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 20.7 m-85 -59.33 -29.07 67.37 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.499 -0.319 . . . . 3.54 111.434 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.6 -49.79 15.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.554 0.692 . . . . 1.8100000000000001 109.699 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' C ' ' H ' ' A' ' 122' ' ' GLY . 55.2 ttt180 -58.54 -18.08 26.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.582 -1.19 . . . . 3.3799999999999999 111.14 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 121' ' ' MET . 24.2 ttt -65.83 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.003 0.921 . . . . 2.4300000000000002 112.466 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 152.93 151.03 5.57 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.177 -1.011 . . . . 1.6100000000000001 112.085 172.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.9 m -60.39 -36.2 77.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.28 0.562 . . . . 2.5800000000000001 109.657 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -71.58 -39.34 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.436 -0.802 . . . . 3.7999999999999998 110.467 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 5.3 m170 -63.8 -46.23 86.12 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 121.26 0.552 . . . . 2.1400000000000001 110.631 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -66.87 -31.51 72.17 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.92000000000000004 111.262 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.42 -39.38 81.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 2.8300000000000001 110.639 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.625 ' HB2' HD12 ' A' ' 89' ' ' ILE . 16.8 ptm180 -76.25 -24.95 54.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 2.5899999999999999 111.737 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.645 HG22 ' HG3' ' A' ' 91' ' ' PRO . 61.5 t -83.52 -54.79 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.304 0.853 . . . . 1.48 113.304 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 35.5 ttt180 -62.66 -23.86 67.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.519 0.563 . . . . 3.8300000000000001 112.519 -167.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.437 ' CG ' ' HD2' ' A' ' 88' ' ' ARG . 16.7 p30 -55.41 -22.32 19.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.353 -0.385 . . . . 2.48 111.817 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.904 ' HA3' ' HG ' ' A' ' 83' ' ' LEU . . . -100.3 -96.75 2.19 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.456 -0.878 . . . . 1.6100000000000001 114.038 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.589 ' HB3' ' CH2' ' A' ' 81' ' ' TRP . 54.2 ttm -79.29 -27.44 42.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.844 0.683 . . . . 4.8300000000000001 112.844 -164.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 20.9 t70 -65.11 -21.93 66.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.948 0.404 . . . . 2.8300000000000001 111.482 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -79.46 -15.92 56.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.111 0.411 . . . . 4.1500000000000004 112.111 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.623 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -117.07 -17.25 5.88 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.351 -0.7 . . . . 1.04 111.351 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.562 ' O ' HD13 ' A' ' 141' ' ' LEU . 38.0 t-105 -55.4 -54.49 50.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 123.061 0.544 . . . . 2.7799999999999998 111.453 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.601 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 18.7 Cg_endo -60.22 -34.62 93.86 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.837 1.691 . . . . 0.68000000000000005 111.623 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.1 m -66.29 -49.96 65.3 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 121.733 0.777 . . . . 0.87 110.447 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 136' ' ' GLY . 59.1 mt -55.44 -54.58 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.018 -0.992 . . . . 0.71999999999999997 110.053 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 137' ' ' TRP . 7.0 mp -56.34 -26.86 53.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.25 0.833 . . . . 0.68999999999999995 113.25 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 28.4 mm-40 -69.14 -54.33 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.484 -0.561 . . . . 1.49 109.484 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . 37.3 t -70.16 -23.81 63.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 1.1499999999999999 110.745 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 64.6 t80 -58.35 -53.15 61.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.479 -0.782 . . . . 0.80000000000000004 109.489 174.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.93 -22.11 61.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.508 -0.769 . . . . 1.6299999999999999 110.508 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.12 -52.09 10.85 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.94 -0.573 . . . . 1.46 111.698 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.841 ' HG3' ' HE3' ' A' ' 30' ' ' TRP . 2.4 tmtt? -66.94 -39.78 87.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.508 -0.477 . . . . 1.74 109.962 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.778 HG21 HG13 ' A' ' 12' ' ' VAL . 22.6 mt -57.92 -35.27 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.303 0.573 . . . . 0.5 110.545 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.423 ' OD2' ' HE2' ' A' ' 154' ' ' LYS . 24.1 t0 -61.26 -35.49 77.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.638 -0.71 . . . . 0.84999999999999998 110.002 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 63.6 mt-10 -68.32 -26.75 65.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.39 0.614 . . . . 1.5 110.809 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 11.1 mm-40 -88.89 5.69 42.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.713 -0.676 . . . . 1.74 110.325 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.29 -78.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.171 -1.014 . . . . 1.3200000000000001 114.02 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.47 -45.69 10.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.114 0.483 . . . . 1.9199999999999999 111.652 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 31.5 ttpt -87.74 114.28 24.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.94 -0.573 . . . . 2.04 109.991 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.883 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.791 -0.623 . . . . 4.2199999999999998 109.719 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.697 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 19.7 p30 . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.801 -0.074 . . . . 1.6599999999999999 110.801 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.484 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -171.77 -51.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.334 0.494 . . . . 3.73 112.334 176.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.535 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.7 t70 -66.71 -61.85 4.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 112.042 0.386 . . . . 2.7799999999999998 112.042 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.04 -58.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.115 1.21 . . . . 1.6299999999999999 112.098 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.697 ' O ' ' HB2' ' A' ' 1' ' ' ASN . 47.0 p90 -154.8 143.63 20.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.566 . . . . 3.21 110.195 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.809 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 95.2 t -103.88 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.138 -1.06 . . . . 1.4399999999999999 108.138 164.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 58.8 ttp180 -101.04 134.86 43.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.427 0.632 . . . . 3.3700000000000001 111.939 -170.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.789 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -109.9 131.82 54.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.426 -0.953 . . . . 0.79000000000000004 108.426 167.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 50.0 m -135.52 110.35 8.73 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.584 -0.735 . . . . 1.28 110.35 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.3 t -121.46 135.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.824 -1.08 . . . . 1.27 111.032 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -100.95 115.71 31.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.38 0.61 . . . . 0.56999999999999995 109.546 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 148' ' ' ILE . 42.2 t -93.4 127.58 45.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.91000000000000003 111.264 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.953 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -86.91 12.82 10.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.168 -0.924 . . . . 0.97999999999999998 113.131 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.564 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.77 41.46 0.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.011 -0.675 . . . . 0.35999999999999999 112.474 -173.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 11.3 t70 73.32 161.89 0.25 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.252 1.025 . . . . 0.91000000000000003 113.69 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 1.108 ' HE ' ' HB2' ' A' ' 103' ' ' ALA . 8.0 ttp85 -63.45 -28.11 69.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.28 -1.327 . . . . 1.8799999999999999 112.422 -172.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 34.1 mttp -66.85 -40.91 88.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.95 -0.3 . . . . 3.0499999999999998 110.838 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -73.12 -34.86 66.38 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.866 -0.333 . . . . 1.1100000000000001 110.329 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.2 -51.56 67.61 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.131 -0.486 . . . . 0.32000000000000001 110.325 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 70.7 t80 -69.92 -40.54 75.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.38 110.887 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -55.8 -47.09 77.75 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.228 -0.442 . . . . 2.3900000000000001 109.854 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.512 ' N ' ' HG3' ' A' ' 21' ' ' LYS . 16.5 m -77.33 -45.4 26.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.411 -0.358 . . . . 0.68000000000000005 111.01 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 67.4 t80 -65.08 -28.96 69.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.774 0.287 . . . . 0.47999999999999998 111.774 -174.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.767 HD23 ' HE3' ' A' ' 48' ' ' LYS . 16.5 tp -115.46 -56.09 2.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.253 -0.579 . . . . 0.5 112.087 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 51.7 mt-10 -91.41 -3.43 56.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.423 . . . . 1.24 111.634 -172.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.669 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -114.91 25.34 10.15 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.693 -0.963 . . . . 0.82999999999999996 110.693 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.424 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.4 t80 -52.41 -49.37 85.84 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.308 0.484 . . . . 0.73999999999999999 112.308 -174.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 69.5 Cg_endo -81.37 4.3 7.11 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.154 1.903 . . . . 0.76000000000000001 115.142 -176.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -103.14 -1.94 28.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.914 -0.714 . . . . 1.49 111.675 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.804 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.5 m0 -72.29 154.18 41.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.546 0.689 . . . . 4.6200000000000001 111.067 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.593 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 47.5 m95 -83.47 -38.36 0.72 Allowed Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 114.968 -1.015 . . . . 2.7799999999999998 113.071 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 20.0 Cg_endo -59.41 -79.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 122.31 2.007 . . . . 1.3600000000000001 114.414 -165.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.686 ' ND2' HD22 ' A' ' 84' ' ' ASN . 57.3 t30 -106.85 -16.16 14.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.278 0.561 . . . . 1.51 109.864 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.696 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.8 m-20 -97.8 20.66 11.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.709 . . . . 1.79 111.612 -168.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -79.77 -29.8 40.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.449 . . . . 4.4500000000000002 111.492 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.459 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 33.3 mmt180 -90.92 142.97 27.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.538 0.57 . . . . 4.1399999999999997 112.538 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 39' ' ' LYS . 26.9 p -77.01 151.93 35.4 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 2.6800000000000002 111.02 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 57' ' ' ASP . 7.0 p 54.48 6.81 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.396 1.078 . . . . 1.4199999999999999 112.462 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 37' ' ' THR . 72.5 tttt -94.73 -135.45 0.2 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.207 -2.146 . . . . 2.8999999999999999 105.207 161.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 34' ' ' ASN . 17.1 m -93.0 20.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.423 0.63 . . . . 1.8300000000000001 110.71 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -132.54 39.86 1.69 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.68 -0.691 . . . . 2.1699999999999999 112.431 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.051 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -88.78 160.43 44.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.639 -0.874 . . . . 1.1200000000000001 108.639 171.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.6 -17.6 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 124.134 3.223 . . . . 1.48 116.14 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 45' ' ' GLY . 48.1 tp -97.42 -97.38 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.874 -0.516 . . . . 1.75 111.184 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.682 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 109.14 -55.97 0.48 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.67 -0.776 . . . . 0.75 112.722 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.615 HG11 HD11 ' A' ' 24' ' ' LEU . 94.2 t -139.9 139.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.078 0.466 . . . . 0.59999999999999998 111.582 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.703 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 19.4 t70 -105.68 102.71 12.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.422 -0.808 . . . . 1.1100000000000001 109.431 174.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.767 ' HE3' HD23 ' A' ' 24' ' ' LEU . 25.3 mtpt -80.52 -12.17 59.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 2.8100000000000001 111.82 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.46 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.6 ptpp? -83.86 -43.7 15.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.946 -0.302 . . . . 3.1699999999999999 111.214 -174.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.9 -32.9 5.71 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.909 -0.662 . . . . 1.53 111.793 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 102.67 58.4 0.76 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.563 -0.827 . . . . 0.77000000000000002 112.771 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -144.72 149.54 35.77 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.723 -0.281 . . . . 3.7200000000000002 110.532 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -100.33 115.27 29.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.258 -0.645 . . . . 1.28 109.258 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.703 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 6.8 p90 -160.97 149.1 15.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.469 . . . . 1.6599999999999999 110.118 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.051 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.3 mp0 -113.06 169.13 9.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.48 -0.563 . . . . 2.1200000000000001 109.48 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.457 HD12 ' HG2' ' A' ' 61' ' ' GLU . 32.8 mm -77.55 103.3 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.621 -0.511 . . . . 0.92000000000000004 109.621 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.802 ' HB3' HE22 ' A' ' 59' ' ' GLN . 8.1 t70 -101.75 159.52 15.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 1.97 110.267 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.019 1.118 . . . . 2.4300000000000002 114.019 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.802 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -86.31 8.16 22.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.102 -0.639 . . . . 2.3900000000000001 111.441 -175.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.4 62.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.245 -0.978 . . . . 2.29 113.693 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.457 ' HG2' HD12 ' A' ' 56' ' ' ILE . 41.1 mt-10 52.24 35.2 16.28 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.816 0.672 . . . . 2.3100000000000001 112.816 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -108.11 85.43 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.469 0.652 . . . . 2.6099999999999999 110.745 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.533 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -121.84 158.63 28.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 3.7200000000000002 110.05 175.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 3.2 t -134.58 115.41 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.334 -0.393 . . . . 2.27 110.405 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.807 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 37.6 t80 -131.4 -46.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 6.4800000000000004 111.329 174.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.543 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -157.29 156.6 27.39 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.38 -1.391 . . . . 1.23 113.949 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.466 HD22 ' HD2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -116.89 110.42 18.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.397 -0.594 . . . . 1.1699999999999999 109.397 177.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.543 HG21 ' CG2' ' A' ' 71' ' ' VAL . 35.5 mt -80.83 136.29 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 0.60999999999999999 111.228 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -101.94 -34.17 9.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.264 -0.88 . . . . 2.0 109.212 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -149.7 129.27 13.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.687 -0.688 . . . . 1.53 110.97 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 68' ' ' ILE . 44.1 t -112.87 93.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.75 -0.833 . . . . 0.88 108.75 172.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.78 70.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.544 -0.298 . . . . 1.4199999999999999 111.7 -172.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.643 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 47.27 -173.34 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 124.539 1.15 . . . . 0.95999999999999996 112.505 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.4 Cg_exo -61.48 82.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.406 1.404 . . . . 0.38 111.195 166.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.488 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 28.2 t70 -168.29 -68.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.606 . . . . 0.5 110.572 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.8 p -144.55 144.86 31.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.22 0.533 . . . . 0.34999999999999998 112.154 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -135.14 117.33 15.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.672 -0.694 . . . . 0.73999999999999999 109.29 177.312 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 t -93.47 105.66 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.42 -0.956 . . . . 0.67000000000000004 108.42 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.543 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -128.58 130.58 69.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.999 -0.546 . . . . 0.75 111.3 -169.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.791 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.44 153.11 20.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.301 -0.476 . . . . 0.5 112.082 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.685 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 65.0 t-105 -85.82 132.81 34.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 2.79 111.532 -172.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.583 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 6.8 ttt180 -137.56 28.68 2.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.687 -0.688 . . . . 5.46 109.644 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.807 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 19.0 tp 77.52 167.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.87 -1.059 . . . . 1.55 112.147 172.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.686 HD22 ' ND2' ' A' ' 33' ' ' ASN . 1.5 m-20 -82.67 5.29 21.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.711 -0.477 . . . . 1.9299999999999999 109.711 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.98 38.5 92.94 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.691 -0.686 . . . . 2.3999999999999999 113.049 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -137.95 91.56 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.946 0.403 . . . . 5.3799999999999999 112.018 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.6 2.35 21.25 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.628 -0.714 . . . . 2.2999999999999998 114.755 168.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.627 ' HB2' HD11 ' A' ' 83' ' ' LEU . 1.5 mmp_? -112.76 -176.27 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 117.239 0.519 . . . . 4.7699999999999996 110.266 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.402 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -101.78 136.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.111 -0.495 . . . . 1.8600000000000001 110.121 177.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 7.5 p-10 -97.88 140.09 21.71 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.916 0.389 . . . . 3.1800000000000002 110.403 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 36.9 Cg_exo -61.4 -46.02 16.32 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.833 2.355 . . . . 2.3599999999999999 111.856 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 73.05 -40.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.045 0.841 . . . . 2.9900000000000002 112.638 173.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.12 -36.37 58.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.839 0.681 . . . . 3.0600000000000001 112.839 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.5 p -165.79 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.743 -0.383 . . . . 1.8500000000000001 111.773 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.685 ' CB ' ' HB3' ' A' ' 81' ' ' TRP . 44.3 m 55.37 30.24 14.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.419 0.628 . . . . 1.4399999999999999 110.671 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.791 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.8 tt0 -62.71 124.32 20.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.855 -1.066 . . . . 1.8100000000000001 111.275 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.587 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 8.5 p90 -125.9 136.12 52.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.164 0.507 . . . . 0.64000000000000001 110.738 174.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 31.9 m -89.43 115.49 26.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.578 -0.737 . . . . 0.42999999999999999 110.266 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 113' ' ' VAL . 99.2 t -91.0 108.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.283 -0.636 . . . . 0.87 109.283 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.758 ' HA ' HG22 ' A' ' 76' ' ' THR . 15.6 m -106.77 104.96 14.77 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.105 -0.498 . . . . 0.45000000000000001 110.909 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.641 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.7 m-85 -82.64 102.6 11.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.34 -0.615 . . . . 0.34000000000000002 109.34 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -91.54 108.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.319 -0.623 . . . . 0.54000000000000004 109.319 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.108 ' HB2' ' HE ' ' A' ' 16' ' ' ARG . . . -57.4 124.45 18.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.44 109.967 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.766 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 12.7 t70 -109.15 103.3 12.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.969 -0.752 . . . . 2.0299999999999998 108.969 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.2 -106.53 1.91 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.854 -0.898 . . . . 1.97 110.854 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.871 HE21 ' HA ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -153.64 -9.25 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.337 . . . . 4.9299999999999997 110.969 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -119.99 -0.16 10.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 3.5299999999999998 110.722 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 11.6 mptt -127.39 159.98 32.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.969 -0.752 . . . . 2.4399999999999999 108.969 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.437 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 53.4 m -156.26 114.79 3.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.863 0.363 . . . . 0.41999999999999998 110.211 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -100.66 111.32 23.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.94 -0.763 . . . . 2.5899999999999999 108.94 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.641 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 10.9 p -85.9 138.04 19.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 0.40000000000000002 110.319 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -127.41 116.13 19.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.845 . . . . 1.3799999999999999 109.223 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 99' ' ' VAL . 4.1 t -108.37 130.84 60.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.983 -1.008 . . . . 0.91000000000000003 111.189 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.58 111.34 22.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.303 0.573 . . . . 2.3100000000000001 110.141 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.809 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 82.0 t60 -113.43 97.23 6.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.148 -0.933 . . . . 1.6399999999999999 108.864 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.564 ' OG1' ' HA ' ' A' ' 5' ' ' PHE . 34.8 m -145.55 94.71 2.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.967 0.413 . . . . 2.6699999999999999 111.344 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.632 ' O ' ' HG2' ' A' ' 121' ' ' MET . 15.6 t60 -167.16 -73.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.097 -0.501 . . . . 2.6299999999999999 110.212 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.427 ' CZ ' ' HD3' ' A' ' 128' ' ' ARG . 29.4 t80 -64.96 -47.53 77.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.53 -0.759 . . . . 3.54 112.137 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -37.25 67.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.543 0.687 . . . . 1.8100000000000001 110.35 -174.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -55.91 -20.88 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.754 -1.112 . . . . 3.3799999999999999 111.945 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.632 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.9 mmt -81.18 19.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.06 0.393 . . . . 2.4300000000000002 112.06 -171.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.68 163.31 11.24 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.015 -1.088 . . . . 1.6100000000000001 113.007 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.7 p -65.23 -22.51 66.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.593 -0.303 . . . . 2.5800000000000001 111.432 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -67.68 -52.69 35.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.681 0.277 . . . . 3.7999999999999998 110.745 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.761 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 33.4 m170 -60.98 -48.84 79.94 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.602 0.715 . . . . 2.1400000000000001 110.5 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.81 68.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.213 -0.903 . . . . 0.92000000000000004 111.037 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 130' ' ' ARG . 35.1 ttpt -75.84 -41.86 51.27 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.798 0.296 . . . . 2.8300000000000001 111.798 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.761 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.9 ptm180 -64.03 -30.58 71.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.915 -0.314 . . . . 2.5899999999999999 110.68 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.71 -32.13 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 120.423 -0.511 . . . . 1.48 110.593 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.555 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 21.9 tpp85 -61.77 -15.17 38.99 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.489 0.716 . . . . 3.8300000000000001 111.376 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 53.0 m-20 -52.04 -21.67 3.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.643 0.979 . . . . 2.48 113.643 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.07 -39.16 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 119.252 -1.452 . . . . 1.6100000000000001 114.053 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.644 ' HE3' ' HB2' ' A' ' 84' ' ' ASN . 12.9 mmt -74.24 -9.29 58.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 4.8300000000000001 111.285 -171.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 16.3 t70 -62.22 -22.75 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.635 -0.712 . . . . 2.8300000000000001 111.461 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.65 -30.7 12.32 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.886 -0.326 . . . . 4.1500000000000004 110.857 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.565 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -69.65 -50.21 32.22 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.092 -0.575 . . . . 1.04 112.491 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.6 t-105 -54.85 -52.19 72.74 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.186 0.439 . . . . 2.7799999999999998 112.186 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -60.25 -36.95 86.03 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.646 1.564 . . . . 0.68000000000000005 112.069 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.3 m -68.4 -35.52 77.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.514 0.673 . . . . 0.87 109.623 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.652 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 16.5 mt -58.54 -44.63 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.876 -1.057 . . . . 0.71999999999999997 110.578 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 8' ' ' HIS . 70.9 mt -63.74 -33.23 75.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.187 0.44 . . . . 0.68999999999999995 112.187 -175.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.53 -54.76 12.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.961 0.41 . . . . 1.49 110.314 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.63 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 48.9 m -65.87 -22.02 66.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 1.1499999999999999 111.144 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 23' ' ' PHE . 54.5 t80 -65.95 -53.45 38.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.308 0.575 . . . . 0.80000000000000004 109.559 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.815 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 45.1 mt-30 -61.64 -29.82 70.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.277 -0.874 . . . . 1.6299999999999999 110.25 176.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 143' ' ' SER . 31.9 t70 -73.95 -43.75 57.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.853 -1.067 . . . . 1.46 110.529 -175.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.462 ' HD3' ' NE1' ' A' ' 31' ' ' TRP . 28.1 tptp -65.79 -43.19 89.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.713 0.292 . . . . 1.74 110.584 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.814 HG21 HG13 ' A' ' 12' ' ' VAL . 57.5 mt -62.37 -40.14 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.5 111.368 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.953 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 28.5 t70 -65.53 -27.33 68.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.318 -0.401 . . . . 0.84999999999999998 110.872 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 50.7 mt-10 -64.5 -39.06 93.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.511 0.672 . . . . 1.5 109.537 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 10.7 mm-40 -74.73 -29.26 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.373 -1.285 . . . . 1.74 108.906 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -74.26 -74.94 0.81 Allowed Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 114.817 -1.083 . . . . 1.3200000000000001 112.345 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -164.35 23.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.76 0.652 . . . . 1.9199999999999999 112.76 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 32.0 ttmt -69.9 -75.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.369 -0.532 . . . . 2.04 110.601 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.812 -1.089 . . . . 4.2199999999999998 110.409 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 7' ' ' ARG . 25.3 p-10 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.883 0.373 . . . . 1.6599999999999999 110.457 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.617 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 32.1 p90 179.66 -32.84 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 3.73 109.713 -174.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.711 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.0 t70 -73.16 -55.0 4.02 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 111.959 0.355 . . . . 2.7799999999999998 111.959 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.5 Cg_endo -93.69 -62.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.172 1.914 . . . . 1.6299999999999999 112.998 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.433 ' CD2' HG21 ' A' ' 116' ' ' THR . 96.2 m-85 -144.31 118.88 9.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 3.21 110.421 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.039 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 97.3 t -85.05 125.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.9 -0.778 . . . . 1.4399999999999999 108.9 167.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 36.6 ttp85 -132.38 136.72 47.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.026 -0.534 . . . . 3.3700000000000001 109.787 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 1.112 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 3.2 t-160 -108.38 132.31 53.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.491 -0.929 . . . . 0.79000000000000004 108.491 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 13.4 m -136.17 118.91 16.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.251 0.548 . . . . 1.28 110.716 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 111' ' ' VAL . 2.7 t -137.31 134.19 46.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.158 -0.928 . . . . 1.27 111.086 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -101.8 114.98 29.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.435 0.636 . . . . 0.56999999999999995 109.808 173.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.819 HG13 HG21 ' A' ' 148' ' ' ILE . 38.5 t -95.57 136.27 27.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.296 -0.866 . . . . 0.91000000000000003 109.726 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 36.05 2.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.726 0.269 . . . . 0.97999999999999998 111.726 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.84 31.63 0.36 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.93 0.345 . . . . 0.35999999999999999 111.93 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.8 t70 75.22 164.06 0.27 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.861 0.838 . . . . 0.91000000000000003 112.732 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 14.6 ttp180 -66.47 -25.72 66.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.686 -1.143 . . . . 1.8799999999999999 111.544 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.055 -0.258 . . . . 3.0499999999999998 110.828 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -68.33 -35.14 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.995 -0.282 . . . . 1.1100000000000001 110.362 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.28 -48.98 75.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.32000000000000001 110.613 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.507 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 84.7 t80 -72.57 -50.6 24.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.38 111.207 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -52.35 -49.7 63.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.03 -0.532 . . . . 2.3900000000000001 111.158 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 m -67.56 -51.09 54.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.982 -0.554 . . . . 0.68000000000000005 110.792 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 73.6 t80 -58.93 -40.48 84.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.349 0.5 . . . . 0.47999999999999998 112.349 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -104.46 -50.39 3.33 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.271 -0.572 . . . . 0.5 112.31 -172.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.809 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 53.9 mt-10 -86.24 -6.94 58.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.76 0.314 . . . . 1.24 111.631 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.642 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -117.15 30.1 6.45 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.374 -0.917 . . . . 0.82999999999999996 112.525 -176.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -49.31 -53.84 35.73 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.006 0.373 . . . . 0.73999999999999999 112.006 -172.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 24.9 Cg_endo -90.57 21.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.921 1.747 . . . . 0.76000000000000001 114.644 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.6 pt-20 -113.64 -15.88 12.43 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.562 -0.855 . . . . 1.49 113.045 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -79.61 -176.64 5.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.944 -0.702 . . . . 4.6200000000000001 109.617 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.511 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 10.2 p-90 -115.32 16.9 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 115.36 1.615 . . . . 2.7799999999999998 115.36 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 30' ' ' TRP . 57.8 Cg_endo -85.03 -134.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 121.984 1.744 . . . . 1.3600000000000001 113.136 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.487 ' ND2' HD21 ' A' ' 84' ' ' ASN . 9.7 t30 -67.18 -25.7 66.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 1.51 111.047 -175.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.659 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -85.94 18.72 2.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.469 -0.787 . . . . 1.79 110.997 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -82.69 -4.13 57.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.5 0.667 . . . . 4.4500000000000002 109.421 174.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -106.62 164.24 12.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.735 . . . . 4.1399999999999997 110.199 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 42' ' ' ALA . 1.1 p -98.28 147.29 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.538 -0.301 . . . . 2.6800000000000002 111.272 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.7 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 19.8 p 54.44 25.0 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.799 0.839 . . . . 1.4199999999999999 111.941 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' O ' HG13 ' A' ' 40' ' ' VAL . 20.4 mtmt -111.21 -50.54 2.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.708 -1.133 . . . . 2.8999999999999999 109.146 165.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -177.5 28.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 124.424 1.078 . . . . 1.8300000000000001 110.256 175.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.06 29.96 0.59 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.843 -1.17 . . . . 2.1699999999999999 114.253 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.845 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.64 170.46 16.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 117.282 0.541 . . . . 1.1200000000000001 109.617 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.686 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 28.0 Cg_endo -63.26 72.28 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.475 2.116 . . . . 1.48 112.753 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 tp -169.19 -90.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.474 -0.785 . . . . 1.75 109.687 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.38 -88.9 0.53 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.334 -0.936 . . . . 0.75 112.46 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 53' ' ' TRP . 57.5 t -139.91 139.89 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.738 0.304 . . . . 0.59999999999999998 111.114 -172.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.53 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.742 -0.836 . . . . 1.1100000000000001 108.742 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.809 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 40.3 mtpt -78.93 -18.76 53.27 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.956 0.725 . . . . 2.8100000000000001 112.956 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -89.2 -45.2 9.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.839 -0.344 . . . . 3.1699999999999999 110.962 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.39 -38.4 21.57 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.273 -0.731 . . . . 1.53 111.273 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.92 58.31 1.04 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.915 -0.66 . . . . 0.77000000000000002 112.205 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -159.29 141.07 13.34 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.752 -0.379 . . . . 3.7200000000000002 110.404 177.058 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.956 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -100.97 135.48 42.36 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.597 -0.441 . . . . 1.28 110.654 177.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 0.8 OUTLIER -163.02 -179.36 6.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.673 0.608 . . . . 1.6599999999999999 110.528 179.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 39.9 mt-10 -132.35 177.64 7.43 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 116.639 -0.255 . . . . 2.1200000000000001 111.136 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 mm -102.41 102.83 14.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.414 -0.587 . . . . 0.92000000000000004 109.414 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.7 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-20 -70.27 135.48 48.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.873 0.694 . . . . 1.97 112.873 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.27 -26.57 67.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.854 -1.067 . . . . 2.4300000000000002 111.151 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.636 HE21 ' HB3' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -82.8 -7.23 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 2.3900000000000001 111.447 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.92 72.24 0.63 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.554 -0.832 . . . . 2.29 112.598 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 37.6 77.22 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.408 1.262 . . . . 2.3100000000000001 114.408 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.487 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 18.7 mm-40 -129.18 73.16 1.5 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.6099999999999999 109.929 170.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 1.3 p80 -110.54 157.81 19.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.766 -1.106 . . . . 3.7200000000000002 111.502 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.794 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 37.6 p -83.66 151.96 25.02 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.726 -0.842 . . . . 2.27 108.726 169.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.5 p90 -108.78 111.72 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.228 -0.589 . . . . 6.4800000000000004 110.51 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.718 ' HA3' ' CE2' ' A' ' 53' ' ' TRP . . . -63.36 129.64 40.3 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.047 -0.821 . . . . 1.23 111.047 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 82' ' ' ARG . 4.4 mp -78.74 87.57 4.63 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.824 -0.35 . . . . 1.1699999999999999 110.918 -170.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 71' ' ' VAL . 13.7 mt -92.1 115.35 30.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.001 -1.08 . . . . 0.60999999999999999 109.321 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -104.82 -12.58 16.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.596 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 19.5 ttmm -151.82 107.38 3.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 1.53 111.332 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 68' ' ' ILE . 2.5 m -103.14 85.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.88 108.568 167.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.19 72.82 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 1.4199999999999999 111.08 -172.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.594 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 46.96 -171.88 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 124.684 1.24 . . . . 0.95999999999999996 112.288 175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.3 Cg_exo -64.04 76.05 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.518 1.479 . . . . 0.38 111.411 166.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -159.61 -65.63 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.649 -0.705 . . . . 0.5 110.673 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.8 p -144.96 143.08 30.34 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.427 0.529 . . . . 0.34999999999999998 112.427 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.65 120.15 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 109.668 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 59.0 t -105.73 103.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.474 -0.565 . . . . 0.67000000000000004 109.474 175.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.766 HG13 ' HE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -129.39 135.07 62.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.973 -0.558 . . . . 0.75 111.701 -174.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.793 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.16 147.67 18.69 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.065 -0.814 . . . . 0.5 111.065 174.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.685 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . 52.8 t-105 -78.96 135.65 37.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.237 0.541 . . . . 2.79 111.964 -168.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.794 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.9 tpt180 -130.76 25.93 5.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.423 -0.808 . . . . 5.46 109.641 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.824 HD11 ' HB2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER 81.25 134.78 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.845 -1.07 . . . . 1.55 112.233 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.536 ' HB3' ' SD ' ' A' ' 133' ' ' MET . 5.1 t30 -108.53 109.67 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.023 -0.99 . . . . 1.9299999999999999 109.786 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.07 -24.52 8.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.583 -0.818 . . . . 2.3999999999999999 111.327 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.437 ' H ' HD12 ' A' ' 83' ' ' LEU . 3.3 m-30 74.74 -25.71 0.2 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.589 0.756 . . . . 5.3799999999999999 112.706 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.61 19.11 38.57 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.828 -0.701 . . . . 2.2999999999999998 113.247 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.824 ' HB2' HD11 ' A' ' 83' ' ' LEU . 41.9 mmt180 -124.88 173.66 8.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.622 -0.51 . . . . 4.7699999999999996 109.622 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -74.55 132.12 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.786 0.327 . . . . 1.8600000000000001 110.73 178.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 10.3 p-10 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 3.1800000000000002 110.495 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.685 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 52.7 Cg_exo -58.25 -37.63 94.47 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.267 2.644 . . . . 2.3599999999999999 112.597 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER 78.35 -39.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.87 0.731 . . . . 2.9900000000000002 112.39 169.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -120.06 -30.3 4.71 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.034 0.383 . . . . 3.0600000000000001 112.034 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.45 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 48.9 m -138.95 -140.89 0.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.926 -0.31 . . . . 1.8500000000000001 111.832 -175.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 67.7 m 65.75 24.02 11.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.496 -0.775 . . . . 1.4399999999999999 109.427 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.793 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.7 tt0 -67.28 136.48 54.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.812 -1.085 . . . . 1.8100000000000001 110.442 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.636 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 13.9 p90 -137.62 138.03 39.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.273 0.559 . . . . 0.64000000000000001 110.84 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.575 HG23 HG22 ' A' ' 78' ' ' VAL . 34.1 m -100.26 109.76 21.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.244 -0.889 . . . . 0.42999999999999999 109.663 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.442 HG12 HG22 ' A' ' 113' ' ' VAL . 1.6 m -87.64 121.6 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 119.591 -0.844 . . . . 0.87 109.122 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.512 ' HA ' HG22 ' A' ' 76' ' ' THR . 27.2 m -102.64 106.84 17.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.345 -0.843 . . . . 0.45000000000000001 110.339 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.498 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.9 m-85 -82.37 109.82 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.655 -0.498 . . . . 0.34000000000000002 109.655 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.16 112.52 27.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.572 -0.529 . . . . 0.54000000000000004 109.572 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 124.38 23.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.44 110.568 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.3 t0 -105.69 103.4 12.9 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.425 -0.954 . . . . 2.0299999999999998 108.425 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.27 -111.11 3.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.537 -0.84 . . . . 1.97 111.562 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -147.95 -3.93 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.638 0.256 . . . . 4.9299999999999997 111.255 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -136.51 8.23 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.288 . . . . 3.5299999999999998 111.342 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.797 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 36.1 ttmt -126.78 158.15 37.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.999 -0.741 . . . . 2.4399999999999999 108.999 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.6 m -156.01 130.65 9.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.008 0.433 . . . . 0.41999999999999998 111.096 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -109.37 112.91 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.82 -0.627 . . . . 2.5899999999999999 109.741 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 10' ' ' VAL . 8.7 p -90.95 141.77 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.865 -0.334 . . . . 0.40000000000000002 110.63 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.7 t70 -135.01 105.72 6.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.354 -0.839 . . . . 1.3799999999999999 109.857 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.112 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 9.5 t -86.3 131.57 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.91000000000000003 111.941 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.82 124.03 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.842 0.714 . . . . 2.3100000000000001 109.504 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 1.039 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 7.7 t-160 -142.23 102.72 4.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.526 -0.546 . . . . 1.6399999999999999 109.526 -175.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.433 HG21 ' CD2' ' A' ' 5' ' ' PHE . 8.6 p -149.84 40.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.345 0.498 . . . . 2.6699999999999999 112.345 -174.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.548 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.1 t-160 -113.37 -65.05 1.22 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.999 -0.68 . . . . 2.6299999999999999 111.405 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.524 ' HB2' ' H ' ' A' ' 95' ' ' SER . 11.6 t80 -86.18 -49.67 7.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.896 0.379 . . . . 3.54 110.444 -175.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.84 -51.71 68.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.478 -0.783 . . . . 1.8100000000000001 111.025 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 120' ' ' ARG . 5.8 tmm_? -60.89 -19.43 60.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.779 -1.1 . . . . 3.3799999999999999 111.125 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.548 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 42.3 tpp -80.97 23.07 0.58 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.864 0.364 . . . . 2.4300000000000002 111.879 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.2 170.42 12.86 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.752 -1.214 . . . . 1.6100000000000001 114.333 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 t -66.8 -44.48 81.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.894 -0.653 . . . . 2.5800000000000001 111.676 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 124' ' ' LYS . 16.4 tptm -66.13 -39.09 89.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.574 0.226 . . . . 3.7999999999999998 110.726 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.669 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 10.1 m-70 -61.03 -52.85 63.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 2.1400000000000001 110.486 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -64.73 -35.95 82.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.92000000000000004 111.025 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -64.03 -46.45 84.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 2.8300000000000001 111.405 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 8.3 ptm180 -64.93 -39.57 93.72 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.439 -0.346 . . . . 2.5899999999999999 111.305 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 125' ' ' HIS . 2.8 p -81.33 -17.83 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.315 0.579 . . . . 1.48 110.987 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 61.7 ttt180 -68.74 -9.73 52.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.155 -0.341 . . . . 3.8300000000000001 111.43 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.711 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.3 p30 -47.12 -40.06 14.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.561 0.578 . . . . 2.48 112.561 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -145.52 -11.24 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.072 -1.061 . . . . 1.6100000000000001 113.381 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 84' ' ' ASN . 22.6 mmt -79.43 -11.68 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.342 -0.505 . . . . 4.8300000000000001 110.277 -172.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.66 -39.67 92.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.507 -0.769 . . . . 2.8300000000000001 110.961 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -104.8 14.07 30.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 4.1500000000000004 110.552 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -77.57 -78.18 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.925 -0.579 . . . . 1.04 111.828 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 13.6 m95 -55.62 -47.92 97.6 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 113.58 0.956 . . . . 2.7799999999999998 113.58 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.9 Cg_endo -50.93 -43.64 46.25 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.839 1.693 . . . . 0.68000000000000005 112.213 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.1 m -73.22 -45.72 54.54 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.432 0.634 . . . . 0.87 110.639 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.627 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 56.5 mt -58.38 -44.99 89.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 115.371 -0.831 . . . . 0.71999999999999997 111.361 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 51.2 mt -59.86 -38.81 83.21 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.278 0.361 . . . . 0.68999999999999995 111.054 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.1 mm-40 -61.5 -50.93 70.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.544 -0.462 . . . . 1.49 109.854 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 51.0 m -65.58 -28.4 69.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.604 -0.725 . . . . 1.1499999999999999 110.817 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 60.0 t80 -68.27 -55.3 12.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.80000000000000004 111.135 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -35.1 73.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.855 0.36 . . . . 1.6299999999999999 111.076 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.26 -40.96 62.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.916 -0.584 . . . . 1.46 110.673 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.43 ' HE3' ' HG3' ' A' ' 29' ' ' GLU . 29.7 tptp -60.62 -38.52 85.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.361 0.601 . . . . 1.74 109.902 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.819 HG21 HG13 ' A' ' 12' ' ' VAL . 52.2 mt -74.45 -26.82 20.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.497 -0.774 . . . . 0.5 111.082 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.4 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.0 t70 -64.84 -31.22 72.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.477 -0.564 . . . . 0.84999999999999998 109.477 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.843 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 37.5 mt-10 -66.28 -33.09 74.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 1.5 109.74 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -71.86 -23.46 61.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.081 -0.963 . . . . 1.74 109.646 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -98.89 -88.7 1.95 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.3200000000000001 112.951 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.8 30.58 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.314 0.487 . . . . 1.9199999999999999 112.314 -171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.843 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 16.9 tppt? -68.42 -19.63 64.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.491 0.662 . . . . 2.04 110.361 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 11.2 ptpt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.171 -0.922 . . . . 4.2199999999999998 111.243 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.97 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.7 p-10 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.934 -0.395 . . . . 1.6599999999999999 109.934 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.548 ' HA ' HG12 ' A' ' 6' ' ' VAL . 5.2 p90 69.87 -40.78 0.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.413 1.485 . . . . 3.73 112.684 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.796 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 18.8 t70 -67.06 -54.58 19.47 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.216 -0.29 . . . . 2.7799999999999998 110.216 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 32.6 Cg_endo -87.89 -64.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.66 1.573 . . . . 1.6299999999999999 111.323 169.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.32 152.27 31.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.257 -1.016 . . . . 3.21 108.257 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.97 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -109.58 126.2 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.094 0.473 . . . . 1.4399999999999999 109.98 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 20.6 ttp85 -130.99 135.17 47.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 3.3700000000000001 110.453 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.585 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.79 132.42 54.17 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.567 -0.531 . . . . 0.79000000000000004 109.567 176.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.9 p -135.44 116.27 14.05 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.883 -0.599 . . . . 1.28 110.887 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 111' ' ' VAL . 15.5 m -125.02 156.06 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.845 -0.616 . . . . 1.27 110.869 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.7 m -109.82 116.83 32.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.536 -0.756 . . . . 0.56999999999999995 109.93 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.921 HG13 HG21 ' A' ' 148' ' ' ILE . 37.1 t -93.79 138.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.273 -0.876 . . . . 0.91000000000000003 110.77 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -96.8 7.76 45.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.97999999999999998 112.256 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.03 47.09 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.533 -0.467 . . . . 0.35999999999999999 112.233 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.5 t70 75.07 163.17 0.26 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.075 0.941 . . . . 0.91000000000000003 112.973 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.571 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 27.9 ttp180 -62.34 -25.62 67.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.387 -1.279 . . . . 1.8799999999999999 110.783 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 17' ' ' LYS . 33.8 ttpt -57.65 -49.47 76.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.451 -0.795 . . . . 3.0499999999999998 110.988 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.4 p -75.43 -31.93 60.51 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.808 -0.357 . . . . 1.1100000000000001 110.935 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.836 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -60.98 -46.75 89.48 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.755 -0.378 . . . . 0.32000000000000001 110.637 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 73.4 t80 -67.14 -42.32 84.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.38 110.657 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.917 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 19.8 tptm -56.12 -52.8 63.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.211 -0.45 . . . . 2.3900000000000001 110.518 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.603 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 18.7 m -72.01 -22.58 61.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.952 -0.567 . . . . 0.68000000000000005 111.553 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -88.99 -36.93 15.56 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.182 -0.324 . . . . 0.47999999999999998 111.558 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -119.82 -48.88 2.35 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 113.245 0.832 . . . . 0.5 113.245 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.917 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 20.5 mt-10 -75.08 -29.21 60.58 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.808 0.813 . . . . 1.24 110.354 -171.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.86 99.15 0.7 Allowed Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 108.244 -1.942 . . . . 0.82999999999999996 108.244 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.632 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.6 t80 -96.17 -56.64 0.2 Allowed Pre-proline 0 C--N 1.294 -1.83 0 CA-C-N 115.704 -0.248 . . . . 0.73999999999999999 111.58 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.675 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 40.9 Cg_endo -103.43 39.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.095 2.53 . . . . 0.76000000000000001 114.493 -172.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.81 -2.86 5.28 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.905 -0.718 . . . . 1.49 112.894 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.778 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 17.0 m95 -90.6 -155.87 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 4.6200000000000001 110.748 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 10.6 m95 -110.91 6.15 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.929 1.455 . . . . 2.7799999999999998 114.929 -172.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.999 ' HB2' HD12 ' A' ' 140' ' ' ILE . 74.4 Cg_endo -88.32 -140.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.533 0 CA-C-N 122.108 1.788 . . . . 1.3600000000000001 112.344 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HB3' HD11 ' A' ' 140' ' ' ILE . 62.7 t30 -67.69 -20.42 65.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.848 0.832 . . . . 1.51 110.004 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.865 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.2 m-20 -77.05 19.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.567 -1.197 . . . . 1.79 111.675 -171.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.28 -3.85 19.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.937 0.399 . . . . 4.4500000000000002 110.696 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.87 142.76 27.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.414 . . . . 4.1399999999999997 110.89 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.6 m -76.83 138.63 39.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 2.6800000000000002 111.298 -172.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 46.2 p 57.06 8.16 0.5 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.731 1.212 . . . . 1.4199999999999999 113.32 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.857 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 32.4 ttmt -91.48 -73.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.98 -0.748 . . . . 2.8999999999999999 108.98 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.865 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.7 m -147.08 18.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.404 -0.816 . . . . 1.8300000000000001 109.142 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -140.38 51.02 0.74 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.424 -0.807 . . . . 2.1699999999999999 113.3 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.089 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -94.25 172.8 5.25 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.634 -0.876 . . . . 1.1200000000000001 108.634 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 32.7 Cg_endo -65.01 62.44 0.3 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.659 2.24 . . . . 1.48 113.475 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 42.3 tp -170.51 -91.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 1.75 110.268 175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 27' ' ' PHE . . . 94.76 -63.62 1.54 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.811 -0.709 . . . . 0.75 112.791 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 27' ' ' PHE . 77.1 t -137.87 139.23 43.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.977 -0.379 . . . . 0.59999999999999998 109.977 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.678 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 24.6 t70 -105.43 118.33 36.28 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.054 -0.721 . . . . 1.1100000000000001 109.054 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -80.06 -35.5 36.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.613 -0.721 . . . . 2.8100000000000001 111.622 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.41 -38.88 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.711 0.263 . . . . 3.1699999999999999 111.711 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.49 -36.29 6.24 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.765 -0.731 . . . . 1.53 112.118 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 93.33 65.65 1.07 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.664 -0.779 . . . . 0.77000000000000002 112.155 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' CD2' ' A' ' 54' ' ' TYR . 11.9 ptt180 -159.34 148.06 18.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.647 -0.421 . . . . 3.7200000000000002 111.574 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.8 m0 -95.38 108.53 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.28 110.203 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.678 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -158.57 162.48 37.38 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.993 0.425 . . . . 1.6599999999999999 110.305 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.089 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 11.6 mp0 -122.26 165.74 15.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.122 -0.695 . . . . 2.1200000000000001 109.122 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.593 HG23 ' HG2' ' A' ' 61' ' ' GLU . 47.9 mm -77.37 102.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.937 -0.764 . . . . 0.92000000000000004 108.937 175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -76.79 144.1 39.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 1.97 110.679 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.11 -27.73 69.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.138 -0.937 . . . . 2.4300000000000002 111.918 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -74.91 -22.83 58.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.51 -0.314 . . . . 2.3900000000000001 111.285 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.11 50.18 0.03 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.004 -1.093 . . . . 2.29 113.919 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.593 ' HG2' HG23 ' A' ' 56' ' ' ILE . 44.9 mt-10 63.02 16.34 9.2 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.368 0.877 . . . . 2.3100000000000001 113.368 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 10.1 tp10 -105.34 82.39 1.82 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.638 0.732 . . . . 2.6099999999999999 110.389 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -111.08 148.48 32.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.095 -0.957 . . . . 3.7200000000000002 110.728 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.706 HG23 ' HD3' ' A' ' 82' ' ' ARG . 3.3 t -54.69 140.76 34.63 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.451 -0.944 . . . . 2.27 108.451 167.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.8 p90 -129.89 143.99 51.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.472 0.653 . . . . 6.4800000000000004 112.394 -169.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 128.22 8.44 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.55 -1.02 . . . . 1.23 110.55 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.8 mp -85.87 89.23 7.71 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 111.438 0.162 . . . . 1.1699999999999999 111.438 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.963 HG21 HG13 ' A' ' 71' ' ' VAL . 58.4 mt -80.62 116.16 24.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 120.014 -0.674 . . . . 0.60999999999999999 110.024 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 67' ' ' LEU . 4.9 mpt_? -98.59 -25.24 14.8 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.713 -0.477 . . . . 2.0 109.713 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HD3' ' HB2' ' A' ' 72' ' ' ASP . 18.0 ttmm -139.52 121.56 15.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.1 -0.5 . . . . 1.53 111.774 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.963 HG13 HG21 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -111.79 85.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.665 -0.865 . . . . 0.88 108.665 167.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -96.45 70.74 2.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.16 -0.473 . . . . 1.4199999999999999 110.69 -170.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 8.2 pt-20 49.43 -172.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 O-C-N 124.523 1.139 . . . . 0.95999999999999996 111.188 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 35.7 Cg_exo -63.48 77.33 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.294 1.329 . . . . 0.38 111.058 163.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.6 t70 -159.72 -68.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.5 110.549 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.2 p -139.42 143.05 37.45 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.559 0.577 . . . . 0.34999999999999998 112.559 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.94 117.41 16.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.864 -0.607 . . . . 0.73999999999999999 109.597 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 98' ' ' THR . 41.2 t -104.35 103.18 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.719 -0.475 . . . . 0.67000000000000004 109.719 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.579 HG12 ' N ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -129.5 142.68 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.79 -0.641 . . . . 0.75 112.139 -175.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.579 ' N ' HG12 ' A' ' 79' ' ' ILE . . . -86.5 158.06 30.76 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.56 -0.745 . . . . 0.5 111.523 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.422 ' H ' ' HB2' ' A' ' 95' ' ' SER . 70.9 t-105 -78.78 155.09 29.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.954 0.724 . . . . 2.79 112.954 -170.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.706 ' HD3' HG23 ' A' ' 64' ' ' THR . 0.0 OUTLIER -125.43 -78.34 0.6 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.822 -1.081 . . . . 5.46 110.747 -176.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.639 HD21 ' HG2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 172.0 146.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.971 -1.122 . . . . 1.55 107.971 -176.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.632 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 10.1 t30 -117.88 -62.96 1.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.399 0.518 . . . . 1.9299999999999999 112.399 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.69 -10.6 83.15 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.792 -0.718 . . . . 2.3999999999999999 114.466 -169.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.857 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 19.6 t80 64.95 14.58 9.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.73 0.776 . . . . 5.3799999999999999 110.604 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 34.06 2.44 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.209 -1.156 . . . . 2.2999999999999998 110.209 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.639 ' HG2' HD21 ' A' ' 83' ' ' LEU . 2.6 ttp180 -137.41 162.21 34.24 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.889 -0.655 . . . . 4.7699999999999996 110.878 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.575 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -109.06 127.09 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.509 -0.552 . . . . 1.8600000000000001 109.509 175.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.628 ' HB2' HD23 ' A' ' 83' ' ' LEU . 6.1 m-20 -144.07 149.96 47.39 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.778 -0.647 . . . . 3.1800000000000002 109.657 171.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 16.0 Cg_exo -69.29 -12.95 34.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.192 2.595 . . . . 2.3599999999999999 114.322 -171.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.6 t70 60.88 33.58 19.88 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.459 0.647 . . . . 2.9900000000000002 109.975 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' HA ' HD21 ' A' ' 67' ' ' LEU . 11.6 m-80 -141.87 -80.68 0.23 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.618 . . . . 3.0600000000000001 112.603 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.2 m -78.41 -125.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.401 0.519 . . . . 1.8500000000000001 112.401 -170.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.645 ' HB3' ' HE1' ' A' ' 115' ' ' HIS . 16.2 m 70.85 -75.29 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.733 -0.667 . . . . 1.4399999999999999 110.994 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 60.4 116.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.144 0.794 . . . . 1.8100000000000001 113.144 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HB3' ' CG ' ' A' ' 115' ' ' HIS . 18.6 p90 -132.15 129.39 39.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.14 0.495 . . . . 0.64000000000000001 110.985 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.502 HG23 HG22 ' A' ' 78' ' ' VAL . 47.8 m -89.98 107.35 19.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.23 -0.896 . . . . 0.42999999999999999 109.758 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.754 ' HA ' HG22 ' A' ' 113' ' ' VAL . 98.3 t -81.84 109.73 16.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.866 -0.606 . . . . 0.87 109.961 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.474 ' HA ' HG22 ' A' ' 76' ' ' THR . 27.5 m -105.9 105.95 16.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.835 0.35 . . . . 0.45000000000000001 110.981 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.612 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 49.7 m-85 -86.0 110.97 19.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.75 -0.463 . . . . 0.34000000000000002 109.75 175.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.2 t -91.87 109.35 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.312 -0.625 . . . . 0.54000000000000004 109.312 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.65 132.62 42.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.46 0.648 . . . . 0.44 111.908 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -108.0 123.16 48.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.402 -0.962 . . . . 2.0299999999999998 108.402 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.93 -25.48 37.89 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.623 0.609 . . . . 1.97 114.623 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -85.12 39.5 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.453 0.626 . . . . 4.9299999999999997 110.909 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 42.2 mmtt 58.53 46.74 14.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.996 0.903 . . . . 3.5299999999999998 110.241 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.9 tttm -135.6 155.39 50.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.224 -1.353 . . . . 2.4399999999999999 107.853 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 48.3 m -155.13 119.46 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 121.873 -0.517 . . . . 0.41999999999999998 111.646 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -95.78 112.71 24.37 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.512 -0.767 . . . . 2.5899999999999999 109.705 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.762 HG12 HG22 ' A' ' 10' ' ' VAL . 14.6 p -88.7 136.89 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 C-N-CA 120.119 -0.633 . . . . 0.40000000000000002 109.822 175.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.432 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 7.4 t70 -126.28 108.35 11.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.426 1.079 . . . . 1.3799999999999999 108.607 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 99' ' ' VAL . 10.1 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.622 -0.717 . . . . 0.91000000000000003 111.425 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -96.69 111.49 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.632 0.583 . . . . 2.3100000000000001 109.495 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.645 ' HE1' ' HB3' ' A' ' 95' ' ' SER . 6.1 t60 -123.13 118.02 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.482 -0.562 . . . . 1.6399999999999999 109.482 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.82 HG23 ' HD2' ' A' ' 120' ' ' ARG . 85.0 m -158.78 103.68 1.72 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.124 -0.23 . . . . 2.6699999999999999 111.6 -174.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.98 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.865 0.364 . . . . 2.6299999999999999 111.099 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.483 ' HZ ' ' HD3' ' A' ' 128' ' ' ARG . 50.4 t80 -78.24 -50.36 12.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.092 -0.503 . . . . 3.54 112.139 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -69.67 -38.42 77.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.411 0.624 . . . . 1.8100000000000001 110.041 -174.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.82 ' HD2' HG23 ' A' ' 116' ' ' THR . 20.0 ttt180 -63.6 -20.21 65.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.803 -1.09 . . . . 3.3799999999999999 111.573 -177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 31.0 tpp -80.11 29.87 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.099 0.777 . . . . 2.4300000000000002 113.099 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 118.76 177.42 16.71 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.637 -1.268 . . . . 1.6100000000000001 114.547 168.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -55.88 -60.55 3.3 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.812 -0.694 . . . . 2.5800000000000001 112.745 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.9 -35.54 81.48 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 121.057 -0.257 . . . . 3.7999999999999998 111.306 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.545 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 24.4 m80 -59.51 -50.93 72.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.973 0.416 . . . . 2.1400000000000001 110.165 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.46 63.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 0.92000000000000004 111.118 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 89.0 tttt -69.38 -38.96 78.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.099 -0.5 . . . . 2.8300000000000001 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.42 -31.64 65.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 2.5899999999999999 109.686 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.612 HG12 ' HG2' ' A' ' 133' ' ' MET . 87.0 t -61.63 -49.72 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.912 0.387 . . . . 1.48 111.15 171.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.693 ' HA ' ' HG3' ' A' ' 133' ' ' MET . 0.0 OUTLIER -65.87 -14.54 61.66 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 122.162 -0.336 . . . . 3.8300000000000001 111.443 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -52.51 -28.58 21.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.628 0.371 . . . . 2.48 111.843 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.411 ' H ' ' HD3' ' A' ' 88' ' ' ARG . . . -157.76 15.58 0.3 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.99 -1.1 . . . . 1.6100000000000001 113.857 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.693 ' HG3' ' HA ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -84.22 -26.87 28.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.899 0.85 . . . . 4.8300000000000001 111.438 176.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.56 -34.16 77.28 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.962 0.727 . . . . 2.8300000000000001 112.962 -164.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -106.38 18.13 22.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.011 0.434 . . . . 4.1500000000000004 110.579 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 140' ' ' ILE . . . -122.47 -77.34 0.4 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.04 -1.076 . . . . 1.04 112.871 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.474 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 76.0 t-105 -54.33 -51.91 73.8 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.716 0.636 . . . . 2.7799999999999998 112.716 -169.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -59.8 -33.29 96.23 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.809 1.673 . . . . 0.68000000000000005 111.94 176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -76.56 -33.49 58.52 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.717 -0.674 . . . . 0.87 110.304 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.999 HD12 ' HB2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -55.07 -48.16 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 108.596 -0.89 . . . . 0.71999999999999997 108.596 173.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.0 mt -60.42 -28.36 68.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.261 -0.881 . . . . 0.68999999999999995 112.002 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 26.4 mm-40 -72.13 -57.4 4.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.154 -0.313 . . . . 1.49 110.154 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.6 m -67.6 -25.93 66.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.12 0.486 . . . . 1.1499999999999999 110.522 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.431 ' CE2' HG21 ' A' ' 10' ' ' VAL . 62.0 t80 -57.8 -55.29 36.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.422 -0.808 . . . . 0.80000000000000004 109.956 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.509 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 43.7 mt-30 -68.7 -24.63 64.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.763 -0.653 . . . . 1.6299999999999999 110.939 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.25 -45.39 40.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.574 -0.285 . . . . 1.46 111.593 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.778 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 15.2 tptm -70.23 -31.36 68.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 119.631 -0.828 . . . . 1.74 110.263 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.921 HG21 HG13 ' A' ' 12' ' ' VAL . 49.9 mt -63.43 -37.36 79.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.484 0.659 . . . . 0.5 109.635 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.482 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 11.5 t70 -59.33 -36.97 76.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.174 -0.921 . . . . 0.84999999999999998 109.494 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 3.9 mm-40 -63.72 -41.04 98.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.507 -0.77 . . . . 1.5 110.673 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 5.7 mm-40 -75.96 -16.01 60.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.899 -1.046 . . . . 1.74 109.839 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -102.0 -75.88 1.14 Allowed Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.409 -0.814 . . . . 1.3200000000000001 113.235 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.19 13.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.28 0.845 . . . . 1.9199999999999999 113.28 -169.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 21.9 ttmm -71.47 -39.66 70.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 2.04 109.164 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HB3' ' NZ ' ' A' ' 155' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.475 -0.784 . . . . 4.2199999999999998 110.031 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.643 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 3.5 p-10 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.548 0.214 . . . . 1.6599999999999999 110.989 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.498 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 54.8 p90 169.96 -30.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.567 0.747 . . . . 3.73 109.62 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.835 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 31.6 t70 -65.87 -54.26 29.51 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 2.7799999999999998 110.927 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.835 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -91.23 -68.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.133 1.889 . . . . 1.6299999999999999 111.176 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 12.0 p90 -153.69 159.26 41.96 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.061 -0.518 . . . . 3.21 109.652 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.931 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 79.0 t -97.49 128.63 48.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.965 -0.754 . . . . 1.4399999999999999 108.965 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 15.9 ttp180 -117.33 142.43 47.11 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.954 -0.698 . . . . 3.3700000000000001 111.536 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.522 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -124.04 133.39 53.66 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.387 -0.968 . . . . 0.79000000000000004 108.387 172.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.766 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 6.6 t -139.8 111.35 7.2 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.881 -0.414 . . . . 1.28 109.881 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.744 HG22 ' CG1' ' A' ' 111' ' ' VAL . 6.3 m -126.2 151.45 32.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 1.27 110.955 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.8 m -103.38 115.74 31.12 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.507 -0.769 . . . . 0.56999999999999995 110.158 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.819 HG21 ' HB2' ' A' ' 19' ' ' ALA . 55.9 t -97.51 125.6 50.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.251 -0.886 . . . . 0.91000000000000003 110.013 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.682 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.68 23.94 8.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.799 -0.637 . . . . 0.97999999999999998 111.886 -173.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -148.23 31.04 0.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.35999999999999999 111.055 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 37.7 t70 72.32 167.26 0.31 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.13 0.967 . . . . 0.91000000000000003 113.504 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.547 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 34.3 ttp180 -63.47 -27.79 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.232 -1.349 . . . . 1.8799999999999999 111.226 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.36 -45.08 84.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 3.0499999999999998 111.141 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -77.36 -40.59 43.41 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.798 -0.361 . . . . 1.1100000000000001 110.739 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.819 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.56 -41.68 77.28 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 120.886 -0.325 . . . . 0.32000000000000001 110.904 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -73.31 -47.31 43.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.613 0.244 . . . . 0.38 110.949 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -54.12 -52.53 60.76 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.298 -0.41 . . . . 2.3900000000000001 110.37 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.8 m -65.5 -51.03 62.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.367 -0.379 . . . . 0.68000000000000005 111.031 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.784 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.4 t80 -61.22 -37.55 83.41 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.406 0.521 . . . . 0.47999999999999998 112.406 -173.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.663 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.5 tp -113.02 -50.06 2.9 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.195 -0.602 . . . . 0.5 112.469 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HA ' ' CE ' ' A' ' 48' ' ' LYS . 36.6 mt-10 -78.36 -35.28 47.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.071 0.462 . . . . 1.24 111.15 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.756 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -105.36 35.52 5.01 Favored Glycine 0 C--O 1.219 -0.81 0 CA-C-N 115.642 -0.708 . . . . 0.82999999999999996 112.084 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.578 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 62.0 t80 -52.56 -51.27 74.73 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 112.968 0.729 . . . . 0.73999999999999999 112.968 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.05 -2.01 11.79 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.11 1.873 . . . . 0.76000000000000001 114.801 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.756 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.5 pt-20 -90.75 -5.45 55.68 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.227 -0.589 . . . . 1.49 112.183 -172.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.784 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 9.7 m0 -74.52 -179.07 3.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.397 0.618 . . . . 4.6200000000000001 111.259 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.52 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 79.2 m95 -96.18 -32.63 0.27 Allowed Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 114.237 1.199 . . . . 2.7799999999999998 114.237 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.643 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 68.5 Cg_endo -71.54 -123.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.332 2.021 . . . . 1.3600000000000001 115.244 -165.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.598 HD22 HG21 ' A' ' 40' ' ' VAL . 6.3 t30 -62.33 -22.74 66.31 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.169 -0.469 . . . . 1.51 111.452 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.799 ' HA ' HG23 ' A' ' 40' ' ' VAL . 11.8 p30 -86.91 17.22 4.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.999 -0.546 . . . . 1.79 111.497 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -71.76 -10.22 59.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.377 0.608 . . . . 4.4500000000000002 110.037 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -104.3 118.88 37.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 4.1399999999999997 111.279 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -77.25 151.39 35.14 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.63 -0.714 . . . . 2.6800000000000002 109.64 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 57' ' ' ASP . 51.5 p 55.74 25.39 8.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.919 0.866 . . . . 1.4199999999999999 110.791 -174.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.566 ' HG2' HG22 ' A' ' 40' ' ' VAL . 16.8 ttmm -127.48 -59.67 1.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.61 -1.177 . . . . 2.8999999999999999 109.723 166.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 34' ' ' ASN . 2.8 m -157.72 28.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.955 -0.566 . . . . 1.8300000000000001 110.492 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.88 18.31 0.85 Allowed Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.934 -1.127 . . . . 2.1699999999999999 114.178 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.006 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -73.95 162.67 72.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 117.163 0.482 . . . . 1.1200000000000001 109.974 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 96.1 Cg_exo -50.05 -5.12 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 124.645 3.563 . . . . 1.48 116.53 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 tp -105.33 -85.31 0.48 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.094 -0.379 . . . . 1.75 110.571 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.578 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.37 -48.28 2.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.884 -0.674 . . . . 0.75 112.976 174.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.663 HG11 ' HG ' ' A' ' 24' ' ' LEU . 73.3 t -140.11 141.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.734 0.302 . . . . 0.59999999999999998 111.289 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.875 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 20.7 t70 -96.38 115.07 26.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.508 -0.552 . . . . 1.1100000000000001 109.508 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' CE ' ' HA ' ' A' ' 25' ' ' GLU . 36.4 mmtm -79.65 -27.99 40.85 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.95 0.781 . . . . 2.8100000000000001 112.23 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -83.09 -46.84 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.425 0.528 . . . . 3.1699999999999999 112.425 -170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.66 -32.01 5.56 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.446 -0.883 . . . . 1.53 111.954 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.553 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 103.95 71.18 0.84 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.348 -0.93 . . . . 0.77000000000000002 112.239 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -136.25 162.55 32.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.929 -0.397 . . . . 3.7200000000000002 109.929 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.0 m95 -116.75 107.75 15.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.28 108.886 169.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.875 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.7 p90 -162.64 159.93 25.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.228 0.537 . . . . 1.6599999999999999 111.109 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 23.4 mt-10 -102.23 -176.01 3.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 2.1200000000000001 110.051 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.8 mm -105.22 111.57 35.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.767 -0.827 . . . . 0.92000000000000004 108.767 157.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.713 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 3.5 t70 -91.65 177.72 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.429 . . . . 1.97 110.537 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -84.48 -36.14 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.851 0.686 . . . . 2.4300000000000002 112.851 -171.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.453 HE22 ' CG ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -88.26 14.68 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.55 -0.46 . . . . 2.3900000000000001 111.672 -173.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.75 64.02 0.92 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.356 -0.926 . . . . 2.29 112.811 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.683 ' HA ' ' NE2' ' A' ' 63' ' ' HIS . 0.1 OUTLIER 57.35 74.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.817 1.043 . . . . 2.3100000000000001 113.817 172.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -132.17 73.43 1.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.113 -0.699 . . . . 2.6099999999999999 109.113 169.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.713 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -125.24 163.31 22.78 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.214 -0.903 . . . . 3.7200000000000002 110.883 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.609 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 9.0 t -157.09 135.62 11.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.639 0.257 . . . . 2.27 110.602 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.712 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 33.5 t80 -146.93 -58.43 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.365 -0.38 . . . . 6.4800000000000004 110.558 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.525 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -155.72 159.68 29.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.53 -1.319 . . . . 1.23 114.25 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -119.01 113.81 21.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.668 -0.766 . . . . 1.1699999999999999 109.696 177.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.004 HG21 HG13 ' A' ' 71' ' ' VAL . 72.3 mt -77.26 132.28 33.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 0.60999999999999999 110.858 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -102.87 -24.94 13.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.047 -0.979 . . . . 2.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 47.4 tttm -165.79 108.96 0.8 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.559 -0.746 . . . . 1.53 111.192 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.004 HG13 HG21 ' A' ' 68' ' ' ILE . 1.6 m -100.91 115.5 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.362 -0.607 . . . . 0.88 109.362 170.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.24 74.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.73 -0.388 . . . . 1.4199999999999999 110.779 -177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.15 -170.69 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 124.525 1.14 . . . . 0.95999999999999996 111.944 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 30.7 Cg_exo -64.71 78.26 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.322 1.348 . . . . 0.38 111.093 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 23.5 t70 -161.76 -67.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.648 . . . . 0.5 110.837 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.2 p -142.01 141.97 32.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.076 0.465 . . . . 0.34999999999999998 111.805 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.59 126.94 28.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.433 . . . . 0.73999999999999999 109.845 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 98' ' ' THR . 26.2 t -103.39 109.92 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.629 -0.878 . . . . 0.67000000000000004 108.629 172.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.525 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -127.18 127.12 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.334 -0.394 . . . . 0.75 110.249 -174.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.84 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.56 155.75 23.53 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.5 112.339 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 58.3 t-105 -81.68 138.37 35.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.054 0.39 . . . . 2.79 112.054 -171.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 34.8 ttt-85 -148.54 23.16 1.02 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.859 -0.61 . . . . 5.46 109.997 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 78.48 145.48 0.09 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.083 -0.962 . . . . 1.55 112.917 172.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.551 ' H ' HD13 ' A' ' 83' ' ' LEU . 8.1 m-20 -77.85 48.47 0.7 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.499 -0.773 . . . . 1.9299999999999999 111.37 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.22 46.9 43.19 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 116.126 -0.488 . . . . 2.3999999999999999 113.916 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.471 ' H ' HD12 ' A' ' 83' ' ' LEU . 28.8 m-85 -106.96 1.81 24.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.159 -0.612 . . . . 5.3799999999999999 111.211 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.42 24.62 76.62 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.53 -0.843 . . . . 2.2999999999999998 111.603 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.544 ' HD3' ' HB3' ' A' ' 131' ' ' ASN . 50.3 mtt180 -98.96 -174.28 2.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.41 -0.395 . . . . 4.7699999999999996 110.637 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.67 ' O ' HD23 ' A' ' 83' ' ' LEU . 1.7 pp -54.74 149.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.845 0.716 . . . . 1.8600000000000001 111.292 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 p-10 -146.49 135.15 11.01 Favored Pre-proline 0 C--N 1.313 -1.018 0 N-CA-C 110.0 -0.37 . . . . 3.1800000000000002 110.0 175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 81' ' ' TRP . 3.4 Cg_exo -76.58 -37.89 1.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.446 2.097 . . . . 2.3599999999999999 111.71 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 70.06 -6.59 1.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.388 -0.824 . . . . 2.9900000000000002 111.88 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -137.89 -64.69 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 3.0600000000000001 111.017 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 m -89.54 -161.49 0.78 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.185 -0.461 . . . . 1.8500000000000001 111.293 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 3.7 t 67.4 40.0 2.79 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 122.06 0.933 . . . . 1.4399999999999999 108.605 -176.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.84 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 15.7 mt-10 -81.12 136.76 35.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.359 -1.292 . . . . 1.8100000000000001 110.012 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -120.23 120.67 36.79 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.464 0.65 . . . . 0.64000000000000001 110.563 174.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.536 HG23 HG22 ' A' ' 78' ' ' VAL . 41.7 m -93.35 115.27 27.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.99 -1.005 . . . . 0.42999999999999999 110.085 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.472 ' CB ' HG23 ' A' ' 113' ' ' VAL . 2.0 m -94.59 123.82 46.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.349 0.595 . . . . 0.87 109.459 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' HG22 ' A' ' 76' ' ' THR . 86.5 m -104.89 106.84 17.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.307 -0.86 . . . . 0.45000000000000001 109.805 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.691 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.1 m-85 -82.79 110.39 17.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 0.34000000000000002 109.917 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 109' ' ' THR . 58.8 t -88.17 107.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.759 0.314 . . . . 0.54000000000000004 110.481 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.68 129.28 39.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.928 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 5.9 t0 -128.16 97.3 4.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 2.0299999999999998 110.476 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.45 69.56 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.913 -0.66 . . . . 1.97 113.977 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 66.67 6.64 4.62 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.887 0.699 . . . . 4.9299999999999997 112.887 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 41.2 mtmt -136.26 -0.42 2.47 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 3.5299999999999998 111.378 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 42.4 tttt -138.34 157.97 45.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.223 -0.658 . . . . 2.4399999999999999 109.223 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.532 ' N ' ' HG2' ' A' ' 108' ' ' LYS . 18.1 m -156.67 128.28 7.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.102 0.477 . . . . 0.41999999999999998 110.99 175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 110' ' ' ARG . 8.5 tpt180 -106.33 115.14 29.7 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.763 -0.828 . . . . 2.5899999999999999 108.763 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -95.17 141.55 14.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.291 -0.564 . . . . 0.40000000000000002 111.005 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.563 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 11.5 t70 -128.99 104.1 7.39 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 124.459 1.099 . . . . 1.3799999999999999 109.565 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -85.7 139.17 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-N 116.499 -0.319 . . . . 0.91000000000000003 111.293 178.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 39.8 mt-10 -118.46 110.52 17.52 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.027 0.83 . . . . 2.3100000000000001 109.823 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.931 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 3.0 t-160 -91.89 107.26 19.08 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.098 -0.955 . . . . 1.6399999999999999 108.555 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 22.9 p -118.84 158.59 25.36 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.707 0.765 . . . . 2.6699999999999999 112.383 -172.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.658 ' O ' ' HG3' ' A' ' 121' ' ' MET . 98.9 m-70 99.22 -78.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.486 -1.688 . . . . 2.6299999999999999 111.077 164.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.454 ' HZ ' ' NH1' ' A' ' 128' ' ' ARG . 31.6 t80 -72.47 -48.84 37.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.706 -0.679 . . . . 3.54 112.592 -165.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.48 -43.36 99.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.92 0.867 . . . . 1.8100000000000001 109.5 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 55.2 ttt180 -61.12 -20.71 62.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.194 -1.367 . . . . 3.3799999999999999 111.931 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.658 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 93.8 mtp -78.08 25.14 0.23 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.461 0.541 . . . . 2.4300000000000002 112.461 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.4 155.37 8.9 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.722 -1.228 . . . . 1.6100000000000001 113.293 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 t -51.93 -47.86 64.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.234 -0.483 . . . . 2.5800000000000001 112.279 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -72.66 -25.27 61.2 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.879 -0.329 . . . . 3.7999999999999998 111.168 -174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.554 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 11.5 m170 -68.35 -50.07 55.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.403 0.621 . . . . 2.1400000000000001 109.569 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 2' ' ' TYR . . . -69.9 -30.87 68.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 0.92000000000000004 111.001 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -68.37 -37.83 80.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.061 -0.518 . . . . 2.8300000000000001 111.198 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.7 ptm180 -72.67 -36.27 67.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.887 -0.325 . . . . 2.5899999999999999 110.248 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.403 HG13 ' CD1' ' A' ' 81' ' ' TRP . 93.0 t -68.75 -33.05 57.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.342 0.591 . . . . 1.48 110.346 175.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 32.9 ttm180 -57.39 -21.83 38.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.242 -0.89 . . . . 3.8300000000000001 111.0 177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 91.1 m-20 -64.55 -21.35 66.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 2.48 111.598 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.7 -58.13 0.52 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.007 -1.092 . . . . 1.6100000000000001 114.155 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -80.53 -9.18 59.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.131 0.789 . . . . 4.8300000000000001 113.131 -170.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 6.4 p-10 -53.42 -49.4 67.4 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.842 0.682 . . . . 2.8300000000000001 112.842 -169.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -111.34 -19.88 12.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.96 0.41 . . . . 4.1500000000000004 110.955 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -63.27 -57.27 15.92 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.632 -0.587 . . . . 1.04 111.632 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.433 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 12.6 m0 -55.47 -53.99 56.1 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 113.052 0.76 . . . . 2.7799999999999998 113.052 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.3 Cg_endo -56.91 -37.75 97.55 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.747 1.632 . . . . 0.68000000000000005 112.097 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.9 m -70.16 -45.29 67.06 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.635 0.731 . . . . 0.87 109.958 176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.643 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 27.0 mt -58.54 -54.18 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.957 -1.019 . . . . 0.71999999999999997 111.548 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HB3' HG11 ' A' ' 10' ' ' VAL . 82.2 mt -62.6 -24.66 67.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.255 0.465 . . . . 0.68999999999999995 112.255 -173.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.2 -56.56 4.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.952 0.406 . . . . 1.49 110.234 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.482 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 73.8 m -66.44 -23.09 66.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.106 -0.497 . . . . 1.1499999999999999 110.531 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.77 -55.06 34.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.795 -0.639 . . . . 0.80000000000000004 110.491 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.445 ' CD ' ' HB ' ' A' ' 10' ' ' VAL . 41.5 mt-30 -61.91 -32.44 72.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.961 -0.563 . . . . 1.6299999999999999 110.684 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.1 m-20 -72.84 -40.91 65.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.138 -0.483 . . . . 1.46 111.773 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.3 tptp -65.42 -42.41 92.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 1.74 109.69 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.816 HG21 HG13 ' A' ' 12' ' ' VAL . 72.8 mt -62.36 -38.76 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.433 0.635 . . . . 0.5 110.401 174.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -58.37 -37.1 74.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.84999999999999998 110.169 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 146' ' ' ASP . 38.9 mt-10 -72.9 -35.14 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.551 -0.75 . . . . 1.5 110.439 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 21.6 mm-40 -67.77 -38.0 82.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.905 -0.588 . . . . 1.74 110.142 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -70.94 -66.63 2.11 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.463 -0.79 . . . . 1.3200000000000001 111.684 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -173.25 81.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.708 0.29 . . . . 1.9199999999999999 111.478 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -163.13 85.48 0.52 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.034 -0.53 . . . . 2.04 110.329 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 150' ' ' GLU . 36.7 mtmt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.245 -0.883 . . . . 4.2199999999999998 109.548 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.786 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 15.3 p-10 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.858 -0.115 . . . . 1.6599999999999999 110.754 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 86.67 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.314 1.045 . . . . 3.73 110.175 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.653 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 11.2 t70 -51.39 -52.47 59.29 Favored Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 123.453 0.471 . . . . 2.7799999999999998 111.63 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.4 Cg_endo -85.45 -67.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.165 1.244 . . . . 1.6299999999999999 112.517 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 1' ' ' ASN . 36.3 p90 -153.37 142.17 21.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.153 -0.684 . . . . 3.21 109.153 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.786 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -123.56 136.2 60.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.136 0.493 . . . . 1.4399999999999999 111.284 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.0 ttp180 -141.28 141.78 33.92 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.581 -0.736 . . . . 3.3700000000000001 110.502 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.716 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.1 133.39 53.07 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.846 -0.798 . . . . 0.79000000000000004 108.846 173.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 3.8 t -132.91 111.76 11.32 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.399 0.619 . . . . 1.28 110.214 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.0 t -123.91 138.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.053 -0.976 . . . . 1.27 111.585 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -96.6 117.04 30.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.251 0.548 . . . . 0.56999999999999995 109.994 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.869 HG13 HG21 ' A' ' 148' ' ' ILE . 51.4 t -96.48 129.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.91000000000000003 110.081 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.18 24.9 9.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.967 -0.56 . . . . 0.97999999999999998 111.845 -173.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -153.74 33.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.31 0.485 . . . . 0.35999999999999999 112.31 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 15.8 t70 73.43 165.67 0.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.904 0.859 . . . . 0.91000000000000003 112.607 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -65.66 -26.33 67.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.87 -1.059 . . . . 1.8799999999999999 111.166 -174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.95 -43.69 98.09 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.122 -0.49 . . . . 3.0499999999999998 111.09 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.0 p -74.55 -35.76 63.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.888 -0.325 . . . . 1.1100000000000001 110.361 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.65 -48.16 78.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.32000000000000001 110.444 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.06 -44.47 69.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.38 110.732 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -55.23 -52.33 63.74 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.404 -0.362 . . . . 2.3900000000000001 110.807 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 m -67.3 -51.07 57.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.546 -0.297 . . . . 0.68000000000000005 111.102 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.646 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.0 t80 -65.42 -34.58 78.63 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.059 0.392 . . . . 0.47999999999999998 112.059 -172.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD11 HG11 ' A' ' 46' ' ' VAL . 12.9 tp -111.73 -54.42 2.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.382 -0.527 . . . . 0.5 111.961 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.89 33.7 2.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.871 0.367 . . . . 1.24 111.705 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.747 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -157.73 34.47 0.53 Allowed Glycine 0 C--O 1.217 -0.908 0 C-N-CA 120.734 -0.746 . . . . 0.82999999999999996 111.895 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.61 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 t80 -61.58 -51.39 77.19 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 112.264 0.468 . . . . 0.73999999999999999 112.264 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.676 ' HB3' HD23 ' A' ' 44' ' ' LEU . 93.4 Cg_endo -77.57 15.49 1.23 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.461 2.107 . . . . 0.76000000000000001 115.058 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -113.09 -2.31 14.2 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.835 -0.541 . . . . 1.49 111.151 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.864 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 31.2 m0 -72.43 160.13 32.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.329 0.585 . . . . 4.6200000000000001 111.277 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 58.2 m95 -89.61 -37.01 0.42 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.627 0.973 . . . . 2.7799999999999998 113.627 175.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 18.5 Cg_endo -58.18 -84.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.525 2.15 . . . . 1.3600000000000001 115.448 -163.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HB3' HD11 ' A' ' 140' ' ' ILE . 5.6 t30 -110.76 -4.41 15.33 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.776 0.798 . . . . 1.51 109.425 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.847 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.9 m-20 -86.54 74.39 9.91 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.729 -1.123 . . . . 1.79 111.255 -170.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -154.46 29.09 0.44 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.791 0.663 . . . . 4.4500000000000002 112.791 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 23.3 mmm180 -135.77 152.63 51.32 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 4.1399999999999997 111.728 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.3 p -76.17 135.39 39.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.502 -0.317 . . . . 2.6800000000000002 110.149 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 57' ' ' ASP . 1.7 p 50.22 26.04 2.03 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.632 0.729 . . . . 1.4199999999999999 111.741 -172.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 15.7 ttmm -146.04 71.44 1.26 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.165 -0.925 . . . . 2.8999999999999999 109.1 174.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.847 HG23 ' HA ' ' A' ' 34' ' ' ASN . 6.9 m 53.36 29.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.052 -1.431 . . . . 1.8300000000000001 113.21 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.37 7.35 0.61 Allowed Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.106 -1.521 . . . . 2.1699999999999999 114.171 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.804 ' HB1' ' HD2' ' A' ' 43' ' ' PRO . . . -83.1 -171.25 0.29 Allowed Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.517 -0.549 . . . . 1.1200000000000001 109.517 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.876 ' HG2' ' HB ' ' A' ' 56' ' ' ILE . 18.8 Cg_endo -64.19 74.39 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 120.908 1.072 . . . . 1.48 109.336 161.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.81 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.8 OUTLIER -120.97 -162.44 0.96 Allowed 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.939 0.875 . . . . 1.75 110.266 -166.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.734 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . 135.68 -115.02 1.28 Allowed Glycine 0 N--CA 1.412 -2.909 0 CA-C-N 113.541 -1.663 . . . . 0.75 110.412 166.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.582 HG11 HD11 ' A' ' 24' ' ' LEU . 86.9 t -140.47 136.16 36.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.69 -0.755 . . . . 0.59999999999999998 112.297 -169.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.799 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 8.1 t0 -105.77 104.97 14.8 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.343 -1.298 . . . . 1.1100000000000001 108.071 175.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.62 ' H ' ' HE3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -79.86 -28.69 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.044 0.45 . . . . 2.8100000000000001 111.008 -174.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 50.6 pttt -71.49 -29.25 64.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.587 -0.733 . . . . 3.1699999999999999 111.645 -175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.6 -25.61 4.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.135 -0.555 . . . . 1.53 112.425 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.39 57.91 1.61 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.158 -0.544 . . . . 0.77000000000000002 112.803 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.799 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 26.1 ptt180 -146.33 152.73 39.61 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.583 -0.363 . . . . 3.7200000000000002 111.314 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 32.0 m0 -110.53 113.79 26.69 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.069 -0.715 . . . . 1.28 109.069 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.585 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.7 p90 -151.47 174.03 13.87 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.101 -1.04 . . . . 1.6599999999999999 112.786 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.81 ' HG2' ' HB2' ' A' ' 44' ' ' LEU . 6.1 mt-10 -134.05 143.0 47.79 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.029 -0.532 . . . . 2.1200000000000001 110.932 -171.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.876 ' HB ' ' HG2' ' A' ' 43' ' ' PRO . 25.4 mm -83.06 103.64 10.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.373 -0.531 . . . . 0.92000000000000004 109.785 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 61' ' ' GLU . 1.9 p-10 -66.4 -169.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.491 0.662 . . . . 1.97 111.199 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.73 -27.65 22.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.7 1.0 . . . . 2.4300000000000002 113.7 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.12 -28.64 12.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.658 0.984 . . . . 2.3900000000000001 113.658 -164.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.96 46.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.268 -1.444 . . . . 2.29 113.782 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 16.1 mt-10 73.21 73.46 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.119 0.785 . . . . 2.3100000000000001 113.119 171.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 11.4 tp10 -123.42 74.41 1.24 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.867 -1.16 . . . . 2.6099999999999999 107.867 165.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.463 ' CD2' ' HD1' ' A' ' 54' ' ' TYR . 2.0 p80 -113.07 126.36 55.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.549 -1.205 . . . . 3.7200000000000002 112.143 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.592 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 6.0 m -63.35 135.43 56.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.123 -1.066 . . . . 2.27 108.123 166.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 43.7 p90 -123.22 143.99 49.68 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.539 0.57 . . . . 6.4800000000000004 112.539 -171.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -75.52 151.46 41.56 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.041 -1.224 . . . . 1.23 110.041 169.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.779 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -115.6 94.33 4.65 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 117.043 0.422 . . . . 1.1699999999999999 111.192 -171.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 71' ' ' VAL . 41.5 mt -74.49 132.49 33.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.60999999999999999 110.354 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.565 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 12.8 mmm-85 -103.91 -25.33 13.08 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.716 -0.475 . . . . 2.0 109.716 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 82.6 tttt -145.52 115.52 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.53 111.198 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 68' ' ' ILE . 47.6 t -105.01 91.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 109.245 -0.65 . . . . 0.88 109.245 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 1.1 t70 -106.15 100.61 10.14 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.672 -0.695 . . . . 1.4199999999999999 109.531 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 17.0 pt-20 -24.79 148.06 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 125.105 1.503 . . . . 0.95999999999999996 112.542 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.6 Cg_exo -18.55 78.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 124.839 3.693 . . . . 0.38 114.781 -162.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -164.21 -63.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.844 -1.071 . . . . 0.5 110.614 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -149.69 141.57 23.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.23 0.538 . . . . 0.34999999999999998 112.284 -175.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 77' ' ' LEU . 1.7 mp -134.24 115.06 13.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.354 -0.384 . . . . 0.73999999999999999 110.037 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 61.7 t -97.25 108.31 21.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.235 -0.654 . . . . 0.67000000000000004 109.235 175.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -126.4 130.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.146 -0.479 . . . . 0.75 111.496 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.779 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -84.17 151.71 27.42 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 116.069 -0.514 . . . . 0.5 112.397 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.792 ' HZ2' ' HB3' ' A' ' 133' ' ' MET . 27.2 t-105 -82.06 146.13 29.83 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.836 1.05 . . . . 2.79 113.836 -162.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.74 ' O ' HD12 ' A' ' 83' ' ' LEU . 1.4 ttp180 -139.82 -8.42 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.366 -0.833 . . . . 5.46 111.693 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER 37.07 -160.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 115.764 1.764 . . . . 1.55 115.764 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 94.7 m-20 -126.26 135.23 51.3 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.116 0.566 . . . . 1.9299999999999999 109.867 -171.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -66.58 81.36 0.11 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.201 -0.523 . . . . 2.3999999999999999 113.402 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -128.21 24.17 5.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.468 . . . . 5.3799999999999999 110.298 172.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.09 30.79 2.84 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.334 -1.106 . . . . 2.2999999999999998 110.334 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.541 ' HD2' ' C ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -97.53 163.41 12.87 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.57 -0.815 . . . . 4.7699999999999996 112.899 -171.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.774 HG21 ' HE ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -117.22 128.3 74.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.386 -1.279 . . . . 1.8600000000000001 108.065 159.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.76 136.67 27.58 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.381 -0.6 . . . . 3.1800000000000002 109.381 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.694 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 53.1 Cg_exo -56.41 -43.36 56.37 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 122.998 2.466 . . . . 2.3599999999999999 112.185 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.0 t70 72.09 -28.66 0.19 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.947 0.779 . . . . 2.9900000000000002 112.68 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -124.4 -8.5 7.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.26 0.467 . . . . 3.0600000000000001 112.26 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 95' ' ' SER . 62.6 p -162.28 -147.67 0.13 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.082 -0.247 . . . . 1.8500000000000001 110.994 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.628 ' OG ' ' HB3' ' A' ' 118' ' ' PHE . 32.7 m 67.73 42.71 1.94 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.734 -0.666 . . . . 1.4399999999999999 110.5 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.615 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 43.8 mp0 -70.4 139.3 51.84 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.391 -0.822 . . . . 1.8100000000000001 109.935 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.488 ' HB2' HG13 ' A' ' 113' ' ' VAL . 2.6 p90 -127.37 127.74 44.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.02 0.438 . . . . 0.64000000000000001 110.271 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.1 m -88.4 110.2 20.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.366 -0.833 . . . . 0.42999999999999999 110.466 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.722 ' HA ' HG22 ' A' ' 113' ' ' VAL . 65.9 t -82.35 108.9 15.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.949 -0.569 . . . . 0.87 109.681 176.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 7.0 m -101.54 107.01 18.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.848 0.356 . . . . 0.45000000000000001 110.774 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 26.7 m-85 -94.17 111.11 22.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.222 -0.445 . . . . 0.34000000000000002 110.897 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.24 107.74 19.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.777 -0.453 . . . . 0.54000000000000004 109.777 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.03 145.36 44.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.681 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.824 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 4.4 t70 -140.09 107.49 5.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.389 -0.369 . . . . 2.0299999999999998 110.668 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.27 50.55 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.048 -0.596 . . . . 1.97 113.183 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 58.49 22.42 9.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.32 0.648 . . . . 4.9299999999999997 111.893 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 43.7 mtmt -141.36 -14.87 0.86 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.187 -0.321 . . . . 3.5299999999999998 111.212 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.824 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 27.8 tttp -121.49 155.77 34.23 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.501 -0.925 . . . . 2.4399999999999999 108.501 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.551 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 42.4 m -157.25 135.45 11.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.685 0.279 . . . . 0.41999999999999998 110.333 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -115.12 122.16 45.26 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.035 -0.728 . . . . 2.5899999999999999 109.035 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.7 p -101.89 136.82 32.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.438 -0.505 . . . . 0.40000000000000002 110.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -125.47 113.9 18.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.337 -0.847 . . . . 1.3799999999999999 109.186 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.722 HG22 ' HA ' ' A' ' 99' ' ' VAL . 3.6 t -95.01 120.82 44.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.317 -0.856 . . . . 0.91000000000000003 110.78 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -97.58 111.3 23.63 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.445 -0.798 . . . . 2.3100000000000001 109.597 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.603 ' O ' HG13 ' A' ' 6' ' ' VAL . 45.4 t60 -123.81 109.51 13.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.351 -0.841 . . . . 1.6399999999999999 108.843 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 120' ' ' ARG . 20.2 m -157.42 96.91 1.58 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 121.143 -0.223 . . . . 2.6699999999999999 111.231 -177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.518 ' O ' ' HG3' ' A' ' 121' ' ' MET . 40.5 t60 -162.67 -74.9 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 120.664 0.268 . . . . 2.6299999999999999 111.196 172.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.628 ' HB3' ' OG ' ' A' ' 95' ' ' SER . 37.5 t80 -85.77 -26.82 25.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.593 0.711 . . . . 3.54 110.089 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.1 p-10 -68.64 -51.63 39.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.87 -1.059 . . . . 1.8100000000000001 110.857 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD2' HG22 ' A' ' 116' ' ' THR . 7.9 ptm180 -59.02 -19.03 39.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.457 -0.792 . . . . 3.3799999999999999 112.01 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 117' ' ' HIS . 94.7 mtp -64.15 -9.85 19.27 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.948 0.404 . . . . 2.4300000000000002 110.14 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 55.17 -153.77 11.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.199 -0.91 . . . . 1.6100000000000001 114.407 166.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.7 p 44.38 -125.53 0.99 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.29 0.636 . . . . 2.5800000000000001 111.555 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -74.49 -23.73 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.652 -0.249 . . . . 3.7999999999999998 110.911 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.527 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 39.9 m80 -63.47 -51.6 64.92 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.008 0.432 . . . . 2.1400000000000001 110.253 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.83 79.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.954 -0.566 . . . . 0.92000000000000004 110.403 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -63.48 -42.76 98.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.747 -0.661 . . . . 2.8300000000000001 111.23 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.774 ' HE ' HG21 ' A' ' 89' ' ' ILE . 11.8 ptm180 -73.84 -31.55 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 2.5899999999999999 111.501 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.59 -39.57 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.206 0.527 . . . . 1.48 110.643 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.638 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 69.7 ttt180 -62.42 -16.75 56.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.602 -0.726 . . . . 3.8300000000000001 111.317 -176.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.34 -47.73 62.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.04 0.385 . . . . 2.48 112.04 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.29 -34.98 5.15 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.077 -1.058 . . . . 1.6100000000000001 113.539 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.792 ' HB3' ' HZ2' ' A' ' 81' ' ' TRP . 23.8 ptm -81.12 -21.84 39.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.904 0.705 . . . . 4.8300000000000001 112.904 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.638 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 34.1 t70 -54.7 -43.34 72.44 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.431 0.9 . . . . 2.8300000000000001 113.431 -168.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -114.13 30.88 6.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.456 0.646 . . . . 4.1500000000000004 110.331 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.75 -70.31 0.17 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.493 -0.861 . . . . 1.04 112.124 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.471 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 10.4 t90 -58.19 -52.0 77.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.463 0.542 . . . . 2.7799999999999998 112.463 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.8 Cg_endo -59.35 -37.74 88.6 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.94 1.76 . . . . 0.68000000000000005 112.355 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.1 m -70.02 -36.54 75.17 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.746 0.784 . . . . 0.87 109.671 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.7 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 15.3 mt -55.75 -40.24 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.66 -1.155 . . . . 0.71999999999999997 110.521 174.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 8' ' ' HIS . 79.0 mt -61.7 -30.77 70.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.925 0.343 . . . . 0.68999999999999995 111.925 -178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.63 -51.29 23.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 1.49 110.193 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.531 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 37.1 m -68.67 -22.76 64.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.137 -0.483 . . . . 1.1499999999999999 110.805 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 58.9 t80 -61.64 -54.26 45.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 0.80000000000000004 109.929 175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.495 ' CG ' HG13 ' A' ' 10' ' ' VAL . 38.8 mt-30 -57.37 -37.69 73.03 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.82 -0.627 . . . . 1.6299999999999999 110.77 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.01 -42.91 84.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.43 -0.804 . . . . 1.46 111.26 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -67.12 -41.43 86.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.8 0.333 . . . . 1.74 110.414 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.869 HG21 HG13 ' A' ' 12' ' ' VAL . 47.0 mt -62.08 -34.26 62.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.5 110.905 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.62 -30.58 68.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.985 -0.552 . . . . 0.84999999999999998 110.307 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.784 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 64.8 mt-10 -69.09 -43.83 73.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.5 110.03 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -69.53 -17.75 63.61 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.163 -0.926 . . . . 1.74 109.996 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.67 -40.11 6.44 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.407 -0.815 . . . . 1.3200000000000001 112.62 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -171.95 -26.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.039 0.755 . . . . 1.9199999999999999 113.039 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.784 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 6.2 ttmt -76.07 72.76 2.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.234 0.54 . . . . 2.04 111.609 -174.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 150' ' ' GLU . 68.2 mttm . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.446 -0.787 . . . . 4.2199999999999998 110.048 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.803 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 17.5 p-10 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.825 0.345 . . . . 1.6599999999999999 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 54.6 p90 173.26 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.837 -0.619 . . . . 3.73 109.668 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.804 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 32.8 t70 -66.04 -52.31 40.69 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 2.7799999999999998 111.041 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.804 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 12.5 Cg_endo -92.44 -70.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.153 1.902 . . . . 1.6299999999999999 111.605 169.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -141.25 145.67 35.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.421 -0.354 . . . . 3.21 110.25 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.803 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -118.63 125.72 74.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.419 -0.585 . . . . 1.4399999999999999 109.419 169.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 5.9 ttm105 -132.74 143.28 49.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.056 -0.52 . . . . 3.3700000000000001 112.027 -171.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HE2' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.0 133.01 53.64 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.575 -0.898 . . . . 0.79000000000000004 108.575 170.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 19.7 m -133.76 111.51 10.61 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.589 0.709 . . . . 1.28 110.643 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.596 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.7 t -123.5 142.46 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.824 -1.08 . . . . 1.27 110.139 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.6 m -121.92 116.06 23.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.269 0.557 . . . . 0.56999999999999995 110.074 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.659 ' HB ' HG21 ' A' ' 148' ' ' ILE . 11.0 m -102.91 163.63 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 115.509 -0.768 . . . . 0.91000000000000003 111.028 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.566 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -117.88 26.05 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.97999999999999998 111.661 -171.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB3' HG23 ' A' ' 148' ' ' ILE . . . -143.06 23.98 1.84 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.641 -0.423 . . . . 0.35999999999999999 111.52 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 33.8 t70 72.16 173.88 0.3 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.589 -0.732 . . . . 0.91000000000000003 112.565 173.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 9.7 ttp180 -68.03 -26.43 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.14 -0.936 . . . . 1.8799999999999999 111.321 -172.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -54.44 -48.53 71.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.104 0.478 . . . . 3.0499999999999998 110.755 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.0 p -80.73 -34.17 34.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 1.1100000000000001 111.046 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -59.58 -45.24 92.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.606 0.241 . . . . 0.32000000000000001 110.77 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -67.99 -45.89 72.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.38 110.516 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.701 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 29.6 tptp -54.77 -51.84 64.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 2.3900000000000001 110.452 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.551 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 55.0 m -65.28 -40.4 93.84 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.68000000000000005 111.539 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 99' ' ' VAL . 67.5 t80 -71.33 -37.98 71.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.409 -0.36 . . . . 0.47999999999999998 111.691 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 46' ' ' VAL . 9.6 tp -119.44 -55.78 2.1 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.714 0.635 . . . . 0.5 112.714 -173.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.701 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 2.3 mm-40 -87.85 18.33 4.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.542 0.571 . . . . 1.24 112.542 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -151.51 28.44 0.96 Allowed Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.246 -1.142 . . . . 0.82999999999999996 110.246 175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.623 ' HZ ' ' CE1' ' A' ' 65' ' ' PHE . 71.0 t80 -47.54 -51.77 42.03 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.494 -0.853 . . . . 0.73999999999999999 113.18 -168.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.4 Cg_endo -96.31 11.39 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.027 1.818 . . . . 0.76000000000000001 115.445 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 13.3 pt-20 -106.31 -6.54 18.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.306 0.854 . . . . 1.49 113.306 -172.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.793 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 18.2 m95 -92.66 -152.21 0.31 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.2 -0.312 . . . . 4.6200000000000001 111.75 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.58 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 31.6 m95 -105.77 0.16 0.1 Allowed Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 115.383 1.623 . . . . 2.7799999999999998 115.383 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.902 ' HB3' ' HA ' ' A' ' 140' ' ' ILE . 27.1 Cg_exo -66.07 -150.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.722 0 CA-C-N 122.54 1.943 . . . . 1.3600000000000001 114.342 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.601 ' ND2' HG21 ' A' ' 40' ' ' VAL . 63.5 t30 -63.28 -4.35 2.49 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.485 -0.78 . . . . 1.51 111.646 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.967 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 30.8 p30 -83.6 15.64 3.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.807 -0.633 . . . . 1.79 111.975 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.699 ' HD1' ' HG2' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -69.62 3.28 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.167 0.803 . . . . 4.4500000000000002 113.167 -173.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.699 ' HG2' ' HD1' ' A' ' 35' ' ' PHE . 42.6 mmt-85 -140.13 147.89 40.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.96 0.41 . . . . 4.1399999999999997 111.541 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -76.1 145.08 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.777 -0.647 . . . . 2.6800000000000002 111.13 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 57' ' ' ASP . 62.8 p 50.86 16.38 0.32 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.2 1.0 . . . . 1.4199999999999999 112.279 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.795 ' HD3' HG23 ' A' ' 40' ' ' VAL . 5.8 tmtm? -104.17 -62.88 1.26 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.091 -1.448 . . . . 2.8999999999999999 107.091 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.967 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 31.3 t -146.95 1.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 122.108 0.956 . . . . 1.8300000000000001 108.636 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 28' ' ' PRO . . . -126.73 50.61 0.87 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.538 -0.756 . . . . 2.1699999999999999 112.461 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -90.96 168.34 14.0 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.587 -0.524 . . . . 1.1200000000000001 109.587 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 48.4 Cg_endo -69.53 54.97 1.14 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.729 2.286 . . . . 1.48 114.056 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HB2' HG12 ' A' ' 56' ' ' ILE . 55.1 tp -164.92 -96.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.41 -0.359 . . . . 1.75 110.518 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.625 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 104.85 -59.09 0.45 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.879 -0.677 . . . . 0.75 112.38 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 24' ' ' LEU . 78.9 t -136.74 141.2 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 122.784 -0.245 . . . . 0.59999999999999998 110.37 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.77 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 7.1 t70 -112.36 113.38 25.56 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.491 -0.559 . . . . 1.1100000000000001 109.491 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -79.2 -31.9 43.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.017 0.377 . . . . 2.8100000000000001 112.017 -175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -83.66 -34.84 24.92 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 3.1699999999999999 110.9 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.8 -35.87 30.43 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.606 -0.807 . . . . 1.53 111.718 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' C ' ' HB ' ' A' ' 68' ' ' ILE . . . 85.26 54.24 2.9 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.429 -0.668 . . . . 0.77000000000000002 111.429 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -160.65 165.0 31.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.524 0.202 . . . . 3.7200000000000002 110.949 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.64 117.82 33.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.756 -0.461 . . . . 1.28 109.756 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.77 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -164.36 152.27 12.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.132 0.491 . . . . 1.6599999999999999 109.99 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 2.2 mp0 -112.59 160.53 17.76 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.521 -0.548 . . . . 2.1200000000000001 109.521 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 44' ' ' LEU . 44.4 mm -77.14 103.92 4.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.864 0.364 . . . . 0.92000000000000004 110.091 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.535 ' HA ' HG22 ' A' ' 38' ' ' THR . 4.6 t70 -90.78 170.4 10.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 1.97 110.117 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.91 -37.19 64.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.65 0.982 . . . . 2.4300000000000002 113.65 -165.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.617 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.3 OUTLIER -86.6 -0.76 56.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.223 -0.591 . . . . 2.3900000000000001 111.56 -178.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.79 72.87 0.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 119.648 -1.263 . . . . 2.29 114.064 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 53.0 29.7 8.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.491 0.552 . . . . 2.3100000000000001 112.491 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.574 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 13.7 tp10 -85.73 75.88 10.02 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.404 -0.591 . . . . 2.6099999999999999 109.404 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.419 ' HE1' ' O ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -126.96 163.5 23.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.003 -0.544 . . . . 3.7200000000000002 111.78 177.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.853 HG22 ' HG3' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -134.58 121.26 20.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.734 . . . . 2.27 109.89 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.803 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 3.7 t80 -144.83 -66.7 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 119.787 -0.765 . . . . 6.4800000000000004 113.057 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -158.64 165.14 33.9 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 118.909 -1.615 . . . . 1.23 114.732 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 82' ' ' ARG . 5.6 mp -113.39 107.35 15.74 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.268 0.627 . . . . 1.1699999999999999 110.342 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.863 HG21 HG23 ' A' ' 71' ' ' VAL . 65.0 mt -70.6 116.78 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.407 -0.917 . . . . 0.60999999999999999 110.385 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -90.35 -24.67 20.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.85 -0.613 . . . . 2.0 109.4 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 65.7 tttt -170.99 123.7 0.61 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.957 -0.565 . . . . 1.53 111.623 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.863 HG23 HG21 ' A' ' 68' ' ' ILE . 95.0 t -106.32 113.5 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.959 -0.756 . . . . 0.88 108.959 169.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -117.6 72.1 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.818 -0.353 . . . . 1.4199999999999999 110.11 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 45.17 -168.2 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 124.615 1.197 . . . . 0.95999999999999996 111.9 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.1 Cg_exo -63.33 76.85 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.253 1.302 . . . . 0.38 111.436 166.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.16 -63.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.942 -0.572 . . . . 0.5 110.287 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -144.34 139.66 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.482 0.549 . . . . 0.34999999999999998 112.482 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.96 109.7 6.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.261 -0.644 . . . . 0.73999999999999999 109.261 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 70' ' ' LYS . 1.2 p -101.5 113.54 38.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.519 -0.549 . . . . 0.67000000000000004 109.519 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.535 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -129.39 141.39 46.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.55 -0.75 . . . . 0.75 110.724 -177.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.528 ' HA2' ' H ' ' A' ' 96' ' ' GLU . . . -89.5 172.79 39.75 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.951 -0.568 . . . . 0.5 112.859 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.816 ' H ' ' HB2' ' A' ' 95' ' ' SER . 73.0 t-105 -90.22 156.46 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.517 0.199 . . . . 2.79 111.3 -172.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.853 ' HG3' HG22 ' A' ' 64' ' ' THR . 18.1 tpt180 177.86 42.31 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.854 -0.612 . . . . 5.46 110.483 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.803 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER 84.1 133.35 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.895 0.478 . . . . 1.55 111.135 169.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.601 ' ND2' ' HA3' ' A' ' 136' ' ' GLY . 31.2 t30 -93.66 75.35 4.35 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.588 -0.523 . . . . 1.9299999999999999 109.588 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.46 -62.68 3.77 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.602 -0.809 . . . . 2.3999999999999999 113.609 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -168.41 138.06 2.43 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.465 0.174 . . . . 5.3799999999999999 110.937 -172.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.61 38.1 3.79 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.754 -0.736 . . . . 2.2999999999999998 114.232 170.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.842 ' NH1' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -148.19 163.32 37.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.372 0.586 . . . . 4.7699999999999996 111.021 177.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.592 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -122.17 114.59 43.28 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 122.471 0.308 . . . . 1.8600000000000001 111.357 176.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.842 ' HB3' ' NH1' ' A' ' 88' ' ' ARG . 6.5 t70 -170.22 108.43 0.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.557 -0.534 . . . . 3.1800000000000002 109.557 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD2' ' CZ ' ' A' ' 128' ' ' ARG . 45.1 Cg_endo -87.66 30.48 0.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.565 0 C-N-CA 122.835 2.357 . . . . 2.3599999999999999 111.466 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.586 ' HB2' HH21 ' A' ' 128' ' ' ARG . 3.4 t70 -84.76 170.62 13.04 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.752 0.787 . . . . 2.9900000000000002 110.793 -165.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -150.37 15.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.345 -1.298 . . . . 3.0600000000000001 109.897 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.48 ' HB2' ' CE2' ' A' ' 118' ' ' PHE . 14.8 m -131.67 -78.62 0.51 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.251 -0.886 . . . . 1.8500000000000001 109.14 170.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.816 ' HB2' ' H ' ' A' ' 81' ' ' TRP . 19.9 m 47.92 -77.2 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.206 1.002 . . . . 1.4399999999999999 112.006 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.528 ' H ' ' HA2' ' A' ' 80' ' ' GLY . 49.4 tt0 77.59 112.67 0.07 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 1.8100000000000001 112.979 163.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.575 ' HB2' HG13 ' A' ' 113' ' ' VAL . 51.0 p90 -127.56 124.26 37.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.64000000000000001 110.106 167.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.473 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 41.8 m -88.16 109.2 19.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.384 -0.826 . . . . 0.42999999999999999 109.703 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 113' ' ' VAL . 62.0 t -82.41 110.06 17.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.395 . . . . 0.87 110.009 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.488 ' HA ' HG22 ' A' ' 76' ' ' THR . 28.2 m -103.17 107.31 18.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.45000000000000001 110.518 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.712 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 43.7 m-85 -90.38 111.16 22.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.294 -0.412 . . . . 0.34000000000000002 110.214 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.3 t -93.04 112.61 26.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.914 -0.402 . . . . 0.54000000000000004 109.914 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.54 126.98 31.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.306 -0.406 . . . . 0.44 110.607 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 50.7 m-20 -119.17 114.76 22.94 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.367 -0.379 . . . . 2.0299999999999998 110.49 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.91 -102.84 1.27 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.029 -0.605 . . . . 1.97 112.706 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -145.15 -23.32 0.49 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.807 0.337 . . . . 4.9299999999999997 110.485 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.849 ' HA ' ' HB2' ' A' ' 15' ' ' ASP . 21.6 pttp -142.93 34.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.043 0.449 . . . . 3.5299999999999998 111.625 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 56.2 tttm -136.21 148.18 47.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.235 -0.654 . . . . 2.4399999999999999 109.235 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 39.3 m -155.33 122.19 5.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.159 0.504 . . . . 0.41999999999999998 111.499 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.3 tpp85 -94.38 116.77 29.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.288 -0.869 . . . . 2.5899999999999999 109.839 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.712 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 p -94.5 134.93 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 109.331 -0.618 . . . . 0.40000000000000002 109.331 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.13 114.1 13.49 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.968 -1.015 . . . . 1.3799999999999999 109.405 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 99' ' ' VAL . 2.4 t -106.87 122.87 61.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.178 -0.919 . . . . 0.91000000000000003 111.809 -171.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 25.8 mt-10 -98.21 110.76 23.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.248 -0.433 . . . . 2.3100000000000001 110.067 171.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.579 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.9 t-80 -105.16 103.64 13.22 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.977 -1.49 . . . . 1.6399999999999999 106.977 171.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -153.84 96.99 2.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.368 -0.533 . . . . 2.6699999999999999 110.749 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.628 ' O ' ' HG2' ' A' ' 121' ' ' MET . 1.5 t60 -166.51 -76.3 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.786 -0.643 . . . . 2.6299999999999999 109.552 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 94' ' ' SER . 4.4 m-85 -85.45 -23.71 27.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.529 0.937 . . . . 3.54 113.529 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.31 -53.34 59.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.674 0.749 . . . . 1.8100000000000001 110.69 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -67.89 -17.46 64.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.662 -1.153 . . . . 3.3799999999999999 111.446 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 93.6 mmm -73.74 27.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.889 0.7 . . . . 2.4300000000000002 112.889 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 139.92 -175.42 21.85 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 118.798 -1.668 . . . . 1.6100000000000001 114.016 166.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.4 m -76.47 -53.7 7.74 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.522 -0.839 . . . . 2.5800000000000001 110.959 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.768 ' HA ' ' HB2' ' A' ' 127' ' ' LYS . 20.3 pttp -89.28 -11.7 42.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.922 0.712 . . . . 3.7999999999999998 112.922 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.727 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 16.1 m80 -62.45 -53.4 55.36 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.998 -0.681 . . . . 2.1400000000000001 109.556 167.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.07 -38.36 82.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.92000000000000004 110.996 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.768 ' HB2' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mttp -66.63 -33.01 74.7 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 111.94 0.348 . . . . 2.8300000000000001 111.94 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 27.4 ptt180 -69.89 -52.9 20.83 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.479 -0.488 . . . . 2.5899999999999999 109.728 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.508 HG12 ' SD ' ' A' ' 133' ' ' MET . 35.0 t -56.48 -33.84 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.206 0.527 . . . . 1.48 111.133 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -58.36 -16.47 14.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.044 0.938 . . . . 3.8300000000000001 112.502 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.483 HD22 ' HA ' ' A' ' 88' ' ' ARG . 5.6 t30 -56.06 -40.75 74.02 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.032 0.752 . . . . 2.48 113.032 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -160.31 19.16 0.23 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.015 -1.564 . . . . 1.6100000000000001 114.095 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.508 ' SD ' HG12 ' A' ' 129' ' ' VAL . 17.7 ptt? -80.29 -27.66 38.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.667 0.733 . . . . 4.8300000000000001 109.683 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -80.54 -13.57 58.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 2.8300000000000001 111.932 -170.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.463 ' NZ ' ' HB2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -92.88 1.75 57.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.804 0.335 . . . . 4.1500000000000004 110.539 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.635 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -126.89 -55.38 0.14 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.123 -1.037 . . . . 1.04 113.048 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.503 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 61.7 t-105 -53.81 -52.76 64.77 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.534 0.568 . . . . 2.7799999999999998 112.534 -171.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 25.1 Cg_endo -60.97 -45.42 19.99 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.595 1.53 . . . . 0.68000000000000005 111.768 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.1 m -59.64 -38.7 82.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.652 0.739 . . . . 0.87 110.108 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.902 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 14.0 mt -68.04 -41.67 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.126 -0.943 . . . . 0.71999999999999997 110.766 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 55.0 mt -63.88 -32.93 74.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.68999999999999995 111.53 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.9 -48.0 64.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.62 0.248 . . . . 1.49 110.999 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 31.9 m -71.38 -25.9 62.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.1499999999999999 110.817 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -58.52 -55.37 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.672 -0.695 . . . . 0.80000000000000004 109.941 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.458 ' CG ' HG13 ' A' ' 10' ' ' VAL . 47.3 mt-30 -64.94 -27.6 68.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.905 -0.589 . . . . 1.6299999999999999 110.522 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 2.8 t70 -67.95 -55.35 13.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.575 -0.739 . . . . 1.46 111.133 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.793 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 16.7 tptm -64.12 -39.87 94.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 120.267 -0.573 . . . . 1.74 110.638 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.659 HG21 ' HB ' ' A' ' 12' ' ' VAL . 67.7 mt -63.66 -34.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.5 110.723 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.566 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 18.4 t70 -66.86 -32.06 73.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.814 -0.439 . . . . 0.84999999999999998 109.814 176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.961 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 35.4 mt-10 -67.84 -33.11 74.12 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.235 0.54 . . . . 1.5 110.194 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 4.6 mm-40 -79.68 -12.96 59.79 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.375 -0.83 . . . . 1.74 110.172 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.53 -75.16 1.14 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.713 -0.676 . . . . 1.3200000000000001 112.862 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -151.24 35.88 0.59 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.982 0.391 . . . . 1.9199999999999999 111.777 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.961 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 12.4 tppt? -75.44 -10.93 59.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.44 0.638 . . . . 2.04 109.642 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.0 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.484 -0.78 . . . . 4.2199999999999998 109.833 -176.508 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 30.4 p-10 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 110.209 -0.293 . . . . 1.6599999999999999 110.209 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 1.2 t80 80.59 -50.71 0.32 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.584 0.552 . . . . 3.73 111.372 172.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.686 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.1 t70 -61.87 -49.41 85.9 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.092 -0.243 . . . . 2.7799999999999998 111.213 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.0 Cg_endo -92.47 -65.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.964 1.776 . . . . 1.6299999999999999 111.871 170.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -145.31 156.76 44.0 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.182 -1.414 . . . . 3.21 107.182 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.924 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 88.7 t -85.62 124.05 39.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.657 -0.817 . . . . 1.4399999999999999 109.828 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 14.0 ttp180 -128.82 138.04 51.84 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.954 0.407 . . . . 3.3700000000000001 110.865 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.526 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -115.3 132.33 56.65 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.987 -1.116 . . . . 0.79000000000000004 107.987 170.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 1.0 OUTLIER -136.16 110.47 8.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.746 0.784 . . . . 1.28 109.437 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.469 HG13 ' CG ' ' A' ' 145' ' ' GLN . 1.7 t -125.43 142.6 41.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.434 -1.257 . . . . 1.27 110.966 -177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -102.33 115.19 30.04 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.279 0.561 . . . . 0.56999999999999995 109.742 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.817 HG13 HG21 ' A' ' 148' ' ' ILE . 39.6 t -95.07 128.46 46.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.824 -0.626 . . . . 0.91000000000000003 110.316 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.678 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.59 32.79 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.97999999999999998 111.387 -173.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.41 26.87 0.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.586 -0.279 . . . . 0.35999999999999999 111.666 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.618 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 27.4 t70 73.97 168.42 0.3 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.175 0.512 . . . . 0.91000000000000003 112.349 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.548 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 12.1 ttp180 -69.12 -33.32 73.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.858 -0.61 . . . . 1.8799999999999999 111.815 -170.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.618 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 13.7 pttm -59.01 -43.05 91.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.73 0.3 . . . . 3.0499999999999998 110.566 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -72.51 -37.47 68.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.339 -0.391 . . . . 1.1100000000000001 110.878 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -60.23 -46.25 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.32000000000000001 110.429 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -69.42 -45.81 68.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.959 -0.564 . . . . 0.38 110.607 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.774 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 23.6 tptp -53.47 -50.62 64.94 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.137 -0.483 . . . . 2.3900000000000001 110.736 176.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -68.61 -50.15 53.7 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 121.085 -0.246 . . . . 0.68000000000000005 111.011 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.684 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 68.6 t80 -65.45 -39.35 91.92 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.039 0.385 . . . . 0.47999999999999998 112.039 -173.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 46' ' ' VAL . 14.4 tp -109.54 -49.41 3.11 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.021 -0.672 . . . . 0.5 112.035 -176.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.776 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 30.3 mt-10 -87.72 10.79 17.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.19 0.519 . . . . 1.24 110.598 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.73 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -143.83 26.12 2.08 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.896 -0.882 . . . . 0.82999999999999996 110.896 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 46.8 t80 -49.32 -49.52 70.17 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.41 . . . . 0.73999999999999999 111.45 -177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.9 Cg_endo -90.52 25.32 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.106 1.871 . . . . 0.76000000000000001 114.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.1 pt-20 -112.12 -9.91 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 119.785 -0.766 . . . . 1.49 111.753 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.684 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 11.4 m0 -71.84 152.05 42.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.348 0.594 . . . . 4.6200000000000001 111.163 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.637 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.9 m95 -75.28 -43.58 4.42 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 115.433 -0.803 . . . . 2.7799999999999998 113.131 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 31' ' ' TRP . 14.3 Cg_endo -53.98 -71.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.019 2.479 . . . . 1.3600000000000001 114.684 -165.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' HB3' HD11 ' A' ' 140' ' ' ILE . 8.9 t30 -117.51 -19.98 9.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.339 0.59 . . . . 1.51 110.294 -176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.674 ' HA ' HG23 ' A' ' 40' ' ' VAL . 10.0 m120 -92.75 20.2 6.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.246 -0.888 . . . . 1.79 111.806 -169.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -99.16 15.15 26.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.411 0.624 . . . . 4.4500000000000002 110.137 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -106.29 149.97 26.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.925 -0.58 . . . . 4.1399999999999997 110.752 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.0 p -76.74 136.82 39.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.102 -0.332 . . . . 2.6800000000000002 110.102 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.841 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 43.6 p 66.22 -47.63 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.835 1.254 . . . . 1.4199999999999999 111.759 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 85.1 tttt -71.11 89.28 0.82 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 122.771 0.429 . . . . 2.8999999999999999 110.142 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.674 HG23 ' HA ' ' A' ' 34' ' ' ASN . 34.5 m 49.07 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.952 1.301 . . . . 1.8300000000000001 113.031 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.31 17.0 2.71 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.674 -0.774 . . . . 2.1699999999999999 112.704 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.85 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -74.11 166.84 41.05 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.004 -0.739 . . . . 1.1200000000000001 109.004 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.9 49.67 0.32 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 123.055 2.503 . . . . 1.48 114.011 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.6 tp -162.52 -92.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.586 0.231 . . . . 1.75 110.714 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.768 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.05 -54.62 3.28 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.869 -0.681 . . . . 0.75 112.361 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 24' ' ' LEU . 60.3 t -140.34 140.22 34.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.59999999999999998 110.318 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -109.79 110.0 20.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.214 -0.661 . . . . 1.1100000000000001 109.214 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.776 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 7.8 mtpm? -79.55 -20.48 46.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.068 -0.515 . . . . 2.8100000000000001 111.689 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -83.64 -44.01 15.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.844 -0.342 . . . . 3.1699999999999999 110.943 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.7 -30.44 18.3 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.116 -0.564 . . . . 1.53 112.248 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.64 54.2 2.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.682 . . . . 0.77000000000000002 112.76 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpp180 -142.65 150.2 39.92 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.507 -0.408 . . . . 3.7200000000000002 110.661 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.558 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 17.2 m0 -105.38 114.08 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.675 -0.491 . . . . 1.28 109.675 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.34 148.48 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.207 -0.294 . . . . 1.6599999999999999 110.207 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.6 mp0 -119.58 160.58 22.18 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.952 -0.759 . . . . 2.1200000000000001 108.952 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.98 114.05 16.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.955 0.407 . . . . 0.92000000000000004 110.338 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.668 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.0 t70 -105.15 -170.76 1.8 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.785 -0.643 . . . . 1.97 110.113 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 12.7 pt-20 -71.84 -38.94 70.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.722 0.638 . . . . 2.4300000000000002 112.722 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -88.11 4.19 46.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.173 -0.611 . . . . 2.3900000000000001 110.979 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.69 -106.23 0.41 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.943 -1.122 . . . . 2.29 113.278 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -134.84 21.74 3.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.907 0.384 . . . . 2.3100000000000001 111.071 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -96.07 77.57 3.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.626 0.727 . . . . 2.6099999999999999 110.625 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.668 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -122.81 125.7 45.95 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.229 -0.896 . . . . 3.7200000000000002 110.214 174.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.668 ' HB ' ' HG2' ' A' ' 82' ' ' ARG . 70.2 p 62.03 -66.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.779 1.299 . . . . 2.27 113.363 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.1 t80 74.26 72.52 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.698 0.799 . . . . 6.4800000000000004 110.702 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -83.48 150.48 27.08 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.552 -0.749 . . . . 1.23 112.301 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -108.1 92.52 4.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.828 0.347 . . . . 1.1699999999999999 111.563 -172.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 71' ' ' VAL . 25.2 mt -72.04 136.15 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.60999999999999999 110.06 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -110.13 -24.23 10.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.761 -0.654 . . . . 2.0 109.905 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 20.5 ttmm -162.16 119.75 2.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.879 -0.6 . . . . 1.53 111.261 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 68' ' ' ILE . 60.4 t -108.54 96.16 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.472 -0.936 . . . . 0.88 108.472 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -105.41 65.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.928 -0.309 . . . . 1.4199999999999999 110.53 -174.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 15.5 pt-20 48.07 -170.59 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 O-C-N 124.514 1.134 . . . . 0.95999999999999996 111.926 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.513 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.1 Cg_exo -64.7 75.98 0.2 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.388 1.392 . . . . 0.38 111.545 169.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 11.3 t70 -160.17 -66.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.312 -0.858 . . . . 0.5 110.214 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.4 p -143.85 143.45 31.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.17 0.509 . . . . 0.34999999999999998 112.277 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.8 mp -133.53 121.84 22.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.73999999999999999 109.831 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 45.5 t -109.57 104.72 17.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.194 -0.669 . . . . 0.67000000000000004 109.194 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.493 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.97 146.22 34.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.554 0.216 . . . . 0.75 111.076 -178.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.76 148.54 18.86 Favored Glycine 0 C--O 1.24 0.486 0 CA-C-N 116.223 -0.444 . . . . 0.5 112.54 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -77.06 154.57 33.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.927 0.491 . . . . 2.79 112.322 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.668 ' HG2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -153.95 23.22 0.5 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 5.46 109.463 -176.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 79.85 -164.66 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.815 -1.084 . . . . 1.55 109.933 -172.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.627 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 32.7 t30 -137.87 -70.94 0.43 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.492 -0.322 . . . . 1.9299999999999999 110.524 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' PHE . . . -72.58 -11.27 76.9 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.584 -0.817 . . . . 2.3999999999999999 113.353 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 85' ' ' GLY . 86.2 t80 71.82 120.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.485 0.659 . . . . 5.3799999999999999 110.964 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -27.82 3.54 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.525 -0.761 . . . . 2.2999999999999998 111.314 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.69 ' HB3' ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -94.17 -175.98 3.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 120.907 0.384 . . . . 4.7699999999999996 110.505 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.775 HD13 ' HE ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -71.53 129.72 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.551 -0.749 . . . . 1.8600000000000001 111.491 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 p-10 -99.57 121.03 56.11 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 121.393 0.616 . . . . 3.1800000000000002 109.856 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HB2' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -84.06 36.42 0.59 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.204 2.603 . . . . 2.3599999999999999 111.556 178.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.73 76.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.806 0.812 . . . . 2.9900000000000002 111.594 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -143.77 -47.25 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.402 -1.333 . . . . 3.0600000000000001 107.402 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.7 m -136.87 -95.3 0.22 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 113.778 -1.556 . . . . 1.8500000000000001 108.192 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.583 ' OG ' ' HB2' ' A' ' 91' ' ' PRO . 66.7 m 48.92 23.83 0.76 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.076 0.55 . . . . 1.4399999999999999 112.409 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 33.4 mt-10 -75.1 138.97 42.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.651 -0.704 . . . . 1.8100000000000001 109.619 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CE2' HG23 ' A' ' 79' ' ' ILE . 4.8 p90 -133.26 132.01 40.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.173 0.511 . . . . 0.64000000000000001 110.543 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 25.8 m -91.4 108.47 19.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.063 -0.971 . . . . 0.42999999999999999 109.921 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.828 ' HA ' HG22 ' A' ' 113' ' ' VAL . 95.5 t -81.5 108.53 14.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.743 -0.662 . . . . 0.87 109.326 176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.517 ' HA ' HG22 ' A' ' 76' ' ' THR . 19.3 m -101.68 105.75 16.69 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.272 -0.422 . . . . 0.45000000000000001 110.222 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.548 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.3 m-85 -90.28 111.9 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.385 -0.37 . . . . 0.34000000000000002 110.192 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.21 106.64 18.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 0.54000000000000004 109.588 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.41 125.09 28.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.837 -0.619 . . . . 0.44 110.768 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 28.4 t70 -116.03 114.42 24.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.805 -0.634 . . . . 2.0299999999999998 110.1 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.47 -114.65 6.66 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.618 -0.801 . . . . 1.97 111.666 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -146.64 13.5 1.19 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.176 0.512 . . . . 4.9299999999999997 110.228 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -145.57 -5.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 112.969 0.729 . . . . 3.5299999999999998 112.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 29.5 ttpt -123.38 154.01 39.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.602 -0.686 . . . . 2.4399999999999999 110.304 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.8 m -157.56 114.17 2.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.146 0.498 . . . . 0.41999999999999998 110.973 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -88.3 119.87 29.12 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.823 -0.626 . . . . 2.5899999999999999 109.616 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.1 p -96.18 132.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.249 -0.58 . . . . 0.40000000000000002 109.588 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.54 109.31 12.01 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.561 -0.903 . . . . 1.3799999999999999 108.561 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 99' ' ' VAL . 28.6 t -98.83 120.52 48.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.029 -0.987 . . . . 0.91000000000000003 110.991 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.24 119.23 38.46 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.684 0.754 . . . . 2.3100000000000001 109.431 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.924 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 16.6 t60 -102.74 152.2 21.51 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.595 -1.184 . . . . 1.6399999999999999 109.016 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 118' ' ' PHE . 11.7 t -54.67 169.73 0.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.231 1.015 . . . . 2.6699999999999999 111.604 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -93.92 14.84 18.32 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.503 -1.226 . . . . 2.6299999999999999 111.124 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.506 ' H ' HG23 ' A' ' 116' ' ' THR . 16.2 t80 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.059 0.456 . . . . 3.54 110.09 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -30.51 59.06 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.142 -0.688 . . . . 1.8100000000000001 109.142 178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 57.5 ttt180 -60.29 -19.82 56.61 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.918 -1.037 . . . . 3.3799999999999999 111.397 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 87.9 mmm -61.22 -15.44 34.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.449 -0.341 . . . . 2.4300000000000002 110.271 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.98 -140.38 26.94 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.595 -0.729 . . . . 1.6100000000000001 113.134 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 16.8 p 36.22 -108.44 0.05 OUTLIER 'General case' 0 C--O 1.233 0.217 0 O-C-N 124.766 0.921 . . . . 2.5800000000000001 112.813 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -84.81 -34.55 22.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 3.7999999999999998 111.102 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -63.7 -50.33 69.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 2.1400000000000001 110.71 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 -25.79 59.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.495 -0.32 . . . . 0.92000000000000004 110.667 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' THR . 46.9 tptt -56.51 -52.23 65.53 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.969 0.414 . . . . 2.8300000000000001 110.403 174.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.775 ' HE ' HD13 ' A' ' 89' ' ' ILE . 9.5 ptm85 -72.24 -30.31 64.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.68 -0.691 . . . . 2.5899999999999999 111.9 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.5 -39.18 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.95 0.405 . . . . 1.48 111.589 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -62.79 -16.04 56.37 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.264 -0.425 . . . . 3.8300000000000001 112.067 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 128' ' ' ARG . 65.5 m-80 -54.99 -24.86 26.2 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.907 0.706 . . . . 2.48 112.907 -175.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -134.74 -24.09 0.61 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 119.641 -1.266 . . . . 1.6100000000000001 114.105 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.438 ' SD ' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -73.5 -26.08 60.73 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.431 -0.452 . . . . 4.8300000000000001 112.0 -172.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.99 -14.63 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.388 . . . . 2.8300000000000001 110.886 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -115.21 16.38 16.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.734 0.778 . . . . 4.1500000000000004 109.47 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.68 -91.26 2.21 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.466 -0.788 . . . . 1.04 112.526 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 20.2 m95 -54.89 -47.58 97.97 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.681 0.993 . . . . 2.7799999999999998 113.681 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.2 Cg_endo -52.82 -40.04 75.92 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.813 1.676 . . . . 0.68000000000000005 112.446 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 38.9 m -78.15 -43.32 29.11 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.631 0.729 . . . . 0.87 110.102 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.624 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.2 mt -59.79 -51.97 66.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 115.105 -0.952 . . . . 0.71999999999999997 111.734 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 78.7 mt -58.94 -28.3 66.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.174 0.435 . . . . 0.68999999999999995 112.174 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.3 mm-40 -74.24 -51.74 14.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 1.49 110.296 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 14.9 t -70.52 -23.74 62.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.082 0.468 . . . . 1.1499999999999999 110.321 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.59 -51.97 66.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.816 -0.629 . . . . 0.80000000000000004 109.952 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.469 ' CG ' HG13 ' A' ' 10' ' ' VAL . 45.7 mt-30 -66.1 -28.43 68.81 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.599 -0.728 . . . . 1.6299999999999999 110.437 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 35.2 t70 -75.78 -43.1 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.698 . . . . 1.46 111.222 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.492 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 58.6 tttm -64.8 -40.12 94.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.065 0.46 . . . . 1.74 110.076 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.817 HG21 HG13 ' A' ' 12' ' ' VAL . 70.8 mt -68.85 -26.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.02 -0.537 . . . . 0.5 110.372 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.93 -37.78 76.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.295 -0.631 . . . . 0.84999999999999998 109.295 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.589 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 34.8 mt-10 -64.65 -46.09 83.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 122.18 0.991 . . . . 1.5 108.79 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 148' ' ' ILE . 2.4 tp10 -65.64 -43.63 88.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.4 -1.727 . . . . 1.74 110.506 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.35 -70.49 1.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.912 -0.661 . . . . 1.3200000000000001 112.075 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -161.81 97.55 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.916 0.388 . . . . 1.9199999999999999 111.28 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.0 ttmm -137.3 -46.38 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.969 -0.559 . . . . 2.04 109.678 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HD3' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.496 -0.775 . . . . 4.2199999999999998 111.176 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 25.0 p-10 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.17 0.509 . . . . 1.6599999999999999 110.784 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.844 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 41.9 p90 -168.38 -42.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.155 -0.475 . . . . 3.73 110.647 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.606 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.6 t70 -72.78 -58.67 2.63 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.613 -0.267 . . . . 2.7799999999999998 111.526 -173.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.13 -64.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.165 1.243 . . . . 1.6299999999999999 110.636 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 53.1 p90 -154.66 147.07 23.98 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.958 -0.564 . . . . 3.21 110.135 173.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -110.46 114.47 47.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.796 -1.187 . . . . 1.4399999999999999 107.796 164.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 28.9 ttm180 -112.67 138.65 49.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.716 -0.674 . . . . 3.3700000000000001 111.257 -173.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.579 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.57 133.83 52.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.696 -0.853 . . . . 0.79000000000000004 108.696 172.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.807 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 70.0 m -141.61 113.82 8.11 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.131 -0.486 . . . . 1.28 109.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.967 HG22 HG12 ' A' ' 111' ' ' VAL . 1.9 m -122.92 143.48 35.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 120.345 -0.542 . . . . 1.27 109.983 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.1 m -98.04 115.8 28.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.431 0.634 . . . . 0.56999999999999995 110.158 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.813 HG13 HG21 ' A' ' 148' ' ' ILE . 33.1 t -103.1 133.8 45.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.568 -0.742 . . . . 0.91000000000000003 109.947 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.12 30.2 6.61 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.406 -0.361 . . . . 0.97999999999999998 111.886 -174.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -154.23 35.1 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.988 0.423 . . . . 0.35999999999999999 111.209 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 75.03 173.21 0.26 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-O 122.1 0.952 . . . . 0.91000000000000003 112.705 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.558 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 19.8 ttp180 -71.79 -24.75 61.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.594 -1.185 . . . . 1.8799999999999999 110.711 -171.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 19.6 tptm -61.14 -48.4 81.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 3.0499999999999998 110.671 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.2 p -70.9 -38.54 73.01 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.979 -0.288 . . . . 1.1100000000000001 111.059 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.7 -46.47 81.19 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 120.913 0.387 . . . . 0.32000000000000001 110.647 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -71.69 -47.79 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.872 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 25.6 tptp -52.33 -46.53 66.09 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 120.966 0.412 . . . . 2.3900000000000001 111.1 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 m -70.88 -49.04 50.31 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.192 -0.458 . . . . 0.68000000000000005 110.349 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.55 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 58.3 t80 -62.39 -41.08 98.38 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.231 0.456 . . . . 0.47999999999999998 112.231 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 46' ' ' VAL . 12.5 tp -113.05 -34.24 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.231 -0.588 . . . . 0.5 112.512 -172.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.712 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 35.1 mt-10 -104.82 16.22 26.38 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.234 -0.291 . . . . 1.24 111.419 -173.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.747 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -153.87 38.74 0.69 Allowed Glycine 0 C--O 1.22 -0.722 0 C-N-CA 120.754 -0.736 . . . . 0.82999999999999996 111.482 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.615 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 61.9 t80 -53.66 -54.45 45.94 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 112.806 0.669 . . . . 0.73999999999999999 112.806 -169.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 36.5 Cg_endo -87.5 13.88 2.53 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.76000000000000001 114.496 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.7 pt-20 -97.36 -6.49 34.04 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.159 -0.616 . . . . 1.49 110.586 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.661 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 26.8 m0 -73.3 176.11 6.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.482 0.658 . . . . 4.6200000000000001 111.446 -175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 35.0 m95 -97.91 -25.19 0.23 Allowed Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 114.136 1.161 . . . . 2.7799999999999998 114.136 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 30' ' ' TRP . 72.6 Cg_endo -75.2 -151.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 121.726 1.617 . . . . 1.3600000000000001 114.281 -174.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.566 ' ND2' HG21 ' A' ' 40' ' ' VAL . 9.5 t30 -44.73 -43.28 8.36 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.85 -1.068 . . . . 1.51 113.293 -171.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.941 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 2.0 p-10 -79.95 38.95 0.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.395 -0.821 . . . . 1.79 112.323 -173.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -100.35 -6.23 26.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.961 0.41 . . . . 4.4500000000000002 110.722 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 12.4 mmm180 -89.48 131.07 35.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.342 -0.39 . . . . 4.1399999999999997 110.751 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.6 p -76.01 137.38 40.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 2.6800000000000002 110.881 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 36.9 p 52.92 24.46 3.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 1.4199999999999999 111.338 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 36' ' ' ARG . 3.0 tmtp? -121.31 -55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.496 -0.927 . . . . 2.8999999999999999 108.496 174.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.941 ' HB ' ' HA ' ' A' ' 34' ' ' ASN . 1.6 t -150.47 19.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 109.222 -0.659 . . . . 1.8300000000000001 109.222 172.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.48 41.84 0.28 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.584 -1.293 . . . . 2.1699999999999999 114.135 -166.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.925 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -67.95 173.22 3.27 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.247 -0.649 . . . . 1.1200000000000001 109.247 167.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 29.5 Cg_endo -63.44 26.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.049 2.499 . . . . 1.48 115.335 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -142.1 -88.94 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.932 -0.48 . . . . 1.75 110.81 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.531 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 95.2 -49.77 1.91 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.766 -0.73 . . . . 0.75 112.766 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 24' ' ' LEU . 85.8 t -137.12 143.38 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.59999999999999998 110.161 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.854 ' HB3' ' HG2' ' A' ' 52' ' ' ARG . 13.6 t70 -104.95 109.1 20.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.206 -0.664 . . . . 1.1100000000000001 109.206 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -80.95 -13.64 58.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.49 -0.777 . . . . 2.8100000000000001 112.316 -173.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -90.4 -40.05 12.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.665 0.269 . . . . 3.1699999999999999 111.573 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.68 -32.27 4.23 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.986 -0.846 . . . . 1.53 110.986 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 96.16 79.61 1.47 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.77000000000000002 111.946 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.854 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 28.6 ptt180 -157.99 165.28 35.51 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.53 -0.544 . . . . 3.7200000000000002 109.53 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.677 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -111.82 117.93 34.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.74 -0.467 . . . . 1.28 109.74 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.612 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 7.9 p90 -164.02 159.03 20.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.282 0.563 . . . . 1.6599999999999999 111.244 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.925 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 26.2 mt-10 -111.82 153.72 26.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.678 -0.692 . . . . 2.1200000000000001 110.2 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 mm -81.2 103.49 8.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.258 -0.645 . . . . 0.92000000000000004 109.258 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.678 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.0 t70 -90.25 -170.79 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.258 -0.275 . . . . 1.97 110.258 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 11.4 pt-20 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.883 0.327 . . . . 2.4300000000000002 111.883 -172.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.588 ' OE1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -84.5 -10.35 57.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.106 0.479 . . . . 2.3900000000000001 110.61 -178.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.93 -86.79 0.17 Allowed Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.83 -0.623 . . . . 2.29 112.448 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HB3' ' HE1' ' A' ' 54' ' ' TYR . 40.0 mt-10 -148.65 37.13 0.81 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.539 0.209 . . . . 2.3100000000000001 111.285 -172.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -102.45 77.85 1.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.147 0.975 . . . . 2.6099999999999999 110.84 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.678 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.5 OUTLIER -123.22 163.95 19.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.634 -1.166 . . . . 3.7200000000000002 110.275 172.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.604 ' HB ' ' HD2' ' A' ' 82' ' ' ARG . 7.1 p -57.98 106.22 0.34 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 2.27 111.48 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 19.2 p90 -79.61 109.31 13.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.813 -0.63 . . . . 6.4800000000000004 112.162 -173.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -67.41 136.62 32.15 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.987 -0.845 . . . . 1.23 110.987 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.0 mp -87.91 86.88 7.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.45 0.125 . . . . 1.1699999999999999 111.166 -171.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 51' ' ' GLY . 35.5 mt -82.27 116.62 26.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 119.094 -1.042 . . . . 0.60999999999999999 109.568 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -103.21 -12.79 17.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.168 -0.923 . . . . 2.0 110.319 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 36.9 ttmt -156.81 121.12 4.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.75 -0.659 . . . . 1.53 111.511 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 77' ' ' LEU . 59.3 t -109.86 89.06 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.966 -1.124 . . . . 0.88 107.966 167.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 76' ' ' THR . 38.7 t0 -97.8 71.41 2.22 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.879 -0.328 . . . . 1.4199999999999999 110.454 -175.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.559 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 pt-20 46.42 -169.73 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 124.402 1.064 . . . . 0.95999999999999996 111.411 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -67.06 74.38 0.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.107 1.205 . . . . 0.38 110.914 165.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -155.0 -71.35 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.491 -0.322 . . . . 0.5 110.771 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.581 ' C ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -142.31 123.94 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.476 0.547 . . . . 0.34999999999999998 112.476 -175.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD13 ' C ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -118.73 123.2 44.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.862 -0.523 . . . . 0.73999999999999999 110.41 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 58.1 t -103.13 101.72 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.67000000000000004 109.251 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -129.32 140.92 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.138 -0.483 . . . . 0.75 111.12 -176.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -98.38 145.9 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.589 -0.732 . . . . 0.5 112.365 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 1.002 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 72.0 t-105 -72.99 142.62 47.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.581 0.586 . . . . 2.79 112.581 -174.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.604 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 0.3 OUTLIER -145.12 44.41 1.33 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.49 -0.777 . . . . 5.46 109.32 177.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 75.95 145.46 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.337 -0.847 . . . . 1.55 111.954 176.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.629 ' N ' HD13 ' A' ' 83' ' ' LEU . 29.1 t30 -83.11 -66.59 0.87 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.047 -0.979 . . . . 1.9299999999999999 111.306 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 40' ' ' VAL . . . -91.13 29.14 7.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.586 -0.816 . . . . 2.3999999999999999 113.678 -172.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 63' ' ' HIS . 75.7 t80 67.32 -68.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.23 0.612 . . . . 5.3799999999999999 112.563 176.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.77 55.66 4.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.212 -0.518 . . . . 2.2999999999999998 113.944 -170.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.648 ' HB2' HD11 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -140.53 -175.96 4.46 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.719 -0.845 . . . . 4.7699999999999996 108.719 170.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.618 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -92.44 127.66 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.251 0.548 . . . . 1.8600000000000001 111.494 -173.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' OD1' ' HD3' ' A' ' 82' ' ' ARG . 3.2 p30 -135.39 158.92 73.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.62 -0.718 . . . . 3.1800000000000002 109.15 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -91.0 -29.16 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.346 2.03 . . . . 2.3599999999999999 114.089 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.17 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.923 1.289 . . . . 2.9900000000000002 114.418 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -79.56 -20.1 47.87 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.718 -0.613 . . . . 3.0600000000000001 112.211 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.3 p -155.9 -90.09 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.398 -0.593 . . . . 1.8500000000000001 109.398 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 1.002 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.4 m 54.87 25.73 7.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.763 -0.653 . . . . 1.4399999999999999 111.685 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.646 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 39.2 tt0 -77.63 142.63 38.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 1.8100000000000001 112.214 -171.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 79' ' ' ILE . 6.6 p90 -139.92 141.06 36.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.895 -0.593 . . . . 0.64000000000000001 110.52 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 39.0 m -97.04 112.38 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.686 -0.688 . . . . 0.42999999999999999 110.387 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' THR . 84.5 t -84.43 109.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.87 109.71 177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.469 ' HA ' HG22 ' A' ' 76' ' ' THR . 55.6 m -107.13 106.03 16.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.917 0.389 . . . . 0.45000000000000001 110.849 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.558 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 46.0 m-85 -85.08 113.38 21.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.401 -0.363 . . . . 0.34000000000000002 110.05 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.63 109.49 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.645 -0.502 . . . . 0.54000000000000004 109.645 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.67 124.21 28.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.207 0.527 . . . . 0.44 111.041 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 32.8 m-20 -106.59 125.24 50.76 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.318 -0.855 . . . . 2.0299999999999998 109.165 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.86 71.87 0.39 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-N 116.131 -0.486 . . . . 1.97 113.9 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 8.7 tt0 -169.6 25.96 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.055 -1.091 . . . . 4.9299999999999997 108.055 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 57.38 48.74 14.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.859 0.837 . . . . 3.5299999999999998 109.317 -169.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 36.1 tttp -130.22 148.8 52.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.561 -1.199 . . . . 2.4399999999999999 108.613 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.1 m -155.25 113.68 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.124 0.488 . . . . 0.41999999999999998 110.904 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.6 tmm_? -100.37 111.5 23.77 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.593 -0.891 . . . . 2.5899999999999999 108.593 176.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.967 HG12 HG22 ' A' ' 10' ' ' VAL . 13.0 p -85.8 145.51 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.861 -0.336 . . . . 0.40000000000000002 110.862 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -129.19 117.09 20.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 124.177 0.923 . . . . 1.3799999999999999 109.578 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -104.75 128.44 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 110.266 -0.272 . . . . 0.91000000000000003 110.266 175.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -103.63 114.82 29.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.21 -0.663 . . . . 2.3100000000000001 109.21 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 6' ' ' VAL . 41.6 t60 -131.98 125.5 31.7 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.997 -1.001 . . . . 1.6399999999999999 108.864 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 5' ' ' PHE . 5.2 t -176.94 101.86 0.05 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.75 0.786 . . . . 2.6699999999999999 110.198 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.6 t-160 -166.81 -67.1 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.573 -0.74 . . . . 2.6299999999999999 110.302 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.6 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 1.2 p90 -81.83 -24.74 35.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.891 -0.595 . . . . 3.54 110.98 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.844 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . 0.0 OUTLIER -75.46 -52.68 10.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.505 0.722 . . . . 1.8100000000000001 111.352 -176.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 16.4 ptt180 -65.41 -16.7 63.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.213 -0.903 . . . . 3.3799999999999999 110.705 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 41.9 tpp -74.51 26.21 0.08 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.192 -0.913 . . . . 2.4300000000000002 112.721 -169.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.68 172.15 13.09 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.265 -1.445 . . . . 1.6100000000000001 114.718 166.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 m -58.03 -54.24 49.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.674 -0.763 . . . . 2.5800000000000001 111.892 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 124' ' ' LYS . 45.4 mtpt -68.48 -28.64 67.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 3.7999999999999998 110.875 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.764 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 13.4 m-70 -67.93 -47.85 67.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.207 -0.451 . . . . 2.1400000000000001 111.278 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.72 -23.42 58.59 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 120.359 -0.536 . . . . 0.92000000000000004 110.468 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -74.6 -38.16 62.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 2.8300000000000001 110.618 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.764 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 14.5 ptp180 -67.05 -28.35 68.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.738 -0.467 . . . . 2.5899999999999999 109.738 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.719 ' HA ' ' SD ' ' A' ' 133' ' ' MET . 67.5 t -65.27 -46.33 90.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.013 -0.54 . . . . 1.48 109.808 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.645 ' HA ' ' HB2' ' A' ' 134' ' ' ASP . 65.0 ttt180 -65.91 -16.28 63.71 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.484 -0.78 . . . . 3.8300000000000001 110.963 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.655 ' OD1' ' HA ' ' A' ' 128' ' ' ARG . 3.6 m120 -53.76 -55.55 25.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.444 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -153.06 -7.18 0.1 OUTLIER Glycine 0 C--N 1.331 0.255 0 C-N-CA 119.838 -1.172 . . . . 1.6100000000000001 114.923 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 129' ' ' VAL . 10.8 mtt -80.29 -28.11 38.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.3 -1.0 . . . . 4.8300000000000001 108.3 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.645 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 12.3 t70 -56.34 -43.44 79.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 113.941 -1.481 . . . . 2.8300000000000001 112.567 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -108.99 11.19 26.02 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 4.1500000000000004 111.872 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.548 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.12 -65.61 0.7 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.019 -1.086 . . . . 1.04 112.329 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.51 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -57.92 -48.48 97.05 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.818 0.673 . . . . 2.7799999999999998 112.818 -172.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.4 Cg_endo -58.32 -44.38 38.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.781 1.654 . . . . 0.68000000000000005 112.02 176.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 m -59.62 -42.81 93.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.559 0.695 . . . . 0.87 109.672 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.623 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.9 mt -59.38 -50.58 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 114.764 -1.107 . . . . 0.71999999999999997 111.345 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.8 mt -60.42 -34.51 74.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.282 0.475 . . . . 0.68999999999999995 112.282 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.711 ' N ' HE21 ' A' ' 142' ' ' GLN . 0.0 OUTLIER -68.45 -52.65 30.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.019 0.438 . . . . 1.49 110.542 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.449 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.1 m -68.9 -22.03 64.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.997 -0.547 . . . . 1.1499999999999999 110.575 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.97 -53.94 42.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.08 -0.509 . . . . 0.80000000000000004 110.109 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -60.3 -29.31 68.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.844 -0.616 . . . . 1.6299999999999999 110.046 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.83 -47.19 60.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.116 -0.947 . . . . 1.46 110.367 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -61.83 -34.15 75.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.689 . . . . 1.74 110.424 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.813 HG21 HG13 ' A' ' 12' ' ' VAL . 66.4 mt -80.78 -25.19 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.77 -0.65 . . . . 0.5 110.811 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.591 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 25.7 t0 -63.78 -24.58 67.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.84999999999999998 109.512 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 45.0 mt-10 -67.17 -26.81 66.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.214 -0.903 . . . . 1.5 110.338 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -80.07 -7.35 58.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 1.74 109.98 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.15 -80.26 0.67 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.839 -0.618 . . . . 1.3200000000000001 113.244 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.91 30.79 0.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.08 0.44 . . . . 1.9199999999999999 112.173 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 18.0 tppt? -61.53 -38.54 87.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 2.04 111.035 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.405 -0.807 . . . . 4.2199999999999998 111.119 -177.294 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 18.4 p-10 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.71 0.29 . . . . 1.6599999999999999 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.444 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . 6.2 p90 -179.41 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.343 -0.389 . . . . 3.73 110.575 177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.878 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.2 t70 -64.85 -62.79 4.36 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.51 -0.314 . . . . 2.7799999999999998 111.299 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 10.3 Cg_endo -90.42 -57.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.697 1.598 . . . . 1.6299999999999999 111.245 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.429 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 49.7 p90 -152.12 167.36 28.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.063 -0.971 . . . . 3.21 108.849 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.745 ' HA ' ' HB2' ' A' ' 1' ' ' ASN . 4.3 m -104.57 133.65 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.271 -1.011 . . . . 1.4399999999999999 108.271 174.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.4 ttp180 -131.1 150.05 52.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.421 0.629 . . . . 3.3700000000000001 111.041 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.995 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 2.3 t-160 -119.31 132.82 55.94 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.756 -1.202 . . . . 0.79000000000000004 107.756 170.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 7.0 t -139.62 114.43 9.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.362 -0.535 . . . . 1.28 110.155 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.3 t -131.65 139.73 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.664 -0.698 . . . . 1.27 111.067 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -99.08 115.46 29.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.41 -0.589 . . . . 0.56999999999999995 109.41 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.829 HG13 HG21 ' A' ' 148' ' ' ILE . 45.8 t -97.14 130.5 45.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.982 -0.554 . . . . 0.91000000000000003 109.825 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.658 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.76 23.85 12.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.172 -0.467 . . . . 0.97999999999999998 111.517 -174.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.57 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -147.06 29.15 0.99 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.837 -0.345 . . . . 0.35999999999999999 111.747 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 24.3 t70 72.53 165.28 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.778 0.799 . . . . 0.91000000000000003 112.566 175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 17.3 ttp180 -66.1 -25.72 67.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.988 -1.006 . . . . 1.8799999999999999 111.44 -172.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -59.78 -51.13 71.07 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.224 -0.444 . . . . 3.0499999999999998 110.985 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 42.9 p -72.17 -32.9 67.27 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.579 -0.282 . . . . 1.1100000000000001 110.62 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.4 -51.07 69.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.32000000000000001 110.635 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -69.79 -41.5 75.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.38 110.6 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 4.3 tppp? -53.87 -52.81 59.25 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.98 -0.554 . . . . 2.3900000000000001 110.779 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.424 HG22 ' NE1' ' A' ' 30' ' ' TRP . 6.5 m -69.63 -48.64 59.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.009 -0.541 . . . . 0.68000000000000005 110.665 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.876 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 63.1 t80 -62.16 -32.67 73.32 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.22 0.452 . . . . 0.47999999999999998 112.22 -172.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' A' ' 46' ' ' VAL . 15.1 tp -117.82 -51.27 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.754 0.65 . . . . 0.5 112.754 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.443 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 38.7 mt-10 -76.82 -20.94 55.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.924 0.393 . . . . 1.24 111.355 -173.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.667 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -118.95 36.24 3.64 Favored Glycine 0 C--O 1.221 -0.676 0 C-N-CA 120.843 -0.694 . . . . 0.82999999999999996 111.98 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.517 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 58.4 t80 -53.01 -51.74 71.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.629 0.603 . . . . 0.73999999999999999 112.629 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 41.1 Cg_endo -87.5 12.39 2.93 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.757 1.638 . . . . 0.76000000000000001 114.821 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 7.8 pt-20 -102.89 -4.93 24.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.295 -0.562 . . . . 1.49 111.577 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.876 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 34.8 m0 -69.4 168.83 13.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.464 0.65 . . . . 4.6200000000000001 111.873 -175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.501 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 56.5 m95 -86.02 -38.03 0.56 Allowed Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 114.978 -1.01 . . . . 2.7799999999999998 113.435 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.765 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 58.0 Cg_endo -68.65 -105.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.375 2.05 . . . . 1.3600000000000001 115.071 -165.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' ND2' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -79.65 -42.65 24.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.02 0.438 . . . . 1.51 111.051 -175.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -81.88 68.03 8.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.535 0.684 . . . . 1.79 111.08 -179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -132.01 12.06 4.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.091 -0.959 . . . . 4.4500000000000002 109.627 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.445 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.8 OUTLIER -126.47 137.2 53.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.862 -0.608 . . . . 4.1399999999999997 111.252 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -77.09 141.19 40.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 2.6800000000000002 110.89 -174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 56.0 p 55.47 18.43 2.66 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.84 0.856 . . . . 1.4199999999999999 112.3 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.563 ' HE3' ' HA2' ' A' ' 85' ' ' GLY . 45.9 tttp -110.7 -61.85 1.62 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.801 -0.814 . . . . 2.8999999999999999 108.801 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.634 HG11 ' OD1' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -157.46 25.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.887 -1.051 . . . . 1.8300000000000001 110.035 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.36 36.34 0.24 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.305 -0.95 . . . . 2.1699999999999999 113.27 -171.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.006 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.96 170.42 13.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.678 -0.49 . . . . 1.1200000000000001 109.678 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -64.25 67.79 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.698 2.265 . . . . 1.48 113.071 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -175.35 -84.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.554 -0.748 . . . . 1.75 110.16 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.517 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 87.05 -58.68 4.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.963 -0.636 . . . . 0.75 112.474 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 24' ' ' LEU . 91.9 t -135.69 137.91 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.926 0.393 . . . . 0.59999999999999998 110.907 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.651 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 23.7 t70 -103.8 99.36 9.14 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.749 -0.834 . . . . 1.1100000000000001 108.749 173.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -80.76 -9.13 59.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.309 -0.859 . . . . 2.8100000000000001 111.186 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -68.18 -55.58 11.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.984 -0.553 . . . . 3.1699999999999999 110.583 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.12 -54.08 1.05 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.958 -0.639 . . . . 1.53 111.658 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 132.13 64.19 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.82 -0.705 . . . . 0.77000000000000002 112.648 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.76 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 21.4 ptt180 -149.34 140.21 22.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.636 0.255 . . . . 3.7200000000000002 111.54 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.736 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 16.4 m0 -97.21 108.23 20.92 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.67 -0.241 . . . . 1.28 110.591 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.651 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.3 p90 -158.25 176.15 12.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.453 . . . . 1.6599999999999999 110.966 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.006 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 18.5 mt-10 -130.6 155.19 46.96 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 2.1200000000000001 110.595 -174.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.648 HG23 ' HG2' ' A' ' 61' ' ' GLU . 37.4 mm -78.22 103.0 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.499 -0.926 . . . . 0.92000000000000004 108.499 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.659 ' OD2' ' HG3' ' A' ' 59' ' ' GLN . 12.5 t70 -92.68 150.3 20.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.169 -0.468 . . . . 1.97 109.963 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.18 -6.92 58.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.78 0.659 . . . . 2.4300000000000002 112.78 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.659 ' HG3' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -90.12 7.3 38.6 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.473 -0.891 . . . . 2.3900000000000001 110.471 170.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.42 62.11 0.45 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.953 -0.641 . . . . 2.29 113.76 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.648 ' HG2' HG23 ' A' ' 56' ' ' ILE . 40.0 mt-10 44.74 54.07 6.89 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.281 0.845 . . . . 2.3100000000000001 113.281 171.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' H ' HE22 ' A' ' 59' ' ' GLN . 0.8 OUTLIER -127.77 84.68 2.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.413 0.625 . . . . 2.6099999999999999 110.143 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -124.54 158.42 32.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.197 -0.91 . . . . 3.7200000000000002 109.593 172.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -59.65 142.03 53.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.251 -0.648 . . . . 2.27 109.251 170.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.76 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 p90 -121.83 117.48 26.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.097 0.475 . . . . 6.4800000000000004 111.187 -177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -57.15 134.28 52.36 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-N 115.235 -0.893 . . . . 1.23 111.754 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.69 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -92.26 88.1 6.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.191 0.52 . . . . 1.1699999999999999 110.668 -171.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 58.2 mt -74.17 121.32 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.202 0.525 . . . . 0.60999999999999999 110.382 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -31.09 24.65 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.603 -0.726 . . . . 2.0 109.539 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -160.21 119.92 2.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 1.53 111.819 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 68' ' ' ILE . 60.8 t -99.6 100.34 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.152 -1.055 . . . . 0.88 108.152 167.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 1.4 t70 -108.48 70.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.768 -0.373 . . . . 1.4199999999999999 110.96 -172.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 pt-20 47.03 -170.39 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 124.471 1.107 . . . . 0.95999999999999996 111.722 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.8 Cg_exo -64.23 75.21 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.474 1.449 . . . . 0.38 111.342 166.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -157.35 -62.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.75 -0.659 . . . . 0.5 110.413 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.4 p -147.75 148.37 30.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.324 0.49 . . . . 0.34999999999999998 112.324 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 mp -136.59 114.92 11.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.73999999999999999 109.416 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.623 HG22 HG23 ' A' ' 98' ' ' THR . 36.4 t -101.33 104.9 16.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.897 -0.779 . . . . 0.67000000000000004 108.897 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -128.55 144.7 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.826 0.346 . . . . 0.75 111.293 -174.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.69 ' HA3' ' HG ' ' A' ' 67' ' ' LEU . . . -98.47 159.56 20.46 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.774 -0.648 . . . . 0.5 112.717 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.9 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 54.4 t-105 -64.56 157.21 27.5 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 112.794 0.664 . . . . 2.79 112.794 -168.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.2 tmt_? -149.96 -2.19 0.41 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.502 -0.772 . . . . 5.46 110.373 -167.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 88' ' ' ARG . 3.1 tm? 71.19 133.06 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.468 -0.787 . . . . 1.55 110.882 -176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.634 ' OD1' HG11 ' A' ' 40' ' ' VAL . 55.5 t30 -108.15 135.94 48.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.936 -0.575 . . . . 1.9299999999999999 110.324 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.563 ' HA2' ' HE3' ' A' ' 39' ' ' LYS . . . 106.08 -17.21 41.57 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.564 -0.827 . . . . 2.3999999999999999 112.732 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.6 t80 69.87 -54.62 0.61 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.139 0.575 . . . . 5.3799999999999999 111.83 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.34 10.78 47.82 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.947 -0.461 . . . . 2.2999999999999998 111.947 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.696 ' HB3' HD11 ' A' ' 83' ' ' LEU . 1.9 tpp180 -97.33 167.89 10.74 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.559 -1.275 . . . . 4.7699999999999996 107.559 173.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.687 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -113.4 123.22 68.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 119.927 -0.709 . . . . 1.8600000000000001 112.023 -173.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 16.8 t70 -160.17 131.37 3.87 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 108.35 -0.981 . . . . 3.1800000000000002 108.35 166.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 128' ' ' ARG . 7.9 Cg_exo -73.63 1.71 6.62 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.749 2.299 . . . . 2.3599999999999999 113.393 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.2 t70 60.68 81.17 0.19 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.463 -0.569 . . . . 2.9900000000000002 109.463 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -126.96 -64.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.219 0.452 . . . . 3.0600000000000001 112.219 -172.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.9 m -124.19 -145.41 0.34 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.22 -0.446 . . . . 1.8500000000000001 111.24 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.9 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 9.2 t 73.16 67.93 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.28 -0.873 . . . . 1.4399999999999999 111.385 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.88 98.4 10.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.487 -0.779 . . . . 1.8100000000000001 109.847 172.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HA ' ' HB2' ' A' ' 115' ' ' HIS . 7.5 p90 -104.83 130.98 52.85 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.168 -0.613 . . . . 0.64000000000000001 111.323 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.623 HG23 HG22 ' A' ' 78' ' ' VAL . 12.6 m -91.99 110.49 21.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.413 -0.812 . . . . 0.42999999999999999 110.655 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.764 ' HA ' HG22 ' A' ' 113' ' ' VAL . 60.2 t -82.3 109.27 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.394 -0.595 . . . . 0.87 109.394 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.545 ' HA ' HG22 ' A' ' 76' ' ' THR . 8.1 m -101.57 106.92 18.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.321 -0.399 . . . . 0.45000000000000001 110.732 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.722 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.4 m-85 -88.94 107.31 18.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.551 -0.537 . . . . 0.34000000000000002 109.551 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -93.13 108.98 21.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.494 -0.558 . . . . 0.54000000000000004 109.494 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.77 141.01 58.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.832 -0.622 . . . . 0.44 111.014 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.711 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 7.3 t70 -126.65 92.64 3.59 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.043 -0.526 . . . . 2.0299999999999998 109.593 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.15 -108.44 2.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.74 -0.743 . . . . 1.97 112.436 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -140.96 -2.43 1.31 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.714 0.265 . . . . 4.9299999999999997 111.714 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -3.17 1.34 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.758 0.651 . . . . 3.5299999999999998 112.758 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 49.1 tttm -127.46 157.08 41.02 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.486 -0.486 . . . . 2.4399999999999999 109.945 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.1 m -159.18 123.39 3.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.446 -0.343 . . . . 0.41999999999999998 110.548 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -97.23 118.61 34.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.271 -0.64 . . . . 2.5899999999999999 109.271 173.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.722 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 p -99.89 134.53 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.775 -0.454 . . . . 0.40000000000000002 109.775 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.752 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.2 t70 -138.3 114.43 10.15 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.25 -0.887 . . . . 1.3799999999999999 109.877 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.995 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 25.6 t -91.39 124.4 43.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.105 -0.498 . . . . 0.91000000000000003 110.782 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -107.38 115.95 31.06 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 124.003 0.815 . . . . 2.3100000000000001 109.621 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.649 ' HB2' ' HA ' ' A' ' 97' ' ' PHE . 25.8 t60 -154.7 143.33 20.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.426 . . . . 1.6399999999999999 110.744 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 9.7 t -162.36 119.27 2.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.054 0.391 . . . . 2.6699999999999999 112.054 173.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 116' ' ' THR . 76.9 t60 169.16 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.541 -0.754 . . . . 2.6299999999999999 110.788 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -53.23 -50.33 64.97 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.652 0.612 . . . . 3.54 112.652 -169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 8.3 t70 -78.69 -39.92 35.29 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.916 0.388 . . . . 1.8100000000000001 111.548 -177.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -66.3 -27.45 67.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 3.3799999999999999 110.856 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 32.9 tpp -98.55 18.34 16.94 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 107.985 -1.117 . . . . 2.4300000000000002 107.985 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.651 ' HA2' ' HB3' ' A' ' 125' ' ' HIS . . . -66.22 -88.13 0.06 OUTLIER Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.729 -1.578 . . . . 1.6100000000000001 114.339 -168.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 127' ' ' LYS . 28.7 m 57.3 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.703 -0.851 . . . . 2.5800000000000001 108.703 -165.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -65.66 -55.07 19.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.266 -0.642 . . . . 3.7999999999999998 109.266 170.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.651 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 3.0 t-160 -64.51 -48.26 75.79 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.494 -0.775 . . . . 2.1400000000000001 111.208 -173.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.566 ' HB2' ' HA3' ' A' ' 122' ' ' GLY . . . -58.51 -45.98 87.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.163 -0.472 . . . . 0.92000000000000004 111.249 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 123' ' ' THR . 5.7 tmtm? -61.76 -47.38 85.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 2.8300000000000001 110.887 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.687 ' HB2' HG23 ' A' ' 89' ' ' ILE . 7.4 ptp180 -68.3 -35.1 77.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.439 0.533 . . . . 2.5899999999999999 112.439 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.408 HG13 ' CZ2' ' A' ' 81' ' ' TRP . 91.9 t -80.23 -40.87 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.979 0.419 . . . . 1.48 111.25 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -62.56 -15.03 48.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.745 -0.662 . . . . 3.8300000000000001 111.171 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.68 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 94.5 m-20 -58.77 -22.68 58.62 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.97 -0.559 . . . . 2.48 112.243 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.18 -31.83 0.07 OUTLIER Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.005 -1.093 . . . . 1.6100000000000001 114.059 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -65.0 -23.25 67.16 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.557 -0.378 . . . . 4.8300000000000001 110.851 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -66.38 -24.73 66.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.927 -0.579 . . . . 2.8300000000000001 111.983 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -113.26 -48.03 2.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.882 0.372 . . . . 4.1500000000000004 110.833 -176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -61.41 -56.73 21.74 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.858 -0.61 . . . . 1.04 113.236 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.589 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -60.38 -48.52 93.61 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.431 0.53 . . . . 2.7799999999999998 112.431 -173.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 15.6 Cg_endo -58.87 -42.34 53.58 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.648 1.566 . . . . 0.68000000000000005 112.026 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.8 m -64.53 -35.44 80.96 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.685 0.755 . . . . 0.87 109.387 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 137' ' ' TRP . 13.6 mt -54.79 -49.16 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.597 -1.183 . . . . 0.71999999999999997 110.809 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.0 mt -62.9 -29.11 70.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.295 0.48 . . . . 0.68999999999999995 112.295 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.19 -57.5 4.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 1.49 110.318 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.474 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 29.5 m -65.36 -23.4 66.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.103 0.478 . . . . 1.1499999999999999 110.621 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 45.7 t80 -61.56 -54.78 38.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.806 -0.634 . . . . 0.80000000000000004 110.233 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.558 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.2 mt-30 -60.49 -31.81 70.83 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.83 -0.623 . . . . 1.6299999999999999 110.894 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -42.37 69.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.758 -0.655 . . . . 1.46 111.735 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 18.3 tptm -69.97 -35.04 74.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.492 -0.483 . . . . 1.74 109.723 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.829 HG21 HG13 ' A' ' 12' ' ' VAL . 62.2 mt -66.45 -35.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.5 110.393 175.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 154' ' ' LYS . 19.0 t70 -59.14 -40.42 85.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.84999999999999998 109.044 175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 154' ' ' LYS . 43.7 mt-10 -68.38 -35.37 77.59 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.801 -0.636 . . . . 1.5 110.787 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.82 -43.88 97.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 1.74 111.264 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.22 -66.15 1.68 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.529 -0.843 . . . . 1.3200000000000001 111.861 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.482 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . -173.5 89.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.719 -0.474 . . . . 1.9199999999999999 109.719 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 149' ' ' ASP . 11.9 tppt? -73.88 134.41 43.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.976 0.417 . . . . 2.04 110.245 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 153' ' ' ALA . 5.0 mptt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.475 -0.774 . . . . 4.2199999999999998 110.62 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.524 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 19.6 p-10 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.161 0.505 . . . . 1.6599999999999999 110.715 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.505 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 46.6 p90 -176.47 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.867 -0.606 . . . . 3.73 110.751 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.985 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 10.2 t70 -72.57 -64.85 0.85 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.616 -0.266 . . . . 2.7799999999999998 111.009 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.985 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 27.8 Cg_endo -97.51 -67.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.506 2.137 . . . . 1.6299999999999999 113.151 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 4' ' ' PRO . 70.8 m-85 -124.72 113.59 18.18 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.417 -0.356 . . . . 3.21 111.052 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.823 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 46.0 t -90.81 111.91 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.148 -0.686 . . . . 1.4399999999999999 109.148 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.667 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.8 ttp180 -133.22 134.96 44.72 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.043 -0.663 . . . . 3.3700000000000001 111.174 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' HD1' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.92 131.75 54.78 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.886 -0.783 . . . . 0.79000000000000004 108.886 173.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 16.3 m -132.93 110.43 10.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.594 -0.73 . . . . 1.28 109.852 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.2 t -124.63 139.29 51.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.144 -0.934 . . . . 1.27 110.867 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.6 m -103.67 114.61 29.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.71 0.767 . . . . 0.56999999999999995 109.875 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.809 HG13 HG21 ' A' ' 148' ' ' ILE . 25.1 t -90.77 139.06 18.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.098 -0.955 . . . . 0.91000000000000003 109.682 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.641 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -111.61 29.25 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.103 0.478 . . . . 0.97999999999999998 110.871 -176.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.629 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.84 29.41 0.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.35999999999999999 111.635 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 35.3 t70 72.2 162.38 0.25 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.749 0.785 . . . . 0.91000000000000003 112.423 176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 33.6 ttp180 -65.59 -23.65 66.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.133 -0.94 . . . . 1.8799999999999999 111.036 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 17' ' ' LYS . 21.1 ttmt -57.29 -44.99 84.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 3.0499999999999998 110.587 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 68.4 p -80.23 -31.82 38.49 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.336 -0.393 . . . . 1.1100000000000001 110.515 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.41 -47.59 81.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.32000000000000001 110.687 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 83.0 t80 -67.77 -44.32 77.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.38 110.443 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 18' ' ' THR . 42.3 tttp -52.17 -49.49 63.7 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.839 -0.619 . . . . 2.3900000000000001 110.488 175.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.728 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 29.1 m -68.39 -52.49 32.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.297 -0.41 . . . . 0.68000000000000005 111.688 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.761 ' HA ' ' HZ ' ' A' ' 144' ' ' PHE . 60.1 t80 -65.36 -30.72 71.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.889 -0.324 . . . . 0.47999999999999998 111.756 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' CD1' HG11 ' A' ' 46' ' ' VAL . 15.6 tp -120.12 -54.15 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.315 0.857 . . . . 0.5 113.315 -172.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -81.37 -23.7 37.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.568 0.581 . . . . 1.24 112.568 -167.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -110.16 28.98 9.66 Favored Glycine 0 C--N 1.314 -0.665 0 N-CA-C 111.24 -0.744 . . . . 0.82999999999999996 111.24 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.657 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 41.6 t80 -48.01 -54.32 25.4 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.928 -0.636 . . . . 0.73999999999999999 112.447 -170.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 8.1 Cg_endo -95.67 38.06 0.14 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.051 1.834 . . . . 0.76000000000000001 115.298 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.9 pt-20 -132.1 -11.11 3.33 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.481 -0.888 . . . . 1.49 113.03 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.773 ' CE3' ' HG2' ' A' ' 147' ' ' LYS . 11.2 m95 -76.92 172.79 12.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.226 0.536 . . . . 4.6200000000000001 111.746 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.486 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 m95 -74.6 -47.65 5.34 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 113.929 1.085 . . . . 2.7799999999999998 113.929 -175.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.766 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 27.7 Cg_endo -57.87 -87.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.714 2.276 . . . . 1.3600000000000001 115.108 -158.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' HB3' HD11 ' A' ' 140' ' ' ILE . 6.9 t30 -111.12 -3.73 15.33 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.432 -0.951 . . . . 1.51 108.432 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.618 ' HA ' HG23 ' A' ' 40' ' ' VAL . 15.0 m120 -93.83 22.69 5.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.44 -1.255 . . . . 1.79 112.579 -168.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -134.23 58.3 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.392 0.615 . . . . 4.4500000000000002 110.416 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 36.9 mmt180 -136.47 145.58 45.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 4.1399999999999997 109.597 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -75.65 132.43 40.58 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.801 -0.359 . . . . 2.6800000000000002 110.221 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 57' ' ' ASP . 73.0 p 53.69 21.76 2.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.861 0.864 . . . . 1.4199999999999999 111.798 -172.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' HD3' ' HA3' ' A' ' 85' ' ' GLY . 5.1 mmtp -138.58 79.69 1.75 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.851 -0.613 . . . . 2.8999999999999999 110.592 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.618 HG23 ' HA ' ' A' ' 34' ' ' ASN . 22.2 m 42.61 26.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.5 -1.227 . . . . 1.8300000000000001 112.982 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.13 16.41 2.55 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.133 -0.556 . . . . 2.1699999999999999 111.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.038 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.93 162.01 66.45 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 108.991 -0.744 . . . . 1.1200000000000001 108.991 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.34 50.68 0.17 Allowed 'Trans proline' 0 N--CA 1.48 0.717 0 C-N-CA 123.263 2.642 . . . . 1.48 114.679 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.1 tp -166.34 -87.76 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.708 0.289 . . . . 1.75 110.995 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.657 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 91.48 -56.59 3.11 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.817 -0.706 . . . . 0.75 112.59 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.593 HG11 ' CD1' ' A' ' 24' ' ' LEU . 97.3 t -134.47 145.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.014 0.435 . . . . 0.59999999999999998 111.003 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 1.028 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.3 t70 -121.28 102.78 8.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.566 -0.743 . . . . 1.1100000000000001 109.038 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 15.3 mtmt -77.75 -28.45 50.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.213 0.449 . . . . 2.8100000000000001 112.213 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -72.63 -35.08 67.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.961 -0.296 . . . . 3.1699999999999999 111.05 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.72 -42.41 4.47 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.821 -0.704 . . . . 1.53 112.097 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 68' ' ' ILE . . . 102.5 45.48 1.67 Allowed Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.913 -0.661 . . . . 0.77000000000000002 112.921 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -144.06 165.04 28.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.466 -0.432 . . . . 3.7200000000000002 111.607 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.618 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 18.9 m0 -108.15 123.98 49.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.824 -0.625 . . . . 1.28 109.627 173.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 1.028 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 2.7 p90 -163.36 151.43 13.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.954 0.407 . . . . 1.6599999999999999 110.784 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.038 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.6 mp0 -117.95 160.18 21.88 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.488 -0.56 . . . . 2.1200000000000001 109.488 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' HG2' ' A' ' 61' ' ' GLU . 26.8 mm -78.25 103.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.33 -0.395 . . . . 0.92000000000000004 110.017 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.507 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.9 t70 -84.25 -166.53 1.46 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 1.97 110.012 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.56 -37.86 22.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.027 0.38 . . . . 2.4300000000000002 112.027 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.464 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.9 OUTLIER -92.18 23.56 3.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.155 0.503 . . . . 2.3900000000000001 110.937 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.35 -113.27 0.86 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.875 -1.155 . . . . 2.29 113.011 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.568 ' O ' ' HD1' ' A' ' 54' ' ' TYR . 40.4 mt-10 -149.12 2.06 0.56 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.262 0.467 . . . . 2.3100000000000001 112.262 -167.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -93.11 90.82 7.04 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.929 0.871 . . . . 2.6099999999999999 110.683 -168.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.481 ' CD2' ' HB2' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -121.4 87.78 2.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.382 -1.281 . . . . 3.7200000000000002 111.028 -177.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.735 HG23 ' HD1' ' A' ' 86' ' ' PHE . 0.8 OUTLIER 54.25 179.15 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.606 0.717 . . . . 2.27 112.733 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -133.65 99.26 4.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.192 -0.458 . . . . 6.4800000000000004 110.424 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.704 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.78 119.57 9.14 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 109.556 -1.418 . . . . 1.23 109.556 173.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' H ' HD12 ' A' ' 67' ' ' LEU . 3.8 mp -79.91 86.33 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.255 -0.578 . . . . 1.1699999999999999 110.667 -169.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.67 HG21 HG23 ' A' ' 71' ' ' VAL . 19.2 mt -76.43 114.8 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.694 -1.202 . . . . 0.60999999999999999 109.326 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.42 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 18.0 mmm180 -95.54 -25.4 16.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.759 -1.109 . . . . 2.0 109.388 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 72' ' ' ASP . 81.8 tttt -161.01 115.63 2.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.769 -0.65 . . . . 1.53 111.525 -175.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.67 HG23 HG21 ' A' ' 68' ' ' ILE . 89.6 t -107.35 102.01 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.564 -0.902 . . . . 0.88 108.564 168.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 9.1 t0 -112.86 69.23 0.69 Allowed 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.367 -0.533 . . . . 1.4199999999999999 110.462 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.8 pt-20 46.12 -169.05 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.712 0 O-C-N 124.706 1.254 . . . . 0.95999999999999996 111.578 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.596 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 30.0 Cg_exo -64.52 78.47 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.154 1.236 . . . . 0.38 111.408 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 17.9 t70 -161.96 -66.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.717 -0.674 . . . . 0.5 110.445 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.5 p -140.71 141.41 34.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.141 0.496 . . . . 0.34999999999999998 112.308 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD23 HD22 ' A' ' 24' ' ' LEU . 2.7 mp -135.55 122.26 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.73999999999999999 109.717 176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 98' ' ' THR . 41.9 t -110.32 106.81 21.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.423 -0.584 . . . . 0.67000000000000004 109.423 176.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -130.99 133.87 62.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.027 0.441 . . . . 0.75 112.137 -178.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.837 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -80.43 156.92 39.74 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.946 -0.57 . . . . 0.5 112.562 176.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -66.89 144.16 56.42 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.236 0.541 . . . . 2.79 112.347 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.704 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 4.5 ttp180 -136.35 -18.17 1.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.971 -1.013 . . . . 5.46 109.689 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.91 HD21 ' HB2' ' A' ' 88' ' ' ARG . 7.5 tt 80.02 162.08 0.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.271 -0.877 . . . . 1.55 111.311 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.77 97.63 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 1.9299999999999999 110.817 -174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.633 ' HA3' ' HD3' ' A' ' 39' ' ' LYS . . . 103.19 -9.49 54.21 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 119.274 -1.441 . . . . 2.3999999999999999 115.038 165.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.735 ' HD1' HG23 ' A' ' 64' ' ' THR . 36.0 t80 73.15 -19.22 0.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.823 0.812 . . . . 5.3799999999999999 112.154 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.76 -17.82 60.96 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.366 -0.445 . . . . 2.2999999999999998 112.421 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.91 ' HB2' HD21 ' A' ' 83' ' ' LEU . 40.6 mtm105 -108.92 173.61 6.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 122.408 0.283 . . . . 4.7699999999999996 110.248 175.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.4 HG23 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -78.58 115.49 20.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.491 0.662 . . . . 1.8600000000000001 111.676 -172.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.54 138.96 21.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 3.1800000000000002 110.224 176.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 93' ' ' ASN . 33.8 Cg_endo -65.2 -38.61 26.62 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.897 2.398 . . . . 2.3599999999999999 113.481 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 26.3 t70 72.33 -24.3 0.19 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.492 0.663 . . . . 2.9900000000000002 111.154 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 91' ' ' PRO . 39.7 m-80 -130.78 81.94 2.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.939 -1.504 . . . . 3.0600000000000001 106.939 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 95' ' ' SER . 2.6 p -107.06 -164.35 0.98 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.665 1.358 . . . . 1.8500000000000001 114.665 -160.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 1.099 ' HA ' ' HB3' ' A' ' 117' ' ' HIS . 41.3 m -72.87 -45.17 59.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 112.311 -2.222 . . . . 1.4399999999999999 111.963 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.837 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 12.1 tt0 70.89 111.39 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.046 0.841 . . . . 1.8100000000000001 109.793 -174.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.439 ' HB3' ' ND1' ' A' ' 115' ' ' HIS . 40.3 p90 -115.06 150.81 35.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.203 0.525 . . . . 0.64000000000000001 111.589 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.561 HG23 HG22 ' A' ' 78' ' ' VAL . 57.8 m -108.22 114.49 28.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.388 -0.824 . . . . 0.42999999999999999 110.621 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.753 ' HA ' HG22 ' A' ' 113' ' ' VAL . 90.4 t -88.56 110.49 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.618 . . . . 0.87 110.272 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.456 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.6 m -104.36 105.91 16.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.19 -0.459 . . . . 0.45000000000000001 110.526 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.4 m-85 -89.36 109.27 20.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.153 -0.476 . . . . 0.34000000000000002 110.283 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' THR . 59.5 t -89.54 107.9 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.813 -0.44 . . . . 0.54000000000000004 109.813 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.6 33.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.516 . . . . 0.44 110.258 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.7 t70 -125.43 112.96 16.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.92 0.39 . . . . 2.0299999999999998 110.62 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.2 -112.92 5.02 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.87 -0.681 . . . . 1.97 112.161 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 6.5 tt0 -141.05 -17.97 0.82 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.016 0.436 . . . . 4.9299999999999997 110.132 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -131.9 24.87 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 3.5299999999999998 111.799 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.9 ttmp? -140.97 150.87 43.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.27 -0.572 . . . . 2.4399999999999999 110.916 175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.583 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.2 m -158.93 112.29 2.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.878 -0.601 . . . . 0.41999999999999998 110.372 174.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.81 110.64 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.582 -0.525 . . . . 2.5899999999999999 109.582 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 9' ' ' SER . 10.9 p -90.59 138.14 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.647 -0.421 . . . . 0.40000000000000002 110.326 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.465 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 12.0 t70 -128.18 114.67 17.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.895 -0.78 . . . . 1.3799999999999999 108.895 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 99' ' ' VAL . 25.2 t -104.4 121.24 55.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.32 -0.855 . . . . 0.91000000000000003 111.345 -175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -97.59 132.79 42.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 2.3100000000000001 109.629 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.823 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 4.1 t60 -150.91 110.17 3.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.118 -0.697 . . . . 1.6399999999999999 109.118 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.609 ' OG1' ' HD2' ' A' ' 120' ' ' ARG . 8.6 t -163.3 97.44 0.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.693 0.759 . . . . 2.6699999999999999 110.694 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 1.099 ' HB3' ' HA ' ' A' ' 95' ' ' SER . 3.3 t-160 -163.92 -77.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.817 -0.629 . . . . 2.6299999999999999 111.464 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.13 -39.57 17.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.407 0.521 . . . . 3.54 112.407 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.722 ' HB3' HG21 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -75.43 -34.31 60.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.35 0.595 . . . . 1.8100000000000001 109.588 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.609 ' HD2' ' OG1' ' A' ' 116' ' ' THR . 40.3 ttt180 -48.21 -21.5 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.439 -1.255 . . . . 3.3799999999999999 112.075 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 24.2 mmt -82.06 14.11 3.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 2.4300000000000002 111.239 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.49 -155.53 4.93 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.764 -0.653 . . . . 1.6100000000000001 114.18 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 t 38.16 -130.66 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.114 0.966 . . . . 2.5800000000000001 112.141 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 56.4 tttp -50.77 -43.29 58.44 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 122.962 0.505 . . . . 3.7999999999999998 112.063 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 129' ' ' VAL . 38.5 m80 -53.69 -52.2 60.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.336 0.589 . . . . 2.1400000000000001 111.005 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -76.86 -29.75 55.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.399 -0.364 . . . . 0.92000000000000004 110.961 -177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.03 -52.89 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 2.8300000000000001 110.479 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 23.6 ptt85 -61.09 -31.86 71.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 2.5899999999999999 110.842 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' A' ' 119' ' ' ASP . 70.6 t -65.84 -41.99 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 120.677 0.275 . . . . 1.48 110.78 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -64.73 -15.97 62.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.366 -0.379 . . . . 3.8300000000000001 111.557 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.511 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 6.1 m-20 -52.28 -21.55 3.59 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.503 0.557 . . . . 2.48 112.503 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 88' ' ' ARG . . . -169.53 -28.2 0.02 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.021 -1.085 . . . . 1.6100000000000001 114.274 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.407 ' O ' ' HD2' ' A' ' 138' ' ' PRO . 12.7 tmm? -60.97 -40.95 95.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.404 0.602 . . . . 4.8300000000000001 110.281 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.31 -27.21 45.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.973 -0.558 . . . . 2.8300000000000001 112.417 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -107.02 -47.23 3.74 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.003 0.43 . . . . 4.1500000000000004 111.466 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.645 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -65.39 -54.94 23.62 Favored Glycine 0 C--O 1.223 -0.547 0 CA-C-N 116.021 -0.536 . . . . 1.04 113.226 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t90 -60.74 -51.0 82.68 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 112.034 0.383 . . . . 2.7799999999999998 112.034 -171.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 12.5 Cg_endo -57.94 -42.34 59.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.842 1.695 . . . . 0.68000000000000005 112.111 174.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 95.2 m -65.5 -34.99 79.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.336 0.589 . . . . 0.87 110.076 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.766 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 47.7 mt -56.96 -46.07 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.363 -0.835 . . . . 0.71999999999999997 110.331 175.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 65.7 mt -62.38 -31.26 71.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.68999999999999995 112.215 -175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -74.75 -53.8 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.008 -0.277 . . . . 1.49 111.085 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 59.4 m -64.73 -23.42 67.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.11 0.481 . . . . 1.1499999999999999 110.217 177.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.761 ' HZ ' ' HA ' ' A' ' 23' ' ' PHE . 0.1 OUTLIER -59.1 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 0.80000000000000004 110.069 173.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.424 ' CG ' HG13 ' A' ' 10' ' ' VAL . 42.4 mt-30 -63.54 -25.26 68.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 1.6299999999999999 111.007 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.83 -49.87 34.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.46 111.195 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.773 ' HG2' ' CE3' ' A' ' 30' ' ' TRP . 52.3 tptt -68.02 -34.46 76.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.62 -0.432 . . . . 1.74 110.398 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.809 HG21 HG13 ' A' ' 12' ' ' VAL . 75.5 mt -67.67 -29.43 45.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.024 0.44 . . . . 0.5 110.378 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.01 -31.34 72.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.549 -0.537 . . . . 0.84999999999999998 109.549 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 154' ' ' LYS . 41.0 mt-10 -70.71 -29.89 66.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.581 -0.736 . . . . 1.5 109.928 176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -79.34 -23.42 43.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 1.74 110.008 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -97.47 22.97 37.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.634 -0.712 . . . . 1.3200000000000001 111.427 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.592 ' HB1' ' HE3' ' A' ' 155' ' ' LYS . . . 73.57 85.04 0.11 Allowed 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 124.639 0.846 . . . . 1.9199999999999999 110.625 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.631 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 13.3 tppt? -73.54 105.16 4.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.475 -0.784 . . . . 2.04 110.103 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HE3' ' HB1' ' A' ' 153' ' ' ALA . 17.5 ptpt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.863 -0.608 . . . . 4.2199999999999998 110.424 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.807 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 64.7 m-80 . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.415 -0.217 . . . . 1.6599999999999999 110.415 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.531 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 21.6 p90 168.92 -21.85 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 124.036 0.835 . . . . 3.73 109.374 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.983 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -49.54 -59.46 6.65 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.295 -0.866 . . . . 2.7799999999999998 110.541 -176.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.983 ' HD3' ' HB2' ' A' ' 3' ' ' ASP . 26.3 Cg_endo -97.34 -61.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.375 2.05 . . . . 1.6299999999999999 111.489 167.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -153.95 171.58 18.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.447 -1.316 . . . . 3.21 107.447 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.807 ' HA ' ' HB3' ' A' ' 1' ' ' ASN . 40.8 t -91.61 138.31 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 120.651 -0.42 . . . . 1.4399999999999999 111.155 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.8 ttp180 -134.6 146.58 49.73 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.163 -0.471 . . . . 3.3700000000000001 110.96 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.763 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -129.39 134.12 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 0.79000000000000004 109.844 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 14.4 m -129.15 113.39 15.02 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.191 0.52 . . . . 1.28 110.465 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.819 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.5 t -126.09 139.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.374 -0.83 . . . . 1.27 111.06 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -97.58 117.14 31.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.184 0.516 . . . . 0.56999999999999995 109.938 174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.938 HG13 HG21 ' A' ' 148' ' ' ILE . 50.8 t -100.65 122.71 52.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.458 0.646 . . . . 0.91000000000000003 111.323 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.821 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -90.29 13.34 15.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.901 -1.045 . . . . 0.97999999999999998 112.771 -173.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -146.16 27.69 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.301 0.852 . . . . 0.35999999999999999 113.301 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.9 t0 76.49 164.78 0.25 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.598 0.713 . . . . 0.91000000000000003 112.358 176.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.692 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 16.0 ttp180 -69.72 -37.32 76.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.024 -0.989 . . . . 1.8799999999999999 112.212 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 79.2 mttt -58.29 -49.17 78.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.706 0.765 . . . . 3.0499999999999998 109.951 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -66.3 -38.74 88.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.302 -1.317 . . . . 1.1100000000000001 110.909 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.764 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -57.77 -48.62 79.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.32000000000000001 110.479 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.6 t80 -61.25 -45.17 95.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.649 -0.705 . . . . 0.38 110.733 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 4.2 tppp? -58.28 -53.46 58.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 2.3900000000000001 110.798 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.4 m -62.62 -48.74 78.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.202 0.313 . . . . 0.68000000000000005 110.835 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.901 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 72.6 t80 -63.18 -43.67 97.57 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.132 0.419 . . . . 0.47999999999999998 112.132 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.606 HD11 HG11 ' A' ' 46' ' ' VAL . 17.3 tp -101.38 -56.26 2.34 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.519 -0.472 . . . . 0.5 112.119 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 51.6 mt-10 -96.2 15.56 20.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.391 0.615 . . . . 1.24 111.404 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.711 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -126.82 24.13 5.51 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.113 -1.195 . . . . 0.82999999999999996 110.113 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.841 ' HD2' ' HA2' ' A' ' 45' ' ' GLY . 10.3 t80 -52.79 -47.02 96.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 114.642 -0.779 . . . . 0.73999999999999999 112.995 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 23.2 Cg_endo -93.38 19.35 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.793 1.662 . . . . 0.76000000000000001 115.012 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.711 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -110.41 -7.42 14.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.091 -0.643 . . . . 1.49 112.381 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.901 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 19.3 m0 -74.09 169.98 16.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 4.6200000000000001 111.228 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.644 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 28.0 m95 -90.32 -29.54 0.34 Allowed Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.639 0.977 . . . . 2.7799999999999998 113.639 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.724 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 36.6 Cg_endo -66.19 -136.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.328 2.019 . . . . 1.3600000000000001 114.207 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 25.1 t30 -57.48 -35.97 70.87 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.104 0.954 . . . . 1.51 111.181 -173.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.006 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 3.0 p-10 -89.54 23.3 2.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.703 -1.135 . . . . 1.79 112.678 -169.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.73 -18.99 29.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.181 0.515 . . . . 4.4500000000000002 110.683 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.647 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 48.0 mtm105 -88.04 -179.2 6.15 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.455 0.539 . . . . 4.1399999999999997 112.455 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.529 HG23 ' HD3' ' A' ' 43' ' ' PRO . 27.9 m -101.18 137.54 39.41 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.621 -0.718 . . . . 2.6800000000000002 110.009 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 1.012 ' H ' ' HA ' ' A' ' 42' ' ' ALA . 44.5 p 50.22 28.84 3.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.493 0.717 . . . . 1.4199999999999999 111.232 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 1.006 ' HD3' ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -67.52 -71.07 0.22 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.717 -1.129 . . . . 2.8999999999999999 111.21 -177.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.861 ' H ' ' HD2' ' A' ' 39' ' ' LYS . 21.7 m -97.3 -13.01 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 122.217 1.008 . . . . 1.8300000000000001 108.548 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 38' ' ' THR . . . -168.69 -50.65 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 113.471 -1.695 . . . . 2.1699999999999999 110.479 174.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.012 ' HA ' ' H ' ' A' ' 38' ' ' THR . . . 152.01 -173.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 125.186 1.168 . . . . 1.1200000000000001 112.195 -172.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.638 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 20.3 Cg_exo -72.75 74.54 2.78 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.541 2.16 . . . . 1.48 113.34 167.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.79 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 41.7 tp -145.67 -87.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.072 -0.344 . . . . 1.75 110.072 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.841 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 134.58 -92.66 0.24 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.953 -1.118 . . . . 0.75 113.843 170.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 24' ' ' LEU . 87.9 t -132.99 148.06 31.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.314 0.578 . . . . 0.59999999999999998 111.821 -168.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.824 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.1 t70 -92.8 110.6 22.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.224 -0.898 . . . . 1.1100000000000001 109.154 173.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 17.8 tptm -80.75 -25.42 38.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.718 -0.674 . . . . 2.8100000000000001 111.601 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.3 ptpp? -73.97 -38.93 64.04 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.757 0.28 . . . . 3.1699999999999999 111.757 -171.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.72 -41.52 0.72 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.662 -0.78 . . . . 1.53 112.154 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.491 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 118.52 71.31 0.38 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.661 -0.781 . . . . 0.77000000000000002 112.232 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 47' ' ' ASP . 5.4 mpt_? -133.79 157.31 46.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.017 -0.364 . . . . 3.7200000000000002 110.017 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 29.8 m0 -112.81 117.06 31.12 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.607 -0.886 . . . . 1.28 108.607 168.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.824 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.7 p90 -162.22 155.01 19.9 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.047 0.451 . . . . 1.6599999999999999 110.06 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.79 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -139.16 172.73 12.41 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.119 -0.491 . . . . 2.1200000000000001 110.586 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' HG2' ' A' ' 61' ' ' GLU . 13.7 mm -78.59 99.16 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.92000000000000004 111.395 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.767 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 5.5 t70 -96.27 172.87 7.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.627 -0.509 . . . . 1.97 109.627 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.498 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.9 pt-20 -58.47 -40.34 82.4 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.799 1.037 . . . . 2.4300000000000002 113.799 -167.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.708 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -81.54 7.38 12.2 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.464 -0.494 . . . . 2.3900000000000001 112.307 -176.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.2 84.11 1.78 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.043 -1.075 . . . . 2.29 114.421 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 56' ' ' ILE . 43.5 mt-10 55.87 30.89 16.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.772 1.027 . . . . 2.3100000000000001 113.772 167.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -127.61 92.1 3.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.559 0.695 . . . . 2.6099999999999999 111.68 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.767 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -120.58 166.46 13.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.923 -1.035 . . . . 3.7200000000000002 110.599 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.681 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 9.1 p -47.37 105.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.719 0.637 . . . . 2.27 110.637 171.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 28.8 p90 -90.32 118.02 29.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.138 0.494 . . . . 6.4800000000000004 111.77 -173.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' ARG . . . -67.18 137.5 33.43 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.837 -0.905 . . . . 1.23 110.837 173.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.464 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -100.38 94.13 6.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.201 0.5 . . . . 1.1699999999999999 111.481 -171.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.609 HG21 HG22 ' A' ' 71' ' ' VAL . 55.4 mt -76.08 123.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.257 0.551 . . . . 0.60999999999999999 110.158 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HG3' ' HG3' ' A' ' 96' ' ' GLU . 10.5 mmm180 -87.72 -34.56 18.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.396 -0.82 . . . . 2.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -147.21 120.83 9.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.028 -0.533 . . . . 1.53 111.54 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 68' ' ' ILE . 32.1 t -102.75 92.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.284 -1.006 . . . . 0.88 108.284 167.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.63 63.28 0.72 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.789 -0.364 . . . . 1.4199999999999999 110.936 -173.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.654 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.8 pt-20 47.05 -169.37 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 124.476 1.11 . . . . 0.95999999999999996 112.031 175.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 33.2 Cg_exo -61.51 76.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.304 1.336 . . . . 0.38 111.798 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.9 -66.6 0.05 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.454 -0.794 . . . . 0.5 109.754 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.3 p -144.21 143.01 30.86 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.715 0.635 . . . . 0.34999999999999998 112.715 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.0 mp -132.47 116.19 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.145 -0.687 . . . . 0.73999999999999999 109.145 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 98' ' ' THR . 36.5 t -104.72 110.27 30.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.478 -0.564 . . . . 0.67000000000000004 109.478 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.98 140.55 48.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.871 0.367 . . . . 0.75 111.437 -178.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.2 161.1 23.2 Favored Glycine 0 C--O 1.239 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.5 112.639 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 1.073 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 38.9 t-105 -65.04 157.89 27.18 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 113.737 1.014 . . . . 2.79 113.737 -165.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.681 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 2.9 tpt180 -174.41 33.42 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.435 -1.257 . . . . 5.46 108.917 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 88' ' ' ARG . 13.9 tp 69.55 -133.9 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.549 -1.205 . . . . 1.55 111.857 175.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 59.7 t30 -167.41 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 120.877 0.37 . . . . 1.9299999999999999 110.204 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.27 11.02 25.46 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.193 -0.527 . . . . 2.3999999999999999 114.062 -172.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.5 t80 70.71 -43.37 0.55 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.529 0.731 . . . . 5.3799999999999999 112.783 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.94 38.41 2.17 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.237 -0.506 . . . . 2.2999999999999998 113.082 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.001 ' HB2' HD21 ' A' ' 83' ' ' LEU . 4.7 mmp_? -135.09 -175.16 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.52 -0.919 . . . . 4.7699999999999996 108.52 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.606 HD13 ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -112.32 132.68 60.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 120.906 0.384 . . . . 1.8600000000000001 110.918 -177.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -156.47 107.91 2.02 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 115.989 -0.551 . . . . 3.1800000000000002 110.601 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.606 ' HD3' HD13 ' A' ' 89' ' ' ILE . 1.6 Cg_endo -109.63 18.11 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 124.127 3.218 . . . . 2.3599999999999999 110.487 165.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' A' ' 118' ' ' PHE . 10.5 t70 -79.74 -77.23 0.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.366 -0.833 . . . . 2.9900000000000002 111.294 -159.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 33.9 m-80 76.59 -40.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.218 -0.901 . . . . 3.0600000000000001 112.359 172.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.785 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . 70.2 m -77.66 -7.57 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.627 0.232 . . . . 1.8500000000000001 111.627 -176.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 1.073 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 23.1 t -66.55 75.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.074 0.94 . . . . 1.4399999999999999 109.227 169.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.8 tt0 -97.69 123.72 41.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.499 -1.228 . . . . 1.8100000000000001 110.678 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.793 ' HB3' ' HD2' ' A' ' 115' ' ' HIS . 5.4 p90 -120.98 140.28 52.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.468 0.651 . . . . 0.64000000000000001 111.805 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.661 HG23 HG22 ' A' ' 78' ' ' VAL . 32.4 m -98.7 110.48 23.07 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.475 -1.238 . . . . 0.42999999999999999 109.721 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.0 t -81.92 108.28 14.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.357 -0.608 . . . . 0.87 109.357 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.639 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.8 m -102.7 106.7 17.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.086 0.47 . . . . 0.45000000000000001 111.21 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.692 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 47.9 m-85 -87.4 113.3 22.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.961 -0.563 . . . . 0.34000000000000002 109.968 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.79 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.604 -0.517 . . . . 0.54000000000000004 109.604 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.16 124.28 27.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.087 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 108' ' ' LYS . 23.2 m-20 -106.54 100.36 9.89 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.111 -0.7 . . . . 2.0299999999999998 109.111 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.85 -113.37 4.16 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.616 -0.802 . . . . 1.97 111.933 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.409 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 3.1 pt20 -147.02 4.89 0.84 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.544 0.211 . . . . 4.9299999999999997 111.089 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 47.6 mmtm -132.34 -12.23 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.791 0.293 . . . . 3.5299999999999998 111.791 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 104' ' ' ASP . 47.6 tttp -121.46 152.65 38.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.794 -0.447 . . . . 2.4399999999999999 109.794 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.6 m -157.95 119.1 3.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.901 0.381 . . . . 0.41999999999999998 111.087 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -94.37 123.54 37.84 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.511 -0.551 . . . . 2.5899999999999999 109.511 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.599 ' CG1' ' HB ' ' A' ' 10' ' ' VAL . 14.2 p -98.46 135.3 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.112 -0.635 . . . . 0.40000000000000002 110.391 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 6.3 p-10 -127.87 115.87 19.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.783 0.801 . . . . 1.3799999999999999 109.197 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.763 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 2.1 t -89.71 121.33 39.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.292 -0.867 . . . . 0.91000000000000003 110.377 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.73 136.25 44.59 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 124.148 0.905 . . . . 2.3100000000000001 108.715 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 97' ' ' PHE . 65.6 t-80 -128.46 153.53 47.04 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.78 -0.645 . . . . 1.6399999999999999 110.716 -171.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.7 t -64.84 -153.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.55 -0.75 . . . . 2.6699999999999999 110.248 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -143.47 37.65 1.36 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.127 0.788 . . . . 2.6299999999999999 113.127 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 2.4 t80 -71.73 -35.98 70.32 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.287 0.565 . . . . 3.54 109.704 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.44 ' OD2' ' CE1' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -70.84 -28.89 64.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 1.8100000000000001 110.477 177.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -54.92 -20.52 9.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.409 -0.814 . . . . 3.3799999999999999 111.762 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.9 mmt -65.88 -4.52 6.97 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.336 -0.393 . . . . 2.4300000000000002 110.528 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 52.26 -141.46 25.92 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.319 -0.855 . . . . 1.6100000000000001 112.965 169.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.2 p 42.25 -112.04 0.18 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.663 0.86 . . . . 2.5800000000000001 112.264 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -77.72 -39.73 43.58 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.855 -0.612 . . . . 3.7999999999999998 110.835 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -53.26 59.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.939 0.4 . . . . 2.1400000000000001 111.079 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -69.61 -33.46 72.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.986 -0.552 . . . . 0.92000000000000004 111.165 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -70.02 -49.85 47.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.798 -0.361 . . . . 2.8300000000000001 111.077 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -66.78 -33.01 74.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.512 -0.313 . . . . 2.5899999999999999 111.021 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.7 t -78.55 -30.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 1.48 110.864 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.501 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 18.6 ttm180 -56.4 -34.63 66.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 3.8300000000000001 111.336 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.556 ' CB ' ' HD3' ' A' ' 88' ' ' ARG . 15.7 m-80 -63.59 -25.03 68.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.022 0.439 . . . . 2.48 110.797 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.545 ' HA2' ' HG3' ' A' ' 88' ' ' ARG . . . -81.2 -106.88 0.33 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.864 -0.684 . . . . 1.6100000000000001 113.248 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.682 ' HB3' ' HH2' ' A' ' 81' ' ' TRP . 18.2 ttt -79.7 -16.31 55.92 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 111.599 0.222 . . . . 4.8300000000000001 111.599 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 130' ' ' ARG . 25.4 t70 -62.01 -25.91 67.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.664 0.269 . . . . 2.8300000000000001 111.722 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -91.04 -29.64 17.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.072 0.463 . . . . 4.1500000000000004 110.905 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -95.17 -32.17 7.21 Favored Glycine 0 C--O 1.217 -0.955 0 CA-C-N 116.155 -0.475 . . . . 1.04 112.368 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.669 ' HB2' ' HG2' ' A' ' 133' ' ' MET . 3.7 t90 -58.03 -47.06 99.54 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 122.512 0.325 . . . . 2.7799999999999998 111.809 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.81 -32.55 95.62 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.837 1.692 . . . . 0.68000000000000005 111.666 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.2 m -71.65 -43.17 66.55 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 122.268 1.032 . . . . 0.87 108.957 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 60.6 mt -61.83 -54.44 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 113.955 -1.475 . . . . 0.71999999999999997 111.548 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 8' ' ' HIS . 64.8 mt -58.81 -35.33 72.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.68999999999999995 112.202 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.639 ' N ' HE21 ' A' ' 142' ' ' GLN . 0.0 OUTLIER -67.79 -52.84 32.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.923 -0.311 . . . . 1.49 110.406 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.553 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 12.0 t -69.01 -23.85 64.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.348 -0.387 . . . . 1.1499999999999999 110.373 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.422 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 22.5 t80 -65.42 -49.85 67.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.609 -0.515 . . . . 0.80000000000000004 109.609 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.819 ' HG2' HG13 ' A' ' 10' ' ' VAL . 45.5 mt-30 -58.4 -41.93 86.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.331 -0.849 . . . . 1.6299999999999999 111.251 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 14.2 m-20 -75.46 -37.71 60.13 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.567 -0.453 . . . . 1.46 111.829 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 28.7 tptp -57.64 -42.74 84.04 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.398 -0.593 . . . . 1.74 109.398 174.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.938 HG21 HG13 ' A' ' 12' ' ' VAL . 26.5 mt -62.27 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.5 111.109 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.821 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 34.2 t70 -62.38 -30.93 71.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.036 -0.529 . . . . 0.84999999999999998 110.182 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.526 ' O ' ' HE2' ' A' ' 155' ' ' LYS . 49.3 mt-10 -70.46 -39.53 74.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.994 -0.548 . . . . 1.5 109.798 175.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 16.0 mm-40 -62.33 -43.39 98.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.659 -0.7 . . . . 1.74 109.877 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -68.69 -73.27 0.72 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.458 -0.792 . . . . 1.3200000000000001 111.219 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -176.01 81.5 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.827 0.346 . . . . 1.9199999999999999 111.418 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -98.02 -23.93 15.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.046 -0.724 . . . . 2.04 109.046 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.038 -0.983 . . . . 4.2199999999999998 109.323 -177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.863 0.364 . . . . 1.6599999999999999 111.079 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 30.2 p90 -178.12 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.654 -0.703 . . . . 3.73 110.051 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.652 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 28.4 t70 -65.47 -49.74 61.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 2.7799999999999998 111.782 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 16.3 Cg_endo -87.77 -68.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.142 1.228 . . . . 1.6299999999999999 110.92 170.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.74 157.15 37.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 3.21 109.458 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.673 HG22 ' CG ' ' A' ' 115' ' ' HIS . 2.0 m -97.23 113.32 31.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.523 -0.917 . . . . 1.4399999999999999 108.523 168.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.555 ' HD3' ' OD2' ' A' ' 112' ' ' ASP . 20.2 ttm180 -104.35 146.59 28.6 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.365 -0.834 . . . . 3.3700000000000001 112.136 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 1.046 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 9.7 t-160 -112.24 132.84 54.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.614 -1.175 . . . . 0.79000000000000004 108.667 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 38.3 m -140.32 119.64 12.99 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.839 -0.43 . . . . 1.28 109.839 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 145' ' ' GLN . 3.9 t -143.7 132.83 19.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.812 -0.631 . . . . 1.27 110.893 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 m -95.97 115.78 27.95 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.455 -0.572 . . . . 0.56999999999999995 109.455 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.878 HG13 HG21 ' A' ' 148' ' ' ILE . 24.9 t -95.45 140.54 16.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.796 -0.638 . . . . 0.91000000000000003 110.736 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.11 24.22 11.77 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.47 0.544 . . . . 0.97999999999999998 112.47 -173.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.46 34.92 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.735 0.643 . . . . 0.35999999999999999 112.735 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 107' ' ' LYS . 23.7 t70 72.48 166.96 0.31 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.6 0.714 . . . . 0.91000000000000003 112.377 172.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.503 ' NE ' ' HB2' ' A' ' 103' ' ' ALA . 28.3 ttp180 -69.12 -23.68 64.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.42 -0.809 . . . . 1.8799999999999999 111.425 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -58.89 -49.08 79.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.63 0.252 . . . . 3.0499999999999998 111.086 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -73.79 -37.76 64.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.702 0.286 . . . . 1.1100000000000001 110.314 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.33 -45.97 80.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.32000000000000001 111.095 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.503 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 70.2 t80 -71.95 -47.94 48.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.407 -0.361 . . . . 0.38 110.893 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.629 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 26.5 tptp -52.9 -52.45 57.62 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.842 -0.617 . . . . 2.3900000000000001 110.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -50.96 61.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.68000000000000005 111.221 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -62.46 -37.0 84.24 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.246 0.462 . . . . 0.47999999999999998 112.246 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' HG11 ' A' ' 46' ' ' VAL . 13.6 tp -109.02 -53.18 2.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.286 -0.566 . . . . 0.5 112.403 -172.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.629 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 1.4 mm-40 -79.87 -28.64 39.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.105 0.478 . . . . 1.24 111.478 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -100.8 30.58 10.01 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.582 -0.735 . . . . 0.82999999999999996 111.876 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.499 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 56.4 t80 -48.5 -47.18 70.14 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.943 0.497 . . . . 0.73999999999999999 112.279 -176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 15.6 Cg_endo -98.08 19.35 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.19 1.927 . . . . 0.76000000000000001 114.409 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 6.6 pt-20 -105.57 -3.87 21.84 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.134 -0.627 . . . . 1.49 111.505 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.801 ' HB2' HD21 ' A' ' 34' ' ' ASN . 2.9 m0 -80.82 -172.03 3.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.516 0.674 . . . . 4.6200000000000001 111.129 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.539 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 66.4 m95 -102.45 -26.88 0.21 Allowed Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 114.041 1.126 . . . . 2.7799999999999998 114.041 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.761 ' HD2' ' HB2' ' A' ' 30' ' ' TRP . 65.3 Cg_endo -72.74 -143.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.931 1.754 . . . . 1.3600000000000001 114.4 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.483 HD21 ' HA2' ' A' ' 85' ' ' GLY . 8.1 t30 -59.29 -14.73 12.3 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.433 0.901 . . . . 1.51 113.433 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.801 HD21 ' HB2' ' A' ' 30' ' ' TRP . 8.0 p30 -76.28 -10.77 59.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.948 0.351 . . . . 1.79 111.948 -174.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -78.01 69.41 4.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.171 0.51 . . . . 4.4500000000000002 110.596 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -149.11 151.0 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.636 -0.711 . . . . 4.1399999999999997 110.571 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 38' ' ' THR . 7.3 m -87.99 122.75 31.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.916 -0.314 . . . . 2.6800000000000002 110.375 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 73.2 p 56.84 16.22 2.63 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.319 0.859 . . . . 1.4199999999999999 113.319 172.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -103.53 -47.27 4.31 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.815 -1.18 . . . . 2.8999999999999999 107.815 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.598 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -156.21 130.14 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 113.78 -1.555 . . . . 1.8300000000000001 108.582 171.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 55' ' ' GLU . . . 98.91 -72.22 0.55 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.54 -0.838 . . . . 2.1699999999999999 113.291 175.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . 50.36 -164.65 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 109.813 -0.44 . . . . 1.1200000000000001 109.813 -169.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.649 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 23.0 Cg_exo -69.95 16.16 0.23 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.324 1.349 . . . . 1.48 113.656 171.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.475 HD21 ' CE2' ' A' ' 54' ' ' TYR . 56.0 tp -128.66 -92.11 0.47 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.87 -0.518 . . . . 1.75 112.049 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 27' ' ' PHE . . . 109.83 -75.01 0.21 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.457 -0.878 . . . . 0.75 113.132 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.53 HG11 ' CD1' ' A' ' 24' ' ' LEU . 58.5 t -140.48 135.72 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 122.723 -0.28 . . . . 0.59999999999999998 110.799 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.702 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 13.0 t70 -103.64 126.4 50.75 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.411 -0.359 . . . . 1.1100000000000001 110.405 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HE2' ' HG ' ' A' ' 24' ' ' LEU . 1.3 mmpp? -81.38 -24.07 37.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.013 -0.539 . . . . 2.8100000000000001 111.947 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -83.44 -58.7 2.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 3.1699999999999999 110.82 -171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.514 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -77.95 -22.48 68.75 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.613 -0.803 . . . . 1.53 111.507 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.18 63.4 2.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.896 -0.669 . . . . 0.77000000000000002 111.701 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -156.2 143.74 19.32 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.339 -0.544 . . . . 3.7200000000000002 111.395 -179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.574 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 10.5 m0 -87.46 114.26 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.725 -0.843 . . . . 1.28 108.725 174.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.708 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 3.4 p90 -162.65 171.23 17.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.421 0.629 . . . . 1.6599999999999999 111.288 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 8.6 mp0 -127.86 -179.45 4.96 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.288 -1.005 . . . . 2.1200000000000001 108.288 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.1 103.28 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 119.655 -0.818 . . . . 0.92000000000000004 110.665 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 11.6 p-10 -90.55 139.77 30.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.36 0.6 . . . . 1.97 110.189 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.89 -5.13 50.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.681 0.993 . . . . 2.4300000000000002 113.681 -164.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.689 -0.804 . . . . 2.3900000000000001 110.659 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 116.45 49.04 0.45 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.936 -0.65 . . . . 2.29 113.347 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.493 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 45.7 mt-10 60.28 76.68 0.35 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.008 1.114 . . . . 2.3100000000000001 114.008 172.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.46 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 30.4 tt0 -131.37 74.03 1.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.59 0.709 . . . . 2.6099999999999999 110.131 169.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.708 ' CE1' ' HD1' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -120.47 154.24 35.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.326 -0.852 . . . . 3.7200000000000002 110.305 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.7 p -64.9 149.34 49.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.146 -0.687 . . . . 2.27 109.146 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 45.8 p90 -123.38 127.45 48.49 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.189 -0.604 . . . . 6.4800000000000004 111.034 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.38 136.21 28.01 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.116 -0.793 . . . . 1.23 111.116 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -82.8 87.7 6.79 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 121.092 -0.243 . . . . 1.1699999999999999 110.499 -173.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 71' ' ' VAL . 43.5 mt -87.69 116.51 29.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 119.417 -0.913 . . . . 0.60999999999999999 109.718 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -110.19 -10.46 14.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.093 -0.958 . . . . 2.0 110.487 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 37.1 ttmt -145.53 110.4 5.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.981 -0.554 . . . . 1.53 111.359 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 68' ' ' ILE . 38.9 t -102.26 90.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.03 -1.1 . . . . 0.88 108.03 166.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.5 t70 -106.44 59.63 0.64 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.538 -0.465 . . . . 1.4199999999999999 110.613 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.705 ' HB2' ' CD ' ' A' ' 74' ' ' PRO . 12.7 pt-20 39.71 -160.95 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.857 0 O-C-N 124.734 1.271 . . . . 0.95999999999999996 111.924 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.705 ' CD ' ' HB2' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -62.47 80.5 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 CA-C-N 120.494 1.212 . . . . 0.38 112.118 168.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.459 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 13.9 t70 -165.89 -69.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.5 110.66 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.615 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -146.43 130.69 17.52 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.384 0.883 . . . . 0.34999999999999998 113.384 -174.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -123.75 125.96 45.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.041 -0.412 . . . . 0.73999999999999999 110.864 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 99.2 t -103.48 109.83 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.77 -0.456 . . . . 0.67000000000000004 109.77 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.75 126.73 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.385 -0.825 . . . . 0.75 111.616 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.1 163.99 29.49 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.787 -0.525 . . . . 0.5 111.787 175.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 5.3 t-105 -64.31 161.79 16.06 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.563 0.949 . . . . 2.79 113.563 -166.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.481 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 1.6 ttp180 -158.07 -17.69 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.862 -1.063 . . . . 5.46 109.822 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.618 ' HA ' ' CZ2' ' A' ' 81' ' ' TRP . 2.6 tt 79.2 157.35 0.16 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.758 -1.11 . . . . 1.55 111.624 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.504 ' OD1' HG11 ' A' ' 40' ' ' VAL . 49.9 t30 -131.55 147.42 52.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.561 -0.745 . . . . 1.9299999999999999 110.265 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.483 ' HA2' HD21 ' A' ' 33' ' ' ASN . . . 83.31 1.1 90.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.911 -0.661 . . . . 2.3999999999999999 113.645 172.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 18.9 t80 177.55 165.91 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.961 0.381 . . . . 5.3799999999999999 110.479 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.61 69.18 1.24 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.195 -1.562 . . . . 2.2999999999999998 109.195 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 131' ' ' ASN . 12.9 ttm180 -97.5 -179.92 4.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.186 -0.507 . . . . 4.7699999999999996 110.242 -168.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.512 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -54.06 122.5 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.568 0.699 . . . . 1.8600000000000001 110.1 177.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 3.5 p30 -122.9 147.43 51.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.4 -0.818 . . . . 3.1800000000000002 111.38 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HG3' ' HD2' ' A' ' 128' ' ' ARG . 3.4 Cg_exo -80.77 -52.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.892 2.395 . . . . 2.3599999999999999 110.904 168.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 90' ' ' ASP . 5.2 m-20 44.17 42.34 4.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.043 -0.98 . . . . 2.9900000000000002 113.161 175.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.405 ' H ' ' H ' ' A' ' 94' ' ' SER . 10.3 p30 -140.54 -22.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 122.008 0.908 . . . . 3.0600000000000001 109.064 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.463 ' HB2' ' CG ' ' A' ' 118' ' ' PHE . 71.1 m -150.67 -141.85 0.11 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.419 -1.264 . . . . 1.8500000000000001 107.979 173.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 81' ' ' TRP . 21.9 t 60.74 37.27 19.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.368 1.08 . . . . 1.4399999999999999 108.307 -175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.76 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 21.4 mt-10 -74.89 144.37 43.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.175 -1.375 . . . . 1.8100000000000001 110.182 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.57 ' HB2' ' CG1' ' A' ' 113' ' ' VAL . 2.7 p90 -131.56 132.11 43.88 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.229 0.538 . . . . 0.64000000000000001 110.636 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 35.9 m -95.24 114.31 26.09 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.207 -0.906 . . . . 0.42999999999999999 110.209 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.707 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -82.1 108.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.783 -0.644 . . . . 0.87 109.387 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.4 m -101.29 105.52 16.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.126 -0.488 . . . . 0.45000000000000001 109.881 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.87 110.5 21.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.415 -0.357 . . . . 0.34000000000000002 110.062 176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.67 106.41 16.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.137 -0.69 . . . . 0.54000000000000004 109.137 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.503 ' HB2' ' NE ' ' A' ' 16' ' ' ARG . . . -78.52 124.34 28.04 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.638 -0.71 . . . . 0.44 111.46 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -108.27 127.89 54.25 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.726 -0.842 . . . . 2.0299999999999998 108.726 173.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.95 -18.42 40.22 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.525 -0.761 . . . . 1.97 114.832 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -92.87 39.58 1.04 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 117.737 0.769 . . . . 4.9299999999999997 110.812 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.551 ' NZ ' ' HB2' ' A' ' 107' ' ' LYS . 9.7 mtmp? 64.76 33.29 10.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.06 -0.518 . . . . 3.5299999999999998 110.86 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 1.2 ttmp? -122.0 153.19 38.89 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.227 -0.657 . . . . 2.4399999999999999 109.227 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.7 m -155.78 113.82 3.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.187 0.518 . . . . 0.41999999999999998 111.203 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -92.21 111.71 23.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.515 -0.766 . . . . 2.5899999999999999 109.933 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.589 HG12 ' HB ' ' A' ' 10' ' ' VAL . 13.4 p -87.61 138.98 18.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.40000000000000002 110.163 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.555 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 22.7 t70 -133.19 106.93 7.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.302 -0.863 . . . . 1.3799999999999999 109.008 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.046 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 5.3 t -90.61 120.62 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 120.89 -0.324 . . . . 0.91000000000000003 110.597 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -98.71 133.1 43.51 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.701 -0.852 . . . . 2.3100000000000001 108.701 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.673 ' CG ' HG22 ' A' ' 6' ' ' VAL . 34.6 t60 -116.61 153.93 31.39 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.614 -0.721 . . . . 1.6399999999999999 109.789 -173.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 118' ' ' PHE . 14.2 t -64.1 -165.31 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.613 -0.722 . . . . 2.6699999999999999 110.415 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' A' ' 121' ' ' MET . 8.4 p-80 -131.82 27.53 4.6 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.708 -0.678 . . . . 2.6299999999999999 110.571 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' H ' HG23 ' A' ' 116' ' ' THR . 46.2 t80 -64.48 -24.33 67.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.506 0.67 . . . . 3.54 109.985 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -44.59 66.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.817 -1.083 . . . . 1.8100000000000001 109.172 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 2' ' ' TYR . 1.3 tmt_? -58.49 -21.17 50.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.803 -1.09 . . . . 3.3799999999999999 111.832 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 94.1 mmm -73.52 33.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.991 0.424 . . . . 2.4300000000000002 112.107 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 130.09 145.26 5.74 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 121.244 -0.503 . . . . 1.6100000000000001 111.96 172.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.9 m -61.15 -27.12 68.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.815 0.34 . . . . 2.5800000000000001 110.855 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.836 ' HG2' HH21 ' A' ' 128' ' ' ARG . 60.4 tttp -66.25 -47.35 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.461 -0.336 . . . . 3.7999999999999998 110.315 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.671 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 37.0 m80 -65.04 -47.02 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.922 0.391 . . . . 2.1400000000000001 110.944 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.69 -48.65 80.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.314 -0.403 . . . . 0.92000000000000004 111.466 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -65.38 -44.91 86.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.723 -0.217 . . . . 2.8300000000000001 110.924 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.836 HH21 ' HG2' ' A' ' 124' ' ' LYS . 19.2 ptp180 -58.29 -34.04 70.11 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 120.796 0.331 . . . . 2.5899999999999999 110.683 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.5 HG12 ' SD ' ' A' ' 133' ' ' MET . 92.7 t -79.29 -48.71 20.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.867 0.365 . . . . 1.48 110.719 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.975 ' HA ' ' HG2' ' A' ' 133' ' ' MET . 17.2 mtp180 -61.91 -17.85 58.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.06 -0.518 . . . . 3.8300000000000001 111.922 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 4.2 m-80 -51.98 -46.98 65.04 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.493 0.496 . . . . 2.48 111.517 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.01 -15.71 9.74 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.136 -1.031 . . . . 1.6100000000000001 113.15 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.975 ' HG2' ' HA ' ' A' ' 130' ' ' ARG . 21.6 ptm -80.91 -36.88 30.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.48 . . . . 4.8300000000000001 112.167 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -27.43 62.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.933 0.716 . . . . 2.8300000000000001 112.933 -163.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -103.29 -15.85 15.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.167 0.508 . . . . 4.1500000000000004 111.004 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.597 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -104.2 -55.46 0.77 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.427 -0.892 . . . . 1.04 113.102 -174.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.514 ' CH2' ' HB2' ' A' ' 8' ' ' HIS . 6.9 t90 -56.12 -53.34 64.56 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.674 0.62 . . . . 2.7799999999999998 112.674 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.5 Cg_endo -59.25 -45.24 28.26 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.801 1.668 . . . . 0.68000000000000005 111.714 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 m -60.53 -40.16 90.47 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 121.573 0.702 . . . . 0.87 110.34 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 136' ' ' GLY . 49.7 mt -55.67 -45.53 79.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 CA-C-N 114.945 -1.025 . . . . 0.71999999999999997 110.031 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 38.4 mt -59.14 -34.87 72.58 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.45 0.468 . . . . 0.68999999999999995 111.842 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.98 -56.19 11.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.839 0.352 . . . . 1.49 110.636 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.668 ' HB3' ' HD3' ' A' ' 32' ' ' PRO . 23.5 m -68.56 -21.16 64.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.518 -0.31 . . . . 1.1499999999999999 111.161 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.09 -52.14 65.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.941 -0.392 . . . . 0.80000000000000004 109.941 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.692 ' HG2' HG13 ' A' ' 10' ' ' VAL . 52.6 mt-30 -60.41 -36.07 77.26 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.741 -0.663 . . . . 1.6299999999999999 110.046 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.62 -40.26 69.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.892 -1.049 . . . . 1.46 111.208 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 147' ' ' LYS . 37.4 tptt -65.58 -37.71 87.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.216 0.531 . . . . 1.74 109.642 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.878 HG21 HG13 ' A' ' 12' ' ' VAL . 66.0 mt -72.45 -25.66 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.5 110.557 176.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -62.82 -30.9 71.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.554 -0.536 . . . . 0.84999999999999998 109.554 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.696 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 40.1 mt-10 -70.4 -30.54 67.46 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.63 -0.714 . . . . 1.5 110.188 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.87 -36.12 62.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.362 -0.836 . . . . 1.74 109.619 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.68 0.91 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.26 -0.882 . . . . 1.3200000000000001 111.647 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -167.21 86.66 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.413 . . . . 1.9199999999999999 110.967 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.696 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.5 ttmm -107.59 -59.12 1.87 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.41 . . . . 2.04 109.914 176.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 3.9 mptp? . . . . . 0 C--O 1.247 0.946 0 O-C-N 123.777 0.673 . . . . 4.2199999999999998 111.101 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.5 ' ND2' HG13 ' A' ' 6' ' ' VAL . 3.4 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.682 0.277 . . . . 1.6599999999999999 111.333 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 46.8 p90 -176.78 -42.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.776 -0.647 . . . . 3.73 109.812 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.768 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 21.3 t70 -58.23 -55.37 46.21 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.13 -0.486 . . . . 2.7799999999999998 112.099 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 11.2 Cg_endo -92.39 -65.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.453 2.102 . . . . 1.6299999999999999 112.275 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.473 ' HD2' HG21 ' A' ' 116' ' ' THR . 91.7 m-85 -143.1 145.35 32.78 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.226 -0.443 . . . . 3.21 110.543 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 45.2 t -104.58 126.54 59.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.88 -0.785 . . . . 1.4399999999999999 108.88 167.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.2 ttm105 -128.44 135.2 49.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.221 0.534 . . . . 3.3700000000000001 110.96 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.952 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -109.07 130.51 55.48 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.135 -1.061 . . . . 0.79000000000000004 108.135 170.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 8.4 t -136.78 110.5 8.1 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.568 0.699 . . . . 1.28 109.596 176.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.8 t -122.85 134.7 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.601 -1.181 . . . . 1.27 111.038 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -91.75 115.59 28.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.04 -0.527 . . . . 0.56999999999999995 109.756 172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.768 HG13 HG21 ' A' ' 148' ' ' ILE . 42.0 t -96.79 127.85 48.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.496 -0.557 . . . . 0.91000000000000003 109.496 177.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -104.93 33.25 3.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.885 -0.598 . . . . 0.97999999999999998 111.5 -173.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -153.53 31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.655 -0.248 . . . . 0.35999999999999999 111.573 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.71 ' OD1' ' HG2' ' A' ' 17' ' ' LYS . 19.8 t70 71.38 166.9 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.054 0.93 . . . . 0.91000000000000003 112.348 176.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -71.68 -21.91 61.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.111 -0.95 . . . . 1.8799999999999999 111.68 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.71 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 39.5 mmtm -58.33 -50.84 72.2 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.048 0.452 . . . . 3.0499999999999998 109.907 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.1 p -72.57 -37.43 68.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.72 -0.673 . . . . 1.1100000000000001 110.623 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.508 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -55.9 -45.55 78.62 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.853 0.359 . . . . 0.32000000000000001 110.732 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.432 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 59.9 t80 -74.24 -47.64 33.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.148 -0.478 . . . . 0.38 111.204 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 21' ' ' LYS . 4.4 ttmm -56.92 -52.18 66.2 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.592 -0.277 . . . . 2.3900000000000001 111.167 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.6 m -64.01 -50.63 67.77 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.416 -0.356 . . . . 0.68000000000000005 110.577 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.882 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.8 t80 -61.09 -36.84 80.73 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.333 0.494 . . . . 0.47999999999999998 112.333 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 ' CD1' HG11 ' A' ' 46' ' ' VAL . 20.0 tp -106.37 -59.73 1.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.333 0.494 . . . . 0.5 112.333 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.16 -44.78 21.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.236 0.541 . . . . 1.24 111.515 -170.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.779 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -85.19 37.45 3.01 Favored Glycine 0 C--O 1.217 -0.913 0 CA-C-N 115.349 -0.841 . . . . 0.82999999999999996 112.286 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.627 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 23.8 t80 -54.5 -48.91 93.64 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 112.366 0.506 . . . . 0.73999999999999999 112.366 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 48.0 Cg_endo -86.84 12.93 2.85 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.203 1.935 . . . . 0.76000000000000001 114.711 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.779 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -96.08 -4.23 43.27 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.192 -0.603 . . . . 1.49 110.624 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.882 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 17.1 m0 -77.4 -175.58 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.726 0.774 . . . . 4.6200000000000001 112.045 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.522 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 47.4 m95 -109.42 -33.66 0.15 Allowed Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 114.642 -1.163 . . . . 2.7799999999999998 113.454 176.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.851 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 60.7 Cg_endo -71.03 -129.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.98 1.787 . . . . 1.3600000000000001 114.345 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.502 ' CG ' HD21 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -59.87 -47.11 87.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.642 0.734 . . . . 1.51 111.279 -172.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.691 ' HA ' HG13 ' A' ' 40' ' ' VAL . 6.1 p-10 -83.61 34.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.345 -1.298 . . . . 1.79 112.062 -171.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -106.09 5.14 29.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.687 0.756 . . . . 4.4500000000000002 109.404 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -99.53 124.05 44.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 4.1399999999999997 110.693 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -74.88 131.26 40.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.064 -0.517 . . . . 2.6800000000000002 111.51 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.651 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 30.5 p 54.54 22.77 4.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.249 1.02 . . . . 1.4199999999999999 111.74 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -114.0 -46.64 3.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.596 -0.89 . . . . 2.8999999999999999 108.596 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.691 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.6 p -169.43 6.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.053 -0.976 . . . . 1.8300000000000001 110.03 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -159.55 53.64 0.36 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.915 -0.66 . . . . 2.1699999999999999 112.274 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.023 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.6 174.28 3.67 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 109.493 -0.558 . . . . 1.1200000000000001 109.493 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 38.7 Cg_exo -63.15 56.43 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.184 2.589 . . . . 1.48 113.774 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -166.95 -84.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.194 0.598 . . . . 1.75 109.62 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.627 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 89.2 -48.93 3.46 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.043 -0.598 . . . . 0.75 113.012 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG11 ' CD1' ' A' ' 24' ' ' LEU . 75.2 t -137.86 144.83 30.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 110.033 -0.358 . . . . 0.59999999999999998 110.033 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.753 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 29.5 t70 -108.77 116.07 31.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.54 -0.541 . . . . 1.1100000000000001 109.54 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -73.96 -29.8 62.19 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.572 -0.74 . . . . 2.8100000000000001 112.128 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -76.68 -54.04 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.021 0.378 . . . . 3.1699999999999999 112.021 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.03 -22.21 39.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.41 -0.9 . . . . 1.53 112.651 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.486 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 87.3 61.91 1.53 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.543 -0.837 . . . . 0.77000000000000002 111.46 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 3.9 mpt_? -133.17 158.97 41.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.224 . . . . 3.7200000000000002 110.509 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.712 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 17.0 m0 -113.28 106.39 14.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.804 -0.813 . . . . 1.28 108.804 168.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.753 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 8.6 p90 -157.5 167.72 29.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.031 -0.359 . . . . 1.6599999999999999 110.031 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.023 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 4.4 mt-10 -127.89 159.67 34.21 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.488 -0.324 . . . . 2.1200000000000001 110.335 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.65 102.26 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.373 -0.973 . . . . 0.92000000000000004 108.373 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -76.04 163.27 27.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 1.97 109.325 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.84 -22.13 66.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.694 0.283 . . . . 2.4300000000000002 111.056 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -86.83 -15.51 38.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.285 -0.416 . . . . 2.3900000000000001 110.885 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.89 -100.94 0.21 Allowed Glycine 0 C--O 1.224 -0.492 0 C-N-CA 120.395 -0.907 . . . . 2.29 112.95 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.66 27.41 2.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.771 0.32 . . . . 2.3100000000000001 111.432 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.59 82.49 2.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.347 0.594 . . . . 2.6099999999999999 109.838 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 163.85 20.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.247 -0.888 . . . . 3.7200000000000002 110.005 174.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 16.7 p -46.69 120.56 3.02 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.723 -0.473 . . . . 2.27 109.723 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 18.0 p90 -115.33 116.41 28.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.652 0.739 . . . . 6.4800000000000004 112.053 -171.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -72.03 152.0 48.05 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 114.75 -1.113 . . . . 1.23 111.423 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -112.89 92.06 3.88 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.966 0.412 . . . . 1.1699999999999999 111.109 -172.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 71' ' ' VAL . 20.0 mt -85.13 116.53 28.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.682 -0.488 . . . . 0.60999999999999999 109.682 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.611 ' HD3' ' OE2' ' A' ' 96' ' ' GLU . 2.4 mpt_? -88.04 -33.09 18.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.885 0.374 . . . . 2.0 110.733 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 58.0 tttp -129.6 98.97 4.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.297 -0.41 . . . . 1.53 111.294 -174.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 68' ' ' ILE . 44.9 t -98.05 96.72 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.05 -1.093 . . . . 0.88 108.05 169.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -115.66 77.47 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.805 -0.358 . . . . 1.4199999999999999 111.165 -173.11 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.1 pt-20 47.33 -171.64 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 O-C-N 124.367 1.042 . . . . 0.95999999999999996 112.012 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 24.0 Cg_exo -66.41 74.09 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.353 1.369 . . . . 0.38 111.043 166.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 22.3 t70 -156.55 -64.73 0.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.867 -0.606 . . . . 0.5 110.806 -176.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.611 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.6 p -144.48 145.55 31.94 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.665 0.617 . . . . 0.34999999999999998 112.665 -177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 1.1 mp -139.01 116.51 11.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.733 -0.667 . . . . 0.73999999999999999 109.745 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.6 HG22 HG23 ' A' ' 98' ' ' THR . 61.6 t -101.03 106.69 19.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.02 -0.733 . . . . 0.67000000000000004 109.02 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -129.1 127.56 65.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.75 111.95 -171.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -90.7 154.92 23.56 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.427 -0.416 . . . . 0.5 112.896 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 17.4 t-105 -73.19 160.88 31.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.958 0.408 . . . . 2.79 111.889 -171.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.54 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 11.9 ptt180 -137.2 0.63 2.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.967 -0.561 . . . . 5.46 110.732 -169.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.781 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 2.7 tm? 74.55 133.09 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.985 0.803 . . . . 1.55 110.82 -169.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.541 ' HB2' ' CH2' ' A' ' 81' ' ' TRP . 40.4 t-20 -98.94 121.4 40.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 1.9299999999999999 110.367 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.83 -9.22 61.84 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.425 -0.893 . . . . 2.3999999999999999 114.309 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.1 t80 70.98 -42.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.229 0.612 . . . . 5.3799999999999999 112.238 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.75 7.23 51.01 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.234 -0.508 . . . . 2.2999999999999998 112.928 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.625 ' HB2' HD21 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -108.17 178.31 4.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.969 -0.752 . . . . 4.7699999999999996 108.969 177.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.519 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -114.54 128.64 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.963 0.411 . . . . 1.8600000000000001 111.406 -179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.781 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 29.1 t70 -144.36 142.52 19.74 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.153 -0.684 . . . . 3.1800000000000002 109.153 168.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.555 ' HD2' ' OD2' ' A' ' 90' ' ' ASP . 17.3 Cg_endo -58.1 -27.28 79.24 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.948 2.432 . . . . 2.3599999999999999 113.893 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 3.0 t70 67.38 -0.85 1.7 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.88 0.848 . . . . 2.9900000000000002 110.853 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.18 -38.68 60.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.682 -0.69 . . . . 3.0600000000000001 112.191 -171.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.9 m -156.01 -93.46 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.767 -0.197 . . . . 1.8500000000000001 110.958 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.779 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 4.1 m 50.64 39.78 22.33 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.63 0.581 . . . . 1.4399999999999999 110.724 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.763 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 1.7 mm-40 -69.24 144.52 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.34 -0.846 . . . . 1.8100000000000001 112.221 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -139.91 127.95 22.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.56 0.695 . . . . 0.64000000000000001 111.717 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.6 HG23 HG22 ' A' ' 78' ' ' VAL . 52.9 m -93.26 112.12 23.96 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.044 -0.98 . . . . 0.42999999999999999 110.788 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 113' ' ' VAL . 92.1 t -89.59 110.11 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.764 -0.653 . . . . 0.87 109.869 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.611 ' HA ' HG22 ' A' ' 76' ' ' THR . 23.4 m -105.4 106.38 16.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 0.45000000000000001 110.561 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.458 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 29.8 m-85 -88.5 107.59 18.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.726 0.298 . . . . 0.34000000000000002 110.298 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.2 t -91.24 111.22 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.324 -0.398 . . . . 0.54000000000000004 110.303 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.53 133.88 53.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.44 110.453 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.781 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 8.6 t70 -130.7 118.9 21.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.137 -0.483 . . . . 2.0299999999999998 110.534 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.16 -98.78 0.52 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.064 -0.588 . . . . 1.97 112.546 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.01 -20.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 4.9299999999999997 110.259 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -128.14 7.1 5.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 3.5299999999999998 111.53 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.781 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 83.9 tttt -122.7 151.25 41.73 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.584 -0.446 . . . . 2.4399999999999999 110.425 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.7 m -153.76 118.5 4.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.828 -0.624 . . . . 0.41999999999999998 109.936 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -100.79 115.8 31.18 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.532 -0.758 . . . . 2.5899999999999999 109.449 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.2 p -91.76 137.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.285 -0.566 . . . . 0.40000000000000002 110.642 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.4 109.01 11.33 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.156 -0.929 . . . . 1.3799999999999999 109.049 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.952 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 3.9 t -101.64 124.16 55.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.897 -0.592 . . . . 0.91000000000000003 111.263 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -102.76 113.7 27.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.437 0.637 . . . . 2.3100000000000001 109.452 173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.703 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 65.7 t60 -134.2 98.95 4.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.195 -0.911 . . . . 1.6399999999999999 109.219 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.473 HG21 ' HD2' ' A' ' 5' ' ' PHE . 5.1 t -152.92 97.29 2.19 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.918 0.866 . . . . 2.6699999999999999 111.027 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.68 -69.91 0.09 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.334 -0.848 . . . . 2.6299999999999999 110.0 176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.652 ' CE1' ' HB3' ' A' ' 125' ' ' HIS . 13.6 t80 -72.28 -48.73 40.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.531 -0.759 . . . . 3.54 111.173 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.97 78.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 1.8100000000000001 110.097 -176.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 36.4 ttt180 -51.94 -24.94 7.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.222 -1.354 . . . . 3.3799999999999999 112.072 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 95.3 mmm -79.9 -8.85 59.54 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.65 0.262 . . . . 2.4300000000000002 110.706 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 44.43 -135.13 6.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.539 -0.755 . . . . 1.6100000000000001 113.636 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.6 p 40.61 -133.07 0.29 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.763 0.825 . . . . 2.5800000000000001 112.417 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -57.77 -33.25 68.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 3.7999999999999998 111.583 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.652 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 11.8 m-70 -66.51 -52.97 40.24 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.38 0.609 . . . . 2.1400000000000001 110.739 -171.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.73 69.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.637 -0.711 . . . . 0.92000000000000004 111.054 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -73.7 -28.94 61.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 2.8300000000000001 111.668 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 31.6 ptt180 -77.35 -36.66 53.57 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.803 -0.359 . . . . 2.5899999999999999 111.256 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.638 HG21 ' HE2' ' A' ' 118' ' ' PHE . 93.8 t -76.48 -23.86 15.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.356 0.598 . . . . 1.48 110.421 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.51 ' HG3' ' CB ' ' A' ' 134' ' ' ASP . 27.3 ttm180 -58.22 -19.85 36.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.616 -0.72 . . . . 3.8300000000000001 111.142 174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -57.03 -22.72 41.0 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.196 -0.456 . . . . 2.48 111.362 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -137.41 -47.69 0.07 OUTLIER Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.374 -0.917 . . . . 1.6100000000000001 113.469 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.46 -25.58 63.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.879 0.34 . . . . 4.8300000000000001 111.878 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.51 ' CB ' ' HG3' ' A' ' 130' ' ' ARG . 15.0 t70 -59.28 -43.92 92.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 2.8300000000000001 112.064 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -96.71 5.85 49.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 4.1500000000000004 111.146 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -102.41 -62.15 0.73 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.441 -0.885 . . . . 1.04 112.81 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.54 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 1.1 t90 -60.63 -49.25 90.63 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.966 0.728 . . . . 2.7799999999999998 112.966 -169.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 13.6 Cg_endo -58.13 -44.86 35.6 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.662 1.575 . . . . 0.68000000000000005 112.027 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.0 m -59.05 -40.94 86.66 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.761 -0.654 . . . . 0.87 110.228 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.641 HG23 ' HZ3' ' A' ' 30' ' ' TRP . 45.6 mt -54.69 -51.94 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 114.928 -1.033 . . . . 0.71999999999999997 110.894 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 8' ' ' HIS . 59.5 mt -61.67 -30.57 70.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.048 0.388 . . . . 0.68999999999999995 112.048 -175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.0 mm-40 -70.99 -55.51 8.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 1.49 110.524 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.536 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 16.6 m -68.08 -22.52 64.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.072 -0.513 . . . . 1.1499999999999999 110.626 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.79 -52.48 64.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.221 0.534 . . . . 0.80000000000000004 109.771 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.744 ' HG2' HG13 ' A' ' 10' ' ' VAL . 45.9 mt-30 -59.79 -36.25 76.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.155 -0.929 . . . . 1.6299999999999999 110.765 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.6 -40.29 49.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.748 -0.66 . . . . 1.46 111.462 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -62.23 -42.46 99.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 1.74 109.884 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.768 HG21 HG13 ' A' ' 12' ' ' VAL . 57.0 mt -64.44 -35.64 74.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.5 110.306 176.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.493 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 21.7 t70 -59.56 -38.71 81.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.61 -0.723 . . . . 0.84999999999999998 109.716 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.509 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 45.6 mt-10 -66.06 -22.61 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 1.5 111.348 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -73.6 -8.04 54.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.763 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.27 -47.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.576 -1.297 . . . . 1.3200000000000001 114.14 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.61 -39.08 58.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.666 0.617 . . . . 1.9199999999999999 112.666 -170.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.509 ' HD2' ' HG2' ' A' ' 150' ' ' GLU . 24.0 ttmm -69.26 101.23 1.45 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.226 -0.443 . . . . 2.04 111.539 -173.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 155' ' ' LYS . 29.9 mmtp . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.394 -0.821 . . . . 4.2199999999999998 109.391 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.559 0.219 . . . . 1.6599999999999999 110.656 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.527 ' HA ' HG23 ' A' ' 6' ' ' VAL . 52.9 p90 173.53 -36.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.652 0.781 . . . . 3.73 109.92 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.786 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 29.9 t70 -67.97 -57.65 9.13 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.411 -0.359 . . . . 2.7799999999999998 111.525 -173.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 47.7 Cg_endo -83.03 -63.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.248 1.299 . . . . 1.6299999999999999 111.714 174.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.51 139.09 16.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.421 -0.354 . . . . 3.21 110.946 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.69 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 79.6 t -89.11 121.21 38.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.047 -0.723 . . . . 1.4399999999999999 109.047 167.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 47.5 ttt180 -124.88 130.83 53.15 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.3 -0.409 . . . . 3.3700000000000001 110.428 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.79 130.87 55.47 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.807 -0.812 . . . . 0.79000000000000004 108.807 172.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 11.3 p -134.79 111.04 9.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 121.94 0.876 . . . . 1.28 110.498 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 2.3 t -120.37 133.35 67.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.269 -1.332 . . . . 1.27 111.637 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.0 m -96.13 115.51 27.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.693 . . . . 0.56999999999999995 109.782 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG13 HG21 ' A' ' 148' ' ' ILE . 4.6 t -98.64 140.8 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.91000000000000003 111.004 -176.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 11.3 mmtp -100.0 9.88 42.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.919 -0.582 . . . . 0.97999999999999998 112.016 -170.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.497 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.09 37.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.149 -0.62 . . . . 0.35999999999999999 112.452 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 74.08 165.22 0.29 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.784 0.802 . . . . 0.91000000000000003 112.743 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.616 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 10.9 ttp180 -63.1 -30.27 71.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.419 -1.264 . . . . 1.8799999999999999 111.226 -175.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 18' ' ' THR . 61.8 pttt -56.18 -47.18 78.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.117 -0.492 . . . . 3.0499999999999998 110.405 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 27.9 m -74.84 -33.65 62.19 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.874 -0.603 . . . . 1.1100000000000001 110.605 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -60.55 -49.59 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.32000000000000001 110.883 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 52.0 t80 -70.09 -43.37 71.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.236 -0.438 . . . . 0.38 110.773 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -53.72 -51.46 63.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 2.3900000000000001 110.175 177.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' CE2' ' A' ' 30' ' ' TRP . 61.1 m -63.2 -41.38 99.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.982 -0.554 . . . . 0.68000000000000005 111.282 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HA ' ' HE1' ' A' ' 144' ' ' PHE . 73.8 t80 -70.48 -47.19 61.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.329 0.492 . . . . 0.47999999999999998 112.329 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 46' ' ' VAL . 11.3 tp -119.27 -11.7 9.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.119 1.155 . . . . 0.5 114.119 -167.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.622 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 32.9 mt-10 -113.98 -38.92 4.07 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.213 -0.929 . . . . 1.24 111.345 -176.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.19 29.74 7.87 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.373 -0.831 . . . . 0.82999999999999996 111.342 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.614 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 59.4 t80 -46.48 -55.07 15.24 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 114.504 -0.848 . . . . 0.73999999999999999 113.054 -171.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 11.5 Cg_endo -94.37 21.59 0.55 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.13 1.887 . . . . 0.76000000000000001 115.493 -172.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 12.1 pt-20 -120.37 -18.82 7.82 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.97 1.1 . . . . 1.49 113.97 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CE2' HG23 ' A' ' 22' ' ' THR . 25.3 m95 -76.08 -173.09 2.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.391 0.615 . . . . 4.6200000000000001 112.523 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.732 ' HB2' ' HB3' ' A' ' 143' ' ' SER . 51.7 m95 -77.35 -35.16 1.28 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 115.617 1.71 . . . . 2.7799999999999998 115.617 -172.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.645 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 74.3 Cg_endo -72.34 -131.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 121.85 1.7 . . . . 1.3600000000000001 115.02 -161.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 10.7 t30 -67.31 -8.07 29.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.084 -0.962 . . . . 1.51 110.496 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.058 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.3 m-20 -90.66 18.05 6.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.772 -1.103 . . . . 1.79 110.666 -172.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -104.83 68.17 0.83 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.555 . . . . 4.4500000000000002 110.603 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -156.66 -178.06 7.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.002 -0.545 . . . . 4.1399999999999997 109.85 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -110.37 139.16 45.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.522 -0.547 . . . . 2.6800000000000002 109.522 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.539 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 50.3 p 51.74 28.3 4.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.895 0.855 . . . . 1.4199999999999999 111.266 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HD3' HG22 ' A' ' 40' ' ' VAL . 1.1 tmtp? -149.46 84.01 1.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.324 -1.362 . . . . 2.8999999999999999 107.324 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.058 HG23 ' HA ' ' A' ' 34' ' ' ASN . 34.0 m 45.02 32.36 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 124.6 1.188 . . . . 1.8300000000000001 112.589 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.6 11.62 0.21 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.514 -0.851 . . . . 2.1699999999999999 113.873 -175.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.042 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -72.87 -178.27 0.65 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.214 0.507 . . . . 1.1200000000000001 110.591 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.553 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 31.1 Cg_exo -63.37 20.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.712 2.274 . . . . 1.48 114.303 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.824 ' HG ' ' H ' ' A' ' 45' ' ' GLY . 17.0 tp -161.59 -156.68 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.579 -1.267 . . . . 1.75 107.579 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.824 ' H ' ' HG ' ' A' ' 44' ' ' LEU . . . 163.9 -50.64 0.3 Allowed Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.919 -1.134 . . . . 0.75 113.019 -176.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.785 HG11 ' HG ' ' A' ' 24' ' ' LEU . 78.1 t -142.88 135.18 25.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.267 0.534 . . . . 0.59999999999999998 111.502 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -113.74 124.01 51.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.415 -0.357 . . . . 1.1100000000000001 110.562 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.673 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -81.23 -20.83 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.506 . . . . 2.8100000000000001 111.343 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -76.26 -57.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.636 -0.256 . . . . 3.1699999999999999 110.724 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.86 60.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.625 -0.798 . . . . 1.53 111.689 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 52' ' ' ARG . . . 81.0 49.6 5.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.038 -0.601 . . . . 0.77000000000000002 112.495 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 51' ' ' GLY . 7.2 mpt_? -136.29 154.19 50.95 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.599 -0.354 . . . . 3.7200000000000002 110.506 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.695 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 14.8 m0 -98.53 108.35 21.02 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.229 -1.026 . . . . 1.28 108.229 168.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -149.96 144.55 25.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.584 0.707 . . . . 1.6599999999999999 111.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.042 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.5 mt-10 -111.81 170.69 7.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.627 -1.169 . . . . 2.1200000000000001 109.154 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' A' ' 61' ' ' GLU . 28.6 mm -78.87 105.26 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.16 -0.681 . . . . 0.92000000000000004 109.16 174.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.714 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 6.8 t70 -88.61 -164.93 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.139 -0.319 . . . . 1.97 110.139 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 9.4 pt-20 -80.13 -35.51 36.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.76 0.281 . . . . 2.4300000000000002 111.76 -174.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.554 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -96.93 24.09 6.53 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.255 -0.578 . . . . 2.3900000000000001 111.639 177.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.4 -97.27 0.38 Allowed Glycine 0 C--O 1.223 -0.563 0 C-N-CA 120.658 -0.782 . . . . 2.29 113.08 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG2' HD13 ' A' ' 56' ' ' ILE . 34.1 mt-10 -142.53 29.84 1.56 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.634 0.731 . . . . 2.3100000000000001 109.729 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -85.51 76.76 10.0 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.145 -0.934 . . . . 2.6099999999999999 110.286 -171.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.714 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.66 130.11 52.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.229 -1.351 . . . . 3.7200000000000002 109.61 175.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.616 HG22 ' HG3' ' A' ' 82' ' ' ARG . 2.9 m -69.92 -92.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.002 -0.544 . . . . 2.27 111.761 -175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.695 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 91.9 m-85 51.27 -167.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.291 1.219 . . . . 6.4800000000000004 114.291 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.4 141.02 42.04 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.035 -0.984 . . . . 1.23 114.931 -165.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -111.07 99.22 8.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.795 -0.703 . . . . 1.1699999999999999 109.484 177.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.58 HG21 HG22 ' A' ' 71' ' ' VAL . 21.0 mt -84.25 138.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.60999999999999999 111.129 -172.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -99.88 -40.21 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.357 -0.383 . . . . 2.0 110.239 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -138.11 122.69 18.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 1.53 111.463 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.58 HG22 HG21 ' A' ' 68' ' ' ILE . 40.5 t -111.08 108.73 26.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.102 -0.703 . . . . 0.88 109.102 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -115.31 63.64 0.68 Allowed 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.416 -0.514 . . . . 1.4199999999999999 110.966 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.673 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 46.09 -166.45 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 124.658 1.224 . . . . 0.95999999999999996 112.086 173.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 44.5 Cg_exo -60.74 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 121.638 1.558 . . . . 0.38 112.316 167.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.81 -66.81 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.732 -0.667 . . . . 0.5 110.654 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -144.71 148.62 34.39 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.643 0.609 . . . . 0.34999999999999998 112.643 -175.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -138.82 129.02 25.52 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.73999999999999999 110.274 176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 97' ' ' PHE . 21.9 t -109.28 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.005 -0.739 . . . . 0.67000000000000004 109.005 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.18 138.23 55.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.75 111.811 -170.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -91.16 149.05 19.65 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.774 -0.53 . . . . 0.5 111.774 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.83 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 76.2 t-105 -86.13 141.26 29.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.126 0.488 . . . . 2.79 112.092 -170.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.727 ' O ' ' HG ' ' A' ' 83' ' ' LEU . 1.8 tmt_? -113.53 -79.47 0.58 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.29 -0.868 . . . . 5.46 109.053 168.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.015 HD22 ' HB2' ' A' ' 88' ' ' ARG . 53.8 mt -176.68 -111.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.41 1.1 . . . . 1.55 112.864 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 176.53 -161.98 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 103.856 -2.646 . . . . 1.9299999999999999 103.856 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.69 50.25 0.9 Allowed Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.668 -1.253 . . . . 2.3999999999999999 112.222 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -140.22 78.75 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.823 -0.351 . . . . 5.3799999999999999 111.865 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.22 49.79 74.7 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 115.752 -0.658 . . . . 2.2999999999999998 112.42 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.015 ' HB2' HD22 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -129.31 154.12 47.17 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.517 -0.341 . . . . 4.7699999999999996 111.859 -169.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.632 ' O ' HD21 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -115.32 135.26 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 110.243 -0.28 . . . . 1.8600000000000001 110.243 177.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.594 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 5.0 p-10 -102.91 144.92 29.6 Favored Pre-proline 0 CA--C 1.516 -0.34 0 CA-C-O 120.999 0.428 . . . . 3.1800000000000002 111.319 -174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.566 ' HG3' ' CE2' ' A' ' 118' ' ' PHE . 15.6 Cg_exo -65.39 -48.29 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.683 2.256 . . . . 2.3599999999999999 110.658 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.594 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 32.2 t70 64.79 29.5 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.139 -0.937 . . . . 2.9900000000000002 110.367 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -138.88 -55.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 3.0600000000000001 111.649 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.7 p -135.25 -121.4 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.61 -0.436 . . . . 1.8500000000000001 111.567 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.83 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 5.6 t 55.21 54.23 9.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.922 -0.769 . . . . 1.4399999999999999 108.922 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.445 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 44.7 tt0 -88.21 143.82 26.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.965 -1.016 . . . . 1.8100000000000001 111.599 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -107.57 148.36 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.64000000000000001 110.673 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.9 m -112.09 95.81 5.68 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.384 -0.969 . . . . 0.42999999999999999 108.384 158.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.646 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.8 t -83.32 110.14 17.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.818 -0.438 . . . . 0.87 109.818 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.7 m -108.52 107.36 17.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.784 0.326 . . . . 0.45000000000000001 111.143 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.616 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 59.5 m-85 -87.38 113.75 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.331 -0.395 . . . . 0.34000000000000002 110.264 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.0 t -96.21 115.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.176 -0.465 . . . . 0.54000000000000004 110.298 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.67 143.73 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.203 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.709 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -138.73 103.54 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 2.0299999999999998 110.625 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.5 16.58 55.31 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-N 115.99 -0.55 . . . . 1.97 113.864 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 62.69 15.08 7.76 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.182 0.438 . . . . 4.9299999999999997 112.182 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -134.76 -18.78 1.86 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.01 0.433 . . . . 3.5299999999999998 110.793 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 2.0 ttpm? -122.3 158.02 30.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.074 -0.713 . . . . 2.4399999999999999 109.074 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 52.3 m -154.13 122.78 6.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.972 0.415 . . . . 0.41999999999999998 111.227 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 -98.29 108.17 20.8 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.673 -0.694 . . . . 2.5899999999999999 109.278 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 9' ' ' SER . 14.4 p -83.41 134.3 27.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.976 -0.69 . . . . 0.40000000000000002 109.334 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -125.65 107.99 11.11 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.675 -0.861 . . . . 1.3799999999999999 108.675 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 99' ' ' VAL . 13.0 t -103.61 123.3 57.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.394 -0.821 . . . . 0.91000000000000003 112.376 -170.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -92.91 111.22 22.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.069 -0.968 . . . . 2.3100000000000001 108.824 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.69 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 23.6 t-160 -125.32 97.17 5.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.754 -1.202 . . . . 1.6399999999999999 107.754 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.1 m -153.64 108.31 3.11 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.7 -0.8 . . . . 2.6699999999999999 112.584 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -174.8 -63.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.456 -0.793 . . . . 2.6299999999999999 109.647 165.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 129' ' ' VAL . 77.4 t80 -76.94 -28.13 55.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.743 -0.662 . . . . 3.54 109.784 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -46.8 87.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.164 -0.926 . . . . 1.8100000000000001 110.01 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 3' ' ' ASP . 72.9 ttt180 -57.72 -21.3 39.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.676 -1.147 . . . . 3.3799999999999999 112.094 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.38 -17.7 62.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.173 0.511 . . . . 2.4300000000000002 110.606 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 2' ' ' TYR . . . 73.03 -118.15 6.25 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.18 0.832 . . . . 1.6100000000000001 115.18 165.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 m -37.93 -88.88 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.973 1.472 . . . . 2.5800000000000001 114.973 -160.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -77.33 -34.35 55.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.16 0.429 . . . . 3.7999999999999998 112.16 -168.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 29.6 m170 -66.08 -52.13 51.69 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.864 0.364 . . . . 2.1400000000000001 110.9 -176.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -67.02 -37.45 84.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.92000000000000004 110.395 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -61.02 -49.76 76.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.655 0.243 . . . . 2.8300000000000001 111.655 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.14 -29.24 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 2.5899999999999999 111.186 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.569 HG21 ' HE2' ' A' ' 118' ' ' PHE . 15.7 t -75.51 -41.1 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.404 0.621 . . . . 1.48 110.535 172.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 1.033 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 39.5 ttp180 -63.16 -15.41 56.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.139 -0.937 . . . . 3.8300000000000001 111.533 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -50.08 -47.02 53.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.354 -0.385 . . . . 2.48 111.433 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.21 -12.9 22.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.435 -0.888 . . . . 1.6100000000000001 111.952 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.631 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 26.1 ttt -81.23 -35.3 31.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.721 0.267 . . . . 4.8300000000000001 111.721 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 1.033 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 38.7 t70 -63.86 -37.29 86.84 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.833 0.679 . . . . 2.8300000000000001 112.833 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 36.0 tptt -106.66 22.19 16.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.932 0.873 . . . . 4.1500000000000004 109.608 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.64 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.77 -71.36 0.55 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.344 -0.843 . . . . 1.04 111.798 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.443 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.7 t-105 -54.71 -54.1 53.06 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 113.041 0.756 . . . . 2.7799999999999998 113.041 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 27.0 Cg_endo -61.49 -41.32 41.3 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.8 1.667 . . . . 0.68000000000000005 112.199 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -63.28 -40.96 98.84 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.334 0.588 . . . . 0.87 109.962 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 42.3 mt -58.18 -43.65 86.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-N 115.271 -0.877 . . . . 0.71999999999999997 110.645 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.538 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 24.8 mt -60.06 -41.46 92.4 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.166 0.291 . . . . 0.68999999999999995 111.2 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.96 -42.89 97.14 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.192 -0.603 . . . . 1.49 111.121 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.732 ' HB3' ' HB2' ' A' ' 31' ' ' TRP . 13.8 m -75.96 -22.38 56.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 1.1499999999999999 110.594 176.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 63.4 t80 -61.76 -54.87 36.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.528 -0.76 . . . . 0.80000000000000004 109.336 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.44 -29.37 70.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.01 -0.541 . . . . 1.6299999999999999 110.272 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.26 -54.23 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 1.46 111.891 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 147' ' ' LYS . 5.9 tmtt? -74.31 -35.01 63.66 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 120.243 -0.583 . . . . 1.74 110.188 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.735 HG21 HG13 ' A' ' 12' ' ' VAL . 18.7 mt -60.96 -34.88 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.135 0.493 . . . . 0.5 110.418 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 27.5 t70 -59.11 -34.95 72.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.88 -0.6 . . . . 0.84999999999999998 109.924 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.646 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 30.5 mt-10 -69.62 -19.55 63.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.844 -0.616 . . . . 1.5 111.4 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.85 2.41 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.093 -0.503 . . . . 1.74 110.582 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.51 -70.72 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.193 -1.003 . . . . 1.3200000000000001 113.897 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.62 -33.06 21.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.617 0.969 . . . . 1.9199999999999999 113.617 -167.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.689 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 34.5 ttmt -69.51 166.71 18.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.963 -0.384 . . . . 2.04 109.963 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 C-N-CA 123.941 0.896 . . . . 4.2199999999999998 111.244 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 1.004 HD22 ' HB ' ' A' ' 6' ' ' VAL . 19.9 p-10 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 110.276 -0.268 . . . . 1.6599999999999999 110.276 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 84.3 m-85 83.31 -63.58 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.79 0.836 . . . . 3.73 111.044 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.774 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -54.83 -50.59 85.17 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.256 -0.429 . . . . 2.7799999999999998 111.161 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 13.4 Cg_endo -92.58 -72.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.168 1.912 . . . . 1.6299999999999999 111.77 169.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.677 ' CB ' ' HB ' ' A' ' 116' ' ' THR . 39.5 p90 -153.59 153.61 32.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.348 -0.612 . . . . 3.21 109.348 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.004 ' HB ' HD22 ' A' ' 1' ' ' ASN . 0.9 OUTLIER -102.35 143.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.93 -1.137 . . . . 1.4399999999999999 107.93 169.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 4.6 ttt180 -133.32 143.42 49.0 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.417 -0.513 . . . . 3.3700000000000001 110.635 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.832 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.51 132.03 54.52 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.302 -0.999 . . . . 0.79000000000000004 108.302 170.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' ' NH2' ' A' ' 110' ' ' ARG . 21.8 m -130.37 110.41 11.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.329 0.585 . . . . 1.28 109.753 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 2.5 t -134.53 131.12 54.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.153 -0.93 . . . . 1.27 111.588 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -105.65 116.12 31.4 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.142 -0.688 . . . . 0.56999999999999995 109.142 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 19' ' ' ALA . 1.5 m -98.01 158.14 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 115.879 -0.601 . . . . 0.91000000000000003 110.035 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -119.84 55.86 0.97 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.053 -0.521 . . . . 0.97999999999999998 111.002 -174.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -167.17 26.54 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.968 -0.56 . . . . 0.35999999999999999 111.837 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 23.0 t70 73.81 167.41 0.3 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.073 0.463 . . . . 0.91000000000000003 111.797 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.703 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 48.4 ttp180 -71.04 -27.31 63.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.987 -0.552 . . . . 1.8799999999999999 111.162 -173.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -58.19 -52.93 63.53 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.918 -0.583 . . . . 3.0499999999999998 110.266 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 69.3 m -71.04 -34.95 71.74 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.85 -0.614 . . . . 1.1100000000000001 111.24 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -57.07 -47.02 82.02 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.32000000000000001 110.802 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 69.4 t80 -70.8 -43.49 68.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.994 -0.548 . . . . 0.38 110.615 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.677 ' HD2' ' HB2' ' A' ' 25' ' ' GLU . 22.8 tptp -51.92 -52.28 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.595 . . . . 2.3900000000000001 110.711 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.3 m -67.64 -52.23 40.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.54 -0.3 . . . . 0.68000000000000005 110.868 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -59.21 -39.76 83.67 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.452 0.538 . . . . 0.47999999999999998 112.452 -173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 77' ' ' LEU . 27.4 tp -114.21 -47.38 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.158 -0.617 . . . . 0.5 112.205 -175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.677 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 29.4 mt-10 -88.67 17.4 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.765 0.317 . . . . 1.24 111.082 -172.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.67 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -149.46 39.23 0.92 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.798 -0.715 . . . . 0.82999999999999996 112.067 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.617 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 12.6 t80 -51.56 -48.48 86.61 Favored Pre-proline 0 C--N 1.321 -0.646 0 C-N-CA 122.019 0.128 . . . . 0.73999999999999999 111.07 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 30.0 Cg_endo -88.74 24.19 0.7 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.15 1.9 . . . . 0.76000000000000001 114.907 174.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.8 pt-20 -105.12 -12.2 16.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.866 0.757 . . . . 1.49 111.462 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.504 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 2.7 m0 -83.54 -164.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.031 -0.359 . . . . 4.6200000000000001 110.031 -174.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.653 ' H ' ' HD3' ' A' ' 32' ' ' PRO . 12.5 p-90 -140.37 19.01 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 114.464 1.283 . . . . 2.7799999999999998 114.464 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.653 ' HD3' ' H ' ' A' ' 31' ' ' TRP . 54.9 Cg_endo -83.69 -112.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 CA-C-N 121.406 1.538 . . . . 1.3600000000000001 113.001 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 63.0 t30 -79.41 -13.76 59.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.044 0.926 . . . . 1.51 109.727 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.63 ' HA ' HG23 ' A' ' 40' ' ' VAL . 7.8 m120 -90.17 30.91 1.04 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.627 -1.169 . . . . 1.79 110.251 -174.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -97.34 2.16 50.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 4.4500000000000002 110.9 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 21.5 mmt180 -114.0 152.07 31.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.294 0.569 . . . . 4.1399999999999997 112.218 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -81.5 148.31 29.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.776 . . . . 2.6800000000000002 109.714 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 56' ' ' ILE . 44.5 p 52.55 16.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.343 0.657 . . . . 1.4199999999999999 111.715 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.706 ' HD3' HG22 ' A' ' 40' ' ' VAL . 1.2 tmtp? -142.44 80.4 1.7 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.658 -0.701 . . . . 2.8999999999999999 109.263 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.706 HG22 ' HD3' ' A' ' 39' ' ' LYS . 19.1 m 49.33 16.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.148 1.379 . . . . 1.8300000000000001 113.716 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.72 25.4 2.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.378 -0.915 . . . . 2.1699999999999999 112.627 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.795 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -85.28 161.71 51.05 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.367 -0.605 . . . . 1.1200000000000001 109.367 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 39.2 Cg_exo -43.83 -12.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.966 3.777 . . . . 1.48 116.982 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.933 HD21 HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -111.24 -94.54 0.44 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.574 -0.704 . . . . 1.75 111.125 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.617 ' HA3' ' CD2' ' A' ' 27' ' ' PHE . . . 91.88 -36.81 3.53 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.78 -0.724 . . . . 0.75 112.976 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 24' ' ' LEU . 81.9 t -140.1 140.65 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.846 0.355 . . . . 0.59999999999999998 111.168 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.702 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 11.0 t70 -109.88 113.2 25.74 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.327 -0.99 . . . . 1.1100000000000001 108.327 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.541 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 16.8 ttmt -79.6 -23.24 42.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.822 -0.626 . . . . 2.8100000000000001 112.286 -169.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -90.08 -36.48 14.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.747 0.308 . . . . 3.1699999999999999 111.293 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.83 -20.21 31.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.907 -0.663 . . . . 1.53 112.313 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . 79.51 56.77 3.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.746 -0.74 . . . . 0.77000000000000002 111.811 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 7.8 mpt_? -133.78 160.92 36.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.785 0.326 . . . . 3.7200000000000002 111.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.746 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 15.6 m0 -117.31 108.66 15.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.234 -0.654 . . . . 1.28 109.234 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.702 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 11.0 p90 -162.39 146.22 11.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 1.6599999999999999 110.862 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.909 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -114.3 175.21 5.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.841 -0.618 . . . . 2.1200000000000001 109.356 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.933 HG12 HD21 ' A' ' 44' ' ' LEU . 20.6 mm -76.07 111.8 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.645 -0.502 . . . . 0.92000000000000004 109.645 176.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 39.8 t0 -95.64 157.22 15.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.748 -0.66 . . . . 1.97 109.927 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.84 -28.07 62.31 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.398 0.888 . . . . 2.4300000000000002 113.398 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.51 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -85.76 9.69 15.77 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.879 -0.728 . . . . 2.3900000000000001 111.385 -176.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 126.75 47.68 0.19 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.079 -1.058 . . . . 2.29 113.532 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.731 ' HG2' HG23 ' A' ' 56' ' ' ILE . 27.7 mt-10 54.36 36.88 26.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.396 0.617 . . . . 2.3100000000000001 111.278 172.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -120.08 85.35 2.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 2.6099999999999999 110.462 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -109.79 164.1 12.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.774 -0.648 . . . . 3.7200000000000002 110.242 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.8 p -57.48 112.29 1.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.359 -0.382 . . . . 2.27 110.694 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -79.47 102.39 8.75 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.796 0.295 . . . . 6.4800000000000004 111.796 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.746 ' HA3' ' HB2' ' A' ' 53' ' ' TRP . . . -55.89 137.51 46.31 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.509 -1.036 . . . . 1.23 110.509 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -108.59 97.71 7.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 117.379 0.59 . . . . 1.1699999999999999 111.773 -168.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.533 HG21 ' CG2' ' A' ' 71' ' ' VAL . 46.1 mt -84.08 133.71 28.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.835 -0.432 . . . . 0.60999999999999999 109.835 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -96.11 -33.27 12.14 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.846 -0.428 . . . . 2.0 109.846 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.5 ttpp -155.04 130.11 9.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.303 -0.408 . . . . 1.53 111.745 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.533 ' CG2' HG21 ' A' ' 68' ' ' ILE . 97.6 t -114.6 100.54 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.785 -0.82 . . . . 0.88 108.785 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.6 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.0 m-20 -98.15 59.35 1.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 119.489 -0.291 . . . . 1.4199999999999999 111.173 -173.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.0 pt-20 44.25 -165.19 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 O-C-N 124.252 0.97 . . . . 0.95999999999999996 111.635 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.9 Cg_exo -61.59 85.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.067 1.178 . . . . 0.38 111.385 165.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.703 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 26.5 t70 -173.16 -65.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.5 110.561 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.2 p -145.53 158.97 43.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.919 0.39 . . . . 0.34999999999999998 111.809 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' CD2' HD22 ' A' ' 24' ' ' LEU . 4.2 mp -145.99 130.56 17.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 0.73999999999999999 109.913 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.95 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.26 -0.427 . . . . 0.67000000000000004 109.909 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.49 144.53 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.526 -0.306 . . . . 0.75 111.215 -175.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -105.46 155.4 16.95 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.253 -0.43 . . . . 0.5 112.597 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 75.6 t-105 -78.55 137.44 37.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.5 0.556 . . . . 2.79 112.5 -169.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -148.07 40.59 0.97 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.482 -0.781 . . . . 5.46 109.285 176.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 88' ' ' ARG . 0.4 OUTLIER 85.65 166.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.859 1.059 . . . . 1.55 113.859 171.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.486 ' H ' HD13 ' A' ' 83' ' ' LEU . 36.4 t30 -158.1 -37.29 0.07 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 113.925 -1.489 . . . . 1.9299999999999999 108.475 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -81.27 10.25 50.16 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.401 -0.818 . . . . 2.3999999999999999 112.516 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.5 t80 74.4 -74.28 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.396 0.679 . . . . 5.3799999999999999 112.008 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.14 71.56 2.12 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.879 -0.677 . . . . 2.2999999999999998 113.508 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.883 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 15.6 ttp180 -146.15 179.01 7.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.025 -0.361 . . . . 4.7699999999999996 110.025 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.883 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -82.23 126.95 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.063 -0.717 . . . . 1.8600000000000001 109.063 178.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 30.0 p-10 -96.81 129.1 33.55 Favored Pre-proline 0 C--N 1.317 -0.816 0 O-C-N 121.672 -0.643 . . . . 3.1800000000000002 110.098 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' ASN . 23.4 Cg_exo -63.37 -40.01 34.11 Favored 'Trans proline' 0 CA--C 1.519 -0.246 0 C-N-CA 122.926 2.417 . . . . 2.3599999999999999 113.069 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 68.2 -30.88 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.759 0.652 . . . . 2.9900000000000002 112.759 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER -74.64 -60.15 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.355 0.598 . . . . 3.0600000000000001 110.365 -173.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.0 p -155.23 -90.57 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.568 -0.742 . . . . 1.8500000000000001 111.293 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 49.5 m 54.11 36.72 25.45 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 108.52 -0.919 . . . . 1.4399999999999999 108.52 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 35.6 tt0 -71.7 141.75 49.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.445 -1.707 . . . . 1.8100000000000001 111.423 -172.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.598 ' HB2' HG13 ' A' ' 113' ' ' VAL . 6.7 p90 -139.07 134.63 33.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.624 -0.716 . . . . 0.64000000000000001 110.199 174.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -98.87 117.14 32.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.504 -0.771 . . . . 0.42999999999999999 110.273 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 111' ' ' VAL . 85.4 t -82.91 110.63 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 0.87 109.853 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 8.5 m -99.63 105.62 17.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.286 0.366 . . . . 0.45000000000000001 111.426 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 35.4 m-85 -96.46 114.17 25.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.998 0.428 . . . . 0.34000000000000002 110.976 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.3 110.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.327 -0.62 . . . . 0.54000000000000004 109.327 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.09 134.72 41.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.44 111.523 -175.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.644 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 38.2 t70 -120.89 123.16 41.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.101 -0.954 . . . . 2.0299999999999998 108.944 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.96 -10.88 28.54 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.929 -0.578 . . . . 1.97 113.64 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.43 49.8 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.942 0.401 . . . . 4.9299999999999997 110.464 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 60.43 31.84 20.43 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.73 -0.668 . . . . 3.5299999999999998 111.308 174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.644 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 3.8 ttmp? -132.6 155.71 48.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.32 -0.4 . . . . 2.4399999999999999 110.448 -173.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.555 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.5 m -158.29 125.43 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.41999999999999998 110.768 173.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.474 ' NH2' ' HB3' ' A' ' 9' ' ' SER . 20.4 tpt180 -101.0 126.65 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.432 -0.803 . . . . 2.5899999999999999 109.556 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 100' ' ' THR . 9.5 p -114.58 136.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.006 0.432 . . . . 0.40000000000000002 111.063 177.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.588 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 3.2 p-10 -126.73 120.24 28.89 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.81 0.814 . . . . 1.3799999999999999 109.381 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.832 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 1.6 t -90.97 120.24 39.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.958 -1.019 . . . . 0.91000000000000003 110.084 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -96.36 111.3 23.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.808 0.693 . . . . 2.3100000000000001 109.212 174.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.947 ' HB3' HG22 ' A' ' 6' ' ' VAL . 51.8 t-80 -125.27 98.93 5.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.38 -0.827 . . . . 1.6399999999999999 108.769 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.677 ' HB ' ' CB ' ' A' ' 5' ' ' PHE . 5.4 t -151.36 88.1 1.42 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.89 0.852 . . . . 2.6699999999999999 109.621 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -157.47 -76.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 2.6299999999999999 110.253 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.605 ' O ' ' HB3' ' A' ' 125' ' ' HIS . 6.4 t80 -73.2 -38.58 66.07 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.799 -0.815 . . . . 3.54 108.799 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.558 ' OD1' HG13 ' A' ' 6' ' ' VAL . 17.1 p-10 -73.81 -47.59 37.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.413 -0.812 . . . . 1.8100000000000001 111.353 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HD3' ' OG1' ' A' ' 116' ' ' THR . 52.4 ttp180 -56.28 -21.45 23.93 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.35 -0.386 . . . . 3.3799999999999999 111.634 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 33.9 tpp -72.38 -3.48 24.29 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.95 0.405 . . . . 2.4300000000000002 110.371 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.3 -164.49 24.31 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 115.036 0.774 . . . . 1.6100000000000001 115.036 167.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.0 p 39.9 -116.22 0.23 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.394 1.077 . . . . 2.5800000000000001 113.016 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.14 -25.13 64.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.7999999999999998 111.184 -174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.605 ' HB3' ' O ' ' A' ' 118' ' ' PHE . 41.9 m-70 -68.53 -53.93 19.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.037 0.446 . . . . 2.1400000000000001 110.624 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.94 -26.15 63.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.307 0.575 . . . . 0.92000000000000004 109.999 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 87.4 tttt -62.57 -46.44 88.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.102 -0.954 . . . . 2.8300000000000001 111.388 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 1.6 ptm180 -78.4 -28.6 46.93 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.827 -0.349 . . . . 2.5899999999999999 111.587 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 125' ' ' HIS . 88.9 t -72.81 -30.91 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.22 0.452 . . . . 1.48 112.22 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 127' ' ' LYS . 31.8 ptt180 -59.58 -30.01 68.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.809 0.337 . . . . 3.8300000000000001 111.631 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.761 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.0 m-20 -65.15 -21.17 66.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.434 0.531 . . . . 2.48 112.434 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' HA3' HH11 ' A' ' 88' ' ' ARG . . . -96.99 -72.08 1.09 Allowed Glycine 0 C--O 1.226 -0.351 0 C-N-CA 119.975 -1.107 . . . . 1.6100000000000001 114.8 -164.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.693 ' HB2' ' HB2' ' A' ' 137' ' ' TRP . 26.5 ptt? -80.93 -9.59 59.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.441 0.534 . . . . 4.8300000000000001 112.441 -170.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.58 -49.84 69.44 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.405 0.52 . . . . 2.8300000000000001 112.405 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -96.96 22.86 7.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.948 0.351 . . . . 4.1500000000000004 111.948 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.585 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -139.76 -56.26 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 119.73 -1.224 . . . . 1.04 113.101 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.693 ' HB2' ' HB2' ' A' ' 133' ' ' MET . 65.2 t-105 -55.24 -53.31 63.19 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.549 0.574 . . . . 2.7799999999999998 112.549 -170.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 19.6 Cg_endo -59.41 -40.64 65.43 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.81 1.674 . . . . 0.68000000000000005 112.337 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 m -69.21 -38.28 78.51 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.515 0.674 . . . . 0.87 110.258 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.642 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 29.1 mt -59.58 -42.02 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.218 -0.901 . . . . 0.71999999999999997 110.817 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 76.6 mt -62.76 -26.95 68.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.904 0.335 . . . . 0.68999999999999995 111.904 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.18 -54.64 7.32 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.371 -0.233 . . . . 1.49 110.371 176.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -27.5 68.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 1.1499999999999999 110.595 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 47.2 t80 -62.17 -55.06 32.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.45 -0.795 . . . . 0.80000000000000004 110.485 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.447 ' CG ' HG13 ' A' ' 10' ' ' VAL . 39.0 mt-30 -62.9 -34.61 77.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.32 0.581 . . . . 1.6299999999999999 110.816 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.513 ' HB3' ' HE1' ' A' ' 31' ' ' TRP . 13.4 t70 -66.12 -44.99 82.69 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.873 -1.058 . . . . 1.46 110.402 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -69.19 -31.54 70.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.711 -0.677 . . . . 1.74 110.698 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.529 HG21 ' HB ' ' A' ' 12' ' ' VAL . 53.2 mt -71.43 -36.37 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.19 0.519 . . . . 0.5 110.446 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.473 ' HB3' ' HE3' ' A' ' 154' ' ' LYS . 17.8 t0 -66.11 -28.97 69.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.09 -0.504 . . . . 0.84999999999999998 109.675 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 55.7 mt-10 -60.74 -28.56 68.79 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.572 0.701 . . . . 1.5 110.334 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.51 -3.24 58.98 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.239 -0.891 . . . . 1.74 110.383 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.72 -70.4 0.23 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.525 -0.845 . . . . 1.3200000000000001 113.67 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.28 -46.65 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 117.066 0.433 . . . . 1.9199999999999999 111.407 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttpp -81.72 171.15 14.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.356 -0.384 . . . . 2.04 110.013 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.555 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 18.1 tppt? . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.352 -0.981 . . . . 4.2199999999999998 108.352 167.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.0 p-10 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.65 0.262 . . . . 1.6599999999999999 110.509 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 24.6 p90 172.14 -35.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.837 0.855 . . . . 3.73 109.108 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.76 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 19.9 t70 -73.64 -55.35 3.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.523 -0.308 . . . . 2.7799999999999998 111.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 52.8 Cg_endo -84.31 -68.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.512 1.474 . . . . 1.6299999999999999 111.94 175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -148.05 142.78 26.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.169 -0.469 . . . . 3.21 110.073 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.638 ' HB ' ' O ' ' A' ' 115' ' ' HIS . 76.5 t -98.29 112.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.866 -0.791 . . . . 1.4399999999999999 108.866 167.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 45.4 ttm-85 -123.62 135.54 54.0 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.537 -0.465 . . . . 3.3700000000000001 110.97 -177.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.725 ' CD2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -109.66 134.38 52.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.829 -0.804 . . . . 0.79000000000000004 108.829 174.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 22.4 m -143.24 112.23 6.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.154 -0.475 . . . . 1.28 110.455 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.948 HG22 HG12 ' A' ' 111' ' ' VAL . 2.2 m -126.66 140.42 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.125 -0.489 . . . . 1.27 109.77 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.7 m -102.48 114.42 28.61 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.512 -0.921 . . . . 0.56999999999999995 108.512 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' HB ' ' A' ' 109' ' ' THR . 0.3 OUTLIER -103.3 162.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.254 -0.43 . . . . 0.91000000000000003 110.445 -172.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.922 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 9.5 pttt -125.92 35.93 4.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.753 -0.658 . . . . 0.97999999999999998 112.013 -169.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.27 29.19 0.4 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.215 0.45 . . . . 0.35999999999999999 112.215 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 20.6 t70 75.84 163.37 0.25 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.857 0.837 . . . . 0.91000000000000003 112.22 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.881 ' HD2' ' HA ' ' A' ' 75' ' ' ASP . 40.1 ttp180 -64.68 -27.88 69.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.717 -1.129 . . . . 1.8799999999999999 110.96 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 4.3 ttmp? -57.67 -48.55 79.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 3.0499999999999998 110.825 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -77.46 -36.32 52.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.192 -0.458 . . . . 1.1100000000000001 111.023 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.622 ' HA ' HD13 ' A' ' 148' ' ' ILE . . . -59.81 -39.59 85.54 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.79 -0.364 . . . . 0.32000000000000001 110.405 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CG ' ' HA ' ' A' ' 74' ' ' PRO . 55.6 t80 -71.05 -49.97 39.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.463 -0.335 . . . . 0.38 110.77 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -54.18 -53.0 59.41 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.083 0.468 . . . . 2.3900000000000001 110.982 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.475 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.2 m -63.83 -45.31 90.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.359 -0.837 . . . . 0.68000000000000005 110.56 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.719 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 65.3 t80 -63.95 -37.49 87.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.945 0.35 . . . . 0.47999999999999998 111.945 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.87 HD11 HG11 ' A' ' 46' ' ' VAL . 17.1 tp -99.49 -59.65 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.179 -0.608 . . . . 0.5 112.485 -174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -88.72 -19.47 26.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.149 0.5 . . . . 1.24 111.547 -173.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.558 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -89.77 18.48 46.81 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.645 -0.788 . . . . 0.82999999999999996 111.17 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.534 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 10.9 t80 -50.39 -51.78 60.85 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.151 0.58 . . . . 0.73999999999999999 112.256 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 42.0 Cg_endo -86.13 8.01 4.71 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.298 1.999 . . . . 0.76000000000000001 115.525 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 11.7 pt-20 -111.07 -2.36 15.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.851 -0.739 . . . . 1.49 111.999 -175.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.818 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 43.1 m0 -67.64 155.73 38.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.329 0.585 . . . . 4.6200000000000001 111.111 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.547 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 68.0 m95 -75.1 -43.79 4.61 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.389 -0.823 . . . . 2.7799999999999998 112.906 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 29.1 Cg_endo -60.46 -87.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.63 2.22 . . . . 1.3600000000000001 115.199 -162.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.532 ' ND2' HG11 ' A' ' 40' ' ' VAL . 6.1 t30 -110.98 -17.85 13.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.516 0.674 . . . . 1.51 110.451 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.627 ' HA ' HG13 ' A' ' 40' ' ' VAL . 2.9 m-20 -100.89 27.63 5.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.474 -0.784 . . . . 1.79 112.037 -168.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -104.4 13.31 32.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.687 0.756 . . . . 4.4500000000000002 109.44 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -104.74 128.26 52.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.718 -0.674 . . . . 4.1399999999999997 111.066 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -75.61 137.45 40.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 2.6800000000000002 111.151 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 57' ' ' ASP . 79.8 p 57.09 11.53 1.04 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.61 1.164 . . . . 1.4199999999999999 112.956 -178.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.642 ' HG3' ' HB2' ' A' ' 86' ' ' PHE . 83.0 tttt -100.03 -48.81 4.52 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.477 -0.934 . . . . 2.8999999999999999 108.477 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.717 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 12.4 p -174.35 -2.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.418 -1.265 . . . . 1.8300000000000001 109.984 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -127.59 47.09 1.04 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.623 -0.799 . . . . 2.1699999999999999 112.638 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.037 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -79.91 158.46 72.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.013 -1.106 . . . . 1.1200000000000001 108.013 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.69 44.85 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 123.803 3.002 . . . . 1.48 114.786 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -149.51 -84.36 0.09 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.723 -0.473 . . . . 1.75 109.723 173.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.434 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 91.23 -52.95 3.17 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.926 -0.654 . . . . 0.75 112.781 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.87 HG11 HD11 ' A' ' 24' ' ' LEU . 58.9 t -140.33 138.42 36.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.003 0.43 . . . . 0.59999999999999998 111.607 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.647 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 22.3 t70 -100.42 107.27 18.97 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.841 -0.8 . . . . 1.1100000000000001 108.841 172.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -9.83 59.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.19 -0.914 . . . . 2.8100000000000001 111.203 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -75.39 -62.41 1.58 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.035 -0.53 . . . . 3.1699999999999999 110.702 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 52' ' ' ARG . . . -92.59 -39.49 5.28 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.562 -0.828 . . . . 1.53 111.662 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 72.46 0.62 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.654 -0.784 . . . . 0.77000000000000002 112.805 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' NH1' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -154.39 144.33 21.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 3.7200000000000002 111.172 175.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.608 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 22.7 m0 -96.2 110.98 23.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.203 -0.453 . . . . 1.28 110.515 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.647 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 9.8 p90 -153.91 152.91 31.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 1.6599999999999999 110.399 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 6.4 mp0 -119.98 150.71 40.09 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.115 -0.698 . . . . 2.1200000000000001 109.115 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.507 HD12 ' HG2' ' A' ' 61' ' ' GLU . 45.0 mm -77.0 103.37 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.999 0.428 . . . . 0.92000000000000004 109.892 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.814 ' HB3' HE22 ' A' ' 59' ' ' GLN . 8.1 t70 -92.84 148.13 22.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.133 -0.692 . . . . 1.97 109.133 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.88 -10.09 59.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.462 0.912 . . . . 2.4300000000000002 113.462 -166.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.814 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -93.18 10.25 32.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.648 -0.821 . . . . 2.3900000000000001 110.712 177.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.49 50.88 0.32 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.39 -0.91 . . . . 2.29 113.921 173.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.507 ' HG2' HD12 ' A' ' 56' ' ' ILE . 39.2 mt-10 58.1 24.67 11.5 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.175 0.435 . . . . 2.3100000000000001 112.175 174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 25.5 tt0 -90.86 78.05 6.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.499 0.666 . . . . 2.6099999999999999 110.143 -173.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.508 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -123.22 162.74 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.292 -0.867 . . . . 3.7200000000000002 109.68 176.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.566 ' C ' ' HD2' ' A' ' 82' ' ' ARG . 4.9 p -62.97 148.59 47.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.4 -0.593 . . . . 2.27 109.4 172.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 44.4 p90 -120.4 120.87 37.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.396 -0.522 . . . . 6.4800000000000004 111.666 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -69.34 148.17 46.87 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.681 -0.968 . . . . 1.23 110.681 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.491 ' HG ' ' HA3' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -106.0 96.48 6.51 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.263 0.532 . . . . 1.1699999999999999 111.26 -171.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.545 HG21 ' CG2' ' A' ' 71' ' ' VAL . 53.8 mt -77.08 125.29 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.271 0.558 . . . . 0.60999999999999999 109.939 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -96.2 -21.37 17.93 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.399 -0.818 . . . . 2.0 109.786 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -164.64 125.0 2.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.224 -0.443 . . . . 1.53 111.889 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' CG2' HG21 ' A' ' 68' ' ' ILE . 62.6 t -109.36 107.95 24.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.725 -0.843 . . . . 0.88 108.725 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.44 75.85 1.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.649 -0.42 . . . . 1.4199999999999999 111.211 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.3 pt-20 47.67 -170.92 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 124.766 1.291 . . . . 0.95999999999999996 111.961 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 35.9 Cg_exo -63.48 81.32 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.373 1.382 . . . . 0.38 111.122 166.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.881 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 14.9 t70 -166.69 -68.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.405 -0.816 . . . . 0.5 110.984 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -138.67 140.3 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.783 0.66 . . . . 0.34999999999999998 112.783 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -135.47 116.41 14.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.48 -0.782 . . . . 0.73999999999999999 108.977 175.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 98' ' ' THR . 29.9 t -95.26 111.78 26.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.687 -0.857 . . . . 0.67000000000000004 108.687 175.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.21 126.42 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.75 0.31 . . . . 0.75 111.185 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 1.01 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -84.88 146.25 22.06 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.006 -0.837 . . . . 0.5 111.006 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.89 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 68.8 t-105 -73.63 160.18 31.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.585 0.707 . . . . 2.79 112.34 -168.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.568 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 19.3 ttp180 -135.52 -72.56 0.46 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.409 -1.269 . . . . 5.46 109.722 -172.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.769 HD23 ' HB2' ' A' ' 90' ' ' ASP . 2.5 tm? 170.46 145.28 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.343 -0.844 . . . . 1.55 109.539 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.679 ' N ' HD13 ' A' ' 83' ' ' LEU . 54.0 t30 -142.6 146.89 35.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.35 -0.611 . . . . 1.9299999999999999 109.35 171.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.65 -15.56 31.85 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.831 -0.699 . . . . 2.3999999999999999 112.024 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.642 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 71.3 t80 70.39 -63.29 0.41 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.64 0.776 . . . . 5.3799999999999999 111.207 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.59 44.65 3.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.224 -0.512 . . . . 2.2999999999999998 112.037 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.694 ' NH1' ' HA ' ' A' ' 129' ' ' VAL . 2.4 tmm_? -133.86 144.24 48.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.033 -0.729 . . . . 4.7699999999999996 109.033 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.512 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -96.58 131.92 42.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.028 0.442 . . . . 1.8600000000000001 111.292 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.769 ' HB2' HD23 ' A' ' 83' ' ' LEU . 5.2 t70 -143.66 137.15 14.16 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.482 -0.933 . . . . 3.1800000000000002 108.482 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.575 ' HG2' ' CZ ' ' A' ' 118' ' ' PHE . 32.0 Cg_exo -58.72 -25.58 76.28 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.562 2.175 . . . . 2.3599999999999999 112.72 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.4 t70 56.51 75.29 0.36 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.358 0.599 . . . . 2.9900000000000002 110.155 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.32 -75.13 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 3.0600000000000001 110.767 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.7 m -113.5 -97.93 0.43 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.969 -0.56 . . . . 1.8500000000000001 110.384 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.89 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 13.5 m 50.64 37.77 17.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.938 -0.574 . . . . 1.4399999999999999 112.086 175.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 1.01 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 27.9 mt-10 -62.65 143.16 57.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.38 -0.373 . . . . 1.8100000000000001 111.379 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.776 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -136.46 127.66 28.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.939 -0.573 . . . . 0.64000000000000001 110.749 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.63 HG23 HG22 ' A' ' 78' ' ' VAL . 27.7 m -91.1 115.1 27.75 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.42999999999999999 110.696 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HA ' HG23 ' A' ' 113' ' ' VAL . 58.0 t -86.33 109.92 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.872 -0.418 . . . . 0.87 109.872 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.3 m -107.88 106.52 16.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.424 -0.353 . . . . 0.45000000000000001 110.761 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.74 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 52.8 m-85 -88.35 117.72 27.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.556 -0.293 . . . . 0.34000000000000002 110.346 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.98 112.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 110.236 -0.283 . . . . 0.54000000000000004 110.236 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.4 143.33 51.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.887 -0.597 . . . . 0.44 111.593 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 14.8 t70 -137.38 120.31 16.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.892 -0.595 . . . . 2.0299999999999998 109.535 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -71.27 58.64 1.13 Allowed Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.994 -0.548 . . . . 1.97 113.118 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 106' ' ' GLN . 21.0 tt0 -150.98 13.57 0.7 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.315 -0.994 . . . . 4.9299999999999997 108.315 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' GLN . 59.8 mttp 67.09 33.7 5.49 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.175 -0.92 . . . . 3.5299999999999998 109.384 -167.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 7.3 ttpm? -121.65 154.43 36.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.407 -0.59 . . . . 2.4399999999999999 109.407 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.584 ' HB ' HG12 ' A' ' 12' ' ' VAL . 18.7 m -161.14 128.63 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.757 0.313 . . . . 0.41999999999999998 110.728 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.34 114.95 28.81 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.036 -0.727 . . . . 2.5899999999999999 109.036 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.948 HG12 HG22 ' A' ' 10' ' ' VAL . 12.7 p -93.2 144.67 8.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 120.994 -0.283 . . . . 0.40000000000000002 111.199 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.47 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 7.3 t70 -130.26 126.78 38.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.222 -0.899 . . . . 1.3799999999999999 109.51 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.725 ' HB ' ' CD2' ' A' ' 8' ' ' HIS . 1.2 t -111.44 133.22 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 116.662 -0.245 . . . . 0.91000000000000003 110.809 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 49.8 mt-10 -104.31 110.73 23.08 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.907 0.754 . . . . 2.3100000000000001 109.921 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.776 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 79.0 t60 -123.38 99.06 6.14 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.214 -1.032 . . . . 1.6399999999999999 108.214 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 27.7 m -153.07 91.26 1.51 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.116 0.484 . . . . 2.6699999999999999 110.129 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -155.6 -75.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.904 -0.589 . . . . 2.6299999999999999 110.142 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.575 ' CZ ' ' HG2' ' A' ' 91' ' ' PRO . 37.1 t80 -82.31 -25.76 33.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.654 -0.703 . . . . 3.54 110.906 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.87 -43.63 53.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.684 -0.689 . . . . 1.8100000000000001 110.991 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 71.0 ttt180 -53.72 -21.3 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.368 -0.833 . . . . 3.3799999999999999 112.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 79.1 mmm -78.64 2.14 20.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.428 -0.351 . . . . 2.4300000000000002 111.113 -177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.31 -144.38 6.71 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.744 -0.662 . . . . 1.6100000000000001 114.342 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 m 47.48 -132.61 1.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.302 0.641 . . . . 2.5800000000000001 110.85 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -77.59 -13.91 59.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.471 -0.143 . . . . 3.7999999999999998 111.371 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 129' ' ' VAL . 20.8 m170 -72.72 -52.94 13.11 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.472 -0.566 . . . . 2.1400000000000001 109.472 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 -36.0 70.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.767 -0.651 . . . . 0.92000000000000004 111.026 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -64.33 -39.47 93.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.478 -0.328 . . . . 2.8300000000000001 111.098 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.452 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 3.1 ptm180 -73.28 -32.9 64.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 2.5899999999999999 110.336 -177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.694 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 89.5 t -65.06 -40.49 89.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.385 0.612 . . . . 1.48 110.266 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.52 ' HG2' ' HB2' ' A' ' 134' ' ' ASP . 8.5 ttp180 -65.66 -17.25 64.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 3.8300000000000001 111.904 -176.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 88' ' ' ARG . 65.9 t30 -52.99 -46.47 68.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.727 0.298 . . . . 2.48 111.629 -173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' HG3' ' A' ' 88' ' ' ARG . . . -120.01 -20.07 3.83 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.145 -1.026 . . . . 1.6100000000000001 113.031 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 49.6 ttm -79.74 -22.96 42.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.577 -0.366 . . . . 4.8300000000000001 111.165 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.52 ' HB2' ' HG2' ' A' ' 130' ' ' ARG . 10.3 t70 -55.65 -49.15 73.66 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.851 0.685 . . . . 2.8300000000000001 112.851 -174.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -100.42 -39.85 7.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.984 -0.286 . . . . 4.1500000000000004 111.335 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -59.41 -59.59 10.36 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-N 116.46 -0.336 . . . . 1.04 113.324 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.541 ' HH2' HG11 ' A' ' 113' ' ' VAL . 3.4 t90 -59.36 -49.99 89.68 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 112.63 0.604 . . . . 2.7799999999999998 112.63 -172.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 28.6 Cg_endo -62.13 -35.54 74.82 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.002 1.801 . . . . 0.68000000000000005 112.385 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -68.55 -37.04 79.6 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.248 -0.649 . . . . 0.87 109.248 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.687 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 57.8 mt -55.59 -49.35 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.933 -1.031 . . . . 0.71999999999999997 110.244 174.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 60.4 mt -58.79 -33.8 70.75 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.363 0.414 . . . . 0.68999999999999995 112.063 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.51 -57.0 7.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.058 0.456 . . . . 1.49 110.417 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.611 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 70.1 m -65.89 -23.18 66.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.941 -0.572 . . . . 1.1499999999999999 110.532 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.462 ' CZ ' HD11 ' A' ' 148' ' ' ILE . 64.7 t80 -63.85 -53.0 57.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 0.80000000000000004 110.101 175.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 76.1 mt-30 -58.58 -33.57 70.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.233 0.54 . . . . 1.6299999999999999 110.34 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.36 -42.15 45.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.326 -0.852 . . . . 1.46 111.33 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.509 ' HA ' ' OE1' ' A' ' 150' ' ' GLU . 10.0 tptt -62.99 -38.51 91.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.225 0.536 . . . . 1.74 110.442 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 19' ' ' ALA . 66.2 mt -68.49 -30.31 47.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.821 -0.627 . . . . 0.5 110.537 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.922 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 28.1 t0 -61.08 -30.96 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.84999999999999998 109.898 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.803 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 43.8 mt-10 -65.99 -29.98 70.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 1.5 110.392 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -85.13 -5.14 59.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.419 -0.809 . . . . 1.74 110.173 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -115.8 -71.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.943 -0.646 . . . . 1.3200000000000001 113.488 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.64 24.76 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.467 0.543 . . . . 1.9199999999999999 112.467 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.803 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 14.9 tppt? -62.14 -74.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.431 0.158 . . . . 2.04 110.777 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.62 ' NZ ' ' HB2' ' A' ' 155' ' ' LYS . 6.8 mtmp? . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.322 -0.847 . . . . 4.2199999999999998 110.392 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.57 ' O ' HG22 ' A' ' 6' ' ' VAL . 31.8 p-10 . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 121.028 0.442 . . . . 1.6599999999999999 110.78 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.437 ' HA ' HG22 ' A' ' 6' ' ' VAL . 92.1 m-85 -162.01 -41.71 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.44 1.096 . . . . 3.73 108.391 -177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.745 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 20.0 t70 -61.03 -54.73 51.3 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.171 -0.922 . . . . 2.7799999999999998 112.312 -173.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 19.2 Cg_endo -91.69 -63.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 1.6299999999999999 112.493 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HA ' HG22 ' A' ' 116' ' ' THR . 30.9 p90 -152.4 142.86 22.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.082 -0.508 . . . . 3.21 109.856 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.682 ' HB ' ' CE1' ' A' ' 115' ' ' HIS . 16.7 t -103.81 108.58 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.722 -0.473 . . . . 1.4399999999999999 109.722 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.817 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 25.7 ttm180 -109.38 132.92 53.67 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.844 -0.616 . . . . 3.3700000000000001 111.502 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CD2' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.21 135.6 50.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.999 -0.741 . . . . 0.79000000000000004 108.999 173.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.778 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 5.5 p -141.18 112.72 7.55 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.144 0.497 . . . . 1.28 111.488 178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.675 HG22 ' CG1' ' A' ' 111' ' ' VAL . 16.1 m -122.93 152.44 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.978 -0.555 . . . . 1.27 111.317 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -102.18 116.04 31.83 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.509 -0.769 . . . . 0.56999999999999995 110.152 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.968 HG13 HG21 ' A' ' 148' ' ' ILE . 38.4 t -91.37 132.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.019 -0.991 . . . . 0.91000000000000003 109.974 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.716 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -101.45 23.25 11.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.978 -0.555 . . . . 0.97999999999999998 112.139 -171.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ASP . . . -155.35 37.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.244 0.461 . . . . 0.35999999999999999 112.244 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 22.6 t70 75.39 159.6 0.22 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 122.04 0.924 . . . . 0.91000000000000003 112.544 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 32.5 ttp180 -63.04 -25.49 68.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.637 -1.165 . . . . 1.8799999999999999 111.618 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.92 -48.48 79.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.587 -0.279 . . . . 3.0499999999999998 110.272 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.2 p -74.08 -36.4 64.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.952 -0.299 . . . . 1.1100000000000001 111.201 -176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.85 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -59.23 -45.48 91.03 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.414 -0.514 . . . . 0.32000000000000001 110.574 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CE1' HD21 ' A' ' 77' ' ' LEU . 76.1 t80 -71.49 -44.27 65.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.363 -0.38 . . . . 0.38 110.616 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -54.97 -54.27 45.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.132 0.491 . . . . 2.3900000000000001 110.75 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.454 HG22 ' NE1' ' A' ' 30' ' ' TRP . 14.0 m -63.79 -48.54 76.48 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.078 -0.964 . . . . 0.68000000000000005 110.24 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.728 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 61.5 t80 -59.72 -37.78 79.85 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.647 0.592 . . . . 0.47999999999999998 112.223 -173.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.605 ' HG ' HG11 ' A' ' 46' ' ' VAL . 11.0 tp -112.78 -51.39 2.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.818 0.673 . . . . 0.5 112.818 -173.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.985 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 11.8 mt-10 -82.08 -38.62 24.61 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.799 -0.563 . . . . 1.24 111.988 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.651 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -93.07 40.53 2.81 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.876 -0.602 . . . . 0.82999999999999996 112.193 -176.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.613 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 55.0 t80 -61.54 -58.2 20.02 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 112.043 0.386 . . . . 0.73999999999999999 112.043 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 80.7 Cg_endo -80.11 29.26 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.533 2.155 . . . . 0.76000000000000001 114.388 -174.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.3 pt-20 -125.46 2.13 7.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.543 -0.463 . . . . 1.49 110.986 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.782 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 24.9 m0 -75.62 157.87 33.18 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.048 0.451 . . . . 4.6200000000000001 109.908 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.646 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 12.6 m95 -87.4 -34.93 0.45 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.17 0.804 . . . . 2.7799999999999998 113.17 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 14.0 Cg_endo -54.43 -86.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.802 2.335 . . . . 1.3600000000000001 115.295 -165.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.71 HD22 HG11 ' A' ' 40' ' ' VAL . 2.0 t30 -111.23 -34.72 6.07 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.479 0.657 . . . . 1.51 110.465 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.748 ' HA ' HG13 ' A' ' 40' ' ' VAL . 9.5 p-10 -91.51 33.62 1.0 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.061 -0.972 . . . . 1.79 111.823 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -96.34 -2.14 46.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.794 0.807 . . . . 4.4500000000000002 109.115 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 8.2 mmt180 -99.34 126.0 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.198 -0.91 . . . . 4.1399999999999997 110.65 -176.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.2 p -76.58 135.59 39.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.117 -0.492 . . . . 2.6800000000000002 110.821 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 57' ' ' ASP . 61.1 p 57.74 20.08 6.15 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.38 1.072 . . . . 1.4199999999999999 111.727 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -111.56 -46.8 3.23 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.771 -1.196 . . . . 2.8999999999999999 107.771 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.748 HG13 ' HA ' ' A' ' 34' ' ' ASN . 14.3 p -174.52 26.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.711 -1.131 . . . . 1.8300000000000001 109.02 175.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.97 36.33 0.28 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.641 -0.79 . . . . 2.1699999999999999 112.93 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -66.12 164.49 28.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.531 -0.544 . . . . 1.1200000000000001 109.531 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.36 56.96 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.352 2.701 . . . . 1.48 114.202 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.18 -83.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.173 0.589 . . . . 1.75 109.495 173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.575 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 89.59 -55.68 3.82 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.86 -0.686 . . . . 0.75 113.592 170.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.605 HG11 ' HG ' ' A' ' 24' ' ' LEU . 91.3 t -138.73 142.09 35.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.001 0.429 . . . . 0.59999999999999998 111.693 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 12.6 t70 -110.67 110.08 20.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 1.1100000000000001 108.97 175.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.985 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 3.2 mptt -80.93 -29.55 35.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 2.8100000000000001 111.872 -172.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -74.68 -42.43 58.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.031 0.382 . . . . 3.1699999999999999 112.031 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.21 -42.18 3.55 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.638 -0.791 . . . . 1.53 111.612 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.452 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 107.35 68.19 0.66 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.86 -0.686 . . . . 0.77000000000000002 112.745 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 6.8 ptm180 -159.25 139.74 12.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 3.7200000000000002 111.094 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.737 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 12.2 m0 -95.23 110.09 22.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.055 -0.52 . . . . 1.28 110.154 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.529 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 5.1 p90 -152.09 159.45 43.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.158 0.504 . . . . 1.6599999999999999 110.876 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.993 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 24.9 mt-10 -117.18 156.06 28.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.928 -0.578 . . . . 2.1200000000000001 110.89 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.8 mm -78.17 102.53 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.317 -0.994 . . . . 0.92000000000000004 108.317 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.678 ' H ' ' HA ' ' A' ' 61' ' ' GLU . 14.9 t70 -87.71 -177.87 5.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.386 -0.37 . . . . 1.97 110.54 -177.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.45 ' HG2' ' OD2' ' A' ' 57' ' ' ASP . 10.5 pt-20 -60.95 -40.64 94.1 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.348 0.499 . . . . 2.4300000000000002 112.348 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -100.16 25.12 7.82 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 2.3900000000000001 111.039 -178.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.3 -100.66 0.46 Allowed Glycine 0 C--O 1.22 -0.748 0 C-N-CA 120.822 -0.704 . . . . 2.29 111.801 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.678 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -156.02 75.31 0.89 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.357 0.598 . . . . 2.3100000000000001 110.394 175.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -110.01 74.58 0.89 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.817 -0.808 . . . . 2.6099999999999999 108.817 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 2.2 m-70 -124.21 147.47 48.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.238 -0.892 . . . . 3.7200000000000002 110.549 173.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 p -57.68 110.27 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.586 0.554 . . . . 2.27 111.141 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.737 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 48.9 p90 -77.05 122.45 24.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.237 0.541 . . . . 6.4800000000000004 111.553 -175.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 82' ' ' ARG . . . -60.49 134.41 50.0 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.056 -1.218 . . . . 1.23 110.056 170.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -97.63 87.81 4.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.607 0.703 . . . . 1.1699999999999999 110.924 -168.116 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.53 HG12 HG13 ' A' ' 79' ' ' ILE . 51.5 mt -72.99 126.43 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.051 -0.522 . . . . 0.60999999999999999 109.893 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' OE2' ' A' ' 96' ' ' GLU . 6.3 mmm180 -94.33 -26.57 16.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.837 -0.619 . . . . 2.0 109.38 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.598 ' HG2' ' OD2' ' A' ' 72' ' ' ASP . 26.2 ttpp -166.13 133.83 2.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.619 -0.719 . . . . 1.53 111.386 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.527 HG23 HG21 ' A' ' 68' ' ' ILE . 90.7 t -115.26 106.28 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.546 -0.909 . . . . 0.88 108.546 174.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 13.1 m-20 -102.99 59.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.618 -0.265 . . . . 1.4199999999999999 110.936 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 10.5 pt-20 46.89 -168.83 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.247 0.967 . . . . 0.95999999999999996 111.863 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 37.5 Cg_exo -63.52 80.5 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.422 1.414 . . . . 0.38 111.384 167.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 23.7 t70 -167.73 -66.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.45 -0.796 . . . . 0.5 110.275 -177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.6 p -146.71 159.07 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 0.34999999999999998 111.358 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.6 mp -148.03 126.92 12.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.571 -0.529 . . . . 0.73999999999999999 109.571 176.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.28 101.58 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.08 -0.711 . . . . 0.67000000000000004 109.08 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.53 HG13 HG12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -128.86 137.69 56.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.859 0.362 . . . . 0.75 110.796 -176.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.755 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -89.17 145.4 18.51 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.845 -0.616 . . . . 0.5 112.462 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.825 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 73.7 t-105 -64.48 131.24 46.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.036 0.922 . . . . 2.79 113.347 -171.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 5.8 tpt180 -151.51 94.52 2.02 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.751 -1.944 . . . . 5.46 105.751 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 89' ' ' ILE . 1.5 pp -67.72 -170.17 0.15 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.031 -0.532 . . . . 1.55 112.367 -170.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' OD1' HG21 ' A' ' 40' ' ' VAL . 3.0 m-20 -68.21 76.65 0.25 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.611 -0.885 . . . . 1.9299999999999999 108.611 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.26 50.94 4.08 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.058 -0.974 . . . . 2.3999999999999999 113.672 -168.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -132.47 34.66 3.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.828 -1.175 . . . . 5.3799999999999999 107.828 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 88' ' ' ARG . . . 169.9 -26.36 0.11 Allowed Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.473 -1.239 . . . . 2.2999999999999998 111.386 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.713 ' HG3' ' HA3' ' A' ' 132' ' ' GLY . 36.6 mmt-85 -117.15 160.8 20.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.198 -0.297 . . . . 4.7699999999999996 110.198 175.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.585 ' CG2' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -94.12 119.32 41.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.613 0.72 . . . . 1.8600000000000001 111.168 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -88.76 133.92 34.89 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.292 -0.867 . . . . 3.1800000000000002 110.07 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.21 -54.71 2.81 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.566 2.177 . . . . 2.3599999999999999 112.267 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 52.19 86.92 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.935 0.772 . . . . 2.9900000000000002 111.936 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -160.89 -52.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 3.0600000000000001 109.124 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.4 m -142.91 -84.68 0.16 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.534 -1.284 . . . . 1.8500000000000001 107.534 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.825 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 14.6 m 56.81 23.81 8.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.848 . . . . 1.4399999999999999 111.662 169.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.755 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 25.2 mt-10 -71.23 139.63 50.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.873 -0.603 . . . . 1.8100000000000001 111.665 -172.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.996 ' HB3' ' HB3' ' A' ' 115' ' ' HIS . 1.1 p90 -126.94 137.35 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.013 -0.54 . . . . 0.64000000000000001 110.927 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 41.8 m -91.41 109.11 20.39 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.185 -0.916 . . . . 0.42999999999999999 109.977 177.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.664 ' HA ' HG22 ' A' ' 113' ' ' VAL . 45.2 t -89.27 108.6 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.626 -0.509 . . . . 0.87 109.626 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.704 ' HA ' HG22 ' A' ' 76' ' ' THR . 42.1 m -104.09 106.57 17.11 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.443 . . . . 0.45000000000000001 110.563 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.711 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 48.6 m-85 -88.77 107.44 18.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.971 -0.381 . . . . 0.34000000000000002 109.971 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.45 112.98 28.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.813 -0.44 . . . . 0.54000000000000004 109.813 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.39 134.31 52.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.049 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 22.3 t70 -121.86 111.5 17.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.153 -0.476 . . . . 2.0299999999999998 109.762 -177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.62 -99.27 0.81 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.859 -0.686 . . . . 1.97 112.48 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.573 ' HG3' ' HG2' ' A' ' 107' ' ' LYS . 4.1 pt20 -150.05 -25.23 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.454 0.168 . . . . 4.9299999999999997 111.454 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.573 ' HG2' ' HG3' ' A' ' 106' ' ' GLN . 35.7 pttt -137.56 19.4 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.053 0.454 . . . . 3.5299999999999998 111.164 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.77 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 12.3 mptt -122.39 158.38 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.121 -0.696 . . . . 2.4399999999999999 109.121 172.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.571 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 51.7 m -158.07 119.85 3.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.885 0.374 . . . . 0.41999999999999998 110.813 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -101.66 108.5 20.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.114 -0.698 . . . . 2.5899999999999999 109.114 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.2 p -90.82 142.32 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 116.322 -0.399 . . . . 0.40000000000000002 110.245 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.564 ' OD2' ' HD3' ' A' ' 7' ' ' ARG . 16.4 t70 -132.54 113.46 13.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.441 -1.254 . . . . 1.3799999999999999 109.519 -176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 3.0 t -105.13 124.48 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 116.504 -0.317 . . . . 0.91000000000000003 111.131 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.61 125.71 54.46 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.987 -0.685 . . . . 2.3100000000000001 110.04 170.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.996 ' HB3' ' HB3' ' A' ' 97' ' ' PHE . 27.7 p80 -137.35 125.82 23.52 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.822 -0.626 . . . . 1.6399999999999999 109.737 172.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 5' ' ' PHE . 23.2 p -135.06 77.78 1.7 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.211 -0.904 . . . . 2.6699999999999999 110.916 -174.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.64 ' O ' ' HG2' ' A' ' 121' ' ' MET . 2.0 t-160 -158.96 -75.51 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.828 -0.749 . . . . 2.6299999999999999 110.759 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.438 ' HE1' HG11 ' A' ' 129' ' ' VAL . 19.0 p90 -71.47 -29.76 65.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.12 -0.491 . . . . 3.54 111.483 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -51.75 19.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.615 0.766 . . . . 1.8100000000000001 110.867 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.413 ' NH1' ' HB ' ' A' ' 116' ' ' THR . 42.1 ttp180 -58.89 -20.87 55.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.045 -0.98 . . . . 3.3799999999999999 111.6 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.64 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.8 mmt -64.36 -19.31 65.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.511 0.196 . . . . 2.4300000000000002 110.955 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.85 -157.54 3.26 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 114.756 0.662 . . . . 1.6100000000000001 114.756 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 p 40.62 -128.78 0.43 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.032 0.933 . . . . 2.5800000000000001 112.964 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 46.4 mmtm -60.08 -38.54 83.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.18 -0.464 . . . . 3.7999999999999998 111.516 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -60.86 -49.66 76.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.198 0.523 . . . . 2.1400000000000001 110.714 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.28 -30.68 68.82 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.112 -0.495 . . . . 0.92000000000000004 110.491 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -72.37 -41.27 66.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 2.8300000000000001 110.9 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 8.9 ptp180 -68.92 -33.64 74.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.624 0.249 . . . . 2.5899999999999999 111.252 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.438 HG11 ' HE1' ' A' ' 118' ' ' PHE . 88.9 t -70.46 -45.75 73.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.397 0.618 . . . . 1.48 110.267 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.537 ' CG ' ' HB2' ' A' ' 134' ' ' ASP . 42.6 ttt180 -68.47 -14.58 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.382 -0.826 . . . . 3.8300000000000001 111.137 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -52.34 -26.88 13.45 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.036 -0.529 . . . . 2.48 111.841 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.713 ' HA3' ' HG3' ' A' ' 88' ' ' ARG . . . -140.08 -37.43 0.11 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.974 -1.108 . . . . 1.6100000000000001 113.34 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.71 ' HG3' ' HB2' ' A' ' 137' ' ' TRP . 7.7 tpt -73.06 -10.67 60.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.047 0.423 . . . . 4.8300000000000001 111.366 -172.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' HB2' ' CG ' ' A' ' 130' ' ' ARG . 27.8 t70 -62.49 -31.43 72.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.151 0.501 . . . . 2.8300000000000001 111.277 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -103.0 4.27 37.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.052 0.453 . . . . 4.1500000000000004 110.485 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.539 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -106.75 -63.61 0.6 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.738 -0.665 . . . . 1.04 112.471 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.71 ' HB2' ' HG3' ' A' ' 133' ' ' MET . 4.2 t90 -57.96 -51.96 77.98 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.029 0.752 . . . . 2.7799999999999998 113.029 -170.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.9 Cg_endo -60.96 -38.24 70.5 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.845 1.696 . . . . 0.68000000000000005 111.916 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.2 m -67.45 -37.19 82.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.637 -0.71 . . . . 0.87 109.503 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.759 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 17.5 mt -57.39 -50.72 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 114.888 -1.051 . . . . 0.71999999999999997 111.188 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 75.6 mt -57.44 -41.84 81.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.411 0.445 . . . . 0.68999999999999995 111.209 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.92 -51.59 68.62 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.118 0.485 . . . . 1.49 110.866 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.694 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 41.7 m -71.65 -21.51 61.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.198 -0.455 . . . . 1.1499999999999999 110.955 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 61.7 t80 -63.19 -53.02 59.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.238 -0.653 . . . . 0.80000000000000004 109.238 176.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.1 -31.93 69.35 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.868 -0.605 . . . . 1.6299999999999999 110.51 173.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.05 -40.36 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 1.46 112.04 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -69.46 -39.32 77.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.068 0.461 . . . . 1.74 109.956 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.968 HG21 HG13 ' A' ' 12' ' ' VAL . 87.0 mt -65.72 -29.58 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.5 110.343 175.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.408 ' OD2' ' HG3' ' A' ' 154' ' ' LYS . 17.9 t0 -64.39 -25.24 67.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.616 -0.72 . . . . 0.84999999999999998 110.199 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -71.52 -31.01 66.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.639 . . . . 1.5 109.964 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -78.52 -32.55 48.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.598 -0.728 . . . . 1.74 109.885 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -89.05 22.73 21.1 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.745 -0.661 . . . . 1.3200000000000001 111.895 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.12 85.03 0.14 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.085 0.554 . . . . 1.9199999999999999 111.735 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 34.0 ttmt -79.92 66.3 5.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.732 0.777 . . . . 2.04 109.014 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 155' ' ' LYS . 7.8 mtmp? . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.607 -1.179 . . . . 4.2199999999999998 108.586 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 5.9 p30 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 110.346 -0.242 . . . . 1.6599999999999999 110.346 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.533 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.8 p90 -169.21 -57.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.99 0.367 . . . . 3.73 111.99 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.6 t70 -66.55 -57.24 12.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 112.645 0.609 . . . . 2.7799999999999998 112.645 -174.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 2.8 Cg_endo -79.69 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.487 1.458 . . . . 1.6299999999999999 111.971 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -142.3 121.47 13.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.684 0.278 . . . . 3.21 110.581 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 29.3 t -86.35 113.65 24.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.311 -0.996 . . . . 1.4399999999999999 108.311 169.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 2.1 ttt180 -141.85 145.99 35.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.181 0.515 . . . . 3.3700000000000001 111.077 -173.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HE2' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -122.65 131.09 53.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.012 -0.736 . . . . 0.79000000000000004 109.012 169.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.9 p -134.64 111.54 10.09 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-O 121.808 0.813 . . . . 1.28 110.125 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' HB ' ' HE2' ' A' ' 8' ' ' HIS . 0.9 OUTLIER -125.95 146.72 31.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.272 -1.331 . . . . 1.27 111.801 -174.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.6 m -104.45 116.67 32.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.013 -0.539 . . . . 0.56999999999999995 110.473 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.775 HG13 HG21 ' A' ' 148' ' ' ILE . 5.0 t -97.36 141.13 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.918 -0.583 . . . . 0.91000000000000003 109.973 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.606 ' HG3' ' OD1' ' A' ' 149' ' ' ASP . 15.3 mmtp -106.83 14.84 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.575 -0.284 . . . . 0.97999999999999998 111.724 -169.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -150.09 36.96 0.69 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.48 -0.488 . . . . 0.35999999999999999 111.499 -174.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' OD1' ' HG3' ' A' ' 17' ' ' LYS . 35.2 t70 71.73 168.45 0.31 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.053 0.93 . . . . 0.91000000000000003 112.614 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.623 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 11.5 ttp180 -66.48 -23.74 66.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.383 -1.281 . . . . 1.8799999999999999 111.412 -174.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 62.6 mttm -60.96 -52.4 65.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 3.0499999999999998 110.632 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.6 p -68.98 -34.51 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 1.1100000000000001 110.458 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -57.4 -51.24 70.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.02 -0.536 . . . . 0.32000000000000001 110.824 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 81.3 t80 -67.61 -45.06 76.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.223 -0.444 . . . . 0.38 110.673 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 21' ' ' LYS . 18.6 ttmt -57.53 -49.16 77.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 2.3900000000000001 111.18 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.562 HG23 ' CE2' ' A' ' 30' ' ' TRP . 31.1 m -69.72 -33.22 72.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.043 0.449 . . . . 0.68000000000000005 111.11 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -75.95 -37.15 58.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.922 -0.311 . . . . 0.47999999999999998 111.169 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.646 ' HG ' HG11 ' A' ' 46' ' ' VAL . 14.1 tp -120.15 -51.86 2.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.513 0.931 . . . . 0.5 113.513 -171.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.649 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 49.8 mt-10 -75.21 -51.81 12.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.463 0.542 . . . . 1.24 112.463 -168.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -88.12 32.23 4.44 Favored Glycine 0 C--N 1.315 -0.628 0 CA-C-N 115.781 -0.645 . . . . 0.82999999999999996 111.9 -175.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.683 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 62.8 t80 -50.09 -57.84 11.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 123.343 0.657 . . . . 0.73999999999999999 112.135 -170.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 28.1 Cg_endo -87.81 51.17 2.0 Allowed 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.945 1.763 . . . . 0.76000000000000001 114.62 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 8.6 pt-20 -150.07 -11.79 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.258 0.836 . . . . 1.49 113.258 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.774 ' CZ3' ' HG2' ' A' ' 147' ' ' LYS . 11.1 m95 -76.41 -172.31 2.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.155 0.502 . . . . 4.6200000000000001 111.094 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 19.6 m95 -92.56 -26.05 0.28 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 2.7799999999999998 114.758 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 140' ' ' ILE . 93.4 Cg_endo -79.2 -139.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.411 0 CA-C-N 120.972 1.383 . . . . 1.3600000000000001 113.876 -169.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' ND2' HG21 ' A' ' 40' ' ' VAL . 3.4 t-20 -48.07 -45.78 32.85 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.518 -0.765 . . . . 1.51 111.533 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -76.69 26.07 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.368 0.877 . . . . 1.79 113.368 -170.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -102.07 3.8 39.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 4.4500000000000002 110.509 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -100.52 120.83 40.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 4.1399999999999997 111.411 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.8 p -76.99 133.86 39.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.823 0.344 . . . . 2.6800000000000002 111.511 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.474 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 6.3 p 52.86 27.37 5.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.019 0.928 . . . . 1.4199999999999999 111.241 -174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 40' ' ' VAL . 48.3 tttp -124.89 -49.27 1.74 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.732 -1.122 . . . . 2.8999999999999999 108.668 169.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.609 HG12 ' HD1' ' A' ' 65' ' ' PHE . 1.3 m -166.0 30.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 124.127 0.892 . . . . 1.8300000000000001 110.693 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -173.08 31.87 0.11 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 119.813 -1.184 . . . . 2.1699999999999999 114.159 -171.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.801 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -70.41 173.94 3.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.299 -0.63 . . . . 1.1200000000000001 109.299 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.441 ' CD ' ' HB1' ' A' ' 42' ' ' ALA . 34.6 Cg_exo -63.49 41.97 0.1 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 C-N-CA 123.327 2.684 . . . . 1.48 114.71 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.3 tp -149.11 -80.76 0.13 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.676 -0.49 . . . . 1.75 109.676 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.528 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 88.6 -60.87 3.91 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.887 -0.673 . . . . 0.75 112.689 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG11 ' HG ' ' A' ' 24' ' ' LEU . 77.9 t -141.26 133.6 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.547 0.213 . . . . 0.59999999999999998 111.164 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -103.85 113.06 26.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.112 -0.494 . . . . 1.1100000000000001 110.208 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 25' ' ' GLU . 5.5 mptt -81.15 -16.15 53.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.396 -0.365 . . . . 2.8100000000000001 110.847 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -76.36 -62.21 1.69 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.109 -0.496 . . . . 3.1699999999999999 110.7 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.21 17.86 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 1.53 111.424 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.7 60.37 0.59 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.804 -0.713 . . . . 0.77000000000000002 112.097 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.39 150.84 30.11 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.54 -0.388 . . . . 3.7200000000000002 111.279 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 65' ' ' PHE . 6.1 m0 -100.24 110.86 23.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.984 -0.747 . . . . 1.28 108.984 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -162.4 174.55 12.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.429 0.633 . . . . 1.6599999999999999 111.26 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.801 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 25.1 mt-10 -126.8 174.69 8.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.648 -0.705 . . . . 2.1200000000000001 109.834 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' HG2' ' A' ' 61' ' ' GLU . 32.3 mm -100.75 100.78 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.954 -0.758 . . . . 0.92000000000000004 108.954 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.603 ' HB3' ' NE2' ' A' ' 59' ' ' GLN . 2.9 m-20 -67.26 -175.82 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.574 0.702 . . . . 1.97 112.013 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.28 -25.29 29.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.289 -0.868 . . . . 2.4300000000000002 110.925 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 57' ' ' ASP . 2.4 pm0 -95.66 5.05 52.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 2.3900000000000001 110.828 177.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.16 -109.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.235 -0.983 . . . . 2.29 112.56 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' HG2' HD12 ' A' ' 56' ' ' ILE . 28.2 mt-10 -147.97 34.54 0.83 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.478 0.311 . . . . 2.3100000000000001 110.975 -173.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 9.9 pt-20 -97.5 74.43 2.44 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.29 -0.964 . . . . 2.6099999999999999 111.283 -171.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.9 163.32 20.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.01 -0.995 . . . . 3.7200000000000002 111.409 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -131.04 148.67 52.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.411 -0.813 . . . . 2.27 110.534 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 6.6 t80 -165.54 -54.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.587 0.554 . . . . 6.4800000000000004 109.598 172.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -156.12 149.91 21.03 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.186 -1.007 . . . . 1.23 113.415 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.494 HD12 ' CZ ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -114.76 103.92 11.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.625 -0.509 . . . . 1.1699999999999999 109.625 177.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.467 HG21 HG22 ' A' ' 71' ' ' VAL . 43.4 mt -79.5 142.1 14.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.987 0.422 . . . . 0.60999999999999999 110.839 -175.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' CZ ' HD12 ' A' ' 67' ' ' LEU . 3.6 mpt_? -114.04 -25.22 8.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.82 -0.627 . . . . 2.0 110.48 174.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.665 ' HD2' HG23 ' A' ' 78' ' ' VAL . 13.1 ttmm -142.55 106.62 4.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.531 -0.304 . . . . 1.53 111.174 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 68' ' ' ILE . 41.5 t -95.05 92.1 3.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.268 -1.012 . . . . 0.88 108.268 167.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -109.5 70.34 0.73 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.661 -0.416 . . . . 1.4199999999999999 111.12 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 11.9 pt-20 48.37 -172.59 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.507 1.13 . . . . 0.95999999999999996 112.018 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 26.2 Cg_exo -65.45 75.35 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.428 1.419 . . . . 0.38 111.1 166.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -157.46 -66.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 0.5 110.358 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 1.5 p -141.77 143.71 33.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.412 0.625 . . . . 0.34999999999999998 112.079 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.3 mp -131.5 112.05 12.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.509 -0.769 . . . . 0.73999999999999999 109.506 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.665 HG23 ' HD2' ' A' ' 70' ' ' LYS . 86.1 t -90.6 104.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.801 -0.815 . . . . 0.67000000000000004 108.801 172.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.593 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -127.93 122.55 58.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.378 -0.828 . . . . 0.75 111.333 -170.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.924 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -87.25 154.7 26.57 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 111.833 -0.507 . . . . 0.5 111.833 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.767 ' CZ2' ' HA ' ' A' ' 83' ' ' LEU . 68.8 t-105 -91.16 125.93 36.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.466 0.651 . . . . 2.79 111.798 -171.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -124.76 0.27 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 5.46 109.26 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.052 HD21 ' HB2' ' A' ' 88' ' ' ARG . 6.8 tt 78.57 154.26 0.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.706 -1.134 . . . . 1.55 113.416 169.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.551 ' HB2' HG11 ' A' ' 40' ' ' VAL . 22.5 p-10 -117.88 -28.0 6.04 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.129 -0.941 . . . . 1.9299999999999999 112.689 -168.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.47 -29.59 63.84 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-O 119.727 -0.485 . . . . 2.3999999999999999 113.882 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 73.01 -42.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.412 0.685 . . . . 5.3799999999999999 110.769 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.88 3.39 70.59 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.101 -0.8 . . . . 2.2999999999999998 111.101 173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.052 ' HB2' HD21 ' A' ' 83' ' ' LEU . 69.2 mmt-85 -96.75 173.93 7.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.155 -0.313 . . . . 4.7699999999999996 110.155 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.879 HD12 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -101.15 119.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.175 0.512 . . . . 1.8600000000000001 110.319 -177.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 7.6 p-10 -91.24 141.31 26.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.157 0.503 . . . . 3.1800000000000002 111.556 -175.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.602 ' HG3' HG22 ' A' ' 129' ' ' VAL . 10.0 Cg_exo -72.07 -49.97 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.036 2.49 . . . . 2.3599999999999999 111.538 171.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.48 ' HB2' ' OD1' ' A' ' 90' ' ' ASP . 17.4 t70 70.72 -41.93 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.785 0.834 . . . . 2.9900000000000002 112.911 175.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.591 ' HB2' ' HE2' ' A' ' 118' ' ' PHE . 21.2 m-80 -73.32 -31.24 63.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.384 . . . . 3.0600000000000001 111.927 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.521 ' HB2' ' HD2' ' A' ' 118' ' ' PHE . 67.6 m -154.19 -126.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.101 -0.239 . . . . 1.8500000000000001 111.244 -176.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.706 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 58.8 m 57.59 28.67 16.01 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.454 0.645 . . . . 1.4399999999999999 110.352 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.924 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 36.5 tt0 -62.08 138.55 58.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.957 -1.02 . . . . 1.8100000000000001 111.02 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 4.2 p90 -133.92 136.92 44.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.149 0.499 . . . . 0.64000000000000001 110.931 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.8 m -99.17 110.42 22.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 0.42999999999999999 110.174 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.724 ' HA ' HG22 ' A' ' 113' ' ' VAL . 91.8 t -82.8 109.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.828 -0.624 . . . . 0.87 110.103 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' HG22 ' A' ' 76' ' ' THR . 26.7 m -103.52 106.13 16.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.379 -0.373 . . . . 0.45000000000000001 110.67 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.623 ' HB3' ' HG3' ' A' ' 16' ' ' ARG . 40.9 m-85 -87.99 112.7 22.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.304 -0.407 . . . . 0.34000000000000002 110.255 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.13 111.19 25.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.286 -0.415 . . . . 0.54000000000000004 110.125 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.89 133.76 48.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.833 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.754 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.9 t0 -126.99 100.92 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.174 -0.466 . . . . 2.0299999999999998 109.833 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.94 4.7 49.46 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.708 -0.758 . . . . 1.97 113.404 175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 72.22 8.16 5.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.504 0.722 . . . . 4.9299999999999997 111.973 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -128.06 -11.66 5.29 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.828 -0.545 . . . . 3.5299999999999998 110.285 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 77.5 tttt -122.48 158.06 30.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.893 -0.781 . . . . 2.4399999999999999 108.893 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.1 m -157.6 117.64 3.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.95 0.405 . . . . 0.41999999999999998 110.792 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 2.4 tmm_? -102.12 116.22 32.22 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.512 -0.922 . . . . 2.5899999999999999 108.512 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.9 p -90.73 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.313 -0.403 . . . . 0.40000000000000002 111.116 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -129.13 112.58 14.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 1.3799999999999999 108.732 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 99' ' ' VAL . 47.0 t -104.71 120.85 55.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.956 -0.566 . . . . 0.91000000000000003 111.209 -176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -97.46 122.82 40.95 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.765 0.666 . . . . 2.3100000000000001 109.651 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 2.3 t-160 -131.44 97.75 4.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.799 -0.815 . . . . 1.6399999999999999 108.799 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.577 HG22 ' HD2' ' A' ' 120' ' ' ARG . 24.5 p -141.78 103.13 4.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.726 -0.215 . . . . 2.6699999999999999 111.271 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -167.39 -74.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.315 -0.554 . . . . 2.6299999999999999 112.172 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.591 ' HE2' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -85.75 -42.43 14.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 3.54 111.391 -168.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -37.95 73.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.195 -0.911 . . . . 1.8100000000000001 110.719 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.577 ' HD2' HG22 ' A' ' 116' ' ' THR . 44.1 mtp180 -59.59 -19.32 47.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.424 -0.807 . . . . 3.3799999999999999 111.923 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.521 ' HA ' ' CE ' ' A' ' 121' ' ' MET . 11.5 mmt -72.4 23.63 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.69 0.996 . . . . 2.4300000000000002 113.69 -171.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.79 -155.88 15.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.847 -1.168 . . . . 1.6100000000000001 114.406 168.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 p -61.66 -80.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.32 0.859 . . . . 2.5800000000000001 113.32 -170.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.639 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 48.1 mtpt -70.05 -14.31 62.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 3.7999999999999998 112.002 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.67 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 40.3 m80 -73.03 -49.92 26.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.461 0.648 . . . . 2.1400000000000001 109.364 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.89 73.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.92000000000000004 110.024 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.639 ' HB3' ' HA ' ' A' ' 124' ' ' LYS . 2.8 tppp? -71.25 -38.03 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.685 -0.689 . . . . 2.8300000000000001 111.382 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.879 ' HB2' HD12 ' A' ' 89' ' ' ILE . 15.8 ptm180 -67.69 -30.86 70.49 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 120.907 -0.317 . . . . 2.5899999999999999 110.272 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 91' ' ' PRO . 15.4 t -84.61 -30.92 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.319 -0.552 . . . . 1.48 111.605 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.271 -0.422 . . . . 3.8300000000000001 111.928 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.722 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 5.3 p30 -63.56 -33.48 75.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 2.48 111.281 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.89 -71.33 1.28 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.517 -0.849 . . . . 1.6100000000000001 114.213 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.614 ' HB3' ' CZ2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -77.84 -21.89 50.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.961 0.726 . . . . 4.8300000000000001 112.961 -165.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.9 -28.15 68.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 2.8300000000000001 111.244 -174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.822 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 9.3 mmpt? -101.99 15.24 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.035 0.445 . . . . 4.1500000000000004 110.916 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.631 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -134.24 -57.25 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.508 -0.853 . . . . 1.04 112.489 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.433 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 1.6 t90 -56.0 -54.43 52.4 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.693 0.627 . . . . 2.7799999999999998 112.693 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 137' ' ' TRP . 34.9 Cg_endo -65.83 -34.33 40.13 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.708 1.606 . . . . 0.68000000000000005 111.948 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 -41.0 95.23 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.925 -0.58 . . . . 0.87 109.894 176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.667 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 63.2 mt -57.9 -46.43 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 115.334 -0.848 . . . . 0.71999999999999997 109.843 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 144' ' ' PHE . 21.6 mt -54.95 -42.9 72.92 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 123.638 0.586 . . . . 0.68999999999999995 111.385 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -64.02 -46.18 85.6 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.582 -0.447 . . . . 1.49 110.813 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -75.19 -22.19 58.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.027 0.442 . . . . 1.1499999999999999 110.927 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 92.8 t80 -61.18 -55.14 35.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.80000000000000004 109.6 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.464 ' OE1' ' HD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -64.92 -30.7 71.7 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.019 -0.537 . . . . 1.6299999999999999 110.45 175.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.48 -55.77 29.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.591 -0.277 . . . . 1.46 111.342 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.774 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 21.9 tptp -68.0 -39.61 83.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.53 -0.468 . . . . 1.74 110.841 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.775 HG21 HG13 ' A' ' 12' ' ' VAL . 47.2 mt -65.9 -37.83 80.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.547 . . . . 0.5 111.894 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.936 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.1 t70 -64.09 -25.53 68.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.377 -0.374 . . . . 0.84999999999999998 110.333 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.777 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 61.4 mt-10 -69.53 -39.66 77.37 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.38 -20.6 66.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.054 -0.975 . . . . 1.74 108.972 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.95 -82.78 0.9 Allowed Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.06 -0.973 . . . . 1.3200000000000001 111.56 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -155.01 12.37 0.37 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.866 0.691 . . . . 1.9199999999999999 112.866 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.936 ' HE2' ' HB3' ' A' ' 149' ' ' ASP . 21.1 ttmm -63.67 -32.48 73.97 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.942 0.401 . . . . 2.04 111.466 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.6 pttt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 119.22 -0.419 . . . . 4.2199999999999998 110.719 -176.755 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.9 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 32.6 p30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 110.375 -0.232 . . . . 1.6599999999999999 110.375 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 120' ' ' ARG . 0.5 OUTLIER 70.26 -31.76 0.22 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.082 1.353 . . . . 3.73 112.172 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.79 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 23.6 t70 -59.34 -53.63 64.17 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.284 -0.265 . . . . 2.7799999999999998 110.284 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 25.5 Cg_endo -94.64 -64.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.244 1.963 . . . . 1.6299999999999999 111.348 167.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 38.6 p90 -151.77 171.4 17.77 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.936 -1.135 . . . . 3.21 107.936 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.964 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 86.0 t -107.58 103.91 16.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.853 -0.339 . . . . 1.4399999999999999 110.53 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 13.1 ttp180 -93.76 130.59 39.69 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.239 -0.584 . . . . 3.3700000000000001 110.84 176.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.646 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -110.53 133.54 53.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.79000000000000004 108.817 173.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.677 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 9.1 t -134.7 111.08 9.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.518 0.675 . . . . 1.28 110.111 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG22 HE21 ' A' ' 145' ' ' GLN . 3.0 t -124.63 137.78 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.675 -1.148 . . . . 1.27 111.652 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 99.1 m -97.77 116.88 30.86 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.813 -0.63 . . . . 0.56999999999999995 110.443 173.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.904 HG13 HG21 ' A' ' 148' ' ' ILE . 32.9 t -94.7 142.4 13.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.46 -0.791 . . . . 0.91000000000000003 110.868 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -99.23 12.76 35.27 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.25 0.463 . . . . 0.97999999999999998 112.25 -167.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.4 39.66 0.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.975 -0.69 . . . . 0.35999999999999999 112.414 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.572 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 14.3 t70 73.12 167.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.811 0.815 . . . . 0.91000000000000003 111.927 173.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 25.9 ttp180 -69.43 -23.4 63.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.094 -0.957 . . . . 1.8799999999999999 110.707 -174.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 15.1 ptpt -60.76 -39.22 87.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 3.0499999999999998 111.195 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.9 p -82.91 -37.86 23.64 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.928 -0.309 . . . . 1.1100000000000001 110.594 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -56.27 -43.38 78.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.829 0.347 . . . . 0.32000000000000001 110.462 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 79.4 t80 -70.93 -46.01 63.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.322 -0.399 . . . . 0.38 110.48 176.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -55.19 -55.0 36.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.037 -0.529 . . . . 2.3900000000000001 111.382 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.444 HG22 ' NE1' ' A' ' 30' ' ' TRP . 23.6 m -67.23 -46.68 73.07 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.311 -0.859 . . . . 0.68000000000000005 111.028 -175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.647 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 66.5 t80 -64.46 -34.89 79.25 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.103 0.409 . . . . 0.47999999999999998 112.103 -174.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.2 tp -108.67 -53.72 2.6 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.033 -0.667 . . . . 0.5 112.373 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.63 -39.44 37.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 1.24 111.297 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.709 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -91.4 33.53 4.72 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.65 -0.704 . . . . 0.82999999999999996 112.336 -176.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.541 ' HD2' ' HA3' ' A' ' 45' ' ' GLY . 44.8 t80 -52.54 -48.0 91.71 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.216 0.45 . . . . 0.73999999999999999 112.216 -173.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -89.64 15.29 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.869 1.713 . . . . 0.76000000000000001 115.036 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.0 pt-20 -100.44 -5.03 27.71 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.993 -0.683 . . . . 1.49 110.766 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.647 ' HZ2' ' HA ' ' A' ' 23' ' ' PHE . 23.9 m0 -75.73 153.75 36.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.488 0.661 . . . . 4.6200000000000001 111.468 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.647 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 36.8 m95 -80.47 -44.1 1.35 Allowed Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.908 -1.042 . . . . 2.7799999999999998 112.855 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 1.105 ' HD3' ' HB2' ' A' ' 143' ' ' SER . 11.3 Cg_endo -52.12 -76.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.062 2.508 . . . . 1.3600000000000001 114.76 -164.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -120.35 -11.61 9.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 1.51 110.609 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.703 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.4 m-20 -99.14 18.67 16.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.688 . . . . 1.79 111.103 -171.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -95.55 8.37 43.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.142 0.496 . . . . 4.4500000000000002 111.023 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -117.73 140.33 49.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 4.1399999999999997 111.65 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.48 148.03 37.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.5 -0.773 . . . . 2.6800000000000002 110.921 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 57' ' ' ASP . 63.6 p 57.88 8.02 0.67 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.547 1.139 . . . . 1.4199999999999999 112.843 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -95.78 -77.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.479 -0.934 . . . . 2.8999999999999999 108.479 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.703 HG23 ' HA ' ' A' ' 34' ' ' ASN . 3.8 m -147.21 15.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.588 -0.893 . . . . 1.8300000000000001 108.588 172.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.49 55.35 0.77 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.72 -1.127 . . . . 2.1699999999999999 111.876 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -104.05 169.81 6.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.406 -0.961 . . . . 1.1200000000000001 108.406 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.19 53.83 0.26 Allowed 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 123.038 2.492 . . . . 1.48 113.77 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD21 ' CZ ' ' A' ' 54' ' ' TYR . 35.3 tp -170.8 -91.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 122.745 0.418 . . . . 1.75 110.378 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.664 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 87.76 -57.78 4.38 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.991 -0.623 . . . . 0.75 112.487 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 24' ' ' LEU . 89.0 t -134.81 136.66 51.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.839 0.352 . . . . 0.59999999999999998 110.67 -178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.648 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.9 t70 -107.94 122.77 47.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.561 -0.745 . . . . 1.1100000000000001 109.77 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -33.91 40.25 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.403 0.52 . . . . 2.8100000000000001 112.403 -175.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -47.22 52.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.814 0.301 . . . . 3.1699999999999999 111.814 -172.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -91.88 -25.39 22.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.655 -0.784 . . . . 1.53 111.784 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 82.18 60.33 2.16 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.652 -0.785 . . . . 0.77000000000000002 111.207 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 8.3 ptm180 -146.39 139.76 25.85 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.843 0.354 . . . . 3.7200000000000002 111.118 -174.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 24.5 m0 -97.99 108.26 20.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 1.28 110.547 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.648 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 1.4 p90 -153.32 151.71 30.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.997 0.427 . . . . 1.6599999999999999 110.282 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 51.6 mp0 -117.79 160.05 22.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 2.1200000000000001 110.512 -176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.51 HD12 ' HG2' ' A' ' 61' ' ' GLU . 36.8 mm -77.84 103.97 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 0.92000000000000004 110.062 -178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' HA ' HG22 ' A' ' 38' ' ' THR . 7.0 t70 -95.43 -178.12 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 1.97 110.476 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -80.92 -7.68 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.798 0.666 . . . . 2.4300000000000002 112.798 -168.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.511 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -95.98 -4.65 42.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.289 0.566 . . . . 2.3900000000000001 110.194 178.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.21 -85.1 0.18 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.505 -0.771 . . . . 2.29 111.816 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.51 ' HG2' HD12 ' A' ' 56' ' ' ILE . 52.6 mt-10 -156.65 18.94 0.33 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.717 -0.475 . . . . 2.3100000000000001 109.717 -177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -99.86 88.85 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.742 0.782 . . . . 2.6099999999999999 110.274 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -117.84 163.74 16.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.886 -1.052 . . . . 3.7200000000000002 110.254 -178.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -52.7 109.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.67 -0.493 . . . . 2.27 109.67 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 53' ' ' TRP . 30.7 p90 -92.58 130.66 38.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.334 0.588 . . . . 6.4800000000000004 112.016 -170.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.4 157.55 31.72 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.74 -0.944 . . . . 1.23 110.74 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.2 pt? -116.01 99.59 7.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.996 0.398 . . . . 1.1699999999999999 111.261 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 71' ' ' VAL . 40.7 mt -79.37 118.6 27.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.047 -0.661 . . . . 0.60999999999999999 109.907 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -85.94 -23.25 27.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.841 -1.072 . . . . 2.0 109.818 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 78' ' ' VAL . 58.5 tttp -156.39 105.41 2.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.732 -0.667 . . . . 1.53 111.266 -174.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 68' ' ' ILE . 49.8 t -98.92 93.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.652 -0.87 . . . . 0.88 108.652 169.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.02 73.15 0.83 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.535 -0.466 . . . . 1.4199999999999999 111.648 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 12.9 pt-20 48.18 -174.12 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 124.827 1.33 . . . . 0.95999999999999996 112.623 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 39.3 Cg_exo -62.77 82.08 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.504 1.469 . . . . 0.38 110.956 166.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -167.68 -67.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.789 . . . . 0.5 110.506 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 100' ' ' THR . 3.6 p -141.91 140.97 32.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.431 0.53 . . . . 0.34999999999999998 112.431 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 77' ' ' LEU . 2.2 mp -136.6 112.93 9.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.661 -0.7 . . . . 0.73999999999999999 109.621 177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 98' ' ' THR . 39.6 t -103.24 109.9 28.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.007 -0.738 . . . . 0.67000000000000004 109.007 175.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 138.62 53.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.902 0.382 . . . . 0.75 111.947 -176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 150.95 21.8 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.816 -0.629 . . . . 0.5 112.791 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.81 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 61.0 t-105 -89.09 148.94 23.43 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.209 0.604 . . . . 2.79 111.64 -168.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HA ' ' OD2' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -142.87 23.24 1.91 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.995 -0.548 . . . . 5.46 110.374 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.72 HD11 ' HB3' ' A' ' 88' ' ' ARG . 1.6 tm? 84.63 152.83 0.09 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.177 -0.919 . . . . 1.55 111.081 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.554 ' N ' HD13 ' A' ' 83' ' ' LEU . 42.0 t30 -131.79 -29.99 1.66 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.01 -0.541 . . . . 1.9299999999999999 111.52 -175.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -78.7 46.08 2.8 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.304 -0.474 . . . . 2.3999999999999999 113.81 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.3 t80 58.63 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 5.3799999999999999 112.307 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.17 39.23 2.94 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.988 -0.625 . . . . 2.2999999999999998 112.145 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.763 ' HD2' ' ND2' ' A' ' 131' ' ' ASN . 5.6 tpp180 -97.56 -176.62 3.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.729 -0.471 . . . . 4.7699999999999996 109.729 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.457 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 0.6 OUTLIER -94.14 137.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.965 0.412 . . . . 1.8600000000000001 110.47 -175.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -96.0 137.6 21.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.081 -0.509 . . . . 3.1800000000000002 111.428 -179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HG2' ' HD1' ' A' ' 81' ' ' TRP . 50.2 Cg_exo -57.62 -21.72 48.34 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.17 3.247 . . . . 2.3599999999999999 113.807 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.5 t70 77.25 41.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.381 -0.827 . . . . 2.9900000000000002 110.596 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.536 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 80.36 36.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.032 -0.986 . . . . 3.0600000000000001 112.845 158.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 p -122.71 -37.25 2.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.757 -0.377 . . . . 1.8500000000000001 111.682 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.81 ' HB3' ' HB3' ' A' ' 81' ' ' TRP . 20.5 t -55.85 97.06 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.522 -0.763 . . . . 1.4399999999999999 109.292 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -122.57 136.84 54.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.237 -0.438 . . . . 1.8100000000000001 110.673 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.487 ' HD1' ' CE1' ' A' ' 115' ' ' HIS . 12.2 p90 -134.48 139.4 45.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.235 0.541 . . . . 0.64000000000000001 111.855 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.56 HG23 HG22 ' A' ' 78' ' ' VAL . 75.7 m -96.9 109.1 21.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.117 -0.947 . . . . 0.42999999999999999 110.134 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.788 ' HA ' HG22 ' A' ' 113' ' ' VAL . 84.2 t -83.53 109.98 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.87 110.077 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 ' HA ' HG22 ' A' ' 76' ' ' THR . 25.2 m -106.19 106.56 17.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.646 -0.252 . . . . 0.45000000000000001 110.636 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.565 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 38.8 m-85 -88.12 115.8 25.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.657 -0.247 . . . . 0.34000000000000002 110.498 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.2 112.01 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.907 -0.405 . . . . 0.54000000000000004 109.907 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.58 133.89 43.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.844 -0.616 . . . . 0.44 111.372 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 19.3 t70 -121.93 128.85 52.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 2.0299999999999998 109.227 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.65 -13.05 29.79 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.343 -0.844 . . . . 1.97 115.176 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -84.21 33.86 0.5 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.993 0.896 . . . . 4.9299999999999997 111.685 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 12.3 mmtp 56.5 45.72 21.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.746 0.784 . . . . 3.5299999999999998 108.947 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 87.9 tttt -133.87 155.03 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.809 -1.087 . . . . 2.4399999999999999 109.341 -173.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.441 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 25.9 m -155.03 114.63 3.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.139 0.495 . . . . 0.41999999999999998 110.841 173.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.481 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 18.2 tpp85 -91.64 113.98 26.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.543 -0.753 . . . . 2.5899999999999999 109.697 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 9' ' ' SER . 9.8 p -91.04 138.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.768 0.318 . . . . 0.40000000000000002 110.485 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.517 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 17.8 t70 -127.55 109.98 12.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.491 -0.777 . . . . 1.3799999999999999 109.213 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 t -102.93 135.67 39.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.536 -0.756 . . . . 0.91000000000000003 111.578 -175.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -113.04 111.62 22.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 2.3100000000000001 109.683 170.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.964 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -100.77 115.57 30.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.454 -0.794 . . . . 1.6399999999999999 109.235 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.5 p -127.99 168.88 14.67 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.522 -0.471 . . . . 2.6699999999999999 111.619 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 101.98 -66.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 113.804 -1.544 . . . . 2.6299999999999999 110.563 162.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.838 ' HE2' HG21 ' A' ' 129' ' ' VAL . 59.5 t80 -86.97 -52.34 5.51 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.029 -0.532 . . . . 3.54 111.996 -175.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 2' ' ' TYR . 1.7 m-20 -54.82 -33.39 61.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 1.8100000000000001 112.281 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 2' ' ' TYR . 37.7 ttp180 -62.52 -22.73 66.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.362 -0.381 . . . . 3.3799999999999999 111.502 -177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.81 -22.09 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.536 -0.302 . . . . 2.4300000000000002 110.358 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 126' ' ' ALA . . . 48.82 -154.02 2.09 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.39 -0.823 . . . . 1.6100000000000001 114.801 171.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 m 44.76 -101.92 0.05 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.397 1.079 . . . . 2.5800000000000001 113.112 176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.96 -45.16 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.136 -0.32 . . . . 3.7999999999999998 110.136 -172.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -61.15 -49.8 75.76 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.334 0.588 . . . . 2.1400000000000001 110.469 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' A' ' 122' ' ' GLY . . . -64.51 -51.24 63.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.549 -0.751 . . . . 0.92000000000000004 111.222 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -61.91 -34.0 75.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.905 0.335 . . . . 2.8300000000000001 111.905 -173.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -77.16 -32.94 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.419 -0.513 . . . . 2.5899999999999999 111.438 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.838 HG21 ' HE2' ' A' ' 118' ' ' PHE . 79.2 t -78.61 -42.3 25.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.374 0.607 . . . . 1.48 110.664 174.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.901 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 65.9 mtt-85 -68.18 -12.41 60.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.516 -0.766 . . . . 3.8300000000000001 110.957 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.763 ' ND2' ' HD2' ' A' ' 88' ' ' ARG . 45.7 t30 -51.8 -25.09 6.95 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.568 -0.742 . . . . 2.48 110.004 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.18 -17.92 2.64 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.918 -0.583 . . . . 1.6100000000000001 112.422 172.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.811 ' HB3' ' HA ' ' A' ' 130' ' ' ARG . 6.4 tpp -80.07 -42.89 22.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.475 0.546 . . . . 4.8300000000000001 112.475 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.901 ' HB2' ' HB3' ' A' ' 130' ' ' ARG . 7.4 t70 -68.46 -25.92 65.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.975 0.731 . . . . 2.8300000000000001 112.975 -163.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -115.9 24.19 11.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.586 0.708 . . . . 4.1500000000000004 109.922 175.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -113.96 -74.68 0.64 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.36 -0.836 . . . . 1.04 111.583 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 5.5 t90 -58.51 -48.86 96.15 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.76 0.652 . . . . 2.7799999999999998 112.76 -173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 21.0 Cg_endo -59.61 -38.75 80.14 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.189 1.926 . . . . 0.68000000000000005 112.642 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 m -70.9 -37.11 72.98 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.757 0.789 . . . . 0.87 109.347 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.666 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 40.6 mt -54.59 -44.74 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.4 -1.273 . . . . 0.71999999999999997 110.196 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.563 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 68.9 mt -56.68 -33.8 66.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.464 0.478 . . . . 0.68999999999999995 111.608 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -69.15 -57.71 5.03 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.18 0.514 . . . . 1.49 111.002 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 1.105 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -71.93 -21.39 61.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.104 -0.498 . . . . 1.1499999999999999 111.132 -178.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.35 -47.57 85.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.80000000000000004 109.543 171.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 67.6 mt-30 -61.23 -36.22 79.36 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.549 -0.751 . . . . 1.6299999999999999 110.356 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -73.47 -39.75 64.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.492 -0.777 . . . . 1.46 111.506 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -66.56 -35.77 81.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.934 0.397 . . . . 1.74 110.112 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.904 HG21 HG13 ' A' ' 12' ' ' VAL . 50.4 mt -71.47 -32.68 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.288 0.566 . . . . 0.5 110.375 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.425 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 12.8 t70 -58.88 -32.33 69.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.609 -0.723 . . . . 0.84999999999999998 109.727 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.85 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 49.6 mt-10 -66.0 -33.22 75.3 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.538 -0.755 . . . . 1.5 110.413 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -82.15 -17.1 47.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.359 -0.837 . . . . 1.74 109.726 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -96.56 -75.89 1.28 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.467 -0.788 . . . . 1.3200000000000001 112.819 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.55 15.27 1.8 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.697 0.628 . . . . 1.9199999999999999 112.697 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.85 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 22.8 ttmm -79.62 76.94 6.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.232 0.539 . . . . 2.04 110.087 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--O 1.246 0.901 0 CA-C-N 115.7 -0.682 . . . . 4.2199999999999998 109.553 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 35.2 m-80 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.691 -0.485 . . . . 1.6599999999999999 109.691 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 1' ' ' ASN . 28.4 p90 172.96 -26.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.62 0.575 . . . . 3.73 110.288 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.899 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.4 t70 -59.98 -56.74 32.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.129 -0.487 . . . . 2.7799999999999998 111.397 -175.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.899 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 18.9 Cg_endo -96.08 -64.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.392 2.061 . . . . 1.6299999999999999 111.953 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -149.6 154.97 39.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.667 -1.234 . . . . 3.21 107.667 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.734 ' HB ' ' CB ' ' A' ' 115' ' ' HIS . 27.4 t -85.7 106.31 15.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.221 -0.592 . . . . 1.4399999999999999 109.812 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 39.8 ttm180 -111.75 135.38 52.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.805 0.812 . . . . 3.3700000000000001 111.427 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 1.025 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 4.8 t-160 -109.38 132.37 54.19 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.736 -1.209 . . . . 0.79000000000000004 107.736 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 44.2 t -146.04 112.02 5.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.944 -0.391 . . . . 1.28 109.944 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.808 HG22 HG12 ' A' ' 111' ' ' VAL . 10.8 m -138.31 139.21 42.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.921 0.391 . . . . 1.27 110.819 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m -92.84 116.14 28.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.471 -0.786 . . . . 0.56999999999999995 109.906 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.778 HG13 HG21 ' A' ' 148' ' ' ILE . 22.4 t -98.47 125.57 51.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.476 -0.784 . . . . 0.91000000000000003 110.379 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 35.06 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.933 0.397 . . . . 0.97999999999999998 111.567 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.548 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -149.39 26.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.434 -0.348 . . . . 0.35999999999999999 111.039 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.1 t70 72.6 169.21 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 0.91000000000000003 112.857 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.497 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 7.6 ttp180 -63.36 -27.49 69.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.16 -0.927 . . . . 1.8799999999999999 110.978 -174.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -54.28 -53.36 54.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.721 -0.672 . . . . 3.0499999999999998 111.405 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -76.56 -33.57 58.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.39 -0.368 . . . . 1.1100000000000001 111.181 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.621 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -60.47 -48.31 82.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.8 0.333 . . . . 0.32000000000000001 110.79 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -69.1 -33.78 74.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.38 110.537 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.863 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 5.5 tppp? -61.06 -55.7 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.427 . . . . 2.3900000000000001 110.262 176.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.544 HG23 ' CE2' ' A' ' 30' ' ' TRP . 31.2 m -66.55 -23.87 66.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.68000000000000005 111.939 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 99' ' ' VAL . 69.4 t80 -87.81 -37.26 16.72 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.722 -0.391 . . . . 0.47999999999999998 111.467 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.54 HD23 ' HE3' ' A' ' 48' ' ' LYS . 18.9 tp -119.95 -54.89 2.11 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.51 0.93 . . . . 0.5 113.51 -172.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.863 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 29.0 mt-10 -78.68 -24.72 44.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.378 0.609 . . . . 1.24 110.779 -169.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.418 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -120.72 93.84 0.54 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.056 -2.017 . . . . 0.82999999999999996 108.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.863 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 23.0 t80 -95.93 -63.85 0.12 Allowed Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.722 -0.239 . . . . 0.73999999999999999 111.041 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.863 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 29.9 Cg_endo -96.46 37.53 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.282 1.988 . . . . 0.76000000000000001 114.677 -174.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -126.97 5.24 6.53 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.409 0.892 . . . . 1.49 113.409 -175.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.841 ' HE3' ' HG3' ' A' ' 147' ' ' LYS . 18.7 m95 -99.07 -160.89 0.83 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.127 -0.358 . . . . 4.6200000000000001 110.221 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 22.1 m95 -99.05 -8.92 0.12 Allowed Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 114.991 1.478 . . . . 2.7799999999999998 114.991 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HB3' ' HB3' ' A' ' 143' ' ' SER . 92.8 Cg_endo -81.82 -148.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 CA-C-N 122.484 1.923 . . . . 1.3600000000000001 113.292 -170.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.643 ' ND2' HD21 ' A' ' 84' ' ' ASN . 6.5 t30 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.812 . . . . 1.51 111.025 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.784 ' HA ' HG23 ' A' ' 40' ' ' VAL . 30.9 m-20 -78.87 20.98 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.183 -0.462 . . . . 1.79 110.739 -177.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -117.83 22.39 12.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.323 0.582 . . . . 4.4500000000000002 110.33 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -117.66 146.97 43.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 4.1399999999999997 110.108 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 m -76.58 135.66 39.23 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.023 -0.271 . . . . 2.6800000000000002 110.854 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.1 p 58.52 14.49 3.05 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.082 0.953 . . . . 1.4199999999999999 112.133 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' O ' HG22 ' A' ' 40' ' ' VAL . 54.2 tttp -132.6 80.35 1.89 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.985 -0.746 . . . . 2.8999999999999999 108.985 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.784 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.1 m 54.1 17.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.429 1.091 . . . . 1.8300000000000001 112.165 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.614 ' HA2' ' HB3' ' A' ' 28' ' ' PRO . . . -146.28 26.88 1.7 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.56 -0.828 . . . . 2.1699999999999999 113.312 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.892 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -77.56 167.14 38.69 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.45 -0.944 . . . . 1.1200000000000001 108.45 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.02 59.71 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.751 2.301 . . . . 1.48 113.718 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 55' ' ' GLU . 53.4 tp -166.03 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.862 -0.608 . . . . 1.75 110.027 174.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.45 ' HA3' ' HD2' ' A' ' 27' ' ' PHE . . . 94.98 -63.88 1.46 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.872 -0.68 . . . . 0.75 113.06 173.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 24' ' ' LEU . 84.8 t -132.75 147.41 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.84 0.353 . . . . 0.59999999999999998 110.487 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.83 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 8.6 t0 -123.98 96.32 4.9 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.853 -0.795 . . . . 1.1100000000000001 108.853 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.659 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 8.5 mtpt -74.06 -22.31 59.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.112 0.482 . . . . 2.8100000000000001 110.245 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' NZ ' ' HB3' ' A' ' 49' ' ' LYS . 4.2 ttpm? -64.67 -56.61 12.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 3.1699999999999999 110.787 178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.93 -28.72 33.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.966 -0.635 . . . . 1.53 112.595 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.95 49.42 2.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.696 -0.764 . . . . 0.77000000000000002 112.169 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.44 161.31 41.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.735 0.302 . . . . 3.7200000000000002 111.417 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD1' HD11 ' A' ' 68' ' ' ILE . 14.4 m0 -108.99 120.01 41.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.139 -0.482 . . . . 1.28 109.999 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.83 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -163.91 158.11 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.087 0.47 . . . . 1.6599999999999999 110.677 175.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.892 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.1 mp0 -125.71 166.55 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.486 -0.931 . . . . 2.1200000000000001 108.486 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 61' ' ' GLU . 43.2 mm -78.34 103.62 5.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.121 0.486 . . . . 0.92000000000000004 109.958 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 63' ' ' HIS . 20.4 t70 -87.98 145.94 25.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.717 -0.674 . . . . 1.97 110.092 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -61.34 -26.82 68.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.681 0.613 . . . . 2.4300000000000002 112.354 -174.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.427 ' HB3' ' OD2' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -75.8 -17.99 59.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.951 0.405 . . . . 2.3900000000000001 111.226 -175.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.15 54.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.175 -1.012 . . . . 2.29 113.211 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 56' ' ' ILE . 43.6 mt-10 56.0 26.26 9.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.157 0.799 . . . . 2.3100000000000001 113.157 173.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' HB3' ' OE1' ' A' ' 59' ' ' GLN . 12.8 tp10 -112.9 95.83 5.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.424 0.63 . . . . 2.6099999999999999 110.236 -176.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -122.22 165.16 16.61 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.047 -0.978 . . . . 3.7200000000000002 110.602 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 82' ' ' ARG . 3.2 p -47.82 124.77 7.76 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.627 0.58 . . . . 2.27 111.316 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -89.61 112.46 23.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.743 -0.662 . . . . 6.4800000000000004 110.943 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.647 ' HA2' ' HB2' ' A' ' 82' ' ' ARG . . . -83.29 127.21 7.89 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.633 -0.987 . . . . 1.23 110.633 172.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -100.63 96.11 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.016 0.436 . . . . 1.1699999999999999 111.316 -171.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.531 HG21 ' CG2' ' A' ' 71' ' ' VAL . 39.5 mt -83.34 124.49 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.122 0.487 . . . . 0.60999999999999999 110.298 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -104.33 -14.84 15.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.538 -0.755 . . . . 2.0 110.5 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -159.31 118.91 3.0 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.248 -0.433 . . . . 1.53 111.835 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' HG21 ' A' ' 68' ' ' ILE . 57.7 t -103.1 92.96 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.076 -1.083 . . . . 0.88 108.076 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 5.7 t0 -101.38 64.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.628 -0.26 . . . . 1.4199999999999999 111.19 -170.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 7.4 pt-20 48.28 -172.38 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 124.287 1.035 . . . . 0.95999999999999996 112.03 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 31.3 Cg_exo -62.64 72.17 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.38 111.774 166.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 17.5 t70 -156.44 -65.79 0.11 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.452 -0.795 . . . . 0.5 110.183 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 100' ' ' THR . 4.0 p -145.57 152.48 39.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.34999999999999998 112.357 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 24' ' ' LEU . 3.1 mp -138.18 126.36 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.676 -0.693 . . . . 0.73999999999999999 109.526 176.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -108.77 105.56 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.59 -0.522 . . . . 0.67000000000000004 109.59 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.76 137.39 57.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.292 -0.413 . . . . 0.75 111.282 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.09 165.41 26.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.5 111.889 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.978 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 39.6 t-105 -62.17 162.88 8.91 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 114.253 1.205 . . . . 2.79 114.253 -163.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.647 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -158.67 -35.57 0.06 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.608 -1.178 . . . . 5.46 110.023 -169.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.904 ' HG ' ' HA3' ' A' ' 132' ' ' GLY . 4.8 tt 78.11 175.27 0.17 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.753 -0.658 . . . . 1.55 110.599 176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.643 HD21 ' ND2' ' A' ' 33' ' ' ASN . 46.7 t-20 -109.12 -76.03 0.62 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.714 0.292 . . . . 1.9299999999999999 110.416 -173.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.59 0.54 Allowed Glycine 0 C--O 1.217 -0.934 0 C-N-CA 120.663 -0.78 . . . . 2.3999999999999999 111.216 176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -54.48 -6.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.294 0.85 . . . . 5.3799999999999999 113.294 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.08 -0.89 76.84 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.944 -0.862 . . . . 2.2999999999999998 110.944 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HD3' ' H ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -97.55 152.78 18.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.148 0.499 . . . . 4.7699999999999996 110.585 178.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -65.51 124.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.203 -0.908 . . . . 1.8600000000000001 110.477 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.626 ' OD2' ' HB3' ' A' ' 92' ' ' ASP . 4.1 p-10 -101.75 142.81 25.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 121.42 0.628 . . . . 3.1800000000000002 111.45 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.69 ' HD2' ' HD1' ' A' ' 81' ' ' TRP . 59.8 Cg_endo -97.69 37.46 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.915 3.077 . . . . 2.3599999999999999 111.868 167.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.626 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -65.78 89.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.155 0.979 . . . . 2.9900000000000002 111.066 -178.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -167.88 -2.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.437 -1.256 . . . . 3.0600000000000001 108.368 167.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.77 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 74.6 m -160.96 -143.69 0.1 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.976 -1.465 . . . . 1.8500000000000001 108.674 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.978 ' HB2' ' HB2' ' A' ' 81' ' ' TRP . 37.9 m 54.63 38.0 29.14 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.477 0.656 . . . . 1.4399999999999999 111.442 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.636 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 20.2 tt0 -71.77 149.78 45.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.895 -1.048 . . . . 1.8100000000000001 110.69 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.606 ' HB2' HG13 ' A' ' 113' ' ' VAL . 9.0 p90 -146.37 147.43 31.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.96 0.409 . . . . 0.64000000000000001 110.866 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 30.5 m -104.36 115.82 31.05 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.594 -0.73 . . . . 0.42999999999999999 110.374 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.661 ' HA ' HG22 ' A' ' 113' ' ' VAL . 97.4 t -82.42 109.73 16.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.79 -0.641 . . . . 0.87 109.804 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.532 ' HA ' HG22 ' A' ' 76' ' ' THR . 9.5 m -104.12 105.97 16.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.935 0.397 . . . . 0.45000000000000001 111.224 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.502 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 52.1 m-85 -89.9 110.91 21.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.357 -0.383 . . . . 0.34000000000000002 110.138 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.8 t -91.61 108.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 110.123 -0.325 . . . . 0.54000000000000004 110.123 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.25 138.07 53.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.393 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 6.5 t70 -130.12 103.0 6.49 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.3 -0.409 . . . . 2.0299999999999998 110.75 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.34 -97.89 0.63 Allowed Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.946 -0.645 . . . . 1.97 113.223 171.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -146.68 -20.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.095 0.406 . . . . 4.9299999999999997 112.095 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -136.26 3.64 2.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.97 -0.692 . . . . 3.5299999999999998 112.671 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 26.4 ttpp -127.31 153.96 45.52 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.448 -0.901 . . . . 2.4399999999999999 110.911 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.7 m -160.9 124.31 3.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.826 -0.624 . . . . 0.41999999999999998 109.95 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -109.54 120.25 41.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.866 -0.79 . . . . 2.5899999999999999 108.866 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 10' ' ' VAL . 10.0 p -96.55 141.12 16.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.802 -0.359 . . . . 0.40000000000000002 110.791 -177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -129.5 124.23 33.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.08 -0.711 . . . . 1.3799999999999999 109.08 171.23 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.025 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 4.1 t -99.05 121.51 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-N 115.725 -0.671 . . . . 0.91000000000000003 110.086 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.19 121.34 41.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.893 -0.78 . . . . 2.3100000000000001 108.893 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.734 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 t-80 -103.03 152.77 20.96 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.285 -0.87 . . . . 1.6399999999999999 110.114 -176.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.686 HG21 ' HD2' ' A' ' 118' ' ' PHE . 9.0 t -60.13 177.86 0.23 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.12 -0.945 . . . . 2.6699999999999999 110.944 170.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -108.35 18.94 20.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.854 -0.612 . . . . 2.6299999999999999 110.438 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.77 ' CD2' ' HB3' ' A' ' 94' ' ' SER . 20.7 m-85 -59.33 -29.07 67.37 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.499 -0.319 . . . . 3.54 111.434 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.6 -49.79 15.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.554 0.692 . . . . 1.8100000000000001 109.699 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' C ' ' H ' ' A' ' 122' ' ' GLY . 55.2 ttt180 -58.54 -18.08 26.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.582 -1.19 . . . . 3.3799999999999999 111.14 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 121' ' ' MET . 24.2 ttt -65.83 19.97 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.003 0.921 . . . . 2.4300000000000002 112.466 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 120' ' ' ARG . . . 152.93 151.03 5.57 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.177 -1.011 . . . . 1.6100000000000001 112.085 172.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.9 m -60.39 -36.2 77.53 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.28 0.562 . . . . 2.5800000000000001 109.657 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -71.58 -39.34 70.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.436 -0.802 . . . . 3.7999999999999998 110.467 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 5.3 m170 -63.8 -46.23 86.12 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 121.26 0.552 . . . . 2.1400000000000001 110.631 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' CD1' ' A' ' 2' ' ' TYR . . . -66.87 -31.51 72.17 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.018 -0.537 . . . . 0.92000000000000004 111.262 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -68.42 -39.38 81.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 2.8300000000000001 110.639 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.625 ' HB2' HD12 ' A' ' 89' ' ' ILE . 16.8 ptm180 -76.25 -24.95 54.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 2.5899999999999999 111.737 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.645 HG22 ' HG3' ' A' ' 91' ' ' PRO . 61.5 t -83.52 -54.79 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.304 0.853 . . . . 1.48 113.304 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 134' ' ' ASP . 35.5 ttt180 -62.66 -23.86 67.32 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.519 0.563 . . . . 3.8300000000000001 112.519 -167.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.437 ' CG ' ' HD2' ' A' ' 88' ' ' ARG . 16.7 p30 -55.41 -22.32 19.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.353 -0.385 . . . . 2.48 111.817 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.904 ' HA3' ' HG ' ' A' ' 83' ' ' LEU . . . -100.3 -96.75 2.19 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 120.456 -0.878 . . . . 1.6100000000000001 114.038 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.589 ' HB3' ' CH2' ' A' ' 81' ' ' TRP . 54.2 ttm -79.29 -27.44 42.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.844 0.683 . . . . 4.8300000000000001 112.844 -164.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 130' ' ' ARG . 20.9 t70 -65.11 -21.93 66.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.948 0.404 . . . . 2.8300000000000001 111.482 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -79.46 -15.92 56.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.111 0.411 . . . . 4.1500000000000004 112.111 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.623 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -117.07 -17.25 5.88 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.351 -0.7 . . . . 1.04 111.351 -177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.562 ' O ' HD13 ' A' ' 141' ' ' LEU . 38.0 t-105 -55.4 -54.49 50.39 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 123.061 0.544 . . . . 2.7799999999999998 111.453 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.601 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 18.7 Cg_endo -60.22 -34.62 93.86 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.837 1.691 . . . . 0.68000000000000005 111.623 175.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.1 m -66.29 -49.96 65.3 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 121.733 0.777 . . . . 0.87 110.447 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 136' ' ' GLY . 59.1 mt -55.44 -54.58 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.018 -0.992 . . . . 0.71999999999999997 110.053 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 137' ' ' TRP . 7.0 mp -56.34 -26.86 53.95 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.25 0.833 . . . . 0.68999999999999995 113.25 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 28.4 mm-40 -69.14 -54.33 15.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.484 -0.561 . . . . 1.49 109.484 175.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . 37.3 t -70.16 -23.81 63.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.157 0.503 . . . . 1.1499999999999999 110.745 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 64.6 t80 -58.35 -53.15 61.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.479 -0.782 . . . . 0.80000000000000004 109.489 174.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.93 -22.11 61.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.508 -0.769 . . . . 1.6299999999999999 110.508 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.12 -52.09 10.85 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.94 -0.573 . . . . 1.46 111.698 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.841 ' HG3' ' HE3' ' A' ' 30' ' ' TRP . 2.4 tmtt? -66.94 -39.78 87.4 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.508 -0.477 . . . . 1.74 109.962 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.778 HG21 HG13 ' A' ' 12' ' ' VAL . 22.6 mt -57.92 -35.27 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.303 0.573 . . . . 0.5 110.545 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.423 ' OD2' ' HE2' ' A' ' 154' ' ' LYS . 24.1 t0 -61.26 -35.49 77.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.638 -0.71 . . . . 0.84999999999999998 110.002 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 63.6 mt-10 -68.32 -26.75 65.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.39 0.614 . . . . 1.5 110.809 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 11.1 mm-40 -88.89 5.69 42.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.713 -0.676 . . . . 1.74 110.325 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.29 -78.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.171 -1.014 . . . . 1.3200000000000001 114.02 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.47 -45.69 10.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.114 0.483 . . . . 1.9199999999999999 111.652 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 31.5 ttpt -87.74 114.28 24.21 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.94 -0.573 . . . . 2.04 109.991 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.883 ' HA ' ' HE3' ' A' ' 155' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.791 -0.623 . . . . 4.2199999999999998 109.719 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.697 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 19.7 p30 . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.801 -0.074 . . . . 1.6599999999999999 110.801 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.484 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -171.77 -51.54 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.334 0.494 . . . . 3.73 112.334 176.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.535 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 15.7 t70 -66.71 -61.85 4.57 Favored Pre-proline 0 N--CA 1.468 0.438 0 N-CA-C 112.042 0.386 . . . . 2.7799999999999998 112.042 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 56.8 Cg_endo -74.04 -58.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.115 1.21 . . . . 1.6299999999999999 112.098 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.697 ' O ' ' HB2' ' A' ' 1' ' ' ASN . 47.0 p90 -154.8 143.63 20.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.956 -0.566 . . . . 3.21 110.195 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.809 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 95.2 t -103.88 101.21 11.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.138 -1.06 . . . . 1.4399999999999999 108.138 164.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 58.8 ttp180 -101.04 134.86 43.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.427 0.632 . . . . 3.3700000000000001 111.939 -170.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.789 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -109.9 131.82 54.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.426 -0.953 . . . . 0.79000000000000004 108.426 167.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 50.0 m -135.52 110.35 8.73 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.584 -0.735 . . . . 1.28 110.35 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG13 ' HG2' ' A' ' 145' ' ' GLN . 1.3 t -121.46 135.64 60.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.824 -1.08 . . . . 1.27 111.032 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -100.95 115.71 31.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.38 0.61 . . . . 0.56999999999999995 109.546 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 148' ' ' ILE . 42.2 t -93.4 127.58 45.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.91000000000000003 111.264 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.953 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -86.91 12.82 10.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.168 -0.924 . . . . 0.97999999999999998 113.131 -172.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.564 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -156.77 41.46 0.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.011 -0.675 . . . . 0.35999999999999999 112.474 -173.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 14' ' ' ALA . 11.3 t70 73.32 161.89 0.25 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.252 1.025 . . . . 0.91000000000000003 113.69 172.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.108 ' HE ' ' HB2' ' A' ' 103' ' ' ALA . 8.0 ttp85 -63.45 -28.11 69.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.28 -1.327 . . . . 1.8799999999999999 112.422 -172.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 34.1 mttp -66.85 -40.91 88.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.95 -0.3 . . . . 3.0499999999999998 110.838 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.7 p -73.12 -34.86 66.38 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.866 -0.333 . . . . 1.1100000000000001 110.329 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -56.2 -51.56 67.61 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.131 -0.486 . . . . 0.32000000000000001 110.325 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 70.7 t80 -69.92 -40.54 75.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.877 -0.601 . . . . 0.38 110.887 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -55.8 -47.09 77.75 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.228 -0.442 . . . . 2.3900000000000001 109.854 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.512 ' N ' ' HG3' ' A' ' 21' ' ' LYS . 16.5 m -77.33 -45.4 26.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.411 -0.358 . . . . 0.68000000000000005 111.01 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HA ' ' HZ2' ' A' ' 30' ' ' TRP . 67.4 t80 -65.08 -28.96 69.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.774 0.287 . . . . 0.47999999999999998 111.774 -174.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.767 HD23 ' HE3' ' A' ' 48' ' ' LYS . 16.5 tp -115.46 -56.09 2.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.253 -0.579 . . . . 0.5 112.087 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 51.7 mt-10 -91.41 -3.43 56.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.423 . . . . 1.24 111.634 -172.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.669 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -114.91 25.34 10.15 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.693 -0.963 . . . . 0.82999999999999996 110.693 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 36.4 t80 -52.41 -49.37 85.84 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.308 0.484 . . . . 0.73999999999999999 112.308 -174.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 42' ' ' ALA . 69.5 Cg_endo -81.37 4.3 7.11 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.154 1.903 . . . . 0.76000000000000001 115.142 -176.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 10.0 pt-20 -103.14 -1.94 28.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.914 -0.714 . . . . 1.49 111.675 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.804 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.5 m0 -72.29 154.18 41.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.546 0.689 . . . . 4.6200000000000001 111.067 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.593 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 47.5 m95 -83.47 -38.36 0.72 Allowed Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 114.968 -1.015 . . . . 2.7799999999999998 113.071 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.804 ' HD2' ' HB3' ' A' ' 30' ' ' TRP . 20.0 Cg_endo -59.41 -79.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 122.31 2.007 . . . . 1.3600000000000001 114.414 -165.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.686 ' ND2' HD22 ' A' ' 84' ' ' ASN . 57.3 t30 -106.85 -16.16 14.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.278 0.561 . . . . 1.51 109.864 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.696 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.8 m-20 -97.8 20.66 11.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.639 -0.709 . . . . 1.79 111.612 -168.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -79.77 -29.8 40.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.211 -0.449 . . . . 4.4500000000000002 111.492 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.459 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 33.3 mmt180 -90.92 142.97 27.21 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.538 0.57 . . . . 4.1399999999999997 112.538 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 39' ' ' LYS . 26.9 p -77.01 151.93 35.4 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 2.6800000000000002 111.02 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 57' ' ' ASP . 7.0 p 54.48 6.81 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.396 1.078 . . . . 1.4199999999999999 112.462 -174.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 37' ' ' THR . 72.5 tttt -94.73 -135.45 0.2 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.207 -2.146 . . . . 2.8999999999999999 105.207 161.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 34' ' ' ASN . 17.1 m -93.0 20.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.423 0.63 . . . . 1.8300000000000001 110.71 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 28' ' ' PRO . . . -132.54 39.86 1.69 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.68 -0.691 . . . . 2.1699999999999999 112.431 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.051 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -88.78 160.43 44.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.639 -0.874 . . . . 1.1200000000000001 108.639 171.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.6 -17.6 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 124.134 3.223 . . . . 1.48 116.14 -171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 45' ' ' GLY . 48.1 tp -97.42 -97.38 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.874 -0.516 . . . . 1.75 111.184 -178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.682 ' HA2' ' HG3' ' A' ' 55' ' ' GLU . . . 109.14 -55.97 0.48 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.67 -0.776 . . . . 0.75 112.722 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.615 HG11 HD11 ' A' ' 24' ' ' LEU . 94.2 t -139.9 139.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.078 0.466 . . . . 0.59999999999999998 111.582 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.703 ' HB2' ' HE2' ' A' ' 54' ' ' TYR . 19.4 t70 -105.68 102.71 12.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.422 -0.808 . . . . 1.1100000000000001 109.431 174.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.767 ' HE3' HD23 ' A' ' 24' ' ' LEU . 25.3 mtpt -80.52 -12.17 59.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.999 -0.546 . . . . 2.8100000000000001 111.82 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.46 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 10.6 ptpp? -83.86 -43.7 15.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.946 -0.302 . . . . 3.1699999999999999 111.214 -174.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.9 -32.9 5.71 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.909 -0.662 . . . . 1.53 111.793 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 68' ' ' ILE . . . 102.67 58.4 0.76 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.563 -0.827 . . . . 0.77000000000000002 112.771 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -144.72 149.54 35.77 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 122.723 -0.281 . . . . 3.7200000000000002 110.532 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -100.33 115.27 29.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.258 -0.645 . . . . 1.28 109.258 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.703 ' HE2' ' HB2' ' A' ' 47' ' ' ASP . 6.8 p90 -160.97 149.1 15.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.469 . . . . 1.6599999999999999 110.118 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.051 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 5.3 mp0 -113.06 169.13 9.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.48 -0.563 . . . . 2.1200000000000001 109.48 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.457 HD12 ' HG2' ' A' ' 61' ' ' GLU . 32.8 mm -77.55 103.3 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.621 -0.511 . . . . 0.92000000000000004 109.621 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.802 ' HB3' HE22 ' A' ' 59' ' ' GLN . 8.1 t70 -101.75 159.52 15.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 1.97 110.267 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.08 -30.78 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.019 1.118 . . . . 2.4300000000000002 114.019 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.802 HE22 ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -86.31 8.16 22.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.102 -0.639 . . . . 2.3900000000000001 111.441 -175.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.4 62.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.245 -0.978 . . . . 2.29 113.693 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.457 ' HG2' HD12 ' A' ' 56' ' ' ILE . 41.1 mt-10 52.24 35.2 16.28 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.816 0.672 . . . . 2.3100000000000001 112.816 172.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -108.11 85.43 2.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.469 0.652 . . . . 2.6099999999999999 110.745 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.533 ' HD2' ' HB2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -121.84 158.63 28.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 3.7200000000000002 110.05 175.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.583 ' OG1' ' HG2' ' A' ' 82' ' ' ARG . 3.2 t -134.58 115.41 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.334 -0.393 . . . . 2.27 110.405 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.807 ' HA ' ' O ' ' A' ' 83' ' ' LEU . 37.6 t80 -131.4 -46.59 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 6.4800000000000004 111.329 174.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.543 ' HA3' HD11 ' A' ' 79' ' ' ILE . . . -157.29 156.6 27.39 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.38 -1.391 . . . . 1.23 113.949 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.466 HD22 ' HD2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -116.89 110.42 18.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.397 -0.594 . . . . 1.1699999999999999 109.397 177.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.543 HG21 ' CG2' ' A' ' 71' ' ' VAL . 35.5 mt -80.83 136.29 23.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 0.60999999999999999 111.228 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -101.94 -34.17 9.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.264 -0.88 . . . . 2.0 109.212 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -149.7 129.27 13.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.687 -0.688 . . . . 1.53 110.97 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 68' ' ' ILE . 44.1 t -112.87 93.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.75 -0.833 . . . . 0.88 108.75 172.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.78 70.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.544 -0.298 . . . . 1.4199999999999999 111.7 -172.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.643 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 47.27 -173.34 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.958 0 O-C-N 124.539 1.15 . . . . 0.95999999999999996 112.505 174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 32.4 Cg_exo -61.48 82.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.406 1.404 . . . . 0.38 111.195 166.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.488 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 28.2 t70 -168.29 -68.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.606 . . . . 0.5 110.572 -177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 100' ' ' THR . 1.8 p -144.55 144.86 31.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.22 0.533 . . . . 0.34999999999999998 112.154 -177.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -135.14 117.33 15.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.672 -0.694 . . . . 0.73999999999999999 109.29 177.312 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 t -93.47 105.66 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 108.42 -0.956 . . . . 0.67000000000000004 108.42 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.543 HD11 ' HA3' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -128.58 130.58 69.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.999 -0.546 . . . . 0.75 111.3 -169.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.791 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -95.44 153.11 20.62 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.301 -0.476 . . . . 0.5 112.082 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.685 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 65.0 t-105 -85.82 132.81 34.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.173 0.511 . . . . 2.79 111.532 -172.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.583 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 6.8 ttt180 -137.56 28.68 2.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.687 -0.688 . . . . 5.46 109.644 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.807 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 19.0 tp 77.52 167.26 0.23 Allowed 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.87 -1.059 . . . . 1.55 112.147 172.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.686 HD22 ' ND2' ' A' ' 33' ' ' ASN . 1.5 m-20 -82.67 5.29 21.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.711 -0.477 . . . . 1.9299999999999999 109.711 173.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.98 38.5 92.94 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.691 -0.686 . . . . 2.3999999999999999 113.049 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -137.95 91.56 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.946 0.403 . . . . 5.3799999999999999 112.018 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.6 2.35 21.25 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.628 -0.714 . . . . 2.2999999999999998 114.755 168.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.627 ' HB2' HD11 ' A' ' 83' ' ' LEU . 1.5 mmp_? -112.76 -176.27 2.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 117.239 0.519 . . . . 4.7699999999999996 110.266 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.402 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -101.78 136.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.111 -0.495 . . . . 1.8600000000000001 110.121 177.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 7.5 p-10 -97.88 140.09 21.71 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 120.916 0.389 . . . . 3.1800000000000002 110.403 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 36.9 Cg_exo -61.4 -46.02 16.32 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.833 2.355 . . . . 2.3599999999999999 111.856 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 73.05 -40.8 0.48 Allowed 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.045 0.841 . . . . 2.9900000000000002 112.638 173.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.12 -36.37 58.89 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.839 0.681 . . . . 3.0600000000000001 112.839 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.5 p -165.79 -95.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.743 -0.383 . . . . 1.8500000000000001 111.773 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.685 ' CB ' ' HB3' ' A' ' 81' ' ' TRP . 44.3 m 55.37 30.24 14.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.419 0.628 . . . . 1.4399999999999999 110.671 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.791 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.8 tt0 -62.71 124.32 20.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.855 -1.066 . . . . 1.8100000000000001 111.275 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.587 ' HB3' ' HB2' ' A' ' 115' ' ' HIS . 8.5 p90 -125.9 136.12 52.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.164 0.507 . . . . 0.64000000000000001 110.738 174.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 31.9 m -89.43 115.49 26.9 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.578 -0.737 . . . . 0.42999999999999999 110.266 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.793 ' HA ' HG22 ' A' ' 113' ' ' VAL . 99.2 t -91.0 108.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 109.283 -0.636 . . . . 0.87 109.283 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.758 ' HA ' HG22 ' A' ' 76' ' ' THR . 15.6 m -106.77 104.96 14.77 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.105 -0.498 . . . . 0.45000000000000001 110.909 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.641 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 37.7 m-85 -82.64 102.6 11.57 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.34 -0.615 . . . . 0.34000000000000002 109.34 174.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 38.4 t -91.54 108.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.319 -0.623 . . . . 0.54000000000000004 109.319 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.108 ' HB2' ' HE ' ' A' ' 16' ' ' ARG . . . -57.4 124.45 18.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.944 -0.571 . . . . 0.44 109.967 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.766 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 12.7 t70 -109.15 103.3 12.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.969 -0.752 . . . . 2.0299999999999998 108.969 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.2 -106.53 1.91 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.854 -0.898 . . . . 1.97 110.854 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.871 HE21 ' HA ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -153.64 -9.25 0.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.807 0.337 . . . . 4.9299999999999997 110.969 175.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -119.99 -0.16 10.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.91 0.386 . . . . 3.5299999999999998 110.722 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 11.6 mptt -127.39 159.98 32.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.969 -0.752 . . . . 2.4399999999999999 108.969 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.437 ' HB ' ' HB ' ' A' ' 12' ' ' VAL . 53.4 m -156.26 114.79 3.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.863 0.363 . . . . 0.41999999999999998 110.211 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -100.66 111.32 23.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.94 -0.763 . . . . 2.5899999999999999 108.94 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.641 ' HB ' ' CD1' ' A' ' 101' ' ' PHE . 10.9 p -85.9 138.04 19.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 0.40000000000000002 110.319 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -127.41 116.13 19.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.34 -0.845 . . . . 1.3799999999999999 109.223 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 99' ' ' VAL . 4.1 t -108.37 130.84 60.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.983 -1.008 . . . . 0.91000000000000003 111.189 -174.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.58 111.34 22.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.303 0.573 . . . . 2.3100000000000001 110.141 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.809 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 82.0 t60 -113.43 97.23 6.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.148 -0.933 . . . . 1.6399999999999999 108.864 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.564 ' OG1' ' HA ' ' A' ' 5' ' ' PHE . 34.8 m -145.55 94.71 2.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.967 0.413 . . . . 2.6699999999999999 111.344 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.632 ' O ' ' HG2' ' A' ' 121' ' ' MET . 15.6 t60 -167.16 -73.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.097 -0.501 . . . . 2.6299999999999999 110.212 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.427 ' CZ ' ' HD3' ' A' ' 128' ' ' ARG . 29.4 t80 -64.96 -47.53 77.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.53 -0.759 . . . . 3.54 112.137 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -37.25 67.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.543 0.687 . . . . 1.8100000000000001 110.35 -174.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -55.91 -20.88 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.754 -1.112 . . . . 3.3799999999999999 111.945 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.632 ' HG2' ' O ' ' A' ' 117' ' ' HIS . 23.9 mmt -81.18 19.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.06 0.393 . . . . 2.4300000000000002 112.06 -171.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.68 163.31 11.24 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.015 -1.088 . . . . 1.6100000000000001 113.007 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.7 p -65.23 -22.51 66.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.593 -0.303 . . . . 2.5800000000000001 111.432 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -67.68 -52.69 35.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.681 0.277 . . . . 3.7999999999999998 110.745 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.761 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 33.4 m170 -60.98 -48.84 79.94 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.602 0.715 . . . . 2.1400000000000001 110.5 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.81 68.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.213 -0.903 . . . . 0.92000000000000004 111.037 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 130' ' ' ARG . 35.1 ttpt -75.84 -41.86 51.27 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.798 0.296 . . . . 2.8300000000000001 111.798 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.761 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 5.9 ptm180 -64.03 -30.58 71.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.915 -0.314 . . . . 2.5899999999999999 110.68 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.71 -32.13 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 120.423 -0.511 . . . . 1.48 110.593 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.555 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 21.9 tpp85 -61.77 -15.17 38.99 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.489 0.716 . . . . 3.8300000000000001 111.376 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 88' ' ' ARG . 53.0 m-20 -52.04 -21.67 3.37 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.643 0.979 . . . . 2.48 113.643 -177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -175.07 -39.16 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 119.252 -1.452 . . . . 1.6100000000000001 114.053 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.644 ' HE3' ' HB2' ' A' ' 84' ' ' ASN . 12.9 mmt -74.24 -9.29 58.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.003 0.43 . . . . 4.8300000000000001 111.285 -171.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 130' ' ' ARG . 16.3 t70 -62.22 -22.75 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.635 -0.712 . . . . 2.8300000000000001 111.461 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -98.65 -30.7 12.32 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.886 -0.326 . . . . 4.1500000000000004 110.857 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.565 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -69.65 -50.21 32.22 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 121.092 -0.575 . . . . 1.04 112.491 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.465 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 72.6 t-105 -54.85 -52.19 72.74 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.186 0.439 . . . . 2.7799999999999998 112.186 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -60.25 -36.95 86.03 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.646 1.564 . . . . 0.68000000000000005 112.069 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 96.3 m -68.4 -35.52 77.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.514 0.673 . . . . 0.87 109.623 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.652 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 16.5 mt -58.54 -44.63 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.876 -1.057 . . . . 0.71999999999999997 110.578 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.517 HD13 ' CD2' ' A' ' 8' ' ' HIS . 70.9 mt -63.74 -33.23 75.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.187 0.44 . . . . 0.68999999999999995 112.187 -175.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.53 -54.76 12.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.961 0.41 . . . . 1.49 110.314 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.63 ' CB ' ' HD3' ' A' ' 32' ' ' PRO . 48.9 m -65.87 -22.02 66.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 1.1499999999999999 111.144 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 23' ' ' PHE . 54.5 t80 -65.95 -53.45 38.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.308 0.575 . . . . 0.80000000000000004 109.559 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.815 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 45.1 mt-30 -61.64 -29.82 70.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.277 -0.874 . . . . 1.6299999999999999 110.25 176.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 143' ' ' SER . 31.9 t70 -73.95 -43.75 57.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.853 -1.067 . . . . 1.46 110.529 -175.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.462 ' HD3' ' NE1' ' A' ' 31' ' ' TRP . 28.1 tptp -65.79 -43.19 89.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.713 0.292 . . . . 1.74 110.584 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.814 HG21 HG13 ' A' ' 12' ' ' VAL . 57.5 mt -62.37 -40.14 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.5 111.368 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.953 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 28.5 t70 -65.53 -27.33 68.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.318 -0.401 . . . . 0.84999999999999998 110.872 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 50.7 mt-10 -64.5 -39.06 93.09 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.511 0.672 . . . . 1.5 109.537 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 10.7 mm-40 -74.73 -29.26 61.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.373 -1.285 . . . . 1.74 108.906 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -74.26 -74.94 0.81 Allowed Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 114.817 -1.083 . . . . 1.3200000000000001 112.345 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -164.35 23.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.76 0.652 . . . . 1.9199999999999999 112.76 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 32.0 ttmt -69.9 -75.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.369 -0.532 . . . . 2.04 110.601 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.812 -1.089 . . . . 4.2199999999999998 110.409 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 7' ' ' ARG . 25.3 p-10 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.883 0.373 . . . . 1.6599999999999999 110.457 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.617 ' HA ' ' CG2' ' A' ' 6' ' ' VAL . 32.1 p90 179.66 -32.84 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 3.73 109.713 -174.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.711 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.0 t70 -73.16 -55.0 4.02 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 111.959 0.355 . . . . 2.7799999999999998 111.959 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 58.5 Cg_endo -93.69 -62.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.172 1.914 . . . . 1.6299999999999999 112.998 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.433 ' CD2' HG21 ' A' ' 116' ' ' THR . 96.2 m-85 -144.31 118.88 9.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 3.21 110.421 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.039 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 97.3 t -85.05 125.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.9 -0.778 . . . . 1.4399999999999999 108.9 167.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 36.6 ttp85 -132.38 136.72 47.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.026 -0.534 . . . . 3.3700000000000001 109.787 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 1.112 ' HB3' ' HB ' ' A' ' 113' ' ' VAL . 3.2 t-160 -108.38 132.31 53.88 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.491 -0.929 . . . . 0.79000000000000004 108.491 177.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 13.4 m -136.17 118.91 16.1 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.251 0.548 . . . . 1.28 110.716 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 111' ' ' VAL . 2.7 t -137.31 134.19 46.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.158 -0.928 . . . . 1.27 111.086 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.2 m -101.8 114.98 29.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.435 0.636 . . . . 0.56999999999999995 109.808 173.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.819 HG13 HG21 ' A' ' 148' ' ' ILE . 38.5 t -95.57 136.27 27.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.296 -0.866 . . . . 0.91000000000000003 109.726 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.3 36.05 2.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.726 0.269 . . . . 0.97999999999999998 111.726 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 12' ' ' VAL . . . -155.84 31.63 0.36 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.93 0.345 . . . . 0.35999999999999999 111.93 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.8 t70 75.22 164.06 0.27 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.861 0.838 . . . . 0.91000000000000003 112.732 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 14.6 ttp180 -66.47 -25.72 66.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.686 -1.143 . . . . 1.8799999999999999 111.544 -175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.055 -0.258 . . . . 3.0499999999999998 110.828 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -68.33 -35.14 77.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.995 -0.282 . . . . 1.1100000000000001 110.362 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.461 ' HB1' ' CE1' ' A' ' 101' ' ' PHE . . . -56.28 -48.98 75.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.32000000000000001 110.613 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.507 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 84.7 t80 -72.57 -50.6 24.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.38 111.207 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -52.35 -49.7 63.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.03 -0.532 . . . . 2.3900000000000001 111.158 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 m -67.56 -51.09 54.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.982 -0.554 . . . . 0.68000000000000005 110.792 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . 73.6 t80 -58.93 -40.48 84.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.349 0.5 . . . . 0.47999999999999998 112.349 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -104.46 -50.39 3.33 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.271 -0.572 . . . . 0.5 112.31 -172.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.809 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 53.9 mt-10 -86.24 -6.94 58.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.76 0.314 . . . . 1.24 111.631 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.642 ' O ' ' HG2' ' A' ' 29' ' ' GLU . . . -117.15 30.1 6.45 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.374 -0.917 . . . . 0.82999999999999996 112.525 -176.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -49.31 -53.84 35.73 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 112.006 0.373 . . . . 0.73999999999999999 112.006 -172.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 27' ' ' PHE . 24.9 Cg_endo -90.57 21.86 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.921 1.747 . . . . 0.76000000000000001 114.644 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 9.6 pt-20 -113.64 -15.88 12.43 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 119.562 -0.855 . . . . 1.49 113.045 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -79.61 -176.64 5.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.944 -0.702 . . . . 4.6200000000000001 109.617 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.511 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 10.2 p-90 -115.32 16.9 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.327 0 N-CA-C 115.36 1.615 . . . . 2.7799999999999998 115.36 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 30' ' ' TRP . 57.8 Cg_endo -85.03 -134.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 121.984 1.744 . . . . 1.3600000000000001 113.136 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.487 ' ND2' HD21 ' A' ' 84' ' ' ASN . 9.7 t30 -67.18 -25.7 66.27 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 1.51 111.047 -175.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.659 ' HA ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -85.94 18.72 2.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.469 -0.787 . . . . 1.79 110.997 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -82.69 -4.13 57.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.5 0.667 . . . . 4.4500000000000002 109.421 174.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -106.62 164.24 12.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.582 -0.735 . . . . 4.1399999999999997 110.199 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 42' ' ' ALA . 1.1 p -98.28 147.29 24.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.538 -0.301 . . . . 2.6800000000000002 111.272 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.7 ' CG2' ' HA ' ' A' ' 57' ' ' ASP . 19.8 p 54.44 25.0 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.799 0.839 . . . . 1.4199999999999999 111.941 -177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' O ' HG13 ' A' ' 40' ' ' VAL . 20.4 mtmt -111.21 -50.54 2.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.708 -1.133 . . . . 2.8999999999999999 109.146 165.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -177.5 28.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 124.424 1.078 . . . . 1.8300000000000001 110.256 175.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.06 29.96 0.59 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.843 -1.17 . . . . 2.1699999999999999 114.253 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.845 ' HB3' ' HB3' ' A' ' 55' ' ' GLU . . . -78.64 170.46 16.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 117.282 0.541 . . . . 1.1200000000000001 109.617 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.686 ' HD2' ' HB1' ' A' ' 42' ' ' ALA . 28.0 Cg_endo -63.26 72.28 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.475 2.116 . . . . 1.48 112.753 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 tp -169.19 -90.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.474 -0.785 . . . . 1.75 109.687 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.38 -88.9 0.53 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.334 -0.936 . . . . 0.75 112.46 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 53' ' ' TRP . 57.5 t -139.91 139.89 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.738 0.304 . . . . 0.59999999999999998 111.114 -172.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.53 108.56 21.28 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.742 -0.836 . . . . 1.1100000000000001 108.742 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.809 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 40.3 mtpt -78.93 -18.76 53.27 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.956 0.725 . . . . 2.8100000000000001 112.956 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -89.2 -45.2 9.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.839 -0.344 . . . . 3.1699999999999999 110.962 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.39 -38.4 21.57 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.273 -0.731 . . . . 1.53 111.273 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.92 58.31 1.04 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.915 -0.66 . . . . 0.77000000000000002 112.205 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -159.29 141.07 13.34 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.752 -0.379 . . . . 3.7200000000000002 110.404 177.058 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.956 ' HB3' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -100.97 135.48 42.36 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.597 -0.441 . . . . 1.28 110.654 177.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' HD1' ' CE1' ' A' ' 63' ' ' HIS . 0.8 OUTLIER -163.02 -179.36 6.67 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.673 0.608 . . . . 1.6599999999999999 110.528 179.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 39.9 mt-10 -132.35 177.64 7.43 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 116.639 -0.255 . . . . 2.1200000000000001 111.136 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 mm -102.41 102.83 14.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.414 -0.587 . . . . 0.92000000000000004 109.414 170.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.7 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 3.7 m-20 -70.27 135.48 48.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 112.873 0.694 . . . . 1.97 112.873 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.27 -26.57 67.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.854 -1.067 . . . . 2.4300000000000002 111.151 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.636 HE21 ' HB3' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -82.8 -7.23 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 2.3900000000000001 111.447 179.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.92 72.24 0.63 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.554 -0.832 . . . . 2.29 112.598 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 37.6 77.22 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.408 1.262 . . . . 2.3100000000000001 114.408 177.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.487 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 18.7 mm-40 -129.18 73.16 1.5 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.563 0.697 . . . . 2.6099999999999999 109.929 170.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 1.3 p80 -110.54 157.81 19.23 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.766 -1.106 . . . . 3.7200000000000002 111.502 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.794 ' HB ' ' HG3' ' A' ' 82' ' ' ARG . 37.6 p -83.66 151.96 25.02 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.726 -0.842 . . . . 2.27 108.726 169.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.5 p90 -108.78 111.72 23.61 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.228 -0.589 . . . . 6.4800000000000004 110.51 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.718 ' HA3' ' CE2' ' A' ' 53' ' ' TRP . . . -63.36 129.64 40.3 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.047 -0.821 . . . . 1.23 111.047 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.529 HD11 ' HD3' ' A' ' 82' ' ' ARG . 4.4 mp -78.74 87.57 4.63 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.824 -0.35 . . . . 1.1699999999999999 110.918 -170.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 71' ' ' VAL . 13.7 mt -92.1 115.35 30.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.001 -1.08 . . . . 0.60999999999999999 109.321 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -104.82 -12.58 16.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.596 -175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 19.5 ttmm -151.82 107.38 3.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 1.53 111.332 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 68' ' ' ILE . 2.5 m -103.14 85.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.88 108.568 167.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.19 72.82 1.32 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.248 -0.433 . . . . 1.4199999999999999 111.08 -172.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.594 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 13.0 pt-20 46.96 -171.88 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 O-C-N 124.684 1.24 . . . . 0.95999999999999996 112.288 175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 73' ' ' GLU . 38.3 Cg_exo -64.04 76.05 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.518 1.479 . . . . 0.38 111.411 166.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -159.61 -65.63 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.649 -0.705 . . . . 0.5 110.673 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 100' ' ' THR . 2.8 p -144.96 143.08 30.34 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.427 0.529 . . . . 0.34999999999999998 112.427 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.65 120.15 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 109.668 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 59.0 t -105.73 103.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.474 -0.565 . . . . 0.67000000000000004 109.474 175.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.766 HG13 ' HE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -129.39 135.07 62.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.973 -0.558 . . . . 0.75 111.701 -174.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.793 ' HA2' ' HA ' ' A' ' 96' ' ' GLU . . . -94.16 147.67 18.69 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.065 -0.814 . . . . 0.5 111.065 174.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.685 ' HB3' ' HG2' ' A' ' 91' ' ' PRO . 52.8 t-105 -78.96 135.65 37.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.237 0.541 . . . . 2.79 111.964 -168.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.794 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.9 tpt180 -130.76 25.93 5.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.423 -0.808 . . . . 5.46 109.641 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.824 HD11 ' HB2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER 81.25 134.78 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.845 -1.07 . . . . 1.55 112.233 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.536 ' HB3' ' SD ' ' A' ' 133' ' ' MET . 5.1 t30 -108.53 109.67 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.023 -0.99 . . . . 1.9299999999999999 109.786 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.07 -24.52 8.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.583 -0.818 . . . . 2.3999999999999999 111.327 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.437 ' H ' HD12 ' A' ' 83' ' ' LEU . 3.3 m-30 74.74 -25.71 0.2 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.589 0.756 . . . . 5.3799999999999999 112.706 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.61 19.11 38.57 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.828 -0.701 . . . . 2.2999999999999998 113.247 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.824 ' HB2' HD11 ' A' ' 83' ' ' LEU . 41.9 mmt180 -124.88 173.66 8.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.622 -0.51 . . . . 4.7699999999999996 109.622 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -74.55 132.12 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.786 0.327 . . . . 1.8600000000000001 110.73 178.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 10.3 p-10 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 3.1800000000000002 110.495 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.685 ' HG2' ' HB3' ' A' ' 81' ' ' TRP . 52.7 Cg_exo -58.25 -37.63 94.47 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.267 2.644 . . . . 2.3599999999999999 112.597 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER 78.35 -39.19 0.26 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.87 0.731 . . . . 2.9900000000000002 112.39 169.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -120.06 -30.3 4.71 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.034 0.383 . . . . 3.0600000000000001 112.034 -169.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.45 ' HB2' ' HD1' ' A' ' 118' ' ' PHE . 48.9 m -138.95 -140.89 0.14 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.926 -0.31 . . . . 1.8500000000000001 111.832 -175.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 81' ' ' TRP . 67.7 m 65.75 24.02 11.48 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.496 -0.775 . . . . 1.4399999999999999 109.427 -170.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.793 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 32.7 tt0 -67.28 136.48 54.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.812 -1.085 . . . . 1.8100000000000001 110.442 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.636 ' HB3' ' CD2' ' A' ' 115' ' ' HIS . 13.9 p90 -137.62 138.03 39.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.273 0.559 . . . . 0.64000000000000001 110.84 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.575 HG23 HG22 ' A' ' 78' ' ' VAL . 34.1 m -100.26 109.76 21.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.244 -0.889 . . . . 0.42999999999999999 109.663 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.442 HG12 HG22 ' A' ' 113' ' ' VAL . 1.6 m -87.64 121.6 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 119.591 -0.844 . . . . 0.87 109.122 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.512 ' HA ' HG22 ' A' ' 76' ' ' THR . 27.2 m -102.64 106.84 17.58 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.345 -0.843 . . . . 0.45000000000000001 110.339 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.498 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 39.9 m-85 -82.37 109.82 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.655 -0.498 . . . . 0.34000000000000002 109.655 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.16 112.52 27.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.572 -0.529 . . . . 0.54000000000000004 109.572 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 124.38 23.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.44 110.568 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 108' ' ' LYS . 10.3 t0 -105.69 103.4 12.9 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.425 -0.954 . . . . 2.0299999999999998 108.425 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.27 -111.11 3.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.537 -0.84 . . . . 1.97 111.562 -175.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -147.95 -3.93 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.638 0.256 . . . . 4.9299999999999997 111.255 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -136.51 8.23 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.288 . . . . 3.5299999999999998 111.342 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.797 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 36.1 ttmt -126.78 158.15 37.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.999 -0.741 . . . . 2.4399999999999999 108.999 175.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.6 m -156.01 130.65 9.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.008 0.433 . . . . 0.41999999999999998 111.096 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -109.37 112.91 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.82 -0.627 . . . . 2.5899999999999999 109.741 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 10' ' ' VAL . 8.7 p -90.95 141.77 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.865 -0.334 . . . . 0.40000000000000002 110.63 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.589 ' HA ' ' O ' ' A' ' 8' ' ' HIS . 7.7 t70 -135.01 105.72 6.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.354 -0.839 . . . . 1.3799999999999999 109.857 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.112 ' HB ' ' HB3' ' A' ' 8' ' ' HIS . 9.5 t -86.3 131.57 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.91000000000000003 111.941 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.82 124.03 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.842 0.714 . . . . 2.3100000000000001 109.504 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 1.039 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 7.7 t-160 -142.23 102.72 4.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.526 -0.546 . . . . 1.6399999999999999 109.526 -175.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.433 HG21 ' CD2' ' A' ' 5' ' ' PHE . 8.6 p -149.84 40.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.345 0.498 . . . . 2.6699999999999999 112.345 -174.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.548 ' O ' ' HB2' ' A' ' 121' ' ' MET . 3.1 t-160 -113.37 -65.05 1.22 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.999 -0.68 . . . . 2.6299999999999999 111.405 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.524 ' HB2' ' H ' ' A' ' 95' ' ' SER . 11.6 t80 -86.18 -49.67 7.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.896 0.379 . . . . 3.54 110.444 -175.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.84 -51.71 68.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.478 -0.783 . . . . 1.8100000000000001 111.025 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 120' ' ' ARG . 5.8 tmm_? -60.89 -19.43 60.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.779 -1.1 . . . . 3.3799999999999999 111.125 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.548 ' HB2' ' O ' ' A' ' 117' ' ' HIS . 42.3 tpp -80.97 23.07 0.58 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.864 0.364 . . . . 2.4300000000000002 111.879 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.2 170.42 12.86 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.752 -1.214 . . . . 1.6100000000000001 114.333 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 t -66.8 -44.48 81.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.894 -0.653 . . . . 2.5800000000000001 111.676 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 124' ' ' LYS . 16.4 tptm -66.13 -39.09 89.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.574 0.226 . . . . 3.7999999999999998 110.726 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.669 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 10.1 m-70 -61.03 -52.85 63.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 2.1400000000000001 110.486 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 130' ' ' ARG . . . -64.73 -35.95 82.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.826 -0.625 . . . . 0.92000000000000004 111.025 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -64.03 -46.45 84.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 2.8300000000000001 111.405 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 125' ' ' HIS . 8.3 ptm180 -64.93 -39.57 93.72 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.439 -0.346 . . . . 2.5899999999999999 111.305 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 125' ' ' HIS . 2.8 p -81.33 -17.83 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.315 0.579 . . . . 1.48 110.987 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 126' ' ' ALA . 61.7 ttt180 -68.74 -9.73 52.33 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.155 -0.341 . . . . 3.8300000000000001 111.43 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.711 ' HB2' ' HD2' ' A' ' 88' ' ' ARG . 8.3 p30 -47.12 -40.06 14.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.561 0.578 . . . . 2.48 112.561 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -145.52 -11.24 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.072 -1.061 . . . . 1.6100000000000001 113.381 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 84' ' ' ASN . 22.6 mmt -79.43 -11.68 59.91 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.342 -0.505 . . . . 4.8300000000000001 110.277 -172.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.66 -39.67 92.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.507 -0.769 . . . . 2.8300000000000001 110.961 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -104.8 14.07 30.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.056 0.455 . . . . 4.1500000000000004 110.552 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -77.57 -78.18 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.925 -0.579 . . . . 1.04 111.828 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 13.6 m95 -55.62 -47.92 97.6 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 113.58 0.956 . . . . 2.7799999999999998 113.58 -176.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 137' ' ' TRP . 9.9 Cg_endo -50.93 -43.64 46.25 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.839 1.693 . . . . 0.68000000000000005 112.213 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.1 m -73.22 -45.72 54.54 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.432 0.634 . . . . 0.87 110.639 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.627 ' HA ' ' CB ' ' A' ' 32' ' ' PRO . 56.5 mt -58.38 -44.99 89.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 115.371 -0.831 . . . . 0.71999999999999997 111.361 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' TRP . 51.2 mt -59.86 -38.81 83.21 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 123.278 0.361 . . . . 0.68999999999999995 111.054 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 138' ' ' PRO . 27.1 mm-40 -61.5 -50.93 70.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.544 -0.462 . . . . 1.49 109.854 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 32' ' ' PRO . 51.0 m -65.58 -28.4 69.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.604 -0.725 . . . . 1.1499999999999999 110.817 176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 60.0 t80 -68.27 -55.3 12.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.964 -0.562 . . . . 0.80000000000000004 111.135 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -35.1 73.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.855 0.36 . . . . 1.6299999999999999 111.076 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.26 -40.96 62.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.916 -0.584 . . . . 1.46 110.673 -176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.43 ' HE3' ' HG3' ' A' ' 29' ' ' GLU . 29.7 tptp -60.62 -38.52 85.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.361 0.601 . . . . 1.74 109.902 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.819 HG21 HG13 ' A' ' 12' ' ' VAL . 52.2 mt -74.45 -26.82 20.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.497 -0.774 . . . . 0.5 111.082 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.4 ' HB3' ' HE2' ' A' ' 154' ' ' LYS . 17.0 t70 -64.84 -31.22 72.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.477 -0.564 . . . . 0.84999999999999998 109.477 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.843 ' HA ' ' HB3' ' A' ' 154' ' ' LYS . 37.5 mt-10 -66.28 -33.09 74.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 1.5 109.74 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -71.86 -23.46 61.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.081 -0.963 . . . . 1.74 109.646 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -98.89 -88.7 1.95 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.3200000000000001 112.951 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.8 30.58 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.314 0.487 . . . . 1.9199999999999999 112.314 -171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.843 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 16.9 tppt? -68.42 -19.63 64.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.491 0.662 . . . . 2.04 110.361 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 155' ' ' LYS . 11.2 ptpt . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.171 -0.922 . . . . 4.2199999999999998 111.243 -176.273 . . . . . . . . 1 1 . 1 stop_ save_